FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU de Moraes, D
   Mousovich-Neto, F
   Cury, SS
   Oliveira, J
   Souza, JD
   Freire, PP
   Dal-Pai-Silva, M
   Mori, MAD
   Fernandez, GJ
   Carvalho, RF
AF de Moraes, Diogo
   Mousovich-Neto, Felippe
   Cury, Sarah Santiloni
   Oliveira, Jakeline
   Souza, Jeferson dos Santos
   Freire, Paula Paccielli
   Dal-Pai-Silva, Maeli
   Mori, Marcelo Alves da Silva
   Fernandez, Geysson Javier
   Carvalho, Robson Francisco
TI The Transcriptomic Landscape of Age-Induced Changes in Human Visceral
   Fat and the Predicted Omentum-Liver Connectome in Males
SO BIOMEDICINES
LA English
DT Article
DE visceral adipose tissue; aging; obesity; fat-liver crosstalk;
   age-related diseases
ID DIFFERENTIATION; POLYMORPHISMS; ASSOCIATION; MACROPHAGES; LIPOLYSIS;
   FRAILTY; OBESITY; GENES; CELLS; RISK
AB Aging causes alterations in body composition. Specifically, visceral fat mass increases with age and is associated with age-related diseases. The pathogenic potential of visceral fat accumulation has been associated with its anatomical location and metabolic activity. Visceral fat may control systemic metabolism by secreting molecules that act in distal tissues, mainly the liver, through the portal vein. Currently, little is known about age-related changes in visceral fat in humans. Aiming to identify molecular and cellular changes occurring with aging in the visceral fat of humans, we analyzed publicly available transcriptomic data of 355 omentum samples from the Genotype-Tissue Expression portal (GTEx) of 20-79-year-old males and females. We identified the functional enrichment of genes associated with aging, inferred age-related changes in visceral fat cellularity by deconvolution analysis, profiled the senescence-associated secretory phenotype of visceral adipose tissue, and predicted the connectivity of the age-induced visceral fat secretome with the liver. We demonstrate that age induces alterations in visceral fat cellularity, synchronous to changes in metabolic pathways and a shift toward a pro-inflammatory secretory phenotype. Furthermore, our approach identified candidates such as ADIPOQ-ADIPOR1/ADIPOR2, FCN2-LPR1, and TF-TFR2 to mediate visceral fat-liver crosstalk in the context of aging. These findings cast light on how alterations in visceral fat with aging contribute to liver dysfunction and age-related disease etiology.
C1 [de Moraes, Diogo; Cury, Sarah Santiloni; Oliveira, Jakeline; Souza, Jeferson dos Santos; Freire, Paula Paccielli; Dal-Pai-Silva, Maeli; Carvalho, Robson Francisco] UNESP, Sao Paulo State Univ, Inst Biosci Botucatu, Dept Struct & Funct Biol, BR-18618689 Botucatu, SP, Brazil.
   [de Moraes, Diogo; Mousovich-Neto, Felippe; Mori, Marcelo Alves da Silva] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Monteiro Lobato St 255, BR-13083862 Campinas, SP, Brazil.
   [Mori, Marcelo Alves da Silva] Univ Estadual Campinas, Obes & Comorbid Res Ctr OCRC, BR-13083862 Campinas, SP, Brazil.
   [Mori, Marcelo Alves da Silva] Univ Estadual Campinas, Expt Med Res Cluster EMRC, BR-13083862 Campinas, SP, Brazil.
   [Fernandez, Geysson Javier] Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Grp Biol & Control Enfermedades Infeciosas BCEI, Medellin 050010, Colombia.
C3 Universidade Estadual Paulista; Universidade Estadual de Campinas;
   Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidad de Antioquia
RP Carvalho, RF (corresponding author), UNESP, Sao Paulo State Univ, Inst Biosci Botucatu, Dept Struct & Funct Biol, BR-18618689 Botucatu, SP, Brazil.
EM robson.carvalho@unesp.br
RI ; Carvalho, Robson Francisco/E-1161-2012; Paccielli Freire,
   Paula/D-6504-2018
OI Dal Pai, Maeli/0000-0001-7269-9197; Fernandez, Geysson
   Javier/0000-0002-8493-1587; Carvalho, Robson
   Francisco/0000-0002-4901-7714; Mousovich Neto,
   Felippe/0000-0002-8245-9450; Paccielli Freire,
   Paula/0000-0003-0649-8279; souza, jeferson/0000-0002-4129-8769
FU CAPES [001]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   [2017/01184-9]
FX This research was supported by CAPES (Finance Code 001) and Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (2017/01184-9).
CR Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1
   Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447
   Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043
   Brazma A, 2001, MICROBES INFECT, V3, P823, DOI 10.1016/S1286-4579(01)01440-X
   Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120
   Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006
   Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022
   Caso G, 2013, METABOLISM, V62, P337, DOI 10.1016/j.metabol.2012.08.007
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006
   Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047
   Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4
   Duus K, 2010, FEBS J, V277, P4956, DOI 10.1111/j.1742-4658.2010.07901.x
   De Ycaza AEE, 2021, OBESITY, V29, P1320, DOI 10.1002/oby.23202
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Gao H, 2020, CELL METAB, V32, P1, DOI 10.1016/j.cmet.2020.06.007
   García-Esquinas E, 2015, OBESITY, V23, P847, DOI 10.1002/oby.21013
   Greendale GA, 2021, J CLIN ENDOCR METAB, V106, P2520, DOI 10.1210/clinem/dgab389
   Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5
   Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173
   Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x
   Ito H, 2001, EUR J CLIN NUTR, V55, P462, DOI 10.1038/sj.ejcn.1601206
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Le Pelletier L, 2021, ELIFE, V10, DOI [10.7554/eLife.62635, 10.7554/eLife.62635.sa1, 10.7554/eLife.62635.sa2]
   Li N, 2021, ELIFE, V10, DOI 10.7554/eLife.65108
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   McClain DA, 2018, J CLIN ENDOCR METAB, V103, P4197, DOI 10.1210/jc.2018-00770
   McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655
   Heslin AM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051539
   Mulligan AA, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1223-z
   Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x
   Giang NT, 2020, INT J INFECT DIS, V95, P253, DOI 10.1016/j.ijid.2020.02.029
   Nguyen HP, 2021, DEV CELL, V56, P1437, DOI 10.1016/j.devcel.2021.03.026
   Pappas LE, 2019, EUR J CLIN NUTR, V73, P172, DOI 10.1038/s41430-018-0324-6
   Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101
   Surendar J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02555
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134
   Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307
   Torre D, 2018, CELL SYST, V7, P556, DOI 10.1016/j.cels.2018.10.007
   Trim WV, 2022, J PHYSIOL-LONDON, V600, P921, DOI 10.1113/JP280977
   Uhlén M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaz0274
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Yang GC, 2016, CANCER LETT, V378, P80, DOI 10.1016/j.canlet.2016.05.007
   Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1
NR 53
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD MAY 14
PY 2023
VL 11
IS 5
AR 1446
DI 10.3390/biomedicines11051446
PG 14
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA J7IK5
UT WOS:001011318000001
PM 37239116
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kossatz, U
   Breuhahn, K
   Wolf, B
   Hardtke-Wolenski, M
   Wilkens, L
   Steinemann, D
   Singer, S
   Brass, F
   Kubicka, S
   Schlegelberger, B
   Schirmacher, P
   Manns, MP
   Singer, JD
   Malek, NP
AF Kossatz, Uta
   Breuhahn, Kai
   Wolf, Benita
   Hardtke-Wolenski, Matthias
   Wilkens, Ludwig
   Steinemann, Doris
   Singer, Stephan
   Brass, Felicitas
   Kubicka, Stefan
   Schlegelberger, Brigitte
   Schirmacher, Peter
   Manns, Michael P.
   Singer, Jeffrey D.
   Malek, Nisar P.
TI The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells
   from becoming tumor-initiating cells
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID UBIQUITIN-LIGASE; STEM-CELLS; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION
   FACTOR; MAMMALIAN-CELLS; CRE RECOMBINASE; HUMAN LIVER; S PHASE;
   DIFFERENTIATION; PROTEIN
AB Cyclin E is often overexpressed in cancer tissue, leading to genetic instability and aneuploidy. Cullin 3 (Cul3) is a component of the BTB-Cul3-Rbx1 (BCR) ubiquitin ligase that is involved in the turnover of cyclin E. Here we show that liver-specific ablation of Cul3 in mice results in the persistence and massive expansion of hepatic progenitor cells. Upon induction of differentiation, Cul3-deficient progenitor cells underwent substantial DNA damage in vivo and in vitro, thereby triggering the activation of a cellular senescence response that selectively blocked the expansion of the differentiated offspring. Positive selection of undifferentiated progenitor cells required the expression of the tumor suppressor protein p53. Simultaneous loss of Cul3 and p53 in hepatic progenitors turned these cells into highly malignant tumor-initiating cells that formed largely undifferentiated tumors in nude mice. In addition, loss of Cul3 and p53 led to the formation of primary hepatocellular carcinomas. Importantly, loss of Cul3 expression was also detected in a large series of human liver cancers and correlated directly with tumor de-differentiation. The expression of Cul3 during hepatic differentiation therefore safeguards against the formation of progenitor cells that carry a great potential for transformation into tumor-initiating cells.
C1 [Kossatz, Uta; Malek, Nisar P.] Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany.
   [Breuhahn, Kai; Singer, Stephan; Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany.
   [Wolf, Benita; Hardtke-Wolenski, Matthias; Brass, Felicitas; Kubicka, Stefan; Manns, Michael P.; Malek, Nisar P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   [Wilkens, Ludwig] Krankenhaus Nordstadt, Inst Pathol, Hannover, Germany.
   [Steinemann, Doris; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cellular & Mol Pathol, D-30625 Hannover, Germany.
   [Singer, Jeffrey D.] Portland State Univ, Dept Biol, Portland, OR 97207 USA.
C3 Hannover Medical School; Ruprecht Karls University Heidelberg; Hannover
   Medical School; Hannover Medical School; Portland State University
RP Malek, NP (corresponding author), Hannover Med Sch, Inst Mol Biol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Malek.Nisar@MH-Hannover.de
RI Wolf, Benita/AAX-4507-2020; Singer, Jeffrey/JQI-2612-2023;
   Hardtke-Wolenski, Matthias/I-2993-2019; Hardtke-Wolenski,
   Matthias/HPG-4431-2023
OI Wolf, Benita/0000-0001-5673-4239; Hardtke-Wolenski,
   Matthias/0000-0002-2827-7787; Hardtke-Wolenski,
   Matthias/0000-0002-2827-7787; Breuhahn, Kai/0000-0002-2462-1229;
   Kossatz, Uta/0000-0002-9092-7154
FU Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft
FX We thank Sarah Messnard for expert technical assistance. We also thank
   Holly Sundberg Malek, Arnaud Besson, James M. Roberts, Lars Zender, and
   Lenhard Rudolph for critical advice. This work was supported by grants
   from Deutsche Krebshilfe (Max Eder Program) and Deutsche
   Forschungsgemeinschaft to N.P. Malek.
CR Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320
   Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Costa RH, 2003, HEPATOLOGY, V38, p178A
   Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044
   Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735
   Ishii K, 2008, HEPATOLOGY, V48, P597, DOI 10.1002/hep.22362
   Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E
   Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004
   Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017
   Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004
   Li JX, 2000, GENE DEV, V14, P464
   Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258
   Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010
   Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798
   Lüdtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700
   Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083
   Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065
   Marino S, 2000, GENE DEV, V14, P994
   Masaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112
   Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808
   McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06
   Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208
   Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704
   Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016
   Ogawa S, 2005, STEM CELLS, V23, P903, DOI 10.1634/stemcells.2004-0295
   Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299
   Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402
   Ozturk M, 1999, SEMIN LIVER DIS, V19, P235, DOI 10.1055/s-2007-1007113
   Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959
   Roskams TA, 2003, SEMIN LIVER DIS, V23, P385
   Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375
   Singer S, 2007, HEPATOLOGY, V46, P759, DOI 10.1002/hep.21736
   Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836
   Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076
   Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019
   Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066
   Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277
   Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290
   Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101
   Xu DX, 2005, TOXICOL SCI, V87, P38, DOI 10.1093/toxsci/kfi239
   Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004
   Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004
NR 45
TC 42
Z9 49
U1 0
U2 7
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD NOV
PY 2010
VL 120
IS 11
BP 3820
EP 3833
DI 10.1172/JCI41959
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 672XU
UT WOS:000283621800017
PM 20978349
OA Bronze, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Yip, BWP
   Mok, HOL
   Peterson, DR
   Wan, MT
   Taniguchi, Y
   Ge, W
   Au, DWT
AF Yip, Bill W. P.
   Mok, Helen O. L.
   Peterson, Drew R.
   Wan, Miles T.
   Taniguchi, Y.
   Ge, Wei
   Au, Doris W. T.
TI Sex-dependent telomere shortening, telomerase activity and oxidative
   damage in marine medaka <i>Oryzias melastigma</i> during aging
SO MARINE POLLUTION BULLETIN
LA English
DT Article; Proceedings Paper
CT 8th International Conference on Marine Pollution and Ecotoxicology
   (ICMPE)
CY JUN 20-24, 2016
CL Hong Kong, HONG KONG
DE Sex hormones; Telomerase and telomere; TERT; 8-OHdG; Protein carbonyl;
   Biomarker of aging; Longevity gender gap; Post-menopausal decline of E2
ID SINGLE-STRAND BREAKS; DNA-DAMAGE; CATALYTIC SUBUNIT; GENE-EXPRESSION;
   ESTROGEN-RECEPTORS; HTERT EXPRESSION; UP-REGULATION; LIVE LONGER; FISH
   MODEL; LIFE
AB Marine medaka Otyzias melastigma at 4 months (young), 8 months (middle-aged) and 12 months old (senior) were employed to determine age-associated change of sex ratios, sex hormones, telomere length (TL), telomerase activity (TA), telomerase transcription (omTERT) and oxidative damage in the liver. Overall, O. melastigma exhibited gradual senescence, sex differences in longevity (F> M), TL (F> M) and oxidative damage (F < M) during aging. In females, the plasma E2 level was positively correlated with TL (TRF> 5 kb), TA and omTERT expression (p <= 5.0.01), and negatively correlated with liver DNA oxidation (p <= 0.05).The results suggest high levels of E2 in female O. melastigma may retard TL shortening by enhancing TA via TERT transcription and/or reducing oxidative DNA damage. The findings support TL shortening as a biomarker of aging and further development of accelerated TL shortening, abnormal suppression of TA and excessive oxidative DNA damage as early molecular endpoints, indicative of advanced/premature aging in marine medaka/fish. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Yip, Bill W. P.; Mok, Helen O. L.; Peterson, Drew R.; Wan, Miles T.; Au, Doris W. T.] City Univ Hong Kong, Dept Biol & Chem, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China.
   [Taniguchi, Y.] Kyorin Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo 1818611, Japan.
   [Ge, Wei] Univ Macau, Fac Hlth Sci, Ctr Reprod Dev & Aging, Ave Univ, Taipa, Macau, Peoples R China.
C3 City University of Hong Kong; Kyorin University; University of Macau
RP Au, DWT (corresponding author), City Univ Hong Kong, Dept Biol & Chem, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China.
EM bhdwtau@cityu.edu.hk
OI WAN, Teng, Miles/0000-0001-7084-8638
FU Research Grants Council of the Hong Kong Special Administrative Region,
   China [9041943, CityU 160013]; City University of Hong Kong [7004393];
   State Key Laboratory in Marine Pollution
FX The work described in this paper was supported by grants from the
   Research Grants Council of the Hong Kong Special Administrative Region,
   China (Project No. 9041943; CityU 160013), the City University of Hong
   Kong (Grant no. 7004393) and the State Key Laboratory in Marine
   Pollution.
CR Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005
   Aviv A, 2002, J MOL MED, V80, P689, DOI 10.1007/s00109-002-0377-8
   Aviv A., 2005, SCI AGING KNOWL ENV, V23, P6
   Bayne S, 2007, ANN NY ACAD SCI, V1114, P48, DOI 10.1196/annals.1396.023
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Bo J, 2012, COMP BIOCHEM PHYS D, V7, P191, DOI 10.1016/j.cbd.2012.02.005
   Bo J, 2011, MAR POLLUT BULL, V63, P267, DOI 10.1016/j.marpolbul.2011.05.014
   Boggess JF, 2006, GYNECOL ONCOL, V103, P417, DOI 10.1016/j.ygyno.2006.03.032
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Cabral JA, 1999, ACTA OECOL, V20, P607, DOI 10.1016/S1146-609X(99)00102-2
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   CASTILHO R, 1993, FISH RES, V16, P339, DOI 10.1016/0165-7836(93)90145-W
   Cech TR, 2000, ANGEW CHEM INT EDIT, V39, P34, DOI 10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N
   Cha Y, 2008, MOL CELLS, V26, P454
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Chen LW, 1999, FREE RADICAL BIO MED, V26, P695, DOI 10.1016/S0891-5849(98)00254-8
   Cheung NKM, 2013, J FISH BIOL, V83, P295, DOI 10.1111/jfb.12164
   Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   Gopalakrishnan S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-78
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962
   Honda S, 2001, INVEST OPHTH VIS SCI, V42, P2139
   Imanishi T, 2005, J HYPERTENS, V23, P1699, DOI 10.1097/01.hjh.0000176788.12376.20
   Kawagoe J, 2003, J BIOL CHEM, V278, P43363, DOI 10.1074/jbc.M304363200
   KETCHEN KS, 1975, J FISH RES BOARD CAN, V32, P43, DOI 10.1139/f75-006
   Kim BM, 2016, MAR ENVIRON RES, V113, P141, DOI 10.1016/j.marenvres.2015.12.004
   Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582
   Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011
   KRUMHOLZ LA, 1948, ECOL MONOGR, V18, P1, DOI 10.2307/1948627
   Kyo S, 1999, CANCER RES, V59, P5917
   Lai K. P., 2015, BMC GENET
   Lai KP, 2016, AQUAT TOXICOL, V177, P476, DOI 10.1016/j.aquatox.2016.06.023
   Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012
   Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000
   MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002
   Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552
   Peterson DR, 2015, COMP BIOCHEM PHYS C, V178, P51, DOI 10.1016/j.cbpc.2015.09.004
   Ravindranath N, 2001, PROSTATE, V49, P79, DOI 10.1002/pros.1120
   Sarkar P, 2006, INT J ONCOL, V28, P43
   Shalev I, 2012, BIOESSAYS, V34, P943, DOI 10.1002/bies.201200084
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049
   Tardieu D, 1998, CANCER LETT, V134, P1, DOI 10.1016/S0304-3835(98)00228-6
   Tse ACK, 2015, AQUAT TOXICOL, V165, P189, DOI 10.1016/j.aquatox.2015.06.002
   Van Tiem LA, 2011, TOXICOL APPL PHARM, V254, P280, DOI 10.1016/j.taap.2011.05.002
   Viña J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Viña J, 2010, ANTIOXID REDOX SIGN, V13, P269, DOI 10.1089/ars.2009.2952
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805
   WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0
   Ye R. R., 2016, ENV SCI POL IN PRESS
   Ye RR, 2012, ENVIRON SCI POLLUT R, V19, P2477, DOI 10.1007/s11356-012-0887-z
   Yu RM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-27
NR 66
TC 19
Z9 20
U1 1
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-326X
EI 1879-3363
J9 MAR POLLUT BULL
JI Mar. Pollut. Bull.
PD NOV 30
PY 2017
VL 124
IS 2
SI SI
BP 701
EP 709
DI 10.1016/j.marpolbul.2017.01.021
PG 9
WC Environmental Sciences; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA FP9JY
UT WOS:000417964500017
PM 28129920
DA 2024-02-19
ER

PT J
AU Blechman, MB
   Gelb, AM
AF Blechman, MB
   Gelb, AM
TI Aging and gastrointestinal physiology
SO CLINICS IN GERIATRIC MEDICINE
LA English
DT Article
ID HEPATIC-FUNCTION; AGE; GENDER; PROLIFERATION; PARITY; HUMANS
AB This article reviews the effects of aging on the immune system, specifically the role of apoptosis. Nutrition and malnutrition in the elderly and their implications are examined. The structural and functional changes that occur with aging in the gastrointestinal tract are also described. Medical care for the elderly population can significantly be improved by the understanding of the physiology of aging in the gastrointestinal tract. This improved understanding can assist in distinguishing disease states from normal changes that occur with age.
C1 Beth Israel Deaconess Med Ctr, Div Gastroenterol & Liver Dis, New York, NY 10003 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center
RP Gelb, AM (corresponding author), Beth Israel Deaconess Med Ctr, Div Gastroenterol & Liver Dis, 1st Ave & 16th St,Baird Hall,18th Floor, New York, NY 10003 USA.
CR AKERVALL S, 1990, SCAND J GASTROENTERO, V25, P1247, DOI 10.3109/00365529008998561
   ALTMAN DF, 1990, GASTROENTEROL CLIN N, V19, P227
   ARORA S, 1989, GASTROENTEROLOGY, V96, P1560, DOI 10.1016/0016-5085(89)90527-1
   ATILLASOY E, 1993, J GERONTOL, V48, pB43, DOI 10.1093/geronj/48.2.B43
   BANNISTER JJ, 1987, GUT, V28, P353, DOI 10.1136/gut.28.3.353
   Bradley J, 1996, NUTR REV, V54, pS43, DOI 10.1111/j.1753-4887.1996.tb03818.x
   Clarkston WK, 1997, AM J PHYSIOL-REG I, V272, pR243, DOI 10.1152/ajpregu.1997.272.1.R243
   DEW MJ, 1998, PRINCIPLES PRACTICE, P395
   Farthing M, 1997, GUT, V41, P421, DOI 10.1136/gut.41.4.421
   Feldman M, 1996, GASTROENTEROLOGY, V110, P1043, DOI 10.1053/gast.1996.v110.pm8612992
   FRANCESCHI C, 1992, ANN NY ACAD SCI, V663, P4, DOI 10.1111/j.1749-6632.1992.tb38643.x
   GELB AM, 1996, CLIN GASTROENTEROLOG, P1
   Harari D, 1996, ARCH INTERN MED, V156, P315, DOI 10.1001/archinte.156.3.315
   HOLT PR, 1988, GASTROENTEROLOGY, V95, P1556, DOI 10.1016/S0016-5085(88)80077-5
   Lee M, 1997, GUT, V41, P425, DOI 10.1136/gut.41.4.425
   Lovat LB, 1996, GUT, V38, P306, DOI 10.1136/gut.38.3.306
   Majumdar APN, 1997, P SOC EXP BIOL MED, V215, P134, DOI 10.3181/00379727-215-44120
   MCHUGH SM, 1987, DIGEST DIS SCI, V32, P726, DOI 10.1007/BF01296139
   MEIER R, 1995, NEUROGASTROENT MOTIL, V7, P235, DOI 10.1111/j.1365-2982.1995.tb00231.x
   Percival RS, 1996, FEMS IMMUNOL MED MIC, V15, P35, DOI 10.1016/0928-8244(96)00042-9
   RUSSELL RM, 1992, AM J CLIN NUTR, V55, P1203
   SCHMUCKER DL, 1986, J AM GERIATR SOC, V34, P377, DOI 10.1111/j.1532-5415.1986.tb04321.x
   TOWERS AL, 1994, J AM GERIATR SOC, V42, P701, DOI 10.1111/j.1532-5415.1994.tb06527.x
   Warner HR, 1997, J AM GERIATR SOC, V45, P1140, DOI 10.1111/j.1532-5415.1997.tb05981.x
   ZOLI M, 1989, GERONTOLOGY, V35, P61, DOI 10.1159/000213000
NR 25
TC 30
Z9 31
U1 0
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-0690
EI 1879-8853
J9 CLIN GERIATR MED
JI Clin. Geriatr. Med.
PD AUG
PY 1999
VL 15
IS 3
BP 429
EP +
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 216NE
UT WOS:000081448100001
PM 10393733
DA 2024-02-19
ER

PT J
AU Barshishat-Kupper, M
   Tipton, AJ
   McCart, EA
   McCue, J
   Mueller, GP
   Day, RM
AF Barshishat-Kupper, Michal
   Tipton, Ashlee J.
   McCart, Elizabeth A.
   McCue, Jeffrey
   Mueller, Gregory P.
   Day, Regina M.
TI Effect of ionizing radiation on liver protein oxidation and metabolic
   function in C57BL/6J mice
SO INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
LA English
DT Article
DE Protein damage; radiosensitivity; protein biochemistry
ID PROTEOMIC IDENTIFICATION; 2,3-BISPHOSPHOGLYCERATE PHOSPHATASE;
   PHOSPHOGLYCERATE MUTASE; CARBONYLATED PROTEINS; X-IRRADIATION;
   RAT-LIVER; TOXICITY; INJURY; BRAIN; LUNG
AB Purpose : Protein oxidation in response to radiation results in DNA damage, endoplasmic reticulum stress/unfolded protein response, cell cycle arrest, cell death and senescence. The liver, a relatively radiosensitive organ, undergoes measurable alterations in metabolic functions following irradiation. Accordingly, we investigated radiation-induced changes in liver metabolism and alterations in protein oxidation.
   Materials and methods : C57BL/6 mice were sham irradiated or exposed to 8.5 Gy Co-60 (0.6 Gy/min) total body irradiation. Metabolites and metabolic enzymes in the blood and liver tissue were analyzed. Two-dimensional gel electrophoresis and OxyBlot (TM) were used to detect carbonylated proteins that were then identified by peptide mass fingerprinting.
   Results : Analysis of serum metabolites revealed elevated glucose, bilirubin, lactate dehydrogenase (LDH), high-density lipoprotein, and aspartate aminotransferase within 24-72 h post irradiation. Liver tissue LDH and alkaline phosphatase activities were elevated 24-72 h post irradiation. OxyBlotting revealed that the hepatic proteome contains baseline protein carbonylation. Radiation exposure increased carbonylation of specific liver proteins including carbonic anhydrase 1, alpha-enolase, and regucalcin.
   Conclusions : 8.5 Gy irradiation resulted in distinct metabolic alterations in hepatic functions. Coincident with these changes, radiation induced the carbonylation of specific liver enzymes. The oxidation of liver enzymes may underlie some radiation-induced alterations in hepatic function.
C1 [Barshishat-Kupper, Michal; Tipton, Ashlee J.; McCart, Elizabeth A.; Day, Regina M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA.
   [McCue, Jeffrey; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.
C3 Uniformed Services University of the Health Sciences - USA; Uniformed
   Services University of the Health Sciences - USA
RP Day, RM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bldg C Rm 2023,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM regina.day@usuhs.edu
OI McCart, Elizabeth/0000-0001-8368-2753
FU Defense Medical Research and Development Program [D61 I 10 J7 62]
FX We are thankful to Mrs Laura Lewis from the Pathology Department of
   Uniformed Services University of the Health Sciences, for conducting the
   blood metabolic panel experiments in this study. Financial Support: This
   work was supported by Defense Medical Research and Development Program
   Grant D61 I 10 J7 62 to Drs R.M. Day and G.P. Mueller. Some of the
   authors are employees of the U.S. Government, and this manuscript was
   prepared as part of their official duties. Title 17 U.S.C. 105 provides
   that 'Copyright protection under this title is not available for any
   work of the United States Government.' Title 17 U.S.C 101 defined a U.S.
   Government work as a work prepared by a military service member or
   employees of the U.S. Government as part of that person's official
   duties. The views in this article are those of the authors and do not
   necessarily reflect the views, official policy, or position of the
   Uniformed Services University of the Health Sciences, Department of the
   Navy, Department of Defense, or the U.S. Federal Government.
CR Amundson S A, 2001, Expert Rev Mol Diagn, V1, P211, DOI 10.1586/14737159.1.2.211
   An JH, 2004, ANN NY ACAD SCI, V1030, P86, DOI 10.1196/annals.1329.011
   Anraku M, 2004, KIDNEY INT, V66, P841, DOI 10.1111/j.1523-1755.2004.00813.x
   Awasthi S, 1998, TOXICOL LETT, V95, P47, DOI 10.1016/S0378-4274(98)00020-4
   Baker JE, 2009, INT J RADIAT BIOL, V85, P1089, DOI 10.3109/09553000903264473
   Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1
   Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510
   Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x
   Chen CW, 2005, PROTEOMICS, V5, P4254, DOI 10.1002/pmic.200401295
   Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083
   Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516
   Cromheecke M, 2000, RADIAT RES, V154, P537, DOI 10.1667/0033-7587(2000)154[0537:TDASHD]2.0.CO;2
   Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092
   Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570
   Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8
   Day RM, 2008, J RADIAT RES, V49, P361, DOI 10.1269/jrr.07121
   Durany N, 1997, BRIT J CANCER, V75, P969, DOI 10.1038/bjc.1997.168
   Durany N, 1997, BRIT J CANCER, V76, P1139, DOI 10.1038/bjc.1997.525
   El-Missiry MA, 2007, ECOTOX ENVIRON SAFE, V66, P278, DOI 10.1016/j.ecoenv.2006.03.008
   England K, 2004, BIOCHEM BIOPH RES CO, V320, P123, DOI 10.1016/j.bbrc.2004.05.144
   Epperly MW, 2008, RADIAT RES, V170, P437, DOI 10.1667/RR1286.1
   FARBER JM, 1986, J BIOL CHEM, V261, P4574
   Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116
   Hall EJ, 2006, Radiobiology for the radiologist, V6th
   Khozouz RF, 2008, J CLIN ONCOL, V26, P4844, DOI 10.1200/JCO.2008.18.2931
   Leszczynski D, 2014, PROTEOMICS, V14, P481, DOI 10.1002/pmic.201300390
   Lii CK, 2011, ENVIRON TOXICOL, V26, P459, DOI 10.1002/tox.20572
   Linares M, 2011, J PROTEOME RES, V10, P1719, DOI 10.1021/pr101014e
   Madian AG, 2011, J PROTEOME RES, V10, P3959, DOI 10.1021/pr200140x
   MCPHERSON C W, 1963, Lab Anim Care, V13, P737
   Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9
   Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663
   Mori H, 2007, J ALZHEIMERS DIS, V11, P165
   Munden RF, 2005, AM J ROENTGENOL, V184, P1091, DOI 10.2214/ajr.184.4.01841091
   Muth E, 2004, BBA-PROTEINS PROTEOM, V1699, P263, DOI 10.1016/j.bbapap.2004.03.007
   Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502
   Panganiban RAM, 2013, INT J MOL SCI, V14, P15931, DOI 10.3390/ijms140815931
   Pari L, 2011, CHEM-BIOL INTERACT, V194, P40, DOI 10.1016/j.cbi.2011.08.004
   Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500
   Pick Amy M, 2010, J Oncol Pharm Pract, V16, P269, DOI 10.1177/1078155209352821
   Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052
   Seidensticker M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-40
   SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Song CW., 2012, TECHNICAL BASIS RAD, P51, DOI DOI 10.1007/174_2011_264
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Steiner SR, 2011, NEUROTOXICOLOGY, V32, P362, DOI 10.1016/j.neuro.2010.10.009
   Stryker JA, 2007, RADIOLOGY, V242, P1, DOI 10.1148/radiol.2421061103
   Suzuki K, 2012, JPN J CLIN ONCOL, V42, P563, DOI 10.1093/jjco/hys078
   Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887
   Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]
   Wang S, 2013, RADIAT RES, V179, P69, DOI 10.1667/RR3091.1
   Wang TJ, 2011, MOL BIOL REP, V38, P4359, DOI 10.1007/s11033-010-0563-7
   Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814
   Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805
   Xu JS, 2003, TOXICOL APPL PHARM, V189, P112, DOI 10.1016/S0041-008X(03)00090-5
   Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002
NR 59
TC 22
Z9 23
U1 2
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0955-3002
EI 1362-3095
J9 INT J RADIAT BIOL
JI Int. J. Radiat. Biol.
PD DEC
PY 2014
VL 90
IS 12
BP 1169
EP 1178
DI 10.3109/09553002.2014.930536
PG 10
WC Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Nuclear Science &
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA AW0RS
UT WOS:000346001600007
PM 24899392
DA 2024-02-19
ER

PT J
AU Vinod, C
   Jagota, A
AF Vinod, Ch.
   Jagota, Anita
TI Daily NO rhythms in peripheral clocks in aging male Wistar rats:
   protective effects of exogenous melatonin
SO BIOGERONTOLOGY
LA English
DT Article
DE NO; Melatonin; Peripheral clocks; Aging; Daily rhythms
ID NITRIC-OXIDE SYNTHASE; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS;
   VASCULAR DYSFUNCTION; LIPID-PEROXIDATION; OXIDATIVE STRESS; METABOLISM;
   EXPRESSION; HUMANS; SENESCENCE
AB In mammals suprachiasmatic nucleus (SCN), acts as a light entrainable master clock and by generation of temporal oscillations regulates the peripheral organs acting as autonomous clocks resulting in overt behavioral and physiological rhythms. SCN also controls synthesis and release of melatonin (hormonal message for darkness) from pineal. Nitric Oxide (NO) acts as an important neurotransmitter in generating the phase shifts of circadian rhythms and participates in sleep-wake processes, maintenance of vascular tone as well as signalling and regulating inflammatory processes. Aging is associated with disruption of circadian timing system and decline in endogenous melatonin leading to several physiological disorders. Here we report the effect of aging on NO daily rhythms in various peripheral clocks such as kidney, intestine, liver, heart, lungs and testis. NO levels were measured at zeitgeber time (ZT) 0, 6, 12 and 18 in these tissues using Griess assay in male Wistar rats. Aging resulted in alteration of NO levels as well as phase of NO in both 12 and 24 months groups. Correlation analysis demonstrated loss of stoichiometric interaction between the various peripheral clocks with aging. Age induced alterations in NO daily rhythms were found to be most significant in liver and, interestingly least in lungs. Neurohormone melatonin, an endogenous synchroniser and an antiaging agent decreases with aging. We report further differential restoration with exogenous melatonin administration of age induced alterations in NO daily rhythms and mean levels in kidney, intestine and liver and the stoichiometric interactions between the various peripheral clocks.
C1 [Vinod, Ch.; Jagota, Anita] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Telangana, India.
C3 University of Hyderabad
RP Jagota, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Telangana, India.
EM ajsl@uohyd.ernet.in
OI Ch, Vinod/0000-0003-3188-3750
FU ICMR [BMS/NTF/14/2006-2007, 55/7/2012-/BMS]; UGC [32-613/2006 (SR)]; UPE
FX The work is supported by ICMR (Ref. No. BMS/NTF/14/2006-2007;
   55/7/2012-/BMS), UGC (Ref: F. No.: 32-613/2006 (SR) and UPE grants to
   AJ. Ch Vinod is thankful to UGC for fellowship.
CR Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005
   Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006
   Anea CB, 2012, CIRC RES, V111, P1157, DOI 10.1161/CIRCRESAHA.111.261750
   Araujo AB, 2011, BEST PRACT RES CL EN, V25, P303, DOI 10.1016/j.beem.2010.11.004
   Baidanoff FM, 2014, J NEUROCHEM, V129, P60, DOI 10.1111/jnc.12613
   Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200
   Baylis C, 2012, J GERONTOL A-BIOL, V67, P1365, DOI 10.1093/gerona/gls171
   Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012
   Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026
   Cardinali DP, 2017, NEUROENDOCRINOLOGY, V104, P382, DOI 10.1159/000446543
   Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218
   Cespuglio R, 2012, SLEEP MED REV, V16, P265, DOI 10.1016/j.smrv.2012.01.006
   Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Contini MD, 2011, BIOL TRACE ELEM RES, V144, P924, DOI 10.1007/s12011-011-9060-7
   Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347
   Dominguez-Rodriguez A, 2012, REV ESP CARDIOL, V65, P215, DOI [10.1016/j.recesp.2011.10.009, 10.1016/j.rec.2011.10.011]
   du Plessis SS, 2010, ANDROLOGIA, V42, P112, DOI 10.1111/j.1439-0272.2009.00964.x
   El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132
   Erion R, 2016, ELIFE, V5, DOI 10.7554/eLife.13552
   Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012
   Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682
   Gubin Denis G, 2016, Curr Aging Sci, V9, P5
   Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012
   Hamelin-Morrissette J, 2015, EUR J MED CHEM, V96, P259, DOI 10.1016/j.ejmech.2015.04.026
   Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x
   Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009
   Jagota A, 2012, BRAIN AGING THERAPEU, P111
   Jagota A, 2008, BIOGERONTOLOGY, V9, P229, DOI 10.1007/s10522-008-9132-z
   Jagota A, 2007, CELL MOL NEUROBIOL, V27, P997, DOI 10.1007/s10571-007-9203-8
   Jagota A, 2010, BIOGERONTOLOGY, V11, P299, DOI 10.1007/s10522-009-9248-9
   Jenwitheesuk A, 2014, INT J MOL SCI, V15, P16848, DOI 10.3390/ijms150916848
   Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060
   Kirkwood TBL, 2005, EMBO REP, V6, pS4, DOI 10.1038/sj.embor.7400419
   Kovacic JC, 2011, CIRCULATION, V123, P1650, DOI 10.1161/CIRCULATIONAHA.110.007021
   Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230
   Lee NPY, 2008, ADV EXP MED BIOL, V636, P172, DOI 10.1007/978-0-387-09597-4_10
   Levashov M I, 2015, Ross Fiziol Zh Im I M Sechenova, V101, P1181
   Li CJ, 2015, CLIN CHIM ACTA, V446, P175, DOI 10.1016/j.cca.2015.04.029
   Logan RW, 2012, J IMMUNOL, V188, P2583, DOI 10.4049/jimmunol.1102715
   Lu WZ, 2005, ALIMENT PHARM THER, V22, P927, DOI 10.1111/j.1365-2036.2005.02673.x
   Manikonda PK, 2012, BIOGERONTOLOGY, V13, P511, DOI 10.1007/s10522-012-9396-1
   Mattam U, 2014, BIOGERONTOLOGY, V15, P257, DOI 10.1007/s10522-014-9495-2
   Mitome M, 2001, NEUROSCI LETT, V303, P161, DOI 10.1016/S0304-3940(01)01744-X
   Montesanto A, 2013, BIOGERONTOLOGY, V14, P177, DOI 10.1007/s10522-013-9421-z
   Mukda S, 2016, NEUROSCI LETT, V621, P39, DOI 10.1016/j.neulet.2016.04.013
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Nduhirabandi F, 2014, J PINEAL RES, V57, P317, DOI 10.1111/jpi.12171
   Novella S, 2013, EXP GERONTOL, V48, P1329, DOI 10.1016/j.exger.2013.08.003
   Peek CB, 2015, METHOD ENZYMOL, V552, P165, DOI 10.1016/bs.mie.2014.10.006
   Predonzani Andrea, 2015, World J Exp Med, V5, P64, DOI 10.5493/wjem.v5.i2.64
   RECKELHOFF JF, 1994, LIFE SCI, V55, P1895, DOI 10.1016/0024-3205(94)00521-4
   Reddy MY, 2015, BIOGERONTOLOGY, V16, P285, DOI 10.1007/s10522-014-9545-9
   Reddy VDK, 2014, BIOGERONTOLOGY, V15, P245, DOI 10.1007/s10522-014-9494-3
   Reiter RJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00377
   Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014
   Rodella LF, 2013, AGE, V35, P103, DOI 10.1007/s11357-011-9336-z
   Sanchez-Hidalgo M, 2009, EXP GERONTOL, V44, P328, DOI 10.1016/j.exger.2009.02.002
   Seay DJ, 2011, J BIOL RHYTHM, V26, P497, DOI 10.1177/0748730411420080
   Semercioz A, 2003, NEUROENDOCRINOL LETT, V24, P86
   Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005
   Sindler AL, 2014, J APPL PHYSIOL, V116, P463, DOI 10.1152/japplphysiol.01100.2013
   Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274
   Tan DX, 2014, J PINEAL RES, V57, P213, DOI 10.1111/jpi.12152
   Tomás-Zapico C, 2007, RECENT PATENTS ENDOC, V1, P63, DOI 10.2174/187221407779814561
   Tsang AH, 2014, J MOL ENDOCRINOL, V52, pR1, DOI 10.1530/JME-13-0118
   Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943
   Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015
   Vriend J, 2015, J PINEAL RES, V58, P1, DOI 10.1111/jpi.12189
   Wang X, 2011, AM J PHYSIOL-ENDOC M, V301, pE1163, DOI 10.1152/ajpendo.00138.2011
   Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001
   Zand J, 2011, NUTR RES, V31, P262, DOI 10.1016/j.nutres.2011.03.008
   Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002
   Zhou D, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7065
NR 77
TC 11
Z9 11
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD NOV
PY 2016
VL 17
IS 5-6
BP 859
EP 871
DI 10.1007/s10522-016-9656-6
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EA1VX
UT WOS:000386381300006
PM 27614960
DA 2024-02-19
ER

PT J
AU Anderson, JP
   Tchetgen, EJT
   Lo Re, V
   Tate, JP
   Williams, PL
   Seage, GR
   Horsburgh, CR
   Lim, JK
   Goetz, MB
   Rimland, D
   Rodriguez-Barradas, MC
   Butt, AA
   Klein, MB
   Justice, AC
AF Anderson, Jeffrey P.
   Tchetgen, Eric J. Tchetgen
   Lo Re, Vincent, III
   Tate, Janet P.
   Williams, Paige L.
   Seage, George R., III
   Horsburgh, C. Robert
   Lim, Joseph K.
   Goetz, Matthew Bidwell
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Butt, Adeel A.
   Klein, Marina B.
   Justice, Amy C.
TI Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among
   HIV- and Hepatitis C Virus-Coinfected Veterans
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE HIV; hepatitis C; coinfection; hepatic decompensation; marginal
   structural model
ID HUMAN-IMMUNODEFICIENCY-VIRUS; LIVER FIBROSIS PROGRESSION; MARGINAL
   STRUCTURAL MODELS; INFECTED PATIENTS; PROTECTIVE FACTOR; DISEASE;
   IMPACT; HCV; ASSOCIATION; PREVALENCE
AB Background. Human immunodeficiency virus (HIV) coinfection accelerates the rate of liver disease outcomes in individuals chronically infected with hepatitis C virus (HCV). It remains unclear to what degree combination antiretroviral therapy (ART) protects against HCV-associated liver failure.
   Methods. We evaluated 10 090 HIV/HCV-coinfected males from the Veterans Aging Cohort Study Virtual Cohort, who had not initiated ART at entry, for incident hepatic decompensation between 1996 and 2010. We defined ART initiation as the first pharmacy fill date of a qualifying ART regimen of >= 3 drugs from >= 2 classes. Hepatic decompensation was defined as the first occurrence of 1 hospital discharge diagnosis or 2 outpatient diagnoses for ascites, spontaneous bacterial peritonitis, or esophageal variceal hemorrhage. To account for potential confounding by indication, marginal structural models were used to estimate hazard ratios (HRs) of hepatic decompensation, comparing initiation of ART to noninitiation.
   Results. We observed 645 hepatic decompensation events in 46 444 person-years of follow-up (incidence rate, 1.4/100 person-years). Coinfected patients who initiated ART had a significantly reduced rate of hepatic decompensation relative to noninitiators (HR = 0.72; 95% confidence interval [CI], .54-.94). When we removed individuals with HIV RNA <= 400 copies/mL at baseline from the analysis (assuming that they may have received undocumented ART at entry), the hazard ratio became more pronounced (HR = 0.59; 95% CI, .43-.82).
   Conclusions. Initiation of ART significantly reduced the rate of hepatic decompensation by 28%-41% on average. These results suggest that ART should be administered to HIV/HCV-coinfected patients to lower the risk of end-stage liver disease.
C1 [Anderson, Jeffrey P.; Tchetgen, Eric J. Tchetgen; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Tchetgen, Eric J. Tchetgen; Williams, Paige L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Lo Re, Vincent, III] Univ Penn, Sch Med, Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.
   [Horsburgh, C. Robert] Boston Univ, Sch Med, Boston Med Ctr, Infect Dis Sect, Boston, MA 02215 USA.
   [Goetz, Matthew Bidwell] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Rimland, David] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA.
   [Rodriguez-Barradas, Maria C.] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Houston, TX 77030 USA.
   [Butt, Adeel A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.
   [Butt, Adeel A.] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates.
   [Klein, Marina B.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; University of
   Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Philadelphia Veterans Affairs
   Medical Center; University of Pennsylvania; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare
   System; Yale University; Boston University; Boston Medical Center;
   Boston University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Greater Los Angeles Healthcare System;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Atlanta VA Health Care System; Emory University;
   Baylor College of Medicine; Baylor College of Medicine; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; McGill University; Royal Victoria Hospital
RP Tate, JP (corresponding author), VA Connecticut Healthcare Syst, 950 Campbell Ave, West Haven, CT 06516 USA.
EM janet.tate2@va.gov
RI Goetz, Matthew Bidwell/GPX-4090-2022; Tchetgen, Eric
   Tchetgen/AAF-6160-2021; Re, Vincent Lo/N-7817-2015
OI Horsburgh, C./0000-0001-6838-7895; Goetz, Matthew/0000-0003-4542-992X;
   Butt, Adeel/0000-0002-1118-1826; Klein, Marina/0000-0002-3063-8430
FU National Institutes of Health [T32 AI007358, T32 AI007535]; National
   Institute on Alcohol Abuse and Alcoholism [U01 AA13566, U24 AA020794,
   U01 AA020790]; National Heart, Lung and Blood Institute [R01 HL095136,
   R01 HL090342, RCI HL100347]; National Institute of Allergy and
   Infectious Diseases [U01 A1069918]; Veterans Health Administration
   Office of Research and Development [VA REA 08266]; National Institute on
   Aging; National Institute of Mental Health; Veterans Health
   Administration
FX This work was supported by the National Institutes of Health (grant
   numbers T32 AI007358 and T32 AI007535 to J. P. A.). The Veterans Aging
   Cohort Study has been funded by the National Institute on Alcohol Abuse
   and Alcoholism (grant numbers U01 AA13566, U24 AA020794, U01 AA020790);
   the National Heart, Lung and Blood Institute (grant numbers R01
   HL095136, R01 HL090342, RCI HL100347); the National Institute of Allergy
   and Infectious Diseases (grant number U01 A1069918); the Veterans Health
   Administration Office of Research and Development (grant number VA REA
   08266); and an interagency agreement between the National Institute on
   Aging, the National Institute of Mental Health, and the Veterans Health
   Administration.
CR Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517
   Berenguer J, 2008, CLIN INFECT DIS, V46, P137, DOI 10.1086/524080
   Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x
   Brook G, 2010, HIV MED, V11, P1, DOI 10.1111/j.1468-1293.2009.00781.x
   Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164
   Collazos J, 2011, AIDS RES HUM RETROV, V27, P383, DOI 10.1089/aid.2010.0168
   Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Fuster D, 2004, AIDS RES HUM RETROV, V20, P1293, DOI 10.1089/aid.2004.20.1293
   Gandhi NR, 2013, PHARMACOEPIDEM DR S, V22, P1019, DOI 10.1002/pds.3476
   Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   Hernán MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012
   Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Macías J, 2004, AIDS, V18, P767, DOI [10.1097/00002030-200403260-00007, 10.1097/01.aids.0000111417.91384.fd]
   Macias J, 2006, ANTIVIR THER, V11, P839
   McGinnis KA, 2013, ALCOHOL CLIN EXP RES, V37, P435, DOI 10.1111/j.1530-0277.2012.01937.x
   Mehta SH, 2005, HEPATOLOGY, V41, P123, DOI 10.1002/hep.20541
   Mendes-Correa MC, 2008, AIDS PATIENT CARE ST, V22, P701, DOI 10.1089/apc.2007.0216
   Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1
   Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea
   Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035
   Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757
   Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1
   Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011
   Sarkar M, 2012, HEPATOLOGY, V56, P1699, DOI 10.1002/hep.25859
   Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319
   Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74
   Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450
   Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961
   Tural C, 2003, J VIRAL HEPATITIS, V10, P118, DOI 10.1046/j.1365-2893.2003.00413.x
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861
   Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918
NR 40
TC 43
Z9 45
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2014
VL 58
IS 5
BP 719
EP 727
DI 10.1093/cid/cit779
PG 9
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA AB5RR
UT WOS:000331846700023
PM 24285848
OA Green Published
DA 2024-02-19
ER

PT J
AU Vogel, H
   Lim, DS
   Karsenty, G
   Finegold, M
   Hasty, P
AF Vogel, H
   Lim, DS
   Karsenty, G
   Finegold, M
   Hasty, P
TI Deletion of Ku86 causes early onset of senescence in mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DNA-REPAIR; V(D)J RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SYNDROME
   PROTEIN; LIFE-SPAN; BRCA2; DEFICIENT; MUTATION; CANCER; CELLS
AB DNA double-strand breaks formed during the assembly of antigen receptors or after exposure to ionizing radiation are repaired by proteins important for nonhomologous end joining that include Ku86, Ku70, DNA-PKCS, Xrcc4, and DNA ligase IV. Here me show that ku86-mutant mice, compared with control littermates, prematurely exhibited age-specific changes characteristic of senescence that. include osteopenia, atrophic skin, hepatocellular degeneration, hepatocellular inclusions, hepatic hyperplastic foci, and age-specific mortality. Cancer and likely sepsis (indicated by reactive immune responses) partly contributed to age-specific mortality for both cohorts, and both conditions occurred earlier in ku86(-/-) mice. These data indicate that Ku86-dependent chromosomal metabolism is important for determining the onset of age-specific changes characteristic of senescence in mice.
C1 Lexicon Genet, The Woodlands, TX 77381 USA.
   Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA.
C3 Lexicon Pharmaceuticals; Baylor College of Medicine; Baylor College of
   Medicine
RP Hasty, P (corresponding author), Lexicon Genet, 4000 Res Forest Dr, The Woodlands, TX 77381 USA.
RI Lim, Dae-Sik/C-1599-2011
OI Lim, Dae-Sik/0000-0003-2356-7555; Vogel, Otto
   Hannes/0000-0002-0960-3508; Hasty, Paul/0000-0003-3046-0131
FU NCI NIH HHS [R01 CA076317, 1RO1CA76317-01] Funding Source: Medline
CR Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Ershler WB, 1997, JNCI-J NATL CANCER I, V89, P1489, DOI 10.1093/jnci/89.20.1489
   FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9
   Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172
   Friedman LS, 1998, CANCER RES, V58, P1338
   Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6
   Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100
   Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076
   Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410
   HYDE SR, 1990, INFECT IMMUN, V58, P619, DOI 10.1128/IAI.58.3.619-624.1990
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6
   Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097
   Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292
   Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2
   Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1
   LINDSEY J, 1991, MUTAT RES, V4548
   Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5
   MARTIN GM, 1970, LAB INVEST, V23, P86
   Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4
   Masoro EJ, 1995, HDB PHYSL, P3
   Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2
   Morimatsu M, 1998, CANCER RES, V58, P3441
   NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A
   Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0
   OSMAN AAH, 1994, BONE, V15, P437, DOI 10.1016/8756-3282(94)90822-2
   Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921
   Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0
   Percy DH, 1993, PATHOLOGY LAB RODENT
   Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276
   Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313
   Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916
   SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195
   STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0
   Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288
   WEISS A, 1991, BONE, V12, P165, DOI 10.1016/8756-3282(91)90039-L
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
   Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7
NR 47
TC 306
Z9 333
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 14
PY 1999
VL 96
IS 19
BP 10770
EP 10775
DI 10.1073/pnas.96.19.10770
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 235ZQ
UT WOS:000082574100047
PM 10485901
OA Green Published
DA 2024-02-19
ER

PT J
AU Toivola, DM
   Habtezion, A
   Misiorek, JO
   Zhang, LX
   Nyström, JH
   Sharpe, O
   Robinson, WH
   Kwan, R
   Omary, MB
AF Toivola, Diana M.
   Habtezion, Aida
   Misiorek, Julia O.
   Zhang, Linxing
   Nystrom, Joel H.
   Sharpe, Orr
   Robinson, William H.
   Kwan, Raymond
   Omary, M. Bishr
TI Absence of keratin 8 or 18 promotes antimitochondrial autoantibody
   formation in aging male mice
SO FASEB JOURNAL
LA English
DT Article
DE autoimmune liver disease; GDH; HMGCS2; ALDH; intermediate filaments
ID SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; LIVER FIBROSIS;
   RESISTANCE; APOPTOSIS; VARIANTS; FAS; IDENTIFICATION; DEHYDROGENASE;
   PREDISPOSES
AB Human mutations in keratin 8 (K8) and keratin 18 (K18), the intermediate filament proteins of hepatocytes, predispose to several liver diseases. K8-null mice develop chronic liver injury and fragile hepatocytes, dysfunctional mitochondria, and Th2-type colitis. We tested the hypothesis that autoantibody formation accompanies the liver damage that associates with K8/K18 absence. Sera from wild-type control, K8-null, and K18-null mice were analyzed by immunoblotting and immunofluorescence staining of cell and mouse tissue homogenates. Autoantibodies to several antigens were identified in 81% of K8-null male mice 8 mo or older. Similar autoantibodies were detected in aging K18-null male mice that had a related liver phenotype but normal colon compared with K8-null mice, suggesting that the autoantibodies are linked to liver rather than colonic disease. However, these autoantibodies were not observed in nontransgenic mice subjected to 4 chronic injury models. The autoantigens are ubiquitous and partition with mitochondria. Mass spectrometry and purified protein analysis identified, mitochondrial HMG-CoA synthase, aldehyde dehydrogenase, and catalase as the primary autoantigens, and glutamate dehydrogenase and epoxide hydrolase-2 as additional autoantigens. Therefore, absence of the hepatocyte keratins results in production of anti-mitochondrial autoantibodies (AMA) that recognize proteins involved in energy metabolism and oxidative stress, raising the possibility that AMA may be found in patients with keratin mutations that associate with liver and other diseases.
C1 [Toivola, Diana M.; Misiorek, Julia O.; Nystrom, Joel H.] Abo Akad Univ, Dept Sci & Engn, Dept Biosci, FIN-20520 Turku, Finland.
   [Toivola, Diana M.; Misiorek, Julia O.; Nystrom, Joel H.] Abo Akad Univ, Dept Cell Biol, FIN-20520 Turku, Finland.
   [Habtezion, Aida; Zhang, Linxing] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA.
   [Sharpe, Orr; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA.
   [Sharpe, Orr; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.
   [Kwan, Raymond; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
   [Kwan, Raymond; Omary, M. Bishr] Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA.
C3 Abo Akademi University; Abo Akademi University; Stanford University;
   Stanford University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Palo Alto Health Care System; University of
   Michigan System; University of Michigan; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare
   System
RP Toivola, DM (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6A, FIN-20520 Turku, Finland.
EM dtoivola@abo.fi
OI Nystrom, Joel Henrik/0000-0002-3514-6064; Misiorek, Julia
   Oliwia/0000-0001-6263-4461; Omary, Bishr/0000-0002-8624-2347; Toivola,
   Diana M./0000-0001-7165-9839; Robinson, William/0000-0003-4385-704X
FU U.S. National Institutes of Health [DK47918, K08-DK069385, DK56339,
   DK34933]; Academy of Finland [140759/126161, 266582]; Sigrid Juselius
   Foundation; Liv och Halsa Foundation; EU FP7 IRG; AAU Center of
   Excellence; Turku Doctoral Programme for Biomedical Sciences; Makarna
   Agneta och Carl-Erik Olin Foundation; U.S. Department of Veterans
   Affairs; Academy of Finland (AKA) [266582] Funding Source: Academy of
   Finland (AKA)
FX The authors thank Helene Baribault and Thomas Magin for providing the
   K8<SUP>-/-</SUP> and K18<SUP>-/-</SUP> mice, respectively, and P. J. Utz
   for fruitful discussions. Che-Hong Chen is acknowledged for assistance
   with the 2D-PAGE. The authors also thank Matilda Holm, Neeraj Prabhakar,
   Jolanta Lundgren, and Helena Saarento for technical assistance. This
   work was supported by U.S. National Institutes of Health Grants DK47918
   (to M.B.O.), K08-DK069385 (to A.H.), DK56339 (Stanford University), and
   DK34933 (University of Michigan); Academy of Finland #140759/126161 and
   266582, Sigrid Juselius Foundation, Liv och Halsa Foundation, EU FP7
   IRG, and AAU Center of Excellence (D.M.T.); Turku Doctoral Programme for
   Biomedical Sciences (J.O.M.); Makarna Agneta och Carl-Erik Olin
   Foundation (J.H.N.); and the U.S. Department of Veterans Affairs
   (M.B.O.). The authors declare no conflicts of interest.
CR Ballot E, 2003, CLIN CHEM, V49, P634, DOI 10.1373/49.4.634
   BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964
   Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17
   Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009
   Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0
   Edassery SL, 2010, FERTIL STERIL, V94, P2636, DOI 10.1016/j.fertnstert.2010.04.012
   Fallatah Hind I, 2011, Comp Hepatol, V10, P9, DOI 10.1186/1476-5926-10-9
   Fickert P, 2009, HEPATOLOGY, V50, P893, DOI 10.1002/hep.23068
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130
   Gossard AA, 2012, J GASTROENTEROL, V47, P498, DOI 10.1007/s00535-012-0586-z
   Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316
   Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108
   Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436
   Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055
   Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569
   Helenius TO, 2015, MOL BIOL CELL, V26, P2298, DOI 10.1091/mbc.E14-02-0736
   Herszényi L, 2012, DIGEST DIS, V30, P201, DOI 10.1159/000336702
   Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014
   Hohenester S, 2013, HEPATOLOGY, V58, P828, DOI 10.1002/hep.26243
   Karaca M, 2011, NEUROCHEM INT, V59, P510, DOI 10.1016/j.neuint.2011.03.024
   Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797
   Ku NO, 2004, METHOD CELL BIOL, V78, P489
   Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547
   Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108
   Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   Leifeld L, 2009, EUR J CLIN INVEST, V39, P481, DOI 10.1111/j.1365-2362.2009.02133.x
   Loranger A, 1997, AM J PATHOL, V151, P1673
   Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441
   Mathew J, 2013, EXP CELL RES, V319, P474, DOI 10.1016/j.yexcr.2012.11.011
   MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q
   Nakanishi T, 2006, J CHROMATOGR B, V838, P15, DOI 10.1016/j.jchromb.2006.04.009
   Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003
   Odaka C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075101
   Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762
   Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Orth T, 1998, CLIN EXP IMMUNOL, V112, P507
   Orth T, 2000, J HEPATOL, V33, P862, DOI 10.1016/S0168-8278(00)80116-6
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Strnad P, 2008, GASTROENTEROLOGY, V134, P1169, DOI 10.1053/j.gastro.2008.01.035
   Strnad P, 2006, HEPATOLOGY, V43, P1354, DOI 10.1002/hep.21211
   Strnad P, 2012, CURR OPIN GASTROEN, V28, P209, DOI 10.1097/MOG.0b013e3283525cb8
   Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007
   Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652
   Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017
   Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862
   Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011
   Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004
   Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374
   Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103
   Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117
   Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x
   Zhong BH, 2009, HEPATOLOGY, V50, P546, DOI 10.1002/hep.23041
NR 57
TC 11
Z9 13
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD DEC
PY 2015
VL 29
IS 12
BP 5081
EP 5089
DI 10.1096/fj.14-269795
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CX2JS
UT WOS:000365523600031
PM 26399787
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Kim, K
   Cho, SC
   Cova, A
   Jang, IS
   Park, SC
AF Kim, Kyungtae
   Cho, Sung Chun
   Cova, Anthony
   Jang, Ik Soon
   Park, Sang Chul
TI Alterations of epinephrine-induced gluconeogenesis in aging
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Article
DE aging; epinephrine; glucagon; gluconeogenesis; G-protein-coupled
   receptor kinases; hepatocytes
ID ADRENERGIC-RECEPTOR KINASE-2; PROMOTER-REGULATORY REGION; CARBOXYKINASE
   GTP GENE; AGE-RELATED-CHANGES; PHOSPHOENOLPYRUVATE CARBOXYKINASE;
   RAT-LIVER; HEPATIC GLUCONEOGENESIS; SIGNAL-TRANSDUCTION; GLUCAGON
   RECEPTORS; ADENYLATE-CYCLASE
AB The effects of glucagon and epinephrine on gluconeogenesis in young (4 month) and old (24 month) Fisher 344 rat hepatocytes were compared. In contrast to glucagon, which had a similar effect on gluconeogenesis in both young and old cells, epinephrine caused a smaller increase in gluconeogenesis in old rat hepatocytes than in young hepatocytes. beta(2) adrenergic receptor (beta(2)-AR) expression slightly decreased in aged rat liver, and there were differences between young and old hepatocytes in their patterns of G protein coupled receptor kinases, which are involved in the activation Of beta(2)-AR receptor signal desensitization. The major isoform of the kinase changed from GRK2 to GRK3 and the expression of beta-arrestin, which is recruited by the phosphorylated beta(2)-AR for internalization and degradation, increased in aged rat liver. GRK3 overexpression also decreased the glucose output from young rat hepatocytes. We conclude that an age-associated reduction in epinephrine-induced gluconeogenesis occurs through the epinephrine receptor desensitizing system.
C1 [Kim, Kyungtae; Cho, Sung Chun; Cova, Anthony; Park, Sang Chul] Seoul Natl Univ, Coll Med, Aging & Apoptosis Res Ctr, Dept Biochem & Mol Biol, Seoul 110799, South Korea.
   [Kim, Kyungtae] Natl Canc Ctr, Goyang 410769, South Korea.
   [Jang, Ik Soon] Korea Basic Sci Inst, Taejon 305333, South Korea.
C3 Seoul National University (SNU); National Cancer Center - Korea (NCC);
   Korea Basic Science Institute (KBSI)
RP Park, SC (corresponding author), Seoul Natl Univ, Coll Med, Aging & Apoptosis Res Ctr, Dept Biochem & Mol Biol, Seoul 110799, South Korea.
EM scpark@snu.ac.kr
RI Park, SangChul/CAF-6192-2022
OI Park, SangChul/0000-0003-0384-8245
FU Korea Research Foundation of Health Science [R11-2002-097-05001-0];
   Korea Science and Engineering Foundation [R11-2002-097-00001-0]; The
   Korea National Cancer Center [0710280-1]
FX The authors thank Dr. R.J. Leflkowitz (Duke University, Durham, NC) for
   the GRK3 vector and Dr. Yong-Sung Juhnn (Seoul National University,
   Seoul, Korea) for critical discussion. This work was supported by the
   Korea Research Foundation of Health Science (R11-2002-097-05001-0),
   Korea Science and Engineering Foundation (KOSEF, R11-2002-097-00001-0)
   for Aging and Apoptosis Research Center at Seoul National University,
   and The Korea National Cancer Center (0710280-1).
CR BENOVIC JL, 1991, J BIOL CHEM, V266, P14939
   Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200
   DAX EM, 1981, J LIPID RES, V22, P934
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   Dobson JG, 2003, PHYSIOL GENOMICS, V15, P142, DOI 10.1152/physiolgenomics.00076.2003
   Eakes AT, 1996, AM J PHYSIOL-ENDOC M, V270, pE126, DOI 10.1152/ajpendo.1996.270.1.E126
   Erraji-Benchekroun L, 2005, AM J PHYSIOL-ENDOC M, V288, pE715, DOI 10.1152/ajpendo.00113.2004
   Fraeyman N, 2000, BIOCHEM PHARMACOL, V60, P1787, DOI 10.1016/S0006-2952(00)00493-7
   FRAEYMAN N, 1993, MECH AGEING DEV, V70, P115, DOI 10.1016/0047-6374(93)90063-W
   Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0
   Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375
   LIU JS, 1991, J BIOL CHEM, V266, P19095
   MABRY TR, 1995, NEUROBIOL LEARN MEM, V63, P260, DOI 10.1006/nlme.1995.1030
   Marker JC, 1998, AM J PHYSIOL-ENDOC M, V275, pE770, DOI 10.1152/ajpendo.1998.275.5.E770
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   PARRUTI G, 1993, BIOCHEM BIOPH RES CO, V190, P475, DOI 10.1006/bbrc.1993.1072
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   PILKIS SJ, 1975, J BIOL CHEM, V250, P6328
   Podolin DA, 1996, AM J PHYSIOL-REG I, V270, pR365, DOI 10.1152/ajpregu.1996.270.2.R365
   Podolin DA, 2001, AM J PHYSIOL-ENDOC M, V281, pE516, DOI 10.1152/ajpendo.2001.281.3.E516
   Schutzer WE, 2001, AM J PHYSIOL-REG I, V280, pR897, DOI 10.1152/ajpregu.2001.280.3.R897
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SHORT JM, 1986, J BIOL CHEM, V261, P9721
   Sumida KD, 2003, J APPL PHYSIOL, V95, P712, DOI 10.1152/japplphysiol.01125.2002
   Tobias ES, 1997, BIOCHEM J, V326, P545, DOI 10.1042/bj3260545
   VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151
   WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 30
TC 10
Z9 11
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD MAY 31
PY 2009
VL 41
IS 5
BP 334
EP 340
DI 10.3858/emm.2009.41.5.037
PG 7
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA 453HB
UT WOS:000266600400005
PM 19307753
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, FR
   Kerbl-Knapp, J
   Akhmetshina, A
   Korbelius, M
   Kuentzel, KB
   Vujic, N
   Hörl, G
   Paar, M
   Kratky, D
   Steyrer, E
   Madl, T
AF Zhang, Fangrong
   Kerbl-Knapp, Jakob
   Akhmetshina, Alena
   Korbelius, Melanie
   Kuentzel, Katharina Barbara
   Vujic, Nemanja
   Hoerl, Gerd
   Paar, Margret
   Kratky, Dagmar
   Steyrer, Ernst
   Madl, Tobias
TI Tissue-Specific Landscape of Metabolic Dysregulation during Ageing
SO BIOMOLECULES
LA English
DT Article
DE ageing; tissue-specific; metabolomics; biomarker
AB The dysregulation of cellular metabolism is a hallmark of ageing. To understand the metabolic changes that occur as a consequence of the ageing process and to find biomarkers for age-related diseases, we conducted metabolomic analyses of the brain, heart, kidney, liver, lung and spleen in young (9-10 weeks) and old (96-104 weeks) wild-type mice [mixed genetic background of 129/J and C57BL/6] using NMR spectroscopy. We found differences in the metabolic fingerprints of all tissues and distinguished several metabolites to be altered in most tissues, suggesting that they may be universal biomarkers of ageing. In addition, we found distinct tissue-clustered sets of metabolites throughout the organism. The associated metabolic changes may reveal novel therapeutic targets for the treatment of ageing and age-related diseases. Moreover, the identified metabolite biomarkers could provide a sensitive molecular read-out to determine the age of biologic tissues and organs and to validate the effectiveness and potential off-target effects of senolytic drug candidates on both a systemic and tissue-specific level.
C1 [Zhang, Fangrong; Kerbl-Knapp, Jakob; Akhmetshina, Alena; Korbelius, Melanie; Kuentzel, Katharina Barbara; Vujic, Nemanja; Kratky, Dagmar; Steyrer, Ernst; Madl, Tobias] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, A-8010 Graz, Austria.
   [Hoerl, Gerd; Paar, Margret] Med Univ Graz, Physiol Chem, Otto Loewi Res Ctr, A-8010 Graz, Austria.
   [Kratky, Dagmar; Madl, Tobias] BioTechMed Graz, A-8010 Graz, Austria.
C3 Medical University of Graz; Medical University of Graz
RP Madl, T (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, A-8010 Graz, Austria.; Madl, T (corresponding author), BioTechMed Graz, A-8010 Graz, Austria.
EM fangrong.zhang@medunigraz.at; jakob.kerbl-knapp@medunigraz.at;
   alena.akhmetshina@medunigraz.at; m.korbelius@medunigraz.at;
   katharina.kuentzel@medunigraz.at; nemanja.vujic@medunigraz.at;
   gerd.hoerl@medunigraz.at; margret.paar@medunigraz.at;
   dagmar.kratky@medunigraz.at; ernst.steyrer@medunigraz.at;
   tobias.madl@medunigraz.at
RI Kratky, Dagmar/ABF-5699-2021; Madl, Tobias/B-1682-2012; Zhang,
   Fangrong/O-1599-2017
OI Madl, Tobias/0000-0002-9725-5231; Akhmetshina,
   Alena/0000-0002-2346-7258; Zhang, Fangrong/0000-0002-8974-2902;
   Kuentzel, Katharina Barbara/0000-0002-1445-5466; Kratky,
   Dagmar/0000-0003-1357-7573; Hoerl, Gerd/0000-0002-0884-0851; Korbelius,
   Melanie/0000-0002-7609-9436; Paar, Margret/0000-0001-5494-8890; Vujic,
   Nemanja/0000-0003-2977-7799
FU Austrian Science Fund (FWF) [P28854, I3792, DK-MCD W1226]; Austrian
   Research Promotion Agency (FFG) [864690, 870454]; Integrative Metabolism
   Research Center Graz; Austrian Infrastructure Program 2016/2017; Styrian
   Government (Zukunftsfonds); BioTechMed-Graz (flagship project); FWF [SFB
   F73, W1226, P32400, P30882, DP-iDP DOC 31]; BioTechMed-Graz flagship
   project "Lipases and Lipid Signaling"; County of Styria; City of Graz
FX T.M. was supported by Austrian Science Fund (FWF) grants P28854, I3792
   and DK-MCD W1226; Austrian Research Promotion Agency (FFG) grants 864690
   and 870454; the Integrative Metabolism Research Center Graz; the
   Austrian Infrastructure Program 2016/2017, the Styrian Government
   (Zukunftsfonds); and BioTechMed-Graz (flagship project). D.K. was
   supported by the FWF (SFB F73, W1226, P32400, P30882, DP-iDP DOC 31),
   the BioTechMed-Graz flagship project "Lipases and Lipid Signaling," the
   County of Styria, and the City of Graz. F.Z. was trained within the
   frame of the PhD program in Molecular Medicine, Medical University of
   Graz.
CR Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262
   Bingol Kerem, 2018, High Throughput, V7, DOI 10.3390/ht7020009
   Bircan FS, 2011, NEUROCHEM RES, V36, P1978, DOI 10.1007/s11064-011-0521-3
   Brandenberger C, 2017, CELL TISSUE RES, V367, P469, DOI 10.1007/s00441-016-2511-x
   Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337
   Catic A, 2018, PROG MOL BIOL TRANSL, V155, P85, DOI 10.1016/bs.pmbts.2017.12.003
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen CF, 2001, J BIOMED SCI, V8, P446, DOI 10.1007/BF02256606
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   DEFEUDIS FV, 1983, EXPERIENTIA, V39, P845, DOI 10.1007/BF01990401
   Delfarah A., 2018, INHIBITION NUCLEOTID, DOI [10.1101/423665, DOI 10.1101/423665]
   EPSTEIN M, 1979, FED PROC, V38, P168
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Ferrucci L, 2008, RADIOL CLIN N AM, V46, P643, DOI 10.1016/j.rcl.2008.07.005
   Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Guasch-Ferré M, 2016, DIABETES CARE, V39, P833, DOI 10.2337/dc15-2251
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hashimoto M, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129776
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070
   Hunsberger HC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68739-z
   Ivanisevic J, 2016, AGING-US, V8, P1000, DOI 10.18632/aging.100961
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kaiser LG, 2005, NEUROBIOL AGING, V26, P665, DOI 10.1016/j.neurobiolaging.2004.07.001
   Kannan L, 2003, BBA-MOL CELL BIOL L, V1631, P12, DOI 10.1016/S1388-1981(02)00367-0
   Kuehne A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3547-3
   Larsson SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12931-1
   LeBrasseur NK, 2015, NESTLE NUTR WORKS SE, V83, P11, DOI 10.1159/000382054
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Liu J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010054
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107
   Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047
   Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044
   NISHIO S, 1990, MECH AGEING DEV, V52, P125, DOI 10.1016/0047-6374(90)90119-Z
   Ossani G, 2007, FRONT BIOSCI-LANDMRK, V12, P1174, DOI 10.2741/2135
   Pan C, 2021, SCIENCE, V371, P234, DOI 10.1126/science.abf6368
   Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656
   Patterson JM, 1944, J BIOL CHEM, V153, P489
   Pauwels L, 2018, AGING-US, V10, P3645, DOI 10.18632/aging.101696
   Raja G, 2020, PROCESS BIOCHEM, V99, P112, DOI 10.1016/j.procbio.2020.08.023
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Sato Y, 2019, NAT REV NEPHROL, V15, P625, DOI 10.1038/s41581-019-0185-9
   Segovia G, 2001, MECH AGEING DEV, V122, P1, DOI 10.1016/S0047-6374(00)00225-6
   Stryeck S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42937-w
   Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953
   Tobias DK, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002157
   Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644
   Turner VM, 2017, BIOGERONTOLOGY, V18, P723, DOI 10.1007/s10522-017-9707-7
   Uddin GM, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0892-3
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vignoli A, 2019, ANGEW CHEM INT EDIT, V58, P968, DOI 10.1002/anie.201804736
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wilkinson DJ, 2020, AGING-US, V12, P12517, DOI 10.18632/aging.103513
   Woods JA, 2012, AGING DIS, V3, P130
   Xia Xian, 2017, F1000Res, V6, P860, DOI 10.12688/f1000research.10692.1
   Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007
   Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774
   Yuan R, 2011, ILAR J, V52, P4, DOI 10.1093/ilar.52.1.4
   Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112
   Zhang L., 2008, PROGR MOL BIOL TRANS
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 74
TC 17
Z9 18
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD FEB
PY 2021
VL 11
IS 2
AR 235
DI 10.3390/biom11020235
PG 17
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology
GA QM9TL
UT WOS:000622115600001
PM 33562384
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Lei, H
   Cai, LL
   Wang, Y
   Han, JC
   Wang, Q
   Zhang, XX
AF Lei Hong
   Cai Liangliang
   Wang Yi
   Han Juncheng
   Wang Qin
   Zhang Xiaoxiang
TI ANTI-AGING EFFECT OF SESAMIN AND ITS MECHANISM OF ACTION
SO CURRENT TOPICS IN NUTRACEUTICAL RESEARCH
LA English
DT Article
DE Aging; Antioxidant; D-Galactose; Immunomodulation; Sesamin
ID LIGNAN
AB Sesamin (SES), as one of the most abundant lignans in sesame seed and oil exhibits multiple functions. The anti-aging effect of sesamin on D-galactose (D-gal)induced senescent mice model and its mechanism of action were evaluated. The effects of sesamin (50 or 100 mg kg(-1)) on senescent mice were investigated by observing the changes of body weight, motor and memory ability, liver superoxide dismutase (SOD), glutathione peroxidase (GSHpx), reduced glutathione (GSH) and malondialdehyde (MDA). Moreover, the proliferative response and IL-2 production of splenocytes induced by ConA, the levels of macrophage proliferative response and IL-1, NO production by macrophage were observed. Results showed that age-related alternations of both motor and memory activity were ameliorated in the treatment group. Treatment with sesamin significantly increased the body weight, hepatic SOD and GSHpx activities, GSH content, the proliferative response and IL-2 production of splenocytes induced by ConA. Treatment with sesamin significantly decreased hepatic MDA content, the levels of macrophage proliferative response and IL-1 and NO production. In conclusion, sesamin has anti-aging effect on D-gal induced senescent mice, which might be related to its improvement of brain function, antioxidative activity and immunomodulatory effects.
C1 [Lei Hong; Cai Liangliang; Wang Yi; Han Juncheng; Wang Qin; Zhang Xiaoxiang] Hefei Univ Technol, Sch Biol & Food Engn, Hefei 230009, Anhui, Peoples R China.
C3 Hefei University of Technology
RP Lei, H (corresponding author), Hefei Univ Technol, Sch Biol & Food Engn, Tunxi Rd 193, Hefei 230009, Anhui, Peoples R China.
EM leihong56@163.com
CR [Anonymous], 1990, CHINESE J PHARM TOXI
   Ashakumary L, 1999, METABOLISM, V48, P1303, DOI 10.1016/S0026-0495(99)90272-X
   [卞红磊 BIAN Hong-lei], 2008, [中国现代医学杂志, China Journal of Modern Medicine], V18, P3411
   Dong Ying, 2007, Food Science, China, V28, P44
   Duan Z. F., 1993, CHIN J GERIATR, V12, P165
   Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2
   HIROSE N, 1991, J LIPID RES, V32, P629
   HIROSE N, 1992, ANTICANCER RES, V12, P1259
   Hrabák A, 2006, IMMUNOL LETT, V107, P169, DOI 10.1016/j.imlet.2006.09.006
   Ide T, 2001, BBA-MOL CELL BIOL L, V1534, P1, DOI 10.1016/S1388-1981(01)00167-6
   [金 Jin Qingzhe], 2005, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V20, P89
   Kanu PJ, 2007, TRENDS FOOD SCI TECH, V18, P599, DOI 10.1016/j.tifs.2007.06.002
   Kurushima Hirotada, 2000, Mycoscience, V41, P473, DOI 10.1007/BF02461667
   Lei H, 2003, ACTA PHARMACOL SIN, V24, P230
   Matsumura Y, 1998, BIOL PHARM BULL, V21, P469, DOI 10.1248/bpb.21.469
   Miller R. A., 1991, CELL IMMUNOL, V124, P187
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   Song I.K., 2007, ENV TOXICOLOGY PHARM, V23
   Tsuruoka N, 2005, BIOSCI BIOTECH BIOCH, V69, P179, DOI 10.1271/bbb.69.179
   Wang S. K., 2002, J SE U MED SCI EDITI, V21, P217
   [汪五三 Wang Wusan], 2006, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V22, P27
   Wei Y.J., 2008, SHANGDONG MED, V48, P25
   Yasuko F., 1983, AGR BIOL CHEM TOKYO, V49, P301
   ZHAN H, 1990, Acta Physiologica Sinica, V42, P503
   Zhou JC, 2010, J FOOD ENG, V100, P289, DOI 10.1016/j.jfoodeng.2010.04.011
NR 25
TC 8
Z9 8
U1 0
U2 9
PU NEW CENTURY HEALTH PUBLISHERS, LLC
PI COPPELL
PA PO BOX 175, COPPELL, TX 75019 USA
SN 1540-7535
J9 CURR TOP NUTRACEUT R
JI Curr. Top. Nutraceutical Res.
PD AUG-NOV
PY 2012
VL 10
IS 3-4
BP 173
EP 178
PG 6
WC Nutrition & Dietetics; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Pharmacology & Pharmacy
GA V31UW
UT WOS:000208909500004
DA 2024-02-19
ER

PT J
AU Gialluisi, A
   Di Castelnuovo, A
   Costanzo, S
   Bonaccio, M
   Persichillo, M
   Magnacca, S
   De Curtis, A
   Cerletti, C
   Donati, MB
   de Gaetano, G
   Capobianco, E
   Iacoviello, L
AF Gialluisi, Alessandro
   Di Castelnuovo, Augusto
   Costanzo, Simona
   Bonaccio, Marialaura
   Persichillo, Mariarosaria
   Magnacca, Sara
   De Curtis, Amalia
   Cerletti, Chiara
   Donati, Maria Benedetta
   de Gaetano, Giovanni
   Capobianco, Enrico
   Iacoviello, Licia
CA Moli-sani Study Investigators
TI Exploring domains, clinical implications and environmental associations
   of a deep learning marker of biological ageing
SO EUROPEAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article; Early Access
DE Biological ageing; Deep neural networks; Blood markers; Mortality;
   Hospitalizations; Quality of life; Lifestyles; Socioeconomic status
ID SF-36 HEALTH SURVEY; MEDITERRANEAN DIET; BRAIN AGE; METAANALYSIS;
   MORTALITY; ADHERENCE; BIOMARKER; EDUCATION; OLDER; RISK
AB Deep Neural Networks (DNN) have been recently developed for the estimation of Biological Age (BA), the hypothetical underlying age of an organism, which can differ from its chronological age (CA). Although promising, these population-specific algorithms warrant further characterization and validation, since their biological, clinical and environmental correlates remain largely unexplored. Here, an accurate DNN was trained to compute BA based on 36 circulating biomarkers in an Italian population (N = 23,858; age >= 35 years; 51.7% women). This estimate was heavily influenced by markers of metabolic, heart, kidney and liver function. The resulting Delta age (BA-CA) significantly predicted mortality and hospitalization risk for all and specific causes. Slowed biological aging (Delta age < 0) was associated with higher physical and mental wellbeing, healthy lifestyles (e.g. adherence to Mediterranean diet) and higher socioeconomic status (educational attainment, household income and occupational status), while accelerated aging (Delta age > 0) was associated with smoking and obesity. Together, lifestyles and socioeconomic variables explained similar to 48% of the total variance in Delta age, potentially suggesting the existence of a genetic basis. These findings validate blood-based biological aging as a marker of public health in adult Italians and provide a robust body of knowledge on its biological architecture, clinical implications and potential environmental influences.
C1 [Gialluisi, Alessandro; Costanzo, Simona; Bonaccio, Marialaura; Persichillo, Mariarosaria; De Curtis, Amalia; Cerletti, Chiara; Donati, Maria Benedetta; de Gaetano, Giovanni; Iacoviello, Licia] IRCCS Neuromed, Dept Epidemiol & Prevent, Via Elettron, I-86077 Pozzilli, Italy.
   [Di Castelnuovo, Augusto; Magnacca, Sara] Mediterranea Cardioctr, Naples, Italy.
   [Capobianco, Enrico] Univ Miami, Inst Data Sci & Comp, Miami, FL USA.
   [Iacoviello, Licia] Univ Insubria, Res Ctr Epidemiol & Prevent Med EPIMED, Dept Med & Surg, Varese, Italy.
C3 IRCCS Neuromed; University of Miami; University of Insubria
RP Gialluisi, A (corresponding author), IRCCS Neuromed, Dept Epidemiol & Prevent, Via Elettron, I-86077 Pozzilli, Italy.
EM alessandro.gialluisi@gmail.com; licia.iacoviello@moli-sani.org
RI Di Castelnuovo, Augusto Filippo/K-5517-2016; Donati, Maria
   Benedetta/K-6606-2016; Iacoviello, Licia/AGX-7071-2022; Iacoviello,
   Licia/K-4676-2016; Cerletti, Chiara/K-6447-2016; Gialluisi,
   Alessandro/K-1195-2018; Costanzo, Simona/K-5076-2016; Di Castelnuovo,
   Augusto Filippo/AAC-2436-2022
OI Di Castelnuovo, Augusto Filippo/0000-0001-9767-7998; Donati, Maria
   Benedetta/0000-0003-1747-5443; Iacoviello, Licia/0000-0003-0514-5885;
   Iacoviello, Licia/0000-0003-0514-5885; Cerletti,
   Chiara/0000-0002-4759-3179; Gialluisi, Alessandro/0000-0002-7388-4463;
   Costanzo, Simona/0000-0003-4569-1186; Di Castelnuovo, Augusto
   Filippo/0000-0001-9767-7998; Bonaccio, Marialaura/0000-0002-8082-6552;
   Persichillo, Mariarosaria/0000-0002-9731-0173; de curtis,
   amalia/0000-0001-5104-0318
FU Italian Ministry of Economic Development (PLATONE project); PON IC
   2014-2020 [F/080032/01-03/X35]; Italian Ministry of Health
   [RF-2018-12367074]; Hypercan Study AIRC "5xMILLE" [12237]; POR FESR
   2014-2020 [459 27/11/2018]; Fondazione Umberto Veronesi; Pfizer
   Foundation (Rome, Italy); Italian Ministry of University and Research
   (MIUR, Rome, Italy)
FX Funders had no role in this study design, collection, analysis, and
   interpretation of data, nor in the writing and submission phase of the
   manuscript. This study was partially supported by the Italian Ministry
   of Economic Development (PLATONE project, bando "Agenda Digitale" PON
   I&C 2014-2020; Prog. n. F/080032/01-03/X35), by the Italian Ministry of
   Health (grant RF-2018-12367074 to GdG and SC); by the Hypercan Study
   AIRC "5xMILLE" (n.12237 to LI); and by POR FESR 2014-2020: DD n. 459
   27/11/2018. SATIN: Sviluppo di Approcci Terapeutici INnovativi per
   patologie neoplastiche resistenti ai trattamenti). AG, MB and SC were
   supported by Fondazione Umberto Veronesi. The Moli-sani Study
   Investigators thank the Associazione Cuore Sano Onlus (Campobasso,
   Italy) for its cultural and financial support. The enrolment phase of
   the Moli-sani Study was supported by research grants from Pfizer
   Foundation (Rome, Italy), the Italian Ministry of University and
   Research (MIUR, Rome, Italy) -Programma Triennale di Ricerca, Decreto
   no. 1588 and Instrumentation Laboratory, Milan, Italy.
CR Agnes A, ADAGRAD AN OPTIMIZER
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Biecek P., 2018, J MACH LEARN RES, V19, P1
   Bonaccio M, 2019, J INTERN MED, V286, P207, DOI 10.1111/joim.12907
   Bonaccio M, 2019, J EPIDEMIOL COMMUN H, V73, P516, DOI 10.1136/jech-2018-211582
   Bonaccio M, 2018, BRIT J NUTR, V120, P841, DOI 10.1017/S0007114518002179
   Bonaccio M, 2018, CIRCULATION, V137
   Bonaccio M, 2017, INT J EPIDEMIOL, V46, P1478, DOI 10.1093/ije/dyx145
   Bonaccio M, 2017, INT J PUBLIC HEALTH, V62, P551, DOI 10.1007/s00038-016-0939-0
   Bonaccio M, 2016, INT J PUBLIC HEALTH, V61, P765, DOI 10.1007/s00038-016-0822-z
   Bonaccio M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003003
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Chen MY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38238-3
   Christensen Kaare, 2009, BMJ, V339, pb5262
   Cole JH, 2018, MOL PSYCHIATR, V23, P1385, DOI 10.1038/mp.2017.62
   Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001
   Cole JH, 2017, NEUROIMAGE, V163, P115, DOI 10.1016/j.neuroimage.2017.07.059
   Costanzo S, 2019, ADDICTION, V114, P636, DOI 10.1111/add.14490
   Crocker TF, 2019, QUAL LIFE RES, V28, P2041, DOI 10.1007/s11136-019-02149-1
   Crotti G, 2018, IMMUNOL INVEST, V47, P774, DOI 10.1080/08820139.2018.1538237
   D'Innocenzo S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061306
   de Lucia C, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0844-1
   Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437
   Di Castelnuovo A, 2019, STROKE, V50, P610, DOI 10.1161/STROKEAHA.118.023218
   Di Castelnuovo A, 2012, EUR J PREV CARDIOL, V19, P723, DOI 10.1177/1741826711410820
   Fiorito G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16391-5
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gensous N, 2020, GEROSCIENCE, V42, P687, DOI 10.1007/s11357-019-00149-0
   Gialluisi A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00146
   Hägg S, 2020, EJSO-EUR J SURG ONC, V46, P316, DOI 10.1016/j.ejso.2019.11.003
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huan TX, 2018, AGING CELL, V17, DOI 10.1111/acel.12687
   Hughes A, 2018, AM J EPIDEMIOL, V187, P2346, DOI 10.1093/aje/kwy155
   Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248
   Jonsson BA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13163-9
   Joshi PK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00934-5
   Kaufmann T, 2019, NAT NEUROSCI, V22, P1617, DOI 10.1038/s41593-019-0471-7
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004
   Kowarik A, 2016, J STAT SOFTW, V74, DOI 10.18637/jss.v074.i07
   Kresovich JK, 2019, JNCI-J NATL CANCER I, V111, P1051, DOI 10.1093/jnci/djz020
   Kresovich JK, 2019, AM J EPIDEMIOL, V188, P487, DOI 10.1093/aje/kwy246
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Liu Zuyun, 2018, PLoS Med, V15, pe1002718, DOI 10.1371/journal.pmed.1002718
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Mamoshina P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35704-w
   Mamoshina P, 2018, J GERONTOL A-BIOL, V73, P1482, DOI 10.1093/gerona/gly005
   Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6
   Myint PK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1214
   Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968
   Pyrkov TV, 2019, BIOL AGE IS UNIVERSA, DOI [10.1101/578245v1.full, DOI 10.1101/578245V1.FULL]
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Ripley W.N., 2002, MODERN APPL STAT S, VFourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]
   Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010
   Sarnak MJ, 2008, ARCH INTERN MED, V168, P147, DOI 10.1001/archinternmed.2007.40
   Song MY, 2020, LANCET GASTROENTEROL, V5, P537, DOI 10.1016/S2468-1253(20)30009-1
   Steffener J, 2016, NEUROBIOL AGING, V40, P138, DOI 10.1016/j.neurobiolaging.2016.01.014
   Stephan Y, 2016, HEALTH PSYCHOL, V35, P634, DOI 10.1037/hea0000335
   Team RC, 2020, R: A Language and Environment for Statistical
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
   Waziry R, 2019, EUR J EPIDEMIOL, V34, P793, DOI 10.1007/s10654-019-00497-3
   Wood T., 2019, F1000RESEARCH, V8, P1
   Woolcott OO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29362-1
   Yamaguchi K, 2012, RESP PHYSIOL NEUROBI, V183, P108, DOI 10.1016/j.resp.2012.06.025
   Zenin A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0290-0
NR 68
TC 11
Z9 12
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0393-2990
EI 1573-7284
J9 EUR J EPIDEMIOL
JI Eur. J. Epidemiol.
PD 2022 JAN
PY 2022
VL 37
IS 1
BP 35
EP 48
DI 10.1007/s10654-021-00797-7
EA AUG 2021
PG 14
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA YN3GP
UT WOS:000690711600002
PM 34453631
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Li, YJ
   Liang, JR
   Yang, T
   Mena, JM
   Huan, CJ
   Xie, T
   Kurkciyan, A
   Liu, NS
   Jiang, DH
   Noble, PW
AF Li, Yuejuan
   Liang, Jiurong
   Yang, Ting
   Mena, Jessica Monterrosa
   Huan, Caijuan
   Xie, Ting
   Kurkciyan, Adrienne
   Liu, Ningshan
   Jiang, Dianhua
   Noble, Paul W.
TI Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary
   fibrosis
SO MATRIX BIOLOGY
LA English
DT Article
DE Fibrosis; Lung fibrosis; Fibrosis resolution; Cell cycle; Senescence;
   Matrix
ID HUMAN LUNG FIBROBLASTS; CELLULAR SENESCENCE; INDUCED APOPTOSIS; LIVER
   FIBROSIS; EPITHELIAL-CELLS; BREAST-CANCER; TGF-BETA; CD44; EXPRESSION;
   PHENOTYPE
AB Dysregulated repair of lung injury often results in lung fibrosis characterized by unremitting deposition of matrix components including glycosaminoglycan hyaluronan (HA). HA is mainly produced by hyaluronan synthases (HAS) in mesenchymal cells. We previously demonstrated that over-expression of HAS2 in mesenchymal cells in mice regulates the invasiveness of fibroblasts and promotes severe lung fibrosis. The mechanisms that control the resolution of lung fibrosis are unknown. We propose that a critical step in resolving fibrosis is the induction of senescence in fibrotic fibroblasts and hyaluronan synthase 2 may regulate this process. We found that fibrotic fibroblasts developed the characteristics of replicative senescence in culture and that HAS2 expression was dramatically down-regulated. Furthermore, down-regulation of HAS2 initiated and regulated fibroblast senescence through a p27-CDK2-SKP2 pathway. Deletion of HAS2 in mouse mesenchymal cells increased the cellular senescence of fibroblasts in bleomycin-induced mouse lung fibrosis in vivo. These data suggest that HAS2 may be a critical regulator of the fate of pulmonary fibrosis and we propose a model where over-expression of HAS2 promotes an invasive phenotype resulting in severe fibrosis and down-regulation of HAS2 promotes resolution. Targeting HAS2 to induce fibroblast senescence could be an attractive approach to resolve tissue fibrosis. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Li, Yuejuan; Yang, Ting] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA.
   [Li, Yuejuan] JOINN Labs Inc, Dept Pharmacol, Suzhou 215421, Peoples R China.
   [Liang, Jiurong; Mena, Jessica Monterrosa; Huan, Caijuan; Xie, Ting; Kurkciyan, Adrienne; Liu, Ningshan; Jiang, Dianhua; Noble, Paul W.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.
   [Yang, Ting] China Japan Friendship Hosp, Dept Resp Med, Beijing 100013, Peoples R China.
   [Huan, Caijuan] Zhejiang Univ, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310006, Zhejiang, Peoples R China.
C3 Duke University; Cedars Sinai Medical Center; China-Japan Friendship
   Hospital; Zhejiang University
RP Noble, PW (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.
EM paul.noble@cshs.org
RI Xie, Ting/I-9538-2019; Liang, Carol Jiurong/AAI-4963-2021; Jiang,
   Dianhua/B-1421-2009
OI Xie, Ting/0000-0002-9958-3888; Jiang, Dianhua/0000-0002-4508-3829;
   Monterrosa, Jessica/0000-0002-3315-4431; Liang,
   Jiurong/0000-0001-5179-5016
FU National Institutes of Health [AI052201, HL060539, P01 HL108793,
   HL122068]; CIRM [RB5-07302]
FX This study was supported by the National Institutes of Health grants
   AI052201, HL060539, and P01 HL108793 (to P.W.N.), and HL122068 (to
   D.J.), and a grant from CIRM (RB5-07302 to P.W.N.).
CR Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
   Aoshiba K, 2003, EUR RESPIR J, V22, P436, DOI 10.1183/09031936.03.00011903
   Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012
   Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157
   BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126
   Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010
   Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645
   Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b
   Costa ET, 2008, CANCER RES, V68, P6215, DOI 10.1158/0008-5472.CAN-08-0342
   Debidda M, 2006, J BIOL CHEM, V281, P38519, DOI 10.1074/jbc.M604607200
   Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001
   Frankel SK, 2006, AM J RESP CELL MOL, V34, P293, DOI 10.1165/rcmb.2005-0155OC
   Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Henke C, 1996, AM J PATHOL, V149, P1639
   Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC
   Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801
   Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009
   Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuroda Y, 2013, BIOMED RES-TOKYO, V34, P97, DOI 10.2220/biomedres.34.97
   Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507
   Lompardía SL, 2013, GLYCOBIOLOGY, V23, P1463, DOI 10.1093/glycob/cwt074
   Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757
   Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102
   Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550
   Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Lowe D, 2014, AGING CELL, V13, P900, DOI 10.1111/acel.12253
   Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015
   Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200
   Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010
   Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181
   Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531
   Mun GI, 2010, AM J PHYSIOL-HEART C, V298, pH2102, DOI 10.1152/ajpheart.00835.2009
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Noble PW, 2006, CLIN CHEST MED, V27, pS11, DOI 10.1016/j.ccm.2005.08.003
   POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X
   Reed MJ, 2013, MATRIX BIOL, V32, P45, DOI 10.1016/j.matbio.2012.09.004
   Röck K, 2015, J INVEST DERMATOL, V135, P369, DOI 10.1038/jid.2014.422
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802
   Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045
   Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X
   Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622
   Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945
   Wynes MW, 2011, J IMMUNOL, V187, P527, DOI 10.4049/jimmunol.1100447
   Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC
   Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720
NR 62
TC 63
Z9 67
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD SEP
PY 2016
VL 55
BP 35
EP 48
DI 10.1016/j.matbio.2016.03.004
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA EA8CF
UT WOS:000386862200003
PM 26987798
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Chiba, T
   Zheng, YW
   Kita, K
   Yokosuka, O
   Saisho, H
   Onoidera, M
   Miyoshi, H
   Nakano, M
   Zen, Y
   Nakanuma, Y
   Nakauchi, H
   Iwama, A
   Taniguchi, H
AF Chiba, Tetsuhiro
   Zheng, Yun-Wen
   Kita, Kaoru
   Yokosuka, Osamu
   Saisho, Hiromitsu
   Onoidera, Masafumi
   Miyoshi, Hiroyuki
   Nakano, Masayuki
   Zen, Yoh
   Nakanuma, Yasuni
   Nakauchi, Hiromitsu
   Iwama, Atsushi
   Taniguchi, Hideki
TI Enhanced self-renewal capability in hepatic stem/progenitor cells drives
   cancer initiation
SO GASTROENTEROLOGY
LA English
DT Article
ID EMBRYONIC LIVER CULTURES; HEMATOPOIETIC STEM-CELLS; BETA-CATENIN;
   HEPATOCELLULAR CARCINOMAS; PROGENITOR CELLS; GROWTH; BMI-1;
   IDENTIFICATION; SENESCENCE; GENE
AB Background& Aims: Transformed hematopoietic stem/progenitor cells with an enhanced or acquired self-renewal capability function as leukemic stem cells. In a variety of solid cancers, stem/progenitor cells could be also targets of carcinogenesis. However, it remains unclear whether disruption of stem cell function directly contributes to cancer initiation. We sought to elucidate the mechanisms of selfrenewal in hepatic stem/progenitor cells and the relation between stem cell function and hepatocarcinogenesis. Methods: Functional analyses of polycomb-group protein Bmil and Wnt/beta-catenin, the molecules that are responsible for the self-renewal capability of many types of stem cells, were conducted in c-Kit- CD29(+) CD49f(+)/(low)CD45 -Ter- 119- hepatic stem/ progenitor cells using retrovirus- or lentivirus-mediated gene transfer. The tumorigenicity of these cells transduced with the indicated retroviruses was also assessed by transplantation into nonobese diabetic/ severe combined immunodeficient mice. Results: Forced expression of Bmil and constitutively active beta-catenin mutant similarly promoted the self-renewal of hepatic stem/progenitor cells. The transplantation of Bmi1- or P-catenin-transduced cells clonally expanded froiii single hepatic stem/progenitor cells produced tumors, which exhibited the histologic features of combined hepatocellular and cholangiocarcinoma. Conclusions: These observations imply that the dysregulated self-renewal of hepatic stem/progenitor cells serves as an early event in hepatocarcinogenesis, and they highlight the important roles of Bmil and the Wnt/beta-catenin pathway in regulating the seff-renewal of normal or cancer stem cells in liver.
C1 Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 236, Japan.
   Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan.
   Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan.
   Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Clin & Expt Hematol Major Adv Biomed Applicat, Tsukuba, Ibaraki 305, Japan.
   RIKEN, BioResource Ctr, Tsukuba Inst, Tsukuba, Ibaraki, Japan.
   Natl Hosp Org, Med Ctr, Div Lab Investigat, Chiba, Japan.
   Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 920, Japan.
   Univ Tokyo, Ctr Med Expt, Inst Med Sci, Tokyo, Japan.
   RIKEN, Ctr Dev Biol, Inst Phys & Chem Res, Res Inst Organ Regenerat, Kobe, Hyogo, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan.
C3 Yokohama City University; Chiba University; University of Tsukuba;
   RIKEN; Kanazawa University; University of Tokyo; RIKEN; National
   Institute for Materials Science
RP Taniguchi, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 236, Japan.
EM rtanigu@med.yokohama-cu.ac.jp
RI Miyoshi, Hiroyuki/G-9808-2013; Zheng, Yun-Wen/R-2874-2019
OI Zheng, Yun-Wen/0000-0001-9002-3190
CR Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947
   Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100
   BELLUSCI S, 1994, ONCOGENE, V9, P1091
   Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3
   Cadoret A, 2001, CANCER RES, V61, P3245
   Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136
   Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590
   Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435
   GILES RH, 2001, BIOCHIM BIOPHYS ACTA, V1653, P1
   GOYETTE M, 1990, CANCER RES, V50, P4809
   Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   Huang CS, 1996, MOL CELL BIOL, V16, P6427
   Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020
   Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004
   Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476
   Jamieson CHM, 2004, CANCER CELL, V6, P531, DOI 10.1016/j.ccr.2004.12.005
   Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217
   Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0
   Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541
   Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377
   Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385
   Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000
   Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786
   Neo SY, 2004, HEPATOLOGY, V39, P944, DOI 10.1002/hep.20105
   Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477
   Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319
   Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200
   Sekhon SS, 2004, AM J PATHOL, V164, P2229, DOI 10.1016/S0002-9440(10)63779-0
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349
   Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066
   Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042
   Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591
   Theise ND, 2003, HISTOPATHOLOGY, V43, P263, DOI 10.1046/j.1365-2559.2003.01707.x
   Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153
   Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102
   Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030
   Zheng YW, 2003, SEMIN LIVER DIS, V23, P337
   Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068
NR 51
TC 182
Z9 207
U1 1
U2 27
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD SEP
PY 2007
VL 133
IS 3
BP 937
EP 950
DI 10.1053/j.gastro.2007.06.016
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 208NQ
UT WOS:000249326900027
PM 17673212
OA Bronze
DA 2024-02-19
ER

PT J
AU JENA, BS
   PATNAIK, BK
AF JENA, BS
   PATNAIK, BK
TI AGE-RELATED RESPONSES OF HEPATIC ATPASES TO STARVATION AND COLD STRESS
   IN MALE GARDEN LIZARDS
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE LIZARD; AGING; STARVATION; COLD STRESS; LIVER NA+-K+-ATPASE;
   MG2+-ATPASE; CA2+-ATPASE
ID LIVER PLASMA-MEMBRANES; OXYGEN-CONSUMPTION; BRAIN; RAT; THYROXINE;
   THIOUREA; CORTEX
AB Hepatic Na+-K+-ATPase and Mg2+-ATPase activities of male green lizards declined during the maturation phase (juvenile to I-year-old) and stabilized thereafter. On the other hand, the Ca2+-ATPase activity of the liver declined during the later half of the life span (1-year-old to 2-4-year-old), Starvation stress induced a decline in hepatic Na+-K+-ATPase and Mg2+-ATPase activities of juvenile lizards and caused an increase in 1-year-old and 2-4-year-old counterparts. The Ca2+-ATPase activity declined only in starved 1-year-old lizards, Following cold stress, the hepatic Na+-K+-ATPase activity of juvenile lizards showed a higher degree of decline than 2-4-year-old counterparts. The Mg2+-ATPase activity declined in cold-stressed juvenile lizards, but the parameter was elevated in similarly treated 1-year-old lizards, On the other hand, the increase in Ca2+-ATPase activity in response to cold stress was confined only to 2-4-year-old lizards.
C1 BERHAMPUR UNIV,DEPT ZOOL,BERHAMPUR 760007,ORISSA,INDIA.
C3 Berhampur University
RI Jena, Bhabani Sankar/AAC-2937-2022
CR ALBERTS B, 1989, MOL BIOL CELL, P275
   Asana J. J., 1931, Journal of the Bombay Natural History Society, V34, P1041
   ATTERWILL CK, 1987, TOXICOLOGY, V43, P75, DOI 10.1016/0300-483X(87)90075-8
   CARAFOLI E, 1991, ANNU REV PHYSIOL, V53, P531, DOI 10.1146/annurev.ph.53.030191.002531
   CASTANET J, 1994, GERONTOLOGY, V40, P174, DOI 10.1159/000213586
   DARNELL J, 1986, MOL CELL BIOL, P667
   DAS AB, 1969, INDIAN BIOL, V1, P30
   DAS S, 1993, ARCH GERONTOL GERIAT, V17, P111, DOI 10.1016/0167-4943(93)90043-H
   DURAIRAJ G, 1981, INDIAN J BIOCHEM BIO, V18, P166
   DZHAFAROV AI, 1989, VOP MED KHIM, V35, P51
   EAPEN J, 1972, INDIAN J EXP BIOL, V10, P318
   FINCH CE, 1969, J GEN PHYSIOL, V54, P690, DOI 10.1085/jgp.54.6.690
   FINCH CE, 1990, LONGEVITY SENESCENCE, P4
   FROLKIS VV, 1988, GERONTOLOGY, V34, P64, DOI 10.1159/000212932
   GRANNER DK, 1988, HARPERS BIOCH, P445
   HEGNER D, 1975, MECH AGEING DEV, V4, P191, DOI 10.1016/0047-6374(75)90021-4
   IWASA Y, 1982, BIOCHEM BIOPH RES CO, V105, P448
   JACOBS WR, 1987, LIFE SCI, V40, P1571, DOI 10.1016/0024-3205(87)90122-6
   JENA BS, 1990, GERONTOLOGY, V36, P262
   JENA BS, 1995, IN PRESS ARCH GERONT
   JENA BS, 1991, INDIAN J GERONTOL, V5, P12
   JENA BS, 1992, THESIS BERHAMPUR U O
   KIMELBERG HK, 1972, BIOCHIM BIOPHYS ACTA, V282, P277, DOI 10.1016/0005-2736(72)90334-3
   KOHN RR, 1978, PRINCIPLES MAMMALIAN, P143
   LAGERSPETZ KYH, 1977, J THERM BIOL, V2, P27, DOI 10.1016/0306-4565(77)90007-9
   LEE SL, 1977, CAN J PHYSIOL PHARM, V55, P961, DOI 10.1139/y77-130
   LICHT P, 1964, COMP BIOCHEM PHYSIOL, V12, P331, DOI 10.1016/0010-406X(64)90063-5
   LINDHOLM DB, 1984, DEV BRAIN RES, V15, P83, DOI 10.1016/0165-3806(84)90142-1
   LOTERSZTAJN S, 1981, J BIOL CHEM, V257, P11209
   LOWRY OH, 1946, J BIOL CHEM, V162, P421
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MUNDAY KA, 1961, COMP BIOCHEM PHYSIOL, V2, P8, DOI 10.1016/0010-406X(61)90069-X
   MURPHY E, 1991, ANNU REV PHYSIOL, V53, P273, DOI 10.1146/annurev.ph.53.030191.001421
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   NORRIS DO, 1985, VERTEBRATE ENDOCRINO, P162
   PADHI SN, 1978, GROWTH, V42, P31
   PATNAIK BK, 1981, COMP ANIMAL NUTRITIO, V4, P139
   PATNAIK BK, 1994, EXP GERONTOL, V40, P200
   RAO KL, 1973, EXP GERONTOL, V8, P173, DOI 10.1016/0531-5565(73)90009-0
   RAWN JD, 1989, BIOCHEMISTRY-US, P237
   SAHU N, 1988, GERONTOLOGY, V34, P179, DOI 10.1159/000212949
   SAHU N, 1989, ARCH GERONTOL GERIAT, V8, P55, DOI 10.1016/0167-4943(89)90070-8
   SALAS M, 1978, EXP GERONTOL, V13, P213, DOI 10.1016/0531-5565(78)90015-3
   SCHUURMANS, 1981, PHYSIOL REV, V61, P1
   Selye H., 1976, HYPOTHALAMUS PITUITA, P553
   Sun A., 1979, INTERDISCIP TOP GERO, V15, P34, DOI 10.1159/000402896
   SUN AY, 1972, BIOCHIM BIOPHYS ACTA, V266, P350, DOI 10.1016/0005-2736(72)90093-4
   THAPLIYAL JP, 1980, THYROID REPTILES, P1
   UNGER F, 1986, TXB BIOCH CLIN CORRE, P553
   VANPILSUM JF, 1986, TXB BIOCH CLIN CORRE, P807
   VIJAYAKUMAR I, 1980, INDIAN J EXP BIOL, V18, P1465
   WILSON PD, 1972, GERONTOLOGY, V18, P36, DOI 10.1159/000211918
   YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V72, P39
   ZAMAI TN, 1986, VOPR MED KHIM, V31, P137
   ZSNAGY I, 1978, MECH AGEING DEV, V9, P237
NR 55
TC 8
Z9 8
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol B-Biochem. Molec. Biol.
PD AUG
PY 1995
VL 111
IS 4
BP 545
EP 552
DI 10.1016/0305-0491(95)00046-B
PG 8
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA RN896
UT WOS:A1995RN89600004
DA 2024-02-19
ER

PT J
AU Amer, J
   Salhab, A
   Doron, S
   Morali, G
   Safadi, R
AF Amer, Johnny
   Salhab, Ahmad
   Doron, Sarit
   Morali, Gilles
   Safadi, Rifaat
TI A Novel Flow Cytometry Tool for Fibrosis Scoring Through Hepatic
   Stellate Cell Differentiation
SO CYTOMETRY PART A
LA English
DT Article
DE NK cells; hepatic stellate cells; liver fibrosis; flow cytometry
ID LIVER FIBROSIS; FIBROGENESIS; SENESCENCE; STIMULATION; LYMPHOCYTES;
   ACTIVATION; RECEPTORS; MARKER; BETA
AB Hepatic stellate cells (HSCs) are a central fibrogenic cell type that contributes to collagen accumulation during chronic liver disease. Peripheral blood lymphocytes from HCV patients are phagocytized by HSCs and induce their differentiation. This study aimed to characterize HSCs differentiation using a flow cytometry tool for fibrosis scoring. NK cells from healthy donors and from patients with chronic HCV with various severities of fibrosis were co-cultured with a human HSC line (LX2). LX2 phagocytosis of NK cells were stained for NK cells (CD45/CD56/CD3) and NK activation marker (CD107a) as well as INF-gamma, apoptosis (Annexin-V) and alpha-smooth-muscle-actin (alpha SMA, as a marker of LX2 activation). In addition, reactive oxygen species (ROS) and the senescence marker P15 were analyzed prior to flow cytometry analysis. LX2 mono-cultures demonstrated a homogenous cell-population according to size (forward-scattered; FSC), granularity and alpha SMA expressions. However, on their co-culture with NK cells, the HSCs formed four subpopulations, which were stratified by alpha SMA intensities and cell size. NK cells isolated from heathy donors did not activate LX2-cells. In contrast, HCVexposed to NK cells from both F1 and F4 fibrosis grade patients, showed elevated CD107a and INF-gamma levels and increased alpha SMA intensities in two of the four cell populations, with fibrosis scoring showing a linear correlation with aSMA intensities and NK phagocytosis. The alpha SMA(intermediate)/Size(Low) HSCs sub-population showed higher proliferation following F4-NK cells with higher phagocytosis ability, suggesting an active/regulatory population. The alpha SMA(high)/Size(high) subpopulations showed low proliferation and phagocytosis capacity, and were correlated with higher apoptosis, increased ROS and P15 intensities, suggesting senescing cells. Taken together, NK cells lead to heterogeneous differentiation of HSCs. Flow-cytometry may provide a novel means of characterizing HSCs in relation to the severity of liver fibrosis. (C) 2018 International Society for Advancement of Cytometry
C1 [Amer, Johnny] Hadassah Univ, Med Ctr, Liver Unit, POB 12000, IL-91120 Jerusalem, Israel.
   [Amer, Johnny] Hadassah Univ, Med Ctr, Gastroenterol Unit, POB 12000, IL-91120 Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Hebrew University of Jerusalem; Hadassah University Medical Center
RP Amer, J (corresponding author), Hadassah Univ, Med Ctr, Liver Unit, POB 12000, IL-91120 Jerusalem, Israel.; Amer, J (corresponding author), Hadassah Univ, Med Ctr, Gastroenterol Unit, POB 12000, IL-91120 Jerusalem, Israel.
EM johnnyamer@hotmail.com
CR Abu-Tair L, 2013, MITOCHONDRION, V13, P473, DOI 10.1016/j.mito.2012.10.012
   Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436
   Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317
   Cubero FJ, 2016, HEPATOLOGY, V63, P1086, DOI 10.1002/hep.28442
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Ghazwani M, 2014, PHYTOMEDICINE, V21, P254, DOI 10.1016/j.phymed.2013.09.014
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014
   Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043
   MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x
   Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413
   Panebianco C, 2017, CLIN EXP MED, V17, P269, DOI 10.1007/s10238-016-0438-x
   Panth N., 2016, ADV MED, V2016, DOI 10.1155/2016/9152732
   Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Richter K, 2016, CELL TISSUE RES, V365, P591, DOI 10.1007/s00441-016-2445-3
   Robert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153118
   Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Tu T, 2015, J GASTROEN HEPATOL, V30, P1696, DOI 10.1111/jgh.13065
   Viñas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
NR 27
TC 4
Z9 5
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4922
EI 1552-4930
J9 CYTOM PART A
JI Cytom. Part A
PD APR
PY 2018
VL 93A
IS 4
BP 427
EP 435
DI 10.1002/cyto.a.23202
PG 9
WC Biochemical Research Methods; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA GE0PC
UT WOS:000430916400008
PM 29517852
OA Bronze
DA 2024-02-19
ER

PT J
AU Nakano, M
   Nakashima, A
   Nagano, T
   Ishikawa, S
   Kikkawa, U
   Kamada, S
AF Nakano, Masayuki
   Nakashima, Akio
   Nagano, Taiki
   Ishikawa, Shintaro
   Kikkawa, Ushio
   Kamada, Shinji
TI Branched-Chain Amino Acids Enhance Premature Senescence through
   Mammalian Target of Rapamycin Complex I-Mediated Upregulation of p21
   Protein
SO PLOS ONE
LA English
DT Article
ID P53-DEPENDENT CELLULAR SENESCENCE; P70 S6 KINASE; HUMAN FIBROBLASTS;
   DNA-DAMAGE; TELOMERASE ACTIVITY; LIVER-CIRRHOSIS; HUMAN CANCER; G(1)
   ARREST; CELLS; VIVO
AB Branched-chain amino acids (BCAAs) have been applied as an oral supplementation to patients with liver cirrhosis. BCAAs not only improve nutritional status of patients but also decrease the incidence of liver cancer. Mammalian target of rapamycin (mTOR) links cellular metabolism with growth and proliferation in response to nutrients, energy, and growth factors. BCAAs, especially leucine, have been shown to regulate protein synthesis through mTOR activities. On the other hand, cellular senescence is suggested to function as tumor suppressor mechanisms, and induced by a variety of stimuli including DNA damage-inducing drugs. However, it is not clear how BCAA supplementation prevents the incidence of liver cancer in patients with cirrhosis. Here we showed that human cancer cells, HepG2 and U2OS, cultured in medium containing BCAAs with Fischer's ratio about 3, which was shown to have highest activities to synthesize and secrete of albumin, had higher activities to induce premature senescence and elevate mTORC1 activities. Furthermore, BCAAs themselves enhanced the execution of premature senescence induced by DNA damage-inducing drugs, which was effectively prevented by rapamycin. These results strongly suggested the contribution of the mTORC1 pathway to the regulation of premature senescence. Interestingly, the protein levels of p21, a p53 target and well-known gene essential for the execution of cellular senescence, were upregulated in the presence of BCAAs. These results suggested that BCAAs possibly contribute to tumor suppression by enhancing cellular senescence mediated through the mTOR signalling pathway.
C1 [Nakano, Masayuki; Nakashima, Akio; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan.
   [Nakano, Masayuki; Nagano, Taiki; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.
   [Ishikawa, Shintaro] Otsuka Pharmaceut Co Ltd, Minato Ku, Tokyo, Japan.
C3 Kobe University; Kobe University; Otsuka Pharmaceutical
RP Kamada, S (corresponding author), Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan.
EM skamada@kobe-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Japan Society for the Promotion of Science
FX This work was supported in part by Grant-in-Aid for Scientific Research
   on Priority Areas of the Ministry of Education, Culture, Sports, Science
   and Technology of Japan, and by Grant-in-Aid for Scientific Research (B)
   of Japan Society for the Promotion of Science. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anthony JC, 2000, J NUTR, V130, P2413
   Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026
   FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9
   González-Suárez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619
   Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941
   Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hasegawa J, 1996, CANCER RES, V56, P1713
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002
   Marchesini G, 2005, J NUTR, V135, p1596S, DOI 10.1093/jn/135.6.1596S
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   MCCULLOUGH AJ, 1981, GASTROENTEROLOGY, V81, P645
   Medcalf ASC, 1996, CANCER RES, V56, P4582
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0
   Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007
   OKUNO M, 1995, BIOCHEM BIOPH RES CO, V214, P1045, DOI 10.1006/bbrc.1995.2391
   Pópulo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886
   Roninson IB, 2003, CANCER RES, V63, P2705
   Shigemitsu K, 1999, FEBS LETT, V447, P303, DOI 10.1016/S0014-5793(99)00304-X
   te Poele RH, 2002, CANCER RES, V62, P1876
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   YOSHIDA T, 1989, Gastroenterologia Japonica, V24, P692
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 45
TC 30
Z9 33
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2013
VL 8
IS 11
AR e80411
DI 10.1371/journal.pone.0080411
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 247XD
UT WOS:000326656200119
PM 24223226
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Gitto, S
   Magistri, P
   Marzi, L
   Mannelli, N
   De Maria, N
   Mega, A
   Vitale, G
   Valente, G
   Vizzutti, F
   Villa, E
   Marra, F
   Andreone, P
   Falcini, M
   Catellani, B
   Guerrini, GP
   Serra, V
   Di Sandro, S
   Ballarin, R
   Piai, G
   Schepis, F
   Margotti, M
   Cursaro, C
   De Simone, P
   Petruccelli, S
   Carrai, P
   Forte, P
   Campani, C
   Zoller, H
   Di Benedetto, F
AF Gitto, Stefano
   Magistri, Paolo
   Marzi, Luca
   Mannelli, Nicolo
   De Maria, Nicola
   Mega, Andrea
   Vitale, Giovanni
   Valente, Giovanna
   Vizzutti, Francesco
   Villa, Erica
   Marra, Fabio
   Andreone, Pietro
   Falcini, Margherita
   Catellani, Barbara
   Guerrini, Gian Piero
   Serra, Valentina
   Di Sandro, Stefano
   Ballarin, Roberto
   Piai, Guido
   Schepis, Filippo
   Margotti, Marzia
   Cursaro, Carmela
   De Simone, Paolo
   Petruccelli, Stefania
   Carrai, Paola
   Forte, Paolo
   Campani, Claudia
   Zoller, Heinz
   Di Benedetto, Fabrizio
CA MEDITRA Grp
TI Predictors of solid extra-hepatic non-skin cancer in liver transplant
   recipients and analysis of survival: A long-term follow-up study
SO ANNALS OF HEPATOLOGY
LA English
DT Article; Early Access
DE Liver transplant; Cancer; Aging; Diabetes; Metabolic syndrome
ID DE-NOVO MALIGNANCIES; RISK-FACTORS; EPIDEMIOLOGY; IMMUNOSUPPRESSION;
   DISEASE
AB Introduction and objectives: De novo malignancies represent an important cause of death for liver transplant recipients. Our aim was to analyze predictors of extra-hepatic non-skin cancer (ESNSC) and the impact of ESNSC on the long-term outcome.
   Patients: We examined data from patients transplanted between 2000 and 2005 and followed-up in five Italian transplant clinics with a retrospective observational cohort study. Cox Regression was performed to identify predictors of ESNSC. A 1:2 cohort sub-study was developed to analyze the impact of ESNSC on 10-year survival.
   Results: We analyzed data from 367 subjects (median follow-up: 15 years). Patients with ESNSC (n = 47) more often developed post-LT diabetes mellitus (DM) (57.4% versus 35,9%, p = 0.004). At multivariate analysis, post-LT DM independently predicted ESNSC (HR 1.929, CI 1.029-3.616, p = 0.040). Recipients with ESNSC showed a lower 10-year survival than matched controls (46,8% versus 68,1%, p = 0.023).
   Conclusions: Post-LT DM seems to be a relevant risk factor for post-LT ESNSC. ESNSC could have a noteworthy impact on the long-term survival of LT recipients. (C) 2022 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.
C1 [Gitto, Stefano; Mannelli, Nicolo; Vizzutti, Francesco; Marra, Fabio; Falcini, Margherita] Univ Florence, Univ Hosp Careggi, Dept Expt & Clin Med, Internal Med & Liver Unit, Largo Brambilla 3, I-50134 Florence, Italy.
   [Magistri, Paolo; De Maria, Nicola; Catellani, Barbara; Guerrini, Gian Piero; Serra, Valentina; Di Sandro, Stefano; Ballarin, Roberto; Di Benedetto, Fabrizio] Univ Modena & Reggio Emilia, Hepatopancreatobiliary Surg & Liver Transplantat, Modena, Italy.
   [Marzi, Luca; Mega, Andrea; Piai, Guido] Bolzano Reg Hosp, Div Gastroenterol, Bolzano, Italy.
   [Vitale, Giovanni] IRCCS Azienda Osped Univ Bologna, Bologna, Italy.
   [Valente, Giovanna] AORN SantAnna & San Sebastiano, Liver Unit Transplant Management SATTE, Dept Med Sci, Caserta, Italy.
   [Villa, Erica; Schepis, Filippo] Azienda Osped Univ Modena, Dept Gastroenterol, Modena, Italy.
   [Villa, Erica; Andreone, Pietro; Schepis, Filippo; Margotti, Marzia; Cursaro, Carmela] Univ Modena & Reggio Emilia, Modena, Italy.
   [Andreone, Pietro] Univ Bologna, Dept Med & Surg Sci, SantOrsola Malpighi Hosp, Bologna, Italy.
   [Andreone, Pietro; Margotti, Marzia; Cursaro, Carmela] AOU Modena, Internal & Metab Med, Modena, Italy.
   [De Simone, Paolo; Petruccelli, Stefania; Carrai, Paola] Univ Pisa, Hepatobiliary Surg & Liver Transplantat, Med Sch Hosp, Pisa, Italy.
   [Forte, Paolo; Campani, Claudia] Univ Hosp Careggi, Gastroenterol Unit, Florence, Italy.
   [Zoller, Heinz] Med Univ Innsbruck, Dept Med 1, Innsbruck, Austria.
C3 University of Florence; Azienda Ospedaliero Universitaria Careggi;
   Universita di Modena e Reggio Emilia; Krankenhaus Bozen; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; Universita di Modena e Reggio
   Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di
   Modena e Reggio Emilia; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna; University of Bologna; University of Pisa; University of
   Florence; Azienda Ospedaliero Universitaria Careggi; Medical University
   of Innsbruck
RP Gitto, S (corresponding author), Univ Florence, Univ Hosp Careggi, Dept Expt & Clin Med, Internal Med & Liver Unit, Largo Brambilla 3, I-50134 Florence, Italy.
EM stefano.gitto@unifi.it
RI Guerrini, Gian Piero/Q-1565-2016; Marzi, Luca/GOK-1257-2022; Andreone,
   Pietro/K-8050-2016; Campani, Claudia/AAC-4021-2022; Vitale,
   Giovanni/AAP-9000-2020; Vitale, Giovanni/K-6322-2016; Mega,
   Andrea/GLS-8971-2022; Gitto, Stefano/J-9922-2018; De Simone,
   Paolo/AAC-7412-2022; Villa, Erica/A-7576-2012; Magistri,
   Paolo/C-4425-2016
OI Guerrini, Gian Piero/0000-0001-5414-9335; Marzi,
   Luca/0000-0001-8239-395X; Andreone, Pietro/0000-0002-4794-9809; Campani,
   Claudia/0000-0003-3842-782X; Vitale, Giovanni/0000-0003-2603-8245;
   Vitale, Giovanni/0000-0003-2603-8245; Gitto,
   Stefano/0000-0002-8042-6508; De Simone, Paolo/0000-0001-6713-6170; Di
   Sandro, Stefano/0000-0002-5217-8885; Villa, Erica/0000-0001-6388-7022;
   Magistri, Paolo/0000-0001-8326-069X; Mega, Andrea/0000-0002-0458-3763;
   carrai, paola/0000-0002-8117-8796; Piai, Guido/0000-0001-8072-150X
CR Åberg F, 2015, HEPATOLOGY, V61, P668, DOI 10.1002/hep.27538
   Acuna SA, 2017, AM J TRANSPLANT, V17, P103, DOI 10.1111/ajt.13978
   Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba
   Burra P, 2015, WORLD J GASTROENTERO, V21, P8753, DOI 10.3748/wjg.v21.i29.8753
   Carenco C, 2015, AM J TRANSPLANT, V15, P678, DOI 10.1111/ajt.13018
   Chapman JR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015677
   de Carvalho L, 2010, J GASTROEN HEPATOL, V25, P391, DOI 10.1111/j.1440-1746.2009.06033.x
   Desai S, 2010, LIVER INT, V30, P948, DOI 10.1111/j.1478-3231.2010.02274.x
   Dharia A, 2022, TRANSPLANTATION, V106, pE64, DOI 10.1097/TP.0000000000003773
   Dureja P, 2011, TRANSPLANTATION, V91, P684, DOI 10.1097/TP.0b013e31820b6b84
   Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592
   European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006
   Gitto S, 2020, EUR J INTERN MED, V79, P70, DOI 10.1016/j.ejim.2020.05.041
   Gitto S, 2020, KOREAN J INTERN MED, V35, P797, DOI 10.3904/kjim.2019.409
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Habib Samy L, 2013, ISRN Oncol, V2013, P583786, DOI 10.1155/2013/583786
   Herrero JI, 2005, LIVER TRANSPLANT, V11, P89, DOI 10.1002/lt.20319
   Holdaas H, 2016, J TRANSPLANT, V2016, DOI 10.1155/2016/4369574
   Jadlowiec CC, 2016, WORLD J GASTROENTERO, V22, P4438, DOI 10.3748/wjg.v22.i18.4438
   Kotha Sreelakshmi, 2021, World J Transplant, V11, P432, DOI 10.5500/wjt.v11.i10.432
   Madhwal S, 2012, LIVER TRANSPLANT, V18, P1140, DOI 10.1002/lt.23508
   Manzia TM, 2019, WORLD J GASTROENTERO, V25, P5356, DOI 10.3748/wjg.v25.i35.5356
   Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972
   Merchea A, 2019, J ONCOL, V2019, DOI 10.1155/2019/5796108
   Miao Y, 2009, TRANSPLANTATION, V87, P1347, DOI 10.1097/TP.0b013e3181a238f6
   Na R, 2013, AM J TRANSPLANT, V13, P1296, DOI 10.1111/ajt.12192
   Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648
   Piselli P, 2014, BEST PRACT RES CL OB, V28, P1251, DOI 10.1016/j.bpobgyn.2014.08.007
   Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897
   Schrem H, 2013, LIVER TRANSPLANT, V19, P1252, DOI 10.1002/lt.23722
   Seree O, 2018, LIVER TRANSPLANT, V24, P1425, DOI 10.1002/lt.25310
   Shalaby S, 2020, BEST PRACT RES CL GA, V46-47, DOI 10.1016/j.bpg.2020.101680
   Sherston SN, 2014, TRANSPLANTATION, V97, P605, DOI 10.1097/01.TP.0000436907.56425.5c
   Taborelli M, 2019, INT J CANCER, V144, P232, DOI 10.1002/ijc.31782
   Vial T, 2003, TOXICOLOGY, V185, P229, DOI 10.1016/S0300-483X(02)00612-1
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120
   Watt KDS, 2009, GASTROENTEROLOGY, V137, P2010, DOI 10.1053/j.gastro.2009.08.070
   Zhou J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155179
NR 38
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1665-2681
J9 ANN HEPATOL
JI Ann. Hepatol.
PD 2022 MAY-JUN
PY 2022
VL 27
IS 3
AR 100683
DI 10.1016/j.aohep.2022.100683
EA MAR 2022
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 3I4VU
UT WOS:000832717300003
PM 35151902
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Walter, R
   Sierra, F
AF Walter, R
   Sierra, F
TI Changes in hepatic DNA binding proteins as a function of age in rats
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID NF-KAPPA-B; PHENOL-CHLOROFORM EXTRACTION; SP1 TRANSCRIPTION FACTORS;
   ANDROGEN RECEPTOR GENE; SINGLE-STEP METHOD; DEPENDENT REGULATION;
   INVITRO TRANSCRIPTION; NEGATIVE REGULATOR; NUCLEAR EXTRACTS; RNA
   ISOLATION
AB The process of aging is accompanied by many changes in gene expression? occurring in virtually all organs of the affected individual. Here we report on the relative changes in DIVA binding activity of a panel of 15 different transcription factors in the liver of adult (15-month-old) and old (25-month-old) Sprague-Dawley rats. When expressed as a function of nuclear protein concentration, a great majority of the transcription factors analyzed do not show significant differences in DNA binding activities as a function of age, except activator protein I (AP-1) and nuclear factor-kappa B, both of which show increased activities in the older animals, and hepatocyte nuclear factor-3, which undergoes a switch from predominantly alpha and beta subspecies in the adults, to predominantly gamma subspecies in the old animals. Further examination of some of the members of the AP-I complex using Western blot analysis indicates that the increase in binding activity of this particular complex might be due to an increase in the relative mass of Jun B, presumably resulting in a switch from predominantly c-Fos/Jun D in the young to c-Fos/Jun B complexes in the old animals. Nuclear extracts prepared from the liver of old animals yield less proteins per mass of DNA than similar extracts prepared from younger animals. Accordingly, if the data are analyzed as a function of genomic DNA, our results indicate that aging results in a consistent, but generally not statistically significant decrease in most transcription factor DNA binding activities, with AP-I, nuclear factor-kappa B, and transcription factor II D being the exception to this decline.
C1 Allegheny Univ Hlth Sci, Gerontol Res Ctr, Philadelphia, PA 19129 USA.
C3 Drexel University
RP Sierra, F (corresponding author), Allegheny Univ Hlth Sci, Gerontol Res Ctr, 2900 Queen Lane, Philadelphia, PA 19129 USA.
EM Sierra@auhs.edu
FU NIA NIH HHS [AG 00532] Funding Source: Medline
CR Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66
   AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   AMMENDOLA R, 1994, EUR J BIOCHEM, V225, P483, DOI 10.1111/j.1432-1033.1994.t01-1-00483.x
   [Anonymous], 1989, MOL CLONING LAB MANU
   Boulikas Teni, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P117
   CHATTERJEE B, 1990, BIOCHIM BIOPHYS ACTA, V1034, P162, DOI 10.1016/0304-4165(90)90071-4
   CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   FAWCETT TW, 1994, J BIOL CHEM, V269, P32272
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   GRUDA MC, 1994, ONCOGENE, V9, P2537
   HABY C, 1994, BIOCHEM PHARMACOL, V48, P819, DOI 10.1016/0006-2952(94)90061-2
   HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720
   HARMAN D, 1956, J GERONTOL, V11, P289
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   HEYDARI AR, 1994, EXPERIENTIA, V50, P1092, DOI 10.1007/BF01923466
   HUGHES KA, 1994, NATURE, V367, P64, DOI 10.1038/367064a0
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   JAZWINSKI SM, 1993, GENETICA, V91, P35, DOI 10.1007/BF01435986
   JOHNSON TE, 1993, GENETICA, V91, P65, DOI 10.1007/BF01435988
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   RAY A, 1995, J BIOL CHEM, V270, P29201, DOI 10.1074/jbc.270.49.29201
   RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   RYSECK RP, 1991, ONCOGENE, V6, P533
   SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920
   SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SIERRA F, 1990, MOL BIOL MED, V7, P131
   SIERRA F, 1990, BIOMETHODS LAB GUIDE
   SIERRA F, 1993, EUKARYOTIC GENE TRAN, P125
   SIKORA E, 1992, FEBS LETT, V312, P179, DOI 10.1016/0014-5793(92)80930-F
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Supakar PC, 1996, BIOL SIGNAL, V5, P170
   VELLANOWETH RL, 1994, LAB INVEST, V70, P784
   VLACH J, 1995, VIROLOGY, V208, P753, DOI 10.1006/viro.1995.1207
   WHELAN J, 1990, MOL CELL BIOL, V10, P1564, DOI 10.1128/MCB.10.4.1564
NR 44
TC 11
Z9 12
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 1998
VL 53
IS 2
BP B102
EP B110
DI 10.1093/gerona/53A.2.B102
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA ZB926
UT WOS:000072522200004
PM 9520905
OA Bronze
DA 2024-02-19
ER

PT J
AU Garcia-Contreras, C
   Vazquez-Gomez, M
   Torres-Rovira, L
   Gonzalez, J
   Porrini, E
   Gonzalez-Colaço, M
   Isabel, B
   Astiz, S
   Gonzalez-Bulnes, A
AF Garcia-Contreras, Consolacion
   Vazquez-Gomez, Marta
   Torres-Rovira, Laura
   Gonzalez, Jorge
   Porrini, Esteban
   Gonzalez-Colaco, Magali
   Isabel, Beatriz
   Astiz, Susana
   Gonzalez-Bulnes, Antonio
TI Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia
   and Sarcopenic Obesity
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE animal-model; insulin-resistance; lipotoxicity; obesity; sarcopenia;
   swine
ID FATTY LIVER-DISEASE; BETA-CELL FUNCTION; INSULIN-RESISTANCE;
   NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; CLINICAL-IMPLICATIONS;
   LIPID DEPOSITION; NATIONAL-HEALTH; ANIMAL-MODELS; MEN
AB Sarcopenia and sarcopenic obesity are currently considered major global threats for health and well-being. However, there is a lack of adequate preclinical models for their study. The present trial evaluated the suitability of aged swine by determining changes in adiposity, fatty acids composition, antioxidant status and lipid peroxidation, development of metabolic disturbances and structural changes in tissues and organs. Iberian sows with clinical evidence of aging-related sarcopenia were fed a standard diet fulfilling their maintenance requirements or an obesogenic diet for 100 days. Aging and sarcopenia were related to increased lipid accumulation and cellular dysfunction at both adipose tissue and non-adipose ectopic tissues (liver and pancreas). Obesity concomitant to sarcopenia aggravates the condition by increasing visceral adiposity and causing dyslipidemia, insulin resistance and lipotoxicity in non-adipose tissues. These results support that the Iberian swine model represents certain features of sarcopenia and sarcopenic obesity in humans, paving the way for future research on physiopathology of these conditions and possible therapeutic targets.
C1 [Garcia-Contreras, Consolacion; Torres-Rovira, Laura; Astiz, Susana; Gonzalez-Bulnes, Antonio] SGIT INIA, Comparat Physiol Grp, Madrid 28040, Spain.
   [Vazquez-Gomez, Marta; Isabel, Beatriz; Gonzalez-Bulnes, Antonio] Univ Complutense Madrid, Fac Vet Sci, E-28040 Madrid, Spain.
   [Gonzalez, Jorge] Micros Vet, Campus Vegazana, Leon 24007, Spain.
   [Porrini, Esteban] Univ La Laguna, Inst Biomed Technol ITB, Tenerife 38200, Spain.
   [Gonzalez-Colaco, Magali] Univ Hosp Canary Isl, Cent Unit Clin Res & Clin Assays UCICEC, Tenerife 28010, Spain.
C3 Complutense University of Madrid; Universidad de la Laguna; Universidad
   de la Laguna
RP Gonzalez-Bulnes, A (corresponding author), SGIT INIA, Comparat Physiol Grp, Madrid 28040, Spain.; Gonzalez-Bulnes, A (corresponding author), Univ Complutense Madrid, Fac Vet Sci, E-28040 Madrid, Spain.
EM garcia.consolacion@inia.es; mvgomez@ucm.es; torres.laura@inia.es;
   info@microsvet.com; esteban.l.porrini@gmail.com; magaligch@hotmail.com;
   bisabelr@ucm.es; astiz.susana@inia.es; bulnes@inia.es
RI Astiz, Susana/AAN-8769-2021; Garcia Contreras,
   Consolacion/AAX-2057-2021; Astiz, Susana/ACW-7390-2022; Vázquez-Gómez,
   Marta/L-7054-2014; Garcia-Contreras, Consolacion/GSE-0766-2022;
   González-Colaço Harmand, Magali/Y-3637-2018; Gonzalez-Bulnes,
   Antonio/K-7691-2015
OI Astiz, Susana/0000-0002-9718-0903; Vázquez-Gómez,
   Marta/0000-0002-8916-2086; Garcia-Contreras,
   Consolacion/0000-0003-4624-2585; González-Colaço Harmand,
   Magali/0000-0001-9363-3074; Gonzalez-Bulnes,
   Antonio/0000-0002-0917-4475; Torres-Rovira, Laura/0000-0003-1467-7533;
   Porrini, Esteban/0000-0002-3056-4662
FU program Ramon y Cajal [RYC-2014-16573]; EU COST-Action [BM1308]
FX The authors thank the INIA animal staff for his assistance with animal
   care and P. Cuesta and I. Cano (Department of Research Support,
   Universidad Complutense de Madrid) for statistical analyses. Esteban
   Porrini is aresearcher of the program Ramon y Cajal (RYC-2014-16573).
   Consolacion Garcia-Contreras, Marta Vazquez-Gomez, Laura Torres-Rovira,
   Susana Astiz and Antonio Gonzalez-Bulnes are members of the EU
   COST-Action BM1308 "Sharing Advances on Large Animal Models (SALAAM)".
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Barbero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078424
   Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117
   Batsis JA, 2015, NUTR RES, V35, P1031, DOI 10.1016/j.nutres.2015.09.003
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bollheimer LC, 2012, BIOGERONTOLOGY, V13, P609, DOI 10.1007/s10522-012-9405-4
   Bouchonville MF, 2013, CURR OPIN ENDOCRINOL, V20, P412, DOI 10.1097/01.med.0000433071.11466.7f
   Burton LA, 2010, CLIN INTERV AGING, V5, P217
   Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1
   Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927
   Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533
   Corcoran MP, 2007, AM J CLIN NUTR, V85, P662
   Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003
   Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x
   DESPRES JP, 1994, BAILLIERE CLIN ENDOC, V8, P629, DOI 10.1016/S0950-351X(05)80289-7
   Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
   Flisiak Robert, 1997, Polish Journal of Pathology, V48, P139
   FRIENDSHIP RM, 1986, CAN J VET RES, V50, P205
   GOLDBERG RB, 1981, DIABETES CARE, V4, P561, DOI 10.2337/diacare.4.5.561
   Gonzalez-Bulnes A, 2014, J ENDOCRINOL, V223, pM17, DOI 10.1530/JOE-14-0217
   Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1
   KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663
   Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Koopmans SJ, 2015, EUR J PHARMACOL, V759, P231, DOI 10.1016/j.ejphar.2015.03.044
   Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, pE708, DOI 10.1152/ajpendo.1997.273.4.E708
   Lärstad M, 2002, J CHROMATOGR B, V766, P107, DOI 10.1016/S0378-4347(01)00437-6
   Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Li Yiran, 2015, Biophys Rep, V1, P90
   Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012
   Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359
   Minetto MA, 2016, PM&R, V8, P453, DOI 10.1016/j.pmrj.2015.09.014
   Mlinar B, 2011, CLIN CHEM LAB MED, V49, P1925, DOI 10.1515/CCLM.2011.697
   Morley JE, 2001, NUTRITION, V17, P660, DOI 10.1016/S0899-9007(01)00574-3
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   Noel P, 2016, GUT, V65, P100, DOI 10.1136/gutjnl-2014-308043
   Olivares A, 2009, ANIMAL, V3, P1264, DOI 10.1017/S175173110900487X
   Palus S, 2017, INT J CARDIOL, V238, P19, DOI 10.1016/j.ijcard.2017.03.152
   Poudyal Hemant, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P217
   Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742
   Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020
   Rückert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932
   Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001
   Sankin A., 2016, J KIDNEY, P2
   Sanyal Debmalya, 2015, Indian J Endocrinol Metab, V19, P597, DOI 10.4103/2230-8210.163172
   Segura J, 2014, FOOD CHEM, V145, P821, DOI 10.1016/j.foodchem.2013.08.131
   Temelkova-Kurktschiev T, 2004, EXP CLIN ENDOCR DIAB, V112, P75, DOI 10.1055/s-2004-815753
   Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149
   Torres-Rovira L, 2013, ENDOCR METAB IMMUNE, V13, P143, DOI 10.2174/1871530311313020002
   Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326
   Valenzuela R, 2011, FOOD FUNCT, V2, P644, DOI 10.1039/c1fo10133a
   van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2
   Yin W, 2004, J ENDOCRINOL, V180, P399, DOI 10.1677/joe.0.1800399
NR 58
TC 9
Z9 10
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2018
VL 19
IS 3
AR 823
DI 10.3390/ijms19030823
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GA4OO
UT WOS:000428309800180
PM 29534532
OA Green Accepted, Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Takamatsu, Y
   Hayashi, S
   Kumamoto, H
   Imoto, S
   Tanaka, Y
   Mitsuya, H
   Higashi-Kuwata, N
AF Takamatsu, Yuki
   Hayashi, Sanae
   Kumamoto, Hiroki
   Imoto, Shuhei
   Tanaka, Yasuhito
   Mitsuya, Hiroaki
   Higashi-Kuwata, Nobuyo
TI A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced
   senescence-associated cellular marker perturbation in human hepatocytes
SO VIRUS RESEARCH
LA English
DT Article; Early Access
DE Hepatitis b virus; Nucleoside analogs; Cellular senescence; Human
   hepatocytes; p21CIP1
ID X-PROTEIN; INFECTION; LIVER; CYCLE; DNA; LAMIVUDINE; ANALOGS; TYPE-1;
   AKT
AB Cellular senescence is a cellular state with a broad spectrum of age-related physiological conditions that can be affected by various infectious diseases and treatments. Therapy of hepatitis B virus (HBV) infection with nucleos (t)ide analogs [NA(s)] is well established and benefits many HBV-infected patients, but requires long-term, perhaps lifelong, medication. In addition to the effects of HBV infection, the effects of NA administration on hepatocellular senescence are still unclear. This study investigated how HBV infection and NA treatment in-fluence cellular senescence in human hepatocytes and humanized-liver chimeric mice chronically infected with live HBV. HBV infection upregulates or downregulates multiple cellular markers including senescence-associated 8-galactosidase (SA-8-Gal) activity and cell cycle regulatory proteins (e.g., p21CIP1) expression level in hepato-cellular nuclei and humanized-mice liver. A novel highly potent anti-HBV NA, E-CFCP, per se did not have sig-nificant disturbance on markers evaluated. Besides, E-CFCP treatment restored HBV-infected cells to their physiological phenotypes that are comparable to the HBV-uninfected cells. The results reported here demonstrate that, regardless of the mechanism(s), chronic HBV infection perturbates multiple senescence-associated markers in human hepatocytes and humanized-mice liver, but E-CFCP can restore this phenomenon.
C1 [Takamatsu, Yuki; Mitsuya, Hiroaki; Higashi-Kuwata, Nobuyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Refractory Viral Dis, 1-21-1 Toyama,Shinjuku, Tokyo 1628655, Japan.
   [Hayashi, Sanae; Tanaka, Yasuhito] Kumamoto Univ, Fac Life Sci, Dept Gastroenterol & Hepatol, 1-1-1 Honjo,Chuo, Kumamoto 8608556, Japan.
   [Hayashi, Sanae; Tanaka, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, 1 Kawasumi,Mizuho Cho, Nagoya 4678601, Japan.
   [Hayashi, Sanae; Tanaka, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, 1 Kawasumi,Mizuho Cho, Nagoya 4678601, Japan.
   [Kumamoto, Hiroki] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, 10281 Komuro, Ina, Saitama 3620806, Japan.
   [Imoto, Shuhei] Sojo Univ, Fac Pharmaceut Sci, 4-22-1 Ikeda,Nishi, Kumamoto 8600082, Japan.
   [Mitsuya, Hiroaki] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, 10 Ctr Dr,Room 5A11, Bethesda, MD USA.
   [Mitsuya, Hiroaki] Kumamoto Univ Hosp, Dept Clin Sci, 1-1-1 Honjo,Chuo, Kumamoto 8608556, Japan.
C3 National Center for Global Health & Medicine - Japan; Kumamoto
   University; Nagoya City University; Nagoya City University; Sojo
   University; National Institutes of Health (NIH) - USA; NIH National
   Cancer Institute (NCI); Kumamoto University
RP Higashi-Kuwata, N (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Refractory Viral Dis, 1-21-1 Toyama,Shinjuku, Tokyo 1628655, Japan.
EM nkuwata@ri.ncgm.go.jp
RI Masutani, Hiroshi/B-5114-2014; Takamatsu, Yuki/M-9791-2018
OI Takamatsu, Yuki/0000-0001-7967-1576; Tanaka,
   Yasuhito/0000-0002-2473-6966; Higashi-Kuwata, Nobuyo/0000-0002-9404-3532
FU JSPS KAKENHI [18K08460]; Japan Agency for Medical Research and
   Development [JP20fk0310113]; Intramural Research Program of National
   Center for Global Health and Medicine [22A2002]; Intramural Research
   Program of the Center for Cancer Research, National Cancer Institute,
   National Institutes of Health
FX This work was supported in part by the JSPS KAKENHI (grant number
   18K08460 to N.H-K.) ; a grant for the Development of Novel Drugs for
   Treating HBV Infection from Japan Agency for Medical Research and
   Development (grant number JP20fk0310113 to H.M.) ; the Intramural
   Research Program of National Center for Global Health and Medicine
   (grant number 22A2002 to N.H-K.) , and in part by the Intramural
   Research Program of the Center for Cancer Research, National Cancer
   Institute, National Institutes of Health (H.M.) . The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. We are grateful to Miwa Tamura-Nakano
   and Chinatsu Oyama in the communal laboratory of NCGM Research Institute
   for their technical support.
CR Ahn JY, 2001, GENE, V275, P163, DOI 10.1016/S0378-1119(01)00604-7
   Alberts CJ, 2022, LANCET GASTROENTEROL, V7, P724, DOI 10.1016/S2468-1253(22)00050-4
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Chaib S, 2022, NAT MED, V28, P1556, DOI 10.1038/s41591-022-01923-y
   Chang ML, 2015, CLIN GASTROENTEROL H, V13, P979, DOI 10.1016/j.cgh.2014.10.023
   Chin R, 2008, ANTIVIR THER, V13, P221
   Chin R, 2007, J HEPATOL, V47, P325, DOI 10.1016/j.jhep.2007.03.025
   Chin R, 2010, VIRUS RES, V147, P7, DOI 10.1016/j.virusres.2009.09.012
   Durantel D, 2021, J HEPATOL, V74, P1011, DOI 10.1016/j.jhep.2021.01.038
   Dusheiko G, 2023, NEW ENGL J MED, V388, P55, DOI 10.1056/NEJMra2211764
   Gearhart TL, 2011, VIRUS RES, V155, P363, DOI 10.1016/j.virusres.2010.09.023
   Giannakoulis VG, 2021, CANCERS, V13, DOI 10.3390/cancers13184732
   Gindin Y, 2021, CLIN INFECT DIS, V73, pE184, DOI 10.1093/cid/ciaa1371
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09
   Hayashi S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011051
   He YY, 2023, AGEING RES REV, V84, DOI 10.1016/j.arr.2022.101833
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Higashi-Kuwata N., 2021, NAT COMMUN
   Higashi-Kuwata N, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02143-18
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hsu YC, 2021, J INFECT DIS, V224, P1890, DOI 10.1093/infdis/jiab241
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Idrissi ME, 2016, J VIRAL HEPATITIS, V23, P130, DOI 10.1111/jvh.12450
   Igarashi N, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31642-4
   Ikeda H, 2009, HUM PATHOL, V40, P1774, DOI 10.1016/j.humpath.2009.06.009
   Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028
   Karakousis ND, 2020, LIVER INT, V40, P2917, DOI 10.1111/liv.14659
   Kelley WJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02708-2020
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Kim S, 2007, J VIROL, V81, P1714, DOI 10.1128/JVI.01863-06
   Kim YJ, 2010, CANCER LETT, V288, P226, DOI 10.1016/j.canlet.2009.07.007
   Kitayama Y, 2019, GLOB HLTH MED-JPN, V1, P20, DOI 10.35772/ghm.2019.01028
   Kohli J, 2021, EMBO REP, V22, DOI 10.15252/embr.202052243
   Lai CL, 2017, J HEPATOL, V66, P275, DOI 10.1016/j.jhep.2016.08.022
   Lampertico Pietro, 2019, Gastroenterology, V157, P1682, DOI 10.1053/j.gastro.2019.10.011
   Lee S, 2021, NATURE, V599, P283, DOI 10.1038/s41586-021-03995-1
   Liu B, 2014, AUTOPHAGY, V10, P416, DOI 10.4161/auto.27286
   Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07
   Oltmanns C, 2023, J HEPATOL, V78, P90, DOI 10.1016/j.jhep.2022.08.042
   Papatheodoridis G, 2016, HEPATOLOGY, V63, P1481, DOI 10.1002/hep.28438
   Qiao L, 2001, HEPATOLOGY, V34, P906, DOI 10.1053/jhep.2001.28886
   Richman DD, 2000, HEPATOLOGY, V32, P866, DOI 10.1053/jhep.2000.18194
   Shukla R, 2011, CARCINOGENESIS, V32, P978, DOI 10.1093/carcin/bgr057
   Slagle BL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a021402
   Slagle BL, 2015, HEPATOLOGY, V61, P1416, DOI 10.1002/hep.27360
   Tachtatzis P.M., 2015, PLOS ONE, V10
   Takamatsu Yuki, 2022, J Virol, V96, pe0155121, DOI [10.1128/jvi.01551-21, 10.1128/JVI.01551-21]
   Takamatsu Y, 2018, CELL CHEM BIOL, V25, P1268, DOI 10.1016/j.chembiol.2018.07.014
   Takamatsu Y, 2015, HEPATOLOGY, V62, P1024, DOI 10.1002/hep.27962
   Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4
   Team RC, 2020, R: A Language and Environment for Statistical
   Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800
   Torresi J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5916-6
   Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018
   Yamasaki C., 2010, DRUG METAB PHARMACOK
   Yano M, 2013, LIVER INT, V33, P1218, DOI 10.1111/liv.12176
   Yoon EL, 2022, J GASTROEN HEPATOL, V37, P1191, DOI 10.1111/jgh.15856
   Yu Y, 2011, J IMMUNOL, V187, P4844, DOI 10.4049/jimmunol.1100998
   Zai WJ, 2022, MICROBIOL SPECTR, V10, DOI 10.1128/spectrum.01328-21
   Zhang CL, 2021, CANCER RES, V81, P2386, DOI 10.1158/0008-5472.CAN-20-3453
   Zhang L, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158450
   Zhao F, 2008, WORLD J GASTROENTERO, V14, P5059, DOI 10.3748/wjg.14.5059
   Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032
NR 65
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD 2023 MAY
PY 2023
VL 329
AR 199094
DI 10.1016/j.virusres.2023.199094
EA MAR 2023
PG 12
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA C4HN9
UT WOS:000961545200001
PM 36933835
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Chudzik, M
   Maciazek-Jurczyk, M
   Pawelczak, B
   Sulkowska, A
AF Chudzik, Mariola
   Maciazek-Jurczyk, Malgorzata
   Pawelczak, Bartosz
   Sulkowska, Anna
TI Spectroscopic Studies on the Molecular Ageing of Serum Albumin
SO MOLECULES
LA English
DT Article
DE molecular ageing; serum albumin; metoprolol; second derivative; circular
   dichroism
ID N-END RULE; AROMATIC-AMINO-ACIDS; DRUG BINDING-SITES; 2ND-DERIVATIVE
   SPECTROSCOPY; FLUORESCENCE SPECTROSCOPY; BOVINE MERCAPTALBUMIN;
   OXIDATIVE STRESS; PROTEINS; SPECTROPHOTOMETRY; TRANSITIONS
AB Pathological states in the organism, e.g., renal or hepatic diseases, cataract, dysfunction of coronary artery, diabetes mellitus, and also intensive workout, induce the structural modification of proteins called molecular ageing or N-A isomerization. The aim of this study was to analyze the structural changes of serum albumin caused by alkaline ageing using absorption, spectrofluorescence, and circular dichroism spectroscopy. The N-A isomerization generates significant changes in bovine (BSA) and human (HSA) serum albumin subdomainsthe greatest changes were observed close to the tryptophanyl (Trp) and tyrosyl (Tyr) residue regions while a smaller change was observed in phenyloalanine (Phe) environment. Moreover, the changes in the polarity of the Trp neighborhood as well as the impact of the ageing process on alpha-helix, beta-sheet content, and albumin molecule rotation degree have been analyzed. Based on the spectrofluorescence study, the alterations in metoprolol binding affinity to the specific sites that increase the toxicity of the drug were investigated.
C1 [Chudzik, Mariola; Maciazek-Jurczyk, Malgorzata; Pawelczak, Bartosz; Sulkowska, Anna] Med Univ Silesia, Sch Pharm, Chair & Dept Phys Pharm, Div Lab Med Sosnowiec, Jagiellonska 4, PL-41200 Sosnowiec, Poland.
C3 Medical University Silesia
RP Chudzik, M (corresponding author), Med Univ Silesia, Sch Pharm, Chair & Dept Phys Pharm, Div Lab Med Sosnowiec, Jagiellonska 4, PL-41200 Sosnowiec, Poland.
EM mchudzik@sum.edu.pl; mmaciazek@sum.edu.pl; bpawelczak@sum.edu.pl;
   asulkowska@sum.edu.pl
OI Maciazek-Jurczyk, Malgorzata/0000-0003-1054-6309; Pawelczak,
   Bartosz/0000-0003-0759-8183
FU Medical University of Silesia [KNW-1-034/K/6/O, KNW-2-O15/N/6/K];
   Wroclaw Centre for Networking and Supercomputing [382]
FX This work was supported by grants KNW-1-034/K/6/O and KNW-2-O15/N/6/K
   from the Medical University of Silesia. Calculations have been carried
   out using resources provided by the Wroclaw Centre for Networking and
   Supercomputing (http://wcss.pl), Grant No. 382.
CR [Anonymous], 2014, CLC DRUG DISC WORKB
   Anraku M, 2001, PHARMACEUT RES, V18, P632, DOI 10.1023/A:1011029226072
   BALESTRIERI C, 1978, EUR J BIOCHEM, V90, P433, DOI 10.1111/j.1432-1033.1978.tb12622.x
   Bujacz A, 2012, ACTA CRYSTALLOGR D, V68, P1278, DOI 10.1107/S0907444912027047
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   CHEN RF, 1967, ARCH BIOCHEM BIOPHYS, V120, P609, DOI 10.1016/0003-9861(67)90526-7
   Chudzik M, 2016, CURR PROTEIN PEPT SC, V17, P198, DOI 10.2174/1389203716666151102103923
   Dessault Systemes BIOVIA, 2016, DISC STUD MOD ENV RE
   Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042
   Eldeeb M., 2016, J BIOL CHEM
   Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809
   Eldeeb MA, 2014, ONCOTARGET, V5, P2714, DOI 10.18632/oncotarget.1931
   ERA S, 1995, BBA-PROTEIN STRUCT M, V1247, P12, DOI 10.1016/0167-4838(94)00166-E
   ERA S, 1991, INT J PEPT PROT RES, V38, P260
   Era S, 2009, INT J BIOL MACROMOL, V44, P37, DOI 10.1016/j.ijbiomac.2008.09.021
   Foster JF, 1977, Albumin: Structure, Function and Uses, P53, DOI DOI 10.1016/B978-0-08-019603-9.50010-7
   Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   Hazra S, 2014, J PHYS CHEM B, V118, P3771, DOI 10.1021/jp409764z
   Iwao Y, 2006, BBA-PROTEINS PROTEOM, V1764, P743, DOI 10.1016/j.bbapap.2006.01.011
   Kagan VE, 2001, HYPERTENS PREGNANCY, V20, P221, DOI 10.1081/PRG-100107826
   Karpinska J, 2004, TALANTA, V64, P801, DOI 10.1016/j.talanta.2004.03.060
   Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z
   Kosa T, 1998, PHARM RES-DORDR, V15, P592, DOI 10.1023/A:1011986028529
   Kumar V, 2005, INT J PHARMACEUT, V294, P193, DOI 10.1016/j.ijpharm.2005.01.024
   Kus S, 1996, CHEM ANAL-WARSAW, V41, P899
   LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004
   MIHALYI E, 1968, J CHEM ENG DATA, V13, P179, DOI 10.1021/je60037a011
   Mozo-Villarías A, 2002, J BIOCHEM BIOPH METH, V50, P163, DOI 10.1016/S0165-022X(01)00181-6
   NIKKEL HJ, 1971, BIOCHEMISTRY-US, V10, P4479, DOI 10.1021/bi00800a020
   Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251
   Patel DD., 2012, Int. J. Res. Pharm. Biomed. Sci, V3, P935
   Peters T. J., 1996, ALL ALBUMIN BIOCH GE
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   SUDLOW G, 1976, MOL PHARMACOL, V12, P1052
   SUDLOW G, 1975, MOL PHARMACOL, V11, P824
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9
   Talsky G., 1994, DERIVATIVE SPECTROPH
   Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142
   Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666
   Yamasaki K, 1996, BBA-PROTEIN STRUCT M, V1295, P147, DOI 10.1016/0167-4838(96)00013-1
NR 44
TC 23
Z9 23
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2017
VL 22
IS 1
AR 34
DI 10.3390/molecules22010034
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA EM7EE
UT WOS:000395473500034
PM 28035999
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Ceci, L
   Chen, LX
   Baiocchi, L
   Wu, N
   Kennedy, L
   Carpino, G
   Kyritsi, K
   Zhou, TH
   Owen, T
   Kundu, D
   Sybenga, A
   Isidan, A
   Ekser, B
   Franchitto, A
   Onori, P
   Gaudio, E
   Mancinelli, R
   Francis, H
   Alpini, G
   Glaser, S
AF Ceci, Ludovica
   Chen, Lixian
   Baiocchi, Leonardo
   Wu, Nan
   Kennedy, Lindsey
   Carpino, Guido
   Kyritsi, Konstantina
   Zhou, Tianhao
   Owen, Travis
   Kundu, Debjyoti
   Sybenga, Amelia
   Isidan, Abdulkadir
   Ekser, Burcin
   Franchitto, Antonio
   Onori, Paolo
   Gaudio, Eugenio
   Mancinelli, Romina
   Francis, Heather
   Alpini, Gianfranco
   Glaser, Shannon
TI Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in
   Cholestatic Murine Model
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE Cholangiopathies; Ductular Reaction; Circadian Rhythm; TGF beta 1
ID PRIMARY SCLEROSING CHOLANGITIS; SEROTONIN N-ACETYLTRANSFERASE; RECEPTOR
   ANTAGONISTS; NITRIC-OXIDE; MOUSE MODEL; BILIARY; CELLS; PROLIFERATION;
   ANGIOGENESIS; EXPRESSION
AB BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is characterized by biliary senescence and hepatic fibrosis. Melatonin exerts its effects by interacting with Melatonin receptor 1 and 2 (MT1/MT2) melatonin receptors. Short-term (1 wk) melatonin treatment reduces a ductular reaction and liver fibrosis in bile duct-ligated rats by down-regulation of MT1 and clock genes, and in multidrug resistance gene 2 knockout (Mdr2(-/-)) mice by decreased miR200b-dependent angiogenesis. We aimed to evaluate the long-term effects of melatonin on liver phenotype that may be mediated by changes in MT1/clock genes/miR200b/maspin/glutathione-S transferase (GST) signaling.
   METHODS: Male wild-type and Mdr2(-/-) mice had access to drinking water with/without melatonin for 3 months. Liver damage, biliary proliferation/senescence, liver fibrosis, peribiliary inflammation, and angiogenesis were measured by staining in liver sections, and by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay in liver samples. We confirmed a link between MT1/clock genes/miR200b/maspin/GST/angiogenesis signaling by Ingenuity Pathway Analysis software and measured liver phenotypes and the aforementioned signaling pathway in liver samples from the mouse groups, healthy controls, and PSC patients and immortalized human PSC cholangiocytes.
   RESULTS: Chronic administration of melatonin to Mdr2(-/-) mice ameliorates liver phenotypes, which were associated with decreased MT1 and clock gene expression.
   CONCLUSIONS: Melatonin improves liver histology and restores the circadian rhythm by interaction with MT1 through decreased angiogenesis and increased maspin/GST activity.
C1 [Ceci, Ludovica; Chen, Lixian; Wu, Nan; Kennedy, Lindsey; Kyritsi, Konstantina; Zhou, Tianhao; Owen, Travis; Kundu, Debjyoti; Francis, Heather; Alpini, Gianfranco] Indiana Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN USA.
   [Ceci, Ludovica; Franchitto, Antonio; Onori, Paolo; Gaudio, Eugenio; Mancinelli, Romina] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Baiocchi, Leonardo] Tor Vergata Univ, Unit Hepatol, Rome, Italy.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Dept Res, Indianapolis, IN USA.
   [Carpino, Guido] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.
   [Sybenga, Amelia] Univ Vermont, Med Ctr, Dept Pathol & Lab Med, Burlington, VT USA.
   [Isidan, Abdulkadir; Ekser, Burcin] Indiana Univ, Sch Med, Dept Surg, Div Transplant Surg, Indianapolis, IN USA.
   [Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Bryan, TX USA.
   [Glaser, Shannon] Texas A&M Univ, Coll Med, Dept Med Physiol, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Sapienza University Rome; University of Rome Tor Vergata;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; Foro Italico University of Rome;
   University of Vermont; University of Vermont Medical Center; Indiana
   University System; Indiana University-Purdue University Indianapolis;
   Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station
RP Glaser, S (corresponding author), Texas A&M Univ, Coll Med, Dept Med Physiol, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
EM sglaser@tamu.edu
RI Carpino, Guido/AAB-9692-2019
OI CARPINO, Guido/0000-0001-8570-2519; Ekser, Burcin/0000-0003-0741-8007
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative, a Senior Research Career Scientist Award
   [IK6 BX004601]; US Department of Veteran's Affairs, Biomedical
   Laboratory Research and Development Service [1I01BX003031, 5I01BX000574,
   2 1IK2BX005306, IK6BX005226]; US Department of Veteran?s Affairs,
   Biomedical Laboratory Research and Development Service; National
   Institutes of Health [DK108959, DK119421, DK054811, DK115184, DK076898,
   DK107310, DK110035, DK062975, AA025997, AA025157]
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University, the Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative, a Senior
   Research Career Scientist Award (IK6 BX004601) , VA Merit award
   5I01BX000574 (G.A.) , Research Career Scientist Award IK6BX005226 and VA
   Merit award 1I01BX003031 (H.F.) , C<STRONG>areer Development Award -2
   1IK2BX005306 f</STRONG>rom the US Department of Veteran?s Affairs,
   Biomedical Laboratory Research and Development Service (L.K.) , National
   Institutes of Health grants DK108959 and DK119421 (H.F.) , grants
   DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA025997,
   and AA025157 (G.A. and S.G.) , and PSC Partners Seeking a Cure (G.A.) .
   This material is the result of work supported by resources at Indiana
   University and the Richard L. Roudebush VA Medical Center, Indianapolis,
   IN, and Medical Physiology, Medical Research Building, Temple, TX. The
   views expressed in this article are those of the authors and do not
   necessarily represent the views of the Department of Veterans Affairs.
CR ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741
   Andersen LPH, 2016, CLIN DRUG INVEST, V36, P169, DOI 10.1007/s40261-015-0368-5
   Baiocchi L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071692
   Baiocchi L, 2019, AM J PHYSIOL-GASTR L, V317, pG651, DOI 10.1152/ajpgi.00110.2019
   Bertani FR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08121-8
   BETJES MGH, 1991, IMMUNOBIOLOGY, V183, P79, DOI 10.1016/S0171-2985(11)80187-7
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6
   Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285
   Ceci L, 2020, AM J PATHOL, V190, P2251, DOI 10.1016/j.ajpath.2020.07.007
   Chen LX, 2021, HEPATOLOGY, V74, P1845, DOI 10.1002/hep.31871
   Chen LX, 2019, BBA-MOL BASIS DIS, V1865, P1525, DOI 10.1016/j.bbadis.2019.03.002
   Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100
   Christ E, 2010, NEUROSCIENCE, V171, P398, DOI 10.1016/j.neuroscience.2010.09.009
   Colin TS, 2018, EXP MOL PATHOL, V104, P1, DOI 10.1016/j.yexmp.2017.11.012
   Coon SL, 1996, GENOMICS, V34, P76, DOI 10.1006/geno.1996.0243
   Crespo I, 2020, J CELL MOL MED, V24, P7625, DOI 10.1111/jcmm.15398
   Dubocovich ML, 1997, N-S ARCH PHARMACOL, V355, P365, DOI 10.1007/PL00004956
   Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211
   Ferlazzo N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111088
   Forsyth CB, 2015, ALCOHOL, V49, P389, DOI 10.1016/j.alcohol.2014.07.021
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Gaudio E, 1996, GASTROENTEROLOGY, V111, P1118, DOI 10.1016/S0016-5085(96)70081-1
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795
   Gonciarz M, 2010, J PHYSIOL PHARMACOL, V61, P705
   Govaere O, 2019, J PATHOL, V248, P66, DOI 10.1002/path.5228
   Guicciardi ME, 2018, J HEPATOL, V69, P676, DOI 10.1016/j.jhep.2018.05.018
   Han K, 2019, EXP THER MED, V17, P2381, DOI 10.3892/etm.2019.7207
   Han YY, 2011, AM J PHYSIOL-GASTR L, V301, pG623, DOI 10.1152/ajpgi.00118.2011
   He CQ, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.723918
   Hu CX, 2019, J CELL MOL MED, V23, P7151, DOI 10.1111/jcmm.14634
   Hwang SJ, 2021, J PINEAL RES, V71, DOI 10.1111/jpi.12739
   ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8
   Jensen LD, 2012, CELL REP, V2, P231, DOI 10.1016/j.celrep.2012.07.005
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kennedy L, 2020, LAB INVEST, V100, P837, DOI 10.1038/s41374-020-0405-8
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Kim KJ, 2013, J PINEAL RES, V54, P264, DOI 10.1111/j.1600-079X.2012.01030.x
   Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200
   Klein DC, 1997, RECENT PROG HORM RES, V52, P307
   Klein DC, 1997, RECENT PROG HORM RES, V52, P57
   Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990
   Lahiri DK, 2004, J PINEAL RES, V36, P217, DOI 10.1111/j.1600-079X.2004.00120.x
   Lanzoni G, 2016, HEPATOLOGY, V64, P277, DOI 10.1002/hep.28326
   Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45
   Maass Nicolai, 2002, Clin Breast Cancer, V3, P281, DOI 10.3816/CBC.2002.n.032
   Mariotti V, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100251
   Montagnese S, 2013, LIVER INT, V33, P203, DOI 10.1111/liv.12026
   Mühlbauer E, 2012, J PINEAL RES, V52, P446, DOI 10.1111/j.1600-079X.2012.00959.x
   Osawa Y, 2015, EBIOMEDICINE, V2, P1751, DOI 10.1016/j.ebiom.2015.10.010
   Osseni RA, 2000, LIFE SCI, V68, P387, DOI 10.1016/S0024-3205(00)00955-3
   Ostrycharz E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249667
   Pollheimer MJ, 2011, CLIN RES HEPATOL GAS, V35, P792, DOI 10.1016/j.clinre.2011.04.014
   Renzi A, 2013, HEPATOLOGY, V57, P1130, DOI 10.1002/hep.26105
   Renzi A, 2011, AM J PHYSIOL-GASTR L, V301, pG634, DOI 10.1152/ajpgi.00206.2011
   Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033
   Rui BB, 2016, ALCOHOL ALCOHOLISM, V51, P11, DOI 10.1093/alcalc/agv126
   Sato K, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12639
   Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Taysi S, 2003, J PINEAL RES, V34, P173, DOI 10.1034/j.1600-079X.2003.00024.x
   von Gall C, 2001, J NEUROENDOCRINOL, V13, P313, DOI 10.1046/j.1365-2826.2001.00643.x
   Wang J, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.648148
   Wu N, 2022, HEPATOLOGY, V75, P797, DOI 10.1002/hep.32233
   Wu N, 2020, HEPATOLOGY, V72, P2219, DOI 10.1002/hep.31484
   Wu N, 2017, FASEB J, V31, P4305, DOI 10.1096/fj.201700097R
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200
   Yi WJ, 2017, INT IMMUNOPHARMACOL, V48, P146, DOI 10.1016/j.intimp.2017.05.006
   Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200
   YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425
   Zhang BB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00066
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 75
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD 2022 
PY 2022
VL 14
IS 4
BP 877
EP 904
DI 10.1016/j.jcmgh.2022.07.007
EA SEP 2022
PG 28
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4Y7VA
UT WOS:000861730300002
PM 35863741
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Delaval, E
   Perichon, M
   Friguet, B
AF Delaval, E
   Perichon, M
   Friguet, B
TI Age-related impairment of mitochondrial matrix aconitase and
   ATP-stimulated protease in rat liver and heart
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE aconitase; aging; Lon protease; mitochondrial matrix
ID OXIDATIVE STRESS; LON PROTEASE; MODULATION; ACCUMULATION; EXPRESSION;
   DAMAGE
AB Mitochondrial matrix proteins are sensitive to oxidative inactivation, and oxidized proteins are known to accumulate during ageing. The Lon protease is believed to play an important role in the degradation of oxidized matrix proteins such as oxidized aconitase. We reported previously that an age-related accumulation of altered proteins occurs in the liver matrix of rats and that the ATP-stimulated proteolytic activity, referred as to Lon-like protease activity, decreases considerably in 27 month-old rats, whereas no concomitant changes in the levels of Lon protein expression occur in the liver. Here, we report that this decline is associated with a decrease in the activity of aconitase, an essential Krebs' cycle enzyme. Contrary to what we observed in the liver, the ATP-stimulated protease activity was found to remain constant in the heart mitochondrial matrix during ageing, and the levels of expression of the Lon protease increased in the older animals in comparison with the younger ones. Although the ATP-stimulated protease activity remained practically the same in older animals as in younger ones, a decrease in the level of aconitase activity was still observed. Altogether, these results indicate that matrix proteins, such as the critical enzymes aconitase and Lon protease, are inactivated with ageing and that the effects of ageing vary from one organ to another.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, F-75252 Paris, France.
C3 Universite Paris Cite
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, IFR 117,2 Pl Jussieu, F-75252 Paris, France.
EM bfriguet@paris7.jussieu.fr
OI Friguet, Bertrand/0000-0001-8085-1961
CR APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248
   GRAY JE, 1982, J GERONTOL, V37, P142, DOI 10.1093/geronj/37.2.142
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510
   MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677
   Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
NR 19
TC 71
Z9 82
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD NOV
PY 2004
VL 271
IS 22
BP 4559
EP 4564
DI 10.1111/j.1432-1033.2004.04422.x
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 873FC
UT WOS:000225264300022
PM 15560797
OA Bronze
DA 2024-02-19
ER

PT J
AU Koike, H
   Hashimoto, R
   Tomita, M
   Kawagashira, Y
   Iijima, M
   Nakamura, T
   Watanabe, H
   Kamei, H
   Kiuchi, T
   Sobue, G
AF Koike, Haruki
   Hashimoto, Rina
   Tomita, Minoru
   Kawagashira, Yuichi
   Iijima, Masahiro
   Nakamura, Tomohiko
   Watanabe, Hirohisa
   Kamei, Hideya
   Kiuchi, Tetsuya
   Sobue, Gen
TI Impact of aging on the progression of neuropathy after liver
   transplantation in transthyretin Val30Met amyloidosis
SO MUSCLE & NERVE
LA English
DT Article
DE amyloid; familial amyloid polyneuropathy; liver transplantation;
   neuropathy; transthyretin
ID SENILE SYSTEMIC AMYLOIDOSIS; SINGLE-CENTER EXPERIENCE; WILD-TYPE
   TRANSTHYRETIN; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; FIBRIL COMPOSITION;
   PORTUGUESE-TYPE; POLYNEUROPATHY; ONSET; HEREDITARY
AB Introduction: Information related to the long-term follow-up of neuropathy in patients with familial amyloid polyneuropathy after liver transplantation is still scarce. Methods: We describe the neuropathic features of 3 patients with the transthyretin Val30Met mutation. Each patient underwent liver transplantation at an early stage of neuropathy, as indicated by the absence of motor dysfunction and relative preservation of myelinated fibers in sural nerve biopsy specimens. Results: Although the patient with late-onset disease (at age 60 years) presented with the least amount of amyloid deposition, he had neuropathic progression after liver transplantation. An older early-onset (at age 40 years) patient reported a slight exacerbation of both somatic and autonomic neuropathic symptoms 10 years after transplantation. However, the younger early-onset (at age 28 years) patient did not exhibit characteristics suggestive of neuropathy 7 years after transplantation. Conclusion: Aging may determine the progression of neuropathy after liver transplantation. Muscle Nerve 46: 964-970, 2012
C1 [Koike, Haruki; Hashimoto, Rina; Tomita, Minoru; Kawagashira, Yuichi; Iijima, Masahiro; Nakamura, Tomohiko; Watanabe, Hirohisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.
   [Kamei, Hideya; Kiuchi, Tetsuya] Nagoya Univ Hosp, Dept Transplantat Surg, Nagoya, Aichi, Japan.
C3 Nagoya University; Nagoya University
RP Koike, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.
EM koike-haruki@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp
RI Nakamura, tomohiko/I-7424-2014; Kamei, Hideya/B-3467-2016; Nakamura,
   Tomohiko/AAC-1414-2021
OI Nakamura, Tomohiko/0000-0001-7622-4527; Koike,
   Haruki/0000-0002-4612-3183; Watanabe, Hirohisa/0000-0001-8553-8536
FU Ministry of Health, Labor and Welfare; Ministry of Education, Culture,
   Sports, Science and Technology of Japan; Kimi Imai Memorial Foundation
   for Research of Incurable Neuromuscular Diseases
FX This work was supported by grants from the Ministry of Health, Labor and
   Welfare and the Ministry of Education, Culture, Sports, Science and
   Technology of Japan, and the Kimi Imai Memorial Foundation for Research
   of Incurable Neuromuscular Diseases.
CR Adams D, 2001, J NEUROL, V248, P647, DOI 10.1007/s004150170109
   Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495
   ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820
   Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057
   Barreiros AP, 2010, LIVER TRANSPLANT, V16, P314, DOI 10.1002/lt.21996
   Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821
   Bergström J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759
   Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74
   Coelho T, 1996, CURR OPIN NEUROL, V9, P355, DOI 10.1097/00019052-199610000-00007
   Delahaye N, 2006, MEDICINE, V85, P229, DOI 10.1097/01.md.0000232559.22098.c3
   Ericzon BG, 2003, AMYLOID, V10, P67
   Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749
   Herlenius G, 2004, TRANSPLANTATION, V77, P64, DOI 10.1097/01.TP.0000092307.98347.CB
   HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M
   Holmgren G, 1991, CLIN GENET, V40, P24
   Hörnsten R, 2004, TRANSPLANTATION, V78, P112, DOI 10.1097/01.TP.0000133517.20972.27
   Hörnsten R, 2010, AMYLOID, V17, P63, DOI 10.3109/13506129.2010.483114
   Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411
   Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1
   Ikeda S, 1997, ANN INTERN MED, V127, P618, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00006
   Ikeda S, 2002, NEUROLOGY, V58, P1001, DOI 10.1212/WNL.58.7.1001
   Ikeda Shu-Ichi, 2011, Rinsho Shinkeigaku, V51, P1143
   Koike H, 2005, J NEUROL NEUROSUR PS, V76, P1109, DOI 10.1136/jnnp.2004.048140
   Koike H, 2004, NEUROLOGY, V63, P129, DOI 10.1212/01.WNL.0000132966.36437.12
   Koike H, 2012, J NEUROL NEUROSUR PS, V83, P152, DOI 10.1136/jnnp-2011-301299
   Koike Haruki, 2010, Expert Opin Med Diagn, V4, P323, DOI 10.1517/17530059.2010.495384
   Koike H, 2011, AMYLOID, V18, P53, DOI 10.3109/13506129.2011.565524
   Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028
   Koike H, 2008, J NEUROL, V255, P1526, DOI 10.1007/s00415-008-0962-z
   Liepnieks JJ, 2010, NEUROLOGY, V75, P324, DOI 10.1212/WNL.0b013e3181ea15d4
   Macedo B, 2010, PHARMACOL RES, V62, P514, DOI 10.1016/j.phrs.2010.08.001
   Misu K, 1999, BRAIN, V122, P1951, DOI 10.1093/brain/122.10.1951
   Miyazaki Y, 2011, AMYLOID, V18, P87, DOI 10.3109/13506129.2011.569782
   Nakamura T, 2011, MOVEMENT DISORD, V26, P1869, DOI 10.1002/mds.23744
   Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872
   Okamoto S, 2011, LIVER TRANSPLANT, V17, P122, DOI 10.1002/lt.22184
   Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817
   Planté-Bordeneuve V, 2007, NEUROLOGY, V69, P693, DOI 10.1212/01.wnl.0000267338.45673.f4
   Planté-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0
   Said G, 2009, J NEUROL SCI, V284, P149, DOI 10.1016/j.jns.2009.05.001
   Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155
   Sharma P, 2003, LIVER TRANSPLANT, V9, P1273, DOI 10.1016/j.lts.2003.09.016
   Shimojima Y, 2008, J NEUROL, V255, P1220, DOI 10.1007/s00415-008-0884-9
   Stangou AJ, 2004, CURR OPIN NEUROL, V17, P615, DOI 10.1097/00019052-200410000-00012
   SUHR O, 1994, J INTERN MED, V235, P479, DOI 10.1111/j.1365-2796.1994.tb01106.x
   Suhr OB, 2002, LIVER TRANSPLANT, V8, P787, DOI 10.1053/jlts.2002.34386
   Suhr OB, 2006, AMYLOID, V13, P154, DOI 10.1080/13506120600876849
   Takei Y, 1999, ANN INTERN MED, V131, P592, DOI 10.7326/0003-4819-131-8-199910190-00008
   Tashima K, 1999, J NEUROL SCI, V171, P19, DOI 10.1016/S0022-510X(99)00231-2
   Terazaki H, 2006, LAB INVEST, V86, P23, DOI 10.1038/labinvest.3700365
   Tsuchiya A, 2008, LIVER TRANSPLANT, V14, P563, DOI 10.1002/lt.21395
   Tsuchiya-Suzuki A, 2011, HUM PATHOL, V42, P236, DOI 10.1016/j.humpath.2010.06.014
   Watanabe H, 2002, J NEUROL SCI, V195, P63, DOI 10.1016/S0022-510X(01)00678-5
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843
   Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x
   Westermark P, 2003, AMYLOID, V10, P48
   Yamamoto S, 2007, AM J TRANSPLANT, V7, P2597, DOI 10.1111/j.1600-6143.2007.01969.x
   Yazaki M, 2007, AM J TRANSPLANT, V7, P235, DOI 10.1111/j.1600-6143.2006.01585.x
   Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203
NR 59
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
J9 MUSCLE NERVE
JI Muscle Nerve
PD DEC
PY 2012
VL 46
IS 6
BP 964
EP 970
DI 10.1002/mus.23480
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 044JI
UT WOS:000311615100024
PM 23225390
DA 2024-02-19
ER

PT J
AU Mallikarjuna, K
   Shanmugam, KR
   Nishanth, K
   Wu, MC
   Hou, CW
   Kuo, CH
   Reddy, KS
AF Mallikarjuna, K.
   Shanmugam, K. R.
   Nishanth, K.
   Wu, Ming-Chieh
   Hou, Chien-Wen
   Kuo, Chia-Hua
   Reddy, K. Sathyavelu
TI Alcohol-induced deterioration in primary antioxidant and glutathione
   family enzymes reversed by exercise training in the liver of old rats
SO ALCOHOL
LA English
DT Article
DE Aging liver; Ethanol; ROS; Free radical scavenging enzymes; Exercise;
   Oxidative stress
ID LIPID-PEROXIDATION; OXIDATIVE STRESS; ETHANOL; AGE; SUPEROXIDE;
   METABOLISM; SELENIUM; DISEASE; SYSTEM; DAMAGE
AB Chronic alcohol consumption causes severe hepatic oxidative damage, particularly to old subjects by decreasing various antioxidant enzymes. In this study, we test the hypothesis that exercise training can protect the aging liver against alcohol-induced oxidative damage. Two different age groups of Wistar albino rats (3 months young, a = 24; 18 months old, n = 24) were evenly divided into four groups: control (Con), exercise trained (Tr, 23 m/min 30 min/day, 5 days/week for 2 months), ethanol drinking/treated (Et, 2.0 g/kg b.w. orally), and exercise training plus ethanol drinking/treated (Tr + Et). We found significantly (P < .001) lowered hepatic antioxidant enzymes including superoxide dismutase, catalase, selenium (Se)-dependent glutathione peroxidase (Se GSH-Px), Se non-dependent glutathione peroxidase (non-Se GSH-Px), glutathione reductase, and glutathione S-transferase activities in aged rats compared with young. Age-related decrease in antioxidant enzyme status was further exacerbated with ethanol drinking, which indicates liver in aged rats is more susceptible to oxidative damage because of decreased free radical scavenging system in aged/old ethanol-drinking rats. However, the decrease in liver antioxidant enzymes status with ethanol consumption was ameliorated by 2 months exercise training in old and young rats. These results demonstrate that age-associated decrease in hepatic free radical scavenging system exacerbated by ethanol drinking. For the first time, we found that this deterioration was significantly reversed by exercise training in aging liver, thus protects against alcohol-induced oxidative damage. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Mallikarjuna, K.; Shanmugam, K. R.; Reddy, K. Sathyavelu] Sri Venkateswara Univ, Div Mol Biol, Dept Zool, Tirupati 517502, Andhra Pradesh, India.
   [Mallikarjuna, K.; Wu, Ming-Chieh; Hou, Chien-Wen; Kuo, Chia-Hua] Taipei Phys Educ Coll, Lab Exercise Biochem, Taipei 11153, Taiwan.
   [Nishanth, K.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
C3 Sri Venkateswara University; University of Taipei; New Jersey Institute
   of Technology
RP Reddy, KS (corresponding author), Sri Venkateswara Univ, Div Mol Biol, Dept Zool, Tirupati 517502, Andhra Pradesh, India.
EM ksreddy2008@hotmail.com
RI Korivi, Mallikarjuna/C-7952-2012; Shanmugam, KR/AAS-2425-2021
OI Korivi, Mallikarjuna/0000-0002-4038-1368; Shanmugam,
   KR/0000-0002-6453-9991; Kuo, Chia-Hua/0000-0002-1731-4984
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Bailey SM, 2001, ALCOHOL CLIN EXP RES, V25, P726, DOI 10.1111/j.1530-0277.2001.tb02273.x
   Bindu MP, 2002, CURR SCI INDIA, V82, P628
   Cahill A, 2005, AM J PHYSIOL-GASTR L, V289, pG1115, DOI 10.1152/ajpgi.00193.2005
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Chandra R, 2000, Indian J Clin Biochem, V15, P155, DOI 10.1007/BF02883745
   Das SK, 2005, INDIAN J CLIN BIOCHE, V20, P80, DOI 10.1007/BF02893047
   Duncan K, 1997, CANCER LETT, V116, P151, DOI 10.1016/S0304-3835(97)00189-4
   El-Sayed M, 2005, SPORTS MED, V35, P257, DOI 10.2165/00007256-200535030-00005
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   GUPTA S, 2003, IND J CLIN BIOCH, V20, P67
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HIRANO T, 1992, HEPATOLOGY, V16, P1423
   Husain K, 1997, J APPL TOXICOL, V17, P189, DOI 10.1002/(SICI)1099-1263(199705)17:3<189::AID-JAT431>3.0.CO;2-7
   Husain K., 1997, PATHOPHYSIOLOGY, V4, P69
   Jang IS, 2001, MECH AGEING DEV, V122, P561, DOI 10.1016/S0047-6374(01)00236-6
   Jurczuk M, 2006, POL J ENVIRON STUD, V15, P861
   KATO S, 1990, GASTROENTEROLOGY, V98, P203, DOI 10.1016/0016-5085(90)91311-S
   Kim YC, 2003, LIFE SCI, V74, P509, DOI 10.1016/j.lfs.2003.07.009
   KNECHT KT, 1993, ARCH BIOCHEM BIOPHYS, V303, P339, DOI 10.1006/abbi.1993.1293
   Kumaran VS, 2008, EXP GERONTOL, V43, P176, DOI 10.1016/j.exger.2007.10.017
   Ojeda ML, 2009, ALCOHOL ALCOHOLISM, V44, P272, DOI 10.1093/alcalc/agp004
   Mallikarjuna K, 2007, Pathophysiology, V14, P17, DOI 10.1016/j.pathophys.2006.09.005
   Mallikarjuna K, 2009, ALCOHOL, V43, P59, DOI 10.1016/j.alcohol.2008.09.003
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Oh SI, 1998, J NUTR, V128, P758, DOI 10.1093/jn/128.4.758
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Polavarapu R, 1998, HEPATOLOGY, V27, P1317, DOI 10.1002/hep.510270518
   REDDY CC, 1981, BIOCHEM BIOPH RES CO, V101, P970
   RIKANS LE, 1990, GERONTOLOGY, V36, P185, DOI 10.1159/000213198
   RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632
   Savarino L, 2001, EXP GERONTOL, V36, P327, DOI 10.1016/S0531-5565(00)00218-7
   SEITZ HK, 1992, RES EXP MED, V192, P205, DOI 10.1007/BF02576276
   SEN CK, 1992, J APPL PHYSIOL, V73, P1265, DOI 10.1152/jappl.1992.73.4.1265
   Skrzydlewska E, 2005, ALCOHOL, V37, P89, DOI 10.1016/j.alcohol.2005.12.003
   Somani Satu M., 1996, Indian Journal of Physiology and Pharmacology, V40, P205
   Sriram KI, 2001, CURR SCI INDIA, V80, P921
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   Zima T, 2001, J BIOMED SCI, V8, P59, DOI 10.1159/000054014
NR 41
TC 28
Z9 29
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD SEP
PY 2010
VL 44
IS 6
BP 523
EP 529
DI 10.1016/j.alcohol.2010.07.004
PG 7
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA 662YL
UT WOS:000282850100006
PM 20705416
DA 2024-02-19
ER

PT J
AU Fukumitsu, K
   Yagi, H
   Soto-Gutierrez, A
AF Fukumitsu, K.
   Yagi, H.
   Soto-Gutierrez, A.
TI Bioengineering in Organ Transplantation: Targeting the Liver
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Proceedings Paper
CT 11th Congress of the Catalan-Transplantation-Society (SCT)
CY MAR 16-18, 2011
CL Barcelona, SPAIN
ID HEPATOCYTE TRANSPLANTATION; MATRIX; UPDATE; DONORS; HEART
AB About 27,000 deaths are registered annually in the United States due to liver disease. At this time, the only definitive treatment of hepatic failure is orthotopic transplantation. However, there is a critical shortage of organs with the total waiting list for all organs currently at 100,000 requests. The number is increasing by 5% every year. Given that only organs in pristine condition are transplantable and that the hidden demand for organs as an anti-aging solution will be many times the current figures, orthotopic transplantation will always remain a limited pool. The increasing donor organ shortage requires consideration of alternative emerging technologies. Regenerative medicine may offer novel strategies to treat patients with end-stage organ failure. The ultimate aim of cell transplantation, tissue engineering, and stem cells is to regenerate tissues and organs. With the development of whole organ decellularization methods, the equation of organ shortage may dramatically change in the near future. Decellularized organs provide the ideal transplantable scaffold with all the necessary microstructure and extracellular cues for cell attachment, differentiation, vascularization, and function. New techniques to re-engineer organs may have major implications for the fields of drug discovery, regeneration biology, and ultimately organ transplantation. In this review we have provided an overview of complementary approaches to study and enhance the success of organ repopulation strategies creating new grafts/organs for transplantation.
C1 [Fukumitsu, K.; Soto-Gutierrez, A.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Ctr Innovat Regenerat Therapies, Dept Surg,Transplantat Sect,McGowan Inst Regenera, Pittsburgh, PA 15201 USA.
   [Yagi, H.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Keio University
RP Soto-Gutierrez, A (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Ctr Innovat Regenerat Therapies, Dept Surg,Transplantat Sect,McGowan Inst Regenera, 3511 Rangos Res Bldg,530 45th St, Pittsburgh, PA 15201 USA.
EM sotogutierreza@upmc.edu
FU National Institute of Health [K99DK083556]; Japan Society for the
   Promotion of Science; Grants-in-Aid for Scientific Research [23689059]
   Funding Source: KAKEN
FX Supported by The National Institute of Health grant K99DK083556 to
   A.S.-G. Also supported by the Research Fellowship of the Japan Society
   for the Promotion of Science for young scientist to K.F.
CR Abt PL, 2004, ANN SURG, V239, P87, DOI 10.1097/01.sla.0000103063.82181.2c
   García-Valdecasas JC, 2010, CURR OPIN ORGAN TRAN, V15, P173, DOI 10.1097/MOT.0b013e3283373488
   Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac
   Gondolesi GE, 2004, ANN SURG, V239, P142, DOI 10.1097/01.sla.0000109022.32391.eb
   Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230
   Halon A, 2006, TRANSPLANT P, V38, P193, DOI 10.1016/j.transproceed.2005.11.088
   Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040
   Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x
   Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Schneider MKJ, 2010, XENOTRANSPLANTATION, V17, P481, DOI 10.1111/j.1399-3089.2010.00615.x
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Soto-Gutierrez A, 2010, CELL TRANSPLANT, V19, P655, DOI 10.3727/096368910X508753
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573
NR 19
TC 39
Z9 46
U1 1
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD JUL-AUG
PY 2011
VL 43
IS 6
BP 2137
EP 2138
DI 10.1016/j.transproceed.2011.05.014
PG 2
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Immunology; Surgery; Transplantation
GA 810CC
UT WOS:000294102000004
PM 21839215
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Ikeda, H
   Haga, H
   Manabe, T
   Nakanuma, Y
AF Sasaki, M
   Ikeda, H
   Haga, H
   Manabe, T
   Nakanuma, Y
TI Frequent cellular senescence in small bile ducts in primary biliary
   cirrhosis: a possible role in bile duct loss
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE primary biliary cirrhosis; cellular senescence; oxidative stress; nitric
   oxide
ID URSODEOXYCHOLIC ACID PROTECTS; LIVER ALLOGRAFT-REJECTION;
   EPITHELIAL-CELLS; IN-VIVO; IDENTIFICATION; EXPRESSION; STRESS; TREE;
   HEPATOCYTES; POLYPLOIDY
AB The pathogenesis of progressive bile duct loss in primary biliary cirrhosis remains unclear. In this study, the involvement of cellular senescence of biliary epithelial cells was examined in liver tissue samples from patients with primary biliary cirrhosis (n = 33), and compared with control diseased and normal livers (n = 83). In addition, cellular senescence was induced by oxidative stress in cultured mouse biliary epithelial cells. Biliary epithelial cells in small bile ducts in primary biliary cirrhosis, especially those in patients presenting with chronic non-suppurative cholangitis, frequently expressed senescence-associated beta-galactosidase, and senescence-associated p16(INK4) and p21(WAF1/CIP). In contrast, senescence-associated markers were rarely expressed in small bile ducts in control livers. The infiltration of myeloperoxidase-positive inflammatory cells into biliary epithelial cell layers was closely associated with the cellular senescence of biliary epithelial cells in early-stage PBC. Cellular senescence of cultured mouse biliary epithelial cells was induced by treatment with H2O2 via the p38MAPK-dependent pathway and nitric oxide-augmented H2O2-induced cellular senescence. Oxidative stress- and nitric oxide-mediated cellular senescence may be involved in bile duct lesions, which are followed by progressive bile duct loss in primary biliary cirrhosis. Copyright (C) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
   Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan.
C3 Kanazawa University; Kyoto University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
CR Aboutwerat A, 2003, BBA-MOL BASIS DIS, V1637, P142, DOI 10.1016/S0925-4439(02)00225-9
   [Anonymous], 2001, PATHOLOGY LIVER
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Demetris A., 1997, BILIARY PANCREATIC D, P127
   DEMETRIS AJ, 1991, TRANSPLANT P, V23, P3005
   DEMETRIS AJ, 1988, IN VITRO CELL DEV B, V24, P464
   Desmet V. J., 1997, Journal of Hepatology, V26, P31, DOI 10.1016/S0168-8278(97)82330-6
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FREESE DK, 1991, HEPATOLOGY, V13, P882, DOI 10.1016/0270-9139(91)90258-W
   FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654
   Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021
   GERSHWIN ME, 1987, J IMMUNOL, V138, P3525
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Jaiswal M, 2001, GASTROENTEROLOGY, V120, P190, DOI 10.1053/gast.2001.20875
   Kaplan MM, 1996, NEW ENGL J MED, V335, P1570, DOI 10.1056/NEJM199611213352107
   Katayanagi K, 1998, LIVER, V18, P90
   LUDWIG J, 1991, SEMIN LIVER DIS, V11, P11, DOI 10.1055/s-2008-1040417
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Mitsuyoshi H, 1999, BIOCHEM BIOPH RES CO, V263, P537, DOI 10.1006/bbrc.1999.1403
   NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Neuberger J, 1999, HEPATOLOGY, V29, P271, DOI 10.1002/hep.510290126
   Rahman SM, 1996, PATHOL INT, V46, P267, DOI 10.1111/j.1440-1827.1996.tb03609.x
   Saxena R, 2002, HUM PATHOL, V33, P983, DOI 10.1053/hupa.2002.128060
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   Serviddio G, 2004, HEPATOLOGY, V39, P711, DOI 10.1002/hep.20101
   Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Tsuneyama K, 2002, J HEPATOL, V37, P176, DOI 10.1016/S0168-8278(02)00105-8
   van den Heuvel MC, 2004, LIVER TRANSPLANT, V10, P28, DOI 10.1002/lt.20029
   Wu CT, 2003, HEPATOLOGY, V38, P1018, DOI 10.1053/jhep.2003.50407
   Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9
NR 32
TC 93
Z9 95
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD MAR
PY 2005
VL 205
IS 4
BP 451
EP 459
DI 10.1002/path.1729
PG 9
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA 904NS
UT WOS:000227505600005
PM 15685690
DA 2024-02-19
ER

PT J
AU Imai, Y
   Takahashi, A
   Hanyu, A
   Hori, S
   Sato, S
   Naka, K
   Hirao, A
   Ohtani, N
   Hara, E
AF Imai, Yoshinori
   Takahashi, Akiko
   Hanyu, Aki
   Hori, Satoshi
   Sato, Seidai
   Naka, Kazuhito
   Hirao, Atsushi
   Ohtani, Naoko
   Hara, Eiji
TI Crosstalk between the Rb Pathway and AKT Signaling Forms a
   Quiescence-Senescence Switch
SO CELL REPORTS
LA English
DT Article
ID DNA-DAMAGE-RESPONSE; ONCOGENE-INDUCED SENESCENCE; FORKHEAD TRANSCRIPTION
   FACTOR; CELLULAR SENESCENCE; BETA-GALACTOSIDASE; TUMOR-SUPPRESSOR;
   IN-VIVO; PREMATURE SENESCENCE; OXIDATIVE STRESS; G(1) CONTROL
AB Cell-cycle arrest in quiescence and senescence is largely orchestrated by the retinoblastoma (Rb) tumor-suppressor pathway, but the mechanisms underlying the quiescence-senescence switch remain unclear. Here, we show that the crosstalk between the Rb-AKT-signaling pathways forms this switch by controlling the overlapping functions of FoxO3a and FoxM1 transcription factors in cultured fibroblasts. In the absence of mitogenic signals, although FoxM1 expression is repressed by the Rb pathway, FoxO3a prevents reactive oxygen species (ROS) production by maintaining SOD2 expression, leading to quiescence. However, if the Rb pathway is activated in the presence of mitogenic signals, FoxO3a is also inactivated by AKT, thus reducing SOD2 expression and consequently allowing ROS production. This situation elicits senescence through irreparable DNA damage. We demonstrate that this pathway operates in mouse liver, indicating that this machinery may contribute more broadly to tissue homeostasis in vivo.
C1 [Imai, Yoshinori; Takahashi, Akiko; Hanyu, Aki; Hori, Satoshi; Sato, Seidai; Ohtani, Naoko; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.
   [Imai, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan.
   [Naka, Kazuhito; Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan.
   [Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan.
   [Hara, Eiji] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan.
C3 Japanese Foundation for Cancer Research; Tokyo Medical & Dental
   University (TMDU); Kanazawa University; Japan Science & Technology
   Agency (JST); Japan Science & Technology Agency (JST)
RP Hara, E (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.
EM eiji.hara@jfcr.or.jp
RI Naka, Kazuhito/X-3756-2019; Ohtani, Naoko/AAB-1891-2021
OI Naka, Kazuhito/0000-0001-6646-6004; Ohtani, Naoko/0000-0001-8934-0797;
   Takahashi, Akiko/0000-0003-1904-7645
FU Japan Science and Technology Agency (JST); MEXT; Ministry of Health,
   Labour, and Welfare of Japan (MHLW); Japan Society for Promotion of
   Science (JSPS); Grants-in-Aid for Scientific Research [23300352,
   23300343] Funding Source: KAKEN
FX We thank the SCADS Inhibitor Kit Screening Committee supported by the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   for providing us with SCADS inhibitor kits. This work was supported by
   grants from the Japan Science and Technology Agency (JST), MEXT, and the
   Ministry of Health, Labour, and Welfare of Japan (MHLW). Y.I. was
   supported by a fellowship from the Japan Society for Promotion of
   Science (JSPS).
CR Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011
   Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001
   Baker DJ, 2013, J CELL BIOL, V202, P11, DOI 10.1083/jcb.201305155
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Dai CY, 2000, ONCOGENE, V19, P1613, DOI 10.1038/sj.onc.1203438
   Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211
   Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193
   Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003
   Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200
   Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998
   Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105
   Yegorov YE, 1998, EXP CELL RES, V243, P207, DOI 10.1006/excr.1998.4169
NR 60
TC 60
Z9 68
U1 0
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR
PY 2014
VL 7
IS 1
BP 194
EP 207
DI 10.1016/j.celrep.2014.03.006
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA AE9BG
UT WOS:000334298200020
PM 24703840
OA gold
DA 2024-02-19
ER

PT J
AU Ritz, P
   Berrut, G
AF Ritz, P
   Berrut, G
TI Mitochondrial function, energy expenditure, aging and insulin resistance
SO DIABETES & METABOLISM
LA English
DT Article
DE mitochondrial function; energy expenditure; ageing; insulin resistance
ID RAT-LIVER MITOCHONDRIA; RESTING METABOLIC-RATE; HUMAN SKELETAL-MUSCLE;
   OXIDATIVE-PHOSPHORYLATION; CALORIC RESTRICTION; PROTON LEAK;
   DEXAMETHASONE TREATMENT; AGE; PROTEIN; EXPRESSION
AB Mitochondria are the cells' powerhouse that produce the ubiquitous energy currency (ATP) by consuming oxygen, producing water and building up the proton motive force. Oxygen consumption is a classical means of assessing energy expenditure, one component of energy balance. When energy balance is positive, weight increases. This is observed during the dynamic phase of obesity, and during body composition changes associated with aging. Whether intrinsic defaults in mitochondria occur is the matter of this review. Indeed, the ratio of ATP over oxygen consumed, which is not fixed, is one way of regulating heat release and ATP flux, but can also be the consequence of environmental conditions of mitochondrial work. For example, various hormones (T3, glucocorticoids), changes in lipid membrane composition, changes in food intake and exercise, and various drugs, can modify the ratio of ATP over oxygen consumed. Aging and insulin resistance are other regulators of this ratio. Finally there is a rising body of evidence linking diabetes to mitochondrial functions.
C1 INSERM, UMR 694, F-49033 Angers 01, France.
C3 Universite d'Angers; Institut National de la Sante et de la Recherche
   Medicale (Inserm)
RP Ritz, P (corresponding author), INSERM, UMR 694, F-49033 Angers 01, France.
EM patrick.ritz@wanadoo.tr
CR Barbe P, 2001, FASEB J, V15, P13
   Bell C, 2001, J CLIN ENDOCR METAB, V86, P4440, DOI 10.1210/jc.86.9.4440
   Boirie Y, 2003, TRENDS ENDOCRIN MET, V14, P393, DOI 10.1016/j.tem.2003.09.002
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P211, DOI 10.1111/j.1469-7793.2000.00211.x
   Considine MJ, 2003, J BIOL CHEM, V278, P22298, DOI 10.1074/jbc.M301075200
   DELARUE J, 1994, BRIT J NUTR, V71, P295, DOI 10.1079/BJN19940135
   Dumas JF, 2005, DIABETOLOGIA, V48, P328, DOI 10.1007/s00125-004-1631-0
   Dumas JF, 2004, BBA-GEN SUBJECTS, V1670, P126, DOI 10.1016/j.bbagen.2003.11.002
   Dumas JF, 2003, BRIT J NUTR, V90, P969, DOI 10.1079/BJN2003980
   Elia M, 2000, EUR J CLIN NUTR, V54, pS92, DOI 10.1038/sj.ejcn.1601030
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   HOCH FL, 1988, PROG LIPID RES, V27, P199, DOI 10.1016/0163-7827(88)90013-6
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   JAMES WPT, 1989, NUTR AGING ELDERLY
   Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lionetti L, 2004, CELL MOL LIFE SCI, V61, P1366, DOI 10.1007/s00018-004-4073-4
   MCMILLIN JB, 1993, CARDIOVASC RES, V27, P2222, DOI 10.1093/cvr/27.12.2222
   Morio B, 1997, AM J PHYSIOL-ENDOC M, V273, pE321, DOI 10.1152/ajpendo.1997.273.2.E321
   Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200
   Pandya JD, 2004, DRUG CHEM TOXICOL, V27, P389, DOI 10.1081/DCT-200039778
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   POEHLMAN ET, 1992, METABOLISM, V41, P1351, DOI 10.1016/0026-0495(92)90107-L
   PRENTICE AM, 1992, EUR J CLIN NUTR, V43, P21
   Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016
   Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje
   RISING R, 1994, AM J CLIN NUTR, V59, P800, DOI 10.1093/ajcn/59.4.800
   Ritz P, 2005, CURR OPIN CLIN NUTR, V8, P415, DOI 10.1097/01.mco.0000172582.86890.19
   Ritz P, 2001, Public Health Nutr, V4, P561
   Ritz P, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1601021
   Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Roussel D, 2004, BIOCHEM J, V382, P491, DOI 10.1042/BJ20040696
   ROUSSEL D, 2003, FEBS LETT, V24, P541
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100
   VanPelt RE, 1997, J CLIN ENDOCR METAB, V82, P3208, DOI 10.1210/jc.82.10.3208
   WALLACE DC, 2005, ANN REV GENET   0719
   Weinsier RL, 2001, AM J CLIN NUTR, V74, P631
NR 46
TC 48
Z9 61
U1 0
U2 4
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
J9 DIABETES METAB
JI Diabetes Metab.
PD DEC
PY 2005
VL 31
SI 2
BP S67
EP S73
DI 10.1016/S1262-3636(05)73654-5
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 020KU
UT WOS:000235908800010
PM 16415768
DA 2024-02-19
ER

PT J
AU Chen, LX
   Zhou, TH
   White, T
   O'Brien, A
   Chakraborty, S
   Liangpunsakul, S
   Yang, ZH
   Kennedy, L
   Saxena, R
   Wu, CD
   Meng, FY
   Huang, QB
   Francis, H
   Alpini, G
   Glaser, S
AF Chen, Lixian
   Zhou, Tianhao
   White, Tori
   O'Brien, April
   Chakraborty, Sanjukta
   Liangpunsakul, Suthat
   Yang, Zhihong
   Kennedy, Lindsey
   Saxena, Romil
   Wu, Chaodong
   Meng, Fanyin
   Huang, Qiaobing
   Francis, Heather
   Alpini, Gianfranco
   Glaser, Shannon
TI The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and
   Liver Fibrosis During Mouse Models of Cholestasis
SO HEPATOLOGY
LA English
DT Article; Early Access
ID HEPATIC STELLATE CELLS; THERAPEUTIC TARGET; CELLULAR SENESCENCE; APJ;
   SYSTEM; LIGAND; INHIBITION; ACTIVATION; APOPTOSIS; PEPTIDES
AB Background and Aims Apelin (APLN) is the endogenous ligand of its G protein-coupled receptor, apelin receptor (APJ). APLN serum levels are increased in human liver diseases. We evaluated whether the APLN-APJ axis regulates ductular reaction and liver fibrosis during cholestasis.
   Approach and Results We measured the expression of APLN and APJ and serum APLN levels in human primary sclerosing cholangitis (PSC) samples. Following bile duct ligation (BDL) or sham surgery, male wild-type (WT) mice were treated with ML221 (APJ antagonist) or saline for 1 week. WT and APLN(-/-) mice underwent BDL or sham surgery for 1 week. Multidrug resistance gene 2 knockout (Mdr2(-/-)) mice were treated with ML221 for 1 week. APLN levels were measured in serum and cholangiocyte supernatants, and cholangiocyte proliferation/senescence and liver inflammation, fibrosis, and angiogenesis were measured in liver tissues. The regulatory mechanisms of APLN-APJ in (1) biliary damage and liver fibrosis were examined in human intrahepatic biliary epithelial cells (HIBEpiCs) treated with APLN and (2) hepatic stellate cell (HSC) activation in APLN-treated human HSC lines (HHSteCs). APLN serum levels and biliary expression of APLN and APJ increased in PSC samples. APLN levels were higher in serum and cholangiocyte supernatants from BDL and Mdr2(-/-) mice. ML221 treatment or APLN(-/-) reduced BDL-induced and Mdr2(-/-)-induced cholangiocyte proliferation/senescence, liver inflammation, fibrosis, and angiogenesis. In vitro, APLN induced HIBEpiC proliferation, increased nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) expression, reactive oxygen species (ROS) generation, and extracellular signal-regulated kinase (ERK) phosphorylation. Pretreatment of HIBEpiCs with ML221, diphenyleneiodonium chloride (Nox4 inhibitor), N-acetyl-cysteine (NAC, ROS inhibitor), or PD98059 (ERK inhibitor) reduced APLN-induced cholangiocyte proliferation. Activation of HHSteCs was induced by APLN but reduced by NAC.
   Conclusions The APLN-APJ axis induces cholangiocyte proliferation through Nox4/ROS/ERK-dependent signaling and HSC activation through intracellular ROS. Modulation of the APLN-APJ axis may be important for managing cholangiopathies.
C1 [Chen, Lixian; Zhou, Tianhao; White, Tori; O'Brien, April; Chakraborty, Sanjukta; Glaser, Shannon] Texas A&M Univ, Coll Med, Dept Med Physiol, MREB 2,Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
   [Chen, Lixian; Zhou, Tianhao; Liangpunsakul, Suthat; Yang, Zhihong; Kennedy, Lindsey; Meng, Fanyin; Francis, Heather; Alpini, Gianfranco] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
   [Liangpunsakul, Suthat; Meng, Fanyin; Francis, Heather; Alpini, Gianfranco] Indiana Univ Sch Med, Res, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   [Saxena, Romil] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
   [Huang, Qiaobing] Southern Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China.
C3 Texas A&M University System; Texas A&M University College Station;
   Indiana University System; Indiana University Bloomington; Indiana
   University System; Indiana University Bloomington; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; Indiana University System; Indiana
   University Bloomington; Texas A&M University System; Texas A&M
   University College Station; Southern Medical University - China
RP Glaser, S (corresponding author), Texas A&M Univ, Coll Med, Dept Med Physiol, MREB 2,Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
EM sglaser@tamu.edu
RI Chakraborty, Sanjukta/AFO-9240-2022; Chen, Lixian/ABH-3076-2021; Yang,
   Zhihong/L-5024-2019
OI Chakraborty, Sanjukta/0000-0002-4869-3198; 
FU Hickam Endowed Chair, Gastroenterology from Indiana University; VA
   Research Senior Career Scientist Award; National Institutes of Health
   [DK054811, DK07698, DK107310, DK110035, DK062975, AA025997, AA025157,
   DK108959, DK119421, DK107682, AA025208, UH2AA026903, U01AA026917];
   American Heart Association's Scientist Development Grant
   [17SDG33670306]; Indiana University Strategic Research Initiative;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative
FX Supported by the Hickam Endowed Chair, Gastroenterology from Indiana
   University, a VA Research Senior Career Scientist Award, and the
   National Institutes of Health (DK054811, DK07698, DK107310, DK110035,
   DK062975, AA025997, and AA025157, to G.A., F.M., and S.G.; DK108959 and
   DK119421, to H.F.; DK107682, AA025208, UH2AA026903, and U01AA026917, to
   S.L.), and the American Heart Association's Scientist Development Grant
   (17SDG33670306, to S.C.). Portions of this work were also supported by
   the Indiana University Strategic Research Initiative (to G. A., H.F.,
   and F.M.). This material is the result of work supported by resources at
   both the Central Texas Veterans Health Care System (Temple, TX) and the
   Richard L. Roudebush VA Medical Center (Indianapolis, IN). The project
   described was supported by the Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative. The content
   is the responsibility of the author(s) alone and does not necessarily
   reflect the views or policies of the Department of Veterans Affairs or
   the US government.
CR Adachi T, 2005, HEPATOLOGY, V41, P1272, DOI 10.1002/hep.20719
   Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   Antushevich H, 2018, CLIN CHIM ACTA, V483, P241, DOI 10.1016/j.cca.2018.05.012
   Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009
   Chen LX, 2019, BBA-MOL BASIS DIS, V1865, P1525, DOI 10.1016/j.bbadis.2019.03.002
   Chen Q, 2016, INT IMMUNOPHARMACOL, V34, P250, DOI 10.1016/j.intimp.2016.03.011
   Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452
   De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101
   Ehrlich L, 2018, CLIN RES HEPATOL GAS, V42, P296, DOI 10.1016/j.clinre.2018.03.009
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Glaser SS, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000994
   Hall C, 2017, CANCER LETT, V386, P179, DOI 10.1016/j.canlet.2016.11.025
   Hashimoto T, 2007, AM J PATHOL, V171, P1705, DOI 10.2353/ajpath.2007.070471
   Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199
   Huang SF, 2016, CLIN CHIM ACTA, V456, P81, DOI 10.1016/j.cca.2016.02.025
   Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7
   Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Li Q, 2014, FRONT BIOSCI-LANDMRK, V19, P1411, DOI 10.2741/4291
   Liu MQ, 2018, J CELL PHYSIOL, V233, P6839, DOI 10.1002/jcp.26554
   Liu QF, 2013, BIOCHEM BIOPH RES CO, V439, P235, DOI 10.1016/j.bbrc.2013.08.051
   Lv XR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00221
   Maloney PR, 2012, BIOORG MED CHEM LETT, V22, P6656, DOI 10.1016/j.bmcl.2012.08.105
   Melgar-Lesmes P, 2011, GUT, V60, P1404, DOI 10.1136/gut.2010.234690
   Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Mesmin C, 2010, RAPID COMMUN MASS SP, V24, P2875, DOI 10.1002/rcm.4718
   Nieto N, 2002, HEPATOLOGY, V35, P62, DOI 10.1053/jhep.2002.30362
   Paik YH, 2014, ANTIOXID REDOX SIGN, V20, P2854, DOI 10.1089/ars.2013.5619
   Principe A, 2008, HEPATOLOGY, V48, P1193, DOI 10.1002/hep.22467
   Reich M, 2016, GUT, V65, P487, DOI 10.1136/gutjnl-2015-309458
   Reichenbach V, 2012, J PHARMACOL EXP THER, V340, P629, DOI 10.1124/jpet.111.188078
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263
   Szuster-Ciesielska A, 2011, TOXICOLOGY, V280, P152, DOI 10.1016/j.tox.2010.12.006
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Tiam C, 2009, J HEPATOL, V50, P296, DOI 10.1016/j.jhep.2008.09.019
   Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Xie F, 2017, ACTA PHARMACOL SIN, V38, P1589, DOI 10.1038/aps.2017.97
   Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167
   Xu M, 2019, CELL, V178, P1478, DOI 10.1016/j.cell.2019.07.021
   Yokomori H, 2011, J GASTROENTEROL, V46, P222, DOI 10.1007/s00535-010-0296-3
   Zhou QL, 2018, CLIN CHIM ACTA, V487, P233, DOI 10.1016/j.cca.2018.10.011
   Zhou Q, 2016, INT J MOL MED, V37, P1159, DOI 10.3892/ijmm.2016.2544
NR 50
TC 20
Z9 21
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2021 JUN
PY 2021
VL 73
IS 6
BP 2411
EP 2428
DI 10.1002/hep.31545
EA MAY 2021
PG 18
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA SU5AL
UT WOS:000652802200001
PM 32964473
OA Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Tsuneki, H
   Tokai, E
   Nakamura, Y
   Takahashi, K
   Fujita, M
   Asaoka, T
   Kon, K
   Anzawa, Y
   Wada, T
   Takasaki, I
   Kimura, K
   Inoue, H
   Yanagisawa, M
   Sakurai, T
   Sasaoka, T
AF Tsuneki, Hiroshi
   Tokai, Emi
   Nakamura, Yuya
   Takahashi, Keisuke
   Fujita, Mikio
   Asaoka, Takehiro
   Kon, Kanta
   Anzawa, Yuuki
   Wada, Tsutomu
   Takasaki, Ichiro
   Kimura, Kumi
   Inoue, Hiroshi
   Yanagisawa, Masashi
   Sakurai, Takeshi
   Sasaoka, Toshiyasu
TI Hypothalamic Orexin Prevents Hepatic Insulin Resistance via Daily
   Bidirectional Regulation of Autonomic Nervous System in Mice
SO DIABETES
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; HIGH-FAT DIET; CIRCADIAN-RHYTHMS;
   GLUCOSE-HOMEOSTASIS; METABOLIC DISEASES; DIABETES-MELLITUS;
   ENERGY-METABOLISM; KNOCKOUT MICE; MOUSE-LIVER; RAT-BRAIN
AB Circadian rhythm is crucial for preventing hepatic insulin resistance, although the mechanism remains uncovered. Here we report that the wake-active hypothalamic orexin system plays a key role in this regulation. Wildtype mice showed that a daily rhythm in blood glucose levels peaked at the awake period; however, the glucose rhythm disappeared in orexin knockout mice despite normal feeding rhythm. Central administration of orexin A during nighttime awake period acutely elevated blood glucose levels but subsequently lowered daytime glucose levels in normal and diabetic db/db mice. The glucose-elevating and -lowering effects of orexin A were suppressed by adrenergic antagonists and hepatic para-sympathectomy, respectively. Moreover, the expression levels of hepatic gluconeogenic genes, including Pepck, were increased and decreased by orexin A at nanomolar and femtomolar doses, respectively. These results indicate that orexin can bidirectionally regulate hepatic gluconeogenesis via control of autonomic balance, leading to generation of the daily blood glucose oscillation. Furthermore, during aging, orexin deficiency enhanced endoplasmic reticulum (ER) stress in the liver and caused impairment of hepatic insulin signaling and abnormal gluconeogenic activity in pyruvate tolerance test. Collectively, the daily glucose rhythm under control of orexin 459 appears to be important for maintaining ER homeostasis, thereby preventing insulin resistance in the liver.
C1 [Tsuneki, Hiroshi; Tokai, Emi; Nakamura, Yuya; Takahashi, Keisuke; Fujita, Mikio; Asaoka, Takehiro; Kon, Kanta; Anzawa, Yuuki; Wada, Tsutomu; Sasaoka, Toshiyasu] Toyama Univ, Dept Clin Pharmacol, Toyama 930, Japan.
   [Takasaki, Ichiro] Toyama Univ, Div Mol Genet Res, Toyama 930, Japan.
   [Kimura, Kumi; Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan.
   [Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.
   [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75390 USA.
   [Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan.
C3 University of Toyama; University of Toyama; Kanazawa University;
   University of Tsukuba; University of Texas System; University of Texas
   Southwestern Medical Center Dallas; Howard Hughes Medical Institute;
   Kanazawa University
RP Tsuneki, H (corresponding author), Toyama Univ, Dept Clin Pharmacol, Toyama 930, Japan.
EM htsuneki@pha.u-toyama.ac.jp; tsasaoka@pha.u-toyama.ac.jp
RI Wada, Tsutomu/AAY-4450-2020
OI Wada, Tsutomu/0000-0001-5819-8556; Inoue, Hiroshi/0000-0002-7724-6637
FU Japan Society for the Promotion of Science [24591317, 24390056]; Takeda
   Science Foundation; Smoking Research Foundation; Research Foundation for
   Pharmaceutical Sciences; Japan Diabetes Foundation; Foundation for
   Growth Science; Tamura Science and Technology Foundation; Grants-in-Aid
   for Scientific Research [24591317, 24390056] Funding Source: KAKEN
FX This work was supported by the Japan Society for the Promotion of
   Science Grants-in-Aid for Scientific Research (KAKENHI) grants 24591317
   and 24390056 and grants from the Takeda Science Foundation (H.T.), the
   Smoking Research Foundation (H.T.), the Research Foundation for
   Pharmaceutical Sciences (H.T.), the Japan Diabetes Foundation (T.S.),
   the Foundation for Growth Science (T.S.), and the Tamura Science and
   Technology Foundation (T.S.).
CR Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044
   Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816
   Chou TC, 2003, J NEUROSCI, V23, P10691
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507
   Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002
   Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748
   Date Y, 2000, NEUROSCI LETT, V288, P87, DOI 10.1016/S0304-3940(00)01195-2
   DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028
   Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819
   Desarnaud F, 2004, SLEEP, V27, P851, DOI 10.1093/sleep/27.5.851
   DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610
   Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015
   Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014
   Goncalves ACD, 2009, HYPERTENSION, V53, P387, DOI 10.1161/HYPERTENSIONAHA.108.124776
   Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046
   Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019
   Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043
   Hwang LL, 2001, J PHYSIOL-LONDON, V537, P511, DOI 10.1111/j.1469-7793.2001.00511.x
   Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059
   Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x
   Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI [10.1042/bse0490137, 10.1042/BSE0480137]
   Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005
   Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684
   Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743
   Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449
   Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190
   Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011
   Mizuno M, 2008, J PHYSIOL SCI, V58, P381, DOI 10.2170/physiolsci.RP011508
   Poli F, 2009, SLEEP, V32, P1491, DOI 10.1093/sleep/32.11.1491
   Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005
   Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092
   Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013
   Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184
   Takasaki I, 2012, PAIN, V153, P585, DOI 10.1016/j.pain.2011.11.022
   Tanida M, 2006, EXP BIOL MED, V231, P1616
   Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8
   Tsuneki H, 2012, ENDOCR J, V59, P365, DOI 10.1507/endocrj.EJ12-0030
   van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290
   Yamamoto Y, 1999, MOL BRAIN RES, V65, P14, DOI 10.1016/S0169-328X(98)00320-9
   Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3
   Yi CX, 2009, DIABETES, V58, P1998, DOI 10.2337/db09-0385
   Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011
   Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859
   Zeitzer JM, 2003, J NEUROSCI, V23, P3555
   Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619
NR 48
TC 51
Z9 55
U1 0
U2 15
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD FEB
PY 2015
VL 64
IS 2
BP 459
EP 470
DI 10.2337/db14-0695
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CA3ST
UT WOS:000348827100017
PM 25249578
OA Bronze
DA 2024-02-19
ER

PT J
AU Shin, J
   Kim, JH
   Kim, EK
AF Shin, J.
   Kim, J. -H.
   Kim, E. K.
TI Repeated exposure of human fibroblasts to UVR induces secretion of stem
   cell factor and senescence
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Article
ID HUMAN SKIN; MELASMA; PIGMENTATION; EXPRESSION; MELANOCYTES; LIGHT; VIVO
AB Background Some of chronic hyperpigmentary diseases, such as melasma, induced by multiple factors including chronic sunlight exposure, can recur even after chemical epidermal removal. Dermal factors may be involved in the pathogenesis of melasma. Changes in dermal fibroblasts resulting from chronic sun exposure might cause melanocytes to synthesize melanin in the epidermis. Objective This study aimed at determining the effects of repetitive ultraviolet (UV) radiation on cultured fibroblasts and the secretion of melanogenic factors. Methods Cultured human fibroblasts were exposed to ultraviolet A (UVA) or ultraviolet B (UVB) for five consecutive days. After each irradiation, the supernatant medium was isolated from each dish and measured for levels of stem cell factor (SCF) and hepatocyte growth factor using an ELISA kit assay. To assess the effect of the keratinocyte-derived factors on fibroblast-secretion of SCF and hepatocyte growth factor, we added supernatants of the UV-irradiated keratinocytes to the non-irradiated fibroblasts. Finally, the irradiated fibroblasts were stained with senescence associated-beta-galactosidase to assess their senescent change. Results Fibroblasts irradiated with UVA or UVB for five consecutive days, secreted SCF at levels that increased with repeated UVA or UVB exposure. Conditioned culture medium from UV-irradiated keratinocytes also induced SCF release from fibroblasts, depending on the number of UV exposures. UVA- or UVB-irradiated fibroblasts stained positive for senescence associated-beta-galactosidase, and the staining intensity increased with repeated exposure. Conclusion These results suggest that fibroblast senescence and increased SCF secretion after repeated UV irradiation may be related to the pathogenesis of recurring hyperpigmentation disorders induced by chronic sun exposure.
C1 [Kim, J. -H.; Kim, E. K.] Inha Univ, Dept Biol Engn, Inchon, South Korea.
   [Shin, J.] Inha Univ, Sch Med, Dept Dermatol, Inchon, South Korea.
C3 Inha University; Inha University
RP Kim, EK (corresponding author), Inha Univ, Dept Biol Engn, Inchon, South Korea.
EM ekkim@inha.ac.kr
RI Shin, Jeonghyun/U-1912-2019
OI Shin, Jeonghyun/0000-0002-4995-9533
FU Korea Healthcare technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A103017]; Inha University
FX This study was supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea (A103017)
   and, in part, by Inha University.
CR Brenner M, 2005, BRIT J DERMATOL, V153, P733, DOI 10.1111/j.1365-2133.2005.06780.x
   CALDERONE DC, 1995, J AM ACAD DERMATOL, V32, P1016, DOI 10.1016/0190-9622(95)91342-4
   Cario-André M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x
   Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774
   Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003
   GRIMES PE, 1995, ARCH DERMATOL, V131, P1453, DOI 10.1001/archderm.131.12.1453
   Gupta AK, 2006, J AM ACAD DERMATOL, V55, P1048, DOI 10.1016/j.jaad.2006.02.009
   Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9
   Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235
   Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x
   Kang HY, 2006, BRIT J DERMATOL, V154, P1094, DOI 10.1111/j.1365-2133.2006.07179.x
   Kang WH, 2002, BRIT J DERMATOL, V146, P228, DOI 10.1046/j.0007-0963.2001.04556.x
   SANCHEZ NP, 1981, J AM ACAD DERMATOL, V4, P698, DOI 10.1016/S0190-9622(81)70071-9
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x
   Templin C, 2009, EXP DERMATOL, V18, P445, DOI 10.1111/j.1600-0625.2008.00809.x
   VAZQUEZ M, 1988, INT J DERMATOL, V27, P25, DOI 10.1111/j.1365-4362.1988.tb02329.x
   Yamaguchi Y, 2009, J INVEST DERM SYMP P, V14, P73, DOI 10.1038/jidsymp.2009.4
   Yamamoto T, 2001, BRIT J DERMATOL, V144, P199, DOI 10.1046/j.1365-2133.2001.03983.x
NR 19
TC 35
Z9 37
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0926-9959
EI 1468-3083
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD DEC
PY 2012
VL 26
IS 12
BP 1577
EP 1580
DI 10.1111/j.1468-3083.2011.04223.x
PG 4
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA 038IO
UT WOS:000311168600018
PM 21929554
DA 2024-02-19
ER

PT J
AU Yen, SSC
AF Yen, SSC
TI Adrenal andropause and aging
SO JOURNAL OF ANTI-AGING MEDICINE
LA English
DT Article; Proceedings Paper
CT International Symposium on Endocrinology of Aging
CY OCT 27-30, 1999
CL TEMPE, AZ
ID GROWTH-FACTOR-I; HUMAN ADRENOCORTICAL-CELLS; ACTIVATED RECEPTOR-ALPHA;
   ENDOCRINE-METABOLIC PARAMETERS; BETA-OXIDATION PATHWAY;
   DEHYDROEPIANDROSTERONE-SULFATE; PEROXISOME PROLIFERATOR;
   CORTISOL-LEVELS; IGF-I; POSTMENOPAUSAL WOMEN
AB Adrenocortical function undergoes diverse changes throughout development and aging. Aging in humans is accompanied by an increase in adrenal glucocorticoid secretion and a decline in adrenal androgen synthesis and secretion. In recent years, the intense interest in adrenal function and aging is, in large measure, generated by the potential impact of cortisol excess in the development of cognitive impairment and hippocampal neuronal loss, and by the potential beneficial effects in providing hormone replacement (dehydroepiandrosterone; DHEA) acid healthy aging. While the preliminary data is tantalizing, solid scientific evidence is not at hand. It is apparent that both issues are extremely complex. DHEA and its 3 beta -sulfate (DHEA-S) are fascinating molecules, including their synthesis and actions in the brain. Recent studies have shown that DHEA/DHEA-S may have regulatory functions in hepatic lipid metabolism and in the immune system in humans: DHEA-S, but not DHEA, activates hepatic (PPAR alpha) peroxisome proliferator-activated receptor alpha, a nuclear receptor that mediates the induction of enzymes involved in beta -oxidation of lipids. Thus, DHEA-S may serve as a physiological modulator of liver fatty-acid metabolism and peroxisomal enzyme expression and, thereby, may contribute to the regulation of lipid homeostasis. Furthermore, the age-associated elevation of serum interleukin-6 (IL-6) in men and women can be normalized by physiological concentrations of DHEA, an observation that is consistent with endocrine-immune-system interaction. The life-sustaining role of adrenal cortisol secretion and its regulation of metabolism via catabolic actions may be modulated by its partner DHEA and by DHEA-S. During the anabolic growth period (childhood and early adulthood), the body is exposed to relatively high levels of DHEA/DHEA-S, but during infancy and aging relatively high levels of cortisol are dominant. The cortisol/DHEA-S molar ratio during the life span follows a U-shape curve, which may an indicator that we should explore these two critical adrenal steroids in tandem.
C1 Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.
C3 University of California System; University of California San Diego
RP Yen, SSC (corresponding author), Univ Calif San Diego, Dept Reprod Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM dnye@ucsd.edu
CR ALBERT DH, 1980, J BIOL CHEM, V255, P618
   Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401
   BAULIEU EE, 1960, J CLIN ENDOCR METAB, V20, P900, DOI 10.1210/jcem-20-6-900
   Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1
   BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
   BIRD CE, 1978, J CLIN ENDOCR METAB, V47, P818, DOI 10.1210/jcem-47-4-818
   Butenandt A, 1934, Z PHYSL CHEM, V229, P192
   deLeon MJ, 1997, J CLIN ENDOCR METAB, V82, P3251, DOI 10.1210/jc.82.10.3251
   DEPERGOLA G, 1993, INT J OBESITY, V17, P481
   Deuschle M, 1997, LIFE SCI, V61, P2239, DOI 10.1016/S0024-3205(97)00926-0
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0
   Diamond P, 1996, J ENDOCRINOL, V150, pS43
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5
   Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P301
   Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101
   Endoh A, 1996, J CLIN ENDOCR METAB, V81, P3558, DOI 10.1210/jc.81.10.3558
   FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0
   FRIESS E, 1995, AM J PHYSIOL-ENDOC M, V268, pE107, DOI 10.1152/ajpendo.1995.268.1.E107
   Givalois L, 1997, MOL BRAIN RES, V48, P107, DOI 10.1016/S0169-328X(97)00088-0
   Guazzo EP, 1996, J CLIN ENDOCR METAB, V81, P3951, DOI 10.1210/jc.81.11.3951
   HESSE V, 1994, EXP CLIN ENDOCRINOL, V102, P289, DOI 10.1055/s-0029-1211294
   HOLLOWAY L, 1994, J CLIN ENDOCR METAB, V79, P470, DOI 10.1210/jc.79.2.470
   Hornsby PJ, 1997, J AM GERIATR SOC, V45, P1395, DOI 10.1111/j.1532-5415.1997.tb02941.x
   Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47
   JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118
   James K, 1997, MECH AGEING DEV, V93, P15, DOI 10.1016/S0047-6374(96)01807-6
   Janssen JAMJL, 1998, CLIN ENDOCRINOL, V48, P471
   Kalmijn S, 1998, J CLIN ENDOCR METAB, V83, P3487, DOI 10.1210/jc.83.10.3487
   KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160
   Kern W, 1996, J GERONTOL A-BIOL, V51, pM3, DOI 10.1093/gerona/51A.1.M3
   Kipper-Galperin M, 1999, INT J DEV NEUROSCI, V17, P765, DOI 10.1016/S0736-5748(99)00067-2
   Kirschbaum C, 1996, J CLIN ENDOCR METAB, V81, P3639, DOI 10.1210/jc.81.10.3639
   KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9
   Kristiansen SB, 1997, STEROIDS, V62, P258, DOI 10.1016/S0039-128X(96)00223-1
   Kudielka BM, 1998, J CLIN ENDOCR METAB, V83, P1756, DOI 10.1210/jc.83.5.1756
   LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A
   Labrie F, 1997, J CLIN ENDOCR METAB, V82, P3498, DOI 10.1210/jc.82.10.3498
   LAllemand D, 1996, J CLIN ENDOCR METAB, V81, P3892, DOI 10.1210/jc.81.11.3892
   LEGRAIN S, 1995, GERONTOLOGY, V41, P343, DOI 10.1159/000213706
   Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406
   LIU CH, 1990, J CLIN ENDOCR METAB, V71, P900, DOI 10.1210/jcem-71-4-900
   LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994
   Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459
   MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A
   Majewska MD, 1995, ANN NY ACAD SCI, V774, P111, DOI 10.1111/j.1749-6632.1995.tb17375.x
   MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X
   MCEWEN BS, 1991, TRENDS PHARMACOL SCI, V12, P141, DOI 10.1016/0165-6147(91)90531-V
   Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395
   MEIKLE AW, 1988, METABOLISM, V37, P514, DOI 10.1016/0026-0495(88)90164-3
   MIGEON CJ, 1954, J BIOL CHEM, V209, P767
   MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360
   Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x
   MORALES AJ, 1995, J CLIN ENDOCR METAB, V80, P2799
   MORTOLA JF, 1990, J CLIN ENDOCR METAB, V71, P696, DOI 10.1210/jcem-71-3-696
   Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272
   Munson PL, 1944, J BIOL CHEM, V152, P67
   NESTLER JE, 1988, J CLIN ENDOCR METAB, V66, P57, DOI 10.1210/jcem-66-1-57
   Paolisso G, 1997, J CLIN ENDOCR METAB, V82, P2204, DOI 10.1210/jc.82.7.2204
   PARE WP, 1965, J GERONTOL, V20, P78, DOI 10.1093/geronj/20.1.78
   Parker CR, 2000, J CLIN ENDOCR METAB, V85, P48, DOI 10.1210/jc.85.1.48
   Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898
   PARKER CR, 1995, ANN M SOC GYN INV CH
   PARKER CR, 1999, ENDOCRINOL DIABETES, V6, P210
   Peters JM, 1996, MOL PHARMACOL, V50, P67
   PHAMHUUTRUNG MT, 1991, J STEROID BIOCHEM, V39, P903, DOI 10.1016/0960-0760(91)90348-9
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Ravaglia G, 1996, J CLIN ENDOCR METAB, V81, P1173, DOI 10.1210/jc.81.3.1173
   Robel P, 1995, CRIT REV NEUROBIOL, V9, P383
   Robel P, 1995, ANN NY ACAD SCI, V774, P82, DOI 10.1111/j.1749-6632.1995.tb17374.x
   ROTTER JI, 1985, METABOLISM, V34, P731, DOI 10.1016/0026-0495(85)90023-X
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SAPOLSKY RM, 1993, BEHAV BRAIN RES, V57, P175, DOI 10.1016/0166-4328(93)90133-B
   SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990
   SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7
   SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634
   Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908
   SLADEK CD, 1987, ENDOCRINOLOGY, V120, P1576, DOI 10.1210/endo-120-4-1576
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F
   STEINEGER HH, 1994, EUR J BIOCHEM, V225, P967, DOI 10.1111/j.1432-1033.1994.0967b.x
   Straub RH, 1998, J CLIN ENDOCR METAB, V83, P2012, DOI 10.1210/jc.83.6.2012
   THOMAS G, 1994, J CLIN ENDOCR METAB, V79, P1273, DOI 10.1210/jc.79.5.1273
   THOMPSON JL, 1995, J CLIN ENDOCR METAB, V80, P1845, DOI 10.1210/jc.80.6.1845
   USISKIN KS, 1990, INT J OBESITY, V14, P457
   VAMVAKOPOULOS NC, 1993, J CLIN INVEST, V92, P1896, DOI 10.1172/JCI116782
   VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468
   VANCOEVORDEN A, 1991, AM J PHYSIOL, V260, pE651, DOI 10.1152/ajpendo.1991.260.4.E651
   WELLE S, 1990, J CLIN ENDOCR METAB, V71, P1259, DOI 10.1210/jcem-71-5-1259
   Wilkinson CW, 1997, NEUROENDOCRINOLOGY, V65, P79, DOI 10.1159/000127167
   Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1
   Wolf OT, 1997, BIOL PSYCHIAT, V42, P845, DOI 10.1016/S0006-3223(97)00323-5
   Yen SSC, 1998, EXP GERONTOL, V33, P897, DOI 10.1016/S0531-5565(98)00046-1
   Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843
NR 94
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1094-5458
J9 J ANTI-AGING MED
JI J. Anti-Aging Med.
PD FAL
PY 2000
VL 3
IS 3
BP 315
EP 328
DI 10.1089/rej.1.2000.3.315
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 368WY
UT WOS:000090141500010
DA 2024-02-19
ER

PT J
AU HORBACH, GJMJ
   VANASTEN, JG
   VANBEZOOIJEN, CFA
AF HORBACH, GJMJ
   VANASTEN, JG
   VANBEZOOIJEN, CFA
TI THE INFLUENCE OF AGING ON THE INDUCTION OF THE MESSENGER-RNAS OF
   RAT-LIVER CYTOCHROME-P450IIB1 AND CYTOCHROME-P450IIB2
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
RP HORBACH, GJMJ (corresponding author), TNO,INST EXPTL GERONTOL,POB 5815,2280 HV RIJSWIJK,NETHERLANDS.
CR ATCHISON M, 1983, J BIOL CHEM, V258, P1285
   DILELLA AG, 1982, MECH AGEING DEV, V19, P113, DOI 10.1016/0047-6374(82)90003-3
   FUJIIKURIYAMA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2793, DOI 10.1073/pnas.79.9.2793
   FUJITA S, 1982, LIVER AGING 1982, P55
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   KITAHARA A, 1982, LIVER AGING 1982, P135
   LU AYH, 1980, PHARMACOL REV, V31, P277
   MIZUKAMI Y, 1983, P NATL ACAD SCI-BIOL, V80, P3958, DOI 10.1073/pnas.80.13.3958
   NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1
   OMIECINSKI CJ, 1985, J BIOL CHEM, V260, P3247
   RICHARDSON A, 1986, MOL BIOL AGING GENE, V29, P229
   RICHARDSON CC, 1965, P NATL ACAD SCI USA, V54, P158, DOI 10.1073/pnas.54.1.158
   RIKANS LE, 1981, EXP GERONTOL, V16, P253, DOI 10.1016/0531-5565(81)90021-8
   SATO R, 1978, CYTOCHROME P450
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SHORE GC, 1977, J CELL BIOL, V72, P726, DOI 10.1083/jcb.72.3.726
   TUKEY RH, 1984, BIOCHEMISTRY-US, V23, P6003, DOI 10.1021/bi00320a016
   Van Bezooijen C. F. A., 1986, DRUGS AGING, P45
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
NR 19
TC 19
Z9 19
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD AUG 1
PY 1990
VL 40
IS 3
BP 529
EP 533
DI 10.1016/0006-2952(90)90552-V
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DU455
UT WOS:A1990DU45500017
PM 2383285
DA 2024-02-19
ER

PT J
AU Baek, SM
   Lee, SW
   Lee, YJ
   Choi, SK
   Kim, HY
   Seo, MS
   Sung, SE
   Lee, AR
   Kim, TU
   Han, SH
   Son, JH
   Park, SJ
   Kim, TH
   Jeong, KS
   Park, JK
AF Baek, Su-Min
   Lee, Seoung-Woo
   Lee, Young-Jin
   Choi, Seong-Kyoon
   Kim, Hee-Yeon
   Seo, Min-Soo
   Sung, Soo-Eun
   Lee, A-Rang
   Kim, Tae-Un
   Han, Se-Hyeon
   Son, Jun-Hyeok
   Park, Sang-Joon
   Kim, Tae-Hwan
   Jeong, Kyu-Shik
   Park, Jin-Kyu
TI Vitamin C alleviates alcoholic liver injury by suppressing neutrophil
   infiltration in senescence marker protein 30-knockout mice irrespective
   of its antioxidant effects
SO LIFE SCIENCES
LA English
DT Article; Early Access
DE Alcoholic liver disease; Inflammation; SMP30; Vitamin C; Neutrophils;
   Gut-liver axis
ID OXIDATIVE-STRESS; LIPID-PEROXIDATION; ASCORBIC-ACID; DISEASE;
   PATHOGENESIS; DEFICIENCY; TRANSPLANTATION; HEPATOCYTES; MECHANISMS;
   INCREASES
AB Aims: Alcoholic liver disease (ALD) comprises an important component in chronic liver diseases, and its clinical significance has increased due to the high consumption of alcohol worldwide. Vitamin C is a potent antioxidant, and several previous studies have suggested that its therapeutic role in ALD is derived from its antioxidant role. However, its anti-inflammatory role in ALD remains to be elucidated. Especially, the relationship between vitamin C and infiltration of neutrophils in ALD has not been discussed to date. For the reason, the present study investigated the precise role of vitamin C in neutrophil infiltration in ALD. Main methods: In the present study, wild-type C57BL/6 and vitamin C-deficient senescence marker protein 30 knockout mice were pair-fed with a Lieber-DeCarli control or ethanol diet. Ethanol-fed groups were fed with increasing concentrations of EtOH (Lieber-DeCarli control diet for 5 days, 3% EtOH diet for a week, and 5% diet for 2 weeks) with or without vitamin C supplementation. Key findings: Vitamin C dramatically attenuated the ethanol-mediated liver disease in the vitamin C-deficient ethanol-fed mice group by suppressing the infiltration of neutrophils accompanied by less CD68-positive cell infiltration. This attenuating role of vitamin C in neutrophil infiltration in the liver is associated with its protective effect for the ethanol-mediated intestinal damage in vitamin C-deficient ethanol-fed mice. Significance: This study provides a novel possibility of vitamin C to be used as an anti-inflammatory therapeutic agent associated with neutrophil infiltration in ALD, thereby helping to establish strategies for attenuating ALD.
C1 [Baek, Su-Min; Lee, Seoung-Woo; Lee, Young-Jin; Kim, Hee-Yeon; Lee, A-Rang; Kim, Tae-Un; Han, Se-Hyeon; Son, Jun-Hyeok; Kim, Tae-Hwan; Jeong, Kyu-Shik; Park, Jin-Kyu] Kyungpook Natl Univ, Coll Vet Med, Dept Vet Pathol, Daegu 41566, South Korea.
   [Choi, Seong-Kyoon; Kim, Hee-Yeon] Daegu Gyeongbuk Inst Sci & Technol DGIST, Core Prot Resources Ctr, Daegu 42988, South Korea.
   [Seo, Min-Soo; Sung, Soo-Eun] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu 41061, South Korea.
   [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Lab Vet Histol, Daegu 41566, South Korea.
   [Han, Se-Hyeon] Hanyang Univ, Dept Media & Commun, Seoul 04763, South Korea.
   [Park, Jin-Kyu] Kyungpook Natl Univ, Stem Cell Therapeut Res Inst, Daegu 41566, South Korea.
C3 Kyungpook National University; Daegu Gyeongbuk Institute of Science &
   Technology (DGIST); Kyungpook National University; Hanyang University;
   Kyungpook National University
RP Park, JK (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Vet Pathol, Daegu 41566, South Korea.
EM jinkyu820@knu.ac.kr
OI Lee, Seoung-Woo/0000-0002-7678-9242
FU National Research Foundation of Korea (NRF) - Korea government; Ministry
   of Education [2019R1I1A2A01060031]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grants funded by the Korea government, the Ministry of Education
   (grant number 2019R1I1A2A01060031).
CR Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003
   Ali Hadi, 2019, Current Opinion in Toxicology, V13, P110, DOI 10.1016/j.cotox.2018.10.003
   Asrani SK, 2021, HEPATOLOGY, V73, P2039, DOI 10.1002/hep.31583
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9
   Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116
   Cho Y, 2021, HEPATOLOGY, V74, P503, DOI 10.1002/hep.31680
   Chuncharunee L, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1050-9
   De Minicis S, 2008, J GASTROEN HEPATOL, V23, pS98, DOI 10.1111/j.1440-1746.2007.05277.x
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ito F, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8030072
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647
   Jimenez-Lopez Jose M, 2005, Expert Opin Drug Metab Toxicol, V1, P671, DOI 10.1517/17425255.1.4.671
   Julien J, 2020, LANCET PUBLIC HEALTH, V5, pE316, DOI 10.1016/S2468-2667(20)30062-1
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Kondo Y, 2016, GERIATR GERONTOL INT, V16, P4, DOI 10.1111/ggi.12722
   Kondo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065698
   Lee SW, 2021, AM J PATHOL, V191, P1550, DOI 10.1016/j.ajpath.2021.05.020
   Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018
   Liu K, 2021, CELL MOL IMMUNOL, V18, P38, DOI 10.1038/s41423-020-00560-0
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004
   Lucey MR, 2014, NAT REV GASTRO HEPAT, V11, P300, DOI 10.1038/nrgastro.2013.247
   MAVIER P, 1988, HEPATOLOGY, V8, P254, DOI 10.1002/hep.1840080211
   Mortaz E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02171
   Ozturk IC, 2009, CELL BIOCHEM FUNCT, V27, P309, DOI 10.1002/cbf.1575
   PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189
   Park JK, 2010, J GASTROEN HEPATOL, V25, P1769, DOI 10.1111/j.1440-1746.2010.06239.x
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Ramaiah SK, 2007, TOXICOL MECH METHOD, V17, P431, DOI 10.1080/00952990701407702
   Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7
   Su M, 2019, ENVIRON TOXICOL PHAR, V65, P60, DOI 10.1016/j.etap.2018.12.004
   Sugimoto K, 2017, HEPATOL RES, V47, P70, DOI 10.1111/hepr.12736
   Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042
   Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321
   TAKEI Y, 1995, J GASTROEN HEPATOL, V10, pS65, DOI 10.1111/j.1440-1746.1995.tb01802.x
   Tilg H, 2016, HEPATOLOGY, V64, P955, DOI 10.1002/hep.28456
   Tilg H, 2011, J HEPATOL, V55, P1159, DOI 10.1016/j.jhep.2011.05.015
   Torruellas C, 2014, WORLD J GASTROENTERO, V20, P11684, DOI 10.3748/wjg.v20.i33.11684
   World Health Organization, 2018, Global status report on preventing violence against children 2020
   Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370
   Zeng T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00538
   Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011
NR 48
TC 7
Z9 7
U1 2
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD 2022 MAY 15
PY 2022
VL 297
AR 120228
DI 10.1016/j.lfs.2021.120228
EA MAR 2022
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 1C6GI
UT WOS:000793214700003
PM 34921864
DA 2024-02-19
ER

PT J
AU Liu, CC
   Lee, YC
   Huang, SP
   Cheng, KH
   Hsieh, TJ
   Huang, TY
   Lee, CH
   Geng, JH
   Li, CC
   Wu, WJ
AF Liu, Chia-Chu
   Lee, Yung-Chin
   Huang, Shu-Pin
   Cheng, Kai-Hung
   Hsieh, Tusty-Jivan
   Huang, Tsung-Yi
   Lee, Cheng-Hsueh
   Geng, Jiun-Hung
   Li, Ching-Chia
   Wu, Wen-Jeng
TI Hepatocyte Nuclear Factor-4α P2 Promoter Variants Are Associated With
   the Risk of Metabolic Syndrome and Testosterone Deficiency in Aging
   Taiwanese Men
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Article
DE Insulin Resistance; Single-Nucleotide Polymorphism; Testosterone; Aging
   men
ID CAG REPEAT POLYMORPHISM; ERECTILE DYSFUNCTION; NCEP-ATPIII; TYPE-2;
   GENE; PREVALENCE; HNF4A; SUSCEPTIBILITY; LINKAGE
AB Background: Hepatocyte nuclear factor-4 alpha (HNF4A) can influence the risk of insulin resistance that is postulated to be an important link between metabolic syndrome (MetS) and testosterone deficiency (TD) in men.
   Aim: To investigate the relationship between single-nucleotide polymorphisms (SNPs) of HNF4A and the risk of developing MetS and TD in a population of aging Taiwanese men.
   Methods: A free health screening of men over 40 years of age was conducted in a medical center in Kaohsiung City, Taiwan. All participants underwent a physical examination, answered a questionnaire on demographics and medical history, completed the Androgen Deficiency in The Aging Male questionnaire to assess clinical symptoms of TD, and provided 20-mL whole blood samples for biochemical, hormonal, and genetic evaluation.
   Main Outcome Measure: 3 common SNPs (rs11574736, rs1884613, and rs2144908) of HNF4A were selected and identified using a TaqMan 5' allelic discrimination assay.
   Results: 559 men were enrolled for this study (mean age, 55.8 +/- 4.9 years). Prevalence of TDwas significantly higher (P=.031) in subjects with MetS (16.8%) than those without MetS (10.1%). In SNP rs1884613 of HNF4A, subjects with the Callele carried a 1.31- and 1.50-times higher risk of developing MetS and TD, respectively, compared to those with the G allele, after adjusting for potential covariates. In addition, subjects with the CC genotype were exposed to a 1.91- and 2.20-times higher risk of developing MetS and TD, respectively, compared to those with the GG genotype.
   Clinical Implications: Our findings may point to the importance of the role played by insulin resistance in the link between MetS and TD.
   Strength & Limitations: Our current work is the first report with adequate sample size to evaluate the role of genetic variants of HNF4A on the risk of both MetS and TD in men. The limitations included subjects enrolled from a free health screening and single measurement of serum testosterone levels.
   Conclusion: The rs1884613 SNP marker of HNF4A is significantly associated with an increased risk for developing both MetS and TD in aging Taiwanese men. Further population-based studies utilizing larger samples of different ethnicities may be needed to confirm these preliminary results. Copyright (C) 2018, International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
C1 [Liu, Chia-Chu; Lee, Yung-Chin; Huang, Shu-Pin; Huang, Tsung-Yi; Lee, Cheng-Hsueh; Li, Ching-Chia; Wu, Wen-Jeng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.
   [Liu, Chia-Chu; Lee, Yung-Chin; Huang, Shu-Pin; Li, Ching-Chia; Wu, Wen-Jeng] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan.
   [Liu, Chia-Chu] Minist Hlth & Welf, Dept Urol, Pingtung Hosp, Pingtung, Taiwan.
   [Lee, Yung-Chin; Geng, Jiun-Hung] Kaohsiung Municipal Hsiaokang Hosp, Dept Urol, Kaohsiung, Taiwan.
   [Cheng, Kai-Hung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.
   [Hsieh, Tusty-Jivan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.
   [Hsieh, Tusty-Jivan] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.
   [Wu, Wen-Jeng] Kaohsiung Municipal Tatung Hosp, Dept Urol, Kaohsiung, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung
   Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung
   Medical University Hospital; Kaohsiung Medical University; Kaohsiung
   Medical University; Kaohsiung Medical University; Kaohsiung Municipal
   Ta-Tung Hospital
RP Liu, CC (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, 100 Tz You 1st Rd, Kaohsiung, Taiwan.
EM ccliu0204@gmail.com
RI Huang, Shu-Pin/D-5286-2009; Wu, Wen-Jeng/C-7267-2009; Li,
   Ching-Chia/D-5024-2009; LIU, CHIA CHU/T-2880-2019; GENG,
   JIUNHUNG/AAB-2322-2022
OI GENG, JIUNHUNG/0000-0003-0610-1278; Cheng, Kai-Hung/0000-0003-1066-9499;
   wu, wen jeng/0000-0002-9691-7416; Hsieh, Tusty-Jiuan/0000-0001-5387-6522
FU Ministry of Science and Technology, Taiwan [MOST 105-2314-B-037-015-,
   MOST 106-2314-B-037-065-MY3]; Research Center for Environmental
   Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Kaohsiung
   Medical University Hospital, Kaohsiung, Taiwan [KMUH105-5R43,
   KMUH106-6R58]
FX This study was supported by grants from the Ministry of Science and
   Technology, Taiwan (MOST 105-2314-B-037-015-; MOST
   106-2314-B-037-065-MY3), Research Center for Environmental Medicine,
   Kaohsiung Medical University, Kaohsiung, Taiwan, and Kaohsiung Medical
   University Hospital, Kaohsiung, Taiwan (KMUH105-5R43; KMUH106-6R58). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002
   Bagwell AM, 2005, DIABETES, V54, P1185, DOI 10.2337/diabetes.54.4.1185
   Bianchi VE, 2018, OBES REV, V19, P557, DOI 10.1111/obr.12633
   Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409
   Chavali S, 2011, J HUM GENET, V56, P695, DOI 10.1038/jhg.2011.83
   Cheng KH, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/658151
   Cheng KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060295
   Corona G, 2007, J SEX MED, V4, P789, DOI 10.1111/j.1743-6109.2007.00498.x
   Corona G, 2007, J SEX MED, V4, P1038, DOI 10.1111/j.1743-6109.2007.00529.x
   Dean JD, 2015, J SEX MED, V12, P1660, DOI 10.1111/jsm.12952
   Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198
   Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3
   Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513
   Lee YC, 2017, J SEX MED, V14, P510, DOI 10.1016/j.jsxm.2017.02.009
   Lehman DM, 2007, DIABETES, V56, P513, DOI 10.2337/db06-0881
   Li TJ, 2011, MOL CELL BIOCHEM, V353, P259, DOI 10.1007/s11010-011-0794-5
   Liu CC, 2015, ANDROLOGY-US, V3, P902, DOI 10.1111/andr.12068
   Liu CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03078-0
   Liu CC, 2012, J SEX MED, V9, P2429, DOI 10.1111/j.1743-6109.2012.02672.x
   Liu CC, 2009, J SEX MED, V6, P936, DOI 10.1111/j.1743-6109.2008.01171.x
   Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006
   Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d
   Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134
   Marcil V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117238
   Mulhall JP, 2018, J UROLOGY, V200, P423, DOI 10.1016/j.juro.2018.03.115
   Park E, 2015, J CARDIOVASC NURS, V30, P256, DOI 10.1097/JCN.0000000000000142
   Permutt MA, 2001, DIABETES, V50, P681, DOI 10.2337/diabetes.50.3.681
   Rochlani Y, 2015, CARDIOVASC DRUG THER, V29, P329, DOI 10.1007/s10557-015-6593-6
   Saif-Ali R, 2012, BIOCHEM GENET, V50, P298, DOI 10.1007/s10528-011-9472-2
   Saif-Ali R, 2011, ACTA BIOCHIM POL, V58, P179
   Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   Wang C, 2014, DIS MARKERS, V2014
   Weissglas-Volkov D, 2006, DIABETES, V55, P1970, DOI 10.2337/db06-0035
   Winckler W, 2005, DIABETES, V54, P886, DOI 10.2337/diabetes.54.3.886
   Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   Zitzmann M, 2009, NAT REV ENDOCRINOL, V5, P673, DOI 10.1038/nrendo.2009.212
NR 38
TC 5
Z9 6
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1743-6095
EI 1743-6109
J9 J SEX MED
JI J. Sex. Med.
PD NOV
PY 2018
VL 15
IS 11
BP 1527
EP 1536
DI 10.1016/j.jsxm.2018.09.012
PG 10
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA HH9XL
UT WOS:000456094900003
PM 30415809
DA 2024-02-19
ER

PT J
AU Tuncbilek, M
   Guven, EB
   Onder, T
   Atalay, RC
AF Tuncbilek, Meral
   Guven, Ebru Bilget
   Onder, Tugce
   Atalay, Rengul Cetin
TI Synthesis of Novel 6-(4-Substituted
   piperazine-1-yl)-9-(β-D-ribofuranosyl)purine Derivatives, Which Lead to
   Senescence-Induced Cell Death in Liver Cancer Cells
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID THIOPURINES; THERAPY
AB Novel purine ribonucleoside analogues (9-13) containing a 4-substituted piperazine in the substituent at N-6 were synthesized and evaluated for their cytotoxicity on Huh7, HepG2, FOCUS, Mahlavu liver, MCF7 breast, and HCT116 colon carcinoma cell lines. The purine nucleoside analogues were analyzed initially by an anticancer drug-screening method based on a sulforhodamine B assay. Two nucleoside derivatives with promising cytotoxic activities (11 and 12) were further analyzed on the hepatoma cells. The N-6-(4-Trifluoromethylphenyl)piperazine analogue 11 displayed the best antitumor activity, with IC50 values between 5.2 and 9.2 mu M. Similar to previously described nucleoside analogues, compound 11 also interferes with cellular ATP reserves, possibly through influencing cellular kinase activities. Furthermore, the novel nucleoside analogue 11 was shown to induce senescence-associated cell death, as demonstrated by the SA beta-gal assay. The senescence-dependent cytotoxic effect of 11 was also confirmed through phosphorylation of the Rb protein by p15(INK4b) overexpression in the presence of this compound.
C1 [Tuncbilek, Meral; Onder, Tugce] Ankara Univ, Dept Pharmaceut Chem, Fac Pharm, TR-06100 Ankara, Turkey.
   [Guven, Ebru Bilget; Atalay, Rengul Cetin] Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.
   [Atalay, Rengul Cetin] Bilkent Univ, Genet & Biotechnol Res Ctr BilGen, TR-06800 Ankara, Turkey.
C3 Ankara University; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci
   Bilkent University
RP Tuncbilek, M (corresponding author), Ankara Univ, Dept Pharmaceut Chem, Fac Pharm, TR-06100 Ankara, Turkey.
EM tuncbile@pharmacy.ankara.edu.tr; rengul@bilkent.edu.tr
RI Bilget Güven, Ebru/AAI-1629-2019; Cetin-Atalay, Rengul/O-9826-2014;
   Cetin-Atalay, Rengul/F-5780-2013; Tunçbilek, Meral/AAH-1416-2020
OI Bilget Güven, Ebru/0000-0001-9734-9679; Cetin-Atalay,
   Rengul/0000-0003-2408-6606; Cetin-Atalay, Rengul/0000-0003-2408-6606; 
FU Scientific and Technological Research Council of Turkey-TUBITAK
   [TBAG-109T987]; KANILTEK from the State Planning Organization of Turkey
   (DPT); Bilkent University
FX This work was supported by the Scientific and Technological Research
   Council of Turkey-TUBITAK (TBAG-109T987), the KANILTEK Project from the
   State Planning Organization of Turkey (DPT), and Bilkent University
   funds. We thank to Professor Hakan Goker and Dr. Mehmet Alp from Central
   Instrumentation Laboratory of Faculty of Pharmacy, Ankara University for
   NMR and elemental analyses and to Dr. Murat K. Sukuroglu from Faculty of
   Pharmacy, Gazi University for HRMS. We thank R. Nelson for editing the
   English of the final version of our manuscript.
CR Andrzejewska M, 2002, NUCLEOS NUCLEOT NUCL, V21, P73, DOI 10.1081/NCN-120006532
   BOSCH L, 1958, CANCER RES, V18, P335
   Buontempo F, 2011, INVEST NEW DRUG, V29, P1303, DOI 10.1007/s10637-010-9486-3
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   DICK JE, 1985, FEBS LETT, V179, P21, DOI 10.1016/0014-5793(85)80182-4
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Escherich G, 2011, LEUKEMIA, V25, P953, DOI 10.1038/leu.2011.37
   Finn RS, 2012, J HEPATOL, V56, P723, DOI 10.1016/j.jhep.2011.08.023
   Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Irmak MB, 2003, CANCER RES, V63, P6707
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020
   Lech-Maranda E, 2006, MINI-REV MED CHEM, V6, P575, DOI 10.2174/138955706776876212
   Nakamura J, 2010, INT J ONCOL, V37, P845, DOI 10.3892/ijo_00000735
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342
   Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Simon GR, 2012, CANCER-AM CANCER SOC, V118, P2525, DOI 10.1002/cncr.26522
   Wilson PK, 2004, LEUKEMIA RES, V28, P725, DOI 10.1016/j.leukres.2003.11.013
NR 24
TC 44
Z9 47
U1 9
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD APR 12
PY 2012
VL 55
IS 7
BP 3058
EP 3065
DI 10.1021/jm3001532
PG 8
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)
SC Pharmacology & Pharmacy
GA 923AT
UT WOS:000302591100016
PM 22409771
DA 2024-02-19
ER

PT J
AU Bernard, D
   Gosselin, K
   Monte, D
   Vercamer, C
   Bouali, F
   Pourtier, A
   Vandenbunder, B
   Abbadie, C
AF Bernard, D
   Gosselin, K
   Monte, D
   Vercamer, C
   Bouali, F
   Pourtier, A
   Vandenbunder, B
   Abbadie, C
TI Involvement of Rd/nuclear factor-κB transcription factors in
   keratinocyte senescence
SO CANCER RESEARCH
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; MANGANOUS SUPEROXIDE-DISMUTASE; SEVERE LIVER
   DEGENERATION; ALPHA-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH;
   GAMMA-DEFICIENT MICE; HUMAN FIBROBLASTS; REPLICATIVE SENESCENCE;
   HYDROGEN-PEROXIDE; C-REL
AB After a finite doubling number, normal cells become senescent, i.e., nonproliferating and apoptosis resistant. Because Rel/nuclear factor (NF)-kappaB transcription factors regulate both proliferation and apoptosis, we have investigated their involvement in senescence. cRel overexpression in young normal keratinocytes results in premature senescence, as defined by proliferation blockage, apoptosis resistance, enlargement, and appearance of senescence-associated beta-galactosidase (SA-beta-Gal) activity. Normal senescent keratinocytes display a greater endogenous Rel/NF-kappaB DNA binding activity than young cells; inhibiting this activity in presenescent cells decreases the number of cells expressing the SA-beta-Gal marker. Normal senescent keratinocytes and cRel-induced premature senescent keratinocytes overexpressed manganese superoxide dismutase (MnSOD), a redox enzyme encoded by a Rel/NF-kappaB target gene. MnSOD transforms the toxic O<((2))over dot>(-) into H2O2, whereas catalase and glutathione peroxidase convert H2O2 into H2O. Neither catalase nor glutathione peroxidase is up-regulated during cRel-induced premature senescence or during normal senescence, suggesting that H2O2 accumulates. Quenching H2O2 by catalase delays the occurrence of both normal and premature cRel-induced senescence. Conversely, adding a nontoxic dose of H2O2 to the culture medium of young normal keratinocytes induces a premature senescence-like state. All these results indicate that Rel/NF-kappaB factors could take part in the occurrence of senescence by generating an oxidative stress via the induction of MnSOD.
C1 Univ Lille 1, Inst Biol Lille, Inst Pasteur, UMR 8117 CNRS, F-59021 Lille, France.
   Univ Lille 1, Dev Biol Lab, F-59655 Villeneuve Dascq, France.
C3 Le Reseau International des Instituts Pasteur (RIIP); Universite de
   Lille; Institut Pasteur Lille; Universite de Lille
RP Abbadie, C (corresponding author), Univ Lille 1, Inst Biol Lille, Inst Pasteur, UMR 8117 CNRS, 1 Rue Calmette,BP 447, F-59021 Lille, France.
EM corinne.abbadie@ibl.fr
RI ABBADIE, Corinne/F-4949-2018; POURTIER, ALBIN/G-7401-2012; Bernard,
   David/D-6265-2018
OI ABBADIE, Corinne/0000-0002-8174-2393; POURTIER,
   ALBIN/0000-0002-1576-3946; Bernard, David/0000-0002-1557-2074; monte,
   didier/0000-0002-0613-6203
CR ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W
   AGGARWAL BB, 1995, EXP CELL RES, V218, P381, DOI 10.1006/excr.1995.1169
   ANGELLO JC, 1989, J CELL PHYSIOL, V140, P288, DOI 10.1002/jcp.1041400214
   Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741
   Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238
   BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0
   Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536
   Bernard D, 2001, CANCER RES, V61, P2656
   Bernard D, 2001, FREE RADICAL BIO MED, V31, P943, DOI 10.1016/S0891-5849(01)00668-2
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Boyce S.T., 1983, J INVEST DERMATOL S, V81, P33
   BROWNELL E, 1989, ONCOGENE, V4, P935
   BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996
   Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Condliffe AM, 1998, FEBS LETT, V439, P147, DOI 10.1016/S0014-5793(98)01358-1
   Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283
   deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283
   Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489
   DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x
   Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000
   DIMRI GP, 1994, EXP CELL RES, V212, P132, DOI 10.1006/excr.1994.1127
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1
   Gansauge S, 1997, FEBS LETT, V404, P6, DOI 10.1016/S0014-5793(97)00059-8
   Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333
   Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222
   Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0
   GOSSELIN K, 2003, IN PRESS EXP GERONTO
   Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848
   Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663
   Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200
   GUHE C, 1994, AM J PHYSIOL, V266, pF298, DOI 10.1152/ajprenal.1994.266.2.F298
   Harman D, 1998, EXP GERONTOL, V33, P95, DOI 10.1016/S0531-5565(97)00059-4
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Helenius M, 1999, EXP CELL RES, V248, P194, DOI 10.1006/excr.1999.4393
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316
   Huguet C, 1997, CELL DEATH DIFFER, V4, P413, DOI 10.1038/sj.cdd.4400259
   Ikebe T, 2000, J CELL PHYSIOL, V182, P247, DOI 10.1002/(SICI)1097-4652(200002)182:2<247::AID-JCP14>3.3.CO;2-J
   Ikeda K, 1999, BIOCHEM PHARMACOL, V57, P1361, DOI 10.1016/S0006-2952(99)00055-6
   Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54
   Jones SA, 1999, REDOX REP, V4, P291, DOI 10.1179/135100099101535133
   Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219
   Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4
   Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147
   KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965
   Li N, 1999, FREE RADICAL BIO MED, V26, P1554, DOI 10.1016/S0891-5849(99)00024-6
   Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321
   LIMA L, 1972, EXP CELL RES, V70, P279, DOI 10.1016/0014-4827(72)90137-1
   LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552
   Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1
   Moreno-Manzano V, 2000, J BIOL CHEM, V275, P12684, DOI 10.1074/jbc.275.17.12684
   Nevins JR, 1997, METHOD ENZYMOL, V283, P205
   Norsgaard H, 1996, EXP GERONTOL, V31, P563, DOI 10.1016/0531-5565(96)00011-3
   Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829
   PEPIN N, 1994, VIROLOGY, V204, P706, DOI 10.1006/viro.1994.1586
   Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1
   PIGNOLO RJ, 1994, IN VITRO CELL DEV-AN, V30A, P471
   Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221
   Romieu-Mourez R, 2003, MOL CELL BIOL, V23, P5738, DOI 10.1128/MCB.23.16.5738-5754.2003
   Rudolph D, 2000, GENE DEV, V14, P854
   Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4
   Seitz CS, 2000, CANCER RES, V60, P4085
   Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307
   Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630
   Seluanov A, 2001, MOL CELL BIOL, V21, P1552, DOI 10.1128/MCB.21.5.1552-1564.2001
   SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Spaulding C, 1999, EXP GERONTOL, V34, P633, DOI 10.1016/S0531-5565(99)00033-9
   SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091
   Suzuki Y, 1998, FEBS LETT, V425, P209, DOI 10.1016/S0014-5793(98)00228-2
   Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1
   TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   van Hogerlinden M, 1999, CANCER RES, V59, P3299
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992
   WANG E, 1995, CANCER RES, V55, P2284
   WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703
   WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6
   Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999
   Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854
NR 91
TC 91
Z9 104
U1 2
U2 6
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JAN 15
PY 2004
VL 64
IS 2
BP 472
EP 481
DI 10.1158/0008-5472.CAN-03-0005
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 766WX
UT WOS:000188399300008
PM 14744759
OA Bronze
DA 2024-02-19
ER

PT J
AU FUKUDA, H
   KATSURADA, A
   IRITANI, N
AF FUKUDA, H
   KATSURADA, A
   IRITANI, N
TI EFFECTS OF AGING ON TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION
   OF MALIC ENZYME AND GLUCOSE-6-PHOSPHATE-DEHYDROGENASE IN RAT-LIVER
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 TEZUKAYAMA GAKUIN COLL,4 CHO HARUMIDAI,SAKAI,OSAKA,JAPAN.
CR ADELMAN RC, 1975, ENZYME INDUCTION, P303
   Adelman RC, 1972, ADV GERONTOLOGICAL R, V4, P1
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLEMENS MJ, 1984, TRANSCRIPTION TRANSL, P218
   DOZIN B, 1985, BIOCHEMISTRY-US, V24, P5581, DOI 10.1021/bi00341a044
   FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
   FORCIEA MA, 1981, J CLIN INVEST, V67, P1739, DOI 10.1172/JCI110212
   FUKUDA H, 1982, J NUTR SCI VITAMINOL, V28, P527
   GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400
   GONZALEZ FJ, 1982, J BIOL CHEM, V257, P5962
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   HAINING JL, 1971, ARCH BIOCHEM BIOPHYS, V144, P204, DOI 10.1016/0003-9861(71)90469-3
   HIZI A, 1974, EUR J BIOCHEM, V45, P211, DOI 10.1111/j.1432-1033.1974.tb03545.x
   HO YS, 1988, NUCLEIC ACIDS RES, V16, P7746, DOI 10.1093/nar/16.15.7746
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   IRITANI N, 1979, ATHEROSCLEROSIS, V34, P41, DOI 10.1016/0021-9150(79)90104-7
   IRITANI N, 1981, BIOCHIM BIOPHYS ACTA, V665, P636, DOI 10.1016/0005-2760(81)90284-8
   Kanungo MS, 1980, BIOCH AGEING CHANGES, P79
   KATSURADA A, 1982, BIOCHEM BIOPH RES CO, V109, P250, DOI 10.1016/0006-291X(82)91592-3
   KATSURADA A, 1986, BIOCHIM BIOPHYS ACTA, V877, P350, DOI 10.1016/0005-2760(86)90199-2
   KATSURADA A, 1987, EUR J BIOCHEM, V168, P487, DOI 10.1111/j.1432-1033.1987.tb13443.x
   KRYSTOSEK A, 1975, J BIOL CHEM, V250, P6077
   LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137
   MAGNUSON MA, 1986, J BIOL CHEM, V261, P1183
   MAJERUS PW, 1969, J BIOL CHEM, V244, P6254
   Maniatis T., 1982, MOL CLONING
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511
   Rothstein M., 1984, P209
   Schimke RT, 1970, MAMMALIAN PROTEIN ME, V4, P177, DOI [10.1016/B978-0-12-510604-7.50010-4, DOI 10.1016/B978-0-12-510604-7.50010-4]
   SCHOFIELD JD, 1978, EXP GERONTOL, V13, P147, DOI 10.1016/0531-5565(78)90007-4
   STADTMAN ER, 1988, J GERONTOL, V43, pB112, DOI 10.1093/geronj/43.5.B112
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
NR 33
TC 13
Z9 13
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD MAR 30
PY 1990
VL 188
IS 3
BP 517
EP 522
DI 10.1111/j.1432-1033.1990.tb15430.x
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CX627
UT WOS:A1990CX62700004
PM 2185013
OA Bronze
DA 2024-02-19
ER

PT J
AU GORDILLO, E
   AYALA, A
   BAUTISTA, J
   MACHADO, A
AF GORDILLO, E
   AYALA, A
   BAUTISTA, J
   MACHADO, A
TI IMPLICATION OF LYSINE RESIDUES IN THE LOSS OF ENZYMATIC-ACTIVITY IN
   RAT-LIVER 6-PHOSPHOGLUCONATE DEHYDROGENASE FOUND IN AGING
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 UNIV SEVILLA,FAC FARM,DEPT BIOQUIM,E-41012 SEVILLE,SPAIN.
C3 University of Sevilla
RI IBIS, ENVEJECIMIENTO/O-9381-2015
CR AYALA A, 1986, FEBS LETT, V202, P102, DOI 10.1016/0014-5793(86)80657-3
   BRAVO R, 1984, 2 DIMENSIONAL GEL EL
   BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043
   CHAUSER J, 1972, LABORATORY TECHNIQUE, P423
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   GAFNI A, 1981, BIOCHEMISTRY-US, V20, P6035, DOI 10.1021/bi00524a018
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   GORIN P, 1977, FEBS LETT, V84, P83
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   GUPTA SK, 1976, ARCH BIOCHEM BIOPHYS, V174, P324
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   LEVINE RL, 1983, J BIOL CHEM, V258, P1828
   Lewin S., 1976, VITAMIN C ITS MOL BI
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACHADO A, 1983, CARDIOLOGY AGING, P65
   OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x
   OLIVER CN, 1985, CELLULAR REGULATION, P320
   OLIVER CN, 1987, J BIOL CHEM, V262, P5486
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P213
   SAPAGHAGAR M, 1973, BIOCHEM BIOPH RES CO, V50, P179, DOI 10.1016/0006-291X(73)91080-2
   SHARMA HK, 1980, J BIOL CHEM, V255, P5043
   SHARMA HK, 1980, P NATL ACAD SCI-BIOL, V77, P5865, DOI 10.1073/pnas.77.10.5865
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   STARKE PE, 1987, FASEB J, V1, P36, DOI 10.1096/fasebj.1.1.2886388
   TOPHAM CM, 1986, EUR J BIOCHEM, V155, P87, DOI 10.1111/j.1432-1033.1986.tb09461.x
   V Maizel Jr J., 1971, Methods in Virology, V5, P179
   WINTERBOURN CC, 1981, BIOCHEM J, V198, P125, DOI 10.1042/bj1980125
NR 31
TC 31
Z9 32
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 15
PY 1989
VL 264
IS 29
BP 17024
EP 17028
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AT780
UT WOS:A1989AT78000012
PM 2507538
DA 2024-02-19
ER

PT J
AU Jia, RJ
   Yang, F
   Yan, PF
   Ma, LM
   Yang, LF
   Li, LH
AF Jia, Rongjun
   Yang, Fan
   Yan, Pengfei
   Ma, Liman
   Yang, Longfei
   Li, Lihua
TI Paricalcitol inhibits oxidative stress-induced cell senescence of the
   bile duct epithelium dependent on modulating Sirt1 pathway in
   cholestatic mice
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article; Early Access
DE VDR; Cholestatic liver injury; Cell senescence; Sirt1; Oxidative stress
ID VITAMIN-D-RECEPTOR; PRIMARY BILIARY-CIRRHOSIS; LIVER-INJURY; VDR
   EXPRESSION; ACID; ACTIVATION; POLYMORPHISMS; DEFICIENCY; PROTECTS;
   REPAIR
AB Background: Clinical studies indicate that vitamin D receptor (VDR) expression is reduced in primary biliary cirrhosis patient livers. However, the mechanism by which activated VDR effect cholestatic liver injury remains unclear.
   Methods: Mice were injected intraperitoneally with the VDR agonist paricalcitol or a vehicle 3 days prior to bile duct ligation (BDL) and for 5 or 28 days after surgery. The analyses of liver morphology and necrotic areas were based on H&E staining. Serum biochemical indicators of liver damage were analyzed by commercial kits. The mechanisms of paricalcitol on cholestatic liver injury were determined by Western blot analysis.
   Results: Paricalcitol ameliorated the BDL-induced liver damage in mice. Paricalcitol increased the proliferation of BECs to promote the repair of the bile duct. Paricalcitol also reduced the BDL-induced oxidative stress level in the mice. Mechanistic analysis revealed that paricalcitol decreased the number of SA-beta-gal-positive cells and downregulated the expression of p53, p21 and p16 proteins which was associated with reducing oxidative stress. Additionally, paricalcitol exerted the inhibitory effect of cell senescence was through reducing DNA damage and promoting DNA repair. Interesting, we found that paricalcitol prevented the downregulation of oxidative stressinduced Sirt1 expression in the BDL mice and t-BHP-induced BECs models. Moreover, paricalcitol suppressed cell senescence through a Sirt1-dependent pathway. These results were confirmed by antioxidant ALCAR and the Sirt1 inhibitor EX-527.
   Conclusion: Paricalcitol alleviated cholestatic liver injury through promoting the repair of damaged bile ducts and reducing oxidative stress-induced cell senescence of the bile duct via modulating Sirt1 pathway.
C1 [Jia, Rongjun; Ma, Liman; Li, Lihua] Taizhou Univ, Sch Med, Dept Cell Biol, Taizhou, Peoples R China.
   [Jia, Rongjun; Yang, Fan; Yan, Pengfei] Jinzhou Med Univ, Dept Cell Biol, Jinzhou, Peoples R China.
   [Yang, Longfei] Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Peoples R China.
C3 Taizhou University; Jinzhou Medical University; Jilin University
RP Li, LH (corresponding author), Taizhou Univ, Sch Med, Dept Cell Biol, Taizhou, Peoples R China.; Li, LH (corresponding author), 1139 Shifu Ave, Taizhou City, Peoples R China.
EM 1085881994@qq.com; hualala321@163.com; 91216560@qq.com;
   limanma1986@163.com; yanglongfei@jlu.deu.cn; lilihua1018@sina.com
RI Yang, Fan/AAA-6904-2022
OI Yang, Fan/0000-0002-0520-5254
FU National Natural Science Foundation of China [31571184]; Liaoning
   BaiQianWan Talents Program [2017101]; Liaoning Province Natural Science
   Foundation [20170540374]
FX This study was supported by the National Natural Science Foundation of
   China [No. 31571184] and Liaoning BaiQianWan Talents Program [No.
   2017101] and Liaoning Province Natural Science Foundation [No.
   20170540374] .
CR Andress D, 2007, DRUGS, V67, P1999, DOI 10.2165/00003495-200767140-00003
   Beilfuss A, 2015, GUT, V64, P791, DOI 10.1136/gutjnl-2014-307024
   Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049
   Bulut G, 2016, RENAL FAILURE, V38, P751, DOI 10.3109/0886022X.2016.1158071
   Chow ECY, 2013, BIOPHARM DRUG DISPOS, V34, P402, DOI 10.1002/bdd.1856
   Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228
   Desmet V. J., 1997, Journal of Hepatology, V26, P31, DOI 10.1016/S0168-8278(97)82330-6
   Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Donate-Correa J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/670475
   Firrincieli D, 2013, HEPATOLOGY, V58, P1401, DOI 10.1002/hep.26453
   Graziano S, 2016, ONCOGENE, V35, P5362, DOI 10.1038/onc.2016.77
   Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004
   Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875
   Horvath E, 2012, ANTICANCER RES, V32, P4791
   Johnson AL, 2015, ONCOTARGET, V6, P16304, DOI 10.18632/oncotarget.4059
   Keane JT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040496
   Kempinska-Podhorodecka A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176264
   Kempinska-Podhorodecka A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020289
   Kumar S, 2019, FASEB J, V33, P3825, DOI 10.1096/fj.201802015R
   La Marra F, 2017, CANCER BIOL MED, V14, P162, DOI 10.20892/j.issn.2095-3941.2017.0020
   Lee SM, 2018, J STEROID BIOCHEM, V177, P36, DOI 10.1016/j.jsbmb.2017.06.002
   Li RC, 2019, FREE RADICAL BIO MED, V135, P116, DOI 10.1016/j.freeradbiomed.2019.02.005
   Lin LM, 2016, ATHEROSCLEROSIS, V251, P273, DOI 10.1016/j.atherosclerosis.2016.06.005
   Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   Malham M, 2011, WORLD J GASTROENTERO, V17, P922, DOI 10.3748/wjg.v17.i7.922
   Nakamura K, 2017, LIVER TRANSPLANT, V23, P1282, DOI 10.1002/lt.24821
   Nalapareddy PD, 2009, AM J PATHOL, V175, P1077, DOI 10.2353/ajpath.2009.090304
   Qu H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600338
   Rahman SM, 1996, PATHOL INT, V46, P267, DOI 10.1111/j.1440-1827.1996.tb03609.x
   Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768
   Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005
   Sasaki M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/452143
   Schlenker T, 2015, ANTICANCER RES, V35, P5881
   Sokolovic D, 2013, DRUG CHEM TOXICOL, V36, P141, DOI 10.3109/01480545.2012.658919
   Suga T, 2019, TOXICOL APPL PHARM, V379, DOI 10.1016/j.taap.2019.114664
   Tan M, 2015, FREE RADICAL RES, V49, P935, DOI 10.3109/10715762.2015.1016020
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Trivedi T, 2017, ONCOTARGET, V8, P26687, DOI 10.18632/oncotarget.15803
   Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016
   Valdivielso JM, 2009, CONTRIB NEPHROL, V163, P206, DOI 10.1159/000223800
   Vogel A, 2002, HEPATOLOGY, V35, P126, DOI 10.1053/jhep.2002.30084
   Wahsh E, 2016, EUR J PHARMACOL, V789, P362, DOI 10.1016/j.ejphar.2016.07.052
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang MH, 2008, AM J PHYSIOL-GASTR L, V295, pG357, DOI 10.1152/ajpgi.00581.2007
   Weng ZY, 2017, ONCOTARGET, V8, P87903, DOI 10.18632/oncotarget.21233
   Yan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1171-0
   Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887
   Yu Ah Hong, 2017, OXID MED CELL LONGEV, V2017
   Yu DK, 2018, LIVER INT, V38, P1128, DOI 10.1111/liv.13698
   Zare MFR, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116623
   Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814
   Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x
   Zhang ZQ, 2015, INT J CLIN EXP MED, V8, P12086
   Zhong GX, 2019, BIOCHEM BIOPH RES CO, V514, P1204, DOI 10.1016/j.bbrc.2019.05.098
   Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010
NR 59
TC 7
Z9 7
U1 2
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD 2021 JUN
PY 2021
VL 169
BP 158
EP 168
DI 10.1016/j.freeradbiomed.2021.04.019
EA APR 2021
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA SF8UU
UT WOS:000653024500004
PM 33872698
DA 2024-02-19
ER

PT J
AU Nakao, M
   Nakayama, N
   Uchida, Y
   Tomiya, T
   Oketani, M
   Ido, A
   Tsubouchi, H
   Takikawa, H
   Mochida, S
AF Nakao, Masamitsu
   Nakayama, Nobuaki
   Uchida, Yoshihito
   Tomiya, Tomoaki
   Oketani, Makoto
   Ido, Akio
   Tsubouchi, Hirohito
   Takikawa, Hajime
   Mochida, Satoshi
TI Deteriorated outcome of recent patients with acute liver failure and
   late-onset hepatic failure caused by infection with hepatitis A virus: A
   subanalysis of patients seen between 1998 and 2015 and enrolled in
   nationwide surveys in Japan
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE acute liver failure; aging; diabetic mellitus; fulminant hepatitis; HAV;
   LOHF
ID DISEASES STUDY-GROUP; FULMINANT-HEPATITIS; DIAGNOSTIC-CRITERIA;
   CLASSIFICATION; ASSOCIATION; ETIOLOGIES; PROGNOSIS; MORTALITY
AB Aim A nationwide survey of acute liver failure (ALF) and late-onset hepatic failure (LOHF) has revealed that the outcomes of recent patients whose diseases were caused by infection with hepatitis A virus (HAV) have worsened, compared with those of previously reported patients. The factors associated with this deterioration were evaluated. Methods A total of 83 patients with HAV infection seen between 1998 and 2015 were enrolled. All the patients had a prothrombin time-international normalized ratio of 1.5 or more and hepatic encephalopathy of grade 2 or more severe. The demographic and clinical features of 45 patients seen prior to 2003 (cohort 1) and 38 patients seen during 2004 and thereafter (cohort 2) were compared. Results Three and four patients in cohort 1 and cohort 2, respectively, received liver transplantations; the survival rates among the remaining patients were 56% for cohort 2 and 79% for cohort 1 (P < 0.05). The mean age (+/- standard deviation) of the patients was higher in cohort 2 than in cohort 1 (58 +/- 11 vs. 48 +/- 13 years; P < 0.01). The percentages of patients with underlying metabolic diseases were 22% in cohort 1 and 61% in cohort 2 (P < 0.01). Diabetic mellitus was more common among deceased patients than among rescued patients (29% vs. 8%; P < 0.05) among patients who did not receive liver transplantations, and a multivariate analysis revealed that patient age and disease type were significantly and independently associated with the outcome. Conclusion The outcomes of recent patients with ALF or LOHF caused by HAV infection have recently worsened mainly because of an increase in underlying metabolic diseases as a consequence of aging.
C1 [Nakao, Masamitsu; Nakayama, Nobuaki; Uchida, Yoshihito; Tomiya, Tomoaki; Mochida, Satoshi] Saitama Med Univ, Dept Gastroenterol & Hepatol, Moroyama, Saitama, Japan.
   [Oketani, Makoto; Ido, Akio] Kagoshima Univ, Dept Human & Environm Sci, Digest & Lifestyle Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan.
   [Oketani, Makoto] Yoshinohigashi Home Clin, Dept Med, Kagoshima, Japan.
   [Tsubouchi, Hirohito] Kagoshima City Hosp, Dept Gastroenterol & Hepatol, Kagoshima, Japan.
   [Takikawa, Hajime] Teikyo Univ, Fac Med Technol, Tokyo, Japan.
C3 Saitama Medical University; Kagoshima University; Kagoshima City
   Hospital; Teikyo University
RP Mochida, S (corresponding author), Saitama Med Univ, Fac Med, Dept Gastroenterol & Ilepatol, 38 Morohongo, Moroyama, Saitama 3500495, Japan.
EM smochida@saitama-med.ac.jp
OI Nakao, Masamitsu/0000-0002-2850-6973; Uchida,
   Yoshihito/0000-0002-6012-0915
FU Health and Labour Sciences Research Grants from Research on Measures for
   Intractable Diseases; Japan Agency for Medical Research and Development
   (AMED) [JP18fk0210043]; Intractable Hepato-biliary Diseases Study Group
   of Japan
FX Health and Labour Sciences Research Grants from Research on Measures for
   Intractable Diseases, the Intractable Hepato-biliary Diseases Study
   Group of Japan, and Japan Agency for Medical Research and Development
   (AMED) under Grant Number JP18fk0210043.
CR Ajmera V, 2011, J VIRAL HEPATITIS, V18, pE167, DOI 10.1111/j.1365-2893.2010.01410.x
   [Anonymous], 1982, P 12 IN S HEP TYP A
   Chen CM, 2016, J VIRAL HEPATITIS, V23, P940, DOI 10.1111/jvh.12564
   Fujiwara K, 2019, HEPATOL RES, V49, P224, DOI 10.1111/hepr.13255
   Fujiwara K, 2018, HEPATOL RES, V48, P106, DOI 10.1111/hepr.12906
   Fujiwara K, 2008, HEPATOL RES, V38, P646, DOI 10.1111/j.1872-034X.2008.00322.x
   Iba T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1468-1
   Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857
   Kiyohara T, 2007, MICROBIOL IMMUNOL, V51, P185, DOI 10.1111/j.1348-0421.2007.tb03900.x
   Lee HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130728
   Mochida S, 2016, J GASTROENTEROL, V51, P999, DOI 10.1007/s00535-016-1168-2
   Mochida S, 2016, HEPATOL RES, V46, P369, DOI 10.1111/hepr.12626
   Mochida S, 2014, HEPATOL RES, V44, P365, DOI 10.1111/hepr.12295
   Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x
   MORITSUGU Y, 1978, JPN J MED SCI BIOL, V31, P325, DOI 10.7883/yoken1952.31.325
   Nakao M, 2018, J GASTROENTEROL, V53, P752, DOI 10.1007/s00535-017-1394-2
   OGRADY JG, 1993, LANCET, V342, P273
   Oketani M, 2013, HEPATOL RES, V43, P97, DOI 10.1111/j.1872-034X.2012.01105.x
   Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703
   Sato S, 2004, HEPATOL RES, V30, P155, DOI 10.1016/j.hepres.2004.08.003
   Singh KK, 2013, J CLIN EXP HEPATOL, V3, P275, DOI 10.1016/j.jceh.2013.11.003
   Sugawara K, 2012, J GASTROENTEROL, V47, P849, DOI 10.1007/s00535-012-0624-x
   Trey C, 1970, Prog Liver Dis, V3, P282
   TREY C, 1968, NEW ENGL J MED, V279, P798, DOI 10.1056/NEJM196810102791504
   Vogt TM, 2008, J INFECT DIS, V197, P1282, DOI 10.1086/586899
   Win NN, 2017, BIOCHEM BIOPH RES CO, V483, P694, DOI 10.1016/j.bbrc.2016.12.080
   Yamagishi Y, 2005, J GASTROEN HEPATOL, V20, P1843, DOI 10.1111/j.1440-1746.2005.03949.x
NR 27
TC 12
Z9 12
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD AUG
PY 2019
VL 49
IS 8
BP 844
EP 852
DI 10.1111/hepr.13345
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IV8NF
UT WOS:000484521500002
PM 30957325
DA 2024-02-19
ER

PT J
AU Desmarais, F
   Bergeron, KF
   Rassart, E
   Mounier, C
AF Desmarais, Frederik
   Bergeron, Karl-F
   Rassart, Eric
   Mounier, Catherine
TI Apolipoprotein D overexpression alters hepatic prostaglandin and omega
   fatty acid metabolism during the development of a non-inflammatory
   hepatic steatosis
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE Apolipoprotein D; Hepatic steatosis; Prostaglandin 15d-PGJ(2); Omega-6
   fatty acid; Omega-3 fatty acid; Peroxisome proliferator-activated
   receptor gamma
ID PROLIFERATOR-ACTIVATED RECEPTORS; SYNTHASE GENE-EXPRESSION; STELLATE
   CELLS; KUPFFER CELLS; IDENTIFICATION; 15D-PGJ(2); OLEATE; FLUID; MICE;
   AP-1
AB Apolipoprotein D (ApoD) is a secreted lipocalin associated with neuroprotection and lipid metabolism. Overexpression of ApoD in mouse neural tissue induces the development of a non-inflammatory hepatic steatosis in 12-month-old transgenic animals. Previous data indicates that accumulation of arachidonic acid, ApoD's preferential ligand, and overactivation of PPAR gamma are likely the driving forces in the development of the pathology. However, the lack of inflammation under those conditions is surprising. Hence, we further investigated the apparent repression of inflammation during hepatic steatosis development in aging transgenic animals. The earliest modulation of lipid metabolism and inflammation occurred at 6 months with a transient overexpression of L-PGDS and concomitant overproduction of 15d-PGJ(2), a PPAR gamma agonist. Hepatic lipid accumulation was detectable as soon as 9 months. Inflammatory polarization balance varied in time, with a robust anti-inflammatory profile at 6 months coinciding with 15d-PGJ(2) overproduction. Omega-3 and omega-6 fatty acids were preferentially stored in the liver of 12-month-old transgenic mice and resulted in a higher omega-3/omega-6 ratio compared to wild type mice of the same age. Thus, inflammation seems to be controlled by several mechanisms in the liver of transgenic mice: first by an increase in 15d-PGJ(2) production and later by a beneficial omega-3/omega-6 ratio. PPAR gamma seems to play important roles in these processes. The accumulation of several omega fatty acids species in the transgenic mouse liver suggests that ApoD might bind to a broader range of fatty acids than previously thought.
C1 [Desmarais, Frederik; Bergeron, Karl-F; Rassart, Eric; Mounier, Catherine] Univ Quebec Montreal UQAM, BioMed Res Ctr, Biol Sci Dept, Mol Metab Lipids Lab, Montreal, PQ, Canada.
C3 University of Quebec; University of Quebec Montreal
RP Mounier, C (corresponding author), Univ Quebec Montreal UQAM, BioMed Res Ctr, Biol Sci Dept, Mol Metab Lipids Lab, Montreal, PQ, Canada.
EM mounier.catherine@uqam.ca
OI Desmarais, Frederik/0000-0001-5998-1876; Bergeron,
   Karl-F./0000-0002-7215-9104
CR Alves CF, 2011, BRIT J PHARMACOL, V162, P623, DOI 10.1111/j.1476-5381.2010.01057.x
   Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111
   BALBIN M, 1990, BIOCHEM J, V271, P803, DOI 10.1042/bj2710803
   Bécuwe P, 2003, FREE RADICAL BIO MED, V35, P636, DOI 10.1016/S0891-5849(03)00387-3
   Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012
   BOYLES JK, 1990, J LIPID RES, V31, P2243
   BOYLES JK, 1990, J BIOL CHEM, V265, P17805
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q
   Chen K, 2016, BIOMED PHARMACOTHER, V80, P183, DOI 10.1016/j.biopha.2016.03.012
   Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148
   di Masi A, 2016, J CONTROL RELEASE, V228, P191, DOI 10.1016/j.jconrel.2016.02.049
   Do Carmo S, 2007, BBA-MOL CELL RES, V1773, P954, DOI 10.1016/j.bbamcr.2007.03.007
   Do Carmo S, 2009, AM J PHYSIOL-ENDOC M, V296, pE802, DOI 10.1152/ajpendo.90725.2008
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   DRAYNA D, 1986, J BIOL CHEM, V261, P6535
   Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149
   Fujimori K, 2003, J BIOL CHEM, V278, P6018, DOI 10.1074/jbc.M208288200
   Fujita T, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0005-6
   Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871
   Gélinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543
   Hashimoto K, 2003, PANCREAS, V27, P58, DOI 10.1097/00006676-200307000-00009
   Hetherington AM, 2016, CELL PHYSIOL BIOCHEM, V39, P1648, DOI 10.1159/000447866
   Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200
   Kielkopf CS, 2018, J STRUCT BIOL, V203, P205, DOI 10.1016/j.jsb.2018.05.012
   Kim EH, 2008, CARCINOGENESIS, V29, P688, DOI 10.1093/carcin/bgm299
   Kitaura Y, 2015, FEBS OPEN BIO, V5, P485, DOI 10.1016/j.fob.2015.05.008
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318
   KUIPER J, 1988, BIOCHIM BIOPHYS ACTA, V959, P143, DOI 10.1016/0005-2760(88)90025-2
   Labrie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130230
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Leung WCY, 2004, CIRC RES, V95, P179, DOI 10.1161/01.RES.0000135482.74178.14
   Li HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148238
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200
   Miyagi M, 2005, ARTERIOSCL THROM VAS, V25, P970, DOI 10.1161/01.ATV.0000159702.68591.0d
   Muffat J, 2010, CELL CYCLE, V9, P269, DOI 10.4161/cc.9.2.10433
   Najyb O, 2015, J BIOL CHEM, V290, P16077, DOI 10.1074/jbc.M115.644302
   Ong WY, 1997, NEUROSCIENCE, V79, P359, DOI 10.1016/S0306-4522(96)00608-2
   Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787
   Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200
   Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220
   Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X
   Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008
   Roman BL, 2012, BIOMECH MODEL MECHAN, V11, P1149, DOI 10.1007/s10237-012-0412-9
   Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008
   Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844
   Suh J, 2018, CANCER LETT, V424, P30, DOI 10.1016/j.canlet.2018.03.016
   Suzuki A, 2017, ANNU REV MED, V68, P85, DOI 10.1146/annurev-med-051215-031109
   Taba Y, 2000, CIRC RES, V86, P967, DOI 10.1161/01.RES.86.9.967
   Thomas EA, 2003, PROSTAG LEUKOTR ESS, V69, P421, DOI 10.1016/j.plefa.2003.08.014
   Uhlen M., 2015, TISSUE EXPRESSION PT
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   URADE Y, 1989, J IMMUNOL, V143, P2982
   Wheeler MC, 2014, J LIPID RES, V55, P1702, DOI 10.1194/jlr.M048918
   Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010
   Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574
NR 60
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 1879-2618
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD APR
PY 2019
VL 1864
IS 4
BP 522
EP 531
DI 10.1016/j.bbalip.2019.01.001
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA HM3IF
UT WOS:000459366300007
PM 30630053
DA 2024-02-19
ER

PT J
AU FUKUDA, H
   IRITANI, N
AF FUKUDA, H
   IRITANI, N
TI EFFECT OF AGING ON CHANGES IN SUBSTRATE AND EFFECTOR LEVELS OF RAT-LIVER
   GLYCOLYTIC AND LIPOGENIC ENZYMES DURING INDUCTION
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
RP FUKUDA, H (corresponding author), TEZUKAYAMA GAKUIN COLL, SUMIYOSHI KU, OSAKA 558, JAPAN.
CR ABIKO Y, 1967, J BIOCHEM, V61, P10, DOI 10.1093/oxfordjournals.jbchem.a128508
   EGGLESTON LV, 1974, METHOD ENZYMAT AN, V3, P1308
   FUKUDA H, 1982, J NUTR SCI VITAMINOL, V28, P527
   Gibson D M, 1972, Adv Enzyme Regul, V10, P187, DOI 10.1016/0065-2571(72)90014-3
   GLOCK GE, 1953, BIOCHEM J, V55, P400, DOI 10.1042/bj0550400
   Gutmann I, 1974, METHOD ENZYMAT AN, P1585
   HERS HG, 1955, METHOD ENZYMOL, V1, P286, DOI 10.1016/0076-6879(55)01038-0
   IRITANI N, 1981, BIOCHIM BIOPHYS ACTA, V665, P636, DOI 10.1016/0005-2760(81)90284-8
   KATSURADA A, 1982, BIOCHEM BIOPH RES CO, V109, P250, DOI 10.1016/0006-291X(82)91592-3
   KATSURADA A, 1983, BIOCHEM BIOPH RES CO, V112, P176, DOI 10.1016/0006-291X(83)91813-2
   Kemp R G, 1975, Methods Enzymol, V42, P67
   LANG G, 1974, METHOD ENZYMAT AN, V3, P1238
   Michal G., 1974, METHOD ENZYMAT AN, V3, P1314
   NAKANISHI S, 1970, EUR J BIOCHEM, V16, P161, DOI 10.1111/j.1432-1033.1970.tb01068.x
   NISHIKOR.K, 1973, FEBS LETT, V32, P19, DOI 10.1016/0014-5793(73)80725-2
   NOGUCHI T, 1982, EUR J BIOCHEM, V128, P583
   Numa S, 1970, Vitam Horm, V28, P213
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   SAGGERSON ED, 1970, BIOCHEM J, V119, P193, DOI 10.1042/bj1190193
   SAKURAI T, 1974, BIOCHIM BIOPHYS ACTA, V360, P275, DOI 10.1016/0005-2760(74)90057-5
   TANAKA T, 1967, J BIOCHEM-TOKYO, V62, P71, DOI 10.1093/oxfordjournals.jbchem.a128639
   TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550
   WALKER DG, 1955, METHOD ENZYMOL, V9, P382
   Williamson JR, 1969, Method. Enzymol, V13, P434
NR 24
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
JI Biochim. Biophys. Acta
PY 1984
VL 795
IS 1
BP 79
EP 84
DI 10.1016/0005-2760(84)90106-1
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA TG475
UT WOS:A1984TG47500010
PM 6147160
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   SNOWDEN, CD
   MOORE, DR
AF RIKANS, LE
   SNOWDEN, CD
   MOORE, DR
TI EFFECT OF AGING ON ENZYMATIC ANTIOXIDANT DEFENSES IN RAT-LIVER
   MITOCHONDRIA
SO GERONTOLOGY
LA English
DT Article
DE SUPEROXIDE DISMUTASE; GLUTATHIONE REDUCTASE; GLUTATHIONE PEROXIDASE;
   ANTIOXIDANT DEFENSES; MITOCHONDRIA, RAT LIVER
ID SUPEROXIDE-DISMUTASE ACTIVITY; ALLYL ALCOHOL HEPATOTOXICITY;
   GLUTATHIONE-PEROXIDASE; AGE; HEPATOCYTES; HYDROPEROXIDE; OXIDATION;
   INJURY; SEX
AB Antioxidant defenses within liver mitochondria are pivotal in preventing liver damage from oxidative toxicants. In this study we determined the activities of glutathione peroxidase (GPO), superoxide dismutase (SOD) and glutathione reductase (GRD) in mitochondria from livers of variously aged Fischer 344 rats. A mixed pattern of age-associated alterations in mitochondrial antioxidant activities was observed. In male rats, GRD activity decreased in old age, whereas GPO and SOD activities increased. In female rats, GPO activity decreased with age, but SOD activity increased and GRD activity was unchanged. Age-associated decreases in antioxidant protection from mitochondrial enzymes appeared to be counter-balanced by increases in protection from other enzymes.
C1 UNIV OKLAHOMA, SCH MED, DEPT PHARMACOL, OKLAHOMA CITY, OK 73104 USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, DEPT PHARMACOL, BMSB-753, POB 26901, OKLAHOMA CITY, OK 73190 USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Crapo J D, 1978, Methods Enzymol, V53, P382
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   GALINSKY RE, 1990, J PHARMACOL EXP THER, V255, P577
   KELLER BJ, 1990, J PHARMACOL EXP THER, V252, P1355
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   MARIA CS, 1987, MECH AGEING DEV, V37, P183
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V270, P672, DOI 10.1016/0003-9861(89)90550-X
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   NAGELKERKE JF, 1989, BIOCHEM J, V263, P347, DOI 10.1042/bj2630347
   NIEMINEN AL, 1990, BIOCHEM BIOPH RES CO, V167, P600, DOI 10.1016/0006-291X(90)92067-A
   OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457
   REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131
   RIKANS LE, 1990, GERONTOLOGY, V36, P185, DOI 10.1159/000213198
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIKANS LE, 1987, J PHARMACOL EXP THER, V243, P20
   RIKANS LE, 1987, DRUG METAB DISPOS, V15, P356
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   ZHANG LP, 1989, BIOCHIM BIOPHYS ACTA, V1006, P140, DOI 10.1016/0005-2760(89)90336-6
NR 23
TC 21
Z9 23
U1 1
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD MAY-JUN
PY 1992
VL 38
IS 3
BP 133
EP 138
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HW488
UT WOS:A1992HW48800003
PM 1624141
DA 2024-02-19
ER

PT J
AU Rafique, R
   Schapira, AHV
   Cooper, JM
AF Rafique, R
   Schapira, AHV
   Cooper, JM
TI Mitochondrial respiratory chain dysfunction in ageing; Influence of
   vitamin E deficiency
SO FREE RADICAL RESEARCH
LA English
DT Article
DE vitamin E deficiency; mitochondrial function; ageing; lipid peroxidation
ID AGE-RELATED-CHANGES; LIPID-PEROXIDATION; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; ANTIOXIDANT ENZYMES; MEMBRANE FLUIDITY; DNA DELETIONS;
   LIVER; INCREASE; RATS
AB The causes and consequences of ageing are likely to be complex and involve the interaction of many processes. It has been proposed that the decline in mitochondrial function caused by the accumulation of oxidatively damaged molecules plays a significant role in the ageing process. In agreement with previous reports we have shown that the activities of NADH CoQ 1 reductase and cytochrome oxidase declined with increasing age in both rat liver and gastrocnemius muscle mitochondria. However, only in the liver were the changes in lipid peroxidation and membrane fluidity suggestive of an age-related increase in oxidative stress.
   After 12 weeks on a vitamin E deficient diet, vitamin E levels were undetectable in both gastrocnemius muscle and liver. In skeletal muscle, this was associated with a statistically significant increase in lipid peroxidation, a decrease in cytochrome oxidase activity after 48 weeks, and an exacerbation in the age-related rate of decline of NADH CoQ 1 reductase activity. This was consistent with the suggestion that an imbalance between free radical generation and antioxidant defence may contribute to the mitochondrial dysfunction with age. In contrast to this, vitamin E deficiency in the liver caused a significant increase in mitochondrial respiratory chain activities with increasing age despite evidence of increased lipid peroxidation. Comparison of other features in these samples suggested vitamin E deficiency; did not have a significant impact upon mtDNA translation; induced a compensatory increase in glutathione levels in muscle, which was less marked in the liver, but probably most interestingly caused a significant decrease in the mitochondrial membrane fluidity in muscle but not in liver mitochondria.
   These data suggest that while increased lipid peroxidation exacerbated the age-related decline in muscle respiratory chain function this relationship was not observed in liver. Consequently other factors are likely to be contributing to the age-related decline in mitochondrial function and specific stimuli may influence or even reverse these age-related effects as observed with vitamin E deficiency in the liver.
C1 UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England.
   Inst Neurol, London WC1N 3BG, England.
C3 University of London; University College London; UCL Medical School;
   University of London; University College London
RP Cooper, JM (corresponding author), UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England.
EM cooper@rfc.ucl.ac.uk
RI Schapira, Anthony H V/A-1245-2010; Cooper, J Mark/D-5826-2013; Cooper,
   Jonathan/GLS-9195-2022
OI Schapira, Anthony H V/0000-0002-3018-3966; Cooper, J
   Mark/0000-0002-3007-3054; Cooper, Jonathan/0000-0002-2358-1050
CR Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   CARMELI E, 1994, P SOC EXP BIOL MED, V206, P103
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   COOPER JM, 1988, BIOCHEM PHARMACOL, V37, P687, DOI 10.1016/0006-2952(88)90143-8
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715
   Hashimoto M, 2001, EXP GERONTOL, V37, P89, DOI 10.1016/S0531-5565(01)00164-4
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   MOCKEL JJ, 1975, ARCH BIOCHEM BIOPHYS, V167, P301, DOI 10.1016/0003-9861(75)90466-X
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Rafique R, 2001, BIOCHEM J, V357, P887, DOI 10.1042/0264-6021:3570887
   Sasaki T, 2001, NUCL MED BIOL, V28, P25, DOI 10.1016/S0969-8051(00)00180-3
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
   Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
NR 29
TC 29
Z9 30
U1 1
U2 4
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1071-5762
J9 FREE RADICAL RES
JI Free Radic. Res.
PD FEB
PY 2004
VL 38
IS 2
BP 157
EP 165
DI 10.1080/10715760310001643311
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 752GB
UT WOS:000187151700006
PM 15104209
DA 2024-02-19
ER

PT J
AU Dhahbi, JM
   Tillman, JB
   Cao, S
   Mote, PL
   Walford, RL
   Spindler, SR
AF Dhahbi, JM
   Tillman, JB
   Cao, S
   Mote, PL
   Walford, RL
   Spindler, SR
TI Caloric intake alters the efficiency of catalase mRNA translation in the
   liver of old female mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID SUPEROXIDE-DISMUTASE; DIETARY RESTRICTION; LIPID-PEROXIDATION; OXIDATIVE
   DAMAGE; DROSOPHILA-MELANOGASTER; ANTIOXIDANT ENZYMES; FOOD RESTRICTION;
   TISSUE SAMPLES; MOUSE-LIVER; AGING RATS
AB The free radical theory of aging pr edicts that calorie restriction, which extends life span, should reduce oxidant damage. In mammals, the oxidative processes centered in the liver are a major source of free radicals. Liver catalase has the dominant role in the intracellular detoxification of hydrogen peroxide. In male rodents, published studies indicate that aging decreases catalase gene transcription and that calorie restriction obviates this effect. In females, published studies are inconsistent, and no molecular mechanisms have been identified. Here we report that, in female mice, aging can lead to an increase in the translational efficiency of hepatic catalase mRNA, and that calorie restriction obviates this effect. Consideration of these results and published studies leads us to propose that the variability in catalase results in females may arise from the small number of studies or from unique aspects of female physiology, perhaps the estrous cycle and its cessation with age.
C1 Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA.
C3 University of California System; University of California Riverside;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
EM spindler@ucrac1.ucr.edu
OI Tillman, John/0000-0003-2912-2370
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   Ausubel F. M., 1991, CURRENT PROTOCOLS MO
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   Chen LH, 1996, AGE, V19, P101, DOI 10.1007/BF02434089
   CLERCH LB, 1991, AM J PHYSIOL, V260, pL428, DOI 10.1152/ajplung.1991.260.6.L428
   ERIKSSON AM, 1992, FEBS LETT, V308, P211, DOI 10.1016/0014-5793(92)81276-R
   FLOYD RA, 1991, SCIENCE, V254, P1597, DOI 10.1126/science.1684251
   FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761
   Goldberg I H, 1988, Basic Life Sci, V49, P745
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4
   KENSLER TW, 1985, SUPEROXIDE DISMUTASE, V3, P119
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LERNER SP, 1992, EUR J IMMUNOGENET, V19, P361, DOI 10.1111/j.1744-313X.1992.tb00079.x
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   *MIN INC, 1992, MIN STAT SOFTW STAND
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   PRICE VE, 1962, J BIOL CHEM, V237, P3468
   PRICE VE, 1961, NATURE, V189, P62, DOI 10.1038/189062a0
   RADI R, 1991, J BIOL CHEM, V266, P22028
   RAMAN D, 1988, MOL CELL BIOL, V84, P155
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RECHCIGL M, 1967, BIOCHEM BIOPH RES CO, V27, P119, DOI 10.1016/S0006-291X(67)80049-4
   REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SCHISLER NJ, 1987, GENOME, V29, P748, DOI 10.1139/g87-127
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671, DOI 10.1074/jbc.270.26.15671
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   TANFORD C, 1962, J AM CHEM SOC, V84, P1892, DOI 10.1021/ja00869a025
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WHITE BA, 1982, J BIOL CHEM, V257, P8569
NR 43
TC 15
Z9 16
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAY
PY 1998
VL 53
IS 3
BP B180
EP B185
DI 10.1093/gerona/53A.3.B180
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA ZM037
UT WOS:000073498400005
PM 9597041
OA Bronze
DA 2024-02-19
ER

PT J
AU Choi, MR
   Do, LT
   Chung, YH
   Yoo, H
   Yu, R
AF Choi, Mi-Ran
   Le Thanh Do
   Chung, Yong-Hoon
   Yoo, Hoon
   Yu, Rina
TI Antioxidative Activity of Platinum Nanocolloid and Its Protective Effect
   Against Chemical-Induced Hepatic Cellular Damage
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Antioxidant; Platinum Nanocolloid; Oxidative Stress; Cellular Damage
ID SUPEROXIDE; NANOPARTICLE; RADICALS
AB Oxidative stress, a major cause of cellular injuries, is closely associated with a variety of chronic diseases such as cancer, liver diseases, degenerative brain disease and aging. In this study, we investigated antioxidant properties of platinum nanocolloid (PNC) against various oxidative stress conditions in vitro/in vivo by treating PNC on liver cell or tissue. Antioxidant activities of the PNC were determined by measuring quenching capacity on reactive oxygen species and its protective action against hydrogen peroxide or CCl4-induced oxidative cellular damage in HepG2 cell or liver tissue of mice. In vitro study, PNC markedly suppressed the production H2O2, (OH)-O-center dot, alpha,alpha-diphenyl-beta-picrylhydrazyl radical and nitric oxide in a dose-dependent manner. PNC also inhibited hydrogen peroxide-induced oxidative cellular damage in HepG2 hepatocytes. In vivo study with mice, PNC reduced hepatic lipid peroxidation and CCl4 induced toxicity. Our results support that platinum nanocolloid has antioxidant activities and protects hepatic cellular oxidative damage. Thus platinum nanocolloid may have a potential to be used as an antioxidant supplement.
C1 [Choi, Mi-Ran; Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan 680749, South Korea.
   [Le Thanh Do] Duy Tan Univ, Inst Res & Dev, Da Nang 550000, Vietnam.
   [Chung, Yong-Hoon] Solco Nanoadv Co Ltd, Chang Won 641771, Gyeongnam, South Korea.
   [Yoo, Hoon] Chosun Univ, Dept Pharmacol & Dent Therapeut, Coll Dent, Kwangju 501759, South Korea.
C3 University of Ulsan; Duy Tan University; Chosun University
RP Yoo, H (corresponding author), Chosun Univ, Dept Pharmacol & Dent Therapeut, Coll Dent, Kwangju 501759, South Korea.
OI Thanh Do, Le/0000-0003-3359-0986
FU regional industrial technology development program of the Ministry of
   Knowledge Economy [70002378]; National Research Foundation of Korea
   (NRF) - Ministry of science, ICT and Future Planning
   [R13-2008-010-00000-0]
FX This work was supported by the grant from the regional industrial
   technology development program of the Ministry of Knowledge Economy (No.
   70002378), and the National Research Foundation of Korea (NRF) funded by
   the Ministry of science, ICT and Future Planning (No.
   R13-2008-010-00000-0).
CR BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6
   Goo WH, 2009, MOD PHYS LETT B, V23, P3903, DOI 10.1142/S0217984909021983
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   GUTTERIDGE JMC, 1987, BIOCHEM J, V243, P709, DOI 10.1042/bj2430709
   HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9
   Hone M., 2011, METALLOMICS, V3, P11
   Isono R, 2005, J COLLOID INTERF SCI, V288, P177, DOI 10.1016/j.jcis.2005.02.078
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Kajita M., 2007, FREE RADIC BIOL MED, V41, P6
   Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679
   Kim J, 2008, MECH AGEING DEV, V129, P322, DOI 10.1016/j.mad.2008.02.011
   Moure A, 2000, J AGR FOOD CHEM, V48, P3890, DOI 10.1021/jf000048w
   Park Eunju, 2009, [JOURAL OF KOREAN POWER METALLURGY INSTIT, 한국분말야금학회지], V16, P217
   Pong K, 2003, EXPERT OPIN BIOL TH, V3, P127
   RECKNAGE RO, 1967, PHARMACOL REV, V19, P145
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   UENO I, 1984, J PHARMACOBIO-DYNAM, V7, P563
   Watanabe A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455105
NR 19
TC 4
Z9 4
U1 0
U2 51
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2015
VL 15
IS 8
BP 5571
EP 5576
DI 10.1166/jnn.2015.10468
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CC3RW
UT WOS:000350268100012
PM 26369119
DA 2024-02-19
ER

PT J
AU Chen, ER
   Cen, Y
   Lu, DH
   Luo, W
   Jiang, HX
AF Chen, Enran
   Cen, Yu
   Lu, Donghong
   Luo, Wei
   Jiang, Haixing
TI IL-22 inactivates hepatic stellate cells via downregulation of the
   TGF-1/Notch signaling pathway
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE hepatic stellate cells; interleukin-22; TGF-1; Notch pathway
ID NOTCH; INTERLEUKIN-22; INFLAMMATION; FIBROSIS; VIRUS; CONTRIBUTES;
   ACTIVATION; CIRRHOSIS; MICE
AB Interleukin-22 (IL-22) inhibits liver fibrosis by inducing hepatic stellate cell (HSC) senescence, primarily through the activation of signal transducer and activator of transcription 3 signaling. However, whether other signaling pathways are involved remains unknown. The present study assessed the regulatory mechanism between IL-22 and the Notch signaling pathway in vitro. The results revealed that IL-22 had anti-proliferative effects on HSC-T6 cells, and cellular inactivation was reflected by simultaneous inhibition of -smooth muscle actin, transforming growth factor-1 (TGF-1), tumor necrosis factor- and intercellular adhesion molecule 1. Treatment with TGF-1 resulted in significant Notch3 upregulation and activation of its downstream effectors Hes family basic helix-loop-helix (bHLH) transcription factor (Hes)-1, Hes-5 and Hes related family BHLH transcription factor with YRPW motif 1. Furthermore, this effect was markedly reversed by further treatment with IL-22, indicating there may be regulatory cascades of IL-22/TGF-1/Notch signaling in HSC-T6 cells. The results of the present study demonstrated an inhibitory function of IL-22 towards Notch signaling in hepatic cells, providing evidence that Notch may serve as a novel target for liver fibrosis.
C1 [Chen, Enran; Cen, Yu; Lu, Donghong; Luo, Wei; Jiang, Haixing] Guangxi Med Univ, Dept Gastroenterol, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.
C3 Guangxi Medical University
RP Jiang, HX (corresponding author), Guangxi Med Univ, Dept Gastroenterol, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China.
EM gxjianghx@163.com
CR Bansal R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18272
   Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025
   Bolós V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046
   Carmo RF, 2017, CYTOKINE, V98, P107, DOI 10.1016/j.cyto.2016.08.023
   Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397
   Chen YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046512
   Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268
   Ginès P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618
   Lu DH, 2015, WORLD J GASTROENTERO, V21, P1531, DOI 10.3748/wjg.v21.i5.1531
   Mühl H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00163
   Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061
   Pan CX, 2014, INFLAMM RES, V63, P519, DOI 10.1007/s00011-014-0727-3
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Sertorio M, 2015, HEPATOLOGY, V61, P1321, DOI 10.1002/hep.27629
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Trehanpati N, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.17
   Wei X, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00132
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zhang YM, 2016, WORLD J GASTROENTERO, V22, P2081, DOI 10.3748/wjg.v22.i6.2081
   Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447
NR 24
TC 20
Z9 21
U1 0
U2 8
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD APR
PY 2018
VL 17
IS 4
BP 5449
EP 5453
DI 10.3892/mmr.2018.8516
PG 5
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA GA9PA
UT WOS:000428672100076
PM 29393435
OA Bronze
DA 2024-02-19
ER

PT J
AU SEITZ, HK
   XU, Y
   SIMANOWSKI, UA
   OSSWALD, B
AF SEITZ, HK
   XU, Y
   SIMANOWSKI, UA
   OSSWALD, B
TI EFFECT OF AGE AND GENDER ON INVIVO ETHANOL ELIMINATION, HEPATIC
   ALCOHOL-DEHYDROGENASE ACTIVITY, AND NAD+ AVAILABILITY IN F344-RATS
SO RESEARCH IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE ETHANOL METABOLISM; AGING; HEPATIC REDOX STATE; ALCOHOL DEHYDROGENASE;
   NICOTINE ADENINE DINUCLEOTIDE
ID DRUG-METABOLISM; LIVER ALCOHOL; ADVANCING AGE; RAT-LIVER; SEX;
   OXIDATION; TOXICITY; MICE
AB It has been reported that aging strikingly decreases in vivo ethanol metabolism in F344 rats without major effects on hepatic alcohol dehydrogenase (ADH) activity. Because hepatic ADH activity is not always rate limiting in the oxidation of ethanol, we measured in vivo ethanol elimination rate (EER), hepatic ADH activity, and the hepatic-cytoplasmic and mitochondrial redox states after acute ethanol application in 2- and 12-month-old F344 rats of both sexes. In male, but not in female, animals EER decreased with age significantly, by 28% (P<0.01). The body-to-liver weight ratio was significantly increased in male (39.4+/-1.5 vs 46.5+/-2.0; P<0.05), but not in female, animals with age. Specific activity of ADH was not significantly changed by age, while the activity was significantly reduced with age in male, but not female, rats when related to body weight (5.1+/-0.4 vs 3.9+/-0.3-mu-moles/100 g b.wt./min; P<0.05). The cytoplasmic, but not the mitochondrial (NAD+) to (NADH), ratio was significantly decreased with age in male livers (317+/-48 vs 793+/-128, P<0.05), while this was not the case in female livers. In summary, the data show a sex dependence of the effect of age on ethanol metabolism. The observed reduction in in vivo EER with age in male animals is due at least in part to an increased body-to-liver weight ratio, decreased hepatic ADH activity, and reduced availability of NAD+, the cofactor of the ADH reaction. The cause of this may be decreased transport of reducing equivalents through the mitochondrial membrane due to a lack of shuttle systems or a change in the physicochemical properties of the mitochondrial membrane, or decreased reutilization of NADH as NADPH resulting from a reduction of microsomal ethanol oxidation with age.
RP SEITZ, HK (corresponding author), SALEM MED CTR HEIDELBERG,DEPT MED,ALCOHOL RES LIVER DIS & NUTR LAB,ZEPPELINSTR 11-33,W-6900 HEIDELBERG,GERMANY.
CR BERRY MN, 1978, EUR J BIOCHEM, V89, P237, DOI 10.1111/j.1432-1033.1978.tb20918.x
   BONNICHSEN RK, 1955, METHOD ENZYMOL, V1, P496
   Bucher T, 1963, METHOD ENZYMAT AN, P253
   DOMSCHKE S, 1974, LIFE SCI, V15, P1327, DOI 10.1016/0024-3205(74)90314-2
   FUJITA S, 1985, BIOCHEM BIOPH RES CO, V126, P117, DOI 10.1016/0006-291X(85)90579-0
   FUJITA S, 1982, LIVER AGING 1982, P55
   GELLERT J, 1987, GERMAN J GASTROENTER, V8, P464
   HAHN HKJ, 1983, ALCOHOL CLIN EXP RES, V7, P299, DOI 10.1111/j.1530-0277.1983.tb05464.x
   HENSGENS LAM, 1980, EUR J BIOCHEM, V108, P39, DOI 10.1111/j.1432-1033.1980.tb04693.x
   HOHORST HJ, 1963, METHOD ENZYMAT AN, P215
   KAO J, 1980, BIOCHEM PHARMACOL, V291, P1191
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KITANI K, 1986, HEPATOLOGY, V6, P316, DOI 10.1002/hep.1840060227
   LIEBER CS, 1985, ALCOHOL RELATED DISE, P19
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAKAR AB, 1970, BIOCHEM PHARMACOL, V19, P2017, DOI 10.1016/0006-2952(70)90298-4
   MALY IP, 1987, BIOL CHEM H-S, V368, P315, DOI 10.1515/bchm3.1987.368.1.315
   MARQUETTE BW, 1984, EXP AGING RES, V10, P7, DOI 10.1080/03610738408258534
   MEIJER AJ, 1975, BIOCHEM J, V150, P205, DOI 10.1042/bj1500205
   NORDMANN R, 1975, BIOCHEM PHARMACOL, V24, P139, DOI 10.1016/0006-2952(75)90326-3
   OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x
   RACHAMIN G, 1980, BIOCHEM J, V186, P483, DOI 10.1042/bj1860483
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   RIKANS LE, 1987, J PHARMACOL EXP THER, V243, P20
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   RITZMANN RF, 1980, AGE, V3, P15, DOI 10.1007/BF02435001
   SCHOLZ R, 1976, EUR J BIOCHEM, V63, P449, DOI 10.1111/j.1432-1033.1976.tb10247.x
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   SEITZ HK, 1984, HEPATOLOGY, V4, P1231, DOI 10.1002/hep.1840040623
   SEITZ HK, 1987, NUTRITIONAL TOXICOLO, V2, P63
   WIBERG GS, 1970, TOXICOL APPL PHARM, V16, P718, DOI 10.1016/0041-008X(70)90077-3
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
   WILLIAMSON DH, 1963, METHOD ENZYMAT AN, P454
   YORK JL, 1983, PHARMACOL BIOCHEM BE, V19, P687
NR 38
TC 28
Z9 31
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0300-9130
J9 RES EXP MED
JI Res. Exp. Med.
PD JUN
PY 1992
VL 192
IS 3
BP 205
EP 212
DI 10.1007/BF02576276
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HZ055
UT WOS:A1992HZ05500007
PM 1636065
DA 2024-02-19
ER

PT J
AU Zhang, Y
   Chen, XQ
   Yang, L
   Zu, YG
   Lu, Q
AF Zhang, Ying
   Chen, Xiaoqiang
   Yang, Lei
   Zu, Yuangang
   Lu, Qi
TI Effects of rosmarinic acid on liver and kidney antioxidant enzymes,
   lipid peroxidation and tissue ultrastructure in aging mice
SO FOOD & FUNCTION
LA English
DT Article
ID OXIDATIVE STRESS; HYDROXYCINNAMIC ACID; FREE-RADICALS; EXTRACT;
   PHENOLICS; DISEASE; DAMAGE; CELLS; LIFE
AB Rosmarinic acid (RA), which is a natural polyphenol, was isolated from Rosmarinus. officinalis L. The aim of this study is to evaluate the effects of rosmarinic acid on liver and kidney antioxidant enzymes and the tissue ultrastructure in aging mice. RA was administrated at a dosage of 50, 100 or 200 mg kg(-1) once a day with a normal control group and an aging control group for 30 days. The livers and kidneys of the mice were harvested for antioxidant enzyme activities and histological assessments. RA produced significant (p < 0.05 or p < 0.01) increases in the activity of superoxide dismutase (SOD) catalase (CAT) and glutathione peroxidase (GSH- Px) with a decrease in malondialdehyde (MDA) at 200 mg kg(-1) compared to the aging control. The histopathological study showed RA may induce significant structural changes in liver and kidney tissues at 200 mg kg(-1). The results in this study demonstrate that RA has the potential for promoting in vivo antioxidant enzyme activity.
C1 [Zhang, Ying; Chen, Xiaoqiang; Yang, Lei; Zu, Yuangang; Lu, Qi] Northeast Forestry Univ, Key Lab Forest Plant Ecol, Minist Educ, Harbin 150040, Peoples R China.
   [Zhang, Ying; Chen, Xiaoqiang; Yang, Lei; Zu, Yuangang; Lu, Qi] Northeast Forestry Univ, Prov Engn Lab Ecoutilizat Biol Resources, Harbin 150040, Peoples R China.
C3 Northeast Forestry University - China; Northeast Forestry University -
   China
RP Zhang, Y (corresponding author), Northeast Forestry Univ, Key Lab Forest Plant Ecol, Minist Educ, Harbin 150040, Peoples R China.
EM zygorl@aliyun.com
FU Fundamental Research Funds for the Central Universities [2572015CB17,
   2572015CB18]
FX This work was financially supported by "the Fundamental Research Funds
   for the Central Universities" (grant no. 2572015CB17 and 2572015CB18).
CR Alamed J, 2009, J AGR FOOD CHEM, V57, P2969, DOI 10.1021/jf803436c
   Arulselvan P, 2007, CHEM-BIOL INTERACT, V165, P155, DOI 10.1016/j.cbi.2006.10.014
   Astani A, 2012, CHEMOTHERAPY, V58, P70, DOI 10.1159/000335590
   Benavente-García O, 1997, J AGR FOOD CHEM, V45, P4505, DOI 10.1021/jf970373s
   Bulgakov VP, 2012, CRIT REV BIOTECHNOL, V32, P203, DOI 10.3109/07388551.2011.596804
   Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021
   Chen JH, 1997, J AGR FOOD CHEM, V45, P2374, DOI 10.1021/jf970055t
   Del Baño MJ, 2006, J AGR FOOD CHEM, V54, P2064, DOI 10.1021/jf0581574
   Gaté L, 1999, BIOMED PHARMACOTHER, V53, P169, DOI 10.1016/S0753-3322(99)80086-9
   [郭道森 Guo Daosen], 2004, [微生物学通报, Microbiology], V31, P71
   Gupta R, 2012, J DIABETES, V4, P164, DOI 10.1111/j.1753-0407.2011.00173.x
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HARMAN D, 1980, AGE, V3, P100, DOI 10.1007/BF02432267
   Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789
   Kakkar R, 1998, CLIN SCI, V94, P623, DOI 10.1042/cs0940623
   Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010
   LITVINENKO VI, 1975, PLANTA MED, V27, P372, DOI 10.1055/s-0028-1097817
   Manonmani G, 2005, J ETHNOPHARMACOL, V97, P39, DOI 10.1016/j.jep.2004.09.051
   Matsushima H, 1998, J LAB CLIN MED, V131, P518, DOI 10.1016/S0022-2143(98)90060-9
   Mazzanti G, 2008, NAT PROD RES, V22, P1433, DOI 10.1080/14786410802075939
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   Mueller M, 2010, FOOD CHEM, V122, P987, DOI 10.1016/j.foodchem.2010.03.041
   Ponrasu T., 2013, J PHARMACOGN PHYTOCH, V2, P77
   Punitha Issac Sam Raj, 2006, Diabetologia Croatica, V34, P117
   Ram M, 2014, N-S ARCH PHARMACOL, V387, P955, DOI 10.1007/s00210-014-1011-3
   Renzulli C, 2004, J APPL TOXICOL, V24, P289, DOI 10.1002/jat.982
   Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Senanayake SPJN, 2013, J FUNCT FOODS, V5, P1529, DOI 10.1016/j.jff.2013.08.011
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shimojo Y, 2010, J NEUROSCI RES, V88, P896, DOI 10.1002/jnr.22242
   Shino Y, 2003, FREE RADICAL BIO MED, V35, P966, DOI 10.1016/S0891-5849(03)00470-2
   Sögüt S, 2003, CLIN CHIM ACTA, V331, P111, DOI 10.1016/S0009-8981(03)00119-0
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Tavafi M, 2011, TISSUE CELL, V43, P392, DOI 10.1016/j.tice.2011.09.001
   Venukumar M R, 2002, Indian J Clin Biochem, V17, P80, DOI 10.1007/BF02867976
   Zou C, 2008, CARBOHYD POLYM, V73, P322, DOI 10.1016/j.carbpol.2007.11.035
NR 37
TC 66
Z9 68
U1 1
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2015
VL 6
IS 3
BP 927
EP 931
DI 10.1039/c4fo01051e
PG 5
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CD8TE
UT WOS:000351367900029
PM 25635678
DA 2024-02-19
ER

PT J
AU Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
TI Effect of recombinant human growth hormone on age-related hepatocyte
   changes in old male and female Wistar rats
SO ENDOCRINE
LA English
DT Article
DE growth hormone; aging; hepatocytes; estrogens
ID SEPSIS-RELATED CYTOKINES; OXIDATIVE STRESS; BODY-COMPOSITION; FACTOR-I;
   REPLACEMENT THERAPY; DIETARY RESTRICTION; LIPID-PEROXIDATION;
   GENE-EXPRESSION; HEME OXYGENASE; AGING-PROCESS
AB Aging induces changes in several organs, such as the liver, and this process might be due to damage caused by free radicals and inflammatory mediators. The growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis shows a reduction with age, and this fact could be associated with some age-related changes. The aim of this study was to investigate the effect of GH administration on age-induced alterations in hepatocytes. Two and twenty two month-old male and female Wistar rats were used. Old rats were treated with human recombinant GH for 10 wk. At the end of the treatment, hepatocytes were isolated from the liver and cultured, and different parameters were measured in cells and medium. Plasma IGF-1 was also measured. Aging significantly decreased plasma IGF-1 in males. In females, plasma IGF-1 was also reduced, but not significantly. GH treatment restored plasma IGF-1 levels to values similar to young males. Aging was associated with a significant increase in lipid peroxidation (LPO), nitric oxide (NO), carbon monoxide (CO) and cyclic guanosyl-monophosphate (cGMP), as well as a reduction in adenosyl triphosphate (ATP) and phosphatidylcholine (PC) synthesis. GH administration partially prevented all these changes in males. In females, some of the parameters were significantly improved by GH (ATP, CO, cGMP), while others showed a tendency to improvement, although differences did not reach significance. In conclusion, GH administration could exert beneficial effects against age-related changes in hepatocytes, mainly in males.
C1 Univ Complutense, Sch Med, Dept Physiol, Lab Expt Endocrinol, Madrid 28040, Spain.
   Univ Complutense, Sch Med, Dept Biochem & Mol Biol, Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Sch Med, Dept Physiol, Lab Expt Endocrinol, Avda Complutense S-N, Madrid 28040, Spain.
EM guerres@med.ucm.es
CR Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ARIASDIAZ J, 1993, EUR J SURG, V159, P535
   Arivazhagan P, 2001, CHEM-BIOL INTERACT, V138, P189, DOI 10.1016/S0009-2797(01)00268-X
   AZCOITIA I, 2004, IN PRESS NEUROBIOLOG
   Barañano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298
   Bartke A, 2003, TRENDS ENDOCRIN MET, V14, P340, DOI 10.1016/S1043-2760(03)00115-2
   Bartke A, 1998, EXP GERONTOL, V33, P675, DOI 10.1016/S0531-5565(98)00032-1
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   Castillo C, 2003, EXP GERONTOL, V38, P971, DOI 10.1016/S0531-5565(03)00156-6
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419
   COOK SJ, 1991, CELL SIGNAL, V3, P273, DOI 10.1016/0898-6568(91)90055-Y
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   Cuttica CM, 1997, AGING CLIN EXP RES, V9, P193, DOI 10.1007/BF03340149
   Cuzzocrea S, 2001, MOL MED, V7, P478, DOI 10.1007/BF03401853
   De Lama MAR, 2000, EUR J ENDOCRINOL, V142, P517, DOI 10.1530/eje.0.1420517
   Evans LM, 1999, CLIN ENDOCRINOL, V50, P457
   Evans LM, 2000, EUR J ENDOCRINOL, V142, P254, DOI 10.1530/eje.0.1420254
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Guo X, 2001, LIFE SCI, V69, P3113, DOI 10.1016/S0024-3205(01)01417-5
   Gustafsson H, 2002, EUR J ENDOCRINOL, V146, P267, DOI 10.1530/eje.0.1460267
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOLLOWAY L, 1994, J CLIN ENDOCR METAB, V79, P470, DOI 10.1210/jc.79.2.470
   Isaksson OGP, 2000, ENDOCR J, V47, pS9, DOI 10.1507/endocrj.47.SupplMarch_S9
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Jeschke MG, 2002, MOL MED, V8, P238, DOI 10.1007/BF03402149
   Jeschke MG, 2000, ANN SURG, V231, P408, DOI 10.1097/00000658-200003000-00014
   Jeschke MG, 1999, J SURG RES, V83, P122, DOI 10.1006/jsre.1999.5577
   Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414
   Khan AS, 2001, J GERONTOL A-BIOL, V56, pB364, DOI 10.1093/gerona/56.8.B364
   LACORT M, 1995, LIPIDS, V30, P141, DOI 10.1007/BF02538267
   Libby P, 2003, AM J CARDIOL, V91, p3A
   McCann SM, 1998, EXP GERONTOL, V33, P813, DOI 10.1016/S0531-5565(98)00050-3
   Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7
   Nathan L, 1998, SEMIN REPROD ENDOCR, V16, P309, DOI 10.1055/s-2007-1016289
   Neill J.D., 1994, PHYSL REPROD
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   RUDMAN D, 1985, J AM GERIATR SOC, V33, P800, DOI 10.1111/j.1532-5415.1985.tb04195.x
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   SALAZAR V, 2003, J PHYSL P, V548, pP194
   Sastre J, 2000, IUBMB LIFE, V49, P427
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   Shimizu H, 2001, EXP TOXICOL PATHOL, V53, P11, DOI 10.1078/0940-2993-00156
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095
   Szabó C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Tani Yoshiro, 2001, Journal of Toxicological Sciences, V26, P25, DOI 10.2131/jts.26.25
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Toogood AA, 1998, BAILLIERE CLIN ENDOC, V12, P281, DOI 10.1016/S0950-351X(98)80023-2
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vara E, 1996, AM J PHYSIOL-LUNG C, V271, pL359, DOI 10.1152/ajplung.1996.271.3.L359
   VARA E, 1994, HEPATOLOGY, V20, P924, DOI 10.1002/hep.1840200422
   VARELA I, 1986, 1 C BIOCH PHARM CLIN, P25
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
NR 63
TC 14
Z9 14
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-008X
EI 1559-0100
J9 ENDOCRINE
JI Endocrine
PD OCT
PY 2004
VL 25
IS 1
BP 33
EP 39
DI 10.1385/ENDO:25:1:33
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 883JN
UT WOS:000226007500006
PM 15545704
DA 2024-02-19
ER

PT J
AU Chen, LL
   Yang, RL
   Qiao, WX
   Yuan, XQ
   Wang, S
   Goltzman, D
   Miao, DS
AF Chen, Lulu
   Yang, Renlei
   Qiao, Wanxin
   Yuan, Xiaoqin
   Wang, Shui
   Goltzman, David
   Miao, Dengshun
TI 1,25-Dihydroxy vitamin D prevents tumorigenesis by inhibiting oxidative
   stress and inducing tumor cellular senescence in mice
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article
ID CANCER-THERAPY; 25-HYDROXYVITAMIN-D 1-ALPHA-HYDROXYLASE;
   GROWTH-RETARDATION; CALCIUM; INACTIVATION; METASTASIS; INTERFACE;
   SKELETAL; ABLATION; PATHWAY
AB Human epidemiological studies suggest that 1,25(OH)(2)D-3 deficiency might increase cancer incidence, but no spontaneous tumors have been reported in mice lacking 1,25(OH)(2)D-3 or deficient in its receptor. In our study, we detected, for the first time, diverse types of spontaneous tumors in 1,25(OH)(2)D-3 deficient mice more than 1 year of age. This was associated with increased oxidative stress, cellular senescence and senescence-associated secretory phenotype molecules, such as hepatocyte growth factor, mediated via its receptor c-Met. Furthermore, 1,25(OH)(2)D-3 prevented spontaneous tumor development. We also demonstrated that 1,25(OH)(2)D-3 deficiency accelerates allograft tumor initiation and growth by increasing oxidative stress and DNA damage, activating oncogenes, inactivating tumor suppressor genes, stimulating malignant cell proliferation and inhibiting their senescence; in contrast, supplementation with exogenous 1,25(OH)(2)D-3 or antioxidant, or knock-down of the Bmi1 or c-Met oncogene, largely rescued the phenotypes of allograft tumors. Results from our study suggest that 1,25(OH)(2)D-3 deficiency enhances tumorigenesis by increasing malignant cell oxidative stress and DNA damage, stimulating microenvironmental cell senescence and a senescence-associated secretory phenotype, and activating oncogenes and inactivating tumor suppressor genes, thus increasing malignant cell proliferation. Our study provides direct evidence supporting the role of vitamin D deficiency in increasing cancer incidence. Conversely, 1,25(OH)(2)D-3 prevented spontaneous tumor development, suggesting that this inhibitory effect prevents the initiation and progression of tumorigenesis, thus provides a mechanistic basis for 1,25(OH)(2)D-3 to prevent tumorigenesis in an aging organism.
   What's new?
   Vitamin D (1,25(OH)(2)D-3) is thought to play a role in lowering cancer incidence. However, associations between cancer and 1,25(OH)(2)D-3 sufficiency or deficiency are unclear. In this study, diverse types of spontaneous tumors were detected in aged 1,25(OH)(2)D-3-deficient mice. In addition, 1,25(OH)(2)D-3 deficiency was found to accelerate allograft tumor initiation and growth by elevating oxidative stress, by stimulating microenvironmental cell senescence, and by activating oncogenes and inactivating tumor suppressor genes. These effects resulted in increased malignant cell proliferation and inhibition of tumor cellular senescence. By contrast, 1,25(OH)(2)D-3 supplementation in deficient mice blocked spontaneous tumor development and rescued allograft tumor phenotypes.
C1 [Chen, Lulu; Yang, Renlei; Qiao, Wanxin; Yuan, Xiaoqin; Miao, Dengshun] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.
   [Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.
   [Goltzman, David] McGill Univ, Calcium Res Lab, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada.
   [Goltzman, David] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada.
C3 Nanjing Medical University; Nanjing Medical University; McGill
   University; McGill University
RP Goltzman, D (corresponding author), McGill Univ, Calcium Res Lab, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada.; Goltzman, D (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada.; Miao, DS (corresponding author), Nanjing Med Univ, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.
EM david.goltzman@mcgill.ca; dsmiao@njmu.edu.cn
OI Yang, Renlei/0009-0009-0578-8777; Miao, Dengshun/0000-0002-2682-3502
FU National Natural Science Foundation of China [81230009, 81471501];
   National Basic Research Program of China [2014CB942900]; Canadian
   Institutes of Health Research (CIHR)
FX Grant sponsor: The National Natural Science Foundation of China; Grant
   numbers: 81230009 and 81471501; Grant sponsor: National Basic Research
   Program of China; Grant number: 2014CB942900; Grant sponsor: The
   Canadian Institutes of Health Research (CIHR)
CR Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Athreya K, 2017, NUTR CANCER, V69, P1099, DOI 10.1080/01635581.2017.1362445
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957
   Cheung KL, 2014, MOL CARCINOGEN, V53, P77, DOI 10.1002/mc.21950
   Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347
   Cohen HJ, 2007, J CLIN ONCOL, V25, P1945, DOI 10.1200/JCO.2007.10.6807
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002
   Halicka HD, 2012, AGING-US, V4, P270, DOI 10.18632/aging.100450
   HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678
   Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007
   KITTRELL FS, 1992, CANCER RES, V52, P1924
   Krishnan AV, 2010, ENDOCRIN METAB CLIN, V39, P401, DOI 10.1016/j.ecl.2010.02.011
   Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3
   Li ZW, 2014, LAB INVEST, V94, P1431, DOI 10.1038/labinvest.2014.123
   Lin AMY, 2005, ANN NY ACAD SCI, V1053, P319, DOI 10.1196/annals.1344.028
   Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097
   Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105
   Nakai K, 2014, AM J HYPERTENS, V27, P586, DOI 10.1093/ajh/hpt160
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200
   Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schöttker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656
   Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242
   Shen M, 2013, BONE, V55, P400, DOI 10.1016/j.bone.2013.04.015
   Smith DC, 1999, CLIN CANCER RES, V5, P1339
   Sun WW, 2015, AM J PHYSIOL-ENDOC M, V308, pE51, DOI 10.1152/ajpendo.00076.2014
   Tuohimaa P, 2009, J STEROID BIOCHEM, V114, P78, DOI 10.1016/j.jsbmb.2008.12.020
   Wang MC, 2015, ONCOL LETT, V10, P583, DOI 10.3892/ol.2015.3361
   Wu FS, 2007, LIVER INT, V27, P700, DOI 10.1111/j.1478-3231.2007.01487.x
   Yong KJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6066
   Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391
   Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101
   Zhou XY, 2016, BIOMED RES INT, V2016, P1
   Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103
NR 50
TC 47
Z9 49
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD JUL 15
PY 2018
VL 143
IS 2
BP 368
EP 382
DI 10.1002/ijc.31317
PG 15
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA GI1FO
UT WOS:000434116300015
PM 29441580
OA Bronze
DA 2024-02-19
ER

PT J
AU Popovic, B
   Velimirovic, M
   Stojkovic, T
   Brajovic, G
   De Luka, SR
   Milovanovic, I
   Stefanovic, S
   Nikolic, D
   Ristic-Djurovic, JL
   Petronijevic, ND
   Trbovich, AM
AF Popovic, Branka
   Velimirovic, Milica
   Stojkovic, Tihomir
   Brajovic, Gavrilo
   De Luka, Silvio R.
   Milovanovic, Ivan
   Stefanovic, Srdjan
   Nikolic, Dragica
   Ristic-Djurovic, Jasna L.
   Petronijevic, Natasa D.
   Trbovich, Alexander M.
TI The influence of ageing on the extrapineal melatonin synthetic pathway
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE AA-NAT and ASMT; SOD; Catalase; Cu; Zn; Mn
ID N-ACETYLTRANSFERASE; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES; HUMAN SKIN;
   RAT-BRAIN; METABOLISM; SEROTONIN; LIVER; ACETYLSEROTONIN; LOCALIZATION
AB Ageing affects various physiological and metabolic processes in a body and a progressive accumulation of oxidative damage stands out as often used explanation. One of the most powerful scavenger of reactive oxygen species (ROS) in all organs is melatonin. A majority of melatonin supplied to the body via blood originates from the pineal gland. However, we have been interested in a locally produced melatonin.
   We have used 2.5- and 36-months-old Wistar rats. Tissues were collected and gene expression of AA-NAT and ASMT, the two key enzymes in a synthesis of melatonin, was determined in brain, liver, kidney, heart, skin, and intestine. Since melatonin can influence antioxidant enzymes, the activity of superoxide dismutase (SOD) and catalase (CAT), and the level of GSH were measured in liver. In addition, Copper (Cu), Zinc (Zn), and Manganese (Mn) were also determined in liver since these microelements might affect the activity of antioxidant enzymes.
   The expression of AA-NAT and ASMT was increased in liver and skin of old animals. A positive correlation in AA-NAT and ASMT expression was observed in liver, intestine and kidney. Moreover, the activity of CAT enzyme in liver was increased while SOD activity was decreased. SOD and CAT were probably affected by the observed decreased amount of Cu, Zn, and Mn in liver of old animals.
   In our model, extrapineal melatonin pathway in ageing consisted of complex interplay of locally produced melatonin, activities of SOD and CAT, and adequate presence of Cu, Zn and Mn microelements in order to defend organs against oxidative damage.
C1 [Popovic, Branka] Univ Belgrade, Sch Dent Med, Inst Human Genet, Dr Subot 8, Belgrade 11000, Serbia.
   [Velimirovic, Milica; Stojkovic, Tihomir; Petronijevic, Natasa D.] Univ Belgrade, Sch Med, Inst Clin & Med Biochem, Pasterova 2, Belgrade 11000, Serbia.
   [Brajovic, Gavrilo] Univ Belgrade, Sch Dent Med, Dept Physiol, Dr Subot 8, Belgrade 11000, Serbia.
   [De Luka, Silvio R.; Trbovich, Alexander M.] Univ Belgrade, Sch Med, Dept Pathophysiol, Dr Subot 8, Belgrade 11000, Serbia.
   [Milovanovic, Ivan] Univ Childrens Hosp, Tirsova 10, Belgrade, Serbia.
   [Ristic-Djurovic, Jasna L.] Univ Belgrade, Inst Phys, Pregrev 118, Belgrade 11080, Serbia.
   [Stefanovic, Srdjan; Nikolic, Dragica] Inst Meat Hyg & Technol, Kacanskog 13, Belgrade 11000, Serbia.
C3 University of Belgrade; University of Belgrade; University of Belgrade;
   University of Belgrade; University of Belgrade; University of Belgrade
RP Trbovich, AM (corresponding author), Univ Belgrade, Sch Med, Dr Subot 8, Belgrade, Serbia.
EM branka.popovic@stomf.bg.ac.rs; Tihomir.stojkovic@med.bg.ac.rs;
   silvio.de-luka@med.bg.ac.rs; srdjan.stefanovic@inmes.rs;
   dragica.nikolic@inmes.rs; jasna@stanfordalumni.org;
   Natasa.petronijevic@med.bg.ac.rs; Alexander.M.Trbovich@gmail.com
RI Velimirovic, Milica D/R-9449-2017; De Luka, Silvio R./E-4079-2019;
   Milovanović, Ivan/JWP-2566-2024
OI Velimirovic, Milica D/0000-0002-0495-0316; De Luka, Silvio
   R./0000-0002-0859-9252; Stojkovic, Tihomir/0000-0002-2400-6066;
   Stefanovic, Srdjan/0000-0002-8011-5654; Brajovic,
   Gavrilo/0000-0002-3311-0148; Petronijevic, Natasa/0000-0002-4338-1953;
   Milovanovic, Ivan/0000-0001-5262-0891
FU Ministry of Education, Science and Technological Development, Government
   of Serbia [175075, III-41019, 45003]
FX This study was supported by the grants No 175075, No III-41019, and No
   45003 from the Ministry of Education, Science and Technological
   Development, Government of Serbia.
CR Acuña-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2
   Barton GP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00352
   Baydas G, 2002, J PINEAL RES, V32, P225, DOI 10.1034/j.1600-079X.2002.01856.x
   Ben Shahar Y, 2016, EUR J PEDIATR SURG, V26, P47, DOI 10.1055/s-0035-1559886
   Bonomini F, 2010, EXP GERONTOL, V45, P149, DOI 10.1016/j.exger.2009.11.006
   Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919
   DebiecRychter M, 1996, CANCER RES, V56, P1517
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje
   Flores Lisa C, 2012, Longev Healthspan, V1, P4, DOI 10.1186/2046-2395-1-4
   GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M
   Hamezah HS, 2017, EXP GERONTOL, V99, P69, DOI 10.1016/j.exger.2017.09.008
   Hardeland R, 2006, INT J BIOCHEM CELL B, V38, P313, DOI 10.1016/j.biocel.2005.08.020
   HARDELAND R, 1995, J PINEAL RES, V18, P104, DOI 10.1111/j.1600-079X.1995.tb00147.x
   HONG GX, 1995, COMP BIOCHEM PHYS B, V112, P251, DOI 10.1016/0305-0491(95)00083-6
   Jaworek J, 2003, J PINEAL RES, V34, P40, DOI 10.1034/j.1600-079X.2003.02937.x
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kawakubo Y, 2000, J PHARMACOL EXP THER, V292, P150
   Kim TK, 2015, MOL CELL ENDOCRINOL, V404, P1, DOI 10.1016/j.mce.2014.07.024
   Kireev R, 2013, EUR J PHARMACOL, V701, P185, DOI 10.1016/j.ejphar.2012.11.038
   Kobayashi H, 2005, FASEB J, V19, P1710, DOI 10.1096/fj.04-2293fje
   Konturek SJ, 2007, J PHYSIOL PHARMACOL, V58, P381
   Limson J, 1998, J PINEAL RES, V24, P15, DOI 10.1111/j.1600-079X.1998.tb00361.x
   Manikonda PK, 2012, BIOGERONTOLOGY, V13, P511, DOI 10.1007/s10522-012-9396-1
   Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687
   Oxenkrug G, 2005, ANN NY ACAD SCI, V1053, P334, DOI 10.1196/annals.1344.029
   Parmar P, 2002, J PINEAL RES, V32, P237, DOI 10.1034/j.1600-079X.2002.01859.x
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Rotter I, 2015, INT J ENV RES PUB HE, V12, P3944, DOI 10.3390/ijerph120403944
   Sanchez-Hidalgo M, 2009, EXP GERONTOL, V44, P328, DOI 10.1016/j.exger.2009.02.002
   Semak I, 2004, ARCH BIOCHEM BIOPHYS, V421, P61, DOI 10.1016/j.abb.2003.08.036
   Semak I, 2008, J PINEAL RES, V45, P515, DOI 10.1111/j.1600-079X.2008.00630.x
   Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje
   Slominski A, 1996, J BIOL CHEM, V271, P12281, DOI 10.1074/jbc.271.21.12281
   Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev
   Slominski A, 2003, EUR J BIOCHEM, V270, P3335, DOI 10.1046/j.1432-1033.2003.03708.x
   Slominski A, 2008, TRENDS ENDOCRIN MET, V19, P17, DOI 10.1016/j.tem.2007.10.007
   Slominski AT, 2018, J INVEST DERMATOL, V138, P490, DOI 10.1016/j.jid.2017.10.025
   Slominski AT, 2017, CELL MOL LIFE SCI, V74, P3913, DOI 10.1007/s00018-017-2617-7
   Slominski AT, 2017, EXP DERMATOL, V26, P563, DOI 10.1111/exd.13208
   Stefulj J, 2001, J PINEAL RES, V30, P243, DOI 10.1034/j.1600-079X.2001.300408.x
   SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6
   Tan DX, 2016, J PINEAL RES, V61, P27, DOI 10.1111/jpi.12336
   Uz T, 2002, NEUROSCI RES, V42, P309, DOI 10.1016/S0168-0102(02)00011-1
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Xianyong Ma, 2017, BIOCH GENETICS MOL B, P207, DOI [10.5772/65936, DOI 10.5772/65936]
   Xu XY, 2018, MOLECULES, V23, DOI 10.3390/molecules23030703
   Zhan-Poe XY, 1999, J PINEAL RES, V27, P49, DOI 10.1111/j.1600-079X.1999.tb00596.x
NR 50
TC 4
Z9 6
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2018
VL 110
BP 151
EP 157
DI 10.1016/j.exger.2018.06.010
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GR2HA
UT WOS:000442386400022
PM 29906492
DA 2024-02-19
ER

PT J
AU Morita, A
   Abdireyim, D
   Kimura, M
   Itokawa, Y
AF Morita, A
   Abdireyim, D
   Kimura, M
   Itokawa, Y
TI The effect of aging on the mineral status of female SAMP1 and SAMR1
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE aging; female mice; SAM; iron; zinc; copper; calcium; magnesium;
   phosphorus; sulfur; sodium; potassium
ID WILSON-DISEASE GENE; COPPER TRANSPORTING ATPASE; AGE-RELATED-CHANGES;
   BARRIER FUNCTION; BLOOD-PRESSURE; SERUM-ALBUMIN; MURINE MODEL;
   MOUSE-BRAIN; CALCIUM; BONE
AB The effect of aging on the status of macrominerals and trace elements in tissues was studied using two strains (SAMP1 and SAMR1) of senescence accelerated mouse. Two-month-old, 6-mo-old, and 10-mo-old female SAMP1 and SAMR1 mice were fed a commercial diet. Iron, zinc, copper, calcium, magnesium, phosphorus, sulfur, sodium, and potassium concentrations in blood, liver, kidney, brain, and tibia of the mice were determined. The copper concentration in the brain was significantly increased with age in SAMP1 and SAMR1. In addition, the brain copper levels in SAMP1 were significantly higher than that in SAMR1 at respective ages. The calcium concentration in the kidney was significantly increased with age, but the copper and phosphorus concentrations significantly decreased with age in SAMP1 and SAMR1. In the liver of SAMR1, all minerals measured in this study except for sodium and potassium were significantly decreased with age. In addition, all mineral concentrations in the liver of 2-mo-old mice in SAMR1 except for copper and sodium were markedly higher than those in SAMP1 of the same age. These results suggest that the genetic factor is related to the age-associated mineral changes in tissues.
C1 Kinki Univ, Sch Med, Dept Publ Hlth, Osaka 589, Japan.
   Xinjiang Med Univ, Xinjiang, Peoples R China.
   Takeda Res Inst Life Sci, Shimogyo Ku, Kyoto, Japan.
   Fukui Prefectural Univ, Matsuoka, Fukui, Japan.
C3 Kindai University (Kinki University); Xinjiang Medical University; Fukui
   Prefectural University
RP Morita, A (corresponding author), Kinki Univ, Sch Med, Dept Publ Hlth, Ohno Higashi, Osaka 589, Japan.
OI Morita, Akemi/0000-0001-7942-6415
CR BOGDEN JD, 1991, J NUTR, V121, P718, DOI 10.1093/jn/121.5.718
   BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327
   BULLAMORE JR, 1970, LANCET, V2, P535
   HANSARD SL, 1957, J NUTR, V62, P325
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   Hosokawa M, 1999, NEUROBIOL AGING, V20, P117, DOI 10.1016/S0197-4580(99)00029-9
   ITOKAWA Y, 1974, J APPL PHYSIOL, V37, P835, DOI 10.1152/jappl.1974.37.6.835
   LINDEMAN RD, 1982, J AM COLL NUTR, V1, P49
   MAMEESH MS, 1958, J NUTR, V65, P161, DOI 10.1093/jn/65.1.161
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3
   MASSIE HR, 1990, EXP GERONTOL, V25, P469, DOI 10.1016/0531-5565(90)90035-Z
   MASSIE HR, 1979, MECH AGEING DEV, V11, P219, DOI 10.1016/0047-6374(79)90001-0
   MATSUDA A, 1989, Japanese Journal of Hygiene, V44, P887
   MCELROY ST, 1991, J NUTR, V121, P492, DOI 10.1093/jn/121.4.492
   MEEMA HE, 1966, J BONE JOINT SURG AM, VA 48, P1138, DOI 10.2106/00004623-196648060-00011
   MEEMA S, 1973, CALC TISS RES, V12, P101, DOI 10.1007/BF02013725
   MIYAMOTO H, 1995, J EXP ZOOL, V272, P116, DOI 10.1002/jez.1402720205
   MORITA A, 1994, BIOL TRACE ELEM RES, V42, P165, DOI 10.1007/BF02785387
   MORITA A, 1997, JPN J SOC MAG RES S, V16, P143
   PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338
   Pinkham C S, 1988, Magnes Res, V1, P147
   POMMER G, 1885, UNTERSUCHUNGEN OSTEO
   REDDY BS, 1972, J NUTR, V102, P299, DOI 10.1093/jn/102.2.299
   SINAKI M, 1974, ARCH PHYS MED REHAB, V55, P508
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344
   TAYLOR DM, 1962, BIOCHEM J, V83, P25, DOI 10.1042/bj0830025
   UENO M, 1993, ARCH GERONTOL GERIAT, V16, P233, DOI 10.1016/0167-4943(93)90035-G
   Ueno M, 1997, ARCH GERONTOL GERIAT, V25, P321, DOI 10.1016/S0167-4943(97)00022-8
   USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340
   Wisniewski H, 1966, Neuropatol Pol, V4, P33
   WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541
   YAMAGUCHI Y, 1994, BIOCHEM J, V301, P1
   YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471
NR 36
TC 4
Z9 5
U1 1
U2 4
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD APR
PY 2001
VL 80
IS 1
BP 53
EP 65
DI 10.1385/BTER:80:1:53
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 433BJ
UT WOS:000168735200006
PM 11393310
DA 2024-02-19
ER

PT J
AU Loomba, R
   Gindin, Y
   Jiang, ZS
   Lawitz, E
   Caldwell, S
   Djedjos, CS
   Xu, R
   Chung, CH
   Myers, RP
   Subramanian, GM
   Goodman, Z
   Charlton, M
   Afdhal, NH
   Diehl, AM
AF Loomba, Rohit
   Gindin, Yevgeniy
   Jiang, Zhaoshi
   Lawitz, Eric
   Caldwell, Stephen
   Djedjos, C. Stephen
   Xu, Ren
   Chung, Chuhan
   Myers, Robert P.
   Subramanian, G. Mani
   Goodman, Zachary
   Charlton, Michael
   Afdhal, Nezam H.
   Diehl, Anna Mae
TI DNA methylation signatures reflect aging in patients with nonalcoholic
   steatohepatitis
SO JCI INSIGHT
LA English
DT Article
ID FATTY LIVER-DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; HISTOLOGIC FEATURES;
   EPIGENETIC CLOCK; FIBROSIS; AGE; BIOCONDUCTOR; PROGRESSION; INFECTION;
   IMPACT
AB A DNA methylation (DNAm) signature (the "Horvath clock") has been proposed as a measure of human chronological and biological age. We determined peripheral blood DNAm in patients with nonalcoholic steatohepatitis (NASH) and assessed whether accelerated aging occurs in these patients. DNAm signatures were obtained in patients with biopsy-proven NASH and stage 2-3 fibrosis. The DNAm profile from one test and two validation cohorts served as controls. Age acceleration was calculated as the difference between DNAm age and the predicted age based on the linear model derived from controls. Hepatic collagen content was assessed by quantitative morphometry. The Horvath clock accurately predicts the chronological age of the entire cohort. Age acceleration was observed among NASH subjects compared with control data sets and our test controls. Age acceleration in NASH subjects did not differ by fibrosis stage but correlated with hepatic collagen content. A set of 152 differentially methylated CpG islands between NASH subjects and controls identified gene set enrichment for transcription factors and developmental pathways. Patients with NASH exhibit epigenetic age acceleration that correlates with hepatic collagen content.
C1 [Loomba, Rohit] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Gindin, Yevgeniy; Jiang, Zhaoshi; Djedjos, C. Stephen; Xu, Ren; Chung, Chuhan; Myers, Robert P.; Subramanian, G. Mani] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.
   [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA.
   [Caldwell, Stephen] Univ Virginia, Charlottesville, VA USA.
   [Goodman, Zachary] Inova Fairfax Hosp, Falls Church, VA USA.
   [Charlton, Michael] Intermt Med Ctr, Salt Lake City, UT USA.
   [Afdhal, Nezam H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Afdhal, Nezam H.] Harvard Med Sch, Boston, MA USA.
   [Diehl, Anna Mae] Duke Clin Res Inst, Durham, NC USA.
C3 University of California System; University of California San Diego;
   Gilead Sciences; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Virginia; Inova Fairfax
   Hospital; Intermountain Healthcare; Intermountain Medical Center;
   Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School; Duke University
RP Loomba, R (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM roloomba@ucsd.edu
RI Loomba, Rohit/AAE-7831-2019
OI Loomba, Rohit/0000-0002-4845-9991; Afdhal, Nezam/0000-0002-7342-6593
FU Gilead Sciences Inc.
FX This work was supported by Gilead Sciences Inc. We thank Lakshmi
   Alaparthi and Fanny Monge for assistance with the morphometry analyses.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421
   Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016
   Cummings J, 2012, BRIT J CANCER, V106, P1766, DOI 10.1038/bjc.2012.165
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hardy T, 2017, GUT, V66, P1321, DOI 10.1136/gutjnl-2016-311526
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Kirchner H, 2016, MOL METAB, V5, P171, DOI 10.1016/j.molmet.2015.12.004
   Koch CM, 2011, AGING-US, V3, P1018, DOI 10.18632/aging.100395
   Levine AJ, 2016, J NEUROVIROL, V22, P366, DOI 10.1007/s13365-015-0406-3
   Loomba R, 2015, GASTROENTEROLOGY, V149, P278, DOI 10.1053/j.gastro.2015.06.016
   Marioni RE, 1936, INT J EPIDEMIOL, V2015, P44
   McHutchison J, 2010, GASTROENTEROLOGY, V138, P1365, DOI 10.1053/j.gastro.2009.12.003
   Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035
   Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047
   Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020
   Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293
   Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Rickabaugh TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119201
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254
   Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927
   Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109
NR 32
TC 36
Z9 38
U1 1
U2 5
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JAN 25
PY 2018
VL 3
IS 2
AR e96685
DI 10.1172/jci.insight.96685
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FT7MU
UT WOS:000423337400008
PM 29367468
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Burlakova, EB
   Misharina, TA
   Fatkullina, LD
   Terenina, MB
   Krikunova, NI
   Yerokhin, VN
   Vorobieva, AK
AF Burlakova, E. B.
   Misharina, T. A.
   Fatkullina, L. D.
   Terenina, M. B.
   Krikunova, N. I.
   Yerokhin, V. N.
   Vorobieva, A. K.
TI Alterations in Fatty Acid Composition of Mice Brain and Liver with Aging
   and at Savory Essential Oil Administration
SO DOKLADY BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID DIETARY SUPPLEMENTATION; ANTIOXIDANT STATUS; RAT
C1 [Burlakova, E. B.; Misharina, T. A.; Fatkullina, L. D.; Terenina, M. B.; Krikunova, N. I.; Yerokhin, V. N.; Vorobieva, A. K.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow 119991, Russia.
C3 Russian Academy of Sciences; Emanuel Institute of Biochemical Physics
RP Burlakova, EB (corresponding author), Russian Acad Sci, Emanuel Inst Biochem Phys, Ul Kosygina 4, Moscow 119991, Russia.
RI Yerokhin, Vladimir A./R-5147-2016
OI Yerokhin, Vladimir A./0000-0002-2328-8444
FU Department of Chemistry and Material Sciences of the Russian Academy of
   Sciences [10, 01-RAS-01]
FX This work was supported by the Fundamental Research Program of the
   Department of Chemistry and Material Sciences of the Russian Academy of
   Sciences no. 10 "Medical and Biomolecular Chemistry" (project no.
   01-RAS-01, 2009-2010).
CR DEANS SG, 1993, AGE, V16, P71, DOI 10.1007/BF02435040
   Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072
   Erokhin V N, 2003, Radiats Biol Radioecol, V43, P237
   Koroch AR, 2007, FLAVOURS FRAGRANCES, P87, DOI [DOI 10.1007/978-3-540-49339-6_5, 10.1007/978-3-540-49339-6_5]
   MISHARINA TA, 2010, MEDITSINSKAYA FIZIKA, V4, P367
   Nakamura MT, 2001, LIPIDS, V36, P961, DOI 10.1007/s11745-001-0806-5
   Recsan Z., 1997, Journal of Essential Oil Research, V9, P53
   Ruberto G, 2000, FOOD CHEM, V69, P167, DOI 10.1016/S0308-8146(99)00247-2
   Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1
   Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33
   Youdim KA, 2000, BRIT J NUTR, V83, P87, DOI 10.1017/S000711450000012X
   Youdim KA, 1999, MECH AGEING DEV, V109, P163, DOI 10.1016/S0047-6374(99)00033-0
NR 12
TC 9
Z9 12
U1 0
U2 4
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1607-6729
EI 1608-3091
J9 DOKL BIOCHEM BIOPHYS
JI Dokl. Biochem. Biophys.
PD APR
PY 2011
VL 437
IS 1
BP 80
EP 83
DI 10.1134/S1607672911020074
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 786KJ
UT WOS:000292306600007
PM 21590381
DA 2024-02-19
ER

PT J
AU Alameda, JP
   Ramirez, A
   Garcia-Fernandez, RA
   Navarro, M
   Page, A
   Segovia, JC
   Sanchez, R
   Suarez-Cabrera, C
   Paramio, JM
   Bravo, A
   Fernández-Aceñero, MJ
   Casanova, ML
AF Alameda, Josefa P.
   Ramirez, Angel
   Garcia-Fernandez, Rosa A.
   Navarro, Manuel
   Page, Angustias
   Segovia, Jose C.
   Sanchez, Rebeca
   Suarez-Cabrera, Cristian
   Paramio, Jesus M.
   Bravo, Ana
   Jesus Fernandez-Acenero, M.
   Llanos Casanova, M.
TI Premature aging and cancer development in transgenic mice lacking
   functional CYLD
SO AGING-US
LA English
DT Article
DE CYLD; premature aging; tumor suppressor; NF-kappa B; keratinocyte
   differentiation; skin; inflammation
ID NF-KAPPA-B; CELLULAR SENESCENCE; STEM-CELLS; ACTIVATION; EXPRESSION;
   PROMOTES; DIFFERENTIATION; DEFICIENT; BIOMARKER; SURVIVAL
AB CYLD is a deubiquitinating enzyme known for its role as a tumor suppressor whose mutation leads to skin appendages tumors and other cancers. In this manuscript we report that the tumor suppressor CYLD, similarly to other renowned tumor suppressor genes, protects from premature aging and cancer. We have generated transgenic mice expressing the mutant CYLDC/S protein, lacking its deubiquitinase function, under the control of the keratin 5 promoter, the K5-CYLDC/S mice. These mice express the transgene in different organs, including those considered to be more susceptible to aging, such as skin and thymus. Our results show that K5-CYLDC/S mice exhibit epidermal, hair follicle, and sebaceous gland alterations; and, importantly, they show signs of premature aging from an early age. Typically, 3-month-old K5-CYLDC/S mice exhibit a phenotype characterized by alopecia and kyphosis, and, the histological examination reveals that transgenic mice show signs of accelerated aging in numerous organs such as skin, thymus, pancreas, liver and lung. Additionally, they spontaneously develop tumors of diverse origin. Over-activation of the NF-kappa B pathway, along with hyperactivation of Akt, JNK and c-Myc, and chronic inflammation, appear as the mechanisms responsible for the premature aging of the K5-CYLDC/S mice.
C1 [Alameda, Josefa P.; Ramirez, Angel; Navarro, Manuel; Page, Angustias; Suarez-Cabrera, Cristian; Paramio, Jesus M.; Llanos Casanova, M.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid 28040, Spain.
   [Alameda, Josefa P.; Ramirez, Angel; Navarro, Manuel; Page, Angustias; Suarez-Cabrera, Cristian; Paramio, Jesus M.; Llanos Casanova, M.] 12 Octubre Univ Hosp, Biomed Res Inst I 12, Madrid 28040, Spain.
   [Garcia-Fernandez, Rosa A.] UCM, Fac Vet, Dept Anim Med & Surg, Madrid 28040, Spain.
   [Segovia, Jose C.; Sanchez, Rebeca] CIEMAT CIBERER II FJD, Div Hematopoiet Innovat Therapies, Madrid 28040, Spain.
   [Bravo, Ana] Univ Santiago Compostela, Fac Vet Med, Dept Anat Anim Prod & Vet Clin Sci, Lugo, Spain.
   [Jesus Fernandez-Acenero, M.] UCM, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Serv Anat Patol,Dept Anat Patol,Fac Med, Madrid 28040, Spain.
C3 Centro de Investigaciones Energeticas, Medioambientales Tecnologicas;
   Hospital Universitario 12 de Octubre; Complutense University of Madrid;
   Centro de Investigaciones Energeticas, Medioambientales Tecnologicas;
   Universidade de Santiago de Compostela; Complutense University of
   Madrid; Hospital Clinico San Carlos
RP Casanova, ML (corresponding author), Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid 28040, Spain.; Casanova, ML (corresponding author), 12 Octubre Univ Hosp, Biomed Res Inst I 12, Madrid 28040, Spain.
EM llanos.casanova@ciemat.es
RI Cabrera, Cristian Suárez/S-4235-2018; Ramirez, Angel/A-4800-2018;
   Navarro, Manuel/S-1496-2019; Fernández, Rosa Ana García/ABI-2101-2020;
   Sanchez, Rebeca/L-7138-2014; Sanchez, Rebeca/GXH-6596-2022; Moral, Ana
   María Bravo/AAD-3339-2021; Paramio, Jesus M/M-8482-2014; Segovia, Jose
   Carlos/L-2922-2014
OI Cabrera, Cristian Suárez/0000-0003-1897-1596; Ramirez,
   Angel/0000-0001-7745-5108; Navarro, Manuel/0000-0003-1118-8531;
   Fernández, Rosa Ana García/0000-0002-0363-3976; Sanchez,
   Rebeca/0000-0002-2073-2810; Sanchez, Rebeca/0000-0002-2073-2810; Moral,
   Ana María Bravo/0000-0002-5282-8921; Paramio, Jesus
   M/0000-0001-7520-3177; Segovia, Jose Carlos/0000-0003-4101-6124;
   Fernandez-Acenero/0000-0002-2439-3553; Casanova, M.
   Llanos/0000-0001-7742-8265
FU Spanish Government; Fondo Europeo de Desarrollo Regional (FEDER) from
   the Instituto de Salud Carlos III [PI16/00161]; Instituto de Salud
   Carlos III [PI14/01403, PI17/00578]; FEDER [SAF2015-66015-R,
   ISCIII-RETIC RD12/0036/0009, PIE 15/00076, CB/16/00228]
FX This research was supported by grants from the Spanish Government and
   co-financed by Fondo Europeo de Desarrollo Regional (FEDER):
   PI16/00161from the Instituto de Salud Carlos III to M.L. Casanova;
   PI14/01403 from the Instituto de Salud Carlos III to A. Ramirez;
   PI17/00578 from the Instituto de Salud Carlos III to A. Ramirez and M.
   Navarro; and FEDER cofounded MINECO grant SAF2015-66015-R, ISCIII-RETIC
   RD12/0036/0009, PIE 15/00076 and CB/16/00228 to J.M. Paramio.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Alameda JP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.82
   Alameda JP, 2010, ONCOGENE, V29, P6522, DOI 10.1038/onc.2010.378
   Alameda JP, 2016, ONCOTARGET, V7, P29531, DOI 10.18632/oncotarget.8792
   Alameda JP, 2013, J INVEST DERMATOL, V133, P1870, DOI 10.1038/jid.2013.76
   Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3
   Aw D, 2011, AGING DIS, V2, P437
   Balistreri CR, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-24
   Bektas A, 2014, AGING-US, V6, P957, DOI 10.18632/aging.100705
   Bernal GM, 2014, AGING-US, V6, P931, DOI 10.18632/aging.100702
   Bohr VA, 2005, MUTAT RES-FUND MOL M, V577, P252, DOI 10.1016/j.mrfmmm.2005.03.021
   Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811
   Budunova IV, 1999, ONCOGENE, V18, P7423, DOI 10.1038/sj.onc.1203104
   Carrasco-Garcia E, 2017, AGING CELL, V16, P219, DOI 10.1111/acel.12574
   CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360
   Deng LL, 2012, NEOPLASMA, V59, P18, DOI 10.4149/neo_2012_003
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   George AJT, 1996, IMMUNOL TODAY, V17, P267, DOI 10.1016/0167-5699(96)80543-3
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Hayashi M, 2014, BREAST CANCER RES TR, V143, P447, DOI 10.1007/s10549-013-2824-3
   Hinojosa CA, 2014, EXP GERONTOL, V54, P58, DOI 10.1016/j.exger.2014.01.007
   Hsu T, 2016, J GERIATR ONCOL, V7, P390, DOI 10.1016/j.jgo.2016.07.013
   Jin YJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86548
   Kamenisch Y, 2009, J INVEST DERM SYMP P, V14, P8, DOI 10.1038/jidsymp.2009.6
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Masoumi KC, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/614097
   Massoumi R, 2011, FUTURE ONCOL, V7, P285, DOI 10.2217/FON.10.187
   Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x
   Mathis BJ, 2015, CURR DRUG TARGETS, V16, P284, DOI 10.2174/1389450115666141024152421
   MONTAGNA W, 1979, J INVEST DERMATOL, V73, P47, DOI 10.1111/1523-1747.ep12532761
   Munn LL, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1370
   Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002
   Osorio FG, 2016, INT REV CEL MOL BIO, V326, P133, DOI 10.1016/bs.ircmb.2016.04.003
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1046/j.1432-0436.1994.5810053.x
   Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Rittié L, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a015370
   Segrelles C, 2014, STEM CELLS, V32, P1917, DOI 10.1002/stem.1669
   Slavin BG, 1945, AGING CELL STRUCTURE, V2, P198
   STRAILE WE, 1961, J EXP ZOOL, V148, P205, DOI 10.1002/jez.1401480304
   Sueki H, 1999, ACTA DERM-VENEREOL, V79, P347
   Tilstra JS, 2011, AGING DIS, V2, P449
   Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803
   Trueb Ralph M, 2005, J Cosmet Dermatol, V4, P60, DOI 10.1111/j.1473-2165.2005.40203.x
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012
   Zhu MX, 2016, MOL MED REP, V14, P1742, DOI 10.3892/mmr.2016.5413
   Zinger A, 2017, AGING DIS, V8, P611, DOI 10.14336/AD.2016.1230
NR 53
TC 12
Z9 13
U1 0
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JAN 15
PY 2019
VL 11
IS 1
BP 127
EP 159
DI 10.18632/aging.101732
PG 33
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HJ7PB
UT WOS:000457388700017
PM 30631004
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Jia, YJ
   Liu, J
   Guo, YL
   Xu, RX
   Sun, J
   Li, JJ
AF Jia, Yan-Jun
   Liu, Jun
   Guo, Yuan-Lin
   Xu, Rui-Xia
   Sun, Jiang
   Li, Jian-Jun
TI Dyslipidemia in rat fed with high-fat diet is not associated with
   PCSK9-LDL-receptor pathway but ageing
SO JOURNAL OF GERIATRIC CARDIOLOGY
LA English
DT Article
DE PCSK9; High fat diet; Dyslipidemia; Ageing
ID CORONARY-HEART-DISEASE; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA;
   SUBTILISIN/KEXIN TYPE 9; AGE-RELATED-CHANGES; PROPROTEIN CONVERTASE;
   PLASMA PCSK9; LDL-CHOLESTEROL; LIVER; METABOLISM; OBESITY
AB Background Obesity is associated with unfavorable alternations in plasma lipid profile and a broad spectrum of cardio-metabolic disorders. Proprotein convestase subtilisin kexin type 9 (PCSK9) is a novel circulating protein that promotes hypercholesterolemia by decreasing hepatic low lipoprotein density receptor (LDLR) protein. However, the relationship between PCSK9 concentration and lipid profile in an obesity condition has less been investigated. Objective To examine the changes of plasma PCSK9 concentration in a rat model fed with high fat diet (HFD) and its correlation to lipid profile, body weight and ageing. Methods Twenty male Sprague Dawley (SD) rats were divided into two groups, control group (fed with normal pellet for 4 weeks), and high-fat diet group (fed with 3% cholesterol enrich diet for 4 weeks). Blood samples of rats were obtained before and at days 14, 21, and 28 in both groups. The body weight, plasma metabolic parameters (glucose, lipid profile) and PCSK9 were determined at indicated time points. Results The body weights were significantly increased in rats fed with HFD compared to that in rats with normal pellets at day 28. Additionally, total cholesterol (TC), triglyceride (TG), and low density lipoprotein cholesterol (LDL-C) levels in rat fed with HFD were also higher than that in rats fed with control diet while decreased high density lipoprotein cholesterol (HDL-C) levels were found in rats with HFD at day 28. More interesting, there were no differences of plasma PCSK9 concentrations as well as hepatic expression of LDLR between the two groups at day 28. Conclusions Although the body weight and LDL-C were significantly increased in rats fed with HFD at 4 weeks, there were no differences of changes in plasma PCSK9 concentration and LDLR expression of liver tissue in both groups at baseline and day 28, suggesting that dyslipidemia in the rat model with HFD appears not to be associated with PCSK9-LDLR pathway but ageing.
C1 [Jia, Yan-Jun; Liu, Jun; Guo, Yuan-Lin; Xu, Rui-Xia; Sun, Jiang; Li, Jian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis,Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College; Fu
   Wai Hospital - CAMS; Peking Union Medical College
RP Li, JJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis,Div Dyslipidemia, Fu Wai Hosp,Natl Ctr Cardiovasc Dis, BeiLiShi Rd 167, Beijing 100037, Peoples R China.
EM lijianjun938@yahoo.com
FU National Natural Scientific Foundation [81070171, 81241121]; Specialized
   Research Fund for the Doctoral Program of Higher Education of China
   [20111106110013]; Capital Special Foundation of Clinical Application
   Research [Z121107001012015]
FX The authors declared no conflict of interest with respect to the
   research, authorship, and/or publication of this work. There are no
   ethnical problems in this manuscript. This article is partly supported
   by National Natural Scientific Foundation (81070171, 81241121),
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China (20111106110013), Capital Special Foundation of Clinical
   Application Research (Z121107001012015) awarded by Dr. Jian-Jun Li.
CR Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161
   Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280
   Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987
   Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   CASTELLI WP, 1989, AM J CARDIOL, V63, pH12
   Cecilia G, 2007, AM J PHYSIOL-ENDOC M, V293, P737
   CHOI YS, 1987, EXP GERONTOL, V22, P339, DOI 10.1016/0531-5565(87)90032-5
   Chois Korstanje R., 2013, BIOMARK RES, V18, P27
   Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027
   Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017
   Gälman C, 2007, AM J PHYSIOL-ENDOC M, V293, pE737, DOI 10.1152/ajpendo.00166.2007
   Ghosh A, 2004, J R SOC PROMO HEALTH, V124, P86, DOI 10.1177/146642400412400213
   GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341
   Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008
   Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509
   Katcher HI, 2009, ENDOCRIN METAB CLIN, V38, P45, DOI 10.1016/j.ecl.2008.11.010
   Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141
   Le May C, 2009, ARTERIOSCL THROM VAS, V29, P684, DOI 10.1161/ATVBAHA.108.181586
   LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807
   MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   Maxime D, 2012, CIRCULATION, V125, P894
   McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200
   McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Pallottini V, 2004, MECH AGEING DEV, V125, P633, DOI 10.1016/j.mad.2004.08.001
   Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130
   Persson L, 2009, ENDOCRINOLOGY, V150, P1140, DOI 10.1210/en.2008-1281
   Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
   Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9
   Uranga RM, 2010, CURR GERONTOL GERIAT, V2010, P1
   Wu NQ, 2013, CLIN LAB, V59, P901, DOI 10.7754/Clin.Lab.2012.121104
   Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200
   Zhao HL, 2005, INT J OBESITY, V29, P983, DOI 10.1038/sj.ijo.0802948
NR 42
TC 21
Z9 22
U1 0
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1671-5411
J9 J GERIATR CARDIOL
JI J. Geriatr. Cardiol.
PY 2013
VL 10
IS 4
BP 361
EP 368
DI 10.3969/j.issn.1671-5411.2013.04.007
PG 8
WC Cardiac & Cardiovascular Systems; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Geriatrics & Gerontology
GA 283BC
UT WOS:000329218200010
PM 24454330
DA 2024-02-19
ER

PT J
AU da Silva, EFG
   Costa, BP
   Nassr, MT
   Basso, BD
   Bastos, MS
   Antunes, GL
   Reghelin, CK
   Garcia, MCR
   Levorse, VGS
   Carlessi, LP
   Fernandes, KHA
   Schmitz, CRR
   Haute, GV
   Luft, C
   Santarém, E
   Barbé-Tuana, FM
   Donadio, MVF
   Basso, LA
   Machado, P
   de Oliveira, JR
AF Goncalves da Silva, Elisa Feller
   Costa, Bruna Pasqualotto
   Nassr, Marcella Tornquist
   Basso, Bruno de Souza
   Bastos, Matheus Scherer
   Antunes, Gessica Luana
   Reghelin, Camille Kirinus
   Rosa Garcia, Maria Claudia
   Schneider Levorse, Vitor Giancarlo
   Carlessi, Leonardo Pfeiff
   Antunes Fernandes, Krist Helen
   Richter Schmitz, Carine Raquel
   Haute, Gabriela Viegas
   Luft, Carolina
   Santarem, Eliane
   Barbe-Tuana, Florencia Maria
   Fagundes Donadio, Marcio Vinicius
   Basso, Luiz Augusto
   Machado, Pablo
   de Oliveira, Jarbas Rodrigues
TI Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver
   fibrosis <i>in vitro</i> and <i>in vivo</i>
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Uridine phosphorylase 1; Hepatic stellate cells; Liver fibrosis;
   Antifibrotic
ID STELLATE CELLS; SENESCENCE
AB Potassium 5-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-olate (CPBMF65) is a potent inhibitor of the uridine phosphorylase 1 (UPP1) enzyme. Its non-ionized analog has already demonstrated biological properties by reducing adverse effects caused by the chemotherapeutic 5-fluorouracil (5-FU). In addition, it has been demonstrated that uridine inhibits inflammation and fibrosis in bleomycin lung injury, decreasing collagen production. The purpose of this study was to investigate the in vitro and in vivo effects of CPBMF65 on activated hepatic stellate cells (HSC) and on carbon tetrachloride-induced liver fibrosis in mice. After incubation with CPBMF65, decreased cell proliferation and phenotype reversion were observed in vitro. In addition, CPBMF65 promoted a protective effect on tetrachloride-induced liver fibrosis in mice, demonstrated by its antifibrotic and anti-inflammatory actions. The results of the present study indicate that the UPP1 inhibitor (CPBMF65) may have potential as a novel therapeutic agent for the treatment of liver fibrosis.
C1 [Goncalves da Silva, Elisa Feller; Costa, Bruna Pasqualotto; Nassr, Marcella Tornquist; Basso, Bruno de Souza; Bastos, Matheus Scherer; Antunes, Gessica Luana; Reghelin, Camille Kirinus; Rosa Garcia, Maria Claudia; Schneider Levorse, Vitor Giancarlo; Carlessi, Leonardo Pfeiff; Haute, Gabriela Viegas; Luft, Carolina; Fagundes Donadio, Marcio Vinicius; de Oliveira, Jarbas Rodrigues] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Pesquisa Biofis Celular & Inflamacao, BR-90619900 Porto Alegre, RS, Brazil.
   [Antunes Fernandes, Krist Helen] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Imunol Clin & Expt, BR-90619900 Porto Alegre, RS, Brazil.
   [Richter Schmitz, Carine Raquel] Univ Fed Rio Grande Sul UFRGS, Programa Posgrad Biol Celular Bioquim, BR-90619900 Porto Alegre, RS, Brazil.
   [Santarem, Eliane] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biotecnol Vegetal, BR-90619900 Porto Alegre, RS, Brazil.
   [Barbe-Tuana, Florencia Maria] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Imunobiol, BR-90619900 Porto Alegre, RS, Brazil.
   [Basso, Luiz Augusto; Machado, Pablo] Pontificia Univ Catolica Rio Grande Sul PUCRS, Ctr Pesquisas Biol Mol & Func CPBMF, BR-90619900 Porto Alegre, RS, Brazil.
C3 Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia
   Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio
   Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul;
   Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia
   Universidade Catolica Do Rio Grande Do Sul
RP da Silva, EFG (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Pesquisa Biofis Celular & Inflamacao, BR-90619900 Porto Alegre, RS, Brazil.
EM elisa.feller@acad.pucrs.br
RI Donadio, Marcio Vinicius Fagundes/E-7702-2013; Machado,
   Pablo/M-4356-2013; Costa, Bruna/IAQ-7650-2023; Antunes,
   Géssica/AAP-8862-2021
OI Donadio, Marcio Vinicius Fagundes/0000-0001-8836-9109; Machado,
   Pablo/0000-0001-5616-9583; Costa, Bruna/0000-0002-5327-9653; Antunes,
   Géssica/0000-0003-2172-5484; Antunes, Krist/0000-0002-1525-6581;
   Pasqualotto Costa, Bruna/0000-0003-4810-4717; Scherer Bastos,
   Matheus/0000-0002-9206-4663
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Brasil [001]
FX This study was financed, in part, by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Brasil. Finance Code 001.
CR Bárcena C, 2019, EBIOMEDICINE, V43, P513, DOI 10.1016/j.ebiom.2019.04.052
   Bassos BD, 2019, EXCLI J, V18, P91, DOI 10.17179/excli2018-1696
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bobowski-Gerard M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090137
   Cicko S, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0264-9
   D'Argenio G, 2010, DIGEST LIVER DIS, V42, P571, DOI 10.1016/j.dld.2009.11.002
   da Silva EFG, 2020, INVEST NEW DRUG, V38, P1653, DOI 10.1007/s10637-020-00941-2
   de Mesquita FC, 2013, EUR J PHARMACOL, V720, P320, DOI 10.1016/j.ejphar.2013.09.067
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794
   Guimaraes ELM, 2006, LIVER INT, V26, P477, DOI 10.1111/j.1478-3231.2006.01245.x
   Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x
   Kim TM, 2012, J VET SCI, V13, P7, DOI 10.4142/jvs.2012.13.1.7
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5
   Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Renck D, 2013, J MED CHEM, V56, P8892, DOI 10.1021/jm401389u
   Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004
   Schofield Z, 2017, WORLD J GASTROENTERO, V23, P2685, DOI 10.3748/wjg.v23.i15.2685
   Sharma A., 2012, HISTONE H2AX PHOSPHO, P613, DOI [10.1007/978-1-61779-998-3_40, DOI 10.1007/978-1-61779-998-3_40]
   Shin GM, 2018, PHARM BIOL, V56, P632, DOI 10.1080/13880209.2018.1529801
   Sperotto R.A., 2014, PROTOCOLOS METODOS A, DOI [10.13140/RG.2.1.4693.0645, DOI 10.13140/RG.2.1.4693.0645]
   Squadrito F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00224
   Weinberg ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014709
   Zdanov S, 2006, ANN NY ACAD SCI, V1067, P210, DOI 10.1196/annals.1354.025
NR 28
TC 4
Z9 5
U1 7
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD JAN 5
PY 2021
VL 890
AR 173670
DI 10.1016/j.ejphar.2020.173670
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA PH8WR
UT WOS:000600686100034
PM 33098831
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Zhan, JF
   Hu, T
   Shen, JF
   Yang, GL
   Ho, CT
   Li, SM
AF Zhan, Jianfeng
   Hu, Ting
   Shen, Junfeng
   Yang, Guliang
   Ho, Chi-Tang
   Li, Shiming
TI Pterostilbene is more efficacious than hydroxystilbenes in protecting
   liver fibrogenesis in a carbon tetracholride-induced rat model
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article; Early Access
DE Pterostilbene; Hydroxystilbene compounds; Hepatic fibrosis;
   TGF-beta/Smad/ERK signaling pathway
ID HEPATIC STELLATE CELLS; KAPPA-B; FIBROSIS; TETRACHLORIDE; RESVERATROL;
   METABOLISM; PATHWAY; TARGET; POTENT; COX-2
AB Stilbene compounds existing in edible berries have attracted much attention due to their efficacious healthpromoting properties such as antioxidant, anti-aging, modulation of metabolic diseases and cancer prevention among others. Pterostilbene has superior pharmacokinetic profile over hydroxylated stilbenes such as resveratrol and oxyresveratrol. Hence, the current study was to evaluate the anti-hepatic fibrosis effects of pterostilbene in direct comparison to two hydroxylated stilbene compounds. In a carbon tetrachloride (CCl4) stimulated hepatic fibrosis model, rats were co-administrated with pterostilbene and hydroxystilbene via gavage feeding. Results revealed that stilbenes exerted significant efficacious protective effects against rat liver fibrosis, by reducing the expression levels of alpha-SMA, desmin, MMP2 and MMP9 and down-regulating the expression of TGF-beta 1, phosphorylated Smad1/2 and ERK1/2 in the liver tissue, among which pterostilbene demonstrated much potent preventive activity than the hydroxylated stilbenes.
C1 [Zhan, Jianfeng; Hu, Ting; Shen, Junfeng; Li, Shiming] Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement &, Huanggang 438000, Hubei, Peoples R China.
   [Yang, Guliang] Cent South Univ Forestry & Technol, Food Sci & Engn Coll, Changsha 410004, Hunan, Peoples R China.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ USA.
C3 Huanggang Normal University; Central South University of Forestry &
   Technology; Rutgers University System; Rutgers University New Brunswick
RP Li, SM (corresponding author), Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement &, Huanggang 438000, Hubei, Peoples R China.; Yang, GL (corresponding author), Cent South Univ Forestry & Technol, Food Sci & Engn Coll, Changsha 410004, Hunan, Peoples R China.
EM 469436773@qq.com; shiming@rutgers.edu
RI Li, Shiming/CAG-2335-2022
OI Li, Shiming/0000-0002-6167-0660
FU Special Research Grant from Hubei Province, China [2019ABA100]
FX This work was supported by the Special Research Grant from Hubei
   Province, China (GRANT number 2019ABA100) .
CR Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558
   Besheer T, 2017, TURK J GASTROENTEROL, V28, P283, DOI 10.5152/tjg.2017.16640
   Chang J, 2012, NEUROBIOL AGING, V33, P2062, DOI 10.1016/j.neurobiolaging.2011.08.015
   Chen W, 2016, J FUNCT FOODS, V22, P122, DOI 10.1016/j.jff.2016.01.020
   Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466
   Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Hessin AF, 2017, INDIAN J PHARMACOL, V49, P282, DOI 10.4103/ijp.IJP_299_16
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hougee S, 2005, PLANTA MED, V71, P387, DOI 10.1055/s-2005-864130
   Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4
   Kim H, 2020, J AGR FOOD CHEM, V68, P12836, DOI 10.1021/acs.jafc.0c00070
   Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x
   Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5
   Kosuru R, 2017, LIFE SCI, V182, P112, DOI 10.1016/j.lfs.2017.06.015
   Kurzepa J, 2014, HEPATOB PANCREAT DIS, V13, P570, DOI 10.1016/S1499-3872(14)60261-7
   Lacerda DD, 2017, BRIT J PHARMACOL, V174, P3302, DOI 10.1111/bph.13948
   Lee MF, 2013, FOOD CHEM, V138, P802, DOI 10.1016/j.foodchem.2012.11.094
   Liu XJ, 2017, INT IMMUNOPHARMACOL, V49, P50, DOI 10.1016/j.intimp.2017.05.022
   McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482
   NEUBAUER K, 1995, GASTROENTEROLOGY, V108, P1124, DOI 10.1016/0016-5085(95)90211-2
   Paul S, 2009, CANCER PREV RES, V2, P650, DOI 10.1158/1940-6207.CAPR-08-0224
   RAUCY JL, 1993, CRIT REV TOXICOL, V23, P1, DOI 10.3109/10408449309104072
   Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001
   Sireesh D, 2017, J NUTR BIOCHEM, V44, P11, DOI 10.1016/j.jnutbio.2017.02.015
   Stoyanovsky DA, 1999, CHEM RES TOXICOL, V12, P730, DOI 10.1021/tx9900371
   Tsai JH, 2008, J VIRAL HEPATITIS, V15, P508, DOI 10.1111/j.1365-2893.2008.00971.x
   Weerawatanakorn M, 2015, FOOD FUNCT, V6, P1832, DOI [10.1039/c5fo00126a, 10.1039/C5FO00126A]
   Yang GL, 2017, FOOD FUNCT, V8, P4668, DOI [10.1039/c7fo01311f, 10.1039/C7FO01311F]
   Zangar RC, 2000, CHEM-BIOL INTERACT, V125, P233, DOI 10.1016/S0009-2797(00)00149-6
NR 30
TC 4
Z9 4
U1 0
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD 2021 SEP
PY 2021
VL 84
AR 104604
DI 10.1016/j.jff.2021.104604
EA JUN 2021
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA TK9LS
UT WOS:000674477000004
OA gold
DA 2024-02-19
ER

PT J
AU Yang, X
   Liang, L
   Zong, C
   Lai, FB
   Zhu, PX
   Liu, Y
   Jiang, JH
   Yang, Y
   Gao, L
   Ye, F
   Zhao, QD
   Li, R
   Han, ZP
   Wei, LX
AF Yang, Xue
   Liang, Lei
   Zong, Chen
   Lai, Fobao
   Zhu, Pengxi
   Liu, Yu
   Jiang, Jinghua
   Yang, Yang
   Gao, Lu
   Ye, Fei
   Zhao, Qiudong
   Li, Rong
   Han, Zhipeng
   Wei, Lixin
TI Kupffer cells-dependent inflammation in the injured liver increases
   recruitment of mesenchymal stem cells in aging mice
SO ONCOTARGET
LA English
DT Article
DE aging; mesenchymal stem cells; recruitment; liver injury; Gerotarget
ID MARROW STROMAL CELLS; HEART-FAILURE; BONE; AUTOPHAGY; AGE; REPERFUSION;
   GENERATION; MORTALITY; INSIGHTS; CULTURE
AB Mesenchymal stem cells (MSCs) repair tissue injury and may be used to treat immune associated diseases. In carbon tetrachloride (CCl4)-induced liver injury murine model, we administered MSCs. When MSCs were transmitted to young and old mice with liver injury, more MSCs were recruited in old mice. In old mice, inflammation, characterized by TNF-alpha and IL-6, was increased due to hyper-activation and hyper-function of Kupffer cells. Blocking Kupffer cells decreased MSCs migration in old mice. In vitro, Kupffer cells isolated from old mice secreted more inflammatory cytokines and chemokines. Thus, hyper-activation of Kupffer cells in old mice increased recruitment of MSCs after their therapeutic administration.
C1 [Yang, Xue; Liang, Lei; Zong, Chen; Lai, Fobao; Jiang, Jinghua; Yang, Yang; Gao, Lu; Ye, Fei; Zhao, Qiudong; Li, Rong; Han, Zhipeng; Wei, Lixin] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China.
   [Liang, Lei] Soochow Univ, Coll Med, Suzhou, Peoples R China.
   [Zhu, Pengxi] Second Mil Med Univ, Chang Hai Hosp, Dept Pharm, Shanghai, Peoples R China.
   [Liu, Yu] Univ San Francisco, Coll Art & Sci, San Francisco, CA 94117 USA.
C3 Naval Medical University; Soochow University - China; Naval Medical
   University; University of San Francisco
RP Han, ZP; Wei, LX (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China.
EM hanzhipeng0311@126.com; lweilixin_smmu@163.com
RI Wu, Jiaqiang/JUV-0151-2023; Jiang, Tao/IWM-7503-2023; Zhang,
   Zhentao/JQV-7389-2023
OI Wu, Jiaqiang/0009-0004-0536-5364; Wei, Lixin/0000-0002-9526-5348
FU Key Basic Research Project of China [2012CBA01303]; National Natural
   Science Foundation of China [81372312, 81472737, 81402018, 81402020,
   81401308, 81402026, 81372330, 81402454]; Special Funds for National Key
   Sci-Tech Sepcial Project of China [2012ZX10002-016, 2012ZX10002011-011];
   Shanghai Science and Technology Committee [14ZD1900403, 14ZR1409200,
   15PJ1410600]; Shanghai Municipal Education Commission [14ZZ086]
FX This project was supported by the Key Basic Research Project of China
   (Grant NO. 2012CBA01303); National Natural Science Foundation of China
   (Grant No. 81372312, 81472737, 81402018, 81402020, 81401308, 81402026,
   81372330, 81402454); Special Funds for National Key Sci-Tech Sepcial
   Project of China (Grant No. 2012ZX10002-016, 2012ZX10002011-011);
   Shanghai Science and Technology Committee (Grant No. 14ZD1900403,
   14ZR1409200, 15PJ1410600); Shanghai Municipal Education Commission
   (Grant No. 14ZZ086).
CR Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551
   Bianchi G, 2011, HISTOL HISTOPATHOL, V26, P941, DOI 10.14670/HH-26.941
   Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002
   Bilinski T, 2015, ONCOTARGET, V6, P12909, DOI 10.18632/oncotarget.4271
   Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x
   Blagosklonny MV, 2012, AGING-US, V4, P861, DOI 10.18632/aging.100525
   Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Cohen-Solal A, 2008, EUR HEART J, V29, P3022, DOI 10.1093/eurheartj/ehn476
   COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656
   Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364
   Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100
   Gems D, 2013, ANTIOXID REDOX SIGN, V19, P321, DOI 10.1089/ars.2012.4840
   Granero-Molto F, 2008, EXPERT OPIN BIOL TH, V8, P255, DOI 10.1517/14712598.8.3.255 
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338
   in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058
   Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007
   JAESCHKE H, 1991, FREE RADICAL RES COM, V15, P277, DOI 10.3109/10715769109105223
   JAESCHKE H, 1988, J CLIN INVEST, V81, P1240, DOI 10.1172/JCI113441
   Jeon ES, 2008, STEM CELLS, V26, P789, DOI 10.1634/stemcells.2007-0742
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002
   Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA
   Mahmood A, 2003, NEUROSURGERY, V53, P702
   Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Petrie MC, 2001, EUR HEART J, V22, P1978, DOI 10.1053/euhj.2000.2558
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rich MW, 2001, J AM COLL CARDIOL, V38, P806, DOI 10.1016/S0735-1097(01)01442-5
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763
   Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39
   Tavazzi L, 2013, EUR J HEART FAIL, V15, P1296, DOI 10.1093/eurjhf/hft102
   Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50
   Weiss EP, 2011, AGING-US, V3, P533, DOI 10.18632/aging.100327
   Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 39
TC 14
Z9 16
U1 0
U2 8
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JAN 12
PY 2016
VL 7
IS 2
BP 1084
EP 1095
DI 10.18632/oncotarget.6744
PG 12
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DD5GP
UT WOS:000369951100002
PM 26716516
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU CHOU, MW
   SHADDOCK, JG
   KONG, J
   HART, RW
   CASCIANO, DA
AF CHOU, MW
   SHADDOCK, JG
   KONG, J
   HART, RW
   CASCIANO, DA
TI EFFECT OF DIETARY RESTRICTION ON PARTIAL HEPATECTOMY-INDUCED
   LIVER-REGENERATION OF AGED F344 RATS
SO CANCER LETTERS
LA English
DT Article
DE DIETARY RESTRICTION; PARTIAL HEPATECTOMY; DNA ADDUCT; BENZO[A]PYRENE;
   AFLATOXIN B-1
ID CALORIC RESTRICTION; CELL-PROLIFERATION; CARBON-TETRACHLORIDE;
   CARCINOGENESIS; DNA; METABOLISM; CYTOCHROME-P-450; AFLATOXIN-B1;
   EXPOSURE; BINDING
AB Fourteen weeks-old male F344 rats maintained on a reduced calorie diet (60% of ad libitum (AL) food consumption) for 6 weeks or for 14 months did not affect the hepatic cell proliferation in terms of % S phase population, determined by evaluation of DNA synthesis in hepatocytes isolated from either young (5 months) or aged (18 months) rats. However, hepatic basal cellular DNA synthesis estimated by [H-3]thymidine incorporation was reduced through acute dietary restriction (DR) in young rats, but increased in aged animals after 14 months restriction. Partial hepatectomy (PH) on aged rats stimulated hepatocyte regeneration and restored some aging-associated biochemical functions, such as drug metabolizing enzyme-dependent xenobiotic metabolic activation which was determined by measuring the formation of carcinogen-DNA adducts. Forty-eight hours after partial hepatectomy, the % of S phase population and the basal nuclear DNA synthesis of hepatocytes isolated from the partial hepatectomized DR-rats were 4- and 2.8-fold, respectively, greater than those of hepatocytes from AL-animals. DR reduced aflatoxin B-1 (AFB(1)) metabolizing enzyme activity and decreased the AFB(1)-DNA adduct formation in young rats treated with AFB(1). In aged AL-rats, the formation of AFB(1)-DNA adducts diminished to the same level as that of DR-groups and probably was due to the faster decline of drug metabolizing enzymes in aging AL-rats. However, 48 h after PH, the metabolic activation of AFB(1) was restored in AL- and DR-groups which resulted in the increase of AFB(1)-DNA binding by 4.2 and 1.9-fold, respectively. During the liver regeneration of old PH-rats, DR inhibited the AFB(1)-DNA adduct formation after the PH-rats received a single dose of AFB(1). DR increased benzo[a]pyrene (BaP) metabolic activation in both young and aged rats. Aging also decreased BaP-DNA adduct formation in both DR and AL-rats. The increase of BaP-DNA adduct formation in PH-groups was attributed to the restoration of BaP-metabolizing enzyme activity during liver regeneration. The PH-stimulated BaP-DNA adduct formation in AL- and DR-rats was 3.4- and 2.0-fold greater than control aged rats, Our results indicated that the stimulation of PH-induced liver regeneration by DR in aged animals may be attributed to the retardation of aging by DR and the retention of more active biochemical and enzymological functions in old DR-animals,
RP CHOU, MW (corresponding author), NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA.
CR BELAND FA, 1984, J CHROMATOGR, V308, P121, DOI 10.1016/0378-4347(84)80202-9
   BIRNBAUM LS, 1979, CHEM-BIOL INTERACT, V26, P245, DOI 10.1016/0009-2797(79)90028-0
   CASCIANO DA, 1988, MUTAT RES, V208, P129, DOI 10.1016/0165-7992(88)90048-6
   CHEN W, 1995, IN PRESS TOXICOL LET
   CHOU M W, 1991, Biomedical and Environmental Sciences, V4, P134
   CHOU MW, 1993, DRUG CHEM TOXICOL, V16, P1, DOI 10.3109/01480549309038659
   CHOU MW, 1994, POLYCYCL AROMAT COMP, V6, P127, DOI 10.1080/10406639408031176
   CHOU MW, 1993, MUTAT RES, V295, P223, DOI 10.1016/0921-8734(93)90022-U
   CLAYSON DB, 1989, REGUL TOXICOL PHARM, V9, P284, DOI 10.1016/0273-2300(89)90067-6
   COHEN SM, 1990, SCIENCE, V249, P1007, DOI 10.1126/science.2204108
   CRADDOCK VM, 1954, NATURE, V245, P386
   DIX KM, 1984, CARCINOGENESIS, V5, P385, DOI 10.1093/carcin/5.3.385
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HIMENO Y, 1992, P NATL ACAD SCI USA, V89, P5497, DOI 10.1073/pnas.89.12.5497
   HYMER WC, 1964, J HISTOCHEM CYTOCHEM, V12, P359, DOI 10.1177/12.5.359
   JAMES SJ, 1994, CANCER RES, V54, P5508
   KRITCHEVSKY D, 1987, AM J CLIN NUTR, V45, P236, DOI 10.1093/ajcn/45.1.236
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LOK E, 1988, CANCER LETT, V38, P249, DOI 10.1016/0304-3835(88)90016-X
   LOK E, 1990, CANCER LETT, V51, P61
   NEAL GE, 1980, CANCER RES, V40, P4739
   NEWBERNE PM, 1986, DIET NUTRITION CANCE, P205
   OLDHAM JW, 1979, TISSUE CULT ASS MAN, V15, P1047
   PARIZA MW, 1987, AM J CLIN NUTR, V45, P151, DOI 10.1093/ajcn/45.1.151
   POUND AW, 1974, J NATL CANCER I, V53, P423, DOI 10.1093/jnci/53.2.423
   POUND AW, 1973, BRIT J CANCER, V27, P451, DOI 10.1038/bjc.1973.57
   POUND AW, 1978, BRIT J CANCER, V37, P595, DOI 10.1038/bjc.1978.89
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   RIZVI TA, 1989, VIRCHOWS ARCH B, V56, P345
   ROGERS AE, 1971, CANCER RES, V31, P491
   SHADDOCK JG, 1993, MUTAT RES, V295, P19, DOI 10.1016/0921-8734(93)90008-Q
   SOLT DB, 1983, CANCER RES, V43, P188
   TANNENBAUM ALBERT, 1942, CANCER RES, V2, P460
NR 33
TC 16
Z9 19
U1 0
U2 1
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3835
J9 CANCER LETT
JI Cancer Lett.
PD MAY 8
PY 1995
VL 91
IS 2
BP 191
EP 197
DI 10.1016/0304-3835(95)03750-Q
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA RA705
UT WOS:A1995RA70500006
PM 7767909
DA 2024-02-19
ER

PT J
AU Zhang, JL
   Yang, AH
   Wu, Y
   Guan, W
   Xiong, B
   Peng, XQ
   Wei, XJ
   Chen, C
   Liu, ZG
AF Zhang, Jinlin
   Yang, Aihua
   Wu, Yu
   Guan, Wei
   Xiong, Biao
   Peng, Xiaoqing
   Wei, Xiaojin
   Chen, Chang
   Liu, Zhaoguo
TI Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by
   inhibiting inflammation, oxidative stress and regulating MMPs/TIMPs
   system in rats
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Stachydrine; Inflammation; Oxidative stress; Liver fibrosis; Matrix
   metalloproteinase
ID ATTENUATES LIVER FIBROSIS; SUPPRESSING INFLAMMATION; ACTIVATION; CELLS;
   INJURY; MICE; CARCINOMA; APOPTOSIS
AB Inflammation and oxidative stress are two crucial factors mediating liver fibrosis. Stachydrine (STA) is a naturally occurring compound extracted from a medicinal plant Leonuru heterophyllus, which can inhibit the proliferation and induce the apoptosis of breast cancer cells, relieve high glucose-induced endothelial cell senescence and isoproterenol-induced cardiac hypertrophy, and exert antitumor effects. However, its roles in hepatic fibrosis remain largely unknown. We aimed to evaluate the effect of STA on carbon tetrachloride (CCl4)-induced hepatic fibrosis in rats and to elucidate the possible mechanisms. STA alleviated the pathological changes caused by CCl4 injection in livers compared to the normal liver. Hematoxylin-eosin staining further showed that STA treatment remarkably improved the liver histology, as evidenced by mitigated hepatic steatosis, necrosis, and fibrotic septa. STA reduced the liver/body weight ratio and the serum levels of aminotransferase, aspartate aminotransferase and alkaline phosphatase. It also significantly decreased collagen deposition and hydroxyproline level. Both mRNA and protein levels of alpha-SMA, alpha 1(I)-procollagen and fibronectin were decreased by STA compared to those of the model group. STA significantly inhibited the expressions of inflammatory factors interleukin-6 (IL-6), IL-8, IL-1 beta, tumor necrosis factor-alpha, inducible nitric oxide synthase and cyclooxygenase-2. It suppressed oxidative stress by decreasing malondialdehyde level as well as increasing glutathione level and enzymatic activities of superoxide dismutase, catalase, glutathione reductase and glutathione peroxidase. STA also significantly increased the protein expressions of tissue inhibitor of metallopeptidase-1 (TIMP-1) and TIMP-2 but decreased those of matrix metalloproteinase-2 (MMP-2) and MMP-9, indicating excessive basement membrane in the fibrotic liver. Collectively, STA has potent protective effects on the liver, with therapeutic implication for liver fibrosis.
C1 [Zhang, Jinlin; Wei, Xiaojin] Nantong Univ, Affiliated Canc Hosp, Dept Pharm, Nantong 226001, Peoples R China.
   [Guan, Wei; Xiong, Biao; Chen, Chang; Liu, Zhaoguo] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
   [Yang, Aihua] Nantong Maternal & Children Hlth Care Serv Hosp, Nantong 226018, Jiangsu, Peoples R China.
   [Wu, Yu] Nantong Hosp Tradit Chinese Med, Dept Pharm, Nantong 226001, Jiangsu, Peoples R China.
   [Peng, Xiaoqing] Nantong Univ, Lab Anim Ctr, Nantong 226001, Peoples R China.
C3 Nantong University; Nantong University; Nantong University
RP Liu, ZG (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM lzg871014@ntu.edu.cn
FU National Natural Science Foundation of China [81703884]; Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   [17KJB360012]; Undergraduate Innovation Project of Nantong University
   [2017185]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81703884); the Natural Science Foundation of the Jiangsu
   Higher Education Institutions of China (No. 17KJB360012); the
   Undergraduate Innovation Project of Nantong University (No. 2017185).
CR Aoyama T, 2017, LAB INVEST, V97, P890, DOI 10.1038/labinvest.2017.44
   Bartneck M, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/417023
   Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501
   Bingül I, 2016, ENVIRON TOXICOL PHAR, V45, P170, DOI 10.1016/j.etap.2016.05.033
   Bruno G, 2017, J VIRAL HEPATITIS, V24, P174, DOI 10.1111/jvh.12636
   Colak E, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1894-1
   Cui XF, 2017, TOXICOL LETT, V265, P17, DOI 10.1016/j.toxlet.2016.11.010
   de Araujo RF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148868
   Elswefy SES, 2016, INT J EXP PATHOL, V97, P369, DOI 10.1111/iep.12207
   Han XY, 2017, J NUTR SCI VITAMINOL, V63, P35, DOI 10.3177/jnsv.63.35
   Ionica FE, 2016, ROM J MORPHOL EMBRYO, V57, P1261
   Ismail AFM, 2016, J PHOTOCH PHOTOBIO B, V160, P1, DOI 10.1016/j.jphotobiol.2016.03.027
   Khanjarsim Vahid, 2017, Chonnam Med J, V53, P118, DOI 10.4068/cmj.2017.53.2.118
   Kim SK, 2016, PATHOL INT, V66, P543, DOI 10.1111/pin.12435
   Kondo T, 2016, BRIT J CANCER, V115, P34, DOI 10.1038/bjc.2016.155
   Paltseva E. M., 2016, Arkhiv Patologii, V78, P26, DOI 10.17116/patol201678326-31
   Pietruszewska Wioletta, 2016, Otolaryngol Pol, V70, P32, DOI 10.5604/00306657.1202546
   Quoilin C, 2014, BBA-BIOENERGETICS, V1837, P1790, DOI 10.1016/j.bbabio.2014.07.005
   Rajagopalan G, 2017, CLIN EXP PHARMACOL P, V44, P103, DOI 10.1111/1440-1681.12671
   Reza HM, 2016, TOXICOL MECH METHOD, V26, P46, DOI 10.3109/15376516.2015.1124956
   Servillo L, 2013, J CELL BIOCHEM, V114, P2522, DOI 10.1002/jcb.24598
   Servillo L, 2011, J AGR FOOD CHEM, V59, P9410, DOI 10.1021/jf2014815
   Shen CS, 2014, FOOD FUNCT, V5, P1422, DOI 10.1039/c4fo00035h
   Tan HB, 2016, IMMUNOL INVEST, V45, P371, DOI 10.3109/08820139.2015.1137935
   Tong XH, 2015, N-S ARCH PHARMACOL, V388, P831, DOI 10.1007/s00210-015-1112-7
   Török NJ, 2017, CELL MOL GASTROENTER, V3, P299, DOI 10.1016/j.jcmgh.2017.03.002
   Tsedensodnom O, 2013, HEPATOLOGY, V58, P1210, DOI 10.1002/hep.26497
   Wang M, 2017, AM J TRANSL RES, V9, P1834
   Wang XH, 2017, INFLAMMATION, V40, P840, DOI 10.1007/s10753-017-0528-2
   Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033
   Yang JH, 2016, EUR J PHARMACOL, V783, P92, DOI 10.1016/j.ejphar.2016.04.042
   Yang KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174008
   Yang K, 2007, INT J RADIAT BIOL, V83, P665, DOI 10.1080/09553000701558977
   Yin J, 2010, AM J CHINESE MED, V38, P157, DOI 10.1142/S0192415X10007737
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang XP, 2014, FEBS J, V281, P2754, DOI 10.1111/febs.12818
   Zhang ZL, 2016, FREE RADICAL BIO MED, V101, P272, DOI 10.1016/j.freeradbiomed.2016.10.498
   Zhao LL, 2017, INT IMMUNOPHARMACOL, V48, P102, DOI 10.1016/j.intimp.2017.05.002
   Zou Y, 2017, BIOMED PHARMACOTHER, V94, P140, DOI 10.1016/j.biopha.2017.07.074
NR 39
TC 48
Z9 52
U1 1
U2 27
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JAN
PY 2018
VL 97
BP 1586
EP 1594
DI 10.1016/j.biopha.2017.11.117
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FR4NC
UT WOS:000419041300189
PM 29378386
DA 2024-02-19
ER

PT J
AU Gaal, T
   Speake, BK
   Mezes, M
   Noble, RC
   Surai, PF
   Vajdovich, P
AF Gaal, T
   Speake, BK
   Mezes, M
   Noble, RC
   Surai, PF
   Vajdovich, P
TI Antioxidant parameters and ageing in some animal species
SO COMPARATIVE HAEMATOLOGY INTERNATIONAL
LA English
DT Article
DE ageing; antioxidants; calf; chick; dog; lipidperoxidation
ID VITAMIN-E-DEFICIENCY; LIPID-PEROXIDATION; GLUTATHIONE; NEWBORN;
   COMPONENTS; LIVER; MICE
AB Connection between ageing and some tissue antioxidant parameters have been studied in four experiments on different animal species. Prenatal studies on the developing chick embryos showed discrepancies between the lipid-rich liver and brain antioxidant defence. In the liver, high levels of reduced glutathione (GSH), vitamins A and E and high activities of the antioxidant enzymes glutathione peroxidase (GPX) and superoxide dismutase (SOD) were found whereas brain expressed a high vitamin C concentration. In newborn healthy calves during the first two days of life, atmospheric oxygen tension did not cause either increased lipid peroxidation as reflected in a high malondialdehyde (MDA) level or any changes in GSH, GPX, SOD and catalase (CAT) activities in red blood cells (RBC). Plasma vitamin E and carotene concentrations also did not change. In growing healthy calves during two months after birth increasing MDA, decreasing GSH, GPX and CAT are leading features, whereas plasma vitamin E and carotene concentrations significantly increased. In young (1-year-old) and old (9-year-old) dogs RBC results showed significant differences with the highest MDA and lowest GSH levels in the old males. Activity of GPX and SOD was higher in old dogs than in the young ones, especially in the females.
C1 SCOTTISH AGR COLL,DEPT BIOCHEM SCI,AUCHINCRUIVE,SCOTLAND.
   UNIV AGR SCI,DEPT NUTR,GODOLLO,HUNGARY.
C3 Scottish Agricultural College; Hungarian University of Agriculture &
   Life Sciences
RP Gaal, T (corresponding author), UNIV VET SCI BUDAPEST,DEPT MED,ISTVAN ST 2,H-1078 BUDAPEST,HUNGARY.
RI Surai, Peter/T-6183-2019; Mézes, Miklós/H-4115-2012
OI Mézes, Miklós/0000-0003-2323-833X; Surai, Peter/0000-0002-5012-8681
CR BARDOS L, 1988, HUNG VET J, V43, P113
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BIERI JG, 1964, P SOC EXP BIOL MED, V117, P131, DOI 10.3181/00379727-117-29515
   BOROSS M, 1991, Z GERONTOL, V24, P76
   CRUZ CSD, 1983, ACTA PAEDIATR SCAND, V72, P823, DOI 10.1111/j.1651-2227.1983.tb09823.x
   Gaal T, 1995, COMP BIOCHEM PHYS B, V112, P711, DOI 10.1016/0305-0491(95)00125-5
   GAAL T, 1993, RES VET SCI, V55, P104, DOI 10.1016/0034-5288(93)90042-E
   GRIFFIN HD, 1992, WORLD POULTRY SCI J, V48, P101, DOI 10.1079/WPS19920010
   GRITZ BG, 1990, SCHWEIZ ARCH TIERH, V132, P435
   HARMAN D, 1982, J AM COLL NUTR, V1, P27
   IGARASHI T, 1983, J PHARMACOBIO-DYNAM, V6, P941
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Lowseth Lisa A., 1990, Vet Clin Pathol, V19, P13, DOI 10.1111/j.1939-165X.1990.tb00535.x
   MAAS J, 1984, J AM VET MED ASSOC, V184, P201
   MCMURRAY CH, 1980, J ASSOC OFF ANA CHEM, V63, P1258
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mosier J. E., 1988, Clinical Insight, V3
   MULLER DPR, 1987, P NUTR SOC, V46, P69, DOI 10.1079/PNS19870009
   NOBLE RC, 1990, PROG LIPID RES, V29, P107, DOI 10.1016/0163-7827(90)90014-C
   NOHL H, 1984, WIEN TIERARZTL MONAT, V71, P217
   Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9
   PYKE S, 1986, BIOCHEM BIOPH RES CO, V139, P926, DOI 10.1016/S0006-291X(86)80266-2
   QUADRI SK, 1991, VET MED-US, V86, P692
   ROTHUIZEN J, 1991, ACTA ENDOCRINOL-COP, V125, P73
   SARKOZY P, 1989, MAGY ALLATORVOSOK, V44, P91
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SOMASHEKARAIAH BV, 1992, FREE RADICAL BIO MED, V13, P107, DOI 10.1016/0891-5849(92)90071-N
   Speake Brian K., 1996, Biochemical Society Transactions, V24, p182S
   TAPPEL AL, 1973, FED PROC, V32, P1870
   VAJDOVICH P, 1993, OXYGEN FREE RADICALS AND SCAVENGERS IN THE NATURAL SCIENCES, P119
   VALLOIS JM, 1990, SCI TECH ANIM LAB, V15, P241
   VANVLEET JF, 1982, AM J VET RES, V43, P1180
   WILSON JX, 1990, DEV BIOL, V139, P292, DOI 10.1016/0012-1606(90)90298-W
   WILSON JX, 1992, MECH AGEING DEV, V65, P51, DOI 10.1016/0047-6374(92)90125-W
   WISPE JR, 1986, PEDIATR RES, V20, P505, DOI 10.1203/00006450-198606000-00004
NR 37
TC 15
Z9 18
U1 0
U2 6
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0938-7714
J9 COMP HAEMATOL INT
JI Comp. Haematol. Int.
PY 1996
VL 6
IS 4
BP 208
EP 213
DI 10.1007/BF00378112
PG 6
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA WG630
UT WOS:A1996WG63000004
DA 2024-02-19
ER

PT J
AU Rezende, MSD
   de Almeida, AJPO
   Goncalves, TAF
   de Azevedo, FDAA
   Dantas, SH
   Silva, SD
   Soares, EMC
   Alves, HF
   Lima, TT
   de Souza, JF
   Guerra, RR
   Araújo, IGA
   de Medeiros, IA
AF de Almeida Rezende, Mathania Silva
   Pontes Oliveira de Almeida, Arthur Jose
   Felisberto Goncalves, Tays Amanda
   Assuncao Araujo de Azevedo, Fatima de Lourdes
   Dantas, Sabine Helena
   Silva, Sonaly de Lima
   Cardoso Soares, Evyllen Myllena
   Alves, Hayaly Felinto
   Lima, Thais Trajano
   Frederico de Souza Junior, Javanyr
   Guerra, Ricardo Romao
   Albuquerque Araujo, Islania Giselia
   de Medeiros, Isac Almeida
TI D-(+)-Galactose-induced aging: A novel experimental model of erectile
   dysfunction
SO PLOS ONE
LA English
DT Article
ID D-GALACTOSE; VITAMIN-E; SMOOTH-MUSCLE; RATS; OXIDASE; LIVER; HEART
AB Erectile dysfunction (ED) is defined as the inability to achieve and/or maintain penile erection sufficient for satisfactory sexual relations, and aging is one of the main risk factors involved. The D-(+)-Galactose aging model is a consolidated methodology for studies of cardiovascular aging; however, its potential for use with ED remain unexplored. The present study proposed to characterize a new experimental model for ED, using the D-(+)-Galactose aging model. For the experiments, the animals were randomly divided into three groups receiving: vehicle (CTL), D-galactose 150 mg/kg (DGAL), and D-(+)-galactose 150 mg/Kg + sildenafil 1.5 mg/Kg (DGAL+SD1.5) being administered daily for a period of eight weeks. All of the experimental protocols were previously approved by the Ethics Committee on the Use of Animals at the Federal University of Paraiba n degrees 9706070319. During the treatment, we analyzed physical, molecular, and physiological aspects related to the aging process and implicated in the development of ED. Our findings demonstrate for the first time that D-(+)-Galactose-induced aging represents a suitable experimental model for ED assessment. This was evidenced by an observed hyper-contractility in corpora cavernosa, significant endothelial dysfunction, increased ROS levels, an increase in cavernous tissue senescence, and the loss of essential penile erectile components.
C1 [de Almeida Rezende, Mathania Silva; Felisberto Goncalves, Tays Amanda; Assuncao Araujo de Azevedo, Fatima de Lourdes; de Medeiros, Isac Almeida] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil.
   [Pontes Oliveira de Almeida, Arthur Jose; Silva, Sonaly de Lima] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Desenvolvimento & Inovacao Tecno, Joao Pessoa, Paraiba, Brazil.
   [Dantas, Sabine Helena; Albuquerque Araujo, Islania Giselia] Univ Fed Paraiba, Ctr Ciencias Saude, Programa Mestrado Profiss Gerontol, Joao Pessoa, Paraiba, Brazil.
   [Cardoso Soares, Evyllen Myllena; Alves, Hayaly Felinto; Lima, Thais Trajano; Frederico de Souza Junior, Javanyr] Univ Fed Paraiba, Ctr Ciencias Saude, Joao Pessoa, Paraiba, Brazil.
   [Guerra, Ricardo Romao] Univ Fed Paraiba, Ctr Ciencias Agr, Dept Ciencias Veterinarias, Areia, Paraiba, Brazil.
C3 Universidade Federal da Paraiba; Universidade Federal da Paraiba;
   Universidade Federal da Paraiba; Universidade Federal da Paraiba;
   Universidade Federal da Paraiba
RP de Medeiros, IA (corresponding author), Univ Fed Paraiba, Ctr Ciencias Saude, Programa Posgrad Prod Nat & Sintet Bioativos, Joao Pessoa, Paraiba, Brazil.
EM isac.ufpb@gmail.com
RI de Souza Júnior, Javanyr Frederico/AAQ-9213-2021; de Medeiros, Isac
   Almeida/C-5784-2013
OI de Souza Júnior, Javanyr Frederico/0000-0003-0029-3352; de Medeiros,
   Isac Almeida/0000-0001-8783-4806; Dantas, Sabine
   Helena/0000-0001-8724-3029; Jose Pontes Oliveira de Almeida,
   Arthur/0000-0003-2501-3249
FU CAPES [88887507825/202000]; CNPQ [427783/2016-0]
FX Mathania Silva de Almeida Rezende received a scholarship from CAPES
   (process number 88887507825/202000) Isac Almeida de Medeiros received
   grant from CNPQ (process number 427783/2016-0).
CR Akhvlediani ND., UROLOGIIA MOSCOW RUS, V2018, P142
   Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515
   Angulo J, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101271
   Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x
   Aydin K, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13062
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bakircioglu ME, 2001, J UROLOGY, V166, P734, DOI 10.1016/S0022-5347(05)66052-1
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Calabro A, 1996, EUR UROL, V29, P240
   Cardoso A, 2015, REJUV RES, V18, P497, DOI 10.1089/rej.2015.1684
   Chang YM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/2624384
   Chen WK, 2018, AGING-US, V10, P4166, DOI 10.18632/aging.101714
   Cho MC, 2018, SEX MED REV, V6, P572, DOI 10.1016/j.sxmr.2018.02.007
   Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098
   Corrêa LBNS, 2017, INT J MORPHOL, V35, P1043
   Dehghani A, 2019, AGING CLIN EXP RES, V31, P1195, DOI 10.1007/s40520-018-1075-x
   Diaz-Diaz E., 2012, INTECH, P69, DOI [10.5772/31005, DOI 10.5772/31005]
   DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
   Echeverri Tirado Laura C, 2016, Sex Med Rev, V4, P63, DOI 10.1016/j.sxmr.2015.10.011
   Foldvari M, 1998, UROLOGY, V52, P838, DOI 10.1016/S0090-4295(98)00299-4
   Gokçe MI, 2017, TURK J UROL, V43, P247, DOI 10.5152/tud.2017.70482
   Guo B, 2020, BIOGERONTOLOGY, V21, P311, DOI 10.1007/s10522-020-09859-x
   Gur S, 2008, EXPERT OPIN INV DRUG, V17, P855, DOI 10.1517/13543784.17.6.855 
   Helmy MM, 2012, LIFE SCI, V90, P489, DOI 10.1016/j.lfs.2011.12.019
   Jing L, 2019, MOLECULES, V24, DOI 10.3390/molecules24183364
   Kessler A, 2019, BJU INT, V124, P587, DOI 10.1111/bju.14813
   Kim SW, 2019, UROLOGY, V131, P136, DOI 10.1016/j.urology.2019.06.005
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Lafuente-Sanchis A, 2014, ANDROLOGY-US, V2, P537, DOI 10.1111/j.2047-2927.2014.00213.x
   Leal MAS, 2020, VASC PHARMACOL, V124, DOI 10.1016/j.vph.2019.106601
   Li WJ, 2011, J SEX MED, V8, P400, DOI 10.1111/j.1743-6109.2010.01724.x
   Li X, 2016, BIOL TRACE ELEM RES, V173, P433, DOI 10.1007/s12011-016-0681-8
   Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207
   McMurray G, 2006, BRIT J PHARMACOL, V147, pS62, DOI 10.1038/sj.bjp.0706630
   Ni YH, 2018, ENDOCR J, V65, P569, DOI [10.1507/endocrj.ej17-0500, 10.1507/endocrj.EJ17-0500]
   Omidi M, 2019, INT J REPROD BIOMED, V17, P789, DOI 10.18502/ijrm.v17i10.5486
   de Almeida AJPO, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7941563
   Sadigh-Eteghad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184122
   Sheweita S, 2015, TOXICOL REP, V2, P933, DOI 10.1016/j.toxrep.2015.06.002
   Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291
   Silva GC, 2017, EXP GERONTOL, V93, P7, DOI 10.1016/j.exger.2017.04.006
   Tao MF, 2017, INT BRAZ J UROL, V43, P753, DOI [10.1590/s1677-5538.ibju.2016.0454, 10.1590/S1677-5538.IBJU.2016.0454]
   WESPES E, 1991, J UROLOGY, V146, P1015, DOI 10.1016/S0022-5347(17)37990-9
   Wespes E, 1997, J UROLOGY, V157, P1678, DOI 10.1016/S0022-5347(01)64833-X
   Wu C, 2016, EXPERT OPIN DRUG DIS, V11, P185, DOI 10.1517/17460441.2016.1126243
   Wu W, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5707830
   Yafi FA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.3
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   Zheng SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59055-7
NR 49
TC 7
Z9 7
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2021
VL 16
IS 4
AR e0249487
DI 10.1371/journal.pone.0249487
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RP1DC
UT WOS:000641474900005
PM 33857158
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Basbous, S
   Paysan, L
   Sena, S
   Allain, N
   Hiriart, JB
   Dugot-Senant, N
   Rousseau, B
   Chevret, E
   Lagrée, V
   Moreau, V
AF Basbous, Sara
   Paysan, Lisa
   Sena, Sandra
   Allain, Nathalie
   Hiriart, Jean-Baptiste
   Dugot-Senant, Nathalie
   Rousseau, Benoit
   Chevret, Edith
   Lagree, Valerie
   Moreau, Violaine
TI Silencing of <i>RND3/RHOE</i> inhibits the growth of human
   hepatocellular carcinoma and is associated with reversible senescence
SO CANCER GENE THERAPY
LA English
DT Article; Early Access
ID ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; EXPRESSION; PROMOTER;
   CANCER; RHOE
AB Rnd3/RhoE is an atypical Rho GTPase family member, known to be deregulated in many types of cancer. Previously, we showed that RND3 expression is downregulated in hepatocellular carcinoma (HCC) cell lines and tissues. In cancer cells, Rnd3 is involved in the regulation of cell proliferation and cell invasion. The implication of Rnd3 in HCC invasion was importantly studied whereas its role in cell growth needs further investigation. Thus, in this work, we aimed to better understand the impact of Rnd3 on tumor hepatocyte proliferation. Our results indicate that the silencing of RND3 induces a cell growth arrest both in vitro in 2D and 3D culture conditions and in vivo in tumor xenografts. The growth alteration after RND3 silencing in HCC cells is not due to an increase of cell death but to the induction of senescence. This RND3 knockdown-mediated phenomenon is dependent on the decrease of hTERT expression. Interestingly, after re-expression of RND3, these cells are able to bypass senescence and regain the ability to proliferate, with a re-expression of hTERT. Given that a low expression of Rnd3 is linked to the presence of satellite nodules in HCC, the transient senescence state observed might play a role in cancer progression.
C1 [Basbous, Sara; Paysan, Lisa; Sena, Sandra; Allain, Nathalie; Chevret, Edith; Lagree, Valerie; Moreau, Violaine] Univ Bordeaux, INSERM, BaRITOn, F-33000 Bordeaux, France.
   [Hiriart, Jean-Baptiste] Bordeaux Univ Hosp, Hepatol Unit, Bordeaux, France.
   [Dugot-Senant, Nathalie] Histopathol Platform, TBM Core US 005, F-33076 Bordeaux, France.
   [Rousseau, Benoit] Univ Bordeaux, Anim Core Facil, F-33000 Bordeaux, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; CHU Bordeaux; Universite de Bordeaux
RP Moreau, V (corresponding author), Univ Bordeaux, INSERM, BaRITOn, F-33000 Bordeaux, France.
EM violaine.moreau@inserm.fr
OI Moreau, Violaine/0000-0002-4513-7022
FU Fondation ARC/Region Nouvelle-Aquitaine; Fondation pour la Recherche
   Medicale; Region Aquitaine; La Ligue contre le Cancer (comite regional);
   Institut National du Cancer [PLBIO-INCa2014-182]; La Fondation pour la
   Recherche Medicale "Equipe labellisee 2018"
FX We thank V. Guyonnet-Duperat and V. Pitard from the vectorology and flow
   cytometry core facilities, respectively (TBMCore, UMS005, Bordeaux). We
   thank C. Peanne for her help with apoptosis analyses. SB and SS were
   supported by postdoctoral fellowships from, respectively, the Fondation
   ARC/Region Nouvelle-Aquitaine and the Fondation pour la Recherche
   Medicale. L. Paysan was supported by a PhD fellowship from the Region
   Aquitaine. This work was supported by grants from La Ligue contre le
   Cancer (comite regional) and from Institut National du Cancer
   (PLBIO-INCa2014-182) (to VM). VM is supported by La Fondation pour la
   Recherche Medicale "Equipe labellisee 2018".
CR Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Ezzat WM, 2016, ARCH MED RES, V47, P349, DOI 10.1016/j.arcmed.2016.08.003
   Farooqi AA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041051
   Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013
   Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568
   Grise F, 2009, BBA-REV CANCER, V1795, P137, DOI 10.1016/j.bbcan.2008.12.003
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HAYFLICK L, 1964, Postgrad Med, V35, P503
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Luo HS, 2012, J SURG ONCOL, V105, P699, DOI 10.1002/jso.23019
   Ma W, 2013, HEPATOLOGY, V57, P152, DOI 10.1002/hep.25987
   Mendez MG, 2012, INT J BIOCHEM CELL B, V44, P728, DOI 10.1016/j.biocel.2012.02.003
   Merle P, 2009, VIRUSES-BASEL, V1, P852, DOI 10.3390/v1030852
   Nault JC, 2014, HEPATOLOGY, V60, P1983, DOI 10.1002/hep.27372
   Patel PL, 2016, P NATL ACAD SCI USA, V113, pE5024, DOI 10.1073/pnas.1602379113
   Paysan L, 2016, MOL CANCER RES, V14, P1033, DOI 10.1158/1541-7786.MCR-16-0164
   Piquet L, 2018, EXP CELL RES, V370, P227, DOI 10.1016/j.yexcr.2018.06.023
   Saleh T, 2019, BIOCHEM PHARMACOL, V162, P202, DOI 10.1016/j.bcp.2018.12.013
   Wang Q, 2013, INT J CANCER, V132, P1505, DOI 10.1002/ijc.27810
   Xu XS, 2015, ONCOTARGET, V6, P3988, DOI 10.18632/oncotarget.2905
NR 22
TC 3
Z9 3
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0929-1903
EI 1476-5500
J9 CANCER GENE THER
JI Cancer Gene Ther.
PD 2022 MAY
PY 2022
VL 29
IS 5
BP 437
EP 444
DI 10.1038/s41417-022-00445-6
EA MAR 2022
PG 8
WC Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity;
   Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Oncology; Genetics & Heredity;
   Research & Experimental Medicine
GA 1I2BL
UT WOS:000765707300002
PM 35256752
DA 2024-02-19
ER

PT J
AU Kennedy, L
   Francis, H
   Invernizzi, P
   Venter, J
   Wu, N
   Carbone, M
   Gershwin, ME
   Bernuzzi, F
   Franchitto, A
   Alvaro, D
   Marzioni, M
   Onori, P
   Gaudio, E
   Sybenga, A
   Fabris, L
   Meng, FY
   Glaser, S
   Alpini, G
AF Kennedy, Lindsey
   Francis, Heather
   Invernizzi, Pietro
   Venter, Julie
   Wu, Nan
   Carbone, Marco
   Gershwin, M. Eric
   Bernuzzi, Francesca
   Franchitto, Antonio
   Alvaro, Domenico
   Marzioni, Marco
   Onori, Paolo
   Gaudio, Eugenio
   Sybenga, Amelia
   Fabris, Luca
   Meng, Fanyin
   Glaser, Shannon
   Alpini, Gianfranco
TI Secretin/secretin receptor signaling mediates biliary damage and liver
   fibrosis in early-stage primary biliary cholangitis
SO FASEB JOURNAL
LA English
DT Article
DE angiogenesis; cellular senescence; cholangiopathies; miR-125b; liver
   damage
ID NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS; PLACEBO-CONTROLLED TRIAL;
   FUNCTIONAL-HETEROGENEITY; CELLULAR SENESCENCE; OBETICHOLIC ACID;
   UP-REGULATION; BILE-DUCTS; EXPRESSION; CIRRHOSIS; SECRETIN
AB Primary biliary cholangitis (PBC) primarily targets cholangiocytes and is characterized by liver fibrosis and biliary proliferation. Activation of the secretin (Sct)/secretin receptor (SR) axis, expressed only by cholangiocytes, increases biliary proliferation, liver fibrosis, and bicarbonate secretion. We evaluated the effectiveness of SR antagonist treatment for early-stage PBC. Male and female dominant-negative TGF-beta receptor II (dnTGF-beta RII) (model of PBC) and wild-type mice at 12 wk of age were treated with saline or the SR antagonist, Sec 5-27, for 1 wk. dnTGF-beta RII mice expressed features of early-stage PBC along with enhanced Sct/SR axis activation and Sct secretion. dnTGF-beta RII mice had increased biliary proliferation or senescence, inflammation, and liver fibrosis. In dnTGF-beta RII mice, there was increased microRNA-125b/TGF-beta 1/TGF-beta receptor 1/VEGF-A signaling. Human early-stage PBC patients had an increase in hepatobiliary Sct and SR expression and serum Sct levels. Increased biliary Sct/SR signaling promotes biliary and hepatic damage during early-stage PBC.-Kennedy, L., Francis, H., Invernizzi, P., Venter, J., Wu, N., Carbone, M., Gershwin, M. E., Bernuzzi, F., Franchitto, A., Alvaro, D., Marzioni, M., Onori, P., Gaudio, E., Sybenga, A., Fabris, L., Meng, F., Glaser, S., Alpini, G. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.
C1 [Kennedy, Lindsey; Francis, Heather; Meng, Fanyin; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA.
   [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76508 USA.
   [Francis, Heather; Meng, Fanyin; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Digest Dis Res Ctr, Temple, TX USA.
   [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Humanitas Clin & Res Ctr, Rozzano, MI, Italy.
   [Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
   [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy.
   [Alvaro, Domenico] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy.
   [Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Marzioni, Marco] Univ Politecn Marche, Clin Gastroenterol & Hepatol, Ancona, Italy.
   [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Fabris, Luca] Univ Padua, Sch Med, Dept Mol Med, Padua, Italy.
   [Fabris, Luca] Yale Univ, Sch Med, Digest Dis Sect, New Haven, CT USA.
   [Kennedy, Lindsey; Francis, Heather; Venter, Julie; Wu, Nan; Meng, Fanyin; Alpini, Gianfranco] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Invernizzi, Pietro; Carbone, Marco; Bernuzzi, Francesca] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.
C3 Texas A&M University System; Baylor Health Care System; IRCCS Humanitas
   Research Hospital; University of California System; University of
   California Davis; Sapienza University Rome; Sapienza University Rome;
   Marche Polytechnic University; Vanderbilt University; University of
   Padua; Yale University; Indiana University System; Indiana University
   Bloomington; University of Milano-Bicocca
RP Alpini, G (corresponding author), Indiana Univ Sch Med, Indiana Ctr Liver Res, Div Gastroenterol & Hepatol, Dept Med,Richard L Roudebush VA Med Ctr, 1481 W 10th St Dedicat Wing Room C-7151, Indianapolis, IN 46202 USA.
EM galpini@iu.edu
RI Invernizzi, Pietro/AAB-8367-2022; Onori, Paolo/J-9394-2013; Fabris,
   Luca/J-7565-2018; Marzioni, Marco/A-8153-2011; bernuzzi,
   francesca/AAQ-7073-2020; ALVARO, Domenico/J-8600-2018
OI Onori, Paolo/0000-0002-7195-3760; Fabris, Luca/0000-0001-8538-6317;
   Marzioni, Marco/0000-0001-6014-6165; ALVARO,
   Domenico/0000-0003-3771-9644
FU Veterans Affairs Merit Awards from the United States Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service [1I01BX003031, 4I01BX000574, 1I01BX001724]; U.S. National
   Institutes of Health (NIH) National Institute of Diabetes and Digestive
   and Kidney Diseases [DK054811, DK076898, DK107310, DK110035, DK062975,
   DK108959]; NIH National Institute on Alcohol Abuse and Alcoholism Grants
   [AA025997, AA025157]; Partners Seeking a Cure (PSC) [460933-00001];
   Baylor Scott White Health; University of Rome "La Sapienza"
FX Portions of this work were supported by Veterans Affairs Merit Awards
   (1I01BX003031 to H.F., 4I01BX000574 to G.A., and 1I01BX001724 to F.M.)
   from the United States Department of Veteran's Affairs, Biomedical
   Laboratory Research and Development Service; U.S. National Institutes of
   Health (NIH) National Institute of Diabetes and Digestive and Kidney
   Diseases Grants DK054811, DK076898, DK107310, DK110035, DK062975 (to
   G.A., S.G., and F.M.), DK108959 (to H.F.), and NIH National Institute on
   Alcohol Abuse and Alcoholism Grants AA025997 and AA025157 to F.M., S.G.,
   and G.A.; The Partners Seeking a Cure (PSC) Grant Award 460933-00001 and
   Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from
   Baylor Scott & White Health (to G.A.); and Development Service by
   University of Rome "La Sapienza" (to P.O.). This material is the result
   of work supported with resources and the use of facilities at the
   Central Texas Veterans Health Care System (Temple, Texas, USA). The
   content is the responsibility of the authors alone and does not
   necessarily reflect the views or policies of the Department of Veteran's
   Affairs or the United States Government. F.M., S.G., and G.A. share
   senior authorship. The authors declare no conflicts of interest.
CR Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296
   ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Alpini Gianfranco, 1997, American Journal of Physiology, V272, pG1064
   ALVARO D, 1993, J CLIN INVEST, V92, P1314, DOI 10.1172/JCI116705
   Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657
   Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691
   Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x
   Berg PA, 1997, SEMIN LIVER DIS, V17, P115, DOI 10.1055/s-2007-1007189
   Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Corpechot C, 2000, HEPATOLOGY, V32, P1196, DOI 10.1053/jhep.2000.20240
   Erice O, 2018, HEPATOLOGY, V67, P1420, DOI 10.1002/hep.29533
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Harada K, 2005, HEPATOLOGY, V41, P1329, DOI 10.1002/hep.20705
   Harada K, 1997, HEPATOLOGY, V26, P1399
   Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984
   Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005
   Hisamoto S, 2016, J AUTOIMMUN, V75, P150, DOI 10.1016/j.jaut.2016.08.006
   Hohenester S, 2011, DIGEST DIS, V29, P62, DOI 10.1159/000324687
   Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   KNITTEL T, 1995, HEPATOLOGY, V21, P470, DOI 10.1016/0270-9139(95)90109-4
   Körner M, 2006, J HEPATOL, V45, P825, DOI 10.1016/j.jhep.2006.06.016
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239
   LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289
   Lleo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25906
   LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479
   Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677
   MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1016/0270-9139(94)90234-8
   Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024
   Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840
   Podda M, 2013, J AUTOIMMUN, V46, P81, DOI 10.1016/j.jaut.2013.06.015
   ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101
   Rudic JS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000551.pub3
   Salas JT, 2008, GASTROENTEROLOGY, V134, P1482, DOI 10.1053/j.gastro.2008.02.020
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005
   Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6
   SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205
   Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754
   Sood S, 2004, GASTROENTEROLOGY, V127, P470, DOI 10.1053/j.gastro.2004.04.064
   Tsuda M, 2013, HEPATOLOGY, V57, P806, DOI 10.1002/hep.25829
   VUORISTO M, 1995, GASTROENTEROLOGY, V108, P1470, DOI 10.1016/0016-5085(95)90696-7
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yin H, 2015, EXP CELL RES, V339, P252, DOI 10.1016/j.yexcr.2015.09.015
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 51
TC 30
Z9 30
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2019
VL 33
IS 9
BP 10269
EP 10279
DI 10.1096/fj.201802606R
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA IS5TA
UT WOS:000482214200044
PM 31251081
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Suyavaran, A
   Ramamurthy, C
   Mareeswaran, R
   Subastri, A
   Rao, PL
   Thirunavukkarasu, C
AF Suyavaran, Arumugam
   Ramamurthy, Chitteti
   Mareeswaran, Ramachandran
   Subastri, Ariraman
   Rao, Polaki Lokeswara
   Thirunavukkarasu, Chinnasamy
TI TNF-α suppression by glutathione preconditioning attenuates hepatic
   ischemia reperfusion injury in young and aged rats
SO INFLAMMATION RESEARCH
LA English
DT Article
DE Ischemia/reperfusion; TNF-alpha; Glutathione; Ageing; GSH/GSSG ratio
ID INDUCED LIVER-INJURY; ISCHEMIA/REPERFUSION INJURY; KUPFFER CELLS;
   ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; PRINGLE MANEUVER; WARM
   ISCHEMIA; P-SELECTIN; KAPPA-B; PROTECTS
AB Hepatic ischemia reperfusion (I/R) stimulates Kupffer cells and initiates injury through tumor necrosis factor-alpha (TNF-alpha) upregulation. Aim of this study was to compare the variable effects of reduced glutathione (GSH) pre-treatment on I/R liver injury in young and aged rats.
   Wistar male rats were sorted into young (groups I-III) and aged (groups IV-VI). All groups except sham (groups I and IV) were subjected to 90-min ischemia and 2-h reperfusion. The treatment groups received 200 mg/kg bwt (groups III and VI) of GSH, 30 min prior to I/R. Variable effects of GSH were studied by transaminase activities, thiobarbituric acid-reactive substances (TBARS), GSH level, GSH/oxidized GSH (GSSG) ratio, TNF-alpha level, apoptotic markers and confirmed by histopathological observations.
   Our findings revealed that I/R inflicted more liver damage in aged rats than young rats. The GSH treatment prior to surgery significantly lowered the serum transaminase activities, hepatic TBARS level and effectively restored the GSH/GSSG ratio in both young and aged rats more remarkably in the mitochondria. Western analysis depicted that the GSH treatment effectively suppressed TNF-alpha expression and apoptotic markers in both young and aged rats. These findings were further confirmed by terminal deoxynucleotide transferase dUTP nick end labeling assay and histopathological observations of liver sections of young and aged rats.
   Restoration of GSH/GSSG ratio through GSH pre-conditioning inhibits TNF-alpha and apoptosis in hepatic I/R injury. Hence, GSH pre-conditioning may be utilized in both young and aged individuals during liver transplantation/surgery for better post-operative outcomes.
C1 [Suyavaran, Arumugam; Ramamurthy, Chitteti; Mareeswaran, Ramachandran; Subastri, Ariraman; Rao, Polaki Lokeswara; Thirunavukkarasu, Chinnasamy] Pondicherry Univ, Dept Biochem & Mol Biol, Pondicherry 605014, India.
C3 Pondicherry University
RP Thirunavukkarasu, C (corresponding author), Pondicherry Univ, Dept Biochem & Mol Biol, Pondicherry 605014, India.
EM tchinnasamy@hotmail.com
RI Thirunavukkarasu, Chinnasamy/L-7307-2017; RAMAMURTHY,
   CHITTETI/AAI-8421-2021
OI Thirunavukkarasu, Chinnasamy/0000-0002-2339-997X; RAMAMURTHY,
   CHITTETI/0000-0002-5202-8481; Suyavaran, Arumugam/0000-0002-6581-6145
FU Indian Council of Medical Research (ICMR) [52/13/2007]; Department of
   Science and Technology, New Delhi, India [SR/FT/LS-63/2011, DST-FIST];
   UGC, New Delhi, India [CSIR-UGC-JRF] [F.17-115/98 (SA-I)]
FX The authors duly acknowledge the funding support from Indian Council of
   Medical Research (ICMR Ref: 52/13/2007) and Department of Science and
   Technology (NO. SR/FT/LS-63/2011 & DST-FIST), New Delhi, India. Author
   A. Suyavaran acknowledges UGC, New Delhi, India, for financial support
   in the form of Junior Research Fellowship [CSIR-UGC-JRF; S. No.
   F.17-115/98 (SA-I)].
CR Anaya DA, 2011, CRIT REV ONCOL HEMAT, V77, P100, DOI 10.1016/j.critrevonc.2010.02.003
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   BRASS CA, 1995, GASTROENTEROLOGY, V108, P1167, DOI 10.1016/0016-5085(95)90216-3
   Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619
   Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31
   CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001
   Crockett ET, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-3
   Day YJ, 2004, AM J PHYSIOL-GASTR L, V286, pG285, DOI 10.1152/ajpgi.00348.2003
   Essani NA, 1996, J IMMUNOL, V156, P2956
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001
   FernandezCheca JC, 1996, SEMIN LIVER DIS, V16, P147, DOI 10.1055/s-2007-1007228
   Geering B, 2011, BLOOD, V117, P5953, DOI 10.1182/blood-2010-11-322206
   Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504
   Goldberg DS, 2013, CLIN GASTROENTEROL H, V11, P452, DOI 10.1016/j.cgh.2013.02.014
   Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   Hines IN, 2005, BIOMED PHARMACOTHER, V59, P183, DOI 10.1016/j.biopha.2005.03.011
   JAESCHKE H, 1991, FREE RADICAL RES COM, V15, P277, DOI 10.3109/10715769109105223
   JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355
   Kaizu T, 2006, HEPATOLOGY, V43, P464, DOI 10.1002/hep.21067
   Kim DY, 2013, APOPTOSIS, V18, P1481, DOI 10.1007/s10495-013-0896-5
   Kim HG, 2003, MOL CELLS, V16, P278
   Knight TR, 2003, TOXICOL SCI, V76, P229, DOI 10.1093/toxsci/kfg220
   Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7
   Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Lin CM, 2012, TRANSPL P, V44, P974, DOI 10.1016/j.transproceed.2012.01.081
   Mallikarjuna K, 2010, ALCOHOL, V44, P523, DOI 10.1016/j.alcohol.2010.07.004
   Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   Menger MD, 1999, HEPATO-GASTROENTEROL, V46, P1452
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V53, P1123, DOI 10.1016/j.freeradbiomed.2012.05.036
   Özkan E, 2010, J SURG RES, V159, P588, DOI 10.1016/j.jss.2008.08.006
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okajima K, 2002, THROMB HAEMOSTASIS, V88, P473
   Peralta C, 2001, HEPATOLOGY, V33, P100, DOI 10.1053/jhep.2001.20529
   ROSSER BG, 1995, GASTROENTEROLOGY, V108, P252, DOI 10.1016/0016-5085(95)90032-2
   RYMSA B, 1991, AM J PHYSIOL, V261, pG602, DOI 10.1152/ajpgi.1991.261.4.G602
   Sahoo A, 1997, INT J DEV NEUROSCI, V15, P939, DOI 10.1016/S0736-5748(97)00049-X
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schauer RJ, 2004, ANN SURG, V239, P220, DOI 10.1097/01.sla.0000110321.64275.95
   SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Serbetçi K, 2012, MOL BIOL REP, V39, P1173, DOI 10.1007/s11033-011-0847-6
   Smyrniotis VE, 2003, WORLD J SURG, V27, P765, DOI 10.1007/s00268-003-6978-8
   Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447
   Takahashi Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1175, DOI 10.1152/ajpgi.00515.2001
   Tomiyama K, 2008, HEPATOLOGY, V48, P1608, DOI 10.1002/hep.22482
   Tsuchihashi S, 2007, TRANSPLANTATION, V83, P1628, DOI 10.1097/01.tp.0000266917.39958.47
   Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian
   Wu CX, 2011, J SURG RES, V166, pE205, DOI 10.1016/j.jss.2010.10.005
   Xu SQ, 2008, WORLD J GASTROENTERO, V14, P6936, DOI 10.3748/wjg.14.6936
   Xue F, 2008, ANAT REC, V291, P1016, DOI 10.1002/ar.20725
   Zhang W, 2007, TRANSPL P, V39, P1332, DOI 10.1016/j.transproceed.2006.11.021
NR 59
TC 23
Z9 23
U1 0
U2 7
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1023-3830
EI 1420-908X
J9 INFLAMM RES
JI Inflamm. Res.
PD JAN
PY 2015
VL 64
IS 1
BP 71
EP 81
DI 10.1007/s00011-014-0785-6
PG 11
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA AY4MS
UT WOS:000347553300008
PM 25420731
DA 2024-02-19
ER

PT J
AU Xiong, DS
   Yu, LX
   Yan, X
   Guo, CQ
   Xiong, Y
AF Xiong, Dasheng
   Yu, Long-Xi
   Yan, Xiao
   Guo, Chunqiu
   Xiong, Ying
TI Effects of Root and Stem Extracts of <i>Asparagus cochinchinensis</i> on
   Biochemical Indicators Related to Aging in the Brain and Liver of Mice
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE Asparagus cochinchinensis; Aging-Delaying; SOD; MDA
AB Asparagus cochinchinensis is a traditional Chinese medicine used for treating lung and spleen-related diseases. In this study, we compared the medicinal effects of A. cochinchinensis root and stem extracts on the activity of superoxide dismutase (SOD), the content of malonaldehyde (MDA) and total protein content in the brain, liver and plasma of mice. Polysaccharides and aqueous extracts of the roots significantly increased the spleen index and the SOD activity but reduced the MDA content and slowed down the aging process. In contrast, feeding with the stem extracts significantly reduced the SOD activity and increased the MDA accumulation in the brain and liver of mice, suggesting that the stem extracts may not be appropriate for treating aging-related diseases.
C1 [Xiong, Dasheng; Yan, Xiao; Guo, Chunqiu] Hunan Univ Arts & Sci, Coll Life Sci, Changde City 415000, Hunan, Peoples R China.
   [Xiong, Ying] Hunan Univ Arts & Sci, Modern Educ Ctr, Changde City 415000, Hunan, Peoples R China.
   [Yu, Long-Xi] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA.
C3 Hunan University of Arts & Science; Hunan University of Arts & Science;
   Cornell University
RP Xiong, DS (corresponding author), Hunan Univ Arts & Sci, Coll Life Sci, Dongting Rd 170, Changde City 415000, Hunan, Peoples R China.
EM xiongdasheng@126.com
FU National Science and Technology Foundation [2005DKA21004]
FX This work was supported by The National Science and Technology
   Foundation, a platform of the standardized classification, consolidation
   and sharing pilot project of Asparagus cochinchinensis germplasm
   resources (2005DKA21004). This project was collaborated with Professor
   Tasi Liu in Hunan University of Traditional Chinese Medicine, Changsha,
   Hunan, China. We also thank Dr. Pawan Kulwal for his critical reading
   and editing the manuscript.
CR Cong PZ, 2000, HDB ANAL CHEM MASS V, P296
   Gim GT, 2009, AM J CHINESE MED, V37, P227, DOI 10.1142/S0192415X09006795
   GONG YH, 1986, CNMR CHEM SHIFT NATU, P269
   Jun L, 1998, J GUIYANG MED COLL, V23, P132
   Koo HN, 2000, J ETHNOPHARMACOL, V73, P137, DOI 10.1016/S0378-8741(00)00287-7
   Li M, 2005, LISHIZHEN MED MAT ME, V16, P580
   LIANG ZZ, 1988, PLANTA MED, P344, DOI 10.1055/s-2006-962453
   Liu YZ, 2001, HEILONGJIANG MED PHA, V24, P7
   Luo J, 2000, J GUIYANG MED COLL, V25, P15
   Lv B, 2004, J TRADIT CHIN MED, V19, P43
   Ni JM, 1992, CHIN TRADIT HERB DRU, V23, P182
   *PEOPL REP CHIN NA, 2005, PEOPL REP CHIN PHARM, V1, P37
   Qu FY, 1999, ACTA CHIN MED PHARM, V2, P68
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Shen Y, 2007, J 2 MED U, V28, P1241
   Tenji K, 1979, MERR CHEM PHARM B, V27, P3086
   Wen Jing-Yuan, 1993, Acta Academiae Medicinae Shanghai, V20, P107
   XIONG DS, 2010, LISHIZHEN MED MAT ME, V21, P2976
   [徐从立 Xu Congli], 2005, [天然产物研究与开发, Natural Product R & D], V17, P128
   Yang MH, 1981, CHIN TRADIT HERB DRU, V12, P43
   Yang YC, 2002, CHINESE CHEM LETT, V13, P1185
   Yu FR, 2006, ZHONG GUO LIN CHUANG, V10, P57
   Zhao Y, 2005, CHIN WILD PLANT RESO, V24, P49
NR 23
TC 32
Z9 33
U1 4
U2 24
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2011
VL 39
IS 4
BP 719
EP 726
DI 10.1142/S0192415X11009159
PG 8
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA 785CP
UT WOS:000292205300008
PM 21721152
DA 2024-02-19
ER

PT J
AU Sverko, V
   Sobocanec, S
   Balog, T
   Marotti, T
AF Sverko, V
   Sobocanec, S
   Balog, T
   Marotti, T
TI Age and gender differences in antioxidant enzyme activity: potential
   relationship to liver carcinogenesis in male mice
SO BIOGERONTOLOGY
LA English
DT Article
DE antioxidant enzymes; carcinogenesis; gender; lipid peroxidation
ID SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; OXIDATIVE STRESS;
   GLUTATHIONE-PEROXIDASE; DEFENSE-MECHANISMS; CATALASE; OVEREXPRESSION;
   SURVIVAL
AB The present study was undertaken to determine whether age- and gender-related changes in lipid peroxidation (LPO) were attributable to differences in hepatic antioxidant defense mechanisms of aging 1-, 4-, 10- or 18-month-old male and female CBA mice. Specifically, total superoxide dismutase (tSOD), glutathione peroxidase (Gpx) and catalase ( CAT) activities were examined. As an indicator of liver oxidative damage, we determined LPO, expressed in terms of thiobarbituric acid reactive substances (TBARS). LPO increased in both sexes with age. tSOD seems to be a relatively inert antioxidative enzyme in both sexes of mice. The main changes in antioxidant capacity of mice liver during aging were associated with sex-related CAT and Gpx increments observed in males but not in females. Suprisingly, more than 60% of 18-month-old males ( but none of females) which started to appear at 10- months developed hepatic tumors. The results show that ( 1) the increased liver antioxidant capacity of CAT and Gpx in male mice might be a sign of oxidative stress; ( 2) the increase in CAT and Gpx activities in male mice is strongly correlated with incidence of hepatic tumors; ( 3) the significantly increased SOD activity in tumor-bearing mice might have induced damage with accumulated hydrogen peroxide H2O2.
C1 Rudjer Boskovic Inst, Dept Mol Med, Zagreb 10000, Croatia.
C3 Rudjer Boskovic Institute
RP Sverko, V (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Bijenicka C 54, Zagreb 10000, Croatia.
EM asverko@irb.hr
RI Sobocanec, Sandra/AAP-1416-2020
OI Balog, Tihomir/0000-0001-7983-868X; Sobocanec,
   Sandra/0000-0001-8915-6009
CR Allen RG, 1998, AGE, V21, P47, DOI 10.1007/s11357-998-0007-7
   BATIST G, 1986, J BIOL CHEM, V261, P5544
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Chen JQ, 1999, TOXICOL SCI, V51, P224, DOI 10.1093/toxsci/51.2.224
   Coto-Montes A, 2001, FREE RADICAL BIO MED, V30, P785, DOI 10.1016/S0891-5849(01)00468-3
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   FU DD, 1995, BBA-LIPID LIPID MET, V1254, P267, DOI 10.1016/0005-2760(94)00187-4
   Gaal T, 1996, COMP HAEMATOL INT, V6, P208, DOI 10.1007/BF00378112
   Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4
   Gerber M, 1997, CANCER LETT, V114, P211, DOI 10.1016/S0304-3835(97)04665-X
   GONZALEZ MJ, 1992, MED HYPOTHESES, V38, P106, DOI 10.1016/0306-9877(92)90081-M
   Harman D, 1992, EXS, V62, P1
   Janssen AML, 1998, BRIT J CANCER, V78, P1051, DOI 10.1038/bjc.1998.626
   Lapane KL, 2001, NEUROLOGY, V56, P650, DOI 10.1212/WNL.56.5.650
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ou PM, 1996, J BIOCHEM BIOPH METH, V31, P59, DOI 10.1016/0165-022X(95)00039-T
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D
   Sverko V, 2002, EXP GERONTOL, V37, P1031, DOI 10.1016/S0531-5565(02)00083-9
   SZATROWSKI TP, 1991, CANCER RES, V51, P794
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
NR 33
TC 28
Z9 32
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2004
VL 5
IS 4
BP 235
EP 242
DI 10.1023/B:BGEN.0000038024.58911.6e
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 846RE
UT WOS:000223332700003
PM 15314273
DA 2024-02-19
ER

PT J
AU Shen, JH
   Gao, H
   Li, BW
   Huang, Y
   Shi, YF
AF Shen, Jiahui
   Gao, Han
   Li, Bowen
   Huang, Yan
   Shi, Yinfang
TI The integration of machine learning and multi-omics analysis provides a
   powerful approach to screen aging-related genes and predict prognosis
   and immunotherapy efficacy in hepatocellular carcinoma
SO AGING-US
LA English
DT Article
DE machine learning; aging; hepatocellular carcinoma; prognostic model;
   immunotherapy
ID CANCER; SENESCENCE; INFLAMMATION
AB Background: Hepatocellular carcinoma (HCC) is a highly malignant tumor with high incidence and mortality rates. Aging-related genes are closely related to the occurrence and development of cancer. Therefore, it is of great significance to evaluate the prognosis of HCC patients by constructing a model based on aging-related genes. Method: Non-negative matrix factorization (NMF) clustering analysis was used to cluster the samples. The correlation between the risk score and immune cells, immune checkpoints, and Mismatch Repair (MMR) was evaluated through Spearman correlation test. Real Time Quantitative PCR (RT-qPCR) and immunohistochemistry were used to validate the expression levels of key genes in tissue and cells for the constructed model. Result: By performing NMF clustering, we were able to effectively group the liver cancer samples into two distinct clusters. Considering the potential correlation between aging-related genes and the prognosis of liver cancer patients, we used aging-related genes to construct a prognostic model. Spearman correlation analysis showed that the model risk score was closely related to MMR and immune checkpoint expression. Drug sensitivity analysis also provided guidance for the clinical use of chemotherapy drugs. RT-qPCR showed that TFDP1, NDRG1, and FXR1 were expressed at higher levels in different liver cancer cell lines compared to normal liver cells. Conclusion: In summary, we have developed an aging-related model to predict the prognosis of hepatocellular carcinoma and guide clinical drug treatment for different patients.
C1 [Shen, Jiahui] Huzhou Matern & Child Hlth Care Hosp, Dept Pharm, Huzhou, Peoples R China.
   [Gao, Han; Shi, Yinfang] Huzhou Univ, Affiliated Hosp 1, Dept Stomatol, Huzhou, Peoples R China.
   [Li, Bowen; Huang, Yan] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China.
C3 Huzhou University; Anhui Medical University
RP Shi, YF (corresponding author), Huzhou Univ, Affiliated Hosp 1, Dept Stomatol, Huzhou, Peoples R China.; Huang, Y (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Peoples R China.
EM huangyan_@ahmu.edu.cn; 52136@zjhu.edu.cn
RI yang, xiao/JLL-7721-2023; Liu, Zhihao/JUF-7651-2023; Li,
   YiXue/JRW-6306-2023; guo, ppdop/KAL-9865-2024; zhang,
   yimeng/JLL-7337-2023; Li, Wei/JLL-4365-2023; Liu, Yiwei/JUF-2477-2023;
   Wang, Luyao/JLL-2001-2023
CR Alimirah F, 2020, CANCER RES, V80, P3606, DOI 10.1158/0008-5472.CAN-20-0108
   Anwanwan D, 2020, BBA-REV CANCER, V1873, DOI 10.1016/j.bbcan.2019.188314
   Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743
   Bruix J, 2015, J HEPATOL, V62, pS144, DOI 10.1016/j.jhep.2015.02.007
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Cervello M, 2020, AGING-US, V12, P3053, DOI 10.18632/aging.102777
   Cheng J, 2011, CANCER LETT, V310, P35, DOI 10.1016/j.canlet.2011.06.001
   Gilles H, 2022, CRIT CARE NURS CLIN, V34, P289, DOI 10.1016/j.cnc.2022.04.004
   He QF, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac291
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hu DY, 2021, PHARMACOL THERAPEUT, V223, DOI 10.1016/j.pharmthera.2021.107817
   Hu WW, 2021, HEPATOLOGY, V73, P674, DOI 10.1002/hep.31293
   Huang A, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00264-x
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Johnson P, 2022, NAT REV GASTRO HEPAT, V19, P670, DOI 10.1038/s41575-022-00620-y
   Kohrt HE, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0118-0
   Lee WK, 2023, FRONT MOL BIOSCI, V10, DOI 10.3389/fmolb.2023.1147301
   Li WY, 2015, J CLIN INVEST, V125, P4239, DOI 10.1172/JCI81203
   Liu BY, 2022, J IMMUNOTHER CANCER, V10, DOI 10.1136/jitc-2021-003069
   Liu YC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061331
   Llovet JM, 2022, NAT CANCER, V3, P386, DOI 10.1038/s43018-022-00357-2
   Luo Q, 2018, CANCER LETT, V417, P21, DOI 10.1016/j.canlet.2017.12.021
   Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807
   O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8
   Oura K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115801
   Piñero F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061370
   Raskov H, 2021, BRIT J CANCER, V124, P359, DOI 10.1038/s41416-020-01048-4
   Rielland M, 2014, J CLIN INVEST, V124, P2125, DOI 10.1172/JCI72619
   Shen JP, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1130094
   Wang KP, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792781
   Xiong JL, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01192-1
   Xue S, 2021, WORLD J SURG ONCOL, V19, DOI 10.1186/s12957-021-02176-8
   Yasui K, 2003, J HUM GENET, V48, P609, DOI 10.1007/s10038-003-0086-3
   Zhang PF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01222-5
   Zhang RY, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00432-z
   Zhang Z, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1571388
   Zhao K, 2023, ONCOL LETT, V25, DOI 10.3892/ol.2022.13608
NR 37
TC 2
Z9 2
U1 4
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL 31
PY 2023
VL 15
IS 14
BP 6848
EP 6864
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA O5XD1
UT WOS:001044526700018
PM 37517087
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Weinstein, G
   O'Donnell, A
   Frenzel, S
   Xiao, T
   Yaqub, A
   Yilmaz, P
   de Knegt, RJ
   Maestre, GE
   van Lent, DM
   Long, M
   Gireud-Goss, M
   Ittermann, T
   Frost, F
   Bülow, R
   Vasan, RS
   Grabe, HJ
   Ikram, MA
   Beiser, AS
   Seshadri, S
AF Weinstein, Galit
   O'Donnell, Adrienne
   Frenzel, Stefan
   Xiao, Tian
   Yaqub, Amber
   Yilmaz, Pinar
   de Knegt, Robert J.
   Maestre, Gladys E.
   van Lent, Debora Melo
   Long, Michelle
   Gireud-Goss, Monica
   Ittermann, Till
   Frost, Fabian
   Buelow, Robin
   Vasan, Ramachandran S.
   Grabe, Hans J.
   Ikram, M. Arfan
   Beiser, Alexa S.
   Seshadri, Sudha
TI Nonalcoholic fatty liver disease, liver fibrosis, and structural brain
   imaging: The Cross-Cohort Collaboration
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article; Early Access
DE brain aging; brain MRI; liver fibrosis; nonalcoholic fatty liver
   disease; observational study
ID MIDDLE-AGED ADULTS; DESIGN; HEART
AB Background and purpose: Prior studies reported conflicting findings regarding the association of nonalcoholic fatty liver disease (NAFLD) and liver fibrosis with measures of brain health. We examined whether NAFLD and liver fibrosis are associated with structural brain imaging measures in middle- and old-age adults.
   Methods: In this cross-sectional study among dementia-and stroke-free individuals, data were pooled from the Offspring and Third Generation cohorts of the Framingham Heart Study (FHS), the Rotterdam Study (RS), and the Study of Health in Pomerania. NAFLD was assessed through abdominal imaging. Transient hepatic elastography (FibroScan) was used to assess liver fibrosis in FHS and RS. Linear regression models were used to explore the relation of NAFLD and liver fibrosis with brain volumes, including total brain, gray matter, hippocampus, and white matter hyperintensities, adjusting for potential confounders. Results were combined using fixed effects meta-analysis.
   Results: In total, 5660 and 3022 individuals were included for NAFLD and liver fibrosis analyses, respectively. NAFLD was associated with smaller volumes of total brain (beta = -3.5, 95% confidence interval [CI] = -5.4 to -1.7), total gray matter (beta = -1.9, 95% CI = -3.4 to -0.3), and total cortical gray matter (beta = -1.9, 95% CI = -3.7 to -0.01). In addition, liver fibrosis (defined as liver stiffness measure =8.2 kPa) was related to smaller total brain volumes (beta = -7.3, 95% CI = -11.1 to -3.5). Heterogeneity between studies was low.
   Conclusions: NAFLD and liver fibrosis may be directly related to brain aging. Larger and prospective studies are warranted to validate these findings and identify liver-related preventive strategies for neurodegeneration.
C1 [Weinstein, Galit] Univ Haifa, Sch Publ Hlth, Haifa, Israel.
   [O'Donnell, Adrienne; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [O'Donnell, Adrienne; van Lent, Debora Melo; Vasan, Ramachandran S.; Beiser, Alexa S.] Framingham Study, Framingham, MA USA.
   [Frenzel, Stefan; Grabe, Hans J.] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany.
   [Xiao, Tian; Yaqub, Amber; Buelow, Robin] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.
   [Yilmaz, Pinar; Ikram, M. Arfan] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands.
   [de Knegt, Robert J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.
   [Maestre, Gladys E.] Univ Zulia Maracaibo Venezuela, Biol Res Inst, Neurosci Lab, Maracaibo, Venezuela.
   [Maestre, Gladys E.] Univ Zulia Maracaibo Venezuela, Res Inst Cardiovasc Dis, Fac Med, Maracaibo, Venezuela.
   [Maestre, Gladys E.] Univ Texas Rio Grande Valley, Sch Med, Div Neurosci, Dept Biomed Sci, Edinburg, TX USA.
   [van Lent, Debora Melo; Gireud-Goss, Monica; Seshadri, Sudha] Univ Texas Hlth Sci Ctr, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX USA.
   [van Lent, Debora Melo] Boston Univ, Sch Med, Dept Neurol, Boston, MA USA.
   [Long, Michelle] Boston Univ, Boston Med Ctr, Sch Med, Sect Gastroenterol, Boston, MA USA.
   [Ittermann, Till] Univ Med Greifswald, Inst Commun Med, Greifswald, Germany.
   [Frost, Fabian] Univ Med Greifswald, Dept Med A, Greifswald, Germany.
   [Buelow, Robin] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.
   [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA USA.
   [Vasan, Ramachandran S.; Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Grabe, Hans J.] German Ctr Neurodegenerat Dis, Partner Site Rostock Greifswald, Rostock, Germany.
   [Weinstein, Galit] Univ Haifa, Sch Publ Hlth, 199 Aba Khoushy Ave, Mt Carmel, IL-3498838 Haifa, Israel.
C3 University of Haifa; Boston University; Greifswald Medical School;
   Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of
   Texas System; University of Texas Rio Grande Valley; University of Texas
   System; University of Texas Health Science Center at San Antonio; Boston
   University; Boston University; Boston Medical Center; Greifswald Medical
   School; Greifswald Medical School; Greifswald Medical School; Boston
   University; Boston University; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); University of Haifa
RP Weinstein, G (corresponding author), Univ Haifa, Sch Publ Hlth, 199 Aba Khoushy Ave, Mt Carmel, IL-3498838 Haifa, Israel.
EM gweinstei@univ.haifa.ac.il
RI Frost, Frank/D-1407-2010; De Knegt, Robert/X-4629-2019
OI De Knegt, Robert/0000-0003-0934-6975; Xiao, Tian/0000-0002-5711-2148;
   Yaqub, Amber/0000-0002-3579-8054; Yilmaz, Pinar/0000-0003-2393-3068;
   Melo van Lent, Debora/0000-0002-7392-9289
FU The authors thank the staff and participants of the Framingham Heart
   Study, the Rotterdam Study, and the Study of Health in Pomerania.; Study
   of Health in Pomerania
FX The authors thank the staff and participants of the Framingham Heart
   Study, the Rotterdam Study, and the Study of Health in Pomerania.
CR Alqahtani SA, 2021, HEPATOL COMMUN, V5, P1833, DOI 10.1002/hep4.1765
   [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
   Basu E, 2022, J NEUROL SCI, V434, DOI 10.1016/j.jns.2021.120117
   Beller E, 2019, EUR RADIOL, V29, P6662, DOI 10.1007/s00330-019-06276-8
   Borenstein M., 2007, Meta-Analysis: Fixed effect vs. random effects. Comprehensive meta-analysis
   Boursier J, 2016, J HEPATOL, V65, P570, DOI 10.1016/j.jhep.2016.04.023
   Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993
   Braude M, 2023, LIVER INT, V43, P90, DOI 10.1111/liv.15415
   Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008
   Cheon SY, 2022, CELL BIOSCI, V12, DOI 10.1186/s13578-022-00836-0
   Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042
   FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7
   Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013
   Graupera I., 2021, CLIN GASTROENTEROL H, V73, pS414
   Ikram MA, 2020, EUR J EPIDEMIOL, V35, P483, DOI 10.1007/s10654-020-00640-5
   Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003
   Jang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38357-x
   Jeong SM, 2019, EUR J NEUROL, V26, P1471, DOI 10.1111/ene.14029
   John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255
   Kim YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139227
   Kjærgaard K, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040673
   Lombardi R, 2019, DIGEST LIVER DIS, V51, P1214, DOI 10.1016/j.dld.2019.05.015
   Matsusue E, 2005, AM J NEURORADIOL, V26, P347
   Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045
   Morrow A, 2022, J ALZHEIMERS DIS, V90, P667, DOI 10.3233/JAD-220349
   Nassir F, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12060824
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Nucera S, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05228-5
   Pålhaugen L, 2021, J CEREBR BLOOD F MET, V41, P1162, DOI 10.1177/0271678X20957604
   Parikh NS, 2020, EUR J NEUROL, V27, P1895, DOI 10.1111/ene.14384
   Parikh NS, 2023, ALZHEIMERS DEMENT, V19, P1518, DOI 10.1002/alz.12795
   Parikh NS, 2022, EUR J NEUROL, V29, P2622, DOI 10.1111/ene.15437
   Petta S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003446
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Satapathy SK, 2015, ANN HEPATOL, V14, P789, DOI 10.5604/16652681.1171749
   Shili-Masmoudi S, 2020, LIVER INT, V40, P581, DOI 10.1111/liv.14301
   Siddiqui MS, 2019, CLIN GASTROENTEROL H, V17, P156, DOI 10.1016/j.cgh.2018.04.043
   Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021
   Staufer K, 2019, UNITED EUR GASTROENT, V7, P1113, DOI 10.1177/2050640619865133
   van de Mortel LA, 2021, J ALZHEIMERS DIS, V83, P705, DOI 10.3233/JAD-210173
   Wang LP, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.985109
   Weinstein G, 2019, LIVER INT, V39, P1713, DOI 10.1111/liv.14161
   Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229
   Weinsteina G, 2022, J ALZHEIMERS DIS, V86, P1371, DOI 10.3233/JAD-215409
   Xiao T, 2022, NEUROLOGY, V99, pE565, DOI 10.1212/WNL.0000000000200770
   Xiong SJ, 2022, LIVER INT, V42, P2175, DOI 10.1111/liv.15359
   Younossi ZM, 2022, CLIN GASTROENTEROL H, V20, pE1456, DOI 10.1016/j.cgh.2021.06.048
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
NR 48
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD 2024 JAN
PY 2024
VL 31
IS 1
DI 10.1111/ene.16048
EA AUG 2023
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AM0W1
UT WOS:001063752500001
PM 37641505
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Belloni, L
   Di Cocco, S
   Guerrieri, F
   Nunn, ADG
   Piconese, S
   Salerno, D
   Testoni, B
   Pulito, C
   Mori, F
   Pallocca, M
   Sacconi, A
   Vivoli, E
   Marra, F
   Strano, S
   Blandino, G
   Levrero, M
   Pediconi, N
AF Belloni, Laura
   Di Cocco, Silvia
   Guerrieri, Francesca
   Nunn, Abigail D. G.
   Piconese, Silvia
   Salerno, Debora
   Testoni, Barbara
   Pulito, Claudio
   Mori, Federica
   Pallocca, Matteo
   Sacconi, Andrea
   Vivoli, Elisa
   Marra, Fabio
   Strano, Sabrina
   Blandino, Giovanni
   Levrero, Massimo
   Pediconi, Natalia
TI Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic
   steatosis in an <i>in vitro</i> and <i>in vivo</i> model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FATTY LIVER-DISEASE; SIGNAL TRANSDUCER; TRANSCRIPTION 3; INFLAMMATION;
   STAT3; METABOLISM; ACTIVATION; MECHANISMS; METFORMIN; STRESS
AB Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. Although genetic predisposition and epigenetic factors contribute to the development of NAFLD, our understanding of the molecular mechanism involved in the pathogenesis of the disease is still emerging. Here we investigated a possible role of a microRNAs-STAT3 pathway in the induction of hepatic steatosis. Differentiated HepaRG cells treated with the fatty acid sodium oleate (fatty dHepaRG) recapitulated features of liver vesicular steatosis and activated a cell-autonomous inflammatory response, inducing STAT3-Tyrosine-phosphorylation. With a genome-wide approach (Chromatin Immunoprecipitation Sequencing), many phospho-STAT3 binding sites were identified in fatty dHepaRG cells and several STAT3 and/or NAFLD-regulated microRNAs showed increased expression levels, including miR-21. Innovative CARS (Coherent Anti-Stokes Raman Scattering) microscopy revealed that chemical inhibition of STAT3 activity decreased lipid accumulation and deregulated STAT3-responsive microRNAs, including miR-21, in lipid overloaded dHepaRG cells. We were able to show in vivo that reducing phospho-STAT3-miR-21 levels in C57/BL6 mice liver, by long-term treatment with metformin, protected mice from aging-dependent hepatic vesicular steatosis. Our results identified a microRNAs-phosphoSTAT3 pathway involved in the development of hepatic steatosis, which may represent a molecular marker for both diagnosis and therapeutic targeting.
C1 [Belloni, Laura; Guerrieri, Francesca; Nunn, Abigail D. G.; Salerno, Debora; Levrero, Massimo; Pediconi, Natalia] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.
   [Di Cocco, Silvia; Piconese, Silvia; Levrero, Massimo] Sapienza Univ, Dept Internal Med DMISM, Rome, Italy.
   [Di Cocco, Silvia; Pediconi, Natalia] Sapienza Univ, Dept Mol Med, Rome, Italy.
   [Piconese, Silvia] Fdn Cenci Bolognetti, Pasteur Inst Italy, Rome, Italy.
   [Testoni, Barbara; Levrero, Massimo] CNRS 5286, INSERM, U1052, CRCL,UMR, Lyon, France.
   [Pulito, Claudio; Mori, Federica; Strano, Sabrina] Natl Canc Inst Regina Elena, Mol Chemoprevent Grp, Rome, Italy.
   [Pallocca, Matteo] Natl Canc Inst Regina Elena, UOSD SAFU, Rome, Italy.
   [Sacconi, Andrea; Blandino, Giovanni] Natl Canc Inst Regina Elena, Oncogen & Epigenet Unit, Rome, Italy.
   [Vivoli, Elisa; Marra, Fabio] Univ Florence, Dept Clin & Expt Med, Florence, Italy.
   [Strano, Sabrina] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON, Canada.
   [Levrero, Massimo] Hosp Civils Lyon, Hop Croix Rousse, Hepatogastroenterol, F-69004 Lyon, France.
C3 Istituto Italiano di Tecnologia - IIT; Sapienza University Rome;
   Sapienza University Rome; Fondazione Cenci Bolognetti; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Universite Claude
   Bernard Lyon 1; UNICANCER; Centre Leon Berard; Centre de Recherche en
   cancerologie (CRCL); Centre National de la Recherche Scientifique
   (CNRS); CNRS - National Institute for Biology (INSB); University of
   Florence; McMaster University; CHU Lyon
RP Pediconi, N (corresponding author), Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy.; Pediconi, N (corresponding author), Sapienza Univ, Dept Mol Med, Rome, Italy.
EM natalia.pediconi@iit.it
RI pulito, claudio/K-6713-2016; Salerno, Debora/AAM-9940-2021; Sharma,
   Ashwani/AAK-3879-2020; Strano, Sabrina/K-9654-2016; sacconi,
   andrea/J-3669-2018; Belloni, Laura/S-1432-2019; guerrieri,
   francesca/G-3908-2013; Pallocca, Matteo/K-9259-2016; Levrero,
   Massimo/G-5680-2016; TESTONI, Barbara/F-3767-2017
OI pulito, claudio/0000-0002-0921-6962; Sharma,
   Ashwani/0000-0001-9835-1973; sacconi, andrea/0000-0002-8276-0438;
   Pallocca, Matteo/0000-0002-7756-3579; strano,
   sabrina/0000-0002-6341-4230; Levrero, Massimo/0000-0002-4978-0875;
   Piconese, Silvia/0000-0002-9685-5227; SALERNO,
   DEBORA/0000-0003-0504-1904; TESTONI, Barbara/0000-0001-5588-5465;
   Guerrieri, Francesca/0000-0002-2021-4394
FU CINECA award under ISCRA initiative; MIUR-Ministero dell'istruzione,
   dell'universita e della ricerca (FIRB 2011-2016) [RBAP10XKNC]; Sapienza
   University of Rome [prot. C26A13T8PS, prot. C26A142MCH, prot.
   C26A15LSXL]; AIRC-Associazione Italiana Ricerca Cancro [IG-2017 19784];
   Istituto Pasteur Italia - Fondazione Cenci Bolognetti [2014-2016];
   International Network Institut Pasteur (PTR) [20-16]; Fondazione Roma
   [NCDS-2013-000000345]
FX We are grateful to Rita Appodia for general administrative help. We are
   thankful to all members from prof. Gulino Laboratory and Nicoletta Corbi
   from CNR to greatly support us during the course of this research. We
   acknowledge Marco Cippitelli, Alessandra Soriani, Giovanni Bernardini
   and Fabrizio Antonangeli for sharing reagents. We acknowledge the CINECA
   award under the ISCRA initiative, for the availability of high
   performance computing resources and support (project: IscrC_CASTOE). We
   acknowledge organizations that funded the research: MIUR-Ministero
   dell'istruzione, dell'universita e della ricerca (FIRB 2011-2016
   RBAP10XKNC); Sapienza University of Rome (prot. C26A13T8PS; prot.
   C26A142MCH; prot. C26A15LSXL); AIRC-Associazione Italiana Ricerca Cancro
   (IG-2017 19784); Istituto Pasteur Italia - Fondazione Cenci Bolognetti
   (grant 2014-2016); International Network Institut Pasteur (PTR n.
   20-16); Fondazione Roma (Grants for Biomedical Research
   NCDS-2013-000000345). The funding sources had no involvement in the
   preparation of the article, in study design, in the collection, analysis
   and interpretation of data, in the writing of the report and in the
   decision to submit the article for publication.
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182
   Anthérieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008
   Banini BA, 2017, CURR OPIN GASTROEN, V33, P134, DOI 10.1097/MOG.0000000000000356
   Becker PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142661
   Bhat A, 2015, WORLD J HEPATOL, V7, P1652, DOI 10.4254/wjh.v7.i12.1652
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Calo N, 2016, GUT, V65, P1871, DOI 10.1136/gutjnl-2015-310822
   Cao Q, 2013, PHYSIOL GENOMICS, V45, P1206, DOI 10.1152/physiolgenomics.00122.2013
   Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481
   Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018
   Gerhard GS, 2015, WORLD J HEPATOL, V7, P226, DOI 10.4254/wjh.v7.i2.226
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104
   Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023
   Jin K, 2017, ONCOTARGET, V8, P22145, DOI 10.18632/oncotarget.13530
   Kim BH, 2016, ARCH PHARM RES, V39, P1085, DOI 10.1007/s12272-016-0795-8
   Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092
   Loyer X, 2016, GUT, V65, P1882, DOI 10.1136/gutjnl-2014-308883
   Mankan AK, 2011, EXPERT OPIN INV DRUG, V20, P1263, DOI 10.1517/13543784.2011.601739
   Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088
   Nerstedt A, 2013, MOL CELL ENDOCRINOL, V375, P68, DOI 10.1016/j.mce.2013.05.013
   Nunn ADG, 2016, SCI REP-UK, V6, DOI 10.1038/srep28025
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996
   Rodrigues PM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.172
   Romano G, 2017, CARCINOGENESIS, V38, P485, DOI 10.1093/carcin/bgx026
   Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204
   Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Takahashi Y, 2015, WORLD J GASTROENTERO, V21, P3777, DOI 10.3748/wjg.v21.i13.3777
   Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147
   Yabiku K, 2017, CLIN THER, V39, P558, DOI 10.1016/j.clinthera.2017.01.015
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zhao Z., 2014, PLOS ONE, V9
NR 39
TC 14
Z9 16
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2018
VL 8
AR 13638
DI 10.1038/s41598-018-31835-2
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GT1ZZ
UT WOS:000444279000044
PM 30206377
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Heldring, MM
   Shaw, AH
   Beltman, JB
AF Heldring, M. M.
   Shaw, A. H.
   Beltman, J. B.
TI Unraveling the effect of intra- and intercellular processes on
   acetaminophen-induced liver injury
SO NPJ SYSTEMS BIOLOGY AND APPLICATIONS
LA English
DT Article
ID MITOCHONDRIAL PERMEABILITY TRANSITION; N-ACETYLCYSTEINE TREATMENT;
   INDUCED HEPATIC-NECROSIS; DNA-DAMAGE RESPONSE; INDUCED HEPATOTOXICITY;
   PARACETAMOL METABOLISM; RAT HEPATOCYTES; GENE-EXPRESSION; PROTECTIVE
   ROLE; SYSTEMS-MODEL
AB In high dosages, acetaminophen (APAP) can cause severe liver damage, but susceptibility to liver failure varies across individuals and is influenced by factors such as health status. Because APAP-induced liver injury and recovery is regulated by an intricate system of intra- and extracellular molecular signaling, we here aim to quantify the importance of specific modules in determining the outcome after an APAP insult and of potential targets for therapies that mitigate adversity. For this purpose, we integrated hepatocellular acetaminophen metabolism, DNA damage response induction and cell fate into a multiscale mechanistic liver lobule model which involves various cell types, such as hepatocytes, residential Kupffer cells and macrophages. Our model simulations show that zonal differences in metabolism and detoxification efficiency are essential determinants of necrotic damage. Moreover, the extent of senescence, which is regulated by intracellular processes and triggered by extracellular signaling, influences the potential to recover. In silico therapies at early and late time points after APAP insult indicated that prevention of necrotic damage is most beneficial for recovery, whereas interference with regulation of senescence promotes regeneration in a less pronounced way.
C1 [Heldring, M. M.; Shaw, A. H.; Beltman, J. B.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.
C3 Leiden University - Excl LUMC; Leiden University
RP Beltman, JB (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.
EM j.b.beltman@lacdr.leidenuniv.nl
OI Shaw, Angela/0000-0002-1288-6529
FU eTRANSAFE project - IMI2 Joint Undertaking [777365]; European Union's
   Horizon 2020 research and innovation program; European Federation of
   Pharmaceutical Industries and Associations (EFPIA)
FX This work has received funding from the eTRANSAFE project, which has
   received support from IMI2 Joint Undertaking under Grant Agreement No.
   777365. This Joint Undertaking receives support from the European
   Union's Horizon 2020 research and innovation program and the European
   Federation of Pharmaceutical Industries and Associations (EFPIA). This
   manuscript reflects only the authors' view and IMI JU is not responsible
   for any use that may be made of the information it contains. The authors
   acknowledge Margriet Palm for providing code for efficient
   parallelization of model simulations.
CR Adhyapok P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243451
   Akakpo JY, 2018, HUM EXP TOXICOL, V37, P1310, DOI 10.1177/0960327118774902
   Akakpo JY, 2022, ARCH TOXICOL, V96, P453, DOI 10.1007/s00204-021-03211-z
   ANDREASEN PB, 1979, ACTA MED SCAND, P99
   ANUNDI I, 1993, BIOCHEM PHARMACOL, V45, P1251, DOI 10.1016/0006-2952(93)90277-4
   Aubert J, 2012, J PHARMACOL EXP THER, V342, P676, DOI 10.1124/jpet.112.193813
   Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445
   Bandi S, 2014, ASSAY DRUG DEV TECHN, V12, P272, DOI 10.1089/adt.2014.571
   BARON J, 1981, J BIOL CHEM, V256, P5931
   Bhushan B, 2019, AM J PATHOL, V189, P719, DOI 10.1016/j.ajpath.2018.12.006
   Bhushan B, 2014, AM J PATHOL, V184, P3013, DOI 10.1016/j.ajpath.2014.07.019
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   Borodkina AV, 2018, ACTA NATURAE, V10, P4, DOI 10.32607/20758251-2018-10-1-4-14
   Borude Prachi, 2018, Gene Expression, V18, P115, DOI 10.3727/105221618X15205260749346
   Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668
   Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   CHIBA M, 1995, DRUG METAB DISPOS, V23, P622
   Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370
   Chomchai S, 2018, PHARMACOEPIDEM DR S, V27, P19, DOI 10.1002/pds.4339
   Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898
   Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.t01-1-00220.x
   CUMMINGS AJ, 1967, BRIT J PHARM CHEMOTH, V29, P150, DOI 10.1111/j.1476-5381.1967.tb01948.x
   Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Diener T, 2010, EXP GERONTOL, V45, P638, DOI 10.1016/j.exger.2010.03.002
   DIVOLL M, 1982, J AM GERIATR SOC, V30, P240, DOI 10.1111/j.1532-5415.1982.tb07093.x
   Eichenbaum G, 2020, REGUL TOXICOL PHARM, V118, DOI 10.1016/j.yrtph.2020.104788
   Fan J, 2019, WORLD J GASTROENTERO, V25, P1355, DOI 10.3748/wjg.v25.i11.1355
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Flint RB, 2017, PEDIATR RES, V82, P678, DOI 10.1038/pr.2017.129
   Fontana RJ, 2008, MED CLIN N AM, V92, P761, DOI 10.1016/j.mcna.2008.03.005
   FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93, DOI 10.2165/00003088-198207020-00001
   Fu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198060
   Gallucci RM, 2000, J IMMUNOL, V164, P872, DOI 10.4049/jimmunol.164.2.872
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491
   GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128
   Goldin RD, 1996, J PATHOL, V179, P432
   GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013
   Graubardt N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00626
   Gregory B, 2010, J INVEST MED, V58, P707, DOI 10.231/JIM.0b013e3181db8764
   Hafner A, 2020, CELL SYST, V10, P495, DOI 10.1016/j.cels.2020.05.001
   He M, 2012, FOOD CHEM TOXICOL, V50, P3142, DOI 10.1016/j.fct.2012.06.020
   Heldring MM, 2022, PLOS COMPUT BIOL, V18, DOI [10.5281/zenodo.6458438, 10.1371/journal.pcbi.1010264]
   Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107
   Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173
   Howell BA, 2014, TOXICOL LETT, V226, P163, DOI 10.1016/j.toxlet.2014.02.007
   HOWIE D, 1977, J PHARM PHARMACOL, V29, P235, DOI 10.1111/j.2042-7158.1977.tb11295.x
   Hsu CH, 2019, CELL, V178, P361, DOI 10.1016/j.cell.2019.05.041
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Huo YZ, 2017, FREE RADICAL BIO MED, V106, P111, DOI 10.1016/j.freeradbiomed.2017.02.028
   Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336
   Jaeschke H, 2020, TOXICOL SCI, V174, P159, DOI 10.1093/toxsci/kfaa002
   Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x
   JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195
   Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976
   Käfer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056
   Kane AE, 2016, EXP GERONTOL, V73, P95, DOI 10.1016/j.exger.2015.11.013
   Kang AM, 2020, J MED TOXICOL, V16, P169, DOI 10.1007/s13181-019-00740-z
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008
   Karvellas CJ, 2017, HEPATOLOGY, V65, P938, DOI 10.1002/hep.28945
   KERA Y, 1988, BIOCHEM J, V254, P411, DOI 10.1042/bj2540411
   Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1
   Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1
   Kornmann LM, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/1476-7120-13-1
   Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01
   Kruepunga N, 2019, BBA-MOL BASIS DIS, V1865, P869, DOI 10.1016/j.bbadis.2018.05.019
   Kucera O, 2012, PHYSIOL RES, V61, pS93, DOI 10.33549/physiolres.932395
   Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293
   Lewis PS, 2020, J HEPATOL, V73, P349, DOI 10.1016/j.jhep.2020.02.031
   MACPHEE PJ, 1988, MICROVASC RES, V36, P140, DOI 10.1016/0026-2862(88)90014-3
   Manco R, 2021, J HEPATOL, V74, P466, DOI 10.1016/j.jhep.2020.09.003
   Maree AF, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5
   MARKOSE D, 2018, J IMMUNOL REGEN MED, V2, P1, DOI DOI 10.1016/J.REGEN.2018.03.003
   Martin-Murphy BV, 2013, HEPATOLOGY, V57, P1575, DOI 10.1002/hep.26134
   Masubuchi Y, 2011, TOXICOLOGY, V287, P54, DOI 10.1016/j.tox.2011.05.018
   McGill MR, 2013, TOXICOL APPL PHARM, V269, P240, DOI 10.1016/j.taap.2013.03.026
   Means SA, 2019, DRUG METAB PHARMACOK, V34, P71, DOI 10.1016/j.dmpk.2018.09.266
   Milesi-Hallé A, 2011, CHEM-BIOL INTERACT, V189, P222, DOI 10.1016/j.cbi.2010.12.001
   Mirochnitchenko O, 1999, J BIOL CHEM, V274, P10349, DOI 10.1074/jbc.274.15.10349
   MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185
   Mitchell Sarah J, 2011, Curr Gerontol Geriatr Res, V2011, P624156, DOI 10.1155/2011/624156
   Mohar I, 2014, REDOX BIOL, V2, P377, DOI 10.1016/j.redox.2014.01.008
   Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682
   Moxley AH, 2021, CELL BIOCHEM FUNCT, V39, P235, DOI 10.1002/cbf.3590
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   NELSON E, 1963, J PHARM SCI, V52, P864, DOI 10.1002/jps.2600520911
   Nguyen GC, 2008, HEPATOLOGY, V48, P1336, DOI 10.1002/hep.22536
   Nguyen NT, 2022, ARCH TOXICOL, V96, P305, DOI 10.1007/s00204-021-03183-0
   Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025
   Ochoa JGD, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00204
   Oda M, 2006, CLIN HEMORHEOL MICRO, V34, P11
   Oinonen T, 1998, BIOCHEM J, V329, P17, DOI 10.1042/bj3290017
   Piccinin E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53015-6
   PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002
   PRESCOTT LF, 1973, BRIT J PHARMACOL, V49, P602, DOI 10.1111/j.1476-5381.1973.tb08536.x
   PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x
   Reddyhoff D, 2015, J THEOR BIOL, V386, P132, DOI 10.1016/j.jtbi.2015.08.021
   Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945
   Reith D, 2009, CLIN EXP PHARMACOL P, V36, P35, DOI 10.1111/j.1440-1681.2008.05029.x
   Remien CH, 2014, MATH MED BIOL, V31, P302, DOI 10.1093/imammb/dqt010
   Remien CH, 2012, HEPATOLOGY, V56, P727, DOI 10.1002/hep.25656
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Rubin JB, 2018, CLIN GASTROENTEROL H, V16, P936, DOI 10.1016/j.cgh.2017.11.042
   Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135
   Ruijter JM, 2004, HEPATOLOGY, V39, P343, DOI 10.1002/hep.20068
   RUMACK BH, 1975, PEDIATRICS, V55, P871
   Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267
   Schmidt LE, 2005, GUT, V54, P686, DOI 10.1136/gut.2004.054619
   Schmidt LE, 2005, HEPATOLOGY, V41, P26, DOI 10.1002/hep.20511
   Shankar K, 2003, TOXICOL SCI, V73, P220, DOI 10.1093/toxsci/kfg059
   Sheng YC, 2013, DRUG DISCOV THER, V7, P78, DOI 10.5582/ddt.2013.v7.2.78
   Sluka JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162428
   SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401
   Smith AK, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007622
   Smith AK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005253
   SMITH MT, 1979, BIOCHEM J, V182, P103, DOI 10.1042/bj1820103
   Stamper BD, 2015, GENE REGUL SYST BIO, V9, P1, DOI 10.4137/GRSB.S25388
   Starruy J, 2014, BIOINFORMATICS, V30, P1331, DOI 10.1093/bioinformatics/btt772
   Studencka M, 2017, ONCOTARGET, V8, P30656, DOI 10.18632/oncotarget.15693
   Sturmlechner I, 2021, SCIENCE, V374, DOI 10.1126/science.abb3420
   Taguchi K, 2015, LAB ANIM-UK, V49, P294, DOI 10.1177/0023677215573041
   Tanimizu N, 2020, AGING-US, V12, P18907, DOI 10.18632/aging.103973
   Toda A, 2021, XENOBIOTICA, V51, P316, DOI 10.1080/00498254.2020.1849872
   TONE Y, 1990, J PHARMACOBIO-DYNAM, V13, P327, DOI 10.1248/bpb1978.13.327
   VAANANEN H, 1986, J HEPATOL, V2, P174, DOI 10.1016/S0168-8278(86)80076-9
   VANFURTH R, 1970, J EXP MED, V132, P794, DOI 10.1084/jem.132.4.794
   Viswanathan P, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12445
   Wan J, 2004, EXP MOL MED, V36, P71, DOI 10.1038/emm.2004.10
   Whyte IM, 2007, CURR MED RES OPIN, V23, P2359, DOI 10.1185/030079907X219715
   Woodhead JL, 2012, J PHARMACOL EXP THER, V342, P529, DOI 10.1124/jpet.112.192930
   Xie YC, 2014, TOXICOL APPL PHARM, V279, P266, DOI 10.1016/j.taap.2014.05.010
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09046-8
   Yarema MC, 2021, BRIT J CLIN PHARMACO, V87, P3332, DOI 10.1111/bcp.14755
   Yoon E, 2016, J CLIN TRANSL HEPATO, V4, P131, DOI 10.14218/JCTH.2015.00052
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   Zhu JW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58051-1
   Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574
NR 142
TC 4
Z9 4
U1 0
U2 3
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2056-7189
J9 NPJ SYST BIOL APPL
JI npj Syst. Biol. Appl.
PD AUG 6
PY 2022
VL 8
IS 1
AR 27
DI 10.1038/s41540-022-00238-5
PG 16
WC Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Mathematical & Computational Biology
GA 3O4HV
UT WOS:000836797300001
PM 35933513
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Liu, ZG
   Zhu, PT
   Zhang, L
   Xiong, B
   Tao, JH
   Guan, W
   Li, CL
   Chen, C
   Gu, JY
   Duanmu, JX
   Zhang, W
AF Liu, Zhaoguo
   Zhu, Pingting
   Zhang, Lin
   Xiong, Biao
   Tao, Jinhua
   Guan, Wei
   Li, Chunling
   Chen, Chang
   Gu, Jingya
   Duanmu, Jiaxin
   Zhang, Wei
TI Autophagy inhibition attenuates the induction of anti-inflammatory
   effect of catalpol in liver fibrosis
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Catalpol; Liver fibrosis; Autophagy; Inflammation; Molecular mechanism
ID HEPATIC STELLATE CELL; B SIGNALING PATHWAY; INFLAMMATION; ACTIVATION;
   ANGIOGENESIS; FIBROGENESIS; EXPRESSION; MOUSE; HEPATOCYTES; SENESCENCE
AB Autophagy has been regarded as an inflammation-associated defensive mechanism against chronic liver disease, which has been highlighted as a novel therapeutic target for the treatment of liver fibrosis. We herein aimed to study the effects of catalpol on liver fibrosis in vivo and in vitro, and to elucidate the role of autophagy in catalpol-induced anti-inflammation. Catalpol protected the liver against CCl4-induced injury, as evidenced by mitigated hepatic steatosis, necrosis, and fibrotic septa. Catalpol decreased the serum levels of alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase and bilirubin as well as the liver/body weight ratio. Masson and sirius red staining along with hydroxyproline detection showed that catalpol decreased collagen deposition significantly compared to that of the model group. Catalpol inhibited CCl4-induced liver fibrosis, manifested as decreased expressions of alpha-SMA, fibronectin and alpha 1(I)-procollagen at both transcriptional and translational levels. Inflammatory factors, such as IL-1 beta, TNF-alpha, IL-18, IL-6 and COX-2, were significantly elevated in rats receiving CCl4 and down-regulated by catalpol in a dose-dependent manner in vivo. Western blot and immunofluorescence assay revealed that catalpol activated the autophagy of rats with CCl4-caused liver fibrosis, as indicated by up-regulation of LC3-II and beclin1 and down-regulation of P62. The results of in vitro experiments were consistent. Interestingly, inhibition or depletion of autophagy by LY294002 or Atg5 siRNA significantly attenuated catalpol-induced anti-inflammatory effects on activated hepatic stellate cells in vitro. In conclusion, catalpol relieved liver fibrosis mainly by inhibiting inflammation, and autophagy inhibition attenuated the catalpol-induced anti-inflammatory effect on liver fibrosis.
C1 [Liu, Zhaoguo; Xiong, Biao; Tao, Jinhua; Guan, Wei; Li, Chunling; Chen, Chang; Gu, Jingya; Duanmu, Jiaxin; Zhang, Wei] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong Jiangsu 226001, Peoples R China.
   [Zhu, Pingting] Yangzhou Univ, Sch Nursing, 88 South Univ Ave, Yangzhou 225009, Jiangsu, Peoples R China.
   [Zhang, Lin] Nantong Univ, Maternal & Child Hlth Care Hosp, Dept Pharm, Nantong 226001, Peoples R China.
   [Liu, Zhaoguo; Xiong, Biao; Tao, Jinhua; Guan, Wei; Li, Chunling; Chen, Chang; Gu, Jingya; Zhang, Wei] Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University; Yangzhou University; Nantong University
RP Liu, ZG (corresponding author), Nantong Univ, Sch Pharm, Dept Pharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.; Zhang, W (corresponding author), Nantong Univ, Coll Pharm, Dept Pharmacol, 19 QiXiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM lzg871014@ntu.edu.cn; zhangw@ntu.edu.cn
FU National Natural Science Foundation of China [81703884, 81670243,
   81403260]; Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China [17KJB360012, 17KJB360015]; Natural Science
   Foundation of Jiangsu Province [BK20140493, BK20151276]; China
   Postdoctoral Science Foundation [2014M551639]; Postdoctoral Funding in
   Jiangsu Province [1401138C]; Technical Project of Yangzhou City
   [YZ2017090]; Nantong University Cooperative Innovation Program of Small
   Molecular Compound RD [2016-1]; Undergraduate Innovation Project of
   Nantong University [2017185]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81703884; 81670243; 81403260); the Natural Science Foundation
   of the Jiangsu Higher Education Institutions of China (No. 17KJB360012;
   17KJB360015); Natural Science Foundation of Jiangsu Province (No.
   BK20140493; BK20151276); China Postdoctoral Science Foundation (No.
   2014M551639); Postdoctoral Funding in Jiangsu Province (No.1401138C);
   The Technical Project of Yangzhou City(YZ2017090); Nantong University
   Cooperative Innovation Program of Small Molecular Compound R&D (No.
   2016-1); the Undergraduate Innovation Project of Nantong University (No.
   2017185).
CR Akcora BÖ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44545
   [Anonymous], J HEPATOL
   Bai FC, 2018, INT IMMUNOPHARMACOL, V54, P60, DOI 10.1016/j.intimp.2017.10.028
   Bai FC, 2017, CELL PHYSIOL BIOCHEM, V44, P436, DOI 10.1159/000485009
   Bao QW, 2016, KOREAN J PHYSIOL PHA, V20, P153, DOI 10.4196/kjpp.2016.20.2.153
   Cao FY, 2018, INT IMMUNOPHARMACOL, V55, P183, DOI 10.1016/j.intimp.2017.12.023
   Cao Q, 2018, TOXICOL APPL PHARM, V339, P143, DOI 10.1016/j.taap.2017.12.007
   Chen GT, 2017, NAT PROD RES, V31, P1880, DOI 10.1080/14786419.2016.1263850
   Chen RJ, 2015, ARCH TOXICOL, V89, P1727, DOI 10.1007/s00204-015-1525-6
   Chen YY, 2017, INT IMMUNOPHARMACOL, V43, P140, DOI 10.1016/j.intimp.2016.12.011
   Codogno P, 2013, J HEPATOL, V59, P389, DOI 10.1016/j.jhep.2013.02.031
   Cui L, 2014, J PHARM PHARMACOL, V66, P1615, DOI 10.1111/jphp.12283
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Deng W, 2017, CANCER BIOMARK, V20, P411, DOI 10.3233/CBM-170157
   Elswefy SES, 2016, INT J EXP PATHOL, V97, P369, DOI 10.1111/iep.12207
   Ferreira DW, 2016, BBA-MOL BASIS DIS, V1862, P662, DOI 10.1016/j.bbadis.2016.02.001
   Gan F, 2018, LIFE SCI, V192, P205, DOI 10.1016/j.lfs.2017.11.047
   Gan L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01507
   Greuter T, 2016, J GASTROENTEROL, V51, P511, DOI 10.1007/s00535-016-1190-4
   Han M, 2017, TOXICOL LETT, V273, P10, DOI 10.1016/j.toxlet.2017.03.013
   Jaquet A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21424
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Joven J, 2014, ADV EXP MED BIOL, V824, P43, DOI 10.1007/978-3-319-07320-0_6
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Li X, 2016, TOXICOL LETT, V261, P1, DOI 10.1016/j.toxlet.2016.09.002
   Liang YR, 2017, NEUROTOXICOLOGY, V63, P137, DOI 10.1016/j.neuro.2017.09.015
   Lodder J, 2015, AUTOPHAGY, V11, P1280, DOI 10.1080/15548627.2015.1058473
   Luo L, 2017, EUR J PHARMACOL, V807, P109, DOI 10.1016/j.ejphar.2017.03.047
   Luo L, 2017, EXP TOXICOL PATHOL, V69, P73, DOI 10.1016/j.etp.2016.11.005
   Mallat A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869390
   Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022
   Nallagangula KS, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0083
   Oró D, 2016, J HEPATOL, V64, P691, DOI 10.1016/j.jhep.2015.10.020
   Park KS, 2016, J NAT MED-TOKYO, V70, P620, DOI 10.1007/s11418-016-0988-y
   Peng Y, 2016, ACTA PHARMACOL SIN, V37, P204, DOI 10.1038/aps.2015.129
   Qiang L, 2017, AUTOPHAGY, V13, P2086, DOI 10.1080/15548627.2017.1380757
   Rahmat AA, 2014, PHARMACOGN RES, V6, P19, DOI 10.4103/0974-8490.122913
   Shen X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01450
   Tanaka M, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0025-2
   Wang B., 2017, ONCOTARGET, V8
   Wang XH, 2017, INFLAMMATION, V40, P840, DOI 10.1007/s10753-017-0528-2
   Yuan Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04374-5
   Zhai XG, 2015, EUR J PHARMACOL, V746, P56, DOI 10.1016/j.ejphar.2014.10.055
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang F, 2013, APOPTOSIS, V18, P135, DOI 10.1007/s10495-012-0791-5
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021
   Zhang ZL, 2016, FREE RADICAL BIO MED, V101, P272, DOI 10.1016/j.freeradbiomed.2016.10.498
   Zhao SF, 2017, BIOMED PHARMACOTHER, V86, P521, DOI 10.1016/j.biopha.2016.11.122
   Zhu HF, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-016-0096-7
   Zhu PT, 2017, BIOMED PHARMACOTHER, V95, P68, DOI 10.1016/j.biopha.2017.08.049
NR 52
TC 47
Z9 51
U1 2
U2 25
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUL
PY 2018
VL 103
BP 1262
EP 1271
DI 10.1016/j.biopha.2018.04.156
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GH3UW
UT WOS:000433328800148
PM 29864907
DA 2024-02-19
ER

PT J
AU Zhang, WX
   Hao, HY
   Sha, AL
AF Zhang, Weixin
   Hao, Haiyan
   Sha, Ailong
TI Effects of the <i>Coreopsis</i> <i>tinctoria</i> extracts on anti-aging
   in the aging model mice
SO INDIAN JOURNAL OF ANIMAL RESEARCH
LA English
DT Article
DE Aging model mice; Anti-aging; Antioxidase; Coreopsis tinctoria extracts
ID ANTIOXIDANT; FLAVONOIDS; BUDS
AB The effects of the Coreopsis tinctoria extracts on anti-aging were observed by investigating the cerebral index and viscera indexes, the contents of hydrogen peroxide (H2O2) and malondialdehyde (MDA) in the serums, the activities of glutathione peroxidase (GSH-Px) in the brain tissues and the ones of catalase (CAT) and superoxide dismutase (SOD) in the liver tissues of the aging model mice. The aging model mice were injected subcutaneously with D-galactose in vivo and intragastric administrated with the Coreopsis tinctoria extracts at doses of low (0.5g/kg), medium (1g/ kg) and high (2g/ kg) once daily for 6 weeks. The results showed that all the cerebral index, spleen index, thymus index, liver index and kidney index of the three groups dosed of the Coreopsis tinctoria extracts increased, the activities of GSH-Px in the brain tissues and the ones of CAT and SOD in the liver tissues increased to different degree while the contents of H2O2 and MDA in the serums decreased extremely and significantly (P<0.01) compared with the aging model mice. All of these results suggested that the Coreopsis tinctoria extracts might possess anti-aging effects by improving antioxidant capacity of the mice.
C1 [Zhang, Weixin; Hao, Haiyan; Sha, Ailong] Tarim Univ, Coll Anim Sci, Alar 843300, Xinjiang, Peoples R China.
   [Hao, Haiyan] Southwest Med Univ, Drug Discovery Res Ctr, Luzhou 646000, Sichuan, Peoples R China.
C3 Tarim University; Southwest Medical University
RP Sha, AL (corresponding author), Southwest Med Univ, Dept Physiol, Luzhou 646000, Sichuan, Peoples R China.
EM lyshaailong@163.com
FU National Natural Science Foundation of China [31260604]; Tarim
   University Student Innovation Program [TDZGCX11007]; Startup Fund for
   Talented Scholars of Luzhou Medical College [2014YJRC04]
FX The authors are pleased to acknowledge the financial support of this
   research by National Natural Science Foundation of China (31260604),
   Tarim University Student Innovation Program (TDZGCX11007) and Startup
   Fund for Talented Scholars of Luzhou Medical College (2014YJRC04).
CR Dias T, 2010, J ETHNOPHARMACOL, V132, P483, DOI 10.1016/j.jep.2010.08.048
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Guo LM, 2015, J FUNCT FOODS, V13, P11, DOI 10.1016/j.jff.2014.11.011
   Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2
   Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Li N, 2015, J FUNCT FOODS, V17, P837, DOI 10.1016/j.jff.2015.06.027
   Li YL, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-193
   Liang S.H., 2010, CHIN J EXPT TRADIT M, V6, P234
   Liang S.H., 2009, J NONGKEN MED, V31, P495
   [梁淑红 Liang Shuhong], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P1619
   Liu DongMei, 2015, Journal of Chemical and Pharmaceutical Research, V7, P386
   Liu GS, 2012, LIFE SCI, V91, P872, DOI 10.1016/j.lfs.2012.08.033
   Lü JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   [毛新民 Mao Xinmin], 2014, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V30, P78
   Ming T., 2012, CHIN J EXPT TRADIT M, V18, P249
   Okada Y, 2014, NAT PROD RES, V28, P201, DOI 10.1080/14786419.2013.856905
   Sun YH, 2013, PHARM BIOL, V51, P1158, DOI 10.3109/13880209.2013.782320
   Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3
   Wang W, 2015, J AGR FOOD CHEM, V63, P200, DOI 10.1021/jf504289g
   Yang Q, 2014, CHIN HERB MED, V6, P103, DOI 10.1016/S1674-6384(14)60015-0
   Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015
   Yao XC, 2016, NAT PROD RES, V30, P429, DOI 10.1080/14786419.2015.1015019
   Yu L.J., 2015, CLIN EXP PHARMACOL P, V5, P1
   Zalaru C, 2014, CENT EUR J CHEM, V12, P858, DOI 10.2478/s11532-014-0539-x
   Zhang S.P., 2011, CHIN J EXPT TRADIT M, V17, P166
   Zhang ShuPeng, 2011, Progress in Modern Biomedicine, V11, P1055
   Zhang Y, 2013, FITOTERAPIA, V87, P93, DOI 10.1016/j.fitote.2013.03.024
NR 29
TC 5
Z9 8
U1 0
U2 27
PU AGRICULTURAL RESEARCH COMMUNICATION CENTRE
PI KARNAL
PA 1130 SADAR BAZAR, POST OFFICE MARG, KARNAL 132 001, INDIA
SN 0367-6722
J9 INDIAN J ANIM RES
JI Indian J. Anim. Res.
PD OCT
PY 2016
VL 50
IS 5
BP 769
EP 772
DI 10.18805/ijar.9630
PG 4
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA EE0VD
UT WOS:000389296100024
DA 2024-02-19
ER

PT J
AU Teillet, L
   Gouraud, S
   Preisser, L
   Tordjmann, T
   Morel, A
   Corman, B
AF Teillet, L
   Gouraud, S
   Preisser, L
   Tordjmann, T
   Morel, A
   Corman, B
TI Glucagon and vasopressin V1a receptor signaling in hepatocytes from
   aging rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE V1a receptors; glucagon; hepatocytes; aging
ID PROTEIN-KINASE-C; ADENYLATE-CYCLASE; LIVER; GLYCOGENOLYSIS; GLYCATION;
   AGE; DESENSITIZATION; ACCUMULATION; STIMULATION; EXPRESSION
AB Glucose tolerance is reduced with age. The relationship between this change in glucose homeostasis and signaling of glucagon and vasopressin V1a receptors was investigated in hepatocytes isolated from 10- and 30-month-old female WAG/Rij rats. Binding capacity of hepatocytes for I-125 glucagon and H-3 vasopressin increased 2- and 1.8-fold, respectively, between 10 and 30 months. Intracellular cAMP accumulation induced by glucagon was 40% greater in,hepatocytes of aging rats than of adults, although EC,, were similar in the two groups. Conversely, phosphodiesterases activity and nucleotides leakage out of the cells were unchanged with age. The rise in intracellular calcium consecutive to the stimulation of Via receptor was comparable in adult and senescent animals. Finally, glucose release by hepatocyte suspensions was greater in senescent than in adult animals in absence as in presence of glucagon. These experiments suggest that increase in glucagon receptor expression and cAMP generation would contribute to the impaired glucose tolerance characteristic of the aging process. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 CEA Saclay, Serv Biol Cellulaire, F-91191 Gif Sur Yvette, France.
   Hop St Perine, APHP, F-75016 Paris, France.
   Univ Paris Sud, INSERM U442, F-91405 Orsay, France.
   Univ Angers, F-49000 Angers, France.
C3 Universite Paris Saclay; CEA; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire
   Sainte-Perine - APHP; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Saclay; Universite d'Angers
RP Corman, B (corresponding author), CEA Saclay, Serv Biol Cellulaire, F-91191 Gif Sur Yvette, France.
RI Morel, Alain/AAU-7496-2021; Tordjmann, Thierry/K-4706-2013; Gouraud,
   Sabine S. S/N-3395-2018
OI Gouraud, Sabine S. S/0000-0002-4917-0647; morel,
   alain/0000-0003-0125-1883
CR BAKALA H, 1995, MECH AGEING DEV, V78, P63, DOI 10.1016/0047-6374(94)01527-S
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BERTHON B, 1984, FEBS LETT, V167, P19, DOI 10.1016/0014-5793(84)80824-8
   BORST SE, 1994, J GERONTOL, V49, pB18, DOI 10.1093/geronj/49.1.B18
   BURECK JD, 1978, PATHOLOGY AGING RATS
   Chabardès D, 1999, CELL SIGNAL, V11, P651, DOI 10.1016/S0898-6568(99)00031-5
   CHRISTOPHE J, 1995, BBA-REV BIOMEMBRANES, V1241, P45, DOI 10.1016/0304-4157(94)00015-6
   COMBETTES L, 1986, BIOCHEM J, V237, P675, DOI 10.1042/bj2370675
   CORMAN B, 1987, AM J PHYSIOL, V253, pR555, DOI 10.1152/ajpregu.1987.253.4.R555
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   Exton J H, 1970, Recent Prog Horm Res, V26, P411
   GEELEN G, 1992, AM J PHYSIOL, V262, P826
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   Halter Jeffrey B., 1995, P119
   HAYASHI K, 1982, GERONTOLOGY, V28, P10, DOI 10.1159/000212506
   HEMS DA, 1973, BIOCHEM J, V136, P705, DOI 10.1042/bj1360705
   HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x
   JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KLUG TL, 1979, BIOCHEM BIOPH RES CO, V89, P907, DOI 10.1016/0006-291X(79)91864-3
   MORGAN N, 1983, FEBS LETT, V162, P277
   MURPHY GJ, 1987, BIOCHEM J, V243, P39, DOI 10.1042/bj2430039
   PRADELLES P, 1989, ANAL CHEM, V61, P447, DOI 10.1021/ac00180a014
   SAVAGE A, 1995, BIOCHEM J, V307, P281, DOI 10.1042/bj3070281
   SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1
   TANG EKY, 1992, BIOCHEM J, V283, P341, DOI 10.1042/bj2830341
   Teillet L, 2000, J AM SOC NEPHROL, V11, P1488, DOI 10.1681/ASN.V1181488
   Tordjmann T, 1996, GASTROENTEROLOGY, V111, P1343, DOI 10.1053/gast.1996.v111.pm8898649
   TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325
   VANERMEN A, 1994, J GERONTOL, V49, pB12, DOI 10.1093/geronj/49.1.B12
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804
   YU BP, 1984, MECH AGEING DEV, V24, P67
NR 36
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD APR 15
PY 2001
VL 122
IS 4
BP 385
EP 400
DI 10.1016/S0047-6374(00)00251-7
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 412WU
UT WOS:000167578000003
PM 11240161
DA 2024-02-19
ER

PT J
AU Pasquaré, SJ
   de Boschero, MGI
   Giusto, NM
AF Pasquaré, SJ
   de Boschero, MGI
   Giusto, NM
TI Aging promotes a different phosphatidic acid utilization in cytosolic
   and microsomal fractions from brain and liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; brain; diacylglycerol; liver; phosphatidate phosphohydrolase;
   phosphatidic acid
ID PROTEIN-KINASE-C; RAT-LIVER; SUBCELLULAR-DISTRIBUTION; GLYCEROLIPID
   SYNTHESIS; PHOSPHOHYDROLASE; TRANSLOCATION; ACTIVATION; TISSUE;
   PHOSPHATIDYLCHOLINE; METABOLISM
AB Among the morphological and biochemical changes taking place in the membranes of aged tissues, we reported in previous studies on alterations in phospholipid synthesis and phospholipid-specific fatty acid composition. Phosphatidic acid (PA) and diacylglycerol (DAG) are central intermediates in phosphoglyceride and neutral lipid biosynthetic pathways and have also recently been implicated in signal transduction. The present paper shows the effect of aging on phosphatidate. phosphohydrolase (PAPase) activiy, which operates on phosphatidic acid to synthesize diacylglycerol. Two forms of mammalian PAPase can be indentified on the basis of subcellular localization and enzyme properties, one involved predominantly in lipid synthesis (PAP 1) and the other in signal transduction (PAP 2). Microsomal and cytosolic fractions of brain and liver from 3.5-month-old (adult) and 28.5-month-old (aged) rats were used. PAPase isoform activities were differentiated on the basis of N-ethylmaleimide (NEM) sensitivity and Mg2+-dependency. Our results demonstrate that aging caused PAP 2 to increase in brain microsomal. fractions but did not affect PAP 1, whereas in brain cytosolic fractions, it caused a strong decrease in PAP 1 (57%). The distribution of enzymes between microsomes and cytosol changed in aged rats with respect to adult rats, showing a translocation of PAP 1 from cytosol to microsomes. In addition, an increase in the production of monoacylglycerol (MAG) was observed in microsomes from aged brain. PAP 2 activity in liver microsomal fractions from aged rats showed no changes with respect to adult rats whereas PAP 1 activity increased 228% in microsomal fractions and 76% in cytosolic fractions in this tissue. The distribution of PAP I activity between microsomal and cytosolic fractions in liver tissue was also affected in aged rats, indicating a translocation of this form of the enzyme from cytosolic to microsomal fractions. The production of monoacylglycerol in liver microsomes also increased, whereas there was a decrease in MAG formation from cytosolic fraction. The changes observed in the two PAPase forms in brain and liver of aged rats with respect to adult rats suggest that PA is differently utilized by the PAPase isoforms, probably generating aging-related DAGs different to those present in adults and required for specific cellular functions. The changes observed in liver PAP 1 from aged with respect to adult rats suggest that such changes could be related with modifications in lipid homeostasis induced by age-altered hormonal balance. However, PA-modified utilization during acina throuah PAP 2 activity could be related to alterations in neural signal transduction mechanisms. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Univ Nacl Sur, Inst Invest Bioquim, Bahia Blanca, Buenos Aires, Argentina.
   Consejo Nacl Invest Cient & Tecn, Bahia Blanca, Buenos Aires, Argentina.
C3 National University of the South; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET)
RP Giusto, NM (corresponding author), Univ Nacl Sur, Inst Invest Bioquim, CC 857, Bahia Blanca, Buenos Aires, Argentina.
EM ngiusto@criba.edu.ar
CR ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x
   Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937
   BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281
   Brindley DN, 1996, BIOCHEM CELL BIOL, V74, P469, DOI 10.1139/o96-051
   BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8
   BRUCE M, 1985, LIFE SCI, V37, P1403
   BRUNETTI M, 1979, LIPIDS, V14, P925, DOI 10.1007/BF02533507
   BUTTERWITH SC, 1984, BIOCHEM J, V222, P487, DOI 10.1042/bj2220487
   CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911
   CASCALES C, 1988, BIOCHIM BIOPHYS ACTA, V963, P384, DOI 10.1016/0005-2760(88)90305-0
   COLEMAN R, 1963, BIOCHIM BIOPHYS ACTA, V73, P257
   de Boschero MGI, 2000, EXP GERONTOL, V35, P653, DOI 10.1016/S0531-5565(00)00104-2
   de Boschero MGI, 2000, NEUROCHEM RES, V25, P875, DOI 10.1023/A:1007581810975
   DEGARCIA SJP, 1986, BIOCHIM BIOPHYS ACTA, V875, P195, DOI 10.1016/0005-2760(86)90168-2
   DOBRETSOV GE, 1977, FEBS LETT, V84, P125, DOI 10.1016/0014-5793(77)81071-5
   English D, 1997, BIOCHEM J, V324, P941, DOI 10.1042/bj3240941
   Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49
   FLEMING IN, 1995, BBA-LIPID LIPID MET, V1254, P161, DOI 10.1016/0005-2760(94)00179-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GAITI A, 1979, B MOL BIOL MED, V4, P24
   GIUSTO NM, 1979, EXP EYE RES, V29, P155, DOI 10.1016/0014-4835(79)90081-2
   GOLDBERG DM, 1983, ENZYME, V30, P59, DOI 10.1159/000469546
   HANNUN YA, 1994, J BIOL CHEM, V269, P3125
   Higgins J, 1999, METABOLISM, V48, P1445, DOI 10.1016/S0026-0495(99)90157-9
   Hodges T K, 1974, Methods Enzymol, V32, P392
   Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9
   IDE H, 1985, J BIOCHEM-TOKYO, V97, P45, DOI 10.1093/oxfordjournals.jbchem.a135067
   ISHIZUKA T, 1993, METABOLISM, V42, P420, DOI 10.1016/0026-0495(93)90097-8
   JAMAL Z, 1991, J BIOL CHEM, V266, P2988
   JAMDAR SC, 1994, BIOCHEM J, V301, P793, DOI 10.1042/bj3010793
   JOHNSON NL, 1969, DISTRIBUTIONS STAT, P29
   Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572
   KATES M, 1969, METHOD ENZYMOL, V14, P197
   KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3
   LAWSON N, 1982, FEBS LETT, V146, P204, DOI 10.1016/0014-5793(82)80736-9
   LOPEZ GH, 1995, COMP BIOCH PHYSL, V112, P231
   MARTIN A, 1991, METHOD ENZYMOL, V197, P553
   MARTIN A, 1993, J BIOL CHEM, V268, P23924
   MARTINSANZ P, 1985, FEBS LETT, V179, P262, DOI 10.1016/0014-5793(85)80531-7
   MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8
   Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708
   PASQUARE SJ, 1993, COMP BIOCHEM PHYS B, V104, P141, DOI 10.1016/0305-0491(93)90350-E
   Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207
   Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059
   ROTSTEIN NP, 1987, LIPIDS, V22, P253, DOI 10.1007/BF02533988
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   SAVOLAINEN MJ, 1981, METABOLISM, V30, P706, DOI 10.1016/0026-0495(81)90087-1
   Singer SS, 1996, J AM COLL NUTR, V15, P169
   Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   STURTON RG, 1980, BIOCHIM BIOPHYS ACTA, V619, P494, DOI 10.1016/0005-2760(80)90101-0
   Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3
   VASWANI KK, 1989, J NEUROSCI RES, V24, P431, DOI 10.1002/jnr.490240313
   WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8
   YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P315
   YOUWEI J, 1996, J BIOL CHEM, V271, P29529
NR 58
TC 17
Z9 19
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2001
VL 36
IS 8
BP 1387
EP 1401
DI 10.1016/S0531-5565(01)00106-1
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 470BM
UT WOS:000170850600012
PM 11602212
OA Green Published
DA 2024-02-19
ER

PT J
AU Yoshino, K
   Hamzaoui, Y
   Yoh, T
   Ftériche, FS
   Aussilhou, B
   Beaufrère, A
   Belghiti, J
   Soubrane, O
   Cauchy, F
   Dokmak, S
AF Yoshino, Kenji
   Hamzaoui, Yanis
   Yoh, Tomoaki
   Fteriche, Fadhel Samir
   Aussilhou, Beatrice
   Beaufrere, Aurelie
   Belghiti, Jacques
   Soubrane, Olivier
   Cauchy, Francois
   Dokmak, Safi
TI Liver resection for octogenarians in a French center: prolonged hepatic
   pedicle occlusion and male sex increase major complications
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Article; Early Access
DE Liver resections; Hepatectomy; Octogenerians; Elderly patients; Over 80
   years
ID LONG-TERM OUTCOMES; SUPER-ELDERLY PATIENTS; HEPATOCELLULAR-CARCINOMA;
   SURGICAL-TREATMENT; COLORECTAL-CANCER; RISK-FACTORS; DONOR AGE;
   HEPATECTOMY; METASTASES; SURGERY
AB Purpose The prolonged life expectancy and increase in aging of the population have led surgeons to propose hepatectomy in the elderly population. In this study, we evaluate the surgical outcome of octogenarians in a single French center. Methods Between 2000 and 2020, 78 patients over 80 years old were retrospectively analyzed. The risk factors of major complications (Clavien-Dindo >= grade IIIa) and patient performance after surgery by using textbook outcome (TO) (no surgical complications, no prolonged hospital stay (<= 15 days), no readmission <= 90 days after discharge, and no mortality <= 90 days after surgery) were studied. Results The main surgical indication was for malignancy (96%), including mainly colorectal liver metastases (n = 41; 53%) and hepatocellular carcinoma (n = 22; 28%), and major hepatectomy was performed in 28 patients (36%). There were 6 (8%) postoperative mortalities. The most frequent complications were pulmonary (n = 22; 32%), followed by renal insufficiency (n = 22; 28%) and delirium (n = 16; 21%). Major complications occurred in 19 (24%) patients. On multivariate analysis, the main risk factors for major complications were the median vascular clamping time (0 vs 35; P = 0.04) and male sex (P = 0.046). TO was ultimately achieved in 30 patients (38%), and there was no prognostic factor for achievement of TO. Conclusions Hepatectomy in octogenarians is associated with acceptable morbidity and mortality. Meanwhile, prolonged hepatic pedicle clamping should be avoided especially if hepatectomy is planned in a male patient.
C1 [Yoshino, Kenji; Hamzaoui, Yanis; Yoh, Tomoaki; Fteriche, Fadhel Samir; Aussilhou, Beatrice; Belghiti, Jacques; Soubrane, Olivier; Cauchy, Francois; Dokmak, Safi] Univ Paris, Hop Beaujon, AP HP, Dept HPB Surg & Liver Transplantat,DMU DIGEST, 100 Blvd Gen Leclerc, F-92100 Clichy, France.
   [Beaufrere, Aurelie] Univ Paris, Hop Beaujon, AP HP, Dept Pathol, Clichy, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire Beaujon -
   APHP; Hopital Universitaire Paul-Brousse - APHP; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP;
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital
   Universitaire Beaujon - APHP
RP Dokmak, S (corresponding author), Univ Paris, Hop Beaujon, AP HP, Dept HPB Surg & Liver Transplantat,DMU DIGEST, 100 Blvd Gen Leclerc, F-92100 Clichy, France.
EM safi.dokmak@aphp.fr
RI Beaufrère, Aurélie/AGY-2787-2022; YOH, Tomoaki/AAD-4872-2022; Soubrane,
   Olivier/ABB-4434-2021; François, Cauchy/J-7031-2019
OI YOH, Tomoaki/0000-0001-6518-2077; François, Cauchy/0000-0002-4997-3730
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   Akashi K, 2018, SURGERY, V164, P1023, DOI 10.1016/j.surg.2018.05.051
   Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e
   Cassuto JR, 2008, J SURG RES, V148, P38, DOI 10.1016/j.jss.2008.03.018
   Cauchy F, 2013, BRIT J SURG, V100, P113, DOI 10.1002/bjs.8963
   Choi Seong Woon, 2016, Ann Hepatobiliary Pancreat Surg, V20, P153, DOI 10.14701/ahbps.2016.20.4.153
   Cook EJ, 2012, COLORECTAL DIS, V14, P1210, DOI 10.1111/j.1463-1318.2012.02946.x
   De Blasi V, 2018, DIGEST SURG, V35, P333, DOI 10.1159/000486522
   Dokmak S, 2013, HPB, V15, P908, DOI 10.1111/hpb.12069
   Etele ÉE, 2019, CHIRURGIA-BUCHAREST, V114, P331, DOI 10.21614/chirurgia.114.3.331
   Figueras J, 2007, CLIN TRANSL ONCOL, V9, P392, DOI 10.1007/s12094-007-0072-x
   Fukuoka K, 2017, WORLD J SURG, V41, P1073, DOI 10.1007/s00268-016-3724-6
   Gandy RC, 2018, ANZ J SURG, V88, pE103, DOI 10.1111/ans.13690
   Ghinolfi D, 2018, ANN SURG, V268, P325, DOI 10.1097/SLA.0000000000002305
   Gong C, 2017, INT J SURG, V44, P110, DOI 10.1016/j.ijsu.2017.06.050
   Gupta AK, 2018, ANZ J SURG, V88, pE756, DOI 10.1111/ans.14475
   Hamaoka M, 2017, J HEPATO-BIL-PAN SCI, V24, P58, DOI 10.1002/jhbp.413
   Horiuchi T, 2019, ANTICANCER RES, V39, P5143, DOI 10.21873/anticanres.13709
   Kirchhoff P, 2008, ANN SURG, V248, P259, DOI 10.1097/SLA.0b013e31817bbe3a
   Kolfschoten NE, 2013, EJSO-EUR J SURG ONC, V39, P156, DOI 10.1016/j.ejso.2012.10.007
   Lallement M, 2020, J VISC SURG, V157, P379, DOI 10.1016/j.jviscsurg.2020.01.001
   Leal JN, 2017, HPB, V19, P162, DOI 10.1016/j.hpb.2016.09.009
   Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007
   Merath K, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.0571
   Merath K, 2020, ANN SURG, V271, P1116, DOI 10.1097/SLA.0000000000003105
   Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002
   Nanashima A, 2011, J SURG ONCOL, V104, P284, DOI 10.1002/jso.21932
   Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279
   Nomi T, 2020, SURG ENDOSC, V34, P658, DOI 10.1007/s00464-019-06812-z
   Nozawa A, 2015, SURG TODAY, V45, P851, DOI 10.1007/s00595-014-0994-1
   Okamura Y, 2018, EUR SURG RES, V59, P380, DOI 10.1159/000494733
   Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d
   Phan K, 2015, ANZ J SURG, V85, P815, DOI 10.1111/ans.13211
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048
   Reese PP, 2008, TRANSPLANTATION, V85, P1737, DOI 10.1097/TP.0b013e3181722f75
   Riffat F, 2006, HPB, V8, P206, DOI 10.1080/13651820500497173
   Shimada S, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01899-4
   Shin J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016150
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   Strasberg SM, 2005, J HEPATO-BILIARY-PAN, V12, P351, DOI 10.1007/s00534-005-0999-7
   Takahashi H, 2010, HEPATOL RES, V40, P997, DOI 10.1111/j.1872-034X.2010.00713.x
   Takahashi Y, 2013, J HEPATO-BIL-PAN SCI, V20, P324, DOI 10.1007/s00534-012-0529-3
   Wu CC, 1999, SURGERY, V125, P332, DOI 10.1016/S0039-6060(99)70245-X
   Yamada S, 2012, HEPATOL RES, V42, P454, DOI 10.1111/j.1872-034X.2011.00952.x
NR 45
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1435-2443
EI 1435-2451
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD 2021 AUG
PY 2021
VL 406
IS 5
BP 1543
EP 1552
DI 10.1007/s00423-021-02210-z
EA MAY 2021
PG 10
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA UC6EL
UT WOS:000656443000001
PM 34057599
DA 2024-02-19
ER

PT J
AU Sha, AL
   Hao, HY
   Wang, NN
AF Sha, Ailong
   Hao, Haiyan
   Wang, Nana
TI Anti-fatigue and Anti-aging Effects of <i>Coreopsis tinctoria</i>
   Flavonoids in Mice
SO LATIN AMERICAN JOURNAL OF PHARMACY
LA English
DT Article
DE aging model mice; anti-aging; anti-fatigue; antioxidase; Coreopsis
   tinctoria flavonoids; weight-bearing swimming
ID ANTIOXIDANT; NUTT.; EXTRACTS; BUDS
AB The objectives of this study were to observe the effects of the Coreopsis tinctoria flavonoids (CTFs) on anti-fatigue in common mice and anti-aging in the aging model mice. The common mice were randomly divided into CTFs-treated groups of low (100mg/kg.d), medium (200 mg/kg.d), and high (400 mg/ kg.d) dose and the control group, all the mice were intragastric administration once daily for 21 days. The anti-fatigue effects of the CTFs were designed by using the weight-bearing swimming experiment in mice and then the determination of the serum urea nitrogen (SUN), blood lactic acid (BLA), hepatic glycogen (HGn) and muscle glycogen (MGn) in mice after exercise. The anti-aging effect of the CTFs was investigated by the aging model mice induced by D-galactose. The study was carried out to investigate the immune organ indexes, cerebral index (CI), the contents of malondialdehyde (MDA) in the serums, hydroxy radical (center dot OH) in the liver tissues, hydrogen peroxide (H2O2) in the brain tissues, and the activities of superoxide dismutase (SOD) and catalase (CAT) in the liver tissues of the aging mice administered with D-galactose in vivo by subcutaneous injection together with the CTFs at the three doses mentioned before by intragastric administration once daily for 6 weeks. The anti-fatigue results showed that the CTFs could considerably prolong the weight-bearing swimming time, decrease the contents of the BLA and SUN, and increase the contents of the MGn and HGn after exercise compared with those of the control group. And then these results suggested that the CTFs can enhance the anti-fatigue ability of mice. The anti-aging results showed that the three doses of the CTFs could all decrease the contents of H2O2 in the brain tissues, center dot OH in the liver tissues and MDA in the serums, increase the CI, spleen index (SI), thymus index (TI) and the activities of SOD and CAT in the liver tissues very significant (p < 0.01) compared with those of the aging mice. The above results suggested that the CTFs might have anti-aging effects by improving the human body's antioxidant capacity.
C1 [Sha, Ailong] Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
   [Hao, Haiyan] Chongqing Three Gorges Univ, Sch Environm & Chem Engn, Chongqing 404120, Peoples R China.
   [Wang, Nana] Lanling Cty Peoples Hosp, Dept Clin Pharm, Lanling 277700, Shandong, Peoples R China.
C3 Chongqing Three Gorges University; Chongqing Three Gorges University
RP Sha, AL (corresponding author), Chongqing Three Gorges Univ, Sch Teacher Educ, Chongqing 404120, Peoples R China.
RI wang, na/HSF-2140-2023; long, chen/JVM-8568-2024; wang,
   yixuan/JGM-3893-2023; Zhang, Liqun/JDN-3523-2023
FU Sichuan Education Department of China [18ZB0636, 17ZB0469]; Science and
   technology research project of Chongqing Education Commission
   [KJQN201901235, KJQN20201226, KJQN202101247]
FX The authors are pleased to acknowledge the financial support of this
   research by Sichuan Education Department of China (18ZB0636, 17ZB0469),
   Science and technology research project of Chongqing Education
   Commission (KJQN201901235, KJQN20201226, KJQN202101247).
CR Dias T, 2010, J ETHNOPHARMACOL, V132, P483, DOI 10.1016/j.jep.2010.08.048
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Guo MJ, 2015, REPROD BIOL ENDOCRIN, V13, P1, DOI 10.1186/s12958-015-0013-4
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2
   Hou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45705
   Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Li N, 2015, J FUNCT FOODS, V17, P837, DOI 10.1016/j.jff.2015.06.027
   Li YL, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-193
   Liang S.H., 2010, CHIN J EXPT TRADIT M, V6, P234
   Liang S.H., 2009, J NONGKEN MED, V31, P495
   [梁淑红 Liang Shuhong], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P1619
   Limoli CL, 2001, FREE RADICAL BIO MED, V31, P10, DOI 10.1016/S0891-5849(01)00542-1
   Liu DongMei, 2015, Journal of Chemical and Pharmaceutical Research, V7, P386
   Liu GS, 2012, LIFE SCI, V91, P872, DOI 10.1016/j.lfs.2012.08.033
   Liu X., 2014, Mod. Food Sci. Technol, V30, P25
   Lü JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   [毛新民 Mao Xinmin], 2014, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V30, P78
   Ming T., 2012, CHIN J EXPT TRADIT M, V18, P249
   Okada Y, 2014, NAT PROD RES, V28, P201, DOI 10.1080/14786419.2013.856905
   Sun YH, 2013, PHARM BIOL, V51, P1158, DOI 10.3109/13880209.2013.782320
   Tan W, 2012, INT J BIOL MACROMOL, V50, P59, DOI 10.1016/j.ijbiomac.2011.09.019
   Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3
   Wang W, 2015, J AGR FOOD CHEM, V63, P200, DOI 10.1021/jf504289g
   Yang Q, 2014, CHIN HERB MED, V6, P103, DOI 10.1016/S1674-6384(14)60015-0
   Yao DC, 2005, FREE RADICAL BIO MED, V39, P1385, DOI 10.1016/j.freeradbiomed.2005.07.015
   Yao XC, 2016, NAT PROD RES, V30, P429, DOI 10.1080/14786419.2015.1015019
   [俞浩 Yu Hao], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P365
   Yu L.J., 2015, CLIN EXP PHARMACOL P, V5, P1
   Zalaru C, 2014, CENT EUR J CHEM, V12, P858, DOI 10.2478/s11532-014-0539-x
   Zhang S.P., 2011, CHIN J EXPT TRADIT M, V17, P166
   Zhang ShuPeng, 2011, Progress in Modern Biomedicine, V11, P1055
   Zhang Y, 2016, IRAN J BASIC MED SCI, V19, P1016
   Zhang Y, 2013, FITOTERAPIA, V87, P93, DOI 10.1016/j.fitote.2013.03.024
NR 36
TC 0
Z9 0
U1 5
U2 12
PU COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
PI LA PLATA
PA DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA
SN 0326-2383
J9 LAT AM J PHARM
JI Lat. Am. J. Pharm.
PY 2022
VL 41
IS 6
BP 1165
EP 1171
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 2Z8HV
UT WOS:000826812700001
DA 2024-02-19
ER

PT J
AU Chen, CN
   Yang, LL
   Li, MR
   Gao, L
   Qin, XM
   Du, GH
   Zhou, YZ
AF Chen, Chunni
   Yang, Linlin
   Li, Mengru
   Gao, Li
   Qin, Xuemei
   Du, Guanhua
   Zhou, Yuzhi
TI Study on the targeted regulation of Scutellaria baicalensis leaf on
   glutamine-glutamate metabolism and glutathione synthesis in the liver of
   D-gal ageing rats
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article; Early Access
DE Scutellaria baicalensis leaf; ageing; liver; oxidative stress;
   glutamine--glutamate metabolism pathway; Keap1; Nrf2 signaling pathway
ID OXIDATIVE STRESS; MALONDIALDEHYDE LEVELS; ANTIOXIDANT ENZYME; IN-VITRO;
   NRF2; GENES; INDUCTION; IDENTIFICATION; ELECTROPHILE; HOMEOSTASIS
AB Objectives Scutellaria baicalensis leaf (SLE), the above-ground part of the traditional Chinese medicine Scutellaria baicalensis Georgi, is rich in resources and contains a large number of flavonoids with anti-inflammatory, antioxidant and neuroprotective functions. The present study evaluated the ameliorative effects and related mechanisms of SLE on D-gal-induced ageing rats, providing a theoretical basis for the exploitation of SLE. Methods This experiment investigated the mechanism of SLE for anti-ageing by non-targeted metabonomics technology combined with targeted quantitative analysis and molecular biology technology. Key findings Non-targeted metabonomics analysis showed that 39 different metabolites were screened out. Among them, 38 metabolites were regulated by SLE (0.4 g/kg), and 33 metabolites were regulated by SLE (0.8 g/kg). Through enrichment analysis, glutamine-glutamate metabolic pathway was identified as the key metabolic pathway. Subsequently, the results of targeted quantitative and biochemical analysis displayed that the contents of key metabolites and the activities of enzymes in glutamine-glutamate metabolic pathway and glutathione synthesis could be regulated by SLE. Furthermore, the results of Western blotting indicated that SLE significantly modulated the expression of Nrf2, GCLC, GCLM, HO-1, and NQO1 proteins. Conclusion To sum up, the anti-ageing mechanism of SLE was related to glutamine-glutamate metabolism pathway and Nrf2 signalling pathway.
C1 [Chen, Chunni; Yang, Linlin; Li, Mengru; Gao, Li; Qin, Xuemei; Du, Guanhua; Zhou, Yuzhi] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan, Shanxi, Peoples R China.
   [Chen, Chunni; Yang, Linlin; Li, Mengru; Gao, Li; Qin, Xuemei; Zhou, Yuzhi] Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan, Shanxi, Peoples R China.
   [Chen, Chunni; Yang, Linlin; Li, Mengru; Gao, Li; Qin, Xuemei; Zhou, Yuzhi] Key Lab Effect Subst Res & Utilizat TCM Shanxi Pro, Taiyuan, Shanxi, Peoples R China.
   [Du, Guanhua] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Key Lab Drug Target Res & Drug Screen, Beijing 100050, Peoples R China.
   [Zhou, Yuzhi] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Key Lab Chem Biol & Mol Engn, Minist Educ, 92 Wucheng Rd, Taiyuan 030006, Shanxi, Peoples R China.
C3 Shanxi University; Shanxi University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Peking Union Medical College;
   Shanxi University
RP Zhou, YZ (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Key Lab Chem Biol & Mol Engn, Minist Educ, 92 Wucheng Rd, Taiyuan 030006, Shanxi, Peoples R China.
EM zhouyuzhi@sxu.edu.cn
FU Key Research and Development Program of Shanxi Province
   [201703D321023-3]
FX This study is funded by the Key Research and Development Program of
   Shanxi Province (grant number 201703D321023-3).
CR Atmaca M, 2008, PSYCHIAT RES, V159, P95, DOI 10.1016/j.psychres.2002.12.004
   Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110
   Cao YJ, 2016, ACTA BIOCH BIOPH SIN, V48, P437, DOI 10.1093/abbs/gmw024
   Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4
   Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320
   Chen P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55879-0
   Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564
   Dalton TP, 2004, FREE RADICAL BIO MED, V37, P1511, DOI 10.1016/j.freeradbiomed.2004.06.040
   Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011
   Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006
   Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040
   Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N
   Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Joshi Gururaj, 2012, Recent Pat CNS Drug Discov, V7, P218
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007
   Kristal Bruce S, 2005, Sci Aging Knowledge Environ, V2005, ppe19, DOI 10.1126/sageke.2005.26.pe19
   Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09
   Li MR, 2022, EXP GERONTOL, V170, DOI 10.1016/j.exger.2022.111978
   Liu GZ, 2011, J CHROMATOGR B, V879, P1023, DOI 10.1016/j.jchromb.2011.02.050
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Mironczuk-Chodakowska I, 2018, ADV MED SCI-POLAND, V63, P68, DOI 10.1016/j.advms.2017.05.005
   MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926
   Ookhtens M, 1998, SEMIN LIVER DIS, V18, P313, DOI 10.1055/s-2007-1007167
   Roalf DR, 2020, NEUROBIOL AGING, V95, P240, DOI 10.1016/j.neurobiolaging.2020.07.015
   Roth E, 2002, NUTRITION, V18, P217, DOI 10.1016/S0899-9007(01)00797-3
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Shen Y, 2014, EXP GERONTOL, V58, P166, DOI 10.1016/j.exger.2014.08.006
   Sinclair GM, 2019, METABOLITES, V9, DOI 10.3390/metabo9100229
   Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102
   Tamanna N, 2019, EXP GERONTOL, V127, DOI 10.1016/j.exger.2019.110712
   Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007
   Wang ZL, 2018, PHARM BIOL, V56, P465, DOI 10.1080/13880209.2018.1492620
   Xiao JF, 2012, TRAC-TREND ANAL CHEM, V32, P1, DOI 10.1016/j.trac.2011.08.009
   Yang Y, 2001, J BIOL CHEM, V276, P19220, DOI 10.1074/jbc.M100551200
   Yu C, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6635460
   Yuan H, 2021, MOL CELL BIOCHEM, V476, P247, DOI 10.1007/s11010-020-03901-9
   Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003
   Zhang FY, 2022, INT J LEGAL MED, V136, P941, DOI 10.1007/s00414-022-02783-4
   Zhao HJ, 2017, INT J BIOL MACROMOL, V102, P351, DOI 10.1016/j.ijbiomac.2017.04.039
NR 45
TC 0
Z9 0
U1 4
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD 2023 SEP 1
PY 2023
VL 75
IS 9
BP 1212
EP 1224
DI 10.1093/jpp/rgad050
EA JUN 2023
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA Q3UW8
UT WOS:001009224200001
PM 37329511
DA 2024-02-19
ER

PT J
AU Perichon, R
   Bourre, JM
AF Perichon, R
   Bourre, JM
TI Aging-related decrease in liver peroxisomal fatty acid oxidation in
   control and clofibrate-treated mice. A biochemical study and mechanistic
   approach
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE peroxisome; beta-oxidation; aging; mouse; liver; very long chain fatty
   acid; cytochrome P450; catalase; urate oxidase
ID RAT-LIVER; NEONATAL ADRENOLEUKODYSTROPHY; MEMBRANE-STRUCTURE; INDUCTION;
   BRAIN; PROLIFERATION; HEPATOCYTES; MITOCHONDRIAL; DEFICIENCY; PALMITATE
AB Membrane fatty acid composition affects membrane structure and function. Alterations in membrane composition have been reported in old animals and it is now hypothesized that these alterations may contribute to the onset of age-related diseases. Previously, we proposed that peroxisomes might also be involved in these aging-related membrane alterations. In order to extend our previous work, we have assayed acyl-CoA oxidase activity and cyanide-insensitive fatty acid oxidation activity for both arachidonic 20:4(n-6) and docosahexaenoic 22:6(n-3) acids, catalase and urate oxidase activities, microsomal cytochrome P450 content and cytochrome P4504Al laurate hydroxylase activity in the liver of young and old mice fed either a control or a clofibrate-supplemented diet. Our results suggest a progressive general decrease in peroxisomal function during aging, including a decrease in the fatty acid oxidation pathway that takes place via a specific decrease in acyl-CoA oxidase activity. The aging-related decrease in peroxisomal function is linked to a concomitant decrease in cytochrome P4504A laurate hydroxylase activity in control animals but not in clofibrate-treated mice. This suggests aging impairs a mechanism in peroxisome proliferation that is subsequent to the cytochrome P4504A step. Implications of the aging-related peroxisomal fatty acid oxidation decrease on health through possible alterations in membrane composition and function and very long chain fatty acid accumulation are discussed.
RP Perichon, R (corresponding author), HOP FERNAND WIDAL, INSERM U26, 200 RUE FAUBOURG ST DENIS, F-75010 PARIS, FRANCE.
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   ALVAREZ RA, 1994, INVEST OPHTH VIS SCI, V35, P402
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BIERI F, 1991, BIOCHEM PHARMACOL, V41, P310, DOI 10.1016/0006-2952(91)90493-O
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   BOURRE JM, 1992, NEUROSCI LETT, V141, P65, DOI 10.1016/0304-3940(92)90335-5
   BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0
   BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P344
   DEMONTELLANO PRO, 1992, FASEB J, V6, P695, DOI 10.1096/fasebj.6.2.1537458
   FOURNIER B, 1994, J INHERIT METAB DIS, V17, P470, DOI 10.1007/BF00711362
   GIBSON GM, 1993, P SOC PHOTO-OPT INS, V2204, P119
   HARDWICK JP, 1987, J BIOL CHEM, V262, P801
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HOLLOWAY CT, 1975, ARCH BIOCHEM BIOPHYS, V167, P496, DOI 10.1016/0003-9861(75)90492-0
   JAKOBS BS, 1991, BIOCHEM BIOPH RES CO, V178, P842, DOI 10.1016/0006-291X(91)90967-C
   KONDRUP J, 1985, BIOCHIM BIOPHYS ACTA, V835, P147, DOI 10.1016/0005-2760(85)90041-4
   KYRKLUND T, 1994, COMP BIOCHEM PHYS B, V109, P665, DOI 10.1016/0305-0491(94)90129-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   LOCK EA, 1989, ANNU REV PHARMACOL, V29, P145
   MAKOWSKA JM, 1992, J BIOCHEM TOXICOL, V7, P183, DOI 10.1002/jbt.2570070308
   MALHER HR, 1974, METHOD ENZYMAT AN, V1, P518
   MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585
   MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6
   MARTINEZ M, 1993, NEUROLOGY, V43, P1389, DOI 10.1212/WNL.43.7.1389
   MILTON MN, 1990, BIOCHEM PHARMACOL, V40, P2727, DOI 10.1016/0006-2952(90)90594-B
   NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PEGRAM RA, 1995, TOXICOL LETT, V76, P119, DOI 10.1016/0378-4274(94)03212-P
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   POLLTHE BT, 1988, AM J HUM GENET, V42, P422
   ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1193, DOI 10.1016/0006-2952(88)90770-8
   SINGH I, 1981, BIOCHEM BIOPH RES CO, V102, P1223, DOI 10.1016/S0006-291X(81)80142-8
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   VOSS A, 1991, J BIOL CHEM, V266, P19995
   WANDERS RJA, 1987, BIOCHIM BIOPHYS ACTA, V919, P21, DOI 10.1016/0005-2760(87)90213-X
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
NR 41
TC 20
Z9 21
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN 7
PY 1996
VL 87
IS 2
BP 115
EP 126
DI 10.1016/0047-6374(96)01705-8
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA UN989
UT WOS:A1996UN98900005
PM 8783194
DA 2024-02-19
ER

PT J
AU Wohlgemuth, SE
   Julian, D
   Akin, DE
   Fried, J
   Toscano, K
   Leeuwenburgh, C
   Dunn, WA
AF Wohlgemuth, Stephanie E.
   Julian, David
   Akin, Debora E.
   Fried, Joanna
   Toscano, Kristin
   Leeuwenburgh, Christiaan
   Dunn, William A., Jr.
TI Autophagy in the heart and liver during normal aging and calorie
   restriction
SO REJUVENATION RESEARCH
LA English
DT Article
ID AGE-RELATED-CHANGES; OXIDATIVE STRESS; MACROAUTOPHAGY; PROTEOLYSIS;
   INHIBITION; MECHANISM; DEATH; CELLS; ACCUMULATION; MITOCHONDRIA
AB Autophagy is a highly regulated intracellular process for the degradation of cellular constituents and essential for the maintenance of a healthy cell. We evaluated the effects of age and life-long calorie restriction on autophagy in heart and liver of young (6 months) and old (26 months) Fisher 344 rats. We observed that the occurrence of autophagic vacuoles was higher in heart than liver. The occurrence of autophagic vacuoles was not affected by age in either tissue, but was increased with calorie restriction in heart but not in liver. Next, we examined the expression of proteins involved in the formation and maturation of autophagosomes (beclin-1, LC3, Atg7, Atg9) or associated with autolysosomes and lysosomes (LAMP-1; cathepsin D). In hearts of both ad libitum-fed and calorie-restricted rats, we observed an increase in expression of beclin-1 and procathepsin D, but not mature cathepsin D, and a decrease in expression of LAMP-1 because of aging. In hearts, calorie restriction stimulated the expression of Atg7 and Atg9 and the lipidation of Atg8 (elevated LC3-II/I ratios) in aged rats. In hearts of ad libitum-fed rats, expression of Atg7 and lipidation of Atg8 were unaffected by age, while the cellular levels of Atg9 were lower in aged animals. Furthermore, we observed that the age- and diet-dependent expression levels of those proteins differed between heart and liver. In conclusion, autophagy in heart and liver did not decrease with age in ad libitum-fed rats, but was enhanced by calorie restriction in the heart. Thus, calorie restriction may mediate some of its beneficial effects by stimulating autophagy in the heart, indicating the potential for cardioprotective therapies.
C1 Univ Florida, Dept Aging & Geriatr, Gainesville, FL 32610 USA.
   Univ Florida, Dept Zool, Gainesville, FL 32611 USA.
   Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA.
C3 State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida
RP Wohlgemuth, SE (corresponding author), Univ Florida, Dept Aging & Geriatr, POB 100107, Gainesville, FL 32610 USA.
EM swohlgemuth@aging.ufl.edu
OI Julian, David/0000-0003-1143-2813; Leeuwenburgh,
   Christiaan/0000-0003-0826-4257
FU NCI NIH HHS [CA 95552] Funding Source: Medline; NIA NIH HHS [1
   P30AG028740, AG 21042] Funding Source: Medline
CR Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025
   Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692
   ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7
   Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   Bergamini E, 2004, INT J BIOCHEM CELL B, V36, P2392, DOI 10.1016/j.biocel.2004.05.007
   Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9
   Bergamini E, 1998, AGING-CLIN EXP RES, V10, P174
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 1998, FRONT BIOSCI, V3, pd25
   Cuervo Ana Maria, 2003, Sci Aging Knowledge Environ, V2003, ppe25, DOI 10.1126/sageke.2003.36.pe25
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962
   Davani S, 2005, CARDIOVASC RES, V65, P305, DOI 10.1016/j.cardiores.2004.10.037
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923
   DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935
   Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Fortun J, 2003, J NEUROSCI, V23, P10672
   Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018
   Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43
   Goldspink DF, 2003, EXP PHYSIOL, V88, P447, DOI 10.1113/eph8802549
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061
   Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519
   Klionsky DJ, 2004, AUTOPHAGY
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604
   Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465
   Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7
   Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840
   Rohrbach S, 2006, EXP GERONTOL, V41, P525, DOI 10.1016/j.exger.2006.02.001
   SCHWORER CM, 1981, J BIOL CHEM, V256, P7652
   Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   Stroikin Y, 2005, BIOGERONTOLOGY, V6, P39, DOI 10.1007/s10522-004-7382-y
   Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014
   Terman A, 2004, EXP GERONTOL, V39, P701, DOI 10.1016/j.exger.2004.01.005
   Terman A, 1995, GERONTOLOGY, V41, P319
   Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996
   Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1
   Weindruch R., 1988, RETARDATION AGING DI
   Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200
   Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102
   Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
NR 62
TC 140
Z9 151
U1 0
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD SEP
PY 2007
VL 10
IS 3
BP 281
EP 292
DI 10.1089/rej.2006.0535
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 206UX
UT WOS:000249209500003
PM 17665967
DA 2024-02-19
ER

PT J
AU Sidhom, S
   Schneider, A
   Fang, YM
   McFadden, S
   Darcy, J
   Sathiaseelan, R
   Palmer, AK
   Steyn, FJ
   Grillari, J
   Kopchick, JJ
   Bartke, A
   Siddiqi, S
   Masternak, MM
   Stout, MB
AF Sidhom, Silvana
   Schneider, Augusto
   Fang, Yimin
   McFadden, Samuel
   Darcy, Justin
   Sathiaseelan, Roshini
   Palmer, Allyson K.
   Steyn, Frederik J.
   Grillari, Johannes
   Kopchick, John J.
   Bartke, Andrzej
   Siddiqi, Shadab
   Masternak, Michal M.
   Stout, Michael B.
TI 17α-Estradiol Modulates IGF1 and Hepatic Gene Expression in a
   Sex-Specific Manner
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE 17 alpha-Estradiol; Aging; Growth hormone; Insulin; Insulin-like growth
   factor 1
ID GROWTH-HORMONE RECEPTOR; LIFE-SPAN; ADIPOSE-TISSUE; LIVER-DISEASE;
   ER-BETA; INSULIN; ESTROGEN; ALPHA; RESTRICTION; HEALTHSPAN
AB Aging is the greatest risk factor for most chronic diseases. The somatotropic axis is one of the most conserved biological pathways that regulates aging across species. 17 alpha-Estradiol (17 alpha-E2), a diastereomer of 17 beta-estradiol (17 beta-E2), was recently found to elicit health benefits, including improved insulin sensitivity and extend longevity exclusively in male mice. Given that 17 beta-F2 is known to modulate somatotropic signaling in females through actions in the pituitary and liver, we hypothesized that 17 alpha-E2 may be modulating the somatotropic axis in males, thereby contributing to health benefits. I lerein, we demonstrate that 17 alpha-E2 increases hepatic insulin-like growth factor 1 (IGF1) production in male mice without inducing any changes in pulsatile growth hormone (GH) secretion. Using growth hormone receptor knockout (GHRKO) mice, we subsequently determined that the induction of hepatic IGF1 by 17 alpha-F2 is dependent upon GH signaling in male mice, and that 17 alpha E2 elicits no effects on IGF1 production in female mice. We also determined that 17 alpha-E2 failed to feminize the hepatic transcriptional profile in normal (N) male mice, as evidenced by a clear divergence between the sexes, regardless of treatment. Conversely, significant overlap in transcriptional profiles was observed between sexes in GHRKO mice, and this was unaffected by 17 alpha-E2 treatment. Based on these findings, we propose that 17 alpha-E2 acts as a pleiotropic pathway modulator in male mice by uncoupling IGF1 production from insulin sensitivity. In summary, 17 alpha-E2 treatment upregulates IGF1 production in wild-type (and N) male mice in what appears to be a GH-dependent fashion, while no effects in female IGF1 production are observed following 17 alpha-E2 treatment.
C1 [Sidhom, Silvana; Siddiqi, Shadab; Masternak, Michal M.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.
   [Schneider, Augusto] Univ Fed Pelotas, Fac Nutr, Pelotas, RS, Brazil.
   [Fang, Yimin; McFadden, Samuel; Darcy, Justin; Bartke, Andrzej] Southern Illinois Univ, Dept Physiol, Sch Med, Springfield, IL USA.
   [Sathiaseelan, Roshini; Stout, Michael B.] Univ Oklahoma, Dept Nutr Sci, Hlth Sci Ctr, Oklahoma City, OK 73117 USA.
   [Palmer, Allyson K.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.
   [Steyn, Frederik J.] Univ Queensland, Fac Med, Ctr Clin Res, Brisbane, Qld, Australia.
   [Grillari, Johannes] BOKU Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria.
   [Kopchick, John J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.
   [Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.
   [Stout, Michael B.] Univ Oklahoma, Oklahoma Ctr Gerosci, Hlth Sci Ctr, Oklahoma City, OK 73117 USA.
C3 State University System of Florida; University of Central Florida;
   Universidade Federal de Pelotas; Southern Illinois University System;
   Southern Illinois University; University of Oklahoma System; University
   of Oklahoma Health Sciences Center; Mayo Clinic; University of
   Queensland; University of Natural Resources & Life Sciences, Vienna;
   University System of Ohio; Ohio University; University System of Ohio;
   Ohio University; University of Oklahoma System; University of Oklahoma
   Health Sciences Center
RP Stout, MB (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 1200 North Stonewall Ave,Suite 3057, Oklahoma City, OK 73117 USA.
EM michael-stout@ouhsc.edu
RI Fang, Yimin/C-3278-2018; Schneider, Augusto/B-5011-2014; Palmer,
   Allyson/ABA-5926-2020; McFadden, Samuel A/B-1523-2017; Steyn,
   Frederik/P-4386-2016
OI Fang, Yimin/0000-0002-2735-6782; Schneider, Augusto/0000-0002-3410-2860;
   McFadden, Samuel A/0000-0002-2289-5066; Steyn,
   Frederik/0000-0002-4782-3608
FU National Institutes of Health [R00 AG51661, R56 AG061414, R03 AG059846,
   R15 AG059190]; American Diabetes Association [1-19-IBS-126]
FX This work was supported by the National Institutes of Health (R00
   AG51661 to M.B.S. and R56 AG061414, R03 AG059846, and R15 AG059190 to
   M.M.M.) and American Diabetes Association (1-19-IBS-126 to A.B.).
CR Adams JM, 2015, ENDOCRINOLOGY, V156, P1052, DOI 10.1210/en.2014-1429
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19
   Ashpole NM, 2017, GEROSCIENCE, V39, P129, DOI 10.1007/s11357-017-9971-0
   Austad SN, 2016, GERONTOLOGY, V62, P40, DOI 10.1159/000381472
   Avtanski D, 2014, MOL ENDOCRINOL, V28, P40, DOI 10.1210/me.2013-1245
   Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567
   Buzzetti E, 2017, PHARMACOL RES, V120, P97, DOI 10.1016/j.phrs.2017.03.014
   Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002
   Fernandez-Perez Leandro, 2013, Front Endocrinol (Lausanne), V4, P66, DOI 10.3389/fendo.2013.00066
   Foucaud-Vignault M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023614
   Fournier B, 2001, J BIOL CHEM, V276, P35444, DOI 10.1074/jbc.M105418200
   Garratt M, 2019, AGING CELL, V18, DOI 10.1111/acel.12920
   Garratt M, 2018, AGING CELL, V17, DOI 10.1111/acel.12786
   Garratt M, 2017, AGING CELL, V16, P1256, DOI 10.1111/acel.12656
   Grasfeder LL, 2009, MOL ENDOCRINOL, V23, P1171, DOI 10.1210/me.2009-0024
   Han DH, 1998, J GERONTOL A-BIOL, V53, pB19, DOI 10.1093/gerona/53A.1.B19
   HANSON JR, 1979, ANN REP PROGR CHEM B, V76, P363, DOI 10.1039/oc9797600363
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Lau-Corona D, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00301-17
   Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285
   Mann SN, 2020, HLTH BENEFITS ATTRIB, DOI [10.1101/2020.06.02.130674, DOI 10.1101/2020.06.02.130674]
   Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   McDonnell Anne M, 2013, J Adv Pract Oncol, V4, P263
   Miller BF, 2020, J GERONTOL A-BIOL, V75, P849, DOI 10.1093/gerona/glz113
   Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751
   Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078
   Österreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022
   Steyn FJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12703
   Stout MB, 2017, PHYSIOLOGY, V32, P9, DOI 10.1152/physiol.00012.2016
   Stout MB, 2017, J GERONTOL A-BIOL, V72, P3, DOI 10.1093/gerona/glv309
   Toran-Allerand CD, 2005, ANN NY ACAD SCI, V1052, P136, DOI 10.1196/annals.1347.009
   Venken K, 2005, J BONE MINER RES, V20, P2138, DOI 10.1359/JBMR.050811
   Vermeulen A, 1995, ANN NY ACAD SCI, V774, P121, DOI 10.1111/j.1749-6632.1995.tb17376.x
   Wang XL, 2015, J HEPATOL, V63, P183, DOI 10.1016/j.jhep.2015.02.029
   Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Yakar S, 2012, ENDOCRIN METAB CLIN, V41, P231, DOI 10.1016/j.ecl.2012.04.008
   Zhang H, 2013, J LIPID RES, V54, P345, DOI 10.1194/jlr.M028969
NR 50
TC 14
Z9 14
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAY
PY 2021
VL 76
IS 5
BP 778
EP 785
DI 10.1093/gerona/glaa215
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA SK4XZ
UT WOS:000656221600005
PM 32857104
OA Green Published
DA 2024-02-19
ER

PT J
AU Cao, SX
   Dhahbi, JM
   Mote, PL
   Spindler, SR
AF Cao, SX
   Dhahbi, JM
   Mote, PL
   Spindler, SR
TI Genomic profiling of short- and long-term caloric restriction effects in
   the liver of aging mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID GENE-EXPRESSION PROFILE; METABOLIZING ENZYMES; MOLECULAR CHAPERONES;
   DIETARY RESTRICTION; FOOD RESTRICTION; MESSENGER-RNA; HEAT-SHOCK; AGE;
   PROTEIN; CANCER
AB We present genome-wide microarray expression analysis of 11,000 genes in an aging potentially mitotic tissue, the liver. This organ has a major impact on health and homeostasis during aging. The effects of life- and health-span-extending caloric restriction (CR) on gene expression among young and old mice and between long-term CIR (LT-CR) and short-term CR (ST-CR) were examined. This experimental design allowed us to accurately distinguish the effects of aging from those of CR on gene expression. Aging was accompanied by changes in gene expression associated with increased inflammation, cellular stress, and fibrosis, and reduced capacity for apoptosis, xenobiotic metabolism, normal cell-cycling, and DNA replication. LT-CR and just 4 weeks of ST-CR reversed the majority of these changes. LT-CR produced in young mice a pattern of gene expression that is a subset of the changes found in old LT-CR mice. It is possible that the early changes in gene expression, which extend into old age, are key to the life- and health-span-extending effects of CR. Further, ST-CR substantially shifted the "normo-aging" genomic profile of old control mice toward the "slow-aging" profile associated with LT-CR. Therefore, many of the genomic effects of CR are established rapidly. Thus, expression profiling should prove useful in quickly identifying CR-mimetic drugs and treatments.
C1 Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
C3 University of California System; University of California Riverside
RP Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
EM spindler@mail.ucr.edu
CR ALI B, 1985, LIFE SCI, V37, P1387, DOI 10.1016/0024-3205(85)90077-3
   BUTTLE DJ, 1991, BIOCHEM J, V276, P325, DOI 10.1042/bj2760325
   Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240
   Cherry, 1998, P SOC EXP BIOL MED, V218, P218, DOI 10.3181/00379727-218-44289
   CIOCCA DR, 1992, CANCER RES, V52, P3648
   Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.0.CO;2-I
   Davignon J, 1999, CLIN CHIM ACTA, V286, P115, DOI 10.1016/S0009-8981(99)00097-2
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dhahbi JM, 1997, J NUTR, V127, P1758, DOI 10.1093/jn/127.9.1758
   Dhahbi JM, 1998, J GERONTOL A-BIOL, V53, pB180, DOI 10.1093/gerona/53A.3.B180
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Frystyk J, 1999, AM J PHYSIOL-ENDOC M, V277, pE245, DOI 10.1152/ajpendo.1999.277.2.E245
   GERBER GB, 1962, J BIOL CHEM, V237, P2246
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   Hikita H, 1999, TOXICOL SCI, V52, P17, DOI 10.1093/toxsci/52.suppl_1.17
   Jaeschke H, 1997, AM J PHYSIOL-GASTR L, V273, pG602, DOI 10.1152/ajpgi.1997.273.3.G602
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778
   KATZEFF HL, 1990, AM J CLIN NUTR, V52, P263, DOI 10.1093/ajcn/52.2.263
   KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049
   Kos J, 1998, ONCOL REP, V5, P1349
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523
   MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631
   Merat S, 2000, J GERONTOL A-BIOL, V55, pB85
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322
   PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0
   PETRY F, 1989, FEBS LETT, V258, P89, DOI 10.1016/0014-5793(89)81622-9
   Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026
   Pitot HC, 2000, ALIMENT PHARM THERAP, V14, P153, DOI 10.1046/j.1365-2036.2000.014s1153.x
   Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051
   Reimold AM, 2000, GENE DEV, V14, P152
   SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171
   SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sherman M Y, 1996, EXS, V77, P57
   Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   STUCHLIKOVA E, 1975, EXP GERONTOL, V10, P141, DOI 10.1016/0531-5565(75)90043-1
   Tang NM, 1999, MOL CELL BIOL, V19, P4757
   TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027
   Treister A, 1998, INT J CANCER, V77, P306, DOI 10.1002/(SICI)1097-0215(19980717)77:2<306::AID-IJC22>3.0.CO;2-7
   Verges BL, 1997, DIABETES, V46, P125, DOI 10.2337/diabetes.46.1.125
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Weindruch R., 1988, RETARDATION AGING DI
   Xu XW, 1996, J GERONTOL A-BIOL, V51, pB167, DOI 10.1093/gerona/51A.2.B167
NR 57
TC 329
Z9 366
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 11
PY 2001
VL 98
IS 19
BP 10630
EP 10635
DI 10.1073/pnas.191313598
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 472CZ
UT WOS:000170966800026
PM 11535822
OA Green Published
DA 2024-02-19
ER

PT J
AU Gong, ZW
   Kennedy, O
   Sun, H
   Wu, YJ
   Williams, GA
   Klein, L
   Cardoso, L
   Matheny, RW
   Hubbard, GB
   Ikeno, Y
   Farrar, RP
   Schaffler, MB
   Adamo, ML
   Muzumdar, RH
   Yakar, S
AF Gong, Zhenwei
   Kennedy, Oran
   Sun, Hui
   Wu, YingJie
   Williams, Garry A.
   Klein, Laura
   Cardoso, Luis
   Matheny, Ronald W., Jr.
   Hubbard, Gene B.
   Ikeno, Yuji
   Farrar, Roger P.
   Schaffler, Mitchell B.
   Adamo, Martin L.
   Muzumdar, Radhika H.
   Yakar, Shoshana
TI Reductions in serum IGF-1 during aging impair health span
SO AGING CELL
LA English
DT Article
DE aging; bone; growth hormone; IGF; insulin-sensitivity; LID; lifespan;
   liver; tumor
ID GROWTH-FACTOR-I; CALORIC RESTRICTION; OXIDATIVE STRESS; LIFE-SPAN;
   HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; RHESUS-MONKEYS; TISSUE IGF-1;
   DWARF MICE; HORMONE
AB In lower or simple species, such as worms and flies, disruption of the insulin-like growth factor (IGF)-1 and the insulin signaling pathways has been shown to increase lifespan. In rodents, however, growth hormone (GH) regulates IGF-1 levels in serum and tissues and can modulate lifespan via/or independent of IGF-1. Rodent models, where the GH/IGF-1 axis was ablated congenitally, show increased lifespan. However, in contrast to rodents where serum IGF-1 levels are high throughout life, in humans, serum IGF-1 peaks during puberty and declines thereafter during aging. Thus, animal models with congenital disruption of the GH/IGF-1 axis are unable to clearly distinguish between developmental and age-related effects of GH/IGF-1 on health. To overcome this caveat, we developed an inducible liver IGF-1-deficient (iLID) mouse that allows temporal control of serum IGF-1. Deletion of liver Igf -1 gene at one year of age reduced serum IGF-1 by 70% and dramatically impaired health span of the iLID mice. Reductions in serum IGF-1 were coupled with increased GH levels and increased basal STAT5B phosphorylation in livers of iLID mice. These changes were associated with increased liver weight, increased liver inflammation, increased oxidative stress in liver and muscle, and increased incidence of hepatic tumors. Lastly, despite elevations in serum GH, low levels of serum IGF-1 from 1year of age compromised skeletal integrity and accelerated bone loss. We conclude that an intact GH/IGF-1 axis is essential to maintain health span and that elevated GH, even late in life, associates with increased pathology.
C1 [Gong, Zhenwei; Klein, Laura; Muzumdar, Radhika H.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA.
   [Kennedy, Oran] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA.
   [Sun, Hui; Wu, YingJie; Williams, Garry A.; Yakar, Shoshana] NYU, Coll Dent, David B Kriser Dent Ctr, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.
   [Cardoso, Luis; Schaffler, Mitchell B.] CUNY, Dept Biomed Engn, New York, NY 10031 USA.
   [Matheny, Ronald W., Jr.; Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.
   [Matheny, Ronald W., Jr.; Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Farrar, Roger P.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; NYU Langone
   Medical Center; Hospital for Joint Disease NYULMC; New York University;
   New York University; City University of New York (CUNY) System;
   University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Austin
RP Yakar, S (corresponding author), NYU, Coll Dent, David B Kriser Dent Ctr, Dept Basic Sci & Craniofacial Biol, 345 East 24th St, New York, NY 10010 USA.
EM sy1007@nyu.edu
RI Cardoso, Luis/F-1234-2013; Gong, Zhenwei/G-2435-2012; Yakar,
   Shoshana/IUN-5716-2023
OI Cardoso, Luis/0000-0002-2252-7802; Yakar, Shoshana/0000-0002-2352-1330;
   Kennedy, Oran D./0000-0003-3343-2873; Schaffler,
   Mitchell/0000-0001-5780-7073
FU United States (NIH/NIAMS) [AR054919, AR055141]; UTHSCSA PREF; NIH
   [AG13319]; Glenn Foundation for Medical Research
FX Financial support was received from funding agencies in the United
   States (NIH/NIAMS AR054919 & AR055141) to SY. Supported in part by
   UTHSCSA PREF Award, IGF1/Insulin Signaling in Aging - Project 1 (MLA).
   Supported in part by NIH Grants AG13319 (YI and GBH) and a grant from
   the Glenn Foundation for Medical Research (YI).
CR Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x
   Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164
   Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889
   Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Colao A, 2002, J ENDOCRINOL INVEST, V25, P125, DOI 10.1007/BF03343975
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Courtland HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014762
   Elis S, 2010, J BONE MINER RES, V25, P2051, DOI 10.1002/jbmr.100
   Elis S, 2010, J BONE MINER RES, V25, P1257, DOI 10.1002/jbmr.20
   Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Hauck SJ, 2000, FREE RADICAL BIO MED, V28, P970, DOI 10.1016/S0891-5849(00)00186-6
   Higashi Y, 2013, BBA-MOL BASIS DIS, V1832, P391, DOI 10.1016/j.bbadis.2012.12.005
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510
   Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254
   Laron Z, 2005, MECH AGEING DEV, V126, P305, DOI 10.1016/j.mad.2004.08.022
   Lawless JF, 1990, STAT MODELS METHODS, P1
   Lombardi G, 2005, J Endocrinol Invest, V28, P36
   Lorenzini A, 2013, J GERONTOL IN PRESS
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Miquet JG, 2013, CELL CYCLE, V12, P1042, DOI 10.4161/cc.24026
   Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   O'Neill C, 2012, BIOCHEM SOC T, V40, P721, DOI 10.1042/BST20120080
   Page MM, 2009, FREE RADICAL BIO MED, V46, P1109, DOI 10.1016/j.freeradbiomed.2009.01.014
   Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Sneppen SB, 2002, CLIN ENDOCRINOL, V57, P787, DOI 10.1046/j.1365-2265.2002.01670.x
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Sonntag WE, 2012, J GERONTOL A-BIOL, V67, P587, DOI 10.1093/gerona/gls115
   Stein PK, 2012, AGING CELL, V11, P644, DOI 10.1111/j.1474-9726.2012.00825.x
   Svensson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022640
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847
   Westbrook R, 2009, J GERONTOL A-BIOL, V64, P443, DOI 10.1093/gerona/gln075
   Wolf NS, 2000, EXP EYE RES, V70, P683, DOI 10.1006/exer.2000.0835
   Wu YJ, 2010, CANCER RES, V70, P57, DOI 10.1158/0008-5472.CAN-09-2472
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
NR 43
TC 55
Z9 62
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2014
VL 13
IS 3
BP 408
EP 418
DI 10.1111/acel.12188
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AJ2VV
UT WOS:000337523400003
PM 24341939
OA Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Teofilovic, A
   Vrataric, M
   Velickovic, N
   Milutinovic, DV
   Mladenovic, A
   Prvulovic, M
   Djordjevic, A
AF Teofilovic, Ana
   Vrataric, Milos
   Velickovic, Natasa
   Milutinovic, Danijela Vojnovic
   Mladenovic, Aleksandra
   Prvulovic, Milica
   Djordjevic, Ana
TI Late-Onset Calorie Restriction Improves Lipid Metabolism and Aggravates
   Inflammation in the Liver of Old Wistar Rats
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE calorie restriction; lipid metabolism; inflammation; liver; aging
ID ACTIVATED PROTEIN-KINASE; FREE FATTY-ACIDS; DIETARY RESTRICTION; FOOD
   RESTRICTION; INSULIN-RESISTANCE; HEPATIC STEATOSIS; AGE; EXPRESSION;
   OBESITY; AMPK
AB Aging is a progressive process that could disturb metabolic homeostasis in the liver via ectopic lipid accumulation, oxidative stress, and deterioration of inflammatory response. Although calorie restriction (CR) is recognized as beneficial for life span and health span prolongation, it is still unclear how late-onset CR, characterized by late beginning and short duration, affects age-related processes. The aim of this study was to examine how late-onset CR-induced metabolic adjustments impact lipid status and inflammation in the liver of old rats. The experiments were conducted on aging male Wistar rats fed ad libitum (AL) or exposed to late-onset CR (60% of AL daily intake) from 21st to 24th month. The results showed that late-onset CR reduces body weight, visceral adipose tissue and liver mass, and triglyceride levels when compared to old animals on AL diet. The ameliorating effects of CR on lipid metabolism include increased activity of AMP-activated protein kinase, suppressed de novo fatty acid synthesis, stimulated beta-oxidation, decreased lipotoxicity, and limited triglyceride synthesis and packaging in the liver. Restricted diet regime, however, does not improve expression of antioxidant enzymes, although it leads to progression of age-related inflammation in the liver, partially through lower corticosterone concentration and decreased activation of glucocorticoid receptor. In conclusion, late-onset CR is able to restore age-related imbalance of lipid metabolism in the liver, but has a negative impact on hepatic inflammatory status, implying that the type of diet for older individuals must be balanced and chosen carefully with appropriate duration and start point.
C1 [Teofilovic, Ana; Vrataric, Milos; Velickovic, Natasa; Milutinovic, Danijela Vojnovic; Djordjevic, Ana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Natl Inst Republ Serbia, Dept Biochem, Belgrade, Serbia.
   [Mladenovic, Aleksandra; Prvulovic, Milica] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Natl Inst Republ Serbia, Dept Neurobiol, Belgrade, Serbia.
C3 University of Belgrade; University of Belgrade
RP Teofilovic, A (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Natl Inst Republ Serbia, Dept Biochem, Belgrade, Serbia.
EM avasiljevic@ibiss.bg.ac.rs
RI Mladenovic, Aleksandra/IQR-9118-2023; Vojnović Milutinović,
   Danijela/AAX-8926-2021; Prvulovic, Milica/JMP-9426-2023; Djordjevic, Ana
   D./E-7840-2016; Teofilovic, Ana/AEY-5275-2022
OI Mladenovic, Aleksandra/0000-0001-9011-5634; Vojnović Milutinović,
   Danijela/0000-0002-2584-5048; Prvulovic, Milica/0000-0003-2769-5212;
   Djordjevic, Ana D./0000-0002-7042-1631; Vrataric,
   Milos/0000-0002-7906-9793; Teofilovic, Ana/0000-0001-5731-7525;
   Velickovic, Natasa/0000-0003-3604-5836
FU Ministry of Education, Science, and Technological Development of
   Republic of Serbia [451-03-68/2022-14/200007]
FX Funding This study was supported by the Ministry of Education, Science,
   and Technological Development of Republic of Serbia under Grant
   451-03-68/2022-14/200007.
CR Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32
   Allen BD, 2019, AGING CELL, V18, DOI 10.1111/acel.12944
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Bales CW, 2018, ADV NUTR, V9, P151, DOI 10.1093/advances/nmx016
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Belmonte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35813
   Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x
   Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389
   Bonzón-Kulichenko E, 2018, J GERONTOL A-BIOL, V73, P1139, DOI 10.1093/gerona/gly081
   Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037
   Dogan S, 2017, META GENE, V12, P22, DOI 10.1016/j.mgene.2016.12.013
   DUBUC PU, 1988, AM J PHYSIOL, V255, pR787, DOI 10.1152/ajpregu.1988.255.5.R787
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283
   Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   Frohnert BI, 2013, DIABETES, V62, P3163, DOI 10.2337/db12-1122
   Geng YN, 2021, HEPATOL INT, V15, P21, DOI 10.1007/s12072-020-10121-2
   Guptaand D, 2014, COMPR PHYSIOL, V4, P1495, DOI 10.1002/cphy.c130049
   HAINER V, 1992, AM J CLIN NUTR, V56, p281S, DOI 10.1093/ajcn/56.1.281S
   Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064
   Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015
   Izquierdo AG, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112704
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Kane AE, 2018, CURR OPIN PHYSIOL, V6, P28, DOI 10.1016/j.cophys.2018.03.008
   Kharwanlang B, 2017, HEALTHY AGEING LONG, V6, P37, DOI 10.1007/978-3-319-63001-4_3
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Layec G, 2013, AGE, V35, P1183, DOI 10.1007/s11357-012-9442-6
   Ma LN, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.3668
   MacDonald L, 2014, BRAIN BEHAV IMMUN, V40, P18, DOI 10.1016/j.bbi.2014.01.005
   McInnes KJ, 2004, J BIOL CHEM, V279, P22908, DOI 10.1074/jbc.M402822200
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Park CY, 2017, BIOCHEM BIOPH RES CO, V490, P636, DOI 10.1016/j.bbrc.2017.06.090
   Prvulovic MR, 2022, J GERONTOL A-BIOL, V77, P947, DOI 10.1093/gerona/glab353
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697
   Rogero MM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040432
   Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170
   Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Seimon RV, 2013, HORM MOL BIOL CLIN I, V15, P71, DOI 10.1515/hmbci-2013-0038
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907
   Teofilovic A, 2020, INT J FOOD SCI NUTR, V71, P815, DOI 10.1080/09637486.2020.1728236
   Todorovic ST, 2018, J GERONTOL A-BIOL, V73, P1036, DOI 10.1093/gerona/gly015
   Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x
   Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037
   White PC, 2007, MOL CELL ENDOCRINOL, V265, P89, DOI 10.1016/j.mce.2006.12.022
NR 52
TC 6
Z9 6
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD MAY 23
PY 2022
VL 9
AR 899255
DI 10.3389/fnut.2022.899255
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 1W5ZL
UT WOS:000806852000001
PM 35677539
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wilkinson, HN
   Clowes, C
   Banyard, KL
   Matteuci, P
   Mace, KA
   Hardman, MJ
AF Wilkinson, Holly N.
   Clowes, Christopher
   Banyard, Kayleigh L.
   Matteuci, Paolo
   Mace, Kimberly A.
   Hardman, Matthew J.
TI Elevated Local Senescence in Diabetic Wound Healing Is Linked to
   Pathological Repair via CXCR2
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Article
ID CELLULAR SENESCENCE; SECRETORY PHENOTYPE; CHRONIC INFLAMMATION; CRUCIAL
   ROLE; CELLS; P53; CONTRIBUTES; RECEPTOR; P21; OVEREXPRESSION
AB Cellular senescence can be broadly defined as a stable, but essentially irreversible, loss of proliferative capacity. Historically, senescence has been described as a negative outcome of advanced cellular age. It is now clear, however, that senescence represents a dynamic autonomous stress response, integral to long-term tumor suppression. Transient induction of a senescent phenotype has actually been suggested to promote regeneration in both liver and skin. Here, we explored the role of senescence in pathological aged and diabetic murine wound healing. Aged and diabetic wounds had greater numbers of senescent cells, and diabetic macrophages maintained altered retention of polarization and produced a CXCR2-enriched senescence-associated secretory phenotype (i.e., SASP). Of translational relevance, targeted expression of CXCR2 in primary human dermal fibroblasts led to paracrine induction of nuclear p21. Furthermore, a selective agonist to CXCR2 was able to reverse delayed healing in diabetic mice and accelerate ex vivo human skin wound healing. Collectively, these data suggest a hitherto unappreciated role for CXCR2 in mediating cellular senescence in pathological wound repair.
C1 [Wilkinson, Holly N.; Banyard, Kayleigh L.; Hardman, Matthew J.] Univ Hull, Ctr Atherothrombosis & Metab Dis, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.
   [Clowes, Christopher] Univ Hosp North Midlands Natl Hlth Serv Trust, Royal Stoke Univ Hosp, Res & Dev Dept, Stoke On Trent, Staffs, England.
   [Matteuci, Paolo] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England.
   [Mace, Kimberly A.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.
C3 University of Hull; University of York - UK; Royal Stoke University
   Hospital; University of Manchester
RP Hardman, MJ (corresponding author), Univ Hull, Castle Hill Hosp, Daisy Bldg,2nd Floor, Kingston Upon Hull HU16 5JQ, N Humberside, England.
EM m.hardman@hull.ac.uk
RI Hardman, Matthew/ABE-4936-2020
OI Banyard, Kayleigh/0000-0003-1175-6017; Mace,
   Kimberly/0000-0002-3184-878X; Wilkinson, Holly/0000-0002-8453-7264;
   Matteucci, Paolo/0000-0002-0594-1577; Hardman,
   Matthew/0000-0002-6423-5074
FU MRC (UK) CASE PhD Studentship [MR/M016307/1]
FX An MRC (UK) CASE PhD Studentship supported this work (grant number
   MR/M016307/1). We would like to thank Cheryl Walter (Biomedical
   Sciences, The University of Hull) for sharing materials and advice.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Ågren MS, 1999, J INVEST DERMATOL, V112, P463, DOI 10.1046/j.1523-1747.1999.00549.x
   Ansell DM, 2012, EXP DERMATOL, V21, P581, DOI 10.1111/j.1600-0625.2012.01540.x
   Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029
   Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023
   Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Choudhury AR, 2017, NAT GEN, V39, P99
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3
   Harding Keith G, 2005, Int Wound J, V2, P364, DOI 10.1111/j.1742-4801.2005.00149.x
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200
   Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539
   Kim DJ, 2015, WOUND REPAIR REGEN, V23, P318, DOI 10.1111/wrr.12290
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kroeze KL, 2012, J INVEST DERMATOL, V132, P216, DOI 10.1038/jid.2011.245
   Li YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017421
   Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002
   Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005
   Matthaei M, 2012, INVEST OPHTH VIS SCI, V53, P6718, DOI 10.1167/iovs.12-9669
   McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Müller KM, 2000, CYTOKINE, V12, P1755, DOI 10.1006/cyto.2000.0787
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Peng Y, 2015, AGEING RES REV, V19, P8, DOI 10.1016/j.arr.2014.10.006
   Prattichizzo F, 2018, REDOX BIOL, V15, P170, DOI 10.1016/j.redox.2017.12.001
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sagiv A, 2013, BIOGERONTOLOGY, V14, P617, DOI 10.1007/s10522-013-9473-0
   Satriano J, 2010, AM J PHYSIOL-CELL PH, V299, pC374, DOI 10.1152/ajpcell.00096.2010
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6
   Stanley A, 2001, J VASC SURG, V33, P1206, DOI 10.1067/mva.2001.115379
   Stephens P, 2003, EXP CELL RES, V283, P22, DOI 10.1016/S0014-4827(02)00021-6
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Vande Berg Jerry S., 1998, Wound Repair and Regeneration, V6, P38, DOI 10.1046/j.1524-475X.1998.60107.x
   Weischenfeldt J, 2008, COLD SPRING HARB PRO, V12
   Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x
   Wilkinson HN, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01450
   Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yosef R, 2017, EMBO J, V38
NR 73
TC 63
Z9 65
U1 3
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-202X
EI 1523-1747
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD MAY
PY 2019
VL 139
IS 5
BP 1171
EP +
DI 10.1016/j.jid.2019.01.005
PG 17
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA HU3XV
UT WOS:000465209400027
PM 30684552
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Zhang, XL
   Xu, LN
   Yin, LH
   Qi, Y
   Xu, YW
   Han, X
   Peng, JY
AF Zhang, Xiaoling
   Xu, Lina
   Yin, Lianhong
   Qi, Yan
   Xu, Youwei
   Han, Xu
   Peng, Jinyong
TI Quantitative chemical proteomics for investigating the biomarkers of
   dioscin against liver fibrosis caused by CCl<sub>4</sub> in rats
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID GEL-ELECTROPHORESIS; FUCOSYLATED GLYCOPROTEINS; PROTEIN; EXPRESSION;
   IDENTIFICATION; APOPTOSIS; CELL; MECHANISMS; DIFFERENCE; HEMOPEXIN
AB In the present work, the effect of dioscin against liver fibrosis in rats caused by carbon tetrachloride (CCl4) was confirmed. Then, the differentially expressed proteins from rat liver were identified using two-dimensional differential in-gel electrophoresis technology. Ten new biomarkers including protein disulfide isomerase A3, selenium-binding protein 1, glutamine synthetase, senescence marker protein 30, hemopexin, keratin 8, keratin 18, vimentin, Annexin A5 and dermatopontin associated with liver fibrosis were found and validated, and new insights through affecting multiple drug targets and biological processes were also provided to reveal the mechanisms of dioscin against hepatic fibrosis for the first time.
C1 [Zhang, Xiaoling; Xu, Lina; Yin, Lianhong; Qi, Yan; Xu, Youwei; Han, Xu; Peng, Jinyong] Dalian Med Univ, Coll Pharm, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Peng, JY (corresponding author), Dalian Med Univ, Coll Pharm, Western 9 Lvshunnan Rd, Dalian 116044, Peoples R China.
EM jinyongpeng2005@163.com
RI Peng, Jin/HZH-6965-2023; xu, li/GNH-3667-2022
OI Zhang, Xiaoling/0000-0003-1157-0976
FU National Natural Science Foundation of China [81274195]; Program for
   Liaoning Innovative Research Team in University [LT2013019]; Program for
   New Century Excellent Talents in University [NCET-11-1007]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 81274195), the Program for Liaoning Innovative
   Research Team in University (LT2013019) and the Program for New Century
   Excellent Talents in University (NCET-11-1007).
CR Brautbar N, 2002, INT J HYG ENVIR HEAL, V205, P479, DOI 10.1078/1438-4639-00175
   Cheung KJ, 2009, J VIRAL HEPATITIS, V16, P418, DOI 10.1111/j.1365-2893.2009.01083.x
   Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x
   Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c
   Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672
   Dal Piaz F, 2013, J PROTEOMICS, V82, P14, DOI 10.1016/j.jprot.2013.01.030
   Debruyne EN, 2010, CLIN CHEM, V56, P823, DOI 10.1373/clinchem.2009.139295
   Delanghe JR, 2001, CLIN CHIM ACTA, V312, P13, DOI 10.1016/S0009-8981(01)00586-1
   Desjardins P, 1999, METAB BRAIN DIS, V14, P273, DOI 10.1023/A:1020741226752
   Ding M, 2010, BIOL TRACE ELEM RES, V133, P83, DOI 10.1007/s12011-009-8414-x
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200
   Henkel C, 2005, Z GASTROENTEROL, V43, P23, DOI 10.1055/s-2004-813911
   Issaq HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/elps.201000588
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   Jeong DH, 2013, INT J MOL SCI, V14, P23700, DOI 10.3390/ijms141223700
   Kaskiw MJ, 2009, BIOORGAN MED CHEM, V17, P7670, DOI 10.1016/j.bmc.2009.09.046
   Kato A, 2011, J BIOL CHEM, V286, P14861, DOI 10.1074/jbc.M110.179762
   Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976
   Liang SF, 2012, COMB CHEM HIGH T SCR, V15, P221, DOI 10.2174/138620712799218635
   Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07973
   Lu BN, 2011, PLANTA MED, V77, P407, DOI 10.1055/s-0030-1250461
   Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062
   Martyniuk CJ, 2012, ECOTOX ENVIRON SAFE, V76, P3, DOI 10.1016/j.ecoenv.2011.09.020
   Mermelekas G, 2013, EXPERT REV PROTEOMIC, V10, P537, DOI 10.1586/14789450.2013.855611
   Minden Jonathan S, 2012, Methods Mol Biol, V869, P287, DOI 10.1007/978-1-61779-821-4_24
   Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Patrick A. E., 2004, MOL CELL PROTEOMICS, V3, P729
   Paul D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783131
   Rouach H, 1997, HEPATOLOGY, V25, P351
   Sautour M, 2004, CHEM PHARM BULL, V52, P1353, DOI 10.1248/cpb.52.1353
   Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801
   Strnad P, 2008, GASTROENTEROLOGY, V134, P1169, DOI 10.1053/j.gastro.2008.01.035
   Tonge R, 2001, PROTEOMICS, V1, P377
   Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Xu LN, 2014, RSC ADV, V4, P30704, DOI 10.1039/c4ra03948c
   Zhang HY, 2014, PROTEOMICS, V14, P1977, DOI 10.1002/pmic.201300539
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
   Zhao XM, 2012, TOXICOL LETT, V214, P69, DOI 10.1016/j.toxlet.2012.08.005
NR 42
TC 33
Z9 34
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2015
VL 51
IS 55
BP 11064
EP 11067
DI 10.1039/c4cc09160d
PG 4
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA CL4PE
UT WOS:000356934500018
PM 26069897
DA 2024-02-19
ER

PT J
AU Cheng, Y
   He, CY
   Tian, DY
   Chen, SH
   Ren, JR
   Sun, HL
   Xu, MY
   Tan, CR
   Fan, DY
   Jian, JM
   Sun, PY
   Zeng, GH
   Shen, YY
   Shi, AY
   Jin, WS
   Bu, XL
   Liu, HM
   Xu, YM
   Wang, J
   Wang, YJ
AF Cheng, Yuan
   He, Chen-Yang
   Tian, Ding-Yuan
   Chen, Si-Han
   Ren, Jun-Rong
   Sun, Hao-Lun
   Xu, Man-Yu
   Tan, Cheng-Rong
   Fan, Dong-Yu
   Jian, Jie-Ming
   Sun, Pu-Yang
   Zeng, Gui-Hua
   Shen, Ying-Ying
   Shi, An-Yu
   Jin, Wang-Sheng
   Bu, Xian-Le
   Liu, Hong-Ming
   Xu, Yu-Ming
   Wang, Jun
   Wang, Yan-Jiang
TI Physiological β-amyloid clearance by the liver and its therapeutic
   potential for Alzheimer's disease
SO ACTA NEUROPATHOLOGICA
LA English
DT Article; Early Access
DE Alzheimer's disease; beta-Amyloid; Liver; LRP-1; Clearance
ID MOUSE MODEL; BRAIN; PROTOCOL; PROTEIN
AB Cerebral amyloid-beta (A beta) accumulation due to impaired A beta clearance is a pivotal event in the pathogenesis of Alzheimer's disease (AD). Considerable brain-derived A beta is cleared via transporting to the periphery. The liver is the largest organ responsible for the clearance of metabolites in the periphery. Whether the liver physiologically clears circulating A beta and its therapeutic potential for AD remains unclear. Here, we found that about 13.9% of A beta 42 and 8.9% of A beta 40 were removed from the blood when flowing through the liver, and this capacity was decreased with A beta receptor LRP-1 expression down-regulated in hepatocytes in the aged animals. Partial blockage of hepatic blood flow increased A beta levels in both blood and brain interstitial fluid. The chronic decline in hepatic A beta clearance via LRP-1 knockdown specific in hepatocytes aggravated cerebral A beta burden and cognitive deficits, while enhancing hepatic A beta clearance via LRP-1 overexpression attenuated cerebral A beta deposition and cognitive impairments in APP/PS1 mice. Our findings demonstrate that the liver physiologically clears blood A beta and regulates brain A beta levels, suggesting that a decline of hepatic A beta clearance during aging could be involved in AD development, and hepatic A beta clearance is a novel therapeutic approach for AD.
C1 [Cheng, Yuan; He, Chen-Yang; Tian, Ding-Yuan; Chen, Si-Han; Ren, Jun-Rong; Sun, Hao-Lun; Xu, Man-Yu; Tan, Cheng-Rong; Fan, Dong-Yu; Jian, Jie-Ming; Sun, Pu-Yang; Zeng, Gui-Hua; Shen, Ying-Ying; Shi, An-Yu; Jin, Wang-Sheng; Bu, Xian-Le; Wang, Jun; Wang, Yan-Jiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China.
   [Cheng, Yuan; He, Chen-Yang; Tian, Ding-Yuan; Chen, Si-Han; Ren, Jun-Rong; Sun, Hao-Lun; Xu, Man-Yu; Tan, Cheng-Rong; Fan, Dong-Yu; Jian, Jie-Ming; Sun, Pu-Yang; Zeng, Gui-Hua; Shen, Ying-Ying; Shi, An-Yu; Jin, Wang-Sheng; Bu, Xian-Le; Wang, Jun; Wang, Yan-Jiang] Third Mil Med Univ, Daping Hosp, Ctr Clin Neurosci, Chongqing, Peoples R China.
   [Cheng, Yuan; He, Chen-Yang; Chen, Si-Han; Ren, Jun-Rong; Xu, Man-Yu; Tan, Cheng-Rong; Jian, Jie-Ming; Sun, Pu-Yang; Zeng, Gui-Hua; Shen, Ying-Ying; Shi, An-Yu; Jin, Wang-Sheng; Bu, Xian-Le; Wang, Jun; Wang, Yan-Jiang] Third Mil Med Univ, Inst Brain & Intelligence, Chongqing, Peoples R China.
   [Cheng, Yuan; He, Chen-Yang; Chen, Si-Han; Ren, Jun-Rong; Xu, Man-Yu; Tan, Cheng-Rong; Jian, Jie-Ming; Sun, Pu-Yang; Zeng, Gui-Hua; Shen, Ying-Ying; Shi, An-Yu; Jin, Wang-Sheng; Bu, Xian-Le; Wang, Jun; Wang, Yan-Jiang] Chongqing Key Lab Ageing & Brain Dis, Chongqing, Peoples R China.
   [Cheng, Yuan] Fudan Univ, Shanghai Med Coll, Dept Neurol, Shanghai, Peoples R China.
   [Cheng, Yuan] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai Med Coll, Shanghai, Peoples R China.
   [Cheng, Yuan] Fudan Univ, Shanghai Med Coll, Frontiers Ctr Brain Sci, MOE, Shanghai, Peoples R China.
   [Cheng, Yuan] Natl Ctr Neurol Disorders, Shanghai, Peoples R China.
   [He, Chen-Yang] Gen Hosp Western Theater Command, Dept Neurol, Chengdu 610000, Peoples R China.
   [Tian, Ding-Yuan] Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China.
   [Sun, Hao-Lun; Fan, Dong-Yu] Third Mil Med Univ, Xinqiao Hosp, Shigatse Branch, Shigatse, Peoples R China.
   [Liu, Hong-Ming] Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China.
   [Xu, Yu-Ming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Henan, Peoples R China.
   [Wang, Yan-Jiang] Chongqing Inst Brain & Intelligence, Guangyang Bay Lab, Chongqing, Peoples R China.
   [Wang, Yan-Jiang] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China.
   [Wang, Yan-Jiang] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.
C3 Army Medical University; Army Medical University; Army Medical
   University; Fudan University; Fudan University; Fudan University; Army
   Medical University; Army Medical University; Army Medical University;
   Zhengzhou University; Chinese Academy of Sciences; Center for Excellence
   in Brain Science and Intelligence Technology, CAS; Army Medical
   University
RP Wang, J; Wang, YJ (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China.; Wang, J; Wang, YJ (corresponding author), Third Mil Med Univ, Daping Hosp, Ctr Clin Neurosci, Chongqing, Peoples R China.; Wang, J; Wang, YJ (corresponding author), Third Mil Med Univ, Inst Brain & Intelligence, Chongqing, Peoples R China.; Wang, J; Wang, YJ (corresponding author), Chongqing Key Lab Ageing & Brain Dis, Chongqing, Peoples R China.; Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Henan, Peoples R China.; Wang, YJ (corresponding author), Chongqing Inst Brain & Intelligence, Guangyang Bay Lab, Chongqing, Peoples R China.; Wang, YJ (corresponding author), Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China.; Wang, YJ (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.
EM xuyuming@zzu.edu.cn; qywangjun@163.com; yanjiang_wang@tmmu.edu.cn
RI zhang, ying/JQX-1479-2023; Li, Yan/JRW-0176-2023; Li, J N/JXL-5833-2024;
   zhao, lin/JJF-0406-2023; zhang, ly/JMB-7214-2023; Zhang,
   Wei/JKI-3565-2023; wang, xiaoxuan/JMP-6531-2023; wang,
   wei/JYP-7819-2024; li, xiang/JCN-9316-2023; Wang, Jing/JRW-1512-2023;
   yang, rui/JHI-3328-2023; Wang, Xin/JVE-0200-2024; Liu,
   Yang/JVD-6777-2023; wang, jun/JPY-3635-2023; liu, jingwen/JQW-9270-2023;
   Chen, Yu/JLL-0171-2023; Cheng, Yuan/JKJ-0794-2023; Chen,
   Nuo/JZD-0344-2024; Yun, Ji/KAL-9759-2024; YI, J/JJE-7713-2023; Wang,
   YUJIE/JXY-8442-2024; Wang, yl/JNR-4963-2023; zheng, yan/JKJ-3632-2023;
   lin, qing/JTU-4293-2023; Wang, Yue/JRY-8962-2023; li, li/JVP-2971-2024;
   Zhang, Wenbin/JXX-8070-2024; Zhang, Yuan/JUF-7293-2023; Zhang,
   Yunyi/JHS-3626-2023; LI, WEI/JUE-9796-2023; zhang, yuyang/IVV-5089-2023;
   Zhou, Hong/JKJ-1067-2023; Liu, Jie/JCP-1070-2023; Wang,
   Xuechun/JRX-6509-2023; Li, YU/JQV-2716-2023; wang, zhe/JNE-3510-2023;
   Li, Juan/JEO-6872-2023; zhao, yan/JNT-6961-2023; Hongming,
   Liu/F-9840-2018; liu, yang/JMB-9083-2023; wang, xin/JWA-3772-2024; Chen,
   Liang/JXX-7887-2024; li, yifan/JHU-9272-2023; Li, Wen/JQI-4757-2023; Li,
   Yan/JUU-5189-2023; yang, xiao/JLL-7721-2023; li, Li/JPA-0218-2023;
   zhang, xinyu/JKI-8403-2023; wang, yi/JYO-8193-2024; yuanyuan,
   Li/JEZ-6497-2023; Zhou, Yue/JHS-8791-2023; zhang, xiao/JCN-8822-2023
OI Wang, Yue/0000-0001-8673-6358; 
FU National Natural Science Foundation of China [81930028, 31921003]
FX AcknowledgementsWe sincerely appreciate Dr. Berislav V. Zlokovic at
   Zilkha Neurogenetic Institute, University of Southern California, for
   kindly providing the plasmid information of the LRP-1 minigene. This
   study was supported by the National Natural Science Foundation of China
   (No. 81930028 and 31921003).
CR Alexander GC, 2021, NEW ENGL J MED, V385, P769, DOI 10.1056/NEJMp2110468
   Boada M, 2020, ALZHEIMERS DEMENT, V16, P1412, DOI 10.1002/alz.12137
   CARLISLE KM, 1992, GUT, V33, P92, DOI 10.1136/gut.33.1.92
   Charni-Natan M, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100086
   Chen SH, 2022, NEUROSCI BULL, V38, P290, DOI 10.1007/s12264-021-00779-5
   COLERIDGE JCG, 1958, J PHYSIOL-LONDON, V142, P366, DOI 10.1113/jphysiol.1958.sp006023
   DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Filipovic B, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/9638797
   Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200
   Haeberlein SB, 2022, JPAD-J PREV ALZHEIM, V9, P197, DOI 10.14283/jpad.2022.30
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040
   Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9
   Jin WS, 2017, ACTA NEUROPATHOL, V134, P207, DOI 10.1007/s00401-017-1721-y
   Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5
   Liu YH, 2012, NAT REV NEUROL, V8, P465, DOI 10.1038/nrneurol.2012.118
   Macauley SL, 2015, J CLIN INVEST, V125, P2463, DOI 10.1172/JCI79742
   Mielke MM, 2022, NAT MED, V28, P1398, DOI 10.1038/s41591-022-01822-2
   Mohar I, 2015, METHODS MOL BIOL, V1325, P3, DOI 10.1007/978-1-4939-2815-6_1
   Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Nikolakopoulou AM, 2021, J EXP MED, V218, DOI 10.1084/jem.20202207
   Qosa H, 2014, NEUROPHARMACOLOGY, V79, P668, DOI 10.1016/j.neuropharm.2014.01.023
   Sakai K, 2016, J ALZHEIMERS DIS, V51, P997, DOI 10.3233/JAD-151139
   Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109
   Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210
   Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023
   Seo SW, 2016, NEUROLOGY, V86, P1136, DOI 10.1212/WNL.0000000000002498
   Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0
   Shinohara M, 2017, J LIPID RES, V58, P1267, DOI 10.1194/jlr.R075796
   Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004
   Syrjanen JA, 2022, ALZHEIMERS DEMENT, V18, P1128, DOI 10.1002/alz.12466
   Tamaki C, 2006, PHARM RES-DORDR, V23, P1407, DOI 10.1007/s11095-006-0208-7
   Tian DY, 2021, MOL PSYCHIATR, V26, P6074, DOI 10.1038/s41380-021-01073-6
   van Dyck CH, 2023, NEW ENGL J MED, V388, P9, DOI 10.1056/NEJMoa2212948
   Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111
   Weinstein G, 2019, LIVER INT, V39, P1713, DOI 10.1111/liv.14161
   Weinstein G, 2018, JAMA NEUROL, V75, P97, DOI 10.1001/jamaneurol.2017.3229
   Xiang Y, 2015, ACTA NEUROPATHOL, V130, P487, DOI 10.1007/s00401-015-1477-1
   Yang C, 2021, ZOOL RES, V42, P253, DOI 10.24272/j.issn.2095-8137.2020.368
   Yao XQ, 2015, MOL PSYCHIATR, V20, P1301, DOI 10.1038/mp.2015.49
NR 43
TC 13
Z9 15
U1 11
U2 17
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD 2023 JUN
PY 2023
VL 145
IS 6
BP 717
EP 731
AR s00401-023-02559-z
DI 10.1007/s00401-023-02559-z
EA MAR 2023
PG 15
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA AS4U7
UT WOS:000956115400001
PM 36964213
DA 2024-02-19
ER

PT J
AU Gagliano, N
   Arosio, B
   Grizzi, F
   Vergani, C
   Annoni, G
AF Gagliano, N
   Arosio, B
   Grizzi, F
   Vergani, C
   Annoni, G
TI Acute liver CCl<sub>4</sub> intoxication causes low HSP70 gene
   expression and a delayed transition through the cell cycle in aged rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE liver regeneration; aging; HSP70 gene
ID HEPATOCYTE GROWTH-FACTOR; FACTOR-ALPHA; PROTOONCOGENE EXPRESSION;
   TRANSFORMING GROWTH-FACTOR-BETA-1; PARTIAL-HEPATECTOMY; TRANSGENIC MICE;
   MESSENGER-RNA; TOXIC INJURY; REGENERATION; MYC
AB Since there is still debate about the ability of the aged liver to regenerate, we compared some aspects of this response in young, adult and old rodents. 2, 6, 12 and 19-month-old rats were intraperitoneally injected with CCl4 (3 mg/kg) or left untreated (CT) and killed either 2 h (group A) or 24 h (group 13) after intoxication. Liver injury was checked histologically and by assaying transaminases. mRNA levels of albumin (Alb), c-fos, c-myc, hepatocyte growth factor (HGF), transforming growth factor (TGF)-alpha and TGF-beta1 were also analyzed. Heat shock protein (HSP)70 gene expression was evaluated, and liver GSH content. Transaminases and histology show more damage in aged rats. Alb mRNA was reduced starting at 12 months in group A and at all ages in group B; c-fos and c-myc mRNAs reached the highest levels in 6-month-old rats and the lowest in those aged 12 and 19 months of group A. In group B, c-fos was detectable only in 6-month animals, but c-myc at all ages. HGF, TGF-alpha and TGF-beta1 mRNAs were up-regulated in treated rats, but to a lesser extent in the aged. HSP70 mRNA, absent in CT, was significantly increased at the age of 6 months, undetectable in the oldest rats in group A; in group B it was only visible in 6-month animals. GSH content was reduced with aging. In conclusion, during aging the liver regenerative machinery is preserved but its activation is reduced and delayed. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 IRCCS, Osped Maggiore, Dept Geriatr, Cattedra Geron & Geriatr, Milan, Italy.
   Univ Milan, Dept Internal Med, I-20122 Milan, Italy.
   Ist Clin Humanitas, Sci Direct, Milan, Italy.
   Univ Milano Bicocca, Dept Clin Med Prevent & Med Biotechnol, Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan;
   IRCCS Humanitas Research Hospital; University of Milano-Bicocca
RP Annoni, G (corresponding author), IRCCS, Osped Maggiore, Dept Geriatr, Cattedra Geron & Geriatr, Via Pace 9, Milan, Italy.
EM giorgio.annoni@unimib.it
RI Grizzi, Fabio/K-3448-2018; Gagliano, Nicoletta/L-1485-2016
OI Grizzi, Fabio/0000-0003-0925-742X; Gagliano,
   Nicoletta/0000-0002-3393-3144; Arosio, Beatrice/0000-0002-0615-3580
CR ADAM R, 1991, TRANSPLANT P, V23, P2602
   Akbulut KG, 1999, GERONTOLOGY, V45, P67, DOI 10.1159/000022065
   ARMELLES G, 1993, J PHYS IV, V3, P283, DOI 10.1051/jp4:1993556
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714
   CONI P, 1993, HEPATOLOGY, V17, P1109, DOI 10.1016/0270-9139(93)90130-F
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DUBOIS RD, 1990, HEPATOLOGY, V11, P1079, DOI 10.1002/hep.1840110626
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   Fausto N, 1991, Prog Growth Factor Res, V3, P219, DOI 10.1016/0955-2235(91)90008-R
   FAUSTO N, 1989, LAB INVEST, V60, P4
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831
   GOLDSWORTHY TL, 1994, CELL PROLIFERAT, V27, P269, DOI 10.1111/j.1365-2184.1994.tb01424.x
   HERBST H, 1991, LAB INVEST, V65, P324
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   JANSEN PLM, 1990, SCAND J GASTROENTERO, V25, P112, DOI 10.3109/00365529009107931
   JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q
   KARN J, 1989, ONCOGENE, V4, P773
   LABRECQUE D, 1994, AM J GASTROENTEROL, V89, pS86
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LEE GH, 1992, CANCER RES, V52, P5162
   LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443
   Masson S, 1999, LIVER, V19, P312, DOI 10.1111/j.1478-3231.1999.tb00055.x
   MEAD JE, 1990, CANCER RES, V50, P7023
   MEAD JE, 1989, P NATL ACAD SCI USA, V86, P1558, DOI 10.1073/pnas.86.5.1558
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   NAKATSUKASA H, 1990, LAB INVEST, V63, P171
   PANDURO A, 1987, HEPATOLOGY, V7, pS10, DOI 10.1002/hep.1840070703
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Schiaffonati L, 1997, LIVER, V17, P183
   SCHMIEDEBERG P, 1993, J CELL PHYSIOL, V154, P294, DOI 10.1002/jcp.1041540212
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SHIOTA G, 1994, HEPATOLOGY, V19, P962, DOI 10.1002/hep.1840190423
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SORRENTINO V, 1986, P NATL ACAD SCI USA, V83, P8167, DOI 10.1073/pnas.83.21.8167
   SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   SUBJECK JR, 1986, AM J PHYSIOL, V250, pC1, DOI 10.1152/ajpcell.1986.250.1.C1
   THOMPSON NL, 1986, CANCER RES, V46, P3111
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   TOMIYA T, 1992, HEPATOLOGY, V15, P1, DOI 10.1002/hep.1840150102
   Tomiya T, 1998, AM J PATHOL, V153, P955, DOI 10.1016/S0002-9440(10)65637-4
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   WEBBER EM, 1993, HEPATOLOGY, V18, P1422, DOI 10.1002/hep.1840180622
   WEBBER EM, 1994, HEPATOLOGY, V19, P489
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
NR 53
TC 10
Z9 11
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2002
VL 37
IS 6
BP 791
EP 801
AR PII S0531-5565(02)00022-0
DI 10.1016/S0531-5565(02)00022-0
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 566LD
UT WOS:000176428800006
PM 12175479
DA 2024-02-19
ER

PT J
AU Chen, JC
AF Chen, Jichun
TI Hematopoietic stem cell development, aging and functional failure
SO INTERNATIONAL JOURNAL OF HEMATOLOGY
LA English
DT Article
DE Hematopoietic stem cells; Ontogeny; Niche; Senescence; Bone marrow
   failure
ID TELOMERASE REVERSE-TRANSCRIPTASE; UMBILICAL-CORD BLOOD; COLONY-FORMING
   CELLS; BONE-MARROW FAILURE; APLASTIC-ANEMIA; LONG-TERM;
   DYSKERATOSIS-CONGENITA; PROGENITOR CELLS; MOUSE MODEL; LIFE-SPAN
AB Hematopoietic stem cells (HSCs) are found in yolk sac, fetal liver, umbilical cord blood, placenta, and amniotic fluid during mammalian embryonic development. In adults, HSCs reside in marrow cavity of long bones where they self-renew and differentiate to replenish short-lived mature blood cells. HSCs exist in very low frequencies within specific "niches" where they interact with the surrounding environment through molecular associations. Overall HSC function can last much longer than a normal lifetime, but HSCs do show functional senescence with characteristic features of decreased self-renewal, reduced clonal stability, reduced homing and engraftment, and biased lineage commitment. The progressive shortening of telomeres with increasing age, especially under conditions with specific mutations in the telomerase gene complex, could predispose patients to HSC dysfunction and bone marrow failure diseases. Continuous investigation into HSC biology should facilitate the utilization of HSCs as a therapeutic modality and helps to prevent HSC malfunction.
C1 NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI)
RP Chen, JC (corresponding author), NHLBI, Hematol Branch, NIH, Bldg 10,Clin Res Ctr Room 3E-5132,10 Ctr Dr, Bethesda, MD 20892 USA.
EM chenji@nhlbi.nih.gov
FU NIH
FX This work was supported by NIH intramural research funds.
CR Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822
   ABKOWITZ JL, 1990, P NATL ACAD SCI USA, V87, P9062, DOI 10.1073/pnas.87.22.9062
   Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190
   Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334
   Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917
   Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005
   Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102
   Aspesi A, 2010, PEDIATR BLOOD CANCER, V55, P550, DOI 10.1002/pbc.22589
   AUERBACH AD, 1990, TRANSFUSION, V30, P682, DOI 10.1046/j.1537-2995.1990.30891020324.x
   Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738
   Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bloom ML, 2004, EXP HEMATOL, V32, P1163, DOI 10.1016/j.exphem.2004.08.006
   Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764
   BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828
   Calado RT, 2007, BLOOD, V110, P1141, DOI 10.1182/blood-2007-03-080044
   Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Chen J, 2004, BLOOD, V104, P1671, DOI 10.1182/blood-2004-03-1115
   Chen JC, 2004, EXP HEMATOL, V32, P1025, DOI 10.1016/j.exphem.2004.08.001
   Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1
   Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5
   Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012
   Chen JC, 2007, J IMMUNOL, V178, P4159, DOI 10.4049/jimmunol.178.7.4159
   Chen JC, 2005, CLIN MED RES, V3, P102, DOI 10.3121/cmr.3.2.102
   Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804
   Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173
   de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301
   de Latour RP, 2010, BLOOD, V116, P4175, DOI 10.1182/blood-2010-01-266098
   deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105
   Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760
   Ferkowicz MJ, 2005, EXP HEMATOL, V33, P1041, DOI 10.1016/j.exphem.2005.06.006
   FERREBEE JW, 1959, BLOOD, V14, P140, DOI 10.1182/blood.V14.2.140.140
   Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6
   GLUCKMAN E, 1993, BONE MARROW TRANSPL, V11, P199
   GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570
   Han B, 2010, LEUKEMIA RES, V34, P258, DOI 10.1016/j.leukres.2009.11.001
   HARRISON DE, 1975, J IMMUNOL, V114, P1314
   HARRISON DE, 1979, MECH AGEING DEV, V9, P427, DOI 10.1016/0047-6374(79)90083-6
   Harrison DE, 1997, EXP HEMATOL, V25, P293
   HARRISON DE, 1972, SCIENCE, V177, P187, DOI 10.1126/science.177.4044.187
   HARRISON DE, 1975, J GERONTOL, V30, P279, DOI 10.1093/geronj/30.3.279
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   JORDAN CT, 1995, EXP HEMATOL, V23, P1011
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005
   Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135
   Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Lowry P A, 1996, Biol Blood Marrow Transplant, V2, P15
   Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086
   Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659
   Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829
   Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851
   MOORE MAS, 1970, J CELL PHYSIOL, V75, P181, DOI 10.1002/jcp.1040750207
   MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x
   MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013
   Nilsson SK, 1999, J EXP MED, V189, P729, DOI 10.1084/jem.189.4.729
   Omokaro SO, 2009, J IMMUNOL, V182, P3414, DOI 10.4049/jimmunol.0801430
   QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P348
   Ramshaw H S, 1995, Biol Blood Marrow Transplant, V1, P74
   Rao SS, 1997, EXP HEMATOL, V25, P114
   Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001
   Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725
   Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767
   SANCHEZMEDAL L, 1969, BLOOD-J HEMATOL, V34, P283, DOI 10.1182/blood.V34.3.283.283
   Sarcon AK, 2009, EXP HEMATOL, V37, P477, DOI 10.1016/j.exphem.2008.12.001
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Shepherd BE, 2007, BLOOD, V110, P1806, DOI 10.1182/blood-2007-02-075382
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   STEWART FM, 1993, BLOOD, V81, P2566
   Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273
   Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016
   Tang Y, 2010, BLOOD, V115, P541, DOI 10.1182/blood-2009-03-211383
   THOMAS ED, 1962, TRANSFUSION, V2, P115, DOI 10.1111/j.1537-2995.1962.tb00205.x
   THOMAS ED, 1959, BLOOD, V14, P720, DOI 10.1182/blood.V14.6.720.720
   THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102
   THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949
   VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547
   Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6
   Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389
   WAGNER JE, 1992, BLOOD, V79, P1874
   Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639
   Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089
   Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272
   Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980
   Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335
   Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457
   Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020
   Yoshimoto M, 2009, NATURE, V457, P801, DOI 10.1038/457801a
   Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002
   Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777
   YOUNG NS, 2010, J AM SOC BLOOD MAR S, V16, pS119
   Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256
NR 109
TC 14
Z9 17
U1 0
U2 6
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 0925-5710
EI 1865-3774
J9 INT J HEMATOL
JI Int. J. Hematol.
PD JUL
PY 2011
VL 94
IS 1
BP 3
EP 10
DI 10.1007/s12185-011-0856-1
PG 8
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 789JX
UT WOS:000292512900002
PM 21523336
DA 2024-02-19
ER

PT J
AU Wu, Y
   Dong, JH
   Dai, YF
   Zhu, MZ
   Wang, MY
   Zhang, Y
   Pan, YD
   Yuan, XR
   Guo, ZX
   Wang, CX
   Li, YQ
   Zhu, XH
AF Wu, Yu
   Dong, Jing-Hua
   Dai, Yong-Feng
   Zhu, Min-Zhen
   Wang, Meng-Yao
   Zhang, Yuan
   Pan, Yi-Da
   Yuan, Xin-Rui
   Guo, Zhi-Xin
   Wang, Chen-Xi
   Li, Yuan-Qing
   Zhu, Xin-Hong
TI Hepatic soluble epoxide hydrolase activity regulates cerebral AD
   metabolism and the pathogenesis of Alzheimer's disease in mice
SO NEURON
LA English
DT Article; Early Access
ID COGNITIVE IMPAIRMENT; MEDIATES RESILIENCE; AMYLOID-BETA; MODEL;
   AGGREGATION; CELLS; IDENTIFICATION; METAANALYSIS; MECHANISMS; MUTATIONS
AB Alzheimer's disease (AD) is caused by a complex interaction between genetic and environmental factors. However, how the role of peripheral organ changes in response to environmental stimuli during aging in AD pathogenesis remains unknown. Hepatic soluble epoxide hydrolase (sEH) activity increases with age. Hepatic sEH manipulation bidirectionally attenuates brain amyloid-D (AD) burden, tauopathy, and cognitive deficits in AD mouse models. Moreover, hepatic sEH manipulation bidirectionally regulates the plasma level of 14,15-epoxyeicosatrienoic acid (-EET), which rapidly crosses the blood-brain barrier and modulates brain AD metabolism through multiple pathways. A balance between the brain levels of 14,15-EET and AD is essential for preventing AD deposition. In AD models, 14,15-EET infusion mimicked the neuroprotective effects of hepatic sEH ablation at biological and behavioral levels. These results highlight the liver's key role in AD pathology, and targeting the liver-brain axis in response to environmental stimuli may constitute a promising therapeutic approach for AD prevention.
C1 [Wu, Yu; Zhang, Yuan; Zhu, Xin-Hong] Shenzhen Univ, Sch Psychol, Shenzhen 518060, Peoples R China.
   [Wu, Yu; Dong, Jing-Hua; Dai, Yong-Feng; Zhu, Min-Zhen; Wang, Meng-Yao; Zhang, Yuan; Pan, Yi-Da; Yuan, Xin-Rui; Guo, Zhi-Xin; Wang, Chen-Xi; Zhu, Xin-Hong] Res Ctr Brain Hlth, Pazhou Lab, Guangzhou 510330, Peoples R China.
   [Dai, Yong-Feng; Pan, Yi-Da; Zhu, Xin-Hong] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou 510006, Peoples R China.
   [Zhu, Min-Zhen; Wang, Chen-Xi; Li, Yuan-Qing] South China Univ Technol, Sch Automat Sci & Engn, Guangzhou 510640, Peoples R China.
   [Li, Yuan-Qing] Res Ctr Brain Comp Interface, Pazhou Lab, Guangzhou 510330, Peoples R China.
C3 Shenzhen University; Pazhou Lab; South China University of Technology;
   South China University of Technology; Pazhou Lab
RP Zhu, XH (corresponding author), Shenzhen Univ, Sch Psychol, Shenzhen 518060, Peoples R China.; Zhu, XH (corresponding author), Res Ctr Brain Hlth, Pazhou Lab, Guangzhou 510330, Peoples R China.; Zhu, XH (corresponding author), South China Univ Technol, Sch Biol & Biol Engn, Guangzhou 510006, Peoples R China.
EM zhuxh527@126.com
RI WU, YU/HZL-7897-2023
OI WU, YU/0000-0003-0205-6529
FU National Natural Science Foundation of China [81930034]; Scientificand
   Technological Innovation of China-Major Project;  [2022ZD0211700]
FX We thank Xue-fang Zeng and Sheng-quan Zheng, Pazhou Lab, for their
   technical support. This study was supported by the National Natural
   Science Foundation of China (81930034 to X.-H.Z.) and the Scientificand
   Technological Innovation 2030 of China-Major Project (2022ZD0211700 to
   X.-H.Z.) .
CR Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051
   Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043
   Bellou V, 2017, ALZHEIMERS DEMENT, V13, P406, DOI 10.1016/j.jalz.2016.07.152
   Bergmann CB, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2120691119
   Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013
   Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162
   Carloni S, 2021, SCIENCE, V374, P439, DOI 10.1126/science.abc6108
   Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009
   Chen WJ, 2020, J NEUROSCI, V40, P8188, DOI 10.1523/JNEUROSCI.1246-20.2020
   Chu C, 2019, NATURE, V574, P543, DOI 10.1038/s41586-019-1644-y
   Colombani AL, 2009, DIABETES, V58, P2189, DOI 10.2337/db09-0110
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X
   Emperador-Melero J, 2019, NEUROSCIENCE, V420, P32, DOI 10.1016/j.neuroscience.2018.11.014
   Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Ghosh A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb1206
   Giannisis A, 2022, MOL PSYCHIATR, V27, P3533, DOI 10.1038/s41380-022-01548-0
   Harerimana NV, 2022, BIOL PSYCHIAT, V92, P25, DOI 10.1016/j.biopsych.2021.11.025
   Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008
   He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437
   Hosang L, 2022, NATURE, V603, P138, DOI 10.1038/s41586-022-04427-4
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jais A, 2016, CELL, V165, P882, DOI 10.1016/j.cell.2016.03.033
   Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6
   Koutsodendris N, 2022, ANNU REV PATHOL-MECH, V17, P73, DOI 10.1146/annurev-pathmechdis-030421-112756
   Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851
   Lee HT, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1635-9
   Li HY, 2023, CELL, V186, P1352, DOI 10.1016/j.cell.2023.02.036
   Li W, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.780174
   Li XY, 2013, J NEUROSCI, V33, P19423, DOI 10.1523/JNEUROSCI.2561-13.2013
   Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Liu CC, 2022, NAT NEUROSCI, V25, P1020, DOI 10.1038/s41593-022-01127-0
   Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
   Lu YF, 2021, J ALZHEIMERS DIS, V79, P1775, DOI 10.3233/JAD-201241
   Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718
   Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   Martens YA, 2022, NEURON, V110, P1304, DOI 10.1016/j.neuron.2022.03.004
   Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244
   Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Orefice LL, 2016, CELL, V166, P299, DOI 10.1016/j.cell.2016.05.033
   Qin XH, 2019, CELL REP, V29, P3223, DOI 10.1016/j.celrep.2019.11.006
   Reagh ZM, 2018, NEURON, V97, P1187, DOI 10.1016/j.neuron.2018.01.039
   Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108
   Rubin R, 2022, JAMA-J AM MED ASSOC, V327, P2281, DOI 10.1001/jama.2022.9847
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Scheltens P, 2021, LANCET, V397, P1577, DOI 10.1016/S0140-6736(20)32205-4
   Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721
   Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1
   Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687
   Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035
   Tabula Muris Consortium, 2020, Nature, V583, P590, DOI 10.1038/s41586-020-2496-1
   Tcw J, 2022, CELL, V185, P2213, DOI 10.1016/j.cell.2022.05.017
   Teunissen CE, 2022, LANCET NEUROL, V21, P66, DOI 10.1016/S1474-4422(21)00361-6
   Therriault J, 2022, TRENDS MOL MED, V28, P726, DOI 10.1016/j.molmed.2022.05.008
   Tian DY, 2021, MOL PSYCHIATR, V26, P6074, DOI 10.1038/s41380-021-01073-6
   Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020
   Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223
   Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4
   Xiong WC, 2019, J NEUROSCI, V39, P4606, DOI 10.1523/JNEUROSCI.3069-18.2019
   Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015
   Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976
   Zabaleta N, 2023, NAT REV GASTRO HEPAT, V20, P288, DOI 10.1038/s41575-022-00729-0
   Zhang Y, 2018, J CHROMATOGR A, V1563, P144, DOI 10.1016/j.chroma.2018.05.072
   Zhang Y, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.631424
   Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010
NR 74
TC 4
Z9 4
U1 22
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD 2023 SEP 20
PY 2023
VL 111
IS 18
BP 2847
EP +
DI 10.1016/j.neuron.2023.06.002
EA SEP 2023
PG 27
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA U2MO9
UT WOS:001083198900001
PM 37402372
OA Bronze
DA 2024-02-19
ER

PT J
AU Liu, ZB
   Han, TZ
   Werner, H
   Rosen, CJ
   Schaffler, MB
   Yakar, S
AF Liu, Zhongbo
   Han, Tianzhen
   Werner, Haim
   Rosen, Clifford J.
   Schaffler, Mitchell B.
   Yakar, Shoshana
TI Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main
   Determinant of Low Cortical but Not Trabecular Bone Mass
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article
DE GROWTH HORMONE RECEPTOR; MICRO-CT; DYSLIPIDEMIA; PARATHYROID HORMONE;
   OSTEOCALCIN; OSTEOPROTEGERIN; OSTEOPONTIN
ID FATTY LIVER-DISEASE; MINERAL-DENSITY; OSTEOCALCIN LEVELS; OXIDATIVE
   STRESS; INSULIN SENSITIVITY; FREE-RADICALS; BODY-SIZE; OSTEOPOROSIS;
   GROWTH; CYTOKINES
AB Hepatic osteodystrophy is multifactorial in its pathogenesis. Numerous studies have shown that impairments of the hepatic growth hormone/insulin-like growth factor-1 axis (GH/IGF-1) are common in patients with non-alcoholic fatty liver disease, chronic viral hepatitis, liver cirrhosis, and chronic cholestatic liver disease. Moreover, these conditions are also associated with low bone mineral density (BMD) and greater fracture risk, particularly in cortical bone sites. Hence, we addressed whether disruptions in the GH/IGF-1 axis were causally related to the low bone mass in states of chronic liver disease using a mouse model of liver-specific GH-receptor (GHR) gene deletion (Li-GHRKO). These mice exhibit chronic hepatic steatosis, local inflammation, and reduced BMD. We then employed a crossing strategy to restore liver production of IGF-1 via hepatic IGF-1 transgene (HIT). The resultant Li-GHRKO-HIT mouse model allowed us to dissect the roles of liver-derived IGF-1 in the pathogenesis of osteodystrophy during liver disease. We found that hepatic IGF-1 restored cortical bone acquisition, microarchitecture, and mechanical properties during growth in Li-GHRKO-HIT mice, which was maintained during aging. However, trabecular bone volume was not restored in the Li-GHRKO-HIT mice. We found increased bone resorption indices in vivo as well as increased basal reactive oxygen species and increased mitochondrial stress in osteoblast cultures from Li-GHRKO and the Li-GHRKO-HIT compared with control mice. Changes in systemic markers such as inflammatory cytokines, osteoprotegerin, osteopontin, parathyroid hormone, osteocalcin, or carboxy-terminal collagen cross-links could not fully account for the diminished trabecular bone in the Li-GHRKO-HIT mice. Thus, the reduced serum IGF-1 associated with hepatic osteodystrophy is a main determinant of low cortical but not trabecular bone mass. (c) 2017 American Society for Bone and Mineral Research.
C1 [Liu, Zhongbo; Han, Tianzhen; Yakar, Shoshana] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, David B Kriser Dent Ctr, 345 East 24th St, New York, NY 10010 USA.
   [Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.
   [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA.
   [Schaffler, Mitchell B.] CUNY City Coll, Dept Biomed Engn, New York, NY USA.
C3 New York University; Sackler Faculty of Medicine; Maine Medical Center;
   City University of New York (CUNY) System; City College of New York
   (CUNY)
RP Yakar, S (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, David B Kriser Dent Ctr, 345 East 24th St, New York, NY 10010 USA.
EM sy1007@nyu.edu
RI Liu, Zhongbo/U-3004-2017; Yakar, Shoshana/IUN-5716-2023; ROsen, Dr.
   Clifford/JOZ-3228-2023
OI Yakar, Shoshana/0000-0002-2352-1330; Schaffler,
   Mitchell/0000-0001-5780-7073
FU National Institutes of Health [DK100246]; Bi-national Science Foundation
   [2013282];  [S10OD010751-01A1];  [AR041210];  [AR057139]
FX Financial support was received from National Institutes of Health grant
   DK100246 to SY, Bi-national Science Foundation grant 2013282 to SY and
   HW, S10OD010751-01A1 instrument (micro-CT) grant to NYUCD, and AR041210
   and AR057139 to MBS.
CR Taveira ATA, 2007, CLIN ENDOCRINOL, V66, P518, DOI 10.1111/j.1365-2265.2007.02765.x
   Aller R, 2011, ANN HEPATOL, V10, P50, DOI 10.1016/S1665-2681(19)31587-X
   Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200
   Banfi G, 2008, CLIN CHEM LAB MED, V46, P1550, DOI 10.1515/CCLM.2008.302
   Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400
   BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Burgert TS, 2006, J CLIN ENDOCR METAB, V91, P4287, DOI 10.1210/jc.2006-1010
   Campos RMS, 2012, ENDOCRINE, V42, P146, DOI 10.1007/s12020-012-9613-3
   Collier JD, 2002, GUT, V50, P1
   Courtland HW, 2010, J BONE MINER RES, V25, P2059, DOI 10.1002/jbmr.94
   Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713
   CUTHBERT JA, 1984, HEPATOLOGY, V4, P1, DOI 10.1002/hep.1840040101
   De Benedetti F, 2009, HORM RES, V72, P26, DOI 10.1159/000229760
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Desler Claus, 2011, J Aging Res, V2011, P407536, DOI 10.4061/2011/407536
   DIAMOND TH, 1989, GASTROENTEROLOGY, V96, P213, DOI 10.1016/0016-5085(89)90783-X
   Rodríguez RD, 2014, NUTR HOSP, V30, P1256, DOI 10.3305/nh.2014.30.6.7948
   Dou JX, 2013, CLIN EXP PHARMACOL P, V40, P282, DOI 10.1111/1440-1681.12063
   Du J, 2015, INT J CLIN EXP MED, V8, P21435
   Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372
   Elis S, 2011, AGING CELL, V10, P547, DOI 10.1111/j.1474-9726.2011.00683.x
   Elis S, 2010, J BONE MINER RES, V25, P2051, DOI 10.1002/jbmr.100
   Elis S, 2010, J BONE MINER RES, V25, P1257, DOI 10.1002/jbmr.20
   Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308
   Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030
   GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485
   Gaudio A, 2005, J ENDOCRINOL INVEST, V28, P677, DOI 10.1007/BF03347549
   George J, 2009, WORLD J GASTROENTERO, V15, P3516, DOI 10.3748/wjg.15.3516
   Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639
   Guañabens N, 2009, J BONE MINER METAB, V27, P347, DOI 10.1007/s00774-009-0042-1
   Gur A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-30
   Handzlik-Orlik G, 2016, THER ADV ENDOCRINOL, V7, P128, DOI 10.1177/2042018816641351
   Hegedus C, 2015, FREE RADICAL BIO MED, V82, P179, DOI 10.1016/j.freeradbiomed.2015.01.027
   Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x
   KEY LL, 1994, BONE, V15, P431, DOI 10.1016/8756-3282(94)90821-4
   Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903
   Lakatos Peter Laszlo, 2004, Orv Hetil, V145, P331
   Lavine Joel E, 2004, Clin Liver Dis, V8, P549, DOI 10.1016/j.cld.2004.04.010
   Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010
   Liu JJ, 2013, INT J MOL SCI, V14, P19782, DOI 10.3390/ijms141019782
   Liu ZB, 2016, DIABETES, V65, P3598, DOI 10.2337/db16-0649
   López-Larramona G, 2015, HEPATOL RES, V45, P618, DOI 10.1111/hepr.12395
   López-Larramona G, 2011, WORLD J HEPATOL, V3, P300, DOI 10.4254/wjh.v3.i12.300
   Luo YQ, 2015, ACTA PHARMACOL SIN, V36, P1497, DOI 10.1038/aps.2015.81
   Lupoli R, 2016, CLIN ENDOCRINOL, V84, P30, DOI 10.1111/cen.12780
   Luxon Bruce A, 2011, Curr Gastroenterol Rep, V13, P40, DOI 10.1007/s11894-010-0166-4
   Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294
   Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357
   MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506
   Manolagas SC, 1998, ANN NY ACAD SCI, V840, P194, DOI 10.1111/j.1749-6632.1998.tb09563.x
   Marek B, 2015, ENDOKRYNOL POL, V66, P22, DOI 10.5603/EP.2015.0005
   Mitchell R, 2011, WORLD J HEPATOL, V3, P157, DOI 10.4254/wjh.v3.i6.157
   Moon SS, 2012, ENDOCRINE, V42, P423, DOI 10.1007/s12020-012-9639-6
   Natale VM, 1997, MECH AGEING DEV, V94, P17, DOI 10.1016/S0047-6374(96)01844-1
   Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489
   Nordstrom SM, 2013, MOL ENDOCRINOL, V27, P1333, DOI 10.1210/me.2013-1110
   Okajima H, 2003, LIVER TRANSPLANT, V9, P360, DOI 10.1053/jlts.2001.50038
   Olivier BJ, 2008, HEPATOLOGY, V47, P259, DOI 10.1002/hep.21971
   Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190
   Pacifici R, 2013, AM J TRANSPLANT, V13, P2245, DOI 10.1111/ajt.12380
   Pardee PE, 2012, ALIMENT PHARM THER, V35, P248, DOI 10.1111/j.1365-2036.2011.04924.x
   PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116
   Pirgon O, 2011, CLIN ENDOCRINOL, V75, P189, DOI 10.1111/j.1365-2265.2011.04038.x
   Purnak T, 2012, WIEN KLIN WOCHENSCHR, V124, P526, DOI 10.1007/s00508-012-0211-4
   RASLAN HM, 2010, EGYPT TRANS R SOC TR, V104, P429, DOI DOI 10.1016/J.TRSTMH.2010.01.012
   Robaszkiewicz A, 2012, FREE RADICAL BIO MED, V53, P1552, DOI 10.1016/j.freeradbiomed.2012.08.567
   Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20
   Sangun O, 2011, J CLIN RES PEDIATR E, V3, P70, DOI 10.4274/jcrpe.v3i2.15
   Schlecht SH, 2013, BONE, V56, P127, DOI 10.1016/j.bone.2013.05.012
   Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Smietana MJ, 2010, BIOCHEM BIOPH RES CO, V403, P149, DOI 10.1016/j.bbrc.2010.11.006
   Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284
   Sucur A, 2014, INT ORTHOP, V38, P1893, DOI 10.1007/s00264-014-2386-y
   Taveira ATA, 2010, BRAZ J MED BIOL RES, V43, P1127, DOI 10.1590/S0100-879X2010001100017
   Trost Z, 2010, BONE, V46, P72, DOI 10.1016/j.bone.2009.09.015
   Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Wu YJ, 2013, J BONE MINER RES, V28, P1575, DOI 10.1002/jbmr.1920
   Wu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008054
   Wu YJ, 2009, ENDOCRINOLOGY, V150, P4395, DOI 10.1210/en.2009-0272
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yakar S, 2016, GROWTH HORM IGF RES, V28, P26, DOI 10.1016/j.ghir.2015.09.004
   Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]
   Yang HJ, 2016, EUR J GASTROEN HEPAT, V28, P338, DOI 10.1097/MEG.0000000000000535
   Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P345, DOI 10.1111/j.1365-2036.2012.05196.x
   Yilmaz Y, 2013, DIGEST LIVER DIS, V45, P58, DOI 10.1016/j.dld.2012.08.017
   Yu NY, 2017, CLIN RADIOL, V72
NR 89
TC 19
Z9 19
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD JAN
PY 2018
VL 33
IS 1
BP 123
EP 136
DI 10.1002/jbmr.3290
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FS9FX
UT WOS:000422723400016
PM 28902430
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Nakata, K
   Kawase, M
   Ogino, S
   Kinoshita, C
   Murata, H
   Sakaue, T
   Ogata, K
   Ohmori, S
AF Nakata, K
   Kawase, M
   Ogino, S
   Kinoshita, C
   Murata, H
   Sakaue, T
   Ogata, K
   Ohmori, S
TI Effects of age on levels of cysteine, glutathione and related enzyme
   activities in livers of mice and rats and an attempt to replenish
   hepatic glutathione level of mouse with cysteine derivatives
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE age; cystathionase; cystathionine-synthase; cysteine; cysteine
   derivatives; glutathione
ID ACETAMINOPHEN-INDUCED HEPATOTOXICITY; LIPID-PEROXIDATION; AGING MOUSE;
   METABOLISM; TISSUES; CYSTATHIONINE; HEPATOCYTES; DEPLETION; ACID; GSH
AB There was a large statistically significant decrease in the hepatic level of cysteine and glutathione (GSH) in 24 month-old mice compared to young mice, while, cystine and glutathione disulfide (GSSG) contents in the liver did not differ between young and old mice. Activities of cystathionine gamma-lyase and beta-synthase in mouse liver of the 24 month-old group were significantly decreased. In rats, the hepatic levels of cysteine, cystine, GSH and GSSG exhibited no statistically significant change during aging to 30 month. As the rats matured, total hepatic activities of both cystathionine gamma-lyase and beta-synthase increased with maximum levels at 24 months of age and decreased to the same level found in 5 week old for the former and to 22% of that in 5 week old for the latter. Intraperitoneal administration of diethyl maleate to mice led to depletion of hepatic GSH. When N-acetylcysteine and a thiazolidine derivative were intravenously injected after diethyl maleate administration, the hepatic GSH level of mice was restored to the normal level.
C1 OKAYAMA UNIV,FAC PHARMACEUT SCI,OKAYAMA 700,JAPAN.
   SENJU PHARMACEUT CO LTD,ITAMI,HYOGO 664,JAPAN.
C3 Okayama University; Senju Pharmaceutical Co. Ltd.
CR AWATA S, 1984, SULFUR AMINO ACIDS, V7, P407
   COOPER AJL, 1982, J BIOL CHEM, V257, P816
   CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   ESTRELA JM, 1983, BIOCHEM PHARMACOL, V32, P3483, DOI 10.1016/0006-2952(83)90381-7
   FISCHERNIELSEN A, 1989, J HEPATOL, V9, P190, DOI 10.1016/0168-8278(89)90050-0
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   GAULL G, 1972, PEDIATR RES, V6, P538, DOI 10.1203/00006450-197206000-00002
   HAZELTON GA, 1986, J PHARMACOL EXP THER, V237, P341
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   JENKINSON SG, 1991, AM J MED SCI, V302, P347, DOI 10.1097/00000441-199112000-00004
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KITAMURA Y, 1989, J PHARMACOL EXP THER, V250, P667
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   Matsumoto S, 1996, ANAL SCI, V12, P91, DOI 10.2116/analsci.12.91
   OHMORI S, 1992, J CHROMATOGR-BIOMED, V574, P35, DOI 10.1016/0378-4347(92)80095-8
   OHMORI S, 1983, J CLIN CHEM CLIN BIO, V21, P851
   RICHARDSON RJ, 1975, TOXICOL APPL PHARM, V31, P505, DOI 10.1016/0041-008X(75)90274-4
   RIKANS LE, 1993, TOXICOL APPL PHARM, V118, P263, DOI 10.1006/taap.1993.1032
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670
   SCHONBECK ND, 1975, J BIOL CHEM, V250, P5343
   STOHS SJ, 1984, GEN PHARMACOL, V15, P267, DOI 10.1016/0306-3623(84)90173-3
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   TESHIGAWARA M, 1995, RES EXP MED, V195, P55, DOI 10.1007/BF02576774
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
   VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P
   WHITE RD, 1993, TOXICOL LETT, V69, P15, DOI 10.1016/0378-4274(93)90140-S
   WILLIAMSON JM, 1981, P NATL ACAD SCI-BIOL, V78, P936, DOI 10.1073/pnas.78.2.936
   WLODEK L, 1993, BIOCHEM PHARMACOL, V46, P1917, DOI 10.1016/0006-2952(93)90632-7
NR 31
TC 70
Z9 75
U1 0
U2 6
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP 30
PY 1996
VL 90
IS 3
BP 195
EP 207
DI 10.1016/0047-6374(96)01771-X
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA VK688
UT WOS:A1996VK68800003
PM 8898313
DA 2024-02-19
ER

PT J
AU Wu, J
   Liu, JY
   Lapenta, K
   Desrouleaux, R
   Li, MD
   Yang, XY
AF Wu, Jing
   Liu, Jiayu
   Lapenta, Kalina
   Desrouleaux, Reina
   Li, Min-Dian
   Yang, Xiaoyong
TI Regulation of the urea cycle by CPS1 <i>O</i>-GlcNAcylation in response
   to dietary restriction and aging
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Article; Early Access
DE ageing; O-GlcNAcylation; urea cycle; carbamoyl-phosphate synthetase 1;
   calorie restriction; post-translational modification; dietary
   restriction
ID MEDIATED LIFE-SPAN; GLCNAC MODIFICATION; POSTTRANSLATIONAL MODIFICATION;
   MITOCHONDRIAL PROTEINS; N-ACETYLGLUCOSAMINE; GICNAC MODIFICATION;
   ADIPOSE-TISSUE; GLYCOSYLATION; LIVER; ACETYLTRANSFERASE
AB O-linked N-acetyl-glucosamine glycosylation (O-GlcNAcylation) of intracellular proteins is a dynamic process broadly implicated in age-related disease, yet it remains uncharacterized whether and how O-GlcNAcylation contributes to the natural aging process. O-GlcNAc transferase (OGT) and the opposing enzyme O-GlcNAcase (OGA) control this nutrient-sensing protein modification in cells. Here, we show that global O-GlcNAc levels are increased in multiple tissues of aged mice. In aged liver, carbamoyl phosphate synthetase 1 (CPS1) is among the most heavily O-GlcNAcylated proteins. CPS1 O-GlcNAcylation is reversed by calorie restriction and is sensitive to genetic and pharmacological manipulations of the O-GlcNAc pathway. High glucose stimulates CPS1 O-GlcNAcylation and inhibits CPS1 activity. Liver-specific deletion of OGT potentiates CPS1 activity and renders CPS1 irresponsive to further stimulation by a prolonged fasting. Our results identify CPS1 O-GlcNAcylation as a key nutrient-sensing regulatory step in the urea cycle during aging and dietary restriction, implying a role for mitochondrial O-GlcNAcylation in nutritional regulation of longevity.
C1 [Wu, Jing; Liu, Jiayu; Lapenta, Kalina; Desrouleaux, Reina; Li, Min-Dian; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Comparat Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.
   [Wu, Jing; Liu, Jiayu; Lapenta, Kalina; Desrouleaux, Reina; Li, Min-Dian; Yang, Xiaoyong] Yale Univ, Sch Med, Yale Ctr Mol & Syst Metab, New Haven, CT 06520 USA.
   [Wu, Jing] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China.
C3 Yale University; Yale University; Xi'an Jiaotong University
RP Li, MD; Yang, XY (corresponding author), Yale Univ, Sch Med, Dept Comparat Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.; Li, MD; Yang, XY (corresponding author), Yale Univ, Sch Med, Yale Ctr Mol & Syst Metab, New Haven, CT 06520 USA.
EM mindianli@pku.org.cn; xiaoyong.yang@yale.edu
RI liu, jia/HKE-9796-2023; liu, jia/JAC-7852-2023; liu,
   jiajia/ISS-0316-2023; Li, Jiaxi/HTS-3430-2023; Li, Min-Dian/F-1721-2015;
   liu, jiaming/IWE-3196-2023; Liu, Jiayu/JCO-5073-2023; li,
   jiawei/HOA-5023-2023; liu, peng/JSL-1931-2023; liu,
   jiajia/IUN-0901-2023; Yu, Kun/IAP-9807-2023; liu, jiayu/JCP-0511-2023;
   wang, ya/HQZ-7558-2023
OI Li, Jiaxi/0000-0002-8197-8590; Li, Min-Dian/0000-0002-3650-1507; 
FU National Institutes of Health [R01DK089098, P01DK57751]; American
   Diabetes Association [1-19-IBS-119]; Glenn/AFAR Scholarship for Research
   in the Biology of Aging
FX This work was supported by the National Institutes of Health
   (R01DK089098 and P01DK57751) and American Diabetes Association
   (1-19-IBS-119) to X.Y. and a Glenn/AFAR Scholarship for Research in the
   Biology of Aging to M.-D.L.
CR Alteen MG, 2021, CURR OPIN STRUC BIOL, V68, P157, DOI 10.1016/j.sbi.2020.12.008
   Baldini SF, 2016, J MOL BIOL, V428, P3295, DOI 10.1016/j.jmb.2016.04.035
   Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005
   Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112
   Bindesboll C, 2015, J LIPID RES, V56, P771, DOI 10.1194/jlr.M049130
   Braidy N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00167
   Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   Cao WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076399
   Charles KN, 2017, CELL REP, V21, P393, DOI 10.1016/j.celrep.2017.09.051
   Chatham JC, 2021, PHYSIOL REV, V101, P427, DOI 10.1152/physrev.00043.2019
   Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742
   Chimienti G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041665
   Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861
   Easlon E, 2007, J BIOL CHEM, V282, P6161, DOI 10.1074/jbc.M607661200
   Fülöp N, 2008, BIOGERONTOLOGY, V9, P139, DOI 10.1007/s10522-007-9123-5
   Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782
   Green CL, 2022, NAT REV MOL CELL BIO, V23, P56, DOI 10.1038/s41580-021-00411-4
   Guinez C, 2007, BIOCHEM BIOPH RES CO, V361, P414, DOI 10.1016/j.bbrc.2007.07.020
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Hart GW, 2019, J BIOL CHEM, V294, P2211, DOI 10.1074/jbc.AW119.003226
   Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233
   Hofer A, 2014, EXP GERONTOL, V56, P202, DOI 10.1016/j.exger.2014.03.006
   Hu YJ, 2022, J CELL PHYSIOL, V237, P1341, DOI 10.1002/jcp.30612
   Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200
   Jahangir Zainab, 2014, Advances in Bioinformatics, V2014, P324753, DOI 10.1155/2014/324753
   Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012
   Józwiak P, 2021, CANCERS, V13, DOI 10.3390/cancers13122956
   Józwiak P, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00145
   Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665
   Li MD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07461-x
   Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015
   Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Ma JF, 2021, CHEM REV, V121, P1513, DOI 10.1021/acs.chemrev.0c00884
   Marotta NP, 2012, CHEMBIOCHEM, V13, P2665, DOI 10.1002/cbic.201200478
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Ohashi N, 2017, DIABETES, V66, P2351, DOI 10.2337/db16-1427
   Ong QX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00599
   Papachristoforou E, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/7489795
   Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001
   Peternelj TT, 2015, MOL CELL BIOCHEM, V400, P265, DOI 10.1007/s11010-014-2283-0
   Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524
   Prakoso D, 2022, CARDIOVASC RES, V118, P212, DOI 10.1093/cvr/cvab043
   Qian KV, 2018, J BIOL CHEM, V293, P13989, DOI 10.1074/jbc.RA118.004709
   Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208
   Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117
   Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002
   Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006
   Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001
   Singh JP, 2020, ONCOGENE, V39, P560, DOI 10.1038/s41388-019-0975-3
   Stephen HM, 2021, GLYCOBIOLOGY, V31, P724, DOI 10.1093/glycob/cwab005
   Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790
   Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014
   Tan W, 2021, MOL CELL, V81, P1890, DOI 10.1016/j.molcel.2021.02.009
   Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200
   Wheatley EG, 2019, CURR BIOL, V29, P3359, DOI 10.1016/j.cub.2019.08.003
   Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151
   Wilson KA, 2021, CELL METAB, V33, P2142, DOI 10.1016/j.cmet.2021.08.018
   Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22
   Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278
   Young AJ, 1997, EXP AGING RES, V23, P45, DOI 10.1080/03610739708254026
   Yuzwa SA, 2014, J MOL BIOL, V426, P1736, DOI 10.1016/j.jmb.2014.01.004
   Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200
   Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016
   Zhang BC, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100887
   Zhang BC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127709
   Zhang KS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00221
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhang X, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100622
NR 73
TC 7
Z9 7
U1 1
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD 2022 JUL 5
PY 2022
VL 14
IS 3
DI 10.1093/jmcb/mjac016
EA MAR 2022
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 2R0MU
UT WOS:000768458600001
PM 35285892
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Martinet, KZ
   Bloquet, S
   Bourgeois, C
AF Martinet, Kim Zita
   Bloquet, Stephane
   Bourgeois, Christine
TI Ageing combines CD4 T cell lymphopenia in secondary lymphoid organs and
   T cell accumulation in gut associated lymphoid tissue
SO IMMUNITY & AGEING
LA English
DT Article
DE Immunology; T cell; T cell lymphopenia; T cell homeostasis;
   Immunosenescence; Ageing; Aging; Age; GALT; MALT; CD4 T cell
   lymphopenia; CD4 T cell homeostasis
ID AGE-RELATED-CHANGES; IMMUNE-SYSTEM; LYMPHOCYTES; HOMEOSTASIS; MICE; TCR;
   REGENERATION; EXPANSIONS; DIVERSITY; SUBSETS
AB Background: CD4 T cell lymphopenia is an important T cell defect associated to ageing. Higher susceptibility to infections, cancer, or autoimmune pathologies described in aged individuals is thought to partly rely on T cell lymphopenia. We hypothesize that such diverse effects may reflect anatomical heterogeneity of age related T cell lymphopenia. Indeed, no data are currently available on the impact of ageing on T cell pool recovered from gut associated lymphoid tissue (GALT), a crucial site of CD4 T cell accumulation.
   Results: Primary, secondary and tertiary lymphoid organs of C57BL/6 animals were analysed at three intervals of ages: 2 to 6 months (young), 10 to 14 months (middle-aged) and 22 to 26 months (old). We confirmed that ageing preferentially impacted CD4 T cell compartment in secondary lymphoid organs. Importantly, a different picture emerged from gut associated mucosal sites: during ageing, CD4 T cell accumulation was progressively developing in colon and small intestine lamina propria and Peyer's patches. Similar trend was also observed in middle-aged SJL/B6 F1 mice. Interestingly, an inverse correlation was detected between CD4 T cell numbers in secondary lymphoid organs and colonic lamina propria of C57BL/6 mice whereas no increase in proliferation rate of GALT CD4 T cells was detected. In contrast to GALT, no CD4 T cell accumulation was detected in lungs and liver in middle-aged animals. Finally, the concomitant accumulation of CD4 T cell in GALT and depletion in secondary lymphoid organs during ageing was detected both in male and female animals.
   Conclusions: Our data thus demonstrate that T cell lymphopenia in secondary lymphoid organs currently associated to ageing is not sustained in gut or lung mucosa associated lymphoid tissues or non-lymphoid sites such as the liver. The inverse correlation between CD4 T cell numbers in secondary lymphoid organs and colonic lamina propria and the absence of overt proliferation in GALT suggest that marked CD4 T cell decay in secondary lymphoid organs during ageing reflect redistribution of CD4 T cells rather than generalized CD4 T cell decay. Such anatomical heterogeneity may provide an important rationale for the diversity of immune defects observed during ageing.
C1 [Martinet, Kim Zita; Bourgeois, Christine] Fac Med Paris Sud, INSERM, U1012, F-94276 Le Kremlin Bicetre, France.
   [Martinet, Kim Zita; Bloquet, Stephane; Bourgeois, Christine] Univ Paris 11, UMR S1012, Le Kremlin Bicetre, France.
   [Bloquet, Stephane] Univ Paris 11, Fac Med Paris Sud, Le Kremlin Bicetre, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Saclay; Universite Paris Saclay; Universite Paris
   Saclay
RP Bourgeois, C (corresponding author), Fac Med Paris Sud, INSERM, U1012, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.
EM christine.bourgeois@u-psud.fr
RI Bourgeois, Christine/L-5944-2018; Bourgeois, Christine/ABA-1432-2021
OI Bourgeois, Christine/0000-0003-1146-6087; Bourgeois,
   Christine/0000-0003-1146-6087
FU ANRS (Agence Nationale de la Recherche contre le SIDA et les hepatites
   C); la Fondation pour la Recherche Medicale (FRM)
FX This work was supported by the ANRS (Agence Nationale de la Recherche
   contre le SIDA et les hepatites C), la Fondation pour la Recherche
   Medicale (FRM) and benefited from donations of the CIC bank (Credit
   Industriel et Commercial) and Pericles consulting group. We thank
   Elisabeth Huc and Laurent Potier who kindly provided SJL/B6 F1 mice. We
   thank Dr C. Tanchot and Dr F. Simonetta for critical reading, and Prs M.
   Tardieu and J. F. Delfraissy for their support.
CR Ahmed M, 2009, J IMMUNOL, V182, P784, DOI 10.4049/jimmunol.182.2.784
   [Anonymous], OPEN INFECT DIS J
   Aspinall R, 1997, J IMMUNOL, V158, P3037
   Aspinall R, 2010, J COMP PATHOL, V141, pS111, DOI 10.1016/j.jcpa.2009.10.022
   Bell E B, 1997, Semin Immunol, V9, P347, DOI 10.1006/smim.1997.0092
   Bourgeois C, 2006, IMMUNOL LETT, V107, P89, DOI 10.1016/j.imlet.2006.08.001
   Bourgeois C, 2008, P NATL ACAD SCI USA, V105, P8691, DOI 10.1073/pnas.0803732105
   Bourgeois C, 2006, J IMMUNOL, V177, P4558, DOI 10.4049/jimmunol.177.7.4558
   Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002
   CALLAHAN JE, 1993, J IMMUNOL, V151, P6657
   Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105
   Chen GB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00121
   Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002
   den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006
   Fulop Tamas, 2013, Critical Reviews in Oncogenesis, V18, P489
   Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009
   Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104
   Gupta Sudhir, 2005, Immun Ageing, V2, P12, DOI 10.1186/1742-4933-2-12
   Hall MA, 1998, INT IMMUNOL, V10, P1407, DOI 10.1093/intimm/10.10.1407
   HINGORANI R, 1993, J IMMUNOL, V151, P5762
   Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937
   Ishimoto Y, 2004, IMMUNOLOGY, V113, P371, DOI 10.1111/j.1365-2567.2004.01961.x
   Jankovic V, 2003, BLOOD, V102, P3244, DOI 10.1182/blood-2003-03-0927
   Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430
   Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306
   Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]
   Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569
   Larbi A, 2006, CELL SIGNAL, V18, P1017, DOI 10.1016/j.cellsig.2005.08.016
   Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008
   Lefebvre JS, 2012, AGING CELL, V11, P732, DOI 10.1111/j.1474-9726.2012.00836.x
   LeMaoult J, 2000, J IMMUNOL, V165, P2367, DOI 10.4049/jimmunol.165.5.2367
   LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727
   MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303
   Mackall CL, 1998, EUR J IMMUNOL, V28, P1886, DOI 10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M
   MACKALL CL, 1993, BLOOD, V82, P2585
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Mosley RL, 1998, CELL IMMUNOL, V189, P10, DOI 10.1006/cimm.1998.1369
   Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609
   POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609
   PROUST J, 1985, GERONTOLOGY, V31, P178, DOI 10.1159/000212700
   Rae IM, 1996, LANCET, V347, P328, DOI 10.1016/S0140-6736(96)90504-8
   Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020
   Sauce D, 2012, J IMMUNOL, V189, P5541, DOI 10.4049/jimmunol.1201235
   Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013
   Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029
   Stienen A, 2011, EUR CYTOKINE NETW, V22, P63, DOI 10.1684/ecn.2011.0273
   Strindhall J, 2013, AGE, V35, P985, DOI 10.1007/s11357-012-9400-3
   Tanchot C, 1998, IMMUNOL TODAY, V19, P575, DOI 10.1016/S0167-5699(98)01344-9
   UTSUYAMA M, 1987, MECH AGEING DEV, V40, P89, DOI 10.1016/0047-6374(87)90037-6
   Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   Wick G, 2000, VACCINE, V18, P1567, DOI 10.1016/S0264-410X(99)00489-2
   Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605
NR 55
TC 24
Z9 24
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD MAY 8
PY 2014
VL 11
AR 8
DI 10.1186/1742-4933-11-8
PG 13
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA AK7BS
UT WOS:000338581700001
PM 24829607
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, GL
   Cui, R
   Kang, YX
   Qi, CX
   Ji, XM
   Zhang, TY
   Guo, QQ
   Cui, HX
   Shi, GM
AF Zhang, Guoliang
   Cui, Rui
   Kang, Yunxiao
   Qi, Chunxiao
   Ji, Xiaoming
   Zhang, Tianyun
   Guo, Qiqing
   Cui, Huixian
   Shi, Geming
TI Testosterone propionate activated the Nrf2-ARE pathway in ageing rats
   and ameliorated the age-related changes in liver
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANTIOXIDANT ENZYMES; EXPRESSION; NRF2/ARE; ACID; FIBROSIS; MODEL
AB The present study aimed to evaluate the protective efficacy of testosterone propionate (TP) on age-related liver changes via activation of the nuclear factor erythroid 2-related factor 2-antioxidant response element (Nrf2-ARE) pathway in aged rats. Aged rats received subcutaneous injections of TP (2 mg/kg/d, 84 days). Oxidative stress parameters and the expression levels of signal transducer and activator of transcription 5b (STAT5b), Kelch-like ECH associating protein-1 (Keap1), Nrf2, haem oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase-1 (NQO1) in liver tissues were examined to check whether the Nrf2-ARE pathway was involved in the age-related changes in liver. Our results showed that TP supplementation alleviated liver morphology, liver function and liver fibrosis; improved oxidative stress parameters; and increased the expression of STAT5b, Nrf2, HO-1 and NQO-1 and decreased the expression of Keap1 in the liver tissues of aged rats. These results suggested that TP increased the expression of STAT5b, and then activated the Nrf2-ARE pathway and promoted antioxidant mechanisms in aged rats. These findings may provide new therapeutic uses for TP in patients with age-related liver changes.
C1 [Zhang, Guoliang; Kang, Yunxiao; Ji, Xiaoming; Zhang, Tianyun; Guo, Qiqing; Shi, Geming] Hebei Med Univ, Dept Neurobiol, Shijiazhuang 050017, Hebei, Peoples R China.
   [Zhang, Guoliang; Cui, Rui; Qi, Chunxiao; Cui, Huixian] Hebei Med Univ, Dept Human Anat, Shijiazhuang 050017, Hebei, Peoples R China.
   [Cui, Huixian; Shi, Geming] Hebei Med Univ, Neurosci Res Ctr, Shijiazhuang 050017, Hebei, Peoples R China.
   [Shi, Geming] Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang 050017, Hebei, Peoples R China.
C3 Hebei Medical University; Hebei Medical University; Hebei Medical
   University; Hebei Medical University
RP Shi, GM (corresponding author), Hebei Med Univ, Dept Neurobiol, Shijiazhuang 050017, Hebei, Peoples R China.; Shi, GM (corresponding author), Hebei Med Univ, Neurosci Res Ctr, Shijiazhuang 050017, Hebei, Peoples R China.; Shi, GM (corresponding author), Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang 050017, Hebei, Peoples R China.
EM shigeming@163.com
OI Ji, Xiaoming/0000-0002-6395-9732; Kang, Yunxiao/0000-0003-3021-8863;
   Zhang, Guoliang/0000-0002-1337-9238; Zhang, Tianyun/0000-0001-7870-5316;
   Qi, Chunxiao/0000-0002-5556-6226; Cui, Rui/0000-0002-8290-7698
FU Natural Science Foundation of China [81200252, 81871119]; Natural
   Science Foundation of Hebei Province of China [C2017206072]; Natural
   Science Research Foundation of Higher Education of Hebei Province
   [QN2017097]; university student's innovation project of Hebei Medical
   University [USIP2016070]
FX In the Materials and Methods section, the descriptions of the animals
   and testosterone propionate supplement, histopathologic evaluation,
   oxidative stress parameters, quantitative real-time polymerase chain
   reaction, western blot analysis, immunohistochemistry and densitometric
   analysis and statistical analyses quoted from previously published
   articles. We are grateful to all of the authors who kindly agreed to
   participate in this study. This project was financially supported by the
   Natural Science Foundation of China (No. 81200252, 81871119), the
   Natural Science Foundation of Hebei Province of China (No. C2017206072),
   the Natural Science Research Foundation of Higher Education of Hebei
   Province (QN2017097) and the university student's innovation project of
   Hebei Medical University (USIP2016070).
CR Abdul-Aziz A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/454659
   Anuja GI, 2018, J ETHNOPHARMACOL, V216, P79, DOI 10.1016/j.jep.2017.11.015
   Barakat BM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8296451
   Basaria S, 2013, ENDOCRIN METAB CLIN, V42, P255, DOI 10.1016/j.ecl.2013.02.012
   Bloomer SA, 2014, BLOOD CELL MOL DIS, V52, P19, DOI 10.1016/j.bcmd.2013.07.002
   Bormann CL, 2011, REPRODUCTION, V142, P167, DOI 10.1530/REP-10-0210
   Cai SY, 2017, DIGEST DIS, V35, P232, DOI 10.1159/000450916
   Chen Q, 2018, MAR DRUGS, V16, DOI 10.3390/md16040117
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020
   Giribabu N, 2017, BIOMED PHARMACOTHER, V87, P355, DOI 10.1016/j.biopha.2016.12.106
   Guo W, 2016, ENDOCRINOLOGY, V157, P2937, DOI 10.1210/en.2016-1150
   Hu HX, 2018, J BIOL REG HOMEOS AG, V32, P283
   Jin SW, 2017, FOOD CHEM TOXICOL, V100, P138, DOI 10.1016/j.fct.2016.12.031
   Liu J, 2009, LIVER INT, V29, P1222, DOI 10.1111/j.1478-3231.2009.02007.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma JQ, 2015, CLIN RES HEPATOL GAS, V39, P188, DOI 10.1016/j.clinre.2014.09.007
   Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544
   Mitchell Sarah J, 2011, Curr Gerontol Geriatr Res, V2011, P624156, DOI 10.1155/2011/624156
   Miura Y, 2016, BBA-GEN SUBJECTS, V1860, P1608, DOI 10.1016/j.bbagen.2016.01.013
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Oduwole OO, 2018, J CLIN INVEST, V128, P1787, DOI 10.1172/JCI96794
   Paul RG, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0204-3
   Rastrelli G, 2018, MATURITAS, V112, P46, DOI 10.1016/j.maturitas.2018.04.004
   Roelfsema F, 2018, J CLIN ENDOCR METAB, V103, P4419, DOI 10.1210/jc.2018-00755
   Rooney J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200004
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Wang CJ, 2018, MOL MED REP, V17, P7331, DOI 10.3892/mmr.2018.8750
   Wang LF, 2014, J EXP BIOL, V217, P109, DOI 10.1242/jeb.089920
   Wu HT, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3631565
   Yamaguchi M, 2001, HEPATOL RES, V20, P114, DOI 10.1016/S1386-6346(00)00125-X
   Yang Wei, 2015, EXCLI J, V14, P1273, DOI 10.17179/excli2015-734
   Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028
   Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974
   Zhang GL, 2013, BEHAV BRAIN RES, V252, P388, DOI 10.1016/j.bbr.2013.05.063
   Zhang GH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20719-0
   Zhang GL, 2016, HORM BEHAV, V80, P103, DOI 10.1016/j.yhbeh.2016.02.001
   Zhang YM, 2005, WORLD J GASTROENTERO, V11, P3696, DOI 10.3748/wjg.v11.i24.3696
   Zhong HH, 2017, ONCOTARGET, V8, P102640, DOI 10.18632/oncotarget.21123
   Zhu Y, 2016, MOLECULES, V21, DOI 10.3390/molecules21081033
NR 40
TC 14
Z9 15
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 9
PY 2019
VL 9
AR 18619
DI 10.1038/s41598-019-55148-0
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA JU5ZJ
UT WOS:000501754500008
PM 31819135
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, DL
   Liu, MX
   Cao, JC
   Cheng, YN
   Zhuo, C
   Xu, HY
   Tian, SS
   Zhang, Y
   Zhang, J
   Wang, FS
AF Wang, Dongliang
   Liu, Maoxuan
   Cao, Jichao
   Cheng, Yanna
   Zhuo, Chen
   Xu, Hongyan
   Tian, Shousheng
   Zhang, Yan
   Zhang, Jian
   Wang, Fengshan
TI Effect of <i>Colla corii</i> <i>asini</i> (<i>E</i>'<i>jiao</i>) on
   D-Galactose Induced Aging Mice
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE Colla corii asini (E'jiao); anti-aging; D-galactose; antioxidant;
   aging-related gene
ID OXIDATIVE STRESS; SENESCENCE; EXPRESSION
AB Colla corii asini (E'jiao), donkey-hide gelatin prepared by stewing and concentrating from Equus asinus L. donkey hide, is a traditional Chinese medicine preparation widely used in clinical hematic antanemic therapy in China. The aim of the present study was to investigate potential anti-aging effect of Colic: corii asini and explore related mechanisms in D-galactose (gal) induced aging model mice. The mice were artificially induced aging by subcutaneously injection with D-gal at the dose of 100mg/kg.d for 8 weeks. Colla corii asini was simultaneously treated to them once daily by intragastric gavage. Appetite, mental condition, body weight, and organ index were observed. Activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), as well as levels of malondialdehyde (MDA) in serum, brain, and liver were determined by according assay kits. Western blotting analysis was used to detect p16 and p21 expression. Results indicated that Colla corii asini could improve appetite, mental condition, body weight, and organ condition of model mice, improve SOD, CAT, and GSH-Px activities, reduce MDA levels, and modulate age-related genes expression in D-gal induced mice. Therefore, Colla corii asini may have effect to suppress the aging process through enhancing antioxidant activity, scavenging free radicals, and modulating aging-related gene expression.
C1 [Wang, Dongliang; Liu, Maoxuan; Cao, Jichao; Cheng, Yanna; Zhuo, Chen; Zhang, Jian; Wang, Fengshan] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Peoples R China.
   [Wang, Dongliang; Tian, Shousheng; Zhang, Yan] Shandong Univ, Inst Pharmacol, Jinan 250012, Peoples R China.
   [Xu, Hongyan] Shandong Dong E E Jiao Co Ltd, Donge 252201, Peoples R China.
C3 Shandong University; Shandong University
RP Wang, FS (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Peoples R China.
EM fswang@sdu.edu.cn
RI Liu, Maoxuan/V-6311-2019; yan, wang/JRW-9981-2023
OI Liu, Maoxuan/0000-0002-0953-9673
FU Shandong Dong-E-E-Jiao Co., Ltd. (Dong'e, China)
FX The authors are grateful for financial and pharmaceutical support from
   Shandong Dong-E-E-Jiao Co., Ltd. (Dong'e, China).
CR Burks TN, 2011, AGING ALBANY NY
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen D, 1991, Zhongguo Zhong Yao Za Zhi, V16, P83
   Chen D, 1991, ZHONGGUO ZHONG YAO Z, V16, P126
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Eshkoor SA, 2009, BIOSCI TRENDS, V3, P105
   Goto M, 2012, BIOSCI TRENDS, V6, P33, DOI 10.5582/bst.2012.v6.1.33
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5
   Minamino T, 2010, CIRC J, V74, P2527, DOI 10.1253/circj.CJ-10-0916
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Oliveira BF, 2010, THESCIENTIFICWORLDJO, V10, P1121, DOI 10.1100/tsw.2010.94
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Ren Y, 2011, J AGR FOOD CHEM, V59, P206, DOI 10.1021/jf103938e
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Silva JP, 2010, DRUG DISCOV THER, V4, P144
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   Vranesic-Bender D, 2010, ACTA CLIN CROAT, V49, P537
   Wang M, 2011, CHIN J INTEGR MED, V17, P635, DOI 10.1007/s11655-011-0823-y
   Wu HZ, 2007, AM J CHINESE MED, V35, P853, DOI 10.1142/S0192415X07005326
   Xiong DS, 2011, AM J CHINESE MED, V39, P719, DOI 10.1142/S0192415X11009159
   Yan D, 2006, CHIN J CHROMATOGR, V24, P359
   YAO D, 1989, Zhongguo Zhongyao Zazhi, V14, P44
   Yao DF, 1989, ZHONGGUO ZHONG YAO Z, V14, P64
   Yoo DY, 2012, NEUROCHEM RES, V37, P223, DOI 10.1007/s11064-011-0597-9
   Yu HY, 2009, CHIN J CHROMATOGR, V27, P447
NR 30
TC 50
Z9 60
U1 4
U2 81
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD DEC
PY 2012
VL 35
IS 12
BP 2128
EP 2132
DI 10.1248/bpb.b12-00238
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 046NP
UT WOS:000311772000004
PM 23207764
OA Bronze
DA 2024-02-19
ER

PT J
AU Liu, AJ
   Ma, YH
   Zhu, ZY
AF Liu, Anjun
   Ma, Yanhong
   Zhu, Zhenyuan
TI Protective Effect of Selenoarginine against Oxidative Stress in
   D-Galactose-Induced Aging Mice
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE selenoarginine; D-galactose; oxidative stress; protective effect
ID GLUTATHIONE-PEROXIDASE; FREE-RADICALS; SELENIUM; ANTIOXIDANT;
   SENESCENCE; MECHANISM; DEATH; AGE
AB The protective effect of selenoarginine against oxidation resistance was investigated in D-galactose (D-gal)induced aging mice. The mice were divided into four groups (n = 15): a normal group, a model group, a lowdose selenoarginine group (8.35 mu g of Se/kg b.w./d), and a high dose selenoarginine group (16.78 mu g of Se/kg b.w./d). The aging model was induced by s.c. injection D-galactose dissolved in 0.9% normal saline of a dose of 150 mg/kg/d for 6 weeks. The mice in the normal group received s.c. injection of sterile normal saline at the same dose and frequency. The results showed that oxidative stress in the liver, kidney, and brain tissues and the serum of the mice was induced by D-galactose, but selenoarginine had an obviously protective effect against D-galactose-induced aging mice. Lowdose selenoarginine performed better than high dose selenoarginine. The protective effect of selenoarginine on D-galactose-induced aging mice can be attributed to elevation of the activity of antioxidase and enhanced antioxidant defenses.
C1 [Liu, Anjun; Ma, Yanhong; Zhu, Zhenyuan] Tianjin Univ Sci & Technol, Coll Food Engn & Biotechnol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
   [Ma, Yanhong] Yuncheng Univ, Dept Biol Sci, Yuncheng 044000, Shanxi, Peoples R China.
C3 Tianjin University Science & Technology; Yuncheng University
RP Zhu, ZY (corresponding author), Tianjin Univ Sci & Technol, Coll Food Engn & Biotechnol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
EM zhyuanzhu@tust.edu.cn
RI zhu, zhenyuan/GRX-8969-2022; MA, YAN/HHN-2912-2022
FU National Natural Science Foundation of China [20576101]; Recruited
   faculty research start-up foundation in Tianjin University of Science
   and Technology [0200060]
FX This work was supported by grant from the National Natural Science
   Foundation of China (no. 20576101) and Recruited faculty research
   start-up foundation in Tianjin University of Science and Technology (no.
   0200060).
CR [Anonymous], 1990, CHINESE J PHARM TOXI
   Baraboj V. A., 2004, Ukrainskii Biokhimicheskii Zhurnal, V76, P23
   Broome CS, 2004, AM J CLIN NUTR, V80, P154
   Chan TY, 1996, J PINEAL RES, V20, P187, DOI 10.1111/j.1600-079X.1996.tb00257.x
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   De L.M., 2006, HEART FAIL REV, V11, P13
   De la Fuente M, 2004, CELL MOL BIOL, V50, P683, DOI 10.1170/82
   Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318
   Duntas LH, 2006, THYROID, V16, P455, DOI 10.1089/thy.2006.16.455
   FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0
   Han SN, 2000, J INFECT DIS, V182, pS74, DOI 10.1086/315915
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Lei H, 2003, ACTA PHARMACOL SIN, V24, P230
   Liu L, 2007, J INORG ORGANOMET P, V17, P535, DOI 10.1007/s10904-007-9147-y
   Mahmoud KZ, 2003, COMP BIOCHEM PHYS B, V136, P921, DOI 10.1016/S1096-4959(03)00288-4
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Moskovitz J, 2002, ARCH BIOCHEM BIOPHYS, V397, P354, DOI 10.1006/abbi.2001.2692
   Navarro-Alarcón M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200
   SCHRODER HC, 1987, MECH AGEING DEV, V41, P251, DOI 10.1016/0047-6374(87)90045-5
   Turan B, 1999, REGUL TOXICOL PHARM, V29, P142, DOI 10.1006/rtph.1998.1227
   Xiong SL, 2007, ANTIOXID REDOX SIGN, V9, P457, DOI 10.1089/ars.2006.1363
   Xu F, 2003, SPECTROSC SPECT ANAL, V23, P1163
NR 26
TC 32
Z9 36
U1 2
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD JUL
PY 2009
VL 73
IS 7
BP 1461
EP 1464
DI 10.1271/bbb.80558
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 479WE
UT WOS:000268691600001
PM 19584559
OA Bronze
DA 2024-02-19
ER

PT J
AU Gabriely, I
   Ma, XH
   Yang, XM
   Rossetti, L
   Barzilai, N
AF Gabriely, I
   Ma, XH
   Yang, XM
   Rossetti, L
   Barzilai, N
TI Leptin resistance during aging is independent of fat mass
SO DIABETES
LA English
DT Article
ID HEPATIC INSULIN-RESISTANCE; CALORIC RESTRICTION; VISCERAL FAT; SERUM
   LEPTIN; GENE-EXPRESSION; AGE; ADIPOSITY; RATS; PROTEIN; OBESITY
AB Increased fat mass, abdominal adiposity, and insulin resistance are typical findings in aging mammals and are frequently associated with leptin resistance and increased plasma leptin levels. To examine whether leptin's failure in aging is due to aging per se or to changes in body fat mass or distribution, we studied aging rats that underwent calorie restriction throughout their lives, maintaining their youthful body fat pattern and metabolic profile. Leptin's action was assessed by measuring its ability to regulate food intake, fat mass and its distribution, peripheral and hepatic insulin action, and its own gene expression in fat. Our results show that leptin's action is markedly diminished in aging rats, independently of their body fat pattern. Leptin's failure in this model suggests its causative role in the metabolic decline seen with aging.
C1 Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
   Diabet Res & Training Ctr, Div Endocrinol, Dept Med, Bronx, NY USA.
C3 Yeshiva University; Albert Einstein College of Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, 1300 Morris Pk Ave,Belfer Bldg 701, Bronx, NY 10461 USA.
FU NIA NIH HHS [R01-AG18381] Funding Source: Medline; NIDDK NIH HHS [DK
   20541, R0I-DK 48321, R01-DK 45024] Funding Source: Medline
CR Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113
   Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137
   Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89
   Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   Barzilai N, 1999, ANN NY ACAD SCI, V892, P58, DOI 10.1111/j.1749-6632.1999.tb07785.x
   Baumgartner RN, 1999, OBES RES, V7, P141, DOI 10.1002/j.1550-8528.1999.tb00695.x
   Bjorbæk C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Hazzard William R., 1995, Am J Geriatr Cardiol, V4, P16
   Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954
   Kotz CM, 1999, CLIN GERIATR MED, V15, P391
   Li H, 1997, DIABETES, V46, P2035, DOI 10.2337/diabetes.46.12.2035
   Li H, 1998, AM J PHYSIOL-ENDOC M, V275, pE405, DOI 10.1152/ajpendo.1998.275.3.E405
   Maresh GA, 2001, LIFE SCI, V69, P67, DOI 10.1016/S0024-3205(01)01093-1
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931
   Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266
   Rinn W E, 1988, J Geriatr Psychiatry Neurol, V1, P144, DOI 10.1177/089198878800100304
   Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758
   SAINIO E-L, 1988, Steroids, V51, P609, DOI 10.1016/0039-128X(88)90056-6
   Sánchez-Rodríguez M, 2000, ARCH MED RES, V31, P425, DOI 10.1016/S0188-4409(99)00079-X
   Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431
   Scarpace PJ, 2000, NEUROPHARMACOLOGY, V39, P1872, DOI 10.1016/S0028-3908(00)00014-9
   SHIMOKATA H, 1989, J GERONTOL, V44, P66
   Slieker LJ, 1996, J BIOL CHEM, V271, P5301, DOI 10.1074/jbc.271.10.5301
   TOLLEFSBOL TO, 1986, J AM GERIATR SOC, V34, P282, DOI 10.1111/j.1532-5415.1986.tb04225.x
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   Van den Saffele JK, 1999, CLIN ENDOCRINOL, V51, P81, DOI 10.1046/j.1365-2265.1999.00741.x
   Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474
   Wang ZW, 2000, BIOCHEM BIOPH RES CO, V277, P20, DOI 10.1006/bbrc.2000.3615
   Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com
   WILLIAMS A, 1995, NEUROL DIS, V40, P141
   Zakrzewska KE, 1997, DIABETES, V46, P717, DOI 10.2337/diabetes.46.4.717
NR 43
TC 116
Z9 128
U1 0
U2 1
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1660 DUKE ST, ALEXANDRIA, VA 22314 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD APR
PY 2002
VL 51
IS 4
BP 1016
EP 1021
DI 10.2337/diabetes.51.4.1016
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 537BR
UT WOS:000174737500017
PM 11916920
OA Bronze
DA 2024-02-19
ER

PT J
AU PRASAD, S
   THAKUR, MK
AF PRASAD, S
   THAKUR, MK
TI INVITRO ACETYLATION OF THE LIVER HMG NON-HISTONE PROTEINS AND ITS
   MODULATION BY SPERMINE AND DEXAMETHASONE DURING AGING OF RATS
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
C1 BANARAS HINDU UNIV,CTR ADV STUDY ZOOL,BIOCHEM & MOLEC BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
C3 Banaras Hindu University (BHU)
CR ALEXANDROVA EA, 1988, BIOCHEM BIOPH RES CO, V154, P918, DOI 10.1016/0006-291X(88)90227-6
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   BOHM J, 1980, EUR J BIOCHEM, V112, P353, DOI 10.1111/j.1432-1033.1980.tb07212.x
   Bose R, 1982, Arch Gerontol Geriatr, V1, P339, DOI 10.1016/0167-4943(82)90034-6
   BROTHERTON TW, 1986, BIOCHEMISTRY-US, V25, P3447, DOI 10.1021/bi00359a053
   BUCCI LR, 1984, J BIOL CHEM, V259, P8840
   COOPER E, 1985, MOL CELL ENDOCRINOL, V39, P1, DOI 10.1016/0303-7207(85)90087-5
   DOD B, 1982, EUR J BIOCHEM, V121, P401, DOI 10.1111/j.1432-1033.1982.tb05801.x
   DORBIC T, 1987, EMBO J, V6, P2393, DOI 10.1002/j.1460-2075.1987.tb02517.x
   EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7
   GOODWIN GH, 1977, FEBS LETT, V80, P413, DOI 10.1016/0014-5793(77)80488-2
   JANNE J, 1978, BIOCHIM BIOPHYS ACTA, V473, P241, DOI 10.1016/0304-419X(78)90015-X
   KANUNGO MS, 1980, BIOCH AGING, P18
   LIEW CC, 1973, ENDOCRINOLOGY, V93, P1025, DOI 10.1210/endo-93-5-1025
   PINA B, 1988, EUR J BIOCHEM, V174, P311, DOI 10.1111/j.1432-1033.1988.tb14099.x
   PRASAD S, 1987, MOL BIOL REP, V12, P273, DOI 10.1007/BF00444679
   PRASAD S, 1988, BIOCHEM INT, V16, P375
   REEVES R, 1980, NUCLEIC ACIDS RES, V8, P1947, DOI 10.1093/nar/8.9.1947
   SAXHOLM HJK, 1982, MOL CELL BIOCHEM, V46, P129
   SEN D, 1986, BIOCHEMISTRY-US, V25, P1495, DOI 10.1021/bi00355a004
   Thakur M K, 1983, Arch Gerontol Geriatr, V2, P1, DOI 10.1016/0167-4943(83)90012-2
   THAKUR MK, 1989, MUTAT RES, V219, P107, DOI 10.1016/0921-8734(89)90021-0
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   TREMETHICK DJ, 1989, FEBS LETT, V242, P346, DOI 10.1016/0014-5793(89)80499-5
   VU QA, 1987, FEBS LETT, V220, P79, DOI 10.1016/0014-5793(87)80879-7
   WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735
NR 26
TC 5
Z9 5
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PY 1989
VL 13
IS 4
BP 221
EP 224
DI 10.1007/BF00788174
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CK492
UT WOS:A1989CK49200007
PM 3272347
DA 2024-02-19
ER

PT J
AU Chen, YW
   Harris, RA
   Hatahet, Z
   Chou, KM
AF Chen, Yih-Wen
   Harris, Robert A.
   Hatahet, Zafer
   Chou, Kai-ming
TI Ablation of XP-V gene causes adipose tissue senescence and metabolic
   abnormalities
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE DNA polymerase eta; obesity; senescence; DNA damage; adipose tissue
ID DNA-POLYMERASE-ETA; OXIDATIVE STRESS; OBESITY; CANCER; SURVIVAL;
   PROTEIN; DAMAGE; P53; SUSCEPTIBILITY; HYPERMUTATION
AB Obesity and the metabolic syndrome have evolved to be major health issues throughout the world. Whether loss of genome integrity contributes to this epidemic is an open question. DNA polymerase eta (pol eta), encoded by the xeroderma pigmentosum (XP-V) gene, plays an essential role in preventing cutaneous cancer caused by UV radiation-induced DNA damage. Herein, we demonstrate that pol. deficiency in mice (pol eta(-/-)) causes obesity with visceral fat accumulation, hepatic steatosis, hyperleptinemia, hyperinsulinemia, and glucose intolerance. In comparison to WT mice, adipose tissue from pol eta(-/-) mice exhibits increased DNA damage and a greater DNA damage response, indicated by upregulation and/or phosphorylation of ataxia telangiectasia mutated (ATM), phosphorylated H(2)AX (gamma H(2)AX), and poly[ADP-ribose] polymerase 1 (PARP-1). Concomitantly, increased cellular senescence in the adipose tissue from pol eta(-/-) mice was observed and measured by up-regulation of senescence markers, including p53, p16(Ink4a), p21, senescence-associated (SA) beta-gal activity, and SA secretion of proinflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) as early as 4 wk of age. Treatment of pol eta(-/-) mice with a p53 inhibitor, pifithrin-alpha, reduced adipocyte senescence and attenuated the metabolic abnormalities. Furthermore, elevation of adipocyte DNA damage with a high-fat diet or sodium arsenite exacerbated adipocyte senescence and metabolic abnormalities in pol eta(-/-) mice. In contrast, reduction of adipose DNA damage with N-acetylcysteine or metformin ameliorated cellular senescence and metabolic abnormalities. These studies indicate that elevated DNA damage is a root cause of adipocyte senescence, which plays a determining role in the development of obesity and insulin resistance.
C1 [Chen, Yih-Wen; Chou, Kai-ming] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.
   [Harris, Robert A.] Indiana Univ Sch Med, Richard Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA.
   [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
   [Hatahet, Zafer] Northwestern State Univ Louisiana, Dept Biol & Phys Sci, Natchitoches, LA 71497 USA.
C3 Indiana University System; Indiana University Bloomington; Indiana
   University System; Indiana University Bloomington; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; Indiana University System; Indiana
   University Bloomington; University of Louisiana System; Northwestern
   State University of Louisiana
RP Chou, KM (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.
EM kmchou3@gmail.com
FU NIH [R01 CA 112446]; Veterans Affairs Merit Award
FX We thank Dr. Richard Honkanen (University of South Alabama) for
   suggestions and comments during the study. This study was supported, in
   part, by NIH Grant R01 CA 112446 (to K.-m.C.) and a Veterans Affairs
   Merit Award (to R.A.H.).
CR Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6
   Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242
   Bartsch Helmut, 2007, V174, P19
   Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200
   Busuttil RA, 2008, CANCER RES, V68, P2081, DOI 10.1158/0008-5472.CAN-07-6274
   Ceppi P, 2009, CLIN CANCER RES, V15, P1039, DOI 10.1158/1078-0432.CCR-08-1227
   Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5
   Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105
   Chen YW, 2006, MOL CANCER RES, V4, P257, DOI 10.1158/1541-7786.MCR-05-0118
   Cleaver JE, 2002, DNA REPAIR, V1, P41, DOI 10.1016/S1568-7864(01)00004-0
   De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999
   Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131
   Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Fernyhough ME, 2004, CYTOTECHNOLOGY, V46, P163, DOI 10.1007/s10616-005-2602-0
   Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026
   Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008
   Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169
   Ishida T, 2014, CIRC J, V78, P42, DOI 10.1253/circj.CJ-13-1194
   Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0
   Karakasilioti I, 2013, CELL METAB, V18, P403, DOI 10.1016/j.cmet.2013.08.011
   Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095
   Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733
   Korwek Zbigniew, 2014, Postepy Biochem, V60, P248
   Lei Yu, 2013, Methods Mol Biol, V1031, P59, DOI 10.1007/978-1-62703-481-4_7
   Lin QC, 2006, CANCER RES, V66, P87, DOI 10.1158/0008-5472.CAN-05-1862
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Martomo SA, 2008, DNA REPAIR, V7, P1603, DOI 10.1016/j.dnarep.2008.04.002
   Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Murdolo G, 2013, BIOCHIMIE, V95, P585, DOI 10.1016/j.biochi.2012.12.014
   NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180
   PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776
   Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541
   Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09
   Rodier F, 2009, NAT CELL BIOL, V11, P1272, DOI 10.1038/ncb1009-1272a
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697
   Sampath H, 2011, AM J PHYSIOL-ENDOC M, V300, pE724, DOI 10.1152/ajpendo.00387.2010
   Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002
   Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114
   Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126
   Thakur M, 2001, GENE CHROMOSOME CANC, V32, P222, DOI 10.1002/gcc.1186
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Yang IY, 2009, J BIOL CHEM, V284, P191, DOI 10.1074/jbc.M806414200
   Zhou WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083978
NR 57
TC 56
Z9 62
U1 0
U2 19
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 18
PY 2015
VL 112
IS 33
BP E4556
EP E4564
DI 10.1073/pnas.1506954112
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CP2WL
UT WOS:000359738300008
PM 26240351
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Trzaskalski, NA
   Vulesevic, B
   Nguyen, MA
   Jeraj, N
   Fadzeyeva, E
   Morrow, NM
   Locatelli, CAA
   Travis, N
   Hanson, AA
   Nunes, JRC
   O'Dwyer, C
   van der Veen, JN
   Lorenzen-Schmidt, I
   Seymour, R
   Pulente, SM
   Clément, AC
   Crawley, AM
   Jacobs, RL
   Doyle, MA
   Cooper, CL
   Kim, KH
   Fullerton, MD
   Mulvihill, EE
AF Trzaskalski, Natasha A.
   Vulesevic, Branka
   Nguyen, My-Anh
   Jeraj, Natasha
   Fadzeyeva, Evgenia
   Morrow, Nadya M.
   Locatelli, Cassandra A. A.
   Travis, Nicole
   Hanson, Antonio A.
   Nunes, Julia R. C.
   O'Dwyer, Conor
   van der Veen, Jelske N.
   Lorenzen-Schmidt, Ilka
   Seymour, Rick
   Pulente, Serena M.
   Clement, Andrew C.
   Crawley, Angela M.
   Jacobs, Rene L.
   Doyle, Mary-Anne
   Cooper, Curtis L.
   Kim, Kyoung-Han
   Fullerton, Morgan D.
   Mulvihill, Erin E.
TI Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates
   glucose production, and when absent influences NAFLD progression
SO JCI INSIGHT
LA English
DT Article
ID DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; FATTY LIVER-DISEASE;
   TYPE-2 DIABETES-MELLITUS; INTESTINAL LYMPH; INSULIN-RESISTANCE;
   HEPATITIS-C; INFLAMMATION; OBESITY; MECHANISMS
AB Elevated circulating dipeptidyl peptidase-4 (DPP4) is a biomarker for liver disease, but its involvement in gluconeogenesis and metabolic associated fatty liver disease progression remains unclear. Here, we identified that DPP4 in hepatocytes but not TEK receptor tyrosine kinase-positive endothelial cells regulates the local bioactivity of incretin hormones and gluconeogenesis. However, the complete absence of DPP4 (Dpp4-/-) in aged mice with metabolic syndrome accelerates liver fibrosis without altering dyslipidemia and steatosis. Analysis of transcripts from the livers of Dpp4-/- mice displayed enrichment for inflammasome, p53, and senescence programs compared with littermate controls. High-fat, high-cholesterol feeding decreased Dpp4 expression in F4/80+ cells, with only minor changes in immune signaling. Moreover, in a lean mouse model of severe nonalcoholic fatty liver disease, phosphatidylethanolamine N-methyltransferase mice, we observed a 4-fold increase in circulating DPP4, in contrast with previous findings connecting DPP4 release and obesity. Last, we evaluated DPP4 levels in patients with hepatitis C infection with dysglycemia (Homeostatic Model Assessment of Insulin Resistance > 2) who underwent direct antiviral treatment (with/without ribavirin). DPP4 protein levels decreased with viral clearance; DPP4 activity levels were reduced at long-term follow-up in ribavirin-treated patients; but metabolic factors did not improve. These data suggest elevations in DPP4 during hepatitis C infection are not primarily regulated by metabolic disturbances.
C1 [Trzaskalski, Natasha A.; Vulesevic, Branka; Nguyen, My-Anh; Jeraj, Natasha; Fadzeyeva, Evgenia; Morrow, Nadya M.; Locatelli, Cassandra A. A.; Travis, Nicole; Hanson, Antonio A.; Nunes, Julia R. C.; O'Dwyer, Conor; Pulente, Serena M.; Clement, Andrew C.; Crawley, Angela M.; Fullerton, Morgan D.; Mulvihill, Erin E.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   [Trzaskalski, Natasha A.; Vulesevic, Branka; Nguyen, My-Anh; Jeraj, Natasha; Fadzeyeva, Evgenia; Morrow, Nadya M.; Locatelli, Cassandra A. A.; Travis, Nicole; Hanson, Antonio A.; Lorenzen-Schmidt, Ilka; Seymour, Rick; Pulente, Serena M.; Clement, Andrew C.; Kim, Kyoung-Han; Mulvihill, Erin E.] Univ Ottawa, Heart Inst, 40 Ruskin St, H-3229A, Ottawa, ON K1Y 4W7, Canada.
   [Nunes, Julia R. C.; O'Dwyer, Conor; Crawley, Angela M.; Fullerton, Morgan D.; Mulvihill, Erin E.] Ctr Infect Immun & Inflammat, Ottawa, ON, Canada.
   [Nunes, Julia R. C.; O'Dwyer, Conor; van der Veen, Jelske N.; Fullerton, Morgan D.] Ctr Catalysis Res & Innovat, Ottawa, ON, Canada.
   [Crawley, Angela M.; Cooper, Curtis L.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada.
   [van der Veen, Jelske N.] Univ Alberta, Li Ka Shing LKS Ctr Hlth Res Innovat, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.
   [Crawley, Angela M.] Carleton Univ, Dept Biol, Ottawa, ON, Canada.
   [Doyle, Mary-Anne] Univ Ottawa, Dept Med, Div Endocrinol & Metab, Ottawa, ON, Canada.
   [Cooper, Curtis L.] Univ Ottawa, Dept Med, Div Infect Dis, Ottawa, ON, Canada.
   [Kim, Kyoung-Han] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.
C3 University of Ottawa; University of Ottawa; University of Ottawa Heart
   Institute; University of Ottawa; University of Ottawa; Ottawa Hospital
   Research Institute; University of Alberta; Carleton University;
   University of Ottawa; University of Ottawa; University of Ottawa
RP Mulvihill, EE (corresponding author), Univ Ottawa, Heart Inst, 40 Ruskin St, H-3229A, Ottawa, ON K1Y 4W7, Canada.
EM emulvihi@uottawa.ca
OI Hanson, Antonio/0000-0001-7286-5669; /0000-0002-4056-9766; Nunes,
   Julia/0000-0003-2095-8972
FU Canadian Institutes of Health Research (CIHR); Diabetes Canada
   [ARJ-162628, 156136, 148634, 141981]; University of Ottawa Heart
   Institute endowment scholarship; CIHR postdoctoral fellowship; Ontario
   Graduate Scholarship; CIHR Master's Award
FX We would like to thank Majid Nikpay for statistical support; Xiaoling
   Zhao and the Stewart Whitman Core Histopathology Laboratory for sample
   preparation, sectioning, and staining; and the The Centre for
   Phenogenomics for plasma analysis. EEM is the guarantor of this work
   and, as such, had full access to all the data in the study and takes
   responsibility for the integrity of the data and the accuracy of the
   data analysis. The Canadian Institutes of Health Research (CIHR) and
   Diabetes Canada supported this work (ARJ-162628, Project Grant 156136
   and New Investigator award to EEM and Project Grant 148634 and New
   Investigator award 141981 to MDF) . NAT is supported by a University of
   Ottawa Heart Institute endowment scholarship. BV was supported by a CIHR
   postdoctoral fellowship. CAAL is supported by an Ontario Graduate
   Scholarship. SMP and AMC are each supported by a CIHR Master's Award.
   The graphical abstract was generated with BioRender (publication
   license: ET24NGTPGG) .
CR Aulinger BA, 2020, AM J PHYSIOL-ENDOC M, V318, pE189, DOI 10.1152/ajpendo.00298.2019
   Baggio LL, 2020, MOL METAB, V46, DOI 10.1016/j.molmet.2020.101090
   Baggio LL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17556-z
   Balas B, 2007, J CLIN ENDOCR METAB, V92, P1249, DOI 10.1210/jc.2006-1882
   Barchetta I, 2021, J ENDOCRINOL INVEST, V44, P979, DOI 10.1007/s40618-020-01392-5
   Baumeier C, 2017, MOL METAB, V6, P1254, DOI 10.1016/j.molmet.2017.07.016
   Baumeier C, 2017, DIABETES, V66, P25, DOI 10.2337/db15-1716
   Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732
   Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720
   Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012
   Capozzi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126742
   Carris NW, 2022, ANN PHARMACOTHER, V56, P224, DOI 10.1177/10600280211027204
   Chambers AP, 2017, CELL METAB, V25, P927, DOI 10.1016/j.cmet.2017.02.008
   Chang ML, 2016, WORLD J GASTROENTERO, V22, P1461, DOI 10.3748/wjg.v22.i4.1461
   Chen ZH, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113951
   Chepurny OG, 2019, J BIOL CHEM, V294, P3514, DOI 10.1074/jbc.RA118.005682
   D'Alessio D, 2007, AM J PHYSIOL-REG I, V293, pR2163, DOI 10.1152/ajpregu.00911.2006
   Da B, 2021, NEW ENGL J MED, V385, pE6, DOI 10.1056/NEJMc2106921
   Deacon CF, 2020, NAT REV ENDOCRINOL, V16, P642, DOI 10.1038/s41574-020-0399-8
   Dela Peña A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004
   Díaz-Jiménez D, 2020, J BIOL CHEM, V295, P3213, DOI 10.1074/jbc.RA119.010894
   Doyle MA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030252
   Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001
   El K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1948
   El K, 2020, PEPTIDES, V125, DOI 10.1016/j.peptides.2019.170213
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Frias JP, 2017, CELL METAB, V26, P343, DOI 10.1016/j.cmet.2017.07.011
   Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372
   Gao X, 2015, BBA-MOL CELL BIOL L, V1851, P152, DOI 10.1016/j.bbalip.2014.11.006
   Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138
   Görgens SW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225835
   Grüngreiff K, 2009, MOL MED REP, V2, P63, DOI 10.3892/mmr_00000062
   Guo YW, 2020, ACTA PHARMACOL SIN B, V10, P825, DOI 10.1016/j.apsb.2020.02.005
   Hædersdal S, 2018, MAYO CLIN PROC, V93, P217, DOI 10.1016/j.mayocp.2017.12.003
   Itou M, 2008, J GASTROEN HEPATOL, V23, P244, DOI 10.1111/j.1440-1746.2007.05183.x
   Itou M, 2013, WORLD J GASTROENTERO, V19, P2298, DOI 10.3748/wjg.v19.i15.2298
   Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514
   Jall S, 2017, MOL METAB, V6, P440, DOI 10.1016/j.molmet.2017.02.002
   Jejelava N, 2018, AM J PHYSIOL-REG I, V314, pR724, DOI 10.1152/ajpregu.00120.2017
   Junker AE, 2016, J INTERN MED, V279, P485, DOI 10.1111/joim.12462
   Kaji K, 2014, J GASTROENTEROL, V49, P481, DOI 10.1007/s00535-013-0783-4
   Kawakubo M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57935-6
   Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x
   Kim KM, 2017, GENE DEV, V31, P1529, DOI 10.1101/gad.302570.117
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707
   Lee YS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4176
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Maes M, 2001, MOL PSYCHIATR, V6, P475, DOI 10.1038/sj.mp.4000872
   Malbert CH, 2021, DIABETES, V70, P99, DOI 10.2337/db20-0361
   Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197
   McLean BA, 2021, ENDOCR REV, V42, P101, DOI 10.1210/endrev/bnaa032
   Marques JCMT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16224-5
   Meier JJ, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.645617
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Meissner EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133236
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Miyazaki M, 2012, MOL MED REP, V5, P729, DOI 10.3892/mmr.2011.707
   Mulvihill EE, 2018, PEPTIDES, V100, P158, DOI 10.1016/j.peptides.2017.11.023
   Mulvihill EE, 2017, CELL METAB, V25, P152, DOI 10.1016/j.cmet.2016.10.007
   Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035
   Muscelli E, 2012, J CLIN ENDOCR METAB, V97, P2818, DOI 10.1210/jc.2012-1205
   NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280
   Pala L, 2005, DIABETOLOGIA, V48, P1168, DOI 10.1007/s00125-005-1749-8
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Patel R, 2011, J CLIN INVEST, V121, P431, DOI 10.1172/JCI41681
   Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017
   Qin XF, 2005, AM J PHYSIOL-GASTR L, V288, pG943, DOI 10.1152/ajpgi.00303.2004
   Rao XQ, 2019, EBIOMEDICINE, V41, P50, DOI 10.1016/j.ebiom.2019.01.065
   Romacho T, 2020, AM J PHYSIOL-ENDOC M, V318, pE590, DOI 10.1152/ajpendo.00323.2019
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Ryskjær J, 2006, EUR J ENDOCRINOL, V155, P485, DOI 10.1530/eje.1.02221
   Sarkar J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00505
   Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448
   Shin JW, 2008, EXP CELL RES, V314, P3048, DOI 10.1016/j.yexcr.2008.07.024
   Shinjo T, 2015, AM J PHYSIOL-ENDOC M, V309, pE214, DOI 10.1152/ajpendo.00553.2014
   Slawson DC, 2021, AM FAM PHYSICIAN, V104, P96
   Song YM, 2019, CELL METAB, V30, P976, DOI 10.1016/j.cmet.2019.08.009
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Svendsen B, 2018, CELL REP, V25, P1127, DOI 10.1016/j.celrep.2018.10.018
   Trzaskalski NA, 2020, CLIN MED INSIGHTS-EN, V13, DOI 10.1177/1179551420912972
   Varga T, 2011, PATHOL ONCOL RES, V17, P925, DOI 10.1007/s12253-011-9404-9
   Varin EM, 2019, CELL METAB, V29, P320, DOI 10.1016/j.cmet.2018.10.001
   Wada N, 2017, HEPATOL INT, V11, P115, DOI 10.1007/s12072-016-9773-y
   Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880
   Wang TT, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00528-0
   Weiskirchen R, 2019, MOL ASPECTS MED, V65, P2, DOI 10.1016/j.mam.2018.06.003
   Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183
   Williams KH, 2015, J DIABETES, V7, P809, DOI 10.1111/1753-0407.12237
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Xie YC, 2017, CELL REP, V20, P1692, DOI 10.1016/j.celrep.2017.07.055
   Zeng YM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-32
   Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230
   Zhu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127994
NR 96
TC 0
Z9 0
U1 2
U2 9
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JAN 24
PY 2023
VL 8
IS 2
AR e154314
DI 10.1172/jci.insight.154314
PG 21
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 8N8BG
UT WOS:000925370700001
PM 36472923
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Taguchi, T
   Ohashi, M
AF Taguchi, T
   Ohashi, M
TI Changes in fidelity levels of DNA polymerases α-1, α-2, and β during
   ageing in rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE rat; regenerating liver; DNA polymerases; synthetic template-primer;
   fidelity; ageing
ID AGING HUMAN FIBROBLASTS; MISMATCH REPAIR; DIETARY RESTRICTION; DAMAGE;
   BASE; MICE; 8-HYDROXY-2'-DEOXYGUANOSINE; MECHANISM; TEMPLATES; MUTATION
AB DNA polymerases (deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase EC 2.7.7.7.) were extracted from the regenerating livers of rats of various ages. The extracts were separated into three DNA polymerase fractions (alpha-1, alpha-2, and beta) by phosphocellulose column chromatography, and their fidelity levels were then monitored with the synthetic template-primer, poly (dA-dT), poly dA-dT(10), or poly dC-poly dG. The fidelity levels of the three DNA polymerases from regenerating liver of rats younger than 20 months were high, while those of DNA polymerases from rats older than 20 months were significantly lower with similar profiles on all three template-primers. On the other hand, the fidelity levels of enzymes from 23- and 26-month-old rats were similar. These results indicate that the levels of error-prone DNA polymerases increase rapidly in the regenerating liver of rats from ages 20 to 23 months. This may due to the amplification of DNA polymerase gene mutations by an error-prone enzyme itself. However, the cells in which mutations in the functional gene occur may undergo cell death because the fidelity levels of the DNA polymerases in the older animals did not increase. (C) 1997 Elsevier Science Ireland Ltd.
C1 Tokyo Metropolitan Inst Gerontol, Dept Biol Mol, Itabashi Ku, Tokyo 173, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Taguchi, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Biol Mol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 173, Japan.
CR CARRANO AV, 1989, GENOME, V31, P458, DOI 10.1139/g89-079
   CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986
   DEVRIES FAJ, 1971, MUTAT RES, V11, P438
   FANG WH, 1993, J BIOL CHEM, V268, P11838
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FRY M, 1976, BIOCHEMISTRY-US, V15, P4319, DOI 10.1021/bi00664a028
   GERSHON H, 1973, P NATL ACAD SCI USA, V70, P909, DOI 10.1073/pnas.70.3.909
   HALL ZW, 1968, J MOL BIOL, V36, P321, DOI 10.1016/0022-2836(68)90158-7
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837
   INAMIZU T, 1986, P NATL ACAD SCI USA, V83, P2488, DOI 10.1073/pnas.83.8.2488
   Jinno S, 1995, MECH AGEING DEV, V85, P95, DOI 10.1016/0047-6374(95)01659-7
   JOYCE CM, 1992, J BIOL CHEM, V267, P24485
   Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7
   KRAUSS SW, 1987, J BIOL CHEM, V262, P3432
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   MORLEY AA, 1982, MECH AGEING DEV, V19, P21, DOI 10.1016/0047-6374(82)90046-X
   OHASHI M, 1978, BIOCHEM BIOPH RES CO, V82, P1084, DOI 10.1016/0006-291X(78)90298-X
   RECONDO AMD, 1973, J BIOL CHEM, V248, P131
   REHAKRANTZ LJ, 1977, J MOL BIOL, V116, P99, DOI 10.1016/0022-2836(77)90121-8
   REHAKRANTZ LJ, 1988, J MOL BIOL, V202, P711, DOI 10.1016/0022-2836(88)90552-9
   REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635
   ROTHSTEIN M, 1975, MECH AGEING DEV, V4, P325, DOI 10.1016/0047-6374(75)90033-0
   SAFFHILL R, 1974, BIOCHIM BIOPHYS ACTA, V349, P23, DOI 10.1016/0005-2787(74)90004-5
   SALISBURY JG, 1978, BIOCHIM BIOPHYS ACTA, V517, P181, DOI 10.1016/0005-2787(78)90045-X
   SPRINGGATE CF, 1973, P NATL ACAD SCI USA, V70, P245, DOI 10.1073/pnas.70.1.245
   SRIVASTAVA V, 1992, EXP GERONTOL, V27, P593, DOI 10.1016/0531-5565(92)90014-Q
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P453, DOI 10.1016/0531-5565(91)90034-J
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Taguchi T, 1996, MECH AGEING DEV, V92, P143, DOI 10.1016/S0047-6374(96)01816-7
   TAGUCHI T, 1972, GANN MONOGR, V12, P191
   TRAUTNER TA, 1962, P NATL ACAD SCI USA, V48, P449, DOI 10.1073/pnas.48.3.449
   VARLET I, 1990, P NATL ACAD SCI USA, V87, P7883, DOI 10.1073/pnas.87.20.7883
   VILLANI G, 1978, P NATL ACAD SCI USA, V75, P3037, DOI 10.1073/pnas.75.7.3037
NR 39
TC 12
Z9 12
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC 1
PY 1997
VL 99
IS 1
BP 33
EP 47
DI 10.1016/S0047-6374(97)00092-4
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YM944
UT WOS:000071117500004
PM 9430103
DA 2024-02-19
ER

PT J
AU KUROBE, N
   SUZUKI, F
   KATO, K
   SATO, T
AF KUROBE, N
   SUZUKI, F
   KATO, K
   SATO, T
TI SENSITIVE IMMUNOASSAY OF RAT CU/ZN SUPEROXIDE-DISMUTASE - CONCENTRATIONS
   IN THE BRAIN, LIVER, AND KIDNEY ARE NOT AFFECTED BY AGING
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
C1 AICHI PREFECTURAL COLONY, INST DEV RES, DEPT BIOCHEM, KASUGAI, AICHI 48003, JAPAN.
   AICHI MED UNIV, INST MED SCI AGING, NAGAKUTE, AICHI 48011, JAPAN.
C3 Aichi Medical University
CR ARAI K, 1987, J BIOL CHEM, V262, P16969
   ARAI K, 1987, BIOCHIM BIOPHYS ACTA, V924, P292, DOI 10.1016/0304-4165(87)90025-0
   ASAYAMA K, 1985, J BIOL CHEM, V260, P2212
   BARET A, 1979, BIOCHEM BIOPH RES CO, V88, P337, DOI 10.1016/0006-291X(79)92053-9
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   DELVILLANO BC, 1979, J IMMUNOL METHODS, V29, P253, DOI 10.1016/0022-1759(79)90313-2
   HAIMOTO H, 1989, CLIN CHIM ACTA, V181, P27, DOI 10.1016/0009-8981(89)90314-8
   KATO K, 1980, CLIN CHIM ACTA, V102, P261, DOI 10.1016/0009-8981(80)90043-1
   KATO K, 1983, METHOD ENZYMOL, V92, P345
   KATO K, 1977, J BIOCHEM-TOKYO, V81, P1557
   KATO K, 1976, J IMMUNOL, V116, P1554
   KATO K, 1981, J NEUROCHEM, V37, P998, DOI 10.1111/j.1471-4159.1981.tb04487.x
   KATO K, 1979, J APPL BIOCHEM, V1, P479
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024
   NISHIMURA N, 1982, J PHARMACOBIO-DYNAM, V5, P394
   OKA S, 1989, CLIN CHIM ACTA, V182, P209, DOI 10.1016/0009-8981(89)90079-X
   PEETERSJORIS C, 1975, BIOCHEM J, V150, P31, DOI 10.1042/bj1500031
   PORSTMANN T, 1988, CLIN CHIM ACTA, V171, P1, DOI 10.1016/0009-8981(88)90285-9
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VANELLA A, 1989, J NEUROSCI RES, V22, P351, DOI 10.1002/jnr.490220316
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   YOSHITAKE S, 1982, J BIOCHEM-TOKYO, V92, P1413, DOI 10.1093/oxfordjournals.jbchem.a134065
NR 29
TC 27
Z9 27
U1 0
U2 0
PU BIOMEDICAL RESEARCH PRESS LTD
PI SAPPORO
PA HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA
   15-NISHI 7, SAPPORO, 060-8638, JAPAN
SN 0388-6107
EI 1880-313X
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD JUN
PY 1990
VL 11
IS 3
BP 187
EP 194
DI 10.2220/biomedres.11.187
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DL941
UT WOS:A1990DL94100006
OA Bronze
DA 2024-02-19
ER

PT J
AU NAKAZAWA, T
   MORI, N
   GOTO, S
AF NAKAZAWA, T
   MORI, N
   GOTO, S
TI FUNCTIONAL DETERIORATION OF MOUSE-LIVER RIBOSOMES DURING AGING -
   TRANSLATIONAL ACTIVITY AND ACTIVITY FOR FORMATION OF THE 47-S INITIATION
   COMPLEX
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 TOHO UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM,FUNABASHI,CHIBA 274,JAPAN.
C3 Toho University
CR ANZAI K, 1981, BIOMED GERONTOL TOKY, V5, P62
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   Chatterjee B, 1979, Methods Enzymol, V60, P256
   COOK JR, 1981, MECH AGEING DEV, V17, P41, DOI 10.1016/0047-6374(81)90127-5
   Crystal R G, 1974, Methods Enzymol, V30, P101
   DUNLOP DS, 1977, J NEUROCHEM, V29, P939, DOI 10.1111/j.1471-4159.1977.tb06497.x
   EKSTROM R, 1980, GERONTOLOGY, V26, P121, DOI 10.1159/000212405
   GROSS M, 1979, J BIOL CHEM, V254, P2370
   HARDWICK J, 1981, BIOCHIM BIOPHYS ACTA, V652, P204, DOI 10.1016/0005-2787(81)90223-9
   Henshaw E C, 1979, Methods Enzymol, V60, P275
   KURTZ DI, 1978, EXP GERONTOL, V13, P397, DOI 10.1016/0531-5565(78)90050-5
   LERNER MP, 1970, J BIOL CHEM, V245, P1388
   LODISH HF, 1973, J BIOL CHEM, V248, P3520
   MAINWARING WI, 1969, BIOCHEM J, V113, P869, DOI 10.1042/bj1130869
   MAITRA U, 1982, ANNU REV BIOCHEM, V51, P869, DOI 10.1146/annurev.bi.51.070182.004253
   Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1
   Merrick W C, 1979, Methods Enzymol, V60, P108, DOI 10.1016/S0076-6879(79)60011-3
   MORI N, 1979, MECH AGEING DEV, V10, P379, DOI 10.1016/0047-6374(79)90020-4
   MORI N, 1978, MECH AGEING DEV, V8, P285, DOI 10.1016/0047-6374(78)90029-5
   Richardson A, 1981, CRC HDB BIOCH AGING, P79
   SAFER B, 1983, CELL, V33, P7, DOI 10.1016/0092-8674(83)90326-4
   SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6
   TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VARGAS R, 1983, MECH AGEING DEV, V21, P183, DOI 10.1016/0047-6374(83)90073-8
   WAGNER EGH, 1982, EUR J BIOCHEM, V122, P193, DOI 10.1111/j.1432-1033.1982.tb05866.x
   WEBSTER GC, 1981, MECH AGEING DEV, V16, P71, DOI 10.1016/0047-6374(81)90034-8
NR 27
TC 13
Z9 14
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1984
VL 26
IS 2-3
BP 241
EP 251
DI 10.1016/0047-6374(84)90097-6
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TG518
UT WOS:A1984TG51800009
PM 6482521
DA 2024-02-19
ER

PT J
AU Miller, RA
   Buehner, G
   Chang, Y
   Harper, JM
   Sigler, R
   Smith-Wheelock, M
AF Miller, RA
   Buehner, G
   Chang, Y
   Harper, JM
   Sigler, R
   Smith-Wheelock, M
TI Methionine-deficient diet extends mouse lifespan, slows immune and lens
   aging, alters glucose, T4, IGF-I and insulin levels, and increases
   hepatocyte MIF levels and stress resistance
SO AGING CELL
LA English
DT Article
DE biomarkers; diet; longevity; mice; migration inhibition factor;
   oxidative stress
ID GENETICALLY HETEROGENEOUS MICE; DNA METHYLATION; GENE-EXPRESSION; RATS;
   RESTRICTION; GLUTATHIONE; SYSTEM; GROWTH; MODEL
AB A diet deficient in the amino acid methionine has previously been shown to extend lifespan in several stocks of inbred rats. We report here that a methionine-deficient (Meth-R) diet also increases maximal lifespan in (BALB/cJ x C57BL/6 J)F1 mice. Compared with controls, Meth-R mice have significantly lower levels of serum IGF-I, insulin, glucose and thyroid hormone. Meth-R mice also have higher levels of liver mRNA for MIF (macrophage migration inhibition factor), known to be higher in several other mouse models of extended longevity. Meth-R mice are significantly slower to develop lens turbidity and to show age-related changes in T-cell subsets. They are also dramatically more resistant to oxidative liver cell injury induced by injection of toxic doses of acetaminophen. The spectrum of terminal illnesses in the Meth-R group is similar to that seen in control mice. Studies of the cellular and molecular biology of methionine-deprived mice may, in parallel to studies of calorie-restricted mice, provide insights into the way in which nutritional factors modulate longevity and late-life illnesses.
C1 Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Dept Ophthalmol, Ann Arbor, MI 48109 USA.
   Esperion Therapeut, Ann Arbor, MI USA.
   Ann Arbor VA Med Ctr, Ann Arbor, MI USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan
RP Miller, RA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Room 5316 CCGCB,Box 0940,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
OI Harper, James/0000-0003-0765-8828
FU NIA NIH HHS [AG08808, AG13283, P60 AG008808, P30 AG013283] Funding
   Source: Medline
CR [Anonymous], 1999, FUNDAMENTAL IMMUNOLO
   Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620
   James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S
   MASORO EJ, 1992, J GERONTOL, V47, P202
   Miller RA, 1997, MECH AGEING DEV, V96, P181, DOI 10.1016/S0047-6374(97)01893-9
   Miller RA, 1997, FASEB J, V11, P775, DOI 10.1096/fasebj.11.10.9271362
   Miller RA, 2000, J ZOOL, V250, P95, DOI 10.1111/j.1469-7998.2000.tb00580.x
   Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142
   Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715
   MILLER RA, 2001, HDB BIOL AGING, P369
   Miller Richard A., 1995, P555
   Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S
   OOKA H, 1988, MECH AGEING DEV, V43, P79, DOI 10.1016/0047-6374(88)90099-1
   ORENTREICH N, 1993, J NUTR, V123, P269
   Poirier LA, 2002, J NUTR, V132, p2336S, DOI 10.1093/jn/132.8.2336S
   Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S
   Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171
   SEGALL PE, 1976, MECH AGEING DEV, V5, P109, DOI 10.1016/0047-6374(76)90012-9
   Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521
   Van Remmen Holly, 1995, P171
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   WEINDRUCH R, 1988, RETARDATION AGING DI
   Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3
NR 25
TC 527
Z9 603
U1 2
U2 60
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2005
VL 4
IS 3
BP 119
EP 125
DI 10.1111/j.1474-9726.2005.00152.x
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 929TE
UT WOS:000229368500002
PM 15924568
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Lightle, SA
   Oakley, JI
   Nikolova-Karakashian, MN
AF Lightle, SA
   Oakley, JI
   Nikolova-Karakashian, MN
TI Activation of sphingolipid turnover and chronic generation of ceramide
   and sphingosine in liver during aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
ID GENE-EXPRESSION; PLASMA-MEMBRANE; RAT HEPATOCYTES; AGE; KINASE; PROTEIN;
   GLUTATHIONE; METABOLISM; PATHWAY; SPHINGOMYELINASE
AB Aging leads to a decreased ability of liver to metabolize drugs and increased expression and secretion of acute phase proteins, such as serum amyloid A (SAA), C-reactive protein (CRP), and alpha-1-acid glycoprotein (AGP). This phenomenon resembles some aspects of the acute phase response of host to inflammation; however, the molecular basis for the similarity is unclear. Ceramide and sphingosine are second messenger mediators of cellular responses to stress and inflammation. In liver, they pray important role in mediating acute phase responses to IL-beta. In this study, we use HPLC and thin layer chromatography to evaluate the effects of aging on steady-state level of ceramide and sphingosine. We report that both lipids are elevated in liver of old (24 months) as compared to young (5 months) male Fisher 344 rats. To elucidate the mechanism(s) for ceramide elevation, we test the acidic(ASMase) and neutral sphingomyelinase (NSMase) in vitro using NBD-sphingomyelin as an exogenous substrate. SM synthase is also analyzed in vitro using NBD-ceramide and {H-3}-dipalmitoylphosphatidylcholine (DPPC) as exogenous substrates. In accordance with the increases in the mass of ceramide, the activity of acid and neutral SMase is elevated in old animals. Michaelis-Menten analysis of NSMase implies that the apparent activation of this enzyme is caused by an increase in the V-max of the enzyme. In contrast, SM synthase activity is lower in old animals as compared to young ones. These results show that aging is accompanied by an elevation in SM turnover and a decrease in its synthesis, resulting in accumulation of pro-inflammatory and growth inhibitory second messenger ceramide. Ce ramidase, the only enzyme leading to sphingosine generation, is also measured in vitro using NBD-ceramide as a substrate and liver homogenate as an enzyme source. Its activity is higher in the old rats, as compared to young ones. The acid and neutral forms of the enzyme are affected the most, while the changes in the alkaline enzyme are not significant. The increases in the basal levels of ceramide and sphingosine in old animals may contribute to the onset of inflammatory like state in liver during aging, exemplified by decrease P4502C11mRNA expression and chronic induction of acute phase protein expression, (C) 2000 Published by Elsevier Science Ireland Ltd.
C1 Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Physiol, Lexington, KY 40536 USA.
C3 University of Kentucky
RP Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Physiol, MS 579,800 Rose St, Lexington, KY 40536 USA.
EM mnikolo@pop.uky.edu
CR Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CARLSON DM, 1973, J BIOL CHEM, V248, P5742
   Catania A, 1997, J GERONTOL A-BIOL, V52, pB93, DOI 10.1093/gerona/52A.2.B93
   CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233
   Chin JH, 1996, MECH AGEING DEV, V86, P11, DOI 10.1016/0047-6374(95)01676-7
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347
   FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650
   GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369
   Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855
   HANNUN YA, 1991, METHOD ENZYMOL, V201, P316
   Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197
   Hayashi T, 1998, MECH AGEING DEV, V100, P231, DOI 10.1016/S0047-6374(97)00149-8
   HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217
   Kim SS, 1997, BIOCHEM BIOPH RES CO, V237, P583, DOI 10.1006/bbrc.1997.7133
   Kitano S, 1998, AM J PHYSIOL-CELL PH, V275, pC146, DOI 10.1152/ajpcell.1998.275.1.C146
   LeckaCzernik B, 1996, EXP GERONTOL, V31, P159, DOI 10.1016/0531-5565(95)02014-4
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   Lozanski G, 1997, BIOCHEM J, V328, P271, DOI 10.1042/bj3280271
   Mansat-De Mas V, 1999, MOL PHARMACOL, V56, P867, DOI 10.1124/mol.56.5.867
   MENDENHALL CL, 1993, ALCOHOL CLIN EXP RES, V17, P847, DOI 10.1111/j.1530-0277.1993.tb00852.x
   MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3
   MODE A, 1993, J REPROD FERTIL, P77
   MORGAN ET, 1989, MOL PHARMACOL, V36, P699
   Mori T, 1995, EXP MOL PATHOL, V63, P135, DOI 10.1006/exmp.1995.1038
   Müller G, 1998, EMBO J, V17, P732, DOI 10.1093/emboj/17.3.732
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P194
   Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P31
   NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   Rabek JP, 1998, BBA-GENE STRUCT EXPR, V1398, P137, DOI 10.1016/S0167-4781(98)00038-4
   RANA R, 1992, MECH AGEING DEV, V64, P61, DOI 10.1016/0047-6374(92)90096-V
   Sakakura C, 1996, FEBS LETT, V379, P177, DOI 10.1016/0014-5793(95)01508-6
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509
   ULLMAN MD, 1974, J BIOL CHEM, V249, P1506
   VENABLE ME, 1994, J BIOL CHEM, V269, P26040
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
   VRANCKX R, 1995, AM J PHYSIOL-REG I, V268, pR536, DOI 10.1152/ajpregu.1995.268.2.R536
   WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   Yamamoto K, 1997, HEPATO-GASTROENTEROL, V44, P514
NR 48
TC 99
Z9 108
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC 1
PY 2000
VL 120
IS 1-3
BP 111
EP 125
DI 10.1016/S0047-6374(00)00191-3
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 379PA
UT WOS:000165650600010
PM 11087909
DA 2024-02-19
ER

PT J
AU Shih, PH
   Chan, YC
   Liao, JW
   Wang, MF
   Yen, GC
AF Shih, Ping-Hsiao
   Chan, Yin-Ching
   Liao, Jiunn-Wang
   Wang, Ming-Fu
   Yen, Gow-Chin
TI Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry
   (<i>Morus atropurpurea</i> L.) on senescence-accelerated mice and
   prevention of Alzheimer's disease
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE SAMP8; Amyloid; Anthocyanin; Mulberry; Nrf2; MAPK
ID OXIDATIVE STRESS; METABOLIC SYNDROME; GENE-EXPRESSION; AGE; PROTEIN;
   BRAIN; MODEL; RATS; FLAVONOIDS; PATHWAYS
AB In the present study, we evaluated the beneficial effect of mulberry extracts (ME), which are rich in phenolics and anthocyanins, on the induction of antioxidant enzymes and on the promotion of cognition in senescence-accelerated mice (SAMP). Six-month old SAMP8 and SAMR1 mice were fed a basal diet supplemented with 0.18% and 0.9% ME for consecutive 12 weeks. The results showed that the mice fed the ME supplement demonstrated significantly less amyloid p, protein and showed improved learning and memory ability in avoidance response tests. ME-treated mice showed a higher antioxidant enzyme activity and less lipid oxidation in both the brain and liver, as compared to the control mice. Furthermore, treatment with ME decreased the levels of serum aspartate aminotransferase, alanine aminotransferase, triglyceride and total cholesterol that increase with ageing. The hepatoprotective effect of ME appeared to occur through a mechanism related to regulation of the mitogen-activated protein kinases and activation of the nuclear factor-erythroid 2 related factor 2, where the latter regulates the induction of phase 2 antioxidant enzymes and reduction of oxidative damage. Overall, supplementation of ME might be advantageous to the induction of an antioxidant defense system and for the improvement of memory deterioration in ageing animals. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Shih, Ping-Hsiao; Yen, Gow-Chin] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan.
   [Chan, Yin-Ching; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung 43301, Taiwan.
   [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan.
C3 National Chung Hsing University; Providence University - Taiwan;
   National Chung Hsing University
RP Yen, GC (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan.
EM gcyen@nchu.edu.tw
RI wang, ming/HPC-6329-2023; Yen, Gow-Chin/B-7886-2009; Shih,
   Ping-Hsiao/GPG-2472-2022; Wang, Yin/HCI-9352-2022; Liao,
   Jun/JUF-2784-2023
OI Shih, Ping-Hsiao/0000-0002-8387-105X; Yen, Gow-Chin/0000-0001-9538-4219;
   Liao, Jiunn-Wang/0000-0001-7374-1203; Chan, Yin
   Ching/0000-0001-9602-0775
FU National Science Council, Taiwan, Republic of China
   [NSC95-2313-B-005-066-MY3]
FX This research was partially supported by the National Science Council
   (NSC95-2313-B-005-066-MY3), Taiwan, Republic of China.
CR Abidi P, 2008, AGING CELL, V7, P168, DOI 10.1111/j.1474-9726.2007.00364.x
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Andallu B, 2003, CLIN CHIM ACTA, V338, P3, DOI 10.1016/S0009-8981(03)00322-X
   Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117
   Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65
   BELLOMO G, 1987, BIOCHEM PHARMACOL, V36, P1313, DOI 10.1016/0006-2952(87)90087-6
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6
   Candore G, 2006, ANN NY ACAD SCI, V1089, P516, DOI 10.1196/annals.1386.051
   Chen C, 2004, FREE RADICAL BIO MED, V36, P1505, DOI 10.1016/j.freeradbiomed.2004.03.015
   Chen CC, 2004, CHINESE J PHYSIOL, V47, P7
   COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7
   Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045
   Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701
   Dominguez Ligia J, 2007, J Cardiometab Syndr, V2, P183, DOI 10.1111/j.1559-4564.2007.06673.x
   Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x
   Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Furie KL, 2007, NEUROLOGY, V69, P951, DOI 10.1212/01.wnl.0000271094.43789.0e
   HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879
   Haque AM, 2008, J NUTR BIOCHEM, V19, P619, DOI 10.1016/j.jnutbio.2007.08.008
   Heo SI, 2007, J MED FOOD, V10, P602, DOI 10.1089/jmf.2006.0241
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2
   Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a
   Liao JW, 2006, BRIT J NUTR, V96, P400, DOI 10.1079/BJN20061823
   Maggi S, 2008, ATHEROSCLEROSIS, V197, P877, DOI 10.1016/j.atherosclerosis.2007.08.002
   Mehta PD, 2007, CURR ALZHEIMER RES, V4, P359, DOI 10.2174/156720507781788891
   Moranska Izabella, 2004, Wiad Lek, V57, P427
   Niidome T, 2007, NEUROREPORT, V18, P813, DOI 10.1097/WNR.0b013e3280dce5af
   Rahman MM, 2008, J AGR FOOD CHEM, V56, P7545, DOI 10.1021/jf800930s
   Rivière C, 2008, BIOORG MED CHEM LETT, V18, P828, DOI 10.1016/j.bmcl.2007.11.028
   Sakagami H, 2007, IN VIVO, V21, P499
   Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Shimmyo Y, 2008, BBA-GEN SUBJECTS, V1780, P819, DOI 10.1016/j.bbagen.2008.01.017
   Shin WH, 2006, LIFE SCI, V79, P130, DOI 10.1016/j.lfs.2005.12.033
   Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776
   Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC
   TAKEDA T, 1994, ARCH GERONTOL GERIAT, V19, P185, DOI 10.1016/0167-4943(94)90039-6
   Tarozzi A, 2008, NEUROREPORT, V19, P1483, DOI 10.1097/WNR.0b013e32830fe4b8
   Thomas S, 2007, HEART FAIL CLIN, V3, P381, DOI DOI 10.1016/J.HFC.2007.07.004
   Toor RK, 2005, FOOD RES INT, V38, P487, DOI 10.1016/j.foodres.2004.10.016
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Walton MC, 2006, J AGR FOOD CHEM, V54, P7940, DOI 10.1021/jf061527j
   Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008
   Willis LM, 2009, CURR OPIN CLIN NUTR, V12, P91, DOI 10.1097/MCO.0b013e32831b9c6e
   Yamada K, 1999, EUR J NEUROSCI, V11, P83, DOI 10.1046/j.1460-9568.1999.00408.x
   Yokozawa T, 2007, BRIT J NUTR, V97, P1187, DOI 10.1017/S0007114507691971
NR 53
TC 147
Z9 175
U1 2
U2 82
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUL
PY 2010
VL 21
IS 7
BP 598
EP 605
DI 10.1016/j.jnutbio.2009.03.008
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 618NS
UT WOS:000279363200005
PM 19443193
DA 2024-02-19
ER

PT J
AU Young, A
AF Young, A
TI Ageing and physiological functions
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT Meeting on Ageing - Science, Medicine, and Society
CY MAY 07-08, 1997
CL LONDON, ENGLAND
SP Royal Soc London, British Acad, Royal Coll Physicians
ID WHOLE VASTUS LATERALIS; DIFFERENT FIBER TYPES; ELDERLY MEN;
   WATER-DEPRIVATION; SKELETAL-MUSCLES; CROSS-SECTIONS; STRENGTH; EXERCISE;
   YOUNG; OLDER
AB In youth, most physiological functions have generous spare capacity. Even in health, however, increasing age is characterized by progressive erosion of these 'safety margins'. Examples include the decline of bone mass (towards a threshold for likelihood of fracture), of glomerular filtration rate (towards a threshold for susceptibility to clinical renal failure), of renal tubular function (towards a threshold for clinically important susceptibility to dehydration), of hepatic function (towards a threshold for accumulation following conventional 'young adult' doses of common medications), or of lower limb explosive power (towards thresholds for impaired functional mobility).
   Increasing age is also characterized by a rising prevalence of chronic pathologies, complicating attempts to determine the rate or the mechanism of the age-related decline in a physiological function. Nevertheless, it is clear that in many organs the loss of function is largely attributable to the loss of functioning cells, even in the absence of overt disease. This apparently fundamental aspect of ageing remains poorly understood.
C1 Univ London Royal Free Hosp, Sch Med, Dept Geriatr Med, London NW3 2PF, England.
C3 University of London; University College London; UCL Medical School
RP Young, A (corresponding author), Univ London Royal Free Hosp, Sch Med, Dept Geriatr Med, Rowland Hill St, London NW3 2PF, England.
CR ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812
   ANIANSSON A, 1984, ARCH GERONTOL GERIAT, V3, P229, DOI 10.1016/0167-4943(84)90024-4
   [Anonymous], 1985, DUKE LONGITUDINAL ST
   [Anonymous], 1881, CLIN LECT SENILE CHR
   [Anonymous], 1996, Physiotherapy, DOI DOI 10.1016/S0031-9406(05)66916-7
   BLACK D, 1995, J ROY COLL PHYS LOND, V29, P188
   BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436
   CAMPBELL MJ, 1973, J NEUROL NEUROSUR PS, V36, P174, DOI 10.1136/jnnp.36.2.174
   CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262
   CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912
   Collins Kenneth J., 1992, P93
   COSTA PT, 1977, EPIDEMIOLOGY AGING, P23
   DAVIES AE, 1995, LANCET, V345, P487, DOI 10.1016/S0140-6736(95)90584-7
   DAVIES CTM, 1983, J APPL PHYSIOL, V55, P191, DOI 10.1152/jappl.1983.55.1.191
   DEDEUXCHAISNES CN, 1983, OSTEOPOROSIS MULTIDI, P291
   DOHERTY TJ, 1993, MUSCLE NERVE, V16, P355, DOI 10.1002/mus.880160404
   DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868
   ERICSSON KA, 1990, SUCCESSFUL AGING PER
   Faulkner J A, 1990, Annu Rev Gerontol Geriatr, V10, P147
   FAULKNER JA, 1990, AM J PHYSIOL, V259, pR259, DOI 10.1152/ajpregu.1990.259.2.R259
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147
   GREEN HJ, 1986, SPORTS MED MATURE AT, P17
   Greenfeld Z, 1997, EUR J CLIN INVEST, V27, P346, DOI 10.1046/j.1365-2362.1997.1140651.x
   GREIG CA, 1994, AGE AGEING, V23, P185, DOI 10.1093/ageing/23.3.185
   Greig Carolyn, 1992, P601
   GRIMBY G, 1994, SCAND J REHABIL MED, V26, P121
   HAKKINEN K, 1996, ELECTROMYOG CLIN NEU, V35, P137
   HARRIDGE SDR, 1997, IN PRESS PRINCIPLES
   Holliday R, 1995, Understanding ageing
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x
   LEVY DI, 1994, GERIATRICS 94, P85
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   LEXELL J, 1991, J ANAT, V174, P239
   LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LIGTHART GJ, 1990, MECH AGEING DEV, V55, P89, DOI 10.1016/0047-6374(90)90108-R
   MCCARTNEY N, 1995, J GERONTOL, V41, pB97
   MELTZER DE, 1994, MED SCI SPORT EXER, V26, P1053
   MOORE DH, 1975, NATURE, V253, P264, DOI 10.1038/253264a0
   MORGAN DB, 1983, OSTEOPOROSIS MULTIDI, P81
   Parry-Billings Mark, 1992, P604
   PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202
   Riggs B. Lawrence, 1992, P405
   RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203
   ROMAN WJ, 1993, J APPL PHYSIOL, V74, P750, DOI 10.1152/jappl.1993.74.2.750
   ROWE JW, 1976, NEPHRON, V17, P270, DOI 10.1159/000180731
   ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155
   ROWE JW, 1980, ANNU REV GERONTOL, V1, P161
   SCHOCK NW, 1980, AGING ITS CHEM, P3
   SIPILA S, 1995, J APPL PHYSIOL, V78, P334, DOI 10.1152/jappl.1995.78.1.334
   SKELTON D, 1998, IN PRESS PHYSICAL AC
   SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371
   SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x
   Skelton DA, 1997, AGING-CLIN EXP RES, V9, P106, DOI 10.1007/BF03340135
   SKELTON DA, 1992, CLIN SCI, V83, pP16
   TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7
   Woodhouse K. W., 1992, P256
   Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364
   YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261
   YARASHESKI KE, 1995, AM J PHYSIOL-ENDOC M, V268, pE268, DOI 10.1152/ajpendo.1995.268.2.E268
   YOUNG A, 1986, ACTA MED SCAND, P227
   YOUNG A, 1996, EPIDEMIOLOGY OLD AGE, P190
   YOUNG A, 1988, NEW ISSUES NEUROSCIE, V1, P141
   YOUNG A, 1994, PHYS ACTIVITY AGIN 1, V3, P149
   Young Archie, 1992, P597
   1992, HLTH ELDERLY PEOPLE
NR 67
TC 67
Z9 74
U1 0
U2 8
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD DEC 29
PY 1997
VL 352
IS 1363
BP 1837
EP 1843
DI 10.1098/rstb.1997.0169
PG 7
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Life Sciences & Biomedicine - Other Topics
GA YR674
UT WOS:000071518900011
PM 9460068
OA Green Published
DA 2024-02-19
ER

PT J
AU Haak, JL
   Buettner, GR
   Spitz, DR
   Kregel, KC
AF Haak, Jodie L.
   Buettner, Garry R.
   Spitz, Douglas R.
   Kregel, Kevin C.
TI Aging augments mitochondrial susceptibility to heat stress
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE mitochondria; liver; stress response; ROS; cytochrome c
ID OXYGEN RADICAL GENERATION; TERM CALORIC RESTRICTION; INDUCED
   LIVER-INJURY; AGE-RELATED-CHANGES; OXIDATIVE STRESS;
   SUPEROXIDE-DISMUTASE; DNA MUTATIONS; COENZYME-Q; COMPLEX-I; OLD RATS
AB Haak JL, Buettner GR, Spitz DR, Kregel KC. Aging augments mitochondrial susceptibility to heat stress. Am J Physiol Regul Integr Comp Physiol 296: R812-R820, 2009. First published January 14, 2009; doi:10.1152/ajpregu.90708.2008.-The pathophysiology of aging is accompanied by a decline in tolerance to environmental stress. While mitochondria are primary suspects in the etiology of aging, little is known about their ability to tolerate perturbations to homeostasis in older organisms. To investigate the role of mitochondria in the increased susceptibility to heat stress that accompanies aging, young and old Fischer 344 rats underwent a heat stress protocol known to elicit exaggerated cellular damage with aging. At either 2 or 24 h after heat stress, livers were removed from animals, and hepatic mitochondria were isolated. Electron microscopy revealed extensive morphological damage to mitochondria from young and, to a greater extent, old rats after heat stress. There was also a significant loss of cytochrome c from old, but not young, mitochondria and a persistent increase in 4-hydroxynonenal- modified proteins in old vs. young mitochondria exposed to heat stress. Electron paramagnetic resonance measurements of superoxide indicate greater superoxide production from mitochondria of old compared with young animals and suggest that mitochondrial integrity was altered during heat stress. The mitochondrial stress response, which functions to correct stress-induced damage to mitochondrial proteins, was also blunted in old rats. Delayed and reduced levels of heat shock protein 60 (Hsp60), the main inducible mitochondrial stress protein, were observed in old compared with young mitochondria after heat stress. Additionally, the amount of Hsp10 protein increased in young, but not old, rat liver mitochondria after hyperthermic challenge. Taken together, these data suggest that mitochondria in old animals are more vulnerable to incurring and less able to repair oxidative damage that occurs in response to a physiologically relevant heat stress.
C1 [Haak, Jodie L.; Kregel, Kevin C.] Univ Iowa, Dept Intergrat Physiol, Iowa City, IA 52242 USA.
   [Buettner, Garry R.; Spitz, Douglas R.; Kregel, Kevin C.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Dept Intergrat Physiol, 524 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Buettner, Garry/0000-0002-5594-1903; Spitz, Douglas/0000-0002-1254-8765
FU National Institutes of Health [R01 AG-12350, RO1 CA-100045, P30
   CA-086862]; University of Iowa College of Medicine ESR
FX The research performed in the authors' laboratories was supported by
   National Institutes of Health Grants R01 AG-12350 (to K. C. Kregel) and
   RO1 CA-100045 and P30 CA-086862 (to D. R. Spitz). The University of Iowa
   College of Medicine ESR facility also supported this research. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH.
CR [Anonymous], MMWR MORB MORTAL WKL
   BIZE IB, 1980, CANCER RES, V40, P3686
   Bornman L, 1998, BIOCHEM BIOPH RES CO, V246, P836, DOI 10.1006/bbrc.1998.8717
   Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013
   Cottrell DA, 2000, ANN NY ACAD SCI, V908, P199
   Craig EE, 1997, AM J PHYSIOL-HEART C, V272, pH2983, DOI 10.1152/ajpheart.1997.272.6.H2983
   Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   de Macario EC, 2000, FRONT BIOSCI-LANDMRK, V5, pD780
   Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1
   DICKSON JA, 1979, J APPL PHYSIOL, V47, P712, DOI 10.1152/jappl.1979.47.4.712
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010
   Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14
   Gredilla R, 2004, ANN NY ACAD SCI, V1019, P333, DOI 10.1196/annals.1297.057
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0
   Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184
   Imao M, 2006, LAB INVEST, V86, P959, DOI 10.1038/labinvest.3700451
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   KEW M, 1971, T ROY SOC TROP MED H, V65, P325, DOI 10.1016/0035-9203(71)90007-1
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2
   Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458
   Qian LJ, 2004, CELL STRESS CHAPERON, V9, P281, DOI 10.1379/CSC-20R.1
   Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1
   Sachidhanandam SB, 2003, EUR J PHARMACOL, V474, P121, DOI 10.1016/S0014-2999(03)01997-6
   Sammut IA, 2001, AM J PATHOL, V158, P1821, DOI 10.1016/S0002-9440(10)64138-7
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Skulachev VP, 2005, ANN NY ACAD SCI, V1057, P145, DOI 10.1196/annals.1356.009
   Soti C, 2003, AGING CELL, V2, P39, DOI 10.1046/j.1474-9728.2003.00031.x
   THRALL DE, 1986, CANCER RES, V46, P6229
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063
   Vanhems P, 2003, NEW ENGL J MED, V349, P2077, DOI 10.1056/NEJM200311203492120
   Venkataraman S, 2004, FREE RADICAL RES, V38, P1119, DOI 10.1080/10715760400010470
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Wadhwa R, 2005, BIOCHEM J, V391, P185, DOI 10.1042/BJ20050861
   Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang HJ, 2006, J APPL PHYSIOL, V100, P1385, DOI 10.1152/japplphysiol.01046.2005
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 59
TC 29
Z9 34
U1 0
U2 8
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR
PY 2009
VL 296
IS 3
BP R812
EP R820
DI 10.1152/ajpregu.90708.2008
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 412ST
UT WOS:000263745200038
PM 19144753
OA Green Published
DA 2024-02-19
ER

PT J
AU Corton, JC
   Lee, JS
   Liu, J
   Ren, HZ
   Vallanat, B
   DeVito, M
AF Corton, J. Christopher
   Lee, Janice S.
   Liu, Jie
   Ren, Hongzu
   Vallanat, Beena
   DeVito, Michael
TI Determinants of gene expression in the human liver: Impact of aging and
   sex on xenobiotic metabolism
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE Human liver; Transcript profiling; Age; Sex; P450 enzyme activities;
   Xenobiotic metabolizing genes
ID DRUG-METABOLISM; INTERLEUKIN-6; INFLAMMATION; TISSUE; AGE;
   IDENTIFICATION; COMPENDIUM; PROFILES; BRAIN
AB There is a need to characterize the potential susceptibility of older adults to toxicity from environmental chemical exposures. Liver xenobiotic metabolizing enzymes (XMEs) play important roles in detoxifying and eliminating xenobiotics. We examined global gene expression in the livers of young (21-45 years) and old (69+ years) men and women. Differentially expressed genes (DEG) were identified using two-way ANOVA (p <= 0.05). We identified 1437 and 1670 DEGs between young and old groups in men and women, respectively. Only a minor number of the total number of genes overlapped (146 genes). Aging increased or decreased pathways involved in inflammation and intermediary metabolism, respectively. Aging led to numerous changes in the expression of XME genes or genes known to control their expression (similar to 90 genes). Out of 10 cytochrome P450s activities examined, there were increased activities of CYP1A2 and CYP2C9 enzymes in the old groups. We also identified sex-dependent genes that were more numerous in the young group (1065) than in the old group (202) and included changes in XMEs. These studies indicate that the livers from aging humans when compared to younger adults exhibit changes in XMEs that may lead to differences in the metabolism of xenobiotics.
C1 [Corton, J. Christopher; Liu, Jie; Ren, Hongzu; Vallanat, Beena; DeVito, Michael] US EPA, Ctr Computat Toxicol & Exposure, Res Triangle Pk, NC 27711 USA.
   [Ren, Hongzu] US EPA, Ctr Publ Hlth & Environm Assessment, Res Triangle Pk, NC 27711 USA.
   [Corton, J. Christopher] US EPA, Ctr Computat Toxicol & Exposure, 109 TW Alexander Dr MD-B105-03, Res Triangle Pk, NC 27711 USA.
C3 United States Environmental Protection Agency; United States
   Environmental Protection Agency; United States Environmental Protection
   Agency
RP Corton, JC (corresponding author), US EPA, Ctr Computat Toxicol & Exposure, 109 TW Alexander Dr MD-B105-03, Res Triangle Pk, NC 27711 USA.
EM corton.chris@epa.gov; lee.janices@epa.gov; Liu.jie@epa.gov;
   ren.hongzu@epa.gov; vallanat.beena@epa.gov; devito.michael@epa.gov
OI Lee, Janice/0000-0002-4331-8452; Liu, Jie/0000-0002-4530-1443
CR AOA A., 2004, PROF OLD AM 2009
   Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945
   Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751
   Boylston WH, 2006, AGE, V28, P125, DOI 10.1007/s11357-006-9008-6
   Census U.B.O.T., 1996, POPULATION PROJECTIO, P25
   Cervantes PW, 2021, CHEM RES TOXICOL, V34, P1721, DOI 10.1021/acs.chemrestox.0c00510
   Corton JC, 2019, TOXICOL APPL PHARM, V380, DOI 10.1016/j.taap.2019.114683
   Corton JC, 2018, ENVIRON MOL MUTAGEN, V59, P772, DOI 10.1002/em.22243
   Davis AP, 2021, NUCLEIC ACIDS RES, V49, pD1138, DOI 10.1093/nar/gkaa891
   ERSHLER WB, 1993, J AM GERIATR SOC, V41, P176, DOI 10.1111/j.1532-5415.1993.tb02054.x
   ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225
   FRENI MA, 1995, HEPATOLOGY, V22, P389, DOI 10.1002/hep.1840220203
   Geller AM, 2005, ENVIRON HEALTH PERSP, V113, P1257, DOI 10.1289/ehp.7569
   Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460
   Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001
   Hjelmström P, 2001, J LEUKOCYTE BIOL, V69, P331
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2
   Jackson AC, 2020, METALLOMICS, V12, P1400, DOI 10.1039/d0mt00071j
   Korunes KL, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261854
   Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066
   Landrigan PJ, 2002, ENVIRON HEALTH PERSP, V110, P721, DOI 10.1289/ehp.02110721
   Le Couteur DG, 2018, J GERONTOL A-BIOL, V73, P139, DOI 10.1093/gerona/glx221
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Levin M, 2016, NATURE, V531, P637, DOI 10.1038/nature16994
   Liu J, 2021, DRUG METAB DISPOS, V49, P111, DOI 10.1124/dmd.120.000181
   Liu J, 2021, XENOBIOTICA, V51, P279, DOI 10.1080/00498254.2020.1867929
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Luo SS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02938
   Mitzner TL, 2018, INNOV AGING, V2, DOI 10.1093/geroni/igy008
   Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005
   Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002
   Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rooney JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239367
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Shomer NH, 2003, INFECT IMMUN, V71, P3572, DOI 10.1128/IAI.71.6.3572-3577.2003
   Slatter JG, 2006, XENOBIOTICA, V36, P938, DOI 10.1080/00498250600861728
   Tan JL, 2015, DRUG AGING, V32, P999, DOI 10.1007/s40266-015-0318-1
   Tower J, 2017, TRENDS ENDOCRIN MET, V28, P735, DOI 10.1016/j.tem.2017.07.002
   VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
NR 47
TC 0
Z9 0
U1 2
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2022 NOV
PY 2022
VL 169
AR 111976
DI 10.1016/j.exger.2022.111976
EA OCT 2022
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 5Z1VL
UT WOS:000879766200003
PM 36244585
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Haidurov, A
   Budanov, AV
AF Haidurov, Alexander
   Budanov, Andrei V.
TI Sestrin family - the stem controlling healthy ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Sestrin; GATOR1/2; mTORC1/2; Mitochondria; Cell death
ID AGE-RELATED INTOLERANCE; DNA-DAMAGE; INSULIN-SENSITIVITY;
   PHYSICAL-EXERCISE; LIVER DEVELOPMENT; SKELETAL-MUSCLE; LEUCINE SENSOR;
   INHIBIT MTORC1; CELLS; ACTIVATION
AB Sestrins are a family of stress-responsive antioxidant proteins responsible for regulation of cell viability and metabolism. The best known Sestrin targets are mTORC1 and mTORC2 kinases that control different cellular processes including growth, viability, autophagy, and mitochondrial metabolism. Inactivation of the single Sestrin gene in invertebrates has an adverse impact on their healthspan and longevity, whereas each of the three Sestrin genes in mammals and other vertebrate organisms has a different impact on maintenance of a particular tissue, affecting its stress tolerance, function and regenerative capability. As a result, Sestrins attenuate ageing and suppress development of many age-related diseases including myocardial infarction, muscle atrophy, diabetes, and immune dysfunction, but exacerbate development of chronic obstructive pulmonary disease. Moreover, Sestrins play opposite roles in carcinogenesis in different tissues. Stem cells support tissue remodelling that influences ageing, and Sestrins might suppress ageing and age-related pathologies through control of stem cell biology. In this review, we will discuss the potential link between Sestrins, stem cells, and ageing.
C1 [Haidurov, Alexander; Budanov, Andrei V.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland.
   [Haidurov, Alexander; Budanov, Andrei V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia.
C3 Trinity College Dublin; Russian Academy of Sciences; Engelhardt
   Institute of Molecular Biology, RAS
RP Budanov, AV (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland.
EM budanova@tcd.ie
RI Budanov, Andrei V/HGD-5487-2022
OI Budanov, Andrei V/0000-0002-7943-1000; Haidurov,
   Alexander/0000-0003-4984-6587
FU Wellcome Trust ISSF grant [17-14-01420]; Russian Science Foundation;
   Russian Science Foundation [17-14-01420] Funding Source: Russian Science
   Foundation
FX This work was supported by the Wellcome Trust ISSF grant and the grant
   17-14-01420 from the Russian Science Foundation to AB. We thank Nadusha
   Pryadilova for the help with the manuscript.
CR Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866
   Audesse AJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008097
   Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002
   Brüning A, 2013, MOL ONCOL, V7, P1012, DOI 10.1016/j.molonc.2013.07.010
   Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Budanov AV, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2014.997113
   Budanov Andrei V, 2014, Subcell Biochem, V85, P337, DOI 10.1007/978-94-017-9211-0_18
   Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877
   Cai BL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0403-6
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014
   Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Chen YS, 2014, EXP NEUROL, V253, P63, DOI 10.1016/j.expneurol.2013.12.009
   Crisol BM, 2018, LIFE SCI, V194, P98, DOI 10.1016/j.lfs.2017.12.023
   Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Dalina AA, 2018, MOL BIOL+, V52, P823, DOI [10.1134/S0026893318060043, 10.1134/S0026898418060046]
   Ding Boxiao, 2019, Oncotarget, V10, P6997, DOI 10.18632/oncotarget.27367
   Ding BX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22538
   Ding BX, 2015, CELL CYCLE, V14, P3231, DOI 10.1080/15384101.2015.1084447
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gopinath SD, 2014, STEM CELL REP, V2, P414, DOI 10.1016/j.stemcr.2014.02.002
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Heidler J, 2013, DIS MODEL MECH, V6, P1378, DOI 10.1242/dmm.013482
   Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498
   Hu YB, 2018, CELL PHYSIOL BIOCHEM, V51, P2111, DOI 10.1159/000495829
   Huang MH, 2020, HEPATOLOGY, V71, P76, DOI 10.1002/hep.30820
   Hwang HJ, 2017, BBA-MOL BASIS DIS, V1863, P1436, DOI 10.1016/j.bbadis.2017.02.018
   Hwang I, 2018, AGING CELL, V17, DOI 10.1111/acel.12701
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268
   Johnson MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7031
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9
   Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09
   Kallenborn-Gerhardt W, 2013, ANTIOXID REDOX SIGN, V19, P2013, DOI 10.1089/ars.2012.4958
   Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249
   Kim HY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9997
   Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502
   Kim JR, 2003, EXP MOL MED, V35, P403, DOI 10.1038/emm.2003.53
   Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081
   Kim M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13442-5
   Kim SJ, 2017, CHEM-BIOL INTERACT, V269, P50, DOI 10.1016/j.cbi.2017.02.002
   Kovaleva IE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226862
   Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007
   Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665
   Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Leeman DS, 2018, SCIENCE, V359, P1277, DOI 10.1126/science.aag3048
   Lenhare L, 2017, EXP GERONTOL, V97, P17, DOI 10.1016/j.exger.2017.07.009
   Li G, 2016, LAB INVEST, V96, P741, DOI 10.1038/labinvest.2016.48
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460
   Liu XL, 2015, METABOLISM, V64, P658, DOI 10.1016/j.metabol.2015.01.015
   Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006
   Liu YJ, 2019, BBA-MOL BASIS DIS, V1865, P2685, DOI 10.1016/j.bbadis.2019.07.011
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Meng DL, 2020, J BIOL CHEM, V295, P2890, DOI 10.1074/jbc.AC119.011578
   Meng DL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.152595
   Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nascimento EBM, 2013, AM J PHYSIOL-ENDOC M, V305, pE1408, DOI 10.1152/ajpendo.00212.2013
   Oricchio E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9969
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071
   Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233
   Parmigiani A, 2016, INT REV CEL MOL BIO, V327, P1, DOI 10.1016/bs.ircmb.2016.05.003
   Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019
   Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5
   Quan NH, 2018, J MOL CELL CARDIOL, V115, P170, DOI 10.1016/j.yjmcc.2018.01.005
   Quan NH, 2017, FASEB J, V31, P4153, DOI 10.1096/fj.201700063R
   Reddy K, 2016, CELL REP, V14, P2166, DOI 10.1016/j.celrep.2016.02.006
   Ro SH, 2016, ELIFE, V5, DOI 10.7554/eLife.12204
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925
   Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320
   Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087
   Segalés J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13832-9
   Segrelles C, 2014, STEM CELLS, V32, P1917, DOI 10.1002/stem.1669
   Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05
   Singh P, 2018, CHEMOSPHERE, V191, P302, DOI 10.1016/j.chemosphere.2017.10.037
   Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013
   Soontornniyomkij V, 2012, J NEUROIMMUNE PHARM, V7, P579, DOI 10.1007/s11481-012-9357-0
   Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539
   Tomasovic A, 2015, J BIOL CHEM, V290, P9738, DOI 10.1074/jbc.M114.632133
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274
   Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wempe F, 2010, DIS MODEL MECH, V3, P246, DOI 10.1242/dmm.004234
   Wen YP, 2017, ONCOTARGET, V8, P37974, DOI 10.18632/oncotarget.16467
   Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001
   Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xu DD, 2019, AM J PHYSIOL-ENDOC M, V316, pE817, DOI 10.1152/ajpendo.00522.2018
   Yang JH, 2019, ANTIOXID REDOX SIGN, V31, P243, DOI 10.1089/ars.2018.7559
   Yang JH, 2015, FREE RADICAL BIO MED, V78, P156, DOI 10.1016/j.freeradbiomed.2014.11.002
   Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011
   Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115
   Ye J, 2017, CLIN CHIM ACTA, V472, P51, DOI 10.1016/j.cca.2017.07.020
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484
   Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786
   Zakaria N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1086-3
   Zeltukhin A. O., 2018, Biomedical & Pharmacology Journal, V11, P759
   Zeng NN, 2018, EXP GERONTOL, V110, P23, DOI 10.1016/j.exger.2018.05.006
   Zhao BZ, 2017, PHOTOCHEM PHOTOBIOL, V93, P375, DOI 10.1111/php.12624
   Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397
NR 125
TC 13
Z9 13
U1 0
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC
PY 2020
VL 192
AR 111379
DI 10.1016/j.mad.2020.111379
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA OY0YX
UT WOS:000593981700014
PM 33022334
OA Green Published
DA 2024-02-19
ER

PT J
AU Lim, DW
   Bose, S
   Wang, JH
   Choi, HS
   Kim, YM
   Chin, YW
   Jeon, SH
   Kim, JE
   Kim, H
AF Lim, Dong-Woo
   Bose, Shambhunath
   Wang, Jing-Hua
   Choi, Han Seok
   Kim, Young-Mi
   Chin, Young-Won
   Jeon, Song-Hee
   Kim, Jai-Eun
   Kim, Hojun
TI Modified SJH alleviates FFAs-induced hepatic steatosis through leptin
   signaling pathways
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NONALCOHOLIC FATTY LIVER; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION;
   IN-VITRO; TRADITIONAL MEDICINE; POTENTIAL-MECHANISM; INSULIN-RESISTANCE;
   LIPID-METABOLISM; PROTEIN-KINASE; ACID OXIDATION
AB Samjunghwan (SJH) is an herbal formula used in traditional Korean medicine. This prescription has long been used in treatment of aging and lifestyle diseases. The current study showed the effect and mechanisms of anti-hepatic steatosis action of modified SJH (mSJH) in vitro and in vivo. Treatment with mSJH resulted in significantly decreased intracellular lipid accumulation in steatosis-induced cells. Furthermore, mSJH triggered the phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase as well as increased the expression of leptin at both protein and gene levels. In addition, C57BL6 mice fed high-fat diet (HFD) showed significant improvements in body, liver weights and fat weights; and serum, hepatic and fecal lipid parameters in response to the treatment with mSJH. Furthermore, mSJH showed favorable effects on the hepatic expression of several genes related to lipid metabolism. Betaine, one of constituents of mSJH exerted fundamental beneficial impact on FFAs-induced cells. However, the beneficial effects of mSJH were diminished upon blocking of leptin signaling by dexamethasone, suggesting the leptin signaling as a key component in mSJH-mediated modulation of lipid homeostasis. Our results suggest that mSJH exerts an anti-hepatic steatosis effect via activation of leptin and associated signaling cascades related to lipid metabolism.
C1 [Lim, Dong-Woo; Kim, Jai-Eun] Dongguk Univ, Coll Oriental Med, Dept Pathol, Goyang, South Korea.
   [Lim, Dong-Woo; Wang, Jing-Hua; Kim, Hojun] Dongguk Univ, Coll Oriental Med, Dept Rehabil Med, Goyang, South Korea.
   [Bose, Shambhunath] Appl Surface Technol Inc, Adv Inst Convergence Technol, 11th Floor,Bldg A, Suwon 16229, South Korea.
   [Choi, Han Seok] Dongguk Univ Ilsan Hosp, Dept Internal Med, Div Endocrinol & Metab, Goyang, South Korea.
   [Kim, Young-Mi; Chin, Young-Won] Dongguk Univ Seoul, Coll Pharm, Integrated Res Inst Drug Dev, Goyang, South Korea.
   [Jeon, Song-Hee] Dongguk Univ, Res Inst Biotechnol, Goyang, South Korea.
C3 Dongguk University; Dongguk University; Dongguk University; Dongguk
   University; Dongguk University
RP Kim, H (corresponding author), Dongguk Univ, Coll Oriental Med, Dept Rehabil Med, Goyang, South Korea.
EM kimklar@dongguk.ac.kr
RI Bose, Shambhunath/HKW-2568-2023; Lim, Dongwoo/GLU-0640-2022; Kim,
   Hojun/AAB-8405-2020; Choi, Han Seok/AAG-1493-2019; Wang,
   Jing-hua/AAO-2350-2020
OI Wang, Jing-hua/0000-0002-2034-7429; Bose,
   Shambunath/0000-0003-0737-5713; Lim, Dongwoo/0000-0002-3179-9439; Chin,
   Young-Won/0000-0001-6964-1779
FU Traditional Korean Medicine R&D program - Ministry of Health & Welfare
   through the Korea Health Industry Development Institute (KHIDI)
   [HI14C0556]
FX This study was supported by the Traditional Korean Medicine R&D program
   funded by the Ministry of Health & Welfare through the Korea Health
   Industry Development Institute (KHIDI). (HI14C0556).
CR Abd El-Kader SM, 2015, WORLD J HEPATOL, V7, P846, DOI 10.4254/wjh.v7.i6.846
   Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746
   Ables GP, 2012, PPAR RES, V2012, DOI 10.1155/2012/912351
   Akabame S, 2008, CIRC J, V72, P618
   Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x
   Arumugam S, 2012, J CLIN BIOCHEM NUTR, V50, P139, DOI 10.3164/jcbn.11-44
   Asgharpour A., 2014, AUSTIN J CLIN MED, V1, P5
   Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Charach G, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/949672
   CURZIO M, 1985, INT J TISSUE REACT, V7, P137
   Day CP, 1998, HEPATOLOGY, V27, P1463, DOI 10.1002/hep.510270601
   Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x
   Dong JL, 2014, J FOOD NUTR RES, V2, P510, DOI DOI 10.12691/JFNR-2-8-13
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014
   Ferrante MC, 2014, TOXICOL APPL PHARM, V279, P401, DOI 10.1016/j.taap.2014.06.016
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gao XF, 2011, BIOCHEM J, V435, P723, DOI 10.1042/BJ20101680
   Gómez-Lechón MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004
   Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113
   Ho M, 2006, METABOLISM, V55, P8, DOI 10.1016/j.metabol.2005.06.013
   Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Ishida-Takahashi R, 2004, J BIOL CHEM, V279, P19658, DOI 10.1074/jbc.M310864200
   Jadeja R, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/648308
   Jeong S, 2008, J ETHNOPHARMACOL, V119, P245, DOI 10.1016/j.jep.2008.06.037
   한경선, 2014, [Journal of Korean Medicine for Obesity Research, 한방비만학회지], V14, P47
   Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126
   Kathirvel E, 2010, AM J PHYSIOL-GASTR L, V299, pG1068, DOI 10.1152/ajpgi.00249.2010
   Kim H, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-118
   Kim HG, 2010, J ETHNOPHARMACOL, V130, P625, DOI 10.1016/j.jep.2010.05.040
   Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77
   Kim SJ, 2016, J MED FOOD, V19, P353, DOI 10.1089/jmf.2015.3566
   Lai YS, 2015, J AGR FOOD CHEM, V63, P7873, DOI 10.1021/acs.jafc.5b02830
   LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304
   Lee WH, 2010, PPAR RES, V2010, DOI 10.1155/2010/549101
   Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109
   Li TG, 2009, PPAR RES, V2009, DOI 10.1155/2009/501739
   Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697
   Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105
   Matsusue K, 2004, MOL ENDOCRINOL, V18, P2751, DOI 10.1210/me.2004-0213
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Minokoshi Yasuhiko, 2012, Indian J Endocrinol Metab, V16, pS562, DOI 10.4103/2230-8210.105573
   Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545
   MYANT NB, 1977, J LIPID RES, V18, P135
   Otte C, 2004, EXP CLIN ENDOCR DIAB, V112, P10, DOI 10.1055/s-2004-815720
   Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644
   Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y
   Patrick Lyn, 2002, Altern Med Rev, V7, P276
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789
   Rocco DDFM, 2011, LIPIDS, V46, P617, DOI 10.1007/s11745-011-3555-z
   Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z
   Song ML, 2013, J CLEAN PROD, V42, P42, DOI 10.1016/j.jclepro.2012.11.010
   St-Pierre MV, 2001, J EXP BIOL, V204, P1673
   Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x
   Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06
   Um MY, 2013, BRIT J NUTR, V109, P1590, DOI 10.1017/S0007114512005260
   Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460
   Wan Y, 2014, EXP THER MED, V8, P79, DOI 10.3892/etm.2014.1698
   Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009
   Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108
   Wysocka Anna, 2014, Med Sci Monit, V20, P594, DOI 10.12659/MSM.890025
   Xi YL, 2015, CELL PHYSIOL BIOCHEM, V35, P2349, DOI 10.1159/000374037
   Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200
   Yan LP, 2006, LIFE SCI, V79, P324, DOI 10.1016/j.lfs.2006.01.016
   Yang J, 2016, PHYTOMEDICINE, V23, P181, DOI 10.1016/j.phymed.2015.12.018
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Ying R, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-180
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114
   Zhou L, 2008, WORLD J GASTROENTERO, V14, P2900, DOI 10.3748/wjg.14.2900
   이동준, 2006, [The Journal of Korean Oriental Internal Medicine, 대한한방내과학회지], V27, P178
NR 74
TC 9
Z9 9
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 30
PY 2017
VL 7
AR 45425
DI 10.1038/srep45425
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EQ1HN
UT WOS:000397820700001
PM 28358008
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chen, HA
   Ho, YJ
   Mezzadra, R
   Adrover, JM
   Smolkin, R
   Zhu, CY
   Woess, K
   Bernstein, N
   Schmitt, G
   Fong, L
   Luan, W
   Wuest, A
   Tian, S
   Li, X
   Broderick, C
   Hendrickson, RC
   Egeblad, M
   Chen, ZH
   Alonso-Curbelo, D
   Lowe, SW
AF Chen, Hsuan-An
   Ho, Yu-Jui
   Mezzadra, Riccardo
   Adrover, Jose M.
   Smolkin, Ryan
   Zhu, Changyu
   Woess, Katharina
   Bernstein, Nicholas
   Schmitt, Georgia
   Fong, Linda
   Luan, Wei
   Wuest, Alexandra
   Tian, Sha
   Li, Xiang
   Broderick, Caroline
   Hendrickson, Ronald C.
   Egeblad, Mikala
   Chen, Zhenghao
   Alonso-Curbelo, Direna
   Lowe, Scott W.
TI Senescence Rewires Microenvironment Sensing to Facilitate Antitumor
   Immunity
SO CANCER DISCOVERY
LA English
DT Article
ID CELLULAR SENESCENCE; IFN-GAMMA; SECRETORY PHENOTYPE; TUMOR-CELLS;
   RNA-SEQ; P53; THERAPY; MECHANISMS; RESISTANCE; DYNAMICS
AB Tumor cells triggered to senesce alter how they send and receive microenvironmental signals, leading to tissue remodeling, immune cell recruitment, hypersensitization to environmental IFN gamma, and improved antitumor immunity.
   Cellular senescence involves a stable cell-cycle arrest coupled to a secretory program that, in some instances, stimulates the immune clearance of senescent cells. Using an immune-competent liver cancer model in which senescence triggers CD8 T cell-mediated tumor rejection, we show that senescence also remodels the cell-surface proteome to alter how tumor cells sense environmental factors, as exemplified by type II interferon (IFN gamma). Compared with proliferating cells, senescent cells upregulate the IFN gamma receptor, become hypersensitized to microenvironmental IFN gamma, and more robustly induce the antigen-presenting machinery-effects also recapitulated in human tumor cells undergoing therapy-induced senescence. Disruption of IFN gamma sensing in senescent cells blunts their immune-mediated clearance without disabling the senescence state or its characteristic secretory program. Our results demonstrate that senescent cells have an enhanced ability to both send and receive environmental signals and imply that each process is required for their effective immune surveillance.Significance: Our work uncovers an interplay between tissue remodeling and tissue-sensing programs that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity. See related article by Marin et al., p. 410. This article is highlighted in the In This Issue feature, p. 247Significance: Our work uncovers an interplay between tissue remodeling and tissue-sensing programs that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity. See related article by Marin et al., p. 410. This article is highlighted in the In This Issue feature, p. 247Significance: Our work uncovers an interplay between tissue remodeling and tissue-sensing programs that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity. See related article by Marin et al., p. 410. This article is highlighted in the In This Issue feature, p. 247
C1 [Chen, Hsuan-An; Ho, Yu-Jui; Mezzadra, Riccardo; Zhu, Changyu; Luan, Wei; Wuest, Alexandra; Tian, Sha; Li, Xiang; Broderick, Caroline; Alonso-Curbelo, Direna; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA.
   [Chen, Hsuan-An; Smolkin, Ryan] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY USA.
   [Adrover, Jose M.; Egeblad, Mikala] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA.
   [Woess, Katharina; Alonso-Curbelo, Direna] Inst Res Biomed IRB Barcelona, Barcelona Inst Sci & Technol BIST, Barcelona, Spain.
   [Bernstein, Nicholas; Schmitt, Georgia; Fong, Linda; Chen, Zhenghao] Cal Life Sci, South San Francisco, CA USA.
   [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Lab, New York, NY USA.
   [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, 417 East 68th St, New York, NY 10065 USA.
   [Alonso-Curbelo, Direna] Inst Res Biomed IRB Barcelona, Carrer Baldiri Reixac 10, Barcelona 08028, Spain.
C3 Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer
   Center; Cold Spring Harbor Laboratory; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona;
   Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute;
   Memorial Sloan Kettering Cancer Center; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona
RP Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, 417 East 68th St, New York, NY 10065 USA.; Alonso-Curbelo, D (corresponding author), Inst Res Biomed IRB Barcelona, Carrer Baldiri Reixac 10, Barcelona 08028, Spain.
EM lowes@mskcc.org; direna.alonso-curbelo@irbbarcelona.org
FU NIH F99 Fellowship; NWO (Dutch Research Council-Rubicon Fellowship);
   Cancer Research Institute (CRI Award); Cancer Research
   Institute/Irvington Postdoctoral Fellowship (CRI Award); NIH/NCI
   [F99CA245797]; NCI [LCF/BQ/PI20/11760006]; Cold Spring Harbor Laboratory
   Cancer Center [452182318]; IRB Barcelona [3441]; La Caixa Foundation
   [3435]; NIH/NCI [1F32CA257103]; Calico Life Sciences grants
   [1R01CA237413]
FX We thank J. Simon and the MSKCC animal facility for technical support
   with animal colonies; J.E. Wilkinson and J. Shia for mouse liver cancer
   pathology consulting; E. de Stanchina and A. Kulick from the MSKCC
   Antitumor Assessment Core Facility for animal treatment support; Z. Li,
   A. Gaito, and M. Miele from the MSKCC Microchemistry and Proteomics Core
   for proteomic profiling technical support; N. Prats and M. Aguilera from
   the IRB Barcelona Histopathology Facility for the support of
   immunofluorescence staining protocol; and J.P. Morris IV, S. Houlihan,
   J. Novak, and other members of the Lowe laboratory for advice,
   manuscript editing, and discussions. H.-A. Chen was supported by an NIH
   F99 Fellowship (F99CA245797). D. Alonso-Curbelo is supported by the "la
   Caixa" Foundation Junior Leader Fellowship (LCF/BQ/PI20/11760006). R.
   Mezzadra was supported by NWO (Dutch Research Council-Rubicon Fellowship
   452182318) and is a Cancer Research Institute Irvington Fellow supported
   by the Cancer Research Institute (CRI Award #3441). J.M. Adrover is the
   recipient of a Cancer Research Institute/Irvington Postdoctoral
   Fellowship (CRI Award #3435). C. Zhu is supported by an F32 Postdoctoral
   Fellowship (1F32CA257103) from the NIH/NCI. M. Egeblad is supported by a
   grant from the NCI (1R01CA237413) and the work was supported by the Cold
   Spring Harbor Laboratory Cancer Center (P30CA045508). This work was also
   supported by IRB Barcelona and "la Caixa" Foundation (to D.
   Alonso-Curbelo) and NIH/NCI P01CA087497 and Calico Life Sciences grants
   (to S.W. Lowe). S.W. Lowe is an investigator at the Howard Hughes
   Medical Institute and the Geoffrey Beene Chair for Cancer Biology.
CR Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2
   Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bernstein NJ, 2020, CELL SYST, V11, P95, DOI 10.1016/j.cels.2020.05.010
   Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003
   Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026
   Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dann E, 2022, NAT BIOTECHNOL, V40, P245, DOI 10.1038/s41587-021-01033-z
   De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Demir Ö, 2021, CURR OPIN STRUC BIOL, V67, P187, DOI 10.1016/j.sbi.2020.11.005
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638
   DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Foroutan M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2435-4
   Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Hoekstra ME, 2020, NAT CANCER, V1, P291, DOI 10.1038/s43018-020-0036-4
   Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089
   Jochems F, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109441
   Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X
   Kalaora S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14639-9
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim HD, 2020, HEPATOLOGY, V71, P955, DOI 10.1002/hep.30881
   Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286
   Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0
   Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Levine AJ, 2022, CANCER RES, V82, P362, DOI 10.1158/0008-5472.CAN-21-2709
   Li YH, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1838141
   Llovet JM, 2022, NAT REV CLIN ONCOL, V19, P151, DOI 10.1038/s41571-021-00573-2
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu LG, 2022, GUT, V71, P2551, DOI 10.1136/gutjnl-2021-326350
   Lujambio A, 2016, BIOESSAYS, V38, pS56, DOI 10.1002/bies.201670910
   Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270
   McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021
   McInnes L., 2018, ARXIV, V3, P861, DOI [arXiv:1802.03426, DOI 10.21105/JOSS.00861, 10.21105/joss.00861]
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Paffenholz SV, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2117754119
   Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012
   Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Sangro B, 2021, NAT REV GASTRO HEPAT, V18, P525, DOI 10.1038/s41575-021-00438-0
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004
   Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z
   Xiao YL, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28279-8
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yoshihama S, 2017, TRENDS CANCER, V3, P28, DOI 10.1016/j.trecan.2016.12.003
   Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4
   Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240
   Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120
   Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344
NR 80
TC 0
Z9 0
U1 1
U2 1
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2159-8274
EI 2159-8290
J9 CANCER DISCOV
JI Cancer Discov.
PD FEB 6
PY 2023
VL 13
IS 2
BP 432
EP 453
DI 10.1158/2159-8290.CD-22-0528
PG 22
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA EZ9P5
UT WOS:001142881400007
OA Green Submitted, hybrid, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Lee, JS
   Yoo, JE
   Kim, H
   Rhee, H
   Koh, MJ
   Nahm, JH
   Choi, JS
   Lee, KH
   Park, YN
AF Lee, Jee San
   Yoo, Jeong Eun
   Kim, Haeryoung
   Rhee, Hyungjin
   Koh, Myoung Ju
   Nahm, Ji Hae
   Choi, Jin Sub
   Lee, Kee-Ho
   Park, Young Nyun
TI Tumor stroma with senescence-associated secretory phenotype in
   steatohepatitic hepatocellular carcinoma
SO PLOS ONE
LA English
DT Article
ID METABOLIC SYNDROME; MICROENVIRONMENT; TUMORIGENESIS; FIBROBLASTS;
   INFECTION; CANCER
AB Senescence secretome was recently reported to promote liver cancer in an obese mouse model. Steatohepatitic hepatocellular carcinoma (SH-HCC), a new variant of HCC, has been found in metabolic syndrome patients, and pericellular fibrosis, a characteristic feature of SH-HCC, suggests that alteration of the tumor stroma might play an important role in SHHCC development. Clinicopathological characteristics and tumor stroma showing senescence and senescence-associated secretory phenotype (SASP) were investigated in 21 SH-HCCs and 34 conventional HCCs (C-HCCs). The expression of a-smooth muscle actin (a-SMA), p21(Waf1/Cifi), y-H2AX, and IL-6 was investigated by immunohistochemistry or immunofluorescence. SH-HCCs were associated with older age, higher body mass index, and a higher incidence of metabolic syndrome, compared to C-HCC (P <0.05, all). The numbers of a-SMA-positive cancer-associated fibroblasts (CAFs) (P= 0.049) and a-SMA-positive CAFs co-expressing p21(Waf1/Cif1) (P = 0.038), y-H2AX (P = 0.065), and IL-6 (P = 0.048) were greater for SH-HCCs than C-HCCs. Additionally, non-tumoral liver from SH-HCCs showed a higher incidence of non-alcoholic fatty liver disease and a higher number of aSMA-positive stellate cells expressing y-H2AX and p21(Waf1/Cif1) than that from C-HCCs (P <0.05, all). In conclusion, SH-HCCs are considered to occur more frequently in metabolic syndrome patients. Therein, senescent and damaged CAFs, as well as non-tumoral stellate cells, expressing SASP including IL-6 may contribute to the development of SH-HCC.
C1 [Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.
   [Lee, Jee San; Rhee, Hyungjin; Park, Young Nyun] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea.
   [Lee, Jee San; Yoo, Jeong Eun; Rhee, Hyungjin; Koh, Myoung Ju; Nahm, Ji Hae; Park, Young Nyun] Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea.
   [Kim, Haeryoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, Seongnam, South Korea.
   [Choi, Jin Sub] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.
   [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea.
   [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University
   Health System; Seoul National University (SNU); Yonsei University;
   Yonsei University Health System; Korea Institute of Radiological &
   Medical Sciences; Yonsei University; Yonsei University Health System
RP Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Integrated Genom Res Ctr Metab Regulat, Seoul, South Korea.; Park, YN (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.
EM young0608@yuhs.ac
RI Rhee, Hyungjin/T-7619-2019
OI Rhee, Hyungjin/0000-0001-7759-4458; Kim, Haeryoung/0000-0002-4205-9081;
   Nahm, Ji Hae/0000-0003-0902-866X; Park, Young Nyun/0000-0003-0357-7967
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MISP) [NRF-2012M3A9B6055350]
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MISP) (Grant number:
   NRF-2012M3A9B6055350, to PYN). We declare that the funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ahn SH, 2005, J HEPATOL, V42, P188, DOI 10.1016/j.jhep.2004.10.026
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Chen CL, 2008, GASTROENTEROLOGY, V135, P111, DOI 10.1053/j.gastro.2008.03.073
   Cho HK, 2014, FEBS J, V281, P2228, DOI 10.1111/febs.12776
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Esposito K, 2014, J CLIN GASTROENTEROL, V48, P742, DOI 10.1097/MCG.0000000000000097
   Gupta EK, 2014, CANCER GROWTH METAST, V7, P1, DOI 10.4137/CGM.S14205
   Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002
   Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   KASL, 2013, CLIN MOL HEPATOL, V19, P325, DOI 10.3350/cmh.2013.19.4.325
   Kim GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105094
   Kim K. J., 2007, J CREATIVE INFORM CO, V1, P1, DOI DOI 10.1053/J.GASTR0.2007.03.039
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x
   Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Salomao M, 2012, HUM PATHOL, V43, P737, DOI 10.1016/j.humpath.2011.07.005
   Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa
   Shibahara J, 2014, HISTOPATHOLOGY, V64, P951, DOI 10.1111/his.12343
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 28
TC 31
Z9 34
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 8
PY 2017
VL 12
IS 3
AR e0171922
DI 10.1371/journal.pone.0171922
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EN5VL
UT WOS:000396073700063
PM 28273155
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Bala, K
   Tripathy, BC
   Sharma, D
AF Bala, Kiran
   Tripathy, B. C.
   Sharma, Deepak
TI Neuroprotective and anti-ageing effects of curcumin in aged rat brain
   regions
SO BIOGERONTOLOGY
LA English
DT Article
DE anti-ageing effects; antioxidant enzymes; curcumin; lipofuscin; Na+K+
   stop-ATPase
ID UNIT ACTION-POTENTIALS; LIPID-PEROXIDATION; ANTIOXIDANT MECHANISM;
   OXIDATIVE STRESS; LIVER; CENTROPHENOXINE; PHOSPHOLEMMAN; NA,K-ATPASE;
   PRODUCTS; SYSTEMS
AB This study investigated the influence of chronically administered curcumin on normal ageing-related parameters: lipid peroxidation, lipofuscin concentration and intraneuronal lipofuscin accumulation, activities of the enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), and Na+, K+, -adenosine triphosphatase (Na+, K+, -ATPase) in different brain regions (cerebral cortex, hippocampus, cerebellum and medulla) of 6- and 24-month-old rats. In normal ageing, lipid peroxidation and lipofuscin concentration were found to increase with ageing, the activities of SOD, GPx and Na+, K+, -ATPase, however, decreased with ageing. Chronic curcumin treatment of both 6 and 24 months old rats resulted in significant decreases in lipid peroxide and the lipofuscin contents in brain regions, the activities of SOD, GPx and Na+, K+, -ATPase however, showed significant increase in various brain regions. The present study, thus, demonstrated the antioxidative, antilipofusinogenesic and anti-ageing effects of curcumin in the brain.
C1 Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.
C3 Jawaharlal Nehru University, New Delhi
RP Sharma, D (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.
EM deepak57in@yahoo.co.in
RI Gimenez, Luis E Diaz/D-9291-2011
CR Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t
   Calabrese Vittorio, 2003, Ital J Biochem, V52, P177
   Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6
   Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299
   DEODHAR SD, 1980, INDIAN J MED RES, V71, P632
   DONATUS IA, 1990, BIOCHEM PHARMACOL, V39, P1869, DOI 10.1016/0006-2952(90)90603-I
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Feschenko MS, 2003, J NEUROSCI, V23, P2161
   FLETCHER BL, 1973, ANAL BIOCHEM, V52, P1, DOI 10.1016/0003-2697(73)90327-8
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1
   FULLER W, 2003, FASEB J, V10, P1096
   Gopal PV, 2000, GERONTOLOGY, V46, P7, DOI 10.1159/000022126
   Inano H, 2000, CARCINOGENESIS, V21, P1835, DOI 10.1093/carcin/21.10.1835
   Jovanovic SV, 2001, J AM CHEM SOC, V123, P3064, DOI 10.1021/ja003823x
   KAUL S, 1994, MOL CELL BIOCHEM, V137, P101, DOI 10.1007/BF00944071
   Kaur J, 1998, INDIAN J BIOCHEM BIO, V35, P364
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Masuda T, 2001, J AGR FOOD CHEM, V49, P2539, DOI 10.1021/jf001442x
   Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0
   MUKHOPADHYAY A, 1982, AGENTS ACTIONS, V12, P508, DOI 10.1007/BF01965935
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Osawa T, 2005, ANN NY ACAD SCI, V1043, P440, DOI 10.1196/annals.1333.050
   Park EJ, 2000, J PHARM PHARMACOL, V52, P437, DOI 10.1211/0022357001774048
   PATIL TN, 1971, INDIAN J EXP BIOL, V9, P167
   Piper JT, 1998, INT J BIOCHEM CELL B, V30, P445, DOI 10.1016/S1357-2725(98)00015-6
   Quiles JL, 1998, BIOFACTORS, V8, P51, DOI 10.1002/biof.5520080110
   Rajakrishnan V, 1999, PHYTOTHER RES, V13, P571, DOI 10.1002/(SICI)1099-1573(199911)13:7&lt;571::AID-PTR494&gt;3.0.CO;2-7
   RAJAKUMAR DV, 1994, MOL CELL BIOCHEM, V140, P73, DOI 10.1007/BF00928368
   Reddy A.Ch., 1996, FOOD CHEM TOXICOL, V32, P279
   REDDY ACP, 1994, MOL CELL BIOCHEM, V137, P1, DOI 10.1007/BF00926033
   RIGA S, 1974, BRAIN RES, V72, P265, DOI 10.1016/0006-8993(74)90864-6
   RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J
   SHARMA D, 1993, NEUROBIOL AGING, V14, P319, DOI 10.1016/0197-4580(93)90117-T
   SREEJAYAN, 1994, J PHARM PHARMACOL, V46, P1013, DOI 10.1111/j.2042-7158.1994.tb03258.x
   SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x
   Srinivasan M, 1972, Indian J Med Sci, V26, P269
   Sun YM, 2002, ORG LETT, V4, P2909, DOI 10.1021/ol0262789
   Surh YJ, 1999, MUTAT RES-FUND MOL M, V428, P305, DOI 10.1016/S1383-5742(99)00057-5
   TANAKA Y, 1990, BRAIN RES, V43, P425
   Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042
   Vajragupta O, 2003, FREE RADICAL BIO MED, V35, P1632, DOI 10.1016/j.freeradbiomed.2003.09.011
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   Watanabe S, 2000, J NUTR SCI VITAMINOL, V46, P230, DOI 10.3177/jnsv.46.230
NR 44
TC 139
Z9 166
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD APR
PY 2006
VL 7
IS 2
BP 81
EP 89
DI 10.1007/s10522-006-6495-x
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 057YP
UT WOS:000238631400002
PM 16802111
DA 2024-02-19
ER

PT J
AU Xiao, Y
   Liang, JQ
   Witwer, KW
   Zhang, Y
   Wang, Q
   Yin, H
AF Xiao, Yu
   Liang, Jiaqi
   Witwer, Kenneth W.
   Zhang, Ying
   Wang, Qian
   Yin, Hang
TI Extracellular vesicle-associated microRNA-30b-5p activates macrophages
   through the SIRT1/NF-κB pathway in cell senescence
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE extracellular vesicles; miRNA; SIRT1; cell senescence; NF-kappa B
ID NF-KAPPA-B; ARTERIAL THROMBOSIS; SIRT1; EXOSOMES; CANCER; MICROVESICLES;
   TRANSCRIPTION; INFLAMMATION; MIR-30B-5P; BIOGENESIS
AB Chronic inflammation is widely observed in aging, but it is unclear whether extracellular vesicles (EVs) play a role in chronic disease-associated senescence. In our study, LC/MS profiling revealed that senescent cell derived EVs (SEN EVs) activate the immune response pathways of macrophages. Significantly more EVs were found in the supernatant of SEN than of control (CON) cell cultures, and SEN EVs were enriched in miR-30b-5p, which directly target sirtuin1 (SIRT1). In vitro, we found that SEN EV treatment resulted in increased cellular levels of interleukin-1 beta (IL-1 beta) and IL-6 and decreased levels of SIRT1. Increased cytokine levels could be reversed by SIRT1 activation and miR-30b-5p inhibition. Furthermore, miR-30b-5p significantly increased with age in both mouse liver tissue and EVs harvested from the tissue, with differences in EVs observed both earlier and in the later magnitude of aging. Western blot and qPCR proved that miR-30b-5p downregulated the level of SIRT1 in mouse macrophages. Collectively, we propose that EVs carrying miR-30b-5p from SEN cells can induce chronic inflammation through macrophage activation. This occurs through the downregulation of SIRT1 and the corresponding activation of NF-kappa B pathways that enhance pro-inflammatory cytokine production. Collectively, these results demonstrate that EVs carrying pro-inflammatory signals are released by SEN cells and then activate immune cells in the SEN microenvironment, changing the inflammatory balance. Our results also explain why inflammation increases with age even though SEN cells can be immediately eliminated under rigorous immune surveillance.
C1 [Xiao, Yu; Wang, Qian] Southern Med Univ, Zhujiang Hosp, Dept Lab Med, Guangzhou, Peoples R China.
   [Liang, Jiaqi; Zhang, Ying; Yin, Hang] Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China.
   [Liang, Jiaqi; Zhang, Ying; Yin, Hang] Tsinghua Univ, Peking Univ Joint Ctr Life Sci, Tsinghua Univ, Beijing, Peoples R China.
   [Liang, Jiaqi; Zhang, Ying; Yin, Hang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China.
   [Witwer, Kenneth W.] Dept Mol & Comparat Pathobiol, Baltimore, MD USA.
   [Witwer, Kenneth W.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD USA.
C3 Southern Medical University - China; Tsinghua University; Tsinghua
   University; Tsinghua University; Johns Hopkins University
RP Wang, Q (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Lab Med, Guangzhou, Peoples R China.; Yin, H (corresponding author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China.; Yin, H (corresponding author), Tsinghua Univ, Peking Univ Joint Ctr Life Sci, Tsinghua Univ, Beijing, Peoples R China.; Yin, H (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China.
EM wangqian@smu.edu.cn; yin_hang@tsinghua.edu.cn
RI Witwer, Kenneth W./G-1626-2013
OI Witwer, Kenneth W./0000-0003-1664-4233; Zhang, Ying/0000-0003-3362-3952
FU National Natural Science Foundation of China; Beijing Advanced
   Innovation Center for Structural Biology Funding; Beijing Outstanding
   Young Scientist Program;  [21825702];  [22137004];  [82072334]; 
   [21977061];  [20151551402];  [BJJWZYJH01201910003013]
FX Funding This work was supported by funds from the National Natural
   Science Foundation of China (Grant No. 21825702, 22137004, 82072334, and
   21977061), Beijing Advanced Innovation Center for Structural Biology
   Funding (Grant No. 20151551402), Beijing Outstanding Young Scientist
   Program (Grant No. BJJWZYJH01201910003013).
CR Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321
   Borghesan M, 2019, CELL REP, V27, P3956, DOI 10.1016/j.celrep.2019.05.095
   Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Chen K, 2022, INT J BIOL SCI, V18, P1220, DOI 10.7150/ijbs.67675
   Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Mingo A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.368
   Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069
   Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003
   Eitan E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01386-z
   Fabbiano F, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12043
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Gano LB, 2014, AM J PHYSIOL-HEART C, V307, pH1754, DOI 10.1152/ajpheart.00377.2014
   Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671
   Granchi C, 2018, CURR MED CHEM, V25, P4432, DOI 10.2174/0929867325666180214115438
   Groot M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041044
   Gurunathan S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040307
   György B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595
   Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   Hess C, 1999, J IMMUNOL, V163, P4564
   Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603
   HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666
   Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622
   Karbowska M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01623
   Kobayashi Y, 2005, INT J MOL MED, V16, P237
   Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   Mensà E, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1725285
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13338
   Ong ALC, 2018, AGEING RES REV, V43, P64, DOI 10.1016/j.arr.2018.02.004
   Ota Yu, 2018, Oncotarget, V9, P16400, DOI 10.18632/oncotarget.24711
   Plappert-Helbig U, 2019, ENVIRON MOL MUTAGEN, V60, P4, DOI 10.1002/em.22238
   Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107
   Qiu YQ, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.632383
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40
   Singh V, 2020, INFLAMMATION, V43, P1589, DOI 10.1007/s10753-020-01242-9
   Su Z, 2018, AM J PHYSIOL-RENAL, V315, pF1542, DOI 10.1152/ajprenal.00259.2018
   Teng F, 2021, ADV SCI, V8, DOI 10.1002/advs.202003505
   Terlecki-Zaniewicz L, 2019, J INVEST DERMATOL, V139, P2425, DOI 10.1016/j.jid.2019.05.015
   Théry C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855
   Théry C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Théry C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567
   Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
   Tsukamoto H, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101520
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Vasko R, 2014, J AM SOC NEPHROL, V25, P276, DOI 10.1681/ASN.2013010069
   Wang ZL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0113603, 10.1371/journal.pone.0114792]
   Xiao Y, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1793515
   Yang Y, 2022, CHEMBIOCHEM, V23, DOI 10.1002/cbic.202100344
   Yang YS, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.831168
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yin YJ, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12154
   Zang JN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47504-x
   Zhang GQ, 2015, NUCLEIC ACIDS RES, V43, P6112, DOI 10.1093/nar/gkv518
   Zhang HY, 2018, NAT CELL BIOL, V20, P332, DOI 10.1038/s41556-018-0040-4
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 64
TC 5
Z9 5
U1 1
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 31
PY 2022
VL 13
AR 955175
DI 10.3389/fimmu.2022.955175
PG 14
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 6P6WN
UT WOS:000891069300001
PM 36119099
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shu, X
   Wu, JQ
   Zhang, T
   Ma, XY
   Du, ZQ
   Xu, J
   You, JC
   Wang, LQ
   Chen, N
   Luo, M
   Wu, JB
AF Shu, Xin
   Wu, Jiaqi
   Zhang, Tao
   Ma, Xiaoyu
   Du, Zuoqin
   Xu, Jin
   You, Jingcan
   Wang, Liqun
   Chen, Ni
   Luo, Mao
   Wu, Jianbo
TI Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes
   Ferroptosis-Related Senescence in Adipose Tissue
SO NUTRIENTS
LA English
DT Article
DE obesity; statin; senescence; ferroptosis; adipose tissue
ID IRON ACCUMULATION; INDUCED LIVER; CELL-DEATH; SIMVASTATIN; INHIBITION;
   LOVASTATIN; PATHWAY; PROLIFERATION; INTERLEUKIN-6; ATORVASTATIN
AB Statin treatment is accepted to prevent adverse cardiovascular events. However, atorvastatin, an HMG-CoA reductase inhibitor, has been reported to exhibit distinct effects on senescent phenotypes. Whether atorvastatin can induce adipose tissue senescence and the mechanisms involved are unknown. The effects of atorvastatin-induced senescence were examined in mouse adipose tissue explants. Here, we showed that statin initiated higher levels of mRNA related to cellular senescence markers and senescence-associated secretory phenotype (SASP), as well as increased accumulation of the senescence-associated beta-galactosidase (SA-beta-gal) stain in adipose tissues. Furthermore, we found that the levels of reactive oxygen species (ROS), malondialdehyde (MDA), and Fe2+ were elevated in adipose tissues treated with atorvastatin, accompanied by a decrease in the expression of glutathione (GSH), and glutathione peroxidase 4 (GPX4), indicating an iron-dependent ferroptosis. Atorvastatin-induced was prevented by a selective ferroptosis inhibitor (Fer-1). Moreover, supplementation with geranylgeranyl pyrophosphate (GGPP), a metabolic intermediate, reversed atorvastatin-induced senescence, SASP, and lipid peroxidation in adipose tissue explants. Atorvastatin depleted GGPP production, but not Fer-1. Atorvastatin was able to induce ferroptosis in adipose tissue, which was due to increased ROS and an increase in cellular senescence. Moreover, this effect could be reversed by the supplement of GGPP. Taken together, our results suggest that the induction of ferroptosis contributed to statin-induced cell senescence in adipose tissue.
C1 [Shu, Xin; Wu, Jiaqi; Zhang, Tao; Ma, Xiaoyu; Du, Zuoqin; Xu, Jin; You, Jingcan; Wang, Liqun; Chen, Ni; Luo, Mao; Wu, Jianbo] Southwest Med Univ, Drug Discovery Res Ctr, Luzhou 646000, Peoples R China.
   [Shu, Xin; Wu, Jiaqi; Zhang, Tao; Ma, Xiaoyu; Du, Zuoqin; Xu, Jin; You, Jingcan; Wang, Liqun; Chen, Ni; Luo, Mao; Wu, Jianbo] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Lab Cardiovasc Pharmacol, Luzhou 646000, Peoples R China.
   [Shu, Xin; Wu, Jiaqi; Zhang, Tao; Ma, Xiaoyu; Du, Zuoqin; Xu, Jin; You, Jingcan; Wang, Liqun; Chen, Ni; Luo, Mao; Wu, Jianbo] Southwest Med Univ, Metab Vasc Dis Key Lab Sichuan Prov, Luzhou 646000, Peoples R China.
   [Shu, Xin; Wu, Jiaqi; Zhang, Tao; Ma, Xiaoyu; Du, Zuoqin; Xu, Jin; You, Jingcan; Wang, Liqun; Chen, Ni; Luo, Mao; Wu, Jianbo] Southwest Med Univ, Luzhou Municipal Key Lab Thrombosis & Vasc Biol, Luzhou 646000, Peoples R China.
C3 Southwest Medical University; Southwest Medical University; Southwest
   Medical University; Southwest Medical University
RP Wu, JB (corresponding author), Southwest Med Univ, Drug Discovery Res Ctr, Luzhou 646000, Peoples R China.; Wu, JB (corresponding author), Southwest Med Univ, Sch Pharm, Dept Pharmacol, Lab Cardiovasc Pharmacol, Luzhou 646000, Peoples R China.; Wu, JB (corresponding author), Southwest Med Univ, Metab Vasc Dis Key Lab Sichuan Prov, Luzhou 646000, Peoples R China.; Wu, JB (corresponding author), Southwest Med Univ, Luzhou Municipal Key Lab Thrombosis & Vasc Biol, Luzhou 646000, Peoples R China.
EM jbwucn@163.com
OI Wu, Jianbo/0000-0003-3319-9717; Wang, Liqun/0000-0003-3362-0444
FU Sichuan Province Science and Technology [2020YJ0340]
FX This research was funded by Sichuan Province Science and Technology.
   Agency Grant (2020YJ0340) and the APC was funded by (2020YJ0340).
CR Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C
   DeRuisseau KC, 2013, EXP GERONTOL, V48, P1294, DOI 10.1016/j.exger.2013.08.011
   Feng ZQ, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00711-w
   Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421
   Gendaszewska-Darmach E, 2021, J MED CHEM, V64, P9677, DOI 10.1021/acs.jmedchem.1c00410
   Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93
   He ZQ, 2021, INT J MOL MED, V47, P289, DOI 10.3892/ijmm.2020.4770
   Henriksbo BD, 2019, DIABETES, V68, P1441, DOI 10.2337/db18-0999
   Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398
   Hernandez-Vallejo SJ, 2013, AGING CELL, V12, P955, DOI 10.1111/acel.12119
   Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X
   Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158
   Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106
   Kromer A, 2009, MOL PHARMACOL, V75, P1421, DOI 10.1124/mol.108.053678
   Lee J, 2006, BIOCHEM BIOPH RES CO, V339, P748, DOI 10.1016/j.bbrc.2005.11.075
   Liu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17895
   Luo YL, 2020, INT J CLIN EXP PATHO, V13, P2041
   Fernández-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   Núñez-Cortés JM, 2017, AM J CARDIOVASC DRUG, V17, P135, DOI 10.1007/s40256-016-0197-9
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Nakata M, 2006, DIABETOLOGIA, V49, P1881, DOI 10.1007/s00125-006-0269-5
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ott C, 2016, REDOX BIOL, V10, P266, DOI 10.1016/j.redox.2016.10.015
   Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC
   Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608
   Schwärzler J, 2022, INT J OBESITY, V46, P951, DOI 10.1038/s41366-022-01064-9
   Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]
   Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112
   Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268
   Waller DD, 2019, CRIT REV BIOCHEM MOL, V54, P41, DOI 10.1080/10409238.2019.1568964
   Wang A, 2022, BMC NEPHROL, V23, DOI 10.1186/s12882-022-02815-6
   Wang GH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.1
   Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Yeh YS, 2018, ISCIENCE, V9, P175, DOI 10.1016/j.isci.2018.10.019
   Yeh YS, 2016, BIOCHEM BIOPH RES CO, V478, P1317, DOI 10.1016/j.bbrc.2016.08.119
   Yudoh K, 2010, AGING-US, V2, P990, DOI 10.18632/aging.100213
   Zhang Q, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.806081
   Zhao W, 2015, DRUG DES DEV THER, V9, P6211, DOI 10.2147/DDDT.S87979
NR 40
TC 6
Z9 6
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2022
VL 14
IS 20
AR 4365
DI 10.3390/nu14204365
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 5P8ZX
UT WOS:000873433800001
PM 36297049
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Liu, CC
   Huang, SP
   Lee, YC
   Lee, CH
   Huang, TY
   Geng, JH
   Chang, CW
   Lin, CY
   Juan, YS
   Wu, WJ
   Hsieh, TJ
AF Liu, Chia-Chu
   Huang, Shu-Pin
   Lee, Yung-Chin
   Lee, Cheng-Hsueh
   Huang, Tsung-Yi
   Geng, Jiun-Hung
   Chang, Che-Wei
   Lin, Chung-Yu
   Juan, Yung-Shun
   Wu, Wen-Jeng
   Hsieh, Tusty-Jiuan
TI Metabolic dysfunction-associated fatty liver disease is an early
   predictor for testosterone deficiency in aging men without metabolic
   syndrome
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE metabolic dysfunction-associated fatty liver disease; testosterone
   deficiency; aging men; metabolic syndrome; insulin resistance
ID ANDROGEN DEFICIENCY; RISK; PREVALENCE
AB Background and aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a valuable marker for identifying individuals at increased risk of metabolic dysfunction, liver-related complications, and cardiovascular disease. However, the association between MAFLD and testosterone deficiency (TD) in aging men remains poorly understood. This study aimed to investigate the association between MAFLD and the risk of TD in aging Taiwanese men, with a specific focus on those without metabolic syndrome (MetS).Methods: A free health screening program was conducted for Taiwanese men aged over 40 years in Kaohsiung, Taiwan. Participants underwent physical examinations, completed questionnaires regarding demographics, medical history, and clinical symptoms of TD, and provided 20-mL whole blood samples for biochemical, adipocytokine, and hormonal evaluations. Fatty liver index was used to evaluate the risk of fatty liver. Diagnostic criteria for MAFLD included fatty liver along with overweight/obesity, type 2 diabetes, or evidence of metabolic dysregulation.Results: A total of 631 men (mean age: 54.4 +/- 8.4 years) were enrolled. The prevalence rates of TD and MetS were significantly higher in men with MAFLD compared to those without (both p < 0.001). Additionally, the presence of MAFLD showed a significant correlation with adipocytokines associated with insulin resistance, such as adiponectin, leptin, and retinol-binding protein-4 (RBP-4) levels (all p < 0.001). Among men without MetS, those with MAFLD had a 3.89- and 4.74-fold higher risk of total testosterone < 300 ng/dL and TD, respectively, after adjusting for potential covariates.Conclusion: MAFLD is associated with an elevated risk of TD in aging Taiwanese men, particularly in the absence of MetS. This finding suggests that MAFLD could serve as an early predictor of TD, facilitating the identification of high-risk individuals and enabling timely interventions. Further research is needed to validate these findings and explore the underlying mechanisms linking MAFLD, TD, and MetS in diverse populations.
C1 [Liu, Chia-Chu; Huang, Shu-Pin; Lee, Yung-Chin; Lee, Cheng-Hsueh; Huang, Tsung-Yi; Chang, Che-Wei; Lin, Chung-Yu; Juan, Yung-Shun; Wu, Wen-Jeng] Kaohsiung Med Univ, Dept Urol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.
   [Liu, Chia-Chu; Huang, Shu-Pin; Lee, Yung-Chin; Geng, Jiun-Hung; Juan, Yung-Shun; Wu, Wen-Jeng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, Kaohsiung, Taiwan.
   [Liu, Chia-Chu; Chang, Che-Wei] Pingtung Hosp, Dept Urol, Minist Hlth & Welf, Pingtung, Taiwan.
   [Liu, Chia-Chu; Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Res Ctr Precis Environm Med, Kaohsiung, Taiwan.
   [Lee, Yung-Chin; Geng, Jiun-Hung] Kaohsiung Municipal Siaogang Hosp, Dept Urol, Kaohsiung, Taiwan.
   [Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung
   Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung
   Medical University
RP Hsieh, TJ (corresponding author), Kaohsiung Med Univ, Res Ctr Precis Environm Med, Kaohsiung, Taiwan.; Hsieh, TJ (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.
EM hsiehjun@kmu.edu.tw
FU This study was supported by grants from the Ministry of Science and
   Technology, Taiwan (MOST 109-2314-B-037-104-MY3), National Science and
   Technology Council, Taiwan (NSTC 112-2314-B-037-071), Ministry of Health
   and Welfare, Taiwan (11239), Kaohsiung Medic [MOST
   109-2314-B-037-104-MY3]; Ministry of Science and Technology, Taiwan
   [NSTC 112-2314-B-037-071]; National Science and Technology Council,
   Taiwan [11239]; Ministry of Health and Welfare, Taiwan
   [NHRI-KMU-112-I001]; Kaohsiung Medical University, Kaohsiung, Taiwan
   [KMUH110-0R56, KMUH111-1R57]; Kaohsiung Medical University Hospital,
   Kaohsiung, Taiwan
FX The authors thank Ms. Chao-Shih Chen for her help to hold the healthy
   screening.r This study was supported by grants from the Ministry of
   Science and Technology, Taiwan (MOST 109-2314-B-037-104-MY3), National
   Science and Technology Council, Taiwan (NSTC 112-2314-B-037-071),
   Ministry of Health and Welfare, Taiwan (11239), Kaohsiung Medical
   University, Kaohsiung, Taiwan (NHRI-KMU-112-I001), and Kaohsiung Medical
   University Hospital, Kaohsiung, Taiwan (KMUH110-0R56 and KMUH111-1R57).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Albhaisi S, 2020, HEPATOL COMMUN, V4, P1430, DOI 10.1002/hep4.1571
   Alharthi J, 2022, CURR OPIN GASTROEN, V38, P251, DOI 10.1097/MOG.0000000000000823
   Apostolov R, 2022, WORLD J HEPATOL, V14, P754, DOI 10.4254/wjh.v14.i4.754
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bhasin S, 2018, J CLIN ENDOCR METAB, V103, P1715, DOI 10.1210/jc.2018-00229
   Cao WJ, 2022, ENDOCR J, V69, P1007, DOI 10.1507/endocrj.EJ21-0559
   Cheng KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060295
   Chueh KS, 2012, J ANDROL, V33, P817, DOI 10.2164/jandrol.111.015628
   Ciardullo S, 2023, J CLIN MED, V12, DOI 10.3390/jcm12144783
   Corona G, 2018, J SEX MED, V15, P1260, DOI 10.1016/j.jsxm.2018.06.012
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312
   Fode M, 2019, EUR UROL FOCUS, V5, P539, DOI 10.1016/j.euf.2019.02.021
   Hawksworth DJ, 2020, SEX MED REV, V8, P274, DOI 10.1016/j.sxmr.2019.01.002
   Hermoso DAM, 2020, AGING MALE, V23, P1296, DOI 10.1080/13685538.2020.1764927
   Jaruvongvanich V, 2017, ANN HEPATOL, V16, P382, DOI 10.5604/16652681.1235481
   Kawaguchi T, 2022, HEPATOL RES, V52, P422, DOI 10.1111/hepr.13706
   Khera M, 2016, MAYO CLIN PROC, V91, P908, DOI 10.1016/j.mayocp.2016.04.022
   Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005
   Li S, 2021, IEEE T FUZZY SYST, V29, P833, DOI [10.1155/2020/4732021, 10.1109/TFUZZ.2020.2965917]
   Liu CC, 2021, ANDROLOGY-US, V9, P863, DOI 10.1111/andr.12979
   Liu CC, 2018, J SEX MED, V15, P1527, DOI 10.1016/j.jsxm.2018.09.012
   Liu CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03078-0
   Liu CC, 2009, J SEX MED, V6, P936, DOI 10.1111/j.1743-6109.2008.01171.x
   Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902
   Méndez-Sánchez N, 2022, LANCET GASTROENTEROL, V7, P388, DOI 10.1016/S2468-1253(22)00062-0
   Mintziori G, 2017, MINERVA ENDOCRINOL, V42, P145, DOI 10.23736/S0391-1977.16.02570-0
   Mody A, 2015, CARDIOVASC ENDOCRINO, V4, P83, DOI 10.1097/XCE.0000000000000057
   Mulhall JP, 2018, J UROLOGY, V200, P423, DOI 10.1016/j.juro.2018.03.115
   Phan H, 2021, LIVER INT, V41, P300, DOI 10.1111/liv.14652
   Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 39
TC 1
Z9 1
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD OCT 3
PY 2023
VL 14
AR 1252774
DI 10.3389/fendo.2023.1252774
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA U4XO4
UT WOS:001084847000001
PM 37854195
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Im, CN
   Lee, JS
   Zheng, Y
   Seo, JS
AF Im, Chang-Nim
   Lee, Jae-Seon
   Zheng, Ying
   Seo, Jeong-Sun
TI Iron chelation study in a normal human hepatocyte cell line suggests
   that tumor necrosis factor receptor-associated protein 1 (TRAP1)
   regulates production of reactive oxygen species
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE deferoxamine; mitochondria; TRAP1; ROS
ID MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; APOPTOSIS; GROWTH;
   SENESCENCE; DIFFERENTIATION; INHIBITION; DISRUPTION; HOMOLOG;
   PHOSPHORYLATION
AB Iron is an essential component of many proteins, and has crucial roles in the proper functioning of proteins involved in cellular respiration, proliferation, and differentiation. It has been recently reported that the deferoxamine (DFO), an iron chelator, induces mitochondrial dysfunction, characterized by an attenuation of oxidative phosphorylation, as well as senescence-like cellular morphology. However, the effects of DFO on mitochondrial heat shock proteins (HSPs) remain poorly understood. In this Study, we examined the effect of DFO on tumor necrosis factor receptor-associated protein 1 (TRAP1), a representative mitochondrial HSP, in a normal human hepatocyte cell line, Chang cells. DFO specifically decreased TRAP1 levels, increasing reactive oxygen species (ROS) and caveolin-1 (Cav-1), a marker protein of senescence. To examine whether these effects of DFO are reversed, we established TRAP 1-overexpressing Chang cells. DFO treatment to TRAP1-overexpressing cells resulted in decreases in levels of ROS, Cav-1, glutathione peroxidase (GPX), and manganese superoxide dismutase (MnSOD) levels as well as senescence-associated beta-galactosiclase (SA beta-gal) activity. These results suggest that TRAP1 might play a role in protecting mitochondria against damaging stimuli via decrease of ROS generation.
C1 Seoul Natl Univ, Dept Biochem & Mol Biol, ILCHUN, Inst Mol Med,MRC,Coll Med, Seoul 110799, South Korea.
   Korea Inst Radiol & Med Sci, Lab Funct Genom, Seoul 139706, South Korea.
C3 Seoul National University (SNU); Korea Institute of Radiological &
   Medical Sciences
RP Seo, JS (corresponding author), Seoul Natl Univ, Dept Biochem & Mol Biol, ILCHUN, Inst Mol Med,MRC,Coll Med, 28 Yongondong, Seoul 110799, South Korea.
EM jeongsun@snu.ac.kr
RI Seo, Jeong-Sun/J-2763-2012
OI Im, Chang-Nim/0000-0002-7566-7075
CR ALCANTARA O, 1994, BLOOD, V84, P3510
   BONDY SC, 1992, NEUROTOXICOLOGY, V13, P87
   BRODIE C, 1993, CANCER RES, V53, P3968
   Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Chen CF, 1996, MOL CELL BIOL, V16, P4691
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fan LJ, 2001, CANCER RES, V61, P1073
   Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305
   FRANCIS B, 2001, SEX ED, V1, P1
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055
   Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com
   Inoue M, 2004, REDOX REP, V9, P237, DOI 10.1179/135100004225006010
   KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758
   KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778
   KONTOGHIORGHES GJ, 1986, HEMATOL ONCOL, V4, P195, DOI 10.1002/hon.2900040303
   KUHN LC, 1990, IRON TRANSPORT STORA, P141
   LEDERMAN HM, 1984, BLOOD, V64, P748
   Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604
   Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199
   Liu Y, 2005, MOL CELL BIOCHEM, V268, P45, DOI 10.1007/s11010-005-2996-1
   Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200
   Mates J M, 1999, Front Biosci, V4, pD339
   Men'shchikova EB, 2002, B EXP BIOL MED+, V133, P175, DOI 10.1023/A:1015559124601
   Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064
   Moldovan L, 2004, HISTOCHEM CELL BIOL, V122, P395, DOI 10.1007/s00418-004-0676-y
   Morita T, 2005, EXP CELL RES, V303, P425, DOI 10.1016/j.yexcr.2004.10.010
   Morita T, 2004, J CELL SCI, V117, P5759, DOI 10.1242/jcs.01499
   Morita T, 2002, EXP CELL RES, V280, P45, DOI 10.1006/excr.2002.5620
   NYHOLM S, 1993, J BIOL CHEM, V268, P26200
   Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9
   ROBBINS E, 1970, P NATL ACAD SCI USA, V66, P1244, DOI 10.1073/pnas.66.4.1244
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sauer H, 2005, ANTIOXID REDOX SIGN, V7, P1423, DOI 10.1089/ars.2005.7.1423
   Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574
   Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7
   Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529
   WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969
   Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281
   Ye Z, 1999, BIOCHEM BIOPH RES CO, V264, P709, DOI 10.1006/bbrc.1999.1554
   Yoon YS, 2004, ANN NY ACAD SCI, V1011, P123, DOI 10.1196/annals.1293.013
   Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
NR 49
TC 59
Z9 63
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD FEB 1
PY 2007
VL 100
IS 2
BP 474
EP 486
DI 10.1002/jcb.21064
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 126MR
UT WOS:000243517500018
PM 16927372
DA 2024-02-19
ER

PT J
AU CABISCOL, E
   LEVINE, RL
AF CABISCOL, E
   LEVINE, RL
TI CARBONIC ANHYDRASE-III - OXIDATIVE MODIFICATION IN-VIVO AND LOSS OF
   PHOSPHATASE-ACTIVITY DURING AGING
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AMINO-ACID OXIDATION; S-THIOLATION; GLUTAMINE-SYNTHETASE; PROTEIN
   OXIDATION; HYDROGEN-PEROXIDE; RAT-LIVER; ISCHEMIA-REPERFUSION; CATALYZED
   OXIDATION; OXIDIZED PROTEINS; CREATINE-KINASE
AB Oxidative modification of DNA, lipids, and proteins occurs as a consequence of reaction with free radicals and activated oxygen. Oxidative modification of total cellular proteins has been described under many pathologic and experimental conditions, but no specific proteins have been identified as in vivo targets for oxidative modification. Utilizing an immunochemical method for detection of oxidatively modified proteins, we identified a protein in rat Liver that was highly oxidized. It was purified to homogeneity and identified as carbonic anhydrase, isozyme III. Its characteristics match those previously described for a protein that was lost during aging of the rat, senescence marker protein-1. Carbonic anhydrase III was purified from rats aged 2, 10, and 18 months, and the proteins were characterized. All three preparations were highly oxidatively modified as assessed by their carbonyl content. The enzyme has three known catalytic activities, and the specific activities for carbon dioxide hydration and for ester hydrolysis decreased during aging by similar to 30%. However, the third activity, that of a phosphatase, was virtually lost during aging. While the physiologic role of carbonic anhydrase III is unknown, we suggest that it functions in an oxidizing environment, which leads to its own oxidative modification.
C1 NHLBI,BIOCHEM LAB,BETHESDA,MD 20892.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI)
RI Cabiscol, Elisa/A-4584-2009; Levine, Rodney L/D-9885-2011
OI Cabiscol, Elisa/0000-0003-2795-7999; 
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   [Anonymous], 1994, OXIDATIVE PROCESSES
   AYENE IS, 1993, ARCH BIOCHEM BIOPHYS, V303, P307, DOI 10.1006/abbi.1993.1288
   BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497
   BERLETT BS, 1984, P NATL ACAD SCI USA, V87, P398
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHAI YC, 1991, ARCH BIOCHEM BIOPHYS, V284, P270, DOI 10.1016/0003-9861(91)90295-T
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P939
   CLIMENT I, 1991, ARCH BIOCHEM BIOPHYS, V289, P371, DOI 10.1016/0003-9861(91)90425-I
   COLLISON MW, 1987, BIOCHIM BIOPHYS ACTA, V928, P121, DOI 10.1016/0167-4889(87)90112-1
   COLLISON MW, 1986, BIOCHIM BIOPHYS ACTA, V885, P58, DOI 10.1016/0167-4889(86)90038-8
   ENGBERG P, 1985, ARCH BIOCHEM BIOPHYS, V241, P628, DOI 10.1016/0003-9861(85)90589-2
   ERIKSSON AE, 1993, PROTEINS, V16, P29, DOI 10.1002/prot.340160104
   GARLAND D, 1990, EXP EYE RES, V50, P677, DOI 10.1016/0014-4835(90)90113-9
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Jeffery S, 1991, CARBONIC ANHYDRASES, P289
   KARSEKSTAPLES JA, 1993, FREE RADICAL BIO MED, V14, P115
   KELLER RJ, 1993, CHEM RES TOXICOL, V6, P430, DOI 10.1021/tx00034a007
   KELLY CD, 1988, BIOSCIENCE REP, V8, P401, DOI 10.1007/BF01121636
   KIM KW, 1988, J BIOL CHEM, V263, P4704
   KOESTER MK, 1981, ARCH BIOCHEM BIOPHYS, V211, P632, DOI 10.1016/0003-9861(81)90499-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004
   LEVINE RL, 1983, J BIOL CHEM, V258, P1823
   LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033
   LYNCH CJ, 1993, AM J PHYSIOL, V264, pE621, DOI 10.1152/ajpendo.1993.264.4.E621
   MILLER RM, 1989, ARCH BIOCHEM BIOPHYS, V276, P355
   OLIVER CN, 1987, ARCH BIOCHEM BIOPHYS, V253, P62, DOI 10.1016/0003-9861(87)90637-0
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144
   PARK EM, 1988, BIOCHIM BIOPHYS ACTA, V964, P151, DOI 10.1016/0304-4165(88)90161-4
   PARK Y, 1991, FREE RADICAL RES COM, V14, P179, DOI 10.3109/10715769109088947
   POSTON JM, 1992, ARCH BIOCHEM BIOPHYS, V295, P35, DOI 10.1016/0003-9861(92)90484-E
   REDDY VY, 1994, J BIOL CHEM, V269, P4683
   ROKUTAN K, 1989, EUR J BIOCHEM, V179, P233, DOI 10.1111/j.1432-1033.1989.tb14546.x
   Rothstein M., 1984, P209
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   SHIELS A, 1983, BIOCHIM BIOPHYS ACTA, V760, P335, DOI 10.1016/0304-4165(83)90370-7
   SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SPICER SS, 1990, AM J ANAT, V187, P55, DOI 10.1002/aja.1001870107
   STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STADTMAN ER, 1991, J BIOL CHEM, V266, P17201
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   STARKE PE, 1987, FASEB J, V1, P36, DOI 10.1096/fasebj.1.1.2886388
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0
   Tashian RE, 1991, CARBONIC ANHYDRASES, P247, DOI DOI 10.1007/978-1-4899-0750-9_21
   TASHIAN RE, 1990, BIOESSAYS, V10, P186
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VERPOORTE JA, 1967, J BIOL CHEM, V242, P4221
   WILBUR KM, 1948, J BIOL CHEM, V176, P147
   YIM MB, 1990, P NATL ACAD SCI USA, V87, P394, DOI 10.1073/pnas.87.1.394
   ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007
   ZSNAGY I, 1984, BIOCHIM BIOPHYS ACTA, V790, P238, DOI 10.1016/0167-4838(84)90028-1
   1994, PROTEIN IDENTIFICATI
NR 63
TC 135
Z9 148
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 16
PY 1995
VL 270
IS 24
BP 14742
EP 14747
DI 10.1074/jbc.270.24.14742
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA RD455
UT WOS:A1995RD45500076
PM 7782339
OA hybrid
DA 2024-02-19
ER

PT J
AU FERLAND, G
   AUDET, M
   TUCHWEBER, B
AF FERLAND, G
   AUDET, M
   TUCHWEBER, B
TI EFFECT OF DIETARY RESTRICTION ON LYSOSOMAL BODIES AND TOTAL
   PROTEIN-SYNTHESIS IN HEPATOCYTES OF AGING RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE LYSOSOMAL BODIES; PROTEIN SYNTHESIS; AGING; DIETARY RESTRICTION
ID LIVER PARENCHYMAL-CELLS; FOOD RESTRICTION; ENZYME-ACTIVITY; MICE; AGES;
   ACCUMULATION; LIPOFUSCIN; PIGMENT
AB The accumulation of lysosomal bodies has long been considered to be an important correlate of aging. However it is not well established whether these age related changes interfere with cellular function. In this study, an evaluation of lysosomes by ultrastructural analysis was performed in livers of 4-6 and 20-24-month-old Sprague-Dawley female rats, fed ad libitum (A) or a restricted diet (R). An attempt was made to relate this parameter to hepatic protein synthesis, a liver function known to decrease with age and increase with dietary restriction. Aging was accompanied in both A and R animals with higher number and size of secondary lysosomes (lipofuscin) and by a decrease in total protein synthesis in hepatocytes. When compared to age matched ad libitum fed animals, livers of food restricted rats contained higher number of secondary lysosomes, yet exhibited higher protein synthetic capacity. Thus in hepatocytes, lipofuscin accumulation does not seem to interfere with cellular function.
C1 UNIV MONTREAL,DEPT NUTR,POB 6128,STN A,MONTREAL H3C 3J7,QUEBEC,CANADA.
C3 Universite de Montreal
CR ASANO S, 1979, MECH AGEING DEV, V10, P81, DOI 10.1016/0047-6374(79)90072-1
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   Brizzee K. R., 1975, NEUROBIOL AGING, P463
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   COMOLLI R, 1971, EXP GERONTOL, V6, P219, DOI 10.1016/0531-5565(71)90034-9
   CONIGLIO JJ, 1979, MECH AGEING DEV, V11, P77, DOI 10.1016/0047-6374(79)90026-5
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   ELENS A, 1969, EXP GERONTOL, V4, P131, DOI 10.1016/0531-5565(69)90036-9
   ENESCO HE, 1981, EXP GERONTOL, V16, P357, DOI 10.1016/0531-5565(81)90056-5
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   FERLAND G, 1990, MECH AGEING DEV, V56, P143, DOI 10.1016/0047-6374(90)90005-Z
   FERLAND G, IN PRESS J GERONTOL
   GOTO S, 1969, J GERONTOL, V24, P305, DOI 10.1093/geronj/24.3.305
   HOCHSCHILD R, 1971, EXP GERONTOL, V6, P153, DOI 10.1016/S0531-5565(71)80014-1
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1
   IWASAKI K, 1988, ACTA PATHOL JAPON, V38, P1119
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   MASORO EJ, 1988, BIOL REV, V43, pB59
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   NAKAMURA Y, 1989, NEUROSCI LETT, V97, P215, DOI 10.1016/0304-3940(89)90166-3
   PORTA EA, 1991, ARCH GERONTOL GERIAT, V12, P303, DOI 10.1016/0167-4943(91)90036-P
   PORTA EA, 1987, ADV BIOSCI, V64, P37
   RICCA GA, 1978, J CELL PHYSIOL, V97, P137, DOI 10.1002/jcp.1040970202
   Richardson A, 1981, CRC HDB BIOCH AGING, P79
   SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5
   Sohal R. S., 1981, AGE PIGMENTS
   SOHAL RS, 1989, LIPOFUSCIN CEROID PI, P17
   SOLOMON C, 1984, MECH AGEING DEV, V24, P9, DOI 10.1016/0047-6374(84)90173-8
   TAUCHI H, 1980, MECH AGEING DEV, V12, P183, DOI 10.1016/0047-6374(80)90094-9
   TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   YU BP, 1990, REV BIOL RES AGING, V4, P349
NR 38
TC 12
Z9 12
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN
PY 1992
VL 64
IS 1-2
BP 49
EP 59
DI 10.1016/0047-6374(92)90095-U
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HZ161
UT WOS:A1992HZ16100005
PM 1630159
DA 2024-02-19
ER

PT J
AU Peng, CH
   Hu, WD
   Weng, XY
   Tong, RL
   Cheng, SB
   Ding, CF
   Xiao, H
   Lv, Z
   Xie, HY
   Zhou, L
   Wu, J
   Zheng, SS
AF Peng, Chuanhui
   Hu, Wendi
   Weng, Xiaoyu
   Tong, Rongliang
   Cheng, Shaobing
   Ding, Chaofeng
   Xiao, Heng
   Lv, Zhen
   Xie, Haiyang
   Zhou, Lin
   Wu, Jian
   Zheng, Shusen
TI Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular
   Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POOR-PROGNOSIS; REPLICATIVE SENESCENCE; CANCER STATISTICS; TUMOR
   SUPPRESSION; CELLS; TRANSCRIPTION; PREDICTS
AB It has been reported that long non-coding RNA PANDA was disregulated in varieties types of tumor, but its expression level and biological role in hepatocellular carcinoma (HCC) remains contradictory. We detected PANDA expression in two independent cohorts (48 HCC patients following liver transplantation and 84 HCC patients following liver resection), and found that PANDA was down-regulated in HCC. Thereafter we explored its function in cancer biology by inversing its low expression. Surprisingly, overexpression of PANDA promoted HCC proliferation and carcinogenesis in vitro and in vivo. Mechanistically, PANDA repressed transcriptional activity of senescence associated inflammatory factor IL8, which leaded to inhibition of cellular senescence. Therefore, our research help to better understand the complex role of PANDA in HCC, and suggest more thoughtful strategies should be applied before it can be treated as a potential therapeutic target.
C1 [Peng, Chuanhui; Hu, Wendi; Weng, Xiaoyu; Tong, Rongliang; Cheng, Shaobing; Ding, Chaofeng; Lv, Zhen; Xie, Haiyang; Zhou, Lin; Wu, Jian; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China.
   [Peng, Chuanhui; Hu, Wendi; Weng, Xiaoyu; Tong, Rongliang; Cheng, Shaobing; Ding, Chaofeng; Lv, Zhen; Xie, Haiyang; Zhou, Lin; Wu, Jian; Zheng, Shusen] Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China.
   [Peng, Chuanhui; Hu, Wendi; Weng, Xiaoyu; Tong, Rongliang; Cheng, Shaobing; Ding, Chaofeng; Lv, Zhen; Xie, Haiyang; Zhou, Lin; Wu, Jian; Zheng, Shusen] Collaborat Innovat Ctr Diag Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.
   [Xiao, Heng] Chongqing Med Univ, Affiliated Hosp 5, Dept Hepatobiliary Surg, Chongqing, Peoples R China.
C3 Zhejiang University; Collaborative Innovation Center for Diagnosis &
   Treatment of Infectious Diseases; Chongqing Medical University
RP Wu, J; Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou, Zhejiang, Peoples R China.; Wu, J; Zheng, SS (corresponding author), Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China.; Wu, J; Zheng, SS (corresponding author), Collaborat Innovat Ctr Diag Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.
EM drwujian@hotmail.com; shusenzheng@zju.edu.cn
RI cheng, shaobing/HSI-4624-2023
OI , shaobing/0000-0001-9549-010X; Peng, Chuanhui/0000-0002-0800-1417
FU National Natural Science Foundation of China [91542205]; National Health
   and Family Planning Commission of China [2016138643]; Science Technology
   Department of Zhejiang Province [2015C03034]; Zhejiang Provincial
   Natural Science Foundation [LY15H160016, LQ15H160002]; General Project
   Plan of Zhejiang Medical Technology [2016148875]
FX This study was supported by the Major Research plan of the National
   Natural Science Foundation of China (No. 91542205), the National Health
   and Family Planning Commission of China (No. 2016138643), the Science
   Technology Department of Zhejiang Province (No. 2015C03034), the
   Zhejiang Provincial Natural Science Foundation (No. LY15H160016 and No.
   LQ15H160002) and the General Project Plan of Zhejiang Medical Technology
   (No. 2016148875).
CR Abdelmohsen K, 2015, WIRES RNA, V6, P615, DOI 10.1002/wrna.1297
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001
   Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887
   Han L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.30
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   He Y, 2014, CANCER LETT, V344, P20, DOI 10.1016/j.canlet.2013.10.021
   Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Ma P, 2016, BIOMED PHARMACOTHER, V78, P172, DOI 10.1016/j.biopha.2016.01.025
   Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414
   Peng CH, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/832712
   Peng W, 2015, BIOMED PHARMACOTHER, V72, P113, DOI 10.1016/j.biopha.2015.04.014
   Puvvula PK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6323
   Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10
   Sang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22366
   Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Wang P, 2014, P NATL ACAD SCI USA, V111, P7683, DOI 10.1073/pnas.1310972111
   Wang Q, 2016, CANCER CELL, V29, P523, DOI 10.1016/j.ccell.2016.02.008
   Wu Y, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.48
   Yildiz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064016
NR 33
TC 25
Z9 30
U1 0
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 23
PY 2017
VL 7
AR 4186
DI 10.1038/s41598-017-04045-5
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EY6UL
UT WOS:000404118700076
PM 28646235
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, HY
   Yang, H
   Zhang, CN
   Jing, Y
   Wang, C
   Liu, C
   Zhang, R
   Wang, J
   Zhang, JF
   Zen, K
   Zhang, CY
   Li, DH
AF Zhang, Haiyang
   Yang, Hao
   Zhang, Chunni
   Jing, Ying
   Wang, Cheng
   Liu, Chang
   Zhang, Rui
   Wang, Jin
   Zhang, Junfeng
   Zen, Ke
   Zhang, Chenyu
   Li, Donghai
TI Investigation of MicroRNA Expression in Human Serum During the Aging
   Process
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE MicroRNA; Aging; Serum; Biomarker
ID CELL-PROLIFERATION; MOUSE LUNG; PATHWAY; IDENTIFICATION; SENESCENCE;
   DISEASES; MIR-222; MIRNAS; ADULT; LIVER
AB Background. Although serum microRNAs (miRNAs) play essential roles in the diagnosis of various diseases, little is known about circulating miRNAs in the aging process.
   Methods. Solexa sequencing technology was used for an initial miRNA screening of serum samples pooled from 21 healthy Chinese subjects with an average age of 22 years, 10 subjects with an average age of 40 years, 10 subjects with an average age of 59 years, and 9 subjects with an average age of 70 years. Other serum samples were obtained from 123 normal people with approximately 31 samples in each age period. A stem-loop quantitative reverse transcription-PCR assay was conducted to confirm the concentrations of the miRNAs altered in the aging process.
   Results. Solexa sequencing demonstrated 10 markedly altered miRNAs in the aging process. Quantitative reverse transcription-PCR analysis identified five downregulated miRNAs (miR-29b, miR-106b, miR-130b, miR-142-5p, and miR-340) and three upregulated miRNAs (miR-92a, miR-222, and miR-375) with age. Their target genes, related diseases, molecular and cellular functions, and participated pathways were further analyzed.
   Conclusions. The measurement of miRNAs in serum provides a novel, noninvasive approach for the identification of the aging process. Our bioinformatic analyses could form a useful knowledge base for the potential future development of novel therapeutic treatments.
C1 [Zhang, Haiyang; Yang, Hao; Jing, Ying; Wang, Cheng; Liu, Chang; Zhang, Rui; Wang, Jin; Zhang, Junfeng; Zen, Ke; Zhang, Chenyu; Li, Donghai] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.
   [Zhang, Chunni] Nanjing Univ, Clin Sch Med Coll, Jinling Hosp, Dept Clin Lab, Nanjing 210093, Jiangsu, Peoples R China.
C3 Nanjing University; Nanjing University
RP Li, DH (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.
EM donghaili@nju.edu.cn
RI Liu, Chang/HOC-0971-2023; liu, chang/HCI-5413-2022; Wang,
   Cheng/O-7206-2016; zhang, junfeng/JHT-7871-2023; Liu,
   Chang/ISV-3950-2023
OI Wang, Cheng/0000-0002-1834-2119; Zhang, Chunni/0000-0002-7329-7162
FU National Basic Research Program of China (973 Program) [2012CB517603,
   2011CB504803]; National Natural Science Foundation of China [81250044,
   31000323, 31070672, 81171661, J1103512, J1210026]; Natural Science
   Foundation of Jiangsu Province [BK20131272]; Specialized Research Fund
   for the Doctoral Program of Higher Education of China [20100091120023];
   Fundamental Research Funds for the Central Universities [1095020823]
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2012CB517603 to C.Z., 2011CB504803 to K.Z.); the National
   Natural Science Foundation of China (81250044 to C.Z., 31000323 and
   31070672 to D.L., 81171661 to C.Z., J1103512 and J1210026 to Nanjing
   University); the Natural Science Foundation of Jiangsu Province
   (BK20131272 to D.L.); the Specialized Research Fund for the Doctoral
   Program of Higher Education of China (20100091120023 to D.L.); and the
   Fundamental Research Funds for the Central Universities (1095020823 to
   D.L.)
CR Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497
   Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285
   Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696
   Greer EL, 2008, J CELL SCI, V121, P407, DOI 10.1242/jcs.021519
   Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9
   Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x
   Izzotti A, 2009, FASEB J, V23, P3243, DOI 10.1096/fj.09-135251
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002
   Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020
   Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285
   Nidadavolu LS, 2013, AGING-US, V5, P460, DOI 10.18632/aging.100571
   Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Schraml Elisabeth, 2012, Longev Healthspan, V1, P10, DOI 10.1186/2046-2395-1-10
   Sredni Simone T., 2011, Frontiers in Genetics, V2, P49, DOI 10.3389/fgene.2011.00049
   Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108
   Teixeira Ana L., 2012, Frontiers in Genetics, V3, P286, DOI 10.3389/fgene.2012.00286
   Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083
   Tzatsos A, 2008, CELL STEM CELL, V3, P469, DOI 10.1016/j.stem.2008.10.008
   Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Waldman SA, 2008, CLIN CHEM, V54, P943, DOI 10.1373/clinchem.2008.105353
   Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172
   Yang DG, 2012, CHINESE MED J-PEKING, V125, P3479, DOI 10.3760/cma.j.issn.0366-6999.2012.19.021
   Yang H, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/957607
   Yang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037205
   Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553
   Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116
   Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010
NR 36
TC 91
Z9 99
U1 4
U2 27
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JAN
PY 2015
VL 70
IS 1
BP 102
EP 109
DI 10.1093/gerona/glu145
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CC1RJ
UT WOS:000350119900014
PM 25165030
OA Bronze
DA 2024-02-19
ER

PT J
AU Rodriguez-Iturbe, B
   Sepassi, L
   Quiroz, Y
   Ni, ZM
   Vaziri, ND
AF Rodriguez-Iturbe, Bernardo
   Sepassi, Lili
   Quiroz, Yasmir
   Ni, Zhenmin
   Vaziri, Nosratola D.
TI Association of mitochondrial SOD deficiency with salt-sensitive
   hypertension and accelerated renal senescence
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE renal aging; immune infiltration; oxidative stress; superoxide dismutase
   deficiency
ID MYCOPHENOLATE-MOFETIL PREVENTS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE;
   BLOOD-PRESSURE; INFILTRATION; KIDNEY; AGE; DYSFUNCTION; DISEASE
AB Mitochondria are the major source of superoxide ( O-2(-)) in the aerobic organisms. O-2(-) produced by the mitochondria is converted to hydrogen peroxide by mitochondrial superoxide dismutase ( SOD2). Mice with complete SOD2 deficiency ( SOD2(-/-)) exhibit dilated cardiomyopathy and fatty liver leading to neonatal mortality, whereas mice with partial SOD2 deficiency ( SOD2(+/-)) show evidence of O-2(-)-induced mitochondrial damage resembling cell senescence. Since earlier studies have provided compelling evidence for the role of oxidative stress and tubulointerstitial inflammation in the pathogenesis of hypertension, we tested the hypothesis that partial SOD2 deficiency may result in hypertension. Wild-type ( SOD2(+/+)) and partial SOD2-deficient ( SOD2(+/-)) mice had similar blood pressures at 6 - 7 mo of age, but at 2 yr SOD2(+/-) mice had higher blood pressure. Oxidative stress, renal interstitial T-cell and macrophage infiltration, tubular damage, and glomerular sclerosis were all significantly increased in 2-yr-old SOD2(+/-) mice. High-salt diet induced hypertension in 6-mo-old SOD2-deficient mice but not in wild-type mice. In conclusion, partial SOD2 deficiency results in oxidative stress and renal interstitial inflammation, changes compatible with accelerated renal senescence and salt-sensitive hypertension. These findings are consistent with the pattern described in numerous other models of salt-sensitive hypertension and resemble that commonly seen in elderly humans.
C1 Univ Zulia, Univ Hosp, Inst Invest Biomed, Renal Serv & Lab,Fundacite Zulia, Maracaibo 4011, Venezuela.
   Univ Calif Irvine, Dept Med, Div Nephrol & Hypertens, Irvine, CA 92717 USA.
C3 University of California System; University of California Irvine
RP Rodriguez-Iturbe, B (corresponding author), Hosp Univ Maracaibo, Serv Nefrol, Ave Goajira S-N, Zulia 4001A, Venezuela.
OI Quiroz, Yasmir/0009-0005-4300-6976
FU NHLBI NIH HHS [R01 HL-071792-04] Funding Source: Medline; NIDDK NIH HHS
   [DK-73691] Funding Source: Medline
CR Alvarez V, 2002, AM J PHYSIOL-RENAL, V283, pF1132, DOI 10.1152/ajprenal.00199.2002
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   CARLOS R, 1999, HYPERTENSION, V34, P943
   Cuzzocrea S, 2004, FASEB J, V18, P94, DOI 10.1096/fj.03-0428com
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   Didion SP, 2002, CIRC RES, V91, P938, DOI 10.1161/01.RES.0000043280.65241.04
   Ferder LF, 2003, EXP GERONTOL, V38, P237, DOI 10.1016/S0531-5565(02)00264-4
   Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413
   Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003
   MUGGE A, 1991, AM J PHYSIOL, V260, pC219, DOI 10.1152/ajpcell.1991.260.2.C219
   Parra G, 2003, CLIN EXP IMMUNOL, V133, P44, DOI 10.1046/j.1365-2249.2003.02188.x
   Percy C, 2005, ADV CHRONIC KIDNEY D, V12, P78, DOI 10.1053/j.ackd.2004.10.006
   Quiroz Y, 2001, AM J PHYSIOL-RENAL, V281, pF38, DOI 10.1152/ajprenal.2001.281.1.F38
   Roberts CK, 2000, HYPERTENSION, V36, P423, DOI 10.1161/01.HYP.36.3.423
   Rodríguez- Iturbe B, 2005, J PHARMACOL EXP THER, V315, P51, DOI 10.1124/jpet.105.088062
   Rodríguez-Iturbe B, 2005, ANTIOXID REDOX SIGN, V7, P1269, DOI 10.1089/ars.2005.7.1269
   Rodríguez-Iturbe B, 2004, AM J NEPHROL, V24, P587, DOI 10.1159/000082313
   Rodríguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003
   Rodriguez-Iturbe B, 2003, HYPERTENSION, V41, P341, DOI 10.1161/01.HYP.0000052833.20759.64
   Rodríguez-Iturbe B, 2002, AM J PHYSIOL-RENAL, V282, pF191, DOI 10.1152/ajprenal.0197.2001
   Rodríguez-Iturbe B, 2001, KIDNEY INT, V59, P2222, DOI 10.1046/j.1523-1755.2001.0590062222.x
   Romero F, 1999, KIDNEY INT, V55, P945, DOI 10.1046/j.1523-1755.1999.055003945.x
   Thomas SE, 1998, J AM SOC NEPHROL, V9, P231
   Touyz Rhian M, 2003, Expert Rev Cardiovasc Ther, V1, P91, DOI 10.1586/14779072.1.1.91
   Vaziri ND, 1998, KIDNEY INT, V53, P1748, DOI 10.1046/j.1523-1755.1998.00947.x
   WEINBERGER MH, 1991, HYPERTENSION, V18, P67, DOI 10.1161/01.HYP.18.1.67
   Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005
NR 31
TC 88
Z9 102
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JAN
PY 2007
VL 102
IS 1
BP 255
EP 260
DI 10.1152/japplphysiol.00513.2006
PG 6
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 127QB
UT WOS:000243600300037
PM 17023572
DA 2024-02-19
ER

PT J
AU PACIFICI, GM
   VIANI, A
   TADDEUCCIBRUNELLI, G
   RIZZO, G
   CARRAI, M
   SCHULZ, HU
AF PACIFICI, GM
   VIANI, A
   TADDEUCCIBRUNELLI, G
   RIZZO, G
   CARRAI, M
   SCHULZ, HU
TI EFFECTS OF DEVELOPMENT, AGING, AND RENAL AND HEPATIC INSUFFICIENCY AS
   WELL AS HEMODIALYSIS ON THE PLASMA-CONCENTRATIONS OF ALBUMIN AND
   ALPHA-1-ACID GLYCOPROTEIN - IMPLICATIONS FOR BINDING OF DRUGS
SO THERAPEUTIC DRUG MONITORING
LA English
DT Article
C1 UNIV PISA,SCH MED,DEPT PEDIAT,I-56100 PISA,ITALY.
   MED UNIV LUBECK,DEPT ANGIOL & GERIAT,LUBECK,FED REP GER.
   HOSP PISA,DEPT NEPHROL,PISA,ITALY.
   HOSP PISA,DEPT GASTROENTEROL,PISA,ITALY.
C3 University of Pisa; University of Lubeck
RP PACIFICI, GM (corresponding author), UNIV PISA,SCH MED,DEPT GEN PATHOL,VIA ROMA 55,I-56100 PISA,ITALY.
RI Carrai, Maura/AGZ-4973-2022
CR AFFRIME M, 1975, EUR J CLIN PHARMACOL, V8, P267, DOI 10.1007/BF00567126
   AHLFORS CE, 1972, DEV PHARM THER, V4, P47
   ALBANI F, 1984, BRIT J CLIN PHARMACO, V17, P759, DOI 10.1111/j.1365-2125.1984.tb02414.x
   ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
   ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134
   BLASCHKE TF, 1977, CLIN PHARMACOKINET, V2, P32, DOI 10.2165/00003088-197702010-00003
   DROMGOOLE SH, 1973, CLIN CHIM ACTA, V46, P469, DOI 10.1016/0009-8981(73)90261-1
   DYBKAER R, 1981, ACTA MED SCAND, V209, P1
   GIBALDI M, 1981, EUR J CLIN PHARMACOL, V20, P299, DOI 10.1007/BF00618781
   GILES HG, 1982, CLIN PHARMACOL THER, V31, P77, DOI 10.1038/clpt.1982.12
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HERGREN L, 1983, DEV PHARM THER, V6, P110
   HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276
   JUSKO WJ, 1976, DRUG METAB REV, V5, P43, DOI 10.3109/03602537608995839
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
   MCLENNAN WJ, 1977, GERONTOLOGY, V23, P360
   MORSELLI PL, 1980, CLIN PHARMACOKINET, V5, P485, DOI 10.2165/00003088-198005060-00001
   NATION RL, 1981, CLIN PHARMACOL THER, V29, P472, DOI 10.1038/clpt.1981.65
   PACIFICI GM, 1984, CLIN PHARMACOL THER, V35, P354, DOI 10.1038/clpt.1984.43
   PACIFICI GM, 1984, 5TH INT M PHARM PHYS
   PACIFICI GM, 1985, 5TH INT C DEV PHARM
   PIAFSKY KM, 1980, CLIN PHARMACOKINET, V5, P246, DOI 10.2165/00003088-198005030-00004
   PIKE E, 1981, CLIN PHARMACOKINET, V6, P367, DOI 10.2165/00003088-198106050-00003
   PRICTCHARD JF, 1983, CLIN PHARM THER, V34, P681
   RANE A, 1971, J PEDIATR-US, V78, P877, DOI 10.1016/S0022-3476(71)80369-4
   REIDENBERG M M, 1976, Clinical Pharmacokinetics, V1, P121, DOI 10.2165/00003088-197601020-00003
   REIDENBERG MM, 1971, NEW ENGL J MED, V285, P264, DOI 10.1056/NEJM197107292850506
   REIDENBERG MM, 1984, CLIN PHARMACOKINET, V9, P18, DOI 10.2165/00003088-198400091-00003
   ROWLAND M, 1984, CLIN PHARMACOKINET, V9, P10, DOI 10.2165/00003088-198400091-00002
   RUSTEIN DD, 1969, LANCET, V2, P1003
   SJOQVIST F, 1976, DRUG TREATMENT, P1
   TILLEMENT JP, 1978, CLIN PHARMACOKINET, V3, P144, DOI 10.2165/00003088-197803020-00004
   URIEN S, 1981, INT J CLIN PHARM TH, V19, P319
   VERBEECK RK, 1984, EUR J CLIN PHARMACOL, V27, P91, DOI 10.1007/BF00553161
NR 35
TC 63
Z9 63
U1 0
U2 1
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0163-4356
J9 THER DRUG MONIT
JI Ther. Drug Monit.
PY 1986
VL 8
IS 3
BP 259
EP 263
DI 10.1097/00007691-198609000-00003
PG 5
WC Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology
GA D7027
UT WOS:A1986D702700003
PM 3750366
DA 2024-02-19
ER

PT J
AU BEYER, HS
   SHERMAN, R
   ZIEVE, L
AF BEYER, HS
   SHERMAN, R
   ZIEVE, L
TI AGING IS ASSOCIATED WITH REDUCED LIVER-REGENERATION AND DIMINISHED
   THYMIDINE KINASE MESSENGER-RNA CONTENT AND ENZYME-ACTIVITY IN THE RAT
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID RIBONUCLEIC-ACID; EXPRESSION; HEPATECTOMY; CELLS
AB We studied the effect of aging on rat liver regeneration.  We compared the time course of total hepatic mass, DNA and RNA accumulation, and thymidine kinase (TK) messenger RNA (mRNA) content and enzyme activity, after two-thirds partial hepatectomy in 6-week-old (young adult) and 1-year-old rats.  Whereas 6-week-old rats had completely regenerated all liver mass, DNA, and RNA by 7 days, the regenerating 1-year-old rat livers at 7 days contained only 60% to 70% of the mass, DNA, and RNA in the normal 1-year-old rat liver.  However, rates of tissue regeneration during this time were very similar in both ages.  At 28 days the weight and RNA content of the 1-year-old rat livers were 93% of normal, but total DNA was still reduced, at 78% of normal.  In the younger rats TK mRNA content and enzyme activity increased substantially after partial hepatectomy and were observed to peak at 24 hours.  In the 1-year-old rats TK mRNA was less abundant in normal liver and the peak level observed was lower and delayed until 48 hours.  Nonetheless, the incremental increase from baseline to peak was greater in the 1-year-old than in the 6-week-old rats.  In contrast to the mRNA, TK activity peaked at 24 hours, but at substantially lower levels than in the 6-week-old rats.  Rates of disappearance of TK mRNA and enzyme activity after peak levels were not significantly different by age.  These results indicate that liver regeneration in 1-year-old rats is reduced from the standpoint of proportion of excised tissue that is replaced at 7 days, but the absolute quantities regenerated during this time are similar in rats of both ages.  Regeneration continues in the older rats during the next 3 weeks.  Differences in TK expression occur during induction of the mRNA and TK enzyme activity, but not in the elimination phases.
C1 HENNEPIN CTY OFF PLANNING & DEV,MINNEAPOLIS,MN.
   VET ADM MED CTR,DEPT MED,MINNEAPOLIS,MN 55417.
   UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Minneapolis VA Health Care System; University of Minnesota System;
   University of Minnesota Twin Cities
RP BEYER, HS (corresponding author), HENNEPIN CTY MED CTR,DEPT MED,701 PK AVE S,MINNEAPOLIS,MN 55415, USA.
CR ALISON MR, 1986, PHYSIOL REV, V66, P499, DOI 10.1152/physrev.1986.66.3.499
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BEYER HS, 1985, ENDOCRINOLOGY, V116, P2669, DOI 10.1210/endo-116-6-2669
   BUCHER NLR, 1964, CANCER RES, V24, P509
   BUCHER NLR, 1971, REGENERATION LIVER K, P278
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLAYCOMB WC, 1987, BIOCHEM J, V247, P701, DOI 10.1042/bj2470701
   COLLINS ML, 1985, ANAL BIOCHEM, V151, P211, DOI 10.1016/0003-2697(85)90168-X
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   KAHN D, 1980, GASTROENTEROLOGY, V79, P907
   MARIASH CN, 1982, ANAL BIOCHEM, V121, P388, DOI 10.1016/0003-2697(82)90498-5
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   MURPHY AJM, 1987, P NATL ACAD SCI USA, V84, P8277, DOI 10.1073/pnas.84.23.8277
   NAGEL JE, 1988, J CLIN INVEST, V81, P1096, DOI 10.1172/JCI113422
   OGAWA K, 1985, JPN J CANCER RES, V76, P779
   WARNER HR, 1989, J GERONTOL, V44, pB23, DOI 10.1093/geronj/44.1.B23
   WELLINGER R, 1986, MECH AGEING DEV, V34, P203, DOI 10.1016/0047-6374(86)90035-7
   ZIEVE L, 1985, J LAB CLIN MED, V105, P331
NR 18
TC 48
Z9 49
U1 0
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD FEB
PY 1991
VL 117
IS 2
BP 101
EP 108
PG 8
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA EX656
UT WOS:A1991EX65600004
PM 1704406
DA 2024-02-19
ER

PT J
AU Dai, Z
   Song, GQ
   Balakrishnan, A
   Yang, TH
   Yuan, QG
   Möbus, S
   Weiss, AC
   Bentler, M
   Zhu, JM
   Jiang, XM
   Shen, XZ
   Bantel, H
   Jaeckel, E
   Kispert, A
   Vogel, A
   Saborowski, A
   Büning, H
   Manns, M
   Cantz, T
   Ott, M
   Sharma, AD
AF Dai, Zhen
   Song, Guangqi
   Balakrishnan, Asha
   Yang, Taihua
   Yuan, Qinggong
   Moebus, Selina
   Weiss, Anna-Carina
   Bentler, Martin
   Zhu, Jimin
   Jiang, Xuemei
   Shen, Xizhong
   Bantel, Heike
   Jaeckel, Elmar
   Kispert, Andreas
   Vogel, Arndt
   Saborowski, Anna
   Buening, Hildegard
   Manns, Michael
   Cantz, Tobias
   Ott, Michael
   Sharma, Amar Deep
TI Growth differentiation factor 11 attenuates liver fibrosis via expansion
   of liver progenitor cells
SO GUT
LA English
DT Article
ID STEM-CELLS; GDF11; AGE; PANCREAS; FATE
AB Objective Liver fibrosis and cirrhosis resulting from chronic liver injury represent a major healthcare burden worldwide. Growth differentiation factor (GDF) 11 has been recently investigated for its role in rejuvenation of ageing organs, but its role in chronic liver diseases has remained unknown. Here, we investigated the expression and function of GDF11 in liver fibrosis, a common feature of most chronic liver diseases.
   Design We analysed the expression of GDF11 in patients with liver fibrosis, in a mouse model of liver fibrosis and in hepatic stellate cells (HSCs) as well as in other liver cell types. The functional relevance of GDF11 in toxin-induced and cholestasis-induced mouse models of liver fibrosis was examined by in vivo modulation of Gdf11 expression using adeno-associated virus (AAV) vectors. The effect of GDF11 on leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5)+ liver progenitor cells was studied in mouse and human liver organoid culture. Furthermore, in vivo depletion of LGR5+ cells was induced by injecting AAV vectors expressing diptheria toxin A under the transcriptional control of Lgr5 promoter.
   Results We showed that the expression of GDF11 is upregulated in patients with liver fibrosis and in experimentally induced murine liver fibrosis models. Furthermore, we found that therapeutic application of GDF11 mounts a protective response against fibrosis by increasing the number of LGR5+ progenitor cells in the liver.
   Conclusion Collectively, our findings uncover a protective role of GDF11 during liver fibrosis and suggest a potential application of GDF11 for the treatment of chronic liver disease.
C1 [Dai, Zhen; Balakrishnan, Asha; Yang, Taihua; Yuan, Qinggong; Moebus, Selina; Bantel, Heike; Jaeckel, Elmar; Vogel, Arndt; Saborowski, Anna; Manns, Michael; Cantz, Tobias; Ott, Michael; Sharma, Amar Deep] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
   [Dai, Zhen; Song, Guangqi; Yang, Taihua; Moebus, Selina; Sharma, Amar Deep] Hannover Med Sch, Cluster Excellence Rebirth, Res Grp MicroRNA Liver Regenerat, Hannover, Germany.
   [Song, Guangqi; Zhu, Jimin; Shen, Xizhong] Fudan Univ, Dept Gastroenterol, Zhongshan Hosp, Shanghai, Peoples R China.
   [Balakrishnan, Asha; Yuan, Qinggong; Ott, Michael] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany.
   [Weiss, Anna-Carina; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, Hannover, Germany.
   [Bentler, Martin; Buening, Hildegard] Hannover Med Sch, Inat Expt Hematol, Hannover, Germany.
   [Jiang, Xuemei] Cent South Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Gastroenterol, Haikou, Hainan, Peoples R China.
   [Cantz, Tobias] Hannover Med Sch, Translat Hepatol & Stem Cell Biol, Cluster Excellence REBIRTH, Hannover, Germany.
C3 Hannover Medical School; Hannover Medical School; Fudan University;
   Helmholtz Association; Helmholtz-Center for Infection Research; Hannover
   Medical School; Hannover Medical School; Hannover Medical School
RP Sharma, AD (corresponding author), Hannover Med Sch, Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
EM ott.michael@mh-hannover.de; sharma.amar@mh-hannover.de
RI Balakrishnan, Asha/ITT-6859-2023; Cantz, Tobias/JAC-8522-2023; Buening,
   Hildegard/AAV-9928-2021; Zhu, Ji-Min/HDN-1451-2022; Saborowski,
   Anna/GQH-4609-2022; Buening, Hildegard/AAJ-2352-2020
OI Buening, Hildegard/0000-0002-3365-6933; Zhu, Ji-Min/0000-0002-2150-473X;
   Saborowski, Anna/0000-0003-4857-4276; Song, Guangqi/0000-0002-2409-0771;
   Balakrishnan, Asha/0000-0002-1366-3386; Vogel, Arndt/0000-0003-0560-5538
FU Deutsche Forschungsgemeinschaft [DFG SH640/1-2, DFG EXC 62/2, SFB-738];
   Deutsche Krebshilfe grant [111147]; China Scholarship Council; Plus 3
   Program of Boehringer Ingelheim
FX The work was supported by the grants from Deutsche
   Forschungsgemeinschaft (DFG SH640/1-2, DFG EXC 62/2 and SFB-738) and
   Plus 3 Program of Boehringer Ingelheim. AB is supported from Deutsche
   Krebshilfe grant (111147). ZD and TY received stipends from China
   Scholarship Council.
CR Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127
   Cao WL, 2017, GASTROENTEROLOGY, V153, P1133, DOI 10.1053/j.gastro.2017.07.006
   Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3
   Clevers H, 2018, ANNU REV BIOCHEM, V87, P1015, DOI 10.1146/annurev-biochem-062917-012341
   Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484
   Dorrell C, 2014, STEM CELL RES, V13, P275, DOI 10.1016/j.scr.2014.07.006
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Finkenzeller G, 2015, J SURG RES, V198, P50, DOI 10.1016/j.jss.2015.05.001
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535
   Hirsch T, 2017, NATURE, V551, P327, DOI 10.1038/nature24487
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Jörs S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585
   Jones JE, 2018, CELL REP, V22, P1522, DOI 10.1016/j.celrep.2018.01.044
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175
   Ko SJ, 2019, GASTROENTEROLOGY, V156, P187, DOI 10.1053/j.gastro.2018.09.039
   Lin Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01341-6
   Liu AD, 2018, FASEB J, V32, P5186, DOI 10.1096/fj.201800195R
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Maschmeyer P, 2011, JOVE-J VIS EXP, DOI 10.3791/2710
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320
   Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101
   Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873
   Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995
   Muñoz-Cánoves P, 2018, NATURE, V563, P328, DOI 10.1038/d41586-018-07175-6
   Planas-Paz L, 2019, CELL STEM CELL, V25, P39, DOI 10.1016/j.stem.2019.04.005
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 39
TC 35
Z9 37
U1 0
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUN
PY 2020
VL 69
IS 6
BP 1104
EP 1115
DI 10.1136/gutjnl-2019-318812
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA LV0FW
UT WOS:000538121200021
PM 31767630
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Dini, B
   Dolfi, C
   Santucci, V
   Cavallini, G
   Donati, A
   Gori, Z
   Maccheroni, M
   Bergamini, E
AF Dini, B
   Dolfi, C
   Santucci, V
   Cavallini, G
   Donati, A
   Gori, Z
   Maccheroni, M
   Bergamini, E
TI Effects of ageing and increased haemolysis on the levels of dolichol in
   rat spleen
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE dolichol; ageing; haemolysis; phenylhydrazine; spleen; liver; kidney;
   muscle; rat
ID HUMAN-TISSUES; LIVER; ACCUMULATION; CELL; ERYTHROCYTES; DERIVATIVES;
   METABOLISM; ORGANS; DONOR
AB Dolichol is a long-chain polyisoprenoid. No enzyme pathway for dolichol degradation was discovered. Dolichol accumulates in human and rodent tissues during ageing. Red blood cells contain a larger amount of dolichol and red blood cell life span is shorter in older rats. The effects of age and of the load of dolichol from red blood cell degradation on the ageing-associated accumulation of dolichol in spleen were studied in 2, 6, 12, 18 and 24 month-old male Sprague Dawley rats fed ad libitum (AL) or on an anti-ageing dietary regimen (EOD). Tissue dolichol was extracted and assayed by HPLC [J. Gerontol. 53A (1998) B87]. Levels of dolichol increased in spleen, liver, kidney and muscle in parallel fashion from the age of 2 to 12 months. Unexpectedly, spleen dolichol decreased in older rats whereas liver, kidney and muscle dolichol increased significantly. The effects of haemolysis on spleen dolichol were tested by the administration of phenylhydrazine. Results show that haemolysis does not increase, but rather decreases the levels of dolichol in erythroclastic organs. It is concluded that the levels of spleen dolichol may decrease in the absence of any known enzymatic degradative pathway if the spleen and its resident phagocytes are forced to cope with a higher number of red blood cells to be cleared. Free-radical mediated decomposition of dolichol by phagocytic cells during erythrophagocytosis might be involved in the process. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Univ Pisa, Dipartimento Patol Sperimentale, I-56126 Pisa, Italy.
   Azienda Osped Pisana, Pisa, Italy.
C3 University of Pisa; University of Pisa; Azienda Ospedaliero
   Universitaria Pisana
RP Bergamini, E (corresponding author), Univ Pisa, Dipartimento Patol Sperimentale, Via Roma 55, I-56126 Pisa, Italy.
CR AZEN EA, 1964, J LAB CLIN MED, V63, P122
   BESSLER H, 1985, BLUT, V50, P195, DOI 10.1007/BF00320294
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CHEUNG HT, 1983, MECH AGEING DEV, V22, P23
   CHOINACKI T, 1988, BIOCHEM J, V251, P1
   COLLINS T, 1999, ROBBINS PATHOLOGIC B, P62
   Cottalasso D, 2000, TOXICOLOGY, V143, P283, DOI 10.1016/S0300-483X(99)00181-X
   DANIELS I, 1990, LIPIDS, V25, P586, DOI 10.1007/BF02536006
   De Tata V, 2001, EXP GERONTOL, V36, P507, DOI 10.1016/S0531-5565(00)00259-X
   DOLFI C, 1999, GIORNALE GERONTOL, V47, P275
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   ELMBERGER PG, 1987, EUR J BIOCHEM, V168, P1, DOI 10.1111/j.1432-1033.1987.tb13379.x
   GLASS GA, 1983, EXP HEMATOL, V11, P987
   GLASS GA, 1981, BIOCHEM BIOPH RES CO, V103, P1245, DOI 10.1016/0006-291X(81)90256-4
   HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058
   Holloszy John O., 1995, P633
   Ishinaga M, 1999, BIOSCI BIOTECH BIOCH, V63, P449, DOI 10.1271/bbb.63.449
   ISHINAGA M, 1993, P SOC EXP BIOL MED, V203, P74, DOI 10.3181/00379727-203-43575
   JANDL JH, 1991, BLOOD PATHOPHYSIOLOG
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Karbownik M, 2000, INT J BIOCHEM CELL B, V32, P1045, DOI 10.1016/S1357-2725(00)00056-X
   KELLER RK, 1986, LIPIDS, V21, P353, DOI 10.1007/BF02535700
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   MAINES MD, 1984, BIOCHEM J, V217, P409, DOI 10.1042/bj2170409
   MALTESE WA, 1989, J BIOL CHEM, V264, P18168
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   MARINO M, 1990, BIOCHIM BIOPHYS ACTA, V1047, P192, DOI 10.1016/0005-2760(90)90047-2
   McMillan DC, 1998, J PHARMACOL EXP THER, V287, P868
   Nanni G, 2000, LIFE SCI, V67, P2293, DOI 10.1016/S0024-3205(00)00819-5
   POTTER JER, 1981, J BIOL CHEM, V256, P2371
   PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6
   SORRELL JM, 1982, J MORPHOL, V171, P183, DOI 10.1002/jmor.1051710206
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
NR 36
TC 11
Z9 13
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2001
VL 37
IS 1
BP 99
EP 105
DI 10.1016/S0531-5565(01)00156-5
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 503GU
UT WOS:000172791400011
PM 11738151
DA 2024-02-19
ER

PT J
AU Guillory, B
   Jawanmardi, N
   Iakova, P
   Anderson, B
   Zang, P
   Timchenko, NA
   Garcia, JM
AF Guillory, Bobby
   Jawanmardi, Nicole
   Iakova, Polina
   Anderson, Barbara
   Zang, Pu
   Timchenko, Nikolai A.
   Garcia, Jose M.
TI Ghrelin deletion protects against age-associated hepatic steatosis by
   downregulating the C/EBPα-p300/DGAT1 pathway
SO AGING CELL
LA English
DT Article
DE aging; C/EBP proteins; ghrelin; liver; p300; steatosis
ID GROWTH-HORMONE SECRETAGOGUE; FATTY LIVER-DISEASE; BINDING-PROTEIN;
   PHOSPHOENOLPYRUVATE CARBOXYKINASE; C/EBP-ALPHA; NONALCOHOLIC
   STEATOHEPATITIS; TRANSCRIPTIONAL REGULATION; PROLIFERATION; MICE;
   INHIBITION
AB Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. NAFLD usually begins as low-grade hepatic steatosis which further progresses in an age-dependent manner to nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma in some patients. Ghrelin is a hormone known to promote adiposity in rodents and humans, but its potential role in hepatic steatosis is unknown. We hypothesized that genetic ghrelin deletion will protect against the development of age-related hepatic steatosis. To examine this hypothesis, we utilized ghrelin knockout (KO) mice. Although no different in young animals (3 months old), we found that at 20 months of age, ghrelin KO mice have significantly reduced hepatic steatosis compared to aged-matched wild-type (WT) mice. Examination of molecular pathways by which deletion of ghrelin reduces steatosis showed that the increase in expression of diacylglycerol O-acyltransferase-1 (DGAT1), one of the key enzymes of triglyceride (TG) synthesis, seen with age in WT mice, is not present in KO mice. This was due to the lack of activation of CCAAT/enhancer binding protein-alpha (C/EBP) protein and subsequent reduction of C/EBP-p300 complexes. These complexes were abundant in livers of old WT mice and were bound to and activated the DGAT1 promoter. However, the C/EBP-p300 complexes were not detected on the DGAT1 promoter in livers of old KO mice resulting in lower levels of the enzyme. In conclusion, these studies demonstrate the mechanism by which ghrelin deletion prevents age-associated hepatic steatosis and suggest that targeting this pathway may offer therapeutic benefit for NAFLD.
C1 [Guillory, Bobby; Garcia, Jose M.] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Translat Res Inflammatory Dis, Dept Med,Div Endocrinol Diabet & Metab,MCL, Houston, TX 77030 USA.
   [Guillory, Bobby; Jawanmardi, Nicole; Iakova, Polina; Timchenko, Nikolai A.; Garcia, Jose M.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Jawanmardi, Nicole; Iakova, Polina; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Anderson, Barbara; Zang, Pu; Garcia, Jose M.] Univ Washington, VA Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA.
   [Zang, Pu] Nanjing Jinling Hosp, Dept Endocrinol, Nanjing 210002, Jiangsu, Peoples R China.
   [Timchenko, Nikolai A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.
C3 Baylor College of Medicine; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor
   College of Medicine; Baylor College of Medicine; Geriatric Research
   Education & Clinical Center; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Vet Affairs Puget Sound Health Care System;
   University of Washington; University of Washington Seattle; Cincinnati
   Children's Hospital Medical Center
RP Timchenko, NA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA.; Timchenko, NA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Liver Tumor Program, Cincinnati, OH 45229 USA.; Garcia, JM (corresponding author), Univ Washington, VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 South Columbian Way,S-182-GRECC, Seattle, WA 98108 USA.
EM Nikolai.Timchenko@cchmc.org; jose.garcia@va.gov
FU U.S. Dept of Veterans Affairs (MERIT) [BX002807, CX000174]; NIH
   [AG040583, R01DK102597]; NIA [T32AG000183]; University of Washington
   DERC [P30 DK017047]; NORC [P30 DK035816]; Vanderbilt MMPC [U24 DK59637]
FX This work was funded by The U.S. Dept of Veterans Affairs (MERIT grants
   BX002807 and CX000174) and NIH Grant AG040583 to JMG. This work was also
   supported NIH grant R01DK102597 (NT). Dr Guillory was supported by a
   training grant from the NIA (T32AG000183). We thank the University of
   Washington DERC (P30 DK017047) and NORC (P30 DK035816), Vanderbilt MMPC
   (supported in part by U24 DK59637) for their help. We thank Dr. Roy G.
   Smith for providing the ghrelin WT and KO animals.
CR Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Barazzoni R., 2013, OBESITY SILVER SPRIN
   Browning JD, 2004, AM J GASTROENTEROL, V99, P292, DOI 10.1111/j.1572-0241.2004.04059.x
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Census Bot, 2008, TABL 2 PROJ POP SEL, P42
   Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023
   Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432
   Iwasaki Y, 2015, NEUROPEPTIDES, V52, P55, DOI 10.1016/j.npep.2015.06.003
   Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146
   Jin JL, 2016, CELL REP, V16, P744, DOI 10.1016/j.celrep.2016.06.019
   Jin JL, 2015, HEPATOLOGY, V61, P315, DOI 10.1002/hep.27295
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Murphy MG, 1998, J CLIN ENDOCR METAB, V83, P320, DOI 10.1210/jc.83.2.320
   Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587
   Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011
   PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264
   PARK EA, 1993, J BIOL CHEM, V268, P613
   Porteiro B, 2013, ENDOCRINOLOGY, V154, P3671, DOI 10.1210/en.2013-1176
   Riordan JD, 2014, MAMM GENOME, V25, P473, DOI 10.1007/s00335-014-9521-3
   Schattenberg JM, 2010, DIGEST DIS, V28, P247, DOI 10.1159/000282097
   Stark R, 2015, ENDOCRINOLOGY, V156, P858, DOI 10.1210/en.2014-1733
   Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005
   Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782
   Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003
   Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
   Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Tschöp M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5
   YANUKAKASHLES O, 1994, MOL CELL BIOL, V14, P7124, DOI 10.1128/MCB.14.11.7124
   Zhang YY, 2015, P NATL ACAD SCI USA, V112, P1226, DOI 10.1073/pnas.1423643112
NR 42
TC 31
Z9 32
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD FEB
PY 2018
VL 17
IS 1
AR e12688
DI 10.1111/acel.12688
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FS8KX
UT WOS:000422661300006
PM 29024407
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jiang, WY
   Li, SC
   Wang, CS
   Wang, YM
AF Jiang, WY
   Li, SC
   Wang, CS
   Wang, YM
TI Comparative study of effects of three kinds of herbal mixture decoctions
   on improving immune senescence and free radical metabolism
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
ID CELL
AB Objective To verify from the aspects of immune senescence and free radical metabolism that ''removing blood stasis as well as tonifying kidney is an ideal way to delay aging'' and further investigate the anti-aging mechanism of this therapy.
   Methods In the first period, the old mice were separately fed with the herbal decoction of the recipe of tonifying kidney, or of removing blood stasis, or of tonifying kidney and removing blood stasis for four weeks, and then IL-2 production of splenic lymphocytes, IL-1 production of peritoneal macrophages, SOD, CAT and GSH-Px activity in erythrocytes, and LPO contents in liver and brain were compared between the young control group and the old control group, or the old control group and each of the old medication groups. In the second period, the adult mice inhaled ozone or the splenic lymphocytes from adult mice were cultured in the medium containing peroxide hydrogen. The effects of free radicals on immune system and the reversion of the herbal decoction of the recipe of removing blood stasis as well as tonifying kidney were observed.
   Results The activities of IL-1, IL-2, SOD, CAT and GSH-Px in old mice were significantly lower than those in young mice, and LPO contents were higher. The three herbal decoctions all have reversing effects on each of these parameters except that the decoction of removing blood stasis has inhibitory effects on IL-1 and IL-2 production. The effect of the decoction of removing blood stasis as well as tonifying kidney was the best among the three decoctions, and it can also reverse the impaired production of IL-2 by ozone in vivo and peroxide hydrogen in vitro.
   Conclusions The therapeutic method of removing blood stasis as well as tonifying kidney is an ideal way to delay aging, and its effects to improve immune senescence is correlated with the decrease of free radical damages.
RP Jiang, WY (corresponding author), BEIJING MED UNIV,DEPT INTEGRATED TRADIT CHINESE & WESTERN MED,BEIJING 100083,PEOPLES R CHINA.
CR ASOKAWA T, 1979, LIPIDS, P401
   BAI XQ, 1989, J NORMAN BETHUNE U M, V15, P34
   BRULEYROSSET M, 1984, MECH AGEING DEV, V24, P247, DOI 10.1016/0047-6374(84)90111-8
   CHEN F, 1997, CHINA J TRADIT CHIN, V12, P5
   COFFMAN FD, 1989, EXP GERONTOL, V24, P437, DOI 10.1016/0531-5565(89)90050-8
   GILLIS S, 1978, J IMMUNOL, V120, P2027
   HARA PM, 1977, ARCH BIOCHEM BIOPHYS, V181, P308
   LI SC, 1992, CHINA J TRADIT CHIN, V7, P4
   LIU XQ, 1990, CHIN J IND HYG OCUPA, V8, P365
   LUO LY, 1987, LIAONING J TCM, P37
   MAO TM, 1991, J BEIJING MED U, V23, P100
   MONTI D, 1990, PROTEIN METABOLISM A, P387
   SHEN ZY, 1987, JTCM, P57
   SUNDE RA, 1973, J NUTR, V104, P580
   YANG JH, 1986, CHIN J IMMUNOL, V2
   YAO PF, 1982, SHANGHAI J TCM, P2
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
NR 17
TC 6
Z9 8
U1 0
U2 1
PU CHINESE MEDICAL ASSOCIATION
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD OCT
PY 1997
VL 110
IS 10
BP 750
EP 754
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA YA990
UT WOS:A1997YA99000005
PM 9642303
DA 2024-02-19
ER

PT J
AU Nakladal, D
   Lambooy, SPH
   Misúth, S
   Jepcova, D
   Joschko, CP
   van Buiten, A
   Goris, M
   Hoogstra-Berends, F
   Kloosterhuis, NJ
   Huijkman, N
   van de Sluis, B
   Diercks, GF
   Buikema, JH
   Henning, RH
   Deelman, LE
AF Nakladal, D.
   Lambooy, S. P. H.
   Misuth, S.
   Jepcova, D.
   Joschko, C. P.
   van Buiten, A.
   Goris, M.
   Hoogstra-Berends, F.
   Kloosterhuis, N. J.
   Huijkman, N.
   van de Sluis, B.
   Diercks, G. F.
   Buikema, J. H.
   Henning, R. H.
   Deelman, L. E.
TI Homozygous whole body <i>Cbs</i> knockout in adult mice features minimal
   pathology during ageing despite severe homocysteinemia
SO FASEB JOURNAL
LA English
DT Article
DE cystathionine beta synthase deficiency; hydrogen sulfide;
   hyperhomocysteinemia; inducible mouse model; vascular dysfunction
ID CYSTATHIONINE-BETA-SYNTHASE; DEFICIENT MICE; RISK-FACTOR;
   HYDROGEN-SULFIDE; ANIMAL-MODEL; MOUSE MODEL; STEATOSIS; PHENOTYPE;
   FIBROSIS; DISEASE
AB Deficiencies in Cystathionine-beta-synthase (CBS) lead to hyperhomocysteinemia (HHCy), which is considered a risk factor for cardiovascular, bone and neurological disease. Moreover, CBS is important for the production of cysteine, hydrogen sulfide (H2S) and glutathione. Studying the biological role of CBS in adult mice has been severely hampered by embryological disturbances and perinatal mortality. To overcome these issues and assess the effects of whole-body CBS deficiency in adult mice, we engineered and characterized a Cre-inducible Cbs knockout model during ageing. No perinatal mortality occurred before Cbs(-/-) induction at 10 weeks of age. Mice were followed until 90 weeks of age and ablation of Cbs was confirmed in liver and kidney but not in brain. Severe HHCy was observed in Cbs(-/-) (289 +/- 58 mu M) but not in Cbs(+/-) or control mice (<10 mu M). Cbs(-/-) showed impaired growth, facial alopecia, endothelial dysfunction in absence of increased mortality, and signs of liver or kidney damage. CBS expression in skin localized to sebaceous glands and epidermis, suggesting local effects of Cbs(-/-) on alopecia. Cbs(-/-) showed increased markers of oxidative stress and senescence but expression of other H2S producing enzymes (CSE and 3-MST) was not affected. CBS deficiency severely impaired H2S production capacity in liver, but not in brain or kidney. In summary, Cbs(-/-) mice presented a mild phenotype without mortality despite severe HHCy. The findings demonstrate that HHCy is not directly linked to development of end organ damage.
C1 [Nakladal, D.; Lambooy, S. P. H.; Misuth, S.; Jepcova, D.; Joschko, C. P.; van Buiten, A.; Goris, M.; Hoogstra-Berends, F.; Buikema, J. H.; Henning, R. H.; Deelman, L. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.
   [Misuth, S.; Jepcova, D.] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia.
   [Kloosterhuis, N. J.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.
   [Huijkman, N.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, iPSC CRISPR Ctr Groningen, Groningen, Netherlands.
   [Diercks, G. F.] Univ Groningen, Univ Med Ctr Groningen, Ctr Blistering Dis, Dept Dermatol, Groningen, Netherlands.
C3 University of Groningen; Comenius University Bratislava; University of
   Groningen; University of Groningen; University of Groningen
RP Nakladal, D; Deelman, LE (corresponding author), Univ Med Ctr Groningen UMCG, Dept Clin Pharm & Pharmacol, AP50,Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.
EM d.nakladal@umcg.nl; l.e.deelman@umcg.nl
RI Henning, Robert H/AAY-5222-2020
OI Henning, Robert H/0000-0002-5135-4621; Joschko, Christian
   Paul/0000-0003-2267-5108; van de Sluis, Bart
   (A.J.A.)/0000-0003-3039-4365; Nakladal, Dalibor/0000-0003-0900-0130;
   Diercks, Gilles/0000-0001-8053-216X
FU Graduate School of Medical Sciences, University of Groningen, University
   Medical Center Groningen; Life Sciences and Health-Topconsortium voor
   Kennis en Innovatie (Stichting LSH-TKI) [2019-017]
FX DN was financially supported by an Abel Tasman PhD scholarship by the
   Graduate School of Medical Sciences, University of Groningen, University
   Medical Center Groningen and by Life Sciences and Health-Topconsortium
   voor Kennis en Innovatie (Stichting LSH-TKI): PPP project-2019-017
CR Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097
   Arndt S, 2017, J BIOL CHEM, V292, P7761, DOI 10.1074/jbc.M117.784678
   Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243
   BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049
   BRENTON D P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P277
   Chen XB, 2017, REDOX BIOL, V12, P987, DOI 10.1016/j.redox.2017.04.031
   Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310
   Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54
   Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568
   FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6
   Gupta S, 2021, FASEB J, V35, DOI 10.1096/fj.202100302R
   Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770
   Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598
   Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584
   Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007
   Hanada K, 1998, J INVEST DERMATOL, V110, P259, DOI 10.1046/j.1523-1747.1998.00125.x
   Hine C, 2018, ANTIOXID REDOX SIGN, V28, P1483, DOI 10.1089/ars.2017.7434
   Jiang JY, 2016, CLIN EXP HYPERTENS, V38, P393, DOI 10.3109/10641963.2016.1148155
   Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4
   Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016
   KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431
   Karmin O, 2018, CURR MED CHEM, V25, P367, DOI 10.2174/0929867324666170509145240
   Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250
   Lee HO, 2021, J INHERIT METAB DIS, V44, P1382, DOI 10.1002/jimd.12437
   Leustek Thomas, 2002, Arabidopsis Book, V1, pe0017, DOI 10.1199/tab.0017
   Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469
   Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010
   Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014
   Park I, 2020, HUM MUTAT, V41, P1662, DOI 10.1002/humu.24072
   Polhemus DJ, 2015, CARDIOVASC THER, V33, P216, DOI 10.1111/1755-5922.12128
   QUENTIN R, 1990, EUR J CLIN MICROBIOL, V9, P138, DOI 10.1007/BF01963641
   Rittié L, 2016, J INVEST DERMATOL, V136, P1792, DOI 10.1016/j.jid.2016.05.113
   Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034
   Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082
   Son P., 2021, HYPERHOMOCYSTEINEMIA
   Speir RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126622
   Sundberg JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205775
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a
   WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585
   Hoss GRW, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1214
   Whiting DA, 2001, CLIN DERMATOL, V19, P211, DOI 10.1016/S0738-081X(00)00132-2
   Wu DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2715718
   Yan WJ, 2021, CLIN EXP PHARMACOL P, V48, P524, DOI 10.1111/1440-1681.13442
   Zaric BL, 2019, CURR MED CHEM, V26, P2948, DOI 10.2174/0929867325666180313105949
   Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547
NR 49
TC 6
Z9 6
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2022
VL 36
IS 4
AR e22260
DI 10.1096/fj.202101550R
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA ZZ0HD
UT WOS:000772957100006
PM 35315960
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Park, KM
   Lee, J
   Hussein, KH
   Hong, SH
   Yang, SR
   Lee, E
   Woo, HM
AF Park, Kyung-Mee
   Lee, Joohyeong
   Hussein, Kamal Hany
   Hong, Seok-Ho
   Yang, Se-Ran
   Lee, Eunsong
   Woo, Heung-Myong
TI Generation of liver-specific TGF-α/<i>c</i>-Myc-overexpressing porcine
   induced pluripotent stem-like cells and blastocyst formation using
   nuclear transfer
SO JOURNAL OF VETERINARY MEDICAL SCIENCE
LA English
DT Article
DE hepatocyte; induced pluripotent stem cell; nuclear transfer; porcine;
   transgenic
ID PIG MODELS; MICE; ESTABLISHMENT; CULTURE; LINES
AB Transgenic porcine induced pluripotent stem (iPS) cells are attractive cell sources for the development of genetically engineered pig models, because they can be expanded without senescence and have the potential for multiple gene manipulation. They are also useful cell sources for disease modeling and treatment. However, the generation of transgenic porcine iPS cells is rare, and their embryonic development after nuclear transfer (NT) has not yet been reported. We report here the generation of liver-specific oncogenes (TGF-alpha/cMyc)-overexpressing porcine iPS (T/M iPS)-like cells. They expressed stem cell characteristics and were differentiated into hepatocyte-like cells that express oncogenes. We also confirmed that NT embryos derived from T/M iPS-like cells successfully developed blastocysts in vitro. As an initial approach toward porcine transgenic iPS cell generation and their developmental competence after NT, this study provides foundations for the efficient generation of genetically modified porcine iPS cells and animal models.
C1 [Park, Kyung-Mee; Hussein, Kamal Hany; Hong, Seok-Ho; Yang, Se-Ran; Woo, Heung-Myong] Kangwon Natl Univ, Stem Cell Inst KNU, Chunchon 200701, South Korea.
   [Park, Kyung-Mee; Lee, Joohyeong; Hussein, Kamal Hany; Lee, Eunsong; Woo, Heung-Myong] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, South Korea.
   [Hong, Seok-Ho; Yang, Se-Ran] Kangwon Natl Univ, Coll Med, Chunchon 200701, South Korea.
C3 Kangwon National University; Kangwon National University; Kangwon
   National University
RP Woo, HM (corresponding author), Kangwon Natl Univ, Stem Cell Inst KNU, Coll Vet Med, Chunchon 200701, South Korea.
EM woohm@kangwon.ac.kr
RI Lee, Erin/IUM-4569-2023; Hussein, Kamal/ABF-7678-2020; Lee,
   Eunsong/AAJ-3848-2020; Lee, Joohyeong/ABG-7115-2021
OI Hussein, Kamal/0000-0002-0717-7875; Lee, Eunsong/0000-0001-9654-7788;
   Lee, Joohyeong/0000-0001-7233-6409
FU Rural Development Administration, Republic of Korea [PJ0110022015]
FX This work was carried out with the support of "Cooperative Research
   Program for Agriculture Science & Technology Development (Project No.
   PJ0110022015)" Rural Development Administration, Republic of Korea
CR Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9
   Castiglioni V, 2012, NEUROBIOL DIS, V46, P30, DOI 10.1016/j.nbd.2011.12.032
   Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778
   Ebert AD, 2012, J CARDIOVASC PHARM, V60, P408, DOI 10.1097/FJC.0b013e318247f642
   Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938
   Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106
   Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014
   Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176
   Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008
   Jung SK, 2014, J VET SCI, V15, P519, DOI 10.4142/jvs.2014.15.4.519
   Kim J, 2014, MOL MED REP, V10, P329, DOI 10.3892/mmr.2014.2217
   Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372
   Lee J, 2014, THERIOGENOLOGY, V81, P974, DOI 10.1016/j.theriogenology.2014.01.022
   Liu YB, 2013, CELL REPROGRAM, V15, P107, DOI 10.1089/cell.2012.0062
   Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019
   Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481
   Park KM, 2013, VET RES COMMUN, V37, P293, DOI 10.1007/s11259-013-9574-x
   Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753
   Saito Shigeo, 2004, Hum Cell, V17, P107
   Sato K, 2001, Hum Cell, V14, P301
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt
   Vassiliev I, 2013, METHODS MOL BIOL, V1074, P85, DOI 10.1007/978-1-62703-628-3_7
   Webb S, 2009, NAT REV DRUG DISCOV, V8, P263, DOI 10.1038/nrd2867
   West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458
   Wolf E, 2014, TRANSGENIC RES, V23, P27, DOI 10.1007/s11248-013-9755-y
   Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003
   Zhou SY, 2010, CELL RES, V20, P850, DOI 10.1038/cr.2010.78
NR 28
TC 2
Z9 2
U1 0
U2 7
PU JAPAN SOC VET SCI
PI TOKYO
PA UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN
SN 0916-7250
EI 1347-7439
J9 J VET MED SCI
JI J. Vet. Med. Sci.
PD APR
PY 2016
VL 78
IS 4
BP 709
EP 713
DI 10.1292/jvms.15-0363
PG 5
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA DL0QA
UT WOS:000375336400028
PM 26725870
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Wallace, H
   Miller, T
   Angus, W
   Stott, M
AF Wallace, Hilary
   Miller, Thomas
   Angus, William
   Stott, Matthew
TI Intra-operative anaesthetic management of older patients undergoing
   liver surgery
SO EJSO
LA English
DT Article; Early Access
DE Anaesthesia; Liver surgery; Elderly; Frail; Review
ID CENTRAL VENOUS-PRESSURE; BLOOD-LOSS; EPIDURAL ANALGESIA; TRANSFUSION
   REQUIREMENTS; POSTOPERATIVE DELIRIUM; PERIOPERATIVE CARE; ORGAN
   DYSFUNCTION; SURGICAL OUTCOMES; HEPATIC RESECTION; ENHANCED RECOVERY
AB Older patients represent a growing proportion of the general surgical caseload. This includes those undergoing liver resection, with figures rising faster than the rate of population ageing. The physiology of ageing leads to changes in all body systems which may render the provision of safe anaesthesia more challenging than in younger patients. Anaesthesia for liver surgery has specific principles, largely aimed at reducing venous bleeding from the liver, and those related to complex major surgery. This review explores the principles of anaesthesia for liver resection and describes how they may require modification in the older patient. The traditional approach of low central venous pressure anaesthesia in order to reduce bleeding may need to be altered in the presence of a cardiovascular system less able to tolerate hypotension and hypoperfusion. These changes in physiology should also lower the threshold for invasive monitoring. The provision of effective analgesia perioperatively should be tailored to minimise the surgical stress response and opiate use. Careful consideration of general principles of intra-operative care for older patients, such as positioning, drug dosing, avoidance of excessively deep anaesthesia, and maintenance of normothermia are also important given the prolonged, complex nature of liver surgery. This individualised approach, with careful attention to changes in physiology allows liver resections to be undertaken in older patients without increases in mortality.
   (c) 2020 Elsevier Ltd, BASO The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
C1 [Wallace, Hilary; Miller, Thomas; Stott, Matthew] Aintree Univ Hosp NHS Fdn Trust, Lower Lane, Liverpool L9 7AL, Merseyside, England.
   [Angus, William] Hlth Educ North West, 3 Piccadilly Pl, Manchester M1 3BN, Lancs, England.
C3 Aintree University Hospitals NHS Foundation Trust
RP Wallace, H (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Lower Lane, Liverpool L9 7AL, Merseyside, England.
EM hilary.wallace@iverpoolft.nhs.uk
OI Miller, Thomas/0000-0002-8617-257X
CR AAGBI, 2010, PREOPERATIVE ASSESSM
   Agnew N, 2010, BJA EDUC, V10, P33, DOI 10.1093/bjaceaccp/mkq001
   Amrock L, 2008, CURR OPIN ANESTHESIO, V27, P330
   Andert A, 2016, INT J SURG, V28, P126, DOI 10.1016/j.ijsu.2016.02.060
   Ashton-Clearly D., 2014, KEY CLIN TOPICS ANAE, P106
   Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1
   Belghiti J, 1996, ANN SURG, V224, P155, DOI 10.1097/00000658-199608000-00007
   Bell R, 2015, ANZ J SURG, V85, P16, DOI 10.1111/ans.12683
   Bennett S, 2017, HPB, V19, P321, DOI 10.1016/j.hpb.2016.12.008
   Campbell NL, 2010, NEUROLOGY, V75, P152, DOI 10.1212/WNL.0b013e3181e7f2ab
   Carli F, 1997, ANESTHESIOLOGY, V86, P1033, DOI 10.1097/00000542-199705000-00005
   Carli F, 2011, REGION ANESTH PAIN M, V36, P63, DOI 10.1097/AAP.0b013e31820307f7
   Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185
   Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba
   Chan SK, 2010, ANAESTHESIA, V65, P1180, DOI 10.1111/j.1365-2044.2010.06530.x
   Checketts MR, 2016, ANAESTHESIA, V71, P85, DOI 10.1111/anae.13316
   Chen JH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006460
   Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9
   De Pietri L, 2006, ANESTH ANALG, V102, P1157, DOI 10.1213/01.ane.0000198567.85040.ce
   Decailliot F, 2001, BRIT J ANAESTH, V87, P493, DOI 10.1093/bja/87.3.493
   DELVA E, 1987, ANESTH ANALG, V66, P864
   Dunki-Jacobs EM, 2014, ANN SURG ONCOL, V21, P473, DOI 10.1245/s10434-013-3323-9
   Dunne DFJ, 2014, J SURG ONCOL, V110, P197, DOI 10.1002/jso.23616
   Egan C, 2011, ANESTH ANALG, V113, P1076, DOI 10.1213/ANE.0b013e31822b896d
   Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Futier E, 2017, JAMA-J AM MED ASSOC, V318, P1346, DOI 10.1001/jama.2017.14172
   Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004
   Griffiths R, 2014, ANAESTHESIA, V69, P81, DOI 10.1111/anae.12524
   Halaszynski T, 2013, OCHSNER J, V13, P228
   Hirsch J, 2015, BRIT J ANAESTH, V115, P418, DOI 10.1093/bja/aeu458
   Hofer RE, 2020, TRANSPLANT DIRECT, V6, DOI 10.1097/TXD.0000000000000972
   Hughes MJ, 2015, BRIT J SURG, V102, P1619, DOI 10.1002/bjs.9949
   Jones RM, 1998, BRIT J SURG, V85, P1058
   Kambakamba P, 2015, BRIT J SURG, V102, P805, DOI 10.1002/bjs.9810
   Karanicolas PJ, 2016, HPB, V18, P991, DOI 10.1016/j.hpb.2016.09.005
   Kasivisvanathan R, 2015, HPB, V17, P637, DOI 10.1111/hpb.12420
   Kasivisvanathan R, 2014, HPB, V16, P768, DOI 10.1111/hpb.12222
   Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901
   KURZ A, 1995, J CLIN ANESTH, V7, P359, DOI 10.1016/0952-8180(95)00028-G
   Leslie K, 2010, ANESTH ANALG, V110, P816, DOI 10.1213/ANE.0b013e3181c3bfb2
   Li Z, 2014, WORLD J GASTROENTERO, V20, P303, DOI 10.3748/wjg.v20.i1.303
   Liu SS, 2006, J AM COLL SURGEONS, V203, P914, DOI 10.1016/j.jamcollsurg.2006.08.007
   Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028
   Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331
   McNamara H, 2019, ANAESTHESIA, V74, P984, DOI 10.1111/anae.14628
   McSwain JR., 2015, World J Anesthesiol, V4, P58, DOI [DOI 10.5313/WJA.V4.I3.58, 10.5313/wja. v4. i3.58]
   Melloul E, 2016, WORLD J SURG, V40, P2425, DOI 10.1007/s00268-016-3700-1
   Murray P, 2007, BRIT J ANAESTH, V99, P809, DOI 10.1093/bja/aem305
   Newfield P., 2001, F1000 MED REP, V9, P14
   Nimmo SM, 2004, CONTIN ED ANAESTH CR, V4, P44, DOI [DOI 10.1093/BJACEACCP/MKH014, 10.1093/bjaceaccp /mkh014]
   Older P, 1999, CHEST, V116, P355, DOI 10.1378/chest.116.2.355
   Pandit JJ, 2014, BRIT J ANAESTH, V113, P549, DOI 10.1093/bja/aeu313
   Park WY, 2001, ANN SURG, V234, P560
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52
   Renna M, 2003, ANESTH ANALG, V96, P1380, DOI 10.1213/01.ANE.0000059223.78879.0F
   Reynolds L, 2008, BEST PRACT RES-CLIN, V22, P645, DOI 10.1016/j.bpa.2008.07.005
   Robinson TN, 2009, ANN SURG, V250, P449, DOI 10.1097/SLA.0b013e3181b45598
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007
   Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3
   Schug SA, 2015, APMSE WORKING GROUP, Vfourth
   Shanks AM, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0546-0
   Tohme S, 2016, HPB, V18, P255, DOI 10.1016/j.hpb.2015.09.002
   Tufo A, 2019, EJSO-EUR J SURG ONC, V45, P635, DOI 10.1016/j.ejso.2018.11.024
   Uchino S, 2006, CRIT CARE, V10, DOI 10.1186/cc5126
   Whiting P, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19580
   Wiggans MG, 2013, PERIOPER MED-LONDON, V2, DOI 10.1186/2047-0525-2-21
   Wijeysundera DN, 2020, BRIT J ANAESTH, V124, P261, DOI 10.1016/j.bja.2019.11.025
   Wilson RJT, 2010, BRIT J ANAESTH, V105, P297, DOI 10.1093/bja/aeq128
   World Health Organization, 2010, DEF OLD ELD PERS
   Wu CC, 2006, ANN SURG, V243, P173, DOI 10.1097/01.sla.0000197561.70972.73
   Yokoyama M, 2001, ANESTH ANALG, V92, P470, DOI 10.1213/00000539-200102000-00036
   Yu L, 2020, BMC SURG, V20, DOI 10.1186/s12893-020-0689-z
NR 75
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0748-7983
EI 1532-2157
J9 EJSO-EUR J SURG ONC
JI EJSO
PD 2021 MAR
PY 2021
VL 47
IS 3
SI SI
BP 545
EP 550
DI 10.1016/j.ejso.2020.11.004
EA FEB 2021
PN A
PG 6
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA RB5YQ
UT WOS:000632187300001
PM 33218699
DA 2024-02-19
ER

PT J
AU Wang, JC
   Huang, X
   Zheng, DS
   Li, QL
   Mei, M
   Bao, SL
AF Wang, Jincheng
   Huang, Xiang
   Zheng, Daoshan
   Li, Qiuling
   Mei, Mei
   Bao, Shilai
TI PRMT5 determines the pattern of polyploidization and prevents liver from
   cirrhosis and carcinogenesis
SO JOURNAL OF GENETICS AND GENOMICS
LA English
DT Article
DE Pathological polyploidizaion; Hepatocellular carcinoma; Cirrhosis;
   PRMT5; Aging
ID HISTONE H4R3; HEPATOCELLULAR-CARCINOMA; CELL-DIVISION; HEPATOCYTES;
   PLOIDY; MODELS; GENE; TUMORIGENESIS; DIMETHYLATION; TRANSCRIPTION
AB Human hepatocellular carcinoma (HCC) occurs almost exclusively in cirrhotic livers. Here, we report that hepatic loss of protein arginine methyltransferase 5 (PRMT5) in mice is sufficient to cause cirrhosis and HCC in a clinically relevant way. Furthermore, pathological polyploidization induced by hepatic loss of PRMT5 promotes liver cirrhosis and hepatic tumorigenesis in aged liver. The loss of PRMT5 leads to hyperaccumulation of P21 and endoreplication-dependent formation of pathological mono-nuclear polyploid hepatocytes. PRMT5 and symmetric dimethylation at histone H4 arginine 3 (H4R3me2s) directly associate with chromatin of P21 to suppress its transcription. More importantly, loss of P21 rescues the pathological mono-nuclear polyploidy and prevents PRMT5-deficiency-induced liver cirrhosis and HCC. Thus, our results indicate that PRMT5-mediated symmetric dimethylation at histone H4 arginine 3 (H4R3me2s) is crucial for preventing pathological polyploidization, liver cirrhosis and tumorigenesis in mouse liver. Copyright (c) 2023, The Authors. Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Wang, Jincheng; Huang, Xiang; Zheng, Daoshan; Li, Qiuling; Mei, Mei; Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Huang, Xiang; Zheng, Daoshan; Bao, Shilai] Univ Chinese Acad Sci, Sch Life Sci, Beijing 100049, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Genetics & Developmental
   Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy
   of Sciences, CAS
RP Wang, JC; Bao, SL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Bao, SL (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Beijing 100049, Peoples R China.
EM wangjincheng@genetics.ac.cn; slbao@genetics.ac.cn
OI Mei, Mei/0000-0001-6298-690X
FU National Key R&D Program of China [2022YFC3600202, 2018YFA0800902];
   National Natural Science Foundation of China [31730051, 32170834]
FX This work was financially supported by grants from the National Key R&D
   Program of China (2022YFC3600202, 2018YFA0800902) , and the National
   Natural Science Foundation of China (31730051, 32170834) .
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013
   Bolondi L, 2011, INTERN EMERG MED, V6, P93, DOI 10.1007/s11739-011-0682-8
   Brandão Daniel Ferracioli, 2006, Acta Cir. Bras., V21, P54, DOI 10.1590/S0102-86502006000700013
   Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595
   CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0
   Ding ZH, 2020, ANN HEPATOL, V19, P269, DOI 10.1016/j.aohep.2020.01.002
   Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109
   Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003
   Fan HJ, 2014, PLANT J, V77, P209, DOI 10.1111/tpj.12380
   Forner A, 2012, LANCET ONCOL, V13, P750, DOI 10.1016/S1470-2045(12)70271-1
   Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217
   Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957
   Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035
   Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7
   Gurung B, 2013, EPIGENOMICS-UK, V5, P469, DOI 10.2217/epi.13.47
   He HC, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04129-1
   Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x
   Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233
   Li QL, 2016, J GENET GENOMICS, V43, P187, DOI 10.1016/j.jgg.2016.02.007
   Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749
   Matsumoto T, 2021, CELL MOL GASTROENTER, V11, P1347, DOI 10.1016/j.jcmgh.2020.12.011
   Mei M, 2019, CLIN CANCER RES, V25, P2633, DOI 10.1158/1078-0432.CCR-18-2342
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   MORSELT AFW, 1976, BEITR PATHOL, V159, P195
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008
   Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Palmes D, 2004, BIOMATERIALS, V25, P1601, DOI 10.1016/S0142-9612(03)00508-8
   Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002
   Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Quinton RJ, 2021, NATURE, V590, P492, DOI 10.1038/s41586-020-03133-3
   Reiberger T, 2015, NAT PROTOC, V10, P1264, DOI 10.1038/nprot.2015.080
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tanikawa K, 1993, Nihon Ronen Igakkai Zasshi, V30, P1026
   TAUCHI H, 1994, ARCH GERONTOL GERIAT, V19, P135, DOI 10.1016/0167-4943(94)90035-3
   Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373
   Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647
   Wang YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11031
   Watkins TBK, 2020, NATURE, V587, P126, DOI 10.1038/s41586-020-2698-6
   Yang H, 2016, ONCOTARGET, V7, P72131, DOI 10.18632/oncotarget.12351
   Zhang SH, 2017, CANCER CELL, V31, P669, DOI 10.1016/j.ccell.2017.04.004
   Zhang SY, 2018, DEV CELL, V44, P447, DOI 10.1016/j.devcel.2018.01.010
   Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140
   Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356
   Zhu K, 2020, CARCINOGENESIS, V41, P130, DOI 10.1093/carcin/bgz065
   Zlotorynski E, 2016, NAT REV CANCER, V16, DOI 10.1038/nrc.2016.78
   Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938
NR 54
TC 0
Z9 0
U1 1
U2 1
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1673-8527
EI 1873-5533
J9 J GENET GENOMICS
JI J. Genet. Genomics
PD FEB
PY 2023
VL 50
IS 2
BP 87
EP 98
DI 10.1016/j.jgg.2022.04.008
EA FEB 2023
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA G6XA8
UT WOS:000990553300001
PM 35500745
OA hybrid
DA 2024-02-19
ER

PT J
AU Peyrou, M
   Bourgoin, L
   Poher, AL
   Altirriba, J
   Maeder, C
   Caillon, A
   Fournier, M
   Montet, X
   Rohner-Jeanrenaud, F
   Foti, M
AF Peyrou, Marion
   Bourgoin, Lucie
   Poher, Anne-Laure
   Altirriba, Jordi
   Maeder, Christine
   Caillon, Aurelie
   Fournier, Margot
   Montet, Xavier
   Rohner-Jeanrenaud, Franoise
   Foti, Michelangelo
TI Hepatic <i>PTEN</i> deficiency improves muscle insulin sensitivity and
   decreases adiposity in mice
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Steatosis; Beige adipocyte; Glucose tolerance; Gluconeogenesis; Organ
   crosstalk; FGF21
ID FATTY LIVER; TENSIN HOMOLOG; DOWN-REGULATION; FGF21; HYPERSENSITIVITY;
   PHOSPHATASE; METABOLISM; RESISTANCE; STEATOHEPATITIS; TRIGGERS
AB Background & Aims: PTEN is a dual lipid/protein phosphatase, downregulated in steatotic livers with obesity or HCV infection. Liver-specific PTEN knockout (LPTEN KO) mice develop steatosis, inflammation/fibrosis and hepatocellular carcinoma with aging, but surprisingly also enhanced glucose tolerance. This study aimed at understanding the mechanisms by which hepatic PTEN deficiency improves glucose tolerance, while promoting fatty liver diseases.
   Methods: Control and LPTEN KO mice underwent glucose/pyruvate tolerance tests and euglycemic-hyperinsulinemic clamps. Body fat distribution was assessed by EchoMRI, CT-scan and dissection analyses. Primary/cultured hepatocytes and insulin-sensitive tissues were analysed ex vivo.
   Results: PTEN deficiency in hepatocytes led to steatosis through increased fatty acid (FA) uptake and de novo lipogenesis. Although LPTEN KO mice exhibited hepatic steatosis, they displayed increased skeletal muscle insulin sensitivity and glucose uptake, as assessed by euglycemic-hyperinsulinemic clamps. Surprisingly, white adipose tissue (WAT) depots were also drastically reduced. Analyses of key enzymes involved in lipid metabolism further indicated that FA synthesis/esterification was decreased in WAT. In addition, Ucp1 expression and multilocular lipid droplet structures were observed in this tissue, indicating the presence of beige adipocytes. Consistent with a liver to muscle/adipocyte crosstalk, the expression of liver-derived circulating factors, known to impact on muscle insulin sensitivity and WAT homeostasis (e.g. FGF21), was modulated in LPTEN KO mice.
   Conclusions: Although steatosis develops in LPTEN KO mice, PTEN deficiency in hepatocytes promotes a crosstalk between liver and muscle, as well as adipose tissue, resulting in enhanced insulin sensitivity, improved glucose tolerance and decreased adiposity. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Peyrou, Marion; Bourgoin, Lucie; Maeder, Christine; Fournier, Margot; Foti, Michelangelo] Univ Geneva, Dept Cellular Physiol & Metab, Fac Med, CH-1211 Geneva 4, Switzerland.
   [Poher, Anne-Laure; Altirriba, Jordi; Caillon, Aurelie; Rohner-Jeanrenaud, Franoise] Univ Geneva, Dept Internal Med Specialties, Fac Med, Div Endocrinol Diabetol Hypertens & Nutr, CH-1211 Geneva 4, Switzerland.
   [Montet, Xavier] Univ Geneva, Dept Radiol, Fac Med, CH-1211 Geneva 4, Switzerland.
C3 University of Geneva; University of Geneva; University of Geneva
RP Foti, M (corresponding author), CMU, Dept Cellular Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.
EM Michelangelo.foti@unige.ch
RI Peyrou, Marion/A-7190-2015; Montet, Xavier/GMW-9003-2022
OI Peyrou, Marion/0000-0002-1210-6094; Montet, Xavier/0000-0003-2442-5866;
   Foti, Michelangelo/0000-0001-7199-4135; Poher,
   Anne-Laure/0000-0002-6657-4336
FU Swiss National Science Foundation [310030-152618, CRSII3-141798,
   31003A_134919/1]; EFSD Research Programme in Diabetes and Cancer; Swiss
   Cancer League [KFS-02502-08-2009]; Fondation Romande pour la Recherche
   sur le Diabete; Desiree and Niels Yde Foundation; EU
   [Health-F2-2011-278373]; Swiss National Science Foundation (SNF)
   [31003A_134919, 310030_152618, CRSII3_141798] Funding Source: Swiss
   National Science Foundation (SNF)
FX This work was supported by the Swiss National Science Foundation (grant
   No310030-152618 and NoCRSII3-141798 to M. Foti and grant 31003A_134919/1
   to F. Rohner-Jeanrenaud), the EFSD Research Programme in Diabetes and
   Cancer, The Swiss Cancer League (KFS-02502-08-2009), the Fondation
   Romande pour la Recherche sur le Diabete, the Desiree and Niels Yde
   Foundation to M. Foti and the EU FP7 project DIABAT
   (Health-F2-2011-278373) to F. Rohner-Jeanrenaud.
CR Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204
   Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Clément S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340
   Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030
   Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513
   Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021
   Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005
   Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x
   Luo Yongde, 2013, Front Endocrinol (Lausanne), V4, P194, DOI 10.3389/fendo.2013.00194
   Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375
   Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177
   Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669
   Mithieux G, 2006, COMP BIOCHEM PHYS B, V143, P195, DOI 10.1016/j.cbpb.2005.11.007
   Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   Peyrou M, 2010, DIGEST DIS, V28, P236, DOI 10.1159/000282095
   Qiu W, 2008, HEPATOLOGY, V48, P1799, DOI 10.1002/hep.22565
   Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013
   Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271
   Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042
   Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258
   Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100
   Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007
   VETTOR R, 1994, AM J PHYSIOL-REG I, V267, pR1503, DOI 10.1152/ajpregu.1994.267.6.R1503
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005
   Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x
NR 32
TC 50
Z9 51
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD FEB
PY 2015
VL 62
IS 2
BP 421
EP 429
DI 10.1016/j.jhep.2014.09.012
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AZ2CZ
UT WOS:000348043600025
PM 25234947
OA Green Published
DA 2024-02-19
ER

PT J
AU Rakov, H
   De Angelis, M
   Renko, K
   Hönes, GS
   Zwanziger, D
   Moeller, LC
   Schramm, KW
   Führer, D
AF Rakov, Helena
   De Angelis, Meri
   Renko, Kostja
   Hoenes, Georg Sebastian
   Zwanziger, Denise
   Moeller, Lars Christian
   Schramm, Karl-Werner
   Fuehrer, Dagmar
TI Aging Is Associated with Low Thyroid State and Organ-Specific
   Sensitivity to Thyroxine
SO THYROID
LA English
DT Article; Early Access
DE aging; mice; thyroid hormones; thyroid gland; HPT-axis
ID SUBCLINICAL HYPOTHYROIDISM; CARDIOVASCULAR EVENTS; HYPERTHYROIDISM; AGE;
   GUIDELINES; MORTALITY; HORMONES; GLAND; OLD; SEX
AB Background: Serum thyroid state in older adults correlates with extended longevity. We hypothesized that age impacts not only systemic but also organ-specific thyroid state and response to thyroxine (T4). Methods: Young (3 months) and old (23 months) male mice were analyzed at baseline and after acute T4 challenge. Age effects on circulating thyrotropin (TSH) and thyroid hormone (TH) concentrations, transcript expression in the pituitary and thyroid were compared with organ-specific responses characterized by hepatic and cardiac content of TH and TH metabolites and expression of TH-target genes, as well as hepatic deiodinase 1 activity. Results: Circulating TH concentrations and hepatic and cardiac TH content were lower in old versus young mice. After injection with T4, conversion of T4 to triiodothyronine was decreased in old mice while TH transport in liver and heart was not affected. Organ-specific TH response was augmented in old mice in liver but not heart, indicating age- and tissue-specific sensitivity to TH. A compensatory increase of thyroid stimulating hormone subunit beta expression in the pituitary and increased serum TSH concentrations, but reduced expression of thyroid differentiation markers were found in old mice. Conclusions: We suggest that a reduced activity of the aged thyroid is responsible for the systemic low TH state in old mice. Further, divergent TH metabolism and tissue response in liver and heart occur after T4 treatment in an aged organism. These rodent data are in agreement with a much narrower window for T4 substitution in the older adults to avoid overtreatment.
C1 [Rakov, Helena; Hoenes, Georg Sebastian; Zwanziger, Denise; Moeller, Lars Christian; Fuehrer, Dagmar] Univ Duisburg Essen, Univ Hosp Essen, Dept Endocrinol Diabet & Metab, Essen, Germany.
   [Zwanziger, Denise] Univ Duisburg Essen, Univ Hosp Essen, Dept Endocrinol Diabet & Metab, Clin Chem,Div Lab Res, Essen, Germany.
   [De Angelis, Meri; Schramm, Karl-Werner] Helmholtz Zentrum Munchen German Res Ctr Environm, Mol EXpos, Neuherberg, Germany.
   [Renko, Kostja] Charite Univ Med Berlin, Inst Expt Endokrinol, Berlin, Germany.
   [Renko, Kostja] Free Univ Berlin, Berlin, Germany.
   [Renko, Kostja] Humboldt Univ, Berlin, Germany.
   [Renko, Kostja] Berlin Inst Hlth, Berlin, Germany.
   [Schramm, Karl-Werner] Tech Univ Munich, Wissensch Zentrum Weihenstephan Ernahrung Landnut, Dept Biowissensch, Freising Weihenstephan, Germany.
C3 University of Duisburg Essen; University of Duisburg Essen; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin;
   Humboldt University of Berlin; Berlin Institute of Health; Technical
   University of Munich
RP Führer, D (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Endocrinol Diabet & Metab, Div Lab Res, Hufelandstr 55, D-45122 Essen, Germany.
EM dagmar.fuehrer@uk-essen.de
RI Schramm, Karl-Werner/C-7438-2013
OI Schramm, Karl-Werner/0000-0002-8945-4062; Kerp,
   Helena/0000-0002-6036-0230
FU DFG [FU 356/7-2, MO 1018/2-2, ZW 221-2/1, SPP 1629]
FX This work was funded by DFG FU 356/7-2 to D.F., MO 1018/2-2 to L.C.M.,
   and ZW 221-2/1 to D.Z. in the framework of SPP 1629 THYROID TRANS ACT.
CR Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495
   Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   De Angelis M, 2016, J CHROMATOGR B, V1033, P413, DOI 10.1016/j.jchromb.2016.08.037
   DONDA A, 1987, MOL CELL ENDOCRINOL, V54, P29, DOI 10.1016/0303-7207(87)90136-5
   DONDA A, 1989, NEUROENDOCRINOLOGY, V49, P389, DOI 10.1159/000125143
   Engels K, 2019, J GERONTOL A-BIOL, V74, P1162, DOI 10.1093/gerona/glz040
   Engels K, 2016, ENDOCRINE, V54, P47, DOI 10.1007/s12020-016-1020-8
   Fontes R, 2013, THYROID RES, V6, DOI 10.1186/1756-6614-6-13
   Gesing A, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-16
   Goichot B, 2016, CLIN ENDOCRINOL, V84, P445, DOI 10.1111/cen.12816
   Grossman A, 2018, EUR J INTERN MED, V50, P65, DOI 10.1016/j.ejim.2017.11.010
   Kim MI, 2017, ENDOTEXT, P2000
   Lee J, 2016, J PATHOL TRANSL MED, V50, P426, DOI 10.4132/jptm.2016.07.19
   Li ZM, 2018, J CHROMATOGR A, V1534, P85, DOI 10.1016/j.chroma.2017.12.048
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rakov H, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0159-1
   Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159
   Renko K, 2012, ENDOCRINOLOGY, V153, P2506, DOI 10.1210/en.2011-1863
   REYMOND F, 1992, ACTA ENDOCRINOL-COP, V126, P55, DOI 10.1530/acta.0.1260055
   Ross DS, 2016, THYROID, V26, P1343, DOI 10.1089/thy.2016.0229
   Ruggeri RM, 2017, EUR J ENDOCRINOL, V177, pR199, DOI 10.1530/EJE-17-0321
   Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184
   Stott DJ, 2017, NEW ENGL J MED, V376, P2534, DOI 10.1056/NEJMoa1603825
   Suzuki S, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-1
   Visser WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149941
   Waring AC, 2012, J CLIN ENDOCR METAB, V97, P3944, DOI 10.1210/jc.2012-2481
NR 27
TC 14
Z9 14
U1 0
U2 13
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1050-7256
EI 1557-9077
J9 THYROID
JI Thyroid
PD 2019 DEC 1
PY 2019
VL 29
IS 12
BP 1723
EP 1733
DI 10.1089/thy.2018.0377
EA SEP 2019
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA JX2QQ
UT WOS:000488066400001
PM 31441387
DA 2024-02-19
ER

PT J
AU Jung, K
   Henke, W
AF Jung, K
   Henke, W
TI Developmental changes of antioxidant enzymes in kidney and liver from
   rats
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE superoxide dismutase; catalase; glutathione peroxidase;
   glutathione-S-transferase; glutathione reductase; glutathione; liver;
   kidney; free radicals; development
ID GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; REDUCTASE ACTIVITIES;
   LIPID-PEROXIDATION; AGING RATS; AGE; SYSTEMS; PROTEIN; MOUSE
AB The five principal antioxidant enzymes superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase in the kidney and liver, and the total hepatic glutathione were determined in rats of different ages (1, 2, 3, 6, and 12 months). Variance analysis proved the effect of age on the measured enzymes in the respective organ with the exception of glutathione S-transferase. The behavior of the enzymes was not uniform, and there were both increased and decreased changes in the two organs. A clear correlation between cellular antioxidative capacity and the age-specific processes of growing or aging could not be seen. A far more complicated network of interactions has to be assumed.
RP Jung, K (corresponding author), HUMBOLDT UNIV BERLIN,HOSP CHARITE,DEPT UROL,RES UNIT,SCHUMANNSTR 20-21,D-10098 BERLIN,GERMANY.
RI Jung, Klaus/Z-2122-2018
OI Jung, Klaus/0000-0001-9797-5362
CR [Anonymous], 1983, METHODS ENZYMATIC AN
   ARTUR Y, 1992, FREE RADICALS AGING, P359
   BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   DOUMAS BT, 1981, CLIN CHEM, V27, P1642
   FEINFELD DA, 1986, J CLIN CHEM CLIN BIO, V25, P529
   Goldberg D.M., 1983, METHOD ENZYMAT AN, VIII, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4
   GUO ZY, 1993, GROWTH DEVELOP AGING, V57, P85
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   JUNG K, 1993, ENZYME PROTEIN, V47, P149, DOI 10.1159/000468670
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   RICEEVANS CA, 1993, FREE RADICAL BIO MED, V15, P77, DOI 10.1016/0891-5849(93)90127-G
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   STOHS SJ, 1982, BIOCHEM PHARMACOL, V31, P2113, DOI 10.1016/0006-2952(82)90429-4
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
NR 27
TC 57
Z9 65
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PY 1996
VL 20
IS 4
BP 613
EP 617
DI 10.1016/0891-5849(95)02090-X
PG 5
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA UA293
UT WOS:A1996UA29300015
PM 8904304
DA 2024-02-19
ER

PT J
AU Brodsky, VY
AF Brodsky, V. Ya.
TI Cell-Cell Interaction Disorders Associated with Senescence Can Be
   Repaired
SO RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE cell-cell communication; senescence; protein synthesis; gangliosides;
   catecholamines; melatonin; glutamic acid; regulatory peptides
ID PROTEIN-SYNTHESIS KINETICS; GLUTAMIC-ACID; HEPATOCYTES; GANGLIOSIDES;
   SERUM
AB This minireview summarizes the data concerning the possibility of compensating for one of the senescence disorders. In hepatocyte cultures of old rats, compared to young ones, the ultradian protein synthesis rhythms were reduced in amplitudes. Like other ultradian rhythms detected in vitro, protein synthesis rhythm is a marker of cell population synchronization through direct intercellular interactions. Amplitudes of the rhythm characterize the intensity of interactions. The interactions were enhanced after adding previously identified signaling factors of cell-cell communication to the culture medium: gangliosides, phenylephrine, melatonin, glutamic acid, and some regulatory peptides. The final three factors were also introduced in vivo. The effect lasted for 2-3 days. The addition of the blood serum of young rats to the culture medium increased the amplitudes of protein synthesis rhythm as well. The blood serum of old rats did not change the rhythm amplitudes. However, the blood serum of old rats enriched with gangliosides enhanced the amplitudes as effective as a young rat serum. These data, as well as some literature data, allow for recommending the use of signaling factors of cell-cell communication for improving the condition of elderly people.
C1 [Brodsky, V. Ya.] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow 119334, Russia.
C3 Russian Academy of Sciences; Koltzov Institute of Developmental Biology
   of the Russian Academy of Sciences
RP Brodsky, VY (corresponding author), Russian Acad Sci, Koltzov Inst Dev Biol, Moscow 119334, Russia.
EM Brodsky.idb@bk.ru
CR BERGELSON LD, 1995, IMMUNOL TODAY, V16, P483, DOI 10.1016/0167-5699(95)80032-8
   Brodsky VY, 2018, BIOCHEMISTRY-MOSCOW+, V83, P294, DOI 10.1134/S0006297918030094
   Brodsky VY, 2017, BIOCHEMISTRY-MOSCOW+, V82, P957, DOI 10.1134/S0006297917080119
   Brodsky VY, 2010, CELL BIOL INT, V34, P1199, DOI 10.1042/CBI20100036
   Brodsky VY, 2000, CELL BIOL INT, V24, P211, DOI 10.1006/cbir.1999.0505
   Brodsky VY, 2006, BIOL REV, V81, P143, DOI 10.1017/S1464793105006937
   Brodsky VY, 2004, CELL BIOL INT, V28, P311, DOI 10.1016/j.cellbi.2004.02.001
   Gilbert D. A., 2008, P105, DOI 10.1007/978-1-4020-8352-5_4
   Hammond K.D., 1998, BIOCH PHYSL, P75
   Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005
   Lloyd D, 1998, ADV MICROB PHYSIOL, V39, P291
   Lloyd D, 2008, J BIOSCIENCES, V33, P9, DOI 10.1007/s12038-008-0017-8
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   Murray DB, 1999, MICROBIOL-SGM, V145, P2739, DOI 10.1099/00221287-145-10-2739
   NAKAMURA Y, 1988, J BIOCHEM-TOKYO, V103, P396, DOI 10.1093/oxfordjournals.jbchem.a122281
   Oleskin A. V., 2009, VESTN ROS AKAD NAUK+, V79, P431
   Ozkok Elif, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P337
   PROZOROVSKAYA M P, 1983, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V69, P1244
   Rattan S.I.S., 2009, PROTEIN METABOLISM H
   SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x
   Strakhovskaia M G, 1993, Mikrobiologiia, V62, P46
   Tsavkelova E A, 2000, Dokl Biochem, V372, P115
NR 22
TC 1
Z9 1
U1 0
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1062-3604
EI 1608-3326
J9 RUSS J DEV BIOL+
JI Russ. J. Dev. Biol.
PD JUL
PY 2020
VL 51
IS 4
BP 261
EP 266
DI 10.1134/S1062360420040025
PG 6
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA NI2ID
UT WOS:000565178300006
DA 2024-02-19
ER

PT J
AU Giavarotti, L
   D'Almeida, V
   Giavarotti, KAS
   Azzalis, LA
   Rodrigues, L
   Cravero, AAM
   Videla, LA
   Koch, OR
   Junqueira, VBC
AF Giavarotti, L
   D'Almeida, V
   Giavarotti, KAS
   Azzalis, LA
   Rodrigues, L
   Cravero, AAM
   Videla, LA
   Koch, OR
   Junqueira, VBC
TI Liver necrosis induced by acute intraperitoneal ethanol administration
   in aged rats
SO FREE RADICAL RESEARCH
LA English
DT Article
DE aging; alcoholism; liver injury; oxidative stress
ID LIPID-PEROXIDATION; PENTANE PRODUCTION; VITAMIN-E; GLUTATHIONE;
   INGESTION; LIPOPEROXIDATION; INTOXICATION; TOCOPHEROL; TISSUES; PLASMA
AB It is generally agreed that the deleterious pathophysiological effects of ethanol are caused, at least partially by an increase in free radical production. However, little attention has been directed to the effects of ethanol upon elderly organisms. Male Wistar rats at ages 3, 6,12,18 and 24 months were treated either with a single i.p. dose of 35% ethanol (v/v) at 3 g ethanol/kg body weight or an isovolumetric amount of 0.9% saline solution. We then assessed the plasma levels of transaminases and hepatic levels of oxidative stress-related parameters, followed by liver histological evaluation. The younger rats (3 months old) were not affected by the treatment with ethanol with respect to any of the studied parameters except for a lowering of total hepatic GSH and an increase in hepatic thiobarbituric acid reactants (TBARS) formation, while animals older than 3 months were increasingly more affected by the treatment. Acute ethanol treatment elicited the similar responses to those in the 3 months-old group, plus a decrease in the hepatic and plasma levels of beta-carotene and the plasma level of alpha-tocopherol, as well as an increase in the activity of plasma transaminases. In the 12,18 and 24 months old groups, there was increasing liver necrosis. These findings suggest that liver damage induced by acute ethanol administration in elderly rats may involve a lack of antioxidants.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Ctr Med Genet, Dept Morfol & Pediat, BR-04039032 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Dept Med, Disciplina Geriatr, BR-04039032 Sao Paulo, Brazil.
   Univ Buenos Aires, Fac Med, Dept Patol, Buenos Aires, DF, Argentina.
   Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Farmacol Mol & Clin, Santiago, Chile.
C3 Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP);
   Universidade Federal de Sao Paulo (UNIFESP); University of Buenos Aires;
   Universidad de Chile
RP Junqueira, VBC (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
RI GIAVAROTTI, LEANDRO/AAQ-5221-2021; D'Almeida, Vania/AAB-7115-2020;
   Junqueira, Virginia B C/D-1346-2014; Azzalis, Ligia Ajaime/E-7014-2012;
   D'Almeida, Vânia/B-5092-2011; Simon, Karin A/F-9023-2012
OI GIAVAROTTI, LEANDRO/0000-0003-2653-2307; D'Almeida,
   Vânia/0000-0003-0947-5312; Simon, Karin A/0000-0002-4298-6176
CR Aust SD., 1985, Handbook of methods for oxygen radical research, V1, P203
   AZZALIS LA, 1992, BIOCHEM ARCH, V8, P45
   BELL H, 1992, ALCOHOL ALCOHOLISM, V27, P39
   Beutler E., 1975, RED CELL METABOLISM, P89
   BJORNEBOE GEA, 1987, BIOCHIM BIOPHYS ACTA, V918, P236, DOI 10.1016/0005-2760(87)90226-8
   Boveris A, 1997, TOXICOL LETT, V93, P23, DOI 10.1016/S0378-4274(97)00066-0
   BUTTRISS JL, 1984, METHOD ENZYMOL, V105, P131, DOI 10.1016/S0076-6879(84)05018-7
   COMPORTI M, 1967, LAB INVEST, V16, P616
   DILUZIO NR, 1965, EXP MOL PATHOL, V4, P141, DOI 10.1016/0014-4800(65)90030-4
   DILUZIO NR, 1977, ALCOHOL LIVER, P45
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   INGELMANSUNDBERG M, 1988, BIOCHEM BIOPH RES CO, V157, P55, DOI 10.1016/S0006-291X(88)80010-X
   KAWASE T, 1989, HEPATOLOGY, V10, P815, DOI 10.1002/hep.1840100511
   KNECHT KT, 1990, MOL PHARMACOL, V38, P26
   LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4
   LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8
   LEO MA, 1993, HEPATOLOGY, V17, P977
   LIEBER CS, 1988, NEW ENGL J MED, V319, P1639
   LITOV RE, 1978, LIPIDS, V13, P305, DOI 10.1007/BF02533677
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MEYDANI M, 1991, ALCOHOL CLIN EXP RES, V15, P771, DOI 10.1111/j.1530-0277.1991.tb00598.x
   MOTCHNIK PA, 1994, METHOD ENZYMOL, V234, P269
   MULLER A, 1982, BIOCHEM J, V206, P153, DOI 10.1042/bj2060153
   NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K
   PORTA EA, 1970, EXP MOL PATHOL, V12, P104, DOI 10.1016/0014-4800(70)90078-X
   SHAW S, 1981, J LAB CLIN MED, V98, P417
   SHIGENAGA MK, 1994, NATURAL ANTIOXIDANTS, P63
   SIES H, 1979, FEBS LETT, V103, P287, DOI 10.1016/0014-5793(79)81346-0
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   VALENZUELA A, 1983, TOXICOL APPL PHARM, V70, P87, DOI 10.1016/0041-008X(83)90181-3
   VALENZUELA A, 1980, FEBS LETT, V111, P11, DOI 10.1016/0014-5793(80)80750-2
   VIDELA LA, 1983, BIOCHEM PHARMACOL, V32, P2822, DOI 10.1016/0006-2952(83)90099-0
   VIDELA LA, 1980, FEBS LETT, V111, P6, DOI 10.1016/0014-5793(80)80749-6
   VIDELA LA, 1982, LIFE SCI, V31, P2395, DOI 10.1016/0024-3205(82)90743-3
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
NR 35
TC 9
Z9 9
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1071-5762
J9 FREE RADICAL RES
JI Free Radic. Res.
PD MAR
PY 2002
VL 36
IS 3
BP 269
EP 275
DI 10.1080/10715760290019282
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 536WR
UT WOS:000174725300005
PM 12071345
DA 2024-02-19
ER

PT J
AU Kobayashi, T
   Saito, Y
   Ohtake, Y
   Maruko, A
   Yamamoto, Y
   Yamamoto, F
   Kuwahara, Y
   Fukumoto, M
   Fukumoto, M
   Ohkubo, Y
AF Kobayashi, Tomonori
   Saito, Yohei
   Ohtake, Yosuke
   Maruko, Akiko
   Yamamoto, Yumi
   Yamamoto, Fumihiko
   Kuwahara, Yoshikazu
   Fukumoto, Motoi
   Fukumoto, Manabu
   Ohkubo, Yasuhito
TI Effect of aging on norepinephrine-related proliferative response in
   primary cultured periportal and perivenous hepatocytes
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE transglutaminase; EGF
ID GROWTH-FACTOR RECEPTOR; TISSUE TRANSGLUTAMINASE; RAT-LIVER;
   DNA-SYNTHESIS; ZONAL DIFFERENCES; BINDING PROTEIN; GTP-BINDING; AGE;
   EGF; REGENERATION
AB Kobayashi T, Saito Y, Ohtake Y, Maruko A, Yamamoto Y, Yamamoto F, Kuwahara Y, Fukumoto M, Fukumoto M, Ohkubo Y. Effect of aging on norepinephrine-related proliferative response in primary cultured periportal and perivenous hepatocytes. Am J Physiol Gastrointest Liver Physiol 303: G861-G869, 2012. First published July 25, 2012; doi:10.1152/ajpgi.00081.2012.-Norepinephrine (NE) amplifies the mitogenic effect of EGF in a rat liver through the adrenergic receptor coupled with G protein, Gh alpha. Gh alpha is also known as a transglutaminase 2 (TG2), whose cross-linking activity is implicated in hepatocyte growth. Recently, we found that NE-induced amplification of EGF-induced DNA synthesis in hepatocytes obtained from perivenous regions of liver is caused by inhibiting the down-regulation of EGF receptor (EGFR) by TG2. In the present study, we investigated the effect of aging on NE-related proliferative response. Hepatocytes were obtained from the liver of 7- and 90-wk-old rats. To examine this in detail, periportal hepatocytes (PPH) and perivenous hepatocytes (PVH) were isolated using the digitonin/collagenase perfusion technique. EGF or NE receptor binding was analyzed by Scatchard analysis. Changes in NE-induced DNA synthesis, G protein activity, and TG2 activity were measured. NE slightly potentiated [I-125]EGF binding to EGFR, and EGF-induced DNA synthesis in PVH but not in PPH. [H-3]NE binding studies indicated that PVH have a greater number of receptors than PPH, and that the number of receptors in both subpopulations increased with aging. NE-induced changes in G protein activity and TG2 activity in 90-wk-old rats were slight compared with 7-wk-old rats. These results suggest that NE results in a slight recovery effect on the age-related decline in EGF-induced DNA synthesis because of incomplete switching of the function from TG2 to Gh alpha.
C1 [Saito, Yohei] Tohoku Pharmaceut Univ, Dept Radiopharm, Aoba Ku, Sendai, Miyagi 9818558, Japan.
   [Kuwahara, Yoshikazu; Fukumoto, Motoi; Fukumoto, Manabu] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.
C3 Tohoku Medical & Pharmaceutical University; Tohoku University
RP Saito, Y (corresponding author), Tohoku Pharmaceut Univ, Dept Radiopharm, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.
EM ysaito@tohoku-pharm.ac.jp
RI Fukumoto, Manabu/L-1444-2019; Yamamoto, Fumihiko/AAZ-8541-2020
OI Yamamoto, Yumi/0000-0002-5376-5096
FU Institute of Development, Aging, and Cancer, Tohoku University, Sendai,
   Miyagi, Japan; Grants-in-Aid for Scientific Research [24591821,
   24791331] Funding Source: KAKEN
FX This study was in part supported by the Institute of Development, Aging,
   and Cancer, Tohoku University, Sendai, Miyagi, Japan.
CR ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901
   Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200
   Bonelli RM, 2002, J NEUROL SCI, V203, P207, DOI 10.1016/S0022-510X(02)00292-7
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200
   CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212
   CRUISE JL, 1987, HEPATOLOGY, V7, P1189, DOI 10.1002/hep.1840070604
   Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   Hamada T, 2007, J SURG RES, V142, P170, DOI 10.1016/j.jss.2007.01.007
   HENSLER PJ, 1995, AM J PATHOL, V147, P1
   Imai K, 1998, AM J PHYSIOL-GASTR L, V275, pG1394, DOI 10.1152/ajpgi.1998.275.6.G1394
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Jin W, 2010, J RECEPT SIG TRANSD, V30, P24, DOI 10.3109/10799890903358206
   Kim JH, 2001, ANN NY ACAD SCI, V928, P65
   Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945
   Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024
   Li YF, 2010, AGING CLIN EXP RES, V22, P123, DOI 10.1007/BF03324784
   Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004
   Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105
   Maruko A, 2006, CELL PROLIFERAT, V39, P183, DOI 10.1111/j.1365-2184.2006.00379.x
   Maruko A, 2009, CELL PROLIFERAT, V42, P647, DOI 10.1111/j.1365-2184.2009.00622.x
   Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093
   MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584
   NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253
   Nemes Z, 1997, J BIOL CHEM, V272, P20577, DOI 10.1074/jbc.272.33.20577
   Ohtake Y, 2004, BIOL PHARM BULL, V27, P1758, DOI 10.1248/bpb.27.1758
   Ohtake Y, 2008, J HEPATOL, V48, P246, DOI 10.1016/j.jhep.2007.08.009
   Ohtake Y, 2010, AM J PHYSIOL-GASTR L, V299, pG106, DOI 10.1152/ajpgi.00365.2009
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78
   PEACOCKE M, 1991, J CELL BIOCHEM, V45, P147, DOI 10.1002/jcb.240450205
   QUISTORFF B, 1985, BIOCHEM J, V229, P221, DOI 10.1042/bj2290221
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sakaguchi T, 2002, AUTON NEUROSCI-BASIC, V99, P54, DOI 10.1016/S1566-0702(02)00060-7
   SAYET I, 1993, BRIT J PHARMACOL, V110, P207, DOI 10.1111/j.1476-5381.1993.tb13793.x
   SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413
   Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier
   TAKAHASHI H, 1994, MOL CELL BIOCHEM, V136, P71, DOI 10.1007/BF00931607
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V125, P171, DOI 10.1007/BF00936446
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   TORRESMARQUEZ E, 1991, EUR J PHARM-MOLEC PH, V206, P199, DOI 10.1016/S0922-4106(05)80019-7
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874
   Wu J, 2000, J BIOL CHEM, V275, P22213, DOI 10.1074/jbc.M000091200
NR 51
TC 6
Z9 8
U1 1
U2 10
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD OCT
PY 2012
VL 303
IS 7
BP G861
EP G869
DI 10.1152/ajpgi.00081.2012
PG 9
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 016HJ
UT WOS:000309508100009
PM 22837346
DA 2024-02-19
ER

PT J
AU Weeda, G
   Donker, I
   deWit, J
   Morreau, H
   Janssens, R
   Vissers, CJ
   Nigg, A
   vanSteeg, H
   Bootsma, D
   Hoeijmakers, JHJ
AF Weeda, G
   Donker, I
   deWit, J
   Morreau, H
   Janssens, R
   Vissers, CJ
   Nigg, A
   vanSteeg, H
   Bootsma, D
   Hoeijmakers, JHJ
TI Disruption of mouse ERCC1 results in a novel repair syndrome with growth
   failure, nuclear abnormalities and senescence
SO CURRENT BIOLOGY
LA English
DT Article
ID YEAST DNA-REPAIR; MICE LACKING; GENE ERCC-1; ULTRAVIOLET-B; STEM-CELLS;
   GROUP-A; P53; RECOMBINATION; RAD10; LIVER
AB Background: The structure-specific ERCC1/XPF endonuclease complex that contains the ERCC1 and XPF subunits is implicated in the repair of two distinct types of lesions in DNA: nucleotide excision repair (NER) for ultraviolet-induced lesions and bulky chemical adducts; and recombination repair of the very genotoxic interstrand cross-links.
   Results: Here, we present a detailed analysis of two types of mice with mutations in ERCC1, one in which the gene is 'knocked out', and one in which the encoded protein contains a seven amino-acid carboxy-terminal truncation. In addition to the previously reported symptoms of severe runting, abnormalities of liver nuclei and greatly reduced lifespan (which appeared less severe in the truncation mutant), both types of ERCC1-mutant mouse exhibited an absence of subcutaneous fat, early onset of ferritin deposition in the spleen, kidney malfunction, gross abnormalities of ploidy and cytoplasmic invaginations in nuclei of liver and kidney, and compromised NER and cross-link repair. We also found that heterozygosity for ERCC1 mutations did not appear to provide a selective advantage for chemically induced tumorigenesis. An important clue to the cause of the very severe ERCC1-mutant phenotypes is our finding that ERCC1-mutant cells undergo premature replicative senescence, unlike cells from mice with a defect only in NER.
   Conclusions: Our results strongly suggest that the accumulation in ERCC1-mutant mice of endogenously generated DNA interstrand cross-links, which are normally repaired by ERCC1-dependent recombination repair, underlies both the early onset of cell cycle arrest and polyploidy in the liver and kidney. Thus, our work provides an insight into the molecular basis of ageing and highlights the role of ERCC1 and interstrand DNA cross-links.
C1 ERASMUS UNIV ROTTERDAM,DEPT CELL BIOL & GENET,CTR MED GENET,NL-3000 DR ROTTERDAM,NETHERLANDS.
   UNIV LEIDEN HOSP,DEPT PATHOL,NL-2300 RC LEIDEN,NETHERLANDS.
   ERASMUS UNIV ROTTERDAM,DEPT PATHOL,NL-3000 DR ROTTERDAM,NETHERLANDS.
   NATL INST PUBL HLTH & ENVIRONM,HLTH EFFECTS RES LAB,NL-3720 BA BILTHOVEN,NETHERLANDS.
C3 Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University
   Rotterdam; Leiden University; Leiden University Medical Center (LUMC);
   Erasmus University Rotterdam; Erasmus University Rotterdam - Excl
   Erasmus MC; Netherlands National Institute for Public Health & the
   Environment
RI Hoeijmakers, Jan/AAX-6972-2021
CR AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
   BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273
   BARDWELL L, 1992, MOL CELL BIOL, V12, P3041, DOI 10.1128/MCB.12.7.3041
   BOOTSMA D, 1997, IN PRESS METABOLIC B
   Brookman KW, 1996, MOL CELL BIOL, V16, P6553
   BURNS MA, 1989, MUTAT RES, V216, P243, DOI 10.1016/0165-1161(89)90049-6
   CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172
   Cheo DL, 1996, CURR BIOL, V6, P1691, DOI 10.1016/S0960-9822(02)70794-X
   CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434
   DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0
   DILEONARDO A, 1994, GENE DEV, V8, P3045
   DOOLITTLE RF, 1986, NATURE, V323, P351
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547
   Friedberg E.C., 1995, DNA REPAIR
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   HAYAKAWA H, 1991, MUTAT RES, V80, P381
   HOEIJMAKERS JHJ, 1994, EUR J CANCER, V30A, P1912, DOI 10.1016/0959-8049(94)00381-E
   JOHNSON JE, 1984, AGING CELL STRUCTURE, V2, P37
   KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2
   KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5
   KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
   LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   MORIWAKI S, 1993, BRIT J DERMATOL, V128, P91, DOI 10.1111/j.1365-2133.1993.tb00154.x
   NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0
   SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370
   Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5
   SIMPSON RJ, 1993, J PATHOL, V171, P237, DOI 10.1002/path.1711710313
   SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5
   VANDUIN M, 1989, MOL CELL BIOL, V9, P1794, DOI 10.1128/MCB.9.4.1794
   VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0
   VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1
   VERMEULEN W, 1994, AM J HUM GENET, V54, P191
   WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0
   Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0
NR 42
TC 299
Z9 332
U1 1
U2 10
PU CURRENT BIOLOGY LTD
PI LONDON
PA 34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JUN 1
PY 1997
VL 7
IS 6
BP 427
EP 439
DI 10.1016/S0960-9822(06)00190-4
PG 13
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA XG211
UT WOS:A1997XG21100030
PM 9197240
OA Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Yao, JP
   Liang, X
   Xu, SD
   Liu, YN
   Shui, LY
   Li, SS
   Guo, HT
   Xiao, ZY
   Zhao, YC
   Zheng, M
AF Yao, Jiping
   Liang, Xue
   Xu, Siduo
   Liu, Yanning
   Shui, Liyan
   Li, Shuangshuang
   Guo, Huiting
   Xiao, Zhengyun
   Zhao, Yongchao
   Zheng, Min
TI TRAF2 inhibits senescence in hepatocellular carcinoma cells via
   regulating the ROMO1/ NAD+/SIRT3/SOD2 axis
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article; Early Access
DE Senescence; TRAF2; ROS; Mitochondrial function; HCC
ID CELLULAR SENESCENCE; ROS PRODUCTION; DNA-DAMAGE; CANCER; NAD(+);
   RESISTANCE; MECHANISM; APOPTOSIS; OUTCOMES; GROWTH
AB The suppression of tumor proliferation via cellular senescence has emerged as a promising approach for antitumor therapy. Tumor necrosis factor receptor-associated factor 2 (TRAF2), an adaptor protein involved in the NF-kappa B signaling pathway and reactive oxygen species (ROS) production, has been implicated in hepatocellular carcinoma (HCC) proliferation. However, little is currently known about whether TRAF2 promotes HCC development by inhibiting cellular senescence. Replicative senescence model and IR-induced mouse model demonstrated that TRAF2 expression was decrease in senescence cells or liver tissues. Depletion of TRAF2 could inhibit proliferation and arrest the cell cycle via activating p53/p21WAF1 and p16INK4a/pRb signaling pathways in HCC cells and eventually lead to cellular senescence. Mechanistically, TRAF2 deficiency increased the expression of mitochondrial protein reactive oxygen species modulator 1 (ROMO1) and subsequently activated the NAD+/ SIRT3/SOD2 pathway to promote the production of ROS and cause mitochondrial dysfunction, which eventually contributed to DNA damage response (DDR). Our findings demonstrate that TRAF2 deficiency inhibits the proliferation of HCC by promoting senescence. Therefore, targeting TRAF2 through various approaches holds therapeutic potential for treating HCC.
C1 [Yao, Jiping; Liang, Xue; Xu, Siduo; Liu, Yanning; Shui, Liyan; Li, Shuangshuang; Guo, Huiting; Xiao, Zhengyun; Zheng, Min] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Dis, Natl Clin Res Ctr Infect Dis, Sch Med,State Key Lab Diag & Treatment Infect Dis,, Hangzhou 310003, Zhejiang, Peoples R China.
   [Yao, Jiping] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Dept Gastroenterol, Peoples Hosp, Hangzhou 310014, Peoples R China.
   [Zhao, Yongchao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.
   [Zhao, Yongchao] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China.
   [Zhao, Yongchao] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310029, Peoples R China.
   [Liang, Xue] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Peoples R China.
   [Zheng, Min] Zhejiang Univ, Affiliated Hosp 1, Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.
C3 Collaborative Innovation Center for Diagnosis & Treatment of Infectious
   Diseases; Zhejiang University; Zhejiang Provincial People's Hospital;
   Hangzhou Medical College; Zhejiang University; Zhejiang University;
   Zhejiang University; Zhejiang University; Zhejiang University
RP Zhao, YC (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.; Zheng, M (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.
EM yongchao@zju.edu.cn; minzheng@zju.edu.cn
FU National Natural Science Foundation of China [U20A20348, 81871646];
   National Key Research and Development Program of China [2022YFC3401500];
   National Natural Science Foundation of China [92053117]; Key R & D
   Program of Zhejiang Province [2021C03039]; Ten-Thousands Talents Program
   of Zhejiang Province [2020R52010]; Independent Task of State Key
   Laboratory for Diagnosis and Treatment of Infectious Diseases; Opening
   foundation of the State Key Laboratory for Diagnosis and Treatment of
   Infectious Diseases; First Affiliated Hospital, Zhejiang University
   School of Medicine [SKLID2023KF08]
FX This work was supported by the National Natural Science Foundation of
   China (U20A20348, 81871646); National Key Research and Development
   Program of China (2022YFC3401500 to Y.Z.); National Natural Science
   Foundation of China (92053117 to Y.Z.); the Key R & D Program of
   Zhejiang Province (2021C03039); the Ten-Thousands Talents Program of
   Zhejiang Province (2020R52010); the Independent Task of State Key
   Laboratory for Diagnosis and Treatment of Infectious Diseases; and the
   opening foundation of the State Key Laboratory for Diagnosis and
   Treatment of Infectious Diseases, The First Affiliated Hospital,
   Zhejiang University School of Medicine (SKLID2023KF08).
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870
   Blackwell K, 2009, MOL CELL BIOL, V29, P303, DOI 10.1128/MCB.00699-08
   Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200
   Cheng AW, 2016, CELL METAB, V23, P128, DOI 10.1016/j.cmet.2015.10.013
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chung JS, 2009, FREE RADICAL RES, V43, P729, DOI 10.1080/10715760903038432
   Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140
   Chung YM, 2008, J BIOL CHEM, V283, P33763, DOI 10.1074/jbc.M805334200
   Diao ZQ, 2021, NUCLEIC ACIDS RES, V49, P4203, DOI 10.1093/nar/gkab161
   Dobler C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092012
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031
   Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026
   Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19
   Kim SB, 2019, J GERONTOL A-BIOL, V74, P787, DOI 10.1093/gerona/gly167
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1
   Liang X, 2023, CELL DEATH DIFFER, V30, P1550, DOI 10.1038/s41418-023-01164-7
   Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24
   Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098
   Norton M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004374
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694
   Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043
   Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167
   Robinson AR, 2018, REDOX BIOL, V17, P259, DOI 10.1016/j.redox.2018.04.007
   ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0
   Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Shen JY, 2018, ANN HEPATOL, V17, P134, DOI 10.5604/01.3001.0010.7545
   Shen RR, 2015, ONCOGENE, V34, P209, DOI 10.1038/onc.2013.543
   Sherr CJ, 2016, NEW ENGL J MED, V375, P1920, DOI 10.1056/NEJMp1612343
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.20006, 10.3322/caac.21387, 10.3322/caac.21601, 10.3322/caac.20073, 10.3322/caac.21654, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.21254]
   Sole CV, 2013, EUR J NUCL MED MOL I, V40, P1635, DOI 10.1007/s00259-013-2479-7
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657
   Wang YL, 2017, NUCLEIC ACIDS RES, V45, pD955, DOI 10.1093/nar/gkw1118
   Wang YY, 2010, J CANCER RES CLIN, V136, P135, DOI 10.1007/s00432-009-0644-y
   Wang YJ, 2019, MECH AGEING DEV, V184, DOI 10.1016/j.mad.2019.111160
   Wojtczyk-Miaskowska A, 2018, DNA REPAIR, V69, P14, DOI 10.1016/j.dnarep.2018.07.003
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yan R, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110319
   Yang CY, 2016, CELL SIGNAL, V28, P145, DOI 10.1016/j.cellsig.2015.10.017
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang MH, 2020, ONCOGENE, V39, P322, DOI 10.1038/s41388-019-0987-z
   Zhang ZY, 2022, WORLD J SURG ONCOL, V20, DOI 10.1186/s12957-022-02658-3
   Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 64
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD 2024 FEB 1
PY 2024
VL 211
BP 47
EP 62
DI 10.1016/j.freeradbiomed.2023.11.035
EA DEC 2023
PG 16
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EG2G3
UT WOS:001137697600001
PM 38043870
DA 2024-02-19
ER

PT J
AU Nikopoulou, C
   Kleinenkuhnen, N
   Parekh, S
   Sandoval, T
   Ziegenhain, C
   Schneider, F
   Giavalisco, P
   Donahue, KF
   Vesting, AJ
   Kirchner, M
   Bozukova, M
   Vossen, C
   Altmüller, J
   Wunderlich, T
   Sandberg, R
   Kondylis, V
   Tresch, A
   Tessarz, P
AF Nikopoulou, Chrysa
   Kleinenkuhnen, Niklas
   Parekh, Swati
   Sandoval, Tonantzi
   Ziegenhain, Christoph
   Schneider, Farina
   Giavalisco, Patrick
   Donahue, Kat-Folz
   Vesting, Anna Juliane
   Kirchner, Marcel
   Bozukova, Mihaela
   Vossen, Christian
   Altmueller, Janine
   Wunderlich, Thomas
   Sandberg, Rickard
   Kondylis, Vangelis
   Tresch, Achim
   Tessarz, Peter
TI Spatial and single-cell profiling of the metabolome, transcriptome and
   epigenome of the aging mouse liver
SO NATURE AGING
LA English
DT Article; Early Access
ID GENE-EXPRESSION; CIDE PROTEINS; E-CADHERIN; AGE; PACKAGE; FACTOR-1;
   GROWTH; DAMAGE; MICE
AB Tissues within an organism and even cell types within a tissue can age with different velocities. However, it is unclear whether cells of one type experience different aging trajectories within a tissue depending on their spatial location. Here, we used spatial transcriptomics in combination with single-cell ATAC-seq and RNA-seq, lipidomics and functional assays to address how cells in the male murine liver are affected by age-related changes in the microenvironment. Integration of the datasets revealed zonation-specific and age-related changes in metabolic states, the epigenome and transcriptome. The epigenome changed in a zonation-dependent manner and functionally, periportal hepatocytes were characterized by decreased mitochondrial fitness, whereas pericentral hepatocytes accumulated large lipid droplets. Together, we provide evidence that changing microenvironments within a tissue exert strong influences on their resident cells that can shape epigenetic, metabolic and phenotypic outputs.
   Using spatial and single-cell multiomics, Nikopoulou et al analyze how different cells within the mouse liver age, revealing zonation-specific aging trajectories and highlighting the importance of the local tissue microenvironment.
C1 [Nikopoulou, Chrysa; Kleinenkuhnen, Niklas; Parekh, Swati; Sandoval, Tonantzi; Bozukova, Mihaela; Tessarz, Peter] Max Planck Inst Biol Ageing, Max Planck Res Grp Chromatin & Ageing, Cologne, Germany.
   [Nikopoulou, Chrysa; Wunderlich, Thomas; Tresch, Achim; Tessarz, Peter] Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany.
   [Kleinenkuhnen, Niklas; Tresch, Achim] Univ Cologne, Inst Med Stat & Comp Biol, Fac Med, Cologne, Germany.
   [Ziegenhain, Christoph; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.
   [Schneider, Farina; Kondylis, Vangelis] Univ Hosp Cologne, Inst Pathol, Cologne, Germany.
   [Giavalisco, Patrick] Max Planck Inst Biol Ageing, Metab Core Facil, Cologne, Germany.
   [Donahue, Kat-Folz; Kirchner, Marcel] Max Planck Inst Biol Ageing, FACS & Imaging Core Facil, Cologne, Germany.
   [Vesting, Anna Juliane; Vossen, Christian; Wunderlich, Thomas] Max Planck Inst Metab Res, Cologne, Germany.
   [Altmueller, Janine] Univ Cologne, Cologne Ctr Genom, Cologne, Germany.
   [Altmueller, Janine] Berlin Inst Hlth Charite, Core Facil Genom, Berlin, Germany.
   [Altmueller, Janine] Max Delbruck Ctr Mol Med Helmholtz Assoc, Berlin, Germany.
   [Kondylis, Vangelis] Heinrich Heine Univ, Med Fac, Univ Hosp Duesseldorf, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.
   [Parekh, Swati] Boehringer Ingelheim Pharm, Global Comp Biol & Digital Sci, Biberach, Germany.
   [Tessarz, Peter] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Human Biol, Nijmegen, Netherlands.
C3 Max Planck Society; University of Cologne; Karolinska Institutet;
   University of Cologne; Max Planck Society; Max Planck Society;
   University of Cologne; Berlin Institute of Health; Helmholtz
   Association; Max Delbruck Center for Molecular Medicine; Heinrich Heine
   University Dusseldorf; Boehringer Ingelheim; Radboud University Nijmegen
RP Tessarz, P (corresponding author), Max Planck Inst Biol Ageing, Max Planck Res Grp Chromatin & Ageing, Cologne, Germany.; Tresch, A; Tessarz, P (corresponding author), Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany.; Tresch, A (corresponding author), Univ Cologne, Inst Med Stat & Comp Biol, Fac Med, Cologne, Germany.
EM achim.tresch@uni-koeln.de; ptessarz@age.mpg.de
RI Tessarz, Peter/I-9035-2014
OI Tessarz, Peter/0000-0002-6953-9835
FU We would like to thank all members of the Tessarz and Tresch labs for
   continuous discussion. We are grateful to A. Schaefer and A. Pouikli for
   critical reading of the manuscript. We are indebted to the following
   core facilities of the MPI for Biology of Ag; Max Planck Society; BOOST
   program of the Max Planck Society [415274764]; Deutsche
   Forschungsgemeinschaft (German Research Foundation)
FX We would like to thank all members of the Tessarz and Tresch labs for
   continuous discussion. We are grateful to A. Schaefer and A. Pouikli for
   critical reading of the manuscript. We are indebted to the following
   core facilities of the MPI for Biology of Ageing for technical
   assistance: FACS and Imaging for help with FACS analysis, histology and
   microscopy, metabolomics for lipidomic analysis and comparative biology
   for housing mice. Electron microscopy was performed at the Imaging Core
   Facility of CECAD, University of Cologne. scATAC-seq and spatial
   transcriptomics were performed at the Cologne Center for Genomics,
   University of Cologne. All other libraries were sequenced at the
   Sequencing Core Facility of the MPI for Molecular Genetics, Berlin. This
   work was funded by the Max Planck Society (P.T. and T.W.), the BOOST
   program of the Max Planck Society (C.N.) and the Deutsche
   Forschungsgemeinschaft (German Research Foundation; project no.
   415274764 (V.K. and F.S.) and under Germany's Excellence Strategy - EXC
   2030 - 390661388 (P.T.))
CR Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
   Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485
   Begum HM, 2021, CANCERS, V13, DOI 10.3390/cancers13205054
   Ben-Moshe S, 2019, NAT METAB, V1, P899, DOI 10.1038/s42255-019-0109-9
   Ben-Moshe S, 2019, NAT REV GASTRO HEPAT, V16, P395, DOI 10.1038/s41575-019-0134-x
   Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Bozukova M, 2022, MOL SYST BIOL, V18, DOI 10.15252/msb.202211002
   Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Chen JY, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd7819
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   Eling N, 2018, CELL SYST, V7, P284, DOI 10.1016/j.cels.2018.06.011
   Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400
   Ferrucci L, 2021, J AM GERIATR SOC, V69, P610, DOI 10.1111/jgs.17011
   Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5
   Giralt A, 2018, MOL METAB, V11, P104, DOI 10.1016/j.molmet.2018.02.011
   Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142
   González-Blas CB, 2019, NAT METHODS, V16, P397, DOI 10.1038/s41592-019-0367-1
   Hagemann-Jensen M, 2022, NAT BIOTECHNOL, V40, P1452, DOI 10.1038/s41587-022-01311-4
   Hahn O, 2019, NAT METAB, V1, P1059, DOI 10.1038/s42255-019-0121-0
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027
   Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048
   He XJ, 2020, NAT METAB, V2, P293, DOI 10.1038/s42255-020-0196-7
   Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789
   Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198
   Isildak U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60998-0
   Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731
   Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143
   Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638
   Lai RW, 2019, BMB REP, V52, P86
   Lee BP, 2016, AGING CELL, V15, P903, DOI 10.1111/acel.12499
   Lin WJ, 2021, NUCLEIC ACIDS RES, V49, pW336, DOI 10.1093/nar/gkab419
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Mao Z, 2021, DIABETES, V70, P214, DOI 10.2337/db20-0619
   Marchetti P, 2020, FASEB J, V34, P13106, DOI 10.1096/fj.202000767R
   Matsumura T, 2001, CLIN CANCER RES, V7, P594
   Matsusue K, 2004, MOL ENDOCRINOL, V18, P2751, DOI 10.1210/me.2004-0213
   Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003
   McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011
   Muto Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22368-w
   Nakagawa H, 2014, P NATL ACAD SCI USA, V111, P1090, DOI 10.1073/pnas.1322731111
   Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167
   Ntranos V, 2019, NAT METHODS, V16, P163, DOI 10.1038/s41592-018-0303-9
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Paradies G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070728
   Parekh S, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy059
   Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044
   Pontoglio M, 2000, J AM SOC NEPHROL, V11, pS140
   Richter ML, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24543-5
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sacramento EK, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209596
   Sans A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43928-7
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schleicher J, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0443
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024
   Stuart T., 2020, bioRxiv, DOI [10.1101/2020.11.09.373613, 10.1101/2020.11.09.373613, DOI 10.1101/2020.11.09.373613]
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tabula Muris Consortium, 2020, Nature, V583, P590, DOI 10.1038/s41586-020-2496-1
   Tanami S, 2017, CELL TISSUE RES, V368, P405, DOI 10.1007/s00441-016-2427-5
   Uno Y, 2017, DRUG METAB PHARMACOK, V32, P100, DOI 10.1016/j.dmpk.2016.10.409
   Veum VL, 2012, INT J OBESITY, V36, P1195, DOI 10.1038/ijo.2011.240
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang X, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1438-z
   Wangensteen KJ, 2015, GENE DEV, V29, P904, DOI 10.1101/gad.258855.115
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489
   Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094
   Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102
   Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 82
TC 0
Z9 0
U1 14
U2 14
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 NOV 9
PY 2023
DI 10.1038/s43587-023-00513-y
EA NOV 2023
PG 31
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA Y1PM2
UT WOS:001103055900005
PM 37946043
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Chapman, JR
   Lynch, SV
AF Chapman, Jeremy R.
   Lynch, Stephen V.
TI Donor-Transmitted, Donor-Derived, and De Novo Cancer After Liver
   Transplant
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Hepatic failure; Immunosuppression; Malignancy; Screening; Tumor
ID KIDNEY-TRANSPLANTATION; AUSTRALIAN LIVER; RECIPIENTS; RISK; MALIGNANCY;
   ORGAN
AB Cancer is the third most common cause of death (after cardiovascular disease and infection) for patients who have a functioning kidney allograft. Kidney and liver transplant recipients have similar cancer risks because of immunosuppression but different risks because of differences in primary diseases that cause renal and hepatic failure and the inherent behavior of cancers in the liver. There are 4 types of cancer that may develop in liver allograft recipients: (1) recurrent cancer, (2) donor-transmitted cancer, (3) donor-derived cancer, and (4) de novo cancer. Identification of potential donor cancer transmission may occur at postmortem examination of a deceased donor or when a probable donor-transmitted cancer is identified in another recipient. Donor-transmitted cancer after liver transplant is rare in Australia, the United Kingdom, and the United States. Aging of the donor pool may increase the risk of subclinical cancer in donors. Liver transplant recipients have a greater risk of de novo cancer than the general population, and risk factors for de novo cancer in liver transplant recipients include primary sclerosing cholangitis, alcoholic liver disease, smoking, and increased age. Liver transplant recipients may benefit from cancer screening because they have a high risk, are clearly identifiable, and are under continuous medical supervision.
C1 [Chapman, Jeremy R.] Univ Sydney, Westmead Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia.
   [Lynch, Stephen V.] Princess Alexandra Hosp, Australia & New Zealand Liver Transplant Registry, Woolloongabba, Qld 4102, Australia.
C3 University of Sydney; Westmead Institute for Medical Research
RP Chapman, JR (corresponding author), Univ Sydney, Westmead Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia.
EM Jeremy.Chapman@health.nsw.gov.au
CR [Anonymous], GLOB VIG SURV DAT TR
   [Anonymous], NAT CANC I FACTSH ME
   Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x
   Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592
   Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2
   Lynch SV, 2012, 24 AUSTR NZ LIV TRAN
   Mathew T, 2004, CLIN TRANSPLANT, V18, P446, DOI 10.1111/j.1399-0012.2004.00188.x
   Na R, 2013, AM J TRANSPLANT, V13, P1296, DOI 10.1111/ajt.12192
   Na R, 2013, AM J TRANSPLANT, V13, P174, DOI 10.1111/j.1600-6143.2012.04302.x
   Nalesnik MA, 2011, AM J TRANSPLANT, V11, P1140, DOI 10.1111/j.1600-6143.2011.03565.x
   Puttarajappa C, 2013, CLIN TRANSPLANT, V27, pE264, DOI 10.1111/ctr.12094
   Schrem H, 2013, LIVER TRANSPLANT, DOI [10.1002/It.23722, DOI 10.1002/IT.23722]
   Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823
   Vajdic CM, 2010, BLOOD, V116, P1228, DOI 10.1182/blood-2010-03-272351
   van Leeuwen MT, 2009, BLOOD, V114, P630, DOI 10.1182/blood-2009-02-202507
   Villeneuve PJ, 2007, AM J TRANSPLANT, V7, P941, DOI 10.1111/j.1600-6143.2007.01736.x
   Wimmer CD, 2013, TRANSPL INT, V26, P999, DOI 10.1111/tri.12165
   Wong G, 2008, CLIN J AM SOC NEPHRO, V3, pS87, DOI 10.2215/CJN.03320807
   Xiao D, 2013, AM J TRANSPLANT, V13, P2645, DOI 10.1111/ajt.12430
NR 19
TC 6
Z9 8
U1 0
U2 1
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD MAR
PY 2014
VL 12
SU 1
BP 50
EP 54
DI 10.6002/ect.25Liver.L49
PG 5
WC Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Transplantation
GA AG7VJ
UT WOS:000335626600012
PM 24635793
DA 2024-02-19
ER

PT J
AU Kireev, RA
   Tresguerres, ACF
   Garcia, C
   Borras, C
   Ariznavarreta, C
   Vara, E
   Vina, J
   Tresguerres, JAF
AF Kireev, R. A.
   Tresguerres, A. C. F.
   Garcia, C.
   Borras, C.
   Ariznavarreta, C.
   Vara, E.
   Vina, J.
   Tresguerres, J. A. F.
TI Hormonal regulation of pro-inflammatory and lipid peroxidation processes
   in liver of old ovariectomized female rats
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Liver; Inflammation; Oxidative markers; Hormones
ID GROWTH-FACTOR-I; FACTOR-KAPPA-B; BLOOD MONONUCLEAR-CELLS; BILOBA EXTRACT
   EGB-761; NITRIC-OXIDE; OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN;
   HEPATOCYTE CHANGES; CARBON-MONOXIDE; KUPFFER CELLS
AB There is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in pro-inflammatory cytokines. On the other hand, oxidative stress has been implicated in the pathogenesis of several alterations due to menopause, and can arise through the increased production of lipid peroxides (LPO) and/or a deficiency of antioxidant defense. The aim of the present study was to investigate the effect of aging and ovariectomy on various physiological parameters related to inflammation and oxidative stress in livers obtained from old female rats and the influence of chronic exogenous administration of estrogens, phytoestrogens and growth hormone on these. Thirty-six female Wistar rats of 22 months of age were used in the present study. Twelve of them remained intact, and the other 24 had been ovariectomized at 12 months of age. Intact animals were divided into two groups and treated for 10 weeks with GH or saline, and ovariectomized animals were divided into four groups and treated for the same time with GH, estrogens, phytoestrogens or saline. A group of 2 month old intact female rats was used as young control. Protein expression of iNOS, HO-1, IL-6, TNF alpha, and IL-1 beta were determined by Western blot analysis. The levels of NO (x) , LPO, TNF alpha, IL-1 beta, IL-6 and IL-10 were determined in different fractions of the liver. Levels of LPO in the liver homogenates as well as iNOS protein expression and NO (x) levels were increased in old rats as compared to young animals; this effect was more evident in ovariectomized animals. Pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6 were significantly increased and anti-inflammatory IL-10 decreased during ageing and after ovariectomy. Aging also significantly increased expression of HO-1 protein and ovariectomized rats showed an additional increase. Hormonal administration to the ovariectomized groups decreased NO (x) , LPO levels and pro-inflammatory cytokines as compared with untreated rats. Significant rise in IL-10 and reductions in the iNOS, IL-6, TNF alpha and IL-1 beta proteins expression were also found. Oxidative stress and inflammation induced during aging in the liver are more marked in castrated than in intact old females. Administration of the different hormonal replacement therapies was able to inhibit the induction of pro-inflammatory cytokines and iNOS, decreased the levels of oxidative stress markers and had therapeutic potential in the prevention of liver injury.
C1 [Tresguerres, A. C. F.; Ariznavarreta, C.; Tresguerres, J. A. F.] Univ Complutense Madrid, Lab Expt Endocrinol, Dept Physiol, Sch Med, E-28040 Madrid, Spain.
   [Kireev, R. A.] Res Inst Gen Pathol & Pathophysiol, Moscow, Russia.
   [Garcia, C.; Vara, E.] Univ Complutense Madrid, Sch Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
   [Borras, C.; Vina, J.] Univ Valencia, Fac Med, Dept Physiol, Valencia, Spain.
C3 Complutense University of Madrid; Russian Academy of Medical Sciences;
   Institute of General Pathology & Pathophysiology, RAMS; Complutense
   University of Madrid; University of Valencia
RP Tresguerres, JAF (corresponding author), Univ Complutense Madrid, Lab Expt Endocrinol, Dept Physiol, Sch Med, Complutense S-N, E-28040 Madrid, Spain.
EM rakireev@gmail.com; guerres@med.ucm.es
RI Vina, Jose/AAB-3069-2021; Garcia, Cruz/GRF-6283-2022; borras,
   consuelo/Y-3407-2019
OI Vina, Jose/0000-0001-9709-0089; borras, consuelo/0000-0003-4606-1792;
   Kireev, Roman/0000-0002-6105-2440
FU RETICEF [RD 06/0013]; Instituto Carlos III [66878-C02-01]; Nutricia
   Research Foundation, International Training Fellowship [2007-T4]
FX This work was supported by grants: RETICEF RD 06/0013 (FIS) Instituto
   Carlos III and SAF 2007, 66878-C02-01. Dr. Kireev Roman was supported by
   Nutricia Research Foundation, International Training Fellowship
   (2007-T4).
CR Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256
   Arora A, 1998, FREE RADICAL BIO MED, V24, P1355, DOI 10.1016/S0891-5849(97)00458-9
   AYALA A, 1992, CYTOKINE, V4, P66, DOI 10.1016/1043-4666(92)90039-T
   Berg AO, 2002, ANN INTERN MED, V137, P834, DOI 10.7326/0003-4819-137-10-200211190-00013
   Berg G, 2002, AM J REPROD IMMUNOL, V48, P63, DOI 10.1034/j.1600-0897.2002.01061.x
   Bresson JL, 1999, ENDOCRINOLOGY, V140, P3203, DOI 10.1210/en.140.7.3203
   Carlson S, 2008, GENDER MED, V5, pS76, DOI 10.1016/j.genm.2008.03.008
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Castillo C, 2006, PHYTOMEDICINE, V13, P468, DOI 10.1016/j.phymed.2005.03.012
   Castillo C, 2005, ENDOCRINE, V26, P11, DOI 10.1385/ENDO:26:1:011
   Cho JY, 2000, J ETHNOPHARMACOL, V70, P127, DOI 10.1016/S0378-8741(99)00154-3
   Chung HY, 2005, OXIDAT STRESS DIS, V18, P389
   Cioffi M, 2002, MATURITAS, V41, P187, DOI 10.1016/S0378-5122(01)00286-9
   Dhainaut JF, 2001, CRIT CARE MED, V29, pS42, DOI 10.1097/00003246-200107001-00016
   Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390
   Franco C, 2007, J CLIN ENDOCR METAB, V92, P2644, DOI 10.1210/jc.2007-0068
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Haeffner A, 1997, J IMMUNOL, V158, P1310
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Ho KMT, 1999, J UROLOGY, V161, P1968, DOI 10.1016/S0022-5347(05)68865-9
   Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200
   Inaba K, 2005, J HEPATOL, V42, P719, DOI 10.1016/j.jhep.2004.12.026
   Jeay S, 2000, MOL ENDOCRINOL, V14, P650, DOI 10.1210/me.14.5.650
   Jeschke MG, 2000, CRIT CARE MED, V28, P1578, DOI 10.1097/00003246-200005000-00053
   Kamada M, 2001, AM J OBSTET GYNECOL, V184, P309, DOI 10.1067/mob.2001.109940
   Kankofer M, 2007, J VET MED A, V54, P225, DOI 10.1111/j.1439-0442.2007.00916.x
   Karbownik-Lewinska M, 2008, CLIN ENDOCRINOL, V68, P957, DOI 10.1111/j.1365-2265.2007.03142.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Kooijman R, 1996, ADV IMMUNOL, V63, P377
   Krakauer T, 2001, FEBS LETT, V500, P52, DOI 10.1016/S0014-5793(01)02584-4
   Kröncke KD, 1998, CLIN EXP IMMUNOL, V113, P147
   Kumru S, 2004, J REPROD IMMUNOL, V63, P31, DOI 10.1016/j.jri.2004.02.001
   Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010
   Lee YM, 2005, FREE RADICAL BIO MED, V39, P108, DOI 10.1016/j.freeradbiomed.2005.02.033
   Liu Y, 2002, WORLD J GASTROENTERO, V8, P363
   Luedde T, 2002, EUR CYTOKINE NETW, V13, P377
   Luedde T, 2006, LIVER INT, V26, P1163, DOI 10.1111/j.1478-3231.2006.01366.x
   Martínez-Flórez S, 2005, J NUTR, V135, P1359, DOI 10.1093/jn/135.6.1359
   MESTER M, 1994, SURGERY, V115, P588
   Morales AI, 2006, TOXICOL APPL PHARM, V210, P128, DOI 10.1016/j.taap.2005.09.006
   Moutsatsou Paraskevi, 2007, Hormones (Athens), V6, P173
   Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995
   Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002
   NESIBE A, 2007, GROWTH HORMON IGF RE, V17, P149
   Pang JL, 2006, BIOCHEM PHARMACOL, V71, P818, DOI 10.1016/j.bcp.2005.12.023
   POLAN ML, 1989, J CLIN ENDOCR METAB, V69, P1200, DOI 10.1210/jcem-69-6-1200
   Rachon D, 2002, J ENDOCRINOL, V172, P387, DOI 10.1677/joe.0.1720387
   RAY A, 1994, J BIOL CHEM, V269, P12940
   Saal FS, 1994, PHYSL REPRODUCTION, P1213
   Sabharwal P, 1996, J CLIN ENDOCR METAB, V81, P2663, DOI 10.1210/jc.81.7.2663
   Saucedo R, 2002, GYNECOL OBSTET INVES, V53, P114, DOI 10.1159/000053005
   Scacchi M, 2006, J ENDOCRINOL INVEST, V29, P899, DOI 10.1007/BF03349194
   Seiva FRF, 2008, GROWTH HORM IGF RES, V18, P275, DOI 10.1016/j.ghir.2007.11.002
   Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019
   Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x
   Shiraishi T, 2006, GASTROENTEROLOGY, V130, pA793
   Stachlewitz RF, 1999, HEPATOLOGY, V29, P737, DOI 10.1002/hep.510290335
   Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7
   Suschek CV, 2004, CURR MOL MED, V4, P763, DOI 10.2174/1566524043359908
   SUZUKI S, 1994, J SURG RES, V57, P253, DOI 10.1006/jsre.1994.1140
   Verstraeten SV, 2003, FREE RADICAL BIO MED, V34, P84, DOI 10.1016/S0891-5849(02)01185-1
   Vural P, 2005, ANN CLIN BIOCHEM, V42, P220, DOI 10.1258/0004563053857941
   Wadsworth TL, 2001, CHEM-BIOL INTERACT, V137, P43, DOI 10.1016/S0009-2797(01)00208-3
   Wadsworth TL, 2001, BIOCHEM PHARMACOL, V62, P963, DOI 10.1016/S0006-2952(01)00734-1
   Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248
   Wang SH, 2003, J NUTR, V133, P2367, DOI 10.1093/jn/133.7.2367
   Wong MCY, 2007, METABOLISM, V56, P865, DOI 10.1016/j.metabol.2007.01.005
   Yagi K, 1997, ACTA BIOCHIM POL, V44, P701, DOI 10.18388/abp.1997_4372
   Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307
   Yasui T, 2007, MATURITAS, V56, P396, DOI 10.1016/j.maturitas.2006.11.002
NR 70
TC 51
Z9 58
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD APR
PY 2010
VL 11
IS 2
BP 229
EP 243
DI 10.1007/s10522-009-9242-2
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 563ON
UT WOS:000275142300008
PM 19633997
DA 2024-02-19
ER

PT J
AU Zeng, L
   Lin, L
   Peng, YQ
   Yuan, DY
   Zhang, S
   Gong, ZH
   Xiao, WJ
AF Zeng, Li
   Lin, Ling
   Peng, Yingqi
   Yuan, Dongyin
   Zhang, Sheng
   Gong, Zhihua
   Xiao, Wenjun
TI L-Theanine attenuates liver aging by inhibiting advanced glycation end
   products in D-galactose-induced rats and reversing an imbalance of
   oxidative stress and inflammation
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE L-Theanine; Oxidative stress; Inflammatory response; AGEs; Liver aging
ID UNIQUE AMINO-ACID; MICE; METABOLISM; RECEPTOR; INJURY; DAMAGE; AGE
AB Redox and inflammation imbalances are associated with increased levels of advanced glycation end products (AGEs), leading to the degeneration of body function. L-Theanine, derived from tea, reportedly inhibits AGE formation in vitro. We investigated the effects on AGE content, oxidative stress, and inflammatory factors in D-galactose-induced aging rats for prevention and treatment of age-related liver dysfunction. L-Theanine increased activities of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase, thus enhancing total antioxidant capacity, and decreasing malondialdehyde and nitric oxide synthase levels in serum and liver. Levels of the pro-inflammatory factors, interleukin (IL)-1 beta, tumour necrosis factor-alpha, and IL-6 were decreased in serum and liver, whereas those of anti-inflammatory factors, IL-4 and IL-10, were increased in the serum. Further, L-theanine inhibited AGE production and decreased the levels of the liver function markers, alanine aminotransaminase and aspartate aminotransferase. It also significantly increased the mRNA expression levels of FoxO1 and downregulated NF-kappa B(p65) but suppressed the phosphorylation of both FOXO1 and NF-kappa B (p65). Moreover, L-theanine effectively attenuated n-galactose-induced oedema and vacuole formation, thus protecting the liver. Overall, L-theanine reversed the D-galactose-induced imbalance in oxidative stress and inflammatory responses, reduced AGEs content in aging rats, maintained homeostasis in the body, and ameliorated liver aging.
C1 [Zeng, Li; Lin, Ling; Peng, Yingqi; Yuan, Dongyin; Zhang, Sheng; Gong, Zhihua; Xiao, Wenjun] Hunan Agr Univ, Natl Res Ctr Engn & Technol Utilizat Bot Funct In, Changsha 410128, Peoples R China.
   [Zeng, Li] Shaoyang Univ, Sch Pharm, Shaoyang 422000, Peoples R China.
   [Zeng, Li; Lin, Ling; Peng, Yingqi; Yuan, Dongyin; Zhang, Sheng; Gong, Zhihua; Xiao, Wenjun] Hunan Agr Univ, Key Lab Tea Sci, Minist Educ, Changsha 410128, Hunan, Peoples R China.
C3 Hunan Agricultural University; Shaoyang University; Hunan Agricultural
   University
RP Gong, ZH; Xiao, WJ (corresponding author), Hunan Agr Univ, Natl Res Ctr Engn & Technol Utilizat Bot Funct In, Changsha 410128, Peoples R China.
EM gzh041211@163.com; xiaowenjun88@sina.com
FU National Natural Science Foundation of China [31871804]; Science and
   Technology Major Project of Changsha, China [kq1804003]; Natural Science
   Foundation of Hunan Province, China [2019JJ40272]; Scientific Research
   Foundation of Hunan Provincial Education Department, China [18C0808]
FX This work was financially supported by the National Natural Science
   Foundation of China [grant number 31871804]; Science and Technology
   Major Project of Changsha, China [grant number kq1804003]; the Natural
   Science Foundation of Hunan Province, China [grant number 2019JJ40272];
   and the Scientific Research Foundation of Hunan Provincial Education
   Department, China [grant number 18C0808].
CR Bennmann D, 2015, MECH AGEING DEV, V150, P1, DOI 10.1016/j.mad.2015.07.003
   Borzelleca JF, 2006, FOOD CHEM TOXICOL, V44, P1158, DOI 10.1016/j.fct.2006.03.014
   Bryan S, 2013, CAN J PHYSIOL PHARM, V91, P22, DOI 10.1139/cjpp-2012-0295
   Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030
   Cai WJ, 2014, P NATL ACAD SCI USA, V111, P4940, DOI 10.1073/pnas.1316013111
   CANUTO RA, 1994, CARCINOGENESIS, V15, P1359, DOI 10.1093/carcin/15.7.1359
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Culetu A, 2016, FOOD CHEM, V197, P14, DOI 10.1016/j.foodchem.2015.10.097
   Deng YL, 2016, J FUNCT FOODS, V24, P527, DOI 10.1016/j.jff.2016.04.029
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Fan LM, 2014, J PHARMACOL TOX MET, V70, P40, DOI 10.1016/j.vascn.2014.03.173
   Frimat M, 2017, CLIN SCI, V131, P1069, DOI 10.1042/CS20160823
   Fujita T, 2013, J HEPATOL, V59, P1360, DOI 10.1016/j.jhep.2013.07.038
   Gong ZH, 2019, J FUNCT FOODS, V54, P32, DOI 10.1016/j.jff.2019.01.011
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hipkiss AR, 1998, ANN NY ACAD SCI, V854, P37, DOI 10.1111/j.1749-6632.1998.tb09890.x
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Horiuchi S, 2002, J HEPATOL, V36, P123, DOI 10.1016/S0168-8278(01)00293-8
   Kass DA, 2003, CIRC RES, V92, P704, DOI 10.1161/01.RES.0000069362.52165.C9
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095
   Li GL, 2012, FOOD CHEM TOXICOL, V50, P363, DOI 10.1016/j.fct.2011.10.036
   Li W, 2017, EXP THER MED, V14, P5045, DOI 10.3892/etm.2017.5163
   Liu JH, 2003, METHOD FIND EXP CLIN, V25, P447, DOI 10.1358/mf.2003.25.6.769650
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x
   Massaccesi L, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/6140896
   Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Palma-Duran S.A., 2018, METABOLISM CLIN EXPT
   Polito CA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050655
   Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792
   Pomatto LCD, 2019, MECH AGEING DEV, V177, P80, DOI 10.1016/j.mad.2018.05.006
   Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052
   Rao TP, 2015, J AM COLL NUTR, V34, P436, DOI 10.1080/07315724.2014.926153
   Saeed M, 2017, BIOMED PHARMACOTHER, V95, P1260, DOI 10.1016/j.biopha.2017.09.024
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Scheid L, 2012, J NUTR, V142, P2091, DOI 10.3945/jn.112.166371
   Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074
   Sharma E, 2018, FOOD CHEM, V242, P601, DOI 10.1016/j.foodchem.2017.09.046
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tia N, 2018, GENE, V648, P97, DOI 10.1016/j.gene.2018.01.051
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Wang DX, 2017, ASIA PAC J CLIN NUTR, V26, P384, DOI 10.6133/apjcn.032017.11
   Xiao MH, 2018, EXP THER MED, V16, P4100, DOI 10.3892/etm.2018.6727
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yamada T, 2008, BIOSCI BIOTECH BIOCH, V72, P1352, DOI 10.1271/bbb.70668
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
   Zhao Fan-fan, 2017, Yaoxue Xuebao, V52, P347, DOI 10.16438/j.0513-4870.2016-0696
   Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095
NR 50
TC 37
Z9 39
U1 4
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2020
VL 131
AR 110823
DI 10.1016/j.exger.2019.110823
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KE5YG
UT WOS:000508630900011
PM 31899338
DA 2024-02-19
ER

PT J
AU Zhang, HJ
   Doctrow, SR
   Oberley, LW
   Kregel, KC
AF Zhang, HJ
   Doctrow, SR
   Oberley, LW
   Kregel, KC
TI Chronic antioxidant enzyme mimetic treatment differentially modulates
   hyperthermia-induced liver HSP70 expression with aging
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE heat shock protein; Eukarion-189; oxidative stress; reactive oxygen
   species; heat stress
ID SALEN-MANGANESE COMPLEXES; HEAT-SHOCK-PROTEIN; SUPEROXIDE-DISMUTASE
   ACTIVITY; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; MESSENGER-RNA; FACTOR-I;
   RATS; MITOCHONDRIA; MODEL
AB One postulated mechanism for the reduction in stress tolerance with aging is a decline in the regulation of stress-responsive genes, such as inducible heat shock protein 72 (HSP70). Increased levels of oxidative stress are also associated with aging, but it is unclear what impact a prooxidant environment might have on HSP70 gene expression. This study utilized a superoxide dismutase/catalase mimetic (Eukarion-189) to evaluate the impact of a change in redox environment on age- related HSP70 responses to a physiologically relevant heat challenge. Results demonstrate that liver HSP70 mRNA and protein levels are reduced in old compared with young rats at selected time points over a 48-h recovery period following a heat-stress protocol. While chronic systemic administration of Eukarion-189 suppressed hyperthermia-induced liver HSP70 mRNA expression in both age groups, HSP70 protein accumulation was blunted in old rats but not in their young counterparts. These data suggest that a decline in HSP70 mRNA levels may be responsible for the reduction in HSP70 protein observed in old animals after heat stress. Furthermore, improvements in redox status were associated with reduced HSP70 mRNA levels in both young and old rats, but differential effects were manifested on protein expression, suggesting that HSP70 induction is differentially regulated with aging. These findings highlight the integrated mechanisms of stress protein regulation in eukaryotic organisms responding to environmental stress, which likely involve interactions between a wide range of cellular signals.
C1 Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA.
   Eukarion Inc, Bedford, MA USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Doctrow, Susan/0000-0003-0628-9960
FU NCI NIH HHS [CA-66081] Funding Source: Medline; NIA NIH HHS [AG-12350]
   Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Baker K, 1998, J PHARMACOL EXP THER, V284, P215
   Barrett MJ, 2004, J NEUROSCI RES, V78, P420, DOI 10.1002/jnr.20249
   BAUDRY M, 1993, BIOCHEM BIOPH RES CO, V192, P964, DOI 10.1006/bbrc.1993.1509
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bonelli MA, 1999, EXP CELL RES, V252, P20, DOI 10.1006/excr.1999.4614
   Chandolia RK, 1999, BIOL REPROD, V61, P1644, DOI 10.1095/biolreprod61.6.1644
   CLAIBORNE H, 1985, CRC HDB METHODS OXYG, P283
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   Dai RJ, 2000, J BIOL CHEM, V275, P18210, DOI 10.1074/jbc.M000958200
   Doctrow S R, 1997, Adv Pharmacol, V38, P247
   Doctrow SR, 2002, J MED CHEM, V45, P4549, DOI 10.1021/jm020207y
   GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1
   Ikeda M, 2004, TOHOKU J EXP MED, V203, P353, DOI 10.1620/tjem.203.353
   Jin XF, 2004, CELL STRESS CHAPERON, V9, P69, DOI 10.1379/477.1
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kim Y, 1997, J CELL BIOCHEM, V67, P43, DOI 10.1002/(SICI)1097-4644(19971001)67:1<43::AID-JCB5>3.0.CO;2-W
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   KREGEL KC, 1990, J APPL PHYSIOL, V68, P1337, DOI 10.1152/jappl.1990.68.4.1337
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LEVINE JA, 1969, AM J MED, V47, P251, DOI 10.1016/0002-9343(69)90151-X
   Marini M, 1996, INT J RADIAT BIOL, V70, P337, DOI 10.1080/095530096145076
   McArdle A, 2003, FASEB J, V17, P355, DOI 10.1096/fj.03-0395fje
   Muller M, 2004, CAN J PHYSIOL PHARM, V82, P523, DOI 10.1139/Y04-059
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   POWIS G, 1995, PHARMACOL THERAPEUT, V68, P149, DOI 10.1016/0163-7258(95)02004-7
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9
   Vasilaki A, 2002, MUSCLE NERVE, V25, P902, DOI 10.1002/mus.10094
   Vivinus S, 2001, EUR J BIOCHEM, V268, P1908, DOI 10.1046/j.1432-1327.2001.02064.x
   Wallen ES, 1997, INT J HYPERTHER, V13, P517, DOI 10.3109/02656739709023550
   Yamada N, 2000, CIRCULATION, V102, P457
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhang HJ, 2002, J VIROL, V76, P355, DOI 10.1128/JVI.76.1.355-363.2002
NR 44
TC 22
Z9 24
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD APR
PY 2006
VL 100
IS 4
BP 1385
EP 1391
DI 10.1152/japplphysiol.01046.2005
PG 7
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 033NF
UT WOS:000236854500040
PM 16254069
DA 2024-02-19
ER

PT J
AU Trnovska, J
   Svoboda, P
   Pelantova, H
   Kuzma, M
   Kratochvilova, H
   Kasperova, BJ
   Dvorakova, I
   Rosolova, K
   Malinska, H
   Huttl, M
   Markova, I
   Oliyarnyk, O
   Melcova, M
   Skop, V
   Mraz, M
   Stemberkova-Hubackova, S
   Haluzik, M
AF Trnovska, Jaroslava
   Svoboda, Petr
   Pelantova, Helena
   Kuzma, Marek
   Kratochvilova, Helena
   Kasperova, Barbora Judita
   Dvorakova, Iveta
   Rosolova, Katerina
   Malinska, Hana
   Huttl, Martina
   Markova, Irena
   Oliyarnyk, Olena
   Melcova, Magdalena
   Skop, Vojtech
   Mraz, Milos
   Stemberkova-Hubackova, Sona
   Haluzik, Martin
TI Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver,
   Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats:
   Possible Contribution of Attenuation of Cell Senescence and Oxidative
   Stress
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE empagliflozin; metabolic syndrome; hypertriglyceridemia; insulin
   sensitivity; cell senescence; hereditary hypertriglyceridemic rat model
ID COTRANSPORTER 2 INHIBITOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; HEME
   OXYGENASE-1; GENE-EXPRESSION; IMPROVES; INFLAMMATION; DIFFERENTIATION;
   HYPERGLYCEMIA; MACROPHAGES
AB (1) Background: empagliflozin, sodium-glucose co-transporter 2 (SGLT-2) inhibitor, is an effective antidiabetic agent with strong cardio- and nephroprotective properties. The mechanisms behind its cardio- and nephroprotection are still not fully clarified. (2) Methods: we used male hereditary hypertriglyceridemic (hHTG) rats, a non-obese model of dyslipidaemia, insulin resistance, and endothelial dysfunction fed standard diet with or without empagliflozin for six weeks to explore the molecular mechanisms of empagliflozin effects. Nuclear magnetic resonance (NMR)-based metabolomics; quantitative PCR of relevant genes involved in lipid and glucose metabolism, or senescence; glucose and palmitic acid oxidation in isolated tissues and cell lines of adipocytes and hepatocytes were used. (3) Results: empagliflozin inhibited weight gain and decreased adipose tissue weight, fasting blood glucose, and triglycerides and increased HDL-cholesterol. It also improved insulin sensitivity in white fat. NMR spectroscopy identified higher plasma concentrations of ketone bodies, ketogenic amino acid leucine and decreased levels of pyruvate and alanine. In the liver, adipose tissue and kidney, empagliflozin up-regulated expression of genes involved in gluconeogenesis and down-regulated expression of genes involved in lipogenesis along with reduction of markers of inflammation, oxidative stress and cell senescence. (4) Conclusion: multiple positive effects of empagliflozin, including reduced cell senescence and oxidative stress, could contribute to its long-term cardio- and nephroprotective actions.
C1 [Trnovska, Jaroslava; Svoboda, Petr; Kratochvilova, Helena; Dvorakova, Iveta; Malinska, Hana; Huttl, Martina; Markova, Irena; Oliyarnyk, Olena; Skop, Vojtech] Inst Clin & Expt Med, Ctr Med Expt, Cardiometabol Res Div, Prague 14021, Czech Republic.
   [Svoboda, Petr; Rosolova, Katerina; Melcova, Magdalena; Skop, Vojtech] Univ Chem Technol, Dept Biochem & Microbiol, Lab Anim Biochem, Prague 16628, Czech Republic.
   [Kuzma, Marek] Czech Acad Sci, Inst Microbiol, Lab Mol Struct Characterizat, Prague 14220, Czech Republic.
   [Kuzma, Marek] Palacky Univ Olomouc, Fac Sci, Dept Analyt Chem, Olomouc 77900, Czech Republic.
   [Kasperova, Barbora Judita; Rosolova, Katerina; Mraz, Milos; Haluzik, Martin] Inst Clin & Expt Med, Ctr Diabet, Prague 14021, Czech Republic.
   [Stemberkova-Hubackova, Sona] Czech Acad Sci, Inst Biotechnol, Lab Mol Therapy, Prague 25250, Czech Republic.
   [Haluzik, Martin] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague 12808, Czech Republic.
   [Haluzik, Martin] Gen Univ Hosp, Prague 12808, Czech Republic.
C3 Institute for Clinical & Experimental Medicine (IKEM); University of
   Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of
   Microbiology of the Czech Academy of Sciences; Palacky University
   Olomouc; Institute for Clinical & Experimental Medicine (IKEM); Czech
   Academy of Sciences; Institute of Biotechnology of the Czech Academy of
   Sciences; Charles University Prague; General University Hospital Prague
RP Trnovska, J (corresponding author), Inst Clin & Expt Med, Ctr Med Expt, Cardiometabol Res Div, Prague 14021, Czech Republic.; Haluzik, M (corresponding author), Inst Clin & Expt Med, Ctr Diabet, Prague 14021, Czech Republic.; Haluzik, M (corresponding author), Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague 12808, Czech Republic.; Haluzik, M (corresponding author), Gen Univ Hosp, Prague 12808, Czech Republic.
EM jaroslava.trnovska@ikem.cz; svobodae@vscht.cz; pelantova@biomed.cas.cz;
   kuzma@biomed.cas.cz; helena.kratochvilova@ikem.cz;
   barbora.judita.kasperova@ikem.cz; iveta.dvorakova@ikem.cz;
   katerina.rosolova@ikem.cz; hana.malinska@ikem.cz; martina.huttl@ikem.cz;
   irena.markova@ikem.cz; ooliyarnyk@yahoo.com; melcovam@vscht.cz;
   vojtech.skop@nih.gov; milos.mraz@ikem.cz; stemberkova@ibt.cas.cz;
   martin.haluzik@ikem.cz
RI Pelantová, Helena/R-4974-2017; Svoboda, Petr/B-7865-2014; Kuzma,
   Marek/F-5468-2015; Kratochvilova, Helena/I-3450-2017; Dvorakova,
   Iveta/H-7061-2017
OI Pelantová, Helena/0000-0002-2523-7413; Svoboda,
   Petr/0000-0001-7297-4208; Kuzma, Marek/0000-0001-7415-2734;
   Kratochvilova, Helena/0000-0001-8264-3883; Skop,
   Vojtech/0000-0002-4685-4429; Markova, Irena/0000-0002-4331-7636;
   Dvorakova, Iveta/0000-0002-6894-1558
FU Czech Science Foundation [GA19-06199S]; CZDRO (Institute for Clinical
   and Experimental MedicineIKEM) [00023001]; RVO VFN [64165]
FX This study was supported by grants from the Czech Science Foundation
   (GA19-06199S), by CZDRO (Institute for Clinical and Experimental
   MedicineIKEM, IN 00023001) and by RVO VFN 64165 to M.H. (Martin
   Haluzik).
CR Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965
   Akchurin OM, 2015, BLOOD PURIFICAT, V39, P84, DOI 10.1159/000368940
   Bence KK, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101143
   Besseiche A, 2015, DIABETES METAB, V41, P347, DOI 10.1016/j.diabet.2015.02.002
   Chobot A, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3042
   Contois JH, 2006, CLIN CHIM ACTA, V367, P150, DOI 10.1016/j.cca.2005.12.002
   Daniele G, 2016, DIABETES CARE, V39, P2036, DOI 10.2337/dc15-2688
   Devarajan P, 2008, SCAND J CLIN LAB INV, V68, P89, DOI 10.1080/00365510802150158
   Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59
   Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c
   Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393
   FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2
   Ferrannini E, 2016, DIABETES CARE, V39, P1108, DOI 10.2337/dc16-0330
   Ferrannini E, 2016, DIABETES, V65, P1190, DOI 10.2337/db15-1356
   Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057
   Gallo LA, 2015, DIABETES VASC DIS RE, V12, P78, DOI 10.1177/1479164114561992
   Han J, 2017, DIABETOLOGIA, V60, P364, DOI 10.1007/s00125-016-4158-2
   Hattori S, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0395-5
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Holecek M, 2001, NUTRITION, V17, P70, DOI 10.1016/S0899-9007(00)00483-4
   Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1
   Hubackova S, 2019, CELL DEATH DIFFER, V26, P276, DOI 10.1038/s41418-018-0118-3
   Jojima T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205237
   Kaji K, 2018, INT J CANCER, V142, P1712, DOI 10.1002/ijc.31193
   Kiran S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051004
   Klimes Iwar, 1995, Blood Pressure, V4, P137, DOI 10.3109/08037059509077585
   Kohjima M, 2007, INT J MOL MED, V20, P351
   Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Leoncini G, 2005, J INTERN MED, V257, P454, DOI 10.1111/j.1365-2796.2005.01468.x
   Lever JM, 2016, ANTIOXID REDOX SIGN, V25, P165, DOI 10.1089/ars.2016.6659
   Li LR, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.589273
   Liao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep32887
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Locatelli F, 2006, J AM SOC NEPHROL, V17, pS81, DOI 10.1681/ASN.2005121332
   Lopaschuk GD, 2020, JACC-BASIC TRANSL SC, V5, P632, DOI 10.1016/j.jacbts.2020.02.004
   Malinska H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220377
   Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082
   Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704
   Michel MC, 2015, N-S ARCH PHARMACOL, V388, P801, DOI 10.1007/s00210-015-1134-1
   Mosley Juan F 2nd, 2015, P T, V40, P451
   Mudaliar S, 2016, DIABETES CARE, V39, P1115, DOI 10.2337/dc16-0542
   Ndefo Uche Anadu, 2015, P T, V40, P364
   Neschen S, 2015, DIABETES, V64, P284, DOI 10.2337/db14-0393
   Nishimura R, 2019, ADV THER, V36, P2769, DOI 10.1007/s12325-019-01045-x
   Obara K, 2017, ONCOTARGET, V8, P58353, DOI 10.18632/oncotarget.16874
   Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oshima H, 2019, J PHARMACOL EXP THER, V368, P524, DOI 10.1124/jpet.118.253666
   Packer M, 2020, NEW ENGL J MED, V383, P1413, DOI 10.1056/NEJMoa2022190
   Pandey G, 2017, J CELL BIOCHEM, V118, P276, DOI 10.1002/jcb.25632
   Pillon NJ, 2021, CELL, V184, P1530, DOI 10.1016/j.cell.2021.02.012
   Reiner Z, 2017, NAT REV CARDIOL, V14, P401, DOI 10.1038/nrcardio.2017.31
   Rieg T, 2014, AM J PHYSIOL-RENAL, V306, pF188, DOI 10.1152/ajprenal.00518.2013
   Shakeri H, 2018, AM J PHYSIOL-HEART C, V315, pH448, DOI 10.1152/ajpheart.00287.2018
   Skop V, 2014, DIFFERENTIATION, V87, P220, DOI 10.1016/j.diff.2014.06.002
   Steven S, 2017, REDOX BIOL, V13, P370, DOI 10.1016/j.redox.2017.06.009
   Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x
   Su RC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225604
   Suzuki M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.20
   Svoboda P, 2017, PHYSIOL RES, V66, P709, DOI 10.33549/physiolres.933370
   Svoboda P, 2019, J BIOL CHEM, V294, P8676, DOI 10.1074/jbc.RA118.003505
   Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4
   Trachta P, 2014, PHYSIOL RES, V63, pS299, DOI 10.33549/physiolres.932792
   Tripolt NJ, 2020, AM HEART J, V221, P39, DOI 10.1016/j.ahj.2019.12.004
   Trnovská J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179063
   Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013
   Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012
   Vickers SP, 2014, DIABETES METAB SYNDR, V7, P265, DOI 10.2147/DMSO.S58786
   Vrana A, 1997, ANN NY ACAD SCI, V827, P510, DOI 10.1111/j.1749-6632.1997.tb51861.x
   VRANA A, 1990, TRANSPLANT P, V22, P2579
   Wang LJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24183390
   Wanner C, 2017, AM J CARDIOL, V120, pS59, DOI 10.1016/j.amjcard.2017.05.012
   Wei D, 2020, LIFE SCI, V247, DOI 10.1016/j.lfs.2020.117414
   Welsh P, 2018, DIABETOLOGIA, V61, P1581, DOI 10.1007/s00125-018-4619-x
   Wilding JPH, 2014, METABOLISM, V63, P1228, DOI 10.1016/j.metabol.2014.06.018
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Xu L, 2017, EBIOMEDICINE, V20, P137, DOI 10.1016/j.ebiom.2017.05.028
   Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040
   Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405
   Zicha J, 2006, PHYSIOL RES, V55, pS49, DOI 10.33549/physiolres.930000.55.S1.49
   Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720
NR 84
TC 11
Z9 11
U1 2
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2021
VL 22
IS 19
AR 10606
DI 10.3390/ijms221910606
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA WI0EZ
UT WOS:000708042200001
PM 34638943
OA Green Published, gold
DA 2024-02-19
ER

PT S
AU Martinez-Lopez, N
   Athonvarangkul, D
   Singh, R
AF Martinez-Lopez, Nuria
   Athonvarangkul, Diana
   Singh, Rajat
BE Atzmon, G
TI Autophagy and Aging
SO LONGEVITY GENES: A BLUEPRINT FOR AGING
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID CHAPERONE-MEDIATED AUTOPHAGY; HYPOTHALAMIC POMC NEURONS; EXTENDS
   LIFE-SPAN; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS;
   LYSOSOMAL RECEPTOR; CYTOSOLIC PROTEINS; DISEASE; MTOR
C1 [Singh, Rajat] Albert Einstein Coll Med, Diabet Res Ctr, Dept Med Endocrinol & Mol Pharmacol, Bronx, NY 10461 USA.
   [Martinez-Lopez, Nuria; Athonvarangkul, Diana] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
   [Martinez-Lopez, Nuria; Athonvarangkul, Diana] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP Singh, R (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, Dept Med Endocrinol & Mol Pharmacol, 1300 Morris Pk Ave,Forchheimer Bldg,Room 505D, Bronx, NY 10461 USA.
EM rajat.singh@einstein.yu.edu
RI Athonvarangkul, Diana/AAV-1408-2020
FU NIA NIH HHS [RF1 AG043517, AG043517, P01 AG031782, R01 AG043517] Funding
   Source: Medline; NIDDK NIH HHS [K01 DK087776, DK087776] Funding Source:
   Medline; NIGMS NIH HHS [T32GM007288, T32 GM007288, 5T32GM728837] Funding
   Source: Medline
CR Arias E, 2011, CURR OPIN CELL BIOL, V23, P184, DOI 10.1016/j.ceb.2010.10.009
   Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07
   Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416
   Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606
   Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002
   CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200
   Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153
   Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110
   Del Roso A, 1991, Aging (Milano), V3, P407
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163
   Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Hardie D. Grahame, 1994, Seminars in Cell Biology, V5, P409, DOI 10.1006/scel.1994.1048
   Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003
   Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283
   Kaushik S, 2012, EMBO REP, V13, P258, DOI 10.1038/embor.2011.260
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921
   Matsui A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003245
   Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Papinski D, 2014, AUTOPHAGY, V10, P1338, DOI 10.4161/auto.28971
   Phillips AR, 2008, GENETICS, V178, P1339, DOI 10.1534/genetics.107.086199
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362
   Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020
   Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109
   Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003
   Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997
   Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176
   Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433
   Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200
   Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E
   Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043
   Yang Z, 2012, OBES REV, V13, P58, DOI 10.1111/j.1467-789X.2012.01038.x
   Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhao Z, 2012, DEV CELL, V22, P1001, DOI 10.1016/j.devcel.2011.12.027
NR 80
TC 138
Z9 158
U1 0
U2 20
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-1-4939-2404-2; 978-1-4939-2403-5
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2015
VL 847
BP 73
EP 87
DI 10.1007/978-1-4939-2404-2_3
D2 10.1007/978-1-4939-2404-2
PG 15
WC Biology; Genetics & Heredity; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Genetics & Heredity;
   Research & Experimental Medicine
GA BD5TC
UT WOS:000361797200004
PM 25916586
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Deng, XH
   Lin, BF
   Wang, F
   Xu, PC
   Wang, NN
AF Deng, Xuehui
   Lin, Bingfeng
   Wang, Fang
   Xu, Pingcui
   Wang, Nani
TI Specnuezhenide Ameliorates Age-Related Hepatic Lipid Accumulation via
   Modulating Bile Acid Homeostasis and Gut Microbiota in
   D-Galactose-Induced Mice
SO METABOLITES
LA English
DT Article
DE Specnuezhenide; lipid accumulation; bile acids; gut microbiota
ID FRUCTUS-LIGUSTRI-LUCIDI; OXIDATIVE STRESS; LIVER-INJURY; METABOLISM;
   OBESITY; MODELS; TARGET; BONE
AB Age-related hepatic lipid accumulation has become a major health problem in the elderly population. Specnuezhenide (SPN) is a major active iridoid glycoside from an edible herb Fructus Ligustri Lucidi, which is commonly used for preventing age-related diseases. However, the beneficial effects of SPN on age-related liver injury remain unknown. This study aimed to reveal the effect of SPN on age-related hepatic lipid accumulation and the underlying mechanism. D-galactose (D-gal)-induced aging mice were treated with vehicle or SPN for 12 weeks. Treatment of SPN decreased lipid accumulation and inflammation in the liver of D-gal-induced mice. Untargeted and targeted metabolomics showed that the SPN could regulate the bile acid (BA) synthesis pathway and restore the BA compositions in serum, livers, and feces of the D-gal-induced mice. Furthermore, SPN enhanced the protein and mRNA levels of hepatic BAs synthesis enzymes cytochrome P45027A1, cytochrome P4507A1, cytochrome P4507B1, and cytochrome P4508B1. Meanwhile, SPN alleviated D-gal-induced gut dysbiosis and reversed the proportions of microbes associated with bile salt hydrolase activity, including Lactobacillus, Ruminiclostridium, and Butyrivibrio. Our study revealed that SPN attenuated age-related hepatic lipid accumulation by improving BA profiles via modulating hepatic BA synthesis enzymes and gut microbiota.
C1 [Deng, Xuehui; Wang, Fang; Wang, Nani] Zhejiang Chinese Med Univ, Sch Pharm, Hangzhou 310007, Peoples R China.
   [Lin, Bingfeng; Xu, Pingcui; Wang, Nani] Zhejiang Acad Tradit Chinese Med, Dept Med, Hangzhou 310007, Peoples R China.
C3 Zhejiang Chinese Medical University
RP Wang, NN (corresponding author), Zhejiang Chinese Med Univ, Sch Pharm, Hangzhou 310007, Peoples R China.; Wang, NN (corresponding author), Zhejiang Acad Tradit Chinese Med, Dept Med, Hangzhou 310007, Peoples R China.
EM 202111113611026@zcmu.edu.cn; bingfengl1995@163.com; 11006170@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation of China [LY21H280001,
   2021C03047]; National Natural Science Foundation of China [81973447];
   Zhejiang Provincial Medicine Foundation [2021ZQ018, 2022ZX002,
   2021ZYY28, GZY-ZJ-KJ-23006]; Zhejiang Province Chai Xiujuan Famous old
   TCM expert inheritance studio construction project
FX This work was supported by Zhejiang Provincial Natural Science
   Foundation of China (LY21H280001, 2021C03047), National Natural Science
   Foundation of China (81973447), Zhejiang Provincial Medicine Foundation
   (2021ZQ018, 2022ZX002, 2021ZYY28, GZY-ZJ-KJ-23006), and Zhejiang
   Province Chai Xiujuan Famous old TCM expert inheritance studio
   construction project.
CR Ahmad TR, 2019, NAT REV ENDOCRINOL, V15, P701, DOI 10.1038/s41574-019-0266-7
   Cai JW, 2022, PHARMACOL THERAPEUT, V237, DOI 10.1016/j.pharmthera.2022.108238
   Ceryak S, 1998, HEPATOLOGY, V27, P546, DOI 10.1002/hep.510270232
   Chambers KF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112588
   Chen BB, 2017, MOLECULES, V22, DOI 10.3390/molecules22091469
   Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023
   de Vos WM, 2022, GUT, V71, P1020, DOI 10.1136/gutjnl-2021-326789
   Dell Ralph B, 2002, ILAR J, V43, P207
   Dey P, 2021, FREE RADICAL BIO MED, V176, P265, DOI 10.1016/j.freeradbiomed.2021.09.026
   Dey P, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118172
   Gao XB, 2022, INFLAMMATION, V45, P639, DOI 10.1007/s10753-021-01573-1
   Geng W, 2016, ANIM HEALTH RES REV, V17, P148, DOI 10.1017/S1466252316000153
   Grant SM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21175982
   Guo Q, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072135
   Heinrich M, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112230
   Honda A, 2020, J LIPID RES, V61, P54, DOI 10.1194/jlr.RA119000395
   Hu DM, 2022, J PHARM PHARMACOL, V74, P191, DOI 10.1093/jpp/rgab164
   Huang S, 2019, J ETHNOPHARMACOL, V241, DOI 10.1016/j.jep.2019.111976
   Hurley MJ, 2022, PHARMACOL THERAPEUT, V240, DOI 10.1016/j.pharmthera.2022.108311
   Izzo AA, 2020, BRIT J PHARMACOL, V177, P2169, DOI 10.1111/bph.15054
   Kondoh H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010175
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Li L, 2019, AGING-US, V11, P9348, DOI 10.18632/aging.102376
   Ma CY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00700
   Mullish BH, 2019, GUT, V68, P1791, DOI 10.1136/gutjnl-2018-317842
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Qin XY, 2023, PHARM BIOL, V61, P391, DOI 10.1080/13880209.2023.2168019
   Seo HL, 2017, CHEM-BIOL INTERACT, V262, P57, DOI 10.1016/j.cbi.2016.11.031
   Shi MG, 2022, J ETHNOPHARMACOL, V291, DOI 10.1016/j.jep.2022.115164
   Sosic-Jurjevic B, 2019, J STEROID BIOCHEM, V190, P1, DOI 10.1016/j.jsbmb.2019.03.009
   Tanaka M, 1999, J HEPATOL, V31, P263, DOI 10.1016/S0168-8278(99)80223-2
   Tang XW, 2016, J ETHNOPHARMACOL, V194, P63, DOI 10.1016/j.jep.2016.08.049
   Tian H, 2022, SMALL METHODS, V6, DOI 10.1002/smtd.202200130
   Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028
   Wang SS, 2021, J ADV RES, V34, P109, DOI 10.1016/j.jare.2021.06.001
   Xu J, 2022, FOOD FUNCT, V13, P3050, DOI [10.1039/D1FO04085E, 10.1039/d1fo04085e]
   Yang TT, 2017, J STEROID BIOCHEM, V172, P69, DOI 10.1016/j.jsbmb.2017.05.015
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Zhang YC, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.760338
NR 40
TC 0
Z9 0
U1 11
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD AUG
PY 2023
VL 13
IS 8
AR 960
DI 10.3390/metabo13080960
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA Q3QP7
UT WOS:001056700500001
PM 37623903
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lonardo, A
   Lugari, S
   Nascimbeni, F
AF Lonardo, Amedeo
   Lugari, Simonetta
   Nascimbeni, Fabio
TI Telomere shortening: An innocent bystander at the crossroad of NASH with
   ageing and cardiometabolic risk?
SO LIVER INTERNATIONAL
LA English
DT Article
ID FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; LENGTH; CIRRHOSIS;
   BIOLOGY
C1 [Lonardo, Amedeo; Lugari, Simonetta; Nascimbeni, Fabio] Azienda Osped Univ Modena, Osped Civile Baggiovara, Modena, Italy.
   [Lugari, Simonetta; Nascimbeni, Fabio] Univ Modena & Reggio Emilia, Modena, Italy.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia Hospital; Universita di Modena e Reggio Emilia
RP Lonardo, A (corresponding author), Azienda Osped Univ Modena, Osped Civile Baggiovara, Modena, Italy.
EM a.lonardo@libero.it
RI LONARDO, AMEDEO/I-5911-2019
OI LONARDO, AMEDEO/0000-0001-9886-0698; Nascimbeni,
   Fabio/0000-0002-1051-1272
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370
   Ballestri S, 2017, METABOLISM, V72, P57, DOI 10.1016/j.metabol.2017.04.003
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Carulli L, 2012, HEPATOLOGY, V56, P2001, DOI 10.1002/hep.26089
   Donati B, 2017, CANCER MED-US, V6, P1930, DOI 10.1002/cam4.1078
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886
   Kirchner H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070176
   Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147
   Makino N, 2009, AM J PHYSIOL-HEART C, V297, pH2188, DOI 10.1152/ajpheart.00421.2009
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nilsson PM, 2014, NAT REV ENDOCRINOL, V10, P706, DOI 10.1038/nrendo.2014.182
   Nishikawa T, 2009, LIVER INT, V29, P846, DOI 10.1111/j.1478-3231.2008.01963.x
   Ping F, 2017, J DIABETES INVEST, V8, P174, DOI 10.1111/jdi.12555
   Tzanetakou IP, 2014, CURR VASC PHARMACOL, V12, P726
   Wan SG, 2012, LIVER INT, V32, P1233, DOI 10.1111/j.1478-3231.2012.02801.x
   Wojcicki JM, 2017, INT J HEPATOL, V2017, DOI 10.1155/2017/8435178
NR 19
TC 3
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD OCT
PY 2018
VL 38
IS 10
BP 1730
EP 1732
DI 10.1111/liv.13935
PG 3
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GU8VZ
UT WOS:000445622400003
PM 30256511
DA 2024-02-19
ER

PT J
AU Rutkute, K
   Asmis, RH
   Nikolova-Karakashian, MN
AF Rutkute, Kristina
   Asmis, Reto H.
   Nikolova-Karakashian, Mariana N.
TI Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the
   role of oxidative stress in aging-associated inflammation
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE ceramide; calorie restriction; interleukin-1 receptor-associated
   kinase-1; c-Jun N-terminal kinase; reduced glutathione
ID RECEPTOR-ASSOCIATED KINASE; CYTOCHROME-P450 2C11 CYP2C11; AGE-ASSOCIATED
   INCREASE; KAPPA-B ACTIVITY; ANTIOXIDANT ENZYMES; LIVER GLUTATHIONE;
   PLASMA-MEMBRANE; RAT HEPATOCYTES; CELL-DEATH; CERAMIDE
AB Oxidative stress and inflammation are fundamental for the onset of aging and appear to be causatively linked. Previously, we reported that hepatocytes from aged rats, compared with young rats, are hyperresponsive to interleukin-1 beta (IL-1 beta) stimulation and exhibit more potent c-Jun N-terminal kinase ( JNK) activation and attenuated interleukin-1 receptor-associated kinase-1 ( IRAK-1) degradation. An age-related increase in the activity of neutral sphingomyelinase-2 ( NSMase-2), a plasma membrane enzyme, was found to be responsible for the IL-1 beta hyperresponsiveness. The results reported here show that increased NSMase activity during aging is caused by a 60-70% decrease in hepatocyte GSH levels. GSH, at concentrations typically found in hepatocytes from young animals, inhibits NSMase activity in a biphasic dose-dependent manner. Inhibition of GSH synthesis in young hepatocytes activates NSMase, causing increased JNK activation and IRAK-1 stabilization in response to IL-1 beta, mimicking the hyperresponsiveness typical for aged hepatocytes. Vice versa, increased GSH content in hepatocytes from aged animals by treatment with N-acetylcysteine inhibits NSMase activity and restores normal IL-1 beta response. Importantly, the GSH decline, NSMase activation, and IL-1 beta hyperresponsiveness are not observed in aged, calorie-restricted rats. In summary, this report demonstrates that depletion of cellular GSH during aging plays an important role in regulating the hepatic response to IL-1 beta by inducing NSMase-2 activity.
C1 Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA.
   Univ Texas, Hlth Sci Ctr, Audie L Murphy Vet Hosp, Div Nephrol, San Antonio, TX 78284 USA.
C3 University of Kentucky; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA.
EM mnikolo@uky.edu
RI Asmis, Reto/W-1344-2019
CR Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549
   Adib-Conquy M, 2002, J BIOL CHEM, V277, P27927, DOI 10.1074/jbc.M200705200
   Asmis R, 2005, FASEB J, V19, P1866, DOI 10.1096/fj.04-2991fje
   Ayasolla K, 2004, FREE RADICAL BIO MED, V37, P325, DOI 10.1016/j.freeradbiomed.2004.04.007
   Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224
   Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   Bernardo K, 2000, J BIOL CHEM, V275, P7641, DOI 10.1074/jbc.275.11.7641
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bose C, 2005, MECH AGEING DEV, V126, P740, DOI 10.1016/j.mad.2005.02.003
   Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0
   CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Claycombe KJ, 2002, J BIOL CHEM, V277, P30784, DOI 10.1074/jbc.M204463200
   Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Di Iorio A, 2003, CYTOKINE, V22, P198, DOI 10.1016/S1043-4666(03)00152-2
   DMELLO NP, 1994, J BIOL CHEM, V269, P15451
   Gouazé V, 2001, MOL PHARMACOL, V60, P488
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje
   Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034
   Lang CH, 1999, AM J PHYSIOL-GASTR L, V276, pG719, DOI 10.1152/ajpgi.1999.276.3.G719
   Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281
   Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313
   Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200
   Martín SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007
   MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3
   NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718
   Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20
   RUTKUTE K, 2007, IN PRESS HEPATOLOGY
   Schöndorf T, 2001, CLIN EXP MED, V1, P1, DOI 10.1007/PL00012236
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   Tang YM, 2000, MECH AGEING DEV, V114, P79, DOI 10.1016/S0047-6374(00)00090-7
   Tsyupko AN, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1028, DOI 10.1023/A:1012381928535
   VENABLE ME, 1994, J BIOL CHEM, V269, P26040
   VERICEL E, 1994, MOL CELL BIOCHEM, V132, P25, DOI 10.1007/BF00925671
   Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1
   Wu DY, 2003, J BIOL CHEM, V278, P10983, DOI 10.1074/jbc.M207470200
   Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540
   Yoshimura S, 1999, J NEUROCHEM, V73, P675, DOI 10.1046/j.1471-4159.1999.0730675.x
NR 51
TC 56
Z9 66
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD NOV
PY 2007
VL 48
IS 11
BP 2443
EP 2452
DI 10.1194/jlr.M700227-JLR200
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 220HT
UT WOS:000250148500012
PM 17693623
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Chakraborti, S
   Bahnson, BJ
AF Chakraborti, Subhendu
   Bahnson, Brian J.
TI Crystal Structure of Human Senescence Marker Protein 30: Insights
   Linking Structural, Enzymatic, and Physiological Functions
SO BIOCHEMISTRY
LA English
DT Article
ID SMP30 DEFICIENCY; KNOCKOUT MOUSE; LIVER; REGUCALCIN; GLUCONOLACTONASE;
   CRYSTALLIZATION; MANGANESE(II); BIOSYNTHESIS; PURIFICATION; MICE
AB Human senescence marker protein 30 (SMP30), which functions enzymatically as a lactonase, hydrolyzes various carbohydrate lactones. The penultimate step in vitamin-C biosynthesis is catalyzed by this enzyme in nonprimate mammals. It has also been implicated as an organophosphate hydrolase, with the ability to hydrolyze dnsopropyl phosphofluoridate and other nerve agents SMP30 was originally identified as an aging marker protein, whose expression decreased androgen independently in aging cells. SMP30 is also referred to as regucalcin and has been suggested to have functions in calcium homeostasis The crystal structure of the human enzyme has been solved from X-ray diffraction data collected to a resolution of 1.4 angstrom. The protein has a 6-bladed beta-propeller fold, and it contains a single metal ion Crystal structures have been solved with the metal site bound with either a Ca2+ or a Zn2+ atom. The catalytic role of the metal ion has been confirmed by mutagenesis of the metal coordinating residues. Kinetic studies using the substrate gluconolactone showed a k(cat) preference of divalent cations in the order Zn2+ > Mn2+ > Ca2+ > Mg2+ Notably, the Ca2+ had a significantly higher value of K-d compared to those of the other metal ions tested (566, 82, 7, and 0.6 mu m for Ca2+, Mg2+, Zn2+, and Mn2+, respectively), suggesting that the Ca2+-bound form may be physiologically relevant for stressed cells with an elevated free calcium level.
C1 [Chakraborti, Subhendu; Bahnson, Brian J.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
C3 University of Delaware
RP Bahnson, BJ (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
FU National Center for Research Resources [2P20RR015588]; National Heart,
   Lung and Blood Institute [IR01HL084366]; U S Department of Energy,
   Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]
FX This work was supported by NIH Grants 2P20RR015588 from the National
   Center for Research Resources and IR01HL084366 from the National Heart,
   Lung and Blood Institute; Use of the Advanced Photon Source at the
   Argonne National Laboratory was supported by the U S Department of
   Energy, Office of Science, Office of Basic Energy Sciences, under
   contract DE-AC02-06CH11357. Use of the SGX Collaborative Access Team
   (SGX-CAT) beamline at Sector 31 of the Advanced Photon Source was
   provided by SGX Pharmaceuticals, Inc., who constructed and operated the
   facility We thank Dr. Randy Read of Cambridge University and Chavas Leo
   of University of Manchester for their valuable insights. We also thank
   Dr Danny Ramadan of the Thorpe Lab, for help with the metal binding
   analysts.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ASH DE, 1982, J BIOL CHEM, V257, P9261
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Chen CN, 2008, J MOL BIOL, V384, P604, DOI 10.1016/j.jmb.2008.09.055
   Costello LC, 2004, MITOCHONDRION, V4, P331, DOI 10.1016/j.mito.2004.07.031
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 2002, ADV CELL AGING GERON, V10, P13
   Gaidukov L, 2007, J LIPID RES, V48, P1637, DOI 10.1194/jlr.D600045-JLR200
   GALEOTTI T, 1995, ARCH BIOCHEM BIOPHYS, V322, P453, DOI 10.1006/abbi.1995.1488
   Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5
   Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200
   KHEISONSKY O, 2005, BIOCHEMISTRY-US, V44, P6371
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4
   Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200
   Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Warizaya M, 2004, ACTA CRYSTALLOGR D, V60, P2019, DOI 10.1107/S0907444904020608
   WILLIAMS RJP, 1982, FEBS LETT, V140, P3, DOI 10.1016/0014-5793(82)80508-5
   Yamaguchi M, 2005, INT J MOL MED, V15, P371
   YAMAGUCHI M, 1988, CHEM PHARM BULL, V36, P3532
   Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5
   YAMAGUCHI M, 2002, ADV CELL AGING GERON, V10, P47
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 41
TC 41
Z9 55
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 27
PY 2010
VL 49
IS 16
BP 3436
EP 3444
DI 10.1021/bi9022297
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 585IC
UT WOS:000276817600008
PM 20329768
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Passes, JF
   von Zglinicki, T
   Kirkwood, TBL
AF Passes, Joao F.
   von Zglinicki, Thomas
   Kirkwood, Thomas B. L.
TI Mitochondria and ageing: winning and losing in the numbers game
SO BIOESSAYS
LA English
DT Article
ID TRANSCRIPTION FACTOR-A; OXIDATIVE STRESS; SKELETAL-MUSCLE; DNA
   MUTATIONS; LIFE-SPAN; HUMAN-FIBROBLASTS; IN-VITRO; LIVER-MITOCHONDRIA;
   RADICAL PRODUCTION; STEM-CELLS
AB Mitochondrial dysfunction has long been considered a key mechanism in the ageing process but surprisingly little attention has been paid to the impact of mitochondrial number or density within cells. Recent reports suggest a positive association between mitochondrial density, energy homeostasis and longevity. However, mitochondrial number also determines the number of sites generating reactive oxygen species (ROS) and we suggest that the links between mitochondrial density and ageing are more complex, potentially acting in both directions. The idea that increased density, especially when combined with mitochondrial dysfunction, might accelerate ageing is supported by a negative correlation between mitochondrial density and maximum longevity in an interspecies comparison in mammals, and by evidence for an intimate interconnection between cellular ROS levels, mitochondrial density and cellular ageing. Recent data suggest that retrograde response, which activates mitochondrial biogenesis, accompanies cellular ageing processes. We hypothesise that increased mitochondrial biogenesis, and possibly also impaired degradation and segregation of mitochondria, if occurring as adaptation to pre-existing mitochondrial dysfunction, might aggravate ROS production and thus actively contribute to ageing.
C1 Univ Newcastle, Inst Hlth & Aging, Henry Wellcome Lab Biogerontol Res, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
C3 Newcastle University - UK
RP Kirkwood, TBL (corresponding author), Univ Newcastle, Inst Hlth & Aging, Henry Wellcome Lab Biogerontol Res, Ctr Integrated Syst Biol Ageing & Nutr, Westgate Rd, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
EM tom.kirkwood@ncl.ac.uk
OI von Zglinicki, Thomas/0000-0002-5939-0248; Passos,
   Joao/0000-0001-8765-1890
FU Biotechnology and Biological Sciences Research Council [BB/C008200/1]
   Funding Source: researchfish; Biotechnology and Biological Sciences
   Research Council [BB/C008200/1] Funding Source: Medline
CR Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0
   Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104
   Blackstone NW, 2003, DAHL WS ENV, P309
   Boraldi F, 2003, PROTEOMICS, V3, P917, DOI 10.1002/pmic.200300386
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166
   Cottrell D A, 2000, Curr Opin Clin Nutr Metab Care, V3, P473, DOI 10.1097/00075197-200011000-00009
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   David H., 1977, QUANTITATIVE ULTRAST
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x
   He ZP, 2004, CELL PROLIFERAT, V37, P177, DOI 10.1111/j.1365-2184.2004.00293.x
   HEGGENESS MH, 1978, P NATL ACAD SCI USA, V75, P3863, DOI 10.1073/pnas.75.8.3863
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Hütter E, 2002, EXP GERONTOL, V37, P1165, DOI 10.1016/S0531-5565(02)00136-5
   Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854
   Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040
   Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2
   Keller M, 2004, J EXP BIOL, V207, P2529, DOI 10.1242/jeb.01050
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kirchman PA, 1999, GENETICS, V152, P179
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kowald A, 2000, J THEOR BIOL, V202, P145, DOI 10.1006/jtbi.1999.1046
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1159/000064724
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x
   Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006
   PASSOS JF, 2006, THESIS NEWCASTLE U
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200
   Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x
   POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468
   Rivolta MN, 2002, DEV BRAIN RES, V133, P49, DOI 10.1016/S0165-3806(01)00321-2
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962
   Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004
   Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866
   Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6
   SINGH KK, 2003, OXIDATIVE STRESS AGI, V1, P452
   Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9
   Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Terman A, 2002, ANN NY ACAD SCI, V973, P309, DOI 10.1111/j.1749-6632.2002.tb04657.x
   Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001
   WANG E, 1984, EXP CELL RES, V154, P191, DOI 10.1016/0014-4827(84)90679-7
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu D, 2002, BIOCHEM BIOPH RES CO, V294, P245, DOI 10.1016/S0006-291X(02)00464-3
   Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493
NR 98
TC 55
Z9 59
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD SEP
PY 2007
VL 29
IS 9
BP 908
EP 917
DI 10.1002/bies.20634
PG 10
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 207YA
UT WOS:000249285800009
PM 17688237
DA 2024-02-19
ER

PT J
AU Pastori, GM
   delRio, LA
AF Pastori, GM
   delRio, LA
TI Natural senescence of pea leaves - An activated oxygen-mediated function
   for peroxisomes
SO PLANT PHYSIOLOGY
LA English
DT Article
ID PISUM-SATIVUM-L; RAT-LIVER PEROXISOMES; SUPEROXIDE-DISMUTASE;
   HYDROGEN-PEROXIDE; GLYOXYLATE-CYCLE; LEAF PEROXISOMES; GENE-EXPRESSION;
   PUMPKIN COTYLEDONS; OXIDATIVE STRESS; RADICALS
AB We studied the activated oxygen metabolism of peroxisomes in naturally and dark-induced senescent leaves of pea (Pisum sativum L.). Peroxisomes were purified from three different types of senescent leaves and the activities of different peroxisomal and glyoxysomal enzymes were measured. The activities of the O-2(.-)- and H2O2-producing enzymes were enhanced by natural senescence. Senescence also produced an increase in the generation of active oxygen species (O-2(.-) and H2O2) in leaf peroxisomes and in the activities of two glyoxylate-cycle marker enzymes. A new traction of peroxisomes was detected at an advanced stage of dark-induced senescence. Electron microscopy revealed that this new peroxisomal fraction varied in size and electron density. During senescence, the constitutive Mn-superoxide dismutase (SOD) activity of peroxisomes increased and two new CuZn-SODs were induced, one of which cross-reacted with an antibody against glyoxysomal CuZn-SOD. This fact and the presence of glyoxylate-cycle enzymes support the idea that foliar senescence is associated with the transition of peroxisomes into glyoxysomes. Our results indicate that natural senescence causes the same changes in peroxisome-activated oxygen metabolism as dark-induced senescence, and reinforce the hypothesis of an effective role of peroxisomes and their activated oxygen metabolism in this stage of the life cycle.
RP Pastori, GM (corresponding author), CSIC, DEPT BIOQUIM BIOL CELULAR & MOL PLANTAS, ESTAC EXPT ZAIDIN, APDO 419, E-18080 GRANADA, SPAIN.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   [Anonymous], 1985, Handbook of Methods for Oxygen Radical Research
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   BECKER W, 1993, PLANTA, V189, P74, DOI 10.1007/BF00201346
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUENO P, 1995, PLANT PHYSIOL, V108, P1151, DOI 10.1104/pp.108.3.1151
   DEBELLIS L, 1990, PLANTA, V180, P435, DOI 10.1007/BF00198797
   DEBELLIS L, 1991, PLANT CELL PHYSIOL, V32, P1227
   DEBELLIS L, 1991, PLANT CELL PHYSIOL, V32, P555
   DEFELIPE MR, 1985, J PLANT PHYSL, V132, P67
   DELRIO LA, 1989, PLANT PHYSIOL, V89, P728, DOI 10.1104/pp.89.3.728
   DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F
   DELRIO LA, 1985, J INORG BIOCHEM, V24, P25
   delRio LA, 1996, BIOCHEM SOC T, V24, P434, DOI 10.1042/bst0240434
   DISTEFANO S, 1996, PLANT PHYS BIOCH 10
   DIXON GH, 1962, METHOD ENZYMOL, V5, P633, DOI 10.1016/S0076-6879(62)05287-8
   DROILLARD MJ, 1990, PLANT PHYSIOL, V94, P1187, DOI 10.1104/pp.94.3.1187
   FLATMARK T, 1981, EUR J CELL BIOL, V24, P62
   FREW JE, 1983, ANAL CHIM ACTA, V155, P139, DOI 10.1016/S0003-2670(00)85587-7
   GOGLIA F, 1989, EXP BIOL, V48, P127
   GRAHAM IA, 1992, PLANT CELL, V4, P349, DOI 10.1105/tpc.4.3.349
   GULATI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P90, DOI 10.1016/0003-9861(92)90492-F
   Halliwell B., 1989, Free radicals in biology and medicine, V2nd
   JUST WW, 1982, EUR J CELL BIOL, V26, P249
   KAR M, 1984, PLANTA, V160, P385, DOI 10.1007/BF00429753
   KING GA, 1995, PLANT PHYSIOL, V108, P125, DOI 10.1104/pp.108.1.419
   KORNBERG HL, 1958, BIOCHEM J, V68, pP3
   LANDOLT R, 1990, PLANT SCI, V72, P159, DOI 10.1016/0168-9452(90)90078-3
   LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4
   Lopez-Huertas Eduardo, 1996, Biochemical Society Transactions, V24, p195S
   LOPEZHUERTAS E, 1995, PLANT PHYSIOL BIOCH, V33, P295
   MORRE DJ, 1990, PROTOPLASMA, V155, P58, DOI 10.1007/BF01322615
   MUELLER WC, 1978, CAN J BOT, V56, P1579, DOI 10.1139/b78-187
   NISHIMURA M, 1993, PROTOPLASMA, V175, P131, DOI 10.1007/BF01385011
   PALMA JM, 1991, ARCH BIOCHEM BIOPHYS, V287, P68, DOI 10.1016/0003-9861(91)90389-Z
   PASTORI GM, 1994, P ROY SOC EDINB B, V102, P505, DOI 10.1017/S0269727000014536
   PASTORI GM, 1994, PLANTA, V193, P385, DOI 10.1007/BF00201817
   PISTELLI L, 1991, PLANTA, V184, P151, DOI 10.1007/BF00208249
   PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65
   SANDALIO LM, 1987, PLANT SCI, V51, P1, DOI 10.1016/0168-9452(87)90213-5
   SARAN M, 1989, FREE RADICAL RES COM, V7, P213, DOI 10.3109/10715768909087944
   SAUTTER C, 1981, ANAL BIOCHEM, V113, P179, DOI 10.1016/0003-2697(81)90062-2
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SCHWITZGUEBEL JP, 1984, PLANT PHYSIOL, V75, P670, DOI 10.1104/pp.75.3.670
   THOMPSON JE, 1987, NEW PHYTOL, V105, P317, DOI 10.1111/j.1469-8137.1987.tb00871.x
   TRIPPI VS, 1985, PLANT CELL PHYSIOL, V26, P1303
   WALK RA, 1977, PLANTA, V136, P221, DOI 10.1007/BF00385988
   WILCKE M, 1995, J BIOL CHEM, V270, P6949, DOI 10.1074/jbc.270.12.6949
NR 49
TC 180
Z9 232
U1 1
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD FEB
PY 1997
VL 113
IS 2
BP 411
EP 418
DI 10.1104/pp.113.2.411
PG 8
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA WH572
UT WOS:A1997WH57200013
PM 12223615
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Kawase, M
   Kondoh, C
   Matsumoto, S
   Teshigawara, M
   Chisaka, Y
   Higashiura, M
   Nakata, K
   Ohmori, S
AF Kawase, M
   Kondoh, C
   Matsumoto, S
   Teshigawara, M
   Chisaka, Y
   Higashiura, M
   Nakata, K
   Ohmori, S
TI Contents of D-lactate and its related metabolites as well as enzyme
   activities in the liver, muscle and blood plasma of aging rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE D-lactate; L-lactate; methylglyoxal; glyoxalases; aging rat
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; BIOLOGICAL SAMPLES; SENSITIVE
   DETERMINATION; AGE; METHYLGLYOXAL; PEROXIDATION; RESTRICTION; ENERGY;
   BRAIN
AB As it is generally known, L-Iactate is formed via the Embden-Meyerhof glycolytic pathway from triosephosphates, whereas D-lactate is formed via methylglyoxal in rat. In this paper, age-related changes in the levels of D-lactate and its related compounds in rat tissues, are reported. Rats from 5 weeks to 30 months old were used in these experiments. (1) We observed that rats above 27 months old were decrepit as judged by external appearance movement and other physiological data of them. (2) The hepatic levels of D-lactate, methylglyoxal and pyruvate became markedly lower in aging rats, especially the D-lactate content in 30 month-old rats was lower by 90% than that of the 5 week-old rats. (3) As for plasma, D-lactate and phosphate levels became lower with aging, whereas levels of L-lactate and pyruvate were not altered. (4) In skeletal muscle, aging caused a lower methylglyoxal concentration. The D-lactate level was markedly decreased at the age of 30 months in muscle. (5) As for enzyme, activities of glyoxalase I and II became markedly decreased with age in livers, whereas the activity of glyoxalase I in muscle was maintained at control level and glyoxalase II increased with age.
C1 OKAYAMA UNIV,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,OKAYAMA 700,JAPAN.
C3 Okayama University
CR AURELI T, 1990, BRAIN RES, V526, P108, DOI 10.1016/0006-8993(90)90255-A
   BASS A, 1975, GERONTOLOGY, V21, P31, DOI 10.1159/000212028
   CHAINY GBN, 1976, BIOCHEM BIOPH RES CO, V72, P777, DOI 10.1016/S0006-291X(76)80200-8
   CHEN LH, 1993, ARCH GERONTOL GERIAT, V16, P69, DOI 10.1016/0167-4943(93)90028-G
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   ERMINI M, 1971, GERONTOLOGY, V17, P300, DOI 10.1159/000211836
   FERRANNINI E, 1990, METABOLISM, V39, P1082, DOI 10.1016/0026-0495(90)90170-H
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FISCHERNIELSEN A, 1989, J HEPATOL, V9, P190, DOI 10.1016/0168-8278(89)90050-0
   JULLIEN T, 1989, MECH AGEING DEV, V48, P243, DOI 10.1016/0047-6374(89)90086-9
   KELLUM MW, 1978, ANAL BIOCHEM, V85, P586, DOI 10.1016/0003-2697(78)90258-0
   KONDOH Y, 1992, EUR J APPL PHYSIOL O, V65, P88, DOI 10.1007/BF01466280
   KONDOH Y, 1994, J BIOCHEM-TOKYO, V115, P590, DOI 10.1093/oxfordjournals.jbchem.a124380
   KONDOH Y, 1992, RES EXP MED, V192, P407, DOI 10.1007/BF02576298
   LARKIN LM, 1992, EXP GERONTOL, V27, P179, DOI 10.1016/0531-5565(92)90042-X
   MATSUMOTO S, 1993, 113TH ANN M JAP PHAR, P105
   OHMORI S, 1991, J CHROMATOGR-BIOMED, V566, P1, DOI 10.1016/0378-4347(91)80105-L
   OHMORI S, 1987, J CHROMATOGR-BIOMED, V414, P149, DOI 10.1016/0378-4347(87)80033-6
   OHMORI S, 1988, J CHROMATOGR-BIOMED, V431, P239, DOI 10.1016/S0378-4347(00)83093-5
   OHMORI S, 1987, J CHROMATOGR-BIOMED, V415, P221, DOI 10.1016/S0378-4347(00)83214-4
   PASTORIS O, 1991, EXP GERONTOL, V26, P77, DOI 10.1016/0531-5565(91)90064-S
   RACKER E, 1955, METHOD ENZYMOL, V1, P454, DOI 10.1016/0076-6879(55)01075-6
   RIKANS LE, 1993, TOXICOL APPL PHARM, V118, P263, DOI 10.1006/taap.1993.1032
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SHARMALUTHRA R, 1994, MECH AGEING DEV, V73, P39, DOI 10.1016/0047-6374(94)90036-1
   Valentine W.N., 1966, METHODS ENZYMOL, V9, P468
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
NR 29
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP 29
PY 1995
VL 84
IS 1
BP 55
EP 63
DI 10.1016/0047-6374(95)01632-A
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TK942
UT WOS:A1995TK94200005
PM 8719777
DA 2024-02-19
ER

PT J
AU Maillo, C
   Martín, J
   Sebastián, D
   Hernández-Alvarez, M
   García-Rocha, M
   Reina, O
   Zorzano, A
   Fernandez, M
   Méndez, R
AF Maillo, Carlos
   Martin, Judit
   Sebastian, David
   Hernandez-Alvarez, Maribel
   Garcia-Rocha, Mar
   Reina, Oscar
   Zorzano, Antonio
   Fernandez, Mercedes
   Mendez, Raul
TI Circadian- and UPR-dependent control of CPEB4 mediates a translational
   response to counteract hepatic steatosis under ER stress
SO NATURE CELL BIOLOGY
LA English
DT Article
ID UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA
   TRANSLATION; CELL DIFFERENTIATION; RHYTHMIC ACTIVATION;
   LIPID-METABOLISM; KNOCKOUT MICE; LIVER-DISEASE; MOUSE-LIVER; CLOCK
AB The cytoplasmic polyadenylation element-binding (CPEB) proteins regulate pre-mRNA processing and translation of CPE-containing mRNAs in early embryonic development and synaptic activity. However, specific functions in adult organisms are poorly understood. Here we show that CPEB4 is required for adaptation to high-fat-diet- and ageing-induced endoplasmic reticulum (ER) stress, and subsequent hepatosteatosis. Stress-activated liver CPEB4 expression is dual-mode regulated. First, Cpeb4 mRNA transcription is controlled by the circadian clock, and then its translation is regulated by the unfolded protein response (UPR) through upstream open reading frames within the 5'UTR. Thus, the CPEB4 protein is synthesized only following ER stress but the induction amplitude is circadian. In turn, CPEB4 activates a second wave of UPR translation required to maintain ER and mitochondria! homeostasis. Our results suggest that combined transcriptional and translational Cpeb4 regulation generates a 'circadian mediator', which coordinates hepatic UPR activity with periods of high ER-protein-folding demand. Accordingly, CPEB4 deficiency results in non-alcoholic fatty liver disease.
C1 [Maillo, Carlos; Martin, Judit; Sebastian, David; Hernandez-Alvarez, Maribel; Garcia-Rocha, Mar; Reina, Oscar; Zorzano, Antonio; Mendez, Raul] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Sebastian, David; Hernandez-Alvarez, Maribel; Zorzano, Antonio] Fac Biol, Dept Bioquim & Biol Mol, Barcelona 08028, Spain.
   [Sebastian, David; Hernandez-Alvarez, Maribel; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid 28029, Spain.
   [Fernandez, Mercedes] Univ Barcelona, IDIBAPS Biomed Res Inst, E-08036 Barcelona, Spain.
   [Fernandez, Mercedes] Inst Salud Carlos III, CIBER Hepat & Digest Dis CIBEREHD, Madrid 28029, Spain.
   [Mendez, Raul] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain.
C3 Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III;
   University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBEREHD; ICREA
RP Méndez, R (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Fernandez, M (corresponding author), Univ Barcelona, IDIBAPS Biomed Res Inst, E-08036 Barcelona, Spain.; Fernandez, M (corresponding author), Inst Salud Carlos III, CIBER Hepat & Digest Dis CIBEREHD, Madrid 28029, Spain.; Méndez, R (corresponding author), Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain.
EM mercefernandez@ub.edu; raul.mendez@irbbarcelona.org
RI Hernández-Alvarez, María Isabel/HTO-0233-2023; mendez,
   ramon/L-7415-2014; Zorzano, Antonio/R-5479-2018; Sebastián,
   David/ABH-1574-2020; Hernández-Alvarez, María Isabel/Z-4830-2019
OI mendez, ramon/0000-0002-1419-1165; Hernandez-Alvarez, Maria
   Isabel/0000-0003-2483-7000; Garcia-Rocha, Mar/0000-0003-2467-2090;
   Sebastian, David/0000-0002-7260-3869; Mendez, Raul/0000-0002-1952-6905;
   Reina Garcia, Oscar/0000-0002-1031-2732; Martin,
   Judit/0000-0002-4193-7890
FU Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2011-30121,
   BIO2012-31043, BFU2014-54122-P, CSD2009-00080, SAF2014-55473-R];
   European Union FEDER funds; Fundacion Botin by the Banco Santander
   through its Santander Universities Global Division; Scientific
   Foundation of the Spanish Association Against Cancer (AECC); Worldwide
   Cancer Research Foundation; 'la Caixa' predoctoral fellowship; Severo
   Ochoa Award of Excellence from MINECO (Government of Spain); ICREA
   Funding Source: Custom
FX We thank the Advance Digital Microscopy, Biostatistics/Bioinformatics,
   Histopathology, Mouse Mutant, and Functional Genomics facilities at IRB
   Barcelona. We also thank S. Aznar-Benitah, J. Guinovart and members of
   R.M.'s laboratory for useful discussion and T. Yates for correcting the
   manuscript. This work was supported by grants from the Spanish Ministry
   of Economy and Competitiveness (MINECO, BFU2011-30121, BIO2012-31043,
   BFU2014-54122-P, Consolider RNAREG CSD2009-00080, SAF2014-55473-R), the
   European Union FEDER funds, the Fundacion Botin by the Banco Santander
   through its Santander Universities Global Division, the Scientific
   Foundation of the Spanish Association Against Cancer (AECC), and the
   Worldwide Cancer Research Foundation. C.M. held a 'la Caixa' predoctoral
   fellowship. IRB Barcelona is the recipient of a Severo Ochoa Award of
   Excellence from MINECO (Government of Spain). GIBER is an initiative
   from the Instituto de Salud Carlos III.
CR Afroz T, 2014, GENE DEV, V28, P1498, DOI 10.1101/gad.241133.114
   Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457
   Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901
   Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808
   Calderone V, 2016, GASTROENTEROLOGY, V150, P982, DOI 10.1053/j.gastro.2015.11.038
   Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002
   Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115
   Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fernández-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004
   Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208
   Garcia-Pras E., 2016, GUT
   Giangarrà V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138794
   Guillén-Boixet J, 2016, ELIFE, V5, DOI 10.7554/eLife.19298
   Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685
   Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5
   Hu WQ, 2014, DEV CELL, V30, P660, DOI 10.1016/j.devcel.2014.07.008
   Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111
   Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831
   Jouffe C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24631
   Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10
   Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886
   Kojima S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17059
   Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111
   Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001
   Özcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ortiz-Zapater E, 2012, NAT MED, V18, P83, DOI 10.1038/nm.2540
   Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752
   Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056
   Piqué M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576
   Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928
   Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012
   Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   SAGARA Y, 1991, J BIOL CHEM, V266, P13503
   Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184
   Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9
   van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228
   Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101
   Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106
   Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wang LW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004021
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Wang SY, 2014, CURR OPIN LIPIDOL, V25, P125, DOI 10.1097/MOL.0000000000000056
   Wang XP, 2010, BIOINFORM BIOL INSIG, V4, P61, DOI 10.4137/BBI.S5087
   Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Wethmar K, 2016, ONCOGENE, V35, P1736, DOI 10.1038/onc.2015.233
   Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021
NR 60
TC 51
Z9 57
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD FEB
PY 2017
VL 19
IS 2
BP 94
EP 105
DI 10.1038/ncb3461
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EJ8BL
UT WOS:000393447200005
PM 28092655
DA 2024-02-19
ER

PT J
AU Ishigami, A
   Handa, S
   Maruyama, N
   Supakar, PC
AF Ishigami, A
   Handa, S
   Maruyama, N
   Supakar, PC
TI Nuclear localization of senescence marker protein-30, SMP30, in cultured
   mouse Hepatocytes and its similarity to RNA polymerase
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE SMP30; nuclear localization
ID RAT-LIVER; AGE
AB Senescence marker protein-30 (SMP30), expressed mostly in the liver, protects cells against various injuries by stimulating membrane calcium-pump activity. By immunohistochemistry and western blotting, we found that SMP30 was in both the nuclei and cytoplasm of cultured mouse hepatocytes. By a homology search, we found that a domain of the SMP30 sequence 51 amino acid residues long was 60-66% similar to bacterial and yeast RNA polymerases.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS); Tokyo Metropolitan Institute of Gerontology
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM pscupakar@hotmail.com
OI Ishigami, Akihito/0000-0001-7875-7482
CR FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799
NR 10
TC 27
Z9 33
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD JAN
PY 2003
VL 67
IS 1
BP 158
EP 160
DI 10.1271/bbb.67.158
PG 3
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 641VG
UT WOS:000180767300022
PM 12619687
DA 2024-02-19
ER

PT J
AU Billecke, SS
   Primo-Parmo, SL
   Dunlop, CS
   Doorn, JA
   La Du, BN
   Broomfield, CA
AF Billecke, SS
   Primo-Parmo, SL
   Dunlop, CS
   Doorn, JA
   La Du, BN
   Broomfield, CA
TI Characterization of a soluble mouse liver enzyme capable of hydrolyzing
   diisopropyl phosphorofluoridate
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article; Proceedings Paper
CT 3th International Meeting on Esterases Reacting with Organophosphorus
   Compounds
CY APR 15-18, 1998
CL INTER UNVI CTR, DUBROVNIK, CROATIA
SP INst Med Res & Occupat Hlth, Minist Sci & Technol Republ Croatia, Minist Def Republ Croatia, Us Army Med Res & Mat Command, Assoc European Toxicol & Sci Toxicol, Netherlands & Novartis Crop Protect AG
HO INTER UNVI CTR
DE DFPase; paraoxonase (PON1); senescence marker protein-30; soman; sarin
ID MARKER PROTEIN-30 SMP30; SENESCENCE
AB A novel mouse liver soluble fraction DFPase which has organophosphatase activities with sarin, soman and tabun, was purified and characterized. However, it lacks paraoxonase and arylesterase activities with paraoxon and phenyl acetate, respectively. This DFPase closely resembles and may be identical with the one purified by Little et al. in 1989 from the soluble fraction of rat liver, based on its substrate specificity, size (similar to 39 kDa) and its stimulation by several metal ions, namely magnesium, manganese and cobalt. Sequencing of our purified mouse liver DFPase showed it to be identical in its amino acid sequence with the recently identified senescence marker protein-30 (SMP-30) by Fujita et al. in 1996. Other senescence marker proteins possessing high structural homology with the mouse SMP-30 have also been found and sequenced from human and rat livers. There is no structural homology between the senescence marker protein family and the group of mammalian paraoxonases. Thus,it is clear that there are at least two distinct, unrelated families of mammalian liver enzymes that share DFPase activity. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
   USA, Biochem Pharmacol Branch, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; Research Institute of Chemical
   Defense - China
RP Billecke, SS (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.
OI Doorn, Jonathan/0000-0001-9646-9871
CR FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   MAZUR A, 1946, J BIOL CHEM, V164, P271
   PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225
   TAKAHASHI H, 1995, MOL CELL BIOCHEM, V144, P1, DOI 10.1007/BF00926733
NR 6
TC 32
Z9 38
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD MAY 14
PY 1999
VL 119
BP 251
EP 256
DI 10.1016/S0009-2797(99)00034-4
PG 6
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 211WG
UT WOS:000081184400027
PM 10421459
DA 2024-02-19
ER

PT J
AU Schädel, P
   Wichmann-Costaganna, M
   Czapka, A
   Gebert, N
   Ori, A
   Werz, O
AF Schaedel, Patrick
   Wichmann-Costaganna, Mareike
   Czapka, Anna
   Gebert, Nadja
   Ori, Alessandro
   Werz, Oliver
TI Short-Term Caloric Restriction and Subsequent Re-Feeding Compromise
   Liver Health and Associated Lipid Mediator Signaling in Aged Mice
SO NUTRIENTS
LA English
DT Article
DE liver; aging; caloric restriction; inflammation; lipid mediators; PUFA
   metabolism; lipoxygenase
ID CYCLOOXYGENASE-2; MALONDIALDEHYDE; SUSCEPTIBILITY; INFLAMMATION;
   RESOLUTION; INCREASES; CYTOKINES; REVEALS; HUMANS; CANCER
AB Aging is characterized by alterations in the inflammatory microenvironment, which is tightly regulated by a complex network of inflammatory mediators. Excessive calorie consumption contributes to age- and lifestyle-associated diseases like obesity, type 2 diabetes, cardiovascular disorders, and cancer, while limited nutrient availability may lead to systemic health-promoting adaptations. Geroprotective effects of short-term caloric restriction (CR) can beneficially regulate innate immune receptors and interferon signaling in the liver of aged mice, but how CR impacts the hepatic release of immunomodulatory mediators like cytokines and lipid mediators (LM) is elusive. Here, we investigated the impact of aging on the inflammatory microenvironment in the liver and its linkage to calorie consumption. The livers of female young and aged C57BL/6JRj mice, as well as of aged mice after caloric restriction (CR) up to 28 days, with and without subsequent re-feeding (2 days), were evaluated. Surprisingly, despite differences in the hepatic proteome of young and old mice, aging did not promote a pro-inflammatory environment in the liver, but it reduced lipoxygenase-mediated formation of LM from polyunsaturated fatty acids without affecting the expression of the involved lipoxygenases and related oxygenases. Moreover, CR failed to ameliorate the secretion of pro-inflammatory cytokines but shifted the LM production to the formation of monohydroxylated LM with inflammation-resolving features. Unexpectedly, re-feeding after CR even further decreased the inflammatory response as LM species were markedly downregulated. Our findings raise the question of how short-term CR is indeed beneficial as a nutritional intervention for healthy elderly subjects and further stress the necessity to address tissue-specific inflammatory states.
C1 [Schaedel, Patrick; Wichmann-Costaganna, Mareike; Czapka, Anna; Werz, Oliver] Friedrich Schiller Univ, Dept Pharmaceut Med Chem, Inst Pharm, D-07743 Jena, Germany.
   [Czapka, Anna] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany.
   [Gebert, Nadja; Ori, Alessandro] Fritz Lipmann Inst, Leibniz Inst Aging, D-07745 Jena, Germany.
C3 Friedrich Schiller University of Jena; Hans Knoll Institute (HKI);
   Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)
RP Werz, O (corresponding author), Friedrich Schiller Univ, Dept Pharmaceut Med Chem, Inst Pharm, D-07743 Jena, Germany.
EM patrick.schaedel@uni-jena.de; mareike.wichmann@uni-jena.de;
   anna.czapka@uni-jena.de; nadja.gebert@evotec.com;
   alessandro.ori@leibniz-fli.de; oliver.werz@uni-jena.de
OI Werz, Oliver/0000-0002-5064-4379; Wichmann-Costaganna,
   Mareike/0000-0002-8215-5799; Schadel, Patrick/0000-0002-9586-6653
FU The authors acknowledge the kind support from the mouse facilities of
   the FLI and BIZ, as well as the Proteomics Core Facility at FLI.
FX The authors acknowledge the kind support from the mouse facilities of
   the FLI and BIZ, as well as the Proteomics Core Facility at FLI.
CR Acosta-Rodríguez V, 2022, SCIENCE, V376, P1192, DOI 10.1126/science.abk0297
   Anton S, 2013, EXP GERONTOL, V48, P1003, DOI 10.1016/j.exger.2013.04.011
   Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313
   Beraza N, 2005, HEPATOLOGY, V41, P460, DOI 10.1002/hep.20590
   Busch CJ, 2017, BBA-MOL CELL BIOL L, V1862, P398, DOI 10.1016/j.bbalip.2016.06.016
   Calder PC, 2020, ESSAYS BIOCHEM, V64, P423, DOI 10.1042/EBC20190083
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje
   Chiang N, 2020, ESSAYS BIOCHEM, V64, P443, DOI 10.1042/EBC20200018
   Choi IY, 2017, MOL CELL ENDOCRINOL, V455, P4, DOI 10.1016/j.mce.2017.01.042
   Di Giosia P, 2022, AGEING RES REV, V77, DOI 10.1016/j.arr.2022.101596
   Ding SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183541
   Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001
   Dorling JL, 2021, EUR J NUTR, V60, P1633, DOI 10.1007/s00394-020-02361-7
   Eccles JA, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12010082
   Esser-von Bieren J, 2019, IMMUNOL CELL BIOL, V97, P279, DOI 10.1111/imcb.12226
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gardner EM, 2005, J GERONTOL A-BIOL, V60, P688, DOI 10.1093/gerona/60.6.688
   Gebert N, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107565
   Glovaci D, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1107-y
   Guo Y, 2021, J CLIN ENDOCR METAB, V106, P64, DOI 10.1210/clinem/dgaa644
   Hahn O, 2019, NAT METAB, V1, P1059, DOI 10.1038/s42255-019-0121-0
   Hofer SJ, 2022, EMBO MOL MED, V14, DOI 10.15252/emmm.202114418
   Holmer M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100256
   Hunt ND, 2012, AGE, V34, P1453, DOI 10.1007/s11357-011-9321-6
   Johari MI, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47763-8
   Jové M, 2014, AGING CELL, V13, P828, DOI 10.1111/acel.12241
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111
   Kristan DM, 2007, AGING CELL, V6, P817, DOI 10.1111/j.1474-9726.2007.00345.x
   Kuan V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82459-y
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Maciejewska-Markiewicz D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11070937
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Márquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9
   Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Mohammed S, 2021, AGING CELL, V20, DOI 10.1111/acel.13512
   Moselhy HF, 2013, J LIPID RES, V54, P852, DOI 10.1194/jlr.D032698
   Niu LL, 2022, NAT MED, V28, P1277, DOI 10.1038/s41591-022-01850-y
   Phillips EJ, 2023, GEROSCIENCE, V45, P1263, DOI 10.1007/s11357-022-00691-4
   Powell-Wiley TM, 2021, CIRCULATION, V143, pE984, DOI 10.1161/CIR.0000000000000973
   Rasa SMM, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.111017
   Redman LM, 2010, AGING CELL, V9, P32, DOI 10.1111/j.1474-9726.2009.00530.x
   Reilly TP, 2001, CHEM RES TOXICOL, V14, P1620, DOI 10.1021/tx0155505
   Salvadori G, 2021, CELL METAB, V33, P2247, DOI 10.1016/j.cmet.2021.10.008
   Schädel P, 2021, FASEB J, V35, DOI 10.1096/fj.202002684R
   Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479
   Serre-Miranda C, 2022, J GERONTOL A-BIOL, V77, P883, DOI 10.1093/gerona/glab330
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Spadaro O, 2022, SCIENCE, V375, P671, DOI 10.1126/science.abg7292
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   Sung H, 2019, CA-CANCER J CLIN, V69, P88, DOI 10.3322/caac.21499
   Teofilovic A, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.899255
   Werz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02538-5
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Zhang SH, 2022, FOOD NUTR RES, V66, DOI 10.29219/fnr.v66.7909
NR 59
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2023
VL 15
IS 16
AR 3660
DI 10.3390/nu15163660
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA Q2HK8
UT WOS:001055777200001
PM 37630850
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Krishna, DR
   Sperker, B
   Fritz, P
   Klotz, U
AF Krishna, DR
   Sperker, B
   Fritz, P
   Klotz, U
TI Does pH 6 β-galactosidase activity indicate cell senescence?
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE beta-galactosidase; senescence; human cell lines; liver; HPLC; enzyme
   histochemistry
ID TELOMERASE INHIBITION; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; EXPRESSION
AB Apparently two forms of beta-galactosidase (beta-GAL) in cells or tissue sections can be detected by enzyme histochemical staining (X-GAL). Using a sensitive and specific HPLC method we have determined the pH dependent activity of beta-GAL in cell lines of lung carcinoma (A549), colon carcinoma (Caco2-TC7), promyelocytic leukemia (HL60), hepatoma (HepG2) and human liver homogenates. The HPLC method has been validated and the influence of pH and substrate concentration was studied. There was a good linear correlation between HPLC and quantitative enzyme histochemistry (pH 4.5: r = 0.985; pH 6.0: r = 0.967). Both, pH 4.5 beta-GAL and pH 6 beta-GAL could be demonstrated in all biological material tested and pH 6 beta-GAL activity was always lower (25-50%) than pH 4.5 activity. In Caco2-TC7 cells both activities increased by a factor of 10 from day 3 to day 17 after seeding. In addition, since the beta-GAL activity decreased with increase in pH both in human liver homogenates (independent of the age of the donor) as well as in tumor cell lysates in a similar fashion we believe that the activity at pH 6 can hardly be considered as an exclusive 'senescence marker'. In addition, the more sensitive HPLC method could demonstrate activity in cells that showed negative reaction with X-GAL. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital
RP Klotz, U (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany.
CR Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919
   Carman TA, 1998, EXP CELL RES, V244, P33, DOI 10.1006/excr.1998.4207
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Field M, 1996, ANAL BIOCHEM, V239, P92, DOI 10.1006/abio.1996.0295
   GilMartin E, 1997, CLIN BIOCHEM, V30, P17, DOI 10.1016/S0009-9120(96)00123-3
   GOSSRAU R, 1991, HISTOCHEMISTRY THEOR, P241
   HEYWORTH CM, 1981, BIOCHEM J, V193, P773, DOI 10.1042/bj1930773
   KUO CH, 1978, J BIOL CHEM, V253, P3550
   Litaker JR, 1998, INT J ONCOL, V13, P951
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   MUTOH T, 1988, BIOCHIM BIOPHYS ACTA, V964, P244, DOI 10.1016/0304-4165(88)90172-9
   Naasani I, 1998, BIOCHEM BIOPH RES CO, V249, P391, DOI 10.1006/bbrc.1998.9075
   ROBINSON D, 1967, BIOCHEM J, V102, P525, DOI 10.1042/bj1020525
   SCHWARZMANN P, 1994, ANN QUANT CYTOL HIST, V16, P71
   Sperker B, 1996, J CHROMATOGR B, V685, P181, DOI 10.1016/0378-4347(96)00139-9
   Thomas E, 1997, EXP CELL RES, V236, P355, DOI 10.1006/excr.1997.3760
   van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035
   Vogt M, 1998, CELL GROWTH DIFFER, V9, P139
   Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446
   Yegorov YE, 1998, EXP CELL RES, V243, P207, DOI 10.1006/excr.1998.4169
NR 21
TC 51
Z9 55
U1 0
U2 8
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD AUG 30
PY 1999
VL 109
IS 2
BP 113
EP 123
DI 10.1016/S0047-6374(99)00031-7
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 238AD
UT WOS:000082688000003
PM 10515661
DA 2024-02-19
ER

PT J
AU Vujcic, MT
   Velickovic, N
   Ruzdijic, S
AF Vujcic, Miroslava T.
   Velickovic, Natasa
   Ruzdijic, Sabera
TI Dexamethasone treatment affects nuclear glucocorticoid receptor and
   glucocorticoid response element binding activity in liver of rats
   (<i>Rattus norvegicus</i>) during aging
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE dexamethasone; aging; glucocorticoid receptor; GRE; DNA-protein
   interaction
ID AGED RAT; DOWN-REGULATION; EXPRESSION; GENE; QUANTITATION; TRAFFICKING;
   MECHANISMS; PROTEINS
AB Aging is associated with marked changes in the biochemical processes of many organs. Basal and glucocorticoid induced of liver nuclear glucocorticoid receptor (GR) on the level of protein expression and DNA-binding activity were investigated at different ages (3, 6, 12, 18 and 24 months old) in two groups of rats in: untreated and dexamethasone treated. The results showed a significant decline of GR protein immunopurified from untreated rats of advanced age. In dexamethasone-treated rats, the quantity of GR protein was lower than in controls at all ages. The interactions of liver nuclear proteins with radioactively labelled synthetic oligonucleotide analogue containing consensus GRE sequence were analysed during aging. The results showed that GRE binding activity demonstrated a decrease both in untreated and in dexamethasone treated rats. However, relative to untreated rats, dexamethasone treatment resulted in a significant increase in GRE binding at all ages, except that of three months old animals. In conclusion, the observed alterations in GR protein expression and its DNA binding activity may play a role in the changes of the cell response to glucocorticoid during aging. (c) 2007 Elsevier Inc. All rights reserved.
C1 Inst Chem Technol & Met, Dept Chem, Belgrade 11001, Serbia.
   Inst Nucl Sci Vinca, Lab Mol Biol & Endocrinol, Belgrade 11001, Serbia.
   Inst Biol Res, Dept Neurobiol & Immunol, Belgrade 11060, Serbia.
C3 University of Belgrade; University of Belgrade; University of Belgrade
RP Vujcic, MT (corresponding author), Inst Chem Technol & Met, Dept Chem, Njegoseva 12,POB 815, Belgrade 11001, Serbia.
EM mvujcic@chem.bg.ac.yu
OI Vujcic, Miroslava/0000-0001-6375-0309; Velickovic,
   Natasa/0000-0003-3604-5836
CR ARMANINI D, 1993, J STEROID BIOCHEM, V45, P191, DOI 10.1016/0960-0760(93)90141-I
   BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Committee NRN, 1999, CELL, V97, P161
   CZAR MJ, 1994, J BIOL CHEM, V269, P11155
   DAWSON R, 1984, HORM RES, V20, P89
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256
   DUBOIS DC, 1995, J STEROID BIOCHEM, V54, P237, DOI 10.1016/0960-0760(95)00139-Q
   Dutta D, 2004, BIOGERONTOLOGY, V5, P177, DOI 10.1023/B:BGEN.0000031155.60748.0a
   Freeman AI, 2004, J ENDOCRINOL, V183, P365, DOI 10.1677/joe.1.05773
   GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274
   GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131
   Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113
   Heeley RP, 1998, MAMM GENOME, V9, P198, DOI 10.1007/s003359900725
   Herman JP, 2001, NEUROBIOL AGING, V22, P321
   Ivanisevic-Milovanovic Olivera K., 1997, Acta Physiologica Hungarica, V85, P65
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8
   Montesinos MM, 2006, LIFE SCI, V78, P2584, DOI 10.1016/j.lfs.2005.10.019
   Murphy EK, 2002, ENDOCRINOLOGY, V143, P1362, DOI 10.1210/en.143.4.1362
   Nichols NR, 1998, INTERD T GERONT GERI, V29, P1
   Pei L, 1996, J BIOL CHEM, V271, P20879
   Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201
   PRATT WB, 1993, J BIOL CHEM, V268, P21455
   Ranhotra HS, 2001, BIOGERONTOLOGY, V2, P245, DOI 10.1023/A:1013218528102
   Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004
   Sharma R, 2006, ANN NY ACAD SCI, V1067, P129, DOI 10.1196/annals.1354.016
   TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7
   Vujcic M, 2005, J SERB CHEM SOC, V70, P705, DOI 10.2298/JSC0505705V
   Wikström AC, 2003, J ENDOCRINOL, V178, P331, DOI 10.1677/joe.0.1780331
   Wolden-Hanson T, 1999, J GERONTOL A-BIOL, V54, pB99, DOI 10.1093/gerona/54.3.B99
NR 35
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1096-4959
EI 1879-1107
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD DEC
PY 2007
VL 148
IS 4
BP 463
EP 469
DI 10.1016/j.cbpb.2007.07.090
PG 7
WC Biochemistry & Molecular Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Zoology
GA 238XM
UT WOS:000251481700013
PM 17761446
DA 2024-02-19
ER

PT J
AU MURTY, CVR
   MANCINI, MA
   CHATTERJEE, B
   ROY, AK
AF MURTY, CVR
   MANCINI, MA
   CHATTERJEE, B
   ROY, AK
TI CHANGES IN TRANSCRIPTIONAL ACTIVITY AND MATRIX ASSOCIATION OF
   ALPHA-2U-GLOBULIN GENE FAMILY IN THE RAT-LIVER DURING MATURATION AND
   AGING
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
C1 OAKLAND UNIV,DEPT BIOL SCI,ROCHESTER,MI 48063.
   OAKLAND UNIV,DEPT CHEM,ROCHESTER,MI 48063.
C3 Oakland University; Oakland University
FU NIDDK NIH HHS [DK-14744] Funding Source: Medline
CR AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BARRACK ER, 1983, GENE REGULATION STER, V2, P239
   BERENZNEY R, 1977, J CELL BIOL, V73, P626
   BOUTEILLE M, 1983, INT REV CYTOL, V83, P135, DOI 10.1016/S0074-7696(08)61687-3
   BRASCH K, 1978, VIRCHOWS ARCH B, V27, P193
   BUTTYAN R, 1986, BIOCHEM BIOPH RES CO, V138, P1334, DOI 10.1016/S0006-291X(86)80429-6
   CHATTERJEE B, 1982, BIOCHIM BIOPHYS ACTA, V698, P22, DOI 10.1016/0167-4781(82)90179-8
   CIEZEK EM, 1983, NATURE, V306, P607
   GOLDFISCHER S, 1981, J HISTOCHEM CYTOCHEM, V29, P1105, DOI 10.1177/29.9.6169760
   KURTZ D T, 1981, Journal of Molecular and Applied Genetics, V1, P29
   MANIATIS T, 1982, MOL CLONING LABORATO, P387
   MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050
   MURTY CVR, 1986, BIOCHEMISTRY-US, V25, P4376, DOI 10.1021/bi00363a030
   OMALLEY BW, 1983, STEROID HORMONE RECE, P307
   REEVES R, 1984, BIOCHIM BIOPHYS ACTA, V782, P343, DOI 10.1016/0167-4781(84)90044-7
   ROBERTSON SI, 1982, CELL, V28, P99
   ROSENFELD GC, 1972, BIOCHEM BIOPH RES CO, V46, P1695, DOI 10.1016/0006-291X(72)90805-4
   ROY AK, 1977, BIOCHEM J, V164, P91, DOI 10.1042/bj1640091
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1975, ENDOCRINOLOGY, V97, P1501, DOI 10.1210/endo-97-6-1501
   ROY AK, 1977, EUR J BIOCHEM, V73, P537, DOI 10.1111/j.1432-1033.1977.tb11348.x
   ROY AK, 1982, J BIOL CHEM, V259, P7834
   SHAPER JH, 1979, ADV ENZYME REGUL, V17, P213
   Tata J R, 1974, Methods Enzymol, V31, P253
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
NR 26
TC 21
Z9 21
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD JAN 25
PY 1988
VL 949
IS 1
BP 27
EP 34
DI 10.1016/0167-4781(88)90050-4
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA M1809
UT WOS:A1988M180900003
PM 2446666
DA 2024-02-19
ER

PT J
AU Sebti, S
   Zou, ZJ
   Shiloh, MU
AF Sebti, Salwa
   Zou, Zhongju
   Shiloh, Michael U.
TI BECN1<SUP>F121A</SUP> mutation increases autophagic flux in aged mice
   and improves aging phenotypes in an organ-dependent manner
SO AUTOPHAGY
LA English
DT Article; Early Access
DE Aging; autophagic flux; BECN1; liver; mouse; skeletal muscle
ID STARVATION; PROTEOSTASIS; HOMEOSTASIS; IMPAIRMENT; DISEASE; GENES
AB Macroautophagy/autophagy is necessary for lifespan extension in multiple model organisms and autophagy dysfunction impacts age-related phenotypes and diseases. Introduction of an F121A mutation into the essential autophagy protein BECN1 constitutively increases basal autophagy in young mice and reduces cardiac and renal age-related changes in longer lived Becn1(F121A) mutant mice. However, both autophagic and lysosomal activities decline with age. Thus, whether autophagic flux is maintained during aging and whether it is enhanced in Becn1(F121A) mice is unknown. Here, we demonstrate that old wild-type mice maintained functional autophagic flux in heart, kidney and skeletal muscle but not liver, and old Becn1(F121A) mice had increased autophagic flux in those same organs compared to wild type. In parallel, Becn1(F121A) mice were not protected against age-associated hepatic phenotypes but demonstrated reduced skeletal muscle fiber atrophy. These findings identify an organ-specific role for the ability of autophagy to impact organ aging phenotypes.
C1 [Sebti, Salwa; Zou, Zhongju; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
   [Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX USA.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas; University of Texas System; University of Texas
   Southwestern Medical Center Dallas
RP Sebti, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM salwa.sebti@utsouthwestern.edu
RI Sebti, Salwa/AAB-3188-2020
OI Sebti, Salwa/0000-0003-4327-1129; Shiloh, Michael/0000-0003-4329-2253
FU Fondation Leducq [15CBD04]; National Institute of Allergy and Infectious
   Diseases [U19AI142784]
FX The work was supported by the Fondation Leducq [15CBD04]; National
   Institute of Allergy and Infectious Diseases [U19AI142784].
CR Babcock LW, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00250-5
   Bejarano E, 2018, AGING CELL, V17, DOI 10.1111/acel.12777
   Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061
   Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459
   Cho JM, 2021, AGING CELL, V20, DOI 10.1111/acel.13467
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Fernández AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7
   Gutiérrez-Casado E, 2019, J GERONTOL A-BIOL, V74, P760, DOI 10.1093/gerona/gly161
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363
   Kaushik S, 2021, AGEING RES REV, V72, DOI 10.1016/j.arr.2021.101468
   Kaushik S, 2012, EMBO REP, V13, P258, DOI 10.1038/embor.2011.260
   Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8
   Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774
   Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133
   Nieto-Torres JL, 2021, MOL ASPECTS MED, V82, DOI 10.1016/j.mam.2021.101020
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Rocchi A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006962
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sakellariou GK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33944
   SARKIS GJ, 1988, MECH AGEING DEV, V45, P191, DOI 10.1016/0047-6374(88)90001-2
   Sato S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21325-w
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803
   Stavoe AK, 2019, ELIFE, V8, DOI 10.7554/eLife.44219
   Terman A, 1995, GERONTOLOGY, V41, P319
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Vega-Rubín-de-Celis S, 2018, P NATL ACAD SCI USA, V115, P4176, DOI 10.1073/pnas.1717800115
   Vinatier C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00706
   Wang CR, 2022, AUTOPHAGY, V18, P409, DOI 10.1080/15548627.2021.1936358
   Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001
   Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032
   Yamamoto T, 2016, AUTOPHAGY, V12, P801, DOI 10.1080/15548627.2016.1159376
NR 50
TC 1
Z9 1
U1 3
U2 11
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD 2023 MAR 4
PY 2023
VL 19
IS 3
BP 957
EP 965
DI 10.1080/15548627.2022.2111852
EA AUG 2022
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 9G4PG
UT WOS:000843091900001
PM 35993269
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU OGAWA, K
   MUKAI, H
   MORI, M
AF OGAWA, K
   MUKAI, H
   MORI, M
TI EFFECT OF AGING ON PROLIFERATIVE ACTIVITY OF NORMAL AND
   CARCINOGEN-ALTERED HEPATOCYTES IN RAT-LIVER AFTER A 2/3
   PARTIAL-HEPATECTOMY
SO JAPANESE JOURNAL OF CANCER RESEARCH
LA English
DT Article
RP OGAWA, K (corresponding author), SAPPORO MED COLL,DEPT PATHOL,MINAMI-1-JO NISHI-17-CHOME,CHUO KU,SAPPORO,HOKKAIDO 060,JAPAN.
CR BECKER FF, 1971, CANCER RES, V31, P169
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   BUCHER NLR, 1979, LIVER BILIARY DISEAS, P210
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   EMMELOT P, 1980, BIOCHIM BIOPHYS ACTA, V605, P247, DOI 10.1016/0304-419X(80)90006-2
   FABRIKANT JI, 1968, J CELL BIOL, V36, P551, DOI 10.1083/jcb.36.3.551
   FARBER E, 1976, CANCER RES, V36, P2532
   GELFANT S, 1972, SCIENCE, V178, P357, DOI 10.1126/science.178.4059.357
   GRISHAM JW, 1962, CANCER RES, V22, P842
   KITAGAWA T, 1971, GANN, V62, P217
   LEFFERT HL, 1982, LIVER BIOL PATHOBIOL, P601
   NAPALKOV NP, 1972, IARC PUBL, V4, P1
   OGAWA K, 1981, J NATL CANCER I, V67, P407
   PITOT HC, 1977, AM J PATHOL, V87, P444
   POLLARD M, 1979, LAB ANIM SCI, V29, P74
   POST J, 1960, ARCH PATHOL, V70, P314
   PUGH TD, 1978, CANCER RES, V38, P4450
   RABES H, 1970, EXPERIENTIA, V26, P1356, DOI 10.1007/BF02113030
   RABES H M, 1976, P83
   RUTENBERG AM, 1968, J HISTOCHEM CYTOCHEM, V17, P517
   SCHMIDT G, 1945, J BIOL CHEM, V161, P83
   SCHULTEHERMANN R, 1981, CANCER RES, V41, P2556
   SOLT D, 1976, NATURE, V263, P701, DOI 10.1038/263701a0
   STOCKER E, 1972, VIRCHOW ARCH PATHOL, V390, P339
   WARD JM, 1981, VIRCHOWS ARCH A, V390, P339, DOI 10.1007/BF00496563
   WILLIAMS GM, 1980, BIOCHIM BIOPHYS ACTA, V605, P167, DOI 10.1016/0304-419X(80)90003-7
   1980, J NATL CANCER I, V64, P179
NR 27
TC 10
Z9 11
U1 0
U2 0
PU JAPANESE CANCER ASSOCIATION
PI TOKYO
PA EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN
SN 0910-5050
J9 JPN J CANCER RES
JI Jpn. J. Cancer Res.
PY 1985
VL 76
IS 8
BP 779
EP 784
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA ATQ22
UT WOS:A1985ATQ2200015
PM 2864328
DA 2024-02-19
ER

PT J
AU Lin, H
   Yan, J
   Wang, ZY
   Hua, F
   Yu, JJ
   Sun, W
   Li, K
   Liu, H
   Yang, HZ
   Lv, Q
   Xue, JF
   Hu, ZW
AF Lin, Heng
   Yan, Jun
   Wang, Ziyan
   Hua, Fang
   Yu, Jiaojiao
   Sun, Wei
   Li, Ke
   Liu, Hong
   Yang, Hongzhen
   Lv, Qi
   Xue, Jianfei
   Hu, Zhuo-Wei
TI Loss of immunity-supported senescence enhances susceptibility to
   hepatocellular carcinogenesis and progression in Toll-like receptor
   2-deficient mice
SO HEPATOLOGY
LA English
DT Article
ID CHEMICAL HEPATOCARCINOGENESIS; CELLULAR SENESCENCE; LIVER-CANCER;
   TUMORIGENESIS; APOPTOSIS; AUTOPHAGY; TUMOR; STRESS; P62; INFLAMMATION
AB Hepatocellular carcinoma (HCC) is a complication at the endstage of chronic inflammatory liver diseases with dismal prognosis. Targeting of Toll-like receptor (TLR) 2 attenuates tumor metastases; we hypothesized that blocking TLR2 might also play a crucial role in reducing hepatocarcinogenesis. Surprisingly, we found that the genetic deletion of TLR2 increased susceptibility to diethylnitrosamine (DEN), a genotoxic carcinogen that can induce HCC. Indeed, TLR2-deficient mice showed a significant increase in carcinogenesis and progression of HCC as indicated by increases in tumor nodule size, tumor volume, and animal death. The enhanced susceptibility to DEN-induced HCC was associated with a broad-spectrum reduction in the immune response to DEN-induced liver injury. We found that TLR2 deficiency caused a decrease in the infiltration of macrophages and an attenuation of apoptosis signal regulating kinase 1 (ASK1) / p38 mitogen-activated protein kinase (p38 MAPK) / nuclear factor kappa B (NF-?B) signaling, which led to a decrease in the expression of interferon-gamma (IFN-?), tumor necrosis factor alpha (TNF-a), interleukin (IL)-1a/beta, IL-6, and Cxcl-2 as well as suppression of autophagy flux and increases in oxidative stress and p62 aggregation in liver tissue. The defects in immune networks resulted in suppressed p21- and p16/pRb-dependent senescence, which caused an increase in proliferation and a decrease in apoptotic and autophagy-associated cell death in mouse livers. Restoring cellular senescence and autophagy flux by treating TLR2-deficient mice with IFN-?, a T helper 1 (Th1) cytokine and positive modulator of senescence and autophagy, could attenuate the carcinogenesis and progression of HCC associated with TLR2-deficient animals. Conclusion: The loss of immune networks supporting cellular senescence and autophagy flux is attributed to enhanced susceptibility to DEN-induced hepatocellular carcinogenesis and progression in TLR2-deficient mice. These findings may be used to prevent the development of liver cancer. (HEPATOLOGY 2013; 57: 171-182)
C1 [Lin, Heng; Yan, Jun; Wang, Ziyan; Hua, Fang; Yu, Jiaojiao; Sun, Wei; Li, Ke; Liu, Hong; Yang, Hongzhen; Lv, Qi; Xue, Jianfei; Hu, Zhuo-Wei] Chinese Acad Med Sci, Inst Mat Med, Mol Immunol & Pharmacol Grp, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.
   [Lin, Heng; Yan, Jun; Wang, Ziyan; Hua, Fang; Yu, Jiaojiao; Sun, Wei; Li, Ke; Liu, Hong; Yang, Hongzhen; Lv, Qi; Xue, Jianfei; Hu, Zhuo-Wei] Peking Union Med Coll, Beijing 100050, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences
   - Peking Union Medical College; Peking Union Medical College
RP Hu, ZW (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Mol Immunol & Pharmacol Grp, State Key Lab Bioact Subst & Funct Nat Med, Room 511,1 Xian Nong Tan St, Beijing 100050, Peoples R China.
EM huzhuowei@imm.ac.cn
RI Jiaojiao, Yu/JFJ-6578-2023; Jiang, Yuan/JED-3759-2023; Lv,
   Qi/JJE-1429-2023; Wang, Ziyan/HII-8458-2022; Sun, Wei/AAJ-9828-2021;
   WANG, ZIYAN/IZD-6242-2023
OI Sun, Wei/0000-0001-7661-4031; WANG, ZIYAN/0000-0003-2017-1993; Lv,
   Qi/0000-0001-9076-7042; Yan, Jun/0000-0002-3261-0749
FU National Natural Science Foundation of China [30472025, 30973557,
   30672468]; Major Program of National Natural Science Foundation
   [81030056]; Creation of Major New Drugs [2009ZX09301-003-13]; Basic
   Research Program of Institute of Materia Medica [2010CHX12]
FX Supported by grants from the National Natural Science Foundation of
   China (30472025, 30973557, 30672468), Major Program of National Natural
   Science Foundation (81030056), and Creation of Major New Drugs
   (2009ZX09301-003-13). Dr. Fang Hua is supported by a grant from Basic
   Research Program of Institute of Materia Medica (2010CHX12).
CR Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Curtin JF, 2009, PLOS MED, V6, P83, DOI 10.1371/journal.pmed.1000010
   Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880
   Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217
   Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904
   Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x
   Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020
   Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009
   Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048
   Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023
   Nakagawa H, 2011, HEPATOLOGY, V54, P185, DOI 10.1002/hep.24357
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103
   Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010
   Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306
   Stauffer JK, 2012, HEPATOLOGY
   Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308
   Tu SP, 2011, CANCER RES, V71, P4247, DOI 10.1158/0008-5472.CAN-10-4009
   Yan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024705
   Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019
   Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520
   Yu LX, 2010, HEPATOLOGY, V52, P1322, DOI 10.1002/hep.23845
NR 37
TC 81
Z9 89
U1 0
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JAN
PY 2013
VL 57
IS 1
BP 171
EP 182
DI 10.1002/hep.25991
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 070XO
UT WOS:000313547700020
PM 22859216
OA hybrid
DA 2024-02-19
ER

PT J
AU Kyritsi, K
   Kennedy, L
   Meadows, V
   Hargrove, L
   Demieville, J
   Pham, L
   Sybenga, A
   Kundu, D
   Cerritos, K
   Meng, FN
   Alpini, G
   Francis, H
AF Kyritsi, Konstantina
   Kennedy, Lindsey
   Meadows, Vik
   Hargrove, Laura
   Demieville, Jennifer
   Pham, Linh
   Sybenga, Amelia
   Kundu, Debjyoti
   Cerritos, Karla
   Meng, Fanyin
   Alpini, Gianfranco
   Francis, Heather
TI Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice
   Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling
SO HEPATOLOGY
LA English
DT Article; Early Access
AB Background and Aims Following liver injury, mast cells (MCs) migrate into the liver and are activated in patients with cholestasis. Inhibition of MC mediators decreases ductular reaction (DR) and liver fibrosis. Transforming growth factor beta 1 (TGF-beta 1) contributes to fibrosis and promotes liver disease. Our aim was to demonstrate that reintroduction of MCs induces cholestatic injury through TGF-beta 1.
   Approach and Results Wild-type, Kit(W-sh) (MC-deficient), and multidrug resistance transporter 2/ABC transporter B family member 2 knockout mice lacking l-histidine decarboxylase were injected with vehicle or PKH26-tagged murine MCs pretreated with 0.01% dimethyl sulfoxide (DMSO) or the TGF-beta 1 receptor inhibitor (TGF-beta Ri), LY2109761 (10 mu M) 3 days before sacrifice. Hepatic damage was assessed by hematoxylin and eosin (H&E) and serum chemistry. Injected MCs were detected in liver, spleen, and lung by immunofluorescence (IF). DR was measured by cytokeratin 19 (CK-19) immunohistochemistry and F4/80 staining coupled with real-time quantitative PCR (qPCR) for interleukin (IL)-1 beta, IL-33, and F4/80; biliary senescence was evaluated by IF or qPCR for p16, p18, and p21. Fibrosis was evaluated by sirius red/fast green staining and IF for synaptophysin 9 (SYP-9), desmin, and alpha smooth muscle actin (alpha-SMA). TGF-beta 1 secretion/expression was measured by enzyme immunoassay and qPCR. Angiogenesis was detected by IF for von Willebrand factor and vascular endothelial growth factor C qPCR. In vitro, MC-TGF-beta 1 expression/secretion were measured after TGF-beta Ri treatment; conditioned medium was collected. Cholangiocytes and hepatic stellate cells (HSCs) were treated with MC-conditioned medium, and biliary proliferation/senescence was measured by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium and qPCR; HSC activation evaluated for alpha-SMA, SYP-9, and collagen type-1a expression. MC injection recapitulates cholestatic liver injury characterized by increased DR, fibrosis/TGF-beta 1 secretion, and angiogenesis. Injection of MC-TGF-beta Ri reversed these parameters. In vitro, MCs induce biliary proliferation/senescence and HSC activation that was reversed with MCs lacking TGF-beta 1.
   Conclusions Our study demonstrates that reintroduction of MCs mimics cholestatic liver injury and that MC-derived TGF-beta 1 may be a target in chronic cholestatic liver disease.
C1 [Kyritsi, Konstantina; Kennedy, Lindsey; Meadows, Vik; Pham, Linh; Kundu, Debjyoti; Cerritos, Karla; Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Indiana Univ, Dept Med, Div Gastroenterol & Hepatol, Sch Med Res, Indianapolis, IN USA.
   [Meadows, Vik; Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Indiana Univ, Sch Med Res, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46204 USA.
   [Hargrove, Laura] Texas A&M Univ, Hlth Sci Ctr, Temple, TX USA.
   [Demieville, Jennifer] Cent Texas Vet Hlth Care Syst, Temple, TX USA.
   [Sybenga, Amelia] UVM Hlth Network, Burlington, VT USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Indiana University System; Indiana University-Purdue
   University Indianapolis; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Richard L. Roudebush VA Medical Center;
   Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center
RP Francis, H (corresponding author), Richard L Roudebush VA Med Ctr, 1481 W 10th St, Indianapolis, IN 46202 USA.; Francis, H (corresponding author), Indiana Univ, Gastroenterol, Med, 1481 W 10th St, Indianapolis, IN 46202 USA.
EM heafranc@iu.edu
FU SRCS Award from the United States Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service [5I01BX000574];
   RCS VA Merit Award from the United States Department of Veteran's
   Affairs, Biomedical Laboratory Research and Development Service
   [1I01BX003031]; VA Merit from the United States Department of Veteran's
   Affairs, Biomedical Laboratory Research and Development Service
   [1I01BX001724]; NIH NIDKK grants [DK108959, DK119421, DK115184,
   DK076898]; Indiana University Strategic Research Initiative; Hickam
   Endowed Chair
FX Supported by an SRCS Award (5I01BX000574, to G. A.), an RCS VA Merit
   Award (1I01BX003031, to H. F.), and VA Merit 1I01BX001724 (to F. M.)
   from the United States Department of Veteran's Affairs, Biomedical
   Laboratory Research and Development Service and NIH NIDKK grants
   (DK108959 and DK119421, to H. F., and DK115184 and DK076898, to G. A.
   and F. M.). Portions of the work were also supported by the Indiana
   University Strategic Research Initiative (to H. F., G. A., and F. M.)
   and the Hickam Endowed Chair (to G. A.).
CR Abdelzaher WY, 2020, IMMUNOPHARM IMMUNOT, V42, P101, DOI 10.1080/08923973.2020.1727499
   Aimaiti Y, 2019, CYTOTECHNOLOGY, V71, P881, DOI 10.1007/s10616-019-00329-y
   Chen HM, 2017, EXP THER MED, V14, P4438, DOI 10.3892/etm.2017.5082
   Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419
   Fan WG, 2019, GASTROENTEROLOGY, V157, P1352, DOI 10.1053/j.gastro.2019.07.036
   Grabauskas G, 2020, GASTROENTEROLOGY, V158, P2195, DOI 10.1053/j.gastro.2020.02.022
   Graf A, 2014, AM J PHYSIOL-GASTR L, V307, pG813, DOI 10.1152/ajpgi.00188.2014
   Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119
   Hargrove L, 2017, HEPATOLOGY, V65, P1991, DOI 10.1002/hep.29079
   Hargrove L, 2016, LAB INVEST, V96, P1198, DOI 10.1038/labinvest.2016.89
   Hart KM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3694
   Johnson C, 2015, DIGEST LIVER DIS, V47, P211, DOI 10.1016/j.dld.2014.12.006
   Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704
   Kennedy L, 2020, LAB INVEST, V100, P837, DOI 10.1038/s41374-020-0405-8
   Kennedy L, 2018, HEPATOLOGY, V68, P1042, DOI 10.1002/hep.29898
   Kennedy LL, 2014, LAB INVEST, V94, P1406, DOI 10.1038/labinvest.2014.129
   Kong Ping, 2014, Cell Mol Life Sci, V71, P549, DOI 10.1007/s00018-013-1349-6
   Kyritsi K, 2017, AM J PATHOL, V187, P1551, DOI 10.1016/j.ajpath.2017.03.013
   Lennon EM, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7817360
   Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com
   Liu J, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00403
   Lombardo J, 2019, HUM PATHOL, V86, P129, DOI 10.1016/j.humpath.2018.11.029
   Lyons DO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041498
   Lyons DO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207704
   Mariotti V, 2018, BBA-MOL BASIS DIS, V1864, P1254, DOI 10.1016/j.bbadis.2017.06.027
   Meadows V, 2019, BBA-MOL BASIS DIS, V1865, DOI 10.1016/j.bbadis.2019.165557
   Meng FY, 2018, LAB INVEST, V98, P1465, DOI 10.1038/s41374-018-0101-0
   Nakajima S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54878-5
   Rasky A, 2020, AM J PHYSIOL-LUNG C, V318, pL200, DOI 10.1152/ajplung.00114.2019
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sibilano R, 2014, EUR J IMMUNOL, V44, P2558, DOI 10.1002/eji.201444546
   Van Campenhout S, 2019, METHODS MOL BIOL, V1981, P237, DOI 10.1007/978-1-4939-9420-5_15
   Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5
   Wang YZ, 2019, BBA-MOL BASIS DIS, V1865, P1170, DOI 10.1016/j.bbadis.2019.01.011
   Wu N, 2018, AM J PATHOL, V188, P2264, DOI 10.1016/j.ajpath.2018.06.015
   Yilmaz Y, 2019, EUR J GASTROEN HEPAT, V31, P43, DOI 10.1097/MEG.0000000000001240
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 38
TC 26
Z9 29
U1 2
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2021 JUN
PY 2021
VL 73
IS 6
BP 2397
EP 2410
DI 10.1002/hep.31497
EA APR 2021
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA SU5AL
UT WOS:000640975200001
PM 32761972
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Santiago, KH
   López-López, AL
   Sánchez-Muñoz, F
   Altamirano, JLC
   Alfaro-Rodríguez, A
   Bonilla-Jaime, H
AF Hernandez Santiago, Karina
   Laura Lopez-Lopez, Ana
   Sanchez-Munoz, Fausto
   Cortes Altamirano, Jose Luis
   Alfaro-Rodriguez, Alfonso
   Bonilla-Jaime, Herlinda
TI Sleep deprivation induces oxidative stress in the liver and pancreas in
   young and aging rats
SO HELIYON
LA English
DT Article; Early Access
DE Sleep deprivation; Oxidative stress; Liver; Pancreas; Aging process;
   Glucose
AB The aging process is characterized by a gradual impairment generally caused by oxidative stress and, more specifically, sleep deprivation, which induces oxidative stress in the brain. The objective of this study was to assess the effect of three types of paradoxical sleep deprivation (PSD): 96 h of PSD (96PSD group); 192 h of PSD (192PSD group); 192 h of PSD followed by a recovery period of 20 days (192PSD + Recovery group) on an oral glucose tolerance test (OGTT), lipid peroxidation (LPO), and superoxide dismutase (SOD) and catalase (CAT) activities in the liver and pancreas of young (3-month-old) and adult (14-month-old) rats. The 96PSD and 192PSD groups of young rats showed lower glucose levels on the OGTT than the control group. In the adult rats, only the 96PSD group had lower glucose levels than the control group. However, the areas under the curve for the young and adult 192 and 192PSD thorn Recovery groups showed significant differences. Both LPO and SOD increased in the 192PSD and 192PSD + Recovery groups, but CAT decreased in the liver of young rats in the 192PSD group. Regarding the pancreas, LPO and SOD levels increased after 96 h of PSD. In adult animals, CAT decreased in the liver after 96 and 192 h of PSD, while LPO and SOD increased in the pancreas of the 192PSD and PSD thorn Recovery groups. Differences in the SOD and CAT activities in the liver and SOD activities in the pancreas were also observed between the young and adult rats and maintained across all the PSD groups. In conclusion, PSD induced differential responses that appeared to depend on the duration of the induced condition, the animals' age, and the tissue analyzed. It was found that adult rats were more susceptible to the effects of PSD than young rats.
C1 [Hernandez Santiago, Karina] Univ Autonoma Metropolitana Iztapalapa, Biol Reprod, Mexico City 09340, DF, Mexico.
   [Laura Lopez-Lopez, Ana] CINVESTAV Sede Sur, Dept Farmacol, Calz Tenorios 235, Mexico City 14330, DF, Mexico.
   [Sanchez-Munoz, Fausto] Inst Nacl Cardiol Ignacio Chavez, Dept Inmunol, Juan Badiano 1,Col Secc 16, Mexico City 14080, DF, Mexico.
   [Cortes Altamirano, Jose Luis; Alfaro-Rodriguez, Alfonso] Inst Nacl Rehabil Luis Guillermo Ibarra Ibarra IN, Dept Neurociencias, Mexico City, DF, Mexico.
   [Bonilla-Jaime, Herlinda] Univ Autonoma Metropolitana Iztapalapa, Dept Biol Reprod, Area Biol Conductual & Reprod, Mexico City 09340, DF, Mexico.
C3 Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de
   Investigacion y de Estudios Avanzados del Instituto Politecnico
   Nacional; National Institute of Cardiology - Mexico; Universidad
   Autonoma Metropolitana - Mexico
RP Bonilla-Jaime, H (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Biol Reprod, Area Biol Conductual & Reprod, Mexico City 09340, DF, Mexico.
EM bjh@xanum.uam.mx
RI Altamirano, Jose Luis Cortes/GPF-5955-2022
OI Altamirano, Jose Luis Cortes/0000-0002-9410-8535; Alfaro-Rodriguez,
   Alfonso/0000-0002-4599-1253
FU Universidad Autonoma Metropolitana
FX This work was supported by Universidad Autonoma Metropolitana.
CR Andersen ML, 2004, EXP GERONTOL, V39, P817, DOI 10.1016/j.exger.2004.02.007
   [Anonymous], FREE RADICAL BIO MED, V33, P575
   Lima AMA, 2014, N-S ARCH PHARMACOL, V387, P399, DOI 10.1007/s00210-013-0955-z
   Armstrong JA, 2018, J BIOL CHEM, V293, P8032, DOI 10.1074/jbc.RA118.003200
   Babkoff H, 2005, J SLEEP RES, V14, P7, DOI 10.1111/j.1365-2869.2004.00423.x
   Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033
   Barceló A, 2006, EUR RESPIR J, V27, P756, DOI 10.1183/09031936.06.00067605
   Barf RP, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/819414
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Bingül I, 2017, GERIATR GERONTOL INT, V17, P2610, DOI 10.1111/ggi.13126
   Bohr VA, 2007, NEUROSCIENCE, V145, P1183, DOI 10.1016/j.neuroscience.2007.03.015
   BONNET MH, 1995, SLEEP, V18, P581, DOI 10.1093/sleep/18.7.581
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Briançon-Marjollet A, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0018-3
   Brianza-Padilla M, 2016, APPL PHYSIOL NUTR ME, V41, P235, DOI 10.1139/apnm-2015-0337
   Brown J. E., 2012, BR J DIABETES VASC D, V12, P141, DOI [DOI 10.1177/1474651412446713, 10.1177/1474651412446713]
   Brown MK, 2010, MOL NEUROBIOL, V42, P103, DOI 10.1007/s12035-010-8114-8
   Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699
   Cerf ME, 2013, ENDOCRINE, V44, P303, DOI 10.1007/s12020-013-9917-y
   Chang HM, 2008, J ANAT, V212, P295, DOI 10.1111/j.1469-7580.2008.00860.x
   Curran FJM, 2000, BRIT J SURG, V87, P301, DOI 10.1046/j.1365-2168.2000.01375.x
   d'Alessandro ED, 2011, CLIN TER, V162, pE13
   D'Almeida V, 1998, NEUROREPORT, V9, P2853, DOI 10.1097/00001756-199808240-00031
   Everson CA, 2005, AM J PHYSIOL-REG I, V288, pR374, DOI 10.1152/ajpregu.00565.2004
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Gil-Lozano M, 2016, AM J PHYSIOL-ENDOC M, V310, pE41, DOI 10.1152/ajpendo.00298.2015
   Gopalakrishnan A, 2004, SLEEP, V27, P27, DOI 10.1093/sleep/27.1.27
   Gosselin A, 2005, CLIN NEUROPHYSIOL, V116, P211, DOI 10.1016/j.clinph.2004.07.033
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hipólide DC, 2002, INT J NEUROSCI, V112, P155, DOI 10.1080/00207450212022
   ILAN Y, 1992, EUR J CLIN INVEST, V22, P740, DOI 10.1111/j.1365-2362.1992.tb01438.x
   Kassem M, 2017, ANN TRANSPL, V22, P177, DOI 10.12659/AOT.901009
   Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002
   Kryger M, 2004, GERIATRICS-US, V59, P24
   Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095
   Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Machado RB, 2005, BEHAV BRAIN RES, V160, P356, DOI 10.1016/j.bbr.2005.01.001
   Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586
   Mariño G, 2008, AUTOPHAGY, V4, P807, DOI 10.4161/auto.6478
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Mármol F, 2010, PHYSIOL RES, V59, P553, DOI 10.33549/physiolres.931768
   McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008
   Naidoo N, 2014, AGING CELL, V13, P131, DOI 10.1111/acel.12158
   Periasamy S., 2015, EXCLI J, V14
   Prinz PN, 2004, EXP GERONTOL, V39, P1739, DOI 10.1016/j.exger.2004.06.023
   Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Ramanathan L, 2002, NEUROREPORT, V13, P1387, DOI 10.1097/00001756-200208070-00007
   Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376
   REIMUND E, 1994, MED HYPOTHESES, V43, P231, DOI 10.1016/0306-9877(94)90071-X
   Ricart-Jané D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353
   Samarghandian S, 2015, J BIOCHEM MOL TOXIC, V29, P249, DOI 10.1002/jbt.21691
   Samarghandian S, 2014, INT J CLIN EXP MED, V7, P1449
   Schmid SM, 2011, SLEEP, V34, P371, DOI 10.1093/sleep/34.3.371
   Singh R, 2008, BIOGERONTOLOGY, V9, P153, DOI 10.1007/s10522-008-9124-z
   Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003
   Suchecki D, 2000, BRAIN RES, V875, P14, DOI 10.1016/S0006-8993(00)02531-2
   SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14
   TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152
   Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557
   Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850
   Urrila AS, 2004, J SLEEP RES, V13, P111, DOI 10.1111/j.1365-2869.2004.00401.x
   Villafuerte G, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/234952
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
NR 68
TC 7
Z9 7
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
EI 2405-8440
J9 HELIYON
JI Heliyon
PD 2021 MAR
PY 2021
VL 7
IS 3
AR e06466
DI 10.1016/j.heliyon.2021.e06466
EA MAR 2021
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RJ8IM
UT WOS:000637844000024
PM 33748503
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bhandari, A
   Sharma, AK
   Singh, H
   Singh, A
   Kaur, G
AF Bhandari, Anmol
   Sharma, Ashwani Kumar
   Singh, Harpal
   Singh, Amritpal
   Kaur, Gurcharan
TI Aging-related changes in metabolic indicators in female rats and their
   management with <i>Tinospora cordifolia</i>
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Aging; Dyslipidemia; High-fat diet; Metabolic indicators; Tinospora
   cordifolia
ID INSULIN-RESISTANCE; GENE-EXPRESSION; ADIPOSE-TISSUE; LIPID-METABOLISM;
   AMPK; LIVER; HYPERLIPIDEMIA; ANTIOXIDANT; OVARIECTOMY; MENOPAUSE
AB Conflicting reports of HRT necessitates exploration of therapeutic interventions with the least side effects to preserve metabolic homeodynamics in women later in life. The current study was designed to elucidate the cumulative effects of aging and/or high fat diet (HFD) on some metabolic indicators and their management by Tinospora cordifolia stem powder (TCP) using middle-aged acyclic and young adult cyclic female rats as the model system. Animals were fed on either normal chow or HFD supplemented with or without TCP. Blood and liver tissue were collected for biochemical, and histological studies as well as for expression of proteins regulating lipid metabolism. Animals fed with TCP supplemented normal chow feed showed bodyweight management over 12-weeks despite their high feed and calories intake compared to young and age-matched controls as well as HFD-fed animals. TCP dose used was not toxic and rather prevented age-associated liver dysfunctions and ameliorated dyslipidemia and oxidative stress, normalized blood glucose, insulin, leptin, and secretary pro-inflammatory cytokines. Further, bodyweight management effect of TCP was observed to target AMPK signalling pathway as the mediator of lipogenesis, sterol biosynthesis, lipolysis, and beta-oxidation of fatty acids. These findings suggest that TCP supplementation in diet may be a potential interventional strategy to ameliorate aging-associated hepatic and metabolic dysfunctions and to promote healthy aging.
   [GRAPHICS]
   .
C1 [Bhandari, Anmol; Singh, Amritpal; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Med Biotechnol Lab, Amritsar 143005, Punjab, India.
   [Sharma, Ashwani Kumar; Singh, Harpal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar 143005, Punjab, India.
C3 Guru Nanak Dev University; Guru Nanak Dev University
RP Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Med Biotechnol Lab, Amritsar 143005, Punjab, India.
EM kgurcharan.neuro@yahoo.com
RI Bhandari, Anmol/HSH-3529-2023
OI Bhandari, Anmol/0000-0002-4247-1041; Kaur, Gurcharan/0000-0002-1130-5729
FU Department of Science & Technology under Cognitive Science Research
   Initiative-DST-CSRI, GOI [DST/CSRI/2018/99]; DST
FX The current study was funded by the Department of Science & Technology
   under Cognitive Science Research Initiative-DST-CSRI, GOI grant to Prof.
   Gurcharan Kaur (DST/CSRI/2018/99). Anmol Bhandari is thankful to DST for
   the fellowship from this grant during the course of this work. This
   funding agency has no role in study designing, manuscript writing, and
   data interpretation.
CR Bajaj P, 2022, NEUROMOL MED, V24, P202, DOI 10.1007/s12017-021-08683-x
   BAN YH, 2018, EVID-BASED COMPL ALT, V2018, DOI DOI 10.1155/2018/2929107
   Banin RM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-78528-3
   Barthem CS, 2019, ENDOCR CONNECT, V8, P1568, DOI 10.1530/EC-19-0470
   Basurto L, 2019, GYNECOL ENDOCRINOL, V35, P909, DOI 10.1080/09513590.2019.1604658
   Bjorklund BR., 2015, JOURNEY ADULTHOOD
   Buniam J, 2019, AM J PHYSIOL-ENDOC M, V316, pE908, DOI 10.1152/ajpendo.00466.2018
   D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200
   Dhingra Dinesh, 2014, ISRN Pharmacol, V2014, P243575, DOI 10.1155/2014/243575
   Freeman EW, 2010, MENOPAUSE, V17, P718, DOI [10.1097/gme.0b013e3181cec85d, 10.1097/gme.0b013e3181db9f8b]
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Huang WT, 2019, COMPLEMENT THER MED, V42, P286, DOI 10.1016/j.ctim.2018.11.028
   Kamei Y, 2005, J NUTR SCI VITAMINOL, V51, P110, DOI 10.3177/jnsv.51.110
   Kaur T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0975-6
   Kaushik A, 2017, PHARMACOGN MAG, V13, pS658, DOI 10.4103/pm.pm_448_16
   Kim J, 2016, J NAT MED-TOKYO, V70, P522, DOI 10.1007/s11418-016-0971-7
   Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16
   Kim MR, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/7941391
   Koebele SV, 2016, MATURITAS, V87, P5, DOI 10.1016/j.maturitas.2016.01.015
   Lee M, 2018, J AM SOC NEPHROL, V29, P2326, DOI 10.1681/ASN.2018010050
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Manchanda S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1652-0
   Mandar Bijendra K., 2021, In Silico Pharmacology, V9, P3, DOI 10.1007/s40203-020-00063-w
   Mayer LP, 2004, BIOL REPROD, V71, P130, DOI 10.1095/biolreprod.103.016113
   Mayer LP, 2002, REPROD TOXICOL, V16, P775, DOI 10.1016/S0890-6238(02)00048-5
   Mertens I, 2005, THROMB HAEMOSTASIS, V94, P1190, DOI 10.1160/TH05-01-0024
   Michicotl-Meneses MM, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082577
   Mishra R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25564
   Mishra R, 2015, MOL NEUROBIOL, V52, P719, DOI 10.1007/s12035-014-8892-5
   Mishra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078764
   Mori Hardik, 2016, Ayu, V37, P238, DOI [10.4103/ayu.ayu_109_14, 10.4103/ayu.AYU_109_14]
   Munshi RP, 2014, INDIAN J PHARMACOL, V46, P270, DOI 10.4103/0253-7613.132156
   Nam DE, 2019, J MED FOOD, V22, P1110, DOI 10.1089/jmf.2019.4491
   Nanashima N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051541
   NIA, 2015, NIA AG ROD COL HDB
   Palmisano BT, 2017, ADV EXP MED BIOL, V1043, P227, DOI 10.1007/978-3-319-70178-3_12
   Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159
   Prince PSM, 2004, PHYTOTHER RES, V18, P785, DOI 10.1002/ptr.1567
   Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002
   Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004
   Saha S, 2012, ANC SCI LIFE, V31, P151, DOI 10.4103/0257-7941.107344
   Sangeetha MK, 2011, J NAT MED-TOKYO, V65, P544, DOI 10.1007/s11418-011-0538-6
   Saral S, 2021, EUR CYTOKINE NETW, V32, P31, DOI 10.1684/ecn.2021.0467
   Sharma A, 2020, NEUROMOL MED, V22, P81, DOI 10.1007/s12017-019-08566-2
   Sharma A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2330-6
   Shen HH, 2019, J NUTR BIOCHEM, V67, P111, DOI 10.1016/j.jnutbio.2019.02.001
   Shim KS, 2021, MOLECULES, V26, DOI 10.3390/molecules26040784
   Singh DP, 2015, PHARMACOGN MAG, V11, pS375, DOI 10.4103/0973-1296.168945
   Singh H, 2021, NEUROCHEM INT, V143, DOI 10.1016/j.neuint.2020.104937
   Singh H, 2020, PHARMANUTRITION, V13, DOI 10.1016/j.phanu.2020.100189
   Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460
   Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x
   Tang SF, 2021, PHYTOMEDICINE, V82, DOI 10.1016/j.phymed.2020.153447
   Tomicek NJ, 2011, GENDER MED, V8, P325, DOI 10.1016/j.genm.2011.05.010
   Upadhyay Avnish K, 2010, Int J Ayurveda Res, V1, P112, DOI 10.4103/0974-7788.64405
   Xing XX, 2016, EXP PHYSIOL, V101, P1406, DOI 10.1113/EP085786
NR 57
TC 3
Z9 3
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2022 JUN
PY 2022
VL 23
IS 3
BP 363
EP 380
DI 10.1007/s10522-022-09962-1
EA APR 2022
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 2C9UW
UT WOS:000789071000001
PM 35488997
DA 2024-02-19
ER

PT J
AU Ma, Y
   Li, SW
   Ye, SZ
   Hu, D
   Wei, L
   Xiao, F
AF Ma, Yu
   Li, Siwen
   Ye, Shuzi
   Hu, Die
   Wei, Lai
   Xiao, Fang
TI Hexavalent chromium triggers hepatocytes premature senescence via the
   GATA4/NF-KB signaling pathway mediated by the DNA damage response
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Early Access
DE Hexavalent chromium [Cr(VI)]; Senescence-associated secretion phenotype;
   (SASP); Premature senescence; Zinc finger transcription factor GATA4;
   Nuclear factor kappa-B (NF-KB)
ID NF-KAPPA-B; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; AUTOPHAGY; MTOR;
   P53; ACTIVATION; STRESS; CANCER
AB Hexavalent chromium [Cr(VI)] is a proven toxin, carcinogen and environmental pollutant. Oral intake of Cr(VI) has been shown to lead to an increasing incidence of primary hepatic carcinoma in the population. Cellular senescence is thought to be a natural barrier to malignant transformation of cells, but senescence-associated secretory phenotype (SASP) is secreted and regulated by senescent cells links cellular senescence to malignant transformation in a dynamic way. In the present research, we demonstrated novel mechanisms of premature hepatocytes senescence induced by Cr(VI). Continuous Cr(VI) stimulation led to DNA damaged in hepatocytes, and DNA damage response (DDR) signals were transmitted by ataxia telangiectasia-mutated gene (ATM)/ataxia telangiectasia and Rad-3-related protein (ATR), resulting in zinc finger transcription factor GATA4 escaping p62mediated selective autophagy, thereby regulating nuclear factor kappa-B (NF-KB) to induce premature senescence in hepatocytes. In contrast to the classical senescence pathway p53-p21WAF1 /CIP1 and Rb/p16INK4a, GATA4 can directly regulate the secretion of SASP during premature senescence. The results will provide valuable clues for targeted prevention and further individualized treatment of Cr(VI)-associated cancers.
C1 [Ma, Yu; Li, Siwen; Ye, Shuzi; Hu, Die; Wei, Lai; Xiao, Fang] Cent South Univ, Xiangya Sch Publ Hlth, Changsha 410078, Peoples R China.
   [Xiao, Fang] Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, 238 Shangmayuanling Rd, Changsha 410078, Hunan, Peoples R China.
C3 Central South University; Central South University
RP Xiao, F (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, 238 Shangmayuanling Rd, Changsha 410078, Hunan, Peoples R China.
EM 196901002@csu.edu.cn; lisiwen0529@163.com; fangxiao@csu.edu.cn
RI Xiao, Fang/S-9283-2018
FU National Natural ScienceFoundation of China [81773478]; Natural Science
   Foundation of Hunan Province, China [2020JJ3052]; Fundamental Research
   Funds for the Central Universities of Central South University
   [2020zzts239, 2021zzts0326]
FX Acknowledgments The current work was supported by National Natural
   ScienceFoundation of China (NO. 81773478) , Natural Science Foundation
   of Hunan Province, China (NO. 2020JJ3052) and the Fundamental Research
   Funds for the Central Universities of Central South University
   (2020zzts239, 2021zzts0326) .
CR Abbas A, 2020, INT J PHYTOREMEDIAT, V22, P52, DOI 10.1080/15226514.2019.1644286
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Bagchi D, 2002, TOXICOLOGY, V180, P5, DOI 10.1016/S0300-483X(02)00378-5
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Capell BC, 2016, GENE DEV, V30, P321, DOI 10.1101/gad.271882.115
   Carrà G, 2020, CELL MOL LIFE SCI, V77, P4449, DOI 10.1007/s00018-020-03524-9
   Chen QY, 2019, TOXICOL APPL PHARM, V377, DOI 10.1016/j.taap.2019.114636
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dimitrakopoulos FLD, 2020, CANCER RES, V80, P4025, DOI 10.1158/0008-5472.CAN-19-3578
   Ferrand M, 2015, AGING-US, V7, P986, DOI 10.18632/aging.100845
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Ge H, 2019, CHEM-BIOL INTERACT, V298, P35, DOI 10.1016/j.cbi.2018.10.024
   Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Neto LHJ, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1391
   Jin J, 2018, PLACENTA, V67, P15, DOI 10.1016/j.placenta.2018.05.008
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Li SW, 2022, FOOD CHEM TOXICOL, V164, DOI 10.1016/j.fct.2022.113071
   Li SW, 2021, J HAZARD MATER, V417, DOI 10.1016/j.jhazmat.2021.126025
   Li SW, 2021, J HAZARD MATER, V402, DOI [10.1016/j.hazmat.2020.123933, 10.1016/j.jhazmat.2020.123933]
   Liang YH, 2021, ECOTOX ENVIRON SAFE, V219, DOI 10.1016/j.ecoenv.2021.112343
   Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50
   Liu KJ, 2001, MOL CELL BIOCHEM, V222, P41, DOI 10.1023/A:1017994720562
   Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179
   Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Proctor DM, 2014, TOXICOLOGY, V325, P160, DOI 10.1016/j.tox.2014.08.009
   Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012
   Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Wang YJ, 2019, MECH AGEING DEV, V184, DOI 10.1016/j.mad.2019.111160
   WIEGAND HJ, 1988, SCI TOTAL ENVIRON, V71, P309, DOI 10.1016/0048-9697(88)90202-1
   Wise Sandra S., 2008, Reviews on Environmental Health, V23, P39
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zhang YJ, 2019, ECOTOX ENVIRON SAFE, V183, DOI 10.1016/j.ecoenv.2019.109465
   Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34578
NR 51
TC 3
Z9 3
U1 3
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD 2022 JUL 1
PY 2022
VL 239
AR 113645
DI 10.1016/j.ecoenv.2022.113645
EA MAY 2022
PG 10
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA 1U8PC
UT WOS:000805666600004
PM 35588622
OA gold
DA 2024-02-19
ER

PT J
AU Çoban, J
   Betül-Kalaz, E
   Küçükgergin, C
   Aydin, AF
   Dogan-Ekici, I
   Dogru-Abbasoglu, S
   Uysal, M
AF Coban, Jale
   Betul-Kalaz, Esra
   Kucukgergin, Canan
   Aydin, A. Fatih
   Dogan-Ekici, Isin
   Dogru-Abbasoglu, Semra
   Uysal, Mujdat
TI Blueberry treatment attenuates D-galactose-induced oxidative stress and
   tissue damage in rat liver
SO GERIATRICS & GERONTOLOGY INTERNATIONAL
LA English
DT Article
DE aging; blueberry; galactose; liver; oxidative stress
ID BERRY ANTHOCYANINS; LIFE-SPAN; MICE; CHOLESTEROL; PARAMETERS; EXTRACT;
   DISEASE; SERUM
AB Aimd-galactose (GAL) causes aging-related changes and oxidative stress in the organism. We investigated the effect of whole fresh blueberry (BB; Vaccinium corymbosum L.) treatment on oxidative stress in age-related liver injury model.
   MethodsRats received GAL (300mg/kg, s.c.; 5days per week) alone or together with 5% (BB1) and 10% (BB2) BB-containing chow for 2months. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and hepatic malondialdehyde (MDA), protein carbonyl (PC) and glutathione (GSH) levels, and CuZn-superoxide dismutase (SOD1), glutathione peroxidase (GPx1) and glutathione transferase (GST) activities together with mRNA expressions of SOD1, GPx1, MnSOD (SOD2) and phospholipid hydroperoxide glutathione peroxidase (GPx4) were determined in GAL-treated rats.
   ResultsMDA and PC levels increased, but GSH levels, SOD1 and GPx1 activities decreased together with histopathological structural damage in the liver in GAL-treated rats. There was no change in hepatic mRNA expressions of SOD2 and GPx1, but SOD1 and GPx4 expressions decreased. BB1 and BB2 caused significant decreases in serum ALT and AST activities together with the amelioration in histopathological findings in GAL-treated rats. Both BB1 and BB2 reduced MDA and PC levels, and elevated GSH levels, and SOD1 and GPx1 activities. However, hepatic mRNA expressions of SOD1, SOD2, GPx1 and GPx4 remained unchanged in GAL-treated rats.
   ConclusionsThese results show that BB restored liver pro-oxidant status together with histopathological amelioration by acting as an anti-oxidant (radical scavenger) itself without affecting mRNA expressions of anti-oxidant enzymes in GAL-treated rats. Geriatr Gerontol Int 2014; 14: 490-497.
C1 [Coban, Jale] Yeditepe Univ, Fac Med, Dept Biochem, Istanbul, Turkey.
   [Dogan-Ekici, Isin] Yeditepe Univ, Fac Med, Dept Pathol, Istanbul, Turkey.
   [Betul-Kalaz, Esra; Kucukgergin, Canan; Aydin, A. Fatih; Dogru-Abbasoglu, Semra; Uysal, Mujdat] Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
C3 Yeditepe University; Yeditepe University; Istanbul University
RP Uysal, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
EM m.mujdatuysal@hotmail.com
RI Abbasoglu, Semra/AAD-9014-2020; Küçükgergin, Canan/AAD-9925-2020; Aydın,
   Abdurrahman Fatih/AAD-9170-2020
OI Abbasoglu, Semra/0000-0003-3467-9763; 
FU Istanbul University [16727]
FX The present work was supported by a Research Fund of Istanbul University
   (Project No: 16727).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117
   Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Brigelius-Flohé R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Çoban J, 2013, BIOSCI BIOTECH BIOCH, V77, P389, DOI 10.1271/bbb.120722
   Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410
   Habig W H, 1981, Methods Enzymol, V77, P398
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Joseph JA, 2005, AM J CLIN NUTR, V81, p313S, DOI 10.1093/ajcn/81.1.313S
   Kay CD, 2002, BRIT J NUTR, V88, P389, DOI 10.1079/BJN2002665
   Kim H, 2010, J AGR FOOD CHEM, V58, P3984, DOI 10.1021/jf903230s
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Liu LC, 2010, J SCI FOOD AGR, V90, P329, DOI 10.1002/jsfa.3821
   Malin DH, 2011, NUTRITION, V27, P338, DOI 10.1016/j.nut.2010.05.001
   Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x
   MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3
   Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Osman N, 2007, DIGEST LIVER DIS, V39, P849, DOI 10.1016/j.dld.2007.06.001
   Parildar-Karpuzoglu H, 2008, PHARMACOL REP, V60, P673
   Peng C, 2012, EXP GERONTOL, V47, P170, DOI 10.1016/j.exger.2011.12.001
   Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026
   Ramana BV, 2006, ACTA DIABETOL, V43, P135, DOI 10.1007/s00592-006-0229-z
   Ren Y, 2011, J AGR FOOD CHEM, V59, P206, DOI 10.1021/jf103938e
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sprott RL, 2011, ILAR J, V52, P1
   Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657
   Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x
   Wu XL, 2010, J NUTR, V140, P1628, DOI 10.3945/jn.110.123927
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Yin Jie, 2008, Nutr Res Pract, V2, P247, DOI 10.4162/nrp.2008.2.4.247
   Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002
   Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
NR 44
TC 31
Z9 33
U1 0
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-1586
EI 1447-0594
J9 GERIATR GERONTOL INT
JI Geriatr. Gerontol. Int.
PD APR
PY 2014
VL 14
IS 2
BP 490
EP 497
DI 10.1111/ggi.12096
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AE1TS
UT WOS:000333753700033
PM 23750655
DA 2024-02-19
ER

PT J
AU Donato, MT
   Ponsoda, X
   O'Connor, E
   Castell, JV
   Gómez-Lechón, MJ
AF Donato, MT
   Ponsoda, X
   O'Connor, E
   Castell, JV
   Gómez-Lechón, MJ
TI Role of endogenous nitric oxide in liver-specific functions and survival
   of cultured rat hepatocytes
SO XENOBIOTICA
LA English
DT Article
ID GENE-EXPRESSION; GROWTH-FACTOR; INHIBITION; METABOLISM; APOPTOSIS;
   SYNTHASE; CYTOCHROME-P-450; P450; INDUCTION; INJURY
AB 1. The role of endogenous nitric oxide in rat hepatocyte functionality and survival in cell culture was examined. Towards this aim, cytochrome P450 activities (CYP1A1/2, 2B1, 2A1, 2C11, 2D1, 2E1 and 3A1), liver-specific metabolic functions and cell survival were comparatively evaluated in hepatocytes isolated from the male Sprague-Dawley rat and/or cultured in control conditions or in the presence of N-omega-nitro-L-arginine methyl ester (NAME), an inhibitor of nitric oxide synthesis.
   2. Suppression of nitric oxide production by NAME paralleled a substantial preservation of hepatocyte phenotype in culture. The presence of NAME was particularly important during isolation and/or the 6-24 h culture. By 24 h, beneficial effects were evident in parameters particularly unstable in culture (glycogen content, P450), whereas no changes were produced in well-preserved functions (glucose, urea and albumin synthesis, glutathione, drug-conjugating enzymes).
   3. Long-term treatment of hepatocytes with NAME also produced a reduction in caspase 3 activation and in the percentage of spontaneous apoptotic cells, and an increase in cell survival and transcriptional activity as shown by attached cellular protein content and the protein-DNA ratio respectively.
   4. In conclusion, inhibition of early endogenous nitric oxide formation is an efficient procedure for obtaining hepatocyte cultures with stable expression of differentiated functions, high cell survival and few signs of cell senescence.
C1 Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, E-46009 Valencia, Spain.
   Fac Ciencias Biol, Dept Parasitol & Biol Cellular, E-46014 Burjassot, Spain.
   Fac Med, Dept Bioquim & Biol Mol, E-46010 Valencia, Spain.
C3 Hospital Universitari i Politecnic La Fe
RP Gómez-Lechón, MJ (corresponding author), Hosp Univ La Fe, Ctr Invest, Unidad Hepatol Expt, Avda Campanar 21, E-46009 Valencia, Spain.
RI Donato, M. Teresa/Y-8797-2019; Ponsoda, Xavier/L-8272-2014; Castell,
   Jose V/I-9529-2016
OI Donato, M. Teresa/0000-0003-2532-790X; Ponsoda,
   Xavier/0000-0002-4051-4458; Castell, Jose V/0000-0003-1179-6430
CR Bort R, 1999, BIOCHEM PHARMACOL, V58, P787, DOI 10.1016/S0006-2952(99)00167-7
   BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7
   CASTELL JV, 1985, XENOBIOTICA, V18, P737
   CHAMULITRAT W, 1995, ARCH BIOCHEM BIOPHYS, V316, P30, DOI 10.1006/abbi.1995.1006
   Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148
   DARZYNKIEWICZ Z, 1990, FLOW CYTOMETRY SORTI, P15
   DONATO MT, 1994, IN VITRO CELL DEV-AN, V30A, P825
   Donato MT, 1997, J PHARMACOL EXP THER, V281, P484
   DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381
   DONATO MT, 1992, IN VITRO ALTERNATIVE, P149
   EDWARDS AM, 1984, BIOCHEM PHARMACOL, V33, P1537, DOI 10.1016/0006-2952(84)90425-8
   Fau D, 1997, GASTROENTEROLOGY, V113, P1334, DOI 10.1053/gast.1997.v113.pm9322529
   Gomez-Lechon M.J., 1997, IN VITRO METHODS IN PHARMACEUTICAL RESEARCH, P129
   GOMEZL MJ, 1984, IN VITRO CELL DEV B, V20, P826
   GomezLechon MJ, 1996, ANAL BIOCHEM, V236, P296, DOI 10.1006/abio.1996.0170
   GomezLechon MJ, 1996, HEPATOLOGY, V23, P1012
   GOMEZLECHON MJ, 1995, HEPATOLOGY, V21, P1248, DOI 10.1016/0270-9139(95)90044-6
   GOMEZLECHON MJ, 2000, MATRIX SERIES PROGR, P89
   GOMEZLECHON MJ, 1992, IN VITRO ALTERNATIVE, P85
   HARBRECHT BG, 1995, SHOCK, V3, P79, DOI 10.1097/00024382-199502000-00001
   IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535
   KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147
   KIM SG, 1990, BIOCHEM BIOPH RES CO, V172, P767, DOI 10.1016/0006-291X(90)90740-E
   KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6
   Li JR, 1999, J BIOL CHEM, V274, P17325, DOI 10.1074/jbc.274.24.17325
   Li JR, 1999, AM J PHYSIOL-GASTR L, V276, pG1069, DOI 10.1152/ajpgi.1999.276.5.G1069
   Liu ZZ, 1996, J LEUKOCYTE BIOL, V60, P382, DOI 10.1002/jlb.60.3.382
   López-García MP, 1998, FEBS LETT, V438, P145, DOI 10.1016/S0014-5793(98)01283-6
   López-García MP, 2000, FEBS LETT, V466, P187, DOI 10.1016/S0014-5793(99)01789-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449
   Nicholls-Grzemski FA, 1999, BIOCHEM PHARMACOL, V57, P1223, DOI 10.1016/S0006-2952(99)00053-2
   NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0
   NUSSLER AK, 1995, HEPATOLOGY, V21, P1552, DOI 10.1016/0270-9139(95)90459-X
   OSAWA Y, 1995, DRUG METAB REV, V27, P61, DOI 10.3109/03602539509029815
   PAINE AJ, 1990, CHEM-BIOL INTERACT, V74, P1, DOI 10.1016/0009-2797(90)90055-R
   PAPA S, 1987, CYTOMETRY, V8, P595, DOI 10.1002/cyto.990080611
   Qiao L, 1999, IN VITRO CELL DEV-AN, V35, P417
   Rodriguez-Ariza A, 1999, BIOCHEM BIOPH RES CO, V257, P145, DOI 10.1006/bbrc.1999.0424
   SONDERFAN AJ, 1987, ARCH BIOCHEM BIOPHYS, V255, P27, DOI 10.1016/0003-9861(87)90291-8
   STADLER J, 1994, P NATL ACAD SCI USA, V91, P3559, DOI 10.1073/pnas.91.9.3559
   TASSANEEYAKUL W, 1993, BIOCHEM PHARMACOL, V46, P1975, DOI 10.1016/0006-2952(93)90639-E
   *US NAT I HLTH, GUID CAR US LAB AN
   VARGAS JL, 1987, BIOCHEM BIOPH RES CO, V147, P535, DOI 10.1016/0006-291X(87)90964-8
   Vargiu C, 2000, J HEPATOL, V32, P567, DOI 10.1016/S0168-8278(00)80217-2
   Wang HR, 1998, J BIOCHEM-TOKYO, V124, P892, DOI 10.1093/oxfordjournals.jbchem.a022204
   WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016
   Woodcroft KJ, 1998, DRUG METAB DISPOS, V26, P372
NR 48
TC 16
Z9 18
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI LONDON
PA 11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND
SN 0049-8254
J9 XENOBIOTICA
JI Xenobiotica
PD MAY
PY 2001
VL 31
IS 5
BP 249
EP 264
DI 10.1080/00498250110052111
PG 16
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 453BL
UT WOS:000169896800002
PM 11491387
DA 2024-02-19
ER

PT J
AU Sorensen, M
   Sanz, A
   Gómez, J
   Pamplona, R
   Portero-Otín, M
   Gredilla, R
   Barja, G
AF Sorensen, M
   Sanz, A
   Gómez, J
   Pamplona, R
   Portero-Otín, M
   Gredilla, R
   Barja, G
TI Effects of fasting on oxidative stress in rat liver mitochondria
SO FREE RADICAL RESEARCH
LA English
DT Article
DE free radicals; fasting; mitochondria; lipid peroxidation; protein
   carbonyls
ID TERM CALORIC RESTRICTION; FATTY-ACID-COMPOSITION; DNA-DAMAGE; H2O2
   PRODUCTION; LIFE-SPAN; MEMBRANE PEROXIDIZABILITY; ANTIOXIDANT DEFENSES;
   RADICAL GENERATION; RESPIRATORY-CHAIN; PROTON LEAK
AB While moderate caloric restriction has beneficial effects on animal health state, fasting may be harmful. The present investigation was designed to test how fasting affects oxidative stress, and to find out whether the effects are opposite to those previously found in caloric restriction studies. We have focused on one of the main determinants of aging rate: the rate of mitochondrial free radical generation. Different parameters related to lipid and protein oxidative damage were also analyzed. Liver mitochondria from rats subjected to 72 h of fasting leaked more electrons per unit of O-2 consumed at complex III, than mitochondria from ad libitum fed rats. This increased leak led to a higher free radical generation under state 3 respiration using succinate as substrate. Regarding lipids, fasting altered fatty acid composition of hepatic membranes, increasing the double bond and the peroxidizability indexes. In accordance with this, we observed that hepatic membranes from the fasted animals were more sensitive to lipid peroxidation. Hepatic protein oxidative damage was also increased in fasted rats. Thus, the levels of oxidative modifications, produced either indirectly by reactive carbonyl compounds (N-epsilon-malondialdehyde-lysine), or directly through amino acid oxidation (glutamic and aminoadipic semialdehydes) were elevated due to the fasting treatment in both liver tissue and liver mitochondria. The current study shows that severe food deprivation increases oxidative stress in rat liver, at least in part, by increasing mitochondrial free radical generation during state 3 respiration and by increasing the sensitivity of hepatic membranes to oxidative damage, suggesting that fasting and caloric restriction have different effects on liver mitochondrial oxidative stress.
C1 Univ Complutense Madrid, Dept Physiol Anim Physiol 2, Fac Biol, E-28040 Madrid, Spain.
   Aarhus Univ, Dept Mol Biol, Danish Ctr Mol Gerontol, DK-8000 Aarhus, Denmark.
   Lleida Univ, Fac Med, Dept Basic Med Sci, Lleida 25008, Spain.
C3 Complutense University of Madrid; Aarhus University; Universitat de
   Lleida
RP Barja, G (corresponding author), Univ Complutense Madrid, Dept Fisiol Anim 2, Fac Biol, C Jose Antonio Novais 2, E-28040 Madrid, Spain.
EM barja@bio.ucm.es
RI Portero-Otin, Manuel/B-7122-2009; Barja, Gustavo/AAA-5903-2019; Sanz,
   Alberto/O-2329-2015; SANZ, ALBERTO/F-8432-2011; Gustavo,
   Barja/B-5591-2012; Pamplona, Reinald/A-7359-2010; Gomez,
   Jose/G-9705-2015
OI Portero-Otin, Manuel/0000-0002-1823-0299; Barja,
   Gustavo/0000-0001-5736-4735; Sanz, Alberto/0000-0003-2149-1753;
   Pamplona, Reinald/0000-0003-4337-6107; Gomez, Jose/0000-0003-1758-4746;
   GREDILLA, RICARDO/0000-0003-4501-1355
CR Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   BENUCK M, 1995, BRAIN RES, V678, P259, DOI 10.1016/0006-8993(95)00204-4
   Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003
   CRESCIMANNO M, 1989, FREE RADICAL RES COM, V7, P67, DOI 10.3109/10715768909087925
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   GATSKO G G, 1982, Byulleten' Eksperimental'noi Biologii i Meditsiny, V93, P30
   Gredilla R, 2003, ADV CELL AGING GERON, V14, P105
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7
   Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003
   Lambert AJ, 2004, MECH AGEING DEV, V125, P529, DOI 10.1016/j.mad.2004.06.002
   LAMBERT AJ, 2003, AM J PHYSIOL, V286, pR71
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   LEON TI, 2001, LIPIDS, V36, P589
   LIU PT, 1993, TOXICOLOGY, V80, P37, DOI 10.1016/0300-483X(93)90075-4
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Marczuk-Krynicka Dorota, 2003, Med Sci Monit, V9, pBR131
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008
   NAGASHIMA Y, 1995, JPN J PHYSIOL, V45, P645, DOI 10.2170/jjphysiol.45.645
   NORTH JA, 1994, AM J PHYSIOL, V267, pC177, DOI 10.1152/ajpcell.1994.267.1.C177
   ORELLANA M, 1992, FEBS LETT, V310, P193, DOI 10.1016/0014-5793(92)81327-I
   Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Pamplona R, 2002, FREE RADICAL RES, V36, P47, DOI 10.1080/10715760210165
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   RACLOT T, 1995, J LIPID RES, V36, P2164
   Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387
   Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Weindruch R., 1988, RETARDATION AGING DI
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
   Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200
NR 48
TC 77
Z9 84
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD APR
PY 2006
VL 40
IS 4
BP 339
EP 347
DI 10.1080/10715760500250182
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 018AN
UT WOS:000235735200001
PM 16517498
DA 2024-02-19
ER

PT J
AU Linden, MA
   Sheldon, RD
   Meers, GM
   Ortinau, LC
   Morris, EM
   Booth, FW
   Kanaley, JA
   Vieira-Potter, VJ
   Sowers, JR
   Ibdah, JA
   Thyfault, JP
   Laughlin, MH
   Rector, RS
AF Linden, Melissa A.
   Sheldon, Ryan D.
   Meers, Grace M.
   Ortinau, Laura C.
   Morris, E. Matthew
   Booth, Frank W.
   Kanaley, Jill A.
   Vieira-Potter, Victoria J.
   Sowers, James R.
   Ibdah, Jamal A.
   Thyfault, John P.
   Laughlin, M. Harold
   Rector, R. Scott
TI Aerobic exercise training in the treatment of non-alcoholic fatty liver
   disease related fibrosis
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID HEPATIC STELLATE CELLS; PHYSICAL-ACTIVITY; OLETF RATS; SKELETAL-MUSCLE;
   MATRIX METALLOPROTEINASES; MACROPHAGE INFILTRATION; CALORIC RESTRICTION;
   CELLULAR SENESCENCE; METABOLIC SYNDROME; WEIGHT-LOSS
AB Key points Physiologically relevant rodent models of non-alcoholic steatohepatitis (NASH) that resemble the human condition are limited. Exercise training and energy restriction are first-line recommendations for the treatment of NASH. Hyperphagic Otsuka Long-Evans Tokushima fatty rats fed a western diet high in fat, sucrose and cholesterol for 24weeks developed a severe NASH with fibrosis phenotype. Moderate intensity exercise training and modest energy restriction provided some improvement in the histological features of NASH that coincided with alterations in markers of hepatic stellate cell activation and extracellular matrix remodelling. The present study highlights the importance of lifestyle modification, including exercise training and energy restriction, in the regulation of advanced liver disease.
   AbstractThe incidence of non-alcoholic steatohepatitis (NASH) is rising but the efficacy of lifestyle modifications to improve NASH-related outcomes remain unclear. We hypothesized that a western diet (WD) would induce NASH in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat and that lifestyle modification would improve this condition. Eight-week-old Long-Evans Tokushima Otsuka (L) and OLETF (O) rats consumed a control diet (10%kcal fat, 3.5% sucrose) or a WD (45%kcal fat, 17% sucrose, 1% cholesterol) for 24weeks. At 20weeks of age, additional WD-fed OLETFs were randomized to sedentary (O-SED), food restriction (O-FR; approximate to 25% kcal reduction vs. O-SED) or exercise training (O-EX; treadmill running 20mmin(-1) with a 15% incline, 60minday(-1), 5daysweek(-1)) conditions for 12weeks. WD induced a NASH phenotype in OLETFs characterized by hepatic fibrosis (collagen 11 mRNA and hydroxyproline content), as well as elevated inflammation and non-alcoholic fatty liver disease activity scores, and hepatic stellate cell activation (-smooth muscle actin) compared to Long-Evans Tokushima Otsuka rats. FR and EX modestly improved NASH-related fibrosis markers (FR: hydroxyproline content, P<0.01; EX: collagen 11 mRNA, P<0.05; both: fibrosis score, P<0.01) and inflammation (both: inflammation score; FR: interleukin-1 and tumor necrosis factor ) vs. O-SED. FR reduced hepatic stellate cell activation markers (transforming growth factor- protein and -smooth muscle actin mRNA), whereas EX increased the hepatic stellate cell senescence marker CCN1 (P<0.01vs. O-SED). Additionally, both FR and EX normalized extracellular matrix remodelling markers to levels similar to L-WD (P>0.05). Although neither EX nor FR led to complete resolution of the WD-induced NASH phenotype, both independently benefitted liver fibrosis via altered hepatic stellate cell activation and extracellular matrix remodelling.
C1 [Linden, Melissa A.; Sheldon, Ryan D.; Meers, Grace M.; Sowers, James R.; Ibdah, Jamal A.; Rector, R. Scott] Univ Missouri, Res Serv, Harry S Truman Mem VA Hosp, Columbia, MO USA.
   [Meers, Grace M.; Ibdah, Jamal A.; Rector, R. Scott] Univ Missouri, Dept Med, Div Gastroenterol & Hepatol, Columbia, MO USA.
   [Linden, Melissa A.; Sheldon, Ryan D.; Ortinau, Laura C.; Kanaley, Jill A.; Vieira-Potter, Victoria J.; Rector, R. Scott] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.
   [Booth, Frank W.; Laughlin, M. Harold] Univ Missouri, Dept Biomed Sci, Columbia, MO USA.
   [Booth, Frank W.; Ibdah, Jamal A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA.
   [Booth, Frank W.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA.
   [Sowers, James R.] Univ Missouri, Med Div Endocrinol, Columbia, MO USA.
   [Morris, E. Matthew; Thyfault, John P.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.
   [Thyfault, John P.] Kansas City VA Med Ctr, Kansas City, MO USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Harry S. Truman Memorial Veterans' Hospital; University of Missouri
   System; University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia; University of Kansas; University of
   Kansas Medical Center
RP Rector, RS (corresponding author), Univ ofMissouri, Harry S Truman Mem VA Hosp, Dept Med, Div Gastroenterol & Hepatol & Nutr & Exercise Phy, Columbia, MO 65212 USA.
EM rectors@health.missouri.edu
RI Linden, Melissa/P-3079-2017; Thyfault, John/JMB-3070-2023
OI Thyfault, John/0000-0001-7920-7466; Linden, Melissa/0000-0002-3152-0864;
   Ibdah, Jamal/0000-0002-5646-9014; Sheldon, Ryan/0000-0002-1573-9719;
   Morris, E. Matthew/0000-0001-7046-3623
FU NIH [DK088940, RO1HL036088, HL73101-07, HL107910-03]; VA-Merit System
   [0018]; VHA-CDA2 [IK2BX001299]; University of Missouri Molecular Life
   Sciences Fellowship; University of Missouri Research Council; 
   [1I01BX002567-01]
FX This work was partially supported by NIH DK088940 (JPT), RO1HL036088
   (MHL), HL73101-07 (JRS), HL107910-03 (JRS), VA-Merit System 0018 (JRS),
   1I01BX002567-01 (JPT) and VHA-CDA2 IK2BX001299 (RSR), and University of
   Missouri Molecular Life Sciences Fellowship (RDS) and University of
   Missouri Research Council Grant (RSR).
CR Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Bian ZL, 2013, J LIPID RES, V54, P44, DOI 10.1194/jlr.M026013
   Borkham-Kamphorst E, 2016, CELL SIGNAL, V28, P34, DOI 10.1016/j.cellsig.2015.10.013
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Caldwell S, 2009, ANN HEPATOL, V8, pS60, DOI 10.1016/S1665-2681(19)31828-9
   Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953
   Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010
   D'Amico F, 2010, ACTA HISTOCHEM, V112, P474, DOI 10.1016/j.acthis.2009.05.005
   de Carvalho SN, 2013, CELLS TISSUES ORGANS, V198, P139, DOI 10.1159/000353215
   Elias MC, 2010, NUTRITION, V26, P1094, DOI 10.1016/j.nut.2009.09.001
   Emter CA, 2010, AM J PHYSIOL-HEART C, V299, pH1348, DOI 10.1152/ajpheart.00578.2010
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Giraudi PJ, 2015, EXP MOL PATHOL, V98, P85, DOI 10.1016/j.yexmp.2014.12.006
   Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5
   Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581
   Ichimura M, 2015, HEPATOL RES, V45, P458, DOI 10.1111/hepr.12358
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797
   Kwak HB, 2011, FASEB J, V25, P1106, DOI 10.1096/fj.10-172924
   Larson-Meyer DE, 2008, OBESITY, V16, P1355, DOI 10.1038/oby.2008.201
   Lee S, 2012, DIABETES, V61, P2787, DOI 10.2337/db12-0214
   Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11
   Linden MA, 2015, MED SCI SPORT EXER, V47, P556, DOI 10.1249/MSS.0000000000000430
   Linden MA, 2014, AM J PHYSIOL-ENDOC M, V306, pE300, DOI 10.1152/ajpendo.00427.2013
   Liu XL, 2007, OBES SURG, V17, P486, DOI 10.1007/s11695-007-9086-2
   Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008
   Mells JE, 2015, J NUTR BIOCHEM, V26, P285, DOI 10.1016/j.jnutbio.2014.11.002
   Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857
   Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003
   Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014
   Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264
   Perseghin G, 2007, DIABETES CARE, V30, P683, DOI 10.2337/dc06-2032
   Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429
   Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007
   Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185
   Rector RS, 2011, J APPL PHYSIOL, V111, P1828, DOI 10.1152/japplphysiol.00384.2011
   Rector RS, 2011, AM J PHYSIOL-GASTR L, V300, pG874, DOI 10.1152/ajpgi.00510.2010
   Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009
   Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x
   Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008
   Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789
   Scheede-Bergdahl C, 2014, DIABETES VASC DIS RE, V11, P324, DOI 10.1177/1479164114535943
   Song YS, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/342648
   Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461
   Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Veteläinen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x
   Wanninger J, 2011, EXP MOL PATHOL, V91, P603, DOI 10.1016/j.yexmp.2011.07.001
   Younossi ZM, 2002, HEPATOLOGY, V35, P746, DOI 10.1053/jhep.2002.32483
NR 53
TC 31
Z9 36
U1 5
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD SEP 15
PY 2016
VL 594
IS 18
BP 5271
EP 5284
DI 10.1113/JP272235
PG 14
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA DW3VO
UT WOS:000383571400024
PM 27104887
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Kaibori, M
   Matsui, K
   Ishizaki, M
   Saito, T
   Kitade, H
   Matsui, Y
   Kwon, AH
AF Kaibori, Masaki
   Matsui, Kosuke
   Ishizaki, Morihiko
   Saito, Takamichi
   Kitade, Hiroaki
   Matsui, Yoichi
   Kwon, A-Hon
TI Hepatic Resection for Hepatocellular Carcinoma in the Elderly
SO JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
DE liver cancer; hepatectomy; elderly patients; alcohol abuse
ID PRIMARY LIVER-CANCER; FOLLOW-UP SURVEY; CIRRHOTIC-PATIENTS;
   ALCOHOL-CONSUMPTION; PARTIAL-HEPATECTOMY; BLOOD-FLOW; AGING MAN;
   TRANSPLANTATION; THERAPY; SURGERY
AB Background and Objectives: Aging of the population has significantly increased the number of elderly patients undergoing surgery for hepatocellular carcinoma (HCC). We aimed to compare the results of hepatectomy for HCC in patients >= 70 years old with those for younger patients.
   Methods: Clinicopathological data and outcomes for 155 elderly patients and 333 younger patients with HCC who underwent hepatectomy between 1992 and 2007 were retrospectively compared.
   Results: The elderly group had a higher incidence of associated diseases, but had better preoperative liver function. Although postoperative delirium was more common in the elderly group, there were no significant differences between the two groups with regard to operative morbidity, hospital death, disease-free survival, and overall survival. The overall recurrence rate was significantly higher in the elderly patients with alcohol abuse than in younger patients with alcohol abuse. Multivariate analysis revealed that preoperative alcohol abuse was a prognostic factor for elderly patients.
   Conclusions: The short-term and long-term outcomes of surgery for HCC were similar in elderly and younger patients. Elderly patients with preoperative alcohol abuse should be followed closely, even after R0 surgery, because alcohol abuse is strongly con-elated with postoperative recurrence and worse survival.
C1 [Kaibori, Masaki; Matsui, Kosuke; Ishizaki, Morihiko; Saito, Takamichi; Kitade, Hiroaki; Matsui, Yoichi; Kwon, A-Hon] Kansai Med Univ, Dept Surg, Hirakata Hosp, Osaka 5731191, Japan.
C3 Kansai Medical University
RP Kaibori, M (corresponding author), Kansai Med Univ, Dept Surg, Hirakata Hosp, 2-3-1 Shinmachi, Osaka 5731191, Japan.
EM kaibori@hirtkata.kmu.ac.jp
RI Matsui, Yoichi/Q-9966-2019
OI Matsui, Yoichi/0000-0002-7353-958X
CR ADACHI S, 1991, HEPATOLOGY, V14, P776, DOI 10.1002/hep.1840140506
   ADAMI HO, 1992, INT J CANCER, V51, P898, DOI 10.1002/ijc.2910510611
   [Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
   BARLOW AP, 1989, ANN ROY COLL SURG, V71, P110
   Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411
   BERENYI MR, 1974, AM J DIG DIS, V19, P199, DOI 10.1007/BF01072535
   Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120
   CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1016/0270-9139(91)90289-8
   Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8
   COLAPINTO ND, 1985, CAN J SURG, V28, P323
   Couinaud C., 1957, FOIE ETUDES ANATOMIQ
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9
   Fong Y, 1997, BRIT J SURG, V84, P1386
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Galanakis P, 2001, INT J GERIATR PSYCH, V16, P349, DOI 10.1002/gps.327
   GARRO AJ, 1986, ALCOHOL CLIN EXP RES, V10, P73
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Ikai I, 2005, HEPATOL RES, V32, P163, DOI 10.1016/j.hepres.2005.04.005
   Ikai I, 2004, HEPATOL RES, V28, P21, DOI 10.1016/j.hepres.2003.08.002
   Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x
   INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941
   KOTOH K, 1994, AM J GASTROENTEROL, V89, P194
   Kubo S, 1998, SURGERY, V123, P205, DOI 10.1067/msy.1998.84179
   Kwon A, 1997, HEPATOLOGY, V25, P426
   LIEBER CS, 1986, HEPATOLOGY, V6, P1005, DOI 10.1002/hep.1840060533
   LIEBER CS, 1979, CANCER RES, V39, P2863
   Lui WY, 1999, HEPATO-GASTROENTEROL, V46, P640
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104
   MCKENNA RJ, 1994, CANCER-AM CANCER SOC, V74, P2107, DOI 10.1002/1097-0142(19941001)74:7+<2107::AID-CNCR2820741719>3.0.CO;2-1
   Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X
   MOHAMED AE, 1992, INT J CANCER, V51, P537, DOI 10.1002/ijc.2910510406
   MONFARDINI S, 1993, EUR J CANCER, V29A, P2325, DOI 10.1016/0959-8049(93)90229-9
   NAGASUE N, 1993, SURGERY, V113, P148
   NAMIENO T, 1995, ANN SURG, V221, P308, DOI 10.1097/00000658-199503000-00014
   NOMURA F, 1994, BRIT J CANCER, V70, P590
   Okada S, 1995, HEPATO-GASTROENTEROL, V42, P944
   OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673
   Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Sarasin FP, 1998, HEPATOLOGY, V28, P436, DOI 10.1002/hep.510280222
   SATO T, 2001, MINOPHAGEN MED REV, V46, P265
   SEKI T, 1994, CANCER, V74, P817, DOI 10.1002/1097-0142(19940801)74:3<817::AID-CNCR2820740306>3.0.CO;2-8
   Sobin LH, 1997, TNM CLASSIFICATION M
   TAKENAKA K, 1994, ARCH SURG-CHICAGO, V129, P846
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yamamoto K, 1997, HEPATO-GASTROENTEROL, V44, P514
   YANAGA K, 1988, AM J SURG, V155, P238, DOI 10.1016/S0002-9610(88)80703-7
   ZOLI M, 1989, GERONTOLOGY, V35, P61, DOI 10.1159/000213000
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 52
TC 64
Z9 66
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-4790
J9 J SURG ONCOL
JI J. Surg. Oncol.
PD MAR 1
PY 2009
VL 99
IS 3
BP 154
EP 160
DI 10.1002/jso.21221
PG 7
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA 411BM
UT WOS:000263622700009
PM 19123236
DA 2024-02-19
ER

PT J
AU Goto, SG
AF Goto, SG
TI Expression of <i>Drosophila</i> homologue of senescence marker
   protein-30 during cold acclimation
SO JOURNAL OF INSECT PHYSIOLOGY
LA English
DT Article
DE Drosophila; cold acclimation; Dca; senescence marker protein-30;
   senescence
ID LIVER PLASMA-MEMBRANES; RAT-LIVER; MESSENGER-RNA; C-JUN;
   SACCHAROMYCES-CEREVISIAE; TISSUE DISTRIBUTION; 5'-FLANKING REGION;
   BINDING ACTIVITY; LOW-TEMPERATURE; KAPPA-B
AB Gene expression during cold acclimation at a moderately low temperature (15 degrees C) was studied in Drosophila melanogaster using a subtraction technique. A gene homologous to senescence marker protein-30 (SMP30), which has a Ca2+-binding function, was up-regulated at the transcription level after acclimation to 15 degrees C. This gene (henceforth referred to as Dca) was also expressed at a higher level in individuals reared at 15 degrees C from the egg stage than in those reared at 25 degrees C. Moreover, DCA mRNA increased at the senescent stage in Drosophila, although SMP30 is reported to decrease at senescent stages in mammals. in situ hybridization to polytene chromosomes revealed that the Dca gene was located at 88D on chromosome 3R. The 5' flanking region of this gene had AP-1 (a transcription factor of SMP30) binding sites, stress response element and some other transcription factor binding sites. The function of DCA was discussed in relation to the possible regulation of cytosolic Ca2+ concentration. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.
C3 Hokkaido University
RP Goto, SG (corresponding author), Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.
EM goto@ees.hokudai.ac.jp
RI Goto, Shin G/K-2614-2015
OI Goto, Shin G/0000-0002-4431-7531
CR Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217
   Berger F, 1997, J BACTERIOL, V179, P5670, DOI 10.1128/jb.179.18.5670-5676.1997
   BISHOP JG, 1988, GENE DEV, V2, P567, DOI 10.1101/gad.2.5.567
   BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
   BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523
   ENGELS WR, 1986, FOCUS, V8, P6
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   GAIDO ML, 1991, J BIOL CHEM, V266, P18580
   GILLIS P, 1991, J BIOL CHEM, V266, P3172
   Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1
   Gurskaya NG, 1996, ANAL BIOCHEM, V240, P90, DOI 10.1006/abio.1996.0334
   HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3
   Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Hochachka PW, 1984, BIOCH ADAPTATION
   Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147
   Juni N, 1996, GENETICS, V143, P1257
   Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x
   Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489
   Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x
   KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0
   LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381
   Lee R.E. Jr, 1991, P17
   MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7
   Monroy AF, 1998, PLANT J, V13, P653, DOI 10.1046/j.1365-313X.1998.00070.x
   Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4
   Murata T, 1999, J BIOL CHEM, V274, P1277, DOI 10.1074/jbc.274.3.1277
   Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157
   Murata T, 1998, MOL CELL BIOCHEM, V178, P305, DOI 10.1023/A:1006867531428
   NEVEN LG, 1993, PLANT MOL BIOL, V21, P291, DOI 10.1007/BF00019945
   NICOTERA P, 1994, CELL CALCIUM, V16, P279, DOI 10.1016/0143-4160(94)90091-4
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x
   Ohtsu T, 1999, ENVIRON ENTOMOL, V28, P968, DOI 10.1093/ee/28.6.968
   Pahlavani MA, 1996, AGE, V19, P45, DOI 10.1007/BF02434070
   PEROTTI M, 1990, FEBS LETT, V259, P331, DOI 10.1016/0014-5793(90)80040-P
   RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0
   SAKAI M, 1989, CANCER RES, V49, P5633
   Sambrook J, 1989, MOL CLONING LAB MANU
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SHI L, 1994, EXP GERONTOL, V29, P575, DOI 10.1016/0531-5565(94)90040-X
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087
   Storey K.B., 1991, P64
   TAKAHASHI H, 1994, MOL CELL BIOCHEM, V136, P71, DOI 10.1007/BF00931607
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V125, P171, DOI 10.1007/BF00936446
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209
   Tumer N, 1997, NEUROPHARMACOLOGY, V36, P1065, DOI 10.1016/S0028-3908(97)00093-2
   VARELA JCS, 1995, MOL CELL BIOL, V15, P6232
   YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7
NR 54
TC 62
Z9 72
U1 0
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-1910
EI 1879-1611
J9 J INSECT PHYSIOL
JI J. Insect Physiol.
PD JUL
PY 2000
VL 46
IS 7
BP 1111
EP 1120
DI 10.1016/S0022-1910(99)00221-8
PG 10
WC Entomology; Physiology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Entomology; Physiology; Zoology
GA 322LN
UT WOS:000087511200005
PM 10817837
DA 2024-02-19
ER

PT J
AU Dilley, TK
   Bowden, GT
   Chen, QM
AF Dilley, TK
   Bowden, GT
   Chen, QM
TI Novel mechanisms of sublethal oxidant toxicity: induction of premature
   senescence in human fibroblasts confers tumor promoter activity
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
ID LIVER EPITHELIAL-CELLS; REPLICATIVE SENESCENCE; HYDROGEN-PEROXIDE;
   GROWTH ARREST; IN-VIVO; SERIAL CULTIVATION; OXIDATIVE STRESS; CANCER;
   SKIN; KERATINOCYTES
AB Aging is the highest risk factor for cancer. Although oxidants are thought to contribute to both aging and cancer, the interplay between oxidative stress, aging, and cancer has not been well studied. Human diploid fibroblasts (HDFs) undergo premature senescence in response to sublethal doses of H2O2. To test the hypothesis that senescent or senescent-like HDFs function as a tumor promoter, we have employed an in vitro skin tumor promotion model, in which colony formation is measured using initiated mouse keratinocyte 308 cells seeded at clonal density. 308 cells form colonies when co-cultured with normal HDFs only in the presence of the tumor promoter phorbol 12-myristate 13-acetate (TPA), which induces an average of 5.75 colonies. When co-cultured with H2O2-treated HDFs, 308 cells form an average of 30.3 colonies. To understand the mechanism behind this phenomenon, we tested whether conditioned medium of HDFs, HDF extracellular matrix (ECM), density of HDFs, or the contact between keratinocytes and HDFs plays a role in 308 cell colony formation. The conditioned medium from prematurely senescent cells resulted in an average of eightfold more 308 cell colonies formed than the conditioned medium from normal HDFs, and the growth-promoting effect of the conditioned medium was trypsin sensitive. The ECM alone was not able to induce 308 cell colony formation. Increasing the density of normal HDFs or contact with normal HDFs but not senescent-like HDFs was inhibitory to the growth of 308 cells. Measurement of Connexin 43 indicated a decreased expression of the protein, which suggests an impaired gap junction communication in senescent-like HDFs. We conclude that H2O2-treated fibroblasts not only lose contact inhibition of the growth of initiated keratinocytes perhaps related to reduced gap junction communication but also increase production of secreted protein factors to enhance the growth of 308 keratinocytes. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.
   Univ Arizona, Arizona Canc Ctr, Dept Radiat Oncol, Tucson, AZ 85724 USA.
C3 University of Arizona; University of Arizona; Arizona Center Cancer Care
RP Chen, QM (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
EM qchen@email.arizona.edu
FU NIEHS NIH HHS [R01 ES10826] Funding Source: Medline
CR Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Camougrand N, 2001, RESP PHYSIOL, V128, P393, DOI 10.1016/S0034-5687(01)00314-0
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182
   Chen QM, 2000, J CELL SCI, V113, P4087
   Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HAZZARD W R, 1999, PRINCIPLES GERIATRIC
   HENNINGS H, 1993, P SOC EXP BIOL MED, V202, P1
   HENNINGS H, 1990, CANCER RES, V50, P4794
   HENNINGS H, 1992, CARCINOGENESIS, V13, P2145, DOI 10.1093/carcin/13.11.2145
   Huang RP, 1999, CARCINOGENESIS, V20, P485, DOI 10.1093/carcin/20.3.485
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   KUMAZAKI T, 1991, EXP CELL RES, V195, P13, DOI 10.1016/0014-4827(91)90494-F
   Lowry DT, 1996, CARCINOGENESIS, V17, P699, DOI 10.1093/carcin/17.4.699
   Masoro EJ, 2001, HDB BIOL AGING
   McCullough KD, 1997, CANCER RES, V57, P1807
   Parnigotto Pier Paolo, 1994, Italian Journal of Anatomy and Embryology, V99, P17
   QIAO R, 1993, AM J PHYSIOL, V265, pC439, DOI 10.1152/ajpcell.1993.265.2.C439
   RAO KS, 1992, MUTAT RES, V275, P317
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Simian M, 2001, DEVELOPMENT, V128, P3117
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Smith RS, 1997, AM J PATHOL, V151, P317
   STRICKLAND JE, 1988, CANCER RES, V48, P165
   Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216
   Trosko JE, 2001, MUTAT RES-FUND MOL M, V480, P219, DOI 10.1016/S0027-5107(01)00181-6
   VIVEKANANDA J, 1994, J BIOL CHEM, V269, P25057
   WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961
   Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9
   Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8
   WOODLEY D, 1998, J INVEST DERMATOL, V90, P679
NR 44
TC 44
Z9 50
U1 0
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD OCT 15
PY 2003
VL 290
IS 1
BP 38
EP 48
DI 10.1016/S0014-4827(03)00308-2
PG 11
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 728PA
UT WOS:000185724500004
PM 14516786
DA 2024-02-19
ER

PT J
AU Chen, YL
   Peng, HC
   Tan, SW
   Tsai, CY
   Huang, YH
   Wu, HY
   Yang, SC
AF Chen, Ya-Ling
   Peng, Hsiang-Chi
   Tan, Shan-Wen
   Tsai, Cheng-Yuh
   Huang, Yi-Huei
   Wu, Hao-Yu
   Yang, Suh-Ching
TI Amelioration of ethanol-induced liver injury in rats by nanogold flakes
SO ALCOHOL
LA English
DT Article
DE Alcoholic liver disease; Oxidative stress; Inflammatory response;
   Nanogold flakes
ID GOLD NANOPARTICLES; OXIDATIVE STRESS; INDUCED HYPERHOMOCYSTEINEMIA;
   ANIMAL-TISSUES; ALCOHOL; DISEASE; PATHOGENESIS; GLUTATHIONE; MECHANISMS;
   STEATOSIS
AB The purpose of this study was to investigate the protective effects of nanogold flakes against alcoholic liver disease. Six-week-old male Wistar rats were divided into 6 groups: C (control liquid diet), CLF (control liquid diet with gold flakes at 1.03 mg/kg body weight [BW]/day), CHF (control liquid diet with gold flakes at 5.15 mg/kg BW/day), E (ethanol liquid diet), ELF (ethanol liquid diet with gold flakes at 1.03 mg/kg BW/day), and EHF (ethanol liquid diet with gold flakes at 5.15 mg/kg BW/day). The liquid diets were prepared daily. Gold flakes were added to the ethanol 1 h before preparing the ethanol liquid diets, as an aging process. After 10 weeks, rats in group E showed significantly higher plasma aspartate transaminase (AST) and alanine transaminase (ALT) activities than those in group C. A significantly increased concentration of hepatic triglyceride (TG) was found in group E. Furthermore, higher hepatic glutathione reductase (GRD), superoxide dismutase (SOD), and catalase (CAT) activities together with higher tumor necrosis factor (TNF)-alpha concentration and higher hepatic cytochrome (CYP2E1) protein expression were also observed in group E. In contrast, the hepatic TG concentration in group EHF was significantly lower than that of group E. In addition, hepatic glutathione peroxidase (GPX), SOD, and CAT activities together with TNF-alpha concentration and hepatic CYP2E1 protein expression in group EHF were significantly lower than those in group E. We concluded that nanogold flakes might ameliorate alcohol-induced liver injury by maintaining the hepatic antioxidative status. In addition, nanogold flakes may reduce fat accumulation caused by chronic ethanol feeding via decreasing hepatic TNF-alpha. (c) 2013 Elsevier Inc. All rights reserved.
C1 [Chen, Ya-Ling; Peng, Hsiang-Chi; Yang, Suh-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.
C3 Taipei Medical University
RP Yang, SC (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, 250 Wu Hsing St, Taipei 110, Taiwan.
EM sokei@tmu.edu.tw
RI chen, yaling/HOH-6338-2023
FU Gold Nanotech, Inc., Taiwan, Republic of China
FX This study was supported by Gold Nanotech, Inc., Taiwan, Republic of
   China. Ya-Ling Chen and Hsiang-Chi Peng did the data analysis. Shan-Wen
   Tan, Cheng-Yuh Tsai, Yi-Huei Huang, Hao-Yu Wu, and Suh-Ching Yang
   designed the study. There is no conflict of interest associated with
   this study.
CR Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Cao XD, 2011, ANAL BIOCHEM, V417, P1, DOI 10.1016/j.ab.2011.05.027
   Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0
   Chen YL, 2011, NUTRITION, V27, P1034, DOI 10.1016/j.nut.2010.10.019
   Chen YL, 2011, WORLD J GASTROENTERO, V17, P1063, DOI 10.3748/wjg.v17.i8.1063
   Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005
   Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Homberger M, 2010, PHILOS T R SOC A, V368, P1405, DOI 10.1098/rsta.2009.0275
   Ji C, 2004, HEPATOLOGY, V40, P442, DOI 10.1002/hep.20309
   Ki SH, 2007, CHEM-BIOL INTERACT, V169, P80, DOI 10.1016/j.cbi.2007.05.008
   Leonaviciene L, 2012, MED LITH, V48, P91
   LIEBER CS, 1994, METHOD ENZYMOL, V233, P585
   Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0
   Lin WT, 2009, CELL BIOCHEM FUNCT, V27, P344, DOI 10.1002/cbf.1579
   Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004
   McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065
   MIYACHI Y, 1987, BRIT J DERMATOL, V116, P39, DOI 10.1111/j.1365-2133.1987.tb05789.x
   Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409
   Petrasek J, 2011, HEPATOLOGY, V53, P649, DOI 10.1002/hep.24059
   Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006
   Rüdiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304
   Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209
   Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683
   Tsai CY, 2007, ARTHRITIS RHEUM-US, V56, P544, DOI 10.1002/art.22401
   Tsukuda T, 2011, CHEM-ASIAN J, V6, P736, DOI 10.1002/asia.201000611
   Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008
   Victor EG, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-11
   Xia YN, 2011, ACCOUNTS CHEM RES, V44, P914, DOI 10.1021/ar200061q
   You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200
   Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049
NR 38
TC 14
Z9 19
U1 1
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-8329
J9 ALCOHOL
JI Alcohol
PD SEP
PY 2013
VL 47
IS 6
BP 467
EP 472
DI 10.1016/j.alcohol.2013.05.006
PG 6
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA 204IY
UT WOS:000323360200006
PM 23830375
DA 2024-02-19
ER

PT J
AU Hayashi, M
   Nishida, K
   Endoh, D
   Okui, T
AF Hayashi, M
   Nishida, K
   Endoh, D
   Okui, T
TI Production of age-related DNA strand breakage in brain cells of
   senescence-accelerated prone (SAMP1) mouse
SO EXPERIMENTAL ANIMALS
LA English
DT Article
DE brain; comet assay; SAMP1
ID OXIDATIVE STRESS; INDIVIDUAL CELLS; NERVOUS-SYSTEM; COMET ASSAY;
   LIVER-CELLS; LIFE-SPAN; DAMAGE; MELATONIN; REPAIR; ACCUMULATION
AB Amounts of DNA strand breaks were estimated by the proportion of cells without tails (PCWT) and the average lengths of tail momentum (ALTM) in comet images of tissue cells of senescence-accelerated prone (SAMP1) mouse and senescence-accelerated resistant (SAMR1) mouse. The PCWT and ALTM of brain cells from SAMR1 were unchanged from 4 to 15 months of age. In the case of SAMP1 brain cells, the PCWT decreased and the ALTM increased in an age-related manner from 8 to 15 months of age. In the cases of liver and kidney, the PCWT and the ALTM of both SAMP1 and SAMR1 cells showed constant values from 4 to 15 months of ages.
C1 Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Radiol, Ebetsu, Hokkaido 0698501, Japan.
   Hokkaido Inst Publ Hlth, Sapporo, Hokkaido 0600819, Japan.
C3 Rakuno Gakuen University
RP Hayashi, M (corresponding author), Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Radiol, Ebetsu, Hokkaido 0698501, Japan.
CR CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   DIZUDAROGLU M, 1992, MUTAT RES, V275, P331
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   GEDIK CM, 1992, INT J RADIAT BIOL, V62, P313, DOI 10.1080/09553009214552161
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6
   HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   Hayashi M, 2000, BIOCHEM BIOPH RES CO, V276, P174, DOI 10.1006/bbrc.2000.3454
   Hayashi M, 2002, EXP ANIM TOKYO, V51, P43, DOI 10.1538/expanim.51.43
   KAMIYA H, 1992, CANCER RES, V52, P3483
   KASAI H, 1986, ENVIRON HEALTH PERSP, V67, P111, DOI 10.2307/3430324
   Matuszak Z, 1997, FREE RADICAL BIO MED, V23, P367, DOI 10.1016/S0891-5849(96)00614-4
   Morioka N, 1999, J PINEAL RES, V27, P202, DOI 10.1111/j.1600-079X.1999.tb00616.x
   Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2
   OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587
   Olive PL, 1999, INT J RADIAT BIOL, V75, P395, DOI 10.1080/095530099140311
   Pierre C., 1994, LIFE SCI, V55, P271
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   RADFORD IR, 1986, INT J RADIAT BIOL, V49, P611
   SATO E, 1994, BRAIN RES, V637, P133, DOI 10.1016/0006-8993(94)91226-2
   Sato E, 1996, MECH AGEING DEV, V86, P105, DOI 10.1016/0047-6374(95)01681-3
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tan D-X, 1993, ENDOCR J, V1, P57
   TERAMOTO S, 1995, EUR RESPIR J, V8, P450, DOI 10.1183/09031936.95.08030450
   Xia C, 1999, MAMM GENOME, V10, P235, DOI 10.1007/s003359900979
NR 28
TC 2
Z9 4
U1 0
U2 0
PU INT PRESS EDITING CENTRE INC
PI TOKYO
PA 1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN
SN 1341-1357
J9 EXP ANIM TOKYO
JI Exp. Anim.
PD JUL
PY 2003
VL 52
IS 4
BP 353
EP 357
DI 10.1538/expanim.52.353
PG 5
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA 705YE
UT WOS:000184424200013
PM 14562614
OA Bronze
DA 2024-02-19
ER

PT J
AU Jalan-Sakrikar, N
   De Assuncao, TM
   Navarro-Corcuera, A
   Hamdan, FH
   Loarca, L
   Kirkeby, LA
   Resch, ZT
   O'Hara, SP
   Juran, BD
   Lazaridis, KN
   Rosen, CB
   Heimbach, JK
   Taner, T
   Shah, VH
   LaRusso, NF
   Huebert, RC
AF Jalan-Sakrikar, Nidhi
   De Assuncao, Thiago M.
   Navarro-Corcuera, Amaia
   Hamdan, Feda H.
   Loarca, Lorena
   Kirkeby, Lindsey A.
   Resch, Zachary T.
   O'Hara, Steven P.
   Juran, Brian D.
   Lazaridis, Konstantinos N.
   Rosen, Charles B.
   Heimbach, Julie K.
   Taner, Timucin
   Shah, Vijay H.
   LaRusso, Nicholas F.
   Huebert, Robert C.
TI Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing
   Cholangitis Develop a Senescence Phenotype Following Biliary
   Differentiation
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID IN-VITRO; CHOLANGIOCYTES; GROWTH
AB Primary sclerosing cholangitis (PSC) is a chronic fibroinflammatory disease of the biliary tract characterized by cellular senescence and periportal fibrogenesis. Specific disease features that are cell intrinsic and either genetically or epigenetically mediated remain unclear due in part to a lack of appropriate, patient-specific, in vitro models. Recently, our group developed systems to create induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs) and biliary epithelial organoids (cholangioids). We use these models to investigate whether PSC cholangiocytes are intrinsically predisposed to cellular senescence. Skin fibroblasts from healthy controls and subjects with PSC were reprogrammed to pluripotency, differentiated to cholangiocytes, and subsequently grown in three-dimensional matrigel-based culture to induce formation of cholangioids. RNA sequencing (RNA-seq) on iDCs showed significant differences in gene expression patterns, including enrichment of pathways associated with cell cycle, senescence, and hepatic fibrosis, that correlate with PSC. These pathways also overlapped with RNA-seq analysis on isolated cholangiocytes from subjects with PSC. Exome sequencing on the subjects with PSC revealed genetic variants of unknown significance in the genes identified in these pathways. Three-dimensional culture revealed smaller size, lack of a central lumen, and increased cellular senescence in PSC-derived cholangioids. Congruent with this, PSC-derived iDCs showed increased secretion of the extracellular matrix molecule fibronectin as well as the inflammatory cytokines interleukin-6, and chemokine (C-C motif) ligand 2. Conditioned media (CM) from PSC-derived iDCs more potently activated hepatic stellate cells compared to control CM. Conclusion: We demonstrated efficient generation of iDCs and cholangioids from patients with PSC that show disease-specific features. PSC cholangiocytes are intrinsically predisposed to cellular senescence. These features are unmasked following biliary differentiation of pluripotent stem cells and have functional consequences in epithelial organoids.
C1 [Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Navarro-Corcuera, Amaia; Hamdan, Feda H.; Loarca, Lorena; O'Hara, Steven P.; Juran, Brian D.; Lazaridis, Konstantinos N.; Shah, Vijay H.; LaRusso, Nicholas F.; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Navarro-Corcuera, Amaia; Hamdan, Feda H.; Shah, Vijay H.; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN USA.
   [Loarca, Lorena; O'Hara, Steven P.; Juran, Brian D.; Lazaridis, Konstantinos N.; LaRusso, Nicholas F.] Mayo Clin & Mayo Fdn, Ctr Basic Res Digest Dis, Rochester, MN USA.
   [Kirkeby, Lindsey A.; Resch, Zachary T.] Mayo Clin & Mayo Fdn, Ctr Regenerat Med, Rochester, MN USA.
   [O'Hara, Steven P.; Lazaridis, Konstantinos N.; Shah, Vijay H.; LaRusso, Nicholas F.; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN USA.
   [Rosen, Charles B.; Heimbach, Julie K.; Taner, Timucin; Shah, Vijay H.; LaRusso, Nicholas F.; Huebert, Robert C.] Mayo Clin & Mayo Fdn, William J von Liebig Ctr Transplantat & Clin Rege, Rochester, MN USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo
   Clinic
RP Huebert, RC (corresponding author), Mayo Clin, Gastroenterol Res Unit, 200 First St SW, Rochester, MN 55905 USA.
EM huebert.robert@mayo.edu
RI Taner, Timucin/J-8588-2019
OI Taner, Timucin/0000-0003-0641-2930; Lazaridis,
   Konstantinos/0000-0002-0437-681X; Hamdan, Feda H/0000-0003-2455-2435
FU American Association for the Study of Liver Diseases Foundation Pilot
   Research Award (AASLD) [15]; National Institutes of Health, National
   Institute of Diabetes and Digestive and Kidney Diseases [DK118619,
   DK057993, DK084567, DK059615, DK100575, DK113339, DK117861]; Satter
   Foundation; Mayo Clinic Center for Regenerative Medicine
FX Supported by American Association for the Study of Liver Diseases
   Foundation Pilot Research Award (AASLD #15 to N.J.S.), National
   Institutes of Health, National Institute of Diabetes and Digestive and
   Kidney Diseases (awards DK118619 to K.N.L., DK057993 and DK084567 to
   N.F.L., DK059615 to V. H.S., and DK100575, DK113339, and DK117861 to
   R.C.H.), Satter Foundation (N.J.S), and Mayo Clinic Center for
   Regenerative Medicine.
CR Aseem SO, 2021, GASTROENTEROLOGY, V160, P889, DOI 10.1053/j.gastro.2020.10.008
   De Assuncao TM, 2015, LAB INVEST, V95, P684, DOI 10.1038/labinvest.2015.51
   Duwaerts CC, 2021, GASTROENTEROLOGY, V160, P2591, DOI 10.1053/j.gastro.2021.02.050
   Ellis J, 2011, CLIN PHARMACOL THER, V89, P639, DOI 10.1038/clpt.2011.22
   Fiorotto R, 2019, BBA-MOL BASIS DIS, V1865, P920, DOI 10.1016/j.bbadis.2018.08.038
   Jalan-Sakrikar N, 2019, HEPATOLOGY, V70, P1674, DOI 10.1002/hep.30706
   Ji SG, 2017, NAT GENET, V49, P269, DOI 10.1038/ng.3745
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Loarca L, 2017, LAB INVEST, V97, P1385, DOI 10.1038/labinvest.2017.63
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   O'Hara SP, 2019, J BIOL CHEM, V294, P18698, DOI 10.1074/jbc.RA119.010176
   Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294
   Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107
   Soroka CJ, 2019, HEPATOLOGY, V70, P871, DOI 10.1002/hep.30470
   Spirli C, 2017, J HEPATOL, V66, P571, DOI 10.1016/j.jhep.2016.10.032
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Waisbourd-Zinman O, 2016, HEPATOLOGY, V64, P880, DOI 10.1002/hep.28599
   Yaqoob U, 2020, CELL MOL GASTROENTER, V10, P545, DOI 10.1016/j.jcmgh.2020.05.005
NR 21
TC 11
Z9 11
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2022 FEB
PY 2022
VL 6
IS 2
BP 345
EP 360
DI 10.1002/hep4.1809
EA AUG 2021
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YN6WG
UT WOS:000688285000001
PM 34519176
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tomobe, K
   Shinozuka, T
   Kuroiwa, M
   Nomura, Y
AF Tomobe, Koji
   Shinozuka, Tatsuo
   Kuroiwa, Mie
   Nomura, Yasuyuki
TI Age-related changes of Nrf2 and phosphorylated GSK-3β in a mouse model
   of accelerated aging (SAMP8)
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Nrf2; Keap1; SAMP8; Oxidative stress; GSK-3 beta; Aging
ID TRANSCRIPTION FACTOR NRF2; ACTIVATED-RECEPTOR-GAMMA; OXIDATIVE STRESS;
   INDUCIBLE EXPRESSION; CEREBRAL-CORTEX; IN-VIVO; SENESCENCE; MICE;
   ENZYMES; PROTEIN
AB SAMP8 mice show spontaneously accelerated aging and a short life span with systemic accumulation of oxidative stress. Nrf2 translocates into the nucleus upon oxidative stress and induces the expression of detoxifying and antioxidant enzymes. Recently, several studies reported that Nrf2 is associated with aging and various diseases. In the present study, we investigated the levels of Nrf2 nuclear translocation and phosphorylation of Akt and GSK-3 beta in livers of SAMP8 and normal aging SAMR1 mice. The protein level of Nrf2 in the nucleus of the liver was significantly decreased in SAMP8 at 10 months old compared with that in age-matched SAMR1. The protein level of Keap1, which anchors Nrf2 in the cytoplasm, did not differ between SAMP8 and SAMR1. In addition, the mRNA expression of Nrf2 in the liver of SAMP8 was significantly lower than that of SAMR1. Moreover, mRNA levels of detoxification and antioxidant enzymes, GSTa1 and NQO1, were significantly decreased in SAMP8 compared with SAMR1. These results indicate that a higher level of oxidative stress in SAMP8 might be caused by a lower level of Nrf2. Furthermore, the phosphorylation of Akt and GSK-3 beta was significantly decreased in the liver of SAMP8 at 10 months old. Recent studies have suggested that the Akt/GSK-3 beta signaling pathway is involved in the nuclear translocation of Nrf2. Therefore, it is suggested that the reduction of the translocation of Nrf2 into the nucleus might be induced by a decrease of GSK-3 beta phosphorylation, resulting in an increase of oxidative stress in SAMP8 mice. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Tomobe, Koji; Shinozuka, Tatsuo; Kuroiwa, Mie] Yokohama Coll Pharm, Dept Pathophysiol, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan.
   [Nomura, Yasuyuki] Yokohama Coll Pharm, Dept Pharmacotheraput, Yokohama, Kanagawa 2450066, Japan.
RP Tomobe, K (corresponding author), Yokohama Coll Pharm, Dept Pathophysiol, Totsuka Ku, Matano Cho 601, Yokohama, Kanagawa 2450066, Japan.
EM k.tomobe@hamayaku.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX We are grateful to Dr. K. Tsuzuki for pertinent advice, encouragement,
   and support. This study was supported by Grants-in-Aid from the Ministry
   of Education, Culture, Sports, Science and Technology of Japan (K.T.,
   Y.N.).
CR Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   Canudas AM, 2005, MECH AGEING DEV, V126, P1300, DOI 10.1016/j.mad.2005.07.008
   Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501
   Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9
   Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200
   Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004
   Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200
   Knight TR, 2008, TOXICOL SCI, V106, P329, DOI 10.1093/toxsci/kfn179
   Krönke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638
   Kurokawa T, 2001, NEUROSCI LETT, V298, P135, DOI 10.1016/S0304-3940(00)01755-9
   Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947
   Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200
   Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139
   Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200
   Liu M, 2009, KIDNEY INT, V76, P277, DOI 10.1038/ki.2009.157
   McMahon M, 2001, CANCER RES, V61, P3299
   Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X
   Nogués MR, 2006, J PINEAL RES, V41, P142, DOI 10.1111/j.1600-079X.2006.00344.x
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2
   Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538
   Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x
   Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200
   Sato E, 1996, MECH AGEING DEV, V92, P175, DOI 10.1016/S0047-6374(96)01832-5
   Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005
   Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003
   Shih PH, 2010, J NUTR BIOCHEM, V21, P598, DOI 10.1016/j.jnutbio.2009.03.008
   Tajes M, 2009, MECH AGEING DEV, V130, P253, DOI 10.1016/j.mad.2008.12.006
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150
   Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008
   Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75
   Yasui F, 2003, NEUROSCI LETT, V350, P66, DOI 10.1016/S0304-3940(03)00827-9
   Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545
   Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304
NR 43
TC 61
Z9 68
U1 1
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 2012
VL 54
IS 2
BP E1
EP E7
DI 10.1016/j.archger.2011.06.006
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 910NV
UT WOS:000301647400001
PM 21784539
DA 2024-02-19
ER

PT J
AU Kern, P
   Balzer, NR
   Blank, N
   Cygon, C
   Wunderling, K
   Bender, F
   Frolov, A
   Sowa, JP
   Bonaguro, L
   Ulas, T
   Homrich, M
   Kiermaier, E
   Thiele, C
   Schultze, JL
   Canbay, A
   Bauer, R
   Mass, E
AF Kern, Paul
   Balzer, Nora R.
   Blank, Nelli
   Cygon, Cornelia
   Wunderling, Klaus
   Bender, Franziska
   Frolov, Alex
   Sowa, Jan-Peter
   Bonaguro, Lorenzo
   Ulas, Thomas
   Homrich, Mirka
   Kiermaier, Eva
   Thiele, Christoph
   Schultze, Joachim L.
   Canbay, Ali
   Bauer, Reinhard
   Mass, Elvira
TI Creld2 function during unfolded protein response is essential for liver
   metabolism homeostasis
SO FASEB JOURNAL
LA English
DT Article
DE Creld2; ER stress; liver steatosis; NASH; UPR
ID ENDOPLASMIC-RETICULUM STRESS; HIGH-FAT DIET; ER STRESS; HEPATIC
   STEATOSIS; LIPID-METABOLISM; INSULIN-RESISTANCE; GLUCOSE; ACTIVATION;
   DISEASE; MICE
AB The unfolded protein response (UPR) is associated with hepatic metabolic function, yet it is not well understood how endoplasmic reticulum (ER) disturbance might influence metabolic homeostasis. Here, we describe the physiological function of Cysteine-rich with EGF-like domains 2 (Creld2), previously characterized as a downstream target of the ER-stress signal transducer Atf6. To this end, we generated Creld2-deficient mice and induced UPR by injection of tunicamycin. Creld2 augments protein folding and creates an interlink between the UPR axes through its interaction with proteins involved in the cellular stress response. Thereby, Creld2 promotes tolerance to ER stress and recovery from acute stress. Creld2-deficiency leads to a dysregulated UPR and causes the development of hepatic steatosis during ER stress conditions. Moreover, Creld2-dependent enhancement of the UPR assists in the regulation of energy expenditure. Furthermore, we observed a sex dimorphism in human and mouse livers with only male patients showing an accumulation of CRELD2 protein during the progression from non-alcoholic fatty liver disease to non-alcoholic steatohepatitis and only male Creld2-deficient mice developing hepatic steatosis upon aging. These results reveal a Creld2 function at the intersection between UPR and metabolic homeostasis and suggest a mechanism in which chronic ER stress underlies fatty liver disease in males.
C1 [Kern, Paul; Balzer, Nora R.; Blank, Nelli; Cygon, Cornelia; Frolov, Alex; Mass, Elvira] Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany.
   [Kern, Paul; Bender, Franziska; Bauer, Reinhard] Univ Bonn, Life & Med Sci LIMES Inst, Dev Genet & Mol Physiol, Bonn, Germany.
   [Wunderling, Klaus; Thiele, Christoph] Univ Bonn, Life & Med Sci LIMES Inst, Biochem & Cell Biol Lipids, Bonn, Germany.
   [Sowa, Jan-Peter; Canbay, Ali] Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.
   [Sowa, Jan-Peter; Canbay, Ali] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Med, Bochum, Germany.
   [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany.
   [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Platform Single Cell Genom & Epigen, Bonn, Germany.
   [Homrich, Mirka; Kiermaier, Eva] Univ Bonn, Life & Med Sci LIMES Inst, Immune & Tumor Biol, Bonn, Germany.
   [Schultze, Joachim L.] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Syst Med, Bonn, Germany.
C3 University of Bonn; University of Bonn; University of Bonn; University
   Hospital Magdeburg; Ruhr University Bochum; University of Bonn;
   University of Bonn; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); University of Bonn; Helmholtz
   Association; German Center for Neurodegenerative Diseases (DZNE)
RP Mass, E (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany.
EM emass@uni-bonn.de
RI Kiermaier, Eva/B-2529-2016; Mass, Elvira/AAH-3805-2019; Schultze,
   Joachim L./ABA-8176-2020
OI Mass, Elvira/0000-0003-2318-2356; Schultze, Joachim
   L./0000-0003-2812-9853; Kiermaier, Eva/0000-0001-6165-5738; Homrich,
   Mirka/0000-0003-0539-5198
FU Fritz Thyssen Stiftung (Fritz Thyssen Foundation) [Az.10.18.2.029MN];
   Deutsche Forschungsgemeinschaft (DFG) [EXC2151-390873048, CA267/14-1];
   Bundesministerium fur Bildung und Forschung (BMBF) [01EA1809A]; Daimler
   und Benz Stiftung (Daimler and Benz Foundation) [32-058/18]
FX Fritz Thyssen Stiftung (Fritz Thyssen Foundation), Grant/Award Number:
   Az.10.18.2.029MN; Deutsche Forschungsgemeinschaft (DFG), Grant/Award
   Number: EXC2151-390873048 and CA267/14-1; Bundesministerium fur Bildung
   und Forschung (BMBF), Grant/Award Number: DietBB (01EA1809A); Daimler
   und Benz Stiftung (Daimler and Benz Foundation), Grant/Award Number:
   32-058/18
CR Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044
   Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048
   Alberti A, 2009, AM J PHYSIOL-ENDOC M, V297, pE812, DOI 10.1152/ajpendo.00053.2009
   [Anonymous], 2019, sva: surrogate variable analysis
   Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1
   Beckert V, 2021, J MOL CELL CARDIOL, V156, P45, DOI 10.1016/j.yjmcc.2021.03.008
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019
   Bonaguro L, 2020, NAT IMMUNOL, V21, P1517, DOI 10.1038/s41590-020-00811-2
   Boyle ST, 2020, NAT CELL BIOL, V22, P882, DOI 10.1038/s41556-020-0523-y
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Chen DL, 2012, BIOCHEM BIOPH RES CO, V426, P324, DOI 10.1016/j.bbrc.2012.08.072
   Chen MF, 2019, BONE JOINT RES, V8, P179, DOI 10.1302/2046-3758.84.BJR-2018-0291.R1
   D'Alessandro M, 2018, ELIFE, V7, DOI 10.7554/eLife.39649
   Dennis EP, 2020, J BONE MINER RES, V35, P1452, DOI 10.1002/jbmr.4010
   DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020
   Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968
   Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21
   Gonen N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38705-5
   Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595
   Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383
   Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012
   Horna-Terrón E, 2014, INT J MOL SCI, V15, P23501, DOI 10.3390/ijms151223501
   Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007
   Kim Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92896
   Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331
   Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004
   Liu GM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152510
   Lonardo A, 2019, HEPATOBIL SURG NUTR, V8, P164, DOI 10.21037/hbsn.2018.12.04
   Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005
   Mass E, 2014, DEV CELL, V28, P711, DOI 10.1016/j.devcel.2014.02.012
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87
   Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031
   Özcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Oh-hashi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30362-4
   Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029
   Oh-Hashi K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-664
   Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047
   Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Palmisano BT, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00044
   Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524
   Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]
   Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105
   Rupp PA, 2002, GENE, V293, P47, DOI 10.1016/S0378-1119(02)00696-0
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401
   Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109
   Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4
   Wang SD, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01539
   Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005
   Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52
   Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005
NR 66
TC 11
Z9 12
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2021
VL 35
IS 10
AR e21939
DI 10.1096/fj.202002713RR
PG 20
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA UZ5IH
UT WOS:000702238200063
PM 34549824
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Gao, F
   Taha, AY
   Ma, KZ
   Chang, LS
   Kiesewetter, D
   Rapoport, SI
AF Gao, Fei
   Taha, Ameer Y.
   Ma, Kaizong
   Chang, Lisa
   Kiesewetter, Dale
   Rapoport, Stanley I.
TI RETRACTED: Aging decreases rate of docosahexaenoic acid
   synthesis-secretion from circulating unesterified α-linolenic acid by
   rat liver (Retracted article. See vol. 36, pg. 1565, 2014)
SO AGE
LA English
DT Article; Retracted Publication
DE Liver; Synthesis-secretion rate; Conversion; Aging; Age; Metabolism;
   Alpha-linolenic acid; n-3 Polyunsaturated fatty acids (n-3 PUFAs);
   Docosahexaenoic acid (DHA); Lipid
ID N-3 PUFA DEPRIVATION; AGE-RELATED-CHANGES; POLYUNSATURATED FATTY-ACIDS;
   HORMONE-SENSITIVE LIPASE; BRAIN PHOSPHOLIPIDS; LIPOPROTEIN-LIPASE;
   DELTA-6-DESATURASE ACTIVITY; FISCHER-344 RATS; NERVOUS-SYSTEM;
   FRONTAL-CORTEX
AB Docosahexaenoic acid (DHA, 22:6n-3), an n-3 polyunsaturated fatty acid (PUFA) found at high concentrations in brain and retina and critical to their function, can be obtained from fish products or be synthesized from circulating alpha-linolenic acid (alpha-LNA, 18:3n-3) mainly in the liver. With aging, liver synthetic enzymes are reported reduced or unchanged in the rat. To test whether liver synthesis-secretion of DHA from alpha-LNA changes with age, we measured whole-body DHA conversion coefficients and rates in unanesthetized adult male Fischer-344 rats aged 10, 20, or 30 months, fed an eicosapentaenoic acid (EPA, 20:5n-3)- and DHA-containing diet. Unesterified [U- (13) C]alpha-LNA bound to albumin was infused intravenously for 2 h, while [(13) C]-esterified n-3 PUFAs were measured in arterial plasma, as were unlabeled unesterified and esterified PUFA concentrations. Plasma unesterified n-3 PUFA concentrations declined with age, but esterified n-3 PUFA concentrations did not change significantly. Calculated conversion coefficients were not changed significantly with age, whereas synthesis-secretion rates (product of conversion coefficient and unesterified plasma alpha-LNA concentration) of esterified DHA and n-3 DPA were reduced. Turnovers of esterified n-3 PUFAs in plasma decreased with age, whereas half-lives increased. The results suggest that hepatic capacity to synthesize DHA and other n-3 PUFAs from circulating alpha-LNA is maintained with age in the rat, but that reduced plasma alpha-LNA availability reduces net synthesis-secretion. As unesterified plasma DHA is the form that is incorporated preferentially into brain phospholipid, its reduced synthesis may be deleterious to brain function in aged rats.
C1 [Gao, Fei; Taha, Ameer Y.; Ma, Kaizong; Chang, Lisa; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
   [Kiesewetter, Dale] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA.
   [Gao, Fei] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); National Institutes of Health (NIH) - USA; NIH National
   Institute of Biomedical Imaging & Bioengineering (NIBIB); Harvard
   University; Harvard Medical School; Brigham & Women's Hospital
RP Gao, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM fgao1@partners.org
FU National Institute on Aging; National Institute of Biomedical Imaging
   and Bioengineering, National Institutes of Health
FX This work was supported by the Intramural Research Programs of the
   National Institute on Aging, and National Institute of Biomedical
   Imaging and Bioengineering, National Institutes of Health.
CR Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644
   Aïd S, 2007, BRAIN RES BULL, V73, P108, DOI 10.1016/j.brainresbull.2007.02.015
   Balkan J, 2002, INT J VITAM NUTR RES, V72, P315, DOI 10.1024/0300-9831.72.5.315
   Bey L, 2001, J APPL PHYSIOL, V91, P687, DOI 10.1152/jappl.2001.91.2.687
   BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603
   BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   Bourre J M, 2004, J Nutr Health Aging, V8, P163
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   BOURRE JM, 1992, NEUROSCI LETT, V141, P65, DOI 10.1016/0304-3940(92)90335-5
   BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6
   Caimari A, 2008, INT J OBESITY, V32, P1193, DOI 10.1038/ijo.2008.69
   CARLILE SI, 1985, ARCH GERONTOL GERIAT, V4, P133, DOI 10.1016/0167-4943(85)90027-5
   Chen CT, 2008, J LIPID RES, V49, P147, DOI 10.1194/jlr.M700386-JLR200
   Chen CT, 2011, J NEUROCHEM, V116, P363, DOI 10.1111/j.1471-4159.2010.07116.x
   Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005
   Chen S, 2007, BBA-MOL CELL BIOL L, V1771, P1319, DOI 10.1016/j.bbalip.2007.08.001
   Chowdhury KK, 2011, EXP GERONTOL, V46, P73, DOI 10.1016/j.exger.2010.10.006
   Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3
   DeMar JC, 2006, BBA-MOL CELL BIOL L, V1761, P1050, DOI 10.1016/j.bbalip.2006.06.006
   DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x
   DeMar JC, 2004, J NEUROCHEM, V91, P1125, DOI 10.1111/j.1471-4159.2004.02789.x
   DINH L, 1995, ANN NUTR METAB, V39, P117, DOI 10.1159/000177851
   Engler MM, 1998, BIOCHEM MOL BIOL INT, V46, P1117
   Favrelière S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6
   Fortier M, 2010, PROSTAG LEUKOTR ESS, V82, P277, DOI 10.1016/j.plefa.2010.02.010
   Gao F, 2010, J LIPID RES
   Gao F, 2011, BBA-MOL CELL BIOL L, V1811, P484, DOI 10.1016/j.bbalip.2011.05.008
   Gao F, 2009, J LIPID RES, V50, P749, DOI 10.1194/jlr.D800056-JLR200
   GAVINO VC, 1992, LIPIDS, V27, P950, DOI 10.1007/BF02535570
   Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208
   Goldberg IJ, 1996, J LIPID RES, V37, P693
   Gómez-Pérez Y, 2011, REJUV RES, V14, P153, DOI 10.1089/rej.2010.1107
   Hamilton MT, 2001, INT J SPORT NUTR EXE, V11, pS97, DOI 10.1123/ijsnem.11.s1.s97
   Han LD, 2011, ANAL CHIM ACTA, V689, P85, DOI 10.1016/j.aca.2011.01.034
   HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5
   Igarashi M, 2008, J LIPID RES, V49, P1735, DOI 10.1194/jlr.M800093-JLR200
   Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200
   Igarashi M, 2010, J PSYCHIATR RES, V44, P177, DOI 10.1016/j.jpsychires.2009.08.001
   Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904
   Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137
   Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200
   Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002
   Kuriki K, 2003, J NUTR, V133, P3643, DOI 10.1093/jn/133.11.3643
   LONDON ED, 1981, J NEUROCHEM, V37, P217, DOI 10.1111/j.1471-4159.1981.tb05311.x
   LOPEZ GH, 1995, COMP BIOCHEM PHYS B, V112, P331, DOI 10.1016/0305-0491(95)00079-8
   Plourde M, 2011, NUTR METABOLISM LOND, V27, P8
   Purdon D, 1997, J LIPID RES, V38, P526
   Raclot T, 2001, J LIPID RES, V42, P2049
   Rahman T, 2010, PROSTAG LEUKOTR ESS, V82, P141, DOI 10.1016/j.plefa.2009.11.003
   Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887
   Rapoport SI, 2011, PROSTAGLANDINS OTHER
   Rapoport SI, 2010, PROSTAG LEUKOTR ESS, V82, P273, DOI 10.1016/j.plefa.2010.02.015
   Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6
   SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903
   Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   Song BJ, 2010, LIPIDS, V45, P291, DOI 10.1007/s11745-010-3398-z
   Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9
   Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   Tucker MZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE827, DOI 10.1152/ajpendo.00222.2002
   Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200
   Yi LZ, 2006, FEBS LETT, V580, P6837, DOI 10.1016/j.febslet.2006.11.043
NR 64
TC 10
Z9 12
U1 0
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUN
PY 2013
VL 35
IS 3
BP 597
EP 608
DI 10.1007/s11357-012-9390-1
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 133XL
UT WOS:000318174100007
PM 22388930
OA Green Published
DA 2024-02-19
ER

PT J
AU Rath, B
   Pandey, RS
   Debata, PR
   Maruyama, N
   Supakar, PC
AF Rath, Bandita
   Pandey, Ravi S.
   Debata, Priya R.
   Maruyama, Naoki
   Supakar, Prakash C.
TI Molecular characterization of senescence marker protein-30 gene
   promoter: Identification of repressor elements and functional nuclear
   factor binding sites
SO BMC MOLECULAR BIOLOGY
LA English
DT Article
ID SRY; SMP30; EXPRESSION; BRAIN; ALPHA; LIVER; MICE
AB Background: Senescence marker protein-30 (SMP30), whose expression declines during aging in rat liver, has been proposed as an important aging marker. Besides apoptosis, SMP30 also protects cells against various other injuries by enhancement of membrane calcium-pump activity. The mechanism of this differential gene expression mechanism is not known. DNA-protein interactions, mutation analysis and luciferase reporter assay studies have been performed to elucidate the mechanism of transcriptional regulation of SMP30 gene.
   Results: We have characterized up to -2750 bp of the promoter by DNA-protein interactions studies. Twenty eight transcription factor binding sites have been identified by DNase I footprinting and electrophoretic mobility shift assay (EMSA). Transient transfection of 5' and 3' -deleted promoter-reporter constructs and luciferase assay illustrated the region between -128/+ 157 bp is sufficient to drive promoter activity. We have mapped an essential regulatory region between -513 to -352 bp which causes a drastic decline of reporter activity. This region contains CdxA, GATA2 and SRY transcription factor binding sites. Individual mutation of these three sites showed increase in reporter activity. Mutation in SRY site (-403/-368) showed maximum increase in reporter activity among these three sites. Therefore, we suggest that SRY like protein may be acting as a strong repressor of SMP30 gene along with CdxA and GATA-2. We also report that mutation of both Sp1 (172/-148 bp) and a C/EBP beta (-190/-177 bp) transcription binding site located adjacent to each other on SMP30 gene promoter, causes a significant enhancement in reporter activity than individual mutation, thus may be causing the repression of SMP30 promoter activity.
   Conclusion: These studies provide novel insights into the mechanism that regulate SMP30 gene expression.
C1 [Rath, Bandita; Pandey, Ravi S.; Debata, Priya R.; Supakar, Prakash C.] Inst Life Sci, Bhubaneswar 751023, Orissa, India.
   [Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS); Tokyo Metropolitan Institute of Gerontology
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM bandita27278@rediffmail.com; dr.rspandey@yahoo.com;
   prdebata@yahoo.co.in; naomaru@centm.center.tmig; pcsupakar@hotmail.com
RI Debata, Priya Ranjan/AAY-7142-2021
CR Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017
   DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038
   LIU YH, 1994, J BIOL CHEM, V269, P4152
   MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136
   Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1
   Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799
   Terzic N, 2003, J GERONTOL A-BIOL, V58, P297
   Turner ME, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-11
   Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200
   Yuan X, 2001, J BIOL CHEM, V276, P46647, DOI 10.1074/jbc.M108404200
NR 16
TC 15
Z9 22
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2199
J9 BMC MOL BIOL
JI BMC Mol. Biol.
PD APR 29
PY 2008
VL 9
AR 43
DI 10.1186/1471-2199-9-43
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 307CP
UT WOS:000256295700001
PM 18442420
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Amevor, FK
   Cui, ZF
   Du, XX
   Ning, ZF
   Shu, G
   Jin, NN
   Deng, X
   Tian, YF
   Zhang, ZC
   Kang, XC
   Xu, D
   You, GS
   Zhang, Y
   Li, DY
   Wang, Y
   Zhu, Q
   Zhao, XL
AF Amevor, Felix Kwame
   Cui, Zhifu
   Du, Xiaxia
   Ning, Zifan
   Shu, Gang
   Jin, Ningning
   Deng, Xun
   Tian, Yaofu
   Zhang, Zhichao
   Kang, Xincheng
   Xu, Dan
   You, Guishuang
   Zhang, Yao
   Li, Diyan
   Wang, Yan
   Zhu, Qing
   Zhao, Xiaoling
TI Combination of Quercetin and Vitamin E Supplementation Promotes Yolk
   Precursor Synthesis and Follicle Development in Aging Breeder Hens via
   Liver-Blood-Ovary Signal Axis
SO ANIMALS
LA English
DT Article
DE quercetin; vitamin E; yolk precursor synthesis; liver-blood-ovary signal
   axis; aging breeder chicken
ID ANTIOXIDANT STATUS; EGG-PRODUCTION; LAYING HENS; DIETARY
   SUPPLEMENTATION; RESVERATROL PROTECTS; ALPHA-TOCOPHEROL; PERFORMANCE;
   QUALITY; AGE; PHYTOESTROGENS
AB Simple Summary This study evaluated the capacity of dietary quercetin, vitamin E and their combination to promote follicle development and attenuate organ inflammation by improving the antioxidant capacity of the liver-blood-ovary signal axis of aging broiler breeder hens. The results from this study showed that the combination of quercetin and vitamin E synergistically improved the chicken's reproductive organ characteristics, and also showed protective effects on liver morphology and histology. Moreover, the antioxidant parameters, reproductive hormones and receptors, liver lipid synthesis, and the levels of mRNAs related to yolk precursor synthesis (very low density apolipoprotein-II and vitellogenin-II), lipid transport (microsomal triglyceride transport protein), lipogenesis (fatty acid synthase), and follicle developments were increased remarkably by the combination of quercetin and vitamin E. The results obtained in this study provide an important reference for the combination of quercetin and vitamin E as a functional feed additive for promoting the functions of the liver-blood-ovary axis, and also as a potential chemopreventive and chemotherapeutic agent for improving liver and ovary functions in chickens by acting as a hepatoprotective and oviprotective agent. This could facilitate the transport and exchange of synthetic substances (including hormones, yolk precursors, and other biochemical substances) among the liver-blood-ovary alliances to ensure the synchronous development and functional coordination between the liver and ovary in aging breeder hens. The fertility of female animals is negatively correlated with increasing chronological age. In aging broiler breeder hens, there is a decline in the functionality of the ovary and liver accompanied by hormonal or endocrine changes, a reduction in antioxidant capacity, and a decrease in folliculogenesis. Therefore, improving the reproductive function in aging breeder hens using dietary strategies is of great concern to the poultry breeder. This study evaluated the capacity of dietary quercetin (Q), vitamin E (VE), and their combination (Q + VE) to promote follicle development and attenuate organ inflammation by improving the antioxidant capacity of aging breeder hens. In this study, 400 broiler breeder hens (Tianfu broilers breeder hens, 435 days old) were allotted into four groups (100 birds each) with four replicates each (25 birds each). They were fed diets containing Q (0.4 g/kg), VE (0.2 g/kg), Q + VE (0.4 g/kg + 0.2 g/kg), and a basal diet for 10 weeks. The results showed that Q + VE improved the organ characteristics (p < 0.05), and also that Q + VE showed protective effects on the liver against injury, as well as increasing the antioxidant capacity of the liver, serum, and ovary (p < 0.05). Furthermore, liver lipid synthesis was increased remarkably, as indicated by the changes in triglyceride levels in hens fed Q + VE (p < 0.05). Levels of E2, FSH, and LH, their receptors, and mRNAs related to yolk precursor synthesis were increased by the Q + VE (p < 0.05). Therefore, the combination of quercetin and vitamin E synergistically promotes and regulates the transportation and exchange of synthetic substances among the liver-blood-ovary alliances to ensure the synchronous development and functional coordination between the liver and ovary in aging breeder hens.
C1 [Amevor, Felix Kwame; Cui, Zhifu; Du, Xiaxia; Ning, Zifan; Jin, Ningning; Deng, Xun; Tian, Yaofu; Zhang, Zhichao; Kang, Xincheng; You, Guishuang; Zhang, Yao; Li, Diyan; Wang, Yan; Zhu, Qing; Zhao, Xiaoling] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu 611130, Peoples R China.
   [Shu, Gang; Xu, Dan] Sichuan Agr Univ, Dept Basic Vet Med, Chengdu 611130, Peoples R China.
C3 Sichuan Agricultural University; Sichuan Agricultural University
RP Zhao, XL (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu 611130, Peoples R China.
EM amevorfelix@gmail.com; 2018102013@stu.sicau.edu.cn; 15680811065@163.com;
   ningzifan@163.com; dyysg2005@sicau.edu.cn; jnn233333@163.com;
   dengxun082439@163.com; maikurakitt@163.com; Tiger@sicau.edu.cn;
   kangxincheng@stu.sicau.edu.cn; youguishuang@stu.sicau.edu.cn;
   zhangyao12316@163.com; diyanli@sicau.edu.cn; as519723614@163.com;
   zhuqingsicau@163.com; zhaoxiaoling@sicau.edu.cn
RI Diyan, Li/HSD-0345-2023; du, xiaxia/GXN-2129-2022
OI Diyan, Li/0000-0001-7490-3550; , Xiaoling/0000-0002-0633-4701; zhang,
   zhichao/0000-0002-9293-629X; Amevor, Felix Kwame/0000-0003-2682-1993
FU China Agriculture Research System of the Ministry of Agriculture and
   Rural Areas [CARS-41]; National Natural Science Foundation of China
   [31872347]; Science and Technology Plan Project [2019YFN0001]; Science
   and Technology Innovation and Entrepreneurship Seedling Project of the
   Sichuan Science and Technology Department [2020JDRC0104]; Chengdu
   Science and Technology Project [2019-YF05-01351-SN]; Fifth Batch of
   Construction Enterprise of Luzhou Academician and Expert Workstation
   (2020); Fifth Batch of Construction Enterprise of Yibin Leading Talent
   Expert Workstation (2020)
FX The authors thank the China Agriculture Research System of the Ministry
   of Agriculture and Rural Areas (CARS-41), the National Natural Science
   Foundation of China (31872347), the Science and Technology Plan Project
   (2019YFN0001), the Science and Technology Innovation and
   Entrepreneurship Seedling Project of the Sichuan Science and Technology
   Department (2020JDRC0104), the Chengdu Science and Technology Project
   (2019-YF05-01351-SN), the Fifth Batch of Construction Enterprises of
   Luzhou Academician and Expert Workstation (2020) and Yibin Leading
   Talent Expert Workstation (2020) for funding this work.
CR Abedi P, 2017, VET RES FORUM, V8, P353
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Alvarenga RR, 2011, WORLD POULTRY SCI J, V67, P431, DOI 10.1017/S0043933911000481
   Banu SK, 2016, TOXICOL APPL PHARM, V303, P65, DOI 10.1016/j.taap.2016.04.016
   Ben-Meir A, 2015, AGING CELL, V14, P887, DOI 10.1111/acel.12368
   Bollengier-Lee S, 1998, BRIT POULTRY SCI, V39, P106, DOI 10.1080/00071669889466
   Bollengier-Lee S, 1999, BRIT POULTRY SCI, V40, P102, DOI 10.1080/00071669987917
   Buyuk E, 2010, SEMIN REPROD MED, V28, P370, DOI 10.1055/s-0030-1262896
   Chen JY, 1998, J FOOD SCI, V63, P919, DOI 10.1111/j.1365-2621.1998.tb17927.x
   Çiftçi M, 2005, REV MED VET-TOULOUSE, V156, P107
   Cos P, 2003, PLANTA MED, V69, P589, DOI 10.1055/s-2003-41122
   Cui ZF, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10122348
   D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43
   Dalia AM, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1578-x
   Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224
   Dong YY, 2020, POULTRY SCI, V99, P4892, DOI 10.1016/j.psj.2020.06.028
   Durape N.M, 2007, WORLD POULTRY SCI J, V23, P6
   Grobas S, 2002, POULTRY SCI, V81, P376, DOI 10.1093/ps/81.3.376
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Ishii M, 2012, J TOXICOL SCI, V37, P631
   Jia YD, 2011, REPROD TOXICOL, V31, P477, DOI 10.1016/j.reprotox.2010.12.057
   Johnson AL, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P635
   Khedr NF, 2015, EXP BIOL MED, V240, P1682, DOI 10.1177/1535370215576304
   Li H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1943-0
   Lin YF, 2005, BRIT POULTRY SCI, V46, P366, DOI 10.1080/00071660500098186
   Lin YF, 2004, BRIT POULTRY SCI, V45, P807, DOI 10.1080/00071660400012717
   Liu HN, 2014, POULTRY SCI, V93, P347, DOI 10.3382/ps.2013-03225
   Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437
   Liu XT, 2018, J ZHEJIANG UNIV-SC B, V19, P390, DOI [10.1631/jzus.B1700054, 10.1631/jzus.b1700054]
   Liu XT, 2018, AGING-US, V10, P2016, DOI 10.18632/aging.101526
   Liu XT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9390810
   Liu YJ, 2019, POULTRY SCI, V98, P5847, DOI 10.3382/ps/pez227
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McDermott J H, 2000, J Am Pharm Assoc (Wash), V40, P785
   Mol BW, 2015, LANCET, V385, P507, DOI 10.1016/S0140-6736(15)60199-4
   Naseer Z, 2017, THERIOGENOLOGY, V96, P136, DOI 10.1016/j.theriogenology.2017.03.029
   Okudan N, 2016, ARCH PHYSIOL BIOCHEM, V122, P180, DOI 10.1080/13813455.2016.1199574
   Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364
   Puthpongsiriporn U, 2001, POULTRY SCI, V80, P1190, DOI 10.1093/ps/80.8.1190
   Qazi IH, 2021, BIOL TRACE ELEM RES, V199, P633, DOI 10.1007/s12011-020-02192-x
   Santini SE, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/419891
   Shen YR, 2016, EUR POULTRY SCI, V80, DOI 10.1399/eps.2016.160
   Shi SR, 2013, FOOD CHEM TOXICOL, V55, P684, DOI 10.1016/j.fct.2013.01.009
   Stanley JA, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.113332
   Tian Y., 2021, HEILONGJIANG ANIM HU, V6, P36
   Xu D, 2019, MOLECULES, V24, DOI 10.3390/molecules24061123
   Yang HX, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120634
   Yang JX, 2020, POULTRY SCI, V99, P2305, DOI 10.1016/j.psj.2020.03.003
   Yang JX, 2018, J ANIM PHYSIOL AN N, V102, P505, DOI 10.1111/jpn.12778
   Yilmaz O, 2015, GEN COMP ENDOCR, V221, P16, DOI 10.1016/j.ygcen.2015.01.018
   Zhang CQ, 1997, GEN COMP ENDOCR, V105, P402, DOI 10.1006/gcen.1996.6843
   Zhang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6147345
   Zhao RQ, 2004, COMP BIOCHEM PHYS A, V138, P459, DOI 10.1016/j.cbpb.2004.06.004
NR 54
TC 24
Z9 26
U1 2
U2 38
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-2615
J9 ANIMALS-BASEL
JI Animals
PD JUL
PY 2021
VL 11
IS 7
AR 1915
DI 10.3390/ani11071915
PG 24
WC Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Veterinary Sciences; Zoology
GA UB9TY
UT WOS:000686181300001
PM 34203138
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Moraes, AS
   Guaraldo, AMA
   Mello, MLS
AF Moraes, Alberto S.
   Guaraldo, Ana Maria A.
   Mello, Maria Luiza S.
TI Chromatin supraorganization and extensibility in mouse hepatocytes with
   development and aging
SO CYTOMETRY PART A
LA English
DT Article
DE chromatin supraorganization; extended chromatin fibers; development;
   aging; Con-A-positive glycoproteins; polarization microscopy;
   microspectrophotometry
ID IN-SITU HYBRIDIZATION; EXTENDED CHROMATIN; NUCLEAR-MATRIX;
   CONCANAVALIN-A; HISTONE METHYLATION; SATELLITE DNA; O-GLCNAC;
   HETEROCHROMATIN; PROTEINS; LIVER
AB Background: Chromatin supraorganization and extensibility, which lead to the formation of extended chromatin fibers (ECF), are affected by starvation and refeeding in adult mouse hepatocytes. It is expected that they could also change with mouse development and aging.
   Methods: Methods used involved topochemistry image analysis, microspectrophotometry, gravity action, and polarization microscopy
   Results: Increased nuclear areas and Feulgen-DNA amounts with advancing hepatocyte polyploidy were found with development and aging. A slightly less packed chromatin with more heterogeneously distributed condensation levels was detected in young and old mice. Con-A responsiveness was almost absent in young mice but very deep in aged mice. ECFs formed from nuclei of adult and aged mice but not from nuclei of young mice. The frequency of ECF formation with the long lysis protocol increased with aging.
   Conclusions: in young mice, a less packed chromatin state may be associated with more intense gene activity, thus increasing the DNA-nuclear matrix interactions, and inhibiting ECF formation. Reduced DNA-nuclear matrix interactions besides defects in heterochromatin formation may induce higher ECF formation and chromatin unpackaging in old mice. We suggest that differences in Con-A staining relate to different gene activity with advancing development and aging. (c) 2007 international Society for Analytical Cytology
C1 Univ Estadual Campinas, Inst Biol, Dept Cell Biol, BR-13083863 Campinas, SP, Brazil.
   Univ Estadual Campinas, CEMIB, BR-13083863 Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas; Universidade de Sao Paulo;
   Universidade Estadual de Campinas
RP Mello, MLS (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Cell Biol, BR-13083863 Campinas, SP, Brazil.
EM mlsmello@unicamp.br
RI Mello, Maria Luiza Silveira/D-9158-2012; Moraes, Alberto S/F-9660-2012
OI Mello, Maria Luiza Silveira/0000-0003-1629-5619; Moraes, Alberto
   S/0000-0002-8316-6318
CR Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5
   BEKHOR I, 1969, J MOL BIOL, V39, P351, DOI 10.1016/0022-2836(69)90322-2
   BENSON RW, 1978, J GERONTOL, V33, P323, DOI 10.1093/geronj/33.3.323
   Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003
   BOLLA R, 1979, BIOCHEM J, V184, P669, DOI 10.1042/bj1840669
   BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888
   Burzynski SR, 2005, MED HYPOTHESES, V64, P201, DOI 10.1016/j.mehy.2004.06.010
   CASTRO CE, 1986, FASEB J, V45, P2394
   Chaurasia P, 1996, BIOCHEM MOL BIOL INT, V40, P1261
   Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5
   Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200
   Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002
   Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179
   DAVIE JR, 1995, NUCL MATRIX STRUCTUR, P191
   DEITCH AD, 1966, INTRO QUANTITATIVE C, P451
   EISSENBERG JC, 1992, GENETICS, V131, P345
   FERRARO A, 1991, BIOCHEM BIOPH RES CO, V178, P1365, DOI 10.1016/0006-291X(91)91044-D
   FERRARO A, 1994, CELL BIOL INT, V18, P655, DOI 10.1006/cbir.1994.1092
   FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632
   FLEEGE JC, 1990, LAB INVEST, V63, P270
   GERDES MG, 1994, J CELL BIOL, V126, P289, DOI 10.1083/jcb.126.2.289
   Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887
   Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7
   Guarente L, 2000, GENE DEV, V14, P1021
   Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458
   Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   HAAF T, 1994, HUM MOL GENET, V3, P697, DOI 10.1093/hmg/3.5.697
   HAAF T, 1995, EXP CELL RES, V219, P604, DOI 10.1006/excr.1995.1270
   HART GW, 1989, ANNU REV BIOCHEM, V58, P841
   HAWKES R, 1982, ANAL BIOCHEM, V123, P143, DOI 10.1016/0003-2697(82)90634-0
   HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509
   Iyer SPN, 2003, BIOCHEMISTRY-US, V42, P2493, DOI 10.1021/bi020685a
   KAN FWK, 1986, J CELL BIOL, V102, P576, DOI 10.1083/jcb.102.2.576
   KIERNAN JA, 1975, HISTOCHEMISTRY, V44, P39, DOI 10.1007/BF00490419
   Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2
   MA HJ, 1990, CELL MOL BIOL, V36, P589
   Mahendra G, 1999, ARCH GERONTOL GERIAT, V28, P149, DOI 10.1016/S0167-4943(99)00002-3
   Mello MLS, 2003, CYTOM PART A, V52A, P70, DOI 10.1002/cyto.a.10029
   Mello MLS, 1997, BRAZ J GENET, V20, P257
   MONNIER VM, 1990, J GERONTOL, V45, pB105, DOI 10.1093/geronj/45.4.B105
   MONNIER VM, 1989, MAILLARD REACTION AG, P1
   Moraes Alberto da Silva, 2005, Brazilian Journal of Morphological Sciences, V22, P91
   Moraes AS, 2005, CYTOM PART A, V63A, P94, DOI 10.1002/cyto.a.20113
   Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016
   Poirier M, 2000, MOL BIOL CELL, V11, P269, DOI 10.1091/mbc.11.1.269
   Ranhotra HS, 2001, BIOGERONTOLOGY, V2, P245, DOI 10.1023/A:1013218528102
   Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8
   Shareef MM, 2003, GENETICA, V117, P127
   Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106
   Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835
   STUURMAN N, 1990, J BIOL CHEM, V265, P5460
   VIDAL BC, 1972, BEITR PATHOL, V145, P269
   VIDAL BC, 1997, BRAZ J GENET, V44, P39
   Vidal BD, 2000, CELL BIOL INT, V24, P723, DOI 10.1006/cbir.2000.0555
NR 55
TC 26
Z9 27
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4922
J9 CYTOM PART A
JI Cytom. Part A
PD JAN
PY 2007
VL 71A
IS 1
BP 28
EP 37
DI 10.1002/cyto.a.20356
PG 10
WC Biochemical Research Methods; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 131VY
UT WOS:000243900300006
PM 17211882
OA Bronze
DA 2024-02-19
ER

PT J
AU Qi, H
   Zuo, DY
   Bai, ZS
   Xu, JW
   Li, ZQ
   Shen, QR
   Wang, ZW
   Zhang, WG
   Wu, YL
AF Qi, Huan
   Zuo, Dai-Ying
   Bai, Zhao-Shi
   Xu, Jing-Wen
   Li, Zeng-Qiang
   Shen, Qi-Rong
   Wang, Zhi-Wei
   Zhang, Wei-Ge
   Wu, Ying-Liang
TI COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor
   activity via p53-dependent senescence in hepatocellular carcinoma
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE COH-203; Hepatocellular carcinoma; Microtubules; Senescence; p53
ID CANCER-CELLS; MITOTIC CATASTROPHE; APOPTOSIS; FIBROBLASTS; CONTRIBUTES;
   PACLITAXEL; AUTOPHAGY; SLIPPAGE; THERAPY; GROWTH
AB 5-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyPhenyl)-3H-1,2-dithiol-3-one (COH-203) is a novel synthesized analogue of combretastatin A-4 that can be classified as a microtubule inhibitor. In this study, we evaluated the anti-hepatoma effect of COH-203 in vitro and in vivo and explored the underlying molecular mechanisms. COH-203 was shown to be more effective in inhibiting the proliferation of liver cancer cells compared with normal liver cells. COH-203 also displayed potent anti-tumor activity in a hepatocellular carcinoma xenograft model without significant toxicity. Mechanistic studies dermonstrated that treatment with COH-203 induced mitotic arrest by inhibiting tubulin polymerization in BEL-7402 liver cancer cells. Long-term COH-203 treatment in BEL-7402 cells led to mitotic slippage followed by senescence via the p14(Arf)-p53-p21 and p16(INK4 alpha)-Rb pathways. Furthermore, suppression of p53 via pifithrin-alpha (p53 inhibitor) and p53-siRNA attenuated COH-203-induced senescence in BEL-7402 cells, suggesting that COH-203 induced senescence p53-dependently. In conclusion, we report for the first time that COH-203, one compound in the combretastatin family, promotes anti-proliferative activity through the induction of p-53 dependent senescence. Our findings will provide a molecular rationale for the development of COH-203 as a promising anti-tumor agent. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Qi, Huan; Zuo, Dai-Ying; Bai, Zhao-Shi; Xu, Jing-Wen; Li, Zeng-Qiang; Wu, Ying-Liang] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China.
   [Shen, Qi-Rong; Wang, Zhi-Wei; Zhang, Wei-Ge] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China.
C3 Shenyang Pharmaceutical University; Shenyang Pharmaceutical University
RP Zhang, WG (corresponding author), Minist Educ, Key Lab Struct Based Drug Design & Discovery, 103 Wenhua Rd, Shenyang 110016, Peoples R China.
EM zhangweige2000@sina.com; yingliang_1016@163.com
RI Jiang, Cheng/JHU-0179-2023; Shen, Qirong/AAB-6531-2020
OI Xu, Jingwen/0000-0002-2451-8037; Wu, Yingliang/0000-0002-5155-7568;
   Zhang, Weige/0000-0002-4492-3072
FU National S&T Major Project of China [2012ZX09103101-060]; National
   Natural Science Foundation of China [30973614]
FX The authors would like to thank the National S&T Major Project of China
   (2012ZX09103101-060), the National Natural Science Foundation of China
   (30973614) for financial support.
CR Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076286
   Borlon C, 2008, MECH AGEING DEV, V129, P109, DOI 10.1016/j.mad.2007.10.014
   Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043
   Chen DL, 2012, BIOCHEM BIOPH RES CO, V426, P324, DOI 10.1016/j.bbrc.2012.08.072
   Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002
   Greene LM, 2012, BIOCHEM PHARMACOL, V84, P612, DOI 10.1016/j.bcp.2012.06.005
   Gu YY, 2006, BIOCHEM PHARMACOL, V72, P541, DOI 10.1016/j.bcp.2006.05.026
   Holy JM, 2002, MUTAT RES-GEN TOX EN, V518, P71, DOI 10.1016/S1383-5718(02)00076-1
   Ingemarsdotter CK, 2010, ONCOGENE, V29, P6051, DOI 10.1038/onc.2010.335
   Konwinski RR, 2004, TOXICOL LETT, V153, P343, DOI 10.1016/j.toxlet.2004.06.006
   Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105
   LLeonart ME, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-3
   Loong HH, 2014, ONCOTARGETS THER, V7, P575, DOI 10.2147/OTT.S46019
   Nabha SM, 2002, CLIN CANCER RES, V8, P2735
   Nam NH, 2003, CURR MED CHEM, V10, P1697, DOI 10.2174/0929867033457151
   Qi M, 2013, J PHARMACOL SCI, V121, P200, DOI 10.1254/jphs.12269FP
   Qiao FX, 2013, BIOL PHARM BULL, V36, P193, DOI 10.1248/bpb.b12-00321
   Qiao FX, 2012, CANCER CHEMOTH PHARM, V70, P259, DOI 10.1007/s00280-012-1907-x
   Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Shen CH, 2010, BRIT J PHARMACOL, V160, P2008, DOI 10.1111/j.1476-5381.2010.00861.x
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tron GC, 2005, J MED CHEM, V48, P3260, DOI 10.1021/jm049096o
   Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115
   Wu R, 2009, CANCER LETT, V285, P13, DOI 10.1016/j.canlet.2009.04.042
   Zhou QA, 2011, INT J ONCOL, V38, P721, DOI 10.3892/ijo.2011.902
   Zhu H, 2010, INVEST NEW DRUG, V28, P493, DOI 10.1007/s10637-010-9424-4
NR 29
TC 11
Z9 14
U1 0
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 12
PY 2014
VL 455
IS 3-4
BP 262
EP 268
DI 10.1016/j.bbrc.2014.11.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA AX4CP
UT WOS:000346881900022
PM 25449279
DA 2024-02-19
ER

PT J
AU Hui, L
AF Hui, Liu
TI Assessment of the role of ageing and non-ageing factors in death from
   non-communicable diseases based on a cumulative frequency model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RISK-FACTORS; EPIDEMIOLOGY; PREVENTION; ONSET; AGES
AB To quantify the effects of ageing and non-ageing factors, a characterization of the effects of ageing, genetic, and exogenous variables on 12 major non-communicable diseases was evaluated using a model assessing cumulative frequency of death and survival by age group from dead and surviving populations based on mortality statistics. Indices (0-1) of the roles of ageing (ARD), genetics (GRD) and exogenous (ERD) variables in deaths due to disease were established, and the sum of ARD, GRD and ERD was 1 (value of each indices was < 1). Results showed that ageing plays an important role in death from chronic disease; exogenous factors may contribute more to the pattern of chronic disease than genetic factors (ARD, GRC and ERD were 0.818, 0.058 and 0.124 respectively for all non-communicable diseases). In descending order, ERD for non-communicable diseases were breast cancer, leukaemia, cancer of the cervix uteri and uterus, liver cancer, nephritis and nephropathy, stomach cancer, lung cancer, diabetes, cerebrovascular disease, coronary heart disease, COPD, and Alzheimer's disease, while a smaller ERD indicated a tendency of natural death. An understanding of the aforementioned complex relationships of specific non-communicable diseases will be beneficial in designing primary prevention measures for non-communicable diseases in China.
C1 [Hui, Liu] Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Hui, L (corresponding author), Dalian Med Univ, Dept Clin Immunol, Dalian 116044, Peoples R China.
EM liuhui60@sina.com
CR Ahmadi B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002756
   An WX, 2014, ASIAN PAC J CANCER P, V15, P4125, DOI 10.7314/APJCP.2014.15.10.4125
   Beltrán-Sánchez H, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025957
   Brinks R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152046
   Bullen C, 2015, NEW ZEAL MED J, V128, P55
   Campbell D, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040400
   Chinese C for Disease Control and Prevention, 2011, PEOPL MED PUBL HOUS, P171
   Hanewinckel R, 2016, EUR J EPIDEMIOL, V31, P5, DOI 10.1007/s10654-015-0094-6
   Hui L, 2015, ARCH GERONTOL GERIAT, V60, P178, DOI 10.1016/j.archger.2014.11.002
   Hui L, 2015, EPIDEMIOLOGY, V26, pE9, DOI 10.1097/EDE.0000000000000207
   Hui L, 2012, J THROMB THROMBOLYS, V33, P318, DOI 10.1007/s11239-012-0724-8
   King M, 2015, DM-DIS MON, V61, P467, DOI 10.1016/j.disamonth.2015.09.006
   Liang J, 2010, SURG ONCOL CLIN N AM, V19, P725, DOI 10.1016/j.soc.2010.07.007
   Liu H, 2014, GENE, V540, P32, DOI 10.1016/j.gene.2014.02.033
   Liu H, 2011, ATHEROSCLEROSIS, V218, P151, DOI 10.1016/j.atherosclerosis.2011.05.024
   Nakatani H, 2016, J EPIDEMIOL, V26, P171, DOI 10.2188/jea.JE20160010
   Renehan AG, 2012, AM J EPIDEMIOL, V176, P1130, DOI 10.1093/aje/kws192
   Mañas LR, 2015, NESTLE NUTR WORKS SE, V83, P29, DOI 10.1159/000382057
   STROBER M, 1992, J AM ACAD CHILD PSY, V31, P606, DOI 10.1097/00004583-199207000-00005
   Sun WP, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0487-z
   Sun WP, 2015, CLIN LAB, V61, P1883, DOI 10.7754/Clin.Lab.2015.150405
   Tong FZ, 2012, ONCOL LETT, V3, P517, DOI 10.3892/ol.2011.540
   World Health Organization, 2018, International Statistical Classification of Diseases and Related Health Problems, 10th Revision
   Xin G, 2014, EXP GERONTOL, V60, P83, DOI 10.1016/j.exger.2014.10.005
NR 24
TC 16
Z9 18
U1 0
U2 6
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 15
PY 2017
VL 7
AR 8159
DI 10.1038/s41598-017-08539-0
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FD5KT
UT WOS:000407570000036
PM 28811618
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kalaz, EB
   Çoban, J
   Aydin, AF
   Dogan-Ekici, I
   Dogru-Abbasoglu, S
   Öztezcan, S
   Uysal, M
AF Kalaz, Esra Betul
   Coban, Jale
   Aydin, A. Fatih
   Dogan-Ekici, Isin
   Dogru-Abbasoglu, Semra
   Oztezcan, Serdar
   Uysal, Mujdat
TI Carnosine and taurine treatments decreased oxidative stress and tissue
   damage induced by D-galactose in rat liver
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Carnosine; Taurine; Galactose; Oxidative stress; Rat liver
ID ANTIOXIDANT BALANCE; HEPATOTOXICITY; HISTIDINE; MICE; OLD; PRETREATMENT;
   HEART
AB D-galactose (GAL) causes aging-related changes and oxidative stress in the organism. We investigated the effect of carnosine (CAR) or taurine (TAU), having antioxidant effects, on hepatic injury and oxidative stress in GAL-treated rats. Rats received GAL (300 mg/kg; s.c.; 5 days/week) alone or together with CAR (250 mg/kg/daily; i.p.; 5 days/week) or TAU (2.5% w/w; in rat chow) for 2 months. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities and hepatic malondialdehyde (MDA), protein carbonyl (PC) and glutathione (GSH) levels and superoxide dismutase (SOD), glutathione peroxidase (GSH-0050x), and glutathione transferase (GST) activities were determined. Hepatic expressions of B cell lymphoma-2 (Bcl-2), Bax and Ki-67 were evaluated. Serum ALT, AST, hepatic MDA, and PC levels were observed to increase in GAL-treated rats. Hepatic Bax expression, but not Bcl-2, increased, Ki-67 expression decreased. GAL treatment caused decreases in GSH levels, SOD and GSH-Px activities in the liver. Hepatic mRNA expressions of SOD, but not GSH-Px, also diminished. CAR or TAU treatments caused significant decreases in serum ALT and AST activities. These treatments decreased apoptosis and increased proliferation and ameliorated histopathological findings in the livers of GAL-treated rats. Both CAR and TAU reduced MDA and PC levels and elevated GSH levels, SOD and GSH-Px (non significant in TAU+GAL group) activities. These treatments did not alter hepatic mRNA expressions of SOD and GSH-Px enzymes. Our results indicate that CAR and TAU restored liver prooxidant status together with histopathological amelioration in GAL-induced liver damage.
C1 [Kalaz, Esra Betul; Aydin, A. Fatih; Dogru-Abbasoglu, Semra; Uysal, Mujdat] Istanbul Univ, Istanbul Fac Med, Dept Biochem, Istanbul, Turkey.
   [Coban, Jale; Oztezcan, Serdar] Yeditepe Univ, Fac Med, Dept Biochem, Istanbul, Turkey.
   [Dogan-Ekici, Isin] Yeditepe Univ, Fac Med, Dept Pathol, Istanbul, Turkey.
C3 Istanbul University; Yeditepe University; Yeditepe University
RP Uysal, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Biochem, Istanbul, Turkey.
EM m.mujdatuysal@hotmail.com
RI Abbasoglu, Semra/AAD-9014-2020; Aydın, Abdurrahman Fatih/AAD-9170-2020
OI Abbasoglu, Semra/0000-0003-3467-9763; 
FU Istanbul University [5786]
FX The present work was supported by Research Fund of Istanbul University
   (Project No: 5786).
CR Acharya M, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S35
   Aldini G, 2005, BIOFACTORS, V24, P77, DOI 10.1002/biof.5520240109
   Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Artun BC, 2010, HUM EXP TOXICOL, V29, P659, DOI 10.1177/0960327109359460
   Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   Aydm AF, 2010, PHARM REP, V62, P732
   Balkan J, 2005, EUR J GASTROEN HEPAT, V17, P917, DOI 10.1097/00042737-200509000-00006
   Bellia F, 2011, MOL ASPECTS MED, V32, P258, DOI 10.1016/j.mam.2011.10.009
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Boldyrev A.A., 2001, BIOKHIMIYA, V66, P1430
   Boldyrev AA, 2005, ANN NY ACAD SCI, V1057, P1, DOI DOI 10.1196/ANNALS.1356.013
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Dawson R, 1999, MECH AGEING DEV, V107, P73, DOI 10.1016/S0047-6374(98)00138-9
   Dogru-Abbasoglu S, 2001, HUM EXP TOXICOL, V20, P23, DOI 10.1191/096032701673031525
   Eppler B, 2001, BIOCHEM PHARMACOL, V62, P29, DOI 10.1016/S0006-2952(01)00647-5
   Gallant S, 2000, BIOCHEMISTRY-MOSCOW+, V65, P866
   Habig W H, 1981, Methods Enzymol, V77, P398
   Hansen SH, 2001, DIABETES-METAB RES, V17, P330, DOI 10.1002/dmrr.229
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Kang JH, 2002, BBA-GEN SUBJECTS, V1570, P89, DOI 10.1016/S0304-4165(02)00158-7
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Liu WH, 2008, FOOD CHEM TOXICOL, V46, P1503, DOI 10.1016/j.fct.2007.12.013
   Mehmetçik G, 2008, PEPTIDES, V29, P425, DOI 10.1016/j.peptides.2007.11.008
   Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001
   MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Parildar H, 2008, J NUTR SCI VITAMINOL, V54, P61, DOI 10.3177/jnsv.54.61
   Parildar-Karpuzoglu H, 2008, PHARMACOL REP, V60, P673
   Ramana BV, 2006, ACTA DIABETOL, V43, P135, DOI 10.1007/s00592-006-0229-z
   Ren Y, 2011, J AGR FOOD CHEM, V59, P206, DOI 10.1021/jf103938e
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Schaffer S, 2003, ADV EXP MED BIOL, V526, P307
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sprott RL, 2011, ILAR J, V52, P1
   Stuerenburg HJ, 1999, ARCH GERONTOL GERIAT, V29, P107, DOI 10.1016/S0167-4943(99)00020-5
   Wu H, 2005, BRAIN RES, V1038, P123, DOI 10.1016/j.brainres.2005.01.058
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Yan SL, 2009, J FOOD SCI, V74, pH259, DOI 10.1111/j.1750-3841.2009.01330.x
   Yildirim ZL, 2007, ANN NY ACAD SCI, V1100, P553, DOI 10.1196/annals.1395.061
   Yuneva AO, 2002, B EXP BIOL MED+, V133, P559, DOI 10.1023/A:1020273506970
   Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
NR 50
TC 40
Z9 42
U1 2
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD MAR
PY 2014
VL 70
IS 1
BP 15
EP 25
DI 10.1007/s13105-013-0275-2
PG 11
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA AC2WU
UT WOS:000332377800002
PM 23872881
DA 2024-02-19
ER

PT J
AU Suzuki, A
   Barnhart, H
   Gu, JZ
   Bonkovsky, HL
   Tillmann, HL
   Fontana, RJ
   Kleiner, DE
AF Suzuki, Ayako
   Barnhart, Huiman
   Gu, Jiezhun
   Bonkovsky, Herbert L.
   Tillmann, Hans L.
   Fontana, Robert J.
   Kleiner, David E.
CA DILIN
TI Associations of gender and a proxy of female menopausal status with
   histological features of drug-induced liver injury
SO LIVER INTERNATIONAL
LA English
DT Article
DE drug-induced liver injury; gender difference; hepatotoxicity; liver
   histology; menopause
ID UNITED-STATES; PROGESTERONE; ESTRADIOL; EXPRESSION; SEX; PREVALENCE;
   OUTCOMES; FAILURE; CELLS
AB Background & AimGender and menopause may contribute to type and severity of drug-induced liver injury (DILI) by influencing host responses to injury. The aim of this study was to assess the associations of gender and female age 50 [a proxy of menopause] with histological features of liver injury in 212 adults enrolled in the Drug-Induced Liver Injury Network (DILIN) registry.
   MethodsAll participants had a causality score of at least probable', a liver biopsy within 30days of DILI onset, and no prior chronic liver disease. Biochemical and histological injury types were classified as hepatocellular or cholestatic/mixed injury. The cohort was divided into three gender/age categories: men (41.0%), women <50years (27.4%) and women 50years of age (31.6%). Interaction of gender and age category (50 or not) was assessed.
   ResultsHepatocellular injury was more prevalent in women <50years vs. others (P=.002). After adjusting for biochemical injury types, black race and possible ageing effects, more severe interface hepatitis was noted in biopsies of women <50years compared to those of men and women 50years (P=.009 and P=.055 respectively). Compared to those of men, biopsies of women showed greater plasma cell infiltration, hepatocyte apoptosis, hepatocyte rosettes and lobular disarray but less iron-positive hepatocytes and histological cholestasis (P<.05). These associations persisted after excluding cases of amoxicillin/clavulanic acid, anabolic steroids or nitrofurantoin DILI which showed gender-specific distributions.
   ConclusionGender and a proxy of menopause were associated with various features of inflammation and injury in DILI.
C1 [Suzuki, Ayako] Duke Univ, Gastroenterol, Durham, NC 27708 USA.
   [Barnhart, Huiman; Gu, Jiezhun] Duke Clin Res Inst, Durham, NC USA.
   [Bonkovsky, Herbert L.] Wake Forest Univ, Bowman Gray Sch Med, Sect Gastroenterol & Hepatol, Winston Salem, NC USA.
   [Bonkovsky, Herbert L.] Univ N Carolina, Chapel Hill, NC USA.
   [Tillmann, Hans L.] East Carolina Univ, Gastroenterol, Brody Sch Med, Greenville, NC USA.
   [Fontana, Robert J.] Univ Michigan, Med Ctr, Gastroenterol, Ann Arbor, MI USA.
   [Kleiner, David E.] NCI, Pathol Lab, Bldg 10, Bethesda, MD 20892 USA.
C3 Duke University; Duke University; Wake Forest University; Wake Forest
   Baptist Medical Center; University of North Carolina; University of
   North Carolina Chapel Hill; University of North Carolina; East Carolina
   University; University of Michigan System; University of Michigan;
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI)
RP Suzuki, A (corresponding author), Duke Univ, Gastroenterol, Durham, NC 27708 USA.
EM ayako.suzuki@duke.edu
RI Kleiner, David E/N-2770-2013; Bonkovsky, Herbert L./AAH-1892-2021
OI Kleiner, David E/0000-0003-3442-4453; Bonkovsky, Herbert
   L./0000-0001-7387-3230; Suzuki, Ayako/0000-0003-1824-1067
FU National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK); National Institutes of Health (NIH) [U01DK065211, U01DK065184,
   U01DK065201, U01DK083020, U01DK083027, U01DK100928, U01DK065176];
   Intramural Research Program of the NIH, National Cancer Institute
FX The DILIN is structured as an U01 cooperative agreement supported by the
   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   and the National Institutes of Health (NIH) with funds provided by the
   following grants: U01DK065211 (Indiana University [Purdue]), U01DK065184
   (University of Michigan [Ann Arbor]), U01DK065201 (University of North
   Carolina [Chapel Hill, Asheville, Wake Forest {Wake Forest Baptist
   Medical Center]), U01DK083020 (University of Southern California,
   University of California-Los Angeles [Pfleger Liver Institute]),
   U01DK083027 (Albert Einstein Medical Center), U01DK100928 (Icahn School
   of Medicine at Mount Sinai), U01DK065176 (Duke Clinical Research
   Institute). This research was also supported in part by the Intramural
   Research Program of the NIH, National Cancer Institute
CR Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5
   BENICHOU C, 1990, J HEPATOL, V11, P272
   Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006
   Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011
   Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016
   Cho J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061186
   De Valle MB, 2006, ALIMENT PHARM THER, V24, P1187, DOI 10.1111/j.1365-2036.2006.03117.x
   Fagerland MW, 2013, STAT MED, V32, P2235, DOI 10.1002/sim.5645
   Fontana RJ, 2015, AM J GASTROENTEROL, V110, P1450, DOI 10.1038/ajg.2015.283
   Fontana RJ, 2009, DRUG SAFETY, V32, P55, DOI 10.2165/00002018-200932010-00005
   Guo Ya-Ping, 2014, Curr Ther Res Clin Exp, V76, P116, DOI 10.1016/j.curtheres.2014.06.004
   Haralambieva LH, 2014, VACCINE, V32, P1946, DOI 10.1016/j.vaccine.2014.01.090
   Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465
   Lucena MI, 2006, HEPATOLOGY, V44, P850, DOI 10.1002/hep.21324
   Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895
   Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278
   Jog NR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.251
   Kleiner DE, 2014, HEPATOLOGY, V59, P661, DOI 10.1002/hep.26709
   Liu Zhang-Xu, 2002, Clin Liver Dis, V6, P755, DOI 10.1016/S1089-3261(02)00025-9
   Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038
   Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282
   Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937
   Russo MW, 2004, LIVER TRANSPLANT, V10, P1018, DOI 10.1002/lt.20204
   SHIBA Y, 1990, Hiroshima Journal of Medical Sciences, V39, P11
   Teubner A, 2002, MED KLIN, V97, P645, DOI 10.1007/s00063-002-1207-z
   Toyoda Y, 2012, TOXICOL SCI, V126, P16, DOI 10.1093/toxsci/kfr326
   Toyoda Y, 2011, TOXICOL LETT, V204, P17, DOI 10.1016/j.toxlet.2011.03.031
   Uetrecht J, 2009, SEMIN LIVER DIS, V29, P383, DOI 10.1055/s-0029-1240007
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883
   Yang Lun, 2012, J Drug Metab Toxicol, V3, P1000119, DOI 10.4172/2157-7609.1000119
   Yuan Y, 2008, WORLD J GASTROENTERO, V14, P2200, DOI 10.3748/wjg.14.2200
   Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922
NR 33
TC 16
Z9 18
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD NOV
PY 2017
VL 37
IS 11
BP 1723
EP 1730
DI 10.1111/liv.13380
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FK5VF
UT WOS:000413569100019
PM 28161910
OA Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Beedholm, R
   Clark, BFC
   Rattan, SIS
AF Beedholm, R
   Clark, BFC
   Rattan, SIS
TI Mild heat stress stimulates 20S proteasome and its 11S activator in
   human fibroblasts undergoing aging in vitro
SO CELL STRESS & CHAPERONES
LA English
DT Article
ID INDUCED PREMATURE SENESCENCE; AGE-RELATED DECLINE; PROTEIN OXIDATION;
   MULTICATALYTIC PROTEINASE; PROLIFERATIVE SENESCENCE; OXIDIZED PROTEINS;
   RAT-LIVER; DEGRADATION; SHOCK; PA28
AB Repeated mild heat shock (RMHS) has been shown to have several beneficial hormetic effects on human skin fibroblast undergoing aging in vitro. Because an age-related decline in proteasome activity is 1 of the reasons for the accumulation of abnormal proteins during aging, we have investigated the effects of RMHS on the 20S proteasome, which is the major proteolytic system involved in the removal of abnormal and oxidatively damaged proteins. Serially passaged human skin fibroblasts exposed to RMHS at 41degreesC for 60 minutes twice a week had increased 3 proteasomal activities by 40% to 95% in early- and midpassage cultures. RMHS-treated cells also contained a 2-fold higher amount of the proteasome activator 11S, and the extent of the bound activator was double in early- and midpassage cells only. Furthermore, there was no difference in the content of the 19S proteasome regulator in the stressed and the unstressed cells. Therefore, RMHS-induced proteasome stimulation in early- and midpassage fibroblasts appears to be due to an induction and enhanced binding of 11S proteasome activators. In contrast to this, the proteasomal system in late-passage senescent cells appears to be less responsive to the stimulatory effects of mild heat shock.
C1 Aarhus Univ, Danish Ctr Mol Gerontol, Dept Mol Biol, Lab Cellular Ageing, DK-8000 Aarhus C, Denmark.
C3 Aarhus University
RP Rattan, SIS (corresponding author), Aarhus Univ, Danish Ctr Mol Gerontol, Dept Mol Biol, Lab Cellular Ageing, Gustav Wieds Vej 10-C, DK-8000 Aarhus C, Denmark.
EM rattan@imsb.au.dk
OI Rattan, Suresh I.S./0000-0002-3478-1381
CR Bose S, 2001, BIOCHEM J, V353, P291, DOI 10.1042/0264-6021:3530291
   Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200
   Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379
   Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6
   Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q
   Ciechanover A, 2000, J CELL BIOCHEM, P40
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 1998, FRONT BIOSCI, V3, pd25
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878
   DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123
   DUBIEL W, 1992, J BIOL CHEM, V267, P22369
   Fonager J, 2002, EXP GERONTOL, V37, P1223, DOI 10.1016/S0531-5565(02)00128-6
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9
   Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538
   Kawasaki H, 1996, MOL MEMBR BIOL, V13, P217, DOI 10.3109/09687689609160599
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Kuckelkorn U, 2000, BIOL CHEM, V381, P1017, DOI 10.1515/BC.2000.125
   Kuehn L, 1997, MOL BIOL REP, V24, P89, DOI 10.1023/A:1006897801858
   Kuehn L, 1996, FEBS LETT, V394, P183, DOI 10.1016/0014-5793(96)00946-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MA CP, 1992, J BIOL CHEM, V267, P10515
   McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8
   Minois N, 2000, BIOGERONTOLOGY, V1, P15, DOI 10.1023/A:1010085823990
   Mykles DL, 1996, ARCH BIOCHEM BIOPHYS, V325, P77, DOI 10.1006/abbi.1996.0009
   MYKLES DL, 1989, ARCH BIOCHEM BIOPHYS, V274, P216, DOI 10.1016/0003-9861(89)90433-5
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Ordway GA, 2000, J APPL PHYSIOL, V88, P1134, DOI 10.1152/jappl.2000.88.3.1134
   ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W
   PETERS JM, 1994, J BIOL CHEM, V269, P7709
   Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503
   Rattan SIS, 2001, HUM EXP TOXICOL, V20, P281, DOI 10.1191/096032701701548034
   Rattan SIS, 1998, BIOCHEM MOL BIOL INT, V45, P753
   Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001
   Rivett AJ, 2002, EXP GERONTOL, V37, P1217, DOI 10.1016/S0531-5565(02)00127-4
   Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X
   SCHERRER K, 1994, PROG NUCLEIC ACID RE, V49, P1
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8
   Stolzing A, 2001, CLIN EXP DERMATOL, V26, P566, DOI 10.1046/j.1365-2230.2001.00867.x
   Strack PR, 1996, BIOCHEMISTRY-US, V35, P7142, DOI 10.1021/bi9518048
   TANAKA K, 1986, J BIOL CHEM, V261, P5197
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Toussaint O, 2002, BIOGERONTOLOGY, V3, P13, DOI 10.1023/A:1015226524335
   Verbeke P, 2002, BIOGERONTOLOGY, V3, P117, DOI 10.1023/A:1015284119308
   Verbeke P, 2001, FREE RADICAL BIO MED, V31, P1593, DOI 10.1016/S0891-5849(01)00752-3
   Verbeke P, 2001, CELL BIOL INT, V25, P845, DOI 10.1006/cbir.2001.0789
   Verbeke P, 2000, EXP GERONTOL, V35, P787, DOI 10.1016/S0531-5565(00)00143-1
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35
   Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607
   Zwickl P, 2002, CURR TOP MICROBIOL, V268, P23
NR 60
TC 53
Z9 58
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1355-8145
EI 1466-1268
J9 CELL STRESS CHAPERON
JI Cell Stress Chaperones
PD MAR
PY 2004
VL 9
IS 1
BP 49
EP 57
DI 10.1379/1466-1268(2004)009<0049:MHSSSP>2.0.CO;2
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 809MC
UT WOS:000220639800006
PM 15270077
OA Green Published
DA 2024-02-19
ER

PT J
AU Liu, CC
   Huang, SP
   Hsieh, TJ
   Lee, CH
   Cheng, KH
   Huang, TY
   Geng, JH
   Li, CC
   Wu, WJ
   Lee, YC
AF Liu, Chia-Chu
   Huang, Shu-Pin
   Hsieh, Tusty-Jiuan
   Lee, Cheng-Hsueh
   Cheng, Kai-Hung
   Huang, Tsung-Yi
   Geng, Jiun-Hung
   Li, Ching-Chia
   Wu, Wen-Jeng
   Lee, Yung-Chin
TI Fatty liver index is associated with the risk of testosterone deficiency
   in aging men without metabolic syndrome
SO ANDROLOGY
LA English
DT Article; Early Access
DE non&#8208; alcoholic fatty liver disease; fatty liver index;
   testosterone deficiency; metabolic syndrome; aging men; insulin
   resistance
AB Objectives Non-alcoholic fatty liver disease (NAFLD) is suggested to be a precursor of metabolic syndrome (MetS) and could influence the risk of testosterone deficiency (TD). Fatty liver index (FLI) is a simple and useful screening tool for NAFLD. We determined the association between the risk of NAFLD assessed by FLI and TD in aging Taiwanese men, especially those without MetS.
   Materials and Methods A free health screening program was conducted for men (age: >40 years) in a medical center in Kaohsiung, Taiwan. All participants underwent a physical examination; answered a questionnaire assessing demographics, medical history, and clinical symptoms of TD; and provided 20-mL whole blood samples for biochemical, adipocytokine, and hormonal evaluations. The risk of NAFLD was evaluated using FLI. The presence of NAFLD was ruled out if FLI value was A total of 552 men (mean age: 54.7 +/- 7.7 years) were enrolled. The prevalence rates of TD and MetS were significantly higher among men with NAFLD than those without NAFLD (both p < 0.001). FLI was significantly correlated with total testosterone (TT) and adipocytokines associated with insulin resistance, such as adiponectin, leptin, and retinol-binding protein-4 (RBP-4) levels, respectively (all p < 0.001). Among men without MetS, those at risk of and with NAFLD had a 3.82 and 8.50 times higher risk of TD, respectively, than those without NAFLD after adjusting for potential covariates.
   Conclusion The FLI is associated with the risk of TD in aging Taiwanese men, especially in those without MetS. Our findings also suggest that insulin resistance may be an important link among the inter-relationships of NAFLD, MetS, and TD.
   Further population-based studies with larger sample sizes of different ethnicities are warranted to confirm these preliminary results.
C1 [Liu, Chia-Chu; Huang, Shu-Pin; Lee, Cheng-Hsueh; Huang, Tsung-Yi; Li, Ching-Chia; Wu, Wen-Jeng; Lee, Yung-Chin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.
   [Liu, Chia-Chu; Huang, Shu-Pin; Li, Ching-Chia; Wu, Wen-Jeng; Lee, Yung-Chin] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, Kaohsiung, Taiwan.
   [Liu, Chia-Chu] Minist Hlth & Welf, Dept Urol, Pingtung Hosp, Pingtung, Taiwan.
   [Liu, Chia-Chu; Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.
   [Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.
   [Cheng, Kai-Hung] E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.
   [Geng, Jiun-Hung; Lee, Yung-Chin] Kaohsiung Municipal Siaogang Hosp, Dept Urol, Kaohsiung, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung
   Medical University; E-Da Hospital; Kaohsiung Medical University;
   Kaohsiung Municipal Siao-Gang Hospital
RP Lee, YC (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, 100 Tz You 1st Rd, Kaohsiung 807, Taiwan.
EM leeyc12345@yahoo.com.tw
RI Huang, Shu-Pin/D-5286-2009; LIU, CHIA CHU/T-2880-2019; Li,
   Ching-Chia/D-5024-2009; GENG, JIUNHUNG/AAB-2322-2022
OI GENG, JIUNHUNG/0000-0003-0610-1278; Hsieh,
   Tusty-Jiuan/0000-0001-5387-6522; LIU, CHIA CHU/0000-0001-5797-4613
FU Ministry of Science and Technology, Taiwan [MOST 106-2314-B-037-065-MY3,
   MOST 109-2314-B-037-104-MY3]; Research Center for Environmental
   Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Kaohsiung
   Medical University Hospital, Kaohsiung, Taiwan [KMUH107-7R57,
   KMUH108-8R54, KMUH109-9R62, KMUH-DK109008]
FX This study was supported by grants from the Ministry of Science and
   Technology, Taiwan (MOST 106-2314-B-037-065-MY3; MOST
   109-2314-B-037-104-MY3), Research Center for Environmental Medicine,
   Kaohsiung Medical University, Kaohsiung, Taiwan, and Kaohsiung Medical
   University Hospital, Kaohsiung, Taiwan (KMUH107-7R57; KMUH108-8R54;
   KMUH109-9R62; KMUH-DK109008). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bianchi VE, 2018, OBES REV, V19, P557, DOI 10.1111/obr.12633
   Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409
   Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158
   Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Cheng KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060295
   Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491
   Chueh KS, 2012, J ANDROL, V33, P817, DOI 10.2164/jandrol.111.015628
   Corona G, 2018, J SEX MED, V15, P1260, DOI 10.1016/j.jsxm.2018.06.012
   Fabbrini E, 2015, NUTRIENTS, V7, P4995, DOI 10.3390/nu7064995
   Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682
   Jaruvongvanich Veeravich, 2017, Ann. Hepatol., V16, P382
   Khera M, 2016, J SEX MED, V13, P1787, DOI 10.1016/j.jsxm.2016.10.009
   Khera M, 2016, MAYO CLIN PROC, V91, P908, DOI 10.1016/j.mayocp.2016.04.022
   Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005
   Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031
   Liu CC, 2018, J SEX MED, V15, P1527, DOI 10.1016/j.jsxm.2018.09.012
   Liu CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03078-0
   Liu CC, 2009, J SEX MED, V6, P936, DOI 10.1111/j.1743-6109.2008.01171.x
   Liu CC, 2009, ANN EPIDEMIOL, V19, P539, DOI 10.1016/j.annepidem.2009.02.006
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   López-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053
   Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902
   Mintziori G, 2017, MINERVA ENDOCRINOL, V42, P145, DOI 10.23736/S0391-1977.16.02570-0
   Mulhall JP, 2018, J UROLOGY, V200, P423, DOI 10.1016/j.juro.2018.03.115
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Polyzos SA, 2020, DIABETES METAB SYND, V14, P1571, DOI 10.1016/j.dsx.2020.07.049
   Sarkar M, 2019, CLIN GASTROENTEROL H
   Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443
   Yim JY, 2018, LIVER INT, V38, P2051, DOI 10.1111/liv.13735
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zitzmann M, 2009, NAT REV ENDOCRINOL, V5, P673, DOI 10.1038/nrendo.2009.212
NR 36
TC 3
Z9 3
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
EI 2047-2927
J9 ANDROLOGY-US
JI Andrology
PD 2021 MAY
PY 2021
VL 9
IS 3
BP 863
EP 872
DI 10.1111/andr.12979
EA FEB 2021
PG 10
WC Andrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SD1PU
UT WOS:000616536100001
PM 33484089
OA Bronze
DA 2024-02-19
ER

PT J
AU Soejima, K
   Sato, H
   Hisaka, A
AF Soejima, Kuretake
   Sato, Hiromi
   Hisaka, Akihiro
TI Age-Related Change in Hepatic Clearance Inferred from Multiple
   Population Pharmacokinetic Studies: Comparison with Renal Clearance and
   Their Associations with Organ Weight and Blood Flow
SO CLINICAL PHARMACOKINETICS
LA English
DT Article; Early Access
ID ADVERSE DRUG-REACTIONS; HUMAN LIVER-MICROSOMES; LABELING DECISIONS;
   DISPOSITION; CYTOCHROME-P450; THEOPHYLLINE; PREDICTION; ENZYMES;
   PHARMACODYNAMICS; OXIDATION
AB Objective This study aimed to examine the magnitude of age-related change in hepatic clearance by integrating the data of multiple drugs and to compare this with renal clearance, considering associations with age-related changes in organ weight and blood flow. Methods The results of multiple population pharmacokinetic analyses that detected age-related clearance changes in hepatically eliminated drugs were collected. The relationship between hepatic clearance of the unbound drug and age was then analyzed using the nonlinear least-squares method, adjusting for interdrug differences. The obtained change in hepatic clearance was compared with age-related changes in liver weight and hepatic blood flow in Japanese and Westerners. For comparison, the changes in renal clearance were analyzed similarly. Results In total, 18 drugs were analyzed. The hepatic unbound clearance decreased by 32% at age 80 years and by 40% at age 90 years, compared with age 40 years, suggesting that it decreased by 0.80% per year with aging. The rate of the decrease was consistent with decreases in hepatic weight per person or blood flow per person, regardless of ethnicity and sex. Since age-related change in body weight varied somewhat by sex or ethnicity, hepatic weight per body weight was less consistent to account for age-related change in hepatic clearance. As for an index of renal clearance, the changes in inulin clearance with age were similar to those in renal blood flow, with a decrease of 0.97% per year from the age of 40 years. Conclusions Hepatic clearance consistently decreased by 0.80% per year from the age of 40 years, with aging for multiple drugs analyzed in this study. Changes in organ weight and blood flow are considered to be primarily responsible for the age-related changes in hepatic and renal clearance.
C1 [Soejima, Kuretake; Sato, Hiromi; Hisaka, Akihiro] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.
   [Soejima, Kuretake] Bristol Myers Squibb KK, Shinjuku Ku, 6-5-1 Nishishinjuku, Tokyo 1631328, Japan.
C3 Chiba University; Bristol-Myers Squibb
RP Hisaka, A (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan.
EM ayfa1047@chiba-u.jp; hiromi-s@chiba-u.jp; hisaka@chiba-u.jp
RI Sato, Hiromi/AFV-1641-2022
OI Sato, Hiromi/0000-0001-8815-4829; , Akihiro/0000-0003-4863-9308
FU AMED [JP20mk0101159]
FX This study was partly supported by AMED under Grant number
   JP20mk0101159.
CR ABERNETHY DR, 1985, J PHARMACOL EXP THER, V232, P183
   ABERNETHY DR, 1986, ANN INTERN MED, V105, P329, DOI 10.7326/0003-4819-105-3-329
   ABERNETHY DR, 1983, J CARDIOVASC PHARM, V5, P1093, DOI 10.1097/00005344-198311000-00027
   Achour B, 2014, DRUG METAB DISPOS, V42, P1349, DOI 10.1124/dmd.114.058834
   Achour B, 2014, DRUG METAB DISPOS, V42, P500, DOI 10.1124/dmd.113.055632
   Alhawassi TM, 2014, CLIN INTERV AGING, V9, P2079, DOI 10.2147/CIA.S71178
   ANTAL EJ, 1981, BRIT J CLIN PHARMACO, V12, P637, DOI 10.1111/j.1365-2125.1981.tb01282.x
   AU WYW, 1985, CLIN PHARMACOL THER, V37, P472, DOI 10.1038/clpt.1985.74
   Ayalew Mohammed Biset, 2019, Bull Emerg Trauma, V7, P339, DOI 10.29252/beat-070401
   BAILLIE SP, 1989, AGE AGEING, V18, P258, DOI 10.1093/ageing/18.4.258
   Bhattaram VA, 2005, AAPS J, V7, pE503, DOI 10.1208/aapsj070351
   Bordet R, 2001, EUR J CLIN PHARMACOL, V56, P935, DOI 10.1007/s002280000260
   BRICKER NS, 1960, AM J MED, V28, P77, DOI 10.1016/0002-9343(60)90225-4
   Butler JM, 2008, CLIN PHARMACOKINET, V47, P297, DOI 10.2165/00003088-200847050-00002
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   Davies EA, 2015, BRIT J CLIN PHARMACO, V80, P796, DOI 10.1111/bcp.12596
   GIUSTI DL, 1973, DRUG INTEL CLIN PHAR, V7, P382, DOI 10.1177/106002807300700902
   GREENBLATT DJ, 1980, CLIN PHARMACOL THER, V27, P301, DOI 10.1038/clpt.1980.40
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   GREENBLATT DJ, 1984, ARTHRITIS RHEUM, V27, P1066, DOI 10.1002/art.1780270918
   GUPTA SK, 1995, BRIT J CLIN PHARMACO, V40, P325, DOI 10.1111/j.1365-2125.1995.tb04554.x
   HOLMBERG L, 1982, EUR J CLIN PHARMACOL, V22, P175, DOI 10.1007/BF00542464
   Horio M, 2012, CLIN EXP NEPHROL, V16, P415, DOI 10.1007/s10157-012-0586-6
   International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 1994, ICH TOP E7 STUD SUPP
   Iwatsubo T, 1996, BIOPHARM DRUG DISPOS, V17, P273, DOI 10.1002/(SICI)1099-081X(199605)17:4<273::AID-BDD961>3.0.CO;2-R
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Lee JY, 2011, CLIN PHARMACOKINET, V50, P627, DOI 10.2165/11593210-000000000-00000
   Medical Tribune Inc, PHARM TRIBUNE
   Mould DR, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.4
   Mould D, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.14
   OWEN JA, 1983, CLIN PHARMACOL THER, V34, P364, DOI 10.1038/clpt.1983.180
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   PERUCCA E, 1984, BRIT J CLIN PHARMACO, V17, P665, DOI 10.1111/j.1365-2125.1984.tb02401.x
   Planning and Investigation Committee of the Japanese Society of Legal Medicine, 2015, WEIGHTS SIZ INT ORG
   Polasek TM, 2013, BRIT J CLIN PHARMACO, V75, P1019, DOI 10.1111/j.1365-2125.2012.04446.x
   Pouyanne P, 2000, BRIT MED J, V320, P1036, DOI 10.1136/bmj.320.7241.1036
   ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P227, DOI 10.1007/BF01106706
   Schlender JF, 2016, CLIN PHARMACOKINET, V55, P1573, DOI 10.1007/s40262-016-0422-3
   SCHWARTZ JB, 1987, AM J CARDIOL, V59, P1111, DOI 10.1016/0002-9149(87)90858-7
   SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   SIMONSEN O, 1985, SCAND J CLIN LAB INV, V45, P97, DOI 10.3109/00365518509160980
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Stader F, 2019, CLIN PHARMACOKINET, V58, P483, DOI 10.1007/s40262-018-0709-7
   United Nations Department of Economic and Social Affairs Population Division, 2019, STESASERA427 UN POP, VII
   VEERING BT, 1990, BRIT J CLIN PHARMACO, V29, P201, DOI 10.1111/j.1365-2125.1990.tb03620.x
   VESTAL RE, 1987, J PHARMACOL EXP THER, V241, P488
   Wählby U, 2001, J PHARMACOKINET PHAR, V28, P231, DOI 10.1023/A:1011527125570
   WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377
   Winter ME, 2010, BASIC CLIN PHARMACOK
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 54
TC 9
Z9 10
U1 1
U2 7
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 0312-5963
EI 1179-1926
J9 CLIN PHARMACOKINET
JI Clin. Pharmacokinet.
PD 2022 FEB
PY 2022
VL 61
IS 2
BP 295
EP 305
DI 10.1007/s40262-021-01069-z
EA SEP 2021
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA YS7IJ
UT WOS:000695116700001
PM 34514537
DA 2024-02-19
ER

PT J
AU Breusing, N
   Arndt, J
   Voss, P
   Bresgen, N
   Wiswedel, I
   Gardemann, A
   Siems, W
   Grune, T
AF Breusing, Nicolle
   Arndt, Jana
   Voss, Peter
   Bresgen, Nicolaus
   Wiswedel, Ingrid
   Gardemann, Andreas
   Siems, Werner
   Grune, Tilman
TI Inverse correlation of protein oxidation and proteasome activity in
   liver and lung
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Protein oxidation; Proteasome; Rat
ID HUMAN BJ FIBROBLASTS; 20 S PROTEASOME; CELLULAR SENESCENCE; AGE;
   DEGRADATION; STRESS; DAMAGE; INVOLVEMENT; DYSFUNCTION; INHIBITION
AB Several studies have demonstrated that proteasome activity decreases whereas protein oxidation increases with aging in various tissues. However, no studies are available correlating both parameters directly comparing different tissues of one organism. Therefore, we determined whether there is an age-related change in proteasome activity and protein oxidation in heart, lung, liver, kidney and skeletal muscle samples of 6-, 10-, 18- and 26-month-old rats. There was a significant age-related increase in protein carbonyls at 18 and 26 months compared to young rats. Thereby, protein carbonyl formation was rather due to a general than a specific protein carbonylation as shown by immunblot studies. The highest increase in protein carbonyl formation was found in liver, lung and kidney samples. Proteasome activity decreased significantly with age in lung and liver samples. Proteasome activity in liver and lung decreased by factor five compared to young rats. Strong correlations between proteasome activity and protein oxidation were found in liver and lung, whereas in other tissues only a trend was found. These results demonstrate that the increase in protein oxidation and the decline in proteasome activity are correlating. Further studies are needed to determine the mechanisms which cause organ-specific aging-rates and their consequences. (C) 2009 Published by Elsevier Ireland Ltd.
C1 [Breusing, Nicolle; Arndt, Jana; Voss, Peter; Grune, Tilman] Univ Hohenheim, Inst Biol Chem & Nutr, D-70593 Stuttgart, Germany.
   [Bresgen, Nicolaus] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.
   [Wiswedel, Ingrid; Gardemann, Andreas] Otto Von Guericke Univ, Dept Pathol Biochem, Inst Clin Chem & Pathobiochem, Magdeburg, Germany.
   [Siems, Werner] KortexMed Inst Med Educ, Res Inst Physiotherapy & Gerontol, Bad Harzburg, Germany.
C3 University Hohenheim; Salzburg University; Otto von Guericke University
RP Grune, T (corresponding author), Univ Hohenheim, Inst Biol Chem & Nutr, Garbenstr 28, D-70593 Stuttgart, Germany.
EM grune@uni-hohenheim.de
OI Grune, Tilman/0000-0003-4775-9973
CR Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4
   Çakatay U, 2003, CLIN BIOCHEM, V36, P51, DOI 10.1016/S0009-9120(02)00407-1
   Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969
   Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   GRUNE T, 2001, HDB BIOL AGING, P25
   Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149
   Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200
   Jana CK, 2002, ARCH BIOCHEM BIOPHYS, V397, P433, DOI 10.1006/abbi.2001.2690
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Jung T, 2009, ARCH BIOCHEM BIOPHYS, V483, P127, DOI 10.1016/j.abb.2008.12.007
   Kayali R, 2007, BIOGERONTOLOGY, V8, P653, DOI 10.1007/s10522-007-9107-5
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Kirkwood TBL, 1997, EXP GERONTOL, V32, P395, DOI 10.1016/S0531-5565(96)00171-4
   Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   MARTIN GR, 1993, ANNU REV MED, V44, P419, DOI 10.1146/annurev.me.44.020193.002223
   Mary J, 2004, EXP GERONTOL, V39, P1117, DOI 10.1016/j.exger.2004.06.008
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Safciuc F, 2007, CURR NEUROVASC RES, V4, P228, DOI 10.2174/156720207782446351
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com
   Voss P, 2007, BIOL CHEM, V388, P583, DOI 10.1515/BC.2007.068
   Voss P, 2006, FREE RADICAL RES, V40, P673, DOI 10.1080/10715760500419357
NR 45
TC 40
Z9 46
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV-DEC
PY 2009
VL 130
IS 11-12
BP 748
EP 753
DI 10.1016/j.mad.2009.09.004
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 547DD
UT WOS:000273864900005
PM 19786044
DA 2024-02-19
ER

PT J
AU Mackert, O
   Wirth, EK
   Sun, RW
   Winkler, J
   Liu, AX
   Renko, K
   Kunz, S
   Spranger, J
   Brachs, S
AF Mackert, Olena
   Wirth, Eva Katrin
   Sun, Rongwan
   Winkler, Jennifer
   Liu, Aoxue
   Renko, Kostja
   Kunz, Severine
   Spranger, Joachim
   Brachs, Sebastian
TI Impact of metabolic stress induced by diets, aging and fasting on tissue
   oxygen consumption
SO MOLECULAR METABOLISM
LA English
DT Article; Early Access
DE Mitochondrial respiration; Metabolic stress; Diet; Age; Fasting; Oxygen
   consumption rate
ID NONALCOHOLIC FATTY LIVER; BROWN ADIPOSE-TISSUE; C-OXIDASE ACTIVITY;
   MITOCHONDRIAL DYSFUNCTION; ENERGY-EXPENDITURE; INSULIN SENSITIVITY;
   GLUCAGON TREATMENT; OBESITY; INFLAMMATION; STIMULATION
AB Objective: Alterations in mitochondrial function play an important role in the development of various diseases, such as obesity, insulin resis-tance, steatohepatitis, atherosclerosis and cancer. However, accurate assessment of mitochondrial respiration ex vivo is limited and remains highly challenging. Using our novel method, we measured mitochondrial oxygen consumption (OCR) and extracellular acidification rate (ECAR) of metabolically relevant tissues ex vivo to investigate the impact of different metabolic stressors on mitochondrial function.
   Methods: Comparative analyses of OCR and ECAR were performed in tissue biopsies of young mice fed 12 weeks standard-control (STD), high -fat (HFD), high-sucrose (HSD), or western diet (WD), matured mice with HFD, and 2year-old mice aged on STD with and without fasting.
   Results: While diets had only marginal effects on mitochondrial respiration, respiratory chain complexes II and IV were reduced in adipose tissue (AT). Moreover, matured HFD-fed mice showed a decreased hepatic metabolic flexibility and prolonged aging increased OCR in brown AT. Interestingly, fasting boosted pancreatic and hepatic OCR while decreasing weight of those organs. Furthermore, ECAR measurements in AT could indicate its lipolytic capacity.
   Conclusion: Using ex vivo tissue measurements, we could extensively analyze mitochondrial function of liver, AT, pancreas and heart revealing effects of metabolic stress, especially aging. (C) 2022 The Author(s). Published by Elsevier GmbH.
C1 [Mackert, Olena; Wirth, Eva Katrin; Sun, Rongwan; Winkler, Jennifer; Liu, Aoxue; Spranger, Joachim; Brachs, Sebastian] Charite Univ Med Berlin, Dept Endocrinol & Metab, Berlin, Germany.
   [Mackert, Olena; Wirth, Eva Katrin; Sun, Rongwan; Winkler, Jennifer; Liu, Aoxue; Spranger, Joachim; Brachs, Sebastian] Free Univ Berlin, Berlin, Germany.
   [Mackert, Olena; Wirth, Eva Katrin; Sun, Rongwan; Winkler, Jennifer; Liu, Aoxue; Spranger, Joachim; Brachs, Sebastian] Humboldt Univ, Berlin, Germany.
   [Wirth, Eva Katrin; Sun, Rongwan; Liu, Aoxue; Spranger, Joachim; Brachs, Sebastian] German Ctr Cardiovasc Res DZHK, Partner Site, Berlin, Germany.
   [Renko, Kostja] German Ctr Protect Lab Anim Bf3R, German Fed Inst Risk Assessment BfR, Berlin, Germany.
   [Kunz, Severine] Max Delbruck Ctr Mol Med, Helmholtz Assoc MDC, Technol Platform Electron Microscopy, Berlin, Germany.
   [Spranger, Joachim] Charite Univ Med Berlin, Dept Endocrinol & Metab, Luisenstr 13a, D-10117 Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; German Centre for Cardiovascular Research; Federal
   Institute for Risk Assessment; Helmholtz Association; Max Delbruck
   Center for Molecular Medicine; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Spranger, J (corresponding author), Charite Univ Med Berlin, Dept Endocrinol & Metab, Luisenstr 13a, D-10117 Berlin, Germany.
EM spranger@charite.de
OI Wirth, Eva Katrin/0000-0002-0491-9941; Brachs,
   Sebastian/0000-0002-6336-3939
CR Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012
   Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007
   Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Boland ML, 2018, WORLD J GASTROENTERO, V24, P1748, DOI 10.3748/wjg.v24.i16.1748
   Bolli GB, 1999, ENDOCRIN METAB CLIN, V28, P467, DOI 10.1016/S0889-8529(05)70083-9
   Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026
   Brachs S, 2019, DIABETES, V68, P527, DOI 10.2337/db18-0780
   Brachs S, 2016, MOL METAB, V5, P1072, DOI 10.1016/j.molmet.2016.08.004
   BRETON L, 1983, HORM METAB RES, V15, P429, DOI 10.1055/s-2007-1018747
   Cassim S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190366
   Cheng Z, 2013, EXP GERONTOL, V48, P341, DOI 10.1016/j.exger.2013.01.005
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013
   Darcy J, 2016, ENDOCRINOLOGY, V157, P4744, DOI 10.1210/en.2016-1593
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Drahota Z, 2005, CELL BIOCHEM BIOPHYS, V43, P87, DOI 10.1385/CBB:43:1:087
   Florez-Duquet M, 1998, AM J PHYSIOL-REG I, V274, pR196, DOI 10.1152/ajpregu.1998.274.1.R196
   Gohlke S, 2019, MOL METAB, V24, P1, DOI 10.1016/j.molmet.2019.03.011
   Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005
   HALESTRAP AP, 1987, BIOCHIM BIOPHYS ACTA, V927, P280, DOI 10.1016/0167-4889(87)90145-5
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   JENSEN CB, 1983, BIOCHEM J, V210, P819, DOI 10.1042/bj2100819
   Kespohl M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay1109
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Knight JA, 2011, ANN CLIN LAB SCI, V41, P107
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Lancaster TS, 2012, PHYSIOL GENOMICS, V44, P957, DOI 10.1152/physiolgenomics.00184.2011
   LANOUE KF, 1984, J BIOL CHEM, V259, P4116
   Li YS, 2003, EXP BIOL MED, V228, P207, DOI 10.1177/153537020322800212
   MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Maekawa R, 2017, J NUTR BIOCHEM, V49, P71, DOI 10.1016/j.jnutbio.2017.07.010
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Marchetti P, 2020, FASEB J, V34, P13106, DOI 10.1096/fj.202000767R
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Munhoz AC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041029
   Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200
   Neville KE, 2018, J NEUROSCI METH, V296, P32, DOI 10.1016/j.jneumeth.2017.12.020
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Oeckl J, 2020, STAR PROTOC, V1, DOI 10.1016/j.xpro.2020.100118
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205
   Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613
   Pilling D, 2021, AM J PATHOL, V191, P131, DOI 10.1016/j.ajpath.2020.09.011
   Readnower RD, 2012, PHYSIOL GENOMICS, V44, P1208, DOI 10.1152/physiolgenomics.00129.2012
   Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032
   Schreyer S, 2021, AGING-US, V13, P10891, DOI 10.18632/aging.202978
   Schweizer S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800136
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Takeichi Y, 2021, DIABETOLOGIA, V64, P2092, DOI 10.1007/s00125-021-05488-2
   Vatner DE, 2018, AGING CELL, V17, DOI 10.1111/acel.12751
   VITORICA J, 1981, MECH AGEING DEV, V16, P105, DOI 10.1016/0047-6374(81)90087-7
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wessels B, 2019, OBESITY, V27, P756, DOI 10.1002/oby.22435
   Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   YAMAZAKI RK, 1975, J BIOL CHEM, V250, P7924
   YAMAZAKI RK, 1980, BIOCHIM BIOPHYS ACTA, V592, P1, DOI 10.1016/0005-2728(80)90109-7
   Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042
   Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004
NR 68
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD 2022 OCT
PY 2022
VL 64
AR 101563
DI 10.1016/j.molmet.2022.101563
EA AUG 2022
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 3Z0DV
UT WOS:000844092400002
PM 35944898
OA Green Accepted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Dong, XM
   Cai, R
   Yang, F
   Zhang, YY
   Wang, XG
   Fu, SL
   Zhang, JR
AF Dong, X. -M.
   Cai, R.
   Yang, F.
   Zhang, Y. -Y.
   Wang, X. -G.
   Fu, S. -L.
   Zhang, J. -R.
TI Predictive value of plasma β2-microglobulin on human body function and
   senescence
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE beta 2-microglobulin; Biochemical indexes; Predictive value
ID SERUM BETA-2-MICROGLOBULIN; CARDIOVASCULAR EVENTS; COGNITIVE FUNCTION;
   RENAL-FUNCTION; CYSTATIN C; ALL-CAUSE; BETA(2)-MICROGLOBULIN;
   ATHEROSCLEROSIS; NEUROGENESIS
AB OBJECTIVE: To explore the correlation between plasma beta 2-microglobulin (beta 2-MG) as senescence factor with age, heart, liver and kidney function as well as the predictive value of beta 2-MG in human metabolism function and senescence.
   PATIENTS AND METHODS: 387 cases of healthy people of different ages were selected and the automatic biochemical analyzer was used to test beta 2-MG in plasma based on immuno-turbidimetry and also all biochemical indexes. The correlation between beta 2-MG and age, gender and all biochemical indexes was analyzed.
   RESULTS: beta 2-MG was positively correlated to age, r = 0.373; and the difference was of statistical significance (p < 0.010). It was significantly negative correlated to HDL-C but positively correlated to LP (a), BUN, CREA, UA, CYS-C, LDH, CK-MB, HBDH, AST, GLB and HCY.
   CONCLUSIONS: beta 2-MG was closely correlated to age, heart, kidney and liver biochemical indexes, which can be taken as an important biomarker for human body function and anti-senescence and have significant basic research and clinical guidance values.
C1 [Dong, X. -M.; Cai, R.; Yang, F.; Zhang, J. -R.] Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Y. -Y.; Wang, X. -G.; Fu, S. -L.; Zhang, J. -R.] Guangdong Inst Tumor Target Intervent & Prevent, Qingyuan, Guangdong, Peoples R China.
   [Dong, X. -M.] Inner Mogolia Med Univ, Affiliated Peoples Hosp, Hohhot, Peoples R China.
C3 Southern Medical University - China
RP Zhang, JR (corresponding author), Southern Med Univ, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.; Zhang, JR (corresponding author), Guangdong Inst Tumor Target Intervent & Prevent, Qingyuan, Guangdong, Peoples R China.
EM j75258249diq@163.com
RI Cai, Rui/GRO-1869-2022
FU Department of Sience and Technology of Shandong Province [BS2011YY063];
   Department of Health of Shandong Province [2011QZ030]
FX This reasch was supported by grants from Department of Sience and
   Technology of Shandong Province (Grant No. BS2011YY063), and Department
   of Health of Shandong Province (Grant No. 2011QZ030).
CR Amighi J, 2011, STROKE, V42, P1826, DOI 10.1161/STROKEAHA.110.600312
   Busti C, 2009, ATHEROSCLEROSIS, V203, P38, DOI 10.1016/j.atherosclerosis.2008.06.023
   Cheung CL, 2013, INT J CARDIOL, V168, P4811, DOI 10.1016/j.ijcard.2013.07.014
   Dommergues M, 2000, KIDNEY INT, V58, P312, DOI 10.1046/j.1523-1755.2000.00167.x
   Hartmann P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10521
   Hu SW, 2014, CLIN CHEM LAB MED, V52, P413, DOI 10.1515/cclm-2013-0505
   Karki M, 2015, JIMD REP
   Kepplinger B, 2005, NEUROSIGNALS, V14, P126, DOI 10.1159/000086295
   Kim MK, 2014, DIABETES METAB, V40, P459, DOI 10.1016/j.diabet.2014.08.002
   Li SH, 2015, J COMPUT ASSIST TOMO, V39, P969, DOI 10.1097/RCT.0000000000000294
   Möckel M, 2015, AM J CARDIOL, V116, P1034, DOI 10.1016/j.amjcard.2015.07.017
   Nomura T, 2014, ANTI-CANCER AGENT ME, V14, P343, DOI 10.2174/18715206113139990092
   Papageorgiou N, 2016, EXPER OPIN THER TAR, V1, P1
   Shabunina IV, 2002, KLIN LAB DIAGN, V5, P8
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Tabbi-Anneni I, 2003, FUND CLIN PHARMACOL, V17, P51, DOI 10.1046/j.1472-8206.2003.00146.x
   Tramonti G, 2012, J NEPHROL, V25, P976, DOI 10.5301/jn.5000078
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
NR 18
TC 5
Z9 6
U1 0
U2 4
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD JUN
PY 2016
VL 20
IS 11
BP 2350
EP 2356
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DU8JR
UT WOS:000382459700024
PM 27338061
DA 2024-02-19
ER

PT J
AU Pu, JL
   Huang, ZT
   Luo, YH
   Mou, T
   Li, TT
   Li, ZT
   Wei, XF
   Wu, ZJ
AF Pu, Jun-Liang
   Huang, Zuo-Tian
   Luo, Yun-Hai
   Mou, Tong
   Li, Ting-Ting
   Li, Zhong-Tang
   Wei, Xu-Fu
   Wu, Zhong-Jun
TI Fisetin mitigates hepatic ischemia-reperfusion injury by regulating
   GSK3β/AMPK/NLRP3 inflammasome pathway
SO HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
LA English
DT Article; Early Access
DE Fisetin; Hepatic ischemia-reperfusion injury; GSK3 beta; AMPK; NLRP3
ID NLRP3 INFLAMMASOME; ISCHEMIA/REPERFUSION INJURY; LIVER ISCHEMIA; AMPK;
   ANTIOXIDANT; INHIBITION; ACTIVATION; MECHANISMS; MACROPHAGE; PROTECTS
AB Background: Hepatic ischemia-reperfusion (I/R) injury (IRI) represents a crucial challenge in liver transplantation. Fisetin has anti-inflammatory, anti-aging and anti-oxidative properties. This study aimed to examine whether fisetin mitigates hepatic IRI and examine its underlying mechanisms.
   Methods: Sham or warm hepatic I/R operated mice were pretreated with fisetin (5, 10 or 20 mg/kg). Hepatic histological assessments, TUNEL assays and serum aminotransferase measurements were performed. An in vitro hypoxia/reoxygenation (H/R) model using RAW264.7 macrophages pretreated with fisetin (2.5, 5 or 10 mu mol/L) was also used. Serum and cell supernatant concentrations of interleukin-1 beta (IL-1 beta), IL-18 and tumor necrosis factor alpha (TNF-alpha) were determined by enzyme-linked immunosorbent assay (ELISA). Protein levels of p-GSK3 beta, p-AMPK and NLR family pyrin domain-containing 3 (NLRP3)-associated proteins were detected by Western blotting.
   Results: Compared with the I/R group, fisetin pretreatment reduced pathological liver damage, serum aminotransferase levels, serum concentrations of IL-1 beta, IL-18 and TNF-alpha in the murine IRI model. Fisetin also reduced the expression of NLRP3 inflammasome-associated proteins (NLRP3, cleaved caspase-1, IL-1 beta and IL-18) in I/R-operated liver. The experiments in vitro showed that fisetin decreased the release of IL-1 beta, IL-18 and TNF-alpha, and reduced the expression of NLRP3 inflammasome-associated proteins in H/R-treated RAW264.7 cells. Moreover, fisetin increased the expressions of p-GSK3 beta and p-AMPK in both models, indicating that its anti-inflammatory effects were dependent on GSK3 beta/AMPK signaling. The antiinflammatory effects of fisetin were partially inhibited by the AMPK specific inhibitor compound C.
   Conclusions: Fisetin showed protective effects against hepatic IRI, countering inflammatory responses through mediating the GSK3 beta/AMPK/NLRP3 inflammasome pathway. (C) 2021 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
C1 [Pu, Jun-Liang; Huang, Zuo-Tian; Luo, Yun-Hai; Mou, Tong; Li, Ting-Ting; Wei, Xu-Fu; Wu, Zhong-Jun] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing 400016, Peoples R China.
   [Li, Zhong-Tang] Chongqing Med Univ, Basic Med Coll, Dept Anat, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University; Chongqing Medical University
RP Wu, ZJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing 400016, Peoples R China.
EM wzjtcy@126.com
RI yin, yue/JQV-9753-2023; Chen, Chao/JHS-6563-2023; yang,
   rui/JHI-3328-2023; Li, Tingting/HKE-0812-2023; zhan, xiao/JEZ-3810-2023;
   zhang, xinyi/JWA-0980-2024; Zhang, tong/IAP-2587-2023; zhang,
   tong/JAO-3571-2023; zhang, ting/IYT-0642-2023; YI, J/JJE-7713-2023
OI Huang, Zuotian/0000-0003-4688-5820
FU National Natural Science Foundation of China [81672959, 81873592,
   81703063]; Science and Technology Commission Foundation of Chongqing,
   China [cstc2019jscx-gksbX0 0 05]; Natural Science Foundation of
   Chongqing, China [cstc2018jscx-msybX0133]; graduate tutor team
   construction project of Chongqing Municipal Education Commission
   Foundation, China [dstd201801]
FX This study was supported by grants from the National Natural Science
   Foundation of China (81672959, 81873592 and 81703063), the Science and
   Technology Commission Foundation of Chongqing, China
   (cstc2019jscx-gksbX0 0 05), the Natural Science Foundation of Chongqing,
   China (cstc2018jscx-msybX0133) and the graduate tutor team construction
   project of Chongqing Municipal Education Commission Foundation, China
   (dstd201801).
CR Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007
   Cai LL, 2017, EUR J PHARMACOL, V806, P32, DOI 10.1016/j.ejphar.2017.04.011
   Ci XX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.39
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Garg S, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108572
   Ge CX, 2019, FOOD FUNCT, V10, P2970, DOI 10.1039/c8fo01653d
   Hu JF, 2016, J HEPATOL, V64, P146, DOI 10.1016/j.jhep.2015.08.021
   Huang ZT, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2648-0
   Ito T, 2021, AM J TRANSPLANT, V21, P614, DOI 10.1111/ajt.16219
   Jia SN, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1366-y
   Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901
   Kim HY, 2015, FEBS J, V282, P259, DOI 10.1111/febs.13123
   Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323
   Li YG, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/8704146
   Li ZT, 2020, HEPATOB PANCREAT DIS, V19, P455, DOI 10.1016/j.hbpd.2020.04.003
   Liu H, 2017, J PATHOL, V242, P284, DOI 10.1002/path.4901
   Ma EH, 2017, CURR OPIN IMMUNOL, V46, P45, DOI 10.1016/j.coi.2017.04.004
   Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221
   Molagoda IMN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010312
   Mou T, 2020, INNATE IMMUN-LONDON, V26, P528, DOI 10.1177/1753425920928449
   Ochando J, 2019, CELL MOL IMMUNOL, V16, P350, DOI 10.1038/s41423-019-0216-2
   Pu ZC, 2020, AM J CHINESE MED, V48, P1693, DOI 10.1142/S0192415X20500846
   Qing LM, 2019, AM J TRANSL RES, V11, P655
   Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419
   de Azúa-López ZR, 2018, TRANSPL P, V50, P637, DOI 10.1016/j.transproceed.2017.11.054
   Saravia J, 2020, CELL RES, V30, P328, DOI 10.1038/s41422-020-0301-1
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shanmugam K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9173436
   Shenker BJ, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13194
   SUZUKI S, 1993, TRANSPLANTATION, V55, P1265
   Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022
   Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0
   Wang Q, 2020, IMMUNOL CELL BIOL, V98, P54, DOI 10.1111/imcb.12297
   Xu MX, 2019, FOOD FUNCT, V10, P1302, DOI 10.1039/c8fo01615a
   Xu Y, 2020, FREE RADICAL BIO MED, V160, P871, DOI 10.1016/j.freeradbiomed.2020.09.015
   Yang W, 2019, FOOD CHEM TOXICOL, V134, DOI 10.1016/j.fct.2019.110824
   Ye LP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01193
   Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051
   Zhang P, 2021, INFLAMMATION, V44, P1490, DOI 10.1007/s10753-021-01434-x
   Zhao BB, 2018, J CELL BIOCHEM, V119, P5382, DOI 10.1002/jcb.26685
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
NR 42
TC 20
Z9 21
U1 2
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1499-3872
EI 2352-9377
J9 HEPATOB PANCREAT DIS
JI Hepatob. Pancreatic. Dis. Int.
PD 2021 AUG
PY 2021
VL 20
IS 4
BP 352
EP 360
DI 10.1016/j.hbpd.2021.04.013
EA AUG 2021
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UA6UD
UT WOS:000685294500006
PM 34024736
DA 2024-02-19
ER

PT J
AU Tanaka, K
   Higami, Y
   Tsuchiya, T
   Shiokawa, D
   Tanuma, S
   Ayabe, H
   Shimokawa, I
AF Tanaka, K
   Higami, Y
   Tsuchiya, T
   Shiokawa, D
   Tanuma, S
   Ayabe, H
   Shimokawa, I
TI Aging increases DNase γ, an apoptosis-related endonuclease, in rat liver
   nuclei:: effect of dietary restriction
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE endonuclease; DNase gamma; aging; apoptosis; dietary restriction; liver
ID IN-SITU DETECTION; CELL-DEATH; OXYGEN RADICALS; IDENTIFICATION;
   PURIFICATION; FRAGMENTATION; VULNERABILITY; HEPATOCYTES; EXPRESSION;
   THYMOCYTES
AB Organ-specific endonuclease might play a role in the age-related increase in apoptosis in laboratory rodent tissues. In nuclear extracts from liver tissues of male F344 rats, the DNase activity gel system identified DNase gamma, Ca2+/Mg2+-dependent endonuclease. The enzyme activity, which was measured at 3, 6. 16, and 24 months (me) of age, was significantly increased between 16 and 24 mo in control rats fed ad libitum (AL). The expression level of DNase gamma-mRNA, estimated by a semi-quantitative reverse transcription-polymerase chain reaction method, was also increased at 24 mo in group AL. The proportion of immunohistochemically DNase gamma-positive cells, most of which were light-microscopically confined to apoptotic cells, was also significantly increased between 16 and 24 mo. Dietary restriction, a powerful anti-aging intervention, which was achieved by providing 70% of the mean food intake in group AL from 6 weeks of age, inhibited the age-related increase in the enzyme activity and the proportion of immunostained cells; for the mRNA level, statistical significance was not obtained. The present study suggests that DNase gamma is involved in an age-related increase in the apoptosis of rat liver, and that CR inhibits the increase as it minimized the age-related increase in the fraction of DNA-damaged hepatocytes susceptible to apoptosis. (C) 2003 Elsevier Inc. All fights reserved.
C1 Nagasaki Univ, Sch Med, Dept Resp & Digest Med, Nagasaki 8528523, Japan.
   Nagasaki Univ, Sch Med, Dept Resp & Digest Med, Nagasaki 8528523, Japan.
   Tokyo Univ Sci, Dept Biochem, Fac Pharmaceut Sci, Shinjuku Ku, Tokyo 1620826, Japan.
C3 Nagasaki University; Nagasaki University; Tokyo University of Science
RP Higami, Y (corresponding author), Nagasaki Univ, Sch Med, Dept Resp & Digest Med, Sakamoto 1-12-4, Nagasaki 8528523, Japan.
EM shimo@net.nagasaki-u.ac.jp
OI Higami, Yoshikazu/0000-0003-1381-0777; Tsuchiya,
   Tomoshi/0000-0002-8419-1478; Shimokawa, Isao/0000-0001-8901-1029
CR ARENDS MJ, 1990, AM J PATHOL, V136, P593
   ChristofidouSolomidou M, 1997, AM J PATHOL, V150, P631
   DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361
   Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112
   GAIDO ML, 1991, J BIOL CHEM, V266, P18580
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3
   Grogan SP, 2002, J PATHOL, V198, P5, DOI 10.1002/path.1169
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   Higami Y, 1997, AM J PATHOL, V151, P659
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   HIGAMI Y, 1994, LAB INVEST, V71, P650
   Higami Y, 1996, MUTAT RES-FUND MOL M, V357, P225, DOI 10.1016/0027-5107(96)00127-3
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   KELLEY MR, 1993, ALCOHOL, V10, P185, DOI 10.1016/0741-8329(93)90033-K
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   NIKONOVA LV, 1993, EUR J BIOCHEM, V215, P893, DOI 10.1111/j.1432-1033.1993.tb18107.x
   Nitahara JA, 1998, J MOL CELL CARDIOL, V30, P519, DOI 10.1006/jmcc.1997.0616
   OLIVE PL, 1992, EXP CELL RES, V198, P259, DOI 10.1016/0014-4827(92)90378-L
   Pantelidis P, 1998, J IMMUNOL METHODS, V214, P209, DOI 10.1016/S0022-1759(98)00046-5
   PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x
   Pío R, 1998, BBA-MOL BASIS DIS, V1406, P51, DOI 10.1016/S0925-4439(97)00081-1
   POLLACK M, 2001, J GERONTOL BIOL SC A, V56
   POLZAR B, 1994, EUR J CELL BIOL, V64, P200
   Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/0006-8993(96)00222-3
   RIBEIRO JM, 1993, BIOCHEMISTRY-US, V32, P9129, DOI 10.1021/bi00086a018
   ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3
   SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656
   Shimokawa I, 1996, J GERONTOL A-BIOL, V51, pB396, DOI 10.1093/gerona/51A.6.B396
   Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a
   Shiokawa D, 1997, ARCH BIOCHEM BIOPHYS, V346, P15, DOI 10.1006/abbi.1997.0275
   SHIOKAWA D, 1994, EUR J BIOCHEM, V226, P23, DOI 10.1111/j.1432-1033.1994.tb20022.x
   Shiokawa D, 1998, BIOCHEM J, V332, P713, DOI 10.1042/bj3320713
   Shiokawa D, 2000, BIOCHEM BIOPH RES CO, V275, P343, DOI 10.1006/bbrc.2000.3249
   Snedecor G.W. C., 1989, Statistical methods/George W. Snedecor and William G. Cochran
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Tatton NA, 1998, ANN NEUROL, V44, pS142, DOI 10.1002/ana.410440721
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   Yu BP, 1994, MODULATION AGING PRO
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 47
TC 8
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2004
VL 39
IS 2
BP 195
EP 202
DI 10.1016/j.exger.2003.10.013
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 776PC
UT WOS:000189124100007
PM 15036412
DA 2024-02-19
ER

PT J
AU Dhahbi, JM
   Mote, PL
   Wingo, J
   Tillman, JB
   Walford, RL
   Spindler, SR
AF Dhahbi, JM
   Mote, PL
   Wingo, J
   Tillman, JB
   Walford, RL
   Spindler, SR
TI Calories and aging alter gene expression for gluconeogenic, glycolytic,
   and nitrogen-metabolizing enzymes
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE calorie restriction; enzyme activity; metabolism; mice; mRNA
ID PHOSPHOENOLPYRUVATE CARBOXYKINASE; PYRUVATE-KINASE; MESSENGER-RNA; MICE;
   RESTRICTION; RAT; GLUCOSE; INSULIN; LIVER; AGE
AB We characterized the effects of calorie restriction (CR) on the expression of key glycolytic, gluconeogenic, and nitrogen-metabolizing enzymes in mice. Of the gluconeogenic enzymes investigated, liver glucose-6-phosphatase mRNA increased 1.7- and 2.3-fold in young and old CR mice. Phosphoenolpyruvate carboxykinase mRNA and activity increased 2.5- and 1.7-fold in old CR mice. Of the key glycolytic enzymes, pyruvate kinase mRNA and activity decreased similar to 60% in CR mice. Hepatic phosphofructokinase-1 and pyruvate dehydrogenase mRNA decreased 10-20% in CR mice. Of the genes that detoxify ammonia generated from protein catabolism, hepatic glutaminase, carbamyl phosphate synthase I, and tyrosine aminotransferase mRNAs increased 2.4-, 1.8-, and 1.8-fold with CR, respectively. Muscle glutamine synthetase mRNA increased 1.3- and 2.1-fold in young and old CR mice. Hepatic glutamine synthetase mRNA and activity each decreased 38% in CR mice. These CR-induced changes are consistent with other studies suggesting that CR may decrease enzymatic capacity for glycolysis and increase the enzymatic capacity for hepatic gluconeogenesis and the disposal of byproducts of muscle protein catabolism.
C1 Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA.
C3 University of California System; University of California Riverside;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
EM spindler@ucrac1.ucr.edu
OI Tillman, John/0000-0003-2912-2370
CR CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2
   Dhahbi JM, 1998, J GERONTOL A-BIOL, V53, pB180, DOI 10.1093/gerona/53A.3.B180
   FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441
   Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581
   HARRIS SB, 1994, MECH AGEING DEV, V73, P209, DOI 10.1016/0047-6374(94)90053-1
   IMAMURA K, 1982, METHOD ENZYMOL, V90, P150
   KANNO H, 1995, BLOOD, V86, P3205, DOI 10.1182/blood.V86.8.3205.bloodjournal8683205
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KING PA, 1983, BIOCHEM J, V216, P523, DOI 10.1042/bj2160523
   LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941
   MCCARTER R, 1988, AM J PHYSIOL, V248, pE488
   MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701
   *MIN INC, 1992, MIN STAT SOFTW STAND
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   NOGUCHI T, 1984, J BIOL CHEM, V259, P2651
   OBRIEN RM, 1996, DIABETES MELLITUS, P234
   PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7
   PRUSINER S, 1970, ANAL BIOCHEM, V37, P429, DOI 10.1016/0003-2697(70)90069-2
   ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   SPINDLER SR, 1991, J GERONTOL, V46, pB233, DOI 10.1093/geronj/46.6.B233
   STAATS J, 1976, CANCER RES, V36, P4333
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631
   *SUBC LAB AN NUTR, 1978, NUTR REQ LAB AN RAT, P38
   Tillman JB, 1996, J BIOL CHEM, V271, P3500, DOI 10.1074/jbc.271.7.3500
   Van Remmen Holly, 1995, P171
   WALFORD RL, 1992, P NATL ACAD SCI USA, V89, P11533, DOI 10.1073/pnas.89.23.11533
   WATFORD M, 1994, J NUTR, V124, P493, DOI 10.1093/jn/124.4.493
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   WEINDRUCH R, 1988, RETARDATION AGING DI, P1
   WIMONWATWATEE T, 1994, AM J PHYSIOL, V267, pG201, DOI 10.1152/ajpgi.1994.267.2.G201
   ZHAN ZR, 1994, INT J BIOCHEM, V26, P263, DOI 10.1016/0020-711X(94)90155-4
NR 34
TC 104
Z9 116
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD AUG
PY 1999
VL 277
IS 2
BP E352
EP E360
DI 10.1152/ajpendo.1999.277.2.E352
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 222WW
UT WOS:000081809200021
DA 2024-02-19
ER

PT J
AU Nassir, F
   Arndt, JJ
   Johnson, SA
   Ibdah, JA
AF Nassir, Fatiha
   Arndt, Justin J.
   Johnson, Sarah A.
   Ibdah, Jamal A.
TI Regulation of mitochondrial trifunctional protein modulates nonalcoholic
   fatty liver disease in mice
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE sirtuin 3; acetylation; mitochondrial trifunctional protein;
   mitochondria
ID ACID OXIDATION; INSULIN-RESISTANCE; DOWN-REGULATION; SIRT3;
   STEATOHEPATITIS; OVEREXPRESSION; DEFICIENCY; METABOLISM; STEATOSIS;
   DISORDER
AB Mitochondrial trifunctional protein (MTP) plays a critical role in the oxidation of long-chain fatty acids. We previously reported that aging mice (>9 months old) heterozygous for an MTP defect (MTP+/-) develop nonalcoholic fatty liver disease (NAFLD). We tested whether a high-fat diet (HFD) accelerates NAFLD in young MTP+/- mice, and whether overexpression of the nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase sirtuin 3 (SIRT3) deacetylates MTP and improves mitochondrial function and NAFLD. Three-month-old WT and MTP+/- mice were fed HFD (60% cal fat) for 16 weeks and livers were assessed for fatty acid oxidation (FAO) and NAFLD. Compared with WT, MTP+/- mice displayed reduced hepatic SIRT3 levels and reduced FAO, with increased hepatic steatosis and the inflammatory marker CD68. Hepatic overexpression of SIRT3 in HFD-fed MTP+/- mice increased hepatic MTP protein levels at the posttranscriptional level. Immunoprecipitation of MTP from liver mitochondria followed by Western blot with acetyl-lysine antibody showed higher acetylation of MTP in MTP+/- compared with WT mice. Overexpression of SIRT3 in MTP+/- mice significantly reduced the acetylation of MTP compared with beta-galactosidase controls, increased mitochondrial FAO, and reduced hepatic steatosis, CD68, and serum ALT levels. Taken together, our data indicate that deacetylation of MTP by SIRT3 improves mitochondrial function and rescues NAFLD in MTP+/- mice.
C1 [Nassir, Fatiha; Arndt, Justin J.; Johnson, Sarah A.; Ibdah, Jamal A.] Univ Missouri, Dept Med, Div Gastroenterol & Hepatol, Columbia, MO USA.
   [Nassir, Fatiha; Ibdah, Jamal A.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.
   [Ibdah, Jamal A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA.
   [Nassir, Fatiha; Johnson, Sarah A.; Ibdah, Jamal A.] Harry S Truman Mem Vet Hosp, United States Res Serv, Columbia, MO 65201 USA.
C3 University of Missouri System; University of Missouri Columbia;
   University of Missouri System; University of Missouri Columbia;
   University of Missouri System; University of Missouri Columbia; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Harry S. Truman Memorial Veterans' Hospital
RP Ibdah, JA (corresponding author), Univ Missouri, Dept Med, Div Gastroenterol & Hepatol, Columbia, MO USA.; Ibdah, JA (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.; Ibdah, JA (corresponding author), Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA.; Ibdah, JA (corresponding author), Harry S Truman Mem Vet Hosp, United States Res Serv, Columbia, MO 65201 USA.
EM ibdahj@health.missouri.edu
OI Nassir, Fatiha/0000-0002-3653-3621; Ibdah, Jamal/0000-0002-5646-9014
FU University of Missouri-Columbia; University of Missouri Research Board
   grant
FX This work was funded by institutional funds from the University of
   Missouri-Columbia (J.A.I.) and the University of Missouri Research Board
   grant (F.N.). The authors declare no conflict of interest.
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Cho Eun-Hee, 2014, J Lifestyle Med, V4, P80, DOI 10.15280/jlm.2014.4.2.80
   Filozof C, 2015, DRUGS, V75, P1373, DOI 10.1007/s40265-015-0437-3
   He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Huang W, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8263926
   Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204
   Ijlst L, 1996, J CLIN INVEST, V98, P1028, DOI 10.1172/JCI118863
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Misra Vijay Laxmi, 2009, Curr Gastroenterol Rep, V11, P50
   Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012
   Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167
   Orii KE, 1999, J BIOL CHEM, V274, P8077, DOI 10.1074/jbc.274.12.8077
   Osborne B, 2012, DIABETOLOGIA, V55, pS263
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110
   Rector RS, 2008, ADV DRUG DELIVER REV, V60, P1488, DOI 10.1016/j.addr.2008.04.014
   Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007
   Rector RS, 2013, HEPATOLOGY, V57, P2213, DOI 10.1002/hep.26285
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204
   Schröder T, 2016, MOL METAB, V5, P283, DOI 10.1016/j.molmet.2016.01.010
   Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011
   UCHIDA Y, 1992, J BIOL CHEM, V267, P1034
   WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y
   Wu T, 2014, ANN CLIN LAB SCI, V44, P410
   Zhang WJ, 2016, TOXICOL RES-UK, V5, P461, DOI 10.1039/c5tx00229j
NR 34
TC 26
Z9 30
U1 4
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD JUN
PY 2018
VL 59
IS 6
BP 967
EP 973
DI 10.1194/jlr.M080952
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA GJ4JX
UT WOS:000435348500005
PM 29581157
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Pérez-Estrada, JR
   Hernández-García, D
   Leyva-Castro, F
   Ramos-León, J
   Cuevas-Benítez, O
   Díaz-Muñoz, M
   Castro-Obregón, S
   Ramírez-Solís, R
   García, C
   Covarrubias, L
AF Raul Perez-Estrada, Jose
   Hernandez-Garcia, David
   Leyva-Castro, Francisco
   Ramos-Leon, Javier
   Cuevas-Benitez, Osiris
   Diaz-Munoz, Mauricio
   Castro-Obregon, Susana
   Ramirez-Solis, Ramiro
   Garcia, Celina
   Covarrubias, Luis
TI Reduced lifespan of mice lacking catalase correlates with altered lipid
   metabolism without oxidative damage or premature aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
ID GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; HEPATIC STEATOSIS;
   ADIPOSE-TISSUE; FATTY LIVER; PPAR-GAMMA; GENE; DISRUPTION; KLOTHO;
   STRESS
AB The relationship between the mechanisms that underlie longevity and aging and the metabolic alterations due to feeding conditions has not been completely defined. In the present work, through the deletion of the gene encoding catalase, hydrogen peroxide (H2O2) was uncovered as a relevant regulator of longevity and of liver metabolism. Mice lacking catalase (Cat(-/-)) fed ad libitum with a regular diet showed a shorter lifespan than wild type mice, which correlated with reduced body weight, blood glucose levels and liver fat accumulation, but not with increased oxidative damage or consistent premature aging. High fat diet (HFD) and fasting increased oxidative damage in the liver of wild type animals but, unexpectedly, this was not the case for that of Cat(-/-) mice. Interestingly, although HFD feeding similarly increased the body weight of Cat(-/-) and wild-type mice, hyperglycemia and liver steatosis did not develop in the former. Fat accumulation due to fasting, on the other hand, was diminished in mice lacking catalase, which correlated with increased risk of death and low ketone body blood levels. Alteration in expression of some metabolic genes in livers of catalase deficient mice was consistent with reduced lipogenesis. Specifically, Ppar gamma 2 expression up-regulation in response to a HFD and down-regulation upon fasting was lower and higher, respectively, in livers of Cat(-/-) than of wild type mice, and a marked decay was observed during Cat(-/-) mice aging. We propose that catalase regulates lipid metabolism in the liver by an evolutionary conserved mechanism that is determinant of lifespan without affecting general oxidative damage.
C1 [Raul Perez-Estrada, Jose; Hernandez-Garcia, David; Leyva-Castro, Francisco; Ramos-Leon, Javier; Cuevas-Benitez, Osiris; Castro-Obregon, Susana; Garcia, Celina; Covarrubias, Luis] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Diaz-Munoz, Mauricio] Univ Nacl Autonoma Mexico, Inst Neurobiol, Cuernavaca, Morelos, Mexico.
   [Ramirez-Solis, Ramiro] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.
   [Castro-Obregon, Susana] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Ciudad De Mexico, Mexico.
C3 Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma
   de Mexico; University of Texas System; University of Texas Health
   Science Center at San Antonio; Universidad Nacional Autonoma de Mexico
RP Covarrubias, L (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.
EM covs@ibt.unam.mx
RI Castro-Obregon, Susana/AAE-5105-2020
OI Garcia, Celina/0000-0003-3433-0115; Ramirez-Solis,
   Ramiro/0000-0003-4182-173X; Perez-Estrada, Jose
   Raul/0000-0003-2783-8658; Castro-Obregon, Susana/0000-0003-0549-5690
FU Landsteiner Scientific, SA de CV; PAPIIT-UNAM [IN209813, IN213416];
   CONACYT fellowship
FX We appreciate the support by members of our group throughout fruitful
   discussions. We thank to all service units in our institution, in
   particular, the animal facility (supervised by Graciela Cabeza, Sergio
   Trujillo and Elizabeth Mata) and the DNA synthesis unit, without their
   assistance this work would not be possible. We also appreciate the
   technical contribution of Olivia Vazquez-Martinez, Deisy Gasca-Martinez
   and Mayra L. Lopez-Cervantes of the INB-UNAM, and of Concepcion Valencia
   of the IBT-UNAM. We also thank all the support provided by Landsteiner
   Scientific, SA de CV. This work was supported by grants IN209813 and
   IN213416 from PAPIIT-UNAM. JRPE was recipients of a CONACYT fellowship
   for graduate studies.
CR [Anonymous], BIOCH BIOPHYS ACTA
   Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752
   Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6
   Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369
   Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041
   Cozza G, 2017, FREE RADICAL BIO MED, V112, P1, DOI 10.1016/j.freeradbiomed.2017.07.010
   Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848
   Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027
   Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001
   Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002
   Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638
   Heit C, 2017, FREE RADICAL BIO MED, V103, P48, DOI 10.1016/j.freeradbiomed.2016.12.011
   Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200
   Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171
   Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919
   Jin ES, 2018, AM J PHYSIOL-ENDOC M, V314, pE543, DOI 10.1152/ajpendo.00342.2017
   Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Li Y, 2018, AM J PATHOL, V188, P1833, DOI 10.1016/j.ajpath.2018.04.015
   Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002
   Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013
   Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Longevity C., 2008, SCIENCE, V322, P957
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luna-Moreno D, 2007, COMP BIOCHEM PHYS A, V146, P632, DOI 10.1016/j.cbpa.2006.02.039
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Moldovan L, 2004, HISTOCHEM CELL BIOL, V122, P395, DOI 10.1007/s00418-004-0676-y
   Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017
   More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819
   Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477
   Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007
   Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200
   Piao L, 2017, KOREAN J PHYSIOL PHA, V21, P317, DOI 10.4196/kjpp.2017.21.3.317
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049
   Schrader M, 2015, J INHERIT METAB DIS, V38, P681, DOI 10.1007/s10545-015-9819-7
   Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200
   Shi SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29396-5
   Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836
   Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822
   Tsukita S, 2012, CELL METAB, V16, P825, DOI 10.1016/j.cmet.2012.11.006
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Viscarra JA, 2013, METABOLISM, V62, P889, DOI 10.1016/j.metabol.2012.12.014
   Weng HC, 2013, AM J PHYSIOL-ENDOC M, V304, pE187, DOI 10.1152/ajpendo.00425.2012
   Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197
   Xie M, 2012, CELL METAB, V16, P322, DOI 10.1016/j.cmet.2012.07.016
   Xu YC, 2015, ENDOCR REV, V36, P174, DOI 10.1210/er.2013-1079
   Zhang H, 2008, KIDNEY INT, V74, P732, DOI 10.1038/ki.2008.244
NR 61
TC 14
Z9 15
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 1
PY 2019
VL 135
BP 102
EP 115
DI 10.1016/j.freeradbiomed.2019.02.016
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HV3ZS
UT WOS:000465927200011
PM 30818059
DA 2024-02-19
ER

PT J
AU Mather, M
   Rottenberg, H
AF Mather, M
   Rottenberg, H
TI Aging enhances the activation of the permeability transition pore in
   mitochondria
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE mitochondria; permeability transition pore; calcium; aging; brain;
   liver; lymphocytes; mice
ID OXIDATIVE STRESS; CELL-DEATH; CYCLOSPORINE-A; APOPTOSIS; MECHANISM;
   BRAIN; GLUTATHIONE; NUCLEOTIDES; DYSFUNCTION; MEMBRANE
AB Aging is associated with mitochondrial dysfunction in several tissues. However, it is not known how the observed mitochondrial dysfunction is related to aging-associated tissue degeneration. We have shown previously that the activation of the permeability transition pore (PTP), which is believed to play a critical role in cell necrosis and apoptosis, is enhanced in spleen lymphocytes from old mice. Here we show that the threshold for calcium-induced, cyclosporin-sensitive, calcium release was significantly lower in isolated brain and liver mitochondria from aging mice. Thus, aging mice exhibit enhanced PTP activation in lymphocytes, brain, and liver. These results suggest that aging increases the susceptibility to calcium-dependent cell death (e.g,, excitotoxicity, ischemia-reperfusion damage) in the brain, liver, and possibly other tissues. In addition, other pathways to apoptosis or necrosis that depend on PTP activation are also likely to be enhanced by aging. (C) 2000 Academic Press.
C1 Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA.
C3 Drexel University
RP Mather, M (corresponding author), Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA.
OI Mather, Michael/0000-0002-1062-0137
FU NIA NIH HHS [AG13779] Funding Source: Medline
CR Andreyev A, 1999, CELL DEATH DIFFER, V6, P825, DOI 10.1038/sj.cdd.4400565
   Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3
   Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3
   BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304
   Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2
   Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Grijalba MT, 1999, BIOCHEMISTRY-US, V38, P13279, DOI 10.1021/bi9828674
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x
   Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   LI HL, 1995, BBA-BIOMEMBRANES, V1236, P306
   Nicotera P, 1997, Adv Neurol, V72, P95
   Nieminen AL, 1996, NEUROSCIENCE, V75, P993
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4
   ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P87, DOI 10.1016/0005-2728(90)90010-2
   Rottenberg H, 1997, BIOCHEM BIOPH RES CO, V240, P68, DOI 10.1006/bbrc.1997.7605
   Schinder AF, 1996, J NEUROSCI, V16, P6125
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   1981, MAMMALIAN MODELS RES
NR 28
TC 113
Z9 130
U1 0
U2 5
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 5
PY 2000
VL 273
IS 2
BP 603
EP 608
DI 10.1006/bbrc.2000.2994
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 333JZ
UT WOS:000088128300037
PM 10873652
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Carrard, G
   Dieu, M
   Raes, M
   Toussaint, O
   Friguet, B
AF Carrard, G
   Dieu, M
   Raes, M
   Toussaint, O
   Friguet, B
TI Impact of ageing on proteasome structure and function in human
   lymphocytes
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE proteasome; ageing; post-translational modifications; lymphocyte
ID AGE-RELATED-CHANGES; ATPASE SUBUNITS; 26S PROTEASOME; DEGRADATION;
   INTERFERON; EXPRESSION; LIVER; INACTIVATION; FIBROBLASTS; GAMMA
AB Key actors of the immune response, lymphocytes exhibit functional deficits with advancing age. For instance, the age-related decline in lymphocyte proliferation may be related to alteration in the degradation of crucial proteins such as cell-cycle regulators. Degradation of these proteins is mediated by the ubiquitin-26S proteasome system. The proteasome is also the major "housekeeping" proteolytic complex responsible for eliminating intracellular damaged proteins. To investigate the occurrence of proteasome structural and functional age-related alterations, 26S proteasome was purified from peripheral blood lymphocytes of 20-63-year-old donors. Changes in peptidase activity were measured and modifications in the proteasome particle structure were analysed using bi-dimensional electrophoresis. We found the age-related decline of 26S proteasome-specific activity to be associated with an increased yield of post-translational modifications of proteasome subunits, while proteasome content and subunit composition were unchanged. In particular, some catalytic and assembly subunits of the 20S proteasome were preferentially modified with age. Western blotting of proteasome subunits resolved by bi-dimensional electrophoresis showed some of these modified subunits to be glycated, conjugated with a lipid peroxidation product and/or ubiquitinated. In conclusion, it is suggested that structural alterations of proteasome subunits may contribute to the observed decline of proteasome activity with age and could play a major role in immune senescence. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75251 Paris 05, France.
   Fac Univ Notre Dame Paix, URBC, B-5000 Namur, Belgium.
C3 Universite Paris Cite; University of Namur
RP Friguet, B (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, Case Courrier 7128,2 Pl Jussieu, F-75251 Paris 05, France.
EM bfriguet@paris7.jussieu.fr
OI Dieu, Marc/0000-0002-3902-542X; Friguet, Bertrand/0000-0001-8085-1961
CR AKIYAMA H, 1994, DIS ESOPHAGUS, V7, P2
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173, DOI 10.1093/gerona/53A.3.B173
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200
   Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1
   Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   COUX O, 1994, MOL GEN GENET, V245, P769, DOI 10.1007/BF00297284
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Gerards WLH, 1998, J MOL BIOL, V275, P113, DOI 10.1006/jmbi.1997.1429
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807
   Keller JN, 2000, J CEREBR BLOOD F MET, V20, P1467, DOI 10.1097/00004647-200010000-00008
   Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1
   Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X
   Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572
   KRISTENSEN P, 1994, BIOCHEM BIOPH RES CO, V205, P1785, DOI 10.1006/bbrc.1994.2876
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Mason GGF, 1998, FEBS LETT, V430, P269, DOI 10.1016/S0014-5793(98)00676-0
   MILLER RA, 1994, EXP GERONTOL, V29, P21, DOI 10.1016/0531-5565(94)90060-4
   Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Ponnappan U, 2002, EXP GERONTOL, V37, P359, DOI 10.1016/S0531-5565(01)00203-0
   Ponnappan U, 1999, CELL IMMUNOL, V192, P167, DOI 10.1006/cimm.1998.1418
   Ponnappan Usha, 1998, Frontiers in Bioscience, V3, pD152
   Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162
   Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403
   Rivett AJ, 2001, BIOCHIMIE, V83, P363
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Silva Pereira I., 1992, Gene (Amsterdam), V120, P235
   Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9
   TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571
   vanNocker S, 1996, MOL CELL BIOL, V16, P6020
   VLASSARA H, 1994, LAB INVEST, V70, P138
   Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015
   Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563
   Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494
NR 42
TC 98
Z9 112
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAY
PY 2003
VL 35
IS 5
BP 728
EP 739
DI 10.1016/S1357-2725(02)00356-4
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 668KN
UT WOS:000182290000020
PM 12672464
DA 2024-02-19
ER

PT J
AU MASORO, EJ
AF MASORO, EJ
TI DIETARY RESTRICTION AND AGING
SO JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
LA English
DT Article
ID AGE-RELATED-CHANGES; FOOD RESTRICTION; LIFE-SPAN; FISCHER-344 RAT;
   NUTRITIONAL INFLUENCES; CALORIC RESTRICTION; MICE; LONGEVITY; DISEASE;
   LIVER
C1 UNIV TEXAS, HLTH SCI CTR, CTR AGING RES & EDUC, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP MASORO, EJ (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT PHYSIOL, 7703 FLOYD CURL DR, SAN ANTONIO, TX 78284 USA.
FU NIA NIH HHS [AG-01188] Funding Source: Medline
CR BERG BN, 1960, J NUTR, V71, P255
   BERTRAND HA, 1987, J GERONTOL, V42, P666, DOI 10.1093/geronj/42.6.666
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   FERNANDES G, 1984, PHARMACOL REV, V36, P1235
   FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680
   HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376
   HERLIHY JT, 1980, AM J PHYSIOL, V238, pH652, DOI 10.1152/ajpheart.1980.238.5.H652
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78
   INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148
   KALU DN, 1984, MECH AGEING DEV, V26, P103, DOI 10.1016/0047-6374(84)90169-6
   KALU DN, 1983, ENDOCRINOLOGY, V113, P2010, DOI 10.1210/endo-113-6-2010
   KMENITZ JW, 1993, J GERONTOL, V48, pB17
   KUBO C, 1984, P NATL ACAD SCI-BIOL, V81, P5831, DOI 10.1073/pnas.81.18.5831
   LANG CA, 1989, DIETARY RESTRICTION, P241
   LEVEILLE PJ, 1984, SCIENCE, V224, P1247, DOI 10.1126/science.6729452
   LICASTRO F, 1988, AGE, V11, P48, DOI 10.1007/BF02431772
   LLOYD T, 1984, LIFE SCI, V34, P401, DOI 10.1016/0024-3205(84)90630-1
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Masoro E J, 1991, Aging (Milano), V3, P117
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MASORO EJ, 1992, GERONTOLOGIST, V32, P627, DOI 10.1093/geront/32.5.627
   MASORO EJ, 1992, ANN NY ACAD SCI, V673, P29, DOI 10.1111/j.1749-6632.1992.tb27433.x
   MASORO EJ, 1983, J NUTR, V113, P880, DOI 10.1093/jn/113.4.880
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MERRY BJ, 1979, J REPROD FERTIL, V57, P253, DOI 10.1530/jrf.0.0570253
   MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25
   REHM S, 1985, Z VERSUCHSTIERKD, V27, P249
   Rose MR, 1991, EVOLUTIONARY BIOL AG
   ROSS MH, 1971, J NATL CANCER I, V47, P1095
   ROTH GS, 1984, BRAIN RES, V300, P27, DOI 10.1016/0006-8993(84)91337-4
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171
   Saxton JA, 1944, CANCER RES, V4, P401
   Saxton JA, 1941, ARCH PATHOL, V32, P951
   SCHNEIDER EL, 1987, MODERN BIOL THEORIES, P1
   SHIMOKAWA I, 1991, J GERONTOL, V46, pB228, DOI 10.1093/geronj/46.6.B228
   SHIMOKAWA I, 1993, J GERONTOL, V48, pB27, DOI 10.1093/geronj/48.1.B27
   SMITH JC, 1989, ANN NY ACAD SCI, V561, P291
   TANNENBAUM A., 1940, Amer. F. Cancer, V38, P335
   TAYLOR A, 1989, FASEB J, V3, P1741, DOI 10.1096/fasebj.3.6.2703107
   TUCKER SM, 1976, J GERONTOL, V31, P264, DOI 10.1093/geronj/31.3.264
   WALFORD RL, 1992, P NATL ACAD SCI USA, V89, P11533, DOI 10.1073/pnas.89.23.11533
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Weindruch R., 1988, RETARDATION AGING DI
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   YU BP, 1993, FREE RADICALS AGING, P58
NR 52
TC 159
Z9 162
U1 1
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-8614
EI 1532-5415
J9 J AM GERIATR SOC
JI J. Am. Geriatr. Soc.
PD SEP
PY 1993
VL 41
IS 9
BP 994
EP 999
DI 10.1111/j.1532-5415.1993.tb06767.x
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LW378
UT WOS:A1993LW37800015
PM 8409187
DA 2024-02-19
ER

PT J
AU IIAI, T
   WATANABE, H
   SEKI, S
   SUGIURA, K
   HIROKAWA, K
   UTSUYAMA, M
   TAKAHASHIIWANAGA, H
   IWANAGA, T
   OHTEKI, T
   ABO, T
AF IIAI, T
   WATANABE, H
   SEKI, S
   SUGIURA, K
   HIROKAWA, K
   UTSUYAMA, M
   TAKAHASHIIWANAGA, H
   IWANAGA, T
   OHTEKI, T
   ABO, T
TI ONTOGENY AND DEVELOPMENT OF EXTRATHYMIC T-CELLS IN MOUSE-LIVER
SO IMMUNOLOGY
LA English
DT Article
ID INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; RECEPTOR-GAMMA-DELTA;
   NATURAL-KILLER CELLS; PERIPHERAL-BLOOD; BETA-CHAIN; ATHYMIC MICE; LPR
   MICE; DIFFERENTIATION; EXPRESSION; BEARING
AB We previously demonstrated that the liver may be a major site of extrathymic T-cell differentiation in mice. In the present study, the ontogeny and subsequent development of such T cells in the liver and other organs were investigated. This study was possible because these T cells have T-cell receptors (TcR) of intermediate intensity (i.e. intermediate TcR cells) and constitutively express a high level of interleukin-2 receptor beta chain (IL-2Rbeta). Therefore the two-colour staining for CD3 (or alphabeta TcR) and IL-2Rbeta identifies even a small proportion of intermediate TcR cells. The total numbers of mononuclear cells obtained from the liver, thymus and spleen varied from foetal to adult life. Especially in the liver, many haematopoietic cells were present in the parenchymal space at the foetal stage. There were no lymphocytes in the sinusoidal lumen at this period. In contrast, lymphocytes appeared in the hepatic sinusoids after birth and increased with ageing. Phenotypic analysis revealed that intermediate TcR cells appeared in the liver and spleen on Day 4 after birth. Bright TcR cells of thymic origin were also present in the peripheral organs on Day 4. Thereafter, intermediate TcR cells increased in the liver, whereas bright TcR cells increased in the periphery as a function of age. Similarly, thymectomized and congenitally athymic mice had mainly intermediate TcR cells in the liver and, to some extent, periphery. It is concluded that intermediate TcR cells, possibly of extrathymic origin, are generated only after birth and expand with ageing.
C1 NIIGATA UNIV,SCH MED,DEPT IMMUNOL,ASAHIMACHI DORI 1,NIIGATA 951,JAPAN.
   NIIGATA UNIV,SCH MED,DEPT ANAT 2,NIIGATA 951,JAPAN.
   TOHOKU UNIV,SCH DENT,DEPT MICROBIOL,SENDAI,MIYAGI 980,JAPAN.
   TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT PATHOL,TOKYO 173,JAPAN.
C3 Niigata University; Niigata University; Tohoku University; Tokyo
   Metropolitan Institute of Gerontology
RI Takahashi-Iwanaga, Hiromi/A-4294-2012
CR ABO T, 1991, J EXP MED, V174, P417, DOI 10.1084/jem.174.2.417
   ABO T, 1992, BIOMED RES-TOKYO, V13, P1
   ANDREUSANCHEZ JL, 1991, J EXP MED, V173, P1323, DOI 10.1084/jem.173.6.1323
   BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43
   DEGEUS B, 1990, EUR J IMMUNOL, V20, P291, DOI 10.1002/eji.1830200210
   FANGMANN J, 1991, EUR J IMMUNOL, V21, P753, DOI 10.1002/eji.1830210331
   FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630
   GUYGRAND D, 1991, J EXP MED, V173, P417
   ITOH H, 1988, J IMMUNOL, V141, P315
   KUNG JT, 1988, J IMMUNOL, V140, P3727
   MACDONALD HR, 1987, J EXP MED, V166, P195, DOI 10.1084/jem.166.1.195
   MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361
   MUROSAKI S, 1991, INT IMMUNOL, V3, P1005, DOI 10.1093/intimm/3.10.1005
   NISHIMURA T, 1988, EUR J IMMUNOL, V18, P2077, DOI 10.1002/eji.1830181231
   OHASHI Y, 1989, J IMMUNOL, V143, P3548
   OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7
   OHTEKI T, 1991, EUR J IMMUNOL, V21, P1733, DOI 10.1002/eji.1830210722
   PARDOLL DM, 1988, J IMMUNOL, V140, P4091
   PREFFER FI, 1989, J EXP MED, V170, P177, DOI 10.1084/jem.170.1.177
   ROCHA B, 1990, EUR J IMMUNOL, V20, P919, DOI 10.1002/eji.1830200430
   ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483
   SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785
   SEKI S, 1991, J IMMUNOL, V147, P1214
   SEKI S, 1991, CELL IMMUNOL, V137, P46, DOI 10.1016/0008-8749(91)90055-G
   STEINBERG AD, 1970, ARTHRITIS RHEUM-US, V13, P369, DOI 10.1002/art.1780130402
   TANAKA T, 1991, J IMMUNOL, V147, P2222
   WATANABE H, 1991, J IMMUNOL METHODS, V146, P145
   WILTROUT RH, 1989, J IMMUNOL, V143, P372
   YAGITA H, 1989, J EXP MED, V170, P1445, DOI 10.1084/jem.170.4.1445
   YOSHIKAI Y, 1986, NATURE, V324, P482, DOI 10.1038/324482a0
NR 30
TC 128
Z9 131
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 1992
VL 77
IS 4
BP 556
EP 563
PG 8
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA KB173
UT WOS:A1992KB17300015
PM 1493929
DA 2024-02-19
ER

PT J
AU OOKHTENS, M
   MADDATU, T
AF OOKHTENS, M
   MADDATU, T
TI MECHANISM OF CHANGES IN HEPATIC SINUSOIDAL AND BILIARY GLUTATHIONE
   EFFLUX WITH AGE IN RATS
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE TRANSPORT; KINETICS; AGING; LIVER
ID ISOLATED HEPATOCYTES; LIVER; BILE; INHIBITION; KINETICS
AB To delineate the kinetic mechanism(s) of declining sinusoidal reduced glutathione (GSH) efflux with age, we perfused livers of male rats ages approximately 1-15, approximately 2-3, and approximately 3.5-6 mo old and measured sinusoidal and biliary GSH and oxidized glutathione (GSSG) effluxes.  Our results showed declining GSH transport to be solely due to a falling maximum transport rate (V(max)) and not an increasing Michaelis constant (K(m)) (V(max) = 24.2 +/- 2.95, 15.8 +/- 1.51, and 8.61 +/- 0.75 nmol.min-1.g-1; K(m) = 3.0 +/- 0.42, 2.6 +/- 0.31, and 2.6 +/- 0.43-mu-mol/g for the three age groups, respectively).  Because hepatocyte membrane potential was earlier implicated as a driving force for GSH efflux and hepatocytes of female rats were reported to be less polarized than those of males, we likewise studied the kinetics of sinusoidal GSH efflux from livers of female rats of three age groups comparable to our males.  V(max) in females tended to be lower than in males.  This was more pronounced in the youngest group but was diminished in the older groups.  V(max) was again the only parameter declining with age in the female livers, from 19.1 +/- 2.25 to 15.0 +/- 0.95 and 7.83 +/- 0.99 nmol.min-1.g-1, whereas K(m) remained unchanged at 3.0 +/- 0.45, 3.1 +/- 0.35, and 3.2 +/- 0.72-mu-mol/g, respectively.  Age-dependent changes in GSH efflux were not due to a changing membrane potential.  There was no appreciable change in the paracellular permeability with age either.  From these findings, it appears that the age-dependent decline in sinusoidal GSH efflux may be due to a decreasing density of carrier units in the hepatocyte plasma membrane.  Biliary efflux of glutathione (almost all as GSH) increased with age in livers of both male and female rats from the youngest to the middle-age group but did not increase further in the oldest rats.  There was no tendency for saturation in biliary efflux of GSH and GSSG.  Biliary fraction of total hepatic GSH efflux was highly variable (approximately 5-50%) and dependent on the age and hepatic GSH concentration.  Finally, the kinetics of total glutathione equivalents (GSH + 2GSSG) effluxing from freshly isolated hepatocytes was found to completely overlap with the total, i.e., sinusoidal + biliary GSH equivalents transported from the perfused livers of all age groups.  This outcome strongly implies that isolated hepatocytes retain their polarity and that canalicular component of glutathione efflux appears to remain intact in this model system.
C1 UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024.
   VET AFFAIRS WADSWORTH MED CTR,LIVER RES LAB,LOS ANGELES,CA 90073.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP OOKHTENS, M (corresponding author), UNIV SO CALIF,SCH MED,DEPT MED,DIV GASTROINTESTINAL & LIVER DIS,MMR-428,1333 SON PABLO ST,LOS ANGELES,CA 90033, USA.
FU NIA NIH HHS [AG-074667] Funding Source: Medline
CR AW TY, 1986, AM J PHYSIOL, V250, pG236, DOI 10.1152/ajpgi.1986.250.2.G236
   AW TY, 1984, J BIOL CHEM, V259, P9355
   BALLATORI N, 1989, J PHARMACOL EXP THER, V251, P1069
   BALLATORI N, 1986, J BIOL CHEM, V261, P7860
   BENEDETTI A, 1988, BIOCHEM BIOPH RES CO, V156, P840, DOI 10.1016/S0006-291X(88)80920-3
   BERMAN M, 1977, DHEW NIH76730 PUBL
   BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516
   FARISS MW, 1987, METHOD ENZYMOL, V143, P101
   FERNANDEZCHECA JC, 1988, AM J PHYSIOL, V255, pG403, DOI 10.1152/ajpgi.1988.255.4.G403
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOEK JB, 1980, J BIOL CHEM, V255, P1458
   KAPLOWITZ N, 1983, J PHARMACOL EXP THER, V224, P141
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   OOKHTENS M, 1988, J CLIN INVEST, V82, P608, DOI 10.1172/JCI113639
   OOKHTENS M, 1987, BIOCHEM PHARMACOL, V36, P4015, DOI 10.1016/0006-2952(87)90473-4
   OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   WEISIGER RA, 1988, AM J PHYSIOL, V255, pG822, DOI 10.1152/ajpgi.1988.255.6.G822
   WRIGHT TL, 1988, AM J PHYSIOL, V255, pG547, DOI 10.1152/ajpgi.1988.255.5.G547
NR 20
TC 20
Z9 21
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD OCT
PY 1991
VL 261
IS 4
BP G648
EP G656
DI 10.1152/ajpgi.1991.261.4.G648
PN 1
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA GK867
UT WOS:A1991GK86700052
PM 1928351
DA 2024-02-19
ER

PT J
AU Mastoraki, A
   Tsakali, A
   Papanikolaou, IS
   Danias, N
   Smyrniotis, V
   Arkadopoulos, N
AF Mastoraki, Aikaterini
   Tsakali, Athina
   Papanikolaou, Ioannis S.
   Danias, Nikolaos
   Smyrniotis, Vasilios
   Arkadopoulos, Nikolaos
TI Outcome following major hepatic resection in the elderly patients
SO CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
LA English
DT Article
ID COLORECTAL LIVER METASTASES; HEPATOCELLULAR-CARCINOMA; HEPATECTOMY;
   TUMORS; AGE; MANAGEMENT; SURVIVAL; BENIGN
AB Recent advances in operative techniques, anaesthesiologic management and intensive care have greatly reduced morbidity and mortality of major hepatectomy allowing a progressive broadening of its indications by including patients with chronic liver disorders as well as elderly subjects. It is apparent that with the aging population, more elderly patients are being referred for surgery. Selecting appropriate candidates for surgical resection is therefore crucial to maximize the benefit derived from surgery. Nevertheless, it is not clear whether advanced age itself increases surgical risk or additional age-independent variables are associated with higher operative morbidity. Regardless of the indications for surgery and the extent of planned liver resections, this population is more likely to suffer from relevant disorders. Previous studies on the safety of major liver resections in the elderly patients cite morbidity and mortality rates of approximately 30-40% and 4-5% respectively. In addition, hepatic resections for hepatocellular carcinoma or colorectal liver metastases have been reported as safe in the elderly as in the younger population. Nevertheless, a small number of investigations studied the outcome of major hepatectomy in the population over 70 years of age. The aim of our study was to evaluate overall experience with liver resections in the elderly population by comparing the early as well as the long-term outcome of the procedure in 70 years and older versus the less than 70 age group and to identify whether the age of patients alone is associated with increased rate and severity of postoperative complications. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Mastoraki, Aikaterini; Tsakali, Athina; Danias, Nikolaos; Smyrniotis, Vasilios; Arkadopoulos, Nikolaos] Univ Athens, ATTIKON Univ Hosp, Sch Med, Dept Surg 4, Athens 12462, Greece.
   [Papanikolaou, Ioannis S.] ATTIKON Univ Hosp, Dept Internal Med 2, Hepatogastroenterol Unit, Athens 12462, Greece.
C3 Athens Medical School; National & Kapodistrian University of Athens;
   University Hospital Attikon; University Hospital Attikon
RP Mastoraki, A (corresponding author), Gr Lambraki 112-114, Athens, Greece.
EM dr_kamast@yahoo.gr
RI Papanikolaou, Ioannis S/AAA-8261-2022
CR Abbass MA, 2013, AM SURGEON, V79, P961
   Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   Aldrighetti L, 2006, J SURG ONCOL, V93, P186, DOI 10.1002/jso.20342
   Aldrighetti L, 2003, WORLD J SURG, V27, P1149, DOI 10.1007/s00268-003-7072-y
   Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1
   BISMUTH H, 1989, ANN SURG, V210, P13, DOI 10.1097/00000658-198907000-00002
   Brand MI, 2000, AM SURGEON, V66, P412
   Buell JF, 2000, SURGERY, V128, P686, DOI 10.1067/msy.2000.108220
   Capussotti L, 2008, ARCH SURG-CHICAGO, V143, P978, DOI 10.1001/archsurg.143.10.978
   Chiappa A, 2002, Ann Ital Chir, V73, P397
   Cho SW, 2011, ANN SURG ONCOL, V18, P1088, DOI 10.1245/s10434-010-1404-6
   COSENZA CA, 1995, AM SURGEON, V61, P889
   EZAKI T, 1987, BRIT J SURG, V74, P471, DOI 10.1002/bjs.1800740614
   Fernandes AI, 2013, LIVER INT
   Fong Y, 1997, BRIT J SURG, V84, P1386
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Fujii H, 2012, WORLD J GASTROENTERO, V18, P1926, DOI 10.3748/wjg.v18.i16.1926
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Hirokawa F, 2013, J GASTROINTEST SURG, V17, P1929, DOI 10.1007/s11605-013-2324-0
   Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4
   Huang JT, 2013, J CANCER RES CLIN, V139, P1709, DOI 10.1007/s00432-013-1497-y
   Ide T, 2013, J SURG RES, V185, P614, DOI 10.1016/j.jss.2013.07.016
   Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3
   Kaibori M, 2009, J SURG ONCOL, V99, P154, DOI 10.1002/jso.21221
   Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285
   Koperna T, 1998, WORLD J SURG, V22, P406, DOI 10.1007/s002689900405
   Laporte GA, 2013, ABCD-ARQ BRAS CIR DI, V26, P136, DOI 10.1590/S0102-67202013000200014
   LITWIN DEM, 1987, ANN SURG, V205, P45, DOI 10.1097/00000658-198701000-00008
   Lui WY, 1999, HEPATO-GASTROENTEROL, V46, P640
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Munene G, 2013, J NATL MED ASSOC, V105, P128, DOI 10.1016/S0027-9684(15)30112-7
   Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279
   Nojiri K, 2009, ANTICANCER RES, V29, P583
   Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c
   Reddy KR, 2001, AM SURGEON, V67, P173
   Ryan RS, 2001, IRISH J MED SCI, V170, P251, DOI 10.1007/BF03167790
   Takahashi Y, 2013, J HEPATO-BIL-PAN SCI, V20, P324, DOI 10.1007/s00534-012-0529-3
   TAKENAKA K, 1994, ARCH SURG-CHICAGO, V129, P846
   Tsugawa K, 2002, WORLD J SURG, V26, P544, DOI 10.1007/s00268-001-0264-4
   Tzeng CW, 2013, HPB OXFORD
   Ueno M, 2013, SURG TODAY
   Yedibela S, 2005, ANN SURG ONCOL, V12, P778, DOI 10.1245/ASO.2005.11.018
   Yeh CN, 2006, ANN SURG ONCOL, V13, P1553, DOI 10.1245/s10434-006-9085-x
   Zacharias T, 2004, ANN SURG, V240, P858, DOI 10.1097/01.sla.0000143272.52505.d6
   Zhu C, 2013, J GASTROENTEROL HEPA
NR 45
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 2210-7401
EI 2210-741X
J9 CLIN RES HEPATOL GAS
JI Clin. Res. Hepatol. Gastroenterol.
PD SEP
PY 2014
VL 38
IS 4
BP 462
EP 466
DI 10.1016/j.clinre.2014.01.009
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AP8YE
UT WOS:000342364500021
PM 24582424
DA 2024-02-19
ER

PT J
AU Lee, TY
   Lee, KC
   Chang, HH
AF Lee, Tzung-Yan
   Lee, Ko-Chen
   Chang, Hen-Hong
TI Modulation of the cannabinoid receptors by andrographolide attenuates
   hepatic apoptosis following bile duct ligation in rats with fibrosis
SO APOPTOSIS
LA English
DT Article
DE Apoptosis; Cholestasis; Cannabinoid receptor; Andrographolide
ID N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; CARBON-TETRACHLORIDE;
   CASPASE INHIBITOR; LIVER-DISEASE; P38 KINASE; STRESS; INJURY;
   ENDOCANNABINOIDS; INFLAMMATION
AB Bile acid-induced apoptosis plays an important role in the pathogenesis of cholestatic liver disease, and its prevention is of therapeutic interest. The aim of this study was to test whether the andrographolide limits the evolution of apoptosis in a murine model of bile duct ligation (BDL)-induced hepatic fibrosis. Male Sprague-Dawley rats were divided into four groups and hepatic apoptosis was induced by BDL for 2 weeks. The BDL animals were also treated with andrographolide (50, 100, and 200 mg/kg, i.p.) during the same time period. BDL-induced liver injury was associated with apoptosis and fibrosis, and the latter was significantly reduced in animals receiving andrographolide. The increase in serum alanine aminotransferase, asparate aminotransferase, tumor necrosis factor-alpha and IL-1 beta levels caused by BDL were also significantly reduced by treatment with andrographolide. Andrographolide decreased the intrahepatic protein levels of cannabinoid receptor 1 (CB1), Bax, and cytochrome c, along with of alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-beta (TGF-beta), two markers of fibrogenesis. This effect was mediated by the inactivation of the c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK1/2) phosphorylation cascade, but it did not affect the p38 mitogen-activated protein kinase pathway. Additionally, andrographolide reduced the generation of hepatic lipid peroxidation and enhance senescence marker protein-30 levels to resist the hepatic oxidative stress in the presence of BDL. In conclusion, this study has identified AP as a potent protector against cholestasis-induced apoptosis in vivo. Its anti-apoptotic action largely relies on the inhibition of the oxidative stress pathway.
C1 [Lee, Tzung-Yan; Chang, Hen-Hong] Chang Gung Univ, Grad Inst Tradit Chinese Med, Kwei Shan Tao Yuan 333, Taiwan.
   [Lee, Ko-Chen] Chang Gung Univ, Sch Tradit Chinese Med, Kwei Shan Tao Yuan 333, Taiwan.
   [Lee, Ko-Chen; Chang, Hen-Hong] Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Tao Yuan, Taiwan.
C3 Chang Gung University; Chang Gung University; Chang Gung Memorial
   Hospital
RP Chang, HH (corresponding author), Chang Gung Univ, Grad Inst Tradit Chinese Med, 259 Wen Hwa 1st Rd, Kwei Shan Tao Yuan 333, Taiwan.
EM joyamen@mail.cgu.edu.tw
RI Hen Hong, Chang/ITT-2813-2023
FU National Science Council, Taipei, Taiwan [NSC97-2320-B-182-006-MY3];
   Chang Gung Memorial Hospital [CMRPD170111, CMRPG 380811]
FX This work was supported in part by grants from the National Science
   Council, Taipei, Taiwan, NSC97-2320-B-182-006-MY3 (H. H. Chang), and the
   research grant from the Chang Gung Memorial Hospital, CMRPD170111 (T.Y.
   Lee) and CMRPG 380811 (K. C. Lee).
CR Abu-Ghefreh AA, 2009, INT IMMUNOPHARMACOL, V9, P313, DOI 10.1016/j.intimp.2008.12.002
   Anderson NL, 1996, TOXICOL APPL PHARM, V137, P75, DOI 10.1006/taap.1996.0059
   Avraham Y, 2008, AM J GASTROENTEROL, V103, P3047, DOI 10.1111/j.1572-0241.2008.02155.x
   BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637
   Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D
   Canbay A, 2004, J PHARMACOL EXP THER, V308, P1191, DOI 10.1124/jpet.103.060129
   Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953
   Canturk NZ, 1998, E AFR MED J, V75, P77
   Chen JH, 2004, BIOCHEM PHARMACOL, V67, P1337, DOI 10.1016/j.bcp.2003.12.015
   Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631
   Derkinderen P, 2001, J NEUROCHEM, V77, P957, DOI 10.1046/j.1471-4159.2001.00333.x
   Ebrahimkhani MR, 2005, LIFE SCI, V76, P2497, DOI 10.1016/j.lfs.2004.12.009
   Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460
   Gabbay E, 2005, LIVER INT, V25, P921, DOI 10.1111/j.1478-3231.2005.01180.x
   Gabrielian ES, 2002, PHYTOMEDICINE, V9, P589, DOI 10.1078/094471102321616391
   Hasanein P, 2008, EUR J PHARMACOL, V591, P132, DOI 10.1016/j.ejphar.2008.06.061
   Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9
   Lee TY, 2003, J PHARMACOL SCI, V91, P202, DOI 10.1254/jphs.91.202
   Lee TY, 2007, J PHARM PHARMACOL, V59, P583, DOI 10.1211/jpp.59.4.0014
   Lee TY, 2007, J ETHNOPHARMACOL, V109, P318, DOI 10.1016/j.jep.2006.07.042
   Lee TY, 2009, MOL CELL BIOCHEM, V325, P53, DOI 10.1007/s11010-008-0019-8
   Lee TY, 2009, INT J MOL MED, V23, P477
   Li J, 2007, BIOORG MED CHEM LETT, V17, P6891, DOI 10.1016/j.bmcl.2007.10.009
   Magen I, 2009, J HEPATOL, V51, P528, DOI 10.1016/j.jhep.2009.04.021
   Mallat A, 2007, EXPERT OPIN THER TAR, V11, P403, DOI 10.1517/14728222.11.3.403
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098
   Nollen EAA, 2002, J CELL SCI, V115, P2809
   Ozaki I, 1999, J BIOL CHEM, V274, P5310, DOI 10.1074/jbc.274.9.5310
   Pacher P, 2008, AM J PHYSIOL-GASTR L, V294, pG850, DOI 10.1152/ajpgi.00523.2007
   Peres W, 2000, J HEPATOL, V33, P742, DOI 10.1016/S0168-8278(00)80305-0
   Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x
   Rajesh M, 2007, J LEUKOCYTE BIOL, V82, P1382, DOI 10.1189/jlb.0307180
   Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5
   Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232
   Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814
   Sánchez C, 2001, CANCER RES, V61, P5784
   Schiff ER, 2004, J HEPATOL, V40, P24, DOI 10.1016/S0168-8278(04)90066-9
   Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493
   Singha PK, 2007, J ETHNOPHARMACOL, V111, P13, DOI 10.1016/j.jep.2006.10.026
   SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5
   Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828
   Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421
   Xiao ZL, 2001, AM J PHYSIOL-GASTR L, V281, pG490, DOI 10.1152/ajpgi.2001.281.2.G490
NR 44
TC 40
Z9 44
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1360-8185
EI 1573-675X
J9 APOPTOSIS
JI Apoptosis
PD AUG
PY 2010
VL 15
IS 8
BP 904
EP 914
DI 10.1007/s10495-010-0502-z
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 627TE
UT WOS:000280065000003
PM 20446039
DA 2024-02-19
ER

PT J
AU SANTOS, MC
   RODRIGUES, H
   VASCONCELOS, S
   ANDRADE, V
   LANCA, MJ
   CRESPO, AMV
AF SANTOS, MC
   RODRIGUES, H
   VASCONCELOS, S
   ANDRADE, V
   LANCA, MJ
   CRESPO, AMV
TI THE EFFECT OF AGE AND SELENIUM ON SOME BIOCHEMICAL PARAMETERS IN
   RAT-LIVER
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article; Proceedings Paper
CT 4th International Congress on Trace Elements in Medicine and Biology -
   Trace Elements and Free Radicals in Oxidative Diseases
CY APR 05-09, 1993
CL CHAMONIX, FRANCE
SP MINIST RECH & TECHNOL, INSERM, SOC FRANCAISE BIOL CLIN, CLUB ETUDES RADICAUX LIBRES BIOL, JOSEPH FOURIER UNIV, GRENOBLE UNIV HOSP A MICHALLON, SOC FRANCOPHONE ETUDES & RECH ELEMENTS TRACE ESSENTIALS, SOC FREE RADICAL RES
DE AGING; LIPID PEROXIDATION; SELENIUM; GLUTATHIONE PEROXIDASE; LIVER; RAT
ID HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; TISSUES
AB Two age groups, 3 and 15 mo, were used to investigate whether age-associated changes in some parameters related to lipid peroxidation occur in the liver of male Wistar rats and to observe possible effects of dietary selenium supplementation (0.25 and 0.50 ppm) for 12 mo on the same parameters. At these experimental conditions, the most important observation was that peroxidation did not change by aging, at least until 15 mo of age. In addition, the activity of Se-dependent glutathione peroxidase (GSH-Px, EC 1.11.1.9) was higher in the liver of the older animals. It is suggested that the enzyme could have a role in the unchanged hepatic peroxidation observed in aged male rats. On the other hand, an effect of dietary selenium supplementation on those parameters was not observed, probably because the selenium levels were still at an adequate plateau.
C1 FAC CIENCIAS LISBOA,DEPT ZOOL & ANTHROPOL,P-1700 LISBON,PORTUGAL.
   FAC CIENCIAS LISBOA,DEPT QUIM,LISBON,PORTUGAL.
C3 Universidade de Lisboa; Universidade de Lisboa
RI Lança, Maria João/F-6285-2013; Vasconcelos, silvania/N-4470-2017
OI Lança, Maria João/0000-0001-6372-9702; Vasconcelos,
   silvania/0000-0003-1478-0127
CR Flohe L., 1989, GLUTATHIONE CHEM BIO, P643
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   NEVE J, 1991, NATURA RERUM, V5, P100
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SIMMONS TW, 1988, BIOCHEM J, V251, P913, DOI 10.1042/bj2510913
   TRIBBLE DL, 1987, HEPATOLOGY, V7, P377, DOI 10.1002/hep.1840070227
   URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5
   WATSON D, 1960, CLIN CHIM ACTA, V5, P637, DOI 10.1016/0009-8981(60)90004-8
   ZHANG LP, 1989, BIOCHIM BIOPHYS ACTA, V1006, P140, DOI 10.1016/0005-2760(89)90336-6
NR 14
TC 5
Z9 6
U1 0
U2 3
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07012
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JAN-MAR
PY 1995
VL 47
IS 1-3
BP 257
EP 261
DI 10.1007/BF02790125
PG 5
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA QK149
UT WOS:A1995QK14900032
PM 7779555
OA Green Published
DA 2024-02-19
ER

PT J
AU Rattan, P
   Penrice, DD
   Ahn, JC
   Ferrer, A
   Patnaik, M
   Shah, VH
   Kamath, PS
   Mangaonkar, AA
   Simonetto, DA
AF Rattan, Puru
   Penrice, Daniel D.
   Ahn, Joseph C.
   Ferrer, Alejandro
   Patnaik, Mrinal
   Shah, Vijay H.
   Kamath, Patrick S.
   Mangaonkar, Abhishek A.
   Simonetto, Douglas A.
TI Inverse Association of Telomere Length With Liver Disease and Mortality
   in the US Population
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID EPIDEMIOLOGY; SENESCENCE; CIRRHOSIS; MARKERS; HEALTH
AB Physiologic aging leads to attrition of telomeres and replicative senescence. An acceleration of this process has been hypothesized in the progression of chronic liver disease. We sought to examine the association of telomere length (TL) with liver disease and its impact on mortality risk. A cohort of 7,072 adults with leukocyte TL measurements from the National Health and Nutrition Examination Survey 1999-2002 with mortality follow-up through 2015 was analyzed. Liver disease was defined by aminotransferase levels and classified into etiology-based and advanced fibrosis categories. Multivariable-adjusted linear regression models estimated effect sizes, with 95% confidence intervals (CIs), of the presence of liver disease on TL. Cox regression models evaluated associations between TL and all-cause mortality risk using adjusted hazard ratios (HRs). The cohort was representative of the US population with mean age 46.1 years and mean TL 5.79 kilobase pairs. No overall association between TL and liver disease was found; however, there was a significant negative association of TL and advanced liver fibrosis in individuals aged 65 and above. The liver disease cohort (HR 1.22, 95% CI 0.99-1.51) and those with metabolic syndrome (HR 1.26, 95% CI 0.96-1.67) had increased mortality risk with shorter TL. The relationship between TL and all-cause mortality was stronger in women (HR 1.51, 95% CI 1.02-2.23) and in non-Hispanic Whites (HR 1.37, 95% CI 1.02-1.84). Conclusion: Shortened leukocyte TL is independently associated with advanced liver disease at older ages, and with a higher risk of all-cause mortality in those with liver disease. These associations reaffirm the need to better understand the role of telomeres in the progression of liver disease.
C1 [Rattan, Puru; Penrice, Daniel D.; Ahn, Joseph C.; Shah, Vijay H.; Kamath, Patrick S.; Simonetto, Douglas A.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.
   [Patnaik, Mrinal; Mangaonkar, Abhishek A.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA.
   [Ferrer, Alejandro] Mayo Clin, Hlth Sci Res, Ctr Individualized Med, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Simonetto, DA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.
EM simonetto.douglas@mayo.edu
RI Rattan, Puru/JCO-5702-2023
OI Rattan, Puru/0000-0001-7410-488X; Simonetto,
   Douglas/0000-0003-4095-8144; Ahn, Joseph/0000-0001-6994-2870; Penrice,
   Daniel/0000-0002-9357-9511
FU National Institutes of Health [U01AA026886-03]
FX Supported by the National Institutes of Health (U01AA026886-03).
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Kapuria D, 2019, HEPATOLOGY, V69, P2579, DOI 10.1002/hep.30578
   Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Lapham K, 2015, GENETICS, V200, P1061, DOI 10.1534/genetics.115.178624
   Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105
   Lynch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146723
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Munroe M, 2020, HEPATOLOGY, V72, P1412, DOI 10.1002/hep.31414
   Murphy Sherry L, 2021, Natl Vital Stat Rep, V69, P1
   Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023
   Patnaik MM, 2018, J HEPATOL, V69, P736, DOI 10.1016/j.jhep.2018.05.006
   Penrice DD, 2020, SEMIN LIVER DIS, V40, P385, DOI 10.1055/s-0040-1713007
   Ping F, 2017, J DIABETES INVEST, V8, P174, DOI 10.1111/jdi.12555
   Rehkopf DH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002188
   Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047
   Urabe Y, 1996, LIVER, V16, P293
   Wang Q, 2018, AGEING RES REV, V48, P11, DOI 10.1016/j.arr.2018.09.002
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wojcicki JM, 2017, INT J HEPATOL, V2017, DOI 10.1155/2017/8435178
   Zierer J, 2016, AGING-US, V8, P77, DOI 10.18632/aging.100874
   Zipf George, 2013, Vital Health Stat 1, P1
   Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207
NR 40
TC 60
Z9 60
U1 2
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2022 FEB
PY 2022
VL 6
IS 2
BP 399
EP 410
DI 10.1002/hep4.1803
EA AUG 2021
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YN6WG
UT WOS:000690672900001
PM 34558851
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chang, KCN
   Shen, Q
   Oh, IG
   Jelinsky, SA
   Jenkins, SF
   Wang, W
   Wang, Y
   LaCava, M
   Yudt, MR
   Thompson, CC
   Freedman, LP
   Chung, JH
   Nagpal, S
AF Chang, Ken C. N.
   Shen, Qi
   Oh, Inn Gyung
   Jelinsky, Scott A.
   Jenkins, Susan F.
   Wang, Wei
   Wang, Yihe
   LaCava, Margaret
   Yudt, Matthew R.
   Thompson, Catherine C.
   Freedman, Leonard P.
   Chung, Jin Ho
   Nagpal, Sunil
TI Liver X Receptor Is a Therapeutic Target for Photoaging and
   Chronological Skin Aging
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article
ID HUMAN KERATINOCYTES; AGED SKIN; IN-VIVO; PERMEABILITY BARRIER; DERMAL
   FIBROBLASTS; MURINE EPIDERMIS; GENE-EXPRESSION; LIPID-SYNTHESIS; LXR
   ACTIVATORS; MICE
AB Liver X receptors (LXR alpha and -beta) are liposensors that exert their metabolic effects by orchestrating the expression of macrophage genes involved in lipid metabolism and inflammation. LXRs are also expressed in other tissues, including skin, where their natural oxysterol ligands induce keratinocyte differentiation and improve epidermal barrier function. To extend the potential use of LXR ligands to dermatological indications, we explored the possibility of using LXR as a target for skin aging. We demonstrate that LXR signaling is down-regulated in cell-based models of photoaging, i.e. UV-activated keratinocytes and TNF alpha-activated dermal fibroblasts. We show that a synthetic LXR ligand inhibits the expression of cytokines and metalloproteinases in these in vitro models, thus indicating its potential in decreasing cutaneous inflammation associated with the etiology of photoaging. Furthermore, a synthetic LXR ligand induces the expression of differentiation markers, ceramide biosynthesis enzymes, and lipid synthesis and transport genes in keratinocytes. Remarkably, LXR beta-null mouse skin showed some of the molecular defects that are observed in chronologically aged human skin. Finally, we demonstrate that a synthetic LXR agonist inhibits UV-induced photodamage and skin wrinkle formation in a murine model of photoaging. Therefore, the ability of an LXR ligand to modulate multiple pathways underlying the etiology of skin aging suggests that LXR is a novel target for developing potential therapeutics for photoaging and chronological skin aging indications. (Molecular Endocrinology 22: 2407-2419, 2008)
C1 [Chang, Ken C. N.; Shen, Qi; Jelinsky, Scott A.; Jenkins, Susan F.; Wang, Wei; Wang, Yihe; LaCava, Margaret; Yudt, Matthew R.; Thompson, Catherine C.; Freedman, Leonard P.; Nagpal, Sunil] Wyeth Res, Womens Hlth & Musculoskeletal Biol, Nuclear Receptors & Dermatol, Collegeville, PA 19426 USA.
   [Oh, Inn Gyung; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Lab Cutaneous Aging Res, Seoul 110744, South Korea.
C3 Pfizer; Seoul National University (SNU)
RP Nagpal, S (corresponding author), Wyeth Res, Womens Hlth & Musculoskeletal Biol, Nuclear Receptors & Dermatol, 500 Arcola Rd, Collegeville, PA 19426 USA.
EM jhchung@snu.ac.kr; nagpals@wyeth.com
RI Chung, Jin Ho/C-3604-2011; Nagpal, Sunil/A-8007-2009
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chintalacharuvu SR, 2007, ARTHRITIS RHEUM, V56, P1365, DOI 10.1002/art.22528
   Choi EH, 2007, J INVEST DERMATOL, V127, P2847, DOI 10.1038/sj.jid.5700913
   Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x
   Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049
   Draelos Z. D., 2007, J COSMET DERMATOL-US, V6, P2, DOI DOI 10.1111/J.1473-2165.2007.00313.X
   Fagot D, 2004, PHOTOCHEM PHOTOBIOL, V79, P499, DOI 10.1562/YG-03-11-R1.1
   Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x
   Ghadially R, 1996, J INVEST DERMATOL, V106, P1064, DOI 10.1111/1523-1747.ep12338692
   GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919
   Han JH, 2004, MECH AGEING DEV, V125, P359, DOI 10.1016/j.mad.2004.02.002
   Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x
   Hashizume H, 2004, J DERMATOL, V31, P603, DOI 10.1111/j.1346-8138.2004.tb00565.x
   Inomata S, 2003, J INVEST DERMATOL, V120, P128, DOI 10.1046/j.1523-1747.2003.12021.x
   Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105
   Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200
   Jensen JM, 2005, EXP DERMATOL, V14, P609, DOI 10.1111/j.0906-6705.2005.00342.x
   Jiang YJ, 2006, J LIPID RES, V47, P2248, DOI 10.1194/jlr.M600163-JLR200
   Jiang YJ, 2005, J LIPID RES, V46, P2657, DOI 10.1194/jlr.M500235-JLR200
   JIANG YJ, 2007, J INVEST DERMATOL, V128, P370
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299
   Kim HH, 2006, J LIPID RES, V47, P921, DOI 10.1194/jlr.M500420-JLR200
   Kömüves LG, 2002, J INVEST DERMATOL, V118, P25, DOI 10.1046/j.0022-202x.2001.01628.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027
   Makrantonaki E, 2007, DERMATOLOGY, V214, P352, DOI 10.1159/000100890
   Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046
   Nagpal S, 2003, J INVEST DERMATOL, V120, pVIII, DOI 10.1046/j.1523-1747.2003.t01-1-120022.x
   Nagpal S, 2000, CURR PHARM DESIGN, V6, P919, DOI 10.2174/1381612003400146
   Park CH, 2006, PHOTOCHEM PHOTOBIOL, V82, P574, DOI 10.1562/2005-07-26-RA-623
   Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003
   Rijken F, 2005, BRIT J DERMATOL, V152, P321, DOI 10.1111/J.1365-2133.2004.06335.X
   Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014
   Schmuth M, 2004, J INVEST DERMATOL, V123, P41, DOI 10.1111/j.0022-202X.2004.22707.x
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Seo JY, 2003, MECH AGEING DEV, V124, P903, DOI 10.1016/S0047-6374(03)00150-7
   Singh M, 2006, DERMATOL THER, V19, P297, DOI 10.1111/j.1529-8019.2006.00087.x
   Tanaka K, 2005, J PHARMACOL EXP THER, V315, P624, DOI 10.1124/jpet.105.088674
   Thornfeldt Carl R, 2008, J Cosmet Dermatol, V7, P78, DOI 10.1111/j.1473-2165.2008.00366.x
   Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102
   Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061
   Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302
   Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883
   Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104
   Zeng GY, 1996, EXP CELL RES, V228, P271, DOI 10.1006/excr.1996.0326
   Zettersten EM, 1997, J AM ACAD DERMATOL, V37, P403, DOI 10.1016/S0190-9622(97)70140-3
   Zhang ZY, 2005, EXP GERONTOL, V40, P286, DOI 10.1016/j.exger.2005.01.011
   Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x
NR 54
TC 41
Z9 55
U1 0
U2 2
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0888-8809
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD NOV
PY 2008
VL 22
IS 11
BP 2407
EP 2419
DI 10.1210/me.2008-0232
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 365SZ
UT WOS:000260429400004
PM 18787039
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Li, J
   Zhao, RT
   Zhao, H
   Chen, GY
   Jiang, YH
   Lyu, XL
   Wu, T
AF Li, Jing
   Zhao, Runtian
   Zhao, Huan
   Chen, Guiyun
   Jiang, Yuhan
   Lyu, Xiaoling
   Wu, Tao
TI Reduction of Aging-Induced Oxidative Stress and Activation of Autophagy
   by Bilberry Anthocyanin Supplementation via the AMPK-mTOR Signaling
   Pathway in Aged Female Rats
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE bilberry anthocyanin; aging female rats; intestinal epithelial barrier;
   autophagy; AMPK-mTOR
ID CHAIN FATTY-ACIDS; GUT MICROBIOTA; MASS-SPECTROMETRY; BLUEBERRY;
   DISEASES; RISK; MICE; SEED; SKIN
AB Oxidative-stress-induced senescence constitutes a great risk factor for chronic diseases. Therefore, ameliorating oxidative-stress-induced senescence is expected to prevent chronic diseases. The beneficial effects of bilberry anthocyanin (BA) on healthy aging were evaluated using 12 month old, aging female SD rats in this study. The experimental results suggested that consumption of a middle-dose of BA (MBA) appreciably increased the relative liver mass by 7.34% when compared with that of the AC group. Furthermore, BA significantly increased the total antioxidant capacity, total superoxide dismutase activity, and catalase activities; decreased malondialdehyde, serum low-density lipoprotein cholesterol (LDL-C), serum total cholesterol (TC), serum triglyceride (TG), and glycated serum protein (GSP) levels; and reduced TC/high-density lipoprotein cholesterol (HDL-C) and LDL-C/HDL-C ratios. In addition, MBA decreased the activity of fecal bacterial enzymes and increased the content of fecal short-chain fatty acids. The Western blot results showed that MBA significantly upregulated the expression of OCLN, ZO-1, and autophagy-related proteins (ATP6 V0C, ATG4D, and CTSB) in aging rats. Moreover, it also showed that MBA induced the phosphorylation of AMPK and FOXO3a and inhibited the phosphorylation of mTOR, which indicated that bilberry anthocyanin induced autophagy via the AMPK-mTOR signaling pathways. This induction of autophagy further promoted oxidative stress resistance effects and intestinal epithelial barrier function of bilberry anthocyanin in aging female rats.
C1 [Li, Jing; Zhao, Runtian; Zhao, Huan; Chen, Guiyun; Jiang, Yuhan; Lyu, Xiaoling; Wu, Tao] Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
   [Wu, Tao] Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China.
C3 Tianjin University Science & Technology; Beijing Technology & Business
   University
RP Lyu, XL; Wu, T (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.; Wu, T (corresponding author), Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China.
EM lxling@tust.edu.cn; wutaoxx@gmail.com
RI ; Wu, Tao/E-7769-2011
OI Li, Jing/0000-0002-6896-3474; Wu, Tao/0000-0002-0629-8421
FU Tianjin One Belt and One Road Technological Innovation Project
   [18PTZWHZ00080]; Tianjin Science Technology Fund Planning Project
   [18ZYPTJC00020]; Foundation of the Engineering Research Center of Food
   Biotechnology, Ministry of Education [SPZX002-18]; Innovation of Modern
   Agricultural Project [F18R02]
FX This work was financially supported by the Tianjin One Belt and One Road
   Technological Innovation Project (18PTZWHZ00080); the Tianjin Science
   Technology Fund Planning Project (18ZYPTJC00020); the Foundation
   (SPZX002-18) of the Engineering Research Center of Food Biotechnology,
   Ministry of Education; and the Innovation of Modern Agricultural Project
   (F18R02).
CR Asseburg H, 2016, NEUROMOL MED, V18, P378, DOI 10.1007/s12017-016-8428-4
   Bellantuono I, 2018, NATURE, V554, P293, DOI 10.1038/d41586-018-01668-0
   Biragyn A, 2018, LANCET ONCOL, V19, pE295, DOI 10.1016/S1470-2045(18)30095-0
   Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3
   Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759
   Cani PD, 2019, NAT REV ENDOCRINOL, V15, P69, DOI 10.1038/s41574-018-0143-9
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Figueira I, 2016, MECH AGEING DEV, V160, P69, DOI 10.1016/j.mad.2016.09.009
   Fotschki B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149081
   Ganesan K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050455
   García-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Juskiewicz J, 2011, BRIT J NUTR, V105, P710, DOI 10.1017/S0007114510004344
   Kollia N, 2018, CENT EUR J PUBL HEAL, V26, P3, DOI 10.21101/cejph.a5165
   Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027
   Li DT, 2017, CRIT REV FOOD SCI, V57, P1729, DOI 10.1080/10408398.2015.1030064
   Li FX, 2018, AUTOPHAGY, V14, P66, DOI 10.1080/15548627.2017.1391970
   Li J, 2019, FOOD FUNCT, V10, P333, DOI 10.1039/c8fo01962b
   Li YF, 2018, THERANOSTICS, V8, P5713, DOI 10.7150/thno.28778
   Lila MA, 2016, ANNU REV FOOD SCI T, V7, P375, DOI 10.1146/annurev-food-041715-033346
   Liu XJ, 2018, J FUNCT FOODS, V44, P127, DOI 10.1016/j.jff.2018.03.004
   Ongkowijoyo P, 2018, FOOD CHEM, V250, P113, DOI 10.1016/j.foodchem.2018.01.055
   Osada H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178627
   Popovic D, 2019, CHEM-BIOL INTERACT, V304, P61, DOI 10.1016/j.cbi.2019.02.022
   Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361
   Ruhal P, 2018, INFLAMMOPHARMACOLOGY, V26, P1317, DOI 10.1007/s10787-018-0476-y
   Shakeri H, 2018, AM J PHYSIOL-HEART C, V315, pH448, DOI 10.1152/ajpheart.00287.2018
   Shao XX, 2019, ECOTOX ENVIRON SAFE, V175, P39, DOI 10.1016/j.ecoenv.2019.03.023
   Shi M, 2017, J FUNCT FOODS, V30, P16, DOI 10.1016/j.jff.2016.12.036
   Shimizu S, 2018, BIOMED REP, V8, P198, DOI 10.3892/br.2017.1029
   Tanaka F, 2013, AM J CARDIOL, V112, P1063, DOI 10.1016/j.amjcard.2013.05.049
   Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179
   Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x
   Wei J, 2017, J AGR FOOD CHEM, V65, P5973, DOI 10.1021/acs.jafc.7b02136
   Xiao FH, 2018, GENOME RES, V28, P1601, DOI 10.1101/gr.220780.117
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xue ML, 2018, FOOD FUNCT, V9, P1214, DOI 10.1039/c7fo01677h
   Zeng HL, 2017, J AGR FOOD CHEM, V65, P9217, DOI 10.1021/acs.jafc.7b02860
   Zhang Y, 2018, FOOD FUNCT, V9, P371, DOI [10.1039/c7fo01511a, 10.1039/C7FO01511A]
NR 39
TC 32
Z9 36
U1 3
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 17
PY 2019
VL 67
IS 28
BP 7832
EP 7843
DI 10.1021/acs.jafc.9b02567
PG 12
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA IK6HJ
UT WOS:000476686200005
PM 31242723
DA 2024-02-19
ER

PT J
AU Lim, R
   Hodge, A
   Moore, G
   Wallace, EM
   Sievert, W
AF Lim, Rebecca
   Hodge, Alexander
   Moore, Gregory
   Wallace, Euan M.
   Sievert, William
TI A Pilot Study Evaluating the Safety of Intravenously Administered Human
   Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE liver cirrhosis; phase 1 clinical trial; safety trial; stem cells; cell
   therapy
ID MESENCHYMAL STEM-CELLS; LIVER FIBROSIS; CLINICAL-USE; RAT-LIVER;
   TRANSPLANTATION; CIRRHOSIS; DISEASE; REPAIR
AB Liver cirrhosis is the 6th leading cause of death in adults aged 15-59 years in high-income countries. For many who progress to cirrhosis, the only prospect for survival is liver transplantation. While there is some indication that mesenchymal stem cells may be useful in reversing established liver fibrosis, there are limitations to their widespread use - namely their rarity, the need for extensive serial passaging and the associated potential for genomic instability and cellular senescence. To this end, we propose the use of allogeneic amnion epithelial cells. This clinical trial will assess the safety of intravenously delivered allogeneic human amnion epithelial cells (hAECs) in patients with compensated liver cirrhosis. This will also provide clinical data that will inform phases 2 and 3 clinical trials with the ultimate goal of developing hAECs as a therapeutic option for patients with cirrhosis who are at significant risk of disease progression. We will recruit 12 patients with compensated cirrhosis, based on their hepatic venous pressure gradient, for a dose escalation study. Patients will be closely monitored in the first 24 h post-infusion, then via daily telephone interviews until clinical assessment on day 5. Long term follow up will include standard liver tests, transient elastography and hepatic ultrasound. Ethics approval was obtained from Monash Health for this trial 16052A, "A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Liver Fibrosis, A First in Adult Human Study." The trial will be conducted in accordance to Monash Health Human Ethics guidelines. Outcomes from this study will be disseminated in the form of conference presentations and submission to a peer reviewed journal.
C1 [Lim, Rebecca; Wallace, Euan M.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.
   [Lim, Rebecca; Wallace, Euan M.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.
   [Hodge, Alexander; Moore, Gregory; Sievert, William] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia.
   [Hodge, Alexander; Moore, Gregory; Sievert, William] Monash Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia.
C3 Hudson Institute of Medical Research; Monash University; Monash
   University
RP Lim, R (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.; Lim, R (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.; Sievert, W (corresponding author), Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia.; Sievert, W (corresponding author), Monash Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia.
EM rebecca.lim@hudson.org.au; william.sievert@monash.edu
RI Hodge, Alexander/GRJ-5820-2022; Wallace, Euan M/K-6774-2015; Lim,
   Rebecca/K-5175-2019
OI Wallace, Euan M/0000-0002-4506-5233; Lim, Rebecca/0000-0002-0410-497X;
   Moore, Gregory Thomas Charles/0000-0002-3689-8858
FU National Health and Medical Research Council [1124020]; National Health
   and Medical Research Council of Australia [1124020] Funding Source:
   NHMRC
FX This work was supported by National Health and Medical Research Council
   Project Grant 1124020.
CR AKLE CA, 1981, LANCET, V2, P1003
   Augustin S, 2014, J HEPATOL, V60, P561, DOI 10.1016/j.jhep.2013.10.027
   Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047
   Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149
   Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941
   Chen LJ, 2017, STEM CELL TRANSL MED, V6, P272, DOI 10.5966/sctm.2015-0265
   D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013
   Hodge A, 2014, CYTOTHERAPY, V16, P1132, DOI 10.1016/j.jcyt.2014.01.005
   Hodges RJ, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/709763
   Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Manuelpillai U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038631
   Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496
   Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
   Meier RPH, 2015, J HEPATOL, V62, P634, DOI 10.1016/j.jhep.2014.10.030
   Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13
   Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385
   Murphy SV, 2014, JOVE-J VIS EXP, DOI 10.3791/52085
   Prakoso E, 2010, INTERN MED J, V40, P619, DOI 10.1111/j.1445-5994.2010.02277.x
   Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391
   Suk KT, 2016, HEPATOLOGY, V64, P2185, DOI 10.1002/hep.28693
   Suk KT, 2014, CLIN MOL HEPATOL, V20, P6, DOI 10.3350/cmh.2014.20.1.6
   Tan JL, 2017, STEM CELL TRANSL MED, V6, P1085, DOI 10.5966/sctm.2016-0077
   Tan JL, 2014, CELL TRANSPLANT, V23, P319, DOI 10.3727/096368912X661409
   Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715
   Vosdoganes P, 2013, CELL TRANSPLANT, V22, P1337, DOI 10.3727/096368912X657657
   Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.292
   Wang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-133
   YEAGER AM, 1985, AM J MED GENET, V22, P347, DOI 10.1002/ajmg.1320220219
NR 31
TC 30
Z9 32
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD AUG 23
PY 2017
VL 8
AR 549
DI 10.3389/fphar.2017.00549
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FE9IK
UT WOS:000408517200002
PM 28878671
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wu, SX
   Jiang, XW
   Liu, YY
   Chen, LF
   Tao, J
AF Wu, Su-xi
   Jiang, Xuewei
   Liu, Yu-ying
   Chen, Lin-feng
   Tao, Jun
TI EFFECTS AND MECHANISMS OF A NEW MULTIVITAMIN ON CHRONIC METABOLIC
   SYNDROMES AND AGING
SO AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES
LA English
DT Article
DE Aging; Anti-aging; Metabolic syndrome; Mechanism; Multivitamin
ID AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE; BRAIN
AB Background: Increased occurrence of chronic syndromes has prompted researchers to investigate and develop drugs and methods for controlling chronic syndromes with a view to improve human health and reduce early aging.
   Material and methods: Human trials: After the allotted multivitamin pills or placebo pills had been taken for a stipulated period of about 2 months, the volunteers filled out feedback forms on curative effects of the pills in line with the health examination reports. The effects of the multivitamin on various symptoms or diseases and dysfunctions of the chronic metabolic syndromes were noted and evaluated based on the information provided in forms.
   Animal experiments: Mouse aging model induced by D-galactose were administered the multivitamin by oral gavage every morning. At the end of the sixth week, activity or content of the components associated with ageing and anti-aging in the brain and liver of the aging mice were determined to investigate the mechanisms of the new multivitamin on chronic metabolic syndromes and aging.
   Results: We found that multivitamin can eliminate or attenuate 38 types of symptoms or dysfunctions of the investigated metabolic syndromes; and that it has both preventive and curative/adjunctive therapeutic effects on the metabolic syndromes. The effects of this multivitamin on components associated with aging and anti-aging were significantly decreased - malondialdehyde content and monoamine oxidase activity but significantly increased activity of superoxide dismutase and glutathione peroxidase. This multivitamin has significant anti-aging effects.
   Conclusion: Supplementing with this multivitamin can prevent and provide treatment/adjunctive therapy for these chronic metabolic syndromes and delay the aging process.
C1 [Wu, Su-xi; Jiang, Xuewei; Tao, Jun] Changsha Univ Sci & Technol, Sch Chem & Bioengn, 960 Southern Wanjiali Rd, Changsha 410004, Hunan, Peoples R China.
   [Liu, Yu-ying] Peoples Hosp Hunan Prov, Dept Hlth Care, Changsha 410004, Hunan, Peoples R China.
   [Chen, Lin-feng] Hosp Changsha Univ Sci & Technol, Changsha 410004, Hunan, Peoples R China.
C3 Changsha University of Science & Technology
RP Tao, J (corresponding author), Changsha Univ Sci & Technol, Sch Chem & Bioengn, 960 Southern Wanjiali Rd, Changsha 410004, Hunan, Peoples R China.
EM taojun1954@126.com
FU Construct Program of the Key Discipline in Hunan Province
FX This research was supported by Construct Program of the Key Discipline
   in Hunan Province.
CR [Anonymous], 2013, ELECT J DIFFERENTIAL
   Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426
   BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6
   Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Chen J., 2008, LISHIZHEN MED MAT ME, V19, P15
   Chen JF, 2000, PROG BIOCHEM BIOPHYS, V27, P504
   Chocano-Bedoya PO, 2011, AM J CLIN NUTR, V93, P1080, DOI 10.3945/ajcn.110.009530
   Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031
   Cosgrove MC, 2007, AM J CLIN NUTR, V86, P1225, DOI 10.1093/ajcn/86.4.1225
   Geesaman BJ, 2006, AM J CLIN NUTR, V83, p466S
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huang C., 2003, MED NUTR, P1
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   [李国星 LI GuoXing], 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P820
   Lindley SE, 2005, PSYCHONEUROENDOCRINO, V30, P785, DOI 10.1016/j.psyneuen.2005.03.007
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370
   Pan MH, 2012, MOL NUTR FOOD RES, V56, P88, DOI 10.1002/mnfr.201100509
   Pauling L., 1989, NEW NUTR HLTH LONGEV
   Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005
   Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796
   Ribeiro ML, 2007, MECH AGEING DEV, V128, P577, DOI 10.1016/j.mad.2007.08.002
   Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tao J., 2013, China's invention patents, Patent No. 3013100469819
   Tao J, 2012, FOOD CHEM TOXICOL, V50, P1776, DOI 10.1016/j.fct.2012.02.072
   Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750
   Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216
   Wang J., 2002, BIOCHEMISTRY-US, P433
   Wu K., 2005, NUTR FOOD HYGIENE, P10
   Yang Hong-Zhen, 2009, Sheng Li Ke Xue Jin Zhan, V40, P234
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
NR 33
TC 3
Z9 3
U1 0
U2 6
PU AFRICAN NETWORKS ETHNOMEDICINES
PI ILE-IFE
PA OBAFEMI AWOLOWO UNIV,CLEMENT O ADEWUNMI, DRUG RES PROD UNIT, FAC
   PHARMACY, ILE-IFE, 00000, NIGERIA
SN 0189-6016
J9 AFR J TRADIT COMPLEM
JI Afr. J. Tradit. Complement. Alt. M.
PY 2017
VL 14
IS 1
BP 52
EP 61
DI 10.21010/ajtcam.v14i1.7
PG 10
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA EK1QT
UT WOS:000393701400007
PM 28331914
OA Green Published, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Gielchinsky, Y
   Laufer, N
   Weitman, E
   Abramovitch, R
   Granot, Z
   Bergman, Y
   Pikarsky, E
AF Gielchinsky, Yuval
   Laufer, Neri
   Weitman, Efi
   Abramovitch, Rinat
   Granot, Zvi
   Bergman, Yehudit
   Pikarsky, Eli
TI Pregnancy restores the regenerative capacity of the aged liver via
   activation of an mTORC1-controlled hyperplasia/hypertrophy switch
SO GENES & DEVELOPMENT
LA English
DT Article
DE Liver regeneration; aging; hypertrophy; hyperplasia; mTORC1
ID MICE; GROWTH; PATHWAYS; CELLS; MASS; RAT; DNA; PROLIFERATION;
   HYPERTROPHY; MECHANISM
AB Regenerative capacity is progressively lost with age. Here we show that pregnancy markedly improved liver regeneration in aged mice concomitantly with inducing a switch from proliferation-based liver regeneration to a regenerative process mediated by cell growth. We found that the key mediator of this switch was the Akt/mTORC1 pathway; its inhibition blocked hypertrophy, while increasing proliferation. Moreover, pharmacological activation of this pathway sufficed to induce the hypertrophy module, mimicking pregnancy. This treatment dramatically improved hepatic regenerative capacity and survival of old mice. Thus, cell growth-mediated mass reconstitution, which is relatively resistant to the detrimental effects of aging, is employed in a physiological situation and holds potential as a therapeutic strategy for ameliorating age-related functional deterioration.
C1 [Gielchinsky, Yuval; Granot, Zvi; Bergman, Yehudit] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.
   [Gielchinsky, Yuval; Laufer, Neri] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel.
   [Weitman, Efi; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91120 Jerusalem, Israel.
   [Weitman, Efi; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.
   [Abramovitch, Rinat] Hebrew Univ Jerusalem, Hadassah Med Sch, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel.
C3 Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem; Hebrew
   University of Jerusalem; Hebrew University of Jerusalem
RP Gielchinsky, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.
EM Yehudit.Bergman@huji.ac.il; peli@hadassah.org.il
RI pikarsky, eli/GXV-7099-2022
OI pikarsky, eli/0000-0003-4186-7105
FU Israel Science Foundation; National Institutes of Health; Israel Cancer
   Research Fund; Hadassah Women's Health Fund; Dr. Miriam and Sheldon G.
   Adelson Medical Research Foundation; Horwitz Foundation through The
   Center for Complexity Science
FX We are grateful to Nathalie Corchia, Shafika Alkawasmy, Moran Ephrayim,
   Eti Avraham, and Naama Kanarek for technical assistance; Dr. Rami Yaka
   for help with the open- field recordings; Dr. Ifat Uzi for advice with
   animal care; and Avigail Dreazen for help with confocal imaging. We
   thank Shirley Smith for editorial assistance, and Drs. Ittai Ben-Porath,
   Yosefa Avraham, Roni Seger, Yuval Dor, and Oded Meyuhas for discussions
   and critical reading of the manuscript. We are also indebted to Dr.
   Norman Grover for help with statistical evaluations. This work was
   supported by grants from the Israel Science Foundation (Y. B. and E.
   P.), the National Institutes of Health (Y. B.), the Israel Cancer
   Research Fund (Y. B. and E. P.), the Hadassah Women's Health Fund (Y. G.
   and Y. B.), and the Dr. Miriam and Sheldon G. Adelson Medical Research
   Foundation (E. P.). R. A. is supported by the Horwitz Foundation through
   The Center for Complexity Science. Y. G. is a participant in the
   Hadassah physician scientist program.
CR Asiyanbola B, 2008, J GASTROINTEST SURG, V12, P842, DOI 10.1007/s11605-008-0494-y
   Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221
   Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   ERSKINE MS, 1998, ENCY REPROD, P120
   Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007
   Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027
   Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583
   HOLLISTER A, 1987, LIFE SCI, V40, P11, DOI 10.1016/0024-3205(87)90246-3
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Inderbitzin D, 2004, J GASTROINTEST SURG, V8, P806, DOI 10.1016/j.gassur.2004.07.013
   Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812
   KENNEDY GC, 1958, J ENDOCRINOL, V17, P158, DOI 10.1677/joe.0.0170158
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Labat-Robert J, 2004, AGEING RES REV, V3, P233, DOI 10.1016/j.arr.2003.10.002
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Minamishima YA, 2002, CANCER RES, V62, P995
   Mullany LK, 2007, J BIOL CHEM, V282, P21244, DOI 10.1074/jbc.M702110200
   Nagy P, 2001, HEPATOLOGY, V33, P339, DOI 10.1053/jhep.2001.21326
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Sanders JA, 2008, AM J PHYSIOL-CELL PH, V295, pC406, DOI 10.1152/ajpcell.00450.2007
   Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004
   Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
NR 28
TC 42
Z9 42
U1 0
U2 7
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD MAR 15
PY 2010
VL 24
IS 6
BP 543
EP 548
DI 10.1101/gad.563110
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 569LU
UT WOS:000275599400004
PM 20231314
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lim, JK
   Tate, JP
   Fultz, SL
   Goulet, JL
   Conigliaro, J
   Bryant, KJ
   Gordon, AJ
   Gibert, C
   Rimland, D
   Goetz, MB
   Klein, MB
   Fiellin, DA
   Justice, AC
   Lo Re, V
AF Lim, Joseph K.
   Tate, Janet P.
   Fultz, Shawn L.
   Goulet, Joseph L.
   Conigliaro, Joseph
   Bryant, Kendall J.
   Gordon, Adam J.
   Gibert, Cynthia
   Rimland, David
   Goetz, Matthew Bidwell
   Klein, Marina B.
   Fiellin, David A.
   Justice, Amy C.
   Lo Re, Vincent, III
TI Relationship Between Alcohol Use Categories and Noninvasive Markers of
   Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C
   Virus-Infected, and Uninfected Patients
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE alcohol; liver fibrosis; HIV; hepatitis C; FIB-4
ID PLATELET RATIO INDEX; PREDICTING LIVER FIBROSIS; VETERANS AGING COHORT;
   ASPARTATE-AMINOTRANSFERASE; PSYCHIATRIC-DIAGNOSIS; SAMPLING VARIABILITY;
   CIRRHOSIS; VALIDATION; TESTS; FIB-4
AB Background. It is unclear if the risk of liver disease associated with different levels of alcohol consumption is higher for patients infected with human immunodeficiency virus (HIV) or chronic hepatitis C virus (HCV). We evaluated associations between alcohol use categories and advanced hepatic fibrosis, by HIV and chronic HCV status.
   Methods. We performed a cross-sectional study among participants in the Veterans Aging Cohort Study who reported alcohol consumption at enrollment (701 HIV/HCV-coinfected; 1410 HIV-monoinfected; 296 HCV-monoinfected; 1158 HIV/HCV-uninfected). Alcohol use category was determined by the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) questionnaire and alcohol-related diagnoses and was classified as nonhazardous drinking, hazardous/binge drinking, or alcohol-related diagnosis. Advanced hepatic fibrosis was defined by FIB-4 index >3.25.
   Results. Within each HIV/HCV group, the prevalence of advanced hepatic fibrosis increased as alcohol use category increased. For each alcohol use category, advanced hepatic fibrosis was more common among HIV-infected than uninfected (nonhazardous: 6.7% vs 1.4%; hazardous/binge: 9.5% vs 3.0%; alcohol-related diagnosis: 19.0% vs 8.6%; P < .01) and chronic HCV-infected than uninfected (nonhazardous: 13.6% vs 2.5%; hazardous/binge: 18.2% vs 3.1%; alcohol-related diagnosis: 22.1% vs 6.5%; P < .01) participants. Strong associations with advanced hepatic fibrosis (adjusted odds ratio [95% confidence interval]) were observed among HIV/HCV-coinfected patients with nonhazardous drinking (14.2 [5.91-34.0]), hazardous/binge drinking (18.9 [7.98-44.8]), and alcohol-related diagnoses (25.2 [10.6-59.7]) compared with uninfected nonhazardous drinkers.
   Conclusions. Advanced hepatic fibrosis was present at low levels of alcohol consumption, increased with higher alcohol use categories, and was more prevalent among HIV-infected and chronic HCV-infected patients than uninfected individuals. All alcohol use categories were strongly associated with advanced hepatic fibrosis in HIV/HCV-coinfected patients.
C1 [Lim, Joseph K.; Tate, Janet P.; Goulet, Joseph L.; Justice, Amy C.] Vet Affairs VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Lim, Joseph K.; Tate, Janet P.; Goulet, Joseph L.; Fiellin, David A.; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Fultz, Shawn L.] US FDA, Ctr Tobacco Prod, Washington, DC 20204 USA.
   Hofstra North Shore LIJ Sch Med, Lake Success, NY USA.
   [Conigliaro, Joseph] North Shore LIJ Hlth Syst, Lake Success, NY USA.
   [Bryant, Kendall J.] NIAAA, Bethesda, MD USA.
   [Gordon, Adam J.] Univ Pittsburgh, Pittsburgh, PA 15260 USA.
   [Gordon, Adam J.] Pittsburgh VA Med Ctr, Pittsburgh, PA USA.
   [Gibert, Cynthia] VA Med Ctr, Washington, DC USA.
   [Gibert, Cynthia] George Washington Univ, Med Ctr, Washington, DC 20037 USA.
   [Rimland, David] Atlanta VA Med Ctr, Atlanta, GA USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA 30322 USA.
   [Goetz, Matthew Bidwell] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Klein, Marina B.] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada.
   [Fiellin, David A.; Justice, Amy C.] Yale Univ, Sch Publ Hlth, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT USA.
   [Lo Re, Vincent, III] Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Connecticut Healthcare System; Yale University; US Food & Drug
   Administration (FDA); FDA Center for Tobacco Products (CTP); Northwell
   Health; Hofstra University; Northwell Health; National Institutes of
   Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism
   (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE);
   University of Pittsburgh; George Washington University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA
   Medical Center; Atlanta VA Health Care System; Emory University; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Greater Los Angeles Healthcare System; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill
   University; Yale University; University of Pennsylvania; Pennsylvania
   Medicine; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Philadelphia Veterans Affairs Medical Center;
   University of Pennsylvania
RP Lo Re, V (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Re, Vincent Lo/N-7817-2015; Goetz, Matthew Bidwell/GPX-4090-2022;
   Gordon, Adam Joseph/AAX-9001-2020
OI Gordon, Adam Joseph/0000-0002-2453-8871; Goetz,
   Matthew/0000-0003-4542-992X; Goulet, Joseph Lucien/0000-0002-0842-804X;
   Fiellin, David/0000-0002-4006-010X; Klein, Marina/0000-0002-3063-8430
FU National Institute on Alcohol Abuse and Alcoholism [U01 AA13566, R21
   AA015894]; National Institute of Allergy and Infectious Diseases [K01
   AI070001]
FX This study was supported by the National Institute on Alcohol Abuse and
   Alcoholism (grant numbers U01 AA13566 to A. C. J. and R21 AA015894 to J.
   K. L and A. C. J.) and the National Institute of Allergy and Infectious
   Diseases (grant number K01 AI070001 to V. L. R.).
CR Adler M, 2008, HEPATOLOGY, V47, P762, DOI 10.1002/hep.22085
   Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x
   Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Bhattacharya R, 2003, J CLIN GASTROENTEROL, V36, P242, DOI 10.1097/00004836-200303000-00012
   Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351
   Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199
   Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af
   Campbell JV, 2006, DRUG ALCOHOL DEPEN, V81, P259, DOI 10.1016/j.drugalcdep.2005.07.005
   Chaudhry AA, 2009, HIV MED, V10, P133, DOI 10.1111/j.1468-1293.2008.00662.x
   Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005
   Corrao G, 1998, ALCOHOL ALCOHOLISM, V33, P381
   DAMICO G, 1986, DIGEST DIS SCI, V31, P468, DOI 10.1007/BF01320309
   Friesema IHM, 2004, AM J EPIDEMIOL, V159, P809, DOI 10.1093/aje/kwh102
   Fuster D, 2013, ALCOHOL CLIN EXP RES, V37, P1527, DOI 10.1111/acer.12129
   Fuster D, 2013, AIDS RES HUM RETROV, V29, P1110, DOI [10.1089/aid.2012.0348, 10.1089/AID.2012.0348]
   GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124
   Gordon AJ, 2001, J FAM PRACTICE, V50, P313
   Goulet JL, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000192077.11067.e5
   Hasin DS, 2003, ALCOHOL CLIN EXP RES, V27, P244, DOI 10.1097/01.ALC.0000060878.61384.ED
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66
   Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c
   Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602
   Kim AY, 2005, BLOOD, V105, P1170, DOI 10.1182/blood-2004-06-2336
   Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x
   Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350
   Kranzler HR, 1997, DRUG ALCOHOL DEPEN, V45, P93, DOI 10.1016/S0376-8716(97)01349-5
   KRANZLER HR, 1994, J NERV MENT DIS, V182, P277, DOI 10.1097/00005053-199405000-00005
   Kronenberger B, 2004, HEPATOLOGY, V40, P1442, DOI 10.1002/hep.20487
   Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717
   Lennox R, 2006, DRUG ALCOHOL DEPEN, V83, P95, DOI 10.1016/j.drugalcdep.2005.10.016
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   MAHARAJ B, 1986, LANCET, V1, P523
   Martínez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013
   McGinnis KA, 2013, ALCOHOL CLIN EXP RES, V37, P435, DOI 10.1111/j.1530-0277.2012.01937.x
   McGovern BH, 2007, CLIN INFECT DIS, V44, P431, DOI 10.1086/509580
   Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071
   Muga R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046810
   Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643
   Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576
   Nunes D, 2005, JAIDS-J ACQ IMM DEF, V40, P538, DOI 10.1097/01.qai.0000184856.31695.bf
   Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707
   Price JC, 2012, J INFECT DIS, V205, P1005, DOI 10.1093/infdis/jir885
   Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x
   Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835
   SHAPER AG, 1988, LANCET, V2, P1267
   Soriano V, 2008, AIDS, V22, P1, DOI 10.1097/QAD.0b013e3282f0e2fd
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sullivan LE, 2011, DRUG ALCOHOL DEPEN, V117, P158, DOI 10.1016/j.drugalcdep.2011.01.014
   Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004
   Vallet-Pichard A, 2006, HEPATOLOGY, V44, P769, DOI 10.1002/hep.21334
   Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
NR 60
TC 65
Z9 66
U1 1
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 15
PY 2014
VL 58
IS 10
BP 1449
EP 1458
DI 10.1093/cid/ciu097
PG 10
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA AH3RZ
UT WOS:000336044200020
PM 24569533
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Wang, XJ
   Liu, R
   Wei, C
   Xu, MH
   Li, Y
AF Wang, Xiujuan
   Liu, Rui
   Wei, Chan
   Xu, Meihong
   Li, Yong
TI Exogenous Nucleotides Improved the Oxidative Stress and Sirt-1 Protein
   Level of Brown Adipose Tissue on Senescence-Accelerated Mouse Prone-8
   (SAMP8) Mice
SO NUTRIENTS
LA English
DT Article
DE nucleotides; brown adipose tissue; AMPK; Sirt-1; oxidative stress; aging
ID DIETARY NUCLEOTIDES; METABOLISM; ADIPOCYTE; MODEL; HOMEOSTASIS;
   ACTIVATION; EXPRESSION; PRDM16; IMMUNE; AMPK
AB Brown adipose tissue (BAT) is of great importance in rodents for maintaining their core temperature via non-shivering thermogenesis in the mitochondria. BAT ' s thermogenic function has been shown to decline with age. The activation of adenosine 5 '-monophosphate (AMP)-activated protein kinase/sirtuin-1 (AMPK/Sirt-1) is effective in regulating mitochondrial function. Exogenous nucleotides (NTs) are regulatory factors in many biological processes. Nicotinamide mononucleotide (NMN), which is a derivative of NTs, is widely known as a Sirt-1 activator in liver and muscle, but the effect of NMN and NTs on aging BAT has not been studied before. The purpose of this study was to investigate the effect of NTs on aging senescence-accelerated mouse prone-8 (SAMP8) mice. Senescence-accelerated mouse resistant 1 (SAMR1) mice were set as the model control group and NMN was used as the positive control. Male, 3 month old SAMP8 mice were divided into the SAMP8-normal chow (SAMP8-NC), SAMP8-young-normal chow (SAMP8-young-NC), NMN, NTs-free, NTs-low, NTs-medium, and NTs-high groups for long-term feeding. After 9 months of intervention, interscapular BAT was collected for experiments. Compared to the SAMP8-NC, the body weight and BAT mass were significantly improved in the NT-treated aging SAMP8 mice. NT supplementation had effects on oxidative stress in BAT. The concentration of malondialdehyde (MDA) was reduced and that of superoxide dismutase (SOD) increased significantly. Meanwhile, the expression of the brown adipocyte markers uncoupling protein-1 (UCP-1), peroxisome proliferator-activated receptor-gamma coactlvator-1 alpha (PGC-1 alpha), and PR domain zinc finger protein 16 (PRDM16) were upregulated. The upregulated proteins may be activated via the Sirt-1 pathway. Thus, NT supplementation may be helpful to improve the thermogenesis of BAT by reducing oxidative stress and activating the Sirt-1 pathway.
C1 [Wang, Xiujuan; Liu, Rui; Wei, Chan; Xu, Meihong; Li, Yong] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.
C3 Peking University
RP Li, Y (corresponding author), Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.
EM 1510306116@pku.edu.cn; liuruipku@163.com; chanwei2018@126.com;
   xumeihong@bjmu.edu.cn; liyongbmu@163.com
RI LI, Wenhui/JCD-9947-2023; zhang, yue/JAC-3705-2023; Ma,
   Xiaodong/JAN-7473-2023; Lu, Wang/JVO-0416-2024; LI, Yueyi/JUF-7422-2023
OI Li, Yong/0000-0003-3914-5840; Xu, Meihong/0000-0001-7201-6982
CR Allison DB, 2020, CHRONOBIOL INT, V37, P1119, DOI 10.1080/07420528.2020.1796699
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Cai XX, 2016, MOLECULES, V21, DOI 10.3390/molecules21040435
   CARVER JD, 1994, J NUTR, V124, pS144, DOI 10.1093/jn/124.suppl_1.144S
   Chen C, 2020, MECH AGEING DEV, V187, DOI 10.1016/j.mad.2020.111215
   Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029
   Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746
   Cui XW, 2019, FEBS J, V286, P2753, DOI 10.1111/febs.14838
   Dong WH, 2014, COGN AFFECT BEHAV NE, V14, P879, DOI 10.3758/s13415-013-0218-y
   Eo H, 2015, J AGR FOOD CHEM, V63, P349, DOI 10.1021/jf502830b
   Gao P, 2020, DIABETES, V69, P165, DOI 10.2337/db19-0526
   Graja A, 2019, HANDB EXP PHARMACOL, V251, P55, DOI 10.1007/164_2018_151
   Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Jung SM, 2019, HANDB EXP PHARMACOL, V251, P3, DOI 10.1007/164_2018_168
   Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3
   Kiss T, 2020, GEROSCIENCE, V42, P527, DOI 10.1007/s11357-020-00165-5
   Liu HW, 2017, EXP GERONTOL, V99, P61, DOI 10.1016/j.exger.2017.08.023
   Liu ZH, 2020, CLIN SCI, V134, P315, DOI 10.1042/CS20190966
   Bargut TCL, 2016, EUR J NUTR, V55, P159, DOI 10.1007/s00394-015-0834-0
   Pan RP, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.712372
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Rao Y, 2017, BRIT J PHARMACOL, V174, P2457, DOI 10.1111/bph.13855
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Siahanidou T, 2004, J PEDIATR GASTR NUTR, V38, P56, DOI 10.1097/00005176-200401000-00013
   Tian L, 2019, J PHARMACOL SCI, V139, P352, DOI 10.1016/j.jphs.2019.02.008
   Tint MT, 2021, J CLIN ENDOCR METAB, V106, P2901, DOI 10.1210/clinem/dgab447
   UEJIMA Y, 1991, MECH AGEING DEV, V61, P223, DOI 10.1016/0047-6374(91)90057-7
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Wei ZH, 2015, FISH SHELLFISH IMMUN, V47, P1, DOI 10.1016/j.fsi.2015.08.017
   Xie CY, 2019, J SCI FOOD AGR, V99, P6108, DOI 10.1002/jsfa.9850
   Xu M, 2013, J NUTR HEALTH AGING, V17, P223, DOI 10.1007/s12603-012-0399-z
   Xu MH, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1334485
   Xu WL, 2021, THERANOSTICS, V11, P522, DOI 10.7150/thno.49426
   Yamaguchi S, 2019, P NATL ACAD SCI USA, V116, P23822, DOI 10.1073/pnas.1909917116
   Yang XP, 2020, ADIPOCYTE, V9, P484, DOI 10.1080/21623945.2020.1807850
   Zhang JY, 2016, J THERM BIOL, V58, P72, DOI 10.1016/j.jtherbio.2016.04.003
   Zhou SS, 2015, COMP BIOCHEM PHYS A, V189, P84, DOI 10.1016/j.cbpa.2015.07.017
NR 40
TC 4
Z9 4
U1 7
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2022
VL 14
IS 14
AR 2796
DI 10.3390/nu14142796
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 3H6GZ
UT WOS:000832133800001
PM 35889753
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shibata, N
   Watanabe, T
   Okitsu, T
   Sakaguchi, M
   Takesue, M
   Kunieda, T
   Omoto, K
   Yamamoto, S
   Tanaka, N
   Kobayashi, N
AF Shibata, N
   Watanabe, T
   Okitsu, T
   Sakaguchi, M
   Takesue, M
   Kunieda, T
   Omoto, K
   Yamamoto, S
   Tanaka, N
   Kobayashi, N
TI Establishment of an immortalized human hepatic stellate cell line to
   develop antifibrotic therapies
SO CELL TRANSPLANTATION
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Japanese-Society-for-Regenerative-Medicine
CY APR 18-19, 2002
CL KYOTO, JAPAN
SP Japanese Soc Regenerat Med
DE human hepatic stellate cells; human telomerase reverse transcriptase;
   interferon-gamma; rapamycin; type I collagen
ID RAT-LIVER; GROWTH-FACTOR; GENE-EXPRESSION; IN-VITRO; APOPTOSIS;
   FIBROSIS; ACTIVATION; INHIBITION; RAPAMYCIN; PROLIFERATION
AB Because human hepatic stellate cells (HSCs) perform a crucial role in the progress of hepatic fibrosis, it is of great value to establish an immortalized human cell line that exhibits HSC characteristics and grows well in tissue cultures for the development of antifibrotic therapies. Thus, we engineered an immortalized human hepatic stellate cell (HSC) line TWNT-4 by retrovirally inducing human telomerase reverse transcriptase (hTERT) into LI 90 cells established from a human liver mesenchymal tumor. Parental LI 90 entered replicative senescence, whereas TWNT-4 showed telomerase activity and proliferated for more than population doubling level (PDL) 200 without any crisis. TWNT-4 expressed platelet-derived growth factor-beta receptor (PDGF-betaR), alpha-smooth muscle actin (alpha-SMA), and type I collagen (alpha1) and was considered to be an activated form of HSCs. Treatment of TWNT-4 cells with either 100 U/ml of IFN-gamma or 1 ng/mI of rapamycin (Rapa) for 14 days led to lower expression of type I collagen (alpha1) at RNA and protein levels. Exposure of TWNT-4 cells to both of IFN-gamma (10 U/ml) and Rapa (0.1 ng/ml) for 14 days effectively decreased the expression of type I collagen (alpha1), PDGF-betaR, and alpha-SMA expression and suppressed TGF-beta1 secretion of TWNT-4 cells. We successfully induced apoptosis by transducing TNF-related apoptosis-inducing ligand (TRAIL) into TWNT-4 cells using adenovirus vectors Ad/GT-TRAIL and Ad/PGK-GV-17. These findings suggested that immortalized activated HSC line TWNT-4 would be a useful means to develop antifibrotic therapies.
C1 Okayama Univ, Grad Sch Med & Dent, Dept Surg, Okayama 7008558, Japan.
   Okayama Univ, Grad Sch Med & Dent, Dept Cell Biol, Okayama 7008558, Japan.
   Kawasaki Med Sch, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama 7010114, Japan.
C3 Okayama University; Okayama University; Kawasaki Medical School
RP Kobayashi, N (corresponding author), Okayama Univ, Grad Sch Med & Dent, Dept Surg, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM immortal@md.okayama-u.ac.jp
RI Sakaguchi, Masakiyo/B-2280-2011
CR BACHEM MG, 1992, J CLIN INVEST, V89, P19, DOI 10.1172/JCI115561
   Baroni GS, 1996, HEPATOLOGY, V23, P1189
   Benedetti A, 2001, GASTROENTEROLOGY, V120, P545, DOI 10.1053/gast.2001.21203
   BLOMHOFF R, 1985, J BIOL CHEM, V260, P3560
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   COLLINS K, 1995, CELL, V81, P677, DOI 10.1016/0092-8674(95)90529-4
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   Di Sario A, 1999, GASTROENTEROLOGY, V116, P1155, DOI 10.1016/S0016-5085(99)70019-3
   EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x
   Failli P, 2000, GASTROENTEROLOGY, V119, P479, DOI 10.1053/gast.2000.9354
   Fischer R, 2001, GASTROENTEROLOGY, V120, P1212, DOI 10.1053/gast.2001.23260
   GEERTS A, 1989, J HEPATOL, V9, P59, DOI 10.1016/0168-8278(89)90076-7
   Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864
   Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802
   Hellemans K, 1999, GUT, V45, P134, DOI 10.1136/gut.45.1.134
   HIYAMA E, 1992, JPN J CANCER RES, V83, P159, DOI 10.1111/j.1349-7006.1992.tb00081.x
   Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815
   Hosoi H, 1999, CANCER RES, V59, P886
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Iwamoto H, 1999, J LAB CLIN MED, V134, P83, DOI 10.1016/S0022-2143(99)90057-4
   Kagawa S, 2001, CANCER RES, V61, P3330
   KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866
   Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117
   MURAKAMI K, 1995, LAB INVEST, V72, P731
   OGATA I, 1991, HEPATOLOGY, V14, P361, DOI 10.1016/0270-9139(91)91427-3
   Okuno M, 2001, GASTROENTEROLOGY, V120, P1784, DOI 10.1053/gast.2001.24832
   PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363
   REBOLLO A, 1995, CYTOKINE, V7, P277, DOI 10.1006/cyto.1995.0033
   ROCKEY DC, 1992, HEPATOLOGY, V16, P776, DOI 10.1002/hep.1840160325
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Sakaguchi M, 2000, J CELL BIOL, V149, P1193, DOI 10.1083/jcb.149.6.1193
   Sakaida I, 1998, J HEPATOL, V28, P471, DOI 10.1016/S0168-8278(98)80322-X
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   SHI YF, 1995, CANCER RES, V55, P1982
   Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127
   Sugawara H, 1998, J CELL PHYSIOL, V174, P398, DOI 10.1002/(SICI)1097-4652(199803)174:3<398::AID-JCP14>3.0.CO;2-5
   TIRM N, 2000, AM J PATHOL, V156, P1235
   VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857
   WATANABE T, IN PRESS TRANSPLANTA
   Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971
   Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188
   Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231
   Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3
NR 45
TC 44
Z9 52
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2003
VL 12
IS 5
BP 499
EP 507
DI 10.3727/000000003108747064
PG 9
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 711UU
UT WOS:000184760100007
PM 12953924
DA 2024-02-19
ER

PT J
AU Sun, JY
   Zhu, ZR
   Wang, H
   Li, WW
   Cao, CH
   Liu, L
   Wu, DH
AF Sun, Jing-Yuan
   Zhu, Zhen-Ru
   Wang, Hui
   Li, Wen-Wen
   Cao, Chuan-Hui
   Liu, Li
   Wu, De-Hua
TI Knockdown of <i>UACA</i> inhibitsproliferation and invasion and promotes
   senescence of hepatocellular carcinoma cells
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE UACA; hepatocellular carcinoma; knockdown; proliferation; invasion;
   senescence; HIF1 alpha
ID CELLULAR SENESCENCE; CANCER; APOPTOSIS; EXPRESSION; UPDATE
AB Uveal autoantigen with coiled-coil domains and ankyrin repeats (UACA/Nucling), has been reported to be upregulated in various cancers. However, its expression and function have not been studied in hepatocellular carcinoma (HCC). In the present study, expression of UACA was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and the results revealed that UACA was upregulated in 23 cases of HCC compared with paired corresponding non-tumor liver tissues. In addition, the upregulation of UACA in HCC was further validated by analyzing the datasets from The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA-LIHC) and GSE36376. Furthermore, knockdown of UACA suppressed the proliferative and invasive ability as well as inducing senescence of HCC cells. Besides, the expression level of UACA was positively associated with Hif1 alpha (hypoxia-inducible factor 1 alpha) in HCC datasets from TCGA-LIHC and GSE54236. Moreover, treatment with CoCl2 led to the increased expression and the localization alteration of UACA in HCC cells. In summary, UACA is upregulated in HCC and knockdown of UACA ameliorated malignant behaviors of HCC cells, and UACA was correlated with and under control of Hif1 alpha.
C1 [Sun, Jing-Yuan; Zhu, Zhen-Ru; Wang, Hui; Cao, Chuan-Hui; Wu, De-Hua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China.
   [Li, Wen-Wen; Liu, Li] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Hepatol Unit, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China; Southern Medical University - China
RP Wu, DH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China.; Liu, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Hepatol Unit, Guangzhou 510515, Guangdong, Peoples R China.
EM liuli.fimmu@gmail.com; wudehua.gd@gmail.com
OI Wu, De-Hua/0000-0003-0560-0016
FU National Nature Science Foundation of China [81472711, 81672756,
   81702390, 9154-0111]; Guangdong Province Universities and Colleges Pearl
   River Scholar Funded Scheme; Natural Science Foundation of Guangdong
   Province [2017A03031-0105]
FX This work was supported by the National Nature Science Foundation of
   China (Grant No. 81472711, 81672756, 81702390 and 9154-0111), Guangdong
   Province Universities and Colleges Pearl River Scholar Funded Scheme
   (2015), and the Natural Science Foundation of Guangdong Province (Grant
   No. 2017A03031-0105).
CR Burikhanov R, 2014, CELL REP, V6, P271, DOI 10.1016/j.celrep.2013.12.020
   Burikhanov R, 2013, CANCER RES, V73, P1011, DOI 10.1158/0008-5472.CAN-12-3212
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   El-Deiry WS, 2013, IMPACT GENETIC TARGE
   Hirai K, 2018, INT J ORAL SCI, V10, DOI 10.1038/s41368-018-0015-0
   Inokawa Y, 2016, ONCOL LETT, V12, P3662, DOI 10.3892/ol.2016.5141
   Jin P, 2018, ONCOGENE, V37, P3070, DOI 10.1038/s41388-018-0182-7
   Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300
   Liu L, 2014, ONCOGENE, V33, P909, DOI 10.1038/onc.2013.236
   Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161
   Moravcikova E, 2012, INT J ONCOL, V40, P2111, DOI 10.3892/ijo.2012.1397
   Niu ZS, 2016, WORLD J GASTROENTERO, V22, P9069, DOI 10.3748/wjg.v22.i41.9069
   Ohkura T, 2004, BIOCHEM BIOPH RES CO, V321, P432, DOI 10.1016/j.bbrc.2004.06.162
   Rousalova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077411
   Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200
   Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048
   Teng XC, 2006, J NEUROCHEM, V97, P1126, DOI 10.1111/j.1471-4159.2006.03833.x
   Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578
   Tsoulfas G, 2011, J GASTROENTEROL, V46, P249, DOI 10.1007/s00535-010-0302-9
   Van Dang H, 2015, J BIOL CHEM, V290, P24626, DOI 10.1074/jbc.M115.673848
   Yamada K, 2001, BIOCHEM BIOPH RES CO, V280, P1169, DOI 10.1006/bbrc.2001.4189
NR 22
TC 4
Z9 7
U1 0
U2 5
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PY 2018
VL 11
IS 9
BP 4666
EP 4675
PG 10
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA GV2NN
UT WOS:000445927500046
PM 31949867
DA 2024-02-19
ER

PT J
AU Malikova, AZ
   Shcherbakova, AS
   Konduktorov, KA
   Zemskaya, AS
   Dalina, AA
   Popenko, VI
   Leonova, OG
   Morozov, AV
   Kurochkin, NN
   Smirnova, OA
   Kochetkov, SN
   Kozlov, MV
AF Malikova, Alsu Z.
   Shcherbakova, Anastasia S.
   Konduktorov, Konstantin A.
   Zemskaya, Anastasia S.
   Dalina, Alexandra A.
   Popenko, Vladimir I.
   Leonova, Olga G.
   Morozov, Alexei V.
   Kurochkin, Nikolay N.
   Smirnova, Olga A.
   Kochetkov, Sergey N.
   Kozlov, Maxim V.
TI Pre-Senescence Induction in Hepatoma Cells Favors Hepatitis C Virus
   Replication and Can Be Used in Exploring Antiviral Potential of Histone
   Deacetylase Inhibitors
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hepatitis C virus; TGF-&#946; 1; palbociclib; pre-senescence; DAAs;
   HTAs; HDACi
ID OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; DNA-DAMAGE; GROWTH; LIVER;
   FIBROSIS; INFECTION; REPLICON; THERAPY; ACID
AB Recent evidence suggests that fibrotic liver injury in patients with chronic hepatitis C correlates with cellular senescence in damaged liver tissue. However, it is still unclear how senescence can affect replication of the hepatitis C virus (HCV). In this work, we report that an inhibitor of cyclin-dependent kinases 4/6, palbociclib, not only induced in hepatoma cells a pre-senescent cellular phenotype, including G1 arrest in the cell cycle, but also accelerated viral replicon multiplication. Importantly, suppression of HCV replication by direct acting antivirals (DAAs) was barely affected by pre-senescence induction, and vice versa, the antiviral activities of host-targeting agents (HTAs), such as inhibitors of human histone deacetylases (HDACi), produced a wide range of reactions-from a dramatic reduction to a noticeable increase. It is very likely that under conditions of the G1 arrest in the cell cycle, HDACi exhibit their actual antiviral potency, since their inherent anticancer activity that complicates the interpretation of test results is minimized.
C1 [Malikova, Alsu Z.; Shcherbakova, Anastasia S.; Konduktorov, Konstantin A.; Zemskaya, Anastasia S.; Dalina, Alexandra A.; Popenko, Vladimir I.; Leonova, Olga G.; Morozov, Alexei V.; Kurochkin, Nikolay N.; Smirnova, Olga A.; Kochetkov, Sergey N.; Kozlov, Maxim V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.
C3 Russian Academy of Sciences; Engelhardt Institute of Molecular Biology,
   RAS
RP Kozlov, MV (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia.
EM rasssl44@gmail.com; nas.sherbakova@yandex.ru; kkonduktorov@yandex.ru;
   a.zemskaia@mail.ru; alexandra.dalina@gmail.com; popenko@eimb.ru;
   leonova-kozma@mail.ru; runkel@inbox.ru; nikola.76@mail.ru;
   o.smirnova.imb@gmail.com; snk1952@gmail.com; kozlovmavi@gmail.com
RI Shcherbakova, Anastasia Sergeevna/AAS-5564-2020; Morozov, Alexey
   V/G-2480-2014; Kochetkov, Sergey N./O-1065-2013; Dalina, Alexandra
   A/H-3099-2014; Kozlov, Maxim/GLN-3047-2022; Земская,
   Анастасия/AAU-1932-2021
OI Morozov, Alexey V/0000-0003-4310-8073; Dalina, Alexandra
   A/0000-0002-1413-7580; Kozlov, Maxim/0000-0002-5994-9099; Земская,
   Анастасия/0000-0002-0332-5105; Shcherbakova,
   Anastasia/0000-0002-8099-6877
FU Russian Science Foundation [19-74-10086]; Russian Foundation for Basic
   Research [20-04-00504]; Russian Science Foundation [19-74-10086] Funding
   Source: Russian Science Foundation
FX The experiments on ROS quantification and lysosome analysis were
   supported by the Russian Science Foundation (grant #19-74-10086),
   whereas all other experiments-by the Russian Foundation for Basic
   Research (Grant #20-04-00504).
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007
   BEIGELMAN LN, 1987, CARBOHYD RES, V166, P219, DOI 10.1016/0008-6215(87)80059-9
   Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902
   Bollard J, 2017, GUT, V66, P1286, DOI 10.1136/gutjnl-2016-312268
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Borodkina AV, 2018, ACTA NATURAE, V10, P4, DOI 10.32607/20758251-2018-10-1-4-14
   Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200
   Catanese MT, 2015, VIROLOGY, V479, P221, DOI 10.1016/j.virol.2015.03.014
   Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135
   Crouchet E, 2018, THER ADV GASTROENTER, V11, DOI 10.1177/1756284818759483
   Crowley Lisa C, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087163
   de Jong A, 2012, METHODS MOL BIOL, V803, P183, DOI 10.1007/978-1-61779-364-6_13
   de Souza-Cruz S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0610-6
   Géraldy M, 2019, J MED CHEM, V62, P4426, DOI 10.1021/acs.jmedchem.8b01936
   Gomaa WM, 2014, SAUDI J GASTROENTERO, V20, P59, DOI 10.4103/1319-3767.126324
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hamdane N, 2019, GASTROENTEROLOGY, V156, P2313, DOI 10.1053/j.gastro.2019.02.038
   Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032
   Inoue C, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0011-1
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Kim JA, 2016, IMMUNE NETW, V16, P286, DOI 10.4110/in.2016.16.5.286
   Kim K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155516
   Kozlov MV, 2018, RUSS J BIOORG CHEM+, V44, P453, DOI 10.1134/S1068162018040118
   Kozlov MV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P637, DOI 10.1134/S0006297914070050
   Kozlov MV, 2019, EUR J MED CHEM, V183, DOI 10.1016/j.ejmech.2019.111723
   Kozlov MV, 2019, BIOORG MED CHEM LETT, V29, P2369, DOI 10.1016/j.bmcl.2019.06.006
   Kozlov MV, 2013, BIOORG MED CHEM LETT, V23, P5936, DOI 10.1016/j.bmcl.2013.08.081
   Lam T, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.61
   Lee JS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008021
   Lee JY, 2019, CELL REP, V27, P3602, DOI 10.1016/j.celrep.2019.05.063
   Li CS, 2014, ONCOL LETT, V7, P1673, DOI 10.3892/ol.2014.1957
   Llanos S, 2019, ONCOGENE, V38, P3886, DOI 10.1038/s41388-019-0695-8
   Lu H, 2006, J MED CHEM, V49, P3826, DOI 10.1021/jm0600388
   Malhorta G., 2017, U.S. Patent, Patent No. [No. 9,763,901, 9763901]
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314
   Miettinen TP, 2018, EMBO J, V37, DOI 10.15252/embj.201798359
   Mitchell JK, 2017, MBIO, V8, DOI 10.1128/mBio.00121-17
   Mücke MM, 2018, LIVER INT, V38, P14, DOI 10.1111/liv.13636
   Munakata T, 2014, ANTIVIR RES, V108, P79, DOI 10.1016/j.antiviral.2014.05.011
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Nelson DR, 1997, J VIRAL HEPATITIS, V4, P29, DOI 10.1046/j.1365-2893.1997.00124.x
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006
   Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001
   Ridinger J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28265-5
   Salum GM, 2017, J INTERF CYTOK RES, V37, P310, DOI 10.1089/jir.2016.0127
   Sato A, 2013, J CELL BIOCHEM, V114, P1987, DOI 10.1002/jcb.24541
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Shen SD, 2016, ACS CHEM NEUROSCI, V7, P240, DOI 10.1021/acschemneuro.5b00286
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Stanciu C, 2019, EXPERT OPIN PHARMACO, V20, P379, DOI 10.1080/14656566.2018.1560424
   Te Helen S, 2007, Gastroenterol Hepatol (N Y), V3, P218
   Valgimigli M, 2002, FREE RADICAL RES, V36, P939, DOI 10.1080/107156021000006653
   Vieyres G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030233
   Vijayaraghavan S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15916
   Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Wang YF, 2015, CHEM BIOL, V22, P273, DOI 10.1016/j.chembiol.2014.12.015
   Wijetunga NA, 2017, ONCOGENE, V36, P2030, DOI 10.1038/onc.2016.340
   Yeo W, 2012, J CLIN ONCOL, V30, P3361, DOI 10.1200/JCO.2011.41.2395
   Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528
   Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115
   Zhang Y, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022145
   Zhou H., 2018, WATER INSOLUBLE DRUG, V3rd, P97
   Zhou Y, 2018, VIROL SIN, V33, P418, DOI 10.1007/s12250-018-0057-7
NR 73
TC 4
Z9 4
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2021
VL 22
IS 9
AR 4559
DI 10.3390/ijms22094559
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA SC0ES
UT WOS:000650356800001
PM 33925399
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Koricanac, G
   Stojiljkovic, M
   Radivojsa, S
   Zakula, Z
   Ribarac-Stepic, N
   Isenovic, ER
AF Koricanac, G.
   Stojiljkovic, Mojca
   Radivojsa, Snezana
   Zakula, Zorica
   Ribarac-Stepic, Nevena
   Isenovic, Esma R.
TI Effects of dexamethasone on insulin receptor in aging
SO ACTA BIOLOGICA HUNGARICA
LA English
DT Article
DE dexamethasone; insulin receptor; aging; liver; erythrocytes
ID PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOCORTICOID REGULATION;
   HUMAN-ERYTHROCYTES; GENE-EXPRESSION; MESSENGER-RNA; RAT-LIVER;
   SUBSTRATE-1; RESISTANCE; MUSCLE; DIFFERENTIATION
AB The aim of this study was to examine the effects of dexamethasone (Dex) on functional properties of the rat insulin receptor (IR). Male Mill Hill hooded rats, 3, 6, 12, 18 and 21 months old, were injected with Dex (4 mg/kg) and rat liver and erythrocytes were used for experiments 18 h after Dex administration. Treatment with Dex lowered the specific binding (SB) of insulin ( INS) in the liver of 3- and 18-month-old rats and concentration of INS binding sites (N-1, N-2) and the dissociation constant of low-affinity binding sites (Kd(2)) in the liver of 6- and 18-month-old rats. In addition, Dex treatment lowered the liver IR protein level in all analyzed groups, except 21-month-old rats where it remained unchanged, but raised the IR mRNA level in 18-month-old rats. In erythrocytes, treatment with Dex decreased SB and Kd2 ( in animals 3 and 6 months old) and N1 ( in ones 3 and 18 months old). Following Dex treatment, the INS plasma level increased ( in rats 3, 18 and 21 months old), while glucose (Glu) concentration increased in 3 and 12 months old, but decreased in 6- and 21-month-old rats. In summary, Dex exerts the strongest effect on the erythrocyte IR of 3- and 6- month-old rats and the hepatic IR of 18-month-old rats. IR in both tissues is almost insensitive to Dex in 12- and 21-month-old rats. The pattern of age-related changes of IR induced by Dex does not correlate with changes of plasma Glu and INS.
C1 [Koricanac, G.; Stojiljkovic, Mojca; Radivojsa, Snezana; Zakula, Zorica; Ribarac-Stepic, Nevena] Vinca Inst Nucl Sci, Lab Mol Biol & Endocrinol, Belgrade 11001, Serbia.
   [Isenovic, Esma R.] Vinca Inst Nucl Sci, Lab Radiobiol & Mol Genet, Belgrade 11001, Serbia.
C3 University of Belgrade; University of Belgrade
RP Koricanac, G (corresponding author), Vinca Inst Nucl Sci, Lab Mol Biol & Endocrinol, POB 522, Belgrade 11001, Serbia.
EM gogi@rt270.vin.bg.ac.yu
RI Isenovic, Esma/D-3017-2009; Korićanac, Goran/ABF-6544-2021
OI Isenovic, Esma/0000-0002-0012-2636; Stojiljkovic,
   Mojca/0000-0002-9041-7947; Koricanac, Goran/0000-0002-9852-3330;
   Tepavcevic, Snezana/0000-0002-5758-070X
CR Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
   Barbera M, 2001, EUR J ENDOCRINOL, V145, P799, DOI 10.1530/eje.0.1450799
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Dardevet D, 1998, J ENDOCRINOL, V156, P83, DOI 10.1677/joe.0.1560083
   De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151
   Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743
   ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5
   Folli F, 1996, ACTA DIABETOL, V33, P185
   Fulop T, 2003, PATHOL BIOL, V51, P574, DOI 10.1016/j.patbio.2003.09.007
   GAMBHIR KK, 1977, CLIN CHEM, V23, P1590
   GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424
   HARDING JD, 1978, J BIOL CHEM, V253, P7531
   HINES D, 1994, J RECEPTOR RES, V14, P297, DOI 10.3109/10799899409066038
   HOFFMAN K, 1987, BIOCHEMISTRY-US, V26, P7384
   Klein HH, 2002, J HEPATOL, V37, P432, DOI 10.1016/S0168-8278(02)00217-9
   Koricanac G, 2006, GEN PHYSIOL BIOPHYS, V25, P11
   Koricanac G, 2004, BIOGERONTOLOGY, V5, P345, DOI 10.1007/s10522-004-2576-x
   LEE JK, 1994, MOL ENDOCRINOL, V8, P625, DOI 10.1210/me.8.5.625
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAMULA PW, 1990, DIABETES CARE, V13, P288, DOI 10.2337/diacare.13.3.288
   Masella R., 1995, Journal of Biomedical Science, V2, P242, DOI 10.1007/BF02253384
   MOLDENHAUER I, 1994, INT J TISSUE REACT, V16, P113
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   Novelli M, 1999, J ENDOCRINOL, V162, P425, DOI 10.1677/joe.0.1620425
   Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283
   PETERSON SW, 1983, J BIOL CHEM, V258, P9605
   RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559
   ROUILLER DG, 1988, J BIOL CHEM, V263, P13185
   Rutter GA, 2000, CURR BIOL, V10, pR736, DOI 10.1016/S0960-9822(00)00737-5
   SAAD MJA, 1994, MOL ENDOCRINOL, V8, P545, DOI 10.1210/me.8.5.545
   SAAD MJA, 1995, ENDOCRINOLOGY, V136, P1579, DOI 10.1210/en.136.4.1579
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sevaljevic L, 2001, BIOL SIGNAL RECEPT, V10, P299
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   TIKHONOVA N E, 1991, Problemy Endokria, V37, P47
   Yen SSC, 1998, EXP GERONTOL, V33, P897, DOI 10.1016/S0531-5565(98)00046-1
NR 37
TC 2
Z9 2
U1 1
U2 1
PU AKADEMIAI KIADO ZRT
PI BUDAPEST
PA BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY
SN 0236-5383
EI 1588-256X
J9 ACTA BIOL HUNG
JI Acta Biol. Hung.
PD MAR
PY 2008
VL 59
IS 1
BP 17
EP 29
DI 10.1556/ABiol.59.2008.1.2
PG 13
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 264AC
UT WOS:000253256600002
PM 18401942
DA 2024-02-19
ER

PT J
AU Oberley, TD
   Swanlund, JM
   Zhang, HJ
   Kregel, KC
AF Oberley, Terry D.
   Swanlund, Jamie M.
   Zhang, Hannah J.
   Kregel, Kevin C.
TI Aging results in increased autophagy of mitochondria and protein
   nitration in rat hepatocytes following heat stress
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE mitochondria; 3-nitrotyrosine; autophagy; heat stress; oxidative stress
ID OXIDATIVE STRESS; NITRIC-OXIDE; TYROSINE NITRATION; SHOCK PROTEINS;
   LIVER; EXPRESSION; OXIDANTS; DAMAGE; HSP70; CELLS
AB The natural breakdown of cells, tissues, and organ systems is a significant consequence of aging and is at least partially caused by a decreased ability to tolerate environmental stressors. Based on quantitative ultrastructural analysis using transmission electron microscopy and computer imaging, we show significant differences in hepatocyte morphology between young and old rats during a 48-hr recovery period following a 2-day heat stress protocol. Mitochondrial injury was greater overall in old compared with young rats. Autophagy was observed in both young and old rats, with autophagy greater overall in old compared with young hepatocytes. Lipid peroxidation and protein nitration were evaluated by localization and quantification of 4-hydroxy-2-nonenal (4-HNE)-modified protein adducts and 3-nitrotyrosine (3-NT) levels, respectively. Levels of 3-NT but not 4-HNE-protein adducts were significantly elevated in hepatocytes of old rats in comparison with young at 90 min after heat stress, suggesting a major role for reactive nitrogen species in the pathology observed at this time point. These results show a differential response of hepatocyte mitochondria to heat stress with aging, as well as greater levels of both autophagic and nitrative damage in old vs young hepatocytes. This manuscript contains online supplemental material at http://www.jhc.org. Please visit this article online to view these materials.
C1 [Oberley, Terry D.; Swanlund, Jamie M.] William S Middleton Mem Vet Adm Med Ctr, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Oberley, Terry D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA.
   [Zhang, Hannah J.; Kregel, Kevin C.] Univ Iowa, Dept Radiat Oncol, Radiat Biol Program, Iowa City, IA USA.
   [Zhang, Hannah J.; Kregel, Kevin C.] Univ Iowa, Dept Integrat Physiol & Free Rad, Iowa City, IA USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital; University of Wisconsin
   System; University of Wisconsin Madison; University of Iowa; University
   of Iowa
RP Oberley, TD (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Dept Pathol & Lab Med, Room A-35,2500 Overlook Terrace, Madison, WI 53705 USA.
EM toberley@wisc.edu; kevin-kregel@uiowa.edu
FU NIA NIH HHS [R01 AG012350, AG012350] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Chaiswing L, 2004, TOXICOL PATHOL, V32, P536, DOI 10.1080/01926230490502601
   Chen T, 2003, CURR MOL MED, V3, P519, DOI 10.2174/1566524033479582
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Ghadially F., 1997, ULTRASTRUCTURAL PATH
   HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232
   Heydari AR, 2000, EXP CELL RES, V256, P83, DOI 10.1006/excr.2000.4808
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kabakov AE, 2002, AM J PHYSIOL-CELL PH, V283, pC521, DOI 10.1152/ajpcell.00503.2001
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402
   KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   KREGEL KC, 1990, J APPL PHYSIOL, V68, P1337, DOI 10.1152/jappl.1990.68.4.1337
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738
   Leeuwenburgh C, 1998, AM J PHYSIOL-REG I, V274, pR453, DOI 10.1152/ajpregu.1998.274.2.R453
   Lucocq JM, 2004, J HISTOCHEM CYTOCHEM, V52, P991, DOI 10.1369/jhc.3a6178.2004
   Mayhew TM, 2004, HISTOCHEM CELL BIOL, V122, P171, DOI 10.1007/s00418-004-0685-x
   Misset B, 2006, CRIT CARE MED, V34, P1087, DOI 10.1097/01.CCM.0000206469.33615.02
   Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853
   Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007
   NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795, DOI 10.1152/ajpheart.1994.267.5.H1795
   Oberley TD, 2002, METHOD ENZYMOL, V352, P373
   Oberley TD, 2000, PROSTATE, V44, P144, DOI 10.1002/1097-0045(20000701)44:2<144::AID-PROS7>3.0.CO;2-G
   Putics A, 2008, ANTIOXID REDOX SIGN, V10, P65, DOI 10.1089/ars.2007.1866
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Riezman H, 2004, CELL CYCLE, V3, P61
   RUBBO H, 1994, J BIOL CHEM, V269, P26066
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SPITZ DR, 1991, FREE RADICAL BIO MED, V11, P415, DOI 10.1016/0891-5849(91)90159-Z
   Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22
   Tandara AA, 2006, J SURG RES, V132, P32, DOI 10.1016/j.jss.2005.09.019
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009
   Terman Alexei, 2006, Molecular Aspects of Medicine, V27, P471, DOI 10.1016/j.mam.2006.08.006
   Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013
   TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6
   Zhang HJ, 2006, J APPL PHYSIOL, V100, P1385, DOI 10.1152/japplphysiol.01046.2005
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 51
TC 50
Z9 56
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0022-1554
EI 1551-5044
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD JUN
PY 2008
VL 56
IS 6
BP 615
EP 627
DI 10.1369/jhc.2008.950873
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 301IT
UT WOS:000255890300010
PM 18379016
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU DINI, L
   LENTINI, A
   DEVIRGILIIS, LC
AF DINI, L
   LENTINI, A
   DEVIRGILIIS, LC
TI BINDING AND UPTAKE OF LIGANDS FOR MANNOSE-SPECIFIC RECEPTORS IN
   LIVER-CELLS - AN ELECTRON-MICROSCOPIC STUDY DURING DEVELOPMENT AND AGING
   IN RAT
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV ROME LA SAPIENZA,DEPT CELLULAR & DEV BIOL,I-00173 ROME,ITALY.
C3 Sapienza University Rome
RP DINI, L (corresponding author), UNIV ROME TOR VERGATA,DEPT BIOL,VIA E CARNEVALE,I-00173 ROME,ITALY.
CR ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   BROWN TL, 1978, ARCH BIOCHEM BIOPHYS, V188, P418, DOI 10.1016/S0003-9861(78)80026-5
   DINI L, 1987, EUR J CELL BIOL, V44, P144
   DINI L, 1989, MECH AGEING DEV, V50, P57, DOI 10.1016/0047-6374(89)90059-6
   DINI L, 1989, EXP CELL RES, V27, P794
   ESHDAT Y, 1984, BIOL CELL, V51, P259, DOI 10.1111/j.1768-322X.1984.tb00307.x
   EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185
   HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7440
   HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352
   HUBARD AL, 1979, J CELL BIOL, V83, P47
   KEMPKA G, 1988, EXP CELL RES, V176, P38, DOI 10.1016/0014-4827(88)90118-8
   LENNARTZ MR, 1987, J BIOL CHEM, V262, P9942
   MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651
   MAYNARD Y, 1982, J BIOL CHEM, V257, P3788
   MIZUNO Y, 1981, J BIOL CHEM, V256, P4247
   MORI K, 1983, ARCH BIOCHEM BIOPHYS, V222, P542, DOI 10.1016/0003-9861(83)90552-0
   OSHUMI Y, 1987, J BIOL CHEM, V262, P7955
   PRAANINGVANDALEN DP, 1987, HEPATOLOGY, V7, P672
   SCHLESINGER PH, 1980, BIOCHEM J, V192, P597, DOI 10.1042/bj1920597
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   STAHL PD, 1984, BIOL CELL, V51, P215, DOI 10.1111/j.1768-322X.1984.tb00301.x
   SUMMERFIELD JA, 1986, BIOCHIM BIOPHYS ACTA, V883, P197, DOI 10.1016/0304-4165(86)90309-0
   TOLLESHAUG H, 1984, BIOCHEM J, V223, P151, DOI 10.1042/bj2230151
   TOWNSEND R, 1981, BIOCHEM J, V194, P209, DOI 10.1042/bj1940209
   WARR GA, 1980, BIOCHEM BIOPH RES CO, V93, P737, DOI 10.1016/0006-291X(80)91139-0
   WILD J, 1983, BIOCHEM J, V210, P167, DOI 10.1042/bj2100167
NR 27
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD NOV
PY 1990
VL 56
IS 2
BP 117
EP 128
DI 10.1016/0047-6374(90)90003-X
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EL181
UT WOS:A1990EL18100003
PM 2290351
DA 2024-02-19
ER

PT J
AU ONO, T
   DEAN, RG
   CHATTOPADHYAY, SK
   CUTLER, RG
AF ONO, T
   DEAN, RG
   CHATTOPADHYAY, SK
   CUTLER, RG
TI DYSDIFFERENTIATIVE NATURE OF AGING - AGE-DEPENDENT EXPRESSION OF MULV
   AND GLOBIN GENES IN THYMUS, LIVER AND BRAIN IN THE AKR MOUSE STRAIN
SO GERONTOLOGY
LA English
DT Article
C1 UNIV NEW MEXICO,FAC MED,DEPT FAMILY COMMUN & EMERGENCY MED,ALBUQUERQUE,NM 87131.
   NCI,VIRAL DIS LAB,BETHESDA,MD 20205.
   NIA,FRANCIS SCOTT KEY MED CTR,GERONTOL RES CTR,BALTIMORE,MD 21224.
C3 University of New Mexico; National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); National Institutes of Health (NIH) -
   USA; NIH National Institute on Aging (NIA)
RP ONO, T (corresponding author), UNIV TOKYO,FAC MED,DEPT RADIAT BIOPHYS,TOKYO 113,JAPAN.
CR ASTRIN SM, 1978, P NATL ACAD SCI USA, V75, P5941, DOI 10.1073/pnas.75.12.5941
   BALDA MA, 1972, J VIROL, V10, P1002
   BANTLE JA, 1976, ANAL BIOCHEM, V72, P413, DOI 10.1016/0003-2697(76)90549-2
   BERNS A, 1976, P NATL ACAD SCI USA, V73, P2448, DOI 10.1073/pnas.73.7.2448
   CANAANI E, 1979, P NATL ACAD SCI USA, V76, P1677, DOI 10.1073/pnas.76.4.1677
   CHATTOPADHYAY SK, 1974, COLD SPRING HARB SYM, V39, P1085, DOI 10.1101/SQB.1974.039.01.124
   CHATTOPADHYAY SK, 1974, P NATL ACAD SCI USA, V71, P167, DOI 10.1073/pnas.71.1.167
   CHEN S, 1980, CELL, V21, P849, DOI 10.1016/0092-8674(80)90448-1
   COLETTA G, 1979, EXPL CELL RES, V119, P253
   CROKER BP, 1977, JNCI-J NATL CANCER I, V59, P199, DOI 10.1093/jnci/59.1.199
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   Cutler R.G., 1984, P1
   CUTLER RG, 1982, AGING BRAIN, V20, P25
   Cutler RG., 1982, TESTING THEORIES AGI
   CUTLER RG, 1984, FREE RADICALS MOL BI, P235
   DEAN RG, 1985, UNPUB ARCH GERONTOL
   DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863
   EVANS MJ, 1969, BIOCHEMISTRY-US, V8, P3000, DOI 10.1021/bi00835a048
   FLORINE DL, 1980, CANCER RES, V40, P517
   GETZ MJ, 1977, CELL, V11, P909, DOI 10.1016/0092-8674(77)90302-6
   GETZ MJ, 1976, CELL, V7, P255, DOI 10.1016/0092-8674(76)90025-8
   GETZ MJ, 1981, NIH812194 NATL I AG, P226
   Gross L., 1970, ONCOGENIC VIRUSES
   GROUDINE M, 1975, P NATL ACAD SCI USA, V72, P4464, DOI 10.1073/pnas.72.11.4464
   HARTLEY JW, 1967, J VIROL, V3, P126
   HIGASHI K, 1966, CANCER RES, V26, P1582
   HUEBNER RJ, 1976, RECENT RESULTS CANCE, V54, P61
   HUMPHRIES S, 1976, CELL, V7, P267, DOI 10.1016/0092-8674(76)90026-X
   JAENISCH R, 1975, P NATL ACAD SCI USA, V72, P4008, DOI 10.1073/pnas.72.10.4008
   JAHNER D, 1980, NATURE, V287, P456, DOI 10.1038/287456a0
   KAWASHIMA K, 1976, P NATL ACAD SCI USA, V73, P4680, DOI 10.1073/pnas.73.12.4680
   LERNER RA, 1976, J EXP MED, V143, P151, DOI 10.1084/jem.143.1.151
   MEIER H, 1973, P NATL ACAD SCI USA, V70, P1450, DOI 10.1073/pnas.70.5.1450
   MICHALIDES R, 1978, P NATL ACAD SCI USA, V75, P2368, DOI 10.1073/pnas.75.5.2368
   MINTY AJ, 1978, EXP CELL RES, V115, P1, DOI 10.1016/0014-4827(78)90395-6
   NAKAKUKI K, 1967, ACTA HAEMATOL-BASEL, V38, P317, DOI 10.1159/000209031
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   PERIES J, 1977, J NATL CANCER I, V59, P463, DOI 10.1093/jnci/59.2.463
   PERLMAN SM, 1977, P NATL ACAD SCI USA, V74, P3835, DOI 10.1073/pnas.74.9.3835
   PETERS RL, 1972, INT J CANCER, V10, P283, DOI 10.1002/ijc.2910100208
   PRAGNELL IB, 1977, EXP CELL RES, V108, P269, DOI 10.1016/S0014-4827(77)80034-7
   PROST E, 1979, J MOL BIOL, V135, P709
   ROWE WP, 1972, J EXP MED, V135, P429, DOI 10.1084/jem.135.2.429
   SATO T, 1971, CANCER RES, V31, P1402
   SCHUMANN G, 1977, J NATN CANCER I, V59, P199
   STRAND M, 1974, P NATL ACAD SCI USA, V71, P3682, DOI 10.1073/pnas.71.9.3682
   STROB U, 1977, BIOCHEMISTRY, V16, P5432
   THERWATH A, 1978, P NATL ACAD SCI USA, V75, P3776, DOI 10.1073/pnas.75.8.3776
   TOOZE J, 1973, MOL BIOL TUMOUR VIRU, P616
   VARMUS HE, 1973, J MOL BIOL, V79, P663, DOI 10.1016/0022-2836(73)90070-3
   WOLD BJ, 1978, CELL, V14, P941, DOI 10.1016/0092-8674(78)90348-3
   YOUNG BD, 1974, J MOL BIOL, V84, P555, DOI 10.1016/0022-2836(74)90116-8
NR 52
TC 21
Z9 21
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PY 1985
VL 31
IS 6
BP 362
EP 372
DI 10.1159/000212725
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA ATB01
UT WOS:A1985ATB0100003
PM 2998953
DA 2024-02-19
ER

PT J
AU Baker, DJ
   Betik, AC
   Krause, DJ
   Hepple, RT
AF Baker, David J.
   Betik, Andrew C.
   Krause, Daniel J.
   Hepple, Russell T.
TI No decline in skeletal muscle oxidative capacity with aging in long-term
   calorically restricted rats: Effects are independent of mitochondrial
   DNA integrity
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID DELETION MUTATIONS; PROTON LEAK; LIVER-MITOCHONDRIA; COACTIVATOR PGC-1;
   RHESUS-MONKEYS; FIBER ATROPHY; AGE; ABNORMALITIES; MICE; DAMAGE
AB We investigated if calorie restriction (CR) preserved skeletal muscle oxidative capacity with aging after accounting for life span extension by CR, and determined if mitochondrial content, mitochondrial DNA integrity, and peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) were involved. Ad libitum-fed (AL) and CR animals representing young adult, late middle age, and senescence were studied. Whereas citrate synthase and complex IV activities were lower in plantaris and gastrocnemius muscle of young adult CR animals, in contrast to the 15%-40% decline in senescent AL animals, there was no decline with aging in CR animals. There was no decline in citrate synthase protein in gastrocnemius with aging in either group, suggesting that CR preserves oxidative capacity with aging by protecting mitochondrial function rather than content. This protection was independent of mitochondrial DNA damage between groups. However, there was a slower decline in PGC-1 alpha gene expression with aging in CR versus AL animals, suggesting a better maintenance of mitochondrial biogenesis with aging in CR animals.
C1 Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada.
   Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.
C3 University of Calgary; University of Calgary
RP Hepple, RT (corresponding author), Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada.
EM hepple@ucalgary.ca
OI Hepple, Russell/0000-0003-3640-486X; Betik, Andrew/0000-0001-8294-9719
CR Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   COGGAN AR, 1992, J GERONTOL, V47, P71
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;107::AID-DVG3&gt;3.0.CO;2-D
   ESSENGUSTAVSSON B, 1986, ACTA PHYSIOL SCAND, V126, P107, DOI 10.1111/j.1748-1716.1986.tb07793.x
   Glantz S. A., 2002, PRIMER BIOSTATISTICS
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Hagopian K, 2005, AM J PHYSIOL-ENDOC M, V288, pE674, DOI 10.1152/ajpendo.00382.2004
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje
   Jones SW, 2004, J PHARMACOL EXP THER, V311, P1225, DOI 10.1124/jpet.104.071589
   Kopsidas G, 2002, BIOGERONTOLOGY, V3, P29, DOI 10.1023/A:1015290810222
   Lal SB, 2001, J GERONTOL A-BIOL, V56, pB116, DOI 10.1093/gerona/56.3.B116
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Lee CM, 1998, ANN NY ACAD SCI, V854, P182, DOI 10.1111/j.1749-6632.1998.tb09901.x
   LEE CM, 1993, J GERONTOL, V48, P201
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   MASORO EJ, 2003, SCI AGING KNOWLEDGE, pRE2
   Mathieu-Costello O, 2005, J APPL PHYSIOL, V99, P281, DOI 10.1152/japplphysiol.00750.2004
   Mayhew M, 1998, BIOCHEM BIOPH RES CO, V251, P95, DOI 10.1006/bbrc.1998.9438
   Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4
   ORLANDER J, 1980, ACTA PHYSIOL SCAND, V109, P149, DOI 10.1111/j.1748-1716.1980.tb06580.x
   Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294
   Pak JW, 2004, ANN NY ACAD SCI, V1019, P289, DOI 10.1196/annals.1297.049
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1
   Spindler SR, 2001, ANN NY ACAD SCI, V928, P296
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   Stuart JA, 2005, FREE RADICAL BIO MED, V38, P737, DOI 10.1016/j.freeradbiomed.2004.12.003
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005
   Szibor M, 2003, BASIC RES CARDIOL, V98, P210, DOI 10.1007/s00395-003-0421-z
   Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
NR 61
TC 68
Z9 82
U1 0
U2 7
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1030 15TH ST NW, STE 250, WASHINGTON, DC 20005202-842 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 2006
VL 61
IS 7
BP 675
EP 684
DI 10.1093/gerona/61.7.675
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 071ZO
UT WOS:000239642600007
PM 16870628
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU SLAGBOOM, PE
   DELEEUW, WJF
   VIJG, J
AF SLAGBOOM, PE
   DELEEUW, WJF
   VIJG, J
TI MESSENGER-RNA LEVELS AND METHYLATION PATTERNS OF GAPDH AND BETA-ACTIN
   GENES IN RAT-LIVER, SPLEEN AND BRAIN IN RELATION TO AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 TNO,INST EXPTL GERONTOL,DEPT MOLEC BIOL,POB 5815,2280 HV RIJSWIJK,NETHERLANDS.
C3 Netherlands Organization Applied Science Research
RI Slagboom, Pieternella/R-4790-2016
OI Slagboom, Pieternella/0000-0002-2875-4723
CR AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
   BIRD AP, 1984, NATURE, V307, P503, DOI 10.1038/307503a0
   CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   DELEEUW WJF, 1989, NUCLEIC ACIDS RES, V17, P10137, DOI 10.1093/nar/17.23.10137
   DODEMONT HJ, 1982, EMBO J, V1, P167, DOI 10.1002/j.1460-2075.1982.tb01142.x
   DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431
   GERSHON D, 1985, INTERRELATIONSHIP AG, P143
   GOLDSTEIN S, 1985, NUCLEIC ACIDS RES, V13, P7055, DOI 10.1093/nar/13.19.7055
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   HORBACH GJM, 1986, TOPICS AGING RES EUR, V7, P121
   KRUMLAUF R, 1982, P NATL ACAD SCI-BIOL, V79, P2971, DOI 10.1073/pnas.79.9.2971
   LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951
   RICHARDSON A, 1985, AGING-US, V29, P229
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4
   SLAGBOOM PE, 1989, GENOME, V31, P373, DOI 10.1139/g89-057
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   VANZWIETEN MJ, 1984, RAT ANIMAL MODEL BRE
   WAALWIJK C, 1978, NUCLEIC ACIDS RES, V5, P3232
   WELLINGER R, 1986, MECH AGEING DEV, V34, P203, DOI 10.1016/0047-6374(86)90035-7
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
NR 29
TC 62
Z9 70
U1 3
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD APR 30
PY 1990
VL 53
IS 3
BP 243
EP 257
DI 10.1016/0047-6374(90)90042-E
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DE427
UT WOS:A1990DE42700004
PM 2376984
DA 2024-02-19
ER

PT J
AU Haduch, A
   Danek, PJ
   Kuban, W
   Puklo, R
   Alenina, N
   Golebiowska, J
   Popik, P
   Bader, M
   Daniel, WA
AF Haduch, Anna
   Danek, Przemyslaw J.
   Kuban, Wojciech
   Puklo, Renata
   Alenina, Natalia
   Golebiowska, Joanna
   Popik, Piotr
   Bader, Michael
   Daniel, Wladyslawa A.
TI Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and
   serotonin deficiency in the brain and liver of female Dark Agouti rats
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article; Early Access
DE CYP2D; Aging; TPH2-deficit; Brain; Liver; Females
ID DRUG-METABOLISM; DOPAMINE FORMATION; SEX; AGE; EXPRESSION;
   5-METHOXYTRYPTAMINE; PHARMACODYNAMICS; NEURODEGENERATION;
   PHARMACOKINETICS; INDUCTION
AB Among the enzymes that support brain metabolism, cytochrome P450 (CYP) enzymes occupy an important place. These enzymes catalyze the biotransformation pathways of neuroactive endogenous substrates (neurosteroids, neurotransmitters) and are necessary for the detoxification processes. The aim of the present study was to assess changes in the CYP2D activity and protein level during the aging process and as a result of serotonin deficiency in the female brain. The CYP2D activity was measured in brain and liver microsomes of Dark Agouti wild type (WT) female rats (mature 15-week-old and senescent 18-month-old rats) and in tryptophan hydroxylase 2 (TPH2)deficient senescent female rats. The CYP2D activity in mature WT Dark Agouti females was independent of the changing phases of the estrous cycle. In senescent WT females rats, the CYP2D activity and protein level were decreased in the cerebral cortex, hippocampus, cerebellum and liver, but increased in the brain stem. In the other examined structures (frontal cortex, hypothalamus, thalamus, striatum), the enzyme activity did not change. In aging TPH2-deficient females, the CYP2D activity and protein levels were decreased in the frontal cortex, hypothalamus and brain stem (activity only), remaining unchanged in other brain structures and liver, relative to senescent WT females. In summary, the aging process and TPH2 deficit affect the CYP2D activity and protein level in female rats, which may have a negative impact on the compensatory capacity of CYP2D in the synthesis of serotonin and dopamine in cerebral structures involved in cognitive and emotional functions. In the liver, the CYP2D-catalyzed drug metabolism may be diminished in elderly females. The results in female rats are compared with those obtained previously in males. It is concluded that aging and serotonin deficiency exert sex-dependent effects on brain CYP2D, which seem to be less favorable in females concerning CYP2D-mediated neurotransmitter synthesis, but beneficial regarding slower neurosteroid metabolism.
C1 [Haduch, Anna; Danek, Przemyslaw J.; Kuban, Wojciech; Puklo, Renata; Daniel, Wladyslawa A.] Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Krakow, Poland.
   [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Alenina, Natalia] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia.
   [Golebiowska, Joanna; Popik, Piotr] Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.
   [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany.
   [Bader, Michael] Charite, Berlin, Germany.
   [Bader, Michael] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany.
C3 Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish
   Academy of Sciences; Helmholtz Association; Max Delbruck Center for
   Molecular Medicine; Saint Petersburg State University; Polish Academy of
   Sciences; Maj Institute of Pharmacology of the Polish Academy of
   Sciences; University of Lubeck; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; German Centre
   for Cardiovascular Research
RP Daniel, WA (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Krakow, Poland.
EM nfdaniel@cyf-kr.edu.pl
RI Danek, Przemysław Jan/AAV-8074-2021; Popik, Piotr/R-5383-2016; Bader,
   Michael/K-2124-2013
OI Danek, Przemysław Jan/0000-0002-7137-2990; Popik,
   Piotr/0000-0003-0722-1263; Daniel, Wladyslawa Anna/0000-0002-1226-1721;
   Bader, Michael/0000-0003-4780-4164; Haduch, Anna/0000-0002-3925-3828
FU Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow,
   Poland; St. Petersburg State University [73022475]
FX The Grant ERA-NET Neuron II JTC 2015 Respond and statutory funds from
   the Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow,
   Poland constituted the source of financing for the presented study. NA
   was supported by the project 73022475 of the St. Petersburg State
   University.
CR Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106
   Ansari J, 2016, ANESTH ANALG, V122, P786, DOI 10.1213/ANE.0000000000001143
   Archer T, 2010, EXPERT REV NEUROTHER, V10, P1131, DOI 10.1586/ERN.09.152
   Arivazhagan P, 2002, EXP GERONTOL, V37, P1489, DOI 10.1016/S0531-5565(02)00122-5
   Bäckman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005
   Baum LO, 1997, BRAIN RES, V765, P67, DOI 10.1016/S0006-8993(97)00428-9
   Bergh AF, 1996, MOL CELL BIOCHEM, V162, P31
   Bromek E, 2011, J NEUROCHEM, V118, P806, DOI 10.1111/j.1471-4159.2011.07339.x
   Bromek E, 2010, EUR J PHARMACOL, V626, P171, DOI 10.1016/j.ejphar.2009.09.062
   CARLSSON M, 1988, N-S ARCH PHARMACOL, V338, P345
   CARLSSON M, 1988, PROG NEURO-PSYCHOPH, V12, P53, DOI 10.1016/0278-5846(88)90061-9
   Cheng J, 2013, XENOBIOTICA, V43, P973, DOI 10.3109/00498254.2013.791410
   Chow T, 1999, DRUG METAB DISPOS, V27, P188
   Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   Funae Yoshihiko, 2003, Drug Metab Pharmacokinet, V18, P337, DOI 10.2133/dmpk.18.337
   Galts CPC, 2019, NEUROSCI BIOBEHAV R, V102, P56, DOI 10.1016/j.neubiorev.2019.04.002
   Haduch A, 2020, NEUROCHEM INT, V141, DOI 10.1016/j.neuint.2020.104884
   Haduch A, 2018, DRUG METAB REV, V50, P415, DOI 10.1080/03602532.2018.1554674
   Haduch A, 2018, BIOCHEM PHARMACOL, V156, P398, DOI 10.1016/j.bcp.2018.09.005
   Haduch A, 2016, DRUG METAB DISPOS, V44, P445, DOI 10.1124/dmd.115.067413
   Haduch A, 2015, J NEUROCHEM, V133, P83, DOI 10.1111/jnc.13031
   Haduch A, 2013, PHARMACOL RES, V67, P53, DOI 10.1016/j.phrs.2012.10.009
   Haduch A, 2011, EUR J PHARMACOL, V651, P51, DOI 10.1016/j.ejphar.2010.10.077
   Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334
   Herian M, 2021, PSYCHOPHARMACOLOGY, V238, P2349, DOI 10.1007/s00213-021-05860-5
   Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232
   Hiroi T, 2002, DRUG METAB DISPOS, V30, P970, DOI 10.1124/dmd.30.9.970
   Hiroi T, 1998, BBA-GEN SUBJECTS, V1380, P305, DOI 10.1016/S0304-4165(97)00157-8
   Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1
   Kaplan K, 2016, J APPL PHYSIOL, V120, P1070, DOI 10.1152/japplphysiol.01015.2015
   Kishimoto W, 2004, ENDOCRINOLOGY, V145, P699, DOI 10.1210/en.2003-1109
   Konstandi M, 2020, J ENDOCRINOL, V245, P301, DOI 10.1530/JOE-19-0561
   Kuban W, 2021, DRUG METAB REV, V53, P1, DOI 10.1080/03602532.2020.1858856
   Li J, 2015, BRIT J PHARMACOL, V172, P4639, DOI 10.1111/bph.13206
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malikovic J, 2019, BEHAV BRAIN FUNCT, V15, DOI 10.1186/s12993-019-0161-3
   Mann A, 2012, NEUROBIOL AGING, V33, P2160, DOI 10.1016/j.neurobiolaging.2011.08.014
   Mann A, 2008, NEUROPHARMACOLOGY, V55, P1147, DOI 10.1016/j.neuropharm.2008.07.017
   McMillan DM, 2018, PHARMACOL THERAPEUT, V184, P189, DOI 10.1016/j.pharmthera.2017.10.008
   Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x
   Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128
   Míguez JM, 1999, J NEURAL TRANSM, V106, P1089, DOI 10.1007/s007020050225
   Miksys S, 2013, J PSYCHIATR NEUROSCI, V38, P152, DOI 10.1503/jpn.120133
   Miller RT, 2014, BRIT J PHARMACOL, V171, P3077, DOI 10.1111/bph.12652
   Mordhorst A, 2021, FASEB J, V35, DOI 10.1096/fj.202100366R
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix
   Pérez-Neri I, 2006, NEUROCHEM RES, V31, P1279, DOI 10.1007/s11064-006-9162-3
   Potasiewicz A, 2020, NEUROPHARMACOLOGY, V170, DOI 10.1016/j.neuropharm.2020.108040
   Renton KW, 2000, J PHARMACOL EXP THER, V294, P524
   Riedl AG, 1999, BRAIN RES, V822, P175, DOI 10.1016/S0006-8993(99)01113-0
   Saleem S, 2014, PAK J PHARM SCI, V27, P837
   Salmin SF, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3786
   Satoh A, 2017, NAT REV NEUROSCI, V18, P362, DOI 10.1038/nrn.2017.42
   Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301
   Schulz-Utermoehl T, 1999, PHARMACOGENETICS, V9, P357, DOI 10.1097/00008571-199906000-00011
   Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226
   Stahl S., 2013, Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
   Sullivan EV, 2002, CEREB CORTEX, V12, P438, DOI 10.1093/cercor/12.4.438
   Trifirò G, 2011, CURR DRUG METAB, V12, P611, DOI 10.2174/138920011796504473
   Valle A, 2008, CELL PHYSIOL BIOCHEM, V22, P337, DOI 10.1159/000149812
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   Xu SF, 2019, PEERJ, V7, DOI 10.7717/peerj.7429
   Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007
   Yue J, 2008, J PSYCHIATR NEUROSCI, V33, P54
   Zhang FR, 2018, NEUROSCIENCE, V379, P115, DOI 10.1016/j.neuroscience.2018.03.009
NR 69
TC 8
Z9 8
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD 2022 JAN
PY 2022
VL 152
AR 105223
DI 10.1016/j.neuint.2021.105223
EA NOV 2021
PG 9
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA XN9BE
UT WOS:000729791500001
PM 34780807
DA 2024-02-19
ER

PT J
AU ROELSDESCHRIJVER, MP
AF ROELSDESCHRIJVER, MP
TI INFLUENCE OF FASTING AND REFEEDING ON THE ELONGATION STEP OF
   PROTEIN-SYNTHESIS IN RAT-LIVER OF YOUNG (3M) AND AGING (18M) ANIMALS
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
RP ROELSDESCHRIJVER, MP (corresponding author), STATE UNIV GHENT, FAC VET, PHYSIOL CHEM LAB, B-9000 GHENT, BELGIUM.
CR ADELMAN RC, 1979, FED PROC, V38, P1968
   ADELMAN RC, 1971, EXP GERONTOL, V6, P75, DOI 10.1016/0531-5565(71)90051-9
   BLAZEJOWSKI CA, 1983, MECH AGEING DEV, V6, P293
   BOLLA R, 1975, ARCH BIOCHEM BIOPHYS, V169, P227, DOI 10.1016/0003-9861(75)90336-7
   BREUER CB, 1965, BIOCHEMISTRY-US, V4, P1544, DOI 10.1021/bi00884a013
   BRITTON GW, 1975, EXP GERONTOL, V10, P67, DOI 10.1016/0531-5565(75)90016-9
   CLAESRECKINGER N, 1982, EXP GERONTOL, V17, P281, DOI 10.1016/0531-5565(82)90017-1
   CLEMENS MJ, 1974, BIOCHIM BIOPHYS ACTA, V361, P345, DOI 10.1016/0005-2787(74)90377-3
   COOK JR, 1981, MECH AGEING DEV, V17, P41, DOI 10.1016/0047-6374(81)90127-5
   EKSTROM R, 1980, GERONTOLOGY, V26, P121, DOI 10.1159/000212405
   FELICETTI L, 1968, ARCH BIOCHEM BIOPHYS, V125, P548, DOI 10.1016/0003-9861(68)90613-9
   GABIUS HJ, 1983, FEBS LETT, V160, P115, DOI 10.1016/0014-5793(83)80948-X
   GEHRKE L, 1981, J BIOL CHEM, V256, P2514
   HASSELL JA, 1976, BIOCHEMISTRY-US, V15, P1375, DOI 10.1021/bi00652a004
   HORBACH GJMJ, 1984, BIOCHIM BIOPHYS ACTA, V783, P60, DOI 10.1016/0167-4781(84)90078-2
   HUNT T, 1980, TRENDS BIOCH SCI JUL, P178
   KULISZEWSKI MJ, 1980, BIOCHEM J, V190, P791, DOI 10.1042/bj1900791
   KURTZ DI, 1978, EXP GERONTOL, V13, P397, DOI 10.1016/0531-5565(78)90050-5
   LEGOCKI AB, 1974, ARCH BIOCHEM BIOPHYS, V161, P709, DOI 10.1016/0003-9861(74)90359-2
   LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MOLDAVE K, 1979, FED PROC, V38, P1979
   MOLDAVE K, 1967, METHODS ENZYMOLOGY A, V12
   NICHOLLS DM, 1976, BIOCHEM J, V160, P357, DOI 10.1042/bj1600357
   NIELSEN JBK, 1977, PHYSIOL ZOOL, V50, P22, DOI 10.1086/physzool.50.1.30155712
   NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302
   PAIN VM, 1973, FEBS LETT, V32, P205, DOI 10.1016/0014-5793(73)80834-8
   REIS RJS, 1981, MECH AGEING DEV, V17, P311, DOI 10.1016/0047-6374(81)90049-X
   ROELSDES.MP, 1974, ARCH INT PHYSIOL BIO, V82, P200
   ROELSDESCHRIJVER MP, 1982, ARCH INT PHYSIOL BIO, V90, pB148
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P199
   SAUVE GJ, 1981, INT J BIOCHEM, V13, P981, DOI 10.1016/0020-711X(81)90003-3
   SLOBIN LI, 1975, NATURE, V258, P452, DOI 10.1038/258452a0
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VANDENHAUTE J, 1983, EXP GERONTOL, V18, P355, DOI 10.1016/0531-5565(83)90014-1
   VARGAS R, 1981, J NEUROCHEM, V37, P687
   WALLACH Z, 1974, MECH AGEING DEV, V3, P225, DOI 10.1016/0047-6374(74)90018-9
   WEBSTER GC, 1982, MECH AGEING DEV, V18, P369, DOI 10.1016/0047-6374(82)90039-2
   WILLIS DB, 1971, J BIOL CHEM, V246, P2828
   YOUNG ET, 1978, BIOCHEM J, V172, P479, DOI 10.1042/bj1720479
NR 40
TC 3
Z9 3
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1985
VL 20
IS 3-4
BP 193
EP 200
DI 10.1016/0531-5565(85)90037-3
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA ARF48
UT WOS:A1985ARF4800006
PM 3877643
DA 2024-02-19
ER

PT J
AU DELLWO, M
   BEAUCHENE, RE
AF DELLWO, M
   BEAUCHENE, RE
TI THE EFFECT OF EXERCISE, DIET RESTRICTION, AND AGING ON THE PITUITARY -
   ADRENAL AXIS IN THE RAT
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE DIET RESTRICTION; AGING; EXERCISE; CORTICOSTERONE; ACTH; TYROSINE
   AMINOTRANSFERASE; GLUCOCORTICOID RECEPTORS; ADRENAL-PITUITARY AXIS
ID GLUCOCORTICOID RECEPTORS; MECHANISMS; LIVER; STRESS
AB The effects of calorie restriction, exercise, and aging on the pituitary-adrenal axis were studied in male Wistar rats from 12 to 28 months of age. There were 4 experimental groups: sedentary, ad libitum fed (A); sedentary, diet restricted by feeding on alternate days (R); exercised by swimming on alternate days, ad libitum fed (AE); exercised as AE, diet restricted as R (RE). Pituitary-adrenal function was assessed by measuring serum ACTH and corticosterone concentrations, adrenal weight, hepatic glucocorticoid receptor concentration, and hepatic tyrosine aminotransferase (TAT) activity. Serum corticosterone concentration increased with age while serum ACTH decreased from 12 to 20 months of age and then increased thereafter. TAT activity decreased and receptor concentration remained constant with age. Adrenal weights increased with age; those of AE rats increased dramatically. Analyses for relationships between variables revealed a quadratic relationship between serum ACTH and corticosterone concentrations. There tended to be an inverse relationship between TAT activity and corticosterone concentration. These observations may be indicative of a loss of feedback loop integrity with aging. Neither calorie restriction nor exercise were able to maintain the integrity of pituitary-adrenal function during aging, though dietary restriction did slow age-associated decrements of TAT activity.
C1 UNIV TENNESSEE, COLL HUMAN ECOL, DEPT NUTR & FOOD SCI, KNOXVILLE, TN 37996 USA.
   UNIV TENNESSEE, AGR EXPT STN, KNOXVILLE, TN 37996 USA.
C3 University of Tennessee System; University of Tennessee Knoxville;
   University of Tennessee System; University of Tennessee Knoxville; UT
   Institute of Agriculture
CR ADELMAN RC, 1977, HYPOTHALAMUS PITUITA, P668
   BOLLA R, 1980, MECH AGEING DEV, V12, P249, DOI 10.1016/0047-6374(80)90048-2
   DIAMONDSTONE TI, 1983, METHOD ENZYMAT AN, V3, P456
   EVERITT AV, 1977, HYPOTHALAMUS PITUITA, P570
   FLORINI JR, 1981, CRC HDB BIOCH AGING
   GREGERMAN RI, 1986, EXP GERONTOL, V21, P345, DOI 10.1016/0531-5565(86)90042-2
   HERRERA J, 1980, J STEROID BIOCHEM, V13, P153, DOI 10.1016/0022-4731(80)90186-7
   JACOBUS S, 1980, MECH AGEING DEV, V12, P311, DOI 10.1016/0047-6374(80)90064-0
   KALIMI M, 1983, ENDOCRINOLOGY, V113, P1161
   KALIMI M, 1983, ENDOCRINOLOGY, V112, P341, DOI 10.1210/endo-112-1-341
   KALIMI M, 1988, ANN NY ACAD SCI, V521, P149
   KENT S, 1980, GERIATRICS, V35, P101
   KUROWSKI TT, 1984, J APPL PHYSIOL, V57, P514, DOI 10.1152/jappl.1984.57.2.514
   REES A, 1985, GEN COMP ENDOCR, V59, P100, DOI 10.1016/0016-6480(85)90423-X
   ROTH GS, 1974, ENDOCRINOLOGY, V94, P82, DOI 10.1210/endo-94-1-82
   ROTH GS, 1979, MECH AGEING DEV, V9, P497, DOI 10.1016/0047-6374(79)90090-3
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7
   SARTIN J, 1980, FED PROC, V39, P3163
   SHARMA R, 1987, MECH AGEING DEV, V37, P249, DOI 10.1016/0047-6374(86)90042-4
   SINGER S, 1973, INT J BIOCHEM, V4, P569, DOI 10.1016/0020-711X(73)90035-9
   THARP GD, 1974, J APPL PHYSIOL, V37, P720, DOI 10.1152/jappl.1974.37.5.720
   1987, SAS USERS GUIDE
NR 23
TC 27
Z9 28
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1990
VL 25
IS 6
BP 553
EP 562
DI 10.1016/0531-5565(90)90021-S
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EP517
UT WOS:A1990EP51700005
PM 1982944
DA 2024-02-19
ER

PT J
AU de Sá-Nakanishi, AB
   Soares, AA
   Natali, MRM
   Comar, JF
   Peralta, RM
   Bracht, A
AF de Sa-Nakanishi, Anacharis B.
   Soares, Andreia A.
   Natali, Maria R. M.
   Comar, Jurandir Fernando
   Peralta, Rosane M.
   Bracht, Adelar
TI Effects of the Continuous Administration of an <i>Agaricus blazei</i>
   Extract to Rats on Oxidative Parameters of the Brain and Liver during
   Aging
SO MOLECULES
LA English
DT Article
DE aging; oxidative stress; oxidative damage; brain; liver; A. blazei
   treatment
ID MURILL
AB An investigation of the effects of an aqueous extract of Agaricus blazei, a medicinal mushroom, on the oxidative state of the brain and liver of rats during aging (7 to 23 months) was conducted. The treatment consisted in the daily intragastric administration of 50 mg/kg of the extract. The A. blazei treatment tended to maintain the ROS contents of the brain and liver at lower levels, but a significant difference was found only at the age of 23 months and in the brain. The TBARS levels in the brain were maintained at lower levels by the A. blazei treatment during the whole aging process with a specially pronounced difference at the age of 12 months. The total antioxidant capacity in the brain was higher in treated rats only at the age of 12 months. Compared with previous studies in which old rats (21 months) were treated during a short period of 21 days with 200 mg/kg, the effects of the A. blazei extract in the present study tended to be less pronounced. The results also indicate that the long and constant treatment presented a tendency of becoming less effective at ages above 12 months.
C1 [de Sa-Nakanishi, Anacharis B.; Soares, Andreia A.; Comar, Jurandir Fernando; Peralta, Rosane M.; Bracht, Adelar] Univ Estadual Maringa, Dept Biochem, BR-87020900 Maringa, Parana, Brazil.
   [Natali, Maria R. M.] Univ Estadual Maringa, Dept Morphol Sci, BR-87020900 Maringa, Parana, Brazil.
C3 Universidade Estadual de Maringa; Universidade Estadual de Maringa
RP Bracht, A (corresponding author), Univ Estadual Maringa, Dept Biochem, BR-87020900 Maringa, Parana, Brazil.
EM anacharis@bol.com.br; andasoares7@gmail.com; mrmnatali@uem.br;
   jfcomar@uem.br; rmperalta@uem.br; adebracht@uol.com.br
RI Comar, Jurandir Fernando/D-8160-2019; Bracht, Adelar/A-9700-2011;
   Sá-Nakanishi, Anacharis Babeto/AIC-8301-2022; PERALTA, ROSANE
   MARINA/J-3912-2016; Comar, Jurandir F./I-7285-2013; Soares, Andréia
   A./B-3291-2017
OI Comar, Jurandir Fernando/0000-0002-9518-7589; Sá-Nakanishi, Anacharis
   Babeto/0000-0002-2300-1861; PERALTA, ROSANE MARINA/0000-0001-5749-0723;
   Soares, Andréia A./0000-0002-0632-3121; Natali, Maria Raquel
   Marcal/0000-0002-7486-2581; Bracht, Adelar/0000-0002-8098-5705
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao Araucaria
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Araucaria.
   Anacharis Babeto de Sa-Nakanishi was a fellowship holder of the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Abrahamsson PA, 2010, EUR UROL, V57, P49, DOI 10.1016/j.eururo.2009.07.049
   Aebi H., 1974, Methods of enzymatic analysis, P674, DOI DOI 10.1016/B978-0-12-091302-2.50032-3
   Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P2100
   Biedron R, 2012, FUNCT FOODS HEALTH D, V2, P428, DOI 10.31989/ffhd.v2i11.72
   Carvajal AESS, 2012, LWT-FOOD SCI TECHNOL, V46, P493, DOI 10.1016/j.lwt.2011.11.018
   De Oliveira AL, 2010, J AGR FOOD CHEM, V58, P7202, DOI 10.1021/jf100804k
   de Sa-Nakanishi AB, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/563179
   Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015
   Firenzuoli F, 2008, EVID-BASED COMPL ALT, V5, P3, DOI 10.1093/ecam/nem007
   Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Ker YB, 2005, J AGR FOOD CHEM, V53, P7052, DOI 10.1021/jf0510034
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Nada SA, 2010, FOOD CHEM TOXICOL, V48, P3184, DOI 10.1016/j.fct.2010.08.019
   Nie ZZ, 1998, MOL PHARMACOL, V53, P663, DOI 10.1124/mol.53.4.663
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Peralta R.M., 2008, CURR TRENDS MICROBIO, V4, P45
   RAMKUMAR V, 1995, TRENDS PHARMACOL SCI, V16, P283, DOI 10.1016/S0165-6147(00)89051-3
   Refaie F. M., 2010, Micologia Aplicada International, V22, P1
   Sa-Nakanishi A.B., 2014, EUR J MOL BIOL BIOCH, V1, P43
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   Siqueira IR, 2005, LIFE SCI, V78, P271, DOI 10.1016/j.lfs.2005.04.044
   Soares AA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/469180
   Soares AA, 2009, FOOD CHEM, V112, P775, DOI 10.1016/j.foodchem.2008.05.117
   Xiru L. V., 2010, ACTA EDULIS FUNGI, V17, P73
   Zhang YR, 2009, CHEM J CHINESE U, V30, P293
NR 28
TC 10
Z9 10
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2014
VL 19
IS 11
BP 18590
EP 18603
DI 10.3390/molecules191118590
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA AU4FC
UT WOS:000345564300088
PM 25401401
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Martin, GG
   Atshaves, BP
   McIntosh, AL
   Mackie, JT
   Kier, AB
   Schroeder, F
AF Martin, Gregory G.
   Atshaves, Barbara P.
   McIntosh, Avery L.
   Mackie, John T.
   Kier, Ann B.
   Schroeder, Friedhelin
TI Liver fatty acid-binding protein gene-ablated female mice exhibit
   increased age-dependent obesity
SO JOURNAL OF NUTRITION
LA English
DT Article
ID ACTIVATED RECEPTOR-ALPHA; CARNITINE PALMITOYLTRANSFERASE; HIGH-AFFINITY;
   LONG-CHAIN; ACYL-COAS; L-FABP; METABOLISM; EXPRESSION; LIGANDS; NUCLEUS
AB Previous work conducted in our laboratory suggested a role for liver fatty acid-binding protein (L-FABP) in obesity that develops in aging female L-FABP gene-ablated (-/-) mice. To examine this possibility in more detail, cohorts of wild-type and L-FABP (-/-) female mice were fed a standard, low-fat, nonpurified rodent diet for up to 18 mo. Various obesity-related parameters were examined, including body weight and fat and lean tissue mass. Obesity in (-/-) mice was associated with increased expression of nuclear receptors that induce PPAR alpha (e.g. hepatocyte nuclear factor la, genotype effect) and of PPAR alpha-regulated proteins involved in uptake of free (lipoprotein lipase and fatty acid transport protein, genotype, and/or age effect) and esterified (scavenger receptor class B type 1, genotype effect) long-chain fatty acids (LCFA). Hepatic total lipid and neutral lipid levels were not affected by age or genotype, consistent with absence of gross and histologic steatosis. There was increased mRNA expression of liver proteins involved in LCFA oxidation [mitochondrial 3-oxoacyl-CoA thiolase (genotype effect) and butyryl-CoA dehydrogenase (genotype and/or age effect)], increased expression of LCFA esterification enzymes [glycerol-3-phosphate acyltransferase (age x genotype effect) and acyl-CoA:cholesterol acyltransferase-2 (genotype and/or age effect)], and increased expression of proteins involved in intracellular transfer and secretion of esterified LCFA [liver microsomal triacylglycerol transfer protein (genotype effect), serum apolipoprotein (apo) B (genotype or age effect), and liver apoB (age and age x genotype effect)]. The data support a working model in which obesity development in these mice results from shifts toward reduced energy expenditure and/or more efficient energy uptake in the gut.
C1 [Martin, Gregory G.; Atshaves, Barbara P.; McIntosh, Avery L.; Schroeder, Friedhelin] Texas A&M Univ, Texas Vet Med Coll, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.
   [Mackie, John T.; Kier, Ann B.] Texas A&M Univ, Texas Vet Med Coll, Dept Pathobiol, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station
RP Schroeder, F (corresponding author), Texas A&M Univ, Texas Vet Med Coll, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.
EM fschroeder@cvm.tamu.edu
FU U.S. Public Health Service NIH [DK41402, GM31651]
FX Supported by the U.S. Public Health Service NIH grants DK41402 and
   GM31651.
CR Adida A, 2002, PROSTAG LEUKOTR ESS, V67, P91, DOI 10.1054/plef.2002.0404
   ARSHAVES BP, 1999, J LIPID RES, V40, P610
   Atshaves BP, 2007, AM J PHYSIOL-GASTR L, V292, pG939, DOI 10.1152/ajpgi.00308.2006
   Atshaves BP, 2005, AM J PHYSIOL-CELL PH, V288, pC543, DOI 10.1152/ajpcell.00359.2004
   Atshaves BP, 2004, J LIPID RES, V45, P812, DOI 10.1194/jlr.M300408-JLR200
   Atshaves BP, 2004, MOL CELL BIOCHEM, V259, P115, DOI 10.1023/B:MCBI.0000021357.97765.f2
   Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200
   Atshaves BP, 2002, AM J PHYSIOL-CELL PH, V283, pC688, DOI 10.1152/ajpcell.00586.2001
   BHUIYAN AKMJ, 1994, MOL CELL BIOCHEM, V139, P109, DOI 10.1007/BF01081733
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088
   Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6
   FIELDING PE, 1991, BIOCH LIPIDS LIPOPRO, P427
   Fielding PE Fielding CJ, 2002, BIOCH LIPIDS LIPOPRO, V36, P527
   Frederiksen KS, 2003, J MOL ENDOCRINOL, V30, P317, DOI 10.1677/jme.0.0300317
   Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t
   Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200
   Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l
   Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377
   Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200
   Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318
   Kersten S, 2002, EUR J PHARMACOL, V440, P223, DOI 10.1016/S0014-2999(02)01431-0
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Lawrence JW, 2000, J LIPID RES, V41, P1390
   Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094
   Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296
   Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004
   Martin GG, 2003, BIOCHEMISTRY-US, V42, P11520, DOI 10.1021/bi0346749
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   McArthur MJ, 1999, J LIPID RES, V40, P1371
   Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244
   Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0
   Owada Y, 2002, MOL CELL BIOCHEM, V239, P83, DOI 10.1023/A:1020524621933
   Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6
   Spann NJ, 2006, J BIOL CHEM, V281, P33066, DOI 10.1074/jbc.M607148200
   Vassileva G, 2000, FASEB J, V14, P2040, DOI 10.1096/fj.99-0959com
   Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578
   WOLDEGIORGIS G, 1985, BIOCHIM BIOPHYS ACTA, V837, P135, DOI 10.1016/0005-2760(85)90236-X
   Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898
NR 39
TC 31
Z9 42
U1 0
U2 1
PU AMER SOC NUTRITIONAL SCIENCE
PI BETHESDA
PA 9650 ROCKVILLE PIKE, RM L-2407A, BETHESDA, MD 20814 USA
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD OCT
PY 2008
VL 138
IS 10
BP 1859
EP 1865
DI 10.1093/jn/138.10.1859
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 353GQ
UT WOS:000259554500005
PM 18806093
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Ghiraldíni, FG
   Crispim, ACV
   Mello, MLS
AF Ghiraldini, Flavia Gerelli
   Vitolo Crispim, Ana Carolina
   Silveira Mello, Maria Luiza
TI Effects of hyperglycemia and aging on nuclear sirtuins and DNA damage of
   mouse hepatocytes
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID POLYMERASE-I TRANSCRIPTION; CALORIE RESTRICTION; IMAGE-ANALYSIS; SIRT6;
   CHROMATIN; CELLS; LIVER; MICE; SENESCENCE; REPAIR
AB Hyperglycemia, like aging, induces chromatin remodeling in mouse hepatocytes in comparison to normoglycemia and younger age, respectively. Changes in glucose metabolism also affect the action and expression of sirtuins, promoting changes in chromatin conformation and dynamics. Here we investigate the abundance and activity of the nuclear sirtuins Sirt1, Sirt6, and Sirt7 in mouse hepatocytes in association with specific histone acetylation, DNA damage, and the activation of nucleolar organizing regions (NORs) in hyperglycemic nonobese diabetic (NOD) and old normoglycemic BALB/c mouse strains. Higher levels of Sirt1 and PGC-1 alpha and increased expression of gluconeogenesis pathway genes are found in the hyperglycemic NOD mice. Increased Sirt6 abundance is found in the hyperglycemic NOD mice, which might increase DNA damage repair. With aging, lower Sirt1 abundance and activity, increased acetylated histone modifications and Sirt7 levels, and NOR methylation are found. Thus, whereas in normal aging cell metabolism is reduced, in the diabetic mice a compensatory mechanism may elevate Sirt1 and Sirt6 levels, increasing gluconeogenesis and DNA repair from the oxidative damage caused by hyperglycemia. Therefore understanding the regulation of epigenetic factors in diabetes and aging is crucial for the development of new therapeutic approaches that could prevent diseases and improve quality of life.
C1 [Ghiraldini, Flavia Gerelli; Vitolo Crispim, Ana Carolina; Silveira Mello, Maria Luiza] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas
RP Ghiraldíni, FG (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil.
EM flaviaghi@gmail.com
RI Mello, Maria Luiza Silveira/D-9158-2012; Ghiraldini, Flávia/G-7537-2012
OI Mello, Maria Luiza Silveira/0000-0003-1629-5619; 
FU Sao Paulo State Research Foundation (FAPESP) [2010/50015-6,
   2008/58067-5]; Brazilian National Research and Development Council
   (CNPq) [471303/2009-7, 301943/2009-5]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [10/50015-6] Funding Source: FAPESP
FX We thank Maria C. G. Marcondes for the use of the microplate fluorimeter
   and the Laboratory of Molecular Genetics (FCM-Unicamp) for the use of
   the thermocycler. This work was supported by the Sao Paulo State
   Research Foundation (FAPESP; Grants 2010/50015-6 and 2008/58067-5) and
   the Brazilian National Research and Development Council (CNPq; Grants
   471303/2009-7 and 301943/2009-5).
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Berg JM, 2002, BIOCHEMISTRY-US, P867
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Blazer S, 2005, BIOCHEM BIOPH RES CO, V296, P93
   BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   COLLINS AR, 1995, MUTAT RES-DNA REPAIR, V336, P69, DOI 10.1016/0921-8777(94)00043-6
   DERENZINI M, 1991, INT REV EXP PATHOL, V32, P149
   Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706
   Ghiraldini FG, 2010, CELL BIOL INT REP, V17
   Ghiraldini FG, 2012, CYTOM PART A, V81A, P755, DOI 10.1002/cyto.a.22102
   Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010
   Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382
   Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506
   Herrman CE, 1999, TOXICOL SCI, V50, P146, DOI 10.1093/toxsci/50.1.146
   Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200
   Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4
   Jaloszynski P, 1997, MUTAT RES-DNA REPAIR, V385, P223, DOI 10.1016/S0921-8777(97)00046-3
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34
   Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x
   Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com
   Makino S, 1980, Jikken Dobutsu, V29, P1
   Matunis MJ, 2006, METHODS, V39, P277, DOI 10.1016/j.ymeth.2006.06.003
   McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011
   McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2
   Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027
   Mello MLS, 2008, ACTA HISTOCHEM, V110, P210, DOI 10.1016/j.acthis.2007.10.016
   Mello MLS, 2009, MICRON, V40, P577, DOI 10.1016/j.micron.2009.02.010
   Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367
   Moraes AS, 2007, CYTOM PART A, V71A, P28, DOI 10.1002/cyto.a.20356
   Moraes AS, 2010, CELL BIOL INT, V34, P925, DOI 10.1042/CBI20090457
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030
   Nakamura A, 2010, ANN NY ACAD SCI, V1197, P33, DOI 10.1111/j.1749-6632.2009.05374.x
   Nelson DL, 2004, PRINCIPLES BIOCH, P631
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   RUSCHOFF J, 1990, J PATHOL, V161, P113, DOI 10.1002/path.1711610205
   Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200
   Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006
   Sedivy JM, 2007, EXP CELL RES, V10, P1909
   Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Spindler Sr, 2003, ADV CELL AGING GERON, V14, P69
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009
   Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156
   Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906
   VIDAL BD, 1995, ANAL CELL PATHOL, V9, P39
   Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039
   Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329
   Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041
NR 56
TC 24
Z9 26
U1 0
U2 11
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG 1
PY 2013
VL 24
IS 15
BP 2467
EP 2476
DI 10.1091/mbc.E13-04-0186
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 195XL
UT WOS:000322736800017
PM 23761075
OA Green Published, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Edelman, EJ
   Gordon, KS
   Lo Re, V
   Skanderson, M
   Fiellin, DA
   Justice, AC
AF Edelman, E. Jennifer
   Gordon, Kirsha S.
   Lo Re, Vincent, III
   Skanderson, Melissa
   Fiellin, David A.
   Justice, Amy C.
CA VACS Project Team
TI Acetaminophen receipt among HIV-infected patients with advanced hepatic
   fibrosis
SO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LA English
DT Article
DE acetaminophen; HIV; hepatitis C; Veterans; medication;
   pharmacoepidemiology
ID PRESCRIPTION PATTERNS; LIVER-DISEASE; OVERDOSE; COHORT; PAIN
AB PurposeHIV-infected patients may be at particular risk for acetaminophen-induced hepatotoxicity, but acetaminophen use in the context of liver injury has been incompletely examined among HIV-infected patients. Among a sample of HIV-infected patients, we aimed to determine acetaminophen exposure, assess the cross-sectional association between acetaminophen exposure and advanced hepatic fibrosis, and determine whether factors associated with acetaminophen exposure varied by HCV status.
   MethodsWe conducted a cross-sectional analysis of the Veterans Aging Cohort Study. Advanced hepatic fibrosis was defined as a FIB-4>3.25, a composite score calculated based on age, alanine aminotransferase, aspartate aminotransferase, and platelet count. Multivariable ordered polytomous logistic regression was used to determine the association between FIB-4 status and acetaminophen exposure stratified by HCV status.
   ResultsAmong HIV-infected patients (n=14885), 31% received at least one acetaminophen prescription. Among those receiving acetaminophen, acetaminophen overuse was common among both HIV-monoinfected and HIV/HCV-coinfected patients (846 [31%] vs 596[32%], p=0.79). After stratifying by HCV status, those with evidence of advanced liver fibrosis were equally likely to be exposed to acetaminophen. Furthermore, HIV-monoinfected patients with an alcohol use disorder were more likely to have acetaminophen overuse (OR [95%CI]=1.56 [1.21-2.02]).
   ConclusionsStrategies to minimize acetaminophen exposure, especially for HIV-monoinfected patients, are warranted. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Edelman, E. Jennifer; Fiellin, David A.; Justice, Amy C.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA.
   [Edelman, E. Jennifer; Fiellin, David A.; Justice, Amy C.] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.
   [Gordon, Kirsha S.; Skanderson, Melissa; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Lo Re, Vincent, III] Univ Penn, Dept Med, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Skanderson, Melissa] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.
C3 Yale University; Yale University; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); VA Connecticut Healthcare System;
   University of Pennsylvania; University of Pennsylvania; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh
   Healthcare System
RP Edelman, EJ (corresponding author), Yale Univ, Sch Med, POB 208093, New Haven, CT 06520 USA.
EM ejennifer.edelman@yale.edu
OI Fiellin, David/0000-0002-4006-010X
FU Society of General Internal Medicine's Lawrence Linn Award; Robert Wood
   Johnson Foundation Clinical Scholars Program; Department of Veterans
   Affairs; Veterans Aging Cohort study; National Institute on Alcohol
   Abuse and Alcoholism [U10 AA 13566]
FX This work was generously supported by the Society of General Internal
   Medicine's Lawrence Linn Award, the Robert Wood Johnson Foundation
   Clinical Scholars Program, the Department of Veterans Affairs, and the
   Veterans Aging Cohort study, funded by the National Institute on Alcohol
   Abuse and Alcoholism (U10 AA 13566).
CR Albertson TE, 2010, ANN PHARMACOTHER, V44, P1191, DOI 10.1345/aph.1P012
   Benzon HT, 2013, PAIN PRACT, V13, P440, DOI 10.1111/papr.12011
   Björnsson E, 2006, DIGEST LIVER DIS, V38, P33, DOI 10.1016/j.dld.2005.06.004
   Chandok N, 2010, MAYO CLIN PROC, V85, P451, DOI 10.4065/mcp.2009.0534
   Clark Roderick, 2012, BMC Clin Pharmacol, V12, P11, DOI 10.1186/1472-6904-12-11
   Edelman EJ, 2013, J GEN INTERN MED, V28, P82, DOI 10.1007/s11606-012-2189-z
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Hewitt DJ, 1997, PAIN, V70, P117, DOI 10.1016/S0304-3959(96)03281-2
   Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6
   Lederman JC, 2001, AM J GASTROENTEROL, V96, P3474
   Miaskowski C, 2011, J PAIN, V12, P1004, DOI 10.1016/j.jpain.2011.04.002
   Moling O, 2006, CLIN THER, V28, P755, DOI 10.1016/j.clinthera.2006.05.002
   Mort JR, 2011, DRUG SAFETY, V34, P1079, DOI 10.2165/11593100-000000000-00000
   Myers RP, 2008, CLIN GASTROENTEROL H, V6, P918, DOI 10.1016/j.cgh.2008.02.053
   Nguyen GC, 2008, HEPATOLOGY, V48, P1336, DOI 10.1002/hep.22536
   Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1
   STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Wolf MS, 2012, J GEN INTERN MED, V27, P1587, DOI 10.1007/s11606-012-2096-3
NR 19
TC 8
Z9 10
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1053-8569
EI 1099-1557
J9 PHARMACOEPIDEM DR S
JI Pharmacoepidemiol. Drug Saf.
PD DEC
PY 2013
VL 22
IS 12
BP 1352
EP 1356
DI 10.1002/pds.3517
PG 5
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA 258GG
UT WOS:000327446700014
PM 24285468
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Warrington, JS
   Court, MH
   Greenblatt, DJ
   von Moltke, LL
AF Warrington, JS
   Court, MH
   Greenblatt, DJ
   von Moltke, LL
TI Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344
   rats
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
ID HEPATIC DRUG-METABOLISM; HUMAN LIVER-MICROSOMES; IN-VITRO;
   O-DEETHYLATION; FEMALE RATS; OLD-AGE; CYTOCHROME-P450; MOUSE;
   INDUCIBILITY; EXPRESSION
AB We evaluated the role of specific isoforms in the biotransformation of phenacetin and chlorzoxazone and examined the effect of age on these reactions using liver microsomes from Fischer 344 rats between 3 and 26 months of age. Using rat cDNA-expressed cytochrome P450 (CYP) enzymes, we found that phenacetin biotransformation was primarily mediated by CYP2C6 and CYP1A isoforms, while chlorzoxazone biotransformation was largely mediated by CYP2E1 and CYP1A1. Incubations with liver microsomes prepared from rats of varying ages demonstrated that both phenacetin and chlorzoxazone biotransformation declined with age. Metabolite formation rates in the old rats (25-26 months) were reduced by approximately 60-70% for these reactions. This study suggests that the activity of CYP2E and CYP1A enzymes decline with age in the rat liver. Also, the relative specificity of the index substrates phenacetin (for CYP1A2) and chlorzoxazone (for CYP2E1) in man appears not to be applicable in rats.
C1 Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA.
C3 Tufts University
RP Greenblatt, DJ (corresponding author), Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 136 Harrison Ave, Boston, MA 02111 USA.
EM DJ.Greenblatt@tufts.edu
FU NCCIH NIH HHS [AT-01381] Funding Source: Medline; NCRR NIH HHS
   [RR-00054] Funding Source: Medline; NIA NIH HHS [AG-17880] Funding
   Source: Medline; NIDA NIH HHS [DA-13834, DA-05258, DA-13209] Funding
   Source: Medline; NIDDK NIH HHS [DK/AI-58496] Funding Source: Medline;
   NIGMS NIH HHS [GM-61834] Funding Source: Medline; NIMH NIH HHS
   [MH-58435] Funding Source: Medline
CR *ADM AG HLTH HUM S, 2001, PROF OLD AM 2001
   Anderson MD, 1998, DRUG METAB DISPOS, V26, P1031
   Bogaards JJP, 2000, XENOBIOTICA, V30, P1131, DOI 10.1080/00498250010021684
   BOOBIS AR, 1981, BIOCHEM PHARMACOL, V30, P2451, DOI 10.1016/0006-2952(81)90340-3
   BOONSTRANIEVELD IHJ, 1989, MECH AGEING DEV, V50, P289, DOI 10.1016/0047-6374(89)90106-1
   COTREAU MM, 2004, IN PRESS CLIN PHARMA
   Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   FUJITA S, 1990, DRUG METAB DISPOS, V18, P812
   GEORGE J, 1995, BIOCHEM PHARMACOL, V50, P727, DOI 10.1016/0006-2952(95)00192-3
   Gorski JC, 1997, XENOBIOTICA, V27, P243, DOI 10.1080/004982597240578
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1992, XENOBIOTICA, V22, P515, DOI 10.3109/00498259209053114
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   IMAOKA S, 1990, ARCH BIOCHEM BIOPHYS, V278, P168, DOI 10.1016/0003-9861(90)90245-T
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7
   LEE PC, 1994, BIOCHEM MOL BIOL INT, V34, P861
   Parkinson A, 1996, TOXICOL PATHOL, V24, P45, DOI 10.1177/019262339602400107
   Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618
   Rebhan M., 1997, GeneCards: Encyclopedia for Genes, Proteins and Diseases
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SESARDIC D, 1990, BIOCHEM PHARMACOL, V39, P489, DOI 10.1016/0006-2952(90)90055-P
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Venkatakrishnan K, 1999, DRUG METAB DISPOS, V27, P1519
   Venkatakrishnan K, 1998, J PHARM SCI, V87, P1502, DOI 10.1021/js980255z
   Vestal RE, 1997, CANCER, V80, P1302, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1302::AID-CNCR16>3.0.CO;2-B
   von Moltke LL, 1999, ANNU REV GERONTOL, V19, P53
   vonMoltke LL, 1996, PSYCHOPHARMACOLOGY, V128, P398, DOI 10.1007/s002130050149
   VONMOLTKE LL, 1993, PHARMACOLOGY, V47, P268, DOI 10.1159/000139107
   Warrington JS, 2003, DRUG METAB DISPOS, V31, P1306, DOI 10.1124/dmd.31.11.1306
   Warrington JS, 2002, DRUG METAB DISPOS, V30, P655, DOI 10.1124/dmd.30.6.655
   WARRINGTON JS, 2004, IN PRESS J PHARM EXP
   WEINDRUCH R, 1991, J GERONTOL, V46, pB87, DOI 10.1093/geronj/46.3.B87
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
NR 39
TC 14
Z9 15
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JUN
PY 2004
VL 56
IS 6
BP 819
EP 825
DI 10.1211/0022357023529
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 833BI
UT WOS:000222311000018
PM 15231049
OA Bronze
DA 2024-02-19
ER

PT J
AU Unno, K
   Takabayashi, F
   Kishido, T
   Oku, N
AF Unno, K
   Takabayashi, F
   Kishido, T
   Oku, N
TI Suppressive effect of green tea catechins on morphologic and functional
   regression of the brain in aged mice with accelerated senescence
   (SAMP10)
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE catechin; SAMP10; learning; memory; oxidative stress; senescence
ID SPONTANEOUS-ALTERNATION BEHAVIOR; ANTIOXIDANT ACTIVITY; INDUCED
   IMPAIRMENT; OXIDATIVE STRESS; GARLIC EXTRACT; ANIMAL-MODEL; MOUSE MODEL;
   SAM-P/10; ATROPHY; MEMORY
AB Green tea catechins (GT-catechins) have been reported to have an antioxidative effect. We investigated the effect of long-term GT-catechin intake on aging and oxidative damage using aged mice with accelerated senescence (SAMP10), a model of brain senescence with cerebral atrophy and cognitive dysfunction. Major atrophy was observed in the rhinencephalon, hippocampus and striatum of 12-month-old untreated SAMP10 mice. Similarly, levels of 8-oxodeoxyguanosine (8-oxodG), a marker of oxidative DNA damage, were higher in these parts of the cerebrum than in the cerebral cortex and liver. GT-catechin intake effectively suppressed such atrophy in 12-month-old SAMP10 mice. A preventive effect of GT-catechin intake on oxidative DNA damage was also observed in the rhinencephalon (an area particularly susceptible to atrophy) at 6 months of age, i.e. during the early stages of atrophy. A suppressive effect of GT-catechin intake on cognitive dysfunction, as determined by the learning time needed to acquire an avoidance response and assessments of working memory in a Y-maze, was also found in 12-month-old mice. These results suggest that GT-catechin intake partially improves the morphologic and functional alterations that occur naturally in the brains of aged SAMP 10 mice. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan.
   Univ Shizuoka, Sch Pharmaceut Sci, COE Program Century 21, Shizuoka 4228526, Japan.
   Univ Shizuoka, Jr Coll, Shizuoka 4228021, Japan.
C3 University of Shizuoka; University of Shizuoka; University of Shizuoka
RP Unno, K (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, 52-1 Yada, Shizuoka 4228526, Japan.
EM unno@u-shizuoka-ken.ac.jp
CR DECKER MW, 1990, PSYCHOPHARMACOLOGY, V100, P515, DOI 10.1007/BF02244005
   Esposito E, 2002, NEUROBIOL AGING, V23, P719, DOI 10.1016/S0197-4580(02)00078-7
   Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x
   Guo Q, 1999, BBA-GEN SUBJECTS, V1427, P13, DOI 10.1016/S0304-4165(98)00168-8
   Hagerman AE, 2003, ARCH BIOCHEM BIOPHYS, V414, P115, DOI 10.1016/S0003-9861(03)00158-9
   Hu C, 2001, MOL CELL BIOCHEM, V218, P147, DOI 10.1023/A:1007220928446
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   KHAN SG, 1992, CANCER RES, V52, P4050
   Kimura M, 2002, EUR J CLIN NUTR, V56, P1186, DOI 10.1038/sj.ejcn.1601471
   Miyazaki H, 2003, J PHARMACOL SCI, V92, P28
   Moriguchi T, 1997, CLIN EXP PHARMACOL P, V24, P235, DOI 10.1111/j.1440-1681.1997.tb01813.x
   Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679
   Nishiyama N, 1997, EXP GERONTOL, V32, P149, DOI 10.1016/S0531-5565(96)00062-9
   Numata T, 2002, BIOCHEM BIOPH RES CO, V297, P517, DOI 10.1016/S0006-291X(02)02155-1
   Okuma Y, 2000, MECH AGEING DEV, V114, P191, DOI 10.1016/S0047-6374(00)00103-2
   Rice-Evans C, 1999, P SOC EXP BIOL MED, V220, P262, DOI 10.1046/j.1525-1373.1999.d01-45.x
   Saito T, 2000, BIOCHEM BIOPH RES CO, V279, P505, DOI 10.1006/bbrc.2000.3946
   SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843
   Shimada A, 1999, NEUROBIOL AGING, V20, P125, DOI 10.1016/S0197-4580(99)00044-5
   SHIMADA A, 1993, BRAIN RES, V608, P266, DOI 10.1016/0006-8993(93)91467-7
   SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006
   SHIMADA A, 1994, NEUROSCIENCE, V59, P859, DOI 10.1016/0306-4522(94)90290-9
   Shimada A, 2002, J GERONTOL A-BIOL, V57, pB415, DOI 10.1093/gerona/57.12.B415
   Shimada AS, 2003, SYNAPSE, V48, P198, DOI 10.1002/syn.10209
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Ukai M, 1997, BEHAV BRAIN RES, V83, P169, DOI 10.1016/S0166-4328(97)86063-9
   Valcic S, 2000, CHEM RES TOXICOL, V13, P801, DOI 10.1021/tx000080k
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Yamada K, 1996, J PHARMACOL EXP THER, V276, P460
NR 31
TC 99
Z9 108
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2004
VL 39
IS 7
BP 1027
EP 1034
DI 10.1016/j.exger.2004.03.033
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 840YC
UT WOS:000222895300006
PM 15236762
DA 2024-02-19
ER

PT J
AU Han, XM
   Wu, SX
   Wu, MF
   Yang, XF
AF Han, Xiao-Miao
   Wu, Su-Xi
   Wu, Mei-Fang
   Yang, Xue-Feng
TI Antioxidant effect of peony seed oil on aging mice
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE Peony seed oil; Aging; Anti-aging; Superoxide dismutase
ID AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE;
   D-GALACTOSE; MONOAMINE-OXIDASE; BRAIN; SOD; MODEL; RAT
AB d-galactose was injected into mice of ages 4-5 months, and peony seed oil was administered using an oral gavage to assess its possible anti-aging functions. The content of malondialdehyde (MDA) and the activities of monoamine oxidase (MAO), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) in the brain and liver of these mice were determined using biochemical kits. The significance of the differences in the content of the components associated with aging and anti-aging among each group was analyzed statistically. The MDA content and activities of MAO in the brain and liver of mice in the peony seed oil group were significantly lower than those in the aging group. The activities of GSH-Px, Cu/Zn-SOD, and Mn-SOD in the brain and liver of mice in the peony seed oil group were very significantly higher than those in the aging group. Peony seed oil was determined to have an obvious anti-aging function.
C1 [Han, Xiao-Miao; Wu, Su-Xi; Wu, Mei-Fang] Changsha Univ Sci & Technol, Sch Chem & Bioengn, Changsha 410004, Hunan, Peoples R China.
   [Wu, Su-Xi] Haorui Biol Technol Co Ltd, Changsha 410004, Hunan, Peoples R China.
   [Yang, Xue-Feng] Changsha Univ Sci & Technol, Sch Hosp, Changsha 410004, Hunan, Peoples R China.
C3 Changsha University of Science & Technology; Changsha University of
   Science & Technology
RP Wu, SX (corresponding author), Changsha Univ Sci & Technol, Sch Chem & Bioengn, Changsha 410004, Hunan, Peoples R China.; Wu, SX (corresponding author), Haorui Biol Technol Co Ltd, Changsha 410004, Hunan, Peoples R China.
EM 1309926479@qq.com; wusuxi@126.com; 964703693@qq.com; 2521486228@qq.com
RI YANG, Xue/HPI-0953-2023
FU Research Fund for Science and Technology Project of Hunan Province in
   China [2016NK2136]
FX This work was supported by the Research Fund for Science and Technology
   Project of Hunan Province in China (Grant No. 2016NK2136).
CR Alvarez-García O, 2006, BIOGERONTOLOGY, V7, P43, DOI 10.1007/s10522-005-6041-2
   BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6
   Chang YO, 2004, J KOREAN FORE SOC, V93, P428
   Clarke MW, 2008, CRIT REV CL LAB SCI, V45, P417, DOI 10.1080/10408360802118625 
   Csire G, 2013, POLYHEDRON, V61, P202, DOI 10.1016/j.poly.2013.05.053
   Dai HH, 2016, CEREALS OILS, V29, P4
   Dong Z. X., 2013, ANHUI MED PHARM J, V17, P1286, DOI [10.3969/j.issn.1009-6469.2013.08.008, DOI 10.3969/J.ISSN.1009-6469.2013.08.008]
   He Chunnian, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1428
   Huang C., 2003, MED NUTR, V62
   [金声琅 Jin Shenglang], 2015, [食品工业科技, Science & Technology of Food Industry], V36, P349
   Li H, 2014, AGR SCI TECH, V15, P480
   Li HK, 2009, PLANTA MED, V75, P7, DOI 10.1055/s-0028-1088332
   Li HY, 2009, TOXICON, V53, P595, DOI 10.1016/j.toxicon.2008.11.005
   Li K., 2012, Food Res. Dev, V33, P228
   Li M, 2013, COMP BIOCHEM PHYS C, V157, P310, DOI 10.1016/j.cbpc.2013.02.003
   Li YJ, 2010, VASC PHARMACOL, V53, P169, DOI 10.1016/j.vph.2010.07.001
   Lindley SE, 2005, PSYCHONEUROENDOCRINO, V30, P785, DOI 10.1016/j.psyneuen.2005.03.007
   [刘丛彬 Liu Congbin], 2014, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V29, P53
   Liu HH, 2015, FISH SHELLFISH IMMUN, V43, P491, DOI 10.1016/j.fsi.2015.01.032
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Mao C. X., 2014, MOD FOOD SCI TECHNOL, V30, P142, DOI [10.13982/j.mfst.1673-9078.2014.04.008, DOI 10.13982/J.MFST.1673-9078.2014.04.008]
   Pan MH, 2012, MOL NUTR FOOD RES, V56, P88, DOI 10.1002/mnfr.201100509
   Qi J.C., 2005, J CEREALS OILS, V11, P22
   Qu WT, 2013, J YANTAI U, V26, P147
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun S G, 2013, CHIN J EXP TRAD MED, V19, P283
   Tao HY, 2006, CHINA J MOD MED, V16, P1978
   Wang HZ, 2007, INT J PHARM RES, V34, P254
   Wang Li-Mei, 2013, Food Science and Technology, V38, P280
   Wang Y, 2012, FOOD MACH, V26, P64
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wu J., 2014, ACTA CHIN MED PHARM, V42, P9
   Wu MJ, 2009, EVID-BASED COMPL ALT, V6, P57, DOI 10.1093/ecam/nem066
   Yang ZS, 2011, CHINESE J MED CLIN, V11, P545
   [易军鹏 YI Jun-peng], 2009, [天然产物研究与开发, Natural Product R & D], V21, P604
   Zhang JZ, 2014, J GUANGZHOU U TRADIT, V31, P330
   Zhang T, 2015, J CHONGQING NORMAL U, P143
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
   Zhu LQ, 2004, J PINEAL RES, V37, P71, DOI 10.1111/j.1600-079X.2004.00136.x
   [朱文学 Zhu Wenxue], 2010, [食品科学, Food Science], V31, P248
   [朱献标 Zhu Xianbiao], 2014, [中国油脂, China Oils and Fats], V39, P88
   Zhu Z. L., 2014, FOOD DRUG, V16, P133
NR 42
TC 16
Z9 19
U1 3
U2 78
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD DEC
PY 2017
VL 26
IS 6
BP 1703
EP 1708
DI 10.1007/s10068-017-0225-9
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA FR6CV
UT WOS:000419153900026
PM 30263708
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Huang, C
   Zheng, XB
   Mei, HJ
   Zhou, M
AF Huang, Chen
   Zheng, Xiaobing
   Mei, Haijun
   Zhou, Min
TI Rescuing Impaired Re-endothelialization of Drug-Eluting Stents Using the
   Hepatocyte Growth Factor
SO ANNALS OF VASCULAR SURGERY
LA English
DT Article
ID PROGENITOR-CELL CAPTURE; LOW-DENSITY-LIPOPROTEIN; SIROLIMUS; INHIBITION;
   SENESCENCE; RESTENOSIS; PATHOLOGY; REGISTRY; HUMANS; INJURY
AB Background: Current commercially available drug-eluting stents (DESs) are criticized for the problem of stent thrombosis by induced impaired re-endothelialization (RE). The solving of this challenge could be boosted by endothelial progenitor cells (EPCs). The purpose of this study was to examine the effects of hepatocyte growth factor (HGF) on this process.
   Methods: The abundance and functional capacity of circulating EPC was analyzed by a fluorescence-activated cell sorter and western blot. The in vivo effect of HGF on DES patency, RE, and neointimal formation was investigated in a hypercholesterolemic rabbit model.
   Results: After 7 days of HGF administration, the number of CD34+/CD133+ progenitor cells had increased significantly. HGF also significantly inhibited the onset of senescence of EPC due to a decrease in protein expression of p53 and p21. In the in vivo study, HGF-treated DES had a higher patency rate than the control group (11/12 vs. 6/12, P = 0.032). Moreover, the HGF-treated group exhibited better RE (control group: 69.5 +/- 12.9%, HGF group: 88.8 +/- 8.4%, P = 0.006), but significantly smaller areas of neointima (control group: 0.68 +/- 0.15 mm(2), HGF group: 0.45 +/- 0.18 mm(2), P = 0.02).
   Conclusion: HGF efficiently ameliorates the vascular response to stent implantation, and has an important redeeming influence on the deleterious endothelial effects of DES.
C1 [Huang, Chen; Zheng, Xiaobing; Mei, Haijun] Nantong Univ, Affiliated Hosp, Dept Vasc Surg, Nantong, Peoples R China.
   [Zhou, Min] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Vasc Surg,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.
C3 Nantong University; Nanjing University
RP Huang, C (corresponding author), Nantong Univ, Affiliated Hosp, Dept Vasc Surg, Nantong, Peoples R China.; Zhou, M (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Vasc Surg,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.
EM huangchen132@sina.com
OI Huang, Chen/0000-0001-7145-3013
FU Science Project of Jiangsu Health [Z201308]; Medical Science and
   Technology Development Foundation, Nanjing Department of Health
   [JQX14002]; Social Development Project of Jiangsu Province, China
   [BE2015603]
FX This study was funded by grants from the Science Project of Jiangsu
   Health (grant no. Z201308), the Key Project supported by Medical Science
   and Technology Development Foundation, Nanjing Department of Health
   (grant no.JQX14002), and Social Development Project of Jiangsu Province,
   China (BE2015603).
CR Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571
   Chang H, 2015, J BIOMED MATER RES B, V103, P430, DOI 10.1002/jbm.b.33224
   Chong E, 2010, J INTERV CARDIOL, V23, P101, DOI 10.1111/j.1540-8183.2010.00534.x
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Granada JF, 2010, CIRC-CARDIOVASC INTE, V3, P257, DOI 10.1161/CIRCINTERVENTIONS.109.919936
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   Grube Eberhard, 2002, J Interv Cardiol, V15, P471, DOI 10.1111/j.1540-8183.2002.tb01091.x
   Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x
   Iwabayashi M, 2012, BIOCHEM BIOPH RES CO, V423, P79, DOI 10.1016/j.bbrc.2012.05.086
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F
   Mackay J, 2004, ATLAS HEART DIS STRO, P84
   Maier JAM, 1996, ATHEROSCLEROSIS, V123, P115, DOI 10.1016/0021-9150(95)05793-5
   Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1
   Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015
   Sanada F, 2009, CIRC RES, V105, P667, DOI 10.1161/CIRCRESAHA.109.202713
   Song MB, 2009, VASC PHARMACOL, V51, P205, DOI 10.1016/j.vph.2009.06.009
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   VAN BE, 1997, J AM COLL CARDIOL, V29, P1371
   Walter DH, 2004, CIRCULATION, V110, P36, DOI 10.1161/01.CIR.0000133324.38115.0A
   Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74
NR 26
TC 5
Z9 7
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0890-5096
EI 1615-5947
J9 ANN VASC SURG
JI Ann. Vasc. Surg.
PD OCT
PY 2016
VL 36
BP 273
EP 282
DI 10.1016/j.avsg.2016.07.001
PG 10
WC Surgery; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Cardiovascular System & Cardiology
GA DY2ZE
UT WOS:000384959800038
PM 27423724
DA 2024-02-19
ER

PT J
AU Singh, P
   Goode, T
   Dean, A
   Awad, SS
   Darlington, GJ
AF Singh, Pallavi
   Goode, Triona
   Dean, Adam
   Awad, Samir S.
   Darlington, Gretchen J.
TI Elevated Interferon Gamma Signaling Contributes to Impaired Regeneration
   in the Aged Liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Aging; Inflammation; Gamma interferon; Liver regeneration; Partial
   hepatectomy
ID FULMINANT HEPATIC-FAILURE; GENE-EXPRESSION PROFILE; EXTRATHYMIC T-CELLS;
   AMES DWARF MICE; PARTIAL-HEPATECTOMY; IFN-GAMMA; RAT-LIVER;
   INSULIN-RESISTANCE; METABOLIC SYNDROME; PHYSIOLOGICAL-RESPONSES
AB Our previous study on immune-related changes in the aged liver described immune cell infiltration and elevation of inflammation with age. Levels of interferon (IFN)-gamma, a known cell cycle inhibitor, were elevated in the aging liver. Here, we determine the role played by IFN-gamma in the delayed regenerative response observed in the aged livers. We observed elevated IFN signaling in both aged hepatocytes and regenerating livers post-partial hepatectomy. In vivo deletion of the major IFN-gamma producers-the macrophages and the natural killer cells, leads to a reduction in the IFN-gamma levels accompanied with the restoration of the DNA synthesis kinetics in the aged livers. Eighteen-month-old IFN-gamma-/- mice livers, upon resection, exhibited an earlier entry into the cell cycle compared with age-matched controls. Thus, our study strongly suggests that an age-related elevation in inflammatory conditions in the liver often dubbed as "inflammaging" has a detrimental effect on the regenerative response.
C1 [Singh, Pallavi] Columbia Univ, Med Ctr, Dept Dermatol, Coll Phys & Surg, New York, NY 10032 USA.
   [Singh, Pallavi; Goode, Triona; Dean, Adam; Darlington, Gretchen J.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Awad, Samir S.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA.
C3 Columbia University; Baylor College of Medicine; Baylor College of
   Medicine
RP Singh, P (corresponding author), Columbia Univ, Med Ctr, Dept Dermatol, Coll Phys & Surg, Room 307,1150 St Nicholas Ave, New York, NY 10032 USA.
EM pallavi.singh02@gmail.com
FU National Institutes of Health [PO1 AG20752, AG028865]; Texas Medical
   Center Digestive Disease Center [DK56338, DK53045]; Ellison Medical
   Foundation
FX This work was supported by the National Institutes of Health (PO1
   AG20752 and AG028865); the Texas Medical Center Digestive Disease Center
   (DK56338 and DK53045); and the Ellison Medical Foundation.
CR Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Allman M, 2010, J GASTROEN HEPATOL, V25, P635, DOI 10.1111/j.1440-1746.2009.06112.x
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   Blouin K, 2005, METABOLISM, V54, P1034, DOI 10.1016/j.metabol.2005.03.006
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Bokov AF, 2009, J GERONTOL A-BIOL, V64, P819, DOI 10.1093/gerona/glp052
   Brooling JT, 2005, HEPATOLOGY, V41, P906, DOI 10.1002/hep.20645
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chen GW, 2006, WORLD J GASTROENTERO, V12, P7852, DOI 10.3748/wjg.v12.i48.7852
   CHOU MW, 1995, CANCER LETT, V91, P191, DOI 10.1016/0304-3835(95)03750-Q
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   CORNELL RP, 1990, HEPATOLOGY, V11, P916, DOI 10.1002/hep.1840110603
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Eguchi H, 2000, DIGEST DIS SCI, V45, P1383, DOI 10.1023/A:1005564205755
   Einstein FH, 2010, J GERONTOL A-BIOL, V65, P800, DOI 10.1093/gerona/glq078
   Enami Y, 2001, J Hepatobiliary Pancreat Surg, V8, P250, DOI 10.1007/s005340170025
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   Farges O, 1999, ANN SURG, V229, P210, DOI 10.1097/00000658-199902000-00008
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   FRANCAVILLA A, 1991, HEPATOLOGY, V14, P140, DOI 10.1002/hep.1840140123
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   GERLYNG P, 1994, CARCINOGENESIS, V15, P371, DOI 10.1093/carcin/15.2.371
   Gomez CR, 2008, J GERONTOL A-BIOL, V63, P1299, DOI 10.1093/gerona/63.12.1299
   González AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384
   Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13
   Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hines IN, 2007, HEPATOLOGY, V46, P229, DOI 10.1002/hep.21674
   Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100
   Huang W, 2006, LIVER INT, V26, P339, DOI 10.1111/j.1478-3231.2005.01221.x
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471
   Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276
   Kano A, 1997, J BIOCHEM-TOKYO, V121, P677
   Kimura K, 1999, J HEPATOL, V31, P579, DOI 10.1016/S0168-8278(99)80334-1
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Labbé A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184
   Lalor PF, 2007, SEMIN LIVER DIS, V27, P173, DOI 10.1055/s-2007-979470
   LEBEL M, J GERONTOL A-BIOL, DOI DOI 10.1093/GER0NA/GLR038
   Lee HJ, 2007, J MOL BIOL, V369, P967, DOI 10.1016/j.jmb.2007.03.072
   LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H
   Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947
   Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413
   OHNISHI H, 1993, GASTROENTEROL JPN, V28, P40
   OHNISHI H, 1993, GASTROENTEROL JPN S4, V28, P53
   OHTEKI T, 1991, EUR J IMMUNOL, V21, P1733, DOI 10.1002/eji.1830210722
   OHTEKI T, 1992, J IMMUNOL, V149, P1562
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Rai RM, 1997, HEPATOLOGY, V25, P889, DOI 10.1002/hep.510250417
   Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475
   Sawabe M, 2000, PATHOL INT, V50, P98, DOI 10.1046/j.1440-1827.2000.01005.x
   Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603
   SHIMA A, 1976, EXP GERONTOL, V11, P193, DOI 10.1016/0531-5565(76)90033-4
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Soejima Y, 2003, TRANSPLANTATION, V76, P344, DOI 10.1097/01.TP.0000071205.52835.A4
   Stocker E, 1971, Beitr Pathol, V144, P400
   Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055
   Sun R, 2006, HEPATOLOGY, V44, P955, DOI 10.1002/hep.21344
   Takayama E, 2000, J IMMUNOL, V164, P5652, DOI 10.4049/jimmunol.164.11.5652
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Takubo K, 2001, Nihon Shokakibyo Gakkai Zasshi, V98, P144
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Tsukahara A, 1997, HEPATOLOGY, V26, P301, DOI 10.1002/hep.510260208
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Tura BJ, 2001, INT J EXP PATHOL, V82, P317, DOI 10.1046/j.1365-2613.2001.00207.x
   Veteläinen R, 2007, ANN SURG, V245, P44, DOI 10.1097/01.sla.0000225253.84501.0e
   WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S
   Wüstefeld T, 2000, HEPATOLOGY, V32, P514, DOI 10.1053/jhep.2000.16604
   Yamauchi H, 2003, EXP TOXICOL PATHOL, V54, P281, DOI 10.1078/0940-2993-00265
   YAZICI MK, 2006, ARCH GERONTOL GERIAT, V42, P35
   Zocco MA, 2006, DIGEST LIVER DIS, V38, P563, DOI 10.1016/j.dld.2006.04.015
NR 82
TC 24
Z9 30
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 2011
VL 66
IS 9
BP 944
EP 956
DI 10.1093/gerona/glr094
PG 13
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 809OP
UT WOS:000294066900003
PM 21719609
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Wang, RH
   Zhao, TR
   Cui, KR
   Hu, GQ
   Chen, Q
   Chen, WP
   Wang, XW
   Soto-Gutierrez, A
   Zhao, KJ
   Deng, CX
AF Wang, Rui-Hong
   Zhao, Tingrui
   Cui, Kairong
   Hu, Gangqing
   Chen, Qiang
   Chen, Weiping
   Wang, Xin-Wei
   Soto-Gutierrez, Alejandro
   Zhao, Keji
   Deng, Chu-Xia
TI Negative reciprocal regulation between Sirt1 and Per2 modulates the
   circadian clock and aging
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LIFE-SPAN; CALORIE RESTRICTION; TUMOR-SUPPRESSOR; DNA-DAMAGE; MICE; P53;
   RHYTHMS; PROTEIN; EXPRESSION; MUTANT
AB Sirtuin 1 (SIRT1) is involved in both aging and circadian-clock regulation, yet the link between the two processes in relation to SIRT1 function is not clear. Using Sirt1-deficient mice, we found that Sirt1 and Period 2 (Per2) constitute a reciprocal negative regulation loop that plays important roles in modulating hepatic circadian rhythmicity and aging. Sirt1-deficient mice exhibited profound premature aging and enhanced acetylation of histone H4 on lysine16 (H4K16) in the promoter of Per2, the latter of which leads to its overexpression; in turn, Per2 suppresses Sirt1 transcription through binding to the Sirt1 promoter at the Clock/Bmal1 site. This negative reciprocal relationship between SIRT1 and PER2 was also observed in human hepatocytes. We further demonstrated that the absence of Sirt1 or the ectopic overexpression of Per2 in the liver resulted in a dysregulated pace of the circadian rhythm. The similar circadian rhythm was also observed in aged wild type mice. The interplay between Sirt1 and Per2 modulates aging gene expression and circadian-clock maintenance.
C1 [Wang, Rui-Hong; Chen, Qiang; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Macau, Peoples R China.
   [Wang, Rui-Hong; Zhao, Tingrui; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.
   [Cui, Kairong; Hu, Gangqing; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA.
   [Chen, Weiping] NIDDK, Genom Core Lab, Bethesda, MD 20892 USA.
   [Wang, Xin-Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA.
C3 University of Macau; National Institutes of Health (NIH) - USA; NIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK);
   National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK);
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE);
   University of Pittsburgh
RP Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Macau, Peoples R China.; Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.
EM cxdeng@umac.mo
RI Hu, Gangqing/ABA-3507-2020; Chen, Weiping/C-9550-2011; Wang, Xin
   Wei/B-6162-2009; deng, chuxia/N-6713-2016; Hu, Gangqing/K-5849-2012
OI Wang, Xin Wei/0000-0001-9735-606X; Hu, Gangqing/0000-0001-5453-6888
FU Intramural Research Program of the National Institute of DIDDK, National
   Institutes of Health, Bethesda, MD, USA; Intramural Research Program of
   the National Institute of NHLBI, National Institutes of Health,
   Bethesda, MD, USA; Intramural Research Program of the National Institute
   of NCI, National Institutes of Health, Bethesda, MD, USA; Faculty of
   Health Sciences, University of Macau, Macau SAR, China
FX We gratefully acknowledge members of the Deng laboratory for helpful
   discussions. The ChIP-Seq libraries were sequenced by the DNA Sequencing
   and Computation Core facility of the National Heart, Lung, and Blood
   Institute (NHLBI). Freshly isolated human hepatocytes were obtained from
   the Liver Tissue Cell Distribution System at the University of
   Pittsburgh (Pittsburgh, PA). This work was supported, in part, by the
   Intramural Research Programs of the National Institute of DIDDK, NHLBI,
   and NCI, National Institutes of Health, Bethesda, MD, USA, as well as
   the Faculty of Health Sciences, University of Macau, Macau SAR, China.
CR Aguilar-Arnal L, 2013, CURR OPIN CELL BIOL, V25, P170, DOI 10.1016/j.ceb.2013.01.003
   Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001
   Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006
   Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003
   Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Barzilai N, 2012, NAT REV GENET, V13, P589, DOI 10.1038/nrg3290
   Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Brown SA, 2001, CURR BIOL, V11, pR268, DOI 10.1016/S0960-9822(01)00135-X
   Burgess DJ, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3089
   Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296
   Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003
   Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002
   Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027
   Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100
   Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147
   DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024
   Jiang P, 2012, SLEEP, V35, P1385, DOI 10.5665/sleep.2120
   Jiang WD, 2010, INT J CANCER, V127, P1011, DOI 10.1002/ijc.25118
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Liu ZH, 2013, MOL BIOL REP, V40, P2491, DOI 10.1007/s11033-012-2330-4
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080
   McBurney MW, 2003, MOL CANCER RES, V1, P402
   Meireles ACA, 2014, CURR BIOL, V24, P1, DOI 10.1016/j.cub.2013.11.017
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Sebastián C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004
   Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101
   Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011
   Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001
   Wang RH, 2014, INT J BIOL SCI, V10, P1193, DOI 10.7150/ijbs.11066
   Wang RH, 2013, INT J BIOL SCI, V9, P934, DOI 10.7150/ijbs.7529
   Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243
   Wang RH, 2010, INT J BIOL SCI, V6, P682
   Yang YM, 2012, BIOL OPEN, V1, P789, DOI 10.1242/bio.20121990
NR 57
TC 52
Z9 61
U1 0
U2 18
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 27
PY 2016
VL 6
AR 28633
DI 10.1038/srep28633
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DP5DD
UT WOS:000378515300001
PM 27346580
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kumar, A
   Mahajan, A
   Kumari, P
   Singh, J
   Raik, S
   Saha, L
   Pal, A
   Medhi, B
   Rattan, V
   Bhattacharyya, S
AF Kumar, Ajay
   Mahajan, Aditi
   Kumari, Puja
   Singh, Jagjit
   Raik, Shalini
   Saha, Lekha
   Pal, Arnab
   Medhi, Bikash
   Rattan, Vidya
   Bhattacharyya, Shalmoli
TI Dental pulp stem cell secretome ameliorates d-galactose induced
   accelerated aging in rat model
SO CELL BIOCHEMISTRY AND FUNCTION
LA English
DT Article; Early Access
DE aging; dental pulp; d-galactose; secretome; stem cells
ID LIVER-CANCER; CALCIUM; BRAIN
AB Advancing age is associated with several diseases and disorders due to multiorgan atrophy. The increasing proportion of elderly humans demands the identification of means to counteract aging and age-associated disorders. There is an increased depletion of stem cells in the aged organs, resulting in their inability to repair the damage and hence organ degeneration. Stem cell therapy has been implicated in counteracting aging and shown promise. However, the use of stem cells encounters several side effects and complications such as handling and storage of the cells for transplantation purpose. Stem cells secretome has proven to be of significant importance in a variety of disorders. In this study, we have shown that secretome derived from dental pulp stem cells (DPSCs) can reverse the age-associated degeneration induced by chronic exposure to d-galactose in a rat model. The secretome was able to increase muscle grip strength and animal activity. Secretome also improved the kidney function and hepatic biochemistry similar to healthy controls as evaluated by renal function test and Fourier-transform infrared spectroscopy. We also showed that secretome reduced the levels of monoamine oxidase and acetylcholinesterase in the brain and liver, indicating aging reversal. Finally, proteomic profiling of DPSCs secretome revealed the presence of 13 proteins which have antiaging functions. Thus, our study provides first proof of concept that DPSCs secretome can render protection against d-galactose induced accelerated aging.
C1 [Kumar, Ajay; Mahajan, Aditi; Raik, Shalini; Bhattacharyya, Shalmoli] PGIMER, Dept Biophys, Sect 12, Chandigarh 160012, India.
   [Kumari, Puja; Singh, Jagjit; Saha, Lekha; Medhi, Bikash] PGIMER, Dept Pharmacol, Chandigarh, India.
   [Pal, Arnab] PGIMER, Dept Biochem, Chandigarh, India.
   [Rattan, Vidya] PGIMER, Dept Oral Hlth Sci, Unit Oral & Maxillofacial Surg, Chandigarh, India.
C3 Post Graduate Institute of Medical Education & Research (PGIMER),
   Chandigarh; Post Graduate Institute of Medical Education & Research
   (PGIMER), Chandigarh; Post Graduate Institute of Medical Education &
   Research (PGIMER), Chandigarh; Post Graduate Institute of Medical
   Education & Research (PGIMER), Chandigarh
RP Bhattacharyya, S (corresponding author), PGIMER, Dept Biophys, Sect 12, Chandigarh 160012, India.
EM shalmoli2007@yahoo.co.in
RI KUMARI, PUJA/KBB-2640-2024; Pal, Arnab/B-6024-2012; Kumar,
   Ajay/O-4486-2015
OI KUMARI, PUJA/0000-0002-7726-1503; Pal, Arnab/0000-0002-0850-3118;
   Mahajan, Aditi/0000-0001-7243-5167; Kumar, Ajay/0000-0003-3412-1823;
   Singh, Jagjit/0000-0003-2856-1371; Bhattacharyya,
   Shalmoli/0000-0003-4189-4453
FU Intramural grant, PGIMER, Chandigarh
FX Intramural grant, PGIMER, Chandigarh
CR Ahmed NEB, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8102478
   Allen RG, 1998, AGE, V21, P47, DOI 10.1007/s11357-998-0007-7
   Azman KF, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111372
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Balan V, 2019, MATERIALS, V12, DOI 10.3390/ma12182884
   Belarbi K, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00408-1
   Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913
   Bozkurt O, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076023
   Braverman ER, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-21
   Budni J, 2017, METAB BRAIN DIS, V32, P811, DOI 10.1007/s11011-017-9972-9
   da Silva PFL, 2021, J INVEST DERMATOL, V141, P951, DOI 10.1016/j.jid.2020.11.018
   De Miguel Z, 2021, NATURE, V600, P494, DOI 10.1038/s41586-021-04183-x
   Ding SSL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071784
   Eleuteri S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184597
   Fan XL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143518
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Gong H, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00886-3
   Greig FH, 2014, PHARMACOL THERAPEUT, V143, P265, DOI 10.1016/j.pharmthera.2014.03.006
   He YY, 2013, MOL NEUROBIOL, V48, P783, DOI 10.1007/s12035-013-8466-y
   Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622
   Iskusnykh IY, 2022, MOLECULES, V27, DOI 10.3390/molecules27010324
   Kichenbrand C, 2019, TISSUE ENG PART B-RE, V25, P78, DOI [10.1089/ten.teb.2018.0168, 10.1089/ten.TEB.2018.0168]
   Kolar MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12969-1
   Kumar A, 2018, BIOCHIMIE, V155, P129, DOI 10.1016/j.biochi.2018.10.014
   Kumar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14358-0
   Kumar A, 2017, MOL NEUROBIOL, V54, P4672, DOI 10.1007/s12035-016-0011-3
   Kumar A, 2015, CELL TISSUE BANK, V16, P513, DOI 10.1007/s10561-015-9498-5
   MANTLE TJ, 1976, FEBS LETT, V64, P227, DOI 10.1016/0014-5793(76)80289-X
   Mc Auley MT, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160177
   Muhammad SA, 2018, REV NEUROSCIENCE, V29, P321, DOI 10.1515/revneuro-2017-0069
   Murata D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103589
   Palla AR, 2021, SCIENCE, V371, P483, DOI 10.1126/science.abc8059
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809
   Pintus Gianfranco, 2018, Oncotarget, V9, P27117, DOI 10.18632/oncotarget.25499
   Pontoriero G, 2010, NEPHRON CLIN PRACT, V116, pC263, DOI 10.1159/000318787
   Raik S, 2018, BIOTECHNOL APPL BIOC, V65, P104, DOI 10.1002/bab.1561
   Rodrigues AF, 2017, MOL NEUROBIOL, V54, P4127, DOI 10.1007/s12035-016-9981-4
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Saravanakumar M, 2012, MOL CELL BIOCHEM, V362, P203, DOI 10.1007/s11010-011-1143-4
   Sharma K, 2019, MOL MED REP, V20, P1479, DOI 10.3892/mmr.2019.10374
   Sharma S., 2021, HYPOPHOSPHATEMIA
   Sheng DP, 2015, J MOL STRUCT, V1099, P18, DOI 10.1016/j.molstruc.2015.05.054
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Suksuphew S, 2015, WORLD J STEM CELLS, V7, P502, DOI 10.4252/wjsc.v7.i2.502
   Thumanu K, 2014, J BIOPHOTONICS, V7, P222, DOI 10.1002/jbio.201300183
   Tittelmeier J, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581374
   United Nations, 2019, World population prospects
   Wu H, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112093
   Xiong SQ, 2021, ELIFE, V10, DOI 10.7554/eLife.63677
NR 50
TC 3
Z9 3
U1 4
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0263-6484
EI 1099-0844
J9 CELL BIOCHEM FUNCT
JI Cell Biochem. Funct.
PD 2022 JUL
PY 2022
VL 40
IS 5
BP 535
EP 545
DI 10.1002/cbf.3723
EA JUL 2022
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 3F7YS
UT WOS:000820733000001
PM 35790015
DA 2024-02-19
ER

PT S
AU Spindler, SR
AF Spindler, SR
BE Park, SC
   Hwang, ES
   Kim, HS
   Park, WY
TI Calorie restriction enhances the expression of key metabolic enzymes
   associated with protein renewal during aging
SO HEALTHY AGING FOR FUNCTIONAL LONGEVITY: MOLECULAR AND CELLULAR
   INTERACTIONS IN SENESCENCE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on Healthy Aging for Functional Longevity
CY FEB, 2000
CL KYONGJU, SOUTH KOREA
SP Federat Korean Gerontol Soc, Int Assoc BioMed Gerontol, Korea Sci & Engn Fdn, Korea Res Fdn, Korea Res Fdn Hlth Sci, Seoul Natl Univ
DE hepatic gluconeogenesis; nitrogen; carbon; PEPCK; amino acid catabolism;
   oxaloacetate
ID PHOSPHOENOLPYRUVATE CARBOXYKINASE; GENE; RAT; AGE
AB Our studies show that dietary caloric restriction (CR) alters the expression of key metabolic enzymes in a manner consistent with an increased rate of extrahepatic protein turnover and renewal during aging. Of the key hepatic gluconeogenic enzyme genes affected by CR, glucose 6-phosphatase mRNA increased 1.7- and 2.3-fold in young and old CR mice. Phosphoenolpyruvate carboxykinase mRNA increased 2-fold in young mice, and its mRNA and activity increased 2.5- and 1.7-fold in old mice. These changes indicate that CR enhances the enzymatic capacity for gluconeogenesis. The carbon required for gluconeogenesis appears to be generated from peripheral protein turnover. Muscle glutamine synthetase mRNA increased 1.3- and 2.1-fold in young and old CR mice, suggesting increased disposal of nitrogen and carbon derived from protein catabolism for energy. mRNA for the key liver nitrogen disposal enzymes glutaminase, carbamyl phosphate synthase I, and tyrosine aminotransferase were increased by 2.4-, 1.8-, and 1.8-fold in CR mice. Consistent with increased hepatic nitrogen disposal, hepatic glutamine synthetase mRNA and activity were each decreased about 40% in CR mice. Together, these and our other published data suggest that CR enhances and maintains protein turnover, and thus protein renewal, into old age. These effects are likely to resist the well-documented decline in whole body protein renewal with age. Enhanced renewal may reduce the level of damaged and toxic proteins that accumulate during aging, contributing to the extension of life span by CR.
C1 Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
C3 University of California System; University of California Riverside
RP Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
CR Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   DHAHBI JM, IN PRESS MECH AGEING
   FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441
   Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581
   KING PA, 1983, BIOCHEM J, V216, P523, DOI 10.1042/bj2160523
   MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Tillman JB, 1996, J BIOL CHEM, V271, P3500, DOI 10.1074/jbc.271.7.3500
   Van Remmen Holly, 1995, P171
   WATFORD M, 1994, J NUTR, V124, P493, DOI 10.1093/jn/124.4.493
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WIMONWATWATEE T, 1994, AM J PHYSIOL, V267, pG201, DOI 10.1152/ajpgi.1994.267.2.G201
   ZHAN ZR, 1994, INT J BIOCHEM, V26, P263, DOI 10.1016/0020-711X(94)90155-4
NR 14
TC 46
Z9 52
U1 0
U2 6
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-285-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 928
BP 296
EP 304
PG 9
WC Biochemistry & Molecular Biology; Geriatrics & Gerontology;
   Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Geriatrics & Gerontology; Science &
   Technology - Other Topics
GA BT10T
UT WOS:000171969700029
PM 11795521
DA 2024-02-19
ER

PT J
AU Xu, L
   Badr, MZ
AF Xu, L
   Badr, MZ
TI Enhanced potential for oxidative stress in hyperinsulinemic rats:
   Imbalance between hepatic peroxisomal hydrogen peroxide production and
   decomposition due to hyperinsulinemia
SO HORMONE AND METABOLIC RESEARCH
LA English
DT Article
DE syndrome X; oxidative stress; antioxidants; peroxisomal metabolism;
   obesity
ID TRANSGENIC MICE; BETA-OXIDATION; INSULIN; CATALASE; DISEASE; LIVER;
   HEART
AB Oxidative stress is involved in aging and age-related diseases. Several metabolic alterations similar to those encountered with aging and age-related diseases have been observed in response to hyperinsulinemia. Surprisingly, this metabolic derangement diminished hepatic peroxisomal beta-oxidation which is a major source of H2O2 production in the liver, suggesting a protective effect against oxidative stress. However, the impact of hyperinsulinemia on the balance between H2O2 production and elimination in the liver is not known. Consequently, this study was undertaken to evaluate the effect of sustained high serum insulin levels on the activity of hepatic catalase, a peroxisomal antioxidant enzyme involved in the decomposition of H2O2. Male Sprague-Dawley rats received intravenous infusion of either 30 % glucose, 30 % galactose or normal saline for seven days. Activity of hepatic peroxisomal beta-oxidation and catalase decreased 58% and 74%, respectively, in glucose-infused rats compared with galactose- or saline-infused animals. When infused simultaneously with glucose, diazoxide blocked glucose-enhanced insulin secretion and prevented the decrease in peroxisomal enzyme activities, without altering blood glucose concentration. Neither diazoxide alone nor galactose, which did not alter serum insulin levels, had any effect on enzyme activities. These results suggest that hyperinsulinemia is responsible for the decreased enzyme activities observed in glucose-infused rats. Indeed, a strong negative correlation between serum insulin levels and hepatic peroxisomal enzyme activities was found. To investigate the mechanism by which insulin modulates catalase activity, we studied rates of synthesis and degradation of catalase in saline- and glucose-infused rats. Data show that insulin diminishes rates of catalase synthesis, while exhibiting no effect on its degradation. Upsetting the balance between the cellular capacity to produce and eliminate H2O2 may be a contributing factor to the known deleterious effects of hyperinsulinemia.
C1 Univ Missouri, Sch Pharm, Div Pharmacol, Kansas City, MO 64108 USA.
C3 University of Missouri System; University of Missouri Kansas City
RP Badr, MZ (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol, 2411 Holmes St, Kansas City, MO 64108 USA.
EM badrm@umkc.edu
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   BRADY PS, 1989, BIOCHEM J, V258, P677, DOI 10.1042/bj2580677
   CANONICO PG, 1977, LAB INVEST, V37, P479
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180
   Ferrannini E, 1989, J NEPHROL, V1, P3
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2
   MATTEIS FD, 1991, HEPATOTOXICOLOGY, P437
   Nilakantan V, 1998, FREE RADICAL BIO MED, V24, P1430, DOI 10.1016/S0891-5849(98)00007-0
   OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   ROTH H, 1965, ANAL BIOCHEM, V10, P32, DOI 10.1016/0003-2697(65)90238-1
   Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5
   Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SORENSEN HN, 1992, EUR J BIOCHEM, V208, P705, DOI 10.1111/j.1432-1033.1992.tb17238.x
   TERKEL J, 1972, J APPL PHYSIOL, V33, P519, DOI 10.1152/jappl.1972.33.4.519
   XU L, 1995, HORM METAB RES, V27, P76, DOI 10.1055/s-2007-979912
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182
NR 22
TC 32
Z9 35
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0018-5043
EI 1439-4286
J9 HORM METAB RES
JI Horm. Metab. Res.
PD APR
PY 1999
VL 31
IS 4
BP 278
EP 282
DI 10.1055/s-2007-978733
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 190ZA
UT WOS:000079994400008
PM 10333085
DA 2024-02-19
ER

PT J
AU Eppler, B
   Dawson, R
AF Eppler, B
   Dawson, R
TI Cysteine sulfinate decarboxylase and cysteine dioxygenase activities do
   not correlate with strain-specific changes in hepatic and cerebellar
   taurine content in aged rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; cysteine dioxygenase; cysteine sulfinate decarboxylase; taurine
ID INDUCED LIPID-PEROXIDATION; SULFUR AMINO-ACIDS; DIETARY-PROTEIN; AGING
   RAT; IN-VITRO; METABOLISM; BIOSYNTHESIS; HEPATOCYTES; BRAIN; GLUTATHIONE
AB Taurine is a free sulfur-containing amino acid that is found in abundance in mammalian tissues and fluids. Many biological roles have been proposed for this amino acid, including reducing oxidative stress and cytotoxicity. Taurine has previously been reported to decline in tissues during aging which could exacerbate an age-related increase in oxidative stress. The aim of the present study was to elucidate the mechanism responsible for the observed decline in tissue taurine content. We measured the activity of the major taurine biosynthetic enzymes, cysteine sulfinate decarboxylase and cysteine dioxygenase, in liver and cerebellar tissues of rats. Tissues from male adult and aged Fischer 344 (F344; 10 and 28 months), Sprague-Dawley (SD; 5, 20 and 25 months), and F344/Brown-Norway hybrid (FBNF1; 14 and 33.5 months) rats were used. We observed a significant decline in hepatic taurine content of the F344 animals but the decline in the liver of SD and FBNF1 animals was non-significant. Hepatic cysteine sulfinate decarboxylase and cysteine dioxygenase activities were significantly lower in aged F344 rats but not in the other strains. Cerebellar taurine content was significantly lower in aged F344 and SD rats without a concomitant decline in cysteine sulfinate decarboxylase activity. These results suggest that a decline in hepatic de novo taurine biosynthesis might be partially responsible for a reduction in tissue taurine content in F344 rats. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Florida, Coll Pharm, Dept Pharmacodynam, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida
RP Eppler, B (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacodynam, JHMHC Box 100487, Gainesville, FL 32610 USA.
EM beppler@ufl.edu
CR ALMARGHINI K, 1991, NEUROSCIENCE, V43, P111, DOI 10.1016/0306-4522(91)90421-J
   ALMARGHINI K, 1994, J NEUROCHEM, V62, P1604
   ALVAREZ JG, 1983, BIOL REPROD, V29, P548, DOI 10.1095/biolreprod29.3.548
   BAGLEY PJ, 1995, ANAL BIOCHEM, V227, P40, DOI 10.1006/abio.1995.1250
   BAGLEY PJ, 1994, J NUTR, V124, P2410, DOI 10.1093/jn/124.12.2410
   BAGLEY PJ, 1995, J NUTR, V125, P933
   BANKS MA, 1991, J NUTR BIOCHEM, V2, P308, DOI 10.1016/0955-2863(91)90072-D
   Bella DL, 1999, AM J PHYSIOL-ENDOC M, V276, pE326, DOI 10.1152/ajpendo.1999.276.2.E326
   Bella DL, 1996, J NUTR, V126, P2179, DOI 10.1093/jn/126.9.2179
   Bella DL, 1996, ADV EXP MED BIOL, V403, P73
   BELLA DL, 1995, AM J PHYSIOL-ENDOC M, V269, pE910, DOI 10.1152/ajpendo.1995.269.5.E910
   BENEDETTI MS, 1990, J NEURAL TRANSM-PARK, V2, P239, DOI 10.1007/BF02252919
   BENEDETTI MS, 1991, J NEURAL TRANSM-GEN, V86, P191, DOI 10.1007/BF01250705
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CAVALLINI D, 1976, PHYSIOL CHEM PHYS M, V8, P157
   CHESNEY RW, 1987, UCLA S MOL CELL BIOL, V55, P19
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   CORMAN B, 1985, AM J PHYSIOL, V248, pR282, DOI 10.1152/ajpregu.1985.248.3.R282
   DANIELS KM, 1982, J NUTR, V112, P2130
   DAWSON R, 1992, BRAIN RES BULL, V29, P459, DOI 10.1016/0361-9230(92)90083-A
   Dawson R, 1996, ADV EXP MED BIOL, V403, P37
   DAWSON R, 1992, AGE, V15, P73, DOI 10.1007/BF02435005
   Dawson R, 1999, MECH AGEING DEV, V107, P73, DOI 10.1016/S0047-6374(98)00138-9
   DELAROSA J, 1985, COMP BIOCHEM PHYS B, V81, P565, DOI 10.1016/0305-0491(85)90367-0
   Do KQ, 1996, NEUROCHEM INT, V28, P363, DOI 10.1016/0197-0186(95)00109-3
   Eppler B, 1998, ADV EXP MED BIOL, V442, P55
   FAVILLI F, 1994, NEUROBIOL AGING, V15, P429, DOI 10.1016/0197-4580(94)90074-4
   FRIEDMAN AL, 1983, AM J PHYSIOL, V245, pF159, DOI 10.1152/ajprenal.1983.245.2.F159
   GAFNI A, 1990, REV BIOL RES AGING, V4, P315
   GARCIA RAG, 1992, J NUTR, V122, P1693, DOI 10.1093/jn/122.8.1693
   HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63
   HOPE DB, 1955, BIOCHEM J, V59, P497, DOI 10.1042/bj0590497
   HOSOKAWA Y, 1980, J BIOCHEM-TOKYO, V88, P389, DOI 10.1093/oxfordjournals.jbchem.a132984
   HOSOKAWA Y, 1988, J NUTR, V118, P456, DOI 10.1093/jn/118.4.456
   HOSOKAWA Y, 1978, J BIOCHEM-TOKYO, V84, P419, DOI 10.1093/oxfordjournals.jbchem.a132142
   HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1
   IDA S, 1985, BRAIN RES, V344, P62, DOI 10.1016/0006-8993(85)91189-8
   JEEVANANDAM M, 1990, AM J CLIN NUTR, V51, P1040, DOI 10.1093/ajcn/51.6.1040
   JERKINS AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P534, DOI 10.1016/0003-9861(92)90721-8
   JERKINS AA, 1991, ARCH BIOCHEM BIOPHYS, V286, P428, DOI 10.1016/0003-9861(91)90061-M
   JERKINS AA, 1991, AM J PHYSIOL, V24, pE551
   JONES DP, 1990, KIDNEY INT, V38, P219, DOI 10.1038/ki.1990.189
   KAISAKIA PJ, 1995, BBA-GENE STRUCT EXPR, V1262, P79, DOI 10.1016/0167-4781(95)00058-O
   KOHASHI N, 1978, J BIOCHEM-TOKYO, V84, P159, DOI 10.1093/oxfordjournals.jbchem.a132104
   KURIYAMA K, 1986, J HYPERTENS, V4, pS175
   KURIYAMA K, 1984, J NEUROCHEM, V42, P1600, DOI 10.1111/j.1471-4159.1984.tb12748.x
   MISRA CH, 1979, INT J BIOCHEM, V10, P201, DOI 10.1016/0020-711X(79)90033-8
   MISRA CH, 1975, BRAIN RES, V97, P117, DOI 10.1016/0006-8993(75)90918-X
   NAKAMORI K, 1993, CHEM PHARM BULL, V41, P335
   OGASAWARA M, 1994, ADV EXP MED BIOL, V359, P71
   PALKOVITS M, 1990, PROG CLIN BIOL RES, V351, P45
   PASANTESMORALES H, 1985, BRAIN RES, V330, P154, DOI 10.1016/0006-8993(85)90018-6
   RATHBUN WB, 1991, EXP EYE RES, V53, P205, DOI 10.1016/0014-4835(91)90075-P
   Reymond I, 1996, NEUROSCIENCE, V75, P619, DOI 10.1016/0306-4522(96)00256-4
   ROTHSTEIN M, 1990, MOD AGING RES, V9, P3
   ROZEN R, 1982, P NATL ACAD SCI-BIOL, V79, P2101, DOI 10.1073/pnas.79.6.2101
   Schuller-Levis G, 1994, Adv Exp Med Biol, V359, P31
   SCHULLERLEVIS GB, 1995, EXP LUNG RES, V21, P877, DOI 10.3109/01902149509031768
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420
   STIPANUK MH, 1992, ADV EXP MED BIOL, V315, P413
   STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119
   STURMAN JA, 1973, J NUTR, V103, P1566, DOI 10.1093/jn/103.11.1566
   Tang XW, 1997, J NEUROSCI, V17, P6947
   TAPPAZ M, 1994, ADV EXP MED BIOL, V359, P257
   TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y
   TRACHTMAN H, 1993, BIOCHEM BIOPH RES CO, V191, P759, DOI 10.1006/bbrc.1993.1282
   WALLACE DR, 1990, GERONTOLOGY, V36, P19
   WEINDRUCH R, 1991, J GERONTOL, V46, pB87, DOI 10.1093/geronj/46.3.B87
   WEINSTEIN CL, 1987, J BIOL CHEM, V262, P7254
NR 71
TC 13
Z9 15
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT 1
PY 1999
VL 110
IS 1-2
BP 57
EP 72
DI 10.1016/S0047-6374(99)00040-8
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 249DW
UT WOS:000083318400006
PM 10580692
DA 2024-02-19
ER

PT J
AU Arbo, BD
   Niches, G
   Zanini, P
   Bassuino, DM
   Driemeier, D
   Ribeiro, MF
   Cecconello, AL
AF Arbo, B. D.
   Niches, G.
   Zanini, P.
   Bassuino, D. M.
   Driemeier, D.
   Ribeiro, M. F.
   Cecconello, A. L.
TI Aging affects the response of female rats to a hypercaloric diet
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Obesity; Metabolic syndrome; Dyslipidemia; Insulin resistance; Hepatic
   damage
ID FATTY LIVER-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   PHYSICAL-EXERCISE; OXIDATIVE STRESS; INDUCED OBESITY; GENDER;
   SUPPLEMENTATION; DYSLIPIDEMIA; MECHANISMS
AB Metabolic syndrome is a major risk factor for the development of cardiovascular diseases and diabetes, among other conditions. Studies have shown that aging and metabolic syndrome share several metabolic alterations, and that aged individuals, in particular females, are at an increased risk of developing metabolic disorders. Although several studies have investigated the effects of hypercaloric diets in the development of obesity and metabolic syndrome in young animals, few studies have investigated these parameters in aged animals, especially in females. Therefore, the aim of this study was to investigate the effects of a hypercaloric diet in metabolic parameters of young and aged female rats, including its effects on lipid and glycemic profile and on liver lipid content. When compared to young animals, the aged rats presented increased serum levels of triglycerides and decreased serum levels of HDL cholesterol and glycemia, as well as increased hepatic levels of triglycerides and total cholesterol. The hypercaloric diet increased food intake, body weight gain and adiposity index, leading both young and aged animals to a dyslipidemia, represented by increased serum levels of triglycerides. The hypercaloric diet increased the glycemia and the HOMA index only in the young animals. On the other hand, the diet increased the frequency of hepatocellular microvacuolar degeneration only in the aged animals. In summary, it was observed that the females from different ages respond differently to hypercaloric diet intake: while the aged animals were more resistant to the changes in the glycemic profile, they were more susceptible to the hepatic damage caused by this diet.
C1 [Arbo, B. D.; Niches, G.; Zanini, P.; Ribeiro, M. F.; Cecconello, A. L.] Univ Fed Rio Grande do Sul, ICBS, Dept Physiol, Lab Interacao Neurohumoral, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
   [Arbo, B. D.] Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Farmacol & Terapeu, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
   [Bassuino, D. M.] Univ Fed Rio Grande do Sul, Sch Vet, Dept Vet Clin Pathol, Setor Patol Vet, Av Bento Goncalves 9090, BR-91540000 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul; Universidade Federal do Rio Grande do Sul
RP Arbo, BD (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Farmacol & Terapeu, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
EM brunoarbo@gmail.com
RI Driemeier, David/H-3461-2012; Driemeier, David/IUQ-2007-2023; Arbo,
   Bruno D/T-2263-2017
OI Driemeier, David/0000-0003-3766-0654; Driemeier,
   David/0000-0003-3766-0654; Arbo, Bruno/0000-0001-7929-1688; Niches da
   Silva, Gabriela/0000-0001-7113-4856; Marques Ribeiro, Maria
   Flavia/0000-0002-2265-7332; Mariath Bassuino,
   Daniele/0000-0002-7724-3639
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX Bruno D. Arbo received a PNPD scholarship from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Maria Flavia M.
   Ribeiro received an 1D Researcher Productivity Grant from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192
   Akiyama T, 1996, DIABETES RES CLIN PR, V31, P27, DOI 10.1016/0168-8227(96)01205-3
   Almeda-Valdes P., 2017, CURR MED CHEM
   Armani A, 2017, FASEB J, V31, P4240, DOI 10.1096/fj.201601125RRR
   Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1
   Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488
   Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004
   Carillon J, 2013, FREE RADICAL BIO MED, V65, P254, DOI 10.1016/j.freeradbiomed.2013.06.022
   Cecconello AL, 2015, ENDOCRINE, V48, P985, DOI 10.1007/s12020-014-0396-6
   Chung GE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/131528
   Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gómez-Pérez Y, 2008, CELL PHYSIOL BIOCHEM, V22, P539, DOI 10.1159/000185538
   Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775
   Goularte JF, 2012, BRIT J NUTR, V108, P1511, DOI 10.1017/S0007114511006933
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   Hoefel AL, 2011, CELL BIOCHEM FUNCT, V29, P569, DOI 10.1002/cbf.1789
   Kob R, 2015, J CACHEXIA SARCOPENI, V6, P181, DOI 10.1002/jcsm.12019
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461
   Macdonald IA, 2016, EUR J NUTR, V55, pS17, DOI 10.1007/s00394-016-1340-8
   Masi LN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04308-1
   McDonald SD, 2011, NUTR RES, V31, P707, DOI 10.1016/j.nutres.2011.08.009
   Ministerio da Saude (Brasil), 2016, PESQ VIG FAT RISC PR
   NUNESSOUZA V, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/1987960
   Onat A, 2011, EXPERT OPIN PHARMACO, V12, P1887, DOI 10.1517/14656566.2011.585462
   Roos V, 2017, METAB SYNDR RELAT D, V15, P36, DOI 10.1089/met.2016.0082
   Santos IB, 2017, NUTR RES, V43, P69, DOI 10.1016/j.nutres.2017.05.007
   Siddharth J, 2017, AGING-US, V9, P1698, DOI 10.18632/aging.101262
   Teixeira D., 2017, NUTR NEUROSCI, P1
   Wang ZL, 2015, MENOPAUSE, V22, P667, DOI [10.1097/GME.0000000000000352, 10.1097/gme.0000000000000352]
   Woo Baidal J. A., 2016, SCI TRANSL MED, V8
   Zanini P, 2017, PHYSIOL BEHAV, V180, P91, DOI 10.1016/j.physbeh.2017.08.011
NR 34
TC 3
Z9 3
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2018
VL 101
BP 7
EP 12
DI 10.1016/j.exger.2017.11.008
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FV9QA
UT WOS:000424922000002
PM 29133011
DA 2024-02-19
ER

PT J
AU Xiao, MH
   Xia, JY
   Wang, ZL
   Hu, WX
   Fan, YL
   Jia, DY
   Li, J
   Jing, PW
   Wang, L
   Wang, YP
AF Xiao, Ming-He
   Xia, Jie-Yu
   Wang, Zi-Ling
   Hu, Wen-Xu
   Fan, Yan-Ling
   Jia, Dao-Yong
   Li, Jing
   Jing, Peng-Wei
   Wang, Lu
   Wang, Ya-Ping
TI Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE ginsenoside Rg1; D-galactose; liver injury; underlying mechanism
ID GLYCATION END-PRODUCTS; INDUCED AGING MODEL; OXIDATIVE STRESS; DAMAGE;
   CELLS; MECHANISM; GLUTATHIONE; SENESCENCE; APOPTOSIS
AB The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group), where the mice were intraperitoneally administrated with D-gal (120 mg/kg/day for 42 days); ii) D-gal + Rg1 group where the mice were treated with 120 mg/kg/day D-gal for 42 days and with Rg1 at a dose of 20 mg/kg/day for 35 days. The first dose of Rg1 was administered on the 8th day of treatment with D-gal; and iii) the normal control group, where the mice were injected with an equal volume of saline for 42 days. The day following the final injections in all groups, peripheral blood was collected and serum was prepared to measure the contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBiL), advanced glycation end products (AGEs) and 8-hydroxy-2 deoxyguanosine (8-OH-dG). Liver tissue homogenates were prepared to measure the contents of malondialdehyde (MDA) and glutathione (GSH), and the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Paraffin section were prepared to observe the microscopic structure of the liver. Transmission electron microscopy was used to observe the ultrastructure of hepatocytes. Frozen section were prepared and stained with senescence-associated beta-galactosidase to detect the relative optical density value of senescence-associated markers. Compared with the D-gal group, the contents of AST, ALT, TBiL, AGEs and MDA significantly decreased in the D-gal + Rg1 group, while the activities of SOD and GSH-Px markedly increased, and liver injury and degenerative alterations of hepatocytes were reduced. Administration of Rg1 induced a protective effect on D-gal-induced liver injury in mice by inhibiting the oxidative stress, reducing DNA damage and decreasing the AGE content.
C1 [Xiao, Ming-He; Xia, Jie-Yu; Wang, Zi-Ling; Hu, Wen-Xu; Fan, Yan-Ling; Jia, Dao-Yong; Li, Jing; Jing, Peng-Wei; Wang, Lu; Wang, Ya-Ping] Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, 1 Med Sch Rd, Chongqing 400016, Peoples R China.
   [Xia, Jie-Yu] Chongqing Univ, Canc Hosp, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.
   [Xia, Jie-Yu] Chongqing Canc Inst, Chongqing 400044, Peoples R China.
   [Xia, Jie-Yu] Chongqing Canc Hosp, Chongqing 400044, Peoples R China.
C3 Chongqing Medical University; Chongqing University
RP Wang, YP (corresponding author), Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cells & Tissue Engn, 1 Med Sch Rd, Chongqing 400016, Peoples R China.
EM ypwangcq@aliyun.com
RI 王, 璐/HTO-2844-2023; peng, jy/JMB-2297-2023
OI peng, jy/0000-0001-9665-1059; Wang, Yaping/0000-0001-6122-2756
FU National Natural Science Foundation of China [81673748]
FX The present study was supported by the National Natural Science
   Foundation of China (grant no. 81673748).
CR Arauz J, 2016, ANN HEPATOL, V15, P160, DOI 10.5604/16652681.1193701
   Chandra K., 2015, International Journal of Pharmacognosy and Phytochemical Research, V7, P383
   Chang YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182303
   Chen C, 2014, ACTA PHARMACOL SIN, V35, P143, DOI 10.1038/aps.2013.136
   Chen XC, 2008, J GERONTOL A-BIOL, V63, P253, DOI 10.1093/gerona/63.3.253
   Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x
   Córdoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Dahake H, 2016, INT J RES MED SEI, V4, P730
   Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ELMOFTY SK, 1975, AM J PATHOL, V79, P579
   Fan YL, 2016, PHARM BIOL, V54, P1815, DOI 10.3109/13880209.2015.1129543
   Garcia G, 2004, NEUROTOXICOLOGY, V25, P951, DOI 10.1016/j.neuro.2004.05.004
   Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854
   Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de
   Guerrieri F, 1998, NATO ADV SCI I A-LIF, V296, P109
   Hailiqian Taoerdahong, 2007, Zhongguo Zhong Yao Za Zhi, V32, P729
   Halliwell B, 1985, J FREE RADICALS BIOL, V1, P331, DOI DOI 10.1016/0748-5514(85)90140-0
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   KEPPLER D, 1968, EXP MOL PATHOL, V9, P279, DOI 10.1016/0014-4800(68)90042-7
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Ktari N, 2014, PROCESS BIOCHEM, V49, P890, DOI 10.1016/j.procbio.2014.01.032
   Lieber C S, 2005, Rocz Akad Med Bialymst, V50, P7
   Lieber C S, 1997, Adv Pharmacol, V38, P601
   Liu LM, 2008, DIGEST DIS SCI, V53, P1316, DOI 10.1007/s10620-007-9994-y
   Mizoue T, 2007, CANCER SCI, V98, P1254, DOI 10.1111/j.1349-7006.2007.00511.x
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Park Cheul Ho, 2012, Korean J Ophthalmol, V26, P123, DOI 10.3341/kjo.2012.26.2.123
   Park S, 2013, ACTA HISTOCHEM CYTOC, V46, P111, DOI 10.1267/ahc.13012
   Plumel MI, 2016, J PROTEOMICS, V135, P181, DOI 10.1016/j.jprot.2015.09.008
   Qi BQ, 2017, MOL MED REP, V16, P2814, DOI 10.3892/mmr.2017.6920
   Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010
   Sharma JB, 2006, INT J GYNECOL OBSTET, V94, P23, DOI 10.1016/j.ijgo.2006.03.025
   Sigler K, 1999, FOLIA MICROBIOL, V44, P587, DOI 10.1007/BF02825650
   Tao TZ, 2014, J SURG RES, V191, P231, DOI 10.1016/j.jss.2014.03.067
   Tian W, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019463
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Triantafyllou K, 2010, BEST PRACT RES CL GA, V24, P203, DOI 10.1016/j.bpg.2010.02.004
   Varsha Kashaw, 2011, International Journal of Research in Pharmaceutical and Biomedical Sciences, V2, P360
   Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418
   Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wu YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/356806
   Xue XL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/509705
   Yan HD, 2007, CHINESE MED J-PEKING, V120, P787, DOI 10.1097/00029330-200705010-00010
   Yu J, 2015, POULTRY SCI, V94, P927, DOI 10.3382/ps/pev055
   Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003
   Zhu XF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/580687
NR 51
TC 16
Z9 17
U1 3
U2 17
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD NOV
PY 2018
VL 16
IS 5
BP 4100
EP 4106
DI 10.3892/etm.2018.6727
PG 7
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GY3ES
UT WOS:000448431900047
PM 30402153
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Aini, W
   Miyagawa-Hayashino, A
   Tsuruyama, T
   Hashimoto, S
   Sumiyoshi, S
   Ozeki, M
   Tamaki, K
   Uemoto, S
   Haga, H
AF Aini, Wulamujiang
   Miyagawa-Hayashino, Aya
   Tsuruyama, Tatsuaki
   Hashimoto, Seiji
   Sumiyoshi, Shinji
   Ozeki, Munetaka
   Tamaki, Keiji
   Uemoto, Shinji
   Haga, Hironori
TI Telomere shortening and karyotypic alterations in hepatocytes in
   long-term transplanted human liver allografts
SO TRANSPLANT INTERNATIONAL
LA English
DT Article
DE abnormal karyotype; aneuploidy; FISH; pediatric transplantation;
   telomere
ID IN-SITU HYBRIDIZATION; CELLULAR SENESCENCE; FOLLOW-UP; HEPATITIS;
   DYSFUNCTION; POLYPLOIDY; RECIPIENTS; TOLERANCE; REJECTION; CIRRHOSIS
AB The long-term fate of aged liver allografts in young recipients who received grafts from older donors is unknown. We evaluated graft aging by analyzing hepatocytic telomere length and karyotypic changes. Seventeen pediatric individuals who underwent living-donor liver transplantation for congenital biliary diseases were selected. At a median of 10.4 years post-transplant, ten had tolerated grafts with weaned off immunosuppressants, and seven had idiopathic post-transplantation hepatitis. Fluorescence in situ hybridization was used to evaluate the telomere signal intensity (TI) and karyotypic changes. First, we measured predictive age-dependent TI decline with regression analysis of donor livers. The mean TI at the earliest (within a year) and latest biopsies was significantly lower than the predicted TI of the studied allografts. With univariate analysis, a higher abnormal karyotype ratio in the donor liver was correlated with development of idiopathic post-transplantation hepatitis. With multivariate analysis that included clinical parameters, a greater TI decline at the earliest biopsy was correlated with the development of idiopathic post-transplantation hepatitis. In conclusion, graft aging as measured by TI decline and donor abnormal karyotype ratio was associated with idiopathic post-transplantation hepatitis of long-term transplanted liver allografts.
C1 [Tsuruyama, Tatsuaki] Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, Kyoto 6068507, Japan.
   [Tsuruyama, Tatsuaki; Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.
   [Uemoto, Shinji] Kyoto Univ Hosp, Dept Hepatobiliary Pancreat Surg & Transplantat, Kyoto 6068507, Japan.
C3 Kyoto University; Kyoto University; Kyoto University
RP Tsuruyama, T (corresponding author), Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
EM tsuruyam@kuhp.kyoto-u.ac.jp
RI Tsuruyama, Tatsuaki/G-5017-2011
OI Haga, Hironori/0000-0003-4322-9561
FU Japan Society for the Promotion of Science; Kyoto University;
   Grants-in-Aid for Scientific Research [23590424] Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid for Young Scientists from the
   Japan Society for the Promotion of Science and Young Investigator Grants
   from Kyoto University to A.M-H. No copyright exists, and the
   contribution is in the public domain; therefore, no license needs to be
   granted.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Aloia TA, 2010, LIVER TRANSPLANT, V16, P950, DOI 10.1002/lt.22098
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Demetris AJ, 2006, HEPATOLOGY, V44, P489, DOI 10.1002/hep.21280
   Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Eguchi S, 2011, DIGEST DIS SCI, V56, P1542, DOI 10.1007/s10620-010-1445-5
   Ekong UD, 2008, LIVER TRANSPLANT, V14, P1582, DOI 10.1002/lt.21549
   Evans HM, 2006, HEPATOLOGY, V43, P1109, DOI 10.1002/hep.21152
   Fouquet V, 2005, LIVER TRANSPLANT, V11, P152, DOI 10.1002/lt.20358
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Kelly DA, 2006, PEDIATR TRANSPLANT, V10, P712, DOI 10.1111/j.1399-3046.2006.00567.x
   Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x
   Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352
   Mazariegos GV, 2007, TRANSPL IMMUNOL, V17, P114, DOI 10.1016/j.trim.2006.09.033
   McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Miyagawa-Hayashino A, 2009, TRANSPL INT, V22, P303, DOI 10.1111/j.1432-2277.2008.00803.x
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Neil DAH, 2010, TRANSPL INT, V23, P971, DOI 10.1111/j.1432-2277.2010.01143.x
   Perner S, 2003, AM J PATHOL, V163, P1751, DOI 10.1016/S0002-9440(10)63534-1
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Scheenstra R, 2009, HEPATOLOGY, V49, P880, DOI 10.1002/hep.22686
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Talisetti A, 2010, PEDIATR TRANSPLANT, V14, P976, DOI 10.1111/j.1399-3046.2010.01360.x
   Serrano MT, 2010, CLIN TRANSPLANT, V24, P543, DOI 10.1111/j.1399-0012.2009.01135.x
   Venick RS, 2007, AM J TRANSPLANT, V7, P955, DOI 10.1111/j.1600-6143.2006.01717.x
   Westhoff JH, 2010, J AM SOC NEPHROL, V21, P327, DOI 10.1681/ASN.2009010072
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yoshitomi M, 2009, TRANSPLANTATION, V87, P606, DOI 10.1097/TP.0b013e318195a7cb
NR 34
TC 19
Z9 19
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0934-0874
J9 TRANSPL INT
JI Transpl. Int.
PD SEP
PY 2012
VL 25
IS 9
BP 956
EP 966
DI 10.1111/j.1432-2277.2012.01523.x
PG 11
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 984WV
UT WOS:000307224600010
PM 22775391
OA Green Submitted
DA 2024-02-19
ER

PT J
AU de Moura, LP
   Pauli, LSS
   Cintra, DE
   de Souza, CT
   da Silva, ASR
   Marinho, R
   de Melo, MAR
   Ropelle, ER
   Pauli, JR
AF de Moura, Leandro Pereira
   Souza Pauli, Luciana Santos
   Cintra, Dennys Esper
   de Souza, Claudio Teodoro
   Ramos da Silva, Adelino Sanchez
   Marinho, Rodolfo
   Rostom de Melo, Maria Alice
   Ropelle, Eduardo Rochete
   Pauli, Jose Rodrigo
TI Acute exercise decreases PTP-1B protein level and improves insulin
   signaling in the liver of old rats
SO IMMUNITY & AGEING
LA English
DT Article
ID TYROSINE-PHOSPHATASE 1B; RECEPTOR SUBSTRATE-1; GLUCOSE-INTOLERANCE;
   PHYSICAL INACTIVITY; NEGATIVE REGULATOR; SINGLE BOUT; RESISTANCE;
   MUSCLE; SENSITIVITY; PTP1B
AB It is now commonly accepted that chronic inflammation associated with obesity during aging induces insulin resistance in the liver. In the present study, we investigated whether the improvement in insulin sensitivity and insulin signaling, mediated by acute exercise, could be associated with modulation of protein-tyrosine phosphatase 1B (PTP-1B) in the liver of old rats. Aging rats were subjected to swimming for two 1.5-h long bouts, separated by a 45 min rest period. Sixteen hours after the exercise, the rats were sacrificed and proteins from the insulin signaling pathway were analyzed by immunoblotting. Our results show that the fat mass was increased in old rats. The reduction in glucose disappearance rate (Kitt) observed in aged rats was restored 16 h after exercise. Aging increased the content of PTP-1B and attenuated insulin signaling in the liver of rats, a phenomenon that was reversed by exercise. Aging rats also increased the IR beta/PTP-1B and IRS-1/PTP-1B association in the liver when compared with young rats. Conversely, in the liver of exercised old rats, IR beta/PTP-1B and IRS-1/PTP-1B association was markedly decreased. Moreover, in the hepatic tissue of old rats, the insulin signalling was decreased and PEPCK and G6Pase levels were increased when compared with young rats. Interestingly, 16 h after acute exercise, the PEPCK and G6Pase protein level were decreased in the old exercised group. These results provide new insights into the mechanisms by which exercise restores insulin signalling in liver during aging.
C1 [de Moura, Leandro Pereira; Rostom de Melo, Maria Alice; Pauli, Jose Rodrigo] Univ Estadual Paulista, UNESP, Curso Posgrad Ciencias Motricidade Humana, Rio Claro, SP, Brazil.
   [Souza Pauli, Luciana Santos; Cintra, Dennys Esper; Marinho, Rodolfo; Ropelle, Eduardo Rochete; Pauli, Jose Rodrigo] Univ Estadual Campinas, UNICAMP, Fac Ciencias Aplicadas, Curso Posgrad Nutr Esporte & Metab, Limeira, SP, Brazil.
   [Ramos da Silva, Adelino Sanchez] Univ Extremo Sul Catarinense, Lab Bioquim & Fisiol, Circiuma, SC, Brazil.
   [de Souza, Claudio Teodoro] Univ Sao Paulo, Escola Educ Fis & Esporte, BR-14049 Ribeirao Preto, SP, Brazil.
   [Pauli, Jose Rodrigo] FCA UNICAMP, Curso Ciencias Esporte, Limeira, SP, Brazil.
C3 Universidade Estadual Paulista; Universidade Estadual de Campinas;
   Universidade do Extremo Sul Catarinense; Universidade de Sao Paulo
RP Pauli, JR (corresponding author), Univ Estadual Paulista, UNESP, Curso Posgrad Ciencias Motricidade Humana, Rio Claro, SP, Brazil.
EM rodrigosere@yahoo.com.br
RI Cintra, Dennys E/N-7758-2017; Pauli, José Rdrigo/AAD-2763-2021; Silva,
   Adelino/P-3400-2019; Silva, Adelino/J-7379-2013; Ropelle, Eduardo
   R/C-3977-2012; Marinho, Rodolfo/O-1806-2014
OI Cintra, Dennys E/0000-0002-7954-5630; Pauli, José
   Rdrigo/0000-0002-6129-1521; Silva, Adelino/0000-0002-9679-8357; Silva,
   Adelino/0000-0002-9679-8357; Ropelle, Eduardo R/0000-0003-1655-9557;
   Marinho, Rodolfo/0000-0002-1751-8485
FU FAPESP [2010/12091-2]; CNPq [471498/2011-4]
FX The authors thank Miss Clarice Sibuya and Mr. Jose Roberto da Silva and
   Eduardo Custodio for their technical assistance. The present work was
   received financial support of the FAPESP (process numbers 2010/12091-2)
   and CNPq (process numbers 471498/2011-4).
CR Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267
   Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002
   BARNARD RJ, 1992, AM J PHYSIOL, V262, pE619, DOI 10.1152/ajpendo.1992.262.5.E619
   Bence Kendra K, 2010, J Clin Metab Diabetes, V1, P27
   BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728
   BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Da Silva ASR, 2010, MED SCI SPORT EXER, V42, P2180, DOI 10.1249/MSS.0b013e3181e45d08
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913
   Dumke CL, 2009, EUR J APPL PHYSIOL, V107, P419, DOI 10.1007/s00421-009-1143-1
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283
   González-Rodríguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x
   Heled Y, 2004, METABOLISM, V53, P836, DOI 10.1016/j.metabol.2004.02.001
   Hirata AE, 2003, LIFE SCI, V73, P1369, DOI 10.1016/S0024-3205(03)00477-6
   Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275
   Houmard JA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1055, DOI 10.1152/ajpendo.1999.277.6.E1055
   Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895
   Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149
   Marinho R, 2012, J CELL PHYSIOL, V227, P2917, DOI 10.1002/jcp.23037
   Jorge MLMP, 2011, METABOLISM, V60, P1244, DOI 10.1016/j.metabol.2011.01.006
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mohammad A, 2002, MOL CELL BIOCHEM, V229, P125, DOI 10.1023/A:1017984930836
   O'Gorman DJ, 2006, DIABETOLOGIA, V49, P2983, DOI 10.1007/s00125-006-0457-3
   Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907
   Pauli JR, 2010, MECH AGEING DEV, V131, P323, DOI 10.1016/j.mad.2010.03.004
   Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   REAVEN GM, 1985, J AM GERIATR SOC, V33, P286, DOI 10.1111/j.1532-5415.1985.tb07118.x
   Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje
   Rocha EM, 2003, ACTA OPHTHALMOL SCAN, V81, P639, DOI 10.1111/j.1395-3907.2003.00162.x
   Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465
   Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2069, DOI 10.1113/jphysiol.2008.164202
   Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006
   Ropelle ER, 2012, DIABETES
   Saad MJA, 1997, DIABETOLOGIA, V40, P179, DOI 10.1007/s001250050660
   Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379
   SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014
   Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017
   Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200
   Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199
NR 48
TC 25
Z9 25
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD FEB 25
PY 2013
VL 10
AR 8
DI 10.1186/1742-4933-10-8
PG 9
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA 255DB
UT WOS:000327218400001
PM 23442260
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sacket, SJ
   Chung, HY
   Okajima, F
   Im, DS
AF Sacket, Santosh J.
   Chung, Hae-young
   Okajima, Fumikazu
   Im, Dong-soon
TI Increase in sphingolipid catabolic enzyme activity during aging
SO ACTA PHARMACOLOGICA SINICA
LA English
DT Article
DE aging; sphingolipid; metabolism; sphingomyelinase; ceramidase;
   sphingomyelin synthase; ceramide synthase
ID HUMAN PRIMARY NEURONS; AMYLOID-BETA; CERAMIDE; SPHINGOMYELIN; LIVER;
   ACTIVATION; APOPTOSIS; DIACYLGLYCEROL; SPHINGOSINE; CHOLESTEROL
AB Aim: To understand the contribution of sphingolipid metabolism and its metabolites to development and aging.
   Methods: A systemic analysis on the changes in activity of sphingolipid metabolic enzymes in kidney, liver and brain tissues during development and aging was conducted. The study was conducted using tissues from 1-day-old to 720-day-old rats.
   Results: Catabolic enzyme activities as well as the level of sphingomyelinase (SMase) and ceramidase (CDase) were higher than that of anabolic enzyme activities, sphingomyelin synthase and ceramide synthase. This suggested an accumulation of ceramide and sphingosine during development and aging. The liver showed the highest neutral-SMase activity among the tested enzymes while the kidney and brain exhibited higher neutral-SMase and ceramidase activities, indicating a high production of ceramide in liver and ceramide/sphingosine in the kidney and brain. The activities of sphingolipid metabolic enzymes were significantly elevated in all tested tissues during development and aging, although the onset of significant increase in activity varied on the tissue and enzyme type. During aging, 18 out of 21 enzyme activities were further increased on day 720 compared to day 180.
   Conclusion: Differential increases in sphingolipid metabolic enzyme activities suggest that sphingolipids including ceramide and sphingosine might play important and dynamic roles in proliferation, differentiation and apoptosis during development and aging.
C1 [Sacket, Santosh J.; Im, Dong-soon] Pusan Natl Univ, Longev Inst Life Sci & Technol, Pharmacol Lab, Pusan 609735, South Korea.
   [Chung, Hae-young] Pusan Natl Univ, Longev Inst Life Sci & Technol, Biochem Lab, Coll Pharm,BK21 Project, Pusan 609735, South Korea.
   [Okajima, Fumikazu] Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.
C3 Pusan National University; Pusan National University; Gunma University
RP Im, DS (corresponding author), Pusan Natl Univ, Longev Inst Life Sci & Technol, Pharmacol Lab, Pusan 609735, South Korea.
EM imds@pusan.ac.kr
OI IM, DONG-SOON/0000-0001-8054-8946
FU Pusan National University
FX This work was supported for two years by Pusan National University
   Research Grant.
CR BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9
   Feuillan PP, 1996, ENDOCRINOLOGY, V137, P3992, DOI 10.1210/en.137.9.3992
   FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650
   GIUSTO NM, 1992, LIPIDS, V27, P835, DOI 10.1007/BF02535859
   Grimm MO, 2007, TRENDS MOL MED, V13, P337, DOI 10.1016/j.molmed.2007.06.004
   Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895
   IGARASHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1411, DOI 10.1016/0006-291X(89)91827-5
   Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200
   Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kavok NS, 2003, EXP GERONTOL, V38, P441, DOI 10.1016/S0531-5565(02)00246-2
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 2000, METHOD ENZYMOL, V311, P164
   Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550
   MORELL P, 1970, J BIOL CHEM, V245, P342
   Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P194
   Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9
   Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1
   SPENCE MW, 1986, BIOCHEM CELL BIOL, V64, P400, DOI 10.1139/o86-056
   Strelow A, 2000, J EXP MED, V192, P601, DOI 10.1084/jem.192.5.601
   TACCONI MT, 1991, NEUROBIOL AGING, V12, P55, DOI 10.1016/0197-4580(91)90039-M
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
NR 28
TC 49
Z9 54
U1 2
U2 8
PU NATURE PUBL GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1671-4083
EI 1745-7254
J9 ACTA PHARMACOL SIN
JI Acta Pharmacol. Sin.
PD OCT
PY 2009
VL 30
IS 10
BP 1454
EP 1461
DI 10.1038/aps.2009.136
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy
GA 505XB
UT WOS:000270733600010
PM 19749786
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Ghiraldini, FG
   Silveira, AB
   Kleinjan, DA
   Gilbert, N
   Mello, MLS
AF Ghiraldini, Flavia G.
   Silveira, Andre B.
   Kleinjan, Dirk A.
   Gilbert, Nick
   Mello, Maria Luiza S.
TI Genomic profiling of type-1 adult diabetic and aged normoglycemic mouse
   liver
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Type-1 diabetes; Aging; Liver; NOD mouse; Gene expression
ID GENE-EXPRESSION PROFILES; POLYPLOIDY; DISEASE; TISSUE; TRANSCRIPTION;
   HEPATOCYTES; CHOLESTEROL; METABOLISM; STRESS; GROWTH
AB Background: Hyperglycemia induces chromatin remodeling with consequences on differential gene expression in mouse hepatocytes, similar to what occurs during aging. The liver is the central organ for the regulation of glucose homeostasis and xenobiotic and lipid metabolism and is affected by insulin signaling. The precise transcriptional profiling of the type-1 diabetic liver and its comparison to aging have not been elucidated yet.
   Methods: Here, we studied the differential genomic expression of mouse liver cells under adult hyperglycemic and aged normoglycemic conditions using expression arrays.
   Results: Differential gene expression involved in an increase in glucose and impaired lipid metabolism were detected in the type-1 diabetic liver. In this regard, Ppargc1a presents an increased expression and is a key gene that might be regulating both processes. The differential gene expression observed may also be associated with hepatic steatosis in diabetic mouse liver, as a secondary disease. Similarly, middle-aged mice presented differential expression of genes involved in glucose, lipid and xenobiotic metabolism. These genes could be associated with an increase in polyploidy, but the consequences of differential expression were not as drastic as those observed in diabetic animals.
   Conclusions: Taken together, these findings provide new insights into gene expression profile changes in type-1 diabetic liver. Ppargc1a was found to be the key-gene that increases glucose metabolism and impairs lipid metabolism impairment. The novel results reported here open new areas of investigation in diabetic research and facilitate the development of new strategies for gene therapy.
C1 [Ghiraldini, Flavia G.; Mello, Maria Luiza S.] Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil.
   [Silveira, Andre B.] Ctr Infantil Boldrini, Mol Biol Lab, Campinas, SP, Brazil.
   [Kleinjan, Dirk A.; Gilbert, Nick] Univ Edinburgh, Inst Genet & Mol Med, Human Genet Unit, MRC, Edinburgh, Midlothian, Scotland.
C3 Universidade Estadual de Campinas; University of Edinburgh
RP Ghiraldini, FG (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, BR-13083862 Campinas, SP, Brazil.
EM flaviaghi@gmail.com
RI Ghiraldini, Flávia/G-7537-2012; Silveira, André B/I-8859-2012; Mello,
   Maria Luiza Silveira/D-9158-2012
OI Silveira, André B/0000-0003-3375-1081; Mello, Maria Luiza
   Silveira/0000-0003-1629-5619; Gilbert, Nick/0000-0003-0505-6081
FU Sao Paulo State Research Foundation (FAPESP) [2010/50015-6,
   2008/58067-5]; Brazilian National Research and Development Council
   (CNPq) [471303/2009-7, 301943/2009-5]
FX This work was supported by the Sao Paulo State Research Foundation
   (FAPESP- grants no. 2010/50015-6 and 2008/58067-5) and the Brazilian
   National Research and Development Council (CNPq - grants no.
   471303/2009-7 and 301943/2009-5).
CR Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Anatskaya OV, 2007, GENOMICS, V89, P70, DOI 10.1016/j.ygeno.2006.08.014
   Anatskaya OV, 2010, FUNCT INTEGR GENOMIC, V10, P433, DOI 10.1007/s10142-010-0180-5
   Berg J. M., 2002, BIOCHEMISTRY
   BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Dhahbi Joseph M, 2003, Diabetes Technol Ther, V5, P411, DOI 10.1089/152091503765691910
   Fernandez-Rojo MA, 2012, HEPATOLOGY, V55, P1574, DOI 10.1002/hep.24810
   Fluiter K, 1997, BIOCHEM J, V326, P515, DOI 10.1042/bj3260515
   Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034
   Ghiraldini FG, 2012, CYTOM PART A, V81A, P755, DOI 10.1002/cyto.a.22102
   Ghiraldíni FG, 2013, MOL BIOL CELL, V24, P2467, DOI 10.1091/mbc.E13-04-0186
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233
   Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028
   Lan H, 2003, DIABETES, V52, P688, DOI 10.2337/diabetes.52.3.688
   Liang XY, 2007, IMMUNOLOGY, V120, P251, DOI 10.1111/j.1365-2567.2006.02496.x
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907
   Moraes AS, 2007, CYTOM PART A, V71A, P28, DOI 10.1002/cyto.a.20356
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   Onitilo AA, 2012, CANCER CAUSE CONTROL, V23, P967, DOI 10.1007/s10552-012-9972-3
   Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07
   Sheahan S, 2004, ONCOGENE, V23, P1489, DOI 10.1038/sj.onc.1207280
   Singh BK, 2013, J BIOL CHEM, V288, P30365, DOI 10.1074/jbc.M113.504845
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631
   Suh YH, 2005, J MOL ENDOCRINOL, V34, P299, DOI 10.1677/jme.1.01679
   Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030
   Valentine N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005449.pub2
   Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596
   Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009
   Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766
NR 38
TC 3
Z9 3
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD MAR 3
PY 2014
VL 14
AR 19
DI 10.1186/1472-6823-14-19
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AF3QO
UT WOS:000334627300001
PM 24581510
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU VENKATRAMAN, JT
   FERNANDES, G
AF VENKATRAMAN, JT
   FERNANDES, G
TI INFLUENCE OF FOOD RESTRICTION AND AGING ON THE BINDING OF INSULIN TO
   LIVER NUCLEI IN FISCHER-344 RATS
SO AGE
LA English
DT Article
ID AGE-RELATED-CHANGES; DIETARY RESTRICTION; T-CELLS; ADIPOCYTES; RECEPTOR;
   EXPRESSION; DISEASE; ALPHA-2U-GLOBULIN; MEMBRANES; TRANSPORT
AB Aging is generally associated with the development of insulin resistance.  Food restriction has been accepted as a powerful modulator of the aging process, though the underlying mechanisms are not yet elucidated.  The present study was carried out to determine the effect of food restriction on the binding of insulin to liver nuclei of Fischer-344 rats ranging in age from 3-24 months.  After isolating nuclei from livers of 3m, 6m, 10m, 12m and 24m ad libitum-fed and food-restricted rats, 100-mu-g of nuclear protein was incubated with 0.2 ng of I-125-insulin and 0.2 to 2,000 ng/200-mu-l unlabeled insulin at 23-degrees-C for 2 hr.  Scatchard analysis of the data revealed that insulin binding to nuclei was highest at 6m of age and an age-associated decline occurred in the binding of insulin to liver nuclei.  The maximum number of binding sites for insulin in the liver nuclei of 3m, 6m, 10m and 24m old animals were 24 +/- 2, 37.5 +/- 2, 26 +/- 2.5, 14 +/- 3 for the ad libitum-fed group and 8.3 +/- 3, 38.5 +/- 2.5, 28.5 +/- 3, and 24.5 +/- 3 ng/mg protein for the food-restricted groups, respectively.  The above data suggest that food restriction can delay the loss of insulin binding to liver nuclei.  These observations suggest that food restriction may be an important modulator of insulin binding to liver nuclei which may have a functional role in delaying age-associated insulin resistance.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
CR ADAMO M, 1988, ANNU REV NUTR, V8, P149, DOI 10.1146/annurev.nu.08.070188.001053
   CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964
   DUDL RJ, 1977, METABOLISM, V26, P33, DOI 10.1016/0026-0495(77)90125-1
   FERNANDES G, 1986, FASEB J, V45, P830
   FERNANDES G, 1978, J CLIN INVEST, V61, P243, DOI 10.1172/JCI108933
   FERNANDES G, 1990, P SOC EXP BIOL MED, V193, P16, DOI 10.3181/00379727-193-42983
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   FERNANDES G, 1984, Pharmacological Reviews, V36, p123S
   FREEMAN C, 1973, BIOCHEM BIOPH RES CO, V54, P1573, DOI 10.1016/0006-291X(73)91166-2
   GOIDL JA, 1979, BIOCHEMISTRY-US, V18, P3674
   GOLDFINE I D, 1977, Nature (London), V269, P698, DOI 10.1038/269698a0
   GOLDFINE ID, 1976, P NATL ACAD SCI USA, V73, P1427, DOI 10.1073/pnas.73.5.1427
   GOLDFINE ID, 1985, NUCLEAR ENVELOPE STR, P585
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HORVAT A, 1978, J CELL PHYSIOL, V97, P37, DOI 10.1002/jcp.1040970106
   IWAI H, 1989, IMMUNOL LETT, V23, P125, DOI 10.1016/0165-2478(89)90124-7
   JARETT L, 1974, VITAMINS HORMONES AD, P51
   KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711
   KOLTERMAN OG, 1979, J CLIN ENDOCR METAB, V48, P836, DOI 10.1210/jcem-48-5-836
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LEWIS BK, 1974, J GERONTOL, V29, P139, DOI 10.1093/geronj/29.2.139
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20
   MASORO EJ, 1983, J NUTR, V113, P880, DOI 10.1093/jn/113.4.880
   MASORO EJ, 1988, J GERONTOL, V43, P359
   MILLER RA, 1987, J CELL PHYSIOL, V132, P337, DOI 10.1002/jcp.1041320220
   OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384
   OLEFSKY JM, 1976, DIABETES, V25, P1154, DOI 10.2337/diab.25.12.1154
   OLEFSKY JM, 1976, J CLIN INVEST, V58, P1450, DOI 10.1172/JCI108601
   OLEFSKY JM, 1978, J CLIN INVEST, V61, P329, DOI 10.1172/JCI108943
   PODLECKI DA, 1987, J BIOL CHEM, V262, P3362
   PURRELLO F, 1982, SCIENCE, V216, P1005, DOI 10.1126/science.6281885
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RICHARDSON A, 1985, HDB NUTRITION AGED
   ROY AK, 1980, J BIOL CHEM, V255, P1614
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P286
   SCHUMM DE, 1981, ARCH BIOCHEM BIOPHYS, V210, P275, DOI 10.1016/0003-9861(81)90190-9
   SNYDER DL, 1988, DIETARY RESTRICTION
   VIGNERI R, 1978, J BIOL CHEM, V253, P2098
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WEINDRUCH R, 1985, J AM GERIATR SOC, V33, P125, DOI 10.1111/j.1532-5415.1985.tb02278.x
   WINDELL CC, 1964, BIOCHEM J, V92, P313
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
NR 47
TC 3
Z9 3
U1 0
U2 0
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD APR
PY 1991
VL 14
IS 2
BP 45
EP 51
DI 10.1007/BF02434837
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA FU018
UT WOS:A1991FU01800003
DA 2024-02-19
ER

PT J
AU Simon-Santamaria, J
   Malovic, I
   Warren, A
   Oteiza, A
   Le Couteur, D
   Smedsrod, B
   McCourt, P
   Sorensen, KK
AF Simon-Santamaria, Jaione
   Malovic, Ivana
   Warren, Alessandra
   Oteiza, Ana
   Le Couteur, David
   Smedsrod, Bard
   McCourt, Peter
   Sorensen, Karen Kristine
TI Age-Related Changes in Scavenger Receptor-Mediated Endocytosis in Rat
   Liver Sinusoidal Endothelial Cells
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Aging; Hepatic sinusoid; Porosity; Stabilin; Scavenger endothelial cells
ID GLYCATION END-PRODUCTS; HYALURONAN RECEPTOR; MANNOSE-RECEPTOR; KUPFFER
   CELLS; PSEUDOCAPILLARIZATION; CLEARANCE; ELIMINATION; STABILIN-1;
   EXPRESSION; CAPACITY
AB Liver sinusoidal endothelial cells (LSECs) play an essential role in systemic waste clearance by effective endocytosis of blood-borne waste macromolecules. We aimed to study LSECs' scavenger function during aging, and whether age-related morphological changes (eg, defenestration) affect this function, in F344/BN F1 rats. Endocytosis of the scavenger receptor ligand formaldehyde-treated serum albumin was significantly reduced in LSECs from old rats. Ligand degradation, LSEC protein expression of the major scavenger receptors for formaldehyde-treated serum albumin endocytosis, stabilin-1 and stabilin-2, and their staining patterns along liver sinusoids, was similar at young and old age, suggesting that other parts of the endocytic machinery are affected by aging. Formaldehyde-treated serum albumin uptake per cell, and cell porosity evaluated by electron microscopy, was not correlated, indicating that LSEC defenestration is not linked to impaired endocytosis. We report a significantly reduced LSEC endocytic capacity at old age, which may be especially important in situations with increased circulatory waste loads.
C1 [Sorensen, Karen Kristine] Univ Tromso, Vasc Biol Res Grp, Dept Med Biol, NO-9037 Tromso, Norway.
   [Warren, Alessandra; Le Couteur, David] Univ Sydney, Concord RG Hosp, Ctr Educ & Res Ageing, Concord, Australia.
   [Warren, Alessandra; Le Couteur, David] Univ Sydney, ANZAC Res Inst, Concord RG Hosp, Concord, Australia.
C3 UiT The Arctic University of Tromso; Concord Repatriation General
   Hospital; University of Sydney; University of Sydney; ANZAC Research
   Institute; Concord Repatriation General Hospital
RP Sorensen, KK (corresponding author), Univ Tromso, Vasc Biol Res Grp, Dept Med Biol, NO-9037 Tromso, Norway.
EM karen.sorensen@uit.no
RI McCourt, Peter/B-3043-2009; Ekanayake, Kanchana/P-8817-2016; Research
   Institute, ANZAC/CAE-9030-2022
OI McCourt, Peter/0000-0001-5072-4590; Le Couteur,
   David/0000-0002-4227-5817; Sorensen, Karen Kristine/0000-0002-7570-186X;
   Smedsrod, Bard/0000-0002-3308-8948; Oteiza, Ana/0009-0007-2246-6927;
   Malovic, Ivana/0000-0001-8390-7617
FU Norwegian Research Council [153483/V50]; Tromso University Research
   Foundation, Norway; National Institutes of Health, USA [1.R21
   AG026582-01A1]; Basque Government, Spain [BFI 05.525]; Australian
   National Health and Medical Research Council; Ageing and Alzheimer's
   Research Foundation, Australia
FX The work was supported by the Norwegian Research Council (grant number
   153483/V50); the Tromso University Research Foundation, Norway; the
   National Institutes of Health, USA (grant number 1.R21 AG026582-01A1);
   the Basque Government, Spain (grant number BFI 05.525); the Australian
   National Health and Medical Research Council; and the Ageing and
   Alzheimer's Research Foundation, Australia.
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36, DOI DOI 10.1201/9781420005615.AX4
   Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200
   Birtwistle MR, 2009, MOL ONCOL, V3, P308, DOI 10.1016/j.molonc.2009.05.009
   BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Butler JM, 2008, CLIN PHARMACOKINET, V47, P297, DOI 10.2165/00003088-200847050-00002
   CAPERNA TJ, 1982, MECH AGEING DEV, V20, P205, DOI 10.1016/0047-6374(82)90088-4
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   DANNEVIG BH, 1990, FISH PHYSIOL BIOCHEM, V8, P229, DOI 10.1007/BF00004462
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   DERIJKE YB, 1994, BIOCHEM J, V304, P69, DOI 10.1042/bj3040069
   Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785
   Elvevold K, 2008, HEPATOLOGY, V48, P2007, DOI 10.1002/hep.22527
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855
   HEIL MF, 1984, MECH AGEING DEV, V26, P327, DOI 10.1016/0047-6374(84)90104-0
   HUGHES DA, 1995, EUR J IMMUNOL, V25, P466, DOI 10.1002/eji.1830250224
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Karpen SJ, 2010, HEPATOLOGY, V51, P364, DOI 10.1002/hep.23447
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Ling WH, 1997, J CLIN INVEST, V100, P244, DOI 10.1172/JCI119528
   Lovdal T, 2000, J CELL SCI, V113, P3255
   Malerod L, 2002, CELL TISSUE RES, V307, P173, DOI 10.1007/s00441-001-0476-9
   Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639
   Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020
   Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4
   Matsumoto K, 2000, BIOCHEM J, V352, P233, DOI 10.1042/0264-6021:3520233
   McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521
   McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663
   MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MEGO JL, 1967, J CELL BIOL, V32, P699, DOI 10.1083/jcb.32.3.699
   Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117
   Minor RK, 2010, J GERONTOL A-BIOL, V65, P695, DOI 10.1093/gerona/glq042
   Nakajou K, 2005, J BIOCHEM, V137, P607, DOI 10.1093/jb/mvi071
   O'Reilly JN, 2010, J ELECTRON MICROSC, V59, P65, DOI 10.1093/jmicro/dfp039
   Oie CI, 2008, AM J PHYSIOL-GASTR L, V294, pG520, DOI 10.1152/ajpgi.00489.2007
   Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299
   SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   Smedsrod Bard, 2004, Comp Hepatol, V3 Suppl 1, pS22, DOI 10.1186/1476-5926-2-S1-S22
   Sorensen KK, 2001, COMP BIOCHEM PHYS A, V129, P615, DOI 10.1016/S1095-6433(01)00300-2
   Sorensen KK, 1998, J EXP BIOL, V201, P1707
   SPEILBERG L, 1994, ANAT RECORD, V240, P291, DOI 10.1002/ar.1092400302
   Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0
   Van Berkel TJC, 1998, BIOCHEM J, V331, P29, DOI 10.1042/bj3310029
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5
   Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200
NR 54
TC 39
Z9 40
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 2010
VL 65
IS 9
BP 951
EP 960
DI 10.1093/gerona/glq108
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 638PD
UT WOS:000280906100006
PM 20576648
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Lew, LC
   Hor, YY
   Jaafar, MH
   Lau, ASY
   Ong, JS
   Chuah, LO
   Yap, KP
   Azzam, G
   Azlan, A
   Liong, MT
AF Lew, L. C.
   Hor, Y. Y.
   Jaafar, M. H.
   Lau, A. S. Y.
   Ong, J. S.
   Chuah, L. O.
   Yap, K. P.
   Azzam, G.
   Azlan, A.
   Liong, M. T.
TI Lactobacilli modulated AMPK activity and prevented telomere shortening
   in ageing rats
SO BENEFICIAL MICROBES
LA English
DT Article
DE Lactobacillus; impairment; brain; muscle; telomere
ID INDUCED OXIDATIVE STRESS; LIPID-PEROXIDATION; LIFE-SPAN; IN-VITRO;
   PLASMA; BLOOD; RESTRICTION; EXPRESSION; EXERCISE; OXIDASE
AB This study aimed to evaluate the anti-ageing effects of different strains of lactobacilli putative probiotics on an ageing rat model as induced by D-galactose and a high fat diet. Male Sprague-Dawley rats were fed with high fat diet (54% kcal fat) and injected with D-galactose daily for 12 weeks to induce ageing. The effects of putative probiotic strains on age-related impairment such as telomere length, plasma lipid peroxidation, hepatic 5'adenosine monophosphate-activated protein kinase (AMPK) expression, as well as endurance performance were evaluated. Administration of statin, Lactobacillus plantarum DR7 (LP-DR7), Lactobacillus fermentum DR9 (LF-DR9), and Lactobacillus reuteri 8513d (LR-8513d) significantly reduced the shortening of telomere and increased the expression of AMPK subunit-alpha 1 (P<0.05). Plasma lipid peroxidation was lower (P<0.05) in groups administered with statin and LF-DR9 as compared to the control. AMPK subunit-alpha 2 was elevated in rats administered with LP-DR7 as compared to the control (P<0.05). Using an in vivo ageing rat model, the current study has illustrated the potentials of lactobacilli putative probiotics in alleviation of age-related impairment in a strain-dependent manner.
C1 [Lew, L. C.; Hor, Y. Y.; Jaafar, M. H.; Lau, A. S. Y.; Ong, J. S.; Chuah, L. O.; Liong, M. T.] Univ Sains Malaysia, Sch Ind Technol, George Town 11800, Malaysia.
   [Yap, K. P.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.
   [Azzam, G.; Azlan, A.] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
   [Lew, L. C.; Hor, Y. Y.; Jaafar, M. H.; Azzam, G.; Liong, M. T.] Univ Sains Malaysia, USM RIKEN Int Ctr Ageing Sci URICAS, George Town 11800, Malaysia.
C3 Universiti Sains Malaysia; Universiti Malaya; Universiti Sains Malaysia;
   Universiti Sains Malaysia
RP Liong, MT (corresponding author), Univ Sains Malaysia, Sch Ind Technol, George Town 11800, Malaysia.; Liong, MT (corresponding author), Univ Sains Malaysia, USM RIKEN Int Ctr Ageing Sci URICAS, George Town 11800, Malaysia.
EM mintze.liong@usm.my
RI Li, Yin/C-6644-2009; Liong, Min-Tze/GVT-7267-2022; YAP,
   KIEN-PONG/G-3002-2014; Liong, Min Tze/F-4726-2010; Hor, YY/ACW-4325-2022
OI Li, Yin/0000-0003-0995-3070; Liong, Min-Tze/0000-0002-4471-8271; Hor,
   Yan Yan/0000-0003-1224-4056
FU URICAS grant by Universiti Sains Malaysia [1001/PTEKIND/870030];
   MyBrain15-MyPhD from Ministry of Higher Education (MOHE); Clinical
   Nutrition Intl (M) Sdn. Bhd.
FX This work was supported by the URICAS grant (1001/PTEKIND/870030)
   provided by Universiti Sains Malaysia, MyBrain15-MyPhD from Ministry of
   Higher Education (MOHE) and funding by Clinical Nutrition Intl (M) Sdn.
   Bhd.
CR Adwan-Shekhidem H., 2018, Epigenetics Aging Longev, P119
   Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404
   Berger MJ, 2010, INTERD T GERONT GERI, V37, P94, DOI 10.1159/000319997
   Bouhafs L, 2015, RENAL FAILURE, V37, P1370, DOI 10.3109/0886022X.2015.1073543
   Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Chakraborty D, 2001, CLIN CHIM ACTA, V305, P123, DOI 10.1016/S0009-8981(00)00428-9
   Chong HX, 2019, BENEF MICROBES, V10, P355, DOI 10.3920/BM2018.0135
   Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Delwing-de Lima D, 2017, BIOMED PHARMACOTHER, V86, P686, DOI 10.1016/j.biopha.2016.12.011
   Devi SA, 2003, EXP GERONTOL, V38, P285, DOI 10.1016/S0531-5565(02)00206-1
   Dichtl W, 2003, ARTERIOSCL THROM VAS, V23, P58, DOI 10.1161/01.ATV.0000043456.48735.20
   FAO/WHO, 2006, Probiotics in Food: Health and Nutritional Properties and Guidelines for Evaluation
   Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148
   Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hor YY, 2019, J MED FOOD, V22, P1, DOI 10.1089/jmf.2018.4229
   Hor YY, 2018, J FUNCT FOODS, V44, P235, DOI 10.1016/j.jff.2018.03.017
   Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Lew LC, 2018, KOREAN J FOOD SCI AN, V38, P350, DOI 10.5851/kosfa.2018.38.2.350
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Lin MY, 1999, J AGR FOOD CHEM, V47, P3661, DOI 10.1021/jf981235l
   Manfredini V, 2010, CELL BIOCHEM FUNCT, V28, P360, DOI 10.1002/cbf.1654
   Metchnikoff E., 1907, Lactic acid as inhibiting intestinal putrefaction in the prolongation of life: Optimistic Studies, P161
   Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103
   Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Niki E, 2008, BIOFACTORS, V34, P171, DOI 10.1002/biof.5520340208
   Olivieri F, 2012, CURR VASC PHARMACOL, V10, P216, DOI 10.2174/157016112799305076
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   Otto A, 2006, BRIT J PHARMACOL, V148, P544, DOI 10.1038/sj.bjp.0706738
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476
   Patra A, 2018, Clin Nutr Exp, V19, P12, DOI DOI 10.1016/J.YCLNEX.2018.02.002
   Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002
   Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC
   Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x
   Wang Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050521
NR 47
TC 15
Z9 16
U1 5
U2 14
PU WAGENINGEN ACADEMIC PUBLISHERS
PI WAGENINGEN
PA PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS
SN 1876-2883
EI 1876-2891
J9 BENEF MICROBES
JI Benef. Mirbobes
PY 2019
VL 10
IS 8
BP 883
EP 892
DI 10.3920/BM2019.0058
PG 10
WC Microbiology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Nutrition & Dietetics
GA JU2ZG
UT WOS:000501544400006
PM 31965837
DA 2024-02-19
ER

PT J
AU Vucevic, D
   Mladenovic, D
   Ninkovic, M
   Stankovic, MN
   Jorgacevic, B
   Stankovic, M
   de Luka, S
   Radosavljevic, T
AF Vucevic, D.
   Mladenovic, D.
   Ninkovic, M.
   Stankovic, M. N.
   Jorgacevic, B.
   Stankovic, M. S.
   de Luka, S.
   Radosavljevic, T.
TI Influence of aging on ethanol-induced oxidative stress in digestive
   tract of rats
SO HUMAN & EXPERIMENTAL TOXICOLOGY
LA English
DT Article
DE Aging; ethanol; oxidative stress; digestive system; rats
ID INDUCED LIVER-INJURY; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; ALCOHOL; MICE; PANCREATITIS; CONSUMPTION;
   METABOLISM; DISEASE
AB Aging and ethanol induce oxidative stress due to increased prooxidant production and decreased antioxidative capacity. The aim was to investigate the influence of aging on oxidative stress in liver, stomach and pancreas in acute ethanol intoxication. Adult (3 months) and old (18 months) male Wistar rats were divided into the following groups: control (control group rats aged 3 months (C3) and control group rats aged 18 months (C18)) and ethanol-treated groups (ethanol-treated 3-month-old rats (E3) and ethanol-treated 18-month-old rats (E18)). Ethanol was administered in five doses of 2 g/kg at 12-h intervals by orogastric tube. Tissue samples were collected for the determination of oxidative stress parameters. Malondialdehyde (MDA) concentration was increased in all the experimental groups and investigated organs versus C3 group (p<0.01). The highest MDA level was observed in the stomach in E18 group when compared with C18 and E3 groups (p<0.01). Activity of total superoxide dismutase (SOD) and its isoenzymes (copper-/zinc-SOD and manganese-SOD) in E18 group was significantly decreased when compared with E3 and C18 groups (p<0.01). Nitrates and nitrites (NO (x) ) concentration was increased in stomach and pancreas for all the groups when compared with C3 group (p<0.01). Hepatic, gastric and pancreatic NO (x) level was significantly increased in E18 group when compared with E3 group (p<0.01). Moreover, level of NO (x) in liver and pancreas in E18 group was significantly increased when compared with C18 group (p<0.01). Aging potentiates ethanol-induced oxidative stress in liver, stomach and pancreas due to increased lipid peroxidation and nitrosative stress and decreased antioxidative tissue capacity.
C1 [Vucevic, D.; Mladenovic, D.; Stankovic, M. N.; Jorgacevic, B.; Stankovic, M. S.; de Luka, S.; Radosavljevic, T.] Univ Belgrade, Dept Pathophysiol, Fac Med, Belgrade 11000, Serbia.
   [Ninkovic, M.] Mil Med Acad, Inst Med Res, Belgrade 11002, Serbia.
C3 University of Belgrade; University of Belgrade
RP Radosavljevic, T (corresponding author), Univ Belgrade, Dept Pathophysiol, Fac Med, Dr Subotica 9, Belgrade 11000, Serbia.
EM tanjamm@med.bg.ac.rs
RI Radosavljević, Tatjana/AAE-2792-2020; De Luka, Silvio R./E-4079-2019;
   Veskovic, Milena/U-4519-2019
OI Radosavljević, Tatjana/0000-0002-1701-3313; De Luka, Silvio
   R./0000-0002-0859-9252; Veskovic, Milena/0000-0002-7505-5466; S.
   Stankovic, Marija/0000-0001-5187-6430; Ninkovic,
   Milica/0000-0003-3303-9916; Mladenovic, Dusan/0000-0002-8921-6232
FU Ministry of Education and Science of Serbia [175015]
FX This work was supported by the Ministry of Education and Science of
   Serbia, Grant no. 175015.
CR Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496
   Aparajita D, 2006, HEPATOLOGY, V43, pS63
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Clemens DL, 2010, WORLD J GASTROENTERO, V16, P1314, DOI 10.3748/wjg.v16.i11.1314
   Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005
   Devanshi S, 2011, J GASTROEN HEPATOL, V26, P1089
   Dobrzynska I, 2004, CELL MOL BIOL LETT, V9, P709
   Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba
   GIROTTI MJ, 1991, J TRAUMA, V31, P32, DOI 10.1097/00005373-199101000-00007
   Glaser J, 2000, GERONTOLOGY, V46, P93, DOI 10.1159/000022141
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9
   Rocha KKHR, 2011, ALCOHOL ALCOHOLISM, V46, P10, DOI 10.1093/alcalc/agq085
   Jin-Shui P, 2008, WORLD J GASTROENTERO, V14, P5857
   Kang JM, 2010, AM J PHYSIOL-GASTR L, V299, pG1147, DOI 10.1152/ajpgi.00218.2010
   Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315
   KOCH OR, 1994, BIOCHEM BIOPH RES CO, V201, P1356, DOI 10.1006/bbrc.1994.1853
   Koch Osvaldo R., 2004, Molecular Aspects of Medicine, V25, P191, DOI 10.1016/j.mam.2004.02.019
   Laniewska-Dunaj Magdalena, 2012, Pol Merkur Lekarski, V32, P194
   Lei XG, 2006, BIOCHEM J, V399, P455, DOI 10.1042/BJ20060784
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004
   McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030
   Mladenovic D, 2009, FOOD CHEM TOXICOL, V47, P866, DOI 10.1016/j.fct.2009.01.020
   Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003
   Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478
   Neovi-Ostoji J, 2012, HUM EXP TOXICOL, V31, P387
   Norton ID, 1998, GUT, V42, P426, DOI 10.1136/gut.42.3.426
   Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212
   Pronko P, 2002, ALCOHOL ALCOHOLISM, V37, P229, DOI 10.1093/alcalc/37.3.229
   Radosavljevic T, 2012, J SERB CHEM SOC, V77, P159, DOI 10.2298/JSC110330174R
   Rakesh K, 2011, ANTIOXID RED SIGNAL, V15, P2757
   Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Zima T, 2001, J BIOMED SCI, V8, P59, DOI 10.1159/000054014
NR 37
TC 7
Z9 7
U1 0
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0960-3271
J9 HUM EXP TOXICOL
JI Hum. Exp. Toxicol.
PD JUL
PY 2013
VL 32
IS 7
BP 698
EP 705
DI 10.1177/0960327112467045
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 175DZ
UT WOS:000321211800003
PM 23821589
DA 2024-02-19
ER

PT J
AU De La Fuente, SG
   Bennett, KM
   Scarborough, JE
AF De La Fuente, Sebastian G.
   Bennett, Kyla M.
   Scarborough, John E.
TI Functional Status Determines Postoperative Outcomes in Elderly Patients
   Undergoing Hepatic Resections
SO JOURNAL OF SURGICAL ONCOLOGY
LA English
DT Article
DE liver; hepatectomy; elderly
ID AGE-RELATED-CHANGES; LIVER RESECTION; HEPATOCELLULAR-CARCINOMA;
   BLOOD-FLOW; REGENERATION; HEPATECTOMY; METASTASES; DISEASE
AB Background With the aging population and increasing incidence of hepatic malignancies in elderly patients, establishing the safety of hepatic resections is crucial. The present study investigates early postoperative morbidity and mortality in elderly patients undergoing hepatic resection using a nationally validated database. Methods The National Surgical Quality Improvement Program Participant User Files (NSQIP-PUF) for 20052009 were used for the retrospective analysis of all patients undergoing hepatic resection. The primary outcome measures were 30-day postoperative mortality, overall complication rate, and serious complication rate. The primary predictor variable was patient age, which was treated as a dichotomous variable (age 70 years, age 70 years). Results Five thousand seven hundred six patients were included in the final analysis, 1,280 of which were 70 years of age. Thirty-day postoperative mortality (70 years 1.9% vs. 70 years 4.5%, P<0.0001), serious complications (70 years 15.2% vs. 70 years 18.4%, P<0.006) and overall complications (70 years 23.1% vs. 70 years 26.6%, P<0.01) were more common in the elderly group. Elderly patients had significantly more wound infections, pneumonia, prolonged ventilator support, unplanned re-intubations, renal failure, strokes, myocardial infarction, cardiac arrests, and septic shock. The median length of hospitalization was also significantly longer in the elderly. Conclusions This study shows significantly higher complication rates and mortality following hepatic resections in elderly patients. These findings should be taken into account when considering hepatectomy in this population. J. Surg. Oncol. 2013;107:865870. (c) 2013 Wiley Periodicals, Inc.
C1 [De La Fuente, Sebastian G.] Florida Hosp Orlando, Orlando, FL USA.
   [De La Fuente, Sebastian G.] Univ Cent Florida, Orlando, FL 32816 USA.
   [Bennett, Kyla M.; Scarborough, John E.] Duke Univ, Med Ctr, Durham, NC USA.
C3 Adventist Health Services; AdventHealth; State University System of
   Florida; University of Central Florida; Duke University
RP De La Fuente, SG (corresponding author), 2415 N Orange Ave,Suite 400, Orlando, FL 32804 USA.
EM sebastian.delafuente.MD@flhosp.org
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   Carino ND, 2008, CRIT REV ONCOL HEMAT, V67, P273, DOI 10.1016/j.critrevonc.2008.05.003
   de la Fuente SG, 2011, HPB, V13, P887, DOI 10.1111/j.1477-2574.2011.00390.x
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1991, NEW ENGL J MED, V324, P1691, DOI 10.1056/NEJM199106133242403
   House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040
   Koperna T, 1998, WORLD J SURG, V22, P406, DOI 10.1007/s002689900405
   Kulik U, 2011, WORLD J SURG, V35, P2063, DOI 10.1007/s00268-011-1180-x
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   MACMAHON M, 1994, J CLIN GASTROENTEROL, V18, P330, DOI 10.1097/00004836-199406000-00015
   Sánchez-Hidalgo JM, 2012, J SURG RES, V175, pE1, DOI 10.1016/j.jss.2011.11.1022
   Melloul E, 2012, WORLD J SURG, V36, P2161, DOI 10.1007/s00268-012-1621-1
   Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217
   Pasetto LM, 2007, CRIT REV ONCOL HEMAT, V64, P10, DOI 10.1016/j.critrevonc.2007.08.001
   Portolani N, 2011, JPN J CLIN ONCOL, V41, P1358, DOI 10.1093/jjco/hyr154
   Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   Tsujita E, 2012, HEPATO-GASTROENTEROL, V59, P1553, DOI 10.5754/hge09485
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
NR 26
TC 29
Z9 30
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-4790
EI 1096-9098
J9 J SURG ONCOL
JI J. Surg. Oncol.
PD JUN
PY 2013
VL 107
IS 8
BP 865
EP 870
DI 10.1002/jso.23335
PG 6
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA 150WH
UT WOS:000319421700013
PM 23585324
DA 2024-02-19
ER

PT J
AU Adamopoulos, IE
   Xia, ZD
   Lau, YS
   Athanasou, NA
AF Adamopoulos, Iannis E.
   Xia, Zhidao
   Lau, Yu Sin
   Athanasou, Nicholas A.
TI Hepatocyte growth factor can substitute for M-CSF to support
   osteoclastogenesis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE hepatocyte growth factor; osteoclasts; rheumatoid arthritis; bone
   resorption
ID COLONY-STIMULATING FACTOR; BONE-RESORPTION; TYROSINE KINASE;
   FACTOR-RECEPTOR; DIFFERENTIATION; CELLS; OSTEOBLASTS; SURVIVAL; BEHAVIOR
AB Osteopetrotic mice lacking functional macrophage-colony stimulating factor (M-CSF) recover with ageing, suggesting that alternative osteoclastogenesis pathways exist. Hepatocyte growth factor (HGF) and M-CSF signal through tyrosine kinase receptors and phosphorylate common transducers and effectors such as Src, Grb2, and PI3-Kinase. HGF is known to play a role in osteoclast formation, and in this study we have determined whether HGF could replace M-CSF to support human osteoclastogenesis. We found that the HGF receptor, c-Met, is expressed by the CD14(+) monocyte fraction of human peripheral blood mononuclear cells (PBMC). HGF was able to support monocyte-osteoclast differentiation in the presence of receptor activator for nuclear factor kappa B ligand as evidenced by the formation of numerous multinucleated tartrate-resistant acid phosphatase and vitronectin receptor positive cells which formed F-actin rings and were capable of lacumar resorption. The addition of a neutralising antibody to M-CSF did not inhibit osteoclast differentiation. HGF is a well-established survival factor and viability assays and live/dead staining showed that it promoted the survival and proliferation of monocytes and osteoclasts in a manner similar to M-CSF. Our findings indicate that HGF can substitute for M-CSF to support human osteoclast formation. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Oxford, Nuffield Orthopaed Ctr, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England.
   Univ Oxford, Nuffield Orthopaed Ctr, Dept Pathol, Oxford OX3 7LD, England.
C3 University of Oxford; Nuffield Orthopaedic Centre; Nuffield Orthopaedic
   Centre; University of Oxford
RP Adamopoulos, IE (corresponding author), Univ Oxford, Nuffield Orthopaed Ctr, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England.
EM iadamopoulos@path.wustl.edu
RI Xia, Zhidao/AAA-5192-2019; Adamopoulos, Iannis/A-9728-2012; Adamopoulos,
   Iannis/L-1944-2019; Adamopoulos, Iannis/AAE-5624-2022
OI Xia, Zhidao/0000-0002-2047-7282; Adamopoulos, Iannis/0000-0002-3708-2965
CR Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741
   ATHANASOU NA, 1990, J CLIN PATHOL, V43, P997, DOI 10.1136/jcp.43.12.997
   BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237
   BEGG SK, 1993, EXP HEMATOL, V21, P493
   BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706
   D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7
   Faust J, 1999, J CELL BIOCHEM, V72, P67, DOI 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A
   FELIX R, 1990, ENDOCRINOLOGY, V127, P2592, DOI 10.1210/endo-127-5-2592
   Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058
   FULLER K, 1995, BIOCHEM BIOPH RES CO, V212, P334, DOI 10.1006/bbrc.1995.1974
   FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733
   Gaasch JA, 2006, GENE, V369, P142, DOI 10.1016/j.gene.2005.10.036
   Galimi F, 2001, J IMMUNOL, V166, P1241, DOI 10.4049/jimmunol.166.2.1241
   Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644
   HORTON MA, 1985, CANCER RES, V45, P5663
   Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704
   Lean JM, 2001, BLOOD, V98, P2707, DOI 10.1182/blood.V98.9.2707
   Massey HM, 1999, BRIT J HAEMATOL, V106, P167
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266
   Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293
   PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2
   SATO T, 1995, J CELL PHYSIOL, V164, P197, DOI 10.1002/jcp.1041640124
   Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x
   Taichman RS, 2001, BRIT J HAEMATOL, V112, P438, DOI 10.1046/j.1365-2141.2001.02568.x
   Woo KM, 2002, EXP MOL MED, V34, P340, DOI 10.1038/emm.2002.48
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
   ZHU H, 1994, CELL GROWTH DIFFER, V5, P359
NR 28
TC 39
Z9 41
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 17
PY 2006
VL 350
IS 2
BP 478
EP 483
DI 10.1016/j.bbrc.2006.09.076
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 096PS
UT WOS:000241389900033
PM 17022947
DA 2024-02-19
ER

PT J
AU Mulligan, JD
   Stewart, AM
   Saupe, KW
AF Mulligan, Jacob D.
   Stewart, Annette M.
   Saupe, Kurt W.
TI Downregulation of plasma insulin levels and hepatic PPARγ expression
   during the first week of caloric restriction in mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; caloric restriction; lipogenesis; mice; liver; adipose
ID FATTY-ACID SYNTHASE; GENE-EXPRESSION; GROWTH-HORMONE; DIETARY
   RESTRICTION; BINDING-PROTEINS; PROSTATE-CANCER; LIFE-SPAN; LIVER;
   RETARDATION; LONGEVITY
AB Calorie restriction extends lifespan by decreasing the rate of tumor formation, an effect occurring within 8 weeks of initiating a restricted diet. Our goal was to define how the first weeks of a calorie restricted diet (60% of ad libitum calories) affects putative mediators of the calorie restriction phenotype, focusing on regulators of fatty acid biosynthesis. In C57B1/6 mice, insulin decreased over 50% (p < 0.05) during the first week of calorie restriction whereas IGF-1 was unaffected. In the liver, PPAR gamma mRNA fell to 13% of baseline after I week of calorie restriction (p < 0.05), whereas hepatic SREBP-I c and SIRT1 mRNA levels were unaffected. No changes in abdominal or subcutaneous adipose tissue were observed until after 4 weeks of caloric restriction. We conclude that calorie restriction-induced decreases in insulin and hepatic PPAR gamma are rapid enough to support a role for these molecules in triggering the initial phase of the calorie restriction phenotype. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Mulligan, Jacob D.; Stewart, Annette M.; Saupe, Kurt W.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA.
   [Saupe, Kurt W.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison
RP Saupe, KW (corresponding author), Univ Wisconsin, Dept Med, 1630 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.
EM kws@medicine.wisc.edu
FU Intramural NIH HHS [Z01 AG000908] Funding Source: Medline; NHLBI NIH HHS
   [HL 07936, T32 HL007936] Funding Source: Medline; NIA NIH HHS [AG 00908,
   K01 AG000908-06, K01 AG000908] Funding Source: Medline
CR Argentino DP, 2005, HORM METAB RES, V37, P672, DOI 10.1055/s-2005-870577
   ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8
   Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S
   Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817
   BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x
   De Schrijver E, 2003, CANCER RES, V63, P3799
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2
   FU PP, 1994, CARCINOGENESIS, V15, P159, DOI 10.1093/carcin/15.2.159
   Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X
   Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1394, DOI 10.1093/gerona/60.11.1394
   Masternak MM, 2004, J GERONTOL A-BIOL, V59, P784
   Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310
   Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731
   Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x
   Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912
   Pizer ES, 1998, CANCER RES, V58, P4611
   Rossi S, 2003, MOL CANCER RES, V1, P707
   Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0
   Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003
   Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje
   Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Wolf G, 2006, NUTR REV, V64, P89, DOI [10.1301/nr.2006.feb.89-92, 10.1111/j.1753-4887.2006.tb00192.x]
   Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598
   Yoshida K, 1999, J Nutr Health Aging, V3, P121
NR 34
TC 26
Z9 34
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2008
VL 43
IS 3
BP 146
EP 153
DI 10.1016/j.exger.2007.10.011
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 273GW
UT WOS:000253919400004
PM 18053669
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Shiozaki, M
   Hayakawa, N
   Shibata, M
   Koike, M
   Uchiyama, Y
   Gotow, T
AF Shiozaki, Motoko
   Hayakawa, Naoya
   Shibata, Masahiro
   Koike, Masato
   Uchiyama, Yasuo
   Gotow, Takahiro
TI Closer association of mitochondria with lipid droplets in hepatocytes
   and activation of Kupffer cells in resveratrol-treated
   senescence-accelerated mice
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE Resveratrol; Hepatocyte; Lipid droplet; Mitochondria; SOD2; Kupffer
   cell; Senescence-accelerated mouse
ID LIFE-SPAN; CALORIE RESTRICTION; DIETARY RESTRICTION; OXIDATIVE STRESS;
   PROTEIN-KINASE; IN-VITRO; SIRT1; METABOLISM; SURVIVAL; RAT
AB Resveratrol has been extensively investigated because of its beneficial effects in delaying age-related diseases, thus extending the lifespan, possibly by mimicking calorie restriction. For this study, cell biological techniques were used to examine how resveratrol influenced hepatocytes in a senescence-accelerated mouse P10 (SAMP10), treated from 35 to 55 weeks of age, with special emphasis on the relationship between mitochondria and lipid droplets. Survival ratio, body weight and food intake of SAMP10 did not differ significantly between the control and resveratrol-treated groups. Compared with the control, the treated livers were altered significantly, as follows. Lipid droplets were reduced and mitochondria were increased in number in hepatocytes. Phosphorylation of acetyl-CoA carboxylase and the expression of both the mitochondrial ATP synthase beta subunit and Mn superoxide dismutase (SOD2) were increased. Mitochondria, expressing more SOD2, were more tightly associated with lipid droplets, suggesting the enhancement of lipolysis through the activation of mitochondrial functions. Cathepsin D expression was less in hepatocytes but enhanced in Kupffer cells, which were increased in number and size with more numerous lysosome-related profiles. Together, resveratrol may activate mitochondria resulting in consuming lipids, and may also activate Kupffer cells by which a beneficial milieu for hepatocytes may be created. Both might be related to improvement in the functioning of the liver, which is the organ that is central to metabolic regulation.
C1 [Shiozaki, Motoko; Hayakawa, Naoya; Gotow, Takahiro] Koshien Univ, Coll Nutr, Cell Biol Lab, Takarazuka, Hyogo 6650006, Japan.
   [Shiozaki, Motoko] Osaka Univ, Grad Sch Med, Div Cardiovasc Surg, Suita, Osaka 5650871, Japan.
   [Hayakawa, Naoya] Osaka Univ, Grad Sch Med & Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan.
   [Shibata, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Niigata 9518122, Japan.
   [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 1138421, Japan.
C3 Osaka University; Osaka University; Niigata University; Juntendo
   University
RP Gotow, T (corresponding author), Koshien Univ, Coll Nutr, Cell Biol Lab, Takarazuka, Hyogo 6650006, Japan.
EM gotow@koshien.ac.jp
RI Koike, Masato/F-9584-2010
OI Koike, Masato/0000-0002-3174-5684
FU Science and Culture, Japan [21590225]; Grants-in-Aid for Scientific
   Research [22790183, 21590225] Funding Source: KAKEN
FX This work was supported in part by a Grant-in-Aid for Scientific
   Research (No. 21590225 to T. G.), Science and Culture, Japan.
CR Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018
   Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056
   Barber SC, 2009, FREE RADICAL BIO MED, V46, P1127, DOI 10.1016/j.freeradbiomed.2009.01.019
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Björklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5
   Camins A, 2010, BBA-GENE REGUL MECH, V1799, P740, DOI 10.1016/j.bbagrm.2010.06.005
   Castle JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004369
   Chi TC, 2007, LIFE SCI, V80, P1713, DOI 10.1016/j.lfs.2007.02.002
   Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Das DK, 2010, HEART FAIL REV, V15, P467, DOI 10.1007/s10741-010-9163-9
   Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104
   DEIMANN W, 1980, LAB INVEST, V43, P172
   DEIMANN W, 1980, LAB INVEST, V42, P217
   Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024
   Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008
   Gemma C, 2010, AGING DIS, V1, P169
   GILLUM MP, 2010, TRENDS MOL MED, DOI DOI 10.1016/J.MOL-MED.2010.09.005
   Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694
   Gotow T, 2008, HISTOCHEM CELL BIOL, V130, P583, DOI 10.1007/s00418-008-0473-0
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06
   Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740
   Haynes V, 2010, AM J PHYSIOL-ENDOC M, V298, pE978, DOI 10.1152/ajpendo.00739.2009
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Martin TA, 2010, INT J MOL MED, V26, P721, DOI 10.3892/ijmm_00000519
   Miyamoto K, 2009, J NEUROSCI RES, V87, P556, DOI 10.1002/jnr.21851
   Mukherjee S, 2010, CAN J PHYSIOL PHARM, V88, P1017, DOI [10.1139/Y10-082, 10.1139/y10-082]
   Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005
   Murase T, 2009, BIOGERONTOLOGY, V10, P423, DOI 10.1007/s10522-008-9177-z
   Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153
   Paul A, 2007, MECH AGEING DEV, V128, P706, DOI 10.1016/j.mad.2007.10.013
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Radkar V, 2008, FOOD CHEM TOXICOL, V46, P3664, DOI 10.1016/j.fct.2008.09.043
   Radkar Vijayalaxmi, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P293, DOI 10.2478/v10004-007-0020-8
   Rüweler M, 2009, CHEM-BIOL INTERACT, V182, P128, DOI 10.1016/j.cbi.2009.09.003
   Sadruddin Sarfaraz, 2009, J Cardiometab Syndr, V4, P102, DOI 10.1111/j.1559-4572.2008.00039.x
   Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009
   Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032
   Sugino T, 2010, FEBS LETT, V584, P2821, DOI 10.1016/j.febslet.2010.04.063
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Trincheri NF, 2007, CARCINOGENESIS, V28, P922, DOI 10.1093/carcin/bgl223
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang D, 2011, AGING-US, V3, P158, DOI 10.18632/aging.100283
   Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977
NR 58
TC 27
Z9 29
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD OCT
PY 2011
VL 136
IS 4
BP 475
EP 489
DI 10.1007/s00418-011-0847-6
PG 15
WC Cell Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Microscopy
GA 821EI
UT WOS:000294957300008
PM 21818579
DA 2024-02-19
ER

PT J
AU Mazzoli, A
   Crescenzo, R
   Cigliano, L
   Spagnuolo, MS
   Cancelliere, R
   Gatto, C
   Iossa, S
AF Mazzoli, Arianna
   Crescenzo, Raffaella
   Cigliano, Luisa
   Spagnuolo, Maria Stefania
   Cancelliere, Rosa
   Gatto, Cristina
   Iossa, Susanna
TI Early Hepatic Oxidative Stress and Mitochondrial Changes Following
   Western Diet in Middle Aged Rats
SO NUTRIENTS
LA English
DT Article
DE middle age; liver mitochondria; oxidative stress; high fat-high fructose
   diet; inflammation; hepatic cholesterol
ID HIGH-FAT DIET; INSULIN-RESISTANCE; METABOLIC SYNDROME; HIGH-FRUCTOSE;
   SKELETAL-MUSCLE; ADIPOSE-TISSUE; LIVER; LIPOCALIN-2; STEATOSIS;
   INFLAMMATION
AB To assess the effect of 4 weeks of high fat-high fructose feeding on whole body composition, energy balance, specific markers of oxidative stress and inflammation, and insulin sensitivity in the liver of middle-aged rats, rats (1 year) were fed a diet rich in saturated fatty acids and fructose (HFF rats), mimicking the "Western diet", and compared with rats of the same age that were fed a low fat diet (LF rats). HFF rats exhibited a significant increase in the gain of body weight, energy, and lipids compared to LF rats. HFF rats also showed hepatic insulin resistance, together with an increase in plasma triglycerides, cholesterol, and tumor necrosis factor alpha. Hepatic lipids, triglycerides and cholesterol were higher in HFF rats, while a significant decrease in Stearoyl-CoA desaturase activity was found in this tissue. A marked increase in the protein amount of complex I, concomitant to a decrease in its contribution to mitochondrial respiration, was found in HFF rats. Lipid peroxidation and Nitro-Tyrosine content, taken as markers of oxidative stress, as well as NADPH oxidase activity, were significantly higher in HFF rats, while the antioxidant enzyme catalase decreased in these rats. Myeloperoxidase activity and lipocalin content increased, while peroxisome proliferator activated receptor gamma decreased in HFF rats. The present results provide evidence that middle-aged rats show susceptibility to a short-term "Western diet", exhibiting altered redox homeostasis, insulin resistance, and early mitochondrial alterations in the liver. Therefore, this type of dietary habits should be drastically limited to pursue a "healthy aging".
C1 [Mazzoli, Arianna; Crescenzo, Raffaella; Cigliano, Luisa; Cancelliere, Rosa; Gatto, Cristina; Iossa, Susanna] Univ Naples Federico II, Dept Biol, Via Cintia, I-80126 Naples, Italy.
   [Spagnuolo, Maria Stefania] Natl Res Council Naples CNR ISPAAM, Inst Anim Prod Syst Mediterranean Environm, Dept Bioagrofood Sci, I-80147 Naples, Italy.
C3 University of Naples Federico II; Consiglio Nazionale delle Ricerche
   (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente
   Mediterraneo (ISPAAM-CNR)
RP Iossa, S (corresponding author), Univ Naples Federico II, Dept Biol, Via Cintia, I-80126 Naples, Italy.
EM arianna.mazzoli@unina.it; rcrescen@unina.it; luisa.cigliano@unina.it;
   mariastefania.spagnuolo@cnr.it; cancelliererosa@gmail.com;
   crigatto51@gmail.com; susiossa@unina.it
RI Cigliano, Luisa/AEL-3260-2022; iossa, susanna/O-1625-2016; Spagnuolo,
   Maria Stefania/B-7661-2015
OI iossa, susanna/0000-0001-6103-718X; Spagnuolo, Maria
   Stefania/0000-0001-6980-0661; CRESCENZO, Raffaella/0000-0001-6138-6961;
   mazzoli, arianna/0000-0003-4096-443X; CIGLIANO,
   Luisa/0000-0002-5491-9659; GATTO, CRISTINA/0000-0003-1658-8470
FU University of Naples Federico II-Ricerca Dip 2017-2018; FIRB-Futuro in
   Ricerca grant from the Italian Ministry of Education, University and
   Research (MIUR) [RBFR12QW4I_004]
FX This work was supported by a grant from the University of Naples
   Federico II-Ricerca Dip 2017-2018 and by a FIRB-Futuro in Ricerca grant
   (RBFR12QW4I_004) from the Italian Ministry of Education, University and
   Research (MIUR).
CR Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519
   Alwahsh SM, 2014, WORLD J GASTROENTERO, V20, P1807, DOI 10.3748/wjg.v20.i7.1807
   [Anonymous], NCHS DATA BRIEF, DOI [10.1017/S1368980017000088, DOI 10.1017/S1368980017000088]
   Bettaieb A, 2014, FREE RADICAL BIO MED, V72, P247, DOI 10.1016/j.freeradbiomed.2014.04.011
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Burtscher J, 2015, MITOCHONDRION, V25, P104, DOI 10.1016/j.mito.2015.10.007
   Cheng WH, 2010, MECH AGEING DEV, V131, P223, DOI 10.1016/j.mad.2010.03.011
   Cheranov SY, 2006, AM J PHYSIOL-CELL PH, V290, pC964, DOI 10.1152/ajpcell.00499.2005
   Cigliano L, 2018, MOL NEUROBIOL, V55, P2869, DOI 10.1007/s12035-017-0518-2
   Crescenzo R, 2016, EUR J NUTR, V55, P1, DOI 10.1007/s00394-015-1073-0
   Crescenzo R, 2015, EUR J NUTR, V54, P183, DOI 10.1007/s00394-014-0699-7
   Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632
   Crescenzo R, 2013, BRIT J NUTR, V110, P1996, DOI 10.1017/S0007114513001566
   Crescenzo R, 2012, OBESITY, V20, P1763, DOI 10.1038/oby.2011.167
   Crescenzo R, 2012, BRIT J NUTR, V108, P655, DOI 10.1017/S0007114511005903
   Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630
   De Minicis S, 2010, HEPATOLOGY, V52, P1420, DOI 10.1002/hep.23804
   den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e
   Drake I, 2018, BRIT J NUTR, V119, P1168, DOI 10.1017/S000711451800079X
   Endlicher R, 2009, PHYSIOL RES, V58, P685, DOI 10.33549/physiolres.931635
   Ernster L., 1968, Methods in Enzymology, VX, P574
   Feillet-Coudray C, 2019, LIPIDS, V54, P81, DOI 10.1002/lipd.12128
   Gianotti TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076912
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fouret G, 2018, BRIT J NUTR, V119, P368, DOI [10.1017/S0007114517003713, 10.1017/s0007114517003713]
   García-Ruiz I, 2015, DIS MODEL MECH, V8, P183, DOI 10.1242/dmm.018234
   García-Ruiz I, 2014, DIS MODEL MECH, V7, P1287, DOI 10.1242/dmm.016766
   Garnol T, 2014, PHYSIOL RES, V63, P271, DOI 10.33549/physiolres.932645
   Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920
   Iossa S, 2000, BRIT J NUTR, V84, P377
   Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678
   KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344
   Li YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06506-3
   LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565
   Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Lozano I, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0074-1
   MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357
   Meng R, 2011, ANN CLIN LAB SCI, V41, P236
   Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5
   Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0
   Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021
   PENICAUD L, 1991, BIOCHEM J, V279, P303, DOI 10.1042/bj2790303
   Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Roberts MD, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0382-3
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Silva AKS, 2018, CELL MOL LIFE SCI, V75, P2951, DOI 10.1007/s00018-018-2838-4
   Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7
   STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565
   Sultan S, 2012, SHOCK, V37, P191, DOI 10.1097/SHK.0b013e31823918c2
   Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614
   Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420
NR 54
TC 9
Z9 9
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2019
VL 11
IS 11
AR 2670
DI 10.3390/nu11112670
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JV3OC
UT WOS:000502274600121
PM 31694213
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, HJ
   Xu, LJ
   Drake, VJ
   Xie, LT
   Oberley, LW
   Kregel, KC
AF Zhang, HJ
   Xu, LJ
   Drake, VJ
   Xie, LT
   Oberley, LW
   Kregel, KC
TI Heat-induced liver injury in old rats is associated with exaggerated
   oxidative stress and altered transcription factor activation
SO FASEB JOURNAL
LA English
DT Article
DE free radicals; ROS; aging; hyperthermia; signal transduction
ID NF-KAPPA-B; FREE-RADICAL GENERATION; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; REDOX REGULATION; GLUTATHIONE; CELLS; AP-1;
   DIFFERENTIATION; OVEREXPRESSION
AB A decline in stress tolerance is a hallmark of aging. For instance, older organisms showed extensive hepatic damage, along with increased morbidity and mortality, after environmental heating. We hypothesized that hyperthermic challenge would produce exaggerated oxidative stress in old animals, leading to increased hepatic injury. After a heat-stress protocol, time-course changes in reactive oxygen species (ROS) levels, oxidative damage markers, glutathione (GSH)/glutathione disulfide (GSSG) ratios, and activation of stress-response transcription factors (AP-1 and NF-kappaB) were measured in young and old rats. A small, transient increase in hepatic oxidative damage, with minimal injury, was observed in young rats. However, old rats showed widespread hepatic injury that was manifested over a 24 h period after heating. This pathology was preceded by elevated steady-state levels of ROS, along with large increases in lipid peroxidation products, prolonged hepatic DNA oxidation damage, aberrant GSH/GSSG profiles, and altered activation patterns for AP-1. These data indicate that young animals have an effective oxidation-reduction buffering system in the liver that provides protection from oxidative damage to intracellular macromolecules under stress conditions. In sharp contrast, an environmental challenge in older animals produces exaggerated oxidative stress and alterations in signal transduction pathways, which can contribute to cellular dysfunction and age-related reductions in stress tolerance.
C1 Univ Iowa, Dept Exercise Sci, Integrat Physiol Lab, FH 532, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Dept Exercise Sci, Integrat Physiol Lab, FH 532, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Camandola S, 1997, BIOFACTORS, V6, P173, DOI 10.1002/biof.5520060211
   Cheng JZ, 2001, ARCH BIOCHEM BIOPHYS, V392, P197, DOI 10.1006/abbi.2001.2452
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   HALL DM, 1994, J APPL PHYSIOL, V77, P548, DOI 10.1152/jappl.1994.77.2.548
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Harris AG, 1998, AM J PHYSIOL-HEART C, V274, pH1009, DOI 10.1152/ajpheart.1998.274.3.H1009
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Headrick JP, 1998, J MOL CELL CARDIOL, V30, P1415, DOI 10.1006/jmcc.1998.0710
   HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   KEW M, 1971, T ROY SOC TROP MED H, V65, P325, DOI 10.1016/0035-9203(71)90007-1
   Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8
   Kregel K. C., 1996, J APPL PHYSIOL, V80, P262
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   Kregel KC, 1996, J APPL PHYSIOL, V80, P540, DOI 10.1152/jappl.1996.80.2.540
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leonarduzzi G, 2000, FREE RADICAL BIO MED, V28, P1370, DOI 10.1016/S0891-5849(00)00216-1
   Li N, 2002, AM J PHYSIOL-RENAL, V282, pF1111, DOI 10.1152/ajprenal.00218.2001
   Li WG, 2001, J BIOL CHEM, V276, P29251, DOI 10.1074/jbc.M102124200
   Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30
   Morrison RJ, 1998, TOXICOL APPL PHARM, V148, P229, DOI 10.1006/taap.1997.8339
   Nkabyo YS, 2002, AM J PHYSIOL-GASTR L, V283, pG1352, DOI 10.1152/ajpgi.00183.2002
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   Parola M, 1998, J CLIN INVEST, V102, P1942, DOI 10.1172/JCI1413
   Parola M, 1999, INT J MOL MED, V4, P425
   Piette J, 1997, BIOL CHEM, V378, P1237
   POWIS G, 1995, PHARMACOL THERAPEUT, V68, P149, DOI 10.1016/0163-7258(95)02004-7
   Rikans LE, 1999, MECH AGEING DEV, V108, P173, DOI 10.1016/S0047-6374(99)00012-3
   RYAN AJ, 1995, J APPL PHYSIOL, V78, P38, DOI 10.1152/jappl.1995.78.1.38
   Schafer FQ, 2000, FREE RADICAL BIO MED, V28, P1175, DOI 10.1016/S0891-5849(00)00319-1
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SLATER TF, 1982, BIOCHEM J, V22, P1
   Tani M, 1997, J MOL CELL CARDIOL, V29, P3081, DOI 10.1006/jmcc.1997.0533
   Tjalkens RB, 1999, ARCH BIOCHEM BIOPHYS, V361, P113, DOI 10.1006/abbi.1998.0946
   Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x
   Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zhang HJ, 2002, J BIOL CHEM, V277, P20919, DOI 10.1074/jbc.M109801200
   Zhang HJ, 2002, J VIROL, V76, P355, DOI 10.1128/JVI.76.1.355-363.2002
   Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698
NR 50
TC 85
Z9 98
U1 0
U2 10
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2003
VL 17
IS 12
BP 2293
EP +
DI 10.1096/fj.03-0139fje
PG 25
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 732DG
UT WOS:000185925100013
PM 14500545
DA 2024-02-19
ER

PT J
AU Williams, D
   Woodhouse, K
AF Williams, D
   Woodhouse, K
TI Age-related changes in O-deethylase and aldrin epoxidase activity in
   mouse skin and liver microsomes
SO AGE AND AGEING
LA English
DT Article
DE cytochrome P-450; drug metabolism; ageing
ID DRUG-METABOLIZING-ENZYMES; MONO-OXYGENASE ACTIVITIES; RAT-LIVER;
   STEREOLOGICAL ANALYSIS
AB The metabolism of three model substrates for the cytochrome P-450 dependent mono-oxygenase enzyme system (P-450-MMO) was studied in microsomes isolated from skin and liver of young adult and senescent C57B1/6J mice. The substrates chosen were aldrin (AE), 7-ethoxycoumarin (EOC), and 7-ethoxyresorufin (EOR).
   Both EOC and EOR activities were lower in senescent skin. By contrast, no-age related changes were seen in senescent liver. AE was similar in young and old, in both tissues.
   We suggest that some important age-related differences in cutaneous xenobiotic metabolism do occur, but that these are not mirrored by hepatic differences, and are substrate specific. Previous work from these laboratories would also suggest significant species differences.
RP Williams, D (corresponding author), UNIV WALES COLL MED,LLANDOUGH HOSP,ACAD CTR,DEPT GERIATR MED,3RD FLOOR,PENARTH CF64 2XX,S GLAM,WALES.
CR AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2
   BICKERS DR, 1974, J PHARMACOL EXP THER, V188, P300
   BURKE MD, 1974, DRUG METAB DISPOS, V2, P585
   GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P598
   JACOBSON M, 1974, CLIN PHARMACOL THER, V16, P701
   KATO R, 1970, JPN J PHARMACOL, V20, P572, DOI 10.1254/jjp.20.572
   KREMERS P, 1981, EUR J BIOCHEM, V118, P599, DOI 10.1111/j.1432-1033.1981.tb05561.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MOLONEY SJ, 1982, BIOCHEM PHARMACOL, V31, P4011, DOI 10.1016/0006-2952(82)90649-9
   MUKHTAR H, 1983, DRUG METAB DISPOS, V11, P562
   PANNATIER A, 1978, DRUG METAB REV, V8, P319, DOI 10.3109/03602537808993791
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   POHL RJ, 1976, DRUG METAB DISPOS, V4, P442
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x
   SOUCEK P, 1992, XENOBIOTICA, V22, P83
   ULLRICH V, 1975, BIOCHEM BIOPH RES CO, V64, P808, DOI 10.1016/0006-291X(75)90119-9
   ULLRICH V, 1972, H-S Z PHYSIOL CHEM, V353, P1171, DOI 10.1515/bchm2.1972.353.2.1171
   VANCANTFORT J, 1983, BIOCHEM PHARMACOL, V32, P2697, DOI 10.1016/0006-2952(83)90078-3
   VONBAHR C, 1980, CLIN PHARMACOL THER, V27, P711, DOI 10.1038/clpt.1980.102
   WILLIAMS D, 1995, AGE AGEING, V24, P213, DOI 10.1093/ageing/24.3.213
   WILLIAMS D, 1995, ARCH GERONTOL GERIAT, V21, P191, DOI 10.1016/0167-4943(95)00638-2
   WILLIMAS DE, 1995, THESIS U WALES COLL
   WOLFF T, 1979, DRUG METAB DISPOS, V7, P301
   WYNNE H, 1987, AGE AGEING, V16, P153, DOI 10.1093/ageing/16.3.153
NR 27
TC 7
Z9 7
U1 0
U2 1
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0002-0729
J9 AGE AGEING
JI Age Ageing
PD SEP
PY 1996
VL 25
IS 5
BP 377
EP 380
DI 10.1093/ageing/25.5.377
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA VL987
UT WOS:A1996VL98700008
PM 8921143
DA 2024-02-19
ER

PT J
AU Chen, L
   Zhang, YP
   Jin, LX
AF Chen, L.
   Zhang, Y. P.
   Jin, L. X.
TI PREPARATION, CHARACTERIZATION AND ANTI-AGEING ACTIVITY OF <i>GASTRODIA
   ELATA</i> BLUME POLYSACCHARIDE
SO ACTA ALIMENTARIA
LA English
DT Article
DE Gastrodia elata Blume; polysaccharide; antioxidant activity; anti-ageing
   activity
ID IN-VITRO; ANTIOXIDANT; OLIGOSACCHARIDES; IDENTIFICATION; ANTIBACTERIAL;
   SELENIUM; EXTRACT; DAMAGE
AB Gastrodia elata Blume polysaccharide (GEP) was extracted and then chemically characterised. Its antioxidant activity was evaluated in vitro and in vivo. The results of the in vitro investigation show that GEP consists of glucose with molecular weight of 875 185 Da and exhibits high hydroxyl radical scavenging, as well as 2,2-diphenyl-1picrylhydrazyl activity and reducing capacity. For antioxidant activity in vivo, D-galactose-induced-aged mice were orally administered with three different doses of GEP over a period of 6 weeks. The administration of GEP dose-dependently increased the body weight gain rates, liver and brain indices, superoxide dismutase and glutathione peroxidase activities, and malondialdehyde levels in the sera and brains of ageing mice. These results suggest that GEP exhibits high antioxidant activity and can retard human ageing associated with free radicals.
C1 [Chen, L.; Jin, L. X.] Huaihai Inst Technol, Jiangsu Marine Resources Dev Res Inst, 59 Cangwu Rd, Haizhou 222005, Peoples R China.
   [Zhang, Y. P.] Dalian Univ Technol, Shcool Chem Engn, 2 Linggong Rd, Dalian 116024, Peoples R China.
   [Chen, L.; Jin, L. X.] Huaihai Inst Technol, Jiangsu Key Lab Marine Pharmaceut Compound Screen, Haizhou 222005, Peoples R China.
   [Chen, L.; Jin, L. X.] Huaihai Inst Technol, Coinnovat Ctr Jiangsu Marine Bioind Technol, Haizhou 222005, Peoples R China.
C3 Jiangsu Ocean University; Dalian University of Technology; Jiangsu Ocean
   University; Jiangsu Ocean University
RP Chen, L (corresponding author), Huaihai Inst Technol, Jiangsu Marine Resources Dev Res Inst, 59 Cangwu Rd, Haizhou 222005, Peoples R China.; Chen, L (corresponding author), Huaihai Inst Technol, Jiangsu Key Lab Marine Pharmaceut Compound Screen, Haizhou 222005, Peoples R China.; Chen, L (corresponding author), Huaihai Inst Technol, Coinnovat Ctr Jiangsu Marine Bioind Technol, Haizhou 222005, Peoples R China.
EM chenlhhit@sina.com
FU Open project of Jiangsu Marine Resources Development Research Institute
   [HY201601]; Lianyungang science and technology planning project
   [JC1614]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions
FX This study was supported by the Open project of Jiangsu Marine Resources
   Development Research Institute (HY201601), Lianyungang science and
   technology planning project (JC1614), and the Priority Academic Program
   Development of Jiangsu Higher Education Institutions.
CR Andrews A. T., 1986, ELECTROPHORESIS THEO, P53
   Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A
   Chen X, 2011, CARBOHYD POLYM, V86, P1300, DOI 10.1016/j.carbpol.2011.06.029
   Duh PD, 1999, FOOD CHEM TOXICOL, V37, P1055, DOI 10.1016/S0278-6915(99)00096-4
   Hou M. L, 2004, FOOD ANAL
   Jang YW, 2010, INT IMMUNOPHARMACOL, V10, P147, DOI 10.1016/j.intimp.2009.10.009
   Kwon J, 2014, J PHARMACEUT BIOMED, V94, P132, DOI 10.1016/j.jpba.2014.01.032
   Li HB, 2016, MED SCI MONIT BASIC, V22, P175, DOI 10.12659/MSMBR.901524
   Li ZF, 2015, J CHROMATOGR B, V988, P45, DOI 10.1016/j.jchromb.2015.02.020
   Liu Mingxue, 2009, Food Science, China, V30, P29
   Mahmoud KZ, 2003, COMP BIOCHEM PHYS B, V136, P921, DOI 10.1016/S1096-4959(03)00288-4
   [缪化春 MIAO Huachun], 2006, [高血压杂志, Chinese Journal of Hypertension], V14, P531
   Ming J, 2012, PROCEDIA ENGINEER, V37, P169, DOI 10.1016/j.proeng.2012.04.221
   Qiao DL, 2009, CARBOHYD POLYM, V78, P199, DOI 10.1016/j.carbpol.2009.03.018
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Sheng JC, 2007, FOOD CHEM, V105, P533, DOI 10.1016/j.foodchem.2007.04.018
   Tang W, 1992, CHINESE DRUGS PLANT, P545
   Wu SJ, 2017, INT J BIOL MACROMOL, V102, P376, DOI 10.1016/j.ijbiomac.2017.04.038
   Yao XC, 2013, INT J BIOL MACROMOL, V62, P1, DOI 10.1016/j.ijbiomac.2013.08.022
   Zhang C, 2017, INT J BIOL MACROMOL, V95, P778, DOI 10.1016/j.ijbiomac.2016.12.003
NR 20
TC 8
Z9 9
U1 6
U2 81
PU AKADEMIAI KIADO ZRT
PI BUDAPEST
PA BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY
SN 0139-3006
EI 1588-2535
J9 ACTA ALIMENT HUNG
JI Acta Aliment.
PD JUN
PY 2018
VL 47
IS 2
BP 210
EP 219
DI 10.1556/066.2018.47.2.10
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GO2GF
UT WOS:000439786700010
DA 2024-02-19
ER

PT J
AU Hernández-Silva, D
   Cantón-Sandoval, J
   Martinez-Navarro, FJ
   Pérez-Sánchez, H
   de Oliveira, S
   Mulero, V
   Alcaraz-Pérez, F
   Cayuela, ML
AF Hernandez-Silva, David
   Canton-Sandoval, Joaquin
   Juan Martinez-Navarro, Francisco
   Perez-Sanchez, Horacio
   de Oliveira, Sofia
   Mulero, Victoriano
   Alcaraz-Perez, Francisca
   Luisa Cayuela, Maria
TI Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs
   Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic
   Inflammation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aging; senolytics; chronic inflammation; metainflammation; zebrafish
ID HUMAN-DISEASE; TELOMERES; CELL; INACTIVATION; MECHANISMS; INHIBITOR;
   POTENT
AB Telomere shortening is the main molecular mechanism of aging, but not the only one. The adaptive immune system also ages, and older organisms tend to develop a chronic pro-inflammatory status with low-grade inflammation characterized by chronic activation of the innate immune system, called inflammaging. One of the main stimuli that fuels inflammaging is a high nutrient intake, triggering a metabolic inflammation process called metainflammation. In this study, we report the anti-inflammatory activity of several senolytic drugs in the context of chronic inflammation, by using two different zebrafish models: (i) a chronic skin inflammation model with a hypomorphic mutation in spint1a, the gene encoding the serine protease inhibitor, kunitz-type, 1a (also known as hai1a) and (ii) a non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) model with inflammation induced by a high-fat diet. Our results show that, although these models do not manifest premature aging, the senolytic drugs dasatinib, navitoclax, and venetoclax have an anti-inflammatory effect that results in the amelioration of chronic inflammation.
C1 [Hernandez-Silva, David; Alcaraz-Perez, Francisca; Luisa Cayuela, Maria] Hosp Clin Univ Virgen de la Arrixaca, Telomerase Canc & Aging Grp TCAG, Murcia 30120, Spain.
   [Hernandez-Silva, David; Canton-Sandoval, Joaquin; Mulero, Victoriano; Alcaraz-Perez, Francisca; Luisa Cayuela, Maria] Inst Murciano Invest Biosanitaria Arrixaca IMIB A, Murcia 30120, Spain.
   [Hernandez-Silva, David; Perez-Sanchez, Horacio] Univ Catolica Murcia UCAM, Comp Engn Dept, Struct Bioinformat & High Performance Comp Res Gr, Murcia 30107, Spain.
   [Canton-Sandoval, Joaquin; Mulero, Victoriano] Univ Murcia, Fac Biol, Dept Biol Celular & Histol, Murcia 30100, Spain.
   [Canton-Sandoval, Joaquin; Mulero, Victoriano; Alcaraz-Perez, Francisca; Luisa Cayuela, Maria] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Murcia 30100, Spain.
   [Juan Martinez-Navarro, Francisco; de Oliveira, Sofia] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.
   [Juan Martinez-Navarro, Francisco; de Oliveira, Sofia] Albert Einstein Coll Med, Dept Med Hepatol, Bronx, NY 10461 USA.
C3 Hospital Clinico Universitario Virgen de la Arrixaca; Universidad
   Catolica de Murcia; University of Murcia; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III;
   Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine
RP Alcaraz-Pérez, F; Cayuela, ML (corresponding author), Hosp Clin Univ Virgen de la Arrixaca, Telomerase Canc & Aging Grp TCAG, Murcia 30120, Spain.; Alcaraz-Pérez, F; Cayuela, ML (corresponding author), Inst Murciano Invest Biosanitaria Arrixaca IMIB A, Murcia 30120, Spain.; Alcaraz-Pérez, F; Cayuela, ML (corresponding author), ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Murcia 30100, Spain.
EM palcaraz@um.es; marial.cayuela@carm.es
RI de Oliveira, Sofia/AAV-4304-2020; Mulero, Victoriano/L-2730-2014;
   Perez-Sanchez, Horacio/O-5017-2016
OI de Oliveira, Sofia/0000-0003-0893-111X; Mulero,
   Victoriano/0000-0001-9527-0211; Martinez Navarro, Francisco
   Juan/0000-0002-2093-0040; Canton-Sandoval, Joaquin/0000-0002-6655-3623;
   CAYUELA, MARIA L./0000-0002-2021-9822; Perez-Sanchez,
   Horacio/0000-0003-4468-7898; Alcaraz Perez,
   Francisca/0000-0003-1802-4943
FU Spanish Ministry of Science and Innovation [iscIII PI19/00188,
   BIO2017-84702-R]; Fondos Europeos de Desarrollo Regional (Una manera de
   hacer Europa); Fundacion Ramon Areces; University Catholic of Murcia;
   Cancer Research Institute; Fibrolamellar Cancer Foundation; Consejeria
   de Sanidad de la Region de Murcia (Project ZEBER)
FX This research was funded by the Spanish Ministry of Science and
   Innovation (grants iscIII PI19/00188 to M.L.C. and BIO2017-84702-R to
   V.M.), all co-funded with Fondos Europeos de Desarrollo Regional (Una
   manera de hacer Europa), Fundacion Ramon Areces (grant to M.L.C.), and
   University Catholic of Murcia (predoctoral contract to D.H.-S.).
   F.J.M.-N. is supported by the Cancer Research Institute and
   Fibrolamellar Cancer Foundation and Consejeria de Sanidad de la Region
   de Murcia (Project ZEBER, contract to F.A-P.).
CR Antiga E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/283634
   Antonangeli F, 2019, J LEUKOCYTE BIOL, V105, P1275, DOI 10.1002/JLB.MR0718-299R
   Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616
   Carneiro MC, 2016, DIS MODEL MECH, V9, P737, DOI 10.1242/dmm.025130
   Carneiro MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005798
   Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Cherif H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040433
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Dagher O, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.741542
   de Oliveira S, 2019, J HEPATOL, V70, P710, DOI 10.1016/j.jhep.2018.11.034
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Lau LMS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks781
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Cayuela ML, 2019, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00178
   Mantzorou M, 2018, PHYTOTHER RES, V32, P957, DOI 10.1002/ptr.6037
   Martínez-Morcillo FJ, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001455
   Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159
   Michael C, 2021, JOVE-J VIS EXP, DOI 10.3791/62457
   Novoa B, 2019, AGING CELL, V18, DOI 10.1111/acel.13020
   Pawelec G, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-15
   Prata Larissa G P Langhi, 2018, Semin Immunol, V40, P101275, DOI 10.1016/j.smim.2019.04.003
   Rodríguez-Rodero S, 2011, AGING DIS, V2, P186
   Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762
NR 41
TC 4
Z9 4
U1 9
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2022
VL 23
IS 18
AR 10468
DI 10.3390/ijms231810468
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 4T6CL
UT WOS:000858202600001
PM 36142384
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tao, RY
   Xiong, XW
   Liangpunsakul, S
   Dong, XC
AF Tao, Rongya
   Xiong, Xiwen
   Liangpunsakul, Suthat
   Dong, X. Charlie
TI Sestrin 3 Protein Enhances Hepatic Insulin Sensitivity by Direct
   Activation of the mTORC2-Akt Signaling
SO DIABETES
LA English
DT Article
ID DIET-INDUCED OBESITY; AKT PHOSPHORYLATION; TRANSCRIPTION FACTOR;
   MAMMALIAN TARGET; MTOR; RICTOR; COMPLEX; LIVER; METABOLISM; PATHWAY
AB Sestrin proteins have been implicated in multiple biological processes including resistance to oxidative and genotoxic stresses, protection against aging-related pathologies, and promotion of metabolic homeostasis; however, the underlying mechanisms are incompletely understood. Some evidence suggests that sestrins may inhibit mTORC1 (mechanistic target of rapamycin complex 1) through inhibition of RagA/B GTPases or activation of AMPK; however, whether sestrins are also involved in mTORC2 regulation and function is unclear. To investigate the functions and mechanisms of Sestrin 3 (Sesn3), we generated Sesn3 liver-specific transgenic and knockout mice. Our data show that Sesn3 liver-specific knockout mice exhibit insulin resistance and glucose intolerance, and Sesn3 transgenic mice were protected against insulin resistance induced by a high-fat diet. Using AMPK liver-specific knockout mice, we demonstrate that the Sesn3 insulin-sensitizing effect is largely independent of AMPK. Biochemical analysis reveals that Sesn3 interacts with and activates mTORC2 and subsequently stimulates Akt phosphorylation at Ser473. These findings suggest that Sesn3 can activate Akt via mTORC2 to regulate hepatic insulin sensitivity and glucose metabolism.
C1 [Tao, Rongya; Xiong, Xiwen; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
   [Liangpunsakul, Suthat] Indiana Univ Sch Med, Richard L Roudebush Vet Adm Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Bloomington; Indiana
   University System; Indiana University Bloomington; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center
RP Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
EM xcdong@iu.edu
RI Xiong, Xiwen/GSN-0686-2022; tao, rongya/B-8042-2014
OI tao, rongya/0000-0002-3316-5587
FU National Institutes of Health/National Institute on Alcohol Abuse and
   Alcoholism [K08-AA-016570]; Veterans Affairs Administration
   [1-I01-CX-000361-01]; National Institute of Diabetes and Digestive and
   Kidney Diseases [R01-DK-091592]
FX S.L. received National Institutes of Health/National Institute on
   Alcohol Abuse and Alcoholism grant K08-AA-016570 and Veterans Affairs
   Administration grant 1-I01-CX-000361-01. X.C.D. received National
   Institute of Diabetes and Digestive and Kidney Diseases grant
   R01-DK-091592.
CR Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002
   Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314
   Brüning A, 2013, MOL ONCOL, V7, P1012, DOI 10.1016/j.molonc.2013.07.010
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877
   Cardenas-Rodriguez M, 2013, HUM MOL GENET, V22, P4031, DOI 10.1093/hmg/ddt253
   Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014
   Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590
   Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706
   Glidden EJ, 2012, J BIOL CHEM, V287, P581, DOI 10.1074/jbc.M111.304337
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Jeon YH, 2013, BBA-MOL CELL RES, V1833, P2135, DOI 10.1016/j.bbamcr.2013.05.005
   Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004
   Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328
   Kang XQ, 2014, AM J PHYSIOL-GASTR L, V307, pG58, DOI 10.1152/ajpgi.00373.2013
   Khanna N, 2013, P NATL ACAD SCI USA, V110, P15979, DOI 10.1073/pnas.1310434110
   Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081
   Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107
   Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686
   Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468
   McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Nascimento EBM, 2013, AM J PHYSIOL-ENDOC M, V305, pE1408, DOI 10.1152/ajpendo.00212.2013
   Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233
   Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Ro SH, 2014, P NATL ACAD SCI USA, V111, P7849, DOI 10.1073/pnas.1401787111
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Tao R, 2013, PLOS ONE, V8
   Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473
   Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339
   Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006
   Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8
   Woo HA, 2009, ANTIOXID REDOX SIGN, V11, P739, DOI [10.1089/ars.2008.2360, 10.1089/ARS.2008.2360]
   Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021
   Xiong X, 2013, PLOS ONE, V8
   Xu YF, 2013, CELL SIGNAL, V25, P2239, DOI 10.1016/j.cellsig.2013.07.008
NR 59
TC 72
Z9 87
U1 0
U2 12
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD APR
PY 2015
VL 64
IS 4
BP 1211
EP 1223
DI 10.2337/db14-0539
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CE2CA
UT WOS:000351619300018
PM 25377878
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Liao, NS
   Shi, YJ
   Wang, YC
   Liao, FY
   Zhao, BX
   Zheng, YS
   Zeng, YY
   Liu, XL
   Liu, JF
AF Liao, Naishun
   Shi, Yingjun
   Wang, Yingchao
   Liao, Fangyu
   Zhao, Bixing
   Zheng, Youshi
   Zeng, Yongyi
   Liu, Xiaolong
   Liu, Jingfeng
TI Antioxidant preconditioning improves therapeutic outcomes of adipose
   tissue-derived mesenchymal stem cells through enhancing intrahepatic
   engraftment efficiency in a mouse liver fibrosis model
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Adipose tissue-derived mesenchymal stem cells; Reactive oxygen species;
   Liver fibrosis; Cell engraftment efficiency; Stem cell therapy
ID MELATONIN TREATMENT; OXIDATIVE STRESS; RAT MODEL; TRANSPLANTATION;
   DISEASE; IRRADIATION; GLUTATHIONE; SENESCENCE; ROS
AB Background Although it has been preclinically suggested that adipose tissue-derived mesenchymal stem cell (ADSC)-based therapy could effectively treat chronic liver diseases, the hepatic engraftment of ADSCs is still extremely low, which severely limits their long-term efficacy for chronic liver diseases. This study was designed to investigate the impact of antioxidant preconditioning on hepatic engraftment efficiency and therapeutic outcomes of ADSC transplantation in liver fibrotic mice. Methods Liver fibrosis model was established by using intraperitoneal injection of carbon tetrachloride (CCl4) in the male C57BL/6 mice. Subsequently, the ADSCs with or without antioxidant pretreatment (including melatonin and reduced glutathione (GSH)) were administrated into fibrotic mice via tail vein injection. Afterwards, the ADSC transplantation efficiency was analyzed by ex vivo imaging, and the liver functions were assessed by biochemical analysis and histopathological examination, respectively. Additionally, a typical hydrogen peroxide (H2O2)-induced cell injury model was applied to mimic the cell oxidative injury to further investigate the protective effects of antioxidant preconditioning on cell migration, proliferation, and apoptosis of ADSCs. Results Our data showed that antioxidant preconditioning could enhance the therapeutic effects of ADSCs on liver function recovery by reducing the level of AST, ALT, and TBIL, as well as the content of hepatic hydroxyproline and fibrotic area in liver tissues. Particularly, we also found that antioxidant preconditioning could enhance hepatic engraftment efficiency of ADSCs in liver fibrosis model through inhibiting oxidative injury. Conclusions Antioxidant preconditioning could effectively improve therapeutic effects of ADSC transplantation for liver fibrosis through enhancing intrahepatic engraftment efficiency by reducing oxidative injuries. These findings might provide a practical strategy for enhancing ADSC transplantation and therapeutic efficiency.
C1 [Liao, Naishun; Shi, Yingjun; Wang, Yingchao; Liao, Fangyu; Zhao, Bixing; Zheng, Youshi; Zeng, Yongyi; Liu, Xiaolong; Liu, Jingfeng] Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Fuzhou 350025, Peoples R China.
   [Liao, Naishun; Shi, Yingjun; Wang, Yingchao; Liao, Fangyu; Zhao, Bixing; Zheng, Youshi; Zeng, Yongyi; Liu, Xiaolong; Liu, Jingfeng] Fujian Med Univ, Affiliated Hosp 1, Liver Dis Ctr, Fuzhou 350007, Peoples R China.
   [Liao, Naishun; Shi, Yingjun; Wang, Yingchao; Liao, Fangyu; Zhao, Bixing; Zheng, Youshi; Zeng, Yongyi; Liu, Xiaolong; Liu, Jingfeng] Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350116, Peoples R China.
   [Zeng, Yongyi; Liu, Jingfeng] Fujian Med Univ, Liver Ctr Fujian Prov, Fuzhou 350025, Peoples R China.
C3 Fujian Medical University; Fujian Medical University; Fuzhou University;
   Fujian Medical University
RP Liu, XL; Liu, JF (corresponding author), Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Fuzhou 350025, Peoples R China.; Liu, XL; Liu, JF (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Liver Dis Ctr, Fuzhou 350007, Peoples R China.; Liu, XL; Liu, JF (corresponding author), Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350116, Peoples R China.; Liu, JF (corresponding author), Fujian Med Univ, Liver Ctr Fujian Prov, Fuzhou 350025, Peoples R China.
EM xiaolcong.liu@gmail.com; drjingfeng@126.com
RI wang, yingying/JCE-4984-2023; wang, yan/GSE-6489-2022; wang,
   yingying/GRS-3058-2022; Wang, Ying/HJI-2509-2023; Liao,
   Fang-Yu/AAS-1417-2020; liao, naishun/AAU-2618-2020
OI Liao, Fang-Yu/0000-0002-6912-9174; Liao, Naishun/0000-0002-2781-4229;
   liu, xiaolong/0000-0002-3096-4981
FU Natural Science Foundation of China [81672376]; Youth Scientific
   Research Project of Fujian Provincial Health and Family Planning
   Commission [2017-1-85, 2018-193]; Fuzhou Health and Family Planning
   Science and Technology Project [2017-S-wt2]; Startup Fund for scientific
   research, Fujian Medical University [2018QH1198]
FX This work was supported by the Natural Science Foundation of China
   (grant no. 81672376), the Youth Scientific Research Project of Fujian
   Provincial Health and Family Planning Commission (grant nos. 2017-1-85
   and 2018-193), the Fuzhou Health and Family Planning Science and
   Technology Project (grant no.2017-S-wt2), and the Startup Fund for
   scientific research, Fujian Medical University (grant no. 2018QH1198).
CR Bahde R, 2013, HEPATOLOGY, V57, P320, DOI 10.1002/hep.26005
   Chen HH, 2014, J PINEAL RES, V57, P16, DOI 10.1111/jpi.12140
   Chen YT, 2014, J PINEAL RES, V57, P248, DOI 10.1111/jpi.12164
   Dannenmann B, 2015, STEM CELL REP, V4, P886, DOI 10.1016/j.stemcr.2015.04.004
   Das S, 2017, HEPATOLOGY, V65, P631, DOI 10.1002/hep.28897
   François S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260
   Jin HJ, 2016, ANTIOXID REDOX SIGN, V24, P471, DOI 10.1089/ars.2015.6359
   Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015
   Lee J, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0647-6
   Li Q, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1029-4
   Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300
   Liao NS, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1404-9
   Liao NS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0743-7
   Liao NS, 2016, INT J MOL MED, V37, P1389, DOI 10.3892/ijmm.2016.2528
   Liao NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep18746
   Lin YC, 2017, CELL TRANSPLANT, V26, P449, DOI 10.3727/096368916X693310
   Ma Q, 2018, STEM CELLS, V36, P540, DOI 10.1002/stem.2777
   Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446
   Mortezaee K, 2017, CELL TISSUE RES, V369, P303, DOI 10.1007/s00441-017-2604-1
   Mortezaee Keywan, 2016, Iranian Biomedical Journal, V20, P207, DOI 10.7508/ibj.2016.04.004
   Pan F, 2015, MOL MED REP, V12, P3725, DOI 10.3892/mmr.2015.3847
   Puppi J, 2012, CELL TRANSPLANT, V21, P1, DOI 10.3727/096368911X566208
   Rafat A, 2019, CELL J, V20, P450, DOI 10.22074/cellj.2019.5507
   Sacco R, 2016, MINERVA GASTROENT D, V62, P316
   Seki A, 2013, HEPATOLOGY, V58, P1133, DOI 10.1002/hep.26470
   Shuai Y, 2016, THERANOSTICS, V6, P1899, DOI 10.7150/thno.15412
   Slehria S, 2002, HEPATOLOGY, V35, P1320, DOI 10.1053/jhep.2002.33201
   Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302
   Yagi H, 2013, J CELL BIOCHEM, V114, P1163, DOI 10.1002/jcb.24459
   Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573
   Yamato M, 2019, J GASTROEN HEPATOL, V34, P1432, DOI 10.1111/jgh.14647
   Yip HK, 2013, J PINEAL RES, V54, P207, DOI 10.1111/jpi.12020
   Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397
   Zhu P, 2015, J CELL MOL MED, V19, P2232, DOI 10.1111/jcmm.12610
NR 34
TC 26
Z9 28
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JUN 16
PY 2020
VL 11
IS 1
AR 237
DI 10.1186/s13287-020-01763-y
PG 11
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA MB7RO
UT WOS:000542796800002
PM 32546282
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Jia, YL
   Cao, N
   Zhai, JL
   Zeng, Q
   Zheng, P
   Su, RY
   Liao, TL
   Liu, JJ
   Pei, HY
   Fan, Z
   Zhou, JN
   Xi, JF
   He, LJ
   Chen, L
   Nan, X
   Yue, W
   Pei, XT
AF Jia, Yali
   Cao, Ning
   Zhai, Jinglei
   Zeng, Quan
   Zheng, Pei
   Su, Ruyu
   Liao, Tuling
   Liu, Jiajing
   Pei, Haiyun
   Fan, Zeng
   Zhou, Junnian
   Xi, Jiafei
   He, Lijuan
   Chen, Lin
   Nan, Xue
   Yue, Wen
   Pei, Xuetao
TI HGF Mediates Clinical-Grade Human Umbilical Cord-Derived Mesenchymal
   Stem Cells Improved Functional Recovery in a Senescence-Accelerated
   Mouse Model of Alzheimer's Disease
SO ADVANCED SCIENCE
LA English
DT Article; Early Access
DE AKT-GSK beta signaling pathway; Alzheimer's disease; cMet; hepatocyte
   growth factor; hyperphosphorylated tau; umbilical cord-derived
   mesenchymal stem cells
ID HEPATOCYTE GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA;
   OXIDATIVE STRESS; TYROSINE KINASE; SAMP8 MICE; RECEPTOR; TAU;
   EXPRESSION; MET
AB Stem cells have emerged as a potential therapy for a range of neural insults, but their application in Alzheimer's disease (AD) is still limited and the mechanisms underlying the cognitive benefits of stem cells remain to be elucidated. Here, the effects of clinical-grade human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on the recovery of cognitive ability in SAM P8 mice, a senescence-accelerated mouse model of AD is explored. A functional assay identifies that the core functional factor hepatocyte growth factor (HGF) secreted from hUC-MSCs plays critical roles in hUC-MSC-modulated recovery of damaged neural cells by down-regulating hyperphosphorylated tau, reversing spine loss, and promoting synaptic plasticity in an AD cell model. Mechanistically, structural and functional recovery, as well as cognitive enhancements elicited by exposure to hUC-MSCs, are at least partially mediated by HGF in the AD hippocampus through the activation ofthe cMet-AKT-GSK3 beta signaling pathway. Taken together, these data strongly implicate HGF in mediating hUC-MSC-induced improvements in functional recovery in AD models.
C1 [Jia, Yali; Cao, Ning; Zhai, Jinglei; Zeng, Quan; Zheng, Pei; Liao, Tuling; Liu, Jiajing; Pei, Haiyun; Fan, Zeng; Xi, Jiafei; He, Lijuan; Chen, Lin; Nan, Xue; Yue, Wen; Pei, Xuetao] Inst Hlth Serv & Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China.
   [Jia, Yali; Pei, Haiyun; Zhou, Junnian] Beijing Inst Radiat Med, Expt Hematol & Biochem Lab, Beijing 100850, Peoples R China.
   [Jia, Yali; Zeng, Quan; Su, Ruyu; Fan, Zeng; Zhou, Junnian; Xi, Jiafei; He, Lijuan; Chen, Lin; Nan, Xue; Yue, Wen; Pei, Xuetao] South China Inst Biomed, Guangzhou 510005, Peoples R China.
   [Cao, Ning] 920th Hosp Joint Logist Support Force, Kunming 650032, Yunnan, Peoples R China.
RP Jia, YL; Yue, W; Pei, XT (corresponding author), Inst Hlth Serv & Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China.; Jia, YL (corresponding author), Beijing Inst Radiat Med, Expt Hematol & Biochem Lab, Beijing 100850, Peoples R China.; Jia, YL; Yue, W; Pei, XT (corresponding author), South China Inst Biomed, Guangzhou 510005, Peoples R China.
EM jiayali2016@hotmail.com; yuewen0206@126.com; peixt@nic.bmi.ac.cn
RI Liu, Ying/ISU-1216-2023; Jia, Yali/AAH-1668-2022; Zhou,
   Junnian/CAI-2072-2022; Jia, Yali/AFL-9551-2022
OI Zhou, Junnian/0000-0002-7782-234X; Jia, Yali/0000-0002-2896-6021; Pei,
   Xuetao/0000-0001-7717-3434; Fan, Zeng/0000-0002-3033-4920
FU National Natural Science Foundation of China [81671385]; Guangzhou
   Health Care and Cooperative Innovation Major Project [201604020009,
   201803040005]; National Key Research and Development Program of China
   [2017YFA0103100, 2017YFA0103103, 2017YFA0103104]
FX The authors thank Dr. Shuai Yuan from Beijing Science and Technology
   Cooperation Center, China, for his help in the preliminary discussions
   and statistical analysis. The authors thank Prof. YizhengWang and Prof.
   Haitao Wu from Center of Cognition and Brain Science, Beijing Institute
   of Medical Sciences, China, for their help in animal behavioral
   experiments. This work was supported by grants from the National Natural
   Science Foundation of China (81671385 to Y.L.J.), Guangzhou Health Care
   and Cooperative Innovation Major Project (201604020009 to Y.L.J.,
   201803040005 to W.Y.), and the National Key Research and Development
   Program of China (2017YFA0103100 and 2017YFA0103103 to X.T.P.,
   2017YFA0103104 to H.Y.P.).
CR Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9
   Alvarez-García O, 2006, BIOGERONTOLOGY, V7, P43, DOI 10.1007/s10522-005-6041-2
   Armbrecht HJ, 2014, NEUROBIOL AGING, V35, P159, DOI 10.1016/j.neurobiolaging.2013.07.018
   Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194
   Becker RE, 2010, CURR ALZHEIMER RES, V7, P642
   Becker RE, 2012, EXPERT OPIN DRUG DIS, V7, P367, DOI 10.1517/17460441.2012.672409
   Braszko JJ, 2006, J RENIN-ANGIO-ALDO S, V7, P168, DOI 10.3317/jraas.2006.027
   Canudas AM, 2005, MECH AGEING DEV, V126, P1300, DOI 10.1016/j.mad.2005.07.008
   Cao N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.316
   Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021
   Diaz-Perdigon T, 2020, NEUROPSYCHOPHARMACOL, V45, P347, DOI 10.1038/s41386-019-0503-8
   Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005
   Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37
   Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223
   Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9
   Hamasaki H, 2014, NEUROPATHOLOGY, V34, P284, DOI 10.1111/neup.12095
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Hunsberger JG, 2016, LANCET NEUROL, V15, P219, DOI 10.1016/S1474-4422(15)00332-4
   Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967
   Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103
   Kamat PK, 2014, MOL NEUROBIOL, V50, P852, DOI 10.1007/s12035-014-8699-4
   Lazarov O, 2016, PROG NEUROBIOL, V138, P1, DOI 10.1016/j.pneurobio.2015.12.006
   Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003
   Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009
   Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125
   Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277
   Li Y, 2018, J AM CHEM SOC, V140, P4164, DOI 10.1021/jacs.8b01641
   Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181
   Malsch P, 2014, J NEUROSCI, V34, P9845, DOI 10.1523/JNEUROSCI.5161-13.2014
   Mastroeni D, 2018, ALZHEIMERS DEMENT, V14, P775, DOI 10.1016/j.jalz.2017.12.005
   Mendivil-Perez M, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12415
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9
   Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015
   Nomura Y, 1996, ANN NY ACAD SCI, V786, P410, DOI 10.1111/j.1749-6632.1996.tb39080.x
   Pallas M., 2012, ISRN CELL BIOL, V2012, P1, DOI DOI 10.5402/2012/917167
   Pallas M, 2008, J ALZHEIMERS DIS, V15, P615
   Pan WH, 2006, EXP NEUROL, V201, P99, DOI 10.1016/j.expneurol.2006.03.026
   Perígolo-Vicente R, 2014, BIOCHEM BIOPH RES CO, V449, P477, DOI 10.1016/j.bbrc.2014.05.036
   Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575
   Powell EM, 2003, DEV NEUROSCI-BASEL, V25, P197, DOI 10.1159/000072268
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Ringheim GE, 1998, MOL BRAIN RES, V55, P35, DOI 10.1016/S0169-328X(97)00356-2
   Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736
   Sheth PR, 2008, BIOCHEMISTRY-US, V47, P4028, DOI 10.1021/bi701892f
   SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223
   van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003
   Wang FX, 2017, CELL BIOL INT, V41, P639, DOI 10.1002/cbin.10767
   Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032
   WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145
   Weuve Jennifer, 2014, Alzheimers Dement, V10, pe40, DOI 10.1016/j.jalz.2014.01.004
   Yin JQ, 2019, NAT BIOMED ENG, V3, P90, DOI 10.1038/s41551-018-0325-8
   Zalfa C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1582-5
   Zimmer ER, 2016, MOL NEUROBIOL, V53, P3753, DOI 10.1007/s12035-015-9321-0
NR 55
TC 44
Z9 48
U1 5
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD 2020 SEP
PY 2020
VL 7
IS 17
AR 1903809
DI 10.1002/advs.201903809
EA JUL 2020
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA NQ9XK
UT WOS:000545409600001
PM 32995116
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Arun, P
   Aleti, V
   Parikh, K
   Manne, V
   Chilukuri, N
AF Arun, Peethambaran
   Aleti, Vineela
   Parikh, Kalpana
   Manne, Veeraswamy
   Chilukuri, Nageswararao
TI Senescence Marker Protein 30 (SMP30) Expression in Eukaryotic Cells:
   Existence of Multiple Species and Membrane Localization
SO PLOS ONE
LA English
DT Article
ID NUCLEAR-LOCALIZATION; DIISOPROPYL PHOSPHOROFLUORIDATE; ENDOGENOUS
   REGUCALCIN; SOLUBLE FRACTION; RAT; LIVER; KINASE; MICE; PURIFICATION;
   DEFICIENCY
AB Senescence marker protein (SMP30), also known as regucalcin, is a 34 kDa cytosolic marker protein of aging which plays an important role in intracellular Ca2+ homeostasis, ascorbic acid biosynthesis, oxidative stress, and detoxification of chemical warfare nerve agents. In our goal to investigate the activity of SMP30 for the detoxification of nerve agents, we have produced a recombinant adenovirus expressing human SMP30 as a fusion protein with a hemaglutinin tag (Ad-SMP30-HA). Ad-SMP30-HA transduced the expression of SMP30-HA and two additional forms of SMP30 with molecular sizes similar to 28 kDa and 24 kDa in HEK-293A and C3A liver cells in a dose and time-dependent manner. Intravenous administration of Ad-SMP30-HA in mice results in the expression of all the three forms of SMP30 in the liver and diaphragm. LC-MS/MS results confirmed that the lower molecular weight 28 kDa and 24 kDa proteins are related to the 34 kDa SMP30. The 28 kDa and 24 kDa SMP30 forms were also detected in normal rat liver and mice injected with Ad-SMP30-HA suggesting that SMP30 does exist in multiple forms under physiological conditions. Time course experiments in both cell lines suggest that the 28 kDa and 24 kDa SMP30 forms are likely generated from the 34 kDa SMP30. Interestingly, the 28 kDa and 24 kDa SMP30 forms appeared initially in the cytosol and shifted to the particulate fraction. Studies using small molecule inhibitors of proteolytic pathways revealed the potential involvement of beta and gamma-secretases but not calpains, lysosomal proteases, proteasome and caspases. This is the first report describing the existence of multiple forms of SMP30, their preferential distribution to membranes and their generation through proteolysis possibly mediated by secretase enzymes.
C1 [Arun, Peethambaran; Aleti, Vineela; Parikh, Kalpana; Manne, Veeraswamy; Chilukuri, Nageswararao] Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA.
C3 United States Department of Defense; United States Army; Walter Reed
   Army Institute of Research (WRAIR)
RP Arun, P (corresponding author), Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA.
EM nageswararao.chilukuri@us.army.mil
RI manne, veeraswamy/B-1954-2010
OI manne, veeraswamy/0000-0002-1179-5529
FU Defense Threat Reduction Agency (DTRA) [D0024_07_WR_C]
FX The work is supported by funds from Defense Threat Reduction Agency
   (DTRA, Project # D0024_07_WR_C). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akhter T, 2006, INT J MOL MED, V18, P171
   Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   Boyiri T, 2009, INT J ONCOL, V35, P559, DOI 10.3892/ijo_00000367
   Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4
   Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   Leparc GG, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm989
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200
   Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274
   Misawa H, 2000, INT J MOL MED, V5, P283
   Nakagawa T, 2008, INT J MOL MED, V21, P605
   Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863
   Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7
   Omura M, 1999, J CELL BIOCHEM, V75, P437, DOI 10.1002/(SICI)1097-4644(19991201)75:3<437::AID-JCB9>3.3.CO;2-N
   Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1
   ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Szokalska A, 2009, CANCER RES, V69, P4235, DOI 10.1158/0008-5472.CAN-08-3439
   Tsurusaki Y, 2001, BIOL PHARM BULL, V24, P958, DOI 10.1248/bpb.24.958
   Tsurusaki Y, 2000, INT J MOL MED, V6, P655
   Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9
   Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200
   Yamaguchi M, 2002, INT J MOL MED, V10, P377
   Yamaguchi M, 2005, INT J MOL MED, V15, P371
   YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915
   Yamaguchi M, 2004, INT J MOL MED, V14, P647
   Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359
   YAMAGUCHI M, 1981, CHEM PHARM BULL, V29, P567
   Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5
   Yates Jr, 2000, METH MOL B, V146, P17, DOI 10.1385/1-59259-045-4:17
NR 45
TC 33
Z9 41
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 9
PY 2011
VL 6
IS 2
AR e16545
DI 10.1371/journal.pone.0016545
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 721NN
UT WOS:000287361700020
PM 21347421
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Mondal, SA
   Mann, SN
   van der Linden, C
   Sathiaseelan, R
   Kamal, M
   Das, S
   Bubak, MP
   Logan, S
   Miller, BF
   Stout, MB
AF Mondal, Samim Ali
   Mann, Shivani N.
   van der Linden, Carl
   Sathiaseelan, Roshini
   Kamal, Maria
   Das, Snehasis
   Bubak, Matthew P.
   Logan, Sreemathi
   Miller, Benjamin F.
   Stout, Michael B.
TI Metabolic benefits of 17α-estradiol in liver are partially mediated by
   ERβ in male mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ESTROGEN-RECEPTOR-ALPHA; LIFE-SPAN; ADIPOSE-TISSUE; BINDING-AFFINITY;
   PROTEIN-KINASE; OBESITY; FIBROSIS; BRAIN; 17-ALPHA-ESTRADIOL; MECHANISMS
AB Metabolic dysfunction underlies several chronic diseases. Dietary interventions can reverse metabolic declines and slow aging but remaining compliant is difficult. 17 & alpha;-estradiol (17 & alpha;-E2) treatment improves metabolic parameters and slows aging in male mice without inducing significant feminization. We recently reported that estrogen receptor & alpha; is required for the majority of 17 & alpha;-E2-mediated benefits in male mice, but that 17 & alpha;-E2 also attenuates fibrogenesis in liver, which is regulated by estrogen receptor & beta; (ER & beta;)-expressing hepatic stellate cells (HSC). The current studies sought to determine if 17 & alpha;-E2-mediated benefits on systemic and hepatic metabolism are ER & beta;-dependent. We found that 17 & alpha;-E2 treatment reversed obesity and related systemic metabolic sequela in both male and female mice, but this was partially blocked in female, but not male, ER & beta;KO mice. ER & beta; ablation in male mice attenuated 17 & alpha;-E2-mediated benefits on hepatic stearoyl-coenyzme A desaturase 1 (SCD1) and transforming growth factor & beta;1 (TGF-& beta;1) production, which play critical roles in HSC activation and liver fibrosis. We also found that 17 & alpha;-E2 treatment suppresses SCD1 production in cultured hepatocytes and hepatic stellate cells, indicating that 17 & alpha;-E2 directly signals in both cell-types to suppress drivers of steatosis and fibrosis. We conclude that ER & beta; partially controls 17 & alpha;-E2-mediated benefits on systemic metabolic regulation in female, but not male, mice, and that 17 & alpha;-E2 likely signals through ER & beta; in HSCs to attenuate pro-fibrotic mechanisms.
C1 [Mondal, Samim Ali; van der Linden, Carl; Sathiaseelan, Roshini; Bubak, Matthew P.; Miller, Benjamin F.; Stout, Michael B.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St,Chapman S212, Oklahoma City, OK 73104 USA.
   [Mann, Shivani N.] Univ Arizona, Dept Neurosci, Tucson, AZ USA.
   [Sathiaseelan, Roshini] Univ Oklahoma, Dept Nutr Sci, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Kamal, Maria] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Das, Snehasis] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Das, Snehasis] Univ Oklahoma, Harold Hamm Diabet Ctr, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Logan, Sreemathi] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Miller, Benjamin F.; Stout, Michael B.] Oklahoma City Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA.
C3 Oklahoma Medical Research Foundation; University of Arizona; University
   of Oklahoma System; University of Oklahoma Health Sciences Center;
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; University of Oklahoma System; University of Oklahoma
   Health Sciences Center; University of Oklahoma System; University of
   Oklahoma Health Sciences Center; University of Oklahoma System;
   University of Oklahoma Health Sciences Center
RP Stout, MB (corresponding author), Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St,Chapman S212, Oklahoma City, OK 73104 USA.; Stout, MB (corresponding author), Oklahoma City Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA.
EM michael-stout@omrf.org
RI DAS, SNEHASIS/GNM-8382-2022
OI DAS, SNEHASIS/0000-0002-5269-9269
FU National Institutes of Health [T32 AG052363, R00 AG056662, R00 AG051661,
   R01 AG070035]; US Department of Veterans Affairs [I01 BX005592]
FX We thank Drs. Per Antonson and Jan-Ake Gustafsson from the Karolinska
   Institute for generously providing heterozygous ERKO mice which enabled
   us to generate a colony for these studies. This work was supported by
   the National Institutes of Health (T32 AG052363 to S.N.M. and M.P.B.,
   R00 AG056662 to S.L., and R00 AG051661 and R01 AG070035 to M.B.S.) and
   the US Department of Veterans Affairs (I01 BX005592 to B.F.M. and Pilot
   Research Funding to M.B.S.).
CR Ali Mondal Samim, 2023, Am J Physiol Endocrinol Metab, V324, pE120, DOI 10.1152/ajpendo.00256.2022
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5
   Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239
   Bhattacharya D, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100237
   Bischof GN, 2015, PSYCHOSOM MED, V77, P697, DOI 10.1097/PSY.0000000000000212
   Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008
   Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011
   Debarba LK, 2022, J GERONTOL A-BIOL, V77, P66, DOI 10.1093/gerona/glab216
   Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001
   Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101
   Drenth JPH, 2020, EXPERT OPIN INV DRUG, V29, P1365, DOI 10.1080/13543784.2020.1839888
   Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014
   Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108
   Fraile JM, 2021, DRUG DES DEV THER, V15, P3997, DOI 10.2147/DDDT.S315724
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Garratt M, 2019, AGING CELL, V18, DOI 10.1111/acel.12920
   Garratt M, 2018, AGING CELL, V17, DOI 10.1111/acel.12786
   Garratt M, 2018, AGING-US, V10, P293, DOI 10.18632/aging.101396
   Garratt M, 2017, AGING CELL, V16, P1256, DOI 10.1111/acel.12656
   Green PS, 2000, ANN NY ACAD SCI, V924, P93
   Harrison DE, 2021, AGING CELL, V20, DOI 10.1111/acel.13328
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Huffman DM, 2016, J GERONTOL A-BIOL, V71, P1395, DOI 10.1093/gerona/glw106
   Isola JVV, 2022, GEROSCIENCE, DOI 10.1007/s11357-022-00601-8
   Isola JVV, 2022, EXP GERONTOL, V159, DOI 10.1016/j.exger.2021.111669
   Isola JVV, 2020, EXP GERONTOL, V129, DOI 10.1016/j.exger.2019.110769
   Itoh M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92902
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   KORENMAN SG, 1969, STEROIDS, V13, P163, DOI 10.1016/0039-128X(69)90004-X
   Kurup K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0237199
   Lai KKY, 2017, GASTROENTEROLOGY, V152, P1477, DOI 10.1053/j.gastro.2017.01.021
   Lee MB, 2021, SCIENCE, V374, P953, DOI 10.1126/science.abe7365
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mann SN, 2020, ELIFE, V9, DOI 10.7554/eLife.59616
   Mann SN, 2020, EXP GERONTOL, V142, DOI 10.1016/j.exger.2020.111113
   Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Miller BF, 2020, J GERONTOL A-BIOL, V75, P849, DOI 10.1093/gerona/glz113
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014
   Monsalve DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.40
   Naaz A, 2002, HORM METAB RES, V34, P758, DOI 10.1055/s-2002-38259
   Nevalainen T, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0301-7
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Ratziu V, 2022, J HEPATOL, V76, P1263, DOI 10.1016/j.jhep.2022.04.002
   Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266
   Sathiaseelan R, 2023, J GERONTOL A-BIOL, V78, P771, DOI 10.1093/gerona/glad056
   Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311
   Sidhom S, 2021, J GERONTOL A-BIOL, V76, P778, DOI 10.1093/gerona/glaa215
   Steyn FJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12703
   Stout MB, 2017, PHYSIOLOGY, V32, P9, DOI 10.1152/physiol.00012.2016
   Stout MB, 2017, J GERONTOL A-BIOL, V72, P3, DOI 10.1093/gerona/glv309
   Stout MB, 2011, MOL NUTR FOOD RES, V55, P1010, DOI 10.1002/mnfr.201000413
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Toran-Allerand CD, 2005, ANN NY ACAD SCI, V1052, P136, DOI 10.1196/annals.1347.009
   Toran-Allerand CD, 2005, ENDOCRINOLOGY, V146, P3843, DOI 10.1210/en.2004-1616
   Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391
   Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003
   Varshney R, 2023, ISCIENCE, V26, DOI 10.1016/j.isci.2022.105750
   Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228
   Waters DL, 2013, EXP GERONTOL, V48, P1054, DOI 10.1016/j.exger.2013.02.005
   Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2
   Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0
   Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595
   Yang Yoon Mee, 2015, Curr Pathobiol Rep, V3, P253
   Zhang B, 2018, J GASTROEN HEPATOL, V33, P747, DOI 10.1111/jgh.13976
   Zhou Y, 2001, BIOCHEM BIOPH RES CO, V286, P1059, DOI 10.1006/bbrc.2001.5479
   Zhou YP, 2020, AGING-US, V12, P7350, DOI 10.18632/aging.103082
NR 79
TC 0
Z9 0
U1 1
U2 2
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 17
PY 2023
VL 13
IS 1
AR 9841
DI 10.1038/s41598-023-37007-1
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA J9FR1
UT WOS:001012614800024
PM 37330610
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
AF KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
TI EFFECT OF AGING AND GAMMA-RADIATION ON ACETYLATION OF RAT-LIVER HISTONES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ACETYLATION; AGING; GAMMA RADIATION; HISTONES; RAT LIVER; REGENERATION
ID AGE-RELATED-CHANGES; ACETYLTRANSFERASE ACTIVITY; CHROMATIN;
   TRANSCRIPTION
AB We studied age-related and radiation induced changes in histone acetyltransferase activity and acetylation of histone fractions in normal and regenerating rat livers. Male Wistar rats aged 1-28 months were used through the studies. They were exposed to whole-body doses of 5.7 Gy gamma radiation from a Co-60 source and partial hepatectomy was carried out 30 min after irradiation. Within nuclei isolated from normal and regenerating livers of rats, acetyltransferase activity of histones increased with age. An age-dependent decrease in histone acetyltransferase activity in normal and regenerating rat livers was also obvious at the time of maximum activity (i.e. at the 4th min of incubation). The radiation-induced drop in acetyltransferase activity was mild in normal livers. Twenty-four hours after partial hepatectomy, acetyltransferase activity in regenerating fivers was almost completely inhibited by irradiation. The acetylation of histone fractions and subfractions was not equal. The highest activity among all histone fractions was found in fraction H4. In regenerating livers of non-irradiated and irradiated rats, there was a greater rate of acetylation in tetraacetylated subfractions of histone H4 compared with intact livers.
RP KOZURKOVA, M (corresponding author), SAFARIK UNIV,FAC SCI,DEPT MOLEC & CELLULAR BIOL,MOYZESOVA 11,KOSICE 04167,SLOVAKIA.
RI Kozurkova, Maria/G-7433-2016
OI Kozurkova, Maria/0000-0002-2789-8397; Kozurkova,
   Maria/0000-0002-8344-0671
CR ALBERT MD, 1958, J NATL CANCER I, V20, P309
   AUSIO J, 1992, J CELL SCI, V102, P1
   BOHM L, 1993, 25TH ANN M EUR SOC R
   CSORDAS A, 1990, BIOCHEM J, V256, P23
   DELPECH M, 1982, BIOCHEM BIOPH RES CO, V105, P1561, DOI 10.1016/0006-291X(82)90966-4
   FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0
   GRUNICKE HH, 1989, J CANCER RES CLIN, V115, P435, DOI 10.1007/BF00393332
   GRUNICKE HH, 1988, FALK S, V51, P401
   HARPER JF, 1984, COMPUT BIOL MED, V14, P437, DOI 10.1016/0010-4825(84)90044-1
   HEYDARI AR, 1989, MECH AGEING DEV, V50, P227, DOI 10.1016/0047-6374(89)90102-4
   HIGGINS GM, 1931, ARCH PATHOL, V12, P107
   KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cb.08.110192.003023
   KOZURKOVA M, 1994, NEOPLASMA, V41, P89
   KOZURKOVA M, 1993, MECH AGEING DEV, V72, P37, DOI 10.1016/0047-6374(93)90129-F
   KROPACHOVA K, 1988, Radiobiologiya, V28, P44
   KROPACOVA K, 1992, PHYSIOL RES, V41, P135
   KROPACOVA K, 1971, Biologia (Bratislava), V26, P893
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MISUROVA E, 1974, RADIOBIOL RADIOTHER, V6, P709
   NILLSON P, 1992, FEBS LETT, V313, P67
   OH YH, 1972, LIFE SCI 2-BIOCH GEN, V11, P1207, DOI 10.1016/0024-3205(72)90188-9
   TALASZ H, 1990, FEBS LETT, V264, P141, DOI 10.1016/0014-5793(90)80785-H
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   TORDERA V, 1993, EXPERIENTIA, V49, P780, DOI 10.1007/BF01923548
   VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837
   WAGNER AP, 1982, EXP GERONTOL, V17, P173, DOI 10.1016/0531-5565(82)90022-5
   WEISS G, 1988, FEBS LETT, V238, P205, DOI 10.1016/0014-5793(88)80257-6
   WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735
   Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0
NR 29
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 31
PY 1995
VL 78
IS 1
BP 1
EP 14
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA QH557
UT WOS:A1995QH55700001
PM 7603086
DA 2024-02-19
ER

PT J
AU Gensous, N
   Ravaioli, F
   Pirazzini, C
   Gramignoli, R
   Ellis, E
   Storci, G
   Capri, M
   Strom, S
   Laconi, E
   Franceschi, C
   Garagnani, P
   Marongiu, F
   Bacalini, MG
AF Gensous, Noemie
   Ravaioli, Francesco
   Pirazzini, Chiara
   Gramignoli, Roberto
   Ellis, Ewa
   Storci, Gianluca
   Capri, Miriam
   Strom, Stephen
   Laconi, Ezio
   Franceschi, Claudio
   Garagnani, Paolo
   Marongiu, Fabio
   Bacalini, Maria Giulia
TI Aging and Caloric Restriction Modulate the DNA Methylation Profile of
   the Ribosomal RNA Locus in Human and Rat Liver
SO NUTRIENTS
LA English
DT Article
DE aging; DNA methylation; liver; ribosomal RNA; caloric restriction
ID POLYMERASE-I TRANSCRIPTION; GENES; HYPERMETHYLATION; HETEROCHROMATIN;
   PROTEOSTASIS; HOMEOSTASIS; LANDSCAPES; EXPRESSION; TURNOVER; PROMOTER
AB A growing amount of evidence suggests that the downregulation of protein synthesis is an adaptive response during physiological aging, which positively contributes to longevity and can be modulated by nutritional interventions like caloric restriction (CR). The expression of ribosomal RNA (rRNA) is one of the main determinants of translational rate, and epigenetic modifications finely contribute to its regulation. Previous reports suggest that hypermethylation of ribosomal DNA (rDNA) locus occurs with aging, although with some species- and tissue- specificity. In the present study, we experimentally measured DNA methylation of three regions (the promoter, the 5' of the 18S and the 5' of 28S sequences) in the rDNA locus in liver tissues from rats at two, four, 10, and 18 months. We confirm previous findings, showing age-related hypermethylation, and describe, for the first time, that this gain in methylation also occurs in human hepatocytes. Furthermore, we show that age-related hypermethylation is enhanced in livers of rat upon CR at two and 10 months, and that at two months a trend towards the reduction of rRNA expression occurs. Collectively, our results suggest that CR modulates age-related regulation of methylation at the rDNA locus, thus providing an epigenetic readout of the pro-longevity effects of CR.
C1 [Gensous, Noemie; Ravaioli, Francesco; Storci, Gianluca; Capri, Miriam; Franceschi, Claudio; Garagnani, Paolo] Alma Mater Studiorum, Dept Expt Diagnost & Specialty Med, I-40138 Bologna, Italy.
   [Pirazzini, Chiara; Franceschi, Claudio; Bacalini, Maria Giulia] IRCCS Ist Sci Neurol Bologna, I-40139 Bologna, Italy.
   [Gramignoli, Roberto] Karolinska Inst, Div Pathol, Dept Lab Med, S-17176 Stockholm, Sweden.
   [Ellis, Ewa] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, S-14186 Stockholm, Sweden.
   [Strom, Stephen] Karolinska Inst, Dept Lab Med, S-17176 Stockholm, Sweden.
   [Strom, Stephen] Karolinska Univ Sjukhuset, S-17176 Stockholm, Sweden.
   [Laconi, Ezio; Marongiu, Fabio] Univ Cagliari, Dept Biomed Sci, I-09124 Cagliari, Italy.
   [Franceschi, Claudio] Lobachevsky Univ, Lab Syst Med Hlth Aging, Nizhnii Novgorod 603950, Russia.
   [Franceschi, Claudio] Lobachevsky Univ, Dept Appl Math, Nizhnii Novgorod 603950, Russia.
   [Garagnani, Paolo] Karolinska Inst, Karolinska Univ Hosp, Clin Chem, Dept Lab Med, S-17176 Stockholm, Sweden.
   [Garagnani, Paolo] Policlin S Orsola Malpighi Polyclin, CRBA, I-40138 Bologna, Italy.
   [Garagnani, Paolo] Unit Bologna, CNR, Inst Mol Genet Luigi Luca Cavalli Sforza, I-40136 Bologna, Italy.
C3 IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Karolinska
   Institutet; Karolinska Institutet; Karolinska Institutet; University of
   Cagliari; Lobachevsky State University of Nizhni Novgorod; Lobachevsky
   State University of Nizhni Novgorod; Karolinska Institutet; Karolinska
   University Hospital; Consiglio Nazionale delle Ricerche (CNR)
RP Garagnani, P (corresponding author), Alma Mater Studiorum, Dept Expt Diagnost & Specialty Med, I-40138 Bologna, Italy.; Garagnani, P (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Clin Chem, Dept Lab Med, S-17176 Stockholm, Sweden.; Garagnani, P (corresponding author), Policlin S Orsola Malpighi Polyclin, CRBA, I-40138 Bologna, Italy.; Garagnani, P (corresponding author), Unit Bologna, CNR, Inst Mol Genet Luigi Luca Cavalli Sforza, I-40136 Bologna, Italy.
EM noemieelise.gensous2@unibo.it; francesco.ravaioli2@unibo.it;
   chiara.pirazzini@ausl.bologna.it; roberto.gramignoli@ki.se;
   ewa.ellis@ki.se; gianluca.storci@gmail.com; miriam.capri@unibo.it;
   stephen.strom@ki.se; elaconi@unica.it; claudio.franceschi@unibo.it;
   paolo.garagnani2@unibo.it; fabiomarongiu@unica.it;
   mariagiulia.bacalini@ausl.bologna.it
RI Marongiu, Fabio/E-6294-2016; Storci, Gianluca/AED-6195-2022; Pirazzini,
   Chiara/AAD-9318-2021; Gramignoli, Roberto/AAK-5387-2020; Ravaioli,
   Francesco/IQR-6887-2023; Bacalini, Maria Giulia/K-4931-2016; Ravaioli,
   Francesco/CAA-6674-2022; Ellis, Ewa C S/D-5370-2014
OI Marongiu, Fabio/0000-0001-5860-4227; Storci,
   Gianluca/0000-0001-5145-3091; Pirazzini, Chiara/0000-0001-8248-0295;
   Gramignoli, Roberto/0000-0003-3362-4170; Ravaioli,
   Francesco/0000-0001-6976-8489; Bacalini, Maria
   Giulia/0000-0003-1618-2673; Ravaioli, Francesco/0000-0001-6976-8489;
   Ellis, Ewa C S/0000-0002-3057-5337; Garagnani,
   Paolo/0000-0002-4161-3626; Gensous, Noemie/0000-0002-8428-616X
FU AIRC (Italian Association for Cancer Research) [IG 10604]; European
   Union's Seventh Framework Programme [602757]; European Union's
   Horizon2020 research and innovation program under the Marie
   Sklodowska-Curie grant [675003]; Roberto and Cornelia Pallotti Legacy
   for cancer research; Ministry of Education and Science of the Russian
   Federation [075-15-2019-871]
FX This research was funded by AIRC (Italian Association for Cancer
   Research, grant No. IG 10604), by the European Union's Seventh Framework
   Programme (grant agreement 602757 "HUMAN"), by the European Union's
   Horizon2020 research and innovation program under the Marie
   Sklodowska-Curie grant agreement nffi 675003 (`PANINI: Physical Activity
   and Nutrition Influences In ageing') and by Roberto and Cornelia
   Pallotti Legacy for cancer research. We acknowledge support by the grant
   of the Ministry of Education and Science of the Russian Federation
   Agreement No. 075-15-2019-871.
CR Anisimova AS, 2018, AGING-US, V10, P4269, DOI 10.18632/aging.101721
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Bacalini MG, 2017, MECH AGEING DEV, V165, P156, DOI 10.1016/j.mad.2017.01.006
   Bacalini MG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-361
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Birch JL, 2008, BIOCHEM SOC T, V36, P619, DOI 10.1042/BST0360619
   Boirie Y, 2014, MECH AGEING DEV, V136, P76, DOI 10.1016/j.mad.2014.01.008
   Cadoni E, 2017, ONCOTARGET, V8, P36020, DOI 10.18632/oncotarget.16421
   Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   D'Aquila P, 2018, AGING-US, V10, P7, DOI 10.18632/aging.101369
   D'Aquila P, 2017, AGING CELL, V16, P966, DOI 10.1111/acel.12603
   Denisenko O, 2016, BBA-GENE REGUL MECH, V1859, P906, DOI 10.1016/j.bbagrm.2016.04.001
   Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844
   Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876
   Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118
   Franceschi C, 2000, EXP GERONTOL, V35, P879, DOI 10.1016/S0531-5565(00)00172-8
   Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z
   Gensous N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082022
   Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200
   Gladyshev VN, 2016, AGING CELL, V15, P594, DOI 10.1111/acel.12480
   Gonskikh Y, 2017, MECH AGEING DEV, V168, P30, DOI 10.1016/j.mad.2017.04.003
   Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939
   Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0
   Grummt I, 2010, CELL CYCLE, V9, P225, DOI 10.4161/cc.9.2.10614
   Hamon MP, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201800421
   HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394
   Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269
   Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106
   James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kawakami K, 2012, BIOCHEM BIOPH RES CO, V418, P836, DOI 10.1016/j.bbrc.2012.01.120
   Lai RW, 2019, BMB REP, V52, P86
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033
   Liang YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24146-z
   Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com
   Maharajan N, 2020, J MOL MED, V98, P25, DOI 10.1007/s00109-019-01846-1
   Matos-Perdomo E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080779
   McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259
   Molina-Serrano D, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00192
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100
   Olausson KH, 2014, J BIOL CHEM, V289, P34601, DOI 10.1074/jbc.M114.569244
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585
   Powell MA, 2002, CANCER-AM CANCER SOC, V94, P2941, DOI 10.1002/cncr.10559
   Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009
   Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010
   Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005
   Schiza V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003805
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013
   Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019
   STOYKOVA AS, 1983, J NEUROCHEM, V41, P942, DOI 10.1111/j.1471-4159.1983.tb09038.x
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   Swovick K, 2018, MOL CELL PROTEOMICS, V17, P580, DOI 10.1074/mcp.RA117.000574
   Tanaka Y., 2018, GENE EXPRESSION REGU
   Tanca A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33100-y
   Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083
   Torreira E, 2017, ELIFE, V6, DOI [10.7554/eLife.20832.001, 10.7554/eLife.20832]
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Wang M, 2019, GENOME RES, V29, P325, DOI 10.1101/gr.241745.118
   Wang Y, 2018, CURR STEM CELL RES T, V13, P125, DOI 10.2174/1574888X12666170817141921
   Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885
   Yen PS, 2000, BRIT J CANCER, V82, P514, DOI 10.1054/bjoc.1999.0955
NR 67
TC 11
Z9 12
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2020
VL 12
IS 2
AR 277
DI 10.3390/nu12020277
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KY3GF
UT WOS:000522458700004
PM 31973116
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Davies, KJA
   Forman, HJ
AF Davies, Kelvin J. A.
   Forman, Henry Jay
TI Does Bach1 & c-Myc dependent redox dysregulation of Nrf2 & adaptive
   homeostasis decrease cancer risk in ageing?
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article; Proceedings Paper
CT Symposium on Free Radicals and Redox Regulation in Aging at the Annual
   Meeting of the Gerontological-Society-of-America (GSA)
CY NOV 15, 2018
CL Boston, MA
SP Gerontol Soc Amer, Soc Redox Biol & Med, Publicat Outreach Comm, Soc Free Rad Res Europe, Free Rad Biol & Med, Redox Biol
DE Bach1; c-Myc; Nrf2; Adaptive homeostasis; Cancer; Aging; Ageing;
   Oxidants; Electrophiles; Antioxidants; Antioxidant enzymes; Proteasome
ID VASCULAR OXIDATIVE STRESS; CHOLESTATIC LIVER-INJURY; YA-SUBUNIT GENE;
   NRF2-INTERACTING PROTEIN; TRANSCRIPTIONAL CONTROL; GLUTATHIONE
   SYNTHESIS; TRANSIENT ADAPTATION; SUPEROXIDE-DISMUTASE; INDUCIBLE
   EXPRESSION; POSITIVE CONTROL
AB The Keap1-Nrf2 signal transduction pathway plays a major role in oxidant and electrophile induction of adaptive homeostasis that transiently and reversibly increases cellular and organismal protection from stress. By expanding (and then contracting) the normal homeostatic range of expression of stress-protective genes, Nrf2 allows us to cope with fluctuations in stress levels. Two major inhibitors of Nrf2 are Bach1 and c-Myc which normally serve the important function of turning off adaptation when appropriate. We have found, however, that both Bach1 and c-Myc levels increase substantially with age and that older human cells, worms, flies, and mice loose Nrf2-dependent signaling and adaptive homeostasis. Nrf2 has also been linked with increased risk of cancers, and cancer incidence certainly increases with age. Here we propose that the age-dependent increase in Bach1 and c-Myc may actually cause the age-dependent decline in Nrf2 signaling and adaptive homeostasis, and that this is a coordinated attempt to minimize the age-dependent increase in cancer incidence. In other words, we may trade off adaptive homeostasis for a lower risk of cancer by increasing Bach1 and c-Myc in ageing.
C1 [Davies, Kelvin J. A.; Forman, Henry Jay] Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
   [Davies, Kelvin J. A.] Univ Southern Calif, Div Mol & Computat Biol, Dept Biol Sci, Coll Letters Arts & Sci, Los Angeles, CA 90089 USA.
C3 University of Southern California; University of Southern California
RP Davies, KJA (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.; Davies, KJA (corresponding author), Univ Southern Calif, Div Mol & Computat Biol, Dept Biol Sci, Coll Letters Arts & Sci, Los Angeles, CA 90089 USA.
EM kelvin@usc.edu
FU National Institute of Environmental Health Sciences of the US National
   Institutes of Health [ES003598, ES023864]; National Institute on Aging
   of the US National Institutes of Health [AG052374]
FX KJAD was supported by grant #ES003598 from the National Institute of
   Environmental Health Sciences of the US National Institutes of Health,
   and by grant #AG052374 from the National Institute on Aging of the US
   National Institutes of Health.
CR Cadet J, 2017, FREE RADICAL BIO MED, V107, P13, DOI 10.1016/j.freeradbiomed.2016.12.049
   Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002
   Chang LC, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/8143465
   CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8
   CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484
   COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0
   CRAPO JD, 1974, AM J PHYSIOL, V226, P1401, DOI 10.1152/ajplegacy.1974.226.6.1401
   DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824
   DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128
   Davies KJA, 2016, MOL ASPECTS MED, V49, P1, DOI 10.1016/j.mam.2016.04.007
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1292, DOI 10.1016/S0006-291X(82)80138-1
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DAVIES KJA, 1982, AM J PHYSIOL, V242, pE418, DOI 10.1152/ajpendo.1982.242.6.E418
   DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X
   Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010
   Dickinson DA, 2003, FASEB J, V17, P473, DOI 10.1096/fj.02-0566fje
   Fenton H. J. H., 1894, J CHEM SOC, V65, P899, DOI [DOI 10.1039/CT8946500899, 10.1039/CT8946500899]
   Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003
   Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045
   Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650
   FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258
   GAZZERI S, 1994, INT J CANCER, V58, P24, DOI 10.1002/ijc.2910580106
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Gomberg M, 1900, J AM CHEM SOC, V22, P757, DOI 10.1021/ja02049a006
   Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697
   Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181
   Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653
   GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181
   Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200
   Hollander MC, 1996, NUCLEIC ACIDS RES, V24, P1589, DOI 10.1093/nar/24.9.1589
   Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184
   Jemal A., 2011, CA CANC J CLIN
   Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865
   Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Levy S., 2010, GENES, V47, P1172
   Levy S, 2010, IUBMB LIFE, V62, P237, DOI 10.1002/iub.314
   MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176
   Mann G, 2015, AFR STUD-SER, P93
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MIYAZAKI T, 2010, CANC SCI
   Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835
   Oyake T, 1996, MOL CELL BIOL, V16, P6083
   Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144
   Pickering AM, 2013, FREE RADICAL BIO MED, V55, P109, DOI 10.1016/j.freeradbiomed.2012.11.001
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V121, P86, DOI 10.1016/j.freeradbiomed.2018.04.574
   Pomatto LCD, 2017, CURR BIOL, V27, P1, DOI 10.1016/j.cub.2016.10.044
   Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798
   Raynes R, 2017, J GERONTOL A-BIOL, V72, P143, DOI 10.1093/gerona/glw093
   Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001
   Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638
   RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648
   Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010
   Schmidlin C. J., 2019, FREE RADIC BIOL MED
   Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800
   SEVANIAN A, 1985, Journal of Free Radicals in Biology and Medicine, V1, P263, DOI 10.1016/0748-5514(85)90130-8
   Sies H, 2000, DEV CARDIOVASC MED, V224, P1
   Sies H., 1985, OXIDATIVE STRESS, P5
   Sies H., 2007, ENCY STRESS, P45, DOI DOI 10.1016/B978-012373947-6.00285-3
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Su CY, 2017, TOXICOLOGY, V387, P17, DOI 10.1016/j.tox.2017.06.006
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100
   Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4
   Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Vahteristo P, 2005, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-19
   Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178
   WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225
   Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291
   WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991
   Xu IMJ, 2016, P NATL ACAD SCI USA, V113, pE725, DOI 10.1073/pnas.1508779113
   Yang HP, 2015, ANTIOXID REDOX SIGN, V22, P259, DOI 10.1089/ars.2014.6027
   Yang HP, 2010, HEPATOLOGY, V51, P1291, DOI 10.1002/hep.23471
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042
   Zhang HQ, 2010, BBA-GENE REGUL MECH, V1799, P496, DOI 10.1016/j.bbagrm.2010.05.003
   Zhou L, 2018, REDOX BIOL, V14, P35, DOI 10.1016/j.redox.2017.08.014
NR 84
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD APR
PY 2019
VL 134
BP 708
EP 714
DI 10.1016/j.freeradbiomed.2019.01.028
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA ID6WQ
UT WOS:000471822700064
PM 30695691
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Simo, OK
   Berrougui, H
   Fulop, T
   Khalil, A
AF Simo, Olivier Kamtchueng
   Berrougui, Hicham
   Fulop, Tamas
   Khalil, Abdelouahed
TI The Susceptibility to Diet-Induced Atherosclerosis Is Exacerbated with
   Aging in C57B1/6 Mice
SO BIOMEDICINES
LA English
DT Article
DE HDL; aging; atherogenic diet; reverse cholesterol transport
ID REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; RECEPTOR
   CLASS-B; MOLECULAR-MECHANISMS; MACROPHAGE ABCA1; HDL CHOLESTEROL;
   LOW-FAT; EFFLUX; ABCG1; LIVER
AB The anti-atherogenic activity of HDL is mainly due to their capacity to mediate reverse cholesterol transport (RCT). However, it is not clear to what extent this activity is affected by aging or pro-atherogenic conditions. Three and 24-month-old C57Bl/6 mice were fed an atherogenic diet (high fat, high cholesterol) for 12 weeks. The aged mice displayed a significant reduction in the capacity of HDL to mediate RCT (29.03%, p < 0.0006). Interestingly, the atherogenic diet significantly stimulated the RCT process in both young and aged mice (241% and 201%, respectively, p < 0.01). However, despite this, significant amounts of cholesterol accumulated in the aortas of mice fed an atherogenic diet as compared to regular chow. The accumulation of cholesterol was more marked in the aortas of aged mice (110% increase, p < 0.002). ABCA1 and ABCG1 protein expression on macrophages decreased significantly (52 to 37% reduction, p < 0.002), whereas their expression on hepatic cells increased significantly (up to 590% for ABCA1 and 116% for ABCG1, p < 0.002). On the other hand, SR-BI protein expression on hepatic cells decreased significantly (42.85%, p < 0.0001). ABCG5, ABCG8, and CYP7a protein expression on hepatic cells was also higher in mice fed an atherogenic diet. The increase was age-dependent for both ABCG5 and ABCG8. Our results suggest that the susceptibility to diet-induced atherosclerosis is exacerbated with aging and is a consequence of the dysregulation of the expression levels of membrane cholesterol transporters.
C1 [Simo, Olivier Kamtchueng; Fulop, Tamas; Khalil, Abdelouahed] Univ Sherbrooke, Program Physiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 1N1, Canada.
   [Berrougui, Hicham] Univ Sultan Moulay Slimane, Polydisciplinary Fac, Dept Biol, BP 592, Beni Mellal 23000, Morocco.
   [Fulop, Tamas; Khalil, Abdelouahed] Univ Sherbrooke, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 4N4, Canada.
C3 University of Sherbrooke; Sultan Moulay Slimane University of Beni
   Mellal; University of Sherbrooke
RP Khalil, A (corresponding author), Univ Sherbrooke, Program Physiol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 1N1, Canada.; Khalil, A (corresponding author), Univ Sherbrooke, Dept Med, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 4N4, Canada.
EM Olivier.Kamtchueng.Simo@USherbrooke.ca; hichamberg@gmail.com;
   Tamas.fulop@usherbrooke.ca; Abdelouahed.khalil@usherbrooke.ca
OI berrougui, hicham/0000-0002-0546-6534; Khalil,
   Abdelouahed/0000-0003-0817-3160
FU Canadian Institutes of Health [IAO-134212 ND PJT-162366]
FX This research was funded by Canadian Institutes of Health. Research,
   grant number IAO-134212 ND PJT-162366.
CR ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207
   Alexander ET, 2011, ARTERIOSCL THROM VAS, V31, P320, DOI 10.1161/ATVBAHA.110.216226
   Annema W, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-25
   Back SS, 2013, BMB REP, V46, P322, DOI 10.5483/BMBRep.2013.46.6.246
   Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628
   Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200
   Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019
   Burgess B, 2008, ARTERIOSCL THROM VAS, V28, P1731, DOI 10.1161/ATVBAHA.108.168542
   Escolà-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075
   Delaney B, 2003, J NUTR, V133, P468, DOI 10.1093/jn/133.2.468
   Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200
   Hedrick CC, 2000, ARTERIOSCL THROM VAS, V20, P1946, DOI 10.1161/01.ATV.20.8.1946
   Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044
   Holzer M, 2013, BBA-MOL CELL BIOL L, V1831, P1442, DOI 10.1016/j.bbalip.2013.06.004
   Ikhlef S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173385
   Ikhlef S, 2016, FEBS LETT, V590, P1614, DOI 10.1002/1873-3468.12198
   JENKINS PJ, 1978, BMJ-BRIT MED J, V2, P388, DOI 10.1136/bmj.2.6134.388
   Khaw KT, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020167
   Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689
   Kuniyasu A, 2003, FEBS LETT, V537, P85, DOI 10.1016/S0014-5793(03)00096-6
   Linton S, 2001, EXP GERONTOL, V36, P1503, DOI 10.1016/S0531-5565(01)00136-X
   Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61
   Moon Min-Sun, 2007, Nutr Res Pract, V1, P175, DOI 10.4162/nrp.2007.1.3.175
   Nagashree RS, 2017, J AM COLL NUTR, V36, P330, DOI 10.1080/07315724.2017.1280713
   Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177
   Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481
   Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136
   Ohgami Nobutaka, 2003, J Atheroscler Thromb, V10, P1
   Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935
   Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658
   Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4
   Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200
   Ribas V, 2004, CIRC RES, V95, P789, DOI 10.1161/01.RES.0000146031.94850.5f
   Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610
   Schmitz G, 2009, ARTERIOSCL THROM VAS, V29, P1718, DOI 10.1161/ATVBAHA.108.179507
   Schwingshackl L, 2013, J ACAD NUTR DIET, V113, P1640, DOI 10.1016/j.jand.2013.07.010
   Simo OK, 2017, CAN J PHYSIOL PHARM, V95, P977, DOI 10.1139/cjpp-2017-0170
   Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685
   Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52, DOI 10.5551/jat.E571
   Tang CR, 2010, J LIPID RES, V51, P1719, DOI 10.1194/jlr.M003525
   Toth Peter P, 2003, Curr Atheroscler Rep, V5, P386, DOI 10.1007/s11883-003-0010-5
   Toth PP, 2009, ENDOCRIN METAB CLIN, V38, P151, DOI 10.1016/j.ecl.2008.11.012
   Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184
   Tréguier M, 2011, EUR J CLIN INVEST, V41, P921, DOI 10.1111/j.1365-2362.2011.02478.x
   Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206
   Volek JS, 2003, J NUTR, V133, P2756, DOI 10.1093/jn/133.9.2756
   Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544
   Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057
   Wiersma H, 2009, ATHEROSCLEROSIS, V206, P141, DOI 10.1016/j.atherosclerosis.2009.02.022
   Wu JE, 2004, J BIOL CHEM, V279, P22913, DOI 10.1074/jbc.M402838200
   Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399
   Zanotti I, 2011, BRIT J PHARMACOL, V164, P1642, DOI 10.1111/j.1476-5381.2011.01376.x
   Zhang Y, 2011, PPAR RES, V2011, DOI 10.1155/2011/164925
NR 53
TC 2
Z9 3
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD MAY
PY 2021
VL 9
IS 5
AR 487
DI 10.3390/biomedicines9050487
PG 13
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA SG4HQ
UT WOS:000653402300001
PM 33946646
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Demerdash, HM
   Elyamany, AS
   Arida, E
AF Demerdash, Hala M.
   Elyamany, Amany S.
   Arida, Emad
TI Impact of direct-acting antivirals on leukocytic DNA telomere length in
   hepatitis C virus-related hepatic cirrhosis
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE direct-acting antiviral agents; DNA telomere; hepatic cirrhosis;
   hepatitis C virus
ID HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; LIVER-DISEASE; RISK;
   RECURRENCE; SENESCENCE; CANCER; ASSOCIATION; INFECTION; HCC
AB Background Direct-acting antiviral (DAAs) represent advancement in the management of hepatitis C virus (HCV)-related hepatic cirrhosis. A high proportion of patients achieve a sustained virologic response; eradication of HCV is coupled with a decreased risk of hepatocellular carcinoma. Recent evidence suggests that shortening of the DNA telomere may be linked to cellular senescence as well as predisposition to malignant transformation.
   Objective This study aimed to assess pretreatment leukocytic DNA telomere length in HCV-related cirrhosis and post viral eradication using DAAs. Patients and methods This study included 24 patients with HCV-related cirrhosis, Child-Pugh A. Whole-blood samples were obtained from patients before treatment and 12 weeks after the end of treatment, as well as from 24 healthy controls. Terminal restriction fragment, corresponding to telomere length, was measured using a nonradioactive Southern blot technique, detected by chemiluminescence.
   Results DNA telomere length was significantly shorter before treatment compared with 12 weeks after end of treatment in HCV-related cirrhotic patients. Also, it was significantly shorter in patients before treatment compared with healthy individuals.
   Conclusion Telomere elongation in blood leukocytes can be considered a marker of recovery of inflammation after DAAs-induced HCV eradication. Still, the possibility of activation by cancer initiation cannot be excluded. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Demerdash, Hala M.] Alexandria Univ Hosp, Dept Clin Pathol, 75 Ismail Serry St, Alexandria 21523, Egypt.
   [Elyamany, Amany S.] Alexandria Univ, Fac Med, Dept Internal Med, Alexandria, Egypt.
   [Arida, Emad] Alexandria Univ, Fac Med, Dept Anaesthesia & Intens Care, Alexandria, Egypt.
C3 Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge
   Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB);
   Alexandria University
RP Demerdash, HM (corresponding author), Alexandria Univ Hosp, Dept Clin Pathol, 75 Ismail Serry St, Alexandria 21523, Egypt.
EM demerdashh@yahoo.com
FU Science and Technology Development Fund (STDF), Ministry of Scientific
   Research, Egypt [15243]
FX This work was supported by a grant from the Science and Technology
   Development Fund (STDF), Ministry of Scientific Research, Egypt, Grant
   no. 15243.
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   [Anonymous], J HEPATOL
   Buonfiglioli F, 2016, 51 ANN M EUR ASS STU
   Camma C, 2016, J HEPATOL, V65, P861, DOI 10.1016/j.jhep.2016.04.033
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Chaiteerakij R, 2011, HEPATOLOGY, V53, P1430, DOI 10.1002/hep.24304
   Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015
   D'Ambrosio R, 2016, LIVER INT, V36, P783, DOI 10.1111/liv.13106
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393
   Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896
   Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238
   Hsu YC, 2013, HEPATOLOGY, V58, P150, DOI 10.1002/hep.26300
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kitay-Cohen Y, 2008, CANCER GENET CYTOGEN, V187, P34, DOI 10.1016/j.cancergencyto.2008.08.006
   Kordinas V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090060
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845
   Liu J, 2011, CANCER-AM CANCER SOC, V117, P4247, DOI 10.1002/cncr.26015
   Ma Q, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004970
   Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9
   Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672
   McCaughan GW, 2007, J GASTROEN HEPATOL, V22, P615, DOI 10.1111/j.1440-1746.2007.04883.x
   Nault JC, 2016, J HEPATOL, V65, P663, DOI 10.1016/j.jhep.2016.07.004
   Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003
   Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008
   Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001
   Suruki RY, 2006, CANCER EPIDEM BIOMAR, V15, P2521, DOI 10.1158/1055-9965.EPI-06-0485
   Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 31
TC 3
Z9 3
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-691X
EI 1473-5687
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD APR
PY 2019
VL 31
IS 4
BP 494
EP 498
DI 10.1097/MEG.0000000000001306
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IQ3ZM
UT WOS:000480690600011
PM 30444746
DA 2024-02-19
ER

PT J
AU Fernández, A
   Mazuecos, L
   Pintado, C
   Rubio, B
   López, V
   de Solís, AJ
   Rodríguez, M
   Andrés, A
   Gallardo, N
AF Fernandez, Alejandro
   Mazuecos, Lorena
   Pintado, Cristina
   Rubio, Blanca
   Lopez, Virginia
   de Solis, Alain J.
   Rodriguez, Maria
   Andres, Antonio
   Gallardo, Nilda
TI Effects of Moderate Chronic Food Restriction on the Development of
   Postprandial Dyslipidemia with Ageing
SO NUTRIENTS
LA English
DT Article
DE oral lipid loading test; ageing; postprandial hypertrigliceridemia;
   ChREBP; postprandial thermogenesis; adipose tissue
ID TRIGLYCERIDE-RICH LIPOPROTEINS; FIBROBLAST GROWTH FACTOR-21;
   ELEMENT-BINDING PROTEIN; WHITE ADIPOSE-TISSUE; REMNANT LIPOPROTEINS;
   INSULIN-RESISTANCE; BROWN ADIPOCYTES; PPAR-ALPHA; GLUCOSE; CHREBP
AB Ageing is a major risk factor for the development of metabolic disorders linked to dyslipidemia, usually accompanied by increased adiposity. The goal of this work was to investigate whether avoiding an excessive increase in adiposity with ageing, via moderate chronic food restriction (FR), ameliorates postprandial dyslipidemia in a rat model of metabolic syndrome associated with ageing. Accordingly, we performed an oral lipid loading test (OLLT) in mature middle-aged (7 months) and middle-old-aged (24 months) Wistar rats fed ad libitum (AL) or under moderate FR for 3 months. Briefly, overnight fasted rats were orally administered a bolus of extra-virgin olive oil (1 mL/Kg of body weight) and blood samples were taken from the tail vein before fat load (t = 0) and 30, 60, 90, 120, 180, and 240 min after fat administration. Changes in serum lipids, glucose, insulin, and glucagon levels were measured at different time-points. Expression of liver and adipose tissue metabolic genes were also determined before (t = 0) and after the fat load (t = 240 min). Postprandial dyslipidemia progressively increased with ageing and this could be associated with hepatic ChREBP activity. Interestingly, moderate chronic FR reduced adiposity and avoided excessive postprandial hypertriglyceridemia in 7- and 24-month-old Wistar rats, strengthening the association between postprandial triglyceride levels and adiposity. The 24-month-old rats needed more insulin to maintain postprandial normoglycemia; nevertheless, hyperglycemia occurred at 240 min after fat administration. FR did not alter the fasted serum glucose levels but it markedly decreased glucagon excursion during the OLLT and the postprandial rise of glycemia in the 24-month-old rats, and FGF21 in the 7-month-old Wistar rats. Hence, our results pointed to an important role of FR in postprandial energy metabolism and insulin resistance in ageing. Lastly, our data support the idea that the vWAT might function as an ectopic site for fat deposition in 7-month-old and in 24-month-old Wistar rats that could increase their browning capacity in response to an acute fat load.
C1 [Fernandez, Alejandro; Mazuecos, Lorena; Pintado, Cristina; Rubio, Blanca; Lopez, Virginia; Rodriguez, Maria; Andres, Antonio; Gallardo, Nilda] Univ Castilla La Mancha, Reg Ctr Biomed Res CRIB, E-13071 Ciudad Real, Spain.
   [Fernandez, Alejandro; Mazuecos, Lorena; Rubio, Blanca; Lopez, Virginia; Andres, Antonio; Gallardo, Nilda] Univ Castilla La Mancha, Biochem Sect, Fac Sci & Chem Technol, Avda Camilo Jose Cela 10, E-13071 Ciudad Real, Spain.
   [Pintado, Cristina; Rodriguez, Maria] Univ Castilla La Mancha, Biochem Sect, Fac Enviromental Sci & Biochem, Avda Carlos III S-N, Toledo 45071, Spain.
   [de Solis, Alain J.] Max Planck Inst Metab Res, Gleueler Str 50, D-50931 Cologne, Germany.
C3 Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha;
   Universidad de Castilla-La Mancha
RP Gallardo, N (corresponding author), Univ Castilla La Mancha, Reg Ctr Biomed Res CRIB, E-13071 Ciudad Real, Spain.; Gallardo, N (corresponding author), Univ Castilla La Mancha, Biochem Sect, Fac Sci & Chem Technol, Avda Camilo Jose Cela 10, E-13071 Ciudad Real, Spain.
EM nilda.gallardo@uclm.es
RI Mazuecos, Lorena/GRX-9532-2022; Rodríguez-Pérez, María/AAB-5982-2022;
   Losa, Cristina Pintado/Q-4887-2019; ANDRES, ANTONIO/G-8794-2015; Pintado
   Losa, Cristina/H-5641-2015; Pintado Losa, Cristina/GVR-7935-2022;
   Gallardo, Nilda/AAR-3104-2021
OI Mazuecos, Lorena/0000-0002-7897-1304; Rodríguez-Pérez,
   María/0000-0002-9949-5861; ANDRES, ANTONIO/0000-0002-9892-8338; Pintado
   Losa, Cristina/0000-0002-9369-8318; Pintado Losa,
   Cristina/0000-0002-9369-8318; Gallardo, Nilda/0000-0003-3211-569X; Lopez
   Gomez-Carreno, Virginia/0000-0001-6771-8859; J. de Solis,
   Alain/0000-0002-0181-3287
FU Junta de Comunidades de Castilla-La Mancha (JCCM) [PCI08-0136];
   Ministerio de Ciencia e Innovacion, Spain [BFU2012-39705-C03-01]
FX Research Grants PCI08-0136 from Junta de Comunidades de Castilla-La
   Mancha (JCCM), and BFU2012-39705-C03-01 from Ministerio de Ciencia e
   Innovacion, Spain.
CR Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636
   Bennett BJ, 2015, ANN NY ACAD SCI, V1352, P1, DOI 10.1111/nyas.12945
   Bindesboll C, 2015, J LIPID RES, V56, P771, DOI 10.1194/jlr.M049130
   Bjornstad P, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1101-6
   Bonzón-Kulichenko E, 2018, J GERONTOL A-BIOL, V73, P1139, DOI 10.1093/gerona/gly081
   Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200
   COHN JS, 1993, J LIPID RES, V34, P2033
   COUSIN B, 1992, J CELL SCI, V103, P931
   Cuthbertson DJ, 2017, INT J OBESITY, V41, P853, DOI 10.1038/ijo.2017.4
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Ducheix S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181393
   EGGSTEIN M, 1974, METHOD ENZYMAT AN, V4, P1825
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Færch K, 2016, DIABETES, V65, P3473, DOI 10.2337/db16-0240
   Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001
   Hanks LJ, 2015, J CLIN TRANSL ENDOCR, V2, P77, DOI 10.1016/j.jcte.2015.02.001
   Havel RJ, 2000, CURR OPIN LIPIDOL, V11, P615, DOI 10.1097/00041433-200012000-00008
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Hojna S, 2012, HYPERTENS RES, V35, P279, DOI 10.1038/hr.2011.188
   Horrillo D, 2013, J BIOL REG HOMEOS AG, V27, P377
   Iizuka K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111699
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jackson KG, 2010, CLIN LIPIDOL, V5, P1, DOI 10.2217/CLP.09.87
   Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Krauss RM, 2004, DIABETES CARE, V27, P1496, DOI 10.2337/diacare.27.6.1496
   Lewis JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03607-x
   Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822
   López V, 2018, OBESITY, V26, P877, DOI 10.1002/oby.22152
   Matikainen N, 2012, EUR J ENDOCRINOL, V166, P487, DOI 10.1530/EJE-11-0783
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248
   Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x
   Müller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016
   Nakajima K, 2018, CLIN CHIM ACTA, V485, P126, DOI 10.1016/j.cca.2018.06.029
   Nakajima K, 2018, CLIN CHIM ACTA, V478, P200, DOI 10.1016/j.cca.2017.12.039
   Nakajima K, 2012, CLIN CHIM ACTA, V413, P1077, DOI 10.1016/j.cca.2012.02.026
   Nakajima K, 2011, CLIN CHIM ACTA, V412, P1306, DOI 10.1016/j.cca.2011.04.018
   Nygaard EB, 2014, INT J OBESITY, V38, P183, DOI 10.1038/ijo.2013.79
   Overturf ML, 1992, CURR OPIN LIPIDOL, V3, P179, DOI DOI 10.1097/00041433-199206000-00004
   PORTA EA, 1980, MECH AGEING DEV, V13, P1, DOI 10.1016/0047-6374(80)90128-1
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010
   Salamanca A, 2015, EXP GERONTOL, V69, P9, DOI 10.1016/j.exger.2015.05.009
   Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409
   Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006
   Sepa-Kishi DM, 2018, ADIPOCYTE, V7, P238, DOI 10.1080/21623945.2018.1504591
   Seyer P, 2013, J CLIN INVEST, V123, P1662, DOI 10.1172/JCI65538
   Shin S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020256
   Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383
   Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365
   Villarroya J, 2018, AGING CELL, V17, DOI 10.1111/acel.12822
   Yorke A, 2017, J GERONTOL A-BIOL, V72, P897, DOI 10.1093/gerona/glw339
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
   ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473
NR 59
TC 6
Z9 7
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2019
VL 11
IS 8
AR 1865
DI 10.3390/nu11081865
PG 23
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IV8HH
UT WOS:000484506000046
PM 31405194
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Zhu, Y
   Wang, T
   He, SL
   Pu, SM
   Zhao, HX
   Zhou, ZP
   Wu, Q
AF Zhu, Yu
   Wang, Tao
   He, Shuangli
   Pu, Shiming
   Zhao, Hongxia
   Zhou, Zuping
   Wu, Qiong
TI Comparison of Antiobesity Effects of Adipose-Derived Stromal/Stem Cells
   from Different Sources in a Natural Aging Model
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE adipose-derived stromal; stem cells; different tissue sources; obesity;
   aging
ID STEM-CELLS; TISSUE
AB Purpose: Our previous study found that white adipose stem cells (W-ASCs) derived from abdominal and femoral sulcus white adipose stem cells (ASCs) have antiaging and age related obesity effects. Whether interscapular brown adipose stem cells (B-ASCs) have the same effect has not been reported. The study objective was to compare the effects of ASCs from different tissues on aging and aging-related obesity. Patients and Methods: C57BL/6J mice at 22 months of age were transplanted with either B-ASCs or W-ASCs from young mice at 2 months of age. Changes in body weight, biochemistry, cytokines, hormone secretion, cell senescence, lipid metabolism, and ASC function were assessed after transplanted 1 month. Results: W-ASCs were superior to B-ASCs as aging and age-related obesity indicators, based on change in body weight, organ weight, antioxidant and anti-inflammatory activity, lipid metabolism, and liver and kidney function. Conclusion: Difference in the tissue source was reflected by the heterogeneity of antiaging and age-related obesity effects of transplanted ASCs. Based on the study results, we recommend W-ASCs over B-ASCs in aging and age-related obesity applications.
C1 [Zhu, Yu; Wang, Tao; He, Shuangli; Pu, Shiming; Zhao, Hongxia; Zhou, Zuping; Wu, Qiong] Guangxi Normal Univ, Sch Life Sci, Guilin, Guangxi Zhuang, Peoples R China.
   [Zhu, Yu; Wang, Tao; He, Shuangli; Pu, Shiming; Zhao, Hongxia; Zhou, Zuping; Wu, Qiong] Guangxi Normal Univ, Key Lab Stem Cell & Biopharmaceut Technol, Guilin, Guangxi Zhuang, Peoples R China.
   [Zhu, Yu; Wang, Tao; He, Shuangli; Pu, Shiming; Zhao, Hongxia; Zhou, Zuping; Wu, Qiong] Guangxi Normal Univ, Biomed Sci Res Ctr, Guilin, Guangxi Zhuang, Peoples R China.
C3 Guangxi Normal University; Guangxi Normal University; Guangxi Normal
   University
RP Wu, Q (corresponding author), Guangxi Normal Univ, Sch Life Sci, Guilin, Guangxi Zhuang, Peoples R China.; Wu, Q (corresponding author), Guangxi Normal Univ, Key Lab Stem Cell & Biopharmaceut Technol, Guilin, Guangxi Zhuang, Peoples R China.; Wu, Q (corresponding author), Guangxi Normal Univ, Biomed Sci Res Ctr, Guilin, Guangxi Zhuang, Peoples R China.
EM wubinbin02@163.com
OI Wang, Tao/0000-0002-5564-6496
FU National Natural Science Foundation of China [32160170]; Natural Science
   Foundation of Guangxi [2020GXNSF AA259049]; Guangxi distinguished expert
   funding; Innovation Project of Guangxi Graduate Education [YCSW2021115]
FX This study was supported by grants from National Natural Science
   Foundation of China (32160170 to Qiong Wu) , Natural Science Foundation
   of Guangxi (2020GXNSF AA259049 to QiongWu) , Guangxi distinguished
   expert funding (H.Z.) , Innovation Project of Guangxi Graduate Education
   (YCSW2021115 to Yu Zhu) . We also thank International Science Editing
   for editing this manuscript. Yu Zhu and Tao Wang are co-first authors
   for this study.
CR Aguiar-Oliveira MH, 2019, ENDOCR REV, V40, P575, DOI 10.1210/er.2018-00216
   Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016
   Albayrak E, 2019, J MED ULTRASON, V46, P195, DOI 10.1007/s10396-019-00929-3
   Aw D, 2016, IMMUNOLOGY, V148, P92, DOI 10.1111/imm.12590
   Bakker GJ, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14199
   Börger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450
   Buzhor E, 2014, REGEN MED, V9, P649, DOI [10.2217/RME.14.35, 10.2217/rme.14.35]
   Campbell A, 2015, STEM CELL TRANSL MED, V4, P1155, DOI 10.5966/sctm.2014-0294
   Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110
   Chun SY, 2019, TISSUE ENG REGEN MED, V16, P385
   Denu RA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2989076
   Hye-Youn S, 2019, J CRANIOFAC SURG, V30, P541
   Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982
   Minteer D, 2013, ADV BIOCHEM ENG BIOT, V129, P59, DOI 10.1007/10_2012_146
   Müller S, 2016, HANDB EXP PHARMACOL, V233, P251, DOI 10.1007/164_2015_13
   Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013
   Qiong W, 2020, OBESITY, V29, P12
   Schoettl T, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.162958
   Sendama W, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.101000
   Su T, 2019, ACS NANO, V13, P2450, DOI 10.1021/acsnano.8b09375
   Tam BT, 2020, OBES REV, V21, DOI 10.1111/obr.12991
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Wang CH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz8664
   Zhang DX, 2020, CELLS TISSUES ORGANS, V209, P26, DOI 10.1159/000507434
NR 27
TC 2
Z9 2
U1 2
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2021
VL 14
BP 4535
EP 4546
DI 10.2147/DMSO.S334044
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA XB5WA
UT WOS:000721398200002
PM 34815680
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU SCHLEPPERSCHAFER, J
   KOLBBACHOFEN, V
AF SCHLEPPERSCHAFER, J
   KOLBBACHOFEN, V
TI RED-CELL AGING RESULTS IN A CHANGE OF CELL-SURFACE CARBOHYDRATE EPITOPES
   ALLOWING FOR RECOGNITION BY GALACTOSE-SPECIFIC RECEPTORS OF RAT-LIVER
   MACROPHAGES
SO BLOOD CELLS
LA English
DT Article
C1 UNIV DUSSELDORF, DEPT MED, INST BIOPHYS & ELECTRON MICROSCOPY, D-4000 DUSSELDORF 1, FED REP GER.
C3 Heinrich Heine University Dusseldorf
RP SCHLEPPERSCHAFER, J (corresponding author), UNIV CONSTANCE, FAK BIOL, POSTFACH 5560, D-7750 CONSTANCE, FED REP GER.
CR ALDERMAN EM, 1981, BLOOD, V58, P341
   BISSELL MD, 1972, J CELL BIOL, V54, P107, DOI 10.1083/jcb.54.1.107
   GALILI U, 1986, BRIT J HAEMATOL, V62, P317, DOI 10.1111/j.1365-2141.1986.tb02935.x
   GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519
   GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573
   JAIN SK, 1980, BIOCHEM BIOPH RES CO, V92, P247, DOI 10.1016/0006-291X(80)91545-4
   KAY MMB, 1981, NATURE, V289, P491, DOI 10.1038/289491a0
   KAY MMB, 1975, P NATL ACAD SCI USA, V72, P3521, DOI 10.1073/pnas.72.9.3521
   KHANSARI N, 1983, CELL IMMUNOL, V80, P426, DOI 10.1016/0008-8749(83)90129-6
   KHANSARI N, 1983, CELL IMMUNOL, V78, P114, DOI 10.1016/0008-8749(83)90264-2
   KHANSARI N, 1983, MECH AGEING DEV, V21, P49, DOI 10.1016/0047-6374(83)90015-5
   KOLB H, 1981, BIOCHEM J, V200, P445, DOI 10.1042/bj2000445
   KOLB H, 1980, H-S Z PHYSIOL CHEM, V361, P1747
   KOLBBACHOFEN V, 1982, CELL, V29, P859, DOI 10.1016/0092-8674(82)90447-0
   MURPHY JR, 1973, J LAB CLIN MED, V82, P334
   ROOS PH, 1985, BIOCHIM BIOPHYS ACTA, V847, P115, DOI 10.1016/0167-4889(85)90161-2
   SCHLEPPERSCHAFER J, 1981, EUR J CELL BIOL, V25, P95
   SCHLEPPERSCHAFER J, 1983, BIOCHEM BIOPH RES CO, V115, P551, DOI 10.1016/S0006-291X(83)80180-6
   SCHLEPPERSCHAFER J, 1980, BIOCHEM J, V186, P827, DOI 10.1042/bj1860827
   SCHLUTER K, 1986, P NATL ACAD SCI USA, V83, P6137, DOI 10.1073/pnas.83.16.6137
   SINGER JA, 1986, P NATL ACAD SCI USA, V83, P5498, DOI 10.1073/pnas.83.15.5498
   SKUTELSKY E, 1985, MECH AGEING DEV, V31, P13, DOI 10.1016/0047-6374(85)90023-5
   SMEDSROD B, 1985, AM J HEMATOL, V18, P31, DOI 10.1002/ajh.2830180106
   TANABE T, 1979, J BIOL CHEM, V254, P1038
   VAYSSE J, 1986, P NATL ACAD SCI USA, V83, P1339, DOI 10.1073/pnas.83.5.1339
   VOMEL T, 1982, GERONTOLOGY, V28, P149
NR 26
TC 15
Z9 15
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-4684
J9 BLOOD CELLS
JI Blood Cells
PY 1988
VL 14
IS 1
BP 259
EP 269
PG 11
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA P5172
UT WOS:A1988P517200042
PM 2460164
DA 2024-02-19
ER

PT J
AU Miao, XY
   Zhu, XX
   Gu, ZY
   Fu, B
   Cui, SY
   Zu, Y
   Rong, LJ
   Hu, F
   Chen, XM
   Gong, YP
   Li, CL
AF Miao, Xin-Yu
   Zhu, Xiao-Xiao
   Gu, Zhao-Yan
   Fu, Bo
   Cui, Shao-Yuan
   Zu, Yuan
   Rong, Ling-Jun
   Hu, Fan
   Chen, Xiang-Mei
   Gong, Yan-Ping
   Li, Chun-Lin
TI <i>Astragalus</i> Polysaccharides Reduce High-glucose-induced Rat Aortic
   Endothelial Cell Senescence and Inflammasome Activation by Modulating
   the Mitochondrial Na<SUP>+</SUP>/Ca<SUP>2+</SUP> Exchanger
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Early Access
DE Astragalus polysaccharide; Aging; Aorta; Endothelium; NCLX
ID LIFE-SPAN; PROTEIN; DYSFUNCTION; MECHANISMS; AUTOPHAGY; CALCIUM; STRESS;
   HEALTH; FAMILY
AB Vascular endothelial cells play a vital role in atherosclerotic changes and the progression of cardiovascular disease in older adults. Previous studies have indicated that Astragalus polysaccharides (APS), a main active component of the traditional Chinese medicine Astragalus, protect mitochondria and exert an antiaging effect in the mouse liver and brain. However, the effect of APS on rat aortic endothelial cell (RAEC) senescence and its underlying mechanism have not been investigated. In this study, we extracted RAECs from 2-month-old male Wistar rats by the tissue explant method and found that APS ameliorated the high-glucose-induced increase in the frequency of SA-beta-Gal positivity and the levels of the senescence-related proteins p16, p21, and p53. APS increased the tube formation capacity of RAECs under high-glucose conditions. Moreover, APS enhanced the expression of the mitochondrial Na+/Ca2+ exchanger NCLX, and knockdown of NCLX by small interfering RNA (siRNA) transfection suppressed the antiaging effect of APS under high-glucose conditions. Additionally, APS ameliorated RAEC mitochondrial dysfunction, including increasing ATP production, cytochrome C oxidase activity and the oxygen consumption rate (OCR), and inhibited high-glucose-induced NLRP3 inflammasome activation and IL-1 beta release, which were reversed by siNCLX. These results indicate that APS reduces high-glucose-induced inflammasome activation and ameliorates mitochondrial dysfunction and senescence in RAECs by modulating NCLX. Additionally, APS enhanced the levels of autophagy-related proteins (LC3B-II/I, Atg7) and increased the quantity of autophagic vacuoles under high-glucose conditions. Therefore, these data demonstrate that APS may reduce vascular endothelial cell inflammation and senescence through NCLX.
C1 [Miao, Xin-Yu; Zhu, Xiao-Xiao; Gu, Zhao-Yan; Rong, Ling-Jun; Hu, Fan; Gong, Yan-Ping; Li, Chun-Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Med Ctr 2, Beijing, Peoples R China.
   [Miao, Xin-Yu; Zhu, Xiao-Xiao; Gu, Zhao-Yan; Rong, Ling-Jun; Hu, Fan; Gong, Yan-Ping; Li, Chun-Lin] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China.
   [Fu, Bo; Cui, Shao-Yuan; Chen, Xiang-Mei] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Natl Clin Res Ctr Kidney Dis, Dept Nephrol,Med Ctr 1,Chinese PLA Inst Nephrol, Beijing, Peoples R China.
   [Zu, Yuan] Capital Med Univ, Beijing Chaoyang Hosp, Dept Blood Purificat, Beijing, Peoples R China.
C3 Chinese People's Liberation Army General Hospital; Chinese People's
   Liberation Army General Hospital; Chinese People's Liberation Army
   General Hospital; Capital Medical University
RP Gong, YP; Li, CL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Med Ctr 2, Beijing, Peoples R China.; Gong, YP; Li, CL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China.
EM gypmrp@163.com; lichunlin301@163.com
RI Zhao, Yi/JFA-7988-2023; Wang, zijun/JNS-5435-2023; yan,
   xiao/JVP-0766-2024
FU National Natural Science Foundation of China [81774119, 81300265,
   81900765]; Special Scientific Research Project of Military Healthcare
   [19BJZ29]; Beijing Haidian District Health Development Research and
   Cultivation Program [HP2021-03-80303]
FX The authors would like to express their sincere gratitude to all the
   researchers at the Chinese PLA Institute of Nephrology, State Key
   Laboratory of Kidney Diseases. This study was supported by grants from
   the National Natural Science Foundation of China (No. 81774119,
   81300265, 81900765); Special Scientific Research Project of Military
   Healthcare (19BJZ29), and Beijing Haidian District Health Development
   Research and Cultivation Program (No. HP2021-03-80303).
CR Broniarek I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041485
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cao Y, 2017, ONCOTARGET, V8, P4837, DOI 10.18632/oncotarget.13596
   CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7
   Childs BG, 2019, METHODS MOL BIOL, V1896, P31, DOI 10.1007/978-1-4939-8931-7_4
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158
   Das A, 2019, CELL, V176, P944, DOI 10.1016/j.cell.2019.01.026
   Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047
   Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295
   Huang WM, 2013, EXP THER MED, V6, P199, DOI 10.3892/etm.2013.1074
   Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003
   Kim D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071662
   Lai MH, 2017, CARBOHYD POLYM, V161, P261, DOI 10.1016/j.carbpol.2016.12.068
   Li XT, 2012, INT J MOL SCI, V13, P1747, DOI 10.3390/ijms13021747
   Liu P, 2017, AGING DIS, V8, P868, DOI 10.14336/AD.2017.0816
   Liu Y, 2013, AGE, V35, P1531, DOI 10.1007/s11357-012-9456-0
   Meng QL, 2017, APOPTOSIS, V22, P1138, DOI 10.1007/s10495-017-1387-x
   Miao XY, 2018, PEPTIDES, V100, P127, DOI 10.1016/j.peptides.2017.07.006
   MOLYNEUX RJ, 1982, SCIENCE, V216, P190, DOI 10.1126/science.6801763
   Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013
   Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107
   Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025
   Song JB, 2019, AGING DIS, V10, P1187, DOI 10.14336/AD.2019.0515
   Sun SQ, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1828-7
   Takeuchi A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02766
   Theodorou K, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00082
   Vion AC, 2017, P NATL ACAD SCI USA, V114, pE8675, DOI 10.1073/pnas.1702223114
   Wang N, 2015, J CELL BIOCHEM, V116, P242, DOI 10.1002/jcb.24961
   Wang PC, 2003, MECH AGEING DEV, V124, P1025, DOI 10.1016/j.mad.2003.08.005
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Yang F, 2016, CELL PHYSIOL BIOCHEM, V39, P1369, DOI 10.1159/000447841
   Yang LP, 2013, CHEM BIODIVERS, V10, P1004, DOI 10.1002/cbdv.201100444
   Yau WW, 2019, AUTOPHAGY, V15, P131, DOI 10.1080/15548627.2018.1511263
   Yin YL, 2017, INT J BIOCHEM CELL B, V84, P22, DOI 10.1016/j.biocel.2017.01.001
   Zhang HR, 2012, BIOCHEM J, V441, P417, DOI 10.1042/BJ20110621
   Zhao QP, 2015, INT IMMUNOPHARMACOL, V25, P242, DOI 10.1016/j.intimp.2015.02.001
   Zhou Y, 2018, INT J MOL MED, V42, P3093, DOI 10.3892/ijmm.2018.3868
   Zhu WZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0861-x
   Zhu XX, 2019, J CELL BIOCHEM, V120, P14127, DOI 10.1002/jcb.28688
   Zu Y, 2015, J GERIATR CARDIOL, V12, P270, DOI 10.11909/j.issn.1671-5411.2015.03.003
NR 43
TC 6
Z9 8
U1 1
U2 14
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD 2022 JUN
PY 2022
VL 80
IS 2
BP 341
EP 353
DI 10.1007/s12013-021-01058-w
EA FEB 2022
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 0Q3CZ
UT WOS:000749924600001
PM 35107747
DA 2024-02-19
ER

PT J
AU Kim, SM
   Yoo, JA
   Baek, JM
   Cho, KH
AF Kim, Seong-Min
   Yoo, Jeong-Ah
   Baek, Ji-Mi
   Cho, Kyung-Hyun
TI Diethyl phthalate exposure is associated with embryonic toxicity, fatty
   liver changes, and hypolipidemia via impairment of lipoprotein functions
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Diethyl phthalate; Atherosclerosis; Lipoprotein; Zebrafish; Embryo
   toxicity; Fatty liver
ID HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; URINARY CONCENTRATIONS;
   ACID ESTERS; ZEBRAFISH; ATHEROGENESIS; ACCUMULATION; INFLAMMATION;
   SENESCENCE; EXPRESSION
AB Diethyl phthalates (DEPs) are notorious for their high potential toxicity in endocrinological and reproduction systems in humans and animals. In this study, we investigated the toxic effects of DEP on human lipoproteins, macrophages, and zebrafish embryos. Treatment of human high-density lipoprotein (HDL) with DEP caused oxidation, aggregation, and degradation of lipoproteins. DEP treatment promoted foam cell formation via accelerated phagocytosis of LDL by macrophages as well as exacerbated cellular senescence in human dermal fibroblasts. Injection of DEP (final 5 mu M and 10 mu M) into zebrafish embryos caused severe embryo death and slower developmental speed. Exposure of zebrafish embryos to water containing DEP (final 11 and 22 ppm) caused early embryonic death along with the increased oxidized products and impairment of skeletal development. Adult zebrafish exposed to water containing DEP (final 11 and 22 ppm) for 4 weeks showed severe loss of body weight under both normal diet (ND) and high cholesterol diet (HCD) conditions. ND and HCD groups showed 59% and 49% reduction of plasma total cholesterol (TC), respectively. Serum levels of hepatic inflammation enzymes along with fatty liver changes were significantly elevated by DEP exposure. In conclusion, DEP showed strong pro-atherogenic and pro-senescence effects via severe lipoprotein modification inhuman cells. DEP caused impairment of embryonic development and severe loss of body weight, hypolipidemia, and fatty liver changes in zebrafish. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kim, Seong-Min; Yoo, Jeong-Ah; Baek, Ji-Mi; Cho, Kyung-Hyun] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.
   [Kim, Seong-Min; Yoo, Jeong-Ah; Baek, Ji-Mi; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Gyongsan 712749, South Korea.
   [Kim, Seong-Min; Yoo, Jeong-Ah; Baek, Ji-Mi; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Program Serum Biomed Res & Educ Team BK21Plus, Gyongsan 712749, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University
RP Cho, KH (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.
EM chok@yu.ac.kr
FU Mid-carrier Researcher Program [2014-11049455]; Medical Research Center
   Program through the National Research Foundation (NRF) - Ministry of
   Science, ICT and Future Planning of Korea [2015R1A5A2009124]; BK21 plus
   program of the National Research Foundation
FX This work was supported by a grant from the Mid-carrier Researcher
   Program (2014-11049455) and Medical Research Center Program
   (2015R1A5A2009124) through the National Research Foundation (NRF),
   funded by the Ministry of Science, ICT and Future Planning of Korea. The
   authors are grateful for the BK21 plus program of the National Research
   Foundation for the support of graduate students.
CR Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13
   Biegel LB, 1998, TOXICOL SCI, V44, P143, DOI 10.1006/toxs.1998.2469
   BREWER HB, 1986, METHOD ENZYMOL, V128, P223
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012
   Cheng LJ, 2013, AQUAT TOXICOL, V144, P124, DOI 10.1016/j.aquatox.2013.10.008
   Cho KH, 2011, J GERONTOL A-BIOL, V66, P1274, DOI 10.1093/gerona/glr169
   Daka B, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0034-1
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083
   Fang LH, 2012, FREE RADICAL BIO MED, V53, P1411, DOI 10.1016/j.freeradbiomed.2012.08.004
   FRAENKELCONRAT H, 1957, METHOD ENZYMOL, V4, P247, DOI 10.1016/0076-6879(57)04059-8
   Ghorpade N, 2002, ECOTOX ENVIRON SAFE, V53, P255, DOI 10.1006/eesa.2002.2212
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210
   Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434
   KAMRIN MA, 1991, J CLIN PHARMACOL, V31, P484, DOI 10.1002/j.1552-4604.1991.tb01908.x
   Kang JC, 2010, ECOTOX ENVIRON SAFE, V73, P1449, DOI 10.1016/j.ecoenv.2010.07.025
   Kim JY, 2015, CARDIOVASC TOXICOL, V15, P79, DOI 10.1007/s12012-014-9273-z
   Kim JY, 2013, CARDIOVASC TOXICOL, V13, P148, DOI 10.1007/s12012-012-9193-8
   Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001
   Kim S. M., 2014, CARDIOVASC IN PRESS
   Kumar N, 2014, REPROD TOXICOL, V49, P12, DOI 10.1016/j.reprotox.2014.06.008
   Lin Y., 2015, ENV TOXICOL
   Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004
   MATZ CE, 1982, J BIOL CHEM, V257, P4535
   Milla S, 2011, ECOTOXICOLOGY, V20, P305, DOI 10.1007/s10646-010-0588-7
   NOBLE RP, 1968, J LIPID RES, V9, P693
   Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004
   Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Park KH, 2014, TOXICOL SCI, V140, P16, DOI 10.1093/toxsci/kfu076
   Park KH, 2011, FISH SHELLFISH IMMUN, V31, P904, DOI 10.1016/j.fsi.2011.08.006
   Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016
   Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179
   Parkerton TF, 2000, ECOTOX ENVIRON SAFE, V45, P61, DOI 10.1006/eesa.1999.1841
   Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3
   Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723
   Sonde V, 2000, TOXICOLOGY, V147, P23, DOI 10.1016/S0300-483X(00)00164-5
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1
   Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211
   Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803
   Trede NS, 2001, TRENDS IMMUNOL, V22, P302, DOI 10.1016/S1471-4906(01)01939-1
   Uren-Webster TM, 2010, AQUAT TOXICOL, V99, P360, DOI 10.1016/j.aquatox.2010.05.015
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x
   Xu H, 2013, ECOTOX ENVIRON SAFE, V93, P39, DOI 10.1016/j.ecoenv.2013.03.038
   Yin F, 2013, J BIOCHEM MOL TOXIC, V27, P172, DOI 10.1002/jbt.21475
   Zhou J, 2011, ENVIRON POLLUT, V159, P1114, DOI 10.1016/j.envpol.2011.02.016
   Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681
NR 57
TC 31
Z9 36
U1 1
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD DEC 25
PY 2015
VL 30
IS 1
BP 383
EP 393
DI 10.1016/j.tiv.2015.09.026
PN B
PG 11
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA DA2OK
UT WOS:000367635500019
PM 26423653
DA 2024-02-19
ER

PT J
AU Kumari, S
   Semira, C
   Lee, M
   Lee, B
   Wong, R
   Nott, L
   Shapiro, J
   Gibbs, P
AF Kumari, Seema
   Semira, Christine
   Lee, Margaret
   Lee, Belinda
   Wong, Rachel
   Nott, Louise
   Shapiro, Jeremy
   Gibbs, Peter
TI Resection of colorectal cancer liver metastases in older patients
SO ANZ JOURNAL OF SURGERY
LA English
DT Article; Early Access
DE colorectal cancer; elderly; liver metastasis; liver resection
ID HEPATIC RESECTION; ELDERLY-PATIENTS; SURVIVAL; RECURRENCE; MANAGEMENT
AB Background Colorectal cancer remains a common cancer in the western world, with liver resection being the only potentially curative option for isolated colorectal cancer liver metastases (CRCLM). Cancer is a disease of aging, with the optimum management of elderly patients with CRCLM presenting an ongoing dilemma.
   Methods We analysed the outcome of CRCLM using prospectively collected patient data from the multidisciplinary Treatment of Recurrent and Advanced Colorectal Cancer registry, collected from July 2009 to July 2018 at 12 Australian hospitals.
   Results Of 2742 patients with metastatic colorectal cancer, liver-limited disease was present in 977 (36%) patients, of whom 338 (35%) underwent hepatic resection. Resection rates varied with age, including 186 (43%) of 428 patients aged 64 years and younger, 99 (40%) of 245 aged 65-75 years and 53 (17%) of 303 aged 76 and older (P < 0.001). The 30-day mortality rate was 0.9%. Median survival post resection also varied with age, 96 versus 89 versus 68 months (P < 0.001). In a separate analysis of the oldest patients, those aged over 80 years, where only 11% underwent resection, the median survival was 49 months.
   Conclusion The operative mortality for patients undergoing liver resection at Australian hospitals is low. With advancing age, the rate of liver resection of CRCLM and the post-resection survival decline. However, excellent survival outcomes can be achieved in selected elderly patients.
C1 [Kumari, Seema] Westmead Hosp, Med Oncol, Sydney, NSW, Australia.
   [Semira, Christine; Lee, Margaret; Lee, Belinda; Wong, Rachel; Gibbs, Peter] Walter & Eliza Hall Inst Med Res, Med Oncol, Melbourne, Vic, Australia.
   [Lee, Margaret; Gibbs, Peter] Western Hlth, Med Oncol, Sydney, NSW, Australia.
   [Lee, Margaret] Eastern Hlth, Med Oncol, Melbourne, Vic, Australia.
   [Lee, Margaret; Lee, Belinda; Wong, Rachel; Gibbs, Peter] Univ Melbourne, Med & Oncol, Melbourne, Vic, Australia.
   [Lee, Margaret; Wong, Rachel] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia.
   [Nott, Louise] Royal Hobart Hosp, Med Oncol, Hobart, Tas, Australia.
   [Shapiro, Jeremy] Cabrini Hlth, Med Oncol, Melbourne, Vic, Australia.
C3 NSW Health; Westmead Hospital; University of Sydney; University of
   Melbourne; Monash University; Royal Hobart Hospital; Cabrini Health
RP Kumari, S (corresponding author), Westmead Hosp, Crown Princess Mary Canc Ctr, Hawkesbury Rd, Wentworthville, NSW 2145, Australia.
EM seemaks18@yahoo.in
OI Wong, Rachel/0000-0002-4926-5689; Lee, Belinda/0000-0002-0947-9834
FU Roche Products Pty Ltd (Australia); Roche
FX We wish to thank Mr Michael Harold and Ms Julie Johns for their
   assistance with data extraction and analysis. The TRACC registry is
   supported by Roche Products Pty Ltd (Australia). Roche has provided
   financial assistance for the development, installation and maintenance
   of this clinical database.
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   [Anonymous], [No title captured]
   Australian Institute of Health and Welfare, LIF EXP DEATHS
   Australian Institute of Health and Welfare, DEATHS AUSTR
   Basso M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003722
   Berri RN, 2009, CURR ONCOL REP, V11, P200, DOI 10.1007/s11912-009-0029-z
   Booth CM, 2015, JAMA ONCOL, V1, P1111, DOI 10.1001/jamaoncol.2015.2943
   Charnsangavej C, 2006, ANN SURG ONCOL, V13, P1261, DOI 10.1245/s10434-006-9023-y
   Cummings LC, 2007, CANCER, V109, P718, DOI 10.1002/cncr.22448
   de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b
   de Ridder JAM, 2016, DIGEST SURG, V33, P104, DOI 10.1159/000441802
   Fenton HM, 2019, ANN SURG, V270, P892, DOI 10.1097/SLA.0000000000003534
   Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004
   Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285
   Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278
   Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf
   Misiakos EP, 2011, WORLD J GASTROENTERO, V17, P4067, DOI 10.3748/wjg.v17.i36.4067
   Nardo B, 2016, INT J SURG, V33, pS135, DOI 10.1016/j.ijsu.2016.06.014
   Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2
   't Lam-Boer J, 2015, EJSO-EUR J SURG ONC, V41, P1217, DOI 10.1016/j.ejso.2015.05.014
NR 20
TC 5
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1445-1433
EI 1445-2197
J9 ANZ J SURG
JI ANZ J. Surg.
PD 2020 MAY
PY 2020
VL 90
IS 5
BP 796
EP 801
DI 10.1111/ans.15750
EA FEB 2020
PG 6
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA LO2HB
UT WOS:000514118200001
PM 32072725
OA Green Published
DA 2024-02-19
ER

PT J
AU López-Lluch, G
AF Lopez-Lluch, Guillermo
TI Mitochondrial activity and dynamics changes regarding metabolism in
   ageing and obesity
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Mitochondria; Ageing; Fat; Gender; Inflammation
ID HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE AMPK; BETA-CELL FUNCTION; CALORIE
   RESTRICTION; INSULIN-RESISTANCE; OXIDATIVE STRESS; ADIPOSE-TISSUE;
   DIRECT PHOSPHORYLATION; REGULATE AUTOPHAGY; ISOMERASE PIN1
AB Mitochondria play an essential role in ageing and longevity. During ageing, a general deregulation of metabolism occurs, affecting molecular, cellular and physiological activities in the organism. Dysfunction of mitochondria has been associated with ageing and age-related diseases indicating their importance in the maintenance of cell homeostasis. Three major nutritional sensors, mTOR, AMPI( and Sirtuins are involved in the control of mitochondrial physiology. These nutritional sensors control mitochondrial biogenesis, dynamics by regulating fusion and fission processes, and turnover through mito- and autophagy. Apart of the known factors involved in fusion, OPA1 and mitofusins, and fission, DRP1 and FIS1, emerging factors such as prohibitins and sestrins can play important functions in mitochondrial dynamics regulation. Mitochondria is also affected by sexual hormones that suffer drastic changes during ageing. The recent literature demonstrates the complex interaction between nutritional sensors and mitochondrial homeostasis in the physiology of adipose tissue and in the accumulation of fat in other organs such as muscle and liver. In this article, the role of mitochondrial homeostasis in ageing and age-dependent fat accumulation is revised. This review highlights the importance of mitochondria in the accumulation of fat during ageing and related diseases such as obesity, metabolic syndrome or type 2 diabetes mellitus. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Lopez-Lluch, Guillermo] Univ Pablo Olavide, CABD CSIC, CIBERER, Inst Salud Carlos 3,Dept Fisiol Anatomia & Biol C, Seville 41013, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo
   Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de
   Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)
RP López-Lluch, G (corresponding author), Univ Pablo Olavide, CABD, Dept Physiol Anat & Cell Biol, Carretera Utrera Km 1, Seville 41013, Spain.
EM glopllu@upo.es
RI Lopez-Lluch, Guillermo/N-4742-2014
OI Lopez-Lluch, Guillermo/0000-0001-9830-8502
FU Andalusian Government (FEDER funds of European Commission) [BIO177];
   Spanish Ministry of Economy and Competitiveness [DEP2012-39985]
FX The research group is funded by the Andalusian Government grant BIO177
   (FEDER funds of European Commission). Research has been funded by the
   Spanish Ministry of Economy and Competitiveness grant DEP2012-39985.
   Author is also member of the CIBERER, Instituto Carlos III, of the
   Spanish Ministry of Health.
CR Abdesselem H, 2016, J BIOL CHEM, V291, P2119, DOI 10.1074/jbc.M115.675645
   Abranches MV, 2015, NUTR RES REV, V28, P121, DOI 10.1017/S0954422415000098
   Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11
   Allan CA, 2008, J CLIN ENDOCR METAB, V93, P139, DOI 10.1210/jc.2007-1291
   Ande SR, 2014, DIABETES, V63, P3734, DOI 10.2337/db13-1807
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   [Anonymous], J PHYSL, V526, P203
   Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466
   Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002
   Barbieri Elena, 2013, Muscles Ligaments Tendons J, V3, P254
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2010, SCIENCE, V329, P1012, DOI 10.1126/science.329.5995.1012
   Benigni A, 2016, ANTIOXID REDOX SIGN, V25, P185, DOI 10.1089/ars.2016.6682
   Benkhalifa M, 2014, INT J BIOCHEM CELL B, V55, P60, DOI 10.1016/j.biocel.2014.08.011
   BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219
   Biala AK, 2015, J MOL CELL CARDIOL, V83, P37, DOI 10.1016/j.yjmcc.2015.04.015
   Biel TG, 2016, CELL DEATH DIFFER, V23, P279, DOI 10.1038/cdd.2015.96
   Borengasser SJ, 2014, PHYSIOL GENOMICS, V46, P841, DOI 10.1152/physiolgenomics.00059.2014
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Tung BT, 2015, AGING CLIN EXP RES, V27, P775, DOI 10.1007/s40520-015-0366-8
   Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004
   Tung BT, 2014, J GERONTOL A-BIOL, V69, P398, DOI 10.1093/gerona/glt102
   Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002
   Capt C, 2016, MITOCHONDRIAL DNA A, V27, P3098, DOI 10.3109/19401736.2014.1003924
   Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Cavalcanti-de-Albuquerque JPA, 2014, J APPL PHYSIOL, V116, P779, DOI 10.1152/japplphysiol.00121.2013
   Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51
   Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Choi M, 2015, MOL CELL BIOCHEM, V407, P181, DOI 10.1007/s11010-015-2468-1
   Chung KW, 2015, AGING CELL, V14, P524, DOI 10.1111/acel.12305
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005
   Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019
   DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W
   Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0
   Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004
   Dolinsky VW, 2013, AM J PHYSIOL-ENDOC M, V305, pE243, DOI 10.1152/ajpendo.00044.2013
   Düvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Fabbri E., 2017, DIABETES
   Feige J. N., 2008, CURR PROTOC MOL BIOL, V25
   Fuku N, 2015, AGING CELL, V14, P921, DOI 10.1111/acel.12389
   Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214
   Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442
   Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771
   Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072
   Gonzalez-Freire M., 2015, J GERONTOL A
   Goto T, 2009, ADV EXP MED BIOL, V665, P171
   Gouspillou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103044
   Gram M, 2015, J PHYSIOL-LONDON, V593, P4011, DOI 10.1113/JP270211
   Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200
   Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013
   Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113
   Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629
   Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925
   Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352
   He B, 2011, ENDOCRINOLOGY, V152, P1047, DOI 10.1210/en.2010-0732
   Holmström MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011
   Hou YS, 2015, MOL CELL BIOL, V35, P2740, DOI 10.1128/MCB.00285-15
   Huffman DM, 2009, BBA-GEN SUBJECTS, V1790, P1117, DOI 10.1016/j.bbagen.2009.01.008
   Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jheng HF, 2015, ANN NY ACAD SCI, V1350, P82, DOI 10.1111/nyas.12863
   Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11
   Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z
   Jin SH, 2013, TOXICOL APPL PHARM, V271, P95, DOI 10.1016/j.taap.2013.04.023
   Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200
   Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001
   Kang T, 2013, J BIOL CHEM, V288, P34394, DOI 10.1074/jbc.M113.514372
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Koliaki C, 2016, ANNU REV NUTR, V36, P337, DOI 10.1146/annurev-nutr-071715-050656
   Kovalenko EI, 2014, ONCOTARGET, V5, P11800, DOI 10.18632/oncotarget.2856
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Larsen S, 2012, ACTA PHYSIOL, V205, P423, DOI 10.1111/j.1748-1716.2012.02408.x
   Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565
   Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI [10.1016/j.tem.2013.01.005, 10.1016/j.technovation.2020.102140]
   Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906
   Li G, 2015, J ENERGY INST, V1, P1, DOI DOI 10.1016/J.ATHER0SCLER0SIS.2015.09.020
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613
   Liu XM, 2015, AGING CELL, V14, P409, DOI 10.1111/acel.12331
   Liu YH, 2014, AGING-US, V6, P742, DOI 10.18632/aging.100688
   Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Losón OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721
   Lourenço AB, 2015, BBA-BIOENERGETICS, V1847, P1457, DOI 10.1016/j.bbabio.2015.06.003
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011
   Lupfer CR, 2012, VIRULENCE, V3, P262, DOI 10.4161/viru.20266
   Mahboobi H, 2014, CNS NEUROL DISORD-DR, V13, P543, DOI 10.2174/1871527312666131223110147
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Martin-Montalvo A, 2013, ANTIOXID REDOX SIGN, V19, P310, DOI 10.1089/ars.2012.4866
   Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76
   Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104
   McDonagh B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00005
   McRae S, 2016, J BIOL CHEM, V291, P3254, DOI 10.1074/jbc.M115.694059
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mudali S, 2004, MECH AGEING DEV, V125, P297, DOI 10.1016/j.mad.2004.01.004
   Nakatsu Y, 2015, J BIOL CHEM, V290, P24255, DOI 10.1074/jbc.M115.658559
   Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904
   Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Newsholme P, 2014, CURR OPIN CLIN NUTR, V17, P295, DOI 10.1097/MCO.0000000000000077
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075
   Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029
   Palus S, 2014, J CACHEXIA SARCOPENI, V5, P193, DOI 10.1007/s13539-014-0157-7
   Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Peng J, 2016, MITOCHONDRION, V28, P49, DOI 10.1016/j.mito.2016.03.007
   Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149
   Psarra AMG, 2006, ANN NY ACAD SCI, V1088, P12, DOI 10.1196/annals.1366.019
   Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rhee SG, 2015, FREE RADICAL BIO MED, V88, P205, DOI 10.1016/j.freeradbiomed.2015.06.007
   Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Rodríguez-Bies E, 2016, BRIT J NUTR, V116, P979, DOI 10.1017/S0007114516002920
   Rodríguez-Bies E, 2015, J GERONTOL A-BIOL, V70, P33, DOI 10.1093/gerona/glu002
   Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Sanchis-Gomar F, 2013, J CELL PHYSIOL, V228, P1647, DOI 10.1002/jcp.24338
   Santa-Cruz Calvo S, 2012, BIOENERGETICS, P95
   Santanasto Goodpaster B. H., 2016, J GERONTOL A
   Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71
   Sastre-Serra J, 2013, INT J BIOCHEM CELL B, V45, P1509, DOI 10.1016/j.biocel.2013.04.007
   Sastre-Serra J, 2012, INT J BIOCHEM CELL B, V44, P1901, DOI 10.1016/j.biocel.2012.07.012
   Sataranatarajan K, 2016, J GERONTOL A-BIOL, V71, P850, DOI 10.1093/gerona/glv170
   Scarpace PJ, 2016, J GERONTOL A-BIOL, V71, P891, DOI 10.1093/gerona/glu230
   Scheller K, 2003, INT REV CYTOL, V222, P1
   Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Sekeris C E, 1990, In Vivo, V4, P317
   Senesi P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8274689
   Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509
   Sreekumar PG, 2016, INVEST OPHTH VIS SCI, V57, P1238, DOI 10.1167/iovs.15-17053
   Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434
   Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108
   Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539
   Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033
   Toledo FGS, 2013, MOL CELL ENDOCRINOL, V379, P30, DOI 10.1016/j.mce.2013.06.018
   Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Vasconsuelo A, 2013, AGEING RES REV, V12, P907, DOI 10.1016/j.arr.2013.09.001
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096
   Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043
   Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111
   Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
   Zorzano A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00101
   Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004
NR 204
TC 66
Z9 72
U1 2
U2 31
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2017
VL 162
BP 108
EP 121
DI 10.1016/j.mad.2016.12.005
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA ER5XJ
UT WOS:000398877300015
PM 27993601
OA Green Submitted
DA 2024-02-19
ER

PT J
AU He, QQ
   Au, BJ
   Kulkarni, M
   Shen, Y
   Lim, KJ
   Maimaiti, J
   Wong, CK
   Luijten, MNH
   Chong, HC
   Lim, EH
   Rancati, G
   Sinha, I
   Fu, ZY
   Wang, XM
   Connolly, JE
   Crasta, KC
AF He, Qianqian
   Au, Bijin
   Kulkarni, Madhura
   Shen, Yang
   Lim, Kah J.
   Maimaiti, Jiamila
   Wong, Cheng Kit
   Luijten, Monique N. H.
   Chong, Han C.
   Lim, Elaine H.
   Rancati, Giulia
   Sinha, Indrajit
   Fu, Zhiyan
   Wang, Xiaomeng
   Connolly, John E.
   Crasta, Karen C.
TI Chromosomal instability-induced senescence potentiates cell
   non-autonomous tumourigenic effects
SO ONCOGENESIS
LA English
DT Article
ID TUMOR-CELLS; RNA-SEQ; COLLECTIVE INVASION; LIVER-CANCER; ANEUPLOIDY;
   GENE; EVOLUTION; P53; PROLIFERATION; TETRAPLOIDY
AB Chromosomal instability (CIN), a high rate of chromosome loss or gain, is often associated with poor prognosis and drug resistance in cancers. Aneuploid, including near-polyploid, cells contain an abnormal number of chromosomes and exhibit CIN. The post-mitotic cell fates following generation of different degrees of chromosome mis-segregation and aneuploidy are unclear. Here we used aneuploidy inducers, nocodazole and reversine, to create different levels of aneuploidy. A higher extent of aneuploid and near-polyploid cells in a given population led to senescence. This was in contrast to cells with relatively lower levels of abnormal ploidy that continued to proliferate. Our findings revealed that senescence was accompanied by DNA damage and robust p53 activation. These senescent cells acquired the senescence-associated secretory phenotype (SASP). Depletion of p53 reduced the number of senescent cells with concomitant increase in cells undergoing DNA replication. Characterisation of these SASP factors demonstrated that they conferred paracrine pro-tumourigenic effects such as invasion, migration and angiogenesis both in vitro and in vivo. Finally, a correlation between increased aneuploidy and senescence was observed at the invasive front in breast carcinomas. Our findings demonstrate functional non-equivalence of discernable aneuploidies on tumourigenesis and suggest a cell non-autonomous mechanism by which aneuploidy-induced senescent cells and SASP can affect the tumour microenvironment to promote tumour progression.
C1 [He, Qianqian; Kulkarni, Madhura; Luijten, Monique N. H.; Chong, Han C.; Wang, Xiaomeng; Crasta, Karen C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [He, Qianqian; Crasta, Karen C.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Au, Bijin; Wang, Xiaomeng; Connolly, John E.; Crasta, Karen C.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.
   [Shen, Yang; Fu, Zhiyan] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.
   [Lim, Kah J.; Maimaiti, Jiamila; Sinha, Indrajit] Acenzia Inc, Windsor, ON, Canada.
   [Wong, Cheng Kit; Rancati, Giulia] Agcy Sci Technol & Res, Inst Med Biol, Singapore, Singapore.
   [Lim, Elaine H.] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.
   [Connolly, John E.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Connolly, John E.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA.
   [Crasta, Karen C.] Imperial Coll London, Dept Med, London, England.
   [Kulkarni, Madhura] Indian Inst Sci Educ & Res, Transnatl Canc Res Ctr Prashanti Canc Care Missio, Pune, Maharashtra, India.
C3 Nanyang Technological University; Nanyang Technological University;
   Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Molecular & Cell Biology (IMCB); Agency for Science Technology &
   Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency
   for Science Technology & Research (A*STAR); A*STAR - Institute of
   Medical Biology (IMB); National Cancer Centre Singapore (NCCS); National
   University of Singapore; Baylor University; Imperial College London;
   Indian Institute of Science Education & Research (IISER) Pune
RP Crasta, KC (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Crasta, KC (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Crasta, KC (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.; Crasta, KC (corresponding author), Imperial Coll London, Dept Med, London, England.
EM kccrasta@ntu.edu.sg
RI Kulkarni, Madhura/HTP-5295-2023; Crasta, Karen C/F-8752-2015; Wang,
   Xiaomeng/F-9504-2015
OI Crasta, Karen C/0000-0001-9849-6080; Kulkarni,
   Madhura/0000-0002-0406-5739; Wang, Xiaomeng/0000-0002-1036-2764
FU National Research Foundation, Prime Minister's Office, Singapore, under
   its NRF Fellowship Programme (NRF Award) [NRF-NRFF2013-10]; Nanyang
   Assistant Professorship Grant, Nanyang Technological University;
   Singapore Ministry of Education Academic Research Fund Tier 1
   [2015-T1-002-046-01]; Singapore Ministry of Education Academic Research
   Fund Tier 2 [2015-T2-1-023]
FX We thank members of the Crasta Lab for critical reading of the
   manuscript. This work was supported by the National Research Foundation,
   Prime Minister's Office, Singapore, under its NRF Fellowship Programme
   (NRF Award Number NRF-NRFF2013-10), the Nanyang Assistant Professorship
   Grant, Nanyang Technological University and the Singapore Ministry of
   Education Academic Research Fund Tier 1 (Grant Number:
   2015-T1-002-046-01) and Tier 2 (Grant No.: 2015-T2-1-023). We thank
   Advanced Molecular Pathology Laboratory (AMPL) at SingHealth for FISH
   analyses on tissue sections.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Andriani GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35218
   Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643
   Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485
   Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861
   Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029
   Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Coward J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00123
   Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399
   Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044
   DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196
   Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285
   Dürrbaum M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-139
   Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217
   Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835
   Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7
   Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449
   Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55
   Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828
   Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214
   Johmura Y, 2016, CANCER SCI, V107, P1550, DOI 10.1111/cas.13060
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15208
   Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuo LJ, 2008, IN VIVO, V22, P305
   Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610
   Laughney AM, 2015, CELL REP, V12, P809, DOI 10.1016/j.celrep.2015.06.065
   Li RH, 2005, CANCER GENET CYTOGEN, V163, P44, DOI 10.1016/j.cancergencyto.2005.05.003
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017
   Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411
   McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61
   Orr B, 2016, CELL REP, V17, P1755, DOI 10.1016/j.celrep.2016.10.030
   Passerini V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10754
   Pawlikowski JS, 2013, J CELL SCI, V126, P4061, DOI 10.1242/jcs.109728
   Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061
   Risques RA, 2001, LAB INVEST, V81, P307, DOI 10.1038/labinvest.3780239
   Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022
   Santaguida S, 2015, GENE DEV, V29, P2010, DOI 10.1101/gad.269118.115
   Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   SHACKNEY SE, 1989, CANCER RES, V49, P3344
   Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109
   Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822
   Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019
   te Poele RH, 2002, CANCER RES, V62, P1876
   Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029
   Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034
   Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145
   Wangsa D, 2018, FASEB J, V32, P3502, DOI 10.1096/fj.201700247RR
   Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003
   Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang LX, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.49
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zasadil LM, 2013, SEMIN CELL DEV BIOL, V24, P370, DOI 10.1016/j.semcdb.2013.02.001
NR 68
TC 39
Z9 48
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 2157-9024
J9 ONCOGENESIS
JI Oncogenesis
PD AUG 15
PY 2018
VL 7
AR 62
DI 10.1038/s41389-018-0072-4
PG 18
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA GQ8QH
UT WOS:000442021500002
PM 30108207
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Osborne, B
   Reznick, J
   Wright, LE
   Sinclair, DA
   Cooney, GJ
   Turner, N
AF Osborne, Brenna
   Reznick, Jane
   Wright, Lauren E.
   Sinclair, David A.
   Cooney, Gregory J.
   Turner, Nigel
TI Liver-specific overexpression of SIRT3 enhances oxidative metabolism,
   but does not impact metabolic defects induced by high fat feeding in
   mice
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE SIRT3; Sirtuin; Liver; Obesity; Mouse
ID INDUCED INSULIN-RESISTANCE; ACID OXIDATION; MITOCHONDRIAL-FUNCTION;
   DEACETYLASE SIRT3; DISEASE; ACCUMULATION; DEFICIENCY; SIRTUINS; MUSCLE;
   CHAIN
AB The mitochondrial enzyme SIRT3 is an NAD(+)-dependent deacetylase important in cell metabolism, and a decline in its protein expression or activity has been linked with insulin resistance in obesity, ageing and type 2 diabetes. While studies in SIRT3 knockout mice have dramatically improved our understanding of the function of SIRT3, the impact of increasing SIRT3 levels remains under-examined. In this study we investigated the effects of liver-specific SIRT3 overexpression in mice on mitochondrial function and metabolic profile in both isolated hepatocytes and in vivo. Primary hepatocytes overexpressing SIRT3 displayed increased oxygen consumption and a reduction in triglyceride accumulation. In mice with hepatic SIRT3 overexpression, increased fasting beta-hydroxybutyrate levels were observed, coupled with an increase in oxygen consumption in isolated mitochondria and increased substrate utilization in liver homogenates. However, metabolic profiling of mice exposed to either chow or high-fat diet revealed no effect of hepatic SIRT3 overexpression on glucose tolerance, body composition or tissue triglyceride accumulation. These findings suggest limited whole-body benefit of increasing hepatic SIRT3 during the development of diet-induced insulin resistance. (C) 2022 Published by Elsevier Inc.
C1 [Osborne, Brenna; Turner, Nigel] UNSW, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.
   [Osborne, Brenna; Reznick, Jane; Wright, Lauren E.; Cooney, Gregory J.; Turner, Nigel] Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW, Australia.
   [Sinclair, David A.] Harvard Med Sch, Dept Genet, Boston, MA USA.
   [Osborne, Brenna] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Hlth Aging, Copenhagen, Denmark.
   [Cooney, Gregory J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Turner, Nigel] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.
C3 University of New South Wales Sydney; Garvan Institute of Medical
   Research; Harvard University; Harvard Medical School; University of
   Copenhagen; University of Sydney; Victor Chang Cardiac Research
   Institute
RP Turner, N (corresponding author), UNSW, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.
EM n.turner@victorchang.edu.au
RI Osborne, Brenna/F-5950-2018
OI Osborne, Brenna/0000-0002-0197-3010
FU National Health and Medical Research Council of Australia (NHMRC)
   [APP1043779, APP1017534]; NHMRC [APP1003313]; Australian Research
   Council Future Fellowship [FT120100371]; Australian Research Council
   [FT120100371] Funding Source: Australian Research Council
FX We thank the Biological Testing Facility at the Garvan Institute for
   assistance with animal care. This work was supported by the National
   Health and Medical Research Council of Australia (NHMRC; APP1043779) .
   BO was supported by a PhD scholarship (APP1017534) and GJC by a research
   fellowship from the NHMRC (APP1003313) . NT was supported by an
   Australian Research Council Future Fellowship (FT120100371) .
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226
   Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168
   de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028
   Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007
   Fernandez-Marcos PJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00425
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Lantier L, 2015, DIABETES, V64, P3081, DOI 10.2337/db14-1810
   Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Luongo TS, 2020, NATURE, V588, P174, DOI 10.1038/s41586-020-2741-7
   Montgomery MK, 2016, BBA-MOL CELL BIOL L, V1861, P1828, DOI 10.1016/j.bbalip.2016.08.016
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8
   Osborne B, 2016, FREE RADICAL BIO MED, V100, P164, DOI 10.1016/j.freeradbiomed.2016.04.197
   Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530
   Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004
   Porter LC, 2018, AM J PHYSIOL-ENDOC M, V315, pE520, DOI 10.1152/ajpendo.00057.2018
   Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110
   Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Small L, 2019, MOL METAB, V25, P107, DOI 10.1016/j.molmet.2019.04.006
   Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1
   Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093
   Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179
   Wu T, 2014, ANN CLIN LAB SCI, V44, P410
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
NR 40
TC 6
Z9 7
U1 2
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2022 JUN 4
PY 2022
VL 607
BP 131
EP 137
DI 10.1016/j.bbrc.2022.03.088
EA MAR 2022
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 2R2PI
UT WOS:000820951600019
PM 35367825
DA 2024-02-19
ER

PT J
AU Senturk, S
   Mumcuoglu, M
   Gursoy-Yuzugullu, O
   Cingoz, B
   Akcali, KC
   Ozturk, M
AF Senturk, Serif
   Mumcuoglu, Mine
   Gursoy-Yuzugullu, Ozge
   Cingoz, Burcu
   Akcali, Kamil Can
   Ozturk, Mehmet
TI Transforming Growth Factor-Beta Induces Senescence in Hepatocellular
   Carcinoma Cells and Inhibits Tumor Growth
SO HEPATOLOGY
LA English
DT Article
ID TGF-BETA; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; LIVER;
   HEPATOCYTES; EXPRESSION; APOPTOSIS; HEPATITIS; CIRRHOSIS; PROTEINS
AB Senescence induction could be used as an effective treatment for hepatocellular carcinoma (HCC). However, major senescence inducers (p53 and p16(Ink4a)) are frequently inactivated in these cancers. We tested whether transforming growth factor-beta (TGF-beta) could serve as a potential senescence inducer in HCC. First, we screened for HCC cell lines with intact TGF-beta signaling that leads to small mothers against decapentaplegic (Smad)-targeted gene activation. Five cell lines met this condition, and all of them displayed a strong senescence response to TGF-beta 1 (1-5 ng/mL) treatment. Upon treatment, c-myc was down-regulated, p21(Cip1) and p15(Ink4b) were up-regulated, and cells were arrested at G(1). The expression of p16(Ink4a) was not induced, and the senescence response was independent of p53 status. A short exposure of less than 1 minute was sufficient for a robust senescence response. Forced expression of p21(Cip1) and p15(Ink4b) recapitulated TGF-beta 1 effects. Senescence response was associated with reduced nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4) induction and intracellular reactive oxygen species (ROS) accumulation. The treatment of cells with the ROS scavenger N-acetyl-L-cysteine, or silencing of the NOX4 gene, rescued p21(Cip1) and p15(Ink4b) accumulation as well as the growth arrest in response to TGF-beta. Human HCC tumors raised in immunodeficient mice also displayed TGF-beta 1 induced senescence. More importantly, peritumoral injection of TGF-beta 1 (2 ng) at 4-day intervals reduced tumor growth by more than 75%. In contrast, the deletion of TGF-beta receptor 2 abolished in vitro senescence response and greatly accelerated in vivo tumor growth. Conclusion: TGF-beta induces p53-independent and p16(Ink4a)-independent, but Nox4-dependent, p21(Cip1)-dependent, p15(Ink4b)-dependent, and ROS-dependent senescence arrest in well-differentiated HCC cells. Moreover, TGF-beta induced senescence in vivo is associated with a strong antitumor response against HCC. (HEPATOLOGY 2010;52:966-974)
C1 [Gursoy-Yuzugullu, Ozge; Ozturk, Mehmet] Univ Grenoble 1, Inst Albert Bonniot, INSERM, Ctr Rech,U823, La Tronche, France.
   [Senturk, Serif; Mumcuoglu, Mine; Gursoy-Yuzugullu, Ozge; Cingoz, Burcu; Akcali, Kamil Can; Ozturk, Mehmet] Bilkent Univ, BilGen Res Ctr, Ankara, Turkey.
   [Senturk, Serif; Mumcuoglu, Mine; Gursoy-Yuzugullu, Ozge; Cingoz, Burcu; Akcali, Kamil Can; Ozturk, Mehmet] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA);
   Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University
RP Ozturk, M (corresponding author), UJF, Inst Albert Bonniot, INSERM, Ctr Rech,U823, Grenoble, France.
EM ozturkm@ujf-grenoble.fr
RI ozturk, mehmet/G-3330-2014; Insal, Burcu/AAD-5924-2020; Senturk,
   Serif/A-1263-2017; OZTURK, MEHMET/AAS-7241-2021; Öztürk,
   Mehmet/JFJ-3399-2023
OI Senturk, Serif/0000-0003-3963-2294; OZTURK, MEHMET/0000-0002-6092-9706;
   Akcali, Kamil/0000-0002-7816-6938; Insal, Burcu/0000-0003-3354-6424
FU TUBITAK and State Planning Office (Turkey); Institut National de Cancer
   (France)
FX This work was supported by grants from the TUBITAK and State Planning
   Office (Turkey) and the Institut National de Cancer (France). Additional
   support was provided by the Turkish Academy of Sciences.
CR Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568
   Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021
   Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135
   Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283
   Delhaye M, 1999, J HEPATOL, V30, P461, DOI 10.1016/S0168-8278(99)80106-8
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020
   Herzer K, 2005, HEPATOLOGY, V42, P183, DOI 10.1002/hep.20757
   Ikeda H, 2009, HUM PATHOL, V40, P1774, DOI 10.1016/j.humpath.2009.06.009
   Ikeda H, 2009, PATHOL INT, V59, P471, DOI 10.1111/j.1440-1827.2009.02395.x
   INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359
   Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513
   Kojiro M, 2002, ONCOLOGY-BASEL, V62, P43, DOI 10.1159/000048275
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783
   LIN JK, 1992, CANCER RES, V52, P385
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   OBERHAMMER F, 1991, CANCER RES, V51, P2478
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   PONCHEL F, 1994, CANCER RES, V54, P2064
   Roncalli M, 2002, HEPATOLOGY, V36, P427, DOI 10.1053/jhep.2002.34852
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416
   SANDLER MA, 1994, J BIOL CHEM, V269, P21500
   Sayan BS, 2001, J CELL BIOL, V155, P719, DOI 10.1083/jcb.200106044
   Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208
   Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90
   Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1
NR 43
TC 172
Z9 192
U1 0
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD SEP
PY 2010
VL 52
IS 3
BP 966
EP 974
DI 10.1002/hep.23769
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 645AJ
UT WOS:000281423000019
PM 20583212
OA Bronze
DA 2024-02-19
ER

PT J
AU Sbierski-Kind, J
   Grenkowitz, S
   Schlickeiser, S
   Sandforth, A
   Friedrich, M
   Kunkel, D
   Glauben, R
   Brachs, S
   Mai, K
   Thürmer, A
   Radonic, A
   Drechsel, O
   Turnbaugh, PJ
   Bisanz, JE
   Volk, HD
   Spranger, J
   von Schwartzenberg, RJ
AF Sbierski-Kind, Julia
   Grenkowitz, Sophia
   Schlickeiser, Stephan
   Sandforth, Arvid
   Friedrich, Marie
   Kunkel, Desiree
   Glauben, Rainer
   Brachs, Sebastian
   Mai, Knut
   Thuermer, Andrea
   Radonic, Aleksandar
   Drechsel, Oliver
   Turnbaugh, Peter J.
   Bisanz, Jordan E.
   Volk, Hans-Dieter
   Spranger, Joachim
   von Schwartzenberg, Reiner Jumpertz
TI Effects of caloric restriction on the gut microbiome are linked with
   immune senescence
SO MICROBIOME
LA English
DT Article
DE Gut microbiota; Adaptive immune system; Caloric restriction; Obesity;
   Immune senescence
ID ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; T-CELLS; OBESITY;
   ASSOCIATION; METAGENOME; CANCER
AB Background: Caloric restriction can delay the development of metabolic diseases ranging from insulin resistance to type 2 diabetes and is linked to both changes in the composition and metabolic function of the gut microbiota and immunological consequences. However, the interaction between dietary intake, the microbiome, and the immune system remains poorly described.
   Results: We transplanted the gut microbiota from an obese female before (AdLib) and after (CalRes) an 8-week very-low-calorie diet (800 kcal/day) into germ-free mice. We used 16S rRNA sequencing to evaluate taxa with differential abundance between the AdLib- and CalRes-microbiota recipients and single-cell multidimensional mass cytometry to define immune signatures in murine colon, liver, and spleen. Recipients of the CalRes sample exhibited overall higher alpha diversity and restructuring of the gut microbiota with decreased abundance of several microbial taxa (e.g., Clostridium ramosum, Hungatella hathewayi, Alistipi obesi). Transplantation of CalRes-microbiota into mice decreased their body fat accumulation and improved glucose tolerance compared to AdLib-microbiota recipients. Finally, the CalRes-associated microbiota reduced the levels of intestinal effector memory CD8(+)T cells, intestinal memory B cells, and hepatic effector memory CD4(+) and CD8(+)T cells.
   Conclusion: Caloric restriction shapes the gut microbiome which can improve metabolic health and may induce a shift towards the naive T and B cell compartment and, thus, delay immune senescence. Understanding the role of the gut microbiome as mediator of beneficial effects of low calorie diets on inflammation and metabolism may enhance the development of new therapeutic treatment options for metabolic diseases.
C1 [Sbierski-Kind, Julia; Grenkowitz, Sophia; Sandforth, Arvid; Friedrich, Marie; Brachs, Sebastian; Mai, Knut; Spranger, Joachim; von Schwartzenberg, Reiner Jumpertz] Charite Univ Med Berlin, Dept Endocrinol & Metab, Charitepl 1, D-10117 Berlin, Germany.
   [Sbierski-Kind, Julia; Grenkowitz, Sophia; Sandforth, Arvid; Friedrich, Marie; Glauben, Rainer; Brachs, Sebastian; Mai, Knut; Volk, Hans-Dieter; Spranger, Joachim; von Schwartzenberg, Reiner Jumpertz] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.
   [Sbierski-Kind, Julia; Grenkowitz, Sophia; Sandforth, Arvid; Friedrich, Marie; Glauben, Rainer; Brachs, Sebastian; Mai, Knut; Volk, Hans-Dieter; Spranger, Joachim; von Schwartzenberg, Reiner Jumpertz] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany.
   [Sbierski-Kind, Julia; Schlickeiser, Stephan; Kunkel, Desiree; Mai, Knut; Volk, Hans-Dieter; Spranger, Joachim] Berlin Inst Hlth BIH, Berlin, Germany.
   [Schlickeiser, Stephan] Charite Univ Med Berlin, BIH Ctr Regenerat Therapies BCRT, Berlin, Germany.
   [Sandforth, Arvid; von Schwartzenberg, Reiner Jumpertz] Univ Tubingen, Helmholtz Ctr Munich, Lnstitute Diabet Res & Metab Dis, Tubingen, Germany.
   [Kunkel, Desiree] Charite Univ Med Berlin, Berlin Inst Hlth, Flow & Mass Cytometry Core Facil, Berlin, Germany.
   [Glauben, Rainer] Med Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany.
   [Brachs, Sebastian; Mai, Knut; Spranger, Joachim; von Schwartzenberg, Reiner Jumpertz] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.
   [Thuermer, Andrea; Radonic, Aleksandar; Drechsel, Oliver] Robert Koch Inst, Berlin, Germany.
   [Turnbaugh, Peter J.; Bisanz, Jordan E.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Bisanz, Jordan E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA.
   [Volk, Hans-Dieter] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany.
   [von Schwartzenberg, Reiner Jumpertz] Eberhard Karls Univ Tubingen, Dept Internal Med 4, Div Diabetol Endocrinol & Nephrol, Tubingen, Germany.
   [von Schwartzenberg, Reiner Jumpertz] Univ Tubingen, Cluster Excellence EXC Controlling Microbes 2124, Tubingen, Germany.
   [von Schwartzenberg, Reiner Jumpertz] German Ctr Diabet Res DZD eV, Neuherberg, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Berlin Institute of Health; Free University
   of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research
   Center for Environmental Health; Eberhard Karls University of Tubingen;
   Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; German Centre
   for Cardiovascular Research; Robert Koch Institute; University of
   California System; University of California San Francisco; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Pennsylvania State University - University Park; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Eberhard Karls University of Tubingen;
   Eberhard Karls University of Tubingen
RP Spranger, J (corresponding author), Charite Univ Med Berlin, Dept Endocrinol & Metab, Charitepl 1, D-10117 Berlin, Germany.; Spranger, J (corresponding author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Spranger, J (corresponding author), Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany.; Spranger, J (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.; Spranger, J (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.
EM joachim.spranger@charite.de
RI Turnbaugh, Peter James/JTV-0906-2023; Mai, Knut/W-9904-2019; Bisanz,
   Jordan/AGH-4327-2022
OI Mai, Knut/0000-0003-0126-3155; Schlickeiser,
   Stephan/0000-0003-3142-2890; Turnbaugh, Peter/0000-0002-0888-2875;
   Brachs, Sebastian/0000-0002-6336-3939; Bisanz,
   Jordan/0000-0002-8649-1706; Jumpertz von Schwartzenberg,
   Reiner/0000-0002-5544-099X; Volk, Hans-Dieter/0000-0002-7743-6668
FU Projekt DEAL; Berlin Institute of Health (BIH); Einstein Foundation
   Berlin via the Einstein Center for Regenerative Therapies; DZHK (German
   Centre for Cardiovascular Research), partner site Berlin; German
   Diabetes Association (Deutsche Diabetes Gesellschaft, DDG); Deutsche
   Forschungsgemeinschaft [KFO218, SFB/TR 296]; German Research Foundation
   (DFG, Deutsche Forschungsgemeinschaft)
FX Open Access funding enabled and organized by Projekt DEAL. R.J.v.S. and
   J.S.-K. were funded as clinician scientists by the Berlin Institute of
   Health (BIH). Further funding was provided by the Einstein Foundation
   Berlin via the Einstein Center for Regenerative Therapies to M.F.,
   J.S.-K., and R.J.v.S. R.J.v.S and J.S. were additionally funded by the
   DZHK (German Centre for Cardiovascular Research), partner site Berlin.
   R.J.v.S was supported by the German Diabetes Association (Deutsche
   Diabetes Gesellschaft, DDG) and J.S. by the Deutsche
   Forschungsgemeinschaft (KFO218 and SFB/TR 296). J.S.-K. was supported by
   the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft).
CR Akil L, 2011, J HEALTH CARE POOR U, V22, P61, DOI 10.1353/hpu.2011.0166
   Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103
   Basolo A, 2020, NAT MED, V26, P589, DOI 10.1038/s41591-020-0801-z
   Bisanz JE, 2020, CELL HOST MICROBE, V27, P1001, DOI 10.1016/j.chom.2020.04.006
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x
   Carmody RN, 2019, NAT MICROBIOL, V4, P2052, DOI 10.1038/s41564-019-0569-4
   Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010
   Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790
   Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10
   Clinthorne JF, 2013, J IMMUNOL, V190, P712, DOI 10.4049/jimmunol.1201837
   Crovesy L, 2020, EUR J CLIN NUTR, V74, P1251, DOI 10.1038/s41430-020-0607-6
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572
   Derosa L, 2020, EUR UROL, V78, P195, DOI 10.1016/j.eururo.2020.04.044
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dhakal S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081246
   Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516
   Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010
   Fan JQ, 2017, J ROY STAT SOC B, V79, P405, DOI 10.1111/rssb.12168
   Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9
   Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X
   Fouladi F, 2020, ISME J, V14, P1809, DOI 10.1038/s41396-020-0645-z
   Frost F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219489
   Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022
   Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Jaagura M, 2021, MICROBIOLOGYOPEN, V10, DOI 10.1002/mbo3.1194
   Japp AS, 2017, CYTOM PART A, V91A, P85, DOI 10.1002/cyto.a.22906
   Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kasai C, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0330-2
   Kim CC, 2019, ISME J, V13, P1437, DOI 10.1038/s41396-019-0363-6
   Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Mai K, 2019, DIABETES, V68, P57, DOI 10.2337/db18-0440
   Maifeld A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22097-0
   McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103
   Molinaro A, 2017, MOL METAB, V6, P1371, DOI 10.1016/j.molmet.2017.08.016
   Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082
   Muralidharan J, 2021, AM J CLIN NUTR, V114, P1148, DOI 10.1093/ajcn/nqab150
   Nagayama M, 2020, GUT MICROBES, DOI 10.1080/19490976.2020.1788898
   Newman TM, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01069-y
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12
   Onodera T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16801
   Méndez-Salazar EO, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02494
   Ott B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12109-9
   Peters BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28126-1
   Prehn K, 2017, CEREB CORTEX, V27, P1765, DOI 10.1093/cercor/bhw008
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Sbierski-Kind J, 2020, J IMMUNOL, V205, P45, DOI 10.4049/jimmunol.2000108
   Sbierski-Kind J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01069
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Spranger L, THRIFTY ENERGY PHENO, V2021, DOI [10.1101/2021.03.25.21254300, DOI 10.1101/2021.03.25.21254300]
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876
   von Schwartzenberg RJ, 2021, NATURE, V595, P272, DOI 10.1038/s41586-021-03663-4
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   White Matthew J, 2016, Front Immunol, V7, P667, DOI 10.3389/fimmu.2016.00667
   Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14
   Xia XX, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00847-4
   Xiong T, 2020, SENSOR ACTUAT B-CHEM, V304, DOI [10.1016/j.snb.2019.127310, 10.1126/scitranslmed.3009124]
   Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9
   Zou H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030631
NR 78
TC 28
Z9 29
U1 7
U2 39
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD APR 4
PY 2022
VL 10
IS 1
AR 57
DI 10.1186/s40168-022-01249-4
PG 21
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 0G6BG
UT WOS:000778127700001
PM 35379337
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jiang, TX
   Ma, S
   Han, X
   Luo, ZY
   Zhu, QQ
   Chiba, T
   Xie, W
   Lin, K
   Qiu, XB
AF Jiang, Tian-Xia
   Ma, Shuang
   Han, Xia
   Luo, Zi-Yu
   Zhu, Qian-Qian
   Chiba, Tomoki
   Xie, Wei
   Lin, Kui
   Qiu, Xiao-Bo
TI Proteasome activator PA200 maintains stability of histone marks during
   transcription and aging
SO THERANOSTICS
LA English
DT Article
DE Histone marks; aging; histone degradation; proteasome activator PA200;
   transcription
ID CELLULAR SENESCENCE; DNA METHYLATION; DEGRADATION; CHROMATIN; TURNOVER;
   MECHANISMS; EXPRESSION; DYNAMICS; PURIFICATION; AUTOPHAGY
AB The epigenetic inheritance relies on stability of histone marks, but various diseases, including aging-related disorders, are usually associated with alterations of histone marks. Whether and how the proteasome is responsible for maintaining the histone marks during transcription and aging remain unclear. The core histones can be degraded by the atypical proteasome, which contains the proteasome activator PA200, in an acetylation-dependent manner during somatic DNA damage response and spermiogenesis.
   Methods: By utilizing a substitute of methionine to label proteins metabolically, we analyzed histone degradation genome-wide by sequencing the DNA fragments following pulse-chase assays. The genome-wide RNA-sequencing analysis was performed to analyze transcription and chromatin-immunoprecipitation (ChIP)-sequencing was used for analyses of histone marks. The experimental models included gene-manipulated cells (including both mouse and yeast), mouse liver, and mice.
   Results: Degradation of H4 or the transcription-coupled histone variant H3.3 could be suppressed by deletion of PA200 or its yeast ortholog Blm10. The histone deacetylase inhibitor accelerated the degradation rates of H3, while the mutations of the putative acetyl-lysine-binding region of PA200 abolished histone degradation in the G1-arrested cells. Deletion of PA200 dramatically altered deposition of the active transcriptional hallmarks (H3K4me3 and H3K56ac) and transcription, especially during cellular aging. Furthermore, deletion of PA200 or Blm10 accelerated cellular aging. Notably, the PA200-deficient mice displayed a range of aging-related deteriorations, including immune malfunction, anxiety-like behavior and shorter lifespan.
   Conclusion: PA200 promotes the transcription-coupled degradation of the core histones, and plays an important role in maintaining the stability of histone marks during transcription and aging.
C1 [Jiang, Tian-Xia; Ma, Shuang; Luo, Zi-Yu; Zhu, Qian-Qian; Qiu, Xiao-Bo] Beijing Normal Univ, Coll Life Sci, State Key Lab Cognit Neurosci & Learning, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.
   [Jiang, Tian-Xia; Ma, Shuang; Luo, Zi-Yu; Zhu, Qian-Qian; Qiu, Xiao-Bo] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.
   [Han, Xia; Lin, Kui] Beijing Normal Univ, Coll Life Sci, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.
   [Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.
   [Xie, Wei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
C3 Beijing Normal University; Beijing Normal University; Beijing Normal
   University; University of Tsukuba; Tsinghua University
RP Qiu, XB (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Cognit Neurosci & Learning, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.; Qiu, XB (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.; Lin, K (corresponding author), Beijing Normal Univ, Coll Life Sci, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.
EM linkui@bnu.edu.cn; xqiu@bnu.edu.cn
RI 韩, 夏/AAQ-7455-2021
OI Han, Xia/0000-0001-8116-7694
FU National Key R&D Program of China [2019YFA0802100]; National Natural
   Science Foundation of China [31530014]; Ministry of Science and
   Technology of China [2018YFC1003300]; Beijing Municipal Natural Science
   Foundation [217100029]
FX We greatly appreciate Drs. Lance Barton, Daniel Finley, Alfred L.
   Goldberg, Wei Li, Xiaotao Li, and Yoshinori Ohsumi for kindly providing
   cell lines or strains. This study was supported by the National Key R&D
   Program of China (2019YFA0802100), National Natural Science Foundation
   of China (31530014), Ministry of Science and Technology of China
   (2018YFC1003300) and Beijing Municipal Natural Science Foundation
   (217100029).
CR Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159
   Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105
   Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928
   Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200
   Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023
   Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085
   Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777
   Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109
   Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103
   Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x
   Hauer MH, 2017, NAT STRUCT MOL BIOL, V24, P99, DOI 10.1038/nsmb.3347
   Huang C, 2014, BIOESSAYS, V36, P579, DOI 10.1002/bies.201400005
   Jiang TX, 2018, BIOL REV, V93, P1765, DOI 10.1111/brv.12419
   Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006
   Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Lichtenstein AV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P235, DOI 10.1023/A:1010249510906
   Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mandemaker IK, 2018, EMBO REP, V19, DOI 10.15252/embr.201745566
   Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014
   Meyers EA, 2016, NEUROBIOL AGING, V38, P164, DOI 10.1016/j.neurobiolaging.2015.10.035
   Miller RA, 2001, J GERONTOL A-BIOL, V56, pB180, DOI 10.1093/gerona/56.4.B180
   Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013
   Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481
   Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924
   Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685
   Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032
   Qu YP, 2017, THERANOSTICS, V7, P2092, DOI 10.7150/thno.19884
   Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014
   Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914
   Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036
   Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202
   Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7
   Stejskal S, 2015, CELL CYCLE, V14, P3851, DOI 10.1080/15384101.2015.1106760
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Strub T, 2020, THERANOSTICS, V10, P1777, DOI 10.7150/thno.36218
   Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X
   Ustrell V, 2005, METHOD ENZYMOL, V398, P321, DOI 10.1016/S0076-6879(05)98026-9
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361
NR 55
TC 10
Z9 14
U1 9
U2 25
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2021
VL 11
IS 3
BP 1458
EP 1472
DI 10.7150/thno.48744
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OV7CN
UT WOS:000592363200012
PM 33391545
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Fink, BD
   Yu, LP
   Coppey, L
   Obrosov, A
   Shevalye, H
   Kerns, RJ
   Yorek, MA
   Sivitz, WI
AF Fink, Brian D.
   Yu, Liping
   Coppey, Lawrence
   Obrosov, Alexander
   Shevalye, Hanna
   Kerns, Robert J.
   Yorek, Mark A.
   Sivitz, William, I
TI Effect of mitoquinone on liver metabolism and steatosis in obese and
   diabetic rats
SO PHARMACOLOGY RESEARCH & PERSPECTIVES
LA English
DT Article
DE antioxidants; glucose; insulin; liver; mitochondria; obesity; oxidative
   stress; steatosis
ID MITOCHONDRIAL-TARGETED ANTIOXIDANT; SENESCENCE; MITOQ
AB Previous work by ourselves and others showed that mitoquinone (mitoQ) reduced oxidative damage and prevented hepatic fat accumulation in mice made obese with high-fat (HF) feeding. Here we extended these studies to examine the effect of mitoQ on parameters affecting liver function in rats treated with HF to induce obesity and in rats treated with HF plus streptozotocin (STZ) to model a severe form of type 2 diabetes. In prior reported work, we found that mitoQ significantly improved glycemia based on glucose tolerance data in HF rats but not in the diabetic rats. Here we found only non-significant reductions in insulin and glucose measured in the fed state at sacrifice in the HF mice treated with mitoQ. Metabolomic data showed that mitoQ altered several hepatic metabolic pathways in HF-fed obese rats toward those observed in control normal chow-fed non-obese rats. However, mitoQ had little effect on pathways observed in the diabetic rats, wherein diabetes itself induced marked pathway aberrations. MitoQ did not alter respiration or membrane potential in isolated liver mitochondria. MitoQ reduced liver fat and liver hydroperoxide levels but did not improve liver function as marked by circulating levels of aspartate and alanine aminotransferase (ALT). In summary, our results for HF-fed rats are consistent with past findings in HF-fed mice indicating decreased liver lipid hydroperoxides (LPO) and improved glycemia. However, in contrast to the HF obese mice, mitoQ did not improve glycemia or reset perturbed metabolic pathways in the diabetic rats.
C1 [Fink, Brian D.; Coppey, Lawrence; Obrosov, Alexander; Yorek, Mark A.; Sivitz, William, I] Univ Iowa, Iowa City Vet Affairs Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA 52242 USA.
   [Yu, Liping] Univ Iowa, Dept Biochem, NMR Core Facil, Iowa City, IA 52242 USA.
   [Shevalye, Hanna] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Kerns, Robert J.] Univ Iowa, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA.
C3 University of Iowa; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Iowa City VA Health Care System; University of
   Iowa; University of Iowa; University of Iowa
RP Sivitz, WI (corresponding author), Univ Iowa, Dept Internal Med, Div Endocrinol & Metab, 422GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM william-sivitz@uiowa.edu
OI Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189
FU Department of Veterans Affairs Iowa City Health Care System; Veterans
   Health Administration [I01BX000285, RX000889-05]; Iowa Fraternal Order
   of the Eagles; National Institute of Diabetes and Digestive and Kidney
   Diseases [DK107339-04, DK115256-02]
FX Department of Veterans Affairs Iowa City Health Care System; Veterans
   Health Administration, Grant/Award Number: I01BX000285 and RX000889-05;
   Iowa Fraternal Order of the Eagles; National Institute of Diabetes and
   Digestive and Kidney Diseases, Grant/Award Number: DK107339-04 and
   DK115256-02
CR Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Davidson EP, 2011, EUR J PHARMACOL, V668, P497, DOI 10.1016/j.ejphar.2011.07.016
   Escribano-Lopez Irene, 2019, Cell Physiol Biochem, V52, P186, DOI 10.33594/000000013
   Feillet-Coudray C, 2014, FREE RADICAL RES, V48, P1232, DOI 10.3109/10715762.2014.945079
   Fink B, 2020, FREE RADICAL RES, V54, P311, DOI 10.1080/10715762.2020.1754409
   Fink BD, 2014, J PHARMACOL EXP THER, V351, P699, DOI 10.1124/jpet.114.219329
   Fink BD, 2012, J PHARMACOL EXP THER, V342, P709, DOI 10.1124/jpet.112.195586
   Fink BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004250
   Fouret G, 2015, BBA-BIOENERGETICS, V1847, P1025, DOI 10.1016/j.bbabio.2015.05.019
   Imai Y, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.393
   Imai Y, 2008, PHYSIOL GENOMICS, V36, P43, DOI 10.1152/physiolgenomics.00050.2008
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962
   Kelso GF, 2002, ANN NY ACAD SCI, V959, P263, DOI 10.1111/j.1749-6632.2002.tb02098.x
   Leise MD, 2014, MAYO CLIN PROC, V89, P95, DOI 10.1016/j.mayocp.2013.09.016
   Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802
   Marín-Royo G, 2019, FASEB J, V33, P12060, DOI 10.1096/fj.201900347RR
   Rehman Hasibur, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P14
   Skulachev VP, 2009, CELL MOL LIFE SCI, V66, P1785, DOI 10.1007/s00018-009-9183-6
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161
   Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14
   Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152
NR 24
TC 2
Z9 3
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 2052-1707
J9 PHARMACOL RES PERSPE
JI Pharmacol. Res. Perspect.
PD FEB
PY 2021
VL 9
IS 1
AR e00701
DI 10.1002/prp2.701
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QK1HA
UT WOS:000620129300003
PM 33547885
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU BRAUNBECK, T
   STORCH, V
AF BRAUNBECK, T
   STORCH, V
TI SENESCENCE OF HEPATOCYTES ISOLATED FROM RAINBOW-TROUT
   (ONCORHYNCHUS-MYKISS) IN PRIMARY CULTURE - AN ULTRASTRUCTURAL-STUDY
SO PROTOPLASMA
LA English
DT Article
DE FISH; LIVER; COLLAGENASE PERFUSION; ISOLATED HEPATOCYTES; PRIMARY
   CULTURE; CYTOLOGY; AGING
ID FISH BRACHYDANIO-RERIO; ADULT RAT HEPATOCYTES; SALMO-GAIRDNERI;
   FUNCTIONAL UNITS; LIVER-CELLS; PHYSIOLOGICAL-CHANGES; SUBLETHAL
   EXPOSURE; MONOLAYER-CULTURE; RICHARDSON LIVER; TERM EXPOSURE
AB In order to evaluate the suitability of isolated fish hepatocytes for toxicological studies, hepatocytes were isolated from rainbow trout (Oncorhynchus mykiss) by liver collagenase perfusion. Isolated hepatocytes were investigated for seven days in primary culture on uncoated petri dishes using light and electron microscopy. Viability of isolated hepatocytes, as estimated from trypan blue exclusion, declined from > 90% at the beginning of the incubation to less-than-or-equal-to 80% after eight days of primary culture. Survival of hepatocytes was best at an incubation temperature of 14-degrees-C, and addition of fetal calf serum failed to improve cell performance. Freshly isolated hepatocytes appeared as solitary spherical cells with numerous microvilli at the outer surface. Except for a 30% reduction in cell size due to stress-induced glycogen reduction, the ultrastructure of freshly isolated hepatocytes closely resembled that of rainbow trout hepatocytes in vivo, which is characterized by distinct cytoplasmic segregation into a perinuclear portion containing rough endoplasmic reticulum (RER) arranged in extensive stacks, mitochondria, peroxisomes and the peribiliary complex (dictyosomes, lysosomes), and large peripheral glycogen fields occasionally interspersed with small lipid inclusions. Within one day of culture, about 60-80% of the isolated hepatocytes sedimented to form a monolayer attached to the culture dishes, whereas up to 20% remained in suspension forming hepatocyte aggregates. Cell adhesion was weak, and during prolonged culture increasing amounts of cell detached, whereas the floating cell accumulations grew to aggregates of more than 100 cells. Cell viability and ultrastructure was similar in monolayers and spheroids, and only from the fifth day in culture, did hepatocytes in the centre of floating aggregates become necrotic. From day 1 to day 5, hepatocytes in primary culture displayed only minor cytological alterations. Excellent cytoplasmic compartmentation, restoration of hepatocytic glycogen stores, high secretion rates of very low density lipoproteins by dictyosomes, establishment of cell-to-cell contacts, restitution of cellular polarity and the epithelial character of the cells, as well as formation of bile canaliculi documented recovery of the hepatocytes in primary culture. From day 5 in culture, an increasing number of cells detached from the substratum, and cell senescence was indicated by a marked increase in ultrastructural heterogeneity, with progressive vesiculation and fractionation of the RER, transformation of RER stacks into huge membrane whorls, aggregation and proliferation of peroxisomes and SER, lack of dictyosomal VLDL production, drastic accumulation of lysosomes, myelinated bodies and autophagic vacuoles, as well as successive exhaustion of cellular glycogen deposits. Whereas with conventional methods for assessing cell viability, most hepatocytes appeared intact for up to ten days in culture, cytological investigations revealed severe deterioration of cellular integrity from day 7. However, for incubation periods of up to five days, isolated rainbow trout hepatocytes can be recommended as an excellent model for physiological and toxicological studies.
RP BRAUNBECK, T (corresponding author), UNIV HEIDELBERG, INST ZOOL 1, NEUENHEIMER FELD 230, W-6900 HEIDELBERG, GERMANY.
CR ALBERS C, 1970, FISH PHYSIOL, V4, P173
   ALWEN J, 1974, EXP CELL RES, V89, P197, DOI 10.1016/0014-4827(74)90202-X
   ANDERSSON T, 1985, BIOCHEM PHARMACOL, V34, P1407, DOI 10.1016/0006-2952(85)90677-X
   [Anonymous], BIOL DATA BOOK
   BAKSI SM, 1990, AQUAT TOXICOL, V16, P229, DOI 10.1016/0166-445X(90)90039-R
   BERLIN JD, 1967, J EXP ZOOL, V164, P117, DOI 10.1002/jez.1401640111
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BIRNBAUM MJ, 1976, AM J PHYSIOL, V231, P191, DOI 10.1152/ajplegacy.1976.231.1.191
   BLAIR JB, 1990, IN VITRO CELL DEV B, V26, P237, DOI 10.1007/BF02624453
   BOUCHE G, 1979, BIOL CELLULAIRE, V36, P17
   BRAUNBECK T, 1987, ANAT EMBRYOL, V175, P303, DOI 10.1007/BF00309844
   BRAUNBECK T, 1991, ECOTOX ENVIRON SAFE, V21, P109, DOI 10.1016/0147-6513(91)90014-G
   BRAUNBECK T, 1989, AQUAT TOXICOL, V14, P185, DOI 10.1016/0166-445X(89)90016-7
   BRAUNBECK T, 1990, ECOTOX ENVIRON SAFE, V19, P355, DOI 10.1016/0147-6513(90)90036-5
   BRAUNBECK T, 1990, ARCH ENVIRON CON TOX, V19, P405, DOI 10.1007/BF01054986
   BRAUNBECK T, 1992, IN PRESS TOXICOL PAT
   BRAUNBECK T, 1992, UNPUB AQUAT TOXICOL
   BRAUNBECK T, 1992, IN PRESS SCHRIFTENR
   Braunbeck Thomas, 1990, Limnologie Aktuell, V1, P371
   BUNTON TE, 1990, TOXICOL PATHOL, V18, P313, DOI 10.1177/019262339001800210
   CHAPMAN GB, 1981, J FISH BIOL, V18, P553, DOI 10.1111/j.1095-8649.1981.tb03796.x
   CHAPMAN GS, 1973, J CELL BIOL, V59, P735, DOI 10.1083/jcb.59.3.735
   DROCHMANS P, 1975, J CELL BIOL, V66, P1, DOI 10.1083/jcb.66.1.1
   FOSTER GD, 1987, GEN COMP ENDOCR, V66, P102, DOI 10.1016/0016-6480(87)90355-8
   FRENCH CJ, 1981, EUR J BIOCHEM, V113, P311, DOI 10.1111/j.1432-1033.1981.tb05068.x
   FRIMMER M, 1976, N-S ARCH PHARMACOL, V295, P63, DOI 10.1007/BF00509774
   GLUTH G, 1985, ECOTOX ENVIRON SAFE, V9, P179, DOI 10.1016/0147-6513(85)90020-X
   HACKING MA, 1978, CAN J ZOOL, V56, P477, DOI 10.1139/z78-068
   HAMPTON JA, 1985, ANAT RECORD, V213, P166, DOI 10.1002/ar.1092130208
   HAMPTON JA, 1988, ANAT RECORD, V221, P619, DOI 10.1002/ar.1092210208
   HAMPTON JA, 1989, AM J ANAT, V185, P58, DOI 10.1002/aja.1001850107
   HANKE W, 1983, ECOTOX ENVIRON SAFE, V7, P229, DOI 10.1016/0147-6513(83)90068-4
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   HAWKINS WE, 1988, AQUAT TOXICOL, V11, P113, DOI 10.1016/0166-445X(88)90009-4
   HAWKINS WE, 1988, ECOTOX ENVIRON SAFE, V16, P219, DOI 10.1016/0147-6513(88)90052-8
   HAWKINS WE, 1988, WATER RESOUR BULL, V24, P941
   HAWKINS WE, 1989, AQUAT TOXICOL, V15, P63, DOI 10.1016/0166-445X(89)90006-4
   HAWKINS WE, 1985, WATER CHLORINATION, V5
   HAYASHI S, 1985, B JPN SOC SCI FISH, V51, P765
   HIGHTOWER LE, 1988, J EXP ZOOL, V248, P290, DOI 10.1002/jez.1402480307
   Hinton D E, 1984, Natl Cancer Inst Monogr, V65, P291
   HINTON DE, 1988, MAR ENVIRON RES, V24, P307, DOI 10.1016/0141-1136(88)90326-1
   HINTON DE, 1985, MAR ENVIRON RES, V17, P238, DOI 10.1016/0141-1136(85)90095-9
   HINTON DE, 1988, AQUAT TOXICOL, V11, P77, DOI 10.1016/0166-445X(88)90008-2
   HINTON DE, 1985, WATER CHLORINATION C, V5, P439
   ISOM HC, 1985, P NATL ACAD SCI USA, V82, P3252, DOI 10.1073/pnas.82.10.3252
   JEEJEEBHOY KN, 1976, GASTROENTEROLOGY, V71, P1086
   Karnovsky M.J., 1971, J CELL BIOL, V51, p146a
   KLAASSEN CD, 1982, TOXICOLOGY LIVER, P147
   Klaunig J E, 1984, Natl Cancer Inst Monogr, V65, P163
   KLAUNIG JE, 1985, IN VITRO CELL DEV B, V21, P221, DOI 10.1007/BF02620933
   KOBAN M, 1986, AM J PHYSIOL, V250, pR211, DOI 10.1152/ajpregu.1986.250.2.R211
   KREBS HA, 1974, 6TH A BENZ S, P726
   LANGER M, 1979, Z MIKROSK ANAT FORSC, V93, P829
   LAUREN DJ, 1990, CANCER RES, V50, P5504
   LEATHERLAND JF, 1983, J FISH BIOL, V22, P519, DOI 10.1111/j.1095-8649.1983.tb04212.x
   LEHIR M, 1979, HISTOCHEMISTRY, V64, P51, DOI 10.1007/BF00493354
   LIPSKY MM, 1986, IN VITRO CELL DEV B, V22, P360, DOI 10.1007/BF02623411
   MAITRE JL, 1986, IN VITRO CELL DEV B, V22, P337
   MOMMSEN TP, 1987, J EXP ZOOL, V244, P1, DOI 10.1002/jez.1402440102
   MOMMSEN TP, 1986, FEBS LETT, V195, P269, DOI 10.1016/0014-5793(86)80174-0
   MOON TW, 1985, CAN J FISH AQUAT SCI, V42, P1772, DOI 10.1139/f85-222
   PARKER RS, 1981, COMP BIOCHEM PHYS B, V70, P631, DOI 10.1016/0305-0491(81)90309-6
   Patterson M K Jr, 1979, Methods Enzymol, V58, P141
   PERRY SF, 1988, GEN COMP ENDOCR, V69, P439, DOI 10.1016/0016-6480(88)90036-6
   PHILLIPS MJ, 1974, LAB INVEST, V31, P533
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   SACHS L, 1984, ANGEWANDTE STATISTIK
   SAEZ L, 1982, COMP BIOCHEM PHYS B, V72, P31, DOI 10.1016/0305-0491(82)90007-4
   SCARPELLI DG, 1963, CANCER RES, V23, P848
   SCHREIBER G, 1973, SUB-CELL BIOCHEM, V2, P307
   SEGNER H, 1988, FISH PHYSIOL BIOCHEM, V5, P79, DOI 10.1007/BF01875645
   SEGNER H, 1990, J EXP ZOOL, V255, P171, DOI 10.1002/jez.1402550206
   SINGH I, 1964, Anat Anz, V115, P81
   Sinnhuber R O, 1978, Ann N Y Acad Sci, V298, P389, DOI 10.1111/j.1749-6632.1977.tb19280.x
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   TYSON CA, 1987, ISOLATED HEPATOCYTE, P119
   VANBOHEMEN CG, 1981, GEN COMP ENDOCR, V44, P94, DOI 10.1016/0016-6480(81)90360-9
   WANSON JC, 1977, J CELL BIOL, V74, P858, DOI 10.1083/jcb.74.3.858
   Weibel E.R, 1979, STEREOLOGICAL METHOD, V1, P415
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
NR 82
TC 45
Z9 48
U1 0
U2 12
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0033-183X
EI 1615-6102
J9 PROTOPLASMA
JI Protoplasma
PY 1992
VL 170
IS 3-4
BP 138
EP 159
DI 10.1007/BF01378789
PG 22
WC Plant Sciences; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Cell Biology
GA JY709
UT WOS:A1992JY70900005
DA 2024-02-19
ER

PT J
AU Matveyenko, AV
   Veldhuis, JD
   Butler, PC
AF Matveyenko, Aleksey V.
   Veldhuis, Johannes D.
   Butler, Peter C.
TI Adaptations in pulsatile insulin secretion, hepatic insulin clearance,
   and β-cell mass to age-related insulin resistance in rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE pulse mass; deconvolution analysis; insulin sensitivity; aging; rat
ID GLUCOSE-TOLERANCE; AGING RATS; TYPE-2; EXTRACTION; APOPTOSIS;
   SENSITIVITY; INHIBITION; STRESS; HUMANS; INTERNALIZATION
AB In health insulin is secreted in discrete insulin secretory bursts from pancreatic beta-cells, collectively referred to as beta-cell mass. We sought to establish the relationship between beta-cell mass, insulin secretory-burst mass, and hepatic insulin clearance over a range of age-related insulin sensitivity in adult rats. To address this, we used a novel rat model with chronically implanted portal vein catheters in which we recently established the parameters to permit deconvolution of portal vein insulin concentration profiles to measure insulin secretion and resolve its pulsatile components. In the present study, we examined total and pulsatile insulin secretion, insulin sensitivity, hepatic insulin clearance, and beta-cell mass in 35 rats aged 2-12 mo. With aging, insulin sensitivity declined, but euglycemia was sustained by an adaptive increase in fasting and glucose-stimulated insulin secretion through the mechanism of a selective augmentation of insulin pulse mass. The latter was attributable to a closely related increase in beta-cell mass (r = 0.8, P < 0.001). Hepatic insulin clearance increased with increasing portal vein insulin pulse amplitude, damping the delivery of insulin in the systemic circulation. In consequence, the curvilinear relationship previously reported between insulin secretion and insulin sensitivity was extended to both insulin pulse mass and beta-cell mass vs. insulin sensitivity. These data support a central role of adaptive changes in beta-cell mass to permit appropriate insulin secretion in the setting of decreasing insulin sensitivity in the aging animal. They emphasize the cooperative role of pancreatic beta-cells and the liver in regulating the secretion and delivery of insulin to the systemic circulation.
C1 [Matveyenko, Aleksey V.; Butler, Peter C.] Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA.
   [Veldhuis, Johannes D.] Mayo Clin, Mayo Med & Grad Sch Med, Div Endocrine, Rochester, MN USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Mayo Clinic
RP Matveyenko, AV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, 900A Weyburn Pl, Los Angeles, CA 90095 USA.
EM amatveyenko@mednet.ucla.edu
OI butler, peter/0000-0002-2981-8979
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [DK-59579]; Larry Hillblom Foundation; National Institutes of Health;
   National Research Service
FX Thease studies were supported by National Institute of Diabetes and
   Digestive and Kidney Diseases Grant DK-59579 and the Larry Hillblom
   Foundation to P. C. Butler. A. V. Matveyenko is supported by the
   National Institutes of Health Ruth L. Kirschstein National Research
   Service Award.
CR Ahrén B, 1998, J CLIN ENDOCR METAB, V83, P3350, DOI 10.1210/jc.83.9.3350
   BACKER JM, 1990, J BIOL CHEM, V265, P16450
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738
   BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398
   BONORA E, 1983, METABOLISM, V32, P438, DOI 10.1016/0026-0495(83)90004-5
   Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304
   Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102
   BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752
   CARPENTIER JL, 1993, J CELL BIOL, V122, P1243, DOI 10.1083/jcb.122.6.1243
   Chang AM, 2006, J CLIN ENDOCR METAB, V91, P629, DOI 10.1210/jc.2005-1803
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   DEANGELIS AM, DIABETES IN PRESS
   DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608
   FABER OK, 1981, J CLIN ENDOCR METAB, V53, P618, DOI 10.1210/jcem-53-3-618
   FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249
   FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275
   Fritsche A, 2002, DIABETES, V51, pS234, DOI 10.2337/diabetes.51.2007.S234
   Grubert JM, 2005, AM J PHYSIOL-ENDOC M, V289, pE232, DOI 10.1152/ajpendo.00567.2004
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985
   Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425
   Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197
   KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663
   KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937
   Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812
   Kjems LL, 2001, DIABETES, V50, P2001, DOI 10.2337/diabetes.50.9.2001
   KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110
   KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353
   Laedtke T, 2000, AM J PHYSIOL-ENDOC M, V279, pE520, DOI 10.1152/ajpendo.2000.279.3.E520
   Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z
   LEAHY JL, 1994, DIABETES, V43, P173, DOI 10.2337/diabetes.43.2.173
   Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778
   Matveyenko AV, 2008, AM J PHYSIOL-ENDOC M, V295, pE569, DOI 10.1152/ajpendo.90335.2008
   Matveyenko AV, 2006, DIABETES, V55, P2347, DOI 10.2337/db06-0345
   Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672
   Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649
   Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369
   Meneilly GS, 1999, J CLIN ENDOCR METAB, V84, P1938, DOI 10.1210/jc.84.6.1938
   Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294
   Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116
   Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341
   Muzumdar R, 2004, DIABETES, V53, P441, DOI 10.2337/diabetes.53.2.441
   Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2
   OMEARA NM, 1995, DIABETES CARE, V18, P568, DOI 10.2337/diacare.18.4.568
   PACINI G, 1990, J AM GERIATR SOC, V38, P1283, DOI 10.1111/j.1532-5415.1990.tb03449.x
   PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685
   Porksen N, 1996, DIABETES, V45, P1317, DOI 10.2337/diabetes.45.10.1317
   Porksen N, 1996, AM J PHYSIOL-ENDOC M, V270, pE1043, DOI 10.1152/ajpendo.1996.270.6.E1043
   PORKSEN N, 1995, AM J PHYSIOL-ENDOC M, V269, pE478, DOI 10.1152/ajpendo.1995.269.3.E478
   Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840
   SANDO H, 1980, J CLIN ENDOCR METAB, V51, P1143, DOI 10.1210/jcem-51-5-1143
   SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534
   Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491
   SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570
   TEMPLE RC, 1989, LANCET, V1, P293, DOI 10.1016/S0140-6736(89)91306-8
   Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557
   Wiesenthal SR, 1999, DIABETES, V48, P766, DOI 10.2337/diabetes.48.4.766
NR 60
TC 41
Z9 45
U1 1
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD OCT
PY 2008
VL 295
IS 4
BP E832
EP E841
DI 10.1152/ajpendo.90451.2008
PG 10
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 359DW
UT WOS:000259967600011
PM 18664594
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Bonsignore, LA
   Tooley, JG
   Van Hoose, PM
   Wang, E
   Cheng, A
   Cole, MP
   Tooley, CES
AF Bonsignore, Lindsay A.
   Tooley, John G.
   Van Hoose, Patrick M.
   Wang, Eugenia
   Cheng, Alan
   Cole, Marsha P.
   Tooley, Christine E. Schaner
TI NRMT1 knockout mice exhibit phenotypes associated with impaired DNA
   repair and premature aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE N-terminal methylation; DNA repair; Aging; Mitochondria
ID ALPHA-N-METHYLATION; OXIDATIVE STRESS; SENESCENCE; BINDING;
   METHYLTRANSFERASE; ACCUMULATION; DEFICIENT; PROTEINS; LESSONS; PATHWAY
AB Though defective genome maintenance and DNA repair have long been known to promote phenotypes of premature aging, the role protein methylation plays in these processes is only now emerging. We have recently identified the first N-terminal methyltransferase, NRMT1, which regulates protein-DNA interactions and is necessary for both accurate mitotic division and nucleotide excision repair. To demonstrate if complete loss of NRMT1 subsequently resulted in developmental or aging phenotypes, we constructed the first NRMT1 knockout (Nrmt1(-/-)) mouse. The majority of these mice die shortly after birth. However, the ones that survive, exhibit decreased body size, female-specific infertility, kyphosis, decreased mitochondrial function, and early-onset liver degeneration; phenotypes characteristic of other mouse models deficient in DNA repair. The livers from Nrmt1(-/-) mice produce less reactive oxygen species (ROS) than wild type controls, and Nrmt1(-/-) mouse embryonic fibroblasts show a decreased capacity for handling oxidative damage. This indicates that decreased mitochondrial function may benefit Nrmt1(-/-) mice and protect them from excess internal ROS and subsequent DNA damage. These studies position the NRMT1 knockout mouse as a useful new system for studying the effects of genomic instability and defective DNA damage repair on organismal and tissue-specific aging. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Bonsignore, Lindsay A.; Tooley, John G.; Van Hoose, Patrick M.; Wang, Eugenia; Cheng, Alan; Cole, Marsha P.; Tooley, Christine E. Schaner] Univ Louisville, Gheens Ctr Aging, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40202 USA.
C3 University of Louisville
RP Tooley, CES (corresponding author), Univ Louisville, Gheens Ctr Aging, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40202 USA.
EM cescha05@louisville.edu
RI Cheng, Alan/M-9319-2013
OI Cheng, Alan/0000-0001-7897-4751
FU National Cancer Institute [CA158009]; National Heart, Lung, and Blood
   Institute [HL95769]
FX This research was supported by grants awarded to C.E.S.T. from the
   National Cancer Institute [CA158009] and M.P.C. from the National Heart,
   Lung, and Blood Institute [HL95769].
CR Cai Q, 2014, J BIOL CHEM, V289, P16046, DOI 10.1074/jbc.M114.558510
   Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095
   Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003
   Carr SM, 2014, P NATL ACAD SCI USA, V111, P11341, DOI 10.1073/pnas.1403737111
   Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572
   Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y
   Datta S, 2014, MOL BIOL CELL, V25, P1202, DOI 10.1091/mbc.E13-07-0430
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   Escargueil AE, 2008, MUTAT RES-REV MUTAT, V658, P259, DOI 10.1016/j.mrrev.2008.01.004
   Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057
   GREEN RC, 1991, EPILEPSIA, V32, P22, DOI 10.1111/j.1528-1157.1991.tb05605.x
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Gurtu VE, 2002, GENETICS, V160, P271
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Hu YH, 2014, J BIOL CHEM, V289, P21289, DOI 10.1074/jbc.C114.582122
   Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11
   Li SS, 2012, INT J MOL SCI, V13, P12461, DOI 10.3390/ijms131012461
   Lin PS, 2009, DNA REPAIR, V8, P795, DOI 10.1016/j.dnarep.2009.03.003
   Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035
   Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541
   McCauley BS, 2014, BBA-GENE REGUL MECH, V1839, P1454, DOI 10.1016/j.bbagrm.2014.05.008
   Milton JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034741
   Morris J, 1999, CURR BIOL, V9, pR55, DOI 10.1016/S0960-9822(99)80010-4
   Operaña TN, 2007, J BIOL CHEM, V282, P4821, DOI 10.1074/jbc.M609417200
   Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459
   Park JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002346
   Petkowski JJ, 2013, BIOCHEM J, V456, P453, DOI 10.1042/BJ20131163
   Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f
   PETTIGREW GW, 1977, NATURE, V265, P661, DOI 10.1038/265661a0
   Pratt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018065
   ROWLATT C, 1976, Laboratory Animals (London), V10, P419, DOI 10.1258/002367776780956917
   SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600
   Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721
   Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107
   Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013
   Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564
   Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446
   STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9
   Sudhakar J, 2014, BRIT J OPHTHALMOL, V98, P402, DOI 10.1136/bjophthalmol-2013-304166
   Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343
   Tooley JG, 2014, PROTEIN SCI, V23, P1641, DOI 10.1002/pro.2547
   van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049
   van Houten ELAF, 2014, REPROD BIOL, V14, P32, DOI 10.1016/j.repbio.2013.09.007
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Wang CM, 2010, BIOGERONTOLOGY, V11, P87, DOI 10.1007/s10522-009-9231-5
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050
   Zhao Y, 2014, TRENDS CELL BIOL, V24, P426, DOI 10.1016/j.tcb.2014.01.005
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 51
TC 31
Z9 38
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2015
VL 146
BP 42
EP 52
DI 10.1016/j.mad.2015.03.012
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CK9IA
UT WOS:000356552600005
PM 25843235
OA Green Accepted
DA 2024-02-19
ER

PT J
AU WARD, JM
   HENNEMAN, JR
AF WARD, JM
   HENNEMAN, JR
TI NATURALLY-OCCURRING AGE-DEPENDENT GLUTATHIONE-S-TRANSFERASE-PI
   IMMUNOREACTIVE HEPATOCYTES IN AGING FEMALE F344 RAT-LIVER AS POTENTIAL
   PROMOTABLE TARGETS FOR NONGENOTOXIC CARCINOGENS
SO CANCER LETTERS
LA English
DT Article
C1 NCI, FREDERICK CANC RES FACIL, PROGRAM RESOURCES INC, BIOL CARCINOGENESIS & DEV PROGRAM, FREDERICK, MD 21701 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI)
RP WARD, JM (corresponding author), NCI, DIV CANC ETIOL, COMPARAT CARCINOGENESIS LAB, FREDERICK, MD 21701 USA.
FU NCI NIH HHS [N01-CO-74102] Funding Source: Medline
CR AMES BN, 1989, ENVIRON MOL MUTAGEN, V14, P66, DOI 10.1002/em.2850140614
   AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   BUTTERWORTH BE, 1989, REGUL TOXICOL PHARM, V9, P244, DOI 10.1016/0273-2300(89)90063-9
   CAMERON RG, 1989, CANCER LETT, V47, P163, DOI 10.1016/0304-3835(89)90086-4
   CAMPBELL HA, 1986, JNCI-J NATL CANCER I, V76, P751, DOI 10.1093/jnci/76.4.751
   EKEM J K, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P193
   EVARTS R P, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P191
   GOLD LS, 1989, ENVIRON HEALTH PERSP, V81, P211, DOI 10.2307/3430831
   HAESEN S, 1988, CARCINOGENESIS, V9, P1755, DOI 10.1093/carcin/9.10.1755
   HARADA T, 1990, TOXICOL PATHOL, V17, P579
   IMAIDA K, 1989, JPN J CANCER RES, V80, P326, DOI 10.1111/j.1349-7006.1989.tb02314.x
   ITO N, 1988, CARCINOGENESIS, V9, P387, DOI 10.1093/carcin/9.3.387
   MITAKA T, 1987, JPN J CANCER RES, V78, P785
   MOORE MA, 1987, CARCINOGENESIS, V8, P483, DOI 10.1093/carcin/8.3.483
   OGAWA K, 1981, J NATL CANCER I, V67, P407
   PITOT HC, 1989, TOXICOL APPL PHARM, V97, P23, DOI 10.1016/0041-008X(89)90052-5
   POPP JA, 1985, FUND APPL TOXICOL, V5, P314, DOI 10.1016/0272-0590(85)90079-X
   PUGH TD, 1983, CANCER RES, V43, P1261
   RAO MS, 1986, CANCER RES, V46, P5287
   SARAFOFF M, 1986, CARCINOGENESIS, V7, P1191, DOI 10.1093/carcin/7.7.1191
   SATO K, 1989, ADV CANCER RES, V52, P205
   SATO K, 1988, JPN J CANCER RES, V79, P556, DOI 10.1111/j.1349-7006.1988.tb00022.x
   SATO K, 1984, GANN, V75, P199
   SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964
   SATOH K, 1989, CARCINOGENESIS, V10, P2107, DOI 10.1093/carcin/10.11.2107
   SCHULTEHERMANN R, 1981, CANCER RES, V41, P2556
   SCHULTEHERMANN R, 1983, CANCER RES, V43, P839
   TATEMATSU M, 1985, CARCINOGENESIS, V6, P1621, DOI 10.1093/carcin/6.11.1621
   TSUJI K, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P191
   VANZWIETEN MJ, 1985, MONOGRAPHS PATHOLOGY, P83
   WARD JM, 1990, PROG CLIN BIOL RES, V331, P85
   WARD JM, 1985, CARCINOGENESIS, V6, P1255, DOI 10.1093/carcin/6.9.1255
   WARD JM, 1981, VIRCHOWS ARCH A, V390, P339, DOI 10.1007/BF00496563
   WARD JM, 1983, J NATL CANCER I, V71, P815
   WARD JM, 1985, ENVIRON HEALTH PERSP, V60, P89, DOI 10.2307/3429948
   WILLIAMS GM, 1986, TOXICOLOGY BASIC SCI, P99
NR 36
TC 28
Z9 28
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD JUL 31
PY 1990
VL 52
IS 3
BP 187
EP 195
DI 10.1016/0304-3835(90)90186-2
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA DT536
UT WOS:A1990DT53600004
PM 2199028
DA 2024-02-19
ER

PT J
AU SHADDOCK, JG
   FEUERS, RJ
   CASCIANO, DA
AF SHADDOCK, JG
   FEUERS, RJ
   CASCIANO, DA
TI AGING AND ENZYME-INDUCTION - EFFECT ON CHEMICALLY-INDUCED DNA-REPAIR IN
   NONPROLIFERATING FISCHER F344 RAT HEPATOCYTES
SO AGE
LA English
DT Article
ID DRUG-METABOLIZING ENZYMES; CALORIC RESTRICTION; ASSAY; ACTIVATION;
   CULTURES; CARCINOGENS; CYTOCHROME-P-450; AFLATOXIN-B1
AB Several studies indicate that cancer and other diseases increase as an animal ages. The reasons for these observations are unclear and some have suggested that accumulation of DNA damage and the ability to remove that damage may be responsible. The purpose of this study has been to measure the effect of aging and enzyme induction on the genotoxicity of four carcinogens, representing four different classes of chemicals, in the in vitro rat hepatocyte/DNA repair assay. Hepatocyte cultures were isolated from untreated young male Fischer (F344) rats and old male F344 rats which were either untreated or Aroclor-induced (ARO). Cultures from the untreated old rats, exposed to 2-acetylaminofluorene (2-AAF), aflatoxin B1 (AFB1), 7,12-dimethylbenz[a]anthracene (DMBA) and dimethylnitrosamine (DMN), exhibited age-dependent decreases in DNA excision repair of 75%,49%,40% and 48%, respectively, when compared to untreated young rats. In contrast, cultures from ARO-induced old rats exhibited significant increases in DNA repair of 78%, 43%, 54% and 44% with 2-AAF, AFB1, DMBA and DMN, respectively, when compared to results from untreated old F344 rats. These data indicate that the observed age-dependent decrease in DNA excision repair in the untreated old F344 rats may not be directly related to the DNA repair process, but to the levels of hepatic xenobiotic metabolizing enzymes responsible for the conversion of potentially toxic chemicals to DNA damaging species.
C1 UNIV ARKANSAS MED SCI HOSP,DEPT ANAT,LITTLE ROCK,AR 72205.
   UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM & MOLEC BIOL,LITTLE ROCK,AR 72205.
   UNIV ARKANSAS MED SCI HOSP,DEPT TOXIKOL,LITTLE ROCK,AR 72205.
C3 University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences
RP SHADDOCK, JG (corresponding author), US FDA,NATL CTR TOXICOL RES,DEPT HLTH & HUMAN SERV,DIV GENET TOXICOL,JEFFERSON,AR 72079, USA.
CR BELAND FA, 1990, HDB EXPT PHARM, P280
   BUDROE JD, 1984, MUTAT RES, V135, P131, DOI 10.1016/0165-1218(84)90166-6
   BUTTERWORTH BE, 1987, MUTAT RES, V189, P113, DOI 10.1016/0165-1218(87)90017-6
   CAMPBELL TC, 1976, TOXICOL APPL PHARM, V35, P199, DOI 10.1016/0041-008X(76)90282-9
   Casciano D A, 1990, SAAS Bull Biochem Biotechnol, V3, P102
   CASCIANO DA, 1983, MUTAT RES, V122, P81, DOI 10.1016/0165-7992(83)90146-X
   CASCIANO DA, 1984, ENV MUTAGEN, V6, P49
   CHOU M W, 1991, Biomedical and Environmental Sciences, V4, P134
   GROVER PL, 1986, XENOBIOTICA, V16, P915, DOI 10.3109/00498258609038974
   GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945
   HASS BS, 1985, ENVIRON MUTAGEN, V7, P391, DOI 10.1002/em.2860070313
   HOWARD PC, 1981, CARCINOGENESIS, V2, P97, DOI 10.1093/carcin/2.2.97
   IOANNIDES C, 1990, DRUG METAB REV, V22, P1, DOI 10.3109/03602539008991444
   JAYARAJ A, 1981, MECH AGEING DEV, V17, P163, DOI 10.1016/0047-6374(81)90082-8
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LEAKEY JEA, 1991, BIOL EFFECTS DIETARY, P207
   Magee P N, 1967, Adv Cancer Res, V10, P163, DOI 10.1016/S0065-230X(08)60079-2
   MCMILLAN JM, 1991, MUTAT RES, V249, P81, DOI 10.1016/0027-5107(91)90134-A
   MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z
   MITCHELL AD, 1983, MUTAT RES, V123, P363, DOI 10.1016/0165-1110(83)90029-5
   OLDHAM JW, 1868, TCA MANUAL, V5, P1047
   PROBST GS, 1981, ENVIRON MUTAGEN, V3, P11, DOI 10.1002/em.2860030103
   PROBST GS, 1987, CELL BIOL TOXICOL, V3, P113, DOI 10.1007/BF00058451
   SHADDOCK JG, 1993, MUTAT RES, V295, P19, DOI 10.1016/0921-8734(93)90008-Q
   SHADDOCK JG, 1989, ENVIRON MOL MUTAGEN, V13, P281, DOI 10.1002/em.2850130402
   SHADDOCK JG, 1990, MUTAGENESIS, V4, P387
   SHIMADA T, 1987, TOXICOL APPL PHARM, V91, P13, DOI 10.1016/0041-008X(87)90189-X
   TICE RR, 1986, HDB BIOL AGING
   WILLIAMS G, 1985, REG TOXICOL PHARM, V5, P123
   WILLIAMS GM, 1982, MUTAT RES, V97, P359, DOI 10.1016/0165-1161(82)90003-6
   WILLIAMS GM, 1978, CANCER LETT, V4, P69, DOI 10.1016/S0304-3835(78)93522-X
   WILLIAMS GM, 1977, CANCER RES, V37, P1845
   YANG CS, 1990, DRUG METAB REV, V22, P147, DOI 10.3109/03602539009041082
NR 34
TC 1
Z9 1
U1 0
U2 2
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD JUL
PY 1993
VL 16
IS 3
BP 105
EP 111
DI 10.1007/BF02436142
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA MG022
UT WOS:A1993MG02200005
DA 2024-02-19
ER

PT J
AU KLINGER, W
   MULLER, D
   KLEEBERG, U
   KRETZSCHMAR, M
   SPLINTER, FK
AF KLINGER, W
   MULLER, D
   KLEEBERG, U
   KRETZSCHMAR, M
   SPLINTER, FK
TI THE INFLUENCE OF ESSENTIAL PHOSPHOLIPIDS (EPL) ON PHASE-I-REACTION AND
   PHASE-II-REACTION AND ON THE GLUTATHIONE STATUS IN THE LIVER OF AGING
   RATS
SO EXPERIMENTAL PATHOLOGY
LA English
DT Article
DE PHOSPHOLIPIDS, ESSENTIAL; LIVER, GLUTATHIONE STATUS; GLUTATHIONE STATUS,
   LIVER; AGING; PHASE-I-REACTION AND PHASE-II-REACTION
ID DIFFERENT AGES; MEMBRANES; ASSAY
AB "Essential" phospholipids (EPL; polyene-phosphatidylcholine) were administered orally to aging male rats in doses of 100 and 300 mg/kg b. wt. over 10 weeks.  One and 7 days after the last treatment cytochrome P-450 concentration, epoxide hydrolase and glutathione-S-transferases were found to be unchanged, but ethylmorphine N-demethylation, ethoxycoumarin O-deethylation and UDP-glucuronosyltransferase activities were enhanced, as were the concentrations of both reduced and oxidized glutathione, the values being similar to those in young adult rats.  These results are discussed in terms of an increase in endoplasmic reticulum membrane fluidity.
RP KLINGER, W (corresponding author), UNIV JENA,INST PHARMAKOL & TOXIKOL,LOBDERSTR 1,O-6900 JENA,GERMANY.
CR AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2
   ASAOKA K, 1983, J BIOCHEM-TOKYO, V94, P1685
   BECHER H, 1975, Z VERSUCHSTIERKD, V17, P256
   BOCK KW, 1983, BIOCHEM PHARMACOL, V32, P953, DOI 10.1016/0006-2952(83)90610-X
   BRODIE BB, 1971, HDB EXP PHARM, V28
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FOMICHENKO KV, 1986, VOP MED KHIM, V32, P21
   GERBER GB, 1975, ACTA HEPATO-GASTRO, V22, P175
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GOWER JD, 1986, BIOCHEM PHARMACOL, V35, P1965, DOI 10.1016/0006-2952(86)90728-8
   GRINNA LS, 1977, GERONTOLOGY, V23, P452, DOI 10.1159/000212222
   GRINNA LS, 1977, MECH AGEING DEV, V6, P297
   GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945
   HEGNER D, 1975, MECH AGEING DEV, V4, P191, DOI 10.1016/0047-6374(75)90021-4
   HEGNER D, 1986, PHOSPHATIDYLCHOLINE, P87
   HIRAYAMA C, 1973, FATTY LIVER EXP CLIN, V12, P83
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   JAESCHKE H, 1987, CHEM-BIOL INTERACT, V64, P127, DOI 10.1016/0009-2797(87)90066-4
   KLINGER W, 1985, BIOMED BIOCHIM ACTA, V44, P1181
   KLINGER W, 1974, Z VERSUCHSTIERKD, V16, P149
   KLINGER W, 1982, PHARMACOL THERAPEUT, V16, P377, DOI 10.1016/0163-7258(82)90007-9
   KLINGER W, 1971, Z VERSUCHSTIERKD, V13, P308
   KOLDE G, 1978, Z GASTROENTEROL, V16, P625
   KRETZSCHMAR M, 1989, EXP PATHOL-JENA, V36, P113, DOI 10.1016/S0232-1513(89)80127-6
   KRETZSCHMAR M, 1989, Z VERSUCHSTIERKD, V32, P41
   KRETZSCHMAR M, 1989, LAB DIAGN, V30, P440
   LEKIM D, 1972, H-S Z PHYSIOL CHEM, V353, P949, DOI 10.1515/bchm2.1972.353.1.949
   LEKIM D, 1974, 12TH WORLD C INT SOC
   MATSUBARA T, 1982, JPN J PHARMACOL, V32, P999, DOI 10.1254/jjp.32.999
   MULLER D, 1985, BIOMED BIOCHIM ACTA, V44, P1171
   NEUBERGER J, 1983, GUT, V4, P751
   OBERMAJEROVA H, 1973, CHEM-BIOL INTERACT, V6, P219, DOI 10.1016/0009-2797(73)90049-5
   ORRENIUS S, 1987, B EUR PHYSIOPATH RES, V23, P291
   ORRENIUS S, 1985, TIPS FEST          S, V1
   PROKHNYAK LA, 1987, ANTIBIOT MED BIOTEK, V32, P282
   SCHOKELT B, 1985, 5TH AM E EUR S LIQ C
   THERET CG, 1977, MED CHIR DIG, V6, P69
NR 37
TC 6
Z9 6
U1 0
U2 0
PU GUSTAV FISCHER VERLAG JENA
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0014-4908
J9 EXP PATHOL-JENA
PY 1991
VL 41
IS 3
BP 151
EP 156
DI 10.1016/S0232-1513(11)80104-0
PG 6
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA FB957
UT WOS:A1991FB95700004
PM 1903712
DA 2024-02-19
ER

PT J
AU Kim, Y
   Kwon, OK
   Chae, S
   Jung, HJ
   Ahn, S
   Jeon, JM
   Sung, E
   Kim, S
   Ki, SH
   Chung, KW
   Chung, HY
   Jung, YS
   Hwang, DH
   Lee, S
AF Kim, YounAh
   Kwon, Oh Kwang
   Chae, Sehyun
   Jung, Hee-Jung
   Ahn, Sanghyun
   Jeon, Ju Mi
   Sung, Eunji
   Kim, SunJoo
   Ki, Sung Hwan
   Chung, Ki Wung
   Chung, Hae Young
   Jung, Young Suk
   Hwang, Dae Hee
   Lee, Sangkyu
TI Quantitative Proteomic Analysis of Changes Related to Age and Calorie
   Restriction in Rat Liver Tissue
SO PROTEOMICS
LA English
DT Article
DE aging; caloric restriction; energy metabolism; proteomics; quantitative
   proteomics
ID GENE-EXPRESSION; OXIDATIVE STRESS; IDENTIFICATION; HOMEOSTASIS;
   INTEGRATION; ACCURACY; NETWORKS; INSIGHTS; REVERSE; TOOL
AB Calorie restriction (CR) is the most frequently studied mechanism for increasing longevity, protecting against stress, and delaying age-associated diseases. Most studies have initiated CR in young animals to determine the protective effects against aging. Although aging phenomena are well-documented, the molecular mechanisms of aging and CR remain unclear. In this study, we observe changes in hepatic proteins upon age-related and diet-restricted changes in the rat liver using quantitative proteomics. Quantitative proteomes are measured using tandem mass tag labeling followed by LC-MS/MS. We compare protein levels in livers from young (6 months old) and old (25 months old) rats with 40% calorie-restricted (YCR and OCR, respectively) or ad libitum diets. In total, 44279 peptides and 3134 proteins are identified and 260 differentially expressed proteins are found. Functional enrichment analysis show that these proteins are mainly involved in glucose and fatty acid metabolism-related processes, consistent with the theory that energy metabolism regulation is dependent on age-related and calorie-restricted changes in liver tissue. In addition, proteins mediating inflammation and gluconeogenesis are increased in OCR livers, but not YCR livers. These results show that CR in old rats might not have antiaging benefits because liver inflammation is increased.
C1 [Kim, YounAh; Kwon, Oh Kwang; Jeon, Ju Mi; Sung, Eunji; Kim, SunJoo; Lee, Sangkyu] Kyungpook Natl Univ, Plus KNU Multiom Based Creat Drug Res Team BK21, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea.
   [Kim, YounAh; Jung, Hee-Jung; Ahn, Sanghyun; Hwang, Dae Hee] Inst Basic Sci, Ctr Plant Aging Res, Daegu, South Korea.
   [Chae, Sehyun; Hwang, Dae Hee] DGIST, Dept New Biol, Daegu, South Korea.
   [Ki, Sung Hwan] Chosun Univ, Coll Pharm, Gwangju, South Korea.
   [Chung, Ki Wung; Chung, Hae Young; Jung, Young Suk] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent, Coll Pharm, Busan, South Korea.
C3 Kyungpook National University; Institute for Basic Science - Korea
   (IBS); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Chosun
   University; Pusan National University
RP Lee, S (corresponding author), Kyungpook Natl Univ, Plus KNU Multiom Based Creat Drug Res Team BK21, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea.; Hwang, DH (corresponding author), Inst Basic Sci, Ctr Plant Aging Res, Daegu, South Korea.; Hwang, DH (corresponding author), DGIST, Dept New Biol, Daegu, South Korea.
EM dhwang@dgist.ac.kr; sangkyu@knu.ac.kr
FU National Research Foundation of Korea (NRF) - Korean Ministry of Science
   and ICT [2015R1A2A2A01004286]; Institute for Basic Science - Korean
   Ministry of Education, Science and Technology [IBS-R013-G1]
FX Y.K., O.K.K., and D.H.H. contributed equally to this work. This work was
   supported by a National Research Foundation of Korea (NRF) grant (no.
   2015R1A2A2A01004286) funded by the Korean Ministry of Science and ICT
   (no. 2015R1A2A2A01004286) and was supported by a grant from Institute
   for Basic Science (IBS-R013-G1) funded by the Korean Ministry of
   Education, Science and Technology. The authors thank the Aging Tissue
   Bank (Busan, Korea) for supplying research materials.
CR Amelina H, 2011, J CHROMATOGR B, V879, P3393, DOI 10.1016/j.jchromb.2011.08.044
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Anton S, 2013, EXP GERONTOL, V48, P1003, DOI 10.1016/j.exger.2013.04.011
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Bock KW, 2016, BIOCHEM PHARMACOL, V99, P11, DOI 10.1016/j.bcp.2015.10.001
   Bowman AW., 1997, APPL SMOOTHING TECHN
   Burk RF, 2011, AM J PHYSIOL-GASTR L, V301, pG32, DOI 10.1152/ajpgi.00064.2011
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Chu GH, 2016, AM J TRANSL RES, V8, P842
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006
   Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156
   Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102
   Joseph AM, 2013, EXP GERONTOL, V48, P858, DOI 10.1016/j.exger.2013.05.061
   Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317
   Kim CH, 2016, AGING CELL, V15, P1074, DOI 10.1111/acel.12513
   Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277
   Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731
   Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P811, DOI 10.1074/mcp.M113.035501
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057
   Noblanc A, 2011, J ANDROL, V32, P641, DOI 10.2164/jandrol.110.012823
   Pires RC, 2014, APPL PHYSIOL NUTR ME, V39, P895, DOI 10.1139/apnm-2013-0520
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Recalcati S, 2003, HEPATOLOGY, V38, P1159, DOI 10.1053/jhep.2003.50417
   Roth GS, 2001, ANN NY ACAD SCI, V928, P305
   Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019
   Ryazanov AG, 2002, MECH AGEING DEV, V123, P207, DOI 10.1016/S0047-6374(01)00337-2
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shi R, 2007, J PROTEOME RES, V6, P2963, DOI 10.1021/pr0605668
   Shin B, 2008, MOL CELL PROTEOMICS, V7, P1124, DOI 10.1074/mcp.M700419-MCP200
   Song SX, 2016, J PROTEOME RES, V15, P1135, DOI 10.1021/acs.jproteome.5b00922
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Thompson ACS, 2016, AGING CELL, V15, P118, DOI 10.1111/acel.12414
   Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496
   Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618
   Weindruch R, 2003, ALZ DIS ASSOC DIS, V17, pS58, DOI 10.1097/00002093-200304002-00008
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yan L, 2013, AGE, V35, P2177, DOI 10.1007/s11357-012-9508-5
   Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d
NR 51
TC 6
Z9 6
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2018
VL 18
IS 5-6
SI SI
AR 1700240
DI 10.1002/pmic.201700240
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA GA5AE
UT WOS:000428343700004
PM 29280565
DA 2024-02-19
ER

PT J
AU Samini, M
   Farkhondeh, T
   Azimi-Nezhad, M
   Samarghandian, S
AF Samini, Mohammad
   Farkhondeh, Tahereh
   Azimi-Nezhad, Mohsen
   Samarghandian, Saeed
TI Chrysin's Impact on Oxidative and Inflammation Damages in the Liver of
   Aged Male Rats
SO ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
LA English
DT Article
DE Aging; chrysin; inflammation; liver; oxidative stress; rat
ID STRESS; INHIBITION; DISORDER
AB Aim: The purpose of this research was to investigate the effect of chrysin on one of the natural antioxidants on aging progression in an animal model.
   Background: Oxidative stress and inflammation increase in hepatic tissue during aging, leading to liver dysfunction.
   Objective: The current research was conducted to show the effect of chrysin on the activities of antioxidant enzyme (catalase, glutathione peroxidase, and superoxide dismutase), serum nitric oxide (NO), and lipid peroxidation as well as inflammatory cytokines (TNF-alpha, IL-6, and IL-1 beta) of aging rats.
   Methods: Male Wistar rats of different ages, 2, 10, and 20 months, were randomly divided into six groups as follows (n=8, per each group): young control rats (C2), young CH-treated rats (CH2), middle-aged control rats (C10), middle-aged CH-treated group (CH10), aged control group (C20), and aged CH-treated group (CH20). Chrysin (20 mg/kg) was administered intraperitoneally once a day for 30 days.
   Result: Present findings indicated that chrysin treatment ameliorated the increased liver levels of lipid peroxidation, TNF-alpha, and IL-1 beta as well as serum levels of NO.
   Conclusion: The findings suggest that chrysin could be effective against the progression of age-induced damage by modulation of oxidant-antioxidant system and inflammatory response.
C1 [Samini, Mohammad] Mashhad Univ Med Sci, Fac Med, Mashhad, Razavi Khorasan, Iran.
   [Farkhondeh, Tahereh] Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran.
   [Azimi-Nezhad, Mohsen] Neyshabur Univ Med Sci, Dept Basic Med Sci, PO 9318614139, Neyshabur, Iran.
   [Samarghandian, Saeed] Neyshabur Univ Med Sci, Hlth Ageing Res Ctr, Neyshabur, Iran.
C3 Mashhad University Medical Science
RP Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Dept Basic Med Sci, PO 9318614139, Neyshabur, Iran.
EM samarghandians1@nums.ac.ir
RI Farkhondeh, Tahereh/Y-2083-2018
OI farkhondeh, tahereh/0000-0002-9579-8339; , Saeed/0000-0001-5461-9579
FU Research Affairs of the National Institute for Medical Research
   Development (NIMAD) [971360]
FX The study was funded by the Research Affairs of the National Institute
   for Medical Research Development (NIMAD) (Grant Number: 971360).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Cabello-Verrugio C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4310469
   Choi JH, 2016, NUTRITION, V32, P1002, DOI 10.1016/j.nut.2016.02.007
   Evans LW, 2020, NAT PROD REP, V37, P653, DOI 10.1039/c9np00057g
   Fagundes FL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030760
   Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0
   Farkhondeh T, 2019, BIOMED PHARMACOTHER, V109, P1120, DOI 10.1016/j.biopha.2018.10.059
   Feldman N, 2015, AGEING RES REV, V24, P29, DOI 10.1016/j.arr.2015.01.003
   Fries GR, 2020, NEUROSCI BIOBEHAV R, V112, P107, DOI 10.1016/j.neubiorev.2020.01.035
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Guo B, 2020, BIOGERONTOLOGY, V21, P311, DOI 10.1007/s10522-020-09859-x
   Liu JT, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14331
   MacNee W, 2014, EUR RESPIR J, V44, P1332, DOI 10.1183/09031936.00134014
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mantha AK, 2006, BIOGERONTOLOGY, V7, P19, DOI 10.1007/s10522-005-6044-z
   Mohammadi A, 2019, CHEM RES TOXICOL, V32, P2329, DOI 10.1021/acs.chemrestox.9b00332
   Naz S, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116797
   Pai SA, 2020, J TRADIT COMPL MED, V10, P577, DOI 10.1016/j.jtcme.2019.09.002
   Pani G, 2015, SEMIN CELL DEV BIOL, V40, P106, DOI 10.1016/j.semcdb.2015.03.004
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Peng YF, 2020, PEERJ, V8, DOI 10.7717/peerj.8365
   Pienkowska N, 2020, AGING-US, V12, P1910, DOI 10.18632/aging.102730
   Rashid S, 2016, ARCH BIOCHEM BIOPHYS, V606, P1, DOI 10.1016/j.abb.2016.07.004
   Scarlata E, 2020, ANTIOXID REDOX SIGN, V32, P569, DOI 10.1089/ars.2019.7985
   Shoieb SM, 2018, FOOD CHEM TOXICOL, V111, P650, DOI 10.1016/j.fct.2017.12.017
   Souza LC, 2015, PHARMACOL BIOCHEM BE, V134, P22, DOI 10.1016/j.pbb.2015.04.010
   Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086
   Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002
   Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063
   Wang NQ, 2017, AGING DIS, V8, P740, DOI 10.14336/AD.2017.0720
   Xia Y, 2015, INT J ONCOL, V46, P1835, DOI 10.3892/ijo.2015.2847
   Zeng L, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110823
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
NR 33
TC 4
Z9 4
U1 1
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1871-5303
EI 2212-3873
J9 ENDOCR METAB IMMUNE
JI Endocr. Metab. Immune Disord.-Drug Targets
PY 2021
VL 21
IS 4
BP 743
EP 748
DI 10.2174/1871530320666200717162304
PG 6
WC Endocrinology & Metabolism; Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Immunology; Pharmacology & Pharmacy
GA QS6PG
UT WOS:000626019200018
PM 32679027
DA 2024-02-19
ER

PT J
AU Ishigami, A
   Fujita, T
   Inoue, H
   Handa, S
   Kubo, S
   Kondo, Y
   Maruyama, N
AF Ishigami, A
   Fujita, T
   Inoue, H
   Handa, S
   Kubo, S
   Kondo, Y
   Maruyama, N
TI Senescence marker protein-30 (SMP30) induces formation of microvilli and
   bile canaliculi in Hep G2 cells
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE aging; bile canaliculus; Hep G2 cell line; microvillus; SMP30; hepatoma
   cell line (Hep G2); human
ID RAT-LIVER; ADHESION; GENE; CALRETICULIN; EXPRESSION; CALCIUM;
   LOCALIZATION; HEPATOCYTES; CADHERIN; CLONING
AB Senescence marker protein-30 (SMP30) is an androgen-independent factor that decreases with aging. To elucidate the physiological functions of SMP30, we transfected human SMP30 cDNA into the human hepatoma cell line, Hep G2. These Hep G2/SMP30 transfectants, which stably expressed large amounts of SMP30, proliferated at a slower rate and synthesized less DNA than mock transfectants (Hep G2/pcDNA3 controls). Thus, enhanced expression of SMP30 retarded the growth of Hep G2/SMP30 cells. Ultrastructural studies by scanning electron microscopy revealed numerous microvilli covering the surfaces of Hep G2/SMP30 cells, whereas few microvilli appeared on control cells. Subsequently, transmission electron microscopy revealed that groups of Hep G2/SMP30 cells exhibited bile canaliculi and possessed specialized adhesion contacts, such as tight junctions and desmosomes, at interplasmic membranes. However, in controls, units of only two cells were seen, and these lacked specialized adhesion junctions. Moesin and ZO-1 are known to be concentrated in microvilli and at tight junctions, respectively. Double-immunostaining was performed to examine whether moesin and ZO-1 were expressed in bile canaliculi with microvilli at the apical regions of Hep G2/SMP30 cells. The intensity of moesin and ZO-1 staining in the contact regions of each cell was markedly higher in Hep G2/SMP30 than in control cells. Moreover, moesin stained more interior areas, which corresponded to the microvilli of bile canaliculi. Clearly, bile canaliculi with microvilli formed at the apical ends of Hep G2/SMP30 cells. These results indicate that SMP30 has an important physiological function as a participant in cell-to-cell interactions and imply that the down-regulation of SMP30 during the aging process contributes to the deterioration of cellular interactivity.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482
CR Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T
   ARTERBURN LM, 1995, HEPATOLOGY, V22, P175, DOI 10.1002/hep.1840220128
   Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0
   DEDHAR S, 1994, TRENDS BIOCHEM SCI, V19, P269, DOI 10.1016/0968-0004(94)90001-9
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449
   Jawhari AU, 1999, J PATHOL, V187, P155, DOI 10.1002/(SICI)1096-9896(199901)187:2<155::AID-PATH193>3.0.CO;2-E
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X
   Kudo A, 2004, HEPATOLOGY, V39, P1099, DOI 10.1002/hep.20104
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578
   OSHIO C, 1981, SCIENCE, V212, P1041, DOI 10.1126/science.7015506
   Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 24
TC 14
Z9 15
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAY
PY 2005
VL 320
IS 2
BP 243
EP 249
DI 10.1007/s00441-004-1073-5
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 920XJ
UT WOS:000228728500005
PM 15714273
DA 2024-02-19
ER

PT J
AU Sato, N
   Sudo, K
   Mori, M
   Imai, C
   Muramatsu, M
   Sugimoto, M
AF Sato, Noriko
   Sudo, Katsuko
   Mori, Masayo
   Imai, Chihiro
   Muramatsu, Masaaki
   Sugimoto, Masahiro
TI Early gestational maternal lowprotein diet diminishes hepatic response
   to fasting in young adult male mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PRENATAL EXPOSURE; PPAR-ALPHA; FAMINE; GENE; PROTEINS; HEALTH; LIVER;
   LIFE; METHYLATION; METABOLISM
AB Maternal low-protein (MLP) diet can lead to hepatic steatosis, which only develops with ageing. It is still unclear whether the young offspring show any signs of past exposure to prenatal adverse conditions. We hypothesized that early nutritional insult would first affect the dynamic responsiveness to nutritional challenges rather than the static state. We analyzed the transcriptome and metabolome profiles of the hepatic response to fasting/ refeeding in young male mice offspring to identify changes induced by early gestational MLP diet. Restricted MLP exposure strictly to early gestation was achieved by the embryo transfer method. As a result, the fasting-induced upregulation of genes related to long-chain fatty acid metabolism and of stress response genes related to protein folding were significantly diminished in MLP pups. Lipid profiling after fasting showed that the hepatic signature of triacylglycerols was shifted to longer acyl-chains and higher saturation by the MLP diet. Bioinformatic analyses suggested that these phenomenological changes may be partially linked to the peroxisome proliferator activated receptor a (PPARa) pathway. Taken together, early gestational MLP diet affected the hepatic dynamic response to nutritional stress in seemingly healthy young offspring, accompanied with partial deterioration of PPARa action.
C1 [Sato, Noriko; Imai, Chihiro; Muramatsu, Masaaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet Epidemiol Mol Epidemiol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Shinjyuku Ku, 6-1-1 Shinjyuku, Tokyo 1600022, Japan.
   [Mori, Masayo; Sugimoto, Masahiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan.
   [Sugimoto, Masahiro] AMED CREST, AMED, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan.
C3 Tokyo Medical & Dental University (TMDU); Tokyo Medical University; Keio
   University
RP Sato, N (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet Epidemiol Mol Epidemiol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM nsato.epi@mri.tmd.ac.jp
RI liu, li/HGC-0900-2022; Sato, Noriko/Y-7693-2019
OI Sato, Noriko/0000-0002-0384-5362; Sugimoto, Masahiro/0000-0003-3316-2543
FU Public Health Research Foundation;  [JP24590399]; Grants-in-Aid for
   Scientific Research [26462860, 17H02198, 17K10174, 15K09707] Funding
   Source: KAKEN
FX This work was partly supported by a Grant-in-Aid for Scientific Research
   (C) (JP24590399) and by the Public Health Research Foundation to N.S.
CR Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200
   Carr SK, 2014, FASEB J, V28, P2191, DOI 10.1096/fj.13-242727
   Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]
   Echeverría PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044
   Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006
   Fuhrmeister J, 2016, EMBO MOL MED, V8, P654, DOI 10.15252/emmm.201505801
   Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108
   Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979
   Goldstein I, 2015, TRENDS ENDOCRIN MET, V26, P699, DOI 10.1016/j.tem.2015.09.005
   Goldstein I, 2017, GENOME RES, V27, P427, DOI 10.1101/gr.212175.116
   Greenstein AW, 2017, J ENDOCRINOL, V232, P107, DOI 10.1530/JOE-16-0447
   Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013
   Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105
   Hivert MF, 2016, OBESITY, V24, P1546, DOI 10.1002/oby.21511
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442
   Ishikawa S., 2016, NAT PUBL GR, P2, DOI [10.1038/srep31520, DOI 10.1038/SREP31520]
   Kadota K., 2008, WEIGHTED AVERAGE DIF, V12, P1
   Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002
   Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034
   Langley-Evans SC, 2015, J HUM NUTR DIET, V28, P1, DOI 10.1111/jhn.12212
   Lee S., 2001, FILM
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   Lumey LH, 2011, ANNU REV PUBL HEALTH, V32, P237, DOI 10.1146/annurev-publhealth-031210-101230
   Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798
   Moskophidis D., 2001, 3 GENE, V21, P8575
   Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Ozanne SE, 2011, AGING-US, V3, P548, DOI 10.18632/aging.100330
   Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8
   Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3
   Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108
   Sato N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019278
   Sharp GC, 2015, INT J EPIDEMIOL, V44, P1288, DOI 10.1093/ije/dyv042
   Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241
   Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Szalowska E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1106
   Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034
   Tobi EW, 2015, INT J EPIDEMIOL, V44, P1211, DOI 10.1093/ije/dyv043
   Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592
   Vallanat B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-16
NR 46
TC 4
Z9 4
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 29
PY 2017
VL 7
AR 9812
DI 10.1038/s41598-017-10380-4
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FE9QL
UT WOS:000408538100054
PM 28852200
OA Green Published, gold
DA 2024-02-19
ER

PT S
AU Song, MY
   Xia, L
   Liu, Q
   Sun, MX
   Wang, F
   Yang, CQ
AF Song, Meiyi
   Xia, Lu
   Liu, Qi
   Sun, Mengxue
   Wang, Fei
   Yang, Changqing
BE Xiao, J
TI Sarcopenia in Liver Disease: Current Evidence and Issues to Be Resolved
SO MUSCLE ATROPHY
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Sarcopenia; Nonalcoholic fatty liver disease; Liver fibrosis
ID EUROPEAN WORKING GROUP; OLDER-PEOPLE EWGSOP; CHAIN AMINO-ACIDS; SEVERE
   MUSCLE DEPLETION; INSULIN-RESISTANCE; SKELETAL-MUSCLE;
   HEPATIC-ENCEPHALOPATHY; VITAMIN-D; IDENTIFY SARCOPENIA; BODY-COMPOSITION
AB Sarcopenia is a common clinical symptom in aging and patients with wasting diseases, characterized by a decreased skeletal muscle mass. As a consequence of lifestyle change, the nonalcoholic fatty liver disease (NAFLD) presents a rising trend. In the past three decades, increasing evidence has proved that sarcopenia is related to NAFLD. In this chapter, we will summarize the emerging evidence of the predictive role of sarcopenia in NAFLD and review the diagnosis value, feasible mechanism, and therapy strategies of sarcopenia in NAFLD. Sarcopenia is a potential risk factor for NAFLD, and targeting sarcopenia can benefit NAFLD to some extent.
C1 [Song, Meiyi; Xia, Lu; Sun, Mengxue; Wang, Fei; Yang, Changqing] Tongji Univ, Sch Med, Tongji Hosp, Div Gastroenterol & Hepatol,Digest Dis Inst, Shanghai, Peoples R China.
   [Liu, Qi] Tongji Univ, Sch Med, Tongji Hosp, Dept Endocrinol, Shanghai, Peoples R China.
C3 Tongji University; Tongji University
RP Wang, F; Yang, CQ (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Div Gastroenterol & Hepatol,Digest Dis Inst, Shanghai, Peoples R China.
EM 1132469@tongji.edu.cn; changqingyang_tj@hotmail.com
CR Abdalla M, 2018, GENE, V653, P65, DOI 10.1016/j.gene.2018.02.024
   Afilalo J, 2016, CAN J CARDIOL, V32, P1051, DOI 10.1016/j.cjca.2016.05.017
   Aguiar R, 2014, ACTA REUMATOL PORT, V39, P322
   ALEXANDER WF, 1989, AM J GASTROENTEROL, V84, P91
   Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P547, DOI [10.1007/s12603-014-0465-9, 10.1007/s12603-013-0424-x]
   Amodio P, 2013, HEPATOLOGY, V58, P325, DOI 10.1002/hep.26370
   Astorino TA, 2015, J SPINAL CORD MED, V38, P615, DOI 10.1179/2045772314Y.0000000236
   Bahat G, 2016, CLIN NUTR, V35, P1557, DOI 10.1016/j.clnu.2016.02.002
   Bahat G, 2017, CLIN NUTR, V36, P903, DOI 10.1016/j.clnu.2017.02.023
   Bambha K, 2014, LIVER INT, V34, P1250, DOI 10.1111/liv.12379
   Baracos V, 2013, INT J BIOCHEM CELL B, V45, P2302, DOI 10.1016/j.biocel.2013.06.016
   Beauregard ME, 2018, HEALTH PROMOT CHRON, V38, P64, DOI 10.24095/hpcdp.38.2.03
   Beier JI, 2018, J HEPATOL, V68, P643, DOI 10.1016/j.jhep.2018.01.017
   Bergerson JT, 2015, CLIN TRANSPLANT, V29, P216, DOI 10.1111/ctr.12506
   Björnsson E, 2010, HEPATOLOGY, V51, P2040, DOI 10.1002/hep.23588
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Bril F, 2016, J CLIN ENDOCR METAB, V101, P644, DOI 10.1210/jc.2015-3111
   BUCUVALAS JC, 1990, J PEDIATR-US, V117, P397, DOI 10.1016/S0022-3476(05)81079-0
   Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x
   Cabrera D, 2016, DIGEST DIS SCI, V61, P3190, DOI 10.1007/s10620-016-4285-0
   Camperi A, 2017, ONCOTARGET, V8, P21778, DOI 10.18632/oncotarget.15583
   Carias S, 2016, J GASTROEN HEPATOL, V31, P628, DOI 10.1111/jgh.13166
   Carroll B, 2015, AMINO ACIDS, V47, P2065, DOI 10.1007/s00726-014-1775-2
   Carvalho LP, 2018, CYTOKINE, V107, P118, DOI 10.1016/j.cyto.2017.12.008
   Chang CY, 2011, LIVER INT, V31, P1246, DOI 10.1111/j.1478-3231.2011.02612.x
   Chen LK, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.05.016
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Chung JH, 2016, ANN NUTR METAB, V68, P77, DOI 10.1159/000442004
   Chung JY, 2013, ARCH GERONTOL GERIAT, V56, P270, DOI 10.1016/j.archger.2012.09.007
   Clark K, 2014, LIVER TRANSPLANT, V20, P1423, DOI 10.1002/lt.23959
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dam G, 2013, METAB BRAIN DIS, V28, P217, DOI 10.1007/s11011-013-9377-3
   Damas F, 2015, SPORTS MED, V45, P801, DOI 10.1007/s40279-015-0320-0
   Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040
   Dasarathy S, 2016, CURR OPIN GASTROEN, V32, P159, DOI 10.1097/MOG.0000000000000261
   Dasarathy S, 2012, J CACHEXIA SARCOPENI, V3, P225, DOI 10.1007/s13539-012-0069-3
   Del Pinto R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112360
   DESOUSA C, 1988, CLIN SCI, V75, P437, DOI 10.1042/cs0750437
   Dunn MA, 2016, LIVER TRANSPLANT, V22, P1324, DOI 10.1002/lt.24506
   Durand F, 2014, J HEPATOL, V60, P1151, DOI 10.1016/j.jhep.2014.02.026
   Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377
   FREUND HR, 1986, CLIN NUTR, V5, P135, DOI 10.1016/0261-5614(86)90001-4
   Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1
   Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116
   Gayan-Ramirez G, 1998, J HEPATOL, V29, P241, DOI 10.1016/S0168-8278(98)80009-3
   Giusto M, 2015, EUR J GASTROEN HEPAT, V27, P328, DOI 10.1097/MEG.0000000000000274
   Gluud LL, 2013, J NUTR, V143, P1263, DOI 10.3945/jn.113.174375
   Gowda C, 2014, J VIRAL HEPATITIS, V21, P938, DOI 10.1111/jvh.12273
   Guillet C, 2005, DIABETES METAB, V31, pS20, DOI 10.1016/S1262-3636(05)73648-X
   Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001
   Hadjihambi Anna, 2014, Hepatology, V60, P1101, DOI 10.1002/hep.27282
   Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019
   Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005
   Hara N, 2016, INTERNAL MED, V55, P863, DOI 10.2169/internalmedicine.55.5676
   Hashimoto Y, 2016, ENDOCR J, V63, P877, DOI 10.1507/endocrj.EJ16-0124
   Hiraoka A, 2016, EUR J GASTROEN HEPAT, V28, P940, DOI 10.1097/MEG.0000000000000661
   Holecek M, 2014, METAB BRAIN DIS, V29, P9, DOI 10.1007/s11011-013-9428-9
   Holecek M, 2012, INT J EXP PATHOL, V93, P157, DOI 10.1111/j.1365-2613.2012.00812.x
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103
   Hu SL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01747
   Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473
   Jones JC, 2012, LIVER TRANSPLANT, V18, P146, DOI 10.1002/lt.22472
   Juakiem W, 2014, CLIN LIVER DIS, V18, P179, DOI 10.1016/j.cld.2013.09.004
   Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P7357, DOI 10.3748/wjg.v21.i24.7357
   Kalaitzakis E, 2007, LIVER INT, V27, P1194, DOI 10.1111/j.1478-3231.2007.01562.x
   Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim HY, 2016, HEPATOB PANCREAT DIS, V15, P39, DOI 10.1016/S1499-3872(15)60030-3
   Kim HY, 2015, WORLD J GASTROENTERO, V21, P7637, DOI 10.3748/wjg.v21.i25.7637
   Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130
   Kim Tae Nyun, 2013, J Bone Metab, V20, P1
   Kim TY, 2014, J KOREAN MED SCI, V29, P1253, DOI 10.3346/jkms.2014.29.9.1253
   Kim YP, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.12.010
   Lee YH, 2016, HEPATOLOGY, V63, P776, DOI 10.1002/hep.28376
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Lera L, 2017, J FRALITY AGING, V6, P12, DOI 10.14283/jfa.2016.117
   Li HG, 2017, EXP CELL RES, V354, P18, DOI 10.1016/j.yexcr.2017.03.023
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Lucero C, 2015, CLIN GERIATR MED, V31, P507, DOI 10.1016/j.cld.2015.04.003
   Maestro B, 2003, J STEROID BIOCHEM, V84, P223, DOI 10.1016/S0960-0760(03)00032-3
   MARCHESINI G, 1991, J HEPATOL, V12, P267, DOI 10.1016/0168-8278(91)90954-A
   MARTIN F, 1985, Q J MED, V55, P233
   McDaniel J, 2016, AM J PHYSIOL-GASTR L, V310, pG163, DOI 10.1152/ajpgi.00322.2015
   McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757
   Metcalfe EL, 2014, CLIN NUTR, V33, P958, DOI 10.1016/j.clnu.2014.02.011
   Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825
   Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517
   Mizuno Y, 2016, TRANSPL P, V48, P3348, DOI 10.1016/j.transproceed.2016.08.042
   MOLLER S, 1994, J HEPATOL, V21, P710, DOI 10.1016/S0168-8278(94)80228-9
   Montano-Loza AJ, 2014, LIVER TRANSPLANT, V20, P1424, DOI 10.1002/lt.23978
   Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061
   Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028
   Nishikawa H, 2017, J CACHEXIA SARCOPENI, V8, P915, DOI 10.1002/jcsm.12212
   Nishikawa H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/872152
   Oh C, 2017, NUTRITION, V33, P169, DOI 10.1016/j.nut.2016.06.004
   Orr R, 2004, DRUGS, V64, P725, DOI 10.2165/00003495-200464070-00004
   Patel HP, 2013, AGE AGEING, V42, P378, DOI 10.1093/ageing/afs197
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009
   Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018
   Plauth M, 1997, CLIN NUTR, V16, P43, DOI 10.1016/S0261-5614(97)80022-2
   Poggiogalle E, 2016, J NUTR HEALTH AGING, V20, P958, DOI 10.1007/s12603-015-0638-1
   Reisinger KW, 2015, ANN SURG, V261, P345, DOI 10.1097/SLA.0000000000000628
   Rose CF, 2012, CLIN PHARMACOL THER, V92, P321, DOI 10.1038/clpt.2012.112
   ROVIRA EC, 1987, REV ESP ENFERM APAR, V72, P201
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Seo JA, 2012, J AM GERIATR SOC, V60, P700, DOI 10.1111/j.1532-5415.2012.03887.x
   Sinclair M, 2016, ALIMENT PHARM THER, V43, P765, DOI 10.1111/apt.13549
   Sinclair M, 2016, J HEPATOL, V65, P906, DOI 10.1016/j.jhep.2016.06.007
   Sinclair M, 2016, J GASTROEN HEPATOL, V31, P661, DOI 10.1111/jgh.13182
   Soysal P, 2016, CLIN NUTR, V35, P1586, DOI 10.1016/j.clnu.2016.09.007
   Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337
   Suzuki STN, 2008, BIOCHEM BIOPH RES CO, V369, P767, DOI 10.1016/j.bbrc.2008.02.092
   Tandon P, 2016, CLIN GASTROENTEROL H, V14, P1473, DOI 10.1016/j.cgh.2016.04.040
   Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495
   Tanimoto Y, 2014, ARCH GERONTOL GERIAT, V59, P295, DOI 10.1016/j.archger.2014.04.016
   Thandassery Ragesh B, 2016, Curr Treat Options Gastroenterol, V14, P257, DOI 10.1007/s11938-016-0093-z
   Thorn SR, 2014, DIABETES, V63, P2702, DOI 10.2337/db14-0276
   Toshikuni N, 2014, WORLD J GASTROENTERO, V20, P7286, DOI 10.3748/wjg.v20.i23.7286
   Toshima T, 2015, HEPATOL RES, V45, P1170, DOI 10.1111/hepr.12484
   Tsekoura M, 2017, ADV EXP MED BIOL, V987, P213, DOI 10.1007/978-3-319-57379-3_19
   Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717
   Tsien C, 2013, EUR J GASTROEN HEPAT, V25, P85, DOI 10.1097/MEG.0b013e328359a759
   Watts R, 2014, BIOCHEM CELL BIOL, V92, P226, DOI 10.1139/bcb-2014-0004
   WEBER FL, 1992, GASTROENTEROLOGY, V102, P1700, DOI 10.1016/0016-5085(92)91733-K
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030
   ZOLI M, 1982, CLIN SCI, V62, P683, DOI 10.1042/cs0620683
NR 133
TC 4
Z9 4
U1 0
U2 10
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA 152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE
SN 0065-2598
EI 2214-8019
BN 978-981-13-1435-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2018
VL 1088
BP 413
EP 433
DI 10.1007/978-981-13-1435-3_19
D2 10.1007/978-981-13-1435-3
PG 21
WC Medicine, Research & Experimental; Pathology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA BL9OQ
UT WOS:000457967700019
PM 30390263
DA 2024-02-19
ER

PT J
AU Lee, HS
   Han, SH
   Swerdloff, R
   Pak, Y
   Budoff, M
   Wang, C
AF Lee, Hae Seung
   Han, Sang Hun
   Swerdloff, Ronald
   Pak, Youngju
   Budoff, Matthew
   Wang, Christina
TI The Effect of Testosterone Replacement Therapy on Nonalcoholic Fatty
   Liver Disease in Older Hypogonadal Men
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article; Early Access
DE nonalcoholic fatty liver; male reproductive health; aging
ID COMPUTED-TOMOGRAPHY; NONINVASIVE ASSESSMENT; METABOLIC SYNDROME;
   STEATOSIS; INSULIN
AB Context: Male hypogonadism is associated with visceral obesity and the metabolic syndrome: factors important for the development of nonalcoholic fatty liver disease (NAFLD). The Testosterone Trials (The T Trials) showed testosterone (T) treatment compared with placebo in older hypogonadal men was associated with decreases in cholesterol and insulin levels suggesting that T treatment may improve NAFLD.Objective: Compare effects of T vs placebo treatment on NAFLD scores and liver scans in elderly hypogonadal men.Methods: Secondary data analyses from 479 older hypogonadal men with total T < 275 ng/dL from The T Trials were performed. Three clinical liver fat scores-lipid accumulation product index, hepatic steatosis index, nonalcoholic fatty liver disease-metabolic syndrome score-and liver computed tomography (CT) Hounsfield units and liver to spleen ratio were evaluated at baseline and 12 months after treatment.Results: There were no statistically significant differences of change in lipid accumulation product index (P = .98), hepatic steatosis index (P = .67), and nonalcoholic fatty liver disease-metabolic syndrome (P = .52) in 246 men treated with T compared with 233 treated with placebo for 12 months. Liver CT showed no statistically significant difference of change in Hounsfield units (P = .24; n = 71 for T, n = 69 for placebo) and liver to spleen ratio (P = .74; n = 55 for T, n = 62 for placebo) between the 2 groups.Conclusions: Our study did not show improvement of NAFLD in older hypogonadal men after 12 months of T vs placebo treatment, as assessed by 3 clinical scores and liver CT for hepatic steatosis. Future studies with longer treatment duration and additional NAFLD diagnostic modalities as primary outcome are warranted.
C1 [Lee, Hae Seung; Han, Sang Hun; Swerdloff, Ronald; Pak, Youngju; Wang, Christina] UCLA, Lundquist Inst & Harbor, Dept Med, Div Endocrinol,Med Ctr, Torrance, CA 90502 USA.
   [Pak, Youngju; Wang, Christina] UCLA, Lundquist Inst & Harbor, Clin & Translat Res Ctr, Div Endocrinol,Med Ctr, Torrance, CA 90502 USA.
   [Budoff, Matthew] UCLA, Lundquist Inst & Harbor, Div Cardiol, Div Endocrinol,Med Ctr, Torrance, CA 90502 USA.
   [Wang, Christina] UCLA, Clin & Translat Sci Inst, Lundquist Inst Harbor, Med Ctr, 1124 Carson St, Torrance, CA 90502 USA.
C3 University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles
RP Wang, C (corresponding author), UCLA, Clin & Translat Sci Inst, Lundquist Inst Harbor, Med Ctr, 1124 Carson St, Torrance, CA 90502 USA.
EM wang@lundquist.org
RI Budoff, Matthew/ABD-5175-2021
OI Budoff, Matthew/0000-0002-9616-1946; Wang,
   Christina/0000-0002-8231-792X; Swerdloff, Ronald/0000-0001-6084-6604
FU The authors thank Dr. Peter J. Snyder, Professor of Medicine at the
   Perelman School of Medicine at the University of Pennsylvania, Medical
   Director at Penn Pituitary Center, for providing the data from The T
   Trials.
FX The authors thank Dr. Peter J. Snyder, Professor of Medicine at the
   Perelman School of Medicine at the University of Pennsylvania, Medical
   Director at Penn Pituitary Center, for providing the data from The T
   Trials.
CR Al-Qudimat A, 2021, ARAB J UROL, V19, P376, DOI 10.1080/2090598X.2021.1959261
   Apostolov R, 2022, WORLD J HEPATOL, V14, P754, DOI 10.4254/wjh.v14.i4.754
   Bedogni G, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-98
   Botha J, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/4257875
   Budoff MJ, 2017, JAMA-J AM MED ASSOC, V317, P708, DOI 10.1001/jama.2016.21043
   Chartampilas E, 2018, HORM-INT J ENDOCRINO, V17, P69, DOI 10.1007/s42000-018-0012-x
   Cunningham GR, 2016, J CLIN ENDOCR METAB, V101, P3096, DOI 10.1210/jc.2016-1645
   Dayton KA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251449
   Dhindsa S, 2016, DIABETES CARE, V39, P82, DOI 10.2337/dc15-1518
   Ebrahimi M, 2023, LIPIDS HEALTH DIS, V22, DOI 10.1186/s12944-023-01802-6
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Fennoun H, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.2020.37.270.9087
   Fritz GA, 2006, J COMPUT ASSIST TOMO, V30, P201, DOI 10.1097/00004728-200603000-00006
   Hermoso DAM, 2020, AGING MALE, V23, P1296, DOI 10.1080/13685538.2020.1764927
   Hoyos CM, 2015, EUR J ENDOCRINOL, V173, pX3, DOI 10.1530/EJE-12-0525e
   Huang G, 2013, J GERONTOL A-BIOL, V68, P954, DOI 10.1093/gerona/gls259
   Jia SZ, 2022, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.784221
   Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156
   Lee J, 2021, LIVER INT, V41, P261, DOI 10.1111/liv.14669
   Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002
   Magnussen LV, 2017, EUR J ENDOCRINOL, V177, P157, DOI [10.1530/EJE-17-0071, 10.1530/eje-17-0071]
   Magnussen Line Velling, 2017, Dan Med J, V64
   Maseroli E, 2021, J ENDOCRINOL INVEST, V44, P819, DOI 10.1007/s40618-020-01381-8
   Mody A, 2015, CARDIOVASC ENDOCRINO, V4, P83, DOI 10.1097/XCE.0000000000000057
   Mohler ER, 2018, J CLIN ENDOCR METAB, V103, P681, DOI 10.1210/jc.2017-02243
   Nielsen TL, 2007, J CLIN ENDOCR METAB, V92, P2696, DOI 10.1210/jc.2006-1847
   Nikolaenko L, 2014, ENDOCRINOLOGY, V155, P417, DOI 10.1210/en.2013-1648
   Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361
   Patel K, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100067
   Polyzos SA, 2020, DIABETES METAB SYND, V14, P1571, DOI 10.1016/j.dsx.2020.07.049
   Saokaew S, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023619
   Saokaew S, 2017, LIVER INT, V37, P1535, DOI 10.1111/liv.13413
   Sarkar M, 2021, CLIN GASTROENTEROL H, V19, P400, DOI 10.1016/j.cgh.2019.11.053
   Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023
   SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P
   Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119
   Speliotes EK, 2008, J GASTROEN HEPATOL, V23, P894, DOI 10.1111/j.1440-1746.2008.05420.x
   Van de Velde F, 2020, ASIAN J ANDROL, V22, P252, DOI 10.4103/aja.aja_68_19
   Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013
   Wells MM, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/4930987
   Yang LJ, 2023, J ENDOCRINOL INVEST, V46, P1565, DOI 10.1007/s40618-023-02006-6
   Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Zeb I, 2013, J CARDIOVASC COMPUT, V7, P311, DOI 10.1016/j.jcct.2013.08.011
   Zeb I, 2012, ACAD RADIOL, V19, P811, DOI 10.1016/j.acra.2012.02.022
   Zhang XX, 2022, INT J ENDOCRINOL, V2022, DOI 10.1155/2022/8509204
NR 46
TC 1
Z9 1
U1 1
U2 1
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD 2024 JAN 18
PY 2024
VL 109
IS 2
BP e757
EP e764
DI 10.1210/clinem/dgad511
EA SEP 2023
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GC6T3
UT WOS:001068620900001
PM 37656011
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Bose, C
   Bhuvaneswaran, C
   Udupa, KB
AF Bose, C
   Bhuvaneswaran, C
   Udupa, KB
TI Age-related alteration in hepatic acyl-CoA: cholesterol acyltransferase
   and its relation to LDL receptor and MAPK
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE cholesterol metabolism; Acyl-CoA; cholesterol acyltransferase;
   low-density lipoprotein receptor; mitogen activated protein kinase; ERK;
   JNK; aging; liver
ID DENSITY-LIPOPROTEIN RECEPTOR; KINASE SIGNAL-TRANSDUCTION; ACTIVATED
   PROTEIN-KINASE; MESSENGER-RNA LEVELS; HUMAN GROWTH-HORMONE;
   TRANSCRIPTION FACTOR; ATHEROSCLEROTIC LESIONS; PLASMA-MEMBRANE;
   GENE-EXPRESSION; DEFICIENT MICE
AB The aim of this study was to evaluate changes in the regulation of lipid metabolism and mitogen-activated protein kinases (MAPK) in the liver of C57BL/6 mice as they age. This was done by assessing the status of total cholesterol content and its enzyme, acyl-CoA: cholesterol acyltransferase (ACAT), in liver microsomal preparations and the low-density lipoprotein receptor (LDLr) mRNA expression in the livers of 4-24-month-old C57B/6 mice, without exogenous cholesterol feeding. With aging, there was an increase in cholesterol content and ACAT activity in liver microsomes. Northern blot analysis and real-time quantitative polymerase chain reaction data showed that ACAT-2 mRNA increased with age as well. LDLr expression decreased significantly in an age-dependent manner. In addition, we studied the basal and activated forms of MAPK, e.g. extracellular regulatory kinase (ERK-1/2), c-jun NH2-terminal kinase (JNK-1/2) and p38 MAPK. During aging, there was a considerable decrease in phosphorylated ERK-1/2 level while JNK-1/2 and p38 MAPK levels increased with age. Our studies showed an altered LDLr expression and altered phosphorylated MAPK in the liver of C57BL/6 mice during aging. These alterations might contribute to the development of atherosclerosis, hypercholesterolemia and other cholesterol-related conditions. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA.
   Cent Arkansas Healthcare Syst, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.
   Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.
C3 University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences
RP Udupa, KB (corresponding author), Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, 4300 W 7th St, Little Rock, AR 72205 USA.
EM udupakodetthoor@uams.edu
CR Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747
   ANGELIN B, 1987, AM HEART J, V113, P482, DOI 10.1016/0002-8703(87)90618-1
   [Anonymous], NIH PUBLICATION
   ARBOGAST LY, 1976, P NATL ACAD SCI USA, V73, P368
   Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200
   BHUVANESWARAN C, 1986, BIOCHEM J, V238, P647, DOI 10.1042/bj2380647
   Bose C, 2004, J GERONTOL A-BIOL, V59, P126
   BROWN MS, 1975, J CLIN INVEST, V55, P783, DOI 10.1172/JCI107989
   BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255
   Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613
   CHARLS J, 1999, CURR OPIN LIPIDOL, V10, P89
   CHOI YS, 1987, EXP GERONTOL, V22, P39
   CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728
   Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   DAVIS RJ, 1993, J BIOL CHEM, V268, P14553
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   Gouni-Berthold I, 2002, FASEB J, V16, P1477, DOI 10.1096/fj.02-0260rev
   GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938
   HENSLER PJ, 1995, AM J PATHOL, V147, P1
   HERIJGERS N, 1961, ARTERIOSCLER THROMB, V20
   HEUBI JE, 1983, J CLIN ENDOCR METAB, V57, P885, DOI 10.1210/jcem-57-5-885
   HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229
   Kapoor GS, 2003, J LIPID RES, V44, P584, DOI 10.1194/jlr.M200302-JLR200
   Kumar A, 1998, J BIOL CHEM, V273, P15742, DOI 10.1074/jbc.273.25.15742
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747
   Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568
   Lind S, 2004, ARTERIOSCL THROM VAS, V24, P349, DOI 10.1161/01.ATV.0000110657.67317.90
   Liu JW, 1997, ARTERIOSCL THROM VAS, V17, P2948, DOI 10.1161/01.ATV.17.11.2948
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Makar RSJ, 2000, J LIPID RES, V41, P762
   Metzler B, 2000, AM J PATHOL, V156, P1875, DOI 10.1016/S0002-9440(10)65061-4
   MILLAR JS, 1995, J LIPID RES, V36, P1155
   MILLER NE, 1984, LANCET, V1, P263
   MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683
   Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568
   Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200
   NOSRATOLA DV, 2002, KIDNEY INT, V61, P1769
   Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765
   Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   PAPE ME, 1995, J LIPID RES, V36, P823
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9
   RIABOWOL K, 1992, P NATL ACAD SCI USA, V89, P157, DOI 10.1073/pnas.89.1.157
   RUDEL LL, 1973, J LIPID RES, V14, P364
   RUDLING M, 1992, J LIPID RES, V33, P493
   Rudling M, 2001, FASEB J, V15, P1350, DOI 10.1096/fj.00-0715com
   RUDMAN D, 1981, J CLIN INVEST, V67, P1361, DOI 10.1172/JCI110164
   SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407
   SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401
   Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593
   Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427
   SUCKLING KE, 1985, J LIPID RES, V26, P647
   SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2
   Takeshi K, 1998, JPN QUART, V45, P4
   Tresini M, 2001, EXP CELL RES, V269, P287, DOI 10.1006/excr.2001.5334
   Vahl N, 1999, CLIN ENDOCRINOL, V51, P309, DOI 10.1046/j.1365-2265.1999.00772.x
   Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X
   Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063
   WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106
   Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100
   YUCHANG F, 2003, J LIPID CHEM, V44, P479
   YUSEN L, 1996, J BIOL CHEM, V271, P3604
   Zhu Y, 1999, BBA-MOL CELL BIOL L, V1436, P557, DOI 10.1016/S0005-2760(98)00167-2
NR 70
TC 20
Z9 24
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN-JUL
PY 2005
VL 126
IS 6-7
BP 740
EP 751
DI 10.1016/j.mad.2005.02.003
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 932EC
UT WOS:000229536000016
PM 15888329
DA 2024-02-19
ER

PT J
AU Esrefoglu, M
   Iraz, M
   Ates, B
   Gul, M
AF Esrefoglu, Mukaddes
   Iraz, Mustafa
   Ates, Burhan
   Gul, Mehmet
TI Melatonin and CAPE are Able to Prevent the Liver from Oxidative Damage
   in Rats: An Ultrastructural and Biochemical Study
SO ULTRASTRUCTURAL PATHOLOGY
LA English
DT Article
DE Aging; caffeic acid phenethyl ester; liver; melatonin; oxidative stress
ID ACID PHENETHYL ESTER; ANTIOXIDANT CAPACITY; AGE; EXTRACT; STRESS;
   OXYGEN; BRAIN
AB The liver continuously produces free radicals and reactive oxygen species (ROS) as part of metabolic process. These free radicals are neutralized by an elaborate antioxidant defense system consisting of enzymes and numerous nonenzymatic antioxidants like flavonoids. In this study, we have evaluated effects of melatonin and caffeic acid phenethyl ester (CAPE) to young and aged rat liver. Aging-related hepatic changes examined by light and electron microscopy and biochemical methods. Melatonin and CAPE decreased tissue malondialdehyde (MDA) levels in aged rats. Melatonin elevated tissue glutathione peroxidase (GSH-Px) activity and tGSH level, whereas CAPE elevated tissue catalase activity in aged rats. This study demonstrates that both melatonin and CAPE are beneficial in delaying age-related hepatocellular changes. Melatonin and CAPE supplementation in older ages may support liver to protect itself from various damaging agents including infectious agents and toxins.
C1 [Iraz, Mustafa] Bezmialem Vakif Univ, Dept Pharmacol, Fac Med, TR-34093 Istanbul, Turkey.
   [Esrefoglu, Mukaddes] Bezmialem Vakif Univ, Dept Histol & Embryol, Fac Med, TR-34093 Istanbul, Turkey.
   [Ates, Burhan] Inonu Univ, Dept Chem, Fac Sci & Art, Malatya, Turkey.
   [Gul, Mehmet] Inonu Univ, Dept Histol & Embryol, Fac Med, Malatya, Turkey.
C3 Bezmialem Vakif University; Bezmialem Vakif University; Inonu
   University; Inonu University
RP Iraz, M (corresponding author), Bezmialem Vakif Univ, Dept Pharmacol, Fac Med, Adnan Menderes Bulvari Vatan Cad, TR-34093 Istanbul, Turkey.
EM mustafairaz@yahoo.com
RI Gül, Mehmet/ABI-6336-2020; Eşrefoğlu, Mukaddes/JWA-4590-2024; Ateş,
   Burhan/AAA-3730-2021
OI Gül, Mehmet/0000-0002-1374-0783; Eşrefoğlu,
   Mukaddes/0000-0003-3380-1480; Ateş, Burhan/0000-0001-6080-229X
CR Akerboom T P, 1981, Methods Enzymol, V77, P373
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Arivazhagan P, 2002, EXP GERONTOL, V37, P1489, DOI 10.1016/S0531-5565(02)00122-5
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x
   BOVERIS A, 1999, OXIDAT STRESS DIS, V2, P1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buddhan S, 2007, PROSTAG LEUKOTR ESS, V76, P349, DOI 10.1016/j.plefa.2007.05.001
   Buege J A, 1978, Methods Enzymol, V52, P302
   de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje
   Esrefoglu M, 2006, FUND CLIN PHARMACOL, V20, P605, DOI 10.1111/j.1472-8206.2006.00439.x
   Esrefoglu M, 2011, FUND CLIN PHARMACOL, V25, P580, DOI 10.1111/j.1472-8206.2010.00876.x
   Esrefoglu M, 2010, FUND CLIN PHARMACOL, V24, P305, DOI 10.1111/j.1472-8206.2009.00782.x
   GRUNBERGER D, 1988, EXPERIENTIA, V44, P230, DOI 10.1007/BF01941717
   Hepsen IF, 1999, OPHTHALMIC RES, V31, P426, DOI 10.1159/000055567
   Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001
   Ilhan A, 1999, EUR J CARDIO-THORAC, V16, P458, DOI 10.1016/S1010-7940(99)00246-8
   Iraz M, 2006, CELL BIOCHEM FUNCT, V24, P357, DOI 10.1002/cbf.1232
   Jayakumar T, 2010, J MED FOOD, V13, P771, DOI 10.1089/jmf.2009.1130
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Luck H., 1965, Method of enzymatic analysis, P885, DOI [10.1016/B978-0-12-395630-9.50158-4, DOI 10.1016/B978-0-12-395630-9.50158-4]
   Mahesh R, 2009, CELL BIOCHEM FUNCT, V27, P358, DOI 10.1002/cbf.1581
   Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Miyagi SJ, 2009, J PHARMACOL SCI, V111, P440, DOI 10.1254/jphs.09223SC
   Molpeceres V, 2007, J GERONTOL A-BIOL, V62, P687, DOI 10.1093/gerona/62.7.687
   Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   REITER RJ, 1995, AGING-CLIN EXP RES, V7, P340, DOI 10.1007/BF03324344
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E
   SUDINA GF, 1993, FEBS LETT, V329, P21, DOI 10.1016/0014-5793(93)80184-V
   Vida C, 2011, BIOGERONTOLOGY, V12, P551, DOI 10.1007/s10522-011-9351-6
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
NR 38
TC 17
Z9 17
U1 0
U2 11
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0191-3123
EI 1521-0758
J9 ULTRASTRUCT PATHOL
JI Ultrastruct. Pathol.
PD MAY
PY 2012
VL 36
IS 3
BP 171
EP 178
DI 10.3109/01913123.2011.647262
PG 8
WC Microscopy; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy; Pathology
GA 936RO
UT WOS:000303607900006
PM 22559044
DA 2024-02-19
ER

PT J
AU Field, PA
   Gibbons, GF
AF Field, PA
   Gibbons, GF
TI Decreased hepatic expression of the low-density lipoprotein (LDL)
   receptor and LDL receptor-related protein in aging rats is associated
   with delayed clearance of chylomicrons from the circulation
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID AGE-RELATED-CHANGES; INSULIN SENSITIVITY; PLASMA; METABOLISM;
   CHOLESTEROL; REMNANTS; BINDING; GLUCOSE; MEMBRANES; TRIACYLGLYCEROL
AB Aging in both humans and rats is associated with the development of insulin resistance and the ensuing alterations in the plasma Lipoprotein profile. In this study, young (2 months) and old (15 months) Sprague-Dawley (SD) rats were used to investigate age-related alterations in the chylomicron clearance pathway. Clearance from the blood of an intravenously injected bolus of C-14-labeled cholesterol ester (CE) and H-3-labeled triacylglycerol (TAG) lymph chylomicrons was markedly delayed in the old rats (P <.05). Hepatic expression of the two principal receptors of chylomicron remnant removal, the low-density lipoprotein (LDL) receptor and LDL receptor-related protein (LRP), was determined by ligand blotting and immunoblotting, The old rats expressed 43% +/- 7% of the level of LDL receptor in the young animals (P <.05) and 45% +/- 16%. of the corresponding level of LRP (P <.05). The results suggest that the delayed clearance of chylomicron remnants in this animal model of aging and insulin resistance is due, at least in part, to a decrease in the hepatic expression of LDL receptor and LRP. Copyright (C) 2000 by W.B. Saunders Company.
C1 Univ Oxford, Metab Res Lab, Oxford Lipid Metab Grp, Oxford, England.
C3 University of Oxford
RP Gibbons, GF (corresponding author), Radcliffe Infirm, Metab Res Lab, Woodstock Rd, Oxford OX2 6HE, England.
CR BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   BIERMAN EL, 1979, J GERONTOL, V34, P438
   Bjorkegren J, 1996, J LIPID RES, V37, P76
   BOLLMAN JL, 1948, J LAB CLIN MED, V33, P1348
   Borel P, 1998, J GERONTOL A-BIOL, V53, pB133, DOI 10.1093/gerona/53A.2.B133
   BRIGGS MR, 1993, J BIOL CHEM, V268, P14490
   BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788
   BROWN NF, 1989, BIOCHEM J, V262, P425, DOI 10.1042/bj2620425
   CARRELLA M, 1979, P NATL ACAD SCI USA, V76, P338, DOI 10.1073/pnas.76.1.338
   CODINA J, 1980, DIABETES METAB, V6, P135
   COHN JS, 1988, J LIPID RES, V29, P469
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   Cooper AD, 1997, J LIPID RES, V38, P2173
   DESCAMPS O, 1993, J BIOL CHEM, V268, P974
   EATON RP, 1976, AM J PHYSIOL, V230, P1336, DOI 10.1152/ajplegacy.1976.230.5.1336
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   ERIKSSON M, 1989, J CLIN INVEST, V84, P802, DOI 10.1172/JCI114239
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   GOLDFARB S, 1978, EXP CELL RES, V117, P39, DOI 10.1016/0014-4827(78)90425-1
   GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   Griffin M, 1998, ATHEROSCLEROSIS, V138, P313, DOI 10.1016/S0021-9150(98)00036-7
   HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x
   HOHRT WM, 1993, DIABETES, V42, P273
   HUMPHREYS SM, 1990, ANN CLIN BIOCHEM, V27, P597, DOI 10.1177/000456329002700613
   KARPE F, 1993, J CLIN INVEST, V91, P748, DOI 10.1172/JCI116293
   Karpe F, 1997, J LIPID RES, V38, P949
   KOVANEN PT, 1979, J BIOL CHEM, V254, P1367
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   KUTT H, 1989, BIOCHIM BIOPHYS ACTA, V1009, P229, DOI 10.1016/0167-4781(89)90107-3
   MAHER V, 1987, DIABETOLOGIA, V30, pA553
   MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1
   Mahley RW, 1999, J LIPID RES, V40, P1
   MAHLEY RW, 1981, J CLIN INVEST, V68, P1197, DOI 10.1172/JCI110365
   Mamo JCL, 1998, ATHEROSCLEROSIS, V141, pS63, DOI 10.1016/S0021-9150(98)00220-2
   MOORE RD, 1990, AM J HYPERTENS, V3, P1
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   OWENS D, 1990, DIABETOLOGIA, V33, P93, DOI 10.1007/BF00401046
   OWENS D, 1991, DIABETIC MED, V8, P151, DOI 10.1111/j.1464-5491.1991.tb01562.x
   PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336
   POLI G, 1986, INT J TISSUE REACT, V8, P367
   POTTS JL, 1991, CLIN SCI, V81, P621, DOI 10.1042/cs0810621
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255
   SALTER AM, 1988, ATHEROSCLEROSIS, V77, P77
   SOUTAR AK, 1982, BIOCHEM J, V204, P549, DOI 10.1042/bj2040549
   SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI 10.1146/annurev.nutr.13.1.355
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   SUMMERFIELD JA, 1984, P SOC EXP BIOL MED, V175, P158, DOI 10.3181/00379727-175-41781
   SZANTO A, 1992, BIOCHEM J, V288, P791, DOI 10.1042/bj2880791
   Taskinen MR, 1996, ANN MED, V28, P335, DOI 10.3109/07853899608999090
   WADE DP, 1986, EUR J BIOCHEM, V159, P333, DOI 10.1111/j.1432-1033.1986.tb09872.x
   WADE DP, 1989, EUR J BIOCHEM, V181, P727, DOI 10.1111/j.1432-1033.1989.tb14784.x
   WANG CF, 1949, AM J PHYSIOL, V156, P218, DOI 10.1152/ajplegacy.1949.156.2.218
   ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473
NR 58
TC 34
Z9 34
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD APR
PY 2000
VL 49
IS 4
BP 492
EP 498
DI 10.1016/S0026-0495(00)80014-1
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 303VD
UT WOS:000086444800014
PM 10778874
DA 2024-02-19
ER

PT J
AU Li, XN
   Bartke, A
   Berryman, DE
   Funk, K
   Kopchick, JJ
   List, EO
   Sun, L
   Miller, RA
AF Li, Xinna
   Bartke, Andrzej
   Berryman, Darlene E.
   Funk, Kevin
   Kopchick, John J.
   List, Edward O.
   Sun, Liou
   Miller, Richard A.
TI Direct and indirect effects of growth hormone receptor ablation on liver
   expression of xenobiotic metabolizing genes
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE aging; xenobiotics; xenobiotic metabolizing enzymes
ID MOUSE-LIVER; LIFE-SPAN; CAENORHABDITIS-ELEGANS; NUCLEAR FACTOR-4-ALPHA;
   SEXUAL-DIMORPHISM; DISRUPTED MICE; MESSENGER-RNA; DWARF MICE;
   CYTOCHROME-P450; RESTRICTION
AB Detoxification of ingested xenobiotic chemicals, and of potentially toxic endogenous metabolites, is carried out largely through a series of enzymes synthesized in the liver, sometimes called "xenobiotic metabolizing enzymes" (XME). Expression of these XME is sexually dimorphic in rodents and humans, with many of the XME expressed at higher levels in females. This expression pattern is thought to be regulated, in part, by the sex differences in circadian growth hormone (GH) pulsatility. We have evaluated mRNA, in the liver, for 52 XME genes in male and female mice of four mutant stocks, with diminished levels of GH receptor (GHR) either globally (GKO), or in liver (LKO), fat (FKO), or muscle (MKO) tissue specifically. The data show complex, sex-specific changes. For some XME, the expression pattern is consistent with direct control of hepatic mRNA by GHR in the liver. In contrast, other XME show evidence for indirect pathways in which hepatic XME expression is altered by GH signals in fat or skeletal muscle. The effects of GHR-null mutations on glucose control, responses to dietary interventions, steroid metabolism, detoxification pathways, and lifespan may depend on a mixture of direct hepatic effects and cross talk between different GH-responsive tissues.
C1 [Li, Xinna; Miller, Richard A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Li, Xinna; Miller, Richard A.] Univ Michigan, Sch Med, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Bartke, Andrzej; Sun, Liou] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA.
   [Berryman, Darlene E.; Funk, Kevin; Kopchick, John J.; List, Edward O.] Ohio Univ, Heritage Coll Osteopath Med, Edison Biotechnol Inst, Athens, OH 45701 USA.
   [Berryman, Darlene E.] Ohio Univ, Heritage Coll Osteopath Med, Sch Appl Hlth Sci & Wellness, Athens, OH 45701 USA.
   [Berryman, Darlene E.; Kopchick, John J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.
   [List, Edward O.] Ohio Univ, Heritage Coll Osteopath Med, Dept Specialty Med, Athens, OH 45701 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; Southern Illinois University
   System; Southern Illinois University; University System of Ohio; Ohio
   University; University System of Ohio; Ohio University; University
   System of Ohio; Ohio University; University System of Ohio; Ohio
   University
RP Miller, RA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
RI yang, qing/JBR-8440-2023; Bartke, Andzej/D-6640-2017; List,
   Ed/AAG-7094-2019; Wang, Zhonglin/JVZ-9007-2024; Wang,
   Xiaogang/B-2439-2013
OI Bartke, Andzej/0000-0002-2569-557X; Wang, Xiaogang/0000-0002-7929-5889;
   Berryman, Darlene/0000-0003-4240-9229; Li, Xinna/0000-0002-7461-5628
FU National Institute on Aging [P01-AG-031736]
FX This work was supported by National Institute on Aging Grant
   P01-AG-031736.
CR Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x
   Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103
   Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200
   Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773
   EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555
   Flurkey K, 2010, J GERONTOL A-BIOL, V65, P1275, DOI 10.1093/gerona/glq155
   Gems D, 2007, AGING CELL, V6, P421, DOI 10.1111/j.1474-9726.2007.00309.x
   Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328
   Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   Jarukamjorn K, 2006, DRUG METAB PHARMACOK, V21, P29, DOI 10.2133/dmpk.21.29
   Jover R, 2009, CURR DRUG METAB, V10, P508, DOI 10.2174/138920009788898000
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461
   List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330
   MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395
   McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200
   Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050
   Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x
   Mode A, 2006, DRUG METAB REV, V38, P197, DOI 10.1080/03602530600570057
   Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x
   PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1
   Sakuma T, 2002, ARCH BIOCHEM BIOPHYS, V404, P234, DOI 10.1016/S0003-9861(02)00329-6
   Sanchez-Cardenas C, 2010, P NATL ACAD SCI USA, V107, P21878, DOI 10.1073/pnas.1010849107
   Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915
   Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
NR 35
TC 18
Z9 19
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD OCT
PY 2013
VL 305
IS 8
BP E942
EP E950
DI 10.1152/ajpendo.00304.2013
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 246YN
UT WOS:000326577900003
PM 23941873
OA Green Published
DA 2024-02-19
ER

PT J
AU Gonzalez-Meljem, JM
   Haston, S
   Carreno, G
   Apps, JR
   Pozzi, S
   Stache, C
   Kaushal, G
   Virasami, A
   Panousopoulos, L
   Mousavy-Gharavy, SN
   Guerrero, A
   Rashid, M
   Jani, N
   Goding, CR
   Jacques, TS
   Adams, DJ
   Gil, J
   Andoniadou, CL
   Martinez-Barbera, JP
AF Mario Gonzalez-Meljem, Jose
   Haston, Scott
   Carreno, Gabriela
   Apps, John R.
   Pozzi, Sara
   Stache, Christina
   Kaushal, Grace
   Virasami, Alex
   Panousopoulos, Leonidas
   Mousavy-Gharavy, Seyedeh Neda
   Guerrero, Ana
   Rashid, Mamunur
   Jani, Nital
   Goding, Colin R.
   Jacques, Thomas S.
   Adams, David J.
   Gil, Jesus
   Andoniadou, Cynthia L.
   Martinez-Barbera, Juan Pedro
TI Stem cell senescence drives age-attenuated induction of pituitary
   tumours in mouse models of paediatric craniopharyngioma
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; BETA-CATENIN;
   SECRETORY PHENOTYPE; LIVER-CANCER; GROWTH; EXPRESSION; GALACTOSIDASE;
   ACTIVATION; DIAGNOSIS
AB Senescent cells may promote tumour progression through the activation of a senescence-associated secretory phenotype (SASP), whether these cells are capable of initiating tumourigenesis in vivo is not known. Expression of oncogenic beta-catenin in Sox2+ young adult pituitary stem cells leads to formation of clusters of stem cells and induction of tumours resembling human adamantinomatous craniopharyngioma (ACP), derived from Sox2-cells in a paracrine manner. Here, we uncover the mechanisms underlying this paracrine tumourigenesis. We show that expression of oncogenic beta-catenin in Hesx1+ embryonic precursors also results in stem cell clusters and paracrine tumours. We reveal that human and mouse clusters are analogous and share a common signature of senescence and SASP. Finally, we show that mice with reduced senescence and SASP responses exhibit decreased tumour-inducing potential. Together, we provide evidence that senescence and a stem cell-associated SASP drive cell transformation and tumour initiation in vivo in an age-dependent fashion.
C1 [Mario Gonzalez-Meljem, Jose; Haston, Scott; Carreno, Gabriela; Apps, John R.; Pozzi, Sara; Stache, Christina; Kaushal, Grace; Panousopoulos, Leonidas; Mousavy-Gharavy, Seyedeh Neda; Jacques, Thomas S.; Martinez-Barbera, Juan Pedro] UCL Inst Child Hlth, Birth Defects Res Ctr, Dev Biol & Canc Programme, London WC1N 1EH, England.
   [Mario Gonzalez-Meljem, Jose] Inst Nacl Geriatria, Basic Res Dept, Anillo Periferico 2767, Mexico City 10200, DF, Mexico.
   [Virasami, Alex; Jacques, Thomas S.] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England.
   [Guerrero, Ana; Gil, Jesus] Imperial Coll London, MRC Clin Sci Ctr, Cell Proliferat Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.
   [Rashid, Mamunur; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Cambridge CB10 1SA, England.
   [Jani, Nital] UCL Inst Child Hlth, GOSgene, Genet & Genom Med, London WC1N 1EH, England.
   [Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Old Rd Campus, Oxford OX3 7DQ, England.
   [Andoniadou, Cynthia L.] Kings Coll London, Ctr Craniofacial & Regenerat Biol, Guys Hosp, Floor 27 Tower Wing, London SE1 9RT, England.
   [Andoniadou, Cynthia L.] Tech Univ Dresden, Dept Internal Med 3, Fetscherstr 74, D-01307 Dresden, Germany.
C3 University of London; University College London; University of London;
   University College London; Great Ormond Street Hospital for Children NHS
   Foundation Trust; Imperial College London; Wellcome Trust Sanger
   Institute; University of London; University College London; University
   of Oxford; Ludwig Institute for Cancer Research; University of London;
   King's College London; Guy's & St Thomas' NHS Foundation Trust;
   Technische Universitat Dresden
RP Martinez-Barbera, JP (corresponding author), UCL Inst Child Hlth, Birth Defects Res Ctr, Dev Biol & Canc Programme, London WC1N 1EH, England.
EM j.martinez-barbera@ucl.ac.uk
RI Jacques, Thomas/C-2209-2008; Gonzalez-Meljem, Jose Mario/AAF-9305-2020;
   Gil, Jesus/C-7739-2012; Guerrero, Ana/IXD-6319-2023; Martinez-Barbera,
   Juan Pedro/AAE-9284-2020
OI Jacques, Thomas/0000-0002-7833-2158; Gil, Jesus/0000-0002-4303-6260;
   Guerrero, Ana/0000-0002-4622-9201; Martinez-Barbera, Juan
   Pedro/0000-0002-5292-7276; Apps, John/0000-0001-7902-482X; Andoniadou,
   Cynthia/0000-0003-4311-5855; Rashid, Mamunur/0000-0001-9321-0469;
   Goding, Colin/0000-0002-1614-3909; Haston, Scott/0000-0003-3928-4808;
   Gonzalez-Meljem, Jose Mario/0000-0002-1554-0363; Adams,
   David/0000-0001-9490-0306; Carreno, Gabriela/0000-0003-4725-6225
FU Medical Research Council (MRC) [MR/M000125/1, MR/L016729/1]; Great
   Ormond Street Hospital for Children Charity/Children with Cancer UK
   (GOSHCC/CWCUK) [W1055]; National Institute for Health Research
   Biomedical Research Centre at Great Ormond Street Hospital for Children
   National Health Service Foundation Trust and University College London;
   CONACYT-UCL Postgraduate Fellowship; CONACYT-REDESD travel fellowship;
   Wellcome Trust Ph.D. Fellowship; Cancer Research UK Clinical Research
   Training Fellowship; Cancer Research UK; Wellcome Trust; ERC Synergy
   Programme; Cancer Research UK [S_1731, 13031] Funding Source:
   researchfish; Children with Cancer UK [15-190] Funding Source:
   researchfish; Medical Research Council [MR/L016729/1, MC_U120085810,
   MR/M000125/1] Funding Source: researchfish; MRC [MC_U120085810,
   MR/L016729/1, MR/M000125/1] Funding Source: UKRI
FX We sincerely apologise for not including relevant publications due to
   editorial restrictions. We thank the Developmental Studies Hybridoma
   Bank (University of Iowa) and the National Hormone and Peptide Program
   (Harbor-University of California, Los Angeles Medical Center) for
   providing some of the antibodies used in this study. We thank Dr. Alicia
   Villa-Osaba for technical help with triple immunostaining experiments.
   This work was supported by the Medical Research Council (MRC) (Grants
   MR/M000125/1 and MR/L016729/1), Great Ormond Street Hospital for
   Children Charity/Children with Cancer UK (GOSHCC/CWCUK) (Grant W1055)
   and by the National Institute for Health Research Biomedical Research
   Centre at Great Ormond Street Hospital for Children National Health
   Service Foundation Trust and University College London. J.M.G.-M. is
   supported by a CONACYT-UCL Postgraduate Fellowship and a CONACYT-REDESD
   travel fellowship. S.H. and S.P. are supported by a Wellcome Trust Ph.D.
   Fellowship. J.R.A. is supported by a Cancer Research UK Clinical
   Research Training Fellowship. D.J.A. and M.R. are supported by Cancer
   Research UK, The Wellcome Trust and the ERC Synergy Programme. J.P.M.-B.
   is a Great Ormond Street Hospital for Children's Charity Principal
   Investigator.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Andoniadou CL, 2012, ACTA NEUROPATHOL, V124, P259, DOI 10.1007/s00401-012-0957-9
   Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004
   Arwert EN, 2010, P NATL ACAD SCI USA, V107, P19903, DOI 10.1073/pnas.1007404107
   Arzt E, 2009, CELL CYCLE, V8, P677, DOI 10.4161/cc.8.5.8065
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013
   Boult J. K. R., 2017, BRAIN PATHOL
   Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868
   Buslei R, 2005, ACTA NEUROPATHOL, V109, P589, DOI 10.1007/s00401-005-1004-x
   Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen YM, 2015, CANCER LETT, V365, P174, DOI 10.1016/j.canlet.2015.05.026
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373
   Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605
   Garcia-Lavandeira M., 2011, J CLIN ENDOCRINOL ME
   Gaston-Massuet C, 2011, P NATL ACAD SCI USA, V108, P11482, DOI 10.1073/pnas.1101553108
   Hofmann BM, 2006, AM J SURG PATHOL, V30, P1595, DOI 10.1097/01.pas.0000213328.64121.12
   Holsken A., 2013, PITUITARY
   Jones D., 2016, CURR PROTOC BIOINFOR, V56, p15.10.1, DOI 10.1002/cpbi.20
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kato K, 2004, J PATHOL, V203, P814, DOI 10.1002/path.1562
   Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413
   Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020
   Kipling D, 2009, EXP EYE RES, V88, P277, DOI 10.1016/j.exer.2008.11.030
   Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883
   Kostadinov S, 2014, PEDIATR DEVEL PATHOL, V17, P409, DOI 10.2350/14-06-1506-CR.1
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maciel-Barón LA, 2016, AGE, V38, DOI 10.1007/s11357-016-9886-1
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Müller HL, 2017, NAT REV ENDOCRINOL, V13, P299, DOI 10.1038/nrendo.2016.217
   Müller HL, 2004, J CLIN ENDOCR METAB, V89, P3298, DOI 10.1210/jc.2003-031751
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099
   Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Samulowitz U, 2002, AM J PATHOL, V160, P1669, DOI 10.1016/S0002-9440(10)61114-5
   Sekine S, 2002, AM J PATHOL, V161, P1997, DOI 10.1016/S0002-9440(10)64477-X
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120
   Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028
   Stache C., 2014, BRAIN PATHOL
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   TAMM I, 1994, P NATL ACAD SCI USA, V91, P3329, DOI 10.1073/pnas.91.8.3329
   Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334
   TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x
   Uhrbom L, 1998, CANCER RES, V58, P5275
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhu J, 2015, ONCOL LETT, V9, P75, DOI 10.3892/ol.2014.2690
NR 70
TC 70
Z9 74
U1 0
U2 8
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 28
PY 2017
VL 8
AR 1819
DI 10.1038/s41467-017-01992-5
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FN9YP
UT WOS:000416399400005
PM 29180744
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Donath, H
   Woelke, S
   Theis, M
   Hess, U
   Knop, V
   Herrmann, E
   Krauskopf, D
   Kieslich, M
   Schubert, R
   Zielen, S
AF Donath, Helena
   Woelke, Sandra
   Theis, Marius
   Hess, Ursula
   Knop, Viola
   Herrmann, Eva
   Krauskopf, Dorothea
   Kieslich, Matthias
   Schubert, Ralf
   Zielen, Stefan
TI Progressive Liver Disease in Patients With Ataxia Telangiectasia
SO FRONTIERS IN PEDIATRICS
LA English
DT Article
DE Ataxia telangiectasia; liver disease; hepatic steatosis;
   neurodegeneration; ataxia score
ID ALPHA-FETOPROTEIN; OXIDATIVE STRESS; ATM; PROTEIN; DYSFUNCTION;
   DEFICIENCY; FIBROSIS; SYSTEM
AB Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia, immunodeficiency, genetic instability, premature aging and growth retardation. Due to better care the patients get older than in the past and new disease entities like disturbed glucose tolerance and liver disease emerge. The objective of the present investigation is to determine the evolution of liver disease and its relation to age and neurological deterioration. The study included 67 patients aged 1 to 38 years with classical A-T. At least two measurements of liver enzymes were performed within a minimum interval of 6 months in 56 patients. The median follow-up period was 4 years (1-16 years). A total of 316 liver enzyme measurements were performed. For analysis, patients were divided into two age groups (Group 1: <12 years; group 2: >= 12 years). In addition, ultrasound of the liver and Klockgether Ataxia Score (KAS) were analyzed. We found significantly higher levels of alpha-fetoprotein (AFP) (226,8 +/- 20.87 ng/ml vs. 565,1 +/- 24.3 ng/ml, p < 0.0001), and liver enzymes like ALT (23.52 +/- 0.77 IU/L vs. 87.83 +/- 5.31 IU/L, p < 0.0001) in patients in group 2. In addition, we could show a significant correlation between age and AFP, GGT, and KAS. Ultrasound revealed hepatic steatosis in 11/19 (57.9%) patients in group 2. One female patient aged 37 years died due to a hepato-cellular carcinoma (HCC). Liver disease is present in the majority of older A-T patients. Structural changes, non-alcoholic fatty liver disease and fibrosis are frequent findings. Progress of liver disease is concomitant to neurological deterioration.
C1 [Donath, Helena; Woelke, Sandra; Hess, Ursula; Schubert, Ralf; Zielen, Stefan] Goethe Univ, Dept Children & Adolescents Pulmonol & Cyst Fibro, Div Allergol, Frankfurt, Germany.
   [Theis, Marius; Krauskopf, Dorothea; Kieslich, Matthias] Goethe Univ, Dept Children & Adolescents, Div Pediat Neurol, Frankfurt, Germany.
   [Knop, Viola] Goethe Univ, Dept Internal Med, Frankfurt, Germany.
   [Herrmann, Eva] Goethe Univ, Inst Biostat & Math Modeling, Frankfurt, Germany.
C3 Goethe University Frankfurt; Goethe University Frankfurt; Goethe
   University Frankfurt; Goethe University Frankfurt
RP Donath, H (corresponding author), Goethe Univ, Dept Children & Adolescents Pulmonol & Cyst Fibro, Div Allergol, Frankfurt, Germany.
EM helena.pommerening@kgu.de
RI Zielen, Stefan/AAD-7243-2020; Theis, Marius/HGB-4055-2022
OI Herrmann, Eva/0000-0002-0662-6675
CR Andrade IGA, 2015, ANN NUTR METAB, V66, P196, DOI 10.1159/000430790
   Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80
   Brunt EM, 2004, SEMIN LIVER DIS, V24, P3
   Caballero T, 2014, CASE REP HEPATOL, V2014, P1, DOI [10.1155/2014/761250, DOI 10.1155/2014/761250]
   CASARIL M, 1982, MINERVA MED, V73, P2183
   Castilla-Cortázar I, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-103
   Connelly PJ, 2016, DIABETIC MED, V33, P371, DOI 10.1111/dme.13037
   Daniel LL, 2016, AM J PHYSIOL-HEART C, V311, pH445, DOI 10.1152/ajpheart.00338.2016
   Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259
   Espach Y, 2015, CARDIOVASC DRUG THER, V29, P51, DOI 10.1007/s10557-015-6571-z
   Gungor T, 1997, KLIN PADIATR, V209, P328, DOI 10.1055/s-2008-1043972
   Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323
   JONES EA, 1995, HEPATOLOGY, V22, P1606, DOI 10.1002/hep.1840220538
   Kieslich M, 2010, CEREBELLUM, V9, P190, DOI 10.1007/s12311-009-0138-0
   Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421
   KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297
   McDonald C, 2010, J HEPATOL, V53, P1095, DOI 10.1016/j.jhep.2010.05.036
   McGrath-Morrow SA, 2016, J PEDIATR-US, V171, P256, DOI 10.1016/j.jpeds.2016.01.002
   McGrath-Morrow SA, 2010, J PEDIATR-US, V156, P682, DOI 10.1016/j.jpeds.2009.12.007
   Micol R, 2011, J ALLERGY CLIN IMMUN, V128, P382, DOI 10.1016/j.jaci.2011.03.052
   Nissenkorn A, 2016, PEDIATR RES, V79, P889, DOI 10.1038/pr.2016.19
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Patil MM, 1985, ARCH PATHOL LAB MED, V109, P1000
   Paulino TL, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0689-y
   PILLSBURY LH, 1985, ANN ALLERGY, V55, P539
   PILLSBURY LH, 1985, ANN ALLERGY, V55, P593
   Pommerening H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0373-z
   Reichenbach J, 1999, CLIN EXP IMMUNOL, V117, P535
   Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254
   Renjen Pushpendra Nath, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-009387
   Rothblum-Oviatt C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0543-7
   Schieving JH, 2014, EUR J PAEDIATR NEURO, V18, P243, DOI 10.1016/j.ejpn.2013.09.003
   Schroeder SA, 2014, PEDIATR PULM, V49, P389, DOI 10.1002/ppul.22817
   Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012
   Shiloh Y, 2017, AGEING RES REV, V33, P76, DOI 10.1016/j.arr.2016.05.002
   van Os NJH, 2016, CLIN GENET, V90, P105, DOI 10.1111/cge.12710
   Voss S, 2014, GROWTH FACTORS, V32, P123, DOI 10.3109/08977194.2014.939805
   WALDMANN TA, 1972, LANCET, V2, P1112
   Weiss B, 2016, J PEDIATR GASTR NUTR, V62, P550, DOI 10.1097/MPG.0000000000001036
   Woelke S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02000
   Woelke S, 2017, GROWTH FACTORS, V35, P125, DOI 10.1080/08977194.2017.1367681
   Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100677, 10.1371/journal.pone.0087749, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]
   Zaki-Dizaji M, 2018, INFLAMM RES, V67, P559, DOI 10.1007/s00011-018-1142-y
NR 43
TC 22
Z9 22
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD NOV 7
PY 2019
VL 7
AR 458
DI 10.3389/fped.2019.00458
PG 8
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA JP9WE
UT WOS:000498606400001
PM 31788461
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Su, F
   Yu, L
   Berry, K
   Liou, IW
   Landis, CS
   Rayhill, SC
   Reyes, JD
   Ioannou, GN
AF Su, Feng
   Yu, Lei
   Berry, Kristin
   Liou, Iris W.
   Landis, Charles S.
   Rayhill, Stephen C.
   Reyes, Jorge D.
   Ioannou, George N.
TI Aging of Liver Transplant Registrants and Recipients: Trends and Impact
   on Waitlist Outcomes, Post-Transplantation Outcomes, and
   Transplant-Related Survival Benefit
SO GASTROENTEROLOGY
LA English
DT Article
DE Waitlist Outcomes; Post-Transplantation Outcomes; Transplant-Related
   Survival Benefit
ID C VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC
   STEATOHEPATITIS; MORTALITY; DISEASE; MODEL; CANDIDATES; AGE;
   SEPTUAGENARIANS; PREDICTORS
AB BACKGROUND & AIMS: Epidemiologic factors have generated increased demand for liver transplantation among older patients. We aimed to describe trends in age among liver transplant registrants and recipients and the effect of age on waitlist and post-transplantation outcomes and on transplant-related survival benefit. METHODS: We obtained data from the United Network for Organ Sharing on adults who were listed for liver transplantation (N = 122,606) or underwent liver transplantation (N = 60,820) from 2002 to 2014 in the United States. Competing risks analysis was used to model waitlist outcomes and Cox proportional hazards analysis to model post-transplantation survival. These models were also used to estimate 5-year transplant-related survival benefit for different age groups, calculated as the difference between waitlist and post-transplantation life expectancy. RESULTS: Between 2002 and 2014, the mean age of liver transplant registrants increased from 51.2 to 55.7 years, with a more prominent increase in hepatitis C virus-positive (50.9 - 57.9 years) than hepatitis C virus-negative (51.3 - 54.3 years) registrants. The proportion of registrants aged >= 60 years increased from 19% to 41%. In hepatitis C virus-negative patients, aging trends were driven by increasing proportions of patients with hepatocellular carcinoma or nonalcoholic steatohepatitis. Among transplant registrants, increasing age was associated with increasing mortality before transplantation and decreasing likelihood of transplantation. Among transplant recipients, increasing age was associated with increasing post-transplantation mortality. There was little difference in 5-year transplant-related survival benefit between different age groups who had the same Model for EndStage Liver Disease score. CONCLUSIONS: Dramatic aging of liver transplant registrants and recipients occurred from 2002 to 2014, driven by aging of the hepatitis C virus - positive cohort and increased prevalence of nonalcoholic steatohepatitis and hepatocellular carcinoma. Increasing age does not affect transplant-related survival benefit substantially because age diminishes both post-transplantation survival and waitlist survival approximately equally.
C1 [Su, Feng] Univ Washington, Dept Med, Div Internal Med, Seattle, WA USA.
   [Yu, Lei; Liou, Iris W.; Landis, Charles S.; Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Div Gastroenterol, Seattle, WA USA.
   [Yu, Lei; Liou, Iris W.; Landis, Charles S.; Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA.
   [Berry, Kristin] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA USA.
   [Rayhill, Stephen C.; Reyes, Jorge D.] Univ Washington, Dept Surg, Div Transplant Surg, Seattle, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Vet Affairs Puget Sound Health Care System; University of Washington;
   University of Washington Seattle; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Vet Affairs Puget Sound Health
   Care System; University of Washington; University of Washington Seattle
RP Ioannou, GN (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Gastroenterol, S-111 Gastro 1660 S Columbian Way, Seattle, WA 98108 USA.
EM georgei@medicine.washington.edu
FU Research and Development, Veterans Affairs Puget Sound Healthcare
   System; Health Resources and Services Administration [231-00-0115]
FX This study was funded byResearch and Development, Veterans Affairs Puget
   Sound Healthcare System. This work was supported in part by Health
   Resources and Services Administration contract 231-00-0115.
CR Aduen JF, 2009, MAYO CLIN PROC, V84, P973, DOI 10.1016/S0025-6196(11)60667-8
   Afzali A, 2012, LIVER TRANSPLANT, V18, P29, DOI 10.1002/lt.22435
   Aloia TA, 2010, LIVER TRANSPLANT, V16, P950, DOI 10.1002/lt.22098
   [Anonymous], 2010, TABLE 1 LIFE TABLE T
   Arias Elizabeth, 2014, Natl Vital Stat Rep, V63, P1
   Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332
   Berry K, 2012, AM J TRANSPLANT, V12, P706, DOI 10.1111/j.1600-6143.2011.03853.x
   Berry K, 2015, GASTROENTEROLOGY, V149, P669, DOI 10.1053/j.gastro.2015.05.025
   Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551
   Bilbao I, 2008, CLIN TRANSPLANT, V22, P82, DOI 10.1111/j.1399-0012.2007.00749.x
   Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061
   Collins BH, 2000, TRANSPLANTATION, V70, P780, DOI 10.1097/00007890-200009150-00012
   Cross TJS, 2007, LIVER TRANSPLANT, V13, P1382, DOI 10.1002/lt.21181
   Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Freeman RB, 2006, AM J TRANSPLANT, V6, P1416, DOI 10.1111/j.1600-6143.2006.01321.x
   Garcia CE, 2001, TRANSPLANTATION, V72, P679, DOI 10.1097/00007890-200108270-00021
   Gray B, 2014, CMPRSK SUBDISTRIBUTI
   Halazun KJ, 2014, HEPATOLOGY, V60, P1957, DOI 10.1002/hep.27272
   Ioannou GN, 2008, GASTROENTEROLOGY, V134, P1342, DOI 10.1053/j.gastro.2008.02.013
   Kim W R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13197
   Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209
   Lai JC, 2014, AM J TRANSPLANT, V14, P1870, DOI 10.1111/ajt.12762
   Levy MF, 2001, ANN SURG, V233, P107, DOI 10.1097/00000658-200101000-00016
   Lin N, 2011, STAT INTERFACE, V4, P73
   Lipshutz GS, 2007, ARCH SURG-CHICAGO, V142, P775, DOI 10.1001/archsurg.142.8.775
   Lipshutz GS, 2007, ARCH SURG-CHICAGO, V142, P81
   Luca A, 2007, LIVER TRANSPLANT, V13, P1174, DOI 10.1002/lt.21197
   Malinis MF, 2014, ANN TRANSPL, V19, DOI 10.12659/AOT.890934
   Martin P, 2014, HEPATOLOGY, V59, P1144, DOI 10.1002/hep.26972
   Ow MMG, 2014, LIVER TRANSPLANT, V20, P1081, DOI 10.1002/lt.23907
   R Core Team, 2012, R LANG ENV STAT COMP
   Rudich S, 1999, TRANSPLANT P, V31, P523, DOI 10.1016/S0041-1345(98)01537-1
   Schaubel DE, 2009, AM J TRANSPLANT, V9, P970, DOI 10.1111/j.1600-6143.2009.02571.x
   Schwartz JJ, 2012, LIVER TRANSPLANT, V18, P423, DOI 10.1002/lt.23385
   Sharpton SR, 2014, TRANSPLANTATION, V98, P557, DOI 10.1097/TP.0000000000000090
   Sonny A, 2015, CLIN TRANSPLANT, V29, P197, DOI 10.1111/ctr.12500
   STARZL TE, 1987, NEW ENGL J MED, V316, P484
   Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495
   Vitale A, 2014, J HEPATOL, V60, P1336, DOI 10.1016/j.jhep.2014.02.018
   Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9
   Yadav A, 2015, CLIN TRANSPLANT, V29, P134, DOI 10.1111/ctr.12493
NR 42
TC 124
Z9 128
U1 1
U2 11
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD FEB
PY 2016
VL 150
IS 2
BP 441
EP +
DI 10.1053/j.gastro.2015.10.043
PG 19
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DB6MU
UT WOS:000368629900031
PM 26522262
OA hybrid
DA 2024-02-19
ER

PT J
AU STOUT, RW
AF STOUT, RW
TI GLUCOSE-TOLERANCE AND AGING
SO JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
LA English
DT Article; Proceedings Paper
CT Meeting of the Geriatrics-and-Gerontology-Section of the
   Royal-Society-of-Medicine
CY SEP   29, 1993
CL UNIV WALES, COLL MED, CARDIFF, WALES
SP ROYAL SOC MED, GERIATR & GERONTOL SECT
HO UNIV WALES, COLL MED
DE AGING; GLUCOSE; INSULIN; INSULIN RESISTANCE; DIABETES MELLITUS
ID INSULIN RESISTANCE; MEN; INTOLERANCE; YOUNG; OLD
AB Hyperglycaemia, impaired glucose tolerance and noninsulin dependent diabetes become progressively more common with advancing age. The mechanism is insensitivity to the actions of insulin at the postreceptor level. Inadequate secretion of insulin and decreased hepatic sensitivity to insulin's action in suppressing glucose output also occur. The age-related changes may be made worse by obesity, renal failure or the ingestion of certain drugs, or may be lessened by increased physical activity.
RP STOUT, RW (corresponding author), QUEENS UNIV BELFAST,DEPT GERIATR MED,WHITLA MED BLDG,97 LISBURN RD,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND.
CR BELL PM, 1992, DIABETES ATHEROSCLER, P27
   CAMERON CM, 1987, DIABETES, V36, P88, DOI 10.2337/diabetes.36.1.88
   CHEN M, 1986, J CLIN ENDOCR METAB, V62, P1193, DOI 10.1210/jcem-62-6-1193
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   COON PJ, 1989, METABOLISM, V38, P1201, DOI 10.1016/0026-0495(89)90160-1
   DALLOSSO HM, 1988, J EPIDEMIOL COMMUN H, V42, P121, DOI 10.1136/jech.42.2.121
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   GALE EAM, 1981, DIABETOLOGIA, V21, P25, DOI 10.1007/BF03216218
   HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523
   JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840
   KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273
   LAAKSO M, 1985, DIABETES CARE, V8, P114, DOI 10.2337/diacare.8.2.114
   MCCONNELL JG, 1983, AGE AGEING, V12, P54, DOI 10.1093/ageing/12.1.54
   MCCONNELL JG, 1983, EUR J CLIN INVEST, V12, P55
   MINAKER KL, 1982, DIABETES, V31, P851, DOI 10.2337/diabetes.31.10.851
   NEIL HAW, 1989, DIABETIC MED, V6, P608, DOI 10.1111/j.1464-5491.1989.tb01237.x
   PAOLISSO G, 1993, METABOLISM, V42, P659, DOI 10.1016/0026-0495(93)90228-G
   POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   SEALS DR, 1984, J APPL PHYSIOL, V56, P1521, DOI 10.1152/jappl.1984.56.6.1521
   STENGARD JH, 1993, DIABETES METAB, V19, P121
NR 21
TC 23
Z9 25
U1 0
U2 1
PU ROYAL SOC MEDICINE SERVICES LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON, ENGLAND W1M 8AE
SN 0141-0768
J9 J ROY SOC MED
JI J. R. Soc. Med.
PD OCT
PY 1994
VL 87
IS 10
BP 608
EP 609
PG 2
WC Medicine, General & Internal
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PJ911
UT WOS:A1994PJ91100013
PM 7966111
DA 2024-02-19
ER

PT J
AU Plumel, MI
   Benhaim-Delarbre, M
   Rompais, M
   Thiersé, D
   Sorci, G
   van Dorsselaer, A
   Criscuolo, F
   Bertile, F
AF Plumel, Marine I.
   Benhaim-Delarbre, Margaux
   Rompais, Magali
   Thierse, Daniele
   Sorci, Gabriele
   van Dorsselaer, Alain
   Criscuolo, Francois
   Bertile, Fabrice
TI Differential proteomics reveals age-dependent liver oxidative costs of
   innate immune activation in mice
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Immunosenescence; Liver; Proteomics; Oxidative stress; Ageing; Mice
ID INCREASED SUSCEPTIBILITY; PROXIMATE COST; NITRIC-OXIDE; NOX ENZYMES;
   TRADE-OFFS; STRESS; SYSTEM; PROTEINS; SURVIVAL; IMMUNOSUPPRESSION
AB Individual response to an immune challenge results from the optimization of a trade-off between benefits and costs of immune cell activation. Age-related immune disorders may have several mechanistic bases, from immune cell defects to chronic pro-inflammatory status and oxidative imbalance, but we are still lacking experimental data showing the relative importance of each of these mechanisms. Using a proteomic approach and subsequent biochemical validations of proteomics-derived hypotheses, we found age-dependent regulations in the liver of 3-months and 1-year old-mice in response to an acute innate immune activation. Old mice presented a chronic up-regulation of several proteins involved in pathways related to oxidative stress control. Interestingly, these pathways were weakly affected by the innate immune activation in old compared to young individuals. In addition, old mice suffered from lower glutathione-S-transferase activity and from higher oxidative damage at the end of the experiment, thus suggesting that they paid a higher immune-related cost than young individuals. On the whole, our data showed that a substantial fraction of the liver costs elicited by an activation of the innate immune response is effectively related to oxidative stress, and that ageing impairs the capacity of old individuals to control it.
   Significance: Our paper tackles the open question of the cost of mounting an innate immune response. Evolutionary biologists are familiar since a long time with the concept of trade-offs among key traits of an organism, tradeoffs that shape life history trajectories of species and individuals, ultimately in terms of reproduction and survival. On the other hand, medicine and molecular biologists study the intimate mechanisms of immune senescence and underline that oxidative imbalance is probably playing a key role in the progressive loss of immune function with age. This paper merges the two fields by exploring the nature of the cellular pathways that are mainly affected by age when the innate immunity is triggered. To this purpose, a proteomic approach was used to explore liver protein profiles and provide for the first time convincing data supporting the idea that oxidative stress constitutes a cost of innate immune response in old mice, possibly contributing to senescence. Proteomics-derived hypotheses were furthermore validated using biochemical assays. This paper therefore illustrates the added value of using proteomics to answer evolutionary biology questions, and opens a promising way to study the inter specific variability in the rates of immune-senescence. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Plumel, Marine I.; Benhaim-Delarbre, Margaux; Rompais, Magali; Thierse, Daniele; van Dorsselaer, Alain; Bertile, Fabrice] CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Analyt Sci, UMR7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France.
   [Criscuolo, Francois] CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, UMR7178, 23 Rue Becquerel, F-67087 Strasbourg 2, France.
   [Plumel, Marine I.; Benhaim-Delarbre, Margaux; Rompais, Magali; Thierse, Daniele; van Dorsselaer, Alain; Criscuolo, Francois; Bertile, Fabrice] Univ Strasbourg, 4 Rue Blaise Pascal, F-67081 Strasbourg, France.
   [Sorci, Gabriele] Univ Bourgogne, CNRS, Biogeosci, UMR6282, 6 Blvd Gabriel, F-21000 Dijon, France.
C3 Centre National de la Recherche Scientifique (CNRS); Centre National de
   la Recherche Scientifique (CNRS); Universites de Strasbourg
   Etablissements Associes; Universite de Strasbourg; Centre National de la
   Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment
   (INEE); Universite de Bourgogne
RP Bertile, F (corresponding author), CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Analyt Sci, UMR7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France.
RI Bertile, Fabrice/ABE-1479-2020; Bertile, Fabrice/F-1287-2019
OI Bertile, Fabrice/0000-0001-5510-4868; Bertile,
   Fabrice/0000-0001-5510-4868; Sorci, Gabriele/0000-0002-0799-3995
FU CNRS; Strasbourg University; French Proteomic Infrastructure (ProFI)
   [ANR-10-INSB-08-03]; CNRS "Projets Exploratoires Premier Soutien" (PEPS)
FX This work was supported by the CNRS and Strasbourg University (H2E
   project; IDEX UNISTRA), the French Proteomic Infrastructure (ProFI;
   ANR-10-INSB-08-03), and a CNRS "Projets Exploratoires Premier Soutien"
   (PEPS). We wish to thank Aurelie Hranitsky for her contribution with
   animal husbandry.
CR Adamo SA, 2008, J EXP BIOL, V211, P531, DOI 10.1242/jeb.013136
   Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x
   Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x
   Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200
   Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4
   Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940
   Blagosklonny MV, 2010, CELL CYCLE, V9, P3151, DOI 10.4161/cc.9.16.13120
   Blasco MA, 2002, SPRINGER SEMIN IMMUN, V24, P75, DOI 10.1007/s00281-001-0096-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carapito C, 2014, PROTEOMICS, V14, P1014, DOI 10.1002/pmic.201300415
   Caro AA, 2004, FREE RADICAL BIO MED, V36, P1303, DOI 10.1016/j.freeradbiomed.2004.02.015
   Caruso Calogero, 2009, Immun Ageing, V6, P10, DOI 10.1186/1742-4933-6-10
   Cavallaro RA, 2010, J ALZHEIMERS DIS, V20, P997, DOI 10.3233/JAD-2010-091666
   Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8
   Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002
   CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769
   De la Fuente M, 2002, EUR J CLIN NUTR, V56, pS5, DOI 10.1038/sj.ejcn.1601476
   Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631
   Diz AP, 2012, MOL ECOL, V21, P1060, DOI 10.1111/j.1365-294X.2011.05426.x
   Dowling D.K., 2009, P BIOL SCI, V276, P1737
   Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430
   Fedorka KM, 2004, EVOLUTION, V58, P2478
   Field A., 2009, Discovering statistics with SPSS, V3rd
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Görg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hörak P, 2000, CAN J ZOOL, V78, P905, DOI 10.1139/cjz-78-6-905
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Klandorf H, 2001, COMP BIOCHEM PHYS C, V129, P93, DOI 10.1016/S1532-0456(01)00186-7
   Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6
   Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Le Bourg É, 2001, FEBS LETT, V498, P183, DOI 10.1016/S0014-5793(01)02457-7
   Liaskou E, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/949157
   Licastro Federico, 2005, Immun Ageing, V2, P8
   Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x
   Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166
   NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202
   Ohsawa I, 2003, J NEUROCHEM, V84, P1110, DOI 10.1046/j.1471-4159.2003.01619.x
   Oveland E, 2012, J PROTEOME RES, V11, P5338, DOI 10.1021/pr3005666
   Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5
   Rezeli M., 2014, EUPA OPEN PROTEOMICS, V3, P68, DOI DOI 10.1016/J.EUPR0T.2014.02.003
   Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574
   Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006
   Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x
   Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Siva-Jothy MT, 1998, PHYSIOL ENTOMOL, V23, P274, DOI 10.1046/j.1365-3032.1998.233090.x
   Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151
   Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274
   Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x
   Tanikawa K, 2006, MED MOL MORPHOL, V39, P22, DOI 10.1007/s00795-006-0313-z
   Triantafilou M, 2001, HUM IMMUNOL, V62, P764, DOI 10.1016/S0198-8859(01)00269-5
   Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133
   von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
NR 70
TC 7
Z9 8
U1 0
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD MAR 1
PY 2016
VL 135
SI SI
BP 181
EP 190
DI 10.1016/j.jprot.2015.09.008
PG 10
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA DH3KL
UT WOS:000372685800017
PM 26376096
DA 2024-02-19
ER

PT J
AU Yuan, WG
   Zhang, M
   Wang, CX
   Li, B
   Li, L
   Ye, F
   Xu, CR
AF Yuan, Weigang
   Zhang, Mi
   Wang, Chunxu
   Li, Bin
   Li, Lei
   Ye, Feng
   Xu, Chuanrui
TI Resveratrol Attenuates High-Fat Diet-Induced Hepatic Lipotoxicity by
   Upregulating Bmi-1 Expression
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID DNA-DAMAGE; OXIDATIVE STRESS; LIVER-DISEASE; STEM-CELLS; P53;
   SENESCENCE; STEATOSIS; APOPTOSIS; NAFLD; ACID
AB Resveratrol (RES), a natural polyphenol phytoalexin, has been reported to attenuate nonalcoholic fatty liver disease (NAFLD). However, its roles on protection of liver from lipotoxicity and underlying mechanism are not fully understood. In this study, we investigated the impacts of RES on alleviating hepatic lipotoxicity and corresponding molecular mechanism. Impacts of RES on oleic acid (OA)-induced lipotoxicity were assessed in L02 cells and C57BL/6J mice, respectively. In L02 cells, lipotoxicity was assessed by detection of apoptosis, mitochondrial function, oxidative stress and ROS-related signaling. In mice, lipotoxicity was evaluated by detecting hepatic function, serum enzyme activity, and reactive oxygen species (ROS) levels. We found that RES reduced OA-induced apoptosis, mitochondrial dysfunction, ROS generation, and DNA damage in L02 cells. RES also decreased expression of cleaved caspase-3 and p53 and increased expression of B-cell lymphoma 2 (Bcl-2). Importantly, RES protected mice from high-fat diet-induced hepatic lipotoxicity, demonstrated by reduced ROS levels and lipid peroxidation. Mechanically, B lymphoma Mo-MLV insertion region 1 (Bmi-1) expression and antioxidative superoxide dismutase were increased after RES treatment. Further mechanistic analysis indicated that protection effects of RES against OA-induced lipotoxicity were abrogated by Bmi-1 small interference RNA (siRNA) in L02 cells. SIGNIFICANCE STATEMENT Results from clinical studies about the effect of RES on NAFLD are inconsistent and inconclusive. This study confirms the protective role of RES as an anti-ROS agent and its ability to alleviate DNA damage through a pathway involving p53/p21 signaling. Further mechanistic analysis indicated that protection effects of RES were relative with Bmi-1. This is the first study on the role of Bmi-1 in the pathogenesis of NAFLD and the target of resveratrol against NAFLD.
C1 [Yuan, Weigang; Zhang, Mi; Li, Bin; Li, Lei; Xu, Chuanrui] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Sch Pharm, Wuhan, Peoples R China.
   [Yuan, Weigang; Wang, Chunxu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Sch Basic Med, Wuhan, Peoples R China.
   [Ye, Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China.
   [Zhang, Mi] Lanzhou Univ, Sch Pharm, Lanzhou, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology;
   Lanzhou University
RP Xu, CR (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Sch Pharm, Wuhan, Peoples R China.; Ye, F (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China.
EM doctoryf@126.com; xcr@hust.edu.cn
RI zheng, yi/JOZ-7204-2023
FU National Science Foundation of China [81300251, 82073091, 81872253,
   80811621]
FX This work was supported by the National Science Foundation of China
   [Grants 81300251, 82073091, 81872253, and 80811621].
CR Arroyave-Ospina JC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020174
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Charytoniuk T, 2017, NUTRITION, V34, P108, DOI 10.1016/j.nut.2016.09.001
   Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009
   Das Samarjit, 2007, Inflammation & Allergy Drug Targets, V6, P168, DOI 10.2174/187152807781696464
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010
   Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Farrell GC, 2009, J GASTROEN HEPATOL, V24, P443, DOI 10.1111/j.1440-1746.2009.05785.x
   Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10
   Gómez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753
   Healy DA, 2003, CLIN SCI, V104, P171, DOI 10.1042/CS20020223
   Heeboll S, 2014, WORLD J HEPATOL, V6, P188, DOI 10.4254/wjh.v6.i4.188
   Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Li B, 2020, ONCOGENE, V39, P1063, DOI 10.1038/s41388-019-1043-8
   Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040
   Martinez-Rubio L, 2013, FISH SHELLFISH IMMUN, V34, P1533, DOI 10.1016/j.fsi.2013.03.363
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505
   Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477
   Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036209
   Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800
   Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191
   Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594
   Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866
   Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005
   Schmitt MJ, 1996, MICROBIOL-SGM, V142, P2655, DOI 10.1099/00221287-142-9-2655
   Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9
   Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776
   Spanier G, 2009, J PHYSIOL PHARMACOL, V60, P111
   Tang YH, 2012, J NUTR BIOCHEM, V23, P1410, DOI 10.1016/j.jnutbio.2011.08.008
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Vesterdal LK, 2014, TOXICOL APPL PHARM, V274, P350, DOI 10.1016/j.taap.2013.10.001
   Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0104882, 10.1371/journal.pone.0107012]
   Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161792
NR 43
TC 11
Z9 11
U1 4
U2 17
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD MAY 1
PY 2022
VL 381
IS 2
BP 96
EP 105
DI 10.1124/jpet.121.001018
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 0Y4KP
UT WOS:000790360700003
PM 35221291
OA hybrid
DA 2024-02-19
ER

PT J
AU Zhang, WJ
   Hu, DL
   Ji, WD
   Yang, LQ
   Yang, JP
   Yuan, JH
   Xuan, AG
   Zou, F
   Zhuang, ZX
AF Zhang, Wenjuan
   Hu, Dalin
   Ji, Weidong
   Yang, Linqing
   Yang, Jianping
   Yuan, Jianhui
   Xuan, Aiguo
   Zou, Fei
   Zhuang, Zhixiong
TI Histone modifications contribute to cellular replicative and hydrogen
   peroxide-induced premature senescence in human embryonic lung
   fibroblasts
SO FREE RADICAL RESEARCH
LA English
DT Article
DE cellular senescence; histone acetylation; histone methylation; hydrogen
   peroxide; HATs; HDACs
ID LYSINE METHYLTRANSFERASES; RAT-LIVER; ACETYLATION; DEACETYLATION; H3;
   TRANSCRIPTION; EPIGENETICS; ACTIVATION; DYNAMICS; FAMILY
AB Histone modifications are major post-translational mechanisms responsible for regulation of gene transcription involved in cellular senescence. By using immunofluorescence and Western blot, we showed that the global acetylated levels of histone H3 and H4 were significantly reduced in both replicative and premature senescence of human embryonic lung fibroblasts. However the whole trimethylated level of histone H4 lysine 20 was higher in senescent cells. The alterations in the mRNA and protein levels of histone acetyltransferases (HATs), histone methyltransferase (HMT), and histone deacetylases (HDACs) indicate that differential expression exists between replicative and premature senescent cells. Meanwhile, the reduced activity of HDACs was accompanied by cellular senescence. By employing the quantitative chromatin immunoprecipitation assay in detecting specific histone modifications in senescence-related genes including p53 and p16, it was demonstrated that the mRNA expression of p53 was associated with increased H4 acetylation in replicative senescence and increased H4 acetylation and trimethylation of histone H3 at lysine 4 (H3K4me3) in premature senescence. Both acetylation and trimethylation of H3 were involved in replicative senescence, while the acetylation of histone H3 and H4 was predominant in premature senescence, contributing to the mRNA expression of p16. In summary, the global hypoacetylation of histone H3 and H4 and the hypertrimethylation of histone H4 lysine 20 account for epigenetic characteristics in senescence, controlled by HATs, HMT, and HDACs differentially between replicative and premature senescence. Taken together, these findings suggest that the specific histone modifications are involved in regulating the expression of genes related to senescence of human embryonic lung fibroblasts.
C1 [Zhang, Wenjuan; Hu, Dalin; Zou, Fei] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Toxicol, Guangzhou, Guangdong, Peoples R China.
   [Yang, Linqing; Yang, Jianping; Yuan, Jianhui; Zhuang, Zhixiong] Shenzhen Ctr Dis Control & Prevent, Shenzhen Key Lab Modern Toxicol, Shenzhen 518055, Peoples R China.
   [Ji, Weidong] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.
   [Xuan, Aiguo] Guangzhou Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China.
C3 Southern Medical University - China; Shenzhen Center for Disease Control
   & Prevention (SZCDC); Guangzhou Medical University; Guangzhou Medical
   University
RP Zhuang, ZX (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen Key Lab Modern Toxicol, 8 Longyuan Rd, Shenzhen 518055, Peoples R China.
EM zxzhuang2009@126.com
RI sun, jiamin/JPY-2155-2023; Wang, Xuezhen/IUN-6267-2023; yuan,
   jianhui/GQA-4825-2022; ji, weidong/AAX-7397-2020
FU NSFC [81001259, 81272350, 81371217, 81273127, 81172710]; NSF of
   Guangdong Province [9451051501002539, S2012010008908]; University Talent
   Program of Guangzhou [12A015G]; school of Public Health and Tropical
   Medicine of Southern Medical University, China [GW201312]
FX This study was supported by NSFC (81001259, 81272350, 81371217,
   81273127, 81172710), NSF of Guangdong Province (9451051501002539,
   S2012010008908), the University Talent Program of Guangzhou (12A015G),
   Grant from school of Public Health and Tropical Medicine of Southern
   Medical University, China (GW201312).
CR Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030
   Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
   De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321
   Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Gao Z, 2011, BIOCHEM BIOPH RES CO, V404, P428, DOI 10.1016/j.bbrc.2010.11.138
   Gomez RA, 2009, AM J PHYSIOL-HEART C, V296, pH1255, DOI 10.1152/ajpheart.01266.2008
   Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599
   Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8
   Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466
   Kang HB, 2009, FEBS LETT, V583, P1880, DOI 10.1016/j.febslet.2009.05.038
   Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302
   Kawakami K, 2012, BIOCHEM BIOPH RES CO, V418, P836, DOI 10.1016/j.bbrc.2012.01.120
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654
   Khan AU, 2005, FRONT BIOSCI-LANDMRK, V10, P866, DOI 10.2741/1580
   Khan SN, 2010, CLIN CHIM ACTA, V411, P1401, DOI 10.1016/j.cca.2010.06.020
   Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Kwon B, 2010, BRAIN RES, V1333, P36, DOI 10.1016/j.brainres.2010.03.068
   Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462
   Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002
   Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847
   Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004
   Morishita M, 2011, BIOCHEM BIOPH RES CO, V412, P214, DOI 10.1016/j.bbrc.2011.07.061
   Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007
   Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2
   Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227
   Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023
   Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896
   Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2
   Zhang W, 2013, FREE RADICAL RES, V47, P325, DOI 10.3109/10715762.2013.773589
   Zhang WJ, 2008, LIFE SCI, V83, P475, DOI 10.1016/j.lfs.2008.07.015
   Zhang WJ, 2010, TOXICOLOGY, V278, P189, DOI 10.1016/j.tox.2010.07.011
NR 36
TC 6
Z9 10
U1 1
U2 26
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD MAY
PY 2014
VL 48
IS 5
BP 550
EP 559
DI 10.3109/10715762.2014.893580
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AE8TC
UT WOS:000334273900005
PM 24528089
DA 2024-02-19
ER

PT J
AU Rui, YH
   Cheng, JB
   Qin, LQ
   Shan, C
   Chang, JP
   Wang, GP
   Wan, ZX
AF Rui, Yehua
   Cheng, Jinbo
   Qin, Liqiang
   Shan, Cheng
   Chang, Jie
   Wang, Guiping
   Wan, Zhongxiao
TI Effects of vitamin D and resveratrol on metabolic associated markers in
   liver and adipose tissue from SAMP8 mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Vitamin D; Resveratrol; Insulin resistance; Endoplasmic reticulum
   stress; Adiponectin; Inflammation
ID ENDOPLASMIC-RETICULUM STRESS; SENESCENCE-ACCELERATED MOUSE;
   TYROSINE-PHOSPHATASE 1B; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; HEPATIC
   STEATOSIS; GENE-EXPRESSION; MACROPHAGE-MIGRATION; COGNITIVE DECLINE;
   IN-VITRO
AB SAMP8 mice exhibit multiple metabolic characteristics associated with age, and it is a suitable candidate for researching aging associated metabolic dysfunction.
   Objectives: We aimed to 1) explore how key metabolic markers will be altered in both liver and adipose tissue with aging in SAMP8 mice; and 2) how the combination of vitamin D (VD) with resveratrol (RSV) will affect aging associated metabolic impairment in liver and adipose tissue from SAMP8 mice.
   Methods: SAMP8 mice and their control SAMR1 mice were divided into 5 groups, i.e. SAMR1, SAMP8, SAMP8 mice supplemented with VD, RSV and VD combined with RSV group, respectively. At the end of the intervention, glucose and insulin tolerance, p-AMP-activated protein kinase (AMPK) and amyloid precursor protein (APP), and endoplasmic reticulum (ER) stress markers in liver and adipose tissue, adiponectin secretion, p-NF-kappa Bp65 and TNF-alpha protein expression in adipose tissue were determined.
   Results: Compared to SAMR1 control, SAMP8 mice demonstrate impaired glucose tolerance and reduction in circulating adiponectin level; in the liver, SAMP8 mice have reduction in p-Aktser473, elevation in PI P1B and APP, p-elF2 alpha, GRP78 and p-JNK protein expression. In epididymal (EPI) fat, SAMP8 mice also have elevated pAktser473 and PTP1B compared to SAMR1 mice. In both epididymal (EPI) and subcutaneous (SC) fat, there were elevated ER stress markers, reduced p-AMPK and elevated APP, as well as elevated p-NF-kappa Bp65 and TNF-alpha protein expression from SAMP8 compared to SAMR1 mice. In liver, the combined intervention significantly restored p-Aktser473, p-eIF2 alpha and p-JNK protein expression. In both EPI and SC fat, the combined intervention is effective for reducing p-NF-kappa B p65 and TNF-alpha in both fat depot, while only partially reduced ER stress markers in SC fat. As for adiponectin, their combination is unable to reverse reduction in adiponectin level. Adiponectin secretion in SC fat from VD, RSV and VDRSV group were also significantly reduced compared to SAMR1.
   Conclusion: The combined intervention might exert greater beneficial effects for reversing agitig associated metabolic dysfunction in liver and adipose tissue from SAMP8 mice. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Rui, Yehua; Cheng, Jinbo; Qin, Liqiang; Wan, Zhongxiao] Soochow Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Renai Rd 199, Suzhou 215123, Peoples R China.
   [Shan, Cheng] Univ Waterloo, Waterloo, ON, Canada.
   [Chang, Jie] Soochow Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, 199 Renai Rd, Suzhou 215123, Peoples R China.
   [Wang, Guiping] Soochow Univ, Lab Anim Ctr, 199 Renai Rd, Suzhou 215123, Peoples R China.
   [Wan, Zhongxiao] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Peoples R China.
C3 Soochow University - China; University of Waterloo; Soochow University -
   China; Soochow University - China; Soochow University - China
RP Wan, ZX (corresponding author), Soochow Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Renai Rd 199, Suzhou 215123, Peoples R China.
EM zhxwan@suda.edu.cn
RI wang, wenjuan/JGD-0428-2023; huang, libo/JMB-4345-2023; Jiang,
   Cheng/JHU-0179-2023
OI wang, wenjuan/0000-0002-4220-8817; 
FU Natural Science Foundation of China [81472975]; China Postdoctoral
   Science Foundation [2016M591918]; Postdoctoral Science Foundation of
   Jiangsu Province [1601046A]; University Science Research Project of
   Jiangsu Province [14KJD330002]
FX This study is supported by the Natural Science Foundation of China
   (grant no. 81472975), China Postdoctoral Science Foundation (grant no.
   2016M591918), Postdoctoral Science Foundation of Jiangsu Province
   (1601046A) and the University Science Research Project of Jiangsu
   Province (grant no. 14KJD330002) (to Wan Z).
CR André DM, 2016, INT IMMUNOPHARMACOL, V38, P298, DOI 10.1016/j.intimp.2016.06.017
   Beaudoin MS, 2013, AM J PHYSIOL-REG I, V305, pR542, DOI 10.1152/ajpregu.00200.2013
   Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Carreras A, 2015, ENDOCRINOLOGY, V156, P437, DOI 10.1210/en.2014-1706
   Chen N, 2016, J PHYSIOL BIOCHEM, V72, P453, DOI 10.1007/s13105-016-0493-5
   Chen SF, 2012, CAN J PHYSIOL PHARM, V90, P237, DOI [10.1139/Y11-123, 10.1139/y11-123]
   Cheng J, 2017, CURR ALZHEIMER RES
   Cheng JB, 2016, FOOD CHEM TOXICOL, V93, P32, DOI 10.1016/j.fct.2016.04.021
   Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807
   De Vita F, 2014, AGE, V36, DOI 10.1007/s11357-014-9694-4
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Enciso PLM, 2015, BIOCHEM BIOPH RES CO, V461, P165, DOI 10.1016/j.bbrc.2015.04.008
   Ghosh AK, 2015, J GERONTOL A-BIOL, V70, P1320, DOI 10.1093/gerona/glu186
   González-Rodríguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x
   Haddur E, 2015, BIOCHEM CELL BIOL, V93, P268, DOI 10.1139/bcb-2014-0155
   Haussler MR, 2016, MOLEC NUTRITION, P449, DOI 10.1016/B978-0-12-801816-3.00033-9
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655
   Jeong SI, 2016, NEUROBIOL AGING, V44, P74, DOI 10.1016/j.neurobiolaging.2016.04.007
   JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0
   Karkeni E, 2015, ENDOCRINOLOGY, V156, P1782, DOI 10.1210/en.2014-1647
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Koh SJ, 2008, CLIN CHIM ACTA, V389, P45, DOI 10.1016/j.cca.2007.11.017
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111
   Lee JSW, 2011, J NUTR HEALTH AGING, V15, P857, DOI 10.1007/s12603-011-0134-1
   Lee S, 2014, J EXERC REHABIL, V10, P54
   Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267
   Li MY, 2012, MECH AGEING DEV, V133, P655, DOI 10.1016/j.mad.2012.09.001
   Liu DX, 2014, PROG NEURO-PSYCHOPH, V49, P21, DOI 10.1016/j.pnpbp.2013.10.017
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105
   Ma YN, 2015, COMPR PHYSIOL, V5, P667, DOI 10.1002/cphy.c140041
   Messing Jennifer A, 2013, Curr Aging Sci, V6, P220
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363
   Morley JE, 2012, CURR PHARM DESIGN, V18, P1123
   Nikooyeh B, 2011, AM J CLIN NUTR, V93, P764, DOI 10.3945/ajcn.110.007336
   Palmer A.K., 2016, EXP GERONTOL
   Pan QR, 2015, NUTR RES, V35, P576, DOI 10.1016/j.nutres.2015.05.006
   Poolsup N, 2016, DIABETIC MED, V33, P290, DOI 10.1111/dme.12893
   Porquet D, 2013, AGE, V35, P1851, DOI 10.1007/s11357-012-9489-4
   Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59
   Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516
   Reiter FP, 2015, BIOCHEM BIOPH RES CO, V459, P227, DOI 10.1016/j.bbrc.2015.02.074
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912
   Rojas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113929
   Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Safari F, 2015, INT J VITAM NUTR RES, V85, P174, DOI 10.1024/0300-9831/a000236
   Schautz B, 2012, BRIT J NUTR, V108, P363, DOI 10.1017/S0007114511005605
   Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379
   Rojas JXS, 2016, J GERONTOL A-BIOL, V71, P310, DOI 10.1093/gerona/glv117
   Sozen E, 2015, FREE RADICAL BIO MED, V78, P30, DOI 10.1016/j.freeradbiomed.2014.09.031
   Stone AD, 2015, J CELL BIOCHEM, V116, P1130, DOI 10.1002/jcb.25070
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301
   Thomas J, 2013, J NUTR BIOCHEM, V24, P1735, DOI 10.1016/j.jnutbio.2013.03.002
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Vilarrasa N, 2005, CLIN ENDOCRINOL, V63, P329, DOI 10.1111/j.1365-2265.2005.02346.x
   Vyas P., 2016, CURR DRUG TARGETS
   Wan ZX, 2013, AM J PHYSIOL-CELL PH, V304, pC478, DOI 10.1152/ajpcell.00372.2012
   Wang ZG, 2017, ONCOTARGET, V8, P5400, DOI 10.18632/oncotarget.14284
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
NR 68
TC 11
Z9 13
U1 0
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2017
VL 93
BP 16
EP 28
DI 10.1016/j.exger.2017.03.017
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EV6JU
UT WOS:000401876500003
PM 28411010
DA 2024-02-19
ER

PT J
AU Morgan, AE
   Mooney, KM
   Wilkinson, SJ
   Pickles, NA
   Mc Auley, MT
AF Morgan, A. E.
   Mooney, K. M.
   Wilkinson, S. J.
   Pickles, N. A.
   Mc Auley, M. T.
TI Mathematically modelling the dynamics of cholesterol metabolism and
   ageing
SO BIOSYSTEMS
LA English
DT Article
DE Cholesterol; Ageing; Low density lipoprotein cholesterol (LDL-C); High
   density lipoprotein cholesterol (HDL-C); Cholesterol ester transfer
   protein (CETP)
ID ESTER TRANSFER PROTEIN; BILE-SALT HYDROLASE; DIETARY-CHOLESTEROL;
   FATTY-ACIDS; BIOMODELS DATABASE; LIPOPROTEIN-LIPASE; LIPID-METABOLISM;
   LDL CHOLESTEROL; PLASMA-MEMBRANE; MESSENGER-RNA
AB Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the UK. This condition becomes increasingly prevalent during ageing; 34.1% and 29.8% of males and females respectively, over 75 years of age have an underlying cardiovascular problem. The dysregulation of cholesterol metabolism is inextricably correlated with cardiovascular health and for this reason low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) are routinely used as biomarkers of CVD risk. The aim of this work was to use mathematical modelling to explore how cholesterol metabolism is affected by the ageing process. To do this we updated a previously published whole-body mathematical model of cholesterol metabolism to include an additional 96 mechanisms that are fundamental to this biological system. Additional mechanisms were added to cholesterol absorption, cholesterol synthesis, reverse cholesterol transport (RCT), bile acid synthesis, and their enterohepatic circulation. The sensitivity of the model was explored by the use of both local and global parameter scans. In addition, acute cholesterol feeding was used to explore the effectiveness of the regulatory mechanisms which are responsible for maintaining whole-body cholesterol balance. It was found that our model behaves as a hypo-responder to cholesterol feeding, while both the hepatic and intestinal pools of cholesterol increased significantly. The model was also used to explore the effects of ageing in tandem with three different cholesterol ester transfer protein (CETP) genotypes. Ageing in the presence of an atheroprotective CETP genotype, conferring low CETP activity, resulted in a 0.6% increase in LDL-C. In comparison, ageing with a genotype reflective of high CETP activity, resulted in a 1.6% increase in LDL-C. Thus, the model has illustrated the importance of CETP genotypes such as 1405V, and their potential role in healthy ageing. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Morgan, A. E.; Wilkinson, S. J.; Mc Auley, M. T.] Univ Chester, Dept Chem Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
   [Mooney, K. M.] Edge Hill Univ, Fac Hlth & Social Care, Ormskirk L39 4QP, Lancs, England.
   [Pickles, N. A.] Univ Chester, Dept Biol Sci, Parkgate Rd, Chester CH1 4BJ, Cheshire, England.
C3 University of Chester; Edge Hill University; University of Chester
RP Morgan, AE; Mc Auley, MT (corresponding author), Univ Chester, Dept Chem Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
EM amy.morgan@chester.ac.uk; m.mcauley@chester.ac.uk
OI Morgan, Amy/0000-0001-7557-6651
FU Faculty of Science and Engineering at the University of Chester
FX A.E. Morgan would like to acknowledge the Faculty of Science and
   Engineering at the University of Chester, for providing her with a
   studentship. We would also like to acknowledge the reviewers for their
   helpful suggestions.
CR ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260
   Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Al-Sheraji SH, 2012, FOOD CHEM, V135, P356, DOI 10.1016/j.foodchem.2012.04.120
   Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009
   [Anonymous], 2005, BMC BIOINFORMATICS, V6
   [Anonymous], 2014, AG LIF COURS FACTS A
   Moro-García MA, 2013, AGE, V35, P1311, DOI 10.1007/s11357-012-9434-6
   Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027
   Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026
   ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021
   ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019
   AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
   Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5
   Baptissart M, 2013, BIOCHIMIE, V95, P504, DOI 10.1016/j.biochi.2012.06.022
   Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628
   Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030
   Batta AK, 1999, J LIPID RES, V40, P1148
   Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006
   Bérard AM, 2004, EUR J CLIN NUTR, V58, P881, DOI 10.1038/sj.ejcn.1601890
   Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   Bhattacharya BS, 2014, J THEOR BIOL, V349, P150, DOI 10.1016/j.jtbi.2014.01.013
   Boone L.R., 2011, J LIPIDS, V2011, P9
   BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58
   Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068
   Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399
   Cooney MT, 2009, ATHEROSCLEROSIS, V206, P611, DOI 10.1016/j.atherosclerosis.2009.02.041
   Cooper AD, 1997, J LIPID RES, V38, P2173
   Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027
   Demirezen E.M., 2008, 27 INT C SYST DYN SO
   Duan LP, 2006, AM J PHYSIOL-GASTR L, V290, pG269, DOI 10.1152/ajpgi.00172.2005
   Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   Field PA, 2000, METABOLISM, V49, P492, DOI 10.1016/S0026-0495(00)80014-1
   Fu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032551
   Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014
   Gillotte KL, 1998, J LIPID RES, V39, P1918
   Guo CF, 2013, INT DAIRY J, V32, P144, DOI 10.1016/j.idairyj.2013.04.001
   He L, 1998, NUTR RES, V18, P1003, DOI 10.1016/S0271-5317(98)00083-9
   He YH, 2015, FEBS LETT, V589, P455, DOI 10.1016/j.febslet.2015.01.001
   HENNESSY LK, 1992, J LIPID RES, V33, P351
   Herron KL, 2003, J NUTR, V133, P1036, DOI 10.1093/jn/133.4.1036
   HOLLANDER D, 1979, EXP GERONTOL, V14, P201, DOI 10.1016/0531-5565(79)90020-2
   Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485
   Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448
   Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198
   Hucka M., 2004, Systems Biology, V1, P41, DOI 10.1049/sb:20045008
   Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015
   Hübner K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000079
   Ikeda I, 2002, BBA-GEN SUBJECTS, V1571, P34, DOI 10.1016/S0304-4165(02)00204-0
   Iqbal J., 2009, AM J PHYSIOL-ENDOC M, V296, pE1183
   Jansen S, 2000, AM J CLIN NUTR, V72, P36
   Jarocki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114379
   Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56
   Ji AL, 2011, ATHEROSCLEROSIS, V217, P106, DOI 10.1016/j.atherosclerosis.2011.03.017
   Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233
   JONES PJH, 1994, ARTERIOSCLER THROMB, V14, P542, DOI 10.1161/01.ATV.14.4.542
   Jones PJH, 1996, ARTERIOSCL THROM VAS, V16, P1222, DOI 10.1161/01.ATV.16.10.1222
   Juty N, 2015, CPT-PHARMACOMET SYST, V4, P55, DOI 10.1002/psp4.3
   Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013
   Kervizic G, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-99
   Le Novère N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092
   Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92
   LICHTENSTEIN AH, 1993, ARTERIOSCLER THROMB, V13, P154, DOI 10.1161/01.ATV.13.2.154
   LIN DS, 1980, J LIPID RES, V21, P1042
   Liscum L., 2008, CHOLESTEROL BIOSYNTH, P399
   Lu J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003509
   Lund-Katz S, 2013, J BIOL CHEM, V288, P23150, DOI 10.1074/jbc.M113.495523
   Manavalan APC, 2014, J BIOL CHEM, V289, P4683, DOI 10.1074/jbc.M113.499129
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Mazein A, 2013, BIOCHEM PHARMACOL, V86, P56, DOI 10.1016/j.bcp.2013.03.021
   Mc Auley MT, 2014, EXPERT REV ENDOCRINO, V9, P357, DOI 10.1586/17446651.2014.921569
   Mc Auley MT, 2015, COMPUT STRUCT BIOTEC, V13, P38, DOI 10.1016/j.csbj.2014.11.006
   Mc Auley MT, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-130
   Mc Auley MT, 2015, J INTEGR CARDIOL, V1, P76, DOI 10.15761/jic.1000122
   McAuley MT, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-26
   MCNAMARA DJ, 1987, J CLIN INVEST, V79, P1729, DOI 10.1172/JCI113013
   Micheloni A, 2015, COMPUT METHOD BIOMEC, V18, P1386, DOI 10.1080/10255842.2014.908855
   Millán J, 2009, VASC HEALTH RISK MAN, V5, P757
   MILLAR JS, 1995, J LIPID RES, V36, P1155
   Mishra S, 2014, RSC ADV, V4, P58964, DOI 10.1039/c4ra09397f
   Mooney KM, 2016, WIRES SYST BIOL MED, V8, P123, DOI 10.1002/wsbm.1328
   Morgan AE, 2016, AGEING RES REV, V27, P108, DOI 10.1016/j.arr.2016.03.008
   OFNS, 2013, MORT ASS 2012 BAS NA
   Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136
   OHTANI H, 1990, J LIPID RES, V31, P1413
   Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   PATSCH JR, 1987, J CLIN INVEST, V80, P341, DOI 10.1172/JCI113078
   Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Proctor C. J., 2013, J COMPUT SCI SYST BI, V6, P271, DOI DOI 10.4172/JCSB.1000122
   QUINTAO E, 1971, J LIPID RES, V12, P233
   Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139
   SCHEIBNER J, 1994, J LIPID RES, V35, P690
   Sharma R., 2010, INTERNET J CARDIOVAS, V7
   Shorten PR, 2005, BBA-MOL CELL BIOL L, V1736, P94, DOI 10.1016/j.bbalip.2005.07.007
   Sips FLP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003579
   SORCITHOMAS M, 1990, J BIOL CHEM, V265, P2665
   SPADY DK, 1992, J BIOL CHEM, V267, P5584
   Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2
   TANNOCK GW, 1989, APPL ENVIRON MICROB, V55, P1848, DOI 10.1128/AEM.55.7.1848-1851.1989
   Trautwein EA, 1999, COMP BIOCHEM PHYS A, V124, P93, DOI 10.1016/S1095-6433(99)00095-1
   Tuohy KM, 2003, DRUG DISCOV TODAY, V8, P692, DOI 10.1016/S1359-6446(03)02746-6
   Uchida K, 1996, JPN J PHARMACOL, V71, P113, DOI 10.1254/jjp.71.113
   van de Pas NCA, 2012, J LIPID RES, V53, P2734, DOI 10.1194/jlr.M031930
   Wang YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-4
   Watterson S, 2013, BIOCHIMIE, V95, P613, DOI 10.1016/j.biochi.2012.05.024
   WOOLLETT LA, 1992, J LIPID RES, V33, P77
   Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904
   Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08741
   Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751
NR 112
TC 18
Z9 21
U1 0
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0303-2647
EI 1872-8324
J9 BIOSYSTEMS
JI Biosystems
PD JUL
PY 2016
VL 145
BP 19
EP 32
DI 10.1016/j.biosystems.2016.05.001
PG 14
WC Biology; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA DQ3JH
UT WOS:000379098100003
PM 27157786
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Zhang, ZL
   Yao, Z
   Wang, L
   Ding, H
   Shao, JJ
   Chen, AP
   Zhang, F
   Zheng, SZ
AF Zhang, Zili
   Yao, Zhen
   Wang, Ling
   Ding, Hai
   Shao, Jiangjuan
   Chen, Anping
   Zhang, Feng
   Zheng, Shizhong
TI Activation of ferritinophagy is required for the RNA-binding protein
   ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells
SO AUTOPHAGY
LA English
DT Article
DE Autophagy; ELAVL1; ferritinophagy; ferroptosis; hepatic stellate cell;
   liver fibrosis; therapeutic target
ID INDUCED LIVER FIBROSIS; MESSENGER-RNA; CANCER PROGRESSION;
   LIPID-PEROXIDATION; UP-REGULATION; AUTOPHAGY; HUR; SENESCENCE;
   SORAFENIB; DEATH
AB Ferroptosis is a recently recognized form of regulated cell death that is characterized by lipid peroxidation. However, the molecular mechanisms regulating ferroptosis are largely unknown. In this study, we report that the RNA-binding protein ELAVL1/HuR plays a crucial role in regulating ferroptosis in liver fibrosis. Upon exposure to ferroptosis-inducing compounds, ELAVL1 protein expression was remarkably increased through the inhibition of the ubiquitin-proteasome pathway. ELAVL1 siRNA led to ferroptosis resistance, whereas ELAVL1 plasmid contributed to classical ferroptotic events. Interestingly, upregulated ELAVL1 expression also appeared to increase autophagosome generation and macroautophagic/autophagic flux, which was the underlying mechanism for ELAVL1-enhanced ferroptosis. Autophagy depletion completely impaired ELAVL1-mediated ferroptotic events, whereas autophagy induction showed a synergistic effect with ELAVL1. Importantly, ELAVL1 promoted autophagy activation via binding to the AU-rich elements within the F3 of the 3MODIFIER LETTER PRIME-untranslated region of BECN1/Beclin1 mRNA. The internal deletion of the F3 region abrogated the ELAVL1-mediated BECN1 mRNA stability, and, in turn, prevented ELAVL1-enhanced ferroptosis. In mice, treatment with sorafenib alleviated murine liver fibrosis by inducing hepatic stellate cell (HSC) ferroptosis. HSC-specific knockdown of ELAVL1 impaired sorafenib-induced HSC ferroptosis in murine liver fibrosis. Noteworthy, we retrospectively analyzed the effect of sorafenib on HSC ferroptosis in advanced fibrotic patients with hepatocellular carcinoma receiving sorafenib monotherapy. Attractively, ELAVL1 upregulation, ferritinophagy activation, and ferroptosis induction occurred in primary human HSCs from the collected human liver tissue. Overall, these results reveal novel molecular mechanisms and signaling pathways of ferroptosis, and also identify ELAVL1-autophagy-dependent ferroptosis as a potential target for the treatment of liver fibrosis.
C1 [Zhang, Zili; Yao, Zhen; Wang, Ling; Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.
   [Ding, Hai] Southeast Univ, Sch Med, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.
   [Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China.
   [Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Therapeut Mat Chinese Med, Nanjing, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.
C3 Nanjing University of Chinese Medicine; Southeast University - China;
   Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Saint Louis University
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@163.com
RI zhang, yimeng/JLL-7337-2023
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China (NSFC) [81270514, 31571455,
   31401210, 81600483, 31600653]; Postgraduate Research & Practice
   Innovation Program of Jiangsu Province [KYCX17_1322]; Open Project
   Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation
   of Chinese Materia Medica [JKLPSE 201502]; Project of the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   [PAPD]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) [81270514]; National Natural Science Foundation of China
   (NSFC) [31571455]; National Natural Science Foundation of China (NSFC)
   [31401210]; Postgraduate Research & Practice Innovation Program of
   Jiangsu Province [KYCX17_1322]; National Natural Science Foundation of
   China (NSFC) [81600483]; the Open Project Program of Jiangsu Key
   Laboratory for Pharmacology and Safety Evaluation of Chinese Materia
   Medica [JKLPSE 201502]; Project of the Priority Academic Program
   Development of Jiangsu Higher Education Institutions [PAPD]; National
   Natural Science Foundation of China (NSFC) [31600653].
CR Alvarez SW, 2017, NATURE, V551, P639, DOI 10.1038/nature24637
   Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005
   Aparicio-Vergara M, 2017, METHODS MOL BIOL, V1639, P161, DOI 10.1007/978-1-4939-7163-3_16
   Badawi A, 2017, CANCER LETT, V393, P103, DOI 10.1016/j.canlet.2017.02.010
   Bertrand RL, 2017, MED HYPOTHESES, V101, P69, DOI 10.1016/j.mehy.2017.02.017
   Ceccarelli S, 2011, HEPATOLOGY, V54, P1484, DOI 10.1002/hep.24579
   Chang SH, 2014, CURR OPIN HEMATOL, V21, P235, DOI 10.1097/MOH.0000000000000040
   Chen D, 2017, ONCOGENE, V36, P5593, DOI 10.1038/onc.2017.146
   Chen Q, 2016, INT IMMUNOPHARMACOL, V34, P250, DOI 10.1016/j.intimp.2016.03.011
   Chen YL, 2011, HEPATOLOGY, V53, P1708, DOI 10.1002/hep.24254
   Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115
   Choi HS, 2015, TRANSL RES, V166, P292, DOI 10.1016/j.trsl.2015.04.002
   Conrad M, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.995047
   De Magalhaes Filho C Daniel, 2016, Cell, V166, P789, DOI 10.1016/j.cell.2016.08.001
   Deng YR, 2013, J AUTOIMMUN, V46, P25, DOI 10.1016/j.jaut.2013.07.008
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Dixon SJ, 2017, IMMUNOL REV, V277, P150, DOI 10.1111/imr.12533
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Dodson RE, 2002, PROG NUCLEIC ACID RE, V72, P129, DOI 10.1016/S0079-6603(02)72069-2
   Gao MH, 2018, CURR OPIN CELL BIOL, V51, P58, DOI 10.1016/j.ceb.2017.11.001
   Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95
   Gubin MM, 2010, CELL CYCLE, V9, P3337, DOI 10.4161/cc.9.16.12711
   Hao SH, 2017, NEOPLASIA, V19, P1022, DOI 10.1016/j.neo.2017.10.005
   Hernández-Gea V, 2012, AUTOPHAGY, V8, P849, DOI 10.4161/auto.19947
   Hou W, 2016, AUTOPHAGY, V12, P1425, DOI 10.1080/15548627.2016.1187366
   Huang JS, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00013
   Huang QL, 2016, ONCOL LETT, V11, P1051, DOI 10.3892/ol.2015.3991
   Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344
   Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191
   Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lachaier E, 2014, ANTICANCER RES, V34, P6417
   Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019
   Louandre C, 2015, CANCER LETT, V356, P971, DOI 10.1016/j.canlet.2014.11.014
   Ma BY, 2014, CELL RES, V24, P912, DOI 10.1038/cr.2014.84
   McDaniel K, 2017, J BIOL CHEM, V292, P11336, DOI 10.1074/jbc.M116.773291
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Muratori L, 2010, HEPATOLOGY, V52, P1857, DOI 10.1002/hep.23924
   Nagai H, 2014, CANCER CHEMOTH PHARM, V73, P223, DOI 10.1007/s00280-013-2344-1
   Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420
   Shackel NA, 2014, HEPATOLOGY, V59, P2413, DOI 10.1002/hep.26932
   Shang LS, 2018, J GASTROENTEROL, V53, P6, DOI 10.1007/s00535-017-1404-4
   Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12
   Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921
   Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475
   Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251
   Thoen LFR, 2012, AUTOPHAGY, V8, P126, DOI 10.4161/auto.8.1.18105
   Wang H, 2017, HEPATOLOGY, V66, P449, DOI 10.1002/hep.29117
   Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015
   Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027
   Wen Xin, 2013, BMC Research Notes, V6, P1, DOI 10.1186/1756-0500-6-1
   Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Wu LD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05352-7
   Wu XX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13498
   Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158
   Xu XH, 2018, CANCER RES TREAT, V50, P71, DOI 10.4143/crt.2017.013
   Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021
   Yu DP, 2017, ONCOTARGETS THER, V10, P2609, DOI 10.2147/OTT.S132728
   Yu TX, 2016, AM J PHYSIOL-CELL PH, V310, pC54, DOI 10.1152/ajpcell.00112.2015
   Yu Y, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1054549
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021
   Zhang ZL, 2016, FREE RADICAL BIO MED, V101, P272, DOI 10.1016/j.freeradbiomed.2016.10.498
   Zucal C, 2015, CURR DRUG TARGETS, V16, P499, DOI 10.2174/1389450116666150223163632
NR 67
TC 259
Z9 275
U1 8
U2 80
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD DEC 2
PY 2018
VL 14
IS 12
BP 2083
EP 2103
DI 10.1080/15548627.2018.1503146
PG 21
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GX2PG
UT WOS:000447560800005
PM 30081711
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Lim, BO
   Seong, NS
   Choue, RW
   Kim, JD
   Lee, HY
   Kim, SY
   Yu, BP
   Jeon, TI
   Park, DK
AF Lim, BO
   Seong, NS
   Choue, RW
   Kim, JD
   Lee, HY
   Kim, SY
   Yu, BP
   Jeon, TI
   Park, DK
TI Efficacy of dietary aloe vera supplementation on hepatic cholesterol and
   oxidative status in aged rats
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE aging; aloe vera; oxidative stress; phospholipid hydroperoxide;
   cholesterol
ID CHEMICAL MEDIATOR PRODUCTION; FLOW-INJECTION; GANHUANGENIN; INHIBITION;
   METABOLISM; QUERCETIN; INGESTION; GROWTH
AB In the current study, we show the anti-oxidative and hypocholesterol effects of aloe vera in the liver. Male specific pathogen-free (SPF) Fischer 344 rats were randomly assigned to one of four groups: Group A (control) was fed test chow without aloe supplementation; Group B was fed a diet containing a 1% (per weight basis) freeze-dried aloe filet; Group C was fed a diet containing a 1% (per weight basis) charcoal-processed, freeze-dried aloe filet; and Group D was fed a diet containing a charcoal-processed freeze-dried, whole leaf aloe (0.02% per weight basis) in the drinking water. Our results show that a life-long intake of aloe had superior anti-oxidative action against lipid peroxidation in vivo, as indicated by reduced levels of hepatic phosphatidylcholine hydroperoxide. Additional anti-oxidative action was evidenced by enhanced superoxide dismutase (SOD) and catalase activity in groups B and C. Furthermore, our study revealed that hepatic cholesterol significantly increased in the control group during aging in contrast to the aloe-supplemented groups, which showed approximately 30% lower cholesterol levels, thereby an effective hypocholesteremic efficacy. In this report, we suggest that life-long dietary aloe supplementation suppresses free radical-induced oxidative damage and age-related increases in hepatic cholesterol.
C1 Kyung Hee Univ, Grad Sch EW Med Sci, Seoul, South Korea.
   RDA, Crop Expt Stn, Suwon 441100, South Korea.
   Kangwon Natl Univ, Sch Biotechnol & Bioengn, Chunchon 200701, South Korea.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX USA.
   Konkuk Univ, Dept Appl Biol & Chem, Seoul 143701, South Korea.
   Konkuk Univ, Res Inst Cell Activat, Seoul 143701, South Korea.
C3 Kyung Hee University; Rural Development Administration (RDA), Republic
   of Korea; Kangwon National University; University of Texas System;
   University of Texas Health Science Center at San Antonio; Konkuk
   University; Konkuk University
RP Lim, BO (corresponding author), Kyung Hee Univ, Grad Sch EW Med Sci, 1 Hoeki Dong, Seoul, South Korea.
EM beongou@khu.ac.kr
RI Lim, Beong Ou/AAS-5184-2021
OI Lim, Beong Ou/0000-0002-9618-5956
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AGARWAL OP, 1985, ANGIOLOGY, V36, P485, DOI 10.1177/000331978503600801
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BLITZ J J, 1963, J Am Osteopath Assoc, V62, P731
   Choi HY, 2000, PHYTOTHER RES, V14, P250, DOI 10.1002/1099-1573(200006)14:4&lt;250::AID-PTR587&gt;3.0.CO;2-J
   Choi HY, 1998, ANAL BIOCHEM, V264, P291, DOI 10.1006/abio.1998.2864
   Davis R.H., 1997, Aloe vera: A scientific approach
   DAVIS RH, 1989, J AM PODIAT MED ASSN, V79, P559, DOI 10.7547/87507315-79-11-559
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GHANNAM N, 1986, HORM RES, V24, P288, DOI 10.1159/000180569
   GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1
   Gu JY, 1995, BIOSCI BIOTECH BIOCH, V59, P2198, DOI 10.1271/bbb.59.2198
   HALLER JS, 1990, B NEW YORK ACAD MED, V66, P647
   HART LA, 1990, INT J IMMUNOPHARMACO, V12, P427, DOI 10.1016/0192-0561(90)90026-J
   HART LA, 1988, J ETHNOPHARMACOL, V23, P61, DOI 10.1016/0378-8741(88)90115-8
   HART LA, 1989, PLANTA MED, P509, DOI 10.1055/s-2006-962082
   Herlihy JT, 1998, PHYTOTHER RES, V12, P183, DOI 10.1002/(SICI)1099-1573(199805)12:3&lt;183::AID-PTR219&gt;3.0.CO;2-Q
   Herlihy JT, 1998, PHYTOTHER RES, V12, P355, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;355::AID-PTR314&gt;3.0.CO;2-K
   Hutter JA, 1996, J NAT PROD, V59, P541, DOI 10.1021/np9601519
   IKENO Y, 2001, IN PRESS PHYTOTHER R
   KIM SC, 1996, INT SOC FREE RAD RES, V8, P114
   KLEIN AD, 1988, J AM ACAD DERMATOL, V18, P714, DOI 10.1016/S0190-9622(88)70095-X
   Lee D W, 1990, Aging (Milano), V2, P357
   Lee KY, 2000, FREE RADICAL BIO MED, V28, P261, DOI 10.1016/S0891-5849(99)00235-X
   Lim BO, 1999, PHYTOTHER RES, V13, P479, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;479::AID-PTR484&gt;3.0.CO;2-M
   Lim BO, 2002, PHYTOTHER RES, V16, P166, DOI 10.1002/ptr.1034
   Lim BO, 1998, PHYTOTHER RES, V12, P340, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;340::AID-PTR316&gt;3.0.CO;2-U
   Lim BO, 1998, PHYTOTHER RES, V12, P375, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;375::AID-PTR315&gt;3.0.CO;2-F
   MIYAZAWA T, 1992, J LIPID RES, V33, P1051
   NAGATA Y, 1980, BRIT J NUTR, V44, P113, DOI 10.1079/BJN19800018
   PENNEYS NS, 1982, ACTA DERM-VENEREOL, V62, P59
   SAITO H, 1982, JPN J PHARMACOL, V32, P139, DOI 10.1254/jjp.32.139
   SPERRY WM, 1950, J BIOL CHEM, V187, P97
   TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 38
TC 31
Z9 33
U1 0
U2 5
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD AUG
PY 2003
VL 49
IS 4
BP 292
EP 296
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 717LY
UT WOS:000185092000014
PM 14598919
OA gold
DA 2024-02-19
ER

PT J
AU Kregel, KC
   Moseley, PL
AF Kregel, KC
   Moseley, PL
TI Differential effects of exercise and heat stress on liver HSP70
   accumulation with aging
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE heat shock proteins; hyperthermia
ID SHOCK PROTEINS; MESSENGER-RNA; AGED RATS; EXPRESSION; HYPERTHERMIA;
   INDUCTION; MUSCLE; GENE; CELL
AB Previous reports have suggested that the heat shock response to passive heating may be blunted by aging. However, during exertional heating, factors in addition to elevated temperature may amplify the degree of stress compared with hyperthermia alone. The purpose of this study was to compare the pattern of accumulation of the highly inducible 72-kDa heat shock protein (HSP72) in liver tissue of mature (12-mo-old) and senescent (24-mo-old) male Fischer 344 rats after either passive or exertional heat stress. A euthermic control group was exposed to an ambient temperature (T-a) of 25 degrees C for 4.5 h. A passive heating (heat) group was exposed to an T-a of 42 degrees C until colonic temperature (T-co) reached 41 degrees C. An exertional heating (exercise) group performed intermittent moderate-intensity treadmill exercise (similar absolute intensities for the two age groups) at an T-a of 32 degrees C until T-co reached 41 degrees C. Heating rates were similar in the heat and exercise groups (similar to 0.08 degrees C/min). Rats in both the heat and exercise groups were maintained at a T-co of 41 degrees C for an additional 30 min and subsequently returned to an T-a of 25 degrees C for 3 h. Liver HSP72 accumulation was increased in mature rats after both the heat (+192% vs. control) and exercise (+292%) protocols. In contrast, the senescent rats demonstrated no significant increase in inducible HSP70 with heating but a large increase with exercise (+232%; P < 0.01 compared with control and heat groups). These data suggest that the blunted heat shock protein response to heating observed with aging is not a result of the inability to produce inducible HSP72 because older rats had an robust response to exertional hyperthermia.
C1 UNIV IOWA,DEPT INTERNAL MED,IOWA CITY,IA 52242.
C3 University of Iowa
RP Kregel, KC (corresponding author), UNIV IOWA,DEPT EXERCISE SCI,516 FIELD HOUSE,IOWA CITY,IA 52242, USA.
OI Moseley, Pope/0000-0002-3723-9950
FU NIA NIH HHS [AG-12350] Funding Source: Medline
CR BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663
   BONGRAZIO M, 1994, HYPERTENSION, V24, P620, DOI 10.1161/01.HYP.24.5.620
   BRUCE JL, 1993, CANCER RES, V53, P12
   CAIRO G, 1985, HEPATOLOGY, V5, P357, DOI 10.1002/hep.1840050303
   CURRIE RW, 1983, CAN J BIOCHEM CELL B, V61, P438, DOI 10.1139/o83-059
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FLANAGAN SW, 1995, AM J PHYSIOL-REG I, V268, pR28, DOI 10.1152/ajpregu.1995.268.1.R28
   GAPEN CJ, 1995, J THERM BIOL, V20, P321, DOI 10.1016/0306-4565(94)00063-O
   IWAKI K, 1993, CIRCULATION, V87, P2023, DOI 10.1161/01.CIR.87.6.2023
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P706, DOI 10.1152/jappl.1995.79.3.706
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LI GC, 1983, CANCER RES, V43, P5758
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LOCKE M, 1990, AM J PHYSIOL, V258, pC723, DOI 10.1152/ajpcell.1990.258.4.C723
   MAZZEO RS, 1984, J APPL PHYSIOL, V57, P1369, DOI 10.1152/jappl.1984.57.5.1369
   MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105
   MOSELEY PL, 1993, AM J PHYSIOL, V264, pL533, DOI 10.1152/ajplung.1993.264.6.L533
   NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795, DOI 10.1152/ajpheart.1994.267.5.H1795
   PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135
   SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N
   SKIDMORE R, 1995, AM J PHYSIOL-REG I, V268, pR92, DOI 10.1152/ajpregu.1995.268.1.R92
   Stainsby W N, 1990, Exerc Sport Sci Rev, V18, P29
   TATE CA, 1989, MED SCI SPORT EXER, V21, P393
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
   WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629
NR 28
TC 60
Z9 69
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD FEB
PY 1996
VL 80
IS 2
BP 547
EP 551
DI 10.1152/jappl.1996.80.2.547
PG 5
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA UE824
UT WOS:A1996UE82400026
PM 8929597
DA 2024-02-19
ER

PT J
AU Sato, Y
   Harada, K
   Ozaki, S
   Furubo, S
   Kizawa, K
   Sanzen, T
   Yasoshima, M
   Ikeda, H
   Sasaki, M
   Nakanuma, Y
AF Sato, Yasunori
   Harada, Kenichi
   Ozaki, Satoru
   Furubo, Shinichi
   Kizawa, Kazuo
   Sanzen, Takahiro
   Yasoshima, Mitsue
   Ikeda, Hiroko
   Sasaki, Motoko
   Nakanuma, Yasuni
TI Cholangiocytes with mesenchymal features contribute to progressive
   hepatic fibrosis of the polycystic kidney rat
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID PRIMARY BILIARY-CIRRHOSIS; TISSUE GROWTH-FACTOR; SMALL BILE-DUCTS;
   EPITHELIAL-CELLS; CAROLIS-DISEASE; IN-VITRO; PCK RAT; HEPATOBILIARY
   DISEASES; CELLULAR SENESCENCE; RENAL FIBROSIS
AB The polycystic kidney (PCK) rat is an animal model of Caroli's disease with congenital hepatic fibrosis, in which the mechanism of progressive hepatic fibrosis remains unknown. This study aimed to clarify the mechanism of hepatic fibrosis of the PCK rat from the viewpoint of the contribution of pathological cholangiocytes. In liver sections of the PCK rats, intrahepatic bile ducts were constituted by two different phenotypes: bile ducts lined by cuboidal-shaped and flat-shaped cholangiocytes. The flat-shaped cholangiocytes; showed reduced immunohistochemical expression of the biliary epithelial marker cytokeratin 19 and positive immunoreactivity for vimentin and fibronectin. When cultured cholangiocytes of the PCK rat were treated with transforming growth factor (TGF)-beta 1, a potent inducer of epithelial-mesenchymal transition, induction of vimentin, fibronectin, and collagen expression occurred in the PCK cholangiocytes. Although the TGF-beta 1 treatment reduced cytokeratin 19 expression, the epithelial cell features characterized by the expression of E-cadherin and zonula occludens-1 was maintained, and a-smooth muscle actin expression was not induced in the cholangiocytes. Cholangiocytes; of the PCK rat may acquire mesenchymal features in response to TGF-beta 1 and participate in progressive hepatic fibrosis by producing extracellular matrix molecules, which seems to be a different event from epithelial-mesenchymal transition.
C1 [Sato, Yasunori; Harada, Kenichi; Ozaki, Satoru; Yasoshima, Mitsue; Ikeda, Hiroko; Sasaki, Motoko; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
   [Furubo, Shinichi; Kizawa, Kazuo; Sanzen, Takahiro] Toyama Chem Co Ltd, Drug Safety Res Lab, Toyama, Japan.
C3 Kanazawa University; Toyama Chemical Co., Ltd.
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Ozaki, Satoru/C-3218-2015; Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
CR Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778
   Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341
   Chen YX, 2001, PATHOL RES PRACT, V197, P585, DOI 10.1016/S0344-0338(04)70132-6
   DESMET VJ, 1992, HEPATOLOGY, V16, P1069, DOI 10.1002/hep.1840160434
   Fabris L, 2006, HEPATOLOGY, V43, P1001, DOI 10.1002/hep.21143
   Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4
   Forino M, 2006, INT J EXP PATHOL, V87, P197, DOI 10.1111/j.1365-2613.2006.00479.x
   Harada K, 1998, LIVER, V18, P277
   Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011
   Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Masyuk TV, 2004, AM J PATHOL, V165, P1719, DOI 10.1016/S0002-9440(10)63427-X
   Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1016/j.gastro.2003.09.001
   Moser M, 2005, HEPATOLOGY, V41, P1113, DOI 10.1002/hep.20655
   Muff MA, 2006, LAB INVEST, V86, P940, DOI 10.1038/labinvest.3700448
   NAKANUMA Y, 1982, LIVER, V2, P346
   NAKANUMA Y, 1992, MODERN PATHOL, V5, P550
   Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0
   Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448
   Ozaki S, 2005, LIVER INT, V25, P817, DOI 10.1111/j.1478-3231.2005.01067.x
   Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Sato Y, 2005, AM J PATHOL, V166, P49, DOI 10.1016/S0002-9440(10)62231-6
   Sato Y, 2006, AM J PATHOL, V169, P1238, DOI 10.2353/ajpath.2006.051136
   Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6
   Sweeney WE, 2006, CELL TISSUE RES, V326, P671, DOI 10.1007/s00441-006-0226-0
   TERADA T, 1994, HISTOPATHOLOGY, V25, P143, DOI 10.1111/j.1365-2559.1994.tb01570.x
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   TORRES, 2006, NAT CLIN PRACT NEPHR, V2, P40
   Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833
   Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274
   Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6
   Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747
   Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927
   Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7
NR 38
TC 48
Z9 53
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD DEC
PY 2007
VL 171
IS 6
BP 1859
EP 1871
DI 10.2353/ajpath.2007.070337
PG 13
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 241EE
UT WOS:000251638900013
PM 18055542
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU VANASTEN, JG
   KOPPELE, JMT
   HORBACH, GJMJ
AF VANASTEN, JG
   KOPPELE, JMT
   HORBACH, GJMJ
TI THE INFLUENCE OF AGING ON DIMETHYLNITROSAMINE-DEMETHYLASE
   ENZYME-KINETICS IN RAT-LIVER MICROSOMES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DIMETHYLNITROSAMINE; CYTOCHROME P450; METABOLISM; INDUCTION
ID PARA-NITROPHENOL HYDROXYLATION; AGE-RELATED-CHANGES;
   N-NITROSODIMETHYLAMINE; MESSENGER-RNAS; CYTOCHROME-P-450; METABOLISM;
   INDUCIBILITY; INDUCTION; SEQUENCES; ETHANOL
AB To investigate the observed age-related increased susceptibility to chemically-induced carcinogenesis, liver microsomes from 12- or 36-month-old rats either untreated or maximally induced with phenobarbital or isoniazid were used to determine the V-max and K-m for dimethylnitrosamine-demethylase (DMNA-d). A decrease in cytochrome P450 content between young and old animals was observed in the untreated group, but no change was seen in the treated animals. Inducer-related increases were observed after phenobarbital treatment and in the 36-month-old isoniazid-treated group. The V-max for DMNA-d did not change between 12 and 36 months of age in all experimental groups, but significant changes between the young and old age-group and inducer-related differences were observed in the K-m,K-app for DMNA-d. A high correlation was found between the Cl-int (= V-max/K-m,K-app) of DMNA-d and the V-max of p-nitrophenol-hydroxylation, indicating a major role for CYP2E1 in the metabolism of DMNA-d. The observed changes in the cytochrome-P450 levels and the reduced affinity in DMNA-d metabolism in the untreated group in this study is another indication that aging predominately affects the activity of some constitutive cytochrome P450 enzymes but not the activity of the inducible types of P450.
C1 TNO, LEIDEN, NETHERLANDS.
C3 Netherlands Organization Applied Science Research
CR [Anonymous], 1978, PATHOLOGY AGING RATS
   COECKE S, 1990, MECH AGEING DEV, V55, P189, DOI 10.1016/0047-6374(90)90026-C
   DAVIES DL, 1976, JNCI-J NATL CANCER I, V56, P1057, DOI 10.1093/jnci/56.5.1057
   FREI E, 1983, NATURWISSENSCHAFTEN, V70, P70
   FUKUSHIMA S, 1978, J NATL CANCER I, V79, P263
   GR K, IN PRESS J PHARM EXP
   GROEN K, 1991, THESIS U LEIDEN
   GROEN K, 1994, J PHARMACOL EXP THER, V268, P532
   GUENGERICH FP, 1988, CANCER RES, V48, P2946
   GUO ZY, 1993, GROWTH DEVELOP AGING, V57, P85
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   HORBACH GJMJ, 1990, MUTAT RES, V237, P117, DOI 10.1016/0921-8734(90)90017-L
   HORBACH GJMJ, 1990, BIOCHEM PHARMACOL, V40, P529, DOI 10.1016/0006-2952(90)90552-V
   HORBACH GJMJ, 1992, XENOBIOTICA, V22, P515, DOI 10.3109/00498259209053114
   HORBACH GJMJ, 1991, INT CONGR SER, V940, P183
   JORQUERA R, 1994, CARCINOGENESIS, V15, P389, DOI 10.1093/carcin/15.2.389
   KOOP DR, 1989, DRUG METAB REV, V20, P541, DOI 10.3109/03602538909103560
   KREMERS P, 1989, T AGING RES, V13, P19
   KROEGERKOEPKE MB, 1981, P NATL ACAD SCI-BIOL, V78, P6489, DOI 10.1073/pnas.78.10.6489
   LEVIN W, 1986, ARCH BIOCHEM BIOPHYS, V248, P158, DOI 10.1016/0003-9861(86)90412-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PRASANNA HR, 1986, CANCER LETT, V33, P259, DOI 10.1016/0304-3835(86)90065-0
   REINKE LA, 1985, DRUG METAB DISPOS, V13, P548
   RUTTEN AAJJL, 1987, ARCH TOXICOL, V61, P27, DOI 10.1007/BF00324544
   SONG BJ, 1986, J BIOL CHEM, V261, P6689
   STIJNEN AM, 1992, J PHARMACOL EXP THER, V261, P81
   TACCHI AM, 1987, BIOCHEM PHARMACOL, V36, P881, DOI 10.1016/0006-2952(87)90180-8
   TU YY, 1983, CANCER RES, V43, P623
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   WILLIAMS MT, 1988, BIOCHEM BIOPH RES CO, V155, P392, DOI 10.1016/S0006-291X(88)81098-2
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   WRIGHTON SA, 1987, ARCH BIOCHEM BIOPHYS, V258, P292, DOI 10.1016/0003-9861(87)90347-X
NR 34
TC 0
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG 8
PY 1995
VL 82
IS 2-3
BP 63
EP 72
DI 10.1016/0047-6374(95)01592-N
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA RQ340
UT WOS:A1995RQ34000001
PM 8538245
DA 2024-02-19
ER

PT J
AU RUSSELL, RM
AF RUSSELL, RM
TI CHANGES IN GASTROINTESTINAL FUNCTION ATTRIBUTED TO AGING
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE AGING; ELDERLY SUBJECTS; ABSORPTION; DIGESTION; GASTROINTESTINAL
   FUNCTION; ATROPHIC GASTRITIS
ID ELDERLY MEN; ATROPHIC GASTRITIS; FLOW-RATE; AGE; ABSORPTION;
   MALABSORPTION; HUMANS; HYPOCHLORHYDRIA; VITAMIN-B12; POPULATION
AB There are numerous reports in the literature of impaired gastrointestinal function with aging. However. most gastrointestinal functions remain relatively intact because of the large reserve capacity of the intestine, pancreas. and liver. Clinically important changes in gastrointestinal function with aging in human include decreased taste thresholds, hypochlorhydria due to atrophic gastritis. and decreased liver blood flow and size. Increased absorbability of lipids and large size molecules has been demonstrated in aging animals, but this has not been studied in humans. Nutrients with impaired gastrointestinal bioavailability in aging include dietary B-12, calcium carbonate, and ferric iron in atrophic gastritis; calcium, zinc, and possibly carbohydrate in a mixed meal. The implications of these changes Cor health maintenance and chronic disease in elderly people are in need of study.
C1 TUFTS UNIV, SCH MED, BOSTON, MA 02111 USA.
C3 Tufts University
RP RUSSELL, RM (corresponding author), TUFTS UNIV, USDA, HUMAN NUTR RES CTR AGING, 711 WASHINGTON ST, BOSTON, MA 02111 USA.
CR ALLEN RH, 1982, VIEWPOINTS DIG DIS, V14, P17
   ARORA S, 1989, GASTROENTEROLOGY, V96, P1560, DOI 10.1016/0016-5085(89)90527-1
   BARTOS V, 1969, GERONTOL CLIN, V11, P56, DOI 10.1159/000245215
   BAUM BJ, 1981, J DENT RES, V60, P1292, DOI 10.1177/00220345810600070101
   BAUM BJ, 1989, J AM GERIATR SOC, V37, P453, DOI 10.1111/j.1532-5415.1989.tb02644.x
   BECKER GH, 1950, GASTROENTEROLOGY, V14, P80, DOI 10.1016/S0016-5085(50)80113-0
   BRAUER PM, 1981, AM J CLIN NUTR, V34, P1061, DOI 10.1093/ajcn/34.6.1061
   BULLAMORE JR, 1990, LANCET, V336, P535
   BUSSE EW, 1987, POSTGRAD MED, V63, P118
   CASTELL D O, 1988, Practical Gastroenterology, V12, P37
   CASTELL DO, 1988, PRACT GASTROENTEROL, V12, P28
   Chaberek S., 1959, Organic sequestering agents
   COOPER JK, 1989, J AM GERIATR SOC, V37, P1039, DOI 10.1111/j.1532-5415.1989.tb06917.x
   CORAZZA GR, 1986, GERONTOLOGY, V32, P60, DOI 10.1159/000212766
   DOSCHERHOLMEN A, 1973, GASTROENTEROLOGY, V64, P913
   DUTTA SK, 1985, AM J CLIN NUTR, V41, P517, DOI 10.1093/ajcn/41.3.517
   EVANS MA, 1981, J AM GERIATR SOC, V29, P201, DOI 10.1111/j.1532-5415.1981.tb01766.x
   FAISAL MA, 1990, GASTROENTEROLOGY, V99, P1543, DOI 10.1016/0016-5085(90)91213-P
   FEIBUSCH JM, 1982, DIGEST DIS SCI, V27, P1095, DOI 10.1007/BF01391447
   FICH A, 1989, J CLIN GASTROENTEROL, V11, P416, DOI 10.1097/00004836-198908000-00014
   GREENBERG RE, 1986, DIGEST DIS SCI, V31, P970, DOI 10.1007/BF01303218
   GRZEGORCZYK PB, 1979, J GERONTOL, V34, P834, DOI 10.1093/geronj/34.6.834
   GULLO L, 1986, J AM GERIATR SOC, V34, P790, DOI 10.1111/j.1532-5415.1986.tb03983.x
   GUTH PH, 1968, AM J DIG DIS, V13, P565, DOI 10.1007/BF02233071
   HEFT MW, 1984, J DENT RES, V63, P1182, DOI 10.1177/00220345840630100101
   HOLLANDER D, 1984, J LIPID RES, V25, P129
   HOLLANDER D, 1979, EXP GERONTOL, V14, P301, DOI 10.1016/0531-5565(79)90041-X
   HOLLIS JB, 1974, ANN INTERN MED, V80, P371, DOI 10.7326/0003-4819-80-3-371
   HOLT PR, 1989, DIGEST DIS SCI, V34, P933, DOI 10.1007/BF01540281
   HOLT PR, 1989, DIETARY RESTRICTION, P211
   IRELAND P, 1973, J CLIN INVEST, V52, P2672, DOI 10.1172/JCI107461
   JACOBS P, 1964, J APPL PHYSIOL, V19, P187, DOI 10.1152/jappl.1964.19.2.187
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   KATZ D, 1987, DIGEST DIS SCI, V32, P285, DOI 10.1007/BF01297055
   KHALIL T, 1985, SURGERY, V98, P423
   KHALIL T, 1988, DIGEST DIS SCI, V33, P1544, DOI 10.1007/BF01535944
   KHAN TA, 1977, AM J DIG DIS, V22, P1049, DOI 10.1007/BF01072855
   KING CE, 1979, DIGEST DIS SCI, V24, P397, DOI 10.1007/BF01297127
   KNOX T, IN PRESS AM J CLIN N
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   KRASINSKI SD, 1986, J AM GERIATR SOC, V34, P800, DOI 10.1111/j.1532-5415.1986.tb03985.x
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MCEVOY A, 1983, BMJ-BRIT MED J, V287, P789, DOI 10.1136/bmj.287.6395.789
   MONTGOMERY RD, 1978, Q J MED, V47, P197
   MONTGOMERY RD, 1986, AGE AGEING, V15, P235, DOI 10.1093/ageing/15.4.235
   MUJAMDAR APN, 1989, PROG FOOD NUTR SCI, V13, P139
   NAVAB F, 1988, AM J PHYSIOL, V17, P630
   PIROTTE J, 1983, DIGESTION, V28, P210, DOI 10.1159/000198990
   PRICE HL, 1977, BRIT MED J, V2, P1582
   READ NW, 1987, FALK S, V47, P331
   RYDER JB, 1963, GERONTOLOGY, V5, P30
   SANTAMARIA C, 1988, MECH AGEING DEV, V44, P115, DOI 10.1016/0047-6374(88)90084-X
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCOTT J, 1977, ARCH ORAL BIOL, V22, P221, DOI 10.1016/0003-9969(77)90158-3
   SCOTT J, 1977, J BIOL BUCCALE, V5, P311
   SHAMBUREK RD, 1990, NEW ENGL J MED, V322, P438, DOI 10.1056/NEJM199002153220705
   SIURALA M, 1988, GUT, V29, P909, DOI 10.1136/gut.29.7.909
   STEVENS JC, 1984, CHEM SENSES, V9, P167, DOI 10.1093/chemse/9.2.167
   SUTER PM, 1991, GASTROENTEROLOGY, V101, P1039, DOI 10.1016/0016-5085(91)90731-Y
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   TURNLUND JR, 1986, J NUTR, V116, P1239, DOI 10.1093/jn/116.7.1239
   TURNLUND JR, 1982, AM J CLIN NUTR, V36, P587, DOI 10.1093/ajcn/36.4.587
   WARREN PM, 1978, LANCET, V2, P849
   WERNER I, 1972, NUTRITION OLD AGE, P55
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WOODHOUSE KW, 1987, FALK S, V47, P255
   ZOLI M, 1989, GERONTOLOGY, V35, P61, DOI 10.1159/000213000
NR 67
TC 100
Z9 101
U1 0
U2 12
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JUN
PY 1992
VL 55
IS 6
SU S
BP 1203
EP 1207
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HX761
UT WOS:A1992HX76100004
DA 2024-02-19
ER

PT J
AU Ziv, K
   Meir, G
   Harmelin, A
   Shimoni, E
   Klein, E
   Neeman, M
AF Ziv, Keren
   Meir, Gila
   Harmelin, Alon
   Shimoni, Eyal
   Klein, Eugenia
   Neeman, Michal
TI Ferritin as a reporter gene for MRI: chronic liver over expression of
   h-ferritin during dietary iron supplementation and aging
SO NMR IN BIOMEDICINE
LA English
DT Article
DE ferritin; reporter gene; iron; aging
ID OXIDATIVE STRESS; TRANSGENIC MICE; NMR SIGNAL; PROTEIN; CELLS;
   RELAXATION; CONTRAST
AB The iron storage protein, ferritin, provides an important endogenous MRI contrast that can be used to determine the level of tissue iron. In recent years the impact of modulating ferritin expression on MRI contrast and relaxation rates was evaluated by several groups, using genetically modified cells, viral gene transfer and transgenic animals. This paper reports the follow-up of transgenic mice that chronically over-expressed the heavy chain of ferritin (h-ferritin) in liver hepatocytes (liver-hfer mice) over a period of 2 years, with the aim of investigating the long-term effects of elevated level of h-ferritin on MR signal and on the well-being of the mice. Analysis revealed that aging liver-hfer mice, exposed to chronic elevated expression of h-ferritin, have increased R-2 values compared to WT. As expected for ferritin, R2 difference was strongly enhanced at high magnetic field. Histological analysis of these mice did not reveal liver changes with prolonged over expression of ferritin, and no differences could be detected in other organs. Furthermore, dietary iron supplementation significantly affected MRI contrast, without affecting animal wellbeing, for both wildtype and ferritin over expressing transgenic mice. These results suggest the safety of ferritin overexpression, and support the use of h-ferritin as a reporter gene for MRI. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Ziv, Keren; Meir, Gila; Neeman, Michal] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
   [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel.
   [Shimoni, Eyal; Klein, Eugenia] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel.
C3 Weizmann Institute of Science; Weizmann Institute of Science; Weizmann
   Institute of Science
RP Neeman, M (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
EM michal.neeman@weizmann.ac.il
RI Neeman, Michal/A-8264-2008; Neeman, Michal/AAH-9602-2019
OI Neeman, Michal/0000-0002-6296-816X; Neeman, Michal/0000-0002-6296-816X
FU Minerva Foundation; European Commission; European Research Council
   [232640-IMAGO]
FX Contract/grant sponsor: Minerva Foundation.; Contract/grant sponsor: The
   European Commission 7th Framework ENCITE Integrated project.;
   Contract/grant sponsor: The 7th Framework European Research Council
   Advanced grant; contract/grant number: 232640-IMAGO.
CR Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010
   AUNG W, 2009, GENE THER
   Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76
   Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436
   Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497
   Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842
   Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914
   Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021
   Fowler Christopher, 2008, Crit Care Nurs Clin North Am, V20, P191, DOI 10.1016/j.ccell.2008.01.003
   Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208
   Gossuin Y, 2004, NMR BIOMED, V17, P427, DOI 10.1002/nbm.903
   Gottesfeld Z, 1996, MAGN RESON MED, V35, P514, DOI 10.1002/mrm.1910350410
   Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7
   Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P
   Jensen JH, 2002, MAGNET RESON MED, V47, P1131, DOI 10.1002/mrm.10170
   Kaur D, 2007, BRAIN RES, V1140, P188, DOI 10.1016/j.brainres.2006.03.006
   Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933
   Liu J, 2009, TISSUE ENG PART C-ME, V15, P739, DOI [10.1089/ten.tec.2008.0678, 10.1089/ten.TEC.2008.0678]
   Liu Y, 2008, CLONING STEM CELLS, V10, P421, DOI 10.1089/clo.2008.0015
   Maggi A, 2004, TRENDS PHARMACOL SCI, V25, P337, DOI 10.1016/j.tips.2004.04.007
   ONO K, 2009, BIOCH BIOPHYS RES CO
   Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241
   Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017
   Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003
   Seggewiss R, 2006, BLOOD, V107, P3865, DOI 10.1182/blood-2005-10-4108
   Shapiro MG, 2009, J AM CHEM SOC, V131, P2484, DOI 10.1021/ja8086938
   Siah CW, 2005, CLIN CHIM ACTA, V358, P24, DOI 10.1016/j.cccn.2005.02.022
   Tao W, 2007, STEM CELLS, V25, P670, DOI 10.1634/stemcells.2006-0553
   Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463
   Uchida M, 2008, MAGN RESON MED, V60, P1073, DOI 10.1002/mrm.21761
   Vymazal J, 1998, J INORG BIOCHEM, V71, P153, DOI 10.1016/S0162-0134(98)10047-8
   Zandman-Goddard G, 2008, ISR MED ASSOC J, V10, P83
NR 32
TC 29
Z9 36
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD JUN
PY 2010
VL 23
IS 5
BP 523
EP 531
DI 10.1002/nbm.1491
PG 9
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 620UQ
UT WOS:000279526300011
PM 20175142
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Song, J
   Zhou, YZ
   Pang, YY
   Gao, L
   Du, GH
   Qin, XM
AF Song, Jia
   Zhou, Yu-zhi
   Pang, Yi-yuan
   Gao, Li
   Du, Guan-hua
   Qin, Xue-mei
TI The anti-aging effect of <i>Scutellaria baicalensis</i> Georgi flowers
   extract by regulating the glutamine-glutamate metabolic pathway in
   D-galactose induced aging rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Scutellaria baicalensis Georgi flowers; Anti-aging; Glutamine-glutamate
   metabolic pathway; Metabolomics
ID OXIDATIVE STRESS; GLUTATHIONE; FLAVONOIDS; AGE; ANTIOXIDANT; LIVER
AB Scutellaria baicalensis Georgi flowers is rich in flavonoids resources but not effectively exploited. This study aimed to investigate the anti-aging effects and potential mechanism of Scutellaria baicalensis Georgi flowers extract (SFE). The chemical components of the SFE were analyzed by UPLC-MS and the anti-aging effects of SFE were investigated in D-galactose (D-gal) induced aging rats by behavior examination and biochemical indexes, and the potential anti-aging mechanism of SFE were explored by H-1 NMR-based liver metabolomics. Chemical composition research showed that 19 flavonoids were identified in SFE, and pharmacological research showed that SFE could significantly ameliorate spatial learning and memory ability. SFE could significantly regulate malondialdehyde (MDA), superoxide dismutase (SOD) and advanced glycation end products (AGEs). It also ameliorated the pathological abnormalities in liver. Additionally, anti-aging mechanism of SFE showed that total of 10 potential biomarkers were found by metabolomics techniques, which involved in 6 metabolic pathways. Among them, SFE could significantly increased the levels of D-glutamine and D-glutamate. Furthermore, the levels of glutamine and glutamate, and the levels of the key amino acids, enzymes and final product in the synthesis process of glutathione (GSH) were quantitatively determined in the liver by commercial kits and enzyme-linked immunosorbent assay. These results indicated that regulation of the glutamine-glutamate metabolic pathway is involved in the anti-aging effect of SFE in D-gal induced aging rats.
C1 [Song, Jia; Zhou, Yu-zhi; Pang, Yi-yuan; Gao, Li; Qin, Xue-mei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 WuCheng Rd, Taiyuan 030006, Peoples R China.
   [Song, Jia] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan 030006, Peoples R China.
   [Du, Guan-hua] Chinese Acad Med Sci, Peking Union Med Coll, Inst Mat Med, Beijing 100050, Peoples R China.
C3 Shanxi University; Shanxi University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Institute of Materia Medica -
   CAMS; Peking Union Medical College
RP Zhou, YZ (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 WuCheng Rd, Taiyuan 030006, Peoples R China.
EM zhouyuzhi@sxu.edu.cn
FU National Natural Science Foundation of China [81673572]; Shanxi Key
   Research and Development Plan Project [201703D321023-3]; Applied Basic
   Research Project of Shanxi Province [201601D021164]; Innovation Project
   of Higher Education Institutions in Shanxi Province [2016120]
FX This work was supported by the National Natural Science Foundation of
   China (no. 81673572), the Shanxi Key Research and Development Plan
   Project (no. 201703D321023-3), the Applied Basic Research Project of
   Shanxi Province (no. 201601D021164), the Innovation Project of Higher
   Education Institutions in Shanxi Province (no. 2016120). Furthermore, we
   also thank Scientific Instrument Center of Shanxi University for the
   LC-MS analysis.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bingol K, 2014, ANAL CHEM, V86, P47, DOI 10.1021/ac403520j
   Cao YJ, 2016, ACTA BIOCH BIOPH SIN, V48, P437, DOI 10.1093/abbs/gmw024
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006
   Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699
   Han J, 2007, J CHROMATOGR B, V848, P355, DOI 10.1016/j.jchromb.2006.10.061
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698
   Hung CW, 2010, AGEING RES REV, V9, pS36, DOI 10.1016/j.arr.2010.08.006
   Jeong K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-14
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   Kong XY, 2014, NEURAL REGEN RES, V9, P2066, DOI 10.4103/1673-5374.147933
   Kristal Bruce S, 2005, Sci Aging Knowledge Environ, V2005, ppe19, DOI 10.1126/sageke.2005.26.pe19
   Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782
   Liu GZ, 2011, J CHROMATOGR B, V879, P1023, DOI 10.1016/j.jchromb.2011.02.050
   Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207
   MEISTER A, 1974, LIFE SCI, V15, P177, DOI 10.1016/0024-3205(74)90206-9
   Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   Nedic O, 2013, FREE RADICAL RES, V47, P28, DOI 10.3109/10715762.2013.806798
   Roth E, 2002, NUTRITION, V18, P217, DOI 10.1016/S0899-9007(01)00797-3
   Safwat MH, 2014, BIOCHEMISTRY-MOSCOW+, V79, P450, DOI 10.1134/S0006297914050095
   Seo ON, 2013, J FUNCT FOODS, V5, P1741, DOI 10.1016/j.jff.2013.07.020
   Szpetnar M, 2016, NEUROCHEM RES, V41, P2129, DOI 10.1007/s11064-016-1928-7
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Takahashi M, 2000, J GERONTOL A-BIOL, V55, pM137, DOI 10.1093/gerona/55.3.M137
   Vyskocilová E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/408573
   Ya-Zhen S., 2010, PHYTOTHERAPY RES PTR, V20, P53
   Yi ZJ, 2009, EXP GERONTOL, V44, P760, DOI 10.1016/j.exger.2009.08.011
   Zhao FF, 2018, FOOD FUNCT, V9, P4814, DOI 10.1039/c8fo00740c
   Zhao FF, 2018, METAB BRAIN DIS, V33, P1401, DOI 10.1007/s11011-018-0229-z
   Zhao HJ, 2017, INT J BIOL MACROMOL, V102, P351, DOI 10.1016/j.ijbiomac.2017.04.039
   Zheng YQ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0223-5
NR 35
TC 20
Z9 21
U1 10
U2 59
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2020
VL 134
AR 110843
DI 10.1016/j.exger.2020.110843
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KV3SF
UT WOS:000520402200007
PM 32045633
DA 2024-02-19
ER

PT J
AU Zs-Nagy, I
AF Zs-Nagy, I
TI The biological waste product formation in the light of the membrane
   hypothesis of aging
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Lipofuscin and Ceroid Pigments
CY MAY 19-22, 2001
CL UNIV HAWAII, HONOLULU, HI
HO UNIV HAWAII
DE lipofuscin; biological waste product formation; membrane hypothesis of
   aging; OH center dot free radicals; turnover of proteins; macromolecular
   damage; cross-linking
ID HEPATOCYTE PLASMA-MEMBRANE; LATERAL MOBILITY; FLUORESCENCE RECOVERY;
   PROTEINS; LIVER; AUTOFLUORESCENCE; SMEARS; LIPIDS; FRAP
AB The membrane hypothesis of aging (MHA) explains the biological waste product (lipofuscin) formation as a disbalance between the rates of protein synthesis and damage, as well as of elimination of the damaged components. Although, this concept has not been refuted on the basis of any experimental evidence, it has neither been widely accepted. During the last decade the general interest has turned toward the molecular genetics so intensely, that research aimed at clarifying cell biological mechanisms became so to say hibernated. Nowadays it is being recognized more and more that after the complete description of the human genetic code, attention has to be dedicated again to the cellular mechanisms explaining the function of the gene products (proteins). In this context, our experimental findings described during the recent years may become again the subject of interest. We have shown that the in vivo inhibition of the lysosomal thiol-proteinase functions by sublethal doses of leupeptin in young, adult and old mice results in a considerable increase (about 30%) of the immobile fraction of membrane proteins in hepatocyte plasma membrane, meanwhile the lateral diffusion constant of the still mobile membrane proteins increased. These observations were interpreted as signs of a general slowing down of protein turnover in the plasma membrane, just by inhibiting the elimination mechanisms in the lysosomes. This paper will discuss the theoretical conclusions and significance of these findings for the biological waste product formation, as a basic cell biological function. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Debrecen, Med & Hlth Sci Ctr, Dept Gerontol, VILEG,Hungarian Sect, H-4012 Debrecen, Hungary.
C3 University of Debrecen
RP Zs-Nagy, I (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Gerontol, VILEG,Hungarian Sect, POB 50, H-4012 Debrecen, Hungary.
EM izsnagy@jaguar.dote.hu
CR ELDRED GE, 1988, INT C SERIES, V782, P185
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1989, 14 INT C GER AC MEX, P198
   IVY GO, 1986, LIVER AGING 1986, P389
   IVY GO, 1987, NEUROPLASTICITY LEAR, P125
   IVY GO, 1988, INT C SERIES, V782, P83
   KIKUGAWA K, 1988, INT C SERIES, V782, P51
   KITANI K, 1992, ARCH GERONTOL GERIAT, V14, P27, DOI 10.1016/0167-4943(92)90004-N
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   Kitani K, 1999, MECH AGEING DEV, V107, P299, DOI 10.1016/S0047-6374(98)00139-0
   Kitani K, 1998, ARCH GERONTOL GERIAT, V26, P257, DOI 10.1016/S0167-4943(98)00008-9
   Nagy IZ, 1999, EXP BRAIN RES, V124, P233, DOI 10.1007/s002210050618
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   SMITH GM, 1989, 14 INT C GER AC, P195
   WOLFE LS, 1988, INT C SERIES, V782, P389
   Zs-Nagy I, 2001, MECH AGEING DEV, V122, P811, DOI 10.1016/S0047-6374(01)00237-8
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZsNagy I, 1997, J MOL MED, V75, P703
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
   ZSNAGY I, 1987, ADV BIOSCI, V64, P393
   ZSNAGY I, 1998, INT C SERIES, V782, P23
   ZSNAGY I, 2000, ANN NY ACAD SCI, V6, P3
   ZSNAGY I, 1994, MEMBRANE HYPOTHESIS, P207
   ZSNAGY I, 1989, CRC HDB FREE RADICAL, V1, P199
NR 28
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAY-JUN
PY 2002
VL 34
IS 3
BP 329
EP 341
AR PII S0167-4943(02)00010-9
DI 10.1016/S0167-4943(02)00010-9
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 539PY
UT WOS:000174880700015
PM 14764334
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Kuo, FY
   Huang, CC
   Swanson, PE
   Chen, CL
   Chuang, JH
   Yeh, MM
AF Sasaki, Motoko
   Kuo, Fang-Ying
   Huang, Chao-Cheng
   Swanson, Paul E.
   Chen, Chao-Long
   Chuang, Jiin-Haur
   Yeh, Matthew M.
TI Increased expression of senescence-associated cell cycle regulators in
   the progression of biliary atresia: an immunohistochemical study
SO HISTOPATHOLOGY
LA English
DT Article
DE biliary atresia; cellular senescence; cholangiopathy; neural cell
   adhesion molecule (NCAM); p16(Ink4a); p21(WAF1/Cip1)
ID SMALL BILE-DUCTS; DUCTULAR REACTIONS; EPITHELIAL-CELLS; CIRRHOSIS;
   INHIBITORS; STRESS; HUMANS; MARKER; TREE
AB Aims: Cellular senescence plays a role in tumour suppression and in the pathogenesis of various non-neoplastic diseases, including primary biliary cholangitis and other adult cholangiopathies. Less is known about the role of cellular senescence in cholangiopathies in children. With that in mind, we examined the expression of senescence-associated cell cycle regulators in biliary atresia, the most common form of paediatric obliterative cholangiopathy.
   Methods and results: The expression of senescence-associated cell cycle regulators (p16(Ink4a) and p21(WAF1/Cip1)) and a ductular reaction related marker (neural cell adhesion molecule: NCAM) was examined in bile ducts and bile ductules in liver samples taken from the patients with biliary atresia [n = 80; including 23 samples at the time of the Kasai procedure (KP) and 63 obtained from the explanted liver (LT) (six cases with samples at both surgical stages of disease)] and from appropriate controls (n = 17). The degree of ductular reaction and cholestasis was significantly more extensive in LT than KP (P < 0.01). The expression of p16(INK4a) and NCAM was significantly more extensive in bile ducts and bile ductules in ductular reaction in both KP and LT compared to controls and in LT compared to KP (P < 0.05). The expression of p21(WAF1/Cip1) was significantly more extensive in bile ducts and bile ductules in KP compared to both LT and controls (P < 0.01).
   Conclusions: Cellular senescence may play a role in the progression of bile duct loss in biliary atresia in a manner similar to that of adult cholangiopathies.
C1 [Sasaki, Motoko] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
   [Kuo, Fang-Ying; Huang, Chao-Cheng] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Pathol, Kaohsiung, Taiwan.
   [Swanson, Paul E.; Yeh, Matthew M.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.
   [Chen, Chao-Long] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Surg, Kaohsiung, Taiwan.
   [Chuang, Jiin-Haur] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat Surg, Coll Med, Kaohsiung, Taiwan.
   [Yeh, Matthew M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
C3 Kanazawa University; Chang Gung University; Chang Gung Memorial
   Hospital; University of Washington; University of Washington Seattle;
   Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial
   Hospital; Chang Gung University; University of Washington; University of
   Washington Seattle
RP Sasaki, M (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM m8sasaki@med.kanazawa-u.ac.jp
RI Huang, Chao/JJD-0553-2023; Sasaki, Motoko/K-5913-2015
OI Huang, Chao/0000-0001-8775-3192; Sasaki, Motoko/0000-0003-2514-760X
FU Ministry of Education, Culture, Sports and Science and Technology of
   Japan [15K08341]; Grants-in-Aid for Scientific Research [15K08341]
   Funding Source: KAKEN
FX This study was supported in part by a Grant-in-Aid for Scientific
   Research (C) from the Ministry of Education, Culture, Sports and Science
   and Technology of Japan (15K08341).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Chiba M, 2011, J CLIN PATHOL, V64, P564, DOI 10.1136/jcp.2011.090175
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Crosby HA, 1998, HEPATOLOGY, V28, P980, DOI 10.1002/hep.510280412
   Demetris AJ, 1996, AM J PATHOL, V149, P439
   DEMETRIS AJ, 1988, IN VITRO CELL DEV B, V24, P464
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   Karrer FM, 1996, ARCH SURG-CHICAGO, V131, P493
   Kawano Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093749
   Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238
   Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuo FY, 2015, HUM PATHOL, V46, P1633, DOI 10.1016/j.humpath.2015.07.003
   Lakshminarayanan B, 2016, J AUTOIMMUN, V73, P1, DOI 10.1016/j.jaut.2016.06.005
   Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Portmann B, 2007, DIS BILE DUCTS, P517
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Santos JL, 2009, J PEDIATR SURG, V44, P695, DOI 10.1016/j.jpedsurg.2008.09.013
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Verkade HJ, 2016, J HEPATOL, V65, P631, DOI 10.1016/j.jhep.2016.04.032
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557
NR 39
TC 9
Z9 9
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-0167
EI 1365-2559
J9 HISTOPATHOLOGY
JI Histopathology
PD JUN
PY 2018
VL 72
IS 7
BP 1164
EP 1171
DI 10.1111/his.13476
PG 8
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA GF5GB
UT WOS:000431993600010
PM 29392752
DA 2024-02-19
ER

PT J
AU Ma, FQ
   Ma, Y
   Liu, KK
   Gao, JY
   Li, SS
   Sun, XW
   Li, GR
AF Ma, Fengqiu
   Ma, Yan
   Liu, Keke
   Gao, Junying
   Li, Shasha
   Sun, Xiaowen
   Li, Guorong
TI Resveratrol induces DNA damage-mediated cancer cell senescence through
   the DLC1-DYRK1A-EGFR axis
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID COLORECTAL-CANCER; PROLIFERATION; INHIBITION; GROWTH; EGFR; SUPPRESSOR;
   INDUCTION; APOPTOSIS; MIGRATION; RECEPTOR
AB Inducing cell senescence is widely regarded as a potent tumor suppression mechanism. Resveratrol has attracted increasing attention for its capacity to prevent and suppress cancer. However, the mechanism of resveratrol on the induction of cancer cell senescence has not been well clarified. Our results showed that resveratrol inhibited cell viability and colony formation and promoted cell senescence along with augmentation of SA-beta-gal activity and modulation of senescence-associated molecular markers p53, p21 and LaminB protein in breast and liver cancer cells. The underlying mechanism was that resveratrol increased ROS generation to enhance tumor suppressor gene DLC1 expression, and DLC1 further inhibited the DYRK1A-EGFR axis to trigger DNA damage accompanied by up-regulation of the DNA double strand break marker protein gamma H2AX and down-regulation of the DNA repair related proteins p-BRCA1 and RAD51, eventually leading to cancer cell senescence. Resveratrol also effectively inhibited the volume of transplanted tumor with increased SA-beta-gal activity and DLC1 level in a chicken embryo allantoic membrane xenograft tumor model. This is the first report to investigate whether resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis, which could provide a solid base for resveratrol's application in cancer prevention and clinical treatment as a food additive or adjuvant therapies.
C1 [Ma, Fengqiu; Ma, Yan; Liu, Keke; Gao, Junying; Li, Shasha; Sun, Xiaowen; Li, Guorong] Shandong Normal Univ, Sch Life Sci, Shandong Prov Key Lab Anim Resistant Biol, Jinan 250014, Shandong, Peoples R China.
C3 Shandong Normal University
RP Li, GR (corresponding author), Shandong Normal Univ, Sch Life Sci, Shandong Prov Key Lab Anim Resistant Biol, Jinan 250014, Shandong, Peoples R China.
EM grli@sdnu.edu.cn
RI Yang, Xiao/JCD-7233-2023; Liu, Yuan/JFB-4766-2023; xiao,
   yang/JCD-7195-2023; Zhao, Shuai/JJC-3733-2023; liu,
   shanshan/JPA-0852-2023; bai, suyun/IUN-9317-2023; liu, xy/JEP-3175-2023;
   Li, YiXue/JRW-6306-2023; li, jing/JEF-8436-2023; ZHAO, S/IWV-4219-2023;
   wang, hongyuan/JWP-2279-2024; Chen, Xin/JDN-2017-2023; Liu,
   keke/HKF-4509-2023; qi, qi/JWP-1757-2024; Gu, b/JNS-4761-2023
OI Zhao, Shuai/0000-0003-1320-4283; 
FU National Natural Science Foundation of China [31672377]
FX This work was supported by the National Natural Science Foundation of
   China (grant no. 31672377).
CR de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156
   Baselga J, 2002, ONCOLOGIST, V7, P2
   Benatar T, 2012, BREAST CANCER RES TR, V133, P563, DOI 10.1007/s10549-011-1816-4
   Bian Y, 2022, FOOD FUNCT, V13, P3283, DOI [10.1039/d1fo02365a, 10.1039/D1FO02365A]
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Byeon Hyung Kwon, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-018-0202-2
   Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183
   Chai RF, 2017, MOL MED REP, V16, P8037, DOI 10.3892/mmr.2017.7612
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314
   Frey Y, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-08844-3
   Fu R, 2019, J AGR FOOD CHEM, V67, P4808, DOI 10.1021/acs.jafc.9b00833
   Fukuhara K, 2006, BIOORGAN MED CHEM, V14, P1437, DOI 10.1016/j.bmc.2005.09.070
   Gao JY, 2020, FOOD FUNCT, V11, P9573, DOI [10.1039/d0fo00996b, 10.1039/D0FO00996B]
   Hampl V, 2013, EMBO MOL MED, V5, P1367, DOI 10.1002/emmm.201202406
   Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784
   Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200
   Huang W, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0564-4
   Jeong SH, 2009, BIOCHEM PHARMACOL, V77, P1337, DOI 10.1016/j.bcp.2009.01.002
   Ji SH, 2018, EXP CELL RES, V370, P292, DOI 10.1016/j.yexcr.2018.06.031
   Kim D, 2004, BIOCHEM BIOPH RES CO, V323, P499, DOI 10.1016/j.bbrc.2004.08.102
   Kuo LJ, 2008, IN VIVO, V22, P305
   Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471
   Lee M, 2014, BMB REP, V47, P51, DOI 10.5483/BMBRep.2014.47.2.005
   Li BX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00315-4
   Li L, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5056-4
   Liang QX, 2018, AGING-US, V10, P1586, DOI 10.18632/aging.101494
   Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782
   Liu Q, 2015, MOL CANCER THER, V14, P355, DOI 10.1158/1535-7163.MCT-14-0634
   Liu SY, 2016, ONCOTARGET, V7, P16282, DOI 10.18632/oncotarget.7646
   Liu TT, 2017, ONCOTARGET, V8, P55422, DOI 10.18632/oncotarget.19268
   Liu TT, 2015, REJUV RES, V18, P225, DOI 10.1089/rej.2014.1618
   Luo HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060065
   Ma Long, 2015, Asian Pac J Cancer Prev, V16, P1637
   Martin KR, 2006, EXP BIOL MED, V231, P117
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Ning JY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2095-y
   Oberthür R, 2017, CANCER LETT, V407, P93, DOI 10.1016/j.canlet.2017.08.009
   Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027
   Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251
   Schreyer L, 2021, CANCERS, V13, DOI 10.3390/cancers13215373
   Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250
   Wang Meiling, 2022, Methods Mol Biol, V2444, P207, DOI 10.1007/978-1-0716-2063-2_13
   Wang SK, 2020, FUND CLIN PHARMACOL, V34, P65, DOI 10.1111/fcp.12488
   Wen FC, 2014, CARCINOGENESIS, V35, P1481, DOI 10.1093/carcin/bgu009
   Xu XH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1521-5
   You JHS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247860
   Zhang GJ, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0189-7
   Zhang Y, 2020, J CELL PHYSIOL, V235, P4999, DOI 10.1002/jcp.29402
   Zhou XL, 2020, J CELL MOL MED, V24, P10648, DOI 10.1111/jcmm.15683
NR 54
TC 4
Z9 4
U1 3
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2023 FEB 6
PY 2023
VL 14
IS 3
BP 1484
EP 1497
DI 10.1039/d2fo01188c
EA DEC 2022
PG 14
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 8N5AF
UT WOS:000913310500001
PM 36651299
DA 2024-02-19
ER

PT J
AU Mahmoud, YI
   Hegazy, HG
AF Mahmoud, Y. I.
   Hegazy, H. G.
TI Ginger and alpha lipoic acid ameliorate age-related ultrastructural
   changes in rat liver
SO BIOTECHNIC & HISTOCHEMISTRY
LA English
DT Article
DE aging; alpha lipoic acid; ginger; liver; rat; ultrastructure
ID SPINAL GANGLION NEURONS; OXIDATIVE STRESS; ZINGIBER-OFFICINALE; DIETARY
   SUPPLEMENTATION; STEREOLOGICAL ANALYSIS; MORPHOMETRIC-ANALYSIS;
   QUANTITATIVE CHANGES; LIPID-PEROXIDATION; FINE-STRUCTURE; MOUSE-LIVER
AB Because of the important role that oxidative stress is thought to play in the aging process, antioxidants could be candidates for preventing its related pathologies. We investigated the ameliorative effects of two antioxidant supplements, ginger and alpha lipoic acid (ALA), on hepatic ultrastructural alterations in old rats. Livers of young (4 months) and old (24 months) Wistar rats were studied using transmission electron microscopy. Livers of old rats showed sinusoidal collapse and congestion, endothelial thickening and defenestration, and inconsistent perisinusoidal extracellular matrix deposition. Aged hepatocytes were characterized by hypertrophy, cytoplasmic vacuolization and a significant increase in the volume densities of the nuclei, mitochondria and dense bodies. Lipofuscin accumulation and decreased microvilli in bile canaliculi and space of Disse also were observed. The adverse alterations were ameliorated significantly by both ginger and ALA supplementation; ALA was more effective than ginger. Ginger and ALA appear to be promising anti-aging agents based on their amelioration of ultrastructural alterations in livers of old rats.
C1 [Mahmoud, Y. I.; Hegazy, H. G.] Ain Shams Univ, Fac Sci, Dept Zool, POB 11566, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Ain Shams University
RP Mahmoud, YI (corresponding author), Ain Shams Univ, Fac Sci, Dept Zool, POB 11566, Cairo, Egypt.
EM yomna_ia@yahoo.com
RI Mahmoud, Yomna Ibrahim/H-6872-2019
OI Mahmoud, Yomna Ibrahim/0000-0002-9273-7661; Hegazy, Hoda Gamal
   Eldin/0000-0002-0897-8279
CR Akoachere J F T K, 2002, East Afr Med J, V79, P588
   Al-Amin ZM, 2006, BRIT J NUTR, V96, P660, DOI 10.1079/BJN20061849
   ANDREW W, 1962, AM J ANAT, V110, P1, DOI 10.1002/aja.1001100102
   Arivazhagan P, 2000, PHARMACOL RES, V41, P299, DOI 10.1006/phrs.1999.0594
   Aruoma OI, 1997, FOOD CHEM, V60, P149, DOI 10.1016/S0308-8146(95)00254-5
   Bast A, 2003, BIOFACTORS, V17, P207, DOI 10.1002/biof.5520170120
   BERTONIFREDDARI C, 1993, BRAIN RES, V628, P193, DOI 10.1016/0006-8993(93)90955-M
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Choi YY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/914563
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Corwin EJ, 2008, HDB PATHOPHYSIOLOGY, P21
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Cremer DR, 2006, REGUL TOXICOL PHARM, V46, P193, DOI 10.1016/j.yrtph.2006.06.003
   Deloncle R, 2001, EXP GERONTOL, V36, P231, DOI 10.1016/S0531-5565(00)00214-X
   Dozio E, 2010, EUR J PHARMACOL, V641, P29, DOI 10.1016/j.ejphar.2010.05.009
   Drury RA, 1980, CARLETONS HISTOLOGIC, P122
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   El-Sharaky AS, 2009, FOOD CHEM TOXICOL, V47, P1584, DOI 10.1016/j.fct.2009.04.005
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x
   Ghasemzadeh A, 2010, MOLECULES, V15, P4324, DOI 10.3390/molecules15064324
   Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x
   Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411
   HASAN M, 1973, EXP GERONTOL, V8, P75, DOI 10.1016/0531-5565(73)90017-X
   Hegazy HG, 2011, AFR J PHARM PHARMACO, V5, P1096
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Jeena K, 2011, INT J TOXICOL, V30, P662, DOI 10.1177/1091581811419023
   Karna P, 2012, BRIT J NUTR, V107, P473, DOI 10.1017/S0007114511003308
   Kim MK, 2010, EXP GERONTOL, V45, P419, DOI 10.1016/j.exger.2010.03.005
   Krim M, 2013, ANN BIOL CLIN-PARIS, V71, P165, DOI 10.1684/abc.2013.0806
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P191, DOI 10.1007/978-90-481-8556-6_11
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Ledda M, 2001, BRAIN RES BULL, V54, P455, DOI 10.1016/S0361-9230(01)00446-4
   Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-73
   Li LX, 2010, ANN NY ACAD SCI, V1203, P151, DOI 10.1111/j.1749-6632.2010.05555.x
   Marracci GH, 2002, J NEUROIMMUNOL, V131, P104, DOI 10.1016/S0165-5728(02)00269-2
   Martinelli C, 2006, TISSUE CELL, V38, P93, DOI 10.1016/j.tice.2005.12.002
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006
   Nagy IZ, 2001, ANN NY ACAD SCI, V928, P187
   Oliveira BF, 2010, THESCIENTIFICWORLDJO, V10, P1121, DOI 10.1100/tsw.2010.94
   Onwuka FC, 2011, J MED FOOD, V14, P817, DOI 10.1089/jmf.2010.0106
   Palaniyappan A, 2011, EXP GERONTOL, V46, P709, DOI 10.1016/j.exger.2011.04.004
   Patel NN, 2008, XENOBIOTICA, V38, P435, DOI [10.1080/00498250701830267, 10.1080/00498250701830267 ]
   PIERI C, 1980, MECH AGEING DEV, V13, P275, DOI 10.1016/0047-6374(80)90040-8
   Porta E, 1995, GERONTOLOGY, V41, P81
   PORTA EA, 1981, MECH AGEING DEV, V15, P297, DOI 10.1016/0047-6374(81)90137-8
   Robert L, 2003, PATHOL BIOL, V51, P543, DOI 10.1016/j.patbio.2003.09.008
   Rong XL, 2009, REGUL TOXICOL PHARM, V54, P118, DOI 10.1016/j.yrtph.2009.03.002
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHMUCKER DL, 1974, J GERONTOL, V29, P506, DOI 10.1093/geronj/29.5.506
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SCHMUCKER DL, 1985, MECH AGEING DEV, V31, P89, DOI 10.1016/0047-6374(85)90028-4
   Shila S, 2005, TOXICOLOGY, V210, P25, DOI 10.1016/j.tox.2005.01.003
   SPOERRI PE, 1981, J HIRNFORSCH, V22, P441
   Struys-Ponsar C, 1994, J Neural Transm Suppl, V44, P111
   Suh JH, 2001, FASEB J, V15, P700, DOI 10.1096/fj.00-0176com
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Thaakur S, 2009, J NEURAL TRANSM, V116, P807, DOI 10.1007/s00702-009-0232-y
   Topic B, 2002, NEUROBIOL AGING, V23, P135, DOI 10.1016/S0197-4580(01)00241-X
   Vidal L, 2004, NEUROSCI RES, V48, P387, DOI 10.1016/j.neures.2003.12.004
   VINCENT SL, 1989, ANAT REC, V223, P329, DOI 10.1002/ar.1092230312
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Wang L, 2013, INT J CLIN EXP MED, V6, P90
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   WILSON PD, 1975, GERONTOLOGY, V21, P81, DOI 10.1159/000212035
   Yemitan OK, 2006, PHYTOTHER RES, V20, P997, DOI 10.1002/ptr.1957
   Zhou HL, 2006, J ETHNOPHARMACOL, V105, P301, DOI 10.1016/j.jep.2005.10.022
   Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296
NR 79
TC 7
Z9 8
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1052-0295
EI 1473-7760
J9 BIOTECH HISTOCHEM
JI Biotech. Histochem.
PD FEB 17
PY 2016
VL 91
IS 2
BP 86
EP 95
DI 10.3109/10520295.2015.1076578
PG 10
WC Biotechnology & Applied Microbiology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Cell Biology
GA DB5KK
UT WOS:000368552800002
PM 26528730
DA 2024-02-19
ER

PT J
AU Pich, MM
   Raule, N
   Catani, L
   Fagioli, ME
   Faenza, I
   Cocco, L
   Lenaz, G
AF Pich, MM
   Raule, N
   Catani, L
   Fagioli, ME
   Faenza, I
   Cocco, L
   Lenaz, G
TI Increased transcription of mitochondrial genes for Complex I in human
   platelets during ageing
SO FEBS LETTERS
LA English
DT Article
DE mitochondrial mRNA; ageing; oxidative phosphorylation system; gene
   expression
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; SENESCENT RAT; DNA; LIVER; HEART;
   AGE; EXPRESSION; MUTATION; DISEASES
AB We studied the effect of ageing on the mRNA levels of mitochondria-encoded polypeptides in human platelets. We used quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate the expression of selected cytochrome c oxidase (COX) genes (subunits I and III) and Complex I genes (subunits reduced nicotinamide adenine dinucleotide (NADH) dehydrogenase (ND)1 and ND5) in platelets from young and aged healthy subjects. Northern blot analysis confirmed the PCR results. COX I expression is higher than that of COX III in both young and aged platelets. A significant increase of transcripts for Complex I was found during ageing. On the contrary, the mRNA levels of the two COX subunits did not significantly vary during ageing. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Bologna, Dept Biochem G Moruzzi, I-40126 Bologna, Italy.
   Univ Bologna, Inst Hematol & Med Oncol Le A Seragnoli, I-40126 Bologna, Italy.
   Univ Bologna, Inst Anat, Cellular Signalling Lab, I-40126 Bologna, Italy.
C3 University of Bologna; University of Bologna; University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dept Biochem G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Catani, Lucia/K-3814-2018; Lenaz, Giorgio/B-5751-2013
OI Catani, Lucia/0000-0002-4650-201X
CR Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Catani L, 2002, LEUKEMIA, V16, P1773, DOI 10.1038/sj.leu.2402597
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   D'Aurelio M, 2001, MECH AGEING DEV, V122, P823, DOI 10.1016/S0047-6374(01)00239-1
   Drouet M, 1999, EXP GERONTOL, V34, P843, DOI 10.1016/S0531-5565(99)00058-3
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   Grossman LI, 1998, ELECTROPHORESIS, V19, P1254, DOI 10.1002/elps.1150190805
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V176, P87, DOI 10.1016/0006-291X(91)90893-C
   HOLMSEN H, 1987, HEMOSTASIS THROMBOSI, P631
   KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x
   Lenaz G, 1998, BIOFACTORS, V8, P195, DOI 10.1002/biof.5520080305
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Ozawa T, 1999, J BIOENERG BIOMEMBR, V31, P377, DOI 10.1023/A:1005479920097
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2
   Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P99, DOI 10.1016/S0005-2728(98)00160-1
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
NR 23
TC 13
Z9 18
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JAN 30
PY 2004
VL 558
IS 1-3
BP 19
EP 22
DI 10.1016/S0014-5793(03)01520-5
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 772AJ
UT WOS:000188817900005
PM 14759509
DA 2024-02-19
ER

PT J
AU Senmaru, T
   Yamazaki, M
   Okada, H
   Asano, M
   Fukui, M
   Nakamura, N
   Obayashi, H
   Kondo, Y
   Maruyama, N
   Ishigami, A
   Hasegawa, G
AF Senmaru, Takafumi
   Yamazaki, Masahiro
   Okada, Hiroshi
   Asano, Mai
   Fukui, Michiaki
   Nakamura, Naoto
   Obayashi, Hiroshi
   Kondo, Yoshitaka
   Maruyama, Naoki
   Ishigami, Akihito
   Hasegawa, Goji
TI Pancreatic insulin release in vitamin C-deficient senescence marker
   protein-30/gluconolactonase knockout mice
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE vitamin C; insulin; islet; Senescence marker protein-30;
   gluconolactonase
ID MITOCHONDRIAL GLYCEROL-3-PHOSPHATE DEHYDROGENASE; ASCORBIC-ACID;
   GLUCOSE-TOLERANCE; OXIDATIVE STRESS; PROTEIN-30 SMP30; GUINEA-PIG;
   MOUSE; SECRETION; ISLETS; LIVER
AB We recently identified senescence marker protein-30 as the lactone-hydrolyzing enzyme gluconolactonase, which is involved in vitamin C biosynthesis. In this study, we investigated the effects of vitamin C on insulin secretion from pancreatic beta-cells using senescence marker protein-30/gluconolactonase knockout mice. In intraperitoneal glucose tolerance tests, vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice demonstrated impaired glucose tolerance with significantly lower blood insulin levels at 30 and 120 min post-challenge than in wild type mice (p<0.01-0.05). In contrast, vitamin C-sufficient senescence marker protein-30/gluconolactonase knockout mice demonstrated significantly higher blood glucose and lower insulin only at the 30 min post-challenge time point (p<0.05). Senescence marker protein-30/gluconolactonase knockout mice showed enhanced insulin sensitivity regardless of vitamin C status. Static incubation of islets revealed that 20 mM glucose-stimulated insulin secretion and islet ATP production were significantly decreased at 60 min only in vitamin C-deficient SMP30/GNL knockout mice relative to wild type mice (p<0.05). These results indicate that the site of vitamin C action lies between glycolysis and mitochondrial oxidative phosphorylation, while SMP30 deficiency itself impairs the distal portion of insulin secretion pathway.
C1 [Senmaru, Takafumi; Yamazaki, Masahiro; Okada, Hiroshi; Asano, Mai; Fukui, Michiaki; Nakamura, Naoto; Hasegawa, Goji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, Kyoto 6028556, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Fushimi Ku, Kyoto 6128016, Japan.
   [Kondo, Yoshitaka; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Kyoto Prefectural University of Medicine; Tokyo Metropolitan Institute
   of Gerontology
RP Hasegawa, G (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028556, Japan.
EM goji@koto.kpu-m.ac.jp
RI Yoshitaka, Kondo/AFK-7721-2022; Okada, Hiroshi/AAG-1588-2020
OI Yoshitaka, Kondo/0000-0002-0046-9429; Okada,
   Hiroshi/0000-0002-1707-970X; Ishigami, Akihito/0000-0001-7875-7482;
   Fukui, Michiaki/0000-0003-0903-1797
FU [20591066];  [23591317]; Grants-in-Aid for Scientific Research
   [23790122] Funding Source: KAKEN
FX This study was supported by a Grant-in-Aid for Scientific Research (C)
   (No. 20591066 and 23591317 to GH). We thank Hiroko Kawamura, Sayoko
   Horibe and Sanae Utena for secretarial assistance. Vitamin C powder was
   kindly provided by DSM Nutrition Japan.
CR Alfadda A, 2004, AM J PHYSIOL-REG I, V287, pR147, DOI 10.1152/ajpregu.00103.2004
   Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012
   BANERJEE S, 1952, J BIOL CHEM, V195, P271
   Barberà A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5
   Dou CZ, 1997, BIOCHEM BIOPH RES CO, V231, P820, DOI 10.1006/bbrc.1997.6106
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Furusawa H, 2008, BIOL PHARM BULL, V31, P1673, DOI 10.1248/bpb.31.1673
   HASEGAWA G, 1990, HORM METAB RES, V22, P408, DOI 10.1055/s-2007-1004935
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Jung CH, 1997, BIOCHEM BIOPH RES CO, V239, P457, DOI 10.1006/bbrc.1997.7438
   Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   NISHIKIMI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P842, DOI 10.1016/0003-9861(88)90093-8
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Sigal A, 1936, J BIOL CHEM, V116, P489
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Uchizono Y, 2004, ENDOCRINOLOGY, V145, P2264, DOI 10.1210/en.2003-1152
   WELLS WW, 1995, P NATL ACAD SCI USA, V92, P11869, DOI 10.1073/pnas.92.25.11869
   Wells WW, 2001, J BIOL CHEM, V276, P2404, DOI 10.1074/jbc.M007268200
   Yan J, 2007, GENET MOL BIOL, V30, P322, DOI 10.1590/S1415-47572007000300004
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 31
TC 15
Z9 17
U1 0
U2 3
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD MAR 1
PY 2012
VL 50
IS 2
BP 114
EP 118
DI 10.3164/jcbn.11-52
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 922DB
UT WOS:000302525900003
PM 22448091
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU PUTNAM, AD
   PETERSON, TC
AF PUTNAM, AD
   PETERSON, TC
TI EFFECT OF AGING AND OTHER FACTORS ON MONOCYTE ARYL-HYDROCARBON
   HYDROXYLASE-ACTIVITY
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DRUG METABOLISM; SMOKING; ARYLHYDROCARBON HYDROXYLASE; MONOCYTES
ID RAT-LIVER; SUPEROXIDE-DISMUTASE; DRUG-METABOLISM; AGE; INTERLEUKIN-1;
   MACROPHAGES; ANTIPYRINE; SECRETION; BINDING
AB A measure of the activity of macrophage drug metabolizing enzymes through assay of peripheral monocytes was used to assess the hepatic enzymatic status and thereby evaluate age related changes in drug metabolism.  Blood was obtained from elderly subjects (aged 74.8 +/- 5.2, xBAR +/- S.E., n = 16) and a young control group (aged 23.5 +/- 2.0, n = 27).  Monocyte AHH activity was used as an index of liver drug metabolism, ALT activity as an index of liver function, monocyte media IL-1 and as an index of macrophage activation and serum IL-1 levels as a measure of endogenous pyrogenic activity.  The medium collected from the cultured monocytes was also assessed for the presence of AHH inhibitory activity.  Subjects provided information relating to their age, sex, alcohol consumption, cigarette smoking, recent infection, recent surgery, disease status and medications which could alter drug metabolism.  Elderly patients were drawn both from independent seniors living at home and seniors visiting a geriatric day hospital and compared to a control group of young healthy volunteers.  Using the experimental design AHH activity did not differ within experimental error between aged (0.832 +/- 0.32 nmol/mg prot. per h, n = 16) and young control subjects (0.452 +/- 0.17, n = 27).  ALT activity did not differ between aged (2.83 I.U. +/- 0.46) and young (4.24 +/- 0.82).  Monocyte AHH activity did not differ between males (0.45 +/- 0.14, n = 33) compared to females (0.65 +/- 0.18, n = 29), but was significantly higher in smokers (2.5 +/- 1.0, n = 5) compared to non-smokers (0.35 +/- 0.05, n = 52).  Mild to moderate alcohol use showed no significant effect on AHH activity.  There was no significant difference between the mean level of MCM inhibition of murine hepatocyte AHH between elderly (44.3 +/- 8.32%, n = 8) and control (31.5 +/- 6.21%, n = 15) subjects, but a larger proportion of the elderly population demonstrated such an effect.  Serum IL-1 levels (range 0-55.9 pg/ml) were compared to MCM IL-1 and AHH inhibitory activity in the elderly and young group.
C1 DALHOUSIE UNIV,CLIN RES CTR,DEPT MED,HALIFAX B3H 4H7,NS,CANADA.
C3 Dalhousie University
CR AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622
   ARORA S, 1989, GASTROENTEROLOGY, V96, P1560, DOI 10.1016/0016-5085(89)90527-1
   AZRI S, 1987, J PHARMACOL EXP THER, V1089, P233
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRADLEY SF, 1989, J LEUKOCYTE BIOL, V45, P510, DOI 10.1002/jlb.45.6.510
   CANTRELL E, 1972, J CELL BIOL, V52, P316, DOI 10.1083/jcb.52.2.316
   CAVAILLON JM, 1990, EUR J IMMUNOL, V20, P253, DOI 10.1002/eji.1830200204
   FUJITA S, 1990, J PHARMACOL EXP THER, V369, P251
   HAESLER F, 1977, J RETICULOENDOTHELIA, V569, P6
   ISCHIROPOULOS H, 1990, MECH AGEING DEV, V52, P11, DOI 10.1016/0047-6374(90)90141-2
   LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P259
   LEWIS CE, 1989, EUR J IMMUNOL, V19, P2037, DOI 10.1002/eji.1830191111
   LOI CM, 1988, PHARMACOL THERAPEUT, V36, P131, DOI 10.1016/0163-7258(88)90115-5
   MALONEY AG, 1986, HEPATOLOGY, V282, P2
   MANSON JC, 1989, EUR J IMMUNOL, V19, P271
   MANSUY D, 1989, EUR J BIOCHEM, V184, P267, DOI 10.1111/j.1432-1033.1989.tb15017.x
   MCALLISTER RG, LIPIDS HYPERTENSION
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   NIWA Y, 1989, LIFE SCI, V44, P1655, DOI 10.1016/0024-3205(89)90482-7
   PETERSON TC, 1984, J PHARMACOL EXP THER, V299, P221
   PETERSON TC, 1987, DRUG METABOLIZING EN, V3911, P22
   PETERSON TC, 1987, HEPATOLOGY, V333, P2
   PETERSON TC, 1989, CYTOKINE, V1, P140
   PETERSON TC, 1989, CYTOKINE, V1, P407
   RAWLINS MD, 1987, Q J MMED, V545, P64
   RENTON KW, 1990, CAN J PHYSIOL PHARM, V68, P777, DOI 10.1139/y90-119
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SHEDLOFSKY SI, 1987, LIFE SCI, V40, P2331, DOI 10.1016/0024-3205(87)90506-6
   SUJITA K, 1990, EFFECT INTERLEUKIN 1, V1217, P163
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V2983, P16
   TATSUNO I, 1990, AGENTS ACTIONS, V29, P3
   VANGEEL CAJF, 1990, MECH AGEING DEV, V53, P169, DOI 10.1016/0047-6374(90)90068-Q
   VESTAL RE, 1975, CLIN PHARMACOL THER, V18, P425
   VESTAL RE, 1989, HEPATOLOGY, V331, P2
   WALLACE SM, 1987, CLIN PHARMACOKINET, V12, P41, DOI 10.2165/00003088-198712010-00004
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   WOODHOUSE KW, 1988, AGE RELATED CHANGES, V15, P287
   WYNNE HA, 1989, EFFECT AGE LIVER VOL, V297, P2
   YAMAGUCHI E, 1989, AM REV RESPIR DIS, V140, P397, DOI 10.1164/ajrccm/140.2.397
   ZAR JH, 1974, BIOSTATISTICAL METHO
NR 40
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1991
VL 60
IS 1
BP 61
EP 74
DI 10.1016/0047-6374(91)90110-L
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GH764
UT WOS:A1991GH76400007
PM 1745065
DA 2024-02-19
ER

PT J
AU Patel, K
   Simbi, B
   Ritvos, O
   Vaiyapuri, S
   Dhoot, GK
AF Patel, Ketan
   Simbi, Biggy
   Ritvos, Olli
   Vaiyapuri, Sakthivel
   Dhoot, Gurtej K.
TI Dysregulated cell signalling and reduced satellite cell potential in
   ageing muscle
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE Sulf1; Sulf2; Wnt signalling; RTK signalling; Satellite cells; Ageing
   muscle
ID SKELETAL-MUSCLE; PROLIFERATION; SULF1A
AB Aberrant activation of signalling pathways has been postulated to promote age related changes in skeletal muscle. Cell signalling activation requires not only the expression of ligands and receptors but also an appropriate environment that facilitates their interaction. Here we first examined the expression of SULF1/SULF2 and members of RTK (receptor tyrosine kinase) and the Wnt family in skeletal muscle of normal and a mouse model of accelerated ageing. We show that SULF1/SULF2 and these signalling components, a feature of early muscle development are barely detectable in early postnatal muscle. Real time qPCR and immunocytochemical analysis showed gradual but progressive up-regulation of SULF1/SULF2 and RTK/Wnt proteins not only in the activated satellite cells but also on muscle fibres that gradually increased with age. Satellite cells on isolated muscle fibres showed spontaneous in vivo satellite cell activation and progressive reduction in proliferative potential and responsiveness to HGF (hepatocyte growth factor) and dysregulated myogenic differentiation with age. Finally, we show that SULF1/SULF2 and RTK/Wnt signalling components are expressed in progeric mouse muscles at earlier stage but their expression is attenuated by an intervention that promotes muscle repair and growth.
C1 [Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England.
   [Simbi, Biggy; Dhoot, Gurtej K.] Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England.
   [Ritvos, Olli] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.
   [Vaiyapuri, Sakthivel] Univ Reading, Sch Pharm, Reading, Berks, England.
C3 University of Reading; University of London; University of London Royal
   Veterinary College; University of Helsinki; University of Reading
RP Dhoot, GK (corresponding author), Univ London, Royal Vet Coll, Dept Comparat Biomed Sci, London, England.
EM tdhoot@rvc.ac.uk
RI Ritvos, Olli/GWC-2442-2022
OI Dhoot, Gurtej/0000-0002-1963-6522; Vaiyapuri,
   Sakthivel/0000-0002-6006-6517; Ritvos, Olli/0000-0001-7017-6931
CR Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083
   Alyodawi K, 2019, J CACHEXIA SARCOPENI, V10, P662, DOI 10.1002/jcsm.12404
   Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Dhoot G.K, 2012, RECENT PAT REGEN MED, V2, P137, DOI [10.2174/2210297311202020137, DOI 10.2174/2210297311202020137]
   Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663
   Di Filippo ES, 2016, BIOCHEM BIOPH RES CO, V473, P462, DOI 10.1016/j.bbrc.2016.03.030
   García-Prat L, 2017, MOL CELL ENDOCRINOL, V445, P109, DOI 10.1016/j.mce.2016.08.021
   GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807
   Gill R, 2010, J CELL SCI, V123, P1873, DOI 10.1242/jcs.061242
   Gill RMS, 2016, HISTOCHEM CELL BIOL, V146, P431, DOI 10.1007/s00418-016-1454-3
   Gill RMS, 2014, EXP CELL RES, V324, P157, DOI 10.1016/j.yexcr.2014.04.001
   Hitchins L, 2013, FEBS OPEN BIO, V3, P30, DOI 10.1016/j.fob.2012.11.007
   Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200
   Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534
   Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1
   Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718
   Sahota AP, 2009, EXP CELL RES, V315, P2752, DOI 10.1016/j.yexcr.2009.06.029
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21
   Zaman G, 2016, HISTOCHEM CELL BIOL, V145, P67, DOI 10.1007/s00418-015-1365-8
NR 24
TC 2
Z9 2
U1 1
U2 16
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD DEC 15
PY 2019
VL 385
IS 2
AR 111685
DI 10.1016/j.yexcr.2019.111685
PG 10
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA JU0XU
UT WOS:000501403300003
PM 31647919
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Mathers, JC
AF Mathers, John C.
TI Nutritional modulation of ageing: Genomic and epigenetic approaches
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 2nd Meeting on Inflammatory/Immune Responses in Ageing
CY FEB 06-08, 2005
CL Paris, FRANCE
DE nutrition; genomics; DNA methylation; epigenetics
ID GENE-EXPRESSION PROFILE; DNA METHYLATION; CPG ISLAND; CALORIC
   RESTRICTION; HUMAN COLON; REPAIR; ADULT; LIVER; METHYLTRANSFERASES;
   HYPOMETHYLATION
AB Dietary factors have a profound effect on many aspects of health including ageing and do so, at least partly, through interactions with the genome which result in altered gene expression. The application of high throughput genomics technologies in nutritional research (nutrigenomics) offers a new approach to understanding the molecular mechanisms by which nutrition affects ageing. To date, transcriptional profiling techniques have been applied in studies of the mode of action of energy (caloric) restriction. Two further areas which appear to be particularly promising are (i) nutritional modulation of DNA damage and repair and (ii) nutritional modulation of epigenetic markings. Epigenetic-mediated changes in gene expression in response to dietary and other lifestyle exposures appear to be a major molecular mechanism linking environmental factors with the genome with consequences for cell function and health throughout the life course. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Newcastle Univ, Sch Clin Med Sci, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK
RP Mathers, JC (corresponding author), Newcastle Univ, Sch Clin Med Sci, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM john.mathers@ncl.ac.uk
OI Mathers, John/0000-0003-3406-3002
CR Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835
   Belshaw NJ, 2005, BIOCHEM SOC T, V33, P709, DOI 10.1042/BST0330709
   Bennett-Baker PE, 2003, GENETICS, V165, P2055
   Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395
   Brash DE, 2002, P NATL ACAD SCI USA, V99, P13969, DOI 10.1073/pnas.232574399
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524
   Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601
   Christman Judith K., 2003, P237, DOI 10.1079/9780851996790.0237
   COHN SM, 1991, P NATL ACAD SCI USA, V88, P1034, DOI 10.1073/pnas.88.3.1034
   Collins AR, 2003, CARCINOGENESIS, V24, P511, DOI 10.1093/carcin/24.3.511
   Davis CD, 2000, J NUTR, V130, P2903, DOI 10.1093/jn/130.12.2903
   Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Druesne N, 2004, CARCINOGENESIS, V25, P1227, DOI 10.1093/carcin/bgh123
   Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625
   Fang MZ, 2003, CANCER RES, V63, P7563
   FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0
   Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279
   Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x
   Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1
   Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S
   Issa JPJ, 2001, CANCER RES, V61, P3573
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0
   Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Mariadason JM, 2000, CANCER RES, V60, P4561
   Mathers JC, 2005, NUTR BULL, V30, P6, DOI 10.1111/j.1467-3010.2005.00485.x
   Mathers JC, 2005, GUT, V54, P579, DOI 10.1136/gut.2004.059881
   Mathers JC, 2004, P NUTR SOC, V63, P1, DOI 10.1079/PNS2003322
   MATHERS JC, 1993, BRIT J NUTR, V70, P567, DOI 10.1079/BJN19930149
   MAYSHOOPES LL, 1989, J GERONTOL, V44, P35, DOI 10.1093/geronj/44.6.35
   Müller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047
   NGUYEN CT, 2002, CANCER RES, V62, P6461
   Oommen AA, 2005, J NUTR BIOCHEM, V16, P74, DOI 10.1016/j.jnutbio.2004.08.004
   Pufulete M, 2005, GUT, V54, P648, DOI 10.1136/gut.2004.054718
   RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144
   Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799
   Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603
   van Ommen B, 2002, CURR OPIN BIOTECH, V13, P517, DOI 10.1016/S0958-1669(02)00349-X
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003
   Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011
   Wei QY, 2003, CANCER EPIDEM BIOMAR, V12, P963
   Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850
   Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230
   Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
NR 60
TC 49
Z9 60
U1 1
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN
PY 2006
VL 127
IS 6
BP 584
EP 589
DI 10.1016/j.mad.2006.01.018
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Geriatrics & Gerontology
GA 047YZ
UT WOS:000237915900014
PM 16513160
DA 2024-02-19
ER

PT J
AU YEN, TC
   PANG, CY
   HSIEH, RH
   SU, CH
   KING, KL
   WEI, YH
AF YEN, TC
   PANG, CY
   HSIEH, RH
   SU, CH
   KING, KL
   WEI, YH
TI AGE-DEPENDENT 6KB DELETION IN HUMAN LIVER MITOCHONDRIAL-DNA
SO BIOCHEMISTRY INTERNATIONAL
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; SEQUENCE-ANALYSIS; RAT; MUTATIONS; DISEASE;
   CANCER; GENES; HETEROGENEITY; HETEROPLASMY; SENESCENCE
C1 NATL YANG MING MED COLL,DEPT BIOCHEM,TAIPEI 112,TAIWAN.
   NATL YANG MING MED COLL,DEPT BIOCHEM & GEN SURG,TAIPEI 112,TAIWAN.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University
RI Pang, Cheng-Yoong/R-4990-2019; Wei, Yau-Huei/ABA-6841-2021; Pang,
   Cheng-Yoong/AFO-1562-2022
OI Pang, Cheng-Yoong/0000-0002-9063-2858; Wei,
   Yau-Huei/0000-0002-6429-2546; 
CR AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E
   CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORBISIER P, 1990, MECH AGEING DEV, V51, P249, DOI 10.1016/0047-6374(90)90075-Q
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6827
   CUMMINGS DJ, 1985, J MOL BIOL, V185, P659, DOI 10.1016/0022-2836(85)90052-X
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   ERICKSON GA, 1987, INT J RADIAT BIOL, V51, P147, DOI 10.1080/09553008714550581
   GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P
   HADLER HI, 1989, FEBS LETT, V256, P230, DOI 10.1016/0014-5793(89)81754-5
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8
   MIYAKI M, 1977, CHEM-BIOL INTERACT, V17, P321, DOI 10.1016/0009-2797(77)90095-3
   MONDAL S, 1976, CANCER RES, V36, P2254
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6456
   SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589
   SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   WEI YH, 1984, ARCH BIOCHEM BIOPHYS, V230, P400, DOI 10.1016/0003-9861(84)90420-X
   WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 41
TC 41
Z9 46
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 0158-5231
J9 BIOCHEM INT
PD MAR
PY 1992
VL 26
IS 3
BP 457
EP 468
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA HL775
UT WOS:A1992HL77500009
PM 1627156
DA 2024-02-19
ER

PT J
AU Ward, CP
   Peng, L
   Yuen, S
   Halstead, J
   Palacios, H
   Nyangau, E
   Mohammed, H
   Ziari, N
   Dandan, M
   Frakes, AE
   Gildea, HK
   Dillin, A
   Hellerstein, MK
AF Ward, Catherine P.
   Peng, Lucy
   Yuen, Samuel
   Halstead, John
   Palacios, Hector
   Nyangau, Edna
   Mohammed, Hussein
   Ziari, Naveed
   Dandan, Mohamad
   Frakes, Ashley E.
   Gildea, Holly K.
   Dillin, Andrew
   Hellerstein, Marc K.
TI Aging alters the metabolic flux signature of the ER-unfolded protein
   response in vivo in mice
SO AGING CELL
LA English
DT Article; Early Access
DE aging; de novo lipogenesis; endoplasmic reticulum; proteome dynamics;
   proteomics; unfolded protein response
ID ISOTOPOMER DISTRIBUTION ANALYSIS; ENDOPLASMIC-RETICULUM STRESS; DE-NOVO
   LIPOGENESIS; HEPATIC LIPOGENESIS; CELL-PROLIFERATION; BIOSYNTHESIS;
   CHOLESTEROL; TURNOVER; LIVER; RATES
AB Age is a risk factor for numerous diseases, including neurodegenerative diseases, cancers, and diabetes. Loss of protein homeostasis is a central hallmark of aging. Activation of the endoplasmic reticulum unfolded protein response (UPRER) includes changes in protein translation and membrane lipid synthesis. Using stable isotope labeling, a flux "signature" of the UPRER in vivo in mouse liver was developed by inducing ER stress with tunicamycin and measuring rates of both proteome-wide translation and de novo lipogenesis. Several changes in protein synthesis across ontologies were noted with age, including a more dramatic suppression of translation under ER stress in aged mice as compared with young mice. Binding immunoglobulin protein (BiP) synthesis rates and mRNA levels were increased more in aged than young mice. De novo lipogenesis rates decreased under ER stress conditions in aged mice, including both triglyceride and phospholipid fractions. In young mice, a significant reduction was seen only in the triglyceride fraction. These data indicate that aged mice have an exaggerated metabolic flux response to ER stress, which may indicate that aging renders the UPRER less effective in resolving proteotoxic stress.
C1 [Ward, Catherine P.; Peng, Lucy; Yuen, Samuel; Halstead, John; Palacios, Hector; Nyangau, Edna; Mohammed, Hussein; Ziari, Naveed; Dandan, Mohamad; Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
   [Frakes, Ashley E.; Gildea, Holly K.; Dillin, Andrew] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.
C3 University of California System; University of California Berkeley;
   University of California System; University of California Berkeley
RP Hellerstein, MK (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.
EM march@berkeley.edu
RI L, L/HGA-1686-2022
OI Gildea, Holly/0000-0002-9549-890X; Ward, Catherine/0000-0001-8539-0535
CR Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014
   Beysen C., 2019, TRANSLATIONAL RES ME, P211
   Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420
   Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020
   Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031
   Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007
   Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126
   Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5
   Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146
   Hellerstein MK, 1997, METABOLISM, V46, P1390, DOI 10.1016/S0026-0495(97)90137-2
   Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515
   HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988
   HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206
   Herrema H, 2016, J BIOL CHEM, V291, P17394, DOI 10.1074/jbc.M116.728949
   Ho N, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201909165
   Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Lee JS, 2012, AM J TRANSL RES, V4, P102
   Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702
   Martínez G, 2017, AGING CELL, V16, P615, DOI 10.1111/acel.12599
   NEESE RA, 1993, AM J PHYSIOL, V264, pE136, DOI 10.1152/ajpendo.1993.264.1.E136
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Salvadó L, 2015, TRENDS ENDOCRIN MET, V26, P438, DOI 10.1016/j.tem.2015.05.007
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074
   Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136
   Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440
   Thompson ACS, 2016, AGING CELL, V15, P118, DOI 10.1111/acel.12414
   Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wang LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005220
   Wang LF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004568
   Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041
   Ward CP, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031073
NR 40
TC 4
Z9 4
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 MAR
PY 2022
VL 21
IS 3
AR e13558
DI 10.1111/acel.13558
EA FEB 2022
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA ZW3RO
UT WOS:000755548900001
PM 35170180
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Valencia, AP
   Schappal, AE
   Morris, EM
   Thyfault, JP
   Lowe, DA
   Spangenburg, EE
AF Valencia, Ana P.
   Schappal, Anna E.
   Morris, E. Matthew
   Thyfault, John P.
   Lowe, Dawn A.
   Spangenburg, Espen E.
TI The presence of the ovary prevents hepatic mitochondrial oxidative
   stress in young and aged female mice through glutathione peroxidase 1
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Ovariectomy; Mitochondrial function; Gpx1; Aging; Liver; Oxidative
   stress
ID MUSCLE INSULIN-RESISTANCE; FATTY LIVER-DISEASE; SKELETAL-MUSCLE;
   METABOLIC SYNDROME; OVARIECTOMIZED MICE; POSTMENOPAUSAL WOMEN;
   LIPID-ACCUMULATION; GENE-EXPRESSION; ADIPOSE-TISSUE; PROTEIN-KINASE
AB Background: For unknown reasons a woman's risk for developing Metabolic Syndrome (MetS) increases dramatically with age and/or loss of ovarian function. The MetS is characterized by hepatic insulin resistance (IR), which is strongly associated with intrahepatic lipid (IHL) accumulation, mitochondrial dysfunction, and oxidative stress. Although circumstantial evidence suggests that the endocrine function of the ovary can directly impact hepaticmitochondrial function, this hypothesis remains untested. Thus, the purpose of this study was to assess the influence of age and secretory function of the ovary on mechanisms that regulate hepatic mitochondrial function.
   Methods: Adult (10 week-old) and aged (88 week-old) female C57BL/6 mice were separated into two groups to undergo bilateral ovariectomy (OVX) or control surgery (SHAM). Eight weeks after surgery hepatic tissue was removed for measurements of total IHL and fatty acid species within hepatic triglycerides, mitochondrial function, and reactive oxygen species (ROS) production.
   Results: Hepatic IHL content was not affected by OVX, but was increased by age. OVX had no effect on mitochondrial respiration, however, hepatic mitochondria from aged mice had lower O-2 consumption, lower complex IV and higher complex I content. Mitochondrial H2O2 production was highest in OVX groups and exacerbated by age, while mitochondrial lipid peroxidation was highest in the aged mice and exacerbated by OVX. Regardless of age, OVX resulted in lower mitochondrial content of antioxidant glutathione peroxidase 1 (Gpx1). Isolated liver tissue from a sub-set of animals were acutely treated with conditioned ovarian media which increased Gpx1 mRNA expression compared to vehicle treated liver tissue.
   Conclusion: Ovarian secretory function is necessary for the maintenance of hepatic ROS buffering capacity in the mitochondria, while age significantly influences mitochondrial respiration. These data suggest that when age is coupled with loss of ovarian function there is an increased risk for developing hepatic mitochondrial dysfunction, which may influence the onset of metabolic disease. Thus, in females there is critical organ cross-talk occurring between hepatic tissue and the ovary that impacts hepatic mitochondrial function. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Valencia, Ana P.; Spangenburg, Espen E.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA.
   [Schappal, Anna E.] Univ Maryland, Dept Nutr, College Pk, MD 20742 USA.
   [Morris, E. Matthew; Thyfault, John P.] Univ Missouri, Dept Nutr & Exercise Physiol Med, Div Gastroenterol & Hepatol, Columbia, MO 65201 USA.
   [Morris, E. Matthew; Thyfault, John P.] Harry S Truman Mem VA Hosp, Res Serv, Columbia, MO 65201 USA.
   [Lowe, Dawn A.] Univ Minnesota, Dept Phys Med & Rehabil, Program Phys Therapy, Minneapolis, MN 55455 USA.
   [Lowe, Dawn A.] Univ Minnesota, Dept Phys Med & Rehabil, Program Rehabil Sci, Minneapolis, MN 55455 USA.
C3 University System of Maryland; University of Maryland College Park;
   University System of Maryland; University of Maryland College Park;
   University of Missouri System; University of Missouri Columbia; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Harry S. Truman Memorial Veterans' Hospital; University of Minnesota
   System; University of Minnesota Twin Cities; University of Minnesota
   System; University of Minnesota Twin Cities
RP Spangenburg, EE (corresponding author), E Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Dept Physiol, 115 Heart Dr,ECHI,Mail Stop 743, Greenville, NC 27834 USA.
EM spangenburge14@ecu.edu
RI Thyfault, John/JMB-3070-2023; Valencia, Ana Patricia/HOH-4405-2023
OI Thyfault, John/0000-0001-7920-7466; Valencia, Ana
   Patricia/0000-0002-2833-6492; Morris, E. Matthew/0000-0001-7046-3623;
   Lowe, Dawn/0000-0002-5784-9289
FU Baltimore Diabetes Research Training Center [DRTC-P60DK079637]; National
   Institute on Aging [AG-000268];  [DK088940];  [AG031743]
FX This work was funded in part by the Baltimore Diabetes Research Training
   Center (DRTC-P60DK079637) (E. E Spangenburg); funded in part to JPT
   (DK088940); funded in part to DAL (AG031743); A. P. Valencia was funded
   by National Institute on Aging Grant (AG-000268).
CR Baltgalvis KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010164
   Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Caligioni CS., 2009, CURR PROTOC NEUROSCI, VAppendix 4, pApp, DOI [10.1002/0471142301.nsa04is48, DOI 10.1002/0471142301.NSA04IS48]
   Campbell SE, 2003, J MOL ENDOCRINOL, V31, P37, DOI 10.1677/jme.0.0310037
   Campbell SE, 2001, AM J PHYSIOL-ENDOC M, V281, pE803, DOI 10.1152/ajpendo.2001.281.4.E803
   Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666
   Danilovich N, 2006, EXP GERONTOL, V41, P117, DOI 10.1016/j.exger.2005.10.010
   Dorum A, 2008, GYNECOL ONCOL, V109, P377, DOI 10.1016/j.ygyno.2008.02.025
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Franko A, 2014, J HEPATOL, V60, P816, DOI 10.1016/j.jhep.2013.11.020
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012
   Garcia-Cazarin M., 2011, J VIS EXP, V49
   Gorzek JF, 2007, MED SCI SPORT EXER, V39, P248, DOI 10.1249/01.mss.0000241649.15006.b8
   Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501
   Hao LK, 2010, EUR J APPL PHYSIOL, V109, P879, DOI 10.1007/s00421-010-1426-6
   HOLINKA CF, 1977, BIOL REPROD, V17, P262, DOI 10.1095/biolreprod17.2.262
   Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883
   Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001
   Jackson KC, 2013, AM J PHYSIOL-REG I, V304, pR206, DOI 10.1152/ajpregu.00428.2012
   Jackson KC, 2011, APPL PHYSIOL NUTR ME, V36, P798, DOI [10.1139/H11-099, 10.1139/h11-099]
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lavoie JM, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/914938
   Lin WY, 2006, INT J OBESITY, V30, P912, DOI 10.1038/sj.ijo.0803240
   LINDHEIM SR, 1994, J SOC GYNECOL INVEST, V1, P150, DOI 10.1177/107155769400100210
   Matic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057458
   Nigro M, 2014, ENDOCRINOLOGY, V155, P2881, DOI 10.1210/en.2013-1385
   Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104
   Pighon A, 2011, METABOLISM, V60, P629, DOI 10.1016/j.metabol.2010.06.012
   Pillon NJ, 2012, ENDOCRINOLOGY, V153, P2099, DOI 10.1210/en.2011-1957
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405
   Schönfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stanczyk FZ, 2003, STEROIDS, V68, P1173, DOI 10.1016/j.steroids.2003.08.012
   Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609
   Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007
   Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060
   Valle A, 2007, AM J PHYSIOL-CELL PH, V293, pC1302, DOI 10.1152/ajpcell.00203.2007
   Wohlers LM, 2010, J CELL BIOCHEM, V110, P420, DOI 10.1002/jcb.22553
   Wohlers LM, 2009, J CELL BIOCHEM, V107, P171, DOI 10.1002/jcb.22113
   Zhang D., 2006, PNAS, V104, P17075
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
NR 50
TC 16
Z9 20
U1 2
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2016
VL 73
BP 14
EP 22
DI 10.1016/j.exger.2015.11.011
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DA3CR
UT WOS:000367674000003
PM 26608809
OA Green Accepted
DA 2024-02-19
ER

PT J
AU You, R
   Shi, L
   Chen, SR
   Liu, QP
   Zhang, LK
   Yin, L
   Yang, RC
   Guan, YQ
AF You, Rong
   Shi, Lu
   Chen, Surong
   Liu, Qingpeng
   Zhang, Lingkun
   Yin, Liang
   Yang, Runcai
   Guan, Yan-Qing
TI Fabrication of Resveratrol-Loaded Scaffolds and Their Application for
   Delaying Cell Senescence In Vitro
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article; Early Access
DE cell growth; cell senescence delay; resveratrol; RSV-AA-P(CL-DLLA);
   tissue engineering
ID MESENCHYMAL STEM-CELLS
AB In this research, resveratrol (RSV)-loaded scaffolds have been prepared to control the release of resveratrol and used to delay hepatic stellate cell (HSC) senescence in vitro. The functional carboxyl group-COOH is first introduced to the surface of poly(epsilon-caprolactone/d,l-lactide) (P(CL-DLLA)) under the coadministration of ultra-violet (UV) treatment and photo initiator and then resveratrol are conjugated onto the surface of the modified scaffolds through esterification. The characterization of the structure of RSV-AA-P(CL-DLLA) shows that resveratrol has been successfully conjugated onto the modified surface. Cell growth exhibits a higher level of cell viability and much more obvious agglomeration on the surface of the synthetic RSV-AA-P(CL-DLLA). Meanwhile the activity of senescence-associated beta-galactosidase (SA-beta-gal) and reactive oxygen species (ROS) is downgulated for cells on RSV-AA-P(CL-DLLA), which suggests that cell senescence is delayed on RSV-AA-P(CL-DLLA). And then it is attested that cells have a lower level of p53 but SIRT1 expression is upregulated on RSV-AA-P(CL-DLLA), which might be related to resveratrol release from RSV-AA-P(CL-DLLA). It also suggested cell senescence on RSV-AA-P(CL-DLLA) has been regulated by p53 and the SIRT1 signaling pathway. In all, the present study shows that RSV-AA-P(CL-DLLA) can be successfully prepared to promote cell growth and delay cell senescence and could be used for cell-based therapy in tissue engineering.
C1 [You, Rong; Shi, Lu; Chen, Surong; Liu, Qingpeng; Zhang, Lingkun; Yin, Liang; Guan, Yan-Qing] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Peoples R China.
   [Yang, Runcai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou 510060, Guangdong, Peoples R China.
   [Guan, Yan-Qing] South China Normal Univ, Panyu Cent Hosp, Panyu Cent Hosp Joint Lab Translat Med Res, Guangzhou 511400, Peoples R China.
   [Guan, Yan-Qing] South China Normal Univ, Coll Biophoton, Guangzhou Key Lab Spectral Anal & Funct Probes, Guangzhou 510631, Peoples R China.
C3 South China Normal University; Sun Yat Sen University; South China
   Normal University; South China Normal University
RP Guan, YQ (corresponding author), South China Normal Univ, Sch Life Sci, Guangzhou 510631, Peoples R China.; Guan, YQ (corresponding author), South China Normal Univ, Panyu Cent Hosp, Panyu Cent Hosp Joint Lab Translat Med Res, Guangzhou 511400, Peoples R China.; Guan, YQ (corresponding author), South China Normal Univ, Coll Biophoton, Guangzhou Key Lab Spectral Anal & Funct Probes, Guangzhou 510631, Peoples R China.
EM guanyqscnu@163.com
RI Zhang, Ling-Kun/GYJ-3942-2022; Zhang, Ling-Kun/M-5972-2019
OI Zhang, Ling-Kun/0000-0001-8717-4334; Zhang,
   Ling-Kun/0000-0001-8717-4334; Yang, RunCai/0000-0001-9567-4777; Shi,
   Lu/0000-0002-7015-385X
FU Guangdong Natural Science found project [2021A1515010775]; Guangdong
   province characteristic and innovative project [2016KTSCX023]; Open
   Research Funds of the State Key Laboratory of Ophthalmology, China
FX This work was supported by Guangdong Natural Science found project
   (2021A1515010775), Guangdong province characteristic and innovative
   project (2016KTSCX023) and the Open Research Funds of the State Key
   Laboratory of Ophthalmology, China.
CR Abdelgawad IY, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030627
   Abed E, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1365-2
   Bai RG, 2019, INT J NANOMED, V14, P5753, DOI 10.2147/IJN.S192779
   Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012
   Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93
   Breuss JM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071523
   Geng KY, 2018, INT J MOL MED, V42, P3522, DOI 10.3892/ijmm.2018.3917
   Gentile SD, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00792
   Gey C, 2013, MECH AGEING DEV, V134, P130, DOI 10.1016/j.mad.2013.02.002
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Heydari Z, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020304
   Huang GY, 2017, CHEM REV, V117, P12764, DOI 10.1021/acs.chemrev.7b00094
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Kamath MS, 2014, INT J NANOMED, V9, P183, DOI 10.2147/IJN.S49460
   Kasiotis KM, 2013, FOOD CHEM TOXICOL, V61, P112, DOI 10.1016/j.fct.2013.03.038
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li XM, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00499
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lv YJ, 2018, THERANOSTICS, V8, P2387, DOI 10.7150/thno.23620
   Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8
   Mikula-Pietrasik J, 2012, FREE RADICAL BIO MED, V52, P2234, DOI 10.1016/j.freeradbiomed.2012.03.014
   Murgia D, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9030094
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Pallauf K, 2016, CURR MED CHEM, V23, P4639, DOI 10.2174/0929867323666161024151233
   Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017
   Richbourg NR, 2019, J TISSUE ENG REGEN M, V13, P1275, DOI 10.1002/term.2859
   Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998
   Selvaraj S, 2013, J MED CHEM, V56, P970, DOI 10.1021/jm3014579
   Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684
   Zhou T, 2019, REDOX REP, V24, P62, DOI 10.1080/13510002.2019.1658376
   Zhou XK, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00364
NR 32
TC 1
Z9 1
U1 0
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD 2022 MAR
PY 2022
VL 22
IS 3
AR 2100440
DI 10.1002/mabi.202100440
EA DEC 2021
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA ZS5WX
UT WOS:000734294000001
PM 34919323
DA 2024-02-19
ER

PT J
AU Chipchase, MD
   O'Neill, M
   Melton, DW
AF Chipchase, MD
   O'Neill, M
   Melton, DW
TI Characterization of premature liver polyploidy in DNA repair
   (<i>Ercc1</i>)-deficient mice
SO HEPATOLOGY
LA English
DT Article
ID CELL-CYCLE ARREST; S-PHASE; SACCHAROMYCES-CEREVISIAE; CROSS-LINKS;
   EXPRESSION; P21; P53; DEFICIENCY; LACKING; ENDOREDUPLICATION
AB ERCC1-XPF is the endonuclease that cuts 5' of the damage in nucleotide excision repair (NER). Unlike other NER proteins, ERCC1-XPF is also involved in recombination and the repair of DNA interstrand cross-links. Unique among the NER gene knockouts, Ercc1 null mice are severely runted with high levels of hepatocyte polyploidy. To understand the link between DNA repair deficiency and polyploidy we have compared the premature polyploidy in Ercc1 null liver with the normal development of polyploidy in aging control mice. Polyploidy was accelerated dramatically in Ercc1 null hepatocytes, such that ploidy levels were equivalent in 3-week-old Ercc1 null and 1- to 2-year-old wild-type mouse liver. Levels of the cyclin-dependent kinase inhibitor, p21, were increased in the nuclei of Ercc1 null hepatocytes, and this increase was concentrated in, but not confined to, the polyploid hepatocytes. Much lower levels of p21 messenger RNA (mRNA) were found in old wild-type liver with equivalent levels of ploidy. We suggest that the more rapid accumulation of DNA damage in Ercc1 null liver leads to an increase in p21 levels, but that there is not a simple direct link between p21. levels and premature polyploidy. The failure to observe any link between p21 levels and polyploidy in aged wild-type liver may be attributable to the much lower levels of accumulated DNA damage, the much greater timescale involved, or the existence of a p21-independent mechanism for polyploidy. In conclusion, the premature polyploidy in Ercc1-deficient liver differs from the normal aging-related process.
C1 Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Sir Alastair Currie Canc Res UK Labs, Edinburgh EX4 2XU, Midlothian, Scotland.
C3 University of Edinburgh
RP Melton, DW (corresponding author), Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Sir Alastair Currie Canc Res UK Labs, Crewe Rd, Edinburgh EX4 2XU, Midlothian, Scotland.
CR Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104
   Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083
   BIESTERFELD S, 1994, J CLIN PATHOL, V47, P38, DOI 10.1136/jcp.47.1.38
   BOHM N, 1981, HISTOCHEMISTRY, V72, P55, DOI 10.1007/BF00496779
   DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0
   ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301
   EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0
   Fisher PB, 1996, MOL CELL DIFFER, V4, pU7
   FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Grossmann KF, 1999, MUTAT RES-DNA REPAIR, V434, P29, DOI 10.1016/S0921-8777(99)00011-7
   JIANG HP, 1994, ONCOGENE, V9, P3397
   Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200
   Li L, 1999, MOL CELL BIOL, V19, P5619
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   MEDVEDEV ZA, 1986, EXP GERONTOL, V21, P277, DOI 10.1016/0531-5565(86)90037-9
   Melton DW, 1998, J CELL SCI, V111, P395
   Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629
   Núñez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073
   Pâques F, 1999, MICROBIOL MOL BIOL R, V63, P349
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749
   Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   ZHANG H, 1994, COLD SPRING HARB SYM, V59, P21, DOI 10.1101/SQB.1994.059.01.005
NR 29
TC 40
Z9 46
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2003
VL 38
IS 4
BP 958
EP 966
DI 10.1053/jhep.2003.50421
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 730EP
UT WOS:000185816500019
PM 14512883
DA 2024-02-19
ER

PT J
AU Koepke, JI
   Nakrieko, KA
   Wood, CS
   Boucher, KK
   Terlecky, LJ
   Walton, PA
   Terlecky, SR
AF Koepke, Jay I.
   Nakrieko, Kerry-Ann
   Wood, Christopher S.
   Boucher, Krissy K.
   Terlecky, Laura J.
   Walton, Paul A.
   Terlecky, Stanley R.
TI Restoration of peroxisomal catalase import in a model of human cellular
   aging
SO TRAFFIC
LA English
DT Article
DE catalase; cellular aging; peroxisome; protein; traffic; reactive oxygen
   species
ID TARGETING SIGNAL-1; QUANTITATIVE-ANALYSIS; HYDROGEN-PEROXIDE; HUMAN
   FIBROBLASTS; OXIDATIVE STRESS; RAT-LIVER; IN-VIVO; PROTEINS; BIOGENESIS;
   SENESCENCE
AB Peroxisomes play an important role in human cellular metabolism by housing enzymes involved in a number of essential biochemical pathways. Many of these enzymes are oxidases that transfer hydrogen atoms to molecular oxygen forming hydrogen peroxide. The organelle also contains catalase, which readily decomposes the hydrogen peroxide, a potentially damaging oxidant. Previous work has demonstrated that aging compromises peroxisomal protein import with catalase being particularly affected. The resultant imbalance in the relative ratio of oxidases to catalase was seen as a potential contributor to cellular oxidative stress and aging. Here we report that altering the peroxisomal targeting signal of catalase to the more effective serine-lysine-leucine (SKL) sequence results in a catalase molecule that more strongly interacts with its receptor and is more efficiently imported in both in vitro and in vivo assays. Furthermore, catalase-SKL monomers expressed in cells interact with endogenous catalase subunits resulting in altered trafficking of the latter molecules. A dramatic reduction in cellular hydrogen peroxide levels accompanies this increased peroxisomal import of catalase. Finally, we show that catalase-SKL stably expressed in cells by retroviral-mediated transduction repolarizes mitochondria and reduces the number of senescent cells in a population. These results demonstrate the utility of a catalase-SKL therapy for the restoration of a normal oxidative state in aging cells.
C1 Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.
   Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.
C3 Wayne State University; Western University (University of Western
   Ontario)
RP Terlecky, SR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield Ave, Detroit, MI 48201 USA.
EM srterlecky@med.wayne.edu
FU NIDDK NIH HHS [DK56299] Funding Source: Medline; NIEHS NIH HHS [ES06639]
   Funding Source: Medline
CR Amery L, 2001, BIOCHEM J, V357, P635, DOI 10.1042/0264-6021:3570635
   BASS DA, 1983, J IMMUNOL, V130, P1910
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5
   Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DOWNS TR, 1983, ANAL BIOCHEM, V131, P538, DOI 10.1016/0003-2697(83)90212-9
   Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4
   Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091
   GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541
   Góth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4
   Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200
   Ko TP, 2000, ACTA CRYSTALLOGR D, V56, P241, DOI 10.1107/S0907444999015930
   Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245
   Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X
   OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200
   Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   Rayapuram N, 2006, BBA-MOL CELL RES, V1763, P1613, DOI 10.1016/j.bbamcr.2006.08.035
   Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006
   Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171
   TAKAHARA S, 1952, LANCET, V263, P1101
   Terlecky SR, 2001, EXP CELL RES, V263, P98, DOI 10.1006/excr.2000.5111
   TERLECKY SR, 2002, CURRENT PROTOCOLS CE
   Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017
   WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675
   Wood CS, 2006, TRAFFIC, V7, P97, DOI 10.1111/j.1600-0854.2005.00358.x
   Yildirim Ö, 2004, OPHTHALMOLOGICA, V218, P202, DOI 10.1159/000076845
NR 38
TC 83
Z9 97
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD NOV
PY 2007
VL 8
IS 11
BP 1590
EP 1600
DI 10.1111/j.1600-0854.2007.00633.x
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 223IP
UT WOS:000250363800011
PM 17822396
OA hybrid
DA 2024-02-19
ER

PT J
AU Moreno-Fernandez, ME
   Sharma, V
   Stankiewicz, TE
   Oates, JR
   Doll, JR
   Damen, MSMA
   Almanan, MATA
   Chougnet, CA
   Hildeman, DA
   Divanovic, S
AF Moreno-Fernandez, Maria E.
   Sharma, Vishakha
   Stankiewicz, Traci E.
   Oates, Jarren R.
   Doll, Jessica R.
   Damen, Michelle S. M. A.
   Almanan, Maha A. T. A.
   Chougnet, Claire A.
   Hildeman, David A.
   Divanovic, Senad
TI Aging mitigates the severity of obesity-associated metabolic sequelae in
   a gender independent manner
SO NUTRITION & DIABETES
LA English
DT Article
ID REGULATORY T-CELLS; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA;
   INTERNATIONAL-DIABETES-FEDERATION; ADIPOSE-TISSUE EXPANSION; FATTY
   LIVER-DISEASE; SEXUAL-DIMORPHISM; REG CELLS; MICE; DIET
AB Background Understanding gender-associated bias in aging and obesity-driven metabolic derangements has been hindered by the inability to model severe obesity in female mice. Methods Here, using chow- or high fat diet (HFD)-feeding regimens at standard (T-S) and thermoneutral (T-N) housing temperatures, the latter to model obesity in female mice, we examined the impact of gender and aging on obesity-associated metabolic derangements and immune responsiveness. Analysis included quantification of: (i) weight gain and adiposity; (ii) the development and severity of glucose dysmetabolism and non-alcoholic fatty liver disease (NAFLD); and (iii) induction of inflammatory pathways related to metabolic dysfunction. Results We show that under chow diet feeding regimen, aging was accompanied by increased body weight and white adipose tissue (WAT) expansion in a gender independent manner. HFD feeding regimen in aged, compared to young, male mice at T-S, resulted in attenuated glucose dysmetabolism and hepatic steatosis. However, under T-S housing conditions only aged, but not young, HFD fed female mice developed obesity. At T-N however, both young and aged HFD fed female mice developed severe obesity. Independent of gender or housing conditions, aging attenuated the severity of metabolic derangements in HFD-fed obese mice. Tempered severity of metabolic derangements in aged mice was associated with increased splenic frequency of regulatory T (T-reg) cells, Type I regulatory (Tr1)-like cells and circulating IL-10 levels and decreased vigor of HFD-driven induction of inflammatory pathways in adipose and liver tissues. Conclusion Our findings suggest that aging-associated altered immunological profile and inflammatory vigor may play a dominant role in the attenuation of obesogenic diet-driven metabolic dysfunction.
C1 [Moreno-Fernandez, Maria E.; Sharma, Vishakha; Stankiewicz, Traci E.; Oates, Jarren R.; Doll, Jessica R.; Damen, Michelle S. M. A.; Almanan, Maha A. T. A.; Chougnet, Claire A.; Hildeman, David A.; Divanovic, Senad] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA.
   [Moreno-Fernandez, Maria E.; Sharma, Vishakha; Stankiewicz, Traci E.; Oates, Jarren R.; Doll, Jessica R.; Damen, Michelle S. M. A.; Almanan, Maha A. T. A.; Chougnet, Claire A.; Hildeman, David A.; Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.
   [Sharma, Vishakha; Oates, Jarren R.; Almanan, Maha A. T. A.; Chougnet, Claire A.; Hildeman, David A.; Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Immunol Grad Program, Cincinnati, OH 45220 USA.
   [Sharma, Vishakha; Oates, Jarren R.; Almanan, Maha A. T. A.; Chougnet, Claire A.; Hildeman, David A.; Divanovic, Senad] Univ Cincinnati, Coll Med, Cincinnati, OH 45220 USA.
   [Hildeman, David A.] Cincinnati Childrens Hosp Med Ctr Cincinnati, Ctr Transplant Immunol & Inflammat & Tolerance, Cincinnati, OH 45229 USA.
   [Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45229 USA.
C3 University System of Ohio; University of Cincinnati; University System
   of Ohio; University of Cincinnati; Cincinnati Children's Hospital
   Medical Center; Cincinnati Children's Hospital Medical Center;
   University System of Ohio; University of Cincinnati; Cincinnati
   Children's Hospital Medical Center
RP Divanovic, S (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA.; Divanovic, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.
EM senad.divanovic@cchmc.org
RI Hildeman, David/AAA-1757-2020; Damen, Michelle/IYJ-4560-2023
OI Hildeman, David/0000-0002-0421-8483; Doll, Jessica/0000-0001-5225-801X
FU National Institutes of Health (NIH) [R01DK099222, R01AG033057,
   R01AG053498, T32AI118697, R01DK099222-02S1]; American Diabetes
   Association (ADA) [1-18-IBS-100]; American Heart Association (AHA)
   [17POST33650045, ADA 1-19-PMF-019]; CCRF Endowed Scholar Award;
   University of Cincinnati Provost Graduate Fellowship; Arnold W. Strauss
   Fellow Award; NIH of the Digestive Disease Research Core Center at CCHMC
   [P30 DK078392]
FX This work was supported in part by National Institutes of Health (NIH)
   R01DK099222 and American Diabetes Association (ADA) 1-18-IBS-100 (to
   S.D.), NIH R01DK099222-02S1 (associated with S.D., and M.E.M.-F., and
   J.R.O.), American Heart Association (AHA) 17POST33650045 and ADA
   1-19-PMF-019 (to M.E.M.-F.), CCRF Endowed Scholar Award (to S.D.),
   University of Cincinnati Provost Graduate Fellowship (to J.R.O.), The
   Arnold W. Strauss Fellow Award (to J.R.D.), and NIH P30 DK078392 of the
   Digestive Disease Research Core Center at CCHMC (associated with S.D.),
   NIH R01AG033057 and R01AG053498 (to D.A.H. and C.C.); and NIH
   T32AI118697 (associated with D.A.H and M.A.T.A.A.).
CR Almanan M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb0806
   Alvarez-Rodríguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001
   Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200
   Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005
   Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151
   Berryman DE, 2010, J GERONTOL A-BIOL, V65, P31, DOI 10.1093/gerona/glp175
   Brothers KJ, 2010, CELL METAB, V12, P295, DOI 10.1016/j.cmet.2010.06.010
   Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   CHAFFEE RRJ, 1971, ANNU REV PHYSIOL, V33, P155, DOI 10.1146/annurev.ph.33.030171.001103
   Chan CC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16571-4
   Chougnet CA, 2011, J IMMUNOL, V186, P156, DOI 10.4049/jimmunol.1001505
   Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017
   Cipolletta D, 2015, P NATL ACAD SCI USA, V112, P482, DOI 10.1073/pnas.1423486112
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Cui X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12799
   Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006
   De Leon ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36289-0
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
   Ehrhardt N, 2019, OBESITY, V27, P434, DOI 10.1002/oby.22418
   Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358
   Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   Fève B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Fischer KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126644
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Frasca D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01745
   Ganeshan K, 2017, NAT REV ENDOCRINOL, V13, P458, DOI 10.1038/nrendo.2017.48
   Garcia-Carrizo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00445
   Garg SK, 2014, CRIT REV IMMUNOL, V34, P1
   Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862
   Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092
   Giles DA, 2017, NAT MED, V23, P829, DOI 10.1038/nm.4346
   Giles DA, 2016, MOL METAB, V5, P1121, DOI 10.1016/j.molmet.2016.09.008
   Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267
   Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904
   Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040
   Harley ITW, 2014, HEPATOLOGY, V59, P1830, DOI 10.1002/hep.26746
   He W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20909-w
   HOBBS MV, 1994, CELL IMMUNOL, V154, P264, DOI 10.1006/cimm.1994.1076
   Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hylander BL, 2019, J IMMUNOL, V202, P631, DOI 10.4049/jimmunol.1800621
   Hylander BL, 2016, TRENDS CANCER, V2, P166, DOI 10.1016/j.trecan.2016.03.005
   Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107
   Ishikawa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230885
   JAMES WPT, 1981, BRIT MED BULL, V37, P43, DOI 10.1093/oxfordjournals.bmb.a071674
   Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009
   Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3
   Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988
   Krishna KB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12708
   Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835
   Link JC, 2013, ADIPOCYTE, V2, P74, DOI 10.4161/adip.23320
   Liu HW, 2017, EXP GERONTOL, V99, P61, DOI 10.1016/j.exger.2017.08.023
   Lustig A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01027
   Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006
   Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y
   Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87
   Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215
   Moreno-Fernandez ME, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.93626
   Mukherjee R, 2018, HEPATOL COMMUN, V2, P546, DOI 10.1002/hep4.1162
   NELSON JF, 1992, ENDOCRINOLOGY, V130, P805, DOI 10.1210/en.130.2.805
   Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586
   Nunes-Souza V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1987960
   Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240
   Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029
   Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019
   Paquette A, 2007, MATURITAS, V58, P182, DOI 10.1016/j.maturitas.2007.08.002
   Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59
   Ray MA, 2010, J AM ASSOC LAB ANIM, V49, P282
   Raynor J, 2015, J IMMUNOL, V195, P944, DOI 10.4049/jimmunol.1500443
   Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005
   Roytblat L, 2000, OBES RES, V8, P673, DOI 10.1038/oby.2000.86
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251
   Sock ETN, 2013, HORM METAB RES, V45, P283, DOI 10.1055/s-0032-1329964
   Spinelli R, 2020, J ENDOCRINOL INVEST, V43, P1373, DOI 10.1007/s40618-020-01255-z
   Starr KNP, 2015, CLIN LIVER DIS, V19, P311, DOI 10.1016/j.cger.2015.04.001
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Szafran H, 1998, Przegl Lek, V55, P266
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03
   White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
NR 95
TC 8
Z9 8
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2044-4052
J9 NUTR DIABETES
JI Nutr. Diabetes
PD JUN 7
PY 2021
VL 11
IS 1
AR 15
DI 10.1038/s41387-021-00157-0
PG 13
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA SO1OQ
UT WOS:000658749300001
PM 34099626
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tan, JHL
   Hwang, YY
   Chin, HX
   Liu, M
   Tan, SY
   Chen, QF
AF Tan, Joel H. L.
   Hwang, You Yi
   Chin, Hui Xian
   Liu, Min
   Tan, Sue Yee
   Chen, Qingfeng
TI Towards a better preclinical cancer model - human immune aging in
   humanized mice
SO IMMUNITY & AGEING
LA English
DT Article
DE Humanized mice; Immune aging; T cells; Cancer
ID MHC CLASS-II; CALORIC RESTRICTION; DRUG DEVELOPMENT; T-CELLS;
   INFLAMMATION; MAINTENANCE; MOUSE; RECONSTITUTION; LYMPHOCYTES;
   EXPRESSION
AB BackgroundPreclinical models are often used for cancer studies and evaluation of novel therapeutics. The relevance of these models has vastly improved with mice bearing a human immune system, especially in the context of immunotherapy. Nonetheless, cancer is an age-related disease, and studies often overlook the effects of aging. Here we have established a humanized mouse model of human immune aging to investigate the role of this phenomenon on liver tumor dynamics.MethodsMultiple organs and tissues (blood, thymus, lung, liver, spleen and bone marrow) were harvested from NOD-scid IL2r & gamma;-/- (NIKO) mice reconstituted with human immune cells, over a period of 60 weeks post-birth, for immune profiling. Young and aging immune cells were compared for transcriptomic changes and functional differences. Effect of immune aging was investigated in a liver cancer humanized mouse model.ResultsFocusing on the T cell population, which is central to cancer immunosurveillance and immunotherapy, we showed that the proportion of naive T cells declined while memory subsets and senescent-like cells increased with age. RNA-sequencing revealed that downregulated genes were related to immune responses and processes, and this was corroborated by reduced cytokine production in aging T cells. Finally, we showed faster liver tumor growth in aging than younger humanized mice, which could be attributed to specific pathways of aging T cell exhaustion.ConclusionOur work improves on existing humanized (immune) mouse model and highlights the importance of considering immune aging in liver cancer modeling.
C1 [Tan, Joel H. L.; Liu, Min; Tan, Sue Yee; Chen, Qingfeng] ASTAR, Inst Mol & Cell Biol IMCB, 61 Biopolis Dr, Singapore 138673, Singapore.
   [Hwang, You Yi; Chin, Hui Xian; Chen, Qingfeng] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Level 3&4, Singapore 138648, Singapore.
   [Chen, Qingfeng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Molecular & Cell Biology (IMCB); Agency for Science Technology &
   Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN);
   National University of Singapore
RP Chen, QF (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, 61 Biopolis Dr, Singapore 138673, Singapore.; Chen, QF (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Level 3&4, Singapore 138648, Singapore.; Chen, QF (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
EM qchen@imcb.a-star.edu.sg
FU Singapore Ministry of Health's National Medical Research Council [0038];
   National Research Foundation Singapore [NRF2019-NRF-ISF003-3127]; Agency
   for Science, Technology and Research (A*STAR) [I2101E0001]; Industry
   Alignment Fund-Industry Pre-positioning Program (IAF-PP)
   [H18/01/a0/022]; BMRC Central Research Fund (ATR)
FX This Research is supported by the Singapore Ministry of Health's
   National Medical Research Council under its RIE2025 < OF-LCG
   (OFLCG19May-0038.) >, National Research Foundation Singapore under its <
   NRF-ISF joint grant < NRF2019-NRF-ISF003-3127) >, and Agency for
   Science, Technology and Research (A*STAR) under its < Industry Alignment
   Fund-Industry Collaboration Projects (IAF-ICP) Grant (I2101E0001) >, <
   Industry Alignment Fund-Industry Pre-positioning Program (IAF-PP) Grant
   (H18/01/a0/022) >, and < BMRC Central Research Fund (ATR) > to Q.C.
CR Adams DJ, 2012, TRENDS PHARMACOL SCI, V33, P173, DOI 10.1016/j.tips.2012.02.001
   Alam I, 2013, AGE, V35, P1521, DOI 10.1007/s11357-012-9455-1
   Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Audige A, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0209-9
   Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204
   Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046
   Greenberg Steven A, 2019, Oncotarget, V10, P1399, DOI 10.18632/oncotarget.26659
   Haas L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02746
   Harris DT, 2014, IMMUNOBIOLOGY, V219, P131, DOI 10.1016/j.imbio.2013.08.013
   Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911
   Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005
   Isobe Ken-Ichi, 2017, World J Biol Chem, V8, P129, DOI 10.4331/wjbc.v8.i2.129
   Izgi H, 2022, ELIFE, V11, DOI [10.7554/eLife.68048, 10.7554/eLife.68048.sa0, 10.7554/eLife.68048.sa1, 10.7554/eLife.68048.sa2]
   Jang S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020905
   Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162
   Kared H, 2016, CANCER IMMUNOL IMMUN, V65, P441, DOI 10.1007/s00262-016-1803-z
   Kerbel RS, 1998, CANCER METAST REV, V17, P301, DOI 10.1023/A:1006152915959
   Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Li MD, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0165-8
   Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Markel Justin E, 2018, Sarcoma, V2018, P8694397, DOI 10.1155/2018/8694397
   Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994
   Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318
   Ou YJ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.649279
   Palliyaguru DL, 2021, J GERONTOL A-BIOL, V76, P552, DOI 10.1093/gerona/glaa285
   Peltz G, 2013, TRENDS PHARMACOL SCI, V34, P255, DOI 10.1016/j.tips.2013.03.005
   Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341
   Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014
   Puspitasari YM, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.882211
   Raskov H, 2021, BRIT J CANCER, V124, P359, DOI 10.1038/s41416-020-01048-4
   Rodriguez JE, 2022, EXPERT REV ANTICANC, V22, P915, DOI 10.1080/14737140.2022.2098718
   Saifuddin M, 2000, CLIN EXP IMMUNOL, V121, P324, DOI 10.1046/j.1365-2249.2000.01290.x
   Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081
   Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56
   Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405
   Tay RE, 2021, CANCER GENE THER, V28, P5, DOI 10.1038/s41417-020-0183-x
   Tay SS, 2014, J IMMUNOL, V193, P2087, DOI 10.4049/jimmunol.1400037
   Tong QY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01399
   Tsalamandris S, 2019, EUR CARDIOL REV, V14, P50, DOI 10.15420/ecr.2018.33.1
   Uhl Elizabeth W, 2015, Curr Pathobiol Rep, V3, P219
   Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5
   Wang K, 2017, HUM PATHOL, V69, P110, DOI 10.1016/j.humpath.2017.09.012
   Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6
   Xu WL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081742
   Zhang J, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103409
   Zhao Y, 2017, BLOOD, V130, P1995, DOI 10.1182/blood-2017-04-778779
NR 51
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD SEP 27
PY 2023
VL 20
IS 1
AR 49
DI 10.1186/s12979-023-00374-4
PG 13
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA S8TC0
UT WOS:001073827500001
PM 37752597
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Nishida, N
   Nagasaka, T
   Nishimura, T
   Lkai, I
   Boland, CR
   Goell, A
AF Nishida, Naoshi
   Nagasaka, Takeshi
   Nishimura, Takafumi
   Lkai, Iwao
   Boland, C. Richard
   Goell, Ajay
TI Aberrant methylation of multiple tumor suppressor genes in aging liver,
   chronic hepatitis, and hepatocellular carcinoma
SO HEPATOLOGY
LA English
DT Article
ID DNA METHYLATION; PROMOTER METHYLATION; CPG ISLANDS; HYPERMETHYLATION;
   CANCER
AB Aberrant DNA methylation is an important epigenetic alteration in hepatocellular carcinoma (HCC). However, the molecular processes underlying the methylator phenotype and the contribution of hepatitis viruses are poorly understood. The current study is a comprehensive methylation analysis of human liver tissue specimens. A total of 176 liver tissues, including 77 pairs of HCCs and matching noncancerous liver and 22 normal livers, were analyzed for methylation. Methylation of 19 epigenetic markers was quantified, and the results were correlated with different disease states and the presence or absence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Based on methylation profiles, the 19 loci were categorized into 3 groups. Normal liver tissues showed methylation primarily in group 1 loci (HIC-1, CASP8, GSTP1, SOCS1, RASSF1A, p16, APC), which was significantly higher than group 2 (CDH1, RUNX3, RIZ1, SFRP2, MINT31) and group 3 markers (COX2, MINT1, CACNA1G, RASSF2, MINT2, Reprimo3, DCC) (P < 0.0001). Noncancerous livers demonstrated increased methylation in both group I and group 2 loci. Methylation was significantly more abundant in HCV-positive livers compared with normal liver tissues. Conversely, HCC showed frequent methylation at each locus investigated in all 3 groups. However, the group 3 loci showed more dense and frequent methylation in HCV-positive cancers compared with both HBV-positive cancers and virus-negative cancers (P < 0.0001). Conclusion: Methylation in HCC is frequent but occurs in a gene-specific and disease-specific manner. Methylation profiling allowed us to determine that aberrant methylation is commonly present in normal aging livers, and sequentially progresses with advancing stages of chronic viral infection. Finally, our data provide evidence that HCV infection may accelerate the methylation process and suggests a continuum of increasing methylation with persistent viral infection and carcinogenesis in the liver.
C1 [Nishida, Naoshi; Nagasaka, Takeshi; Boland, C. Richard; Goell, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Dept Internal Med,Div Gastroenterol, Dallas, TX 75246 USA.
   [Nishida, Naoshi; Nagasaka, Takeshi; Boland, C. Richard; Goell, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX 75246 USA.
   [Nishida, Naoshi; Nagasaka, Takeshi; Boland, C. Richard; Goell, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA.
   [Nishida, Naoshi; Nishimura, Takafumi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan.
   [Lkai, Iwao] Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto, Japan.
C3 Baylor University; Baylor University Medical Center; Baylor University;
   Baylor University Medical Center; Baylor University Medical Center;
   Baylor Scott & White Health; Baylor University; Kyoto University; Kyoto
   University
RP Boland, CR (corresponding author), Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Dept Internal Med,Div Gastroenterol, 3500 Gaston Ave,Suite H-250, Dallas, TX 75246 USA.
EM rickbo@baylorhealth.edu
OI Goel, Ajay/0000-0003-1396-6341; Nagasaka, Takeshi/0000-0002-4236-350X
FU NCI NIH HHS [R01 CA098572, R01 CA72851, R01 CA072851, R01 CA072851-13,
   R01 CA098572-05, R01 CA98572] Funding Source: Medline
CR Ahuja N, 1998, CANCER RES, V58, P5489
   Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799
   Braakhuis BJM, 2003, CANCER RES, V63, P1727
   Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3
   Gore Steven D, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS30, DOI 10.1038/ncponc0346
   Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687
   Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797
   Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5
   Nishida N, 2007, CANCER RES, V67, P4586, DOI 10.1158/0008-5472.CAN-06-3464
   OGIK T, 2002, CLIN CANCER RES, V8, P3164
   Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275
   Shen LL, 2002, J NATL CANCER I, V94, P755, DOI 10.1093/jnci/94.10.755
   SILVERMAN LR, 2005, NAT CLIN PRACT ONCOL, V2, P12
   Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339
   Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571
   Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532
   Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4
   Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29
   Zhang JC, 2006, MOL CARCINOGEN, V45, P530, DOI 10.1002/mc.20188
   Zhong S, 2002, CLIN CANCER RES, V8, P1087
NR 22
TC 235
Z9 255
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2008
VL 47
IS 3
BP 908
EP 918
DI 10.1002/hep.22110
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 270CZ
UT WOS:000253698900017
PM 18161048
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Bakala, H
   Ladouce, R
   Baraibar, MA
   Friguet, B
AF Bakala, Hilaire
   Ladouce, Romain
   Baraibar, Martin A.
   Friguet, Bertrand
TI Differential expression and glycative damage affect specific
   mitochondrial proteins with aging in rat liver
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Aging; Mitochondria; Proteomics; 2D-DIGE; Glycation; Protein expression
ID SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; SUPEROXIDE-PRODUCTION;
   INDUCED INACTIVATION; PROTEOME ALTERATIONS; INSULIN-RESISTANCE;
   PPAR-GAMMA; WILD-TYPE; AGE; DEHYDROGENASE
AB Aging is accompanied by the gradual deterioration of cell functions. Particularly, mitochondrial dysfunction, associated with an accumulation of damaged proteins, is of key importance due to the central role of these organelles in cellular metabolism. However, the detailed molecular mechanisrps involved in such impairment have not been completely elucidated. In the present study, proteomic analyses looking at both changes at the expression level as well as to glycative modifications of the mitochondrial proteome were performed. Two-dimensional difference gel electrophoresis analysis revealed 16 differentially expressed proteins with aging. Thirteen exhibited a decreased expression and are crucial enzymes related to OXPHOS chain complex I/V components, TCA cycle or fatty add beta-oxidation reaction. On the other hand, 2 enzymes involved in fatty acid beta-oxidation cycle were increased in aged mitochondria. Immunodetection and further identification of glycated proteins disclosed a set of advanced glycation endproduct-modified proteins, including 6 enzymes involved in the fatty acid beta-oxidation process, and 2 enzymes of the TCA/urea cycles. A crucial antioxidant enzyme, catalase, was among the most strongly glycated proteins. In addition, several AGE-damaged enzymes (aldehyde dehydrogenase 2, medium chain acyl-CoA dehydrogenase and 3-ketoacyl-CoA dehydrogenase) exhibited a decreased activity with age. Taken together, these data suggest that liver mitochondria in old rats suffer from a decline in their capacity for energy production, due to (i) decreased expression of OXPHOS complex I/V components and (ii) glycative damage to key fatty acid beta-oxidation and TCA/urea cycle enzymes. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Bakala, Hilaire] Univ Paris 07, Sorbonne Paris Cite, UFR SDV, F-75205 Paris 13, France.
   [Bakala, Hilaire; Ladouce, Romain; Baraibar, Martin A.; Friguet, Bertrand] Univ Paris 06, Lab Biol Cellulaire Vieillissement, UPMC UR4, IFR 83, F-75252 Paris 05, France.
C3 Universite Paris Cite; Sorbonne Universite
RP Bakala, H (corresponding author), Univ Paris 07, Sorbonne Paris Cite, UFR SDV, F-75205 Paris 13, France.
EM Bakala@univ-paris-diderot.fr
OI Ladouce, Romain/0000-0003-2492-8180; Friguet,
   Bertrand/0000-0001-8085-1961
FU EU [518230]
FX The authors acknowledge the EU-funded project PROTEOMAGE (No. 518230),
   under FP6. In addition, they are very grateful to M. Cedric Broussard at
   the Plate-forme Proteomique universite Paris-Descartes 3P5) for
   performing the mass spectrometry analyses.
CR Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x
   Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Bakala H, 2012, BBA-MOL BASIS DIS, V1822, P1527, DOI 10.1016/j.bbadis.2012.05.016
   Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025
   Ferré P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43
   Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633
   García-Cazorla A, 2006, ANN NEUROL, V59, P121, DOI 10.1002/ana.20709
   Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hamelin M, 2007, FEBS J, V274, P5949, DOI 10.1111/j.1742-4658.2007.06118.x
   Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0
   Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   Kil IS, 2004, FREE RADICAL BIO MED, V37, P1765, DOI 10.1016/j.freeradbiomed.2004.08.025
   Kondo T, 2002, CELL DEATH DIFFER, V9, P682, DOI 10.1038/sj.cdd.4401019
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kumaran S, 2005, MOL CELL BIOCHEM, V280, P83, DOI 10.1007/s11010-005-8234-z
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Liu XJ, 2008, BBA-PROTEINS PROTEOM, V1784, P1742, DOI 10.1016/j.bbapap.2008.06.018
   Lopez ME, 2000, MUTAT RES-FUND MOL M, V452, P123, DOI 10.1016/S0027-5107(00)00059-2
   Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689
   Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014
   Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/S0006-8993(96)00708-1
   Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Shevchenko A, 2001, ELECTROPHORESIS, V22, P1194, DOI 10.1002/1522-2683()22:6<1194::AID-ELPS1194>3.0.CO;2-A
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Smith RAJ, 2003, BIOCHEM SOC T, V31, P1295
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   TANK AW, 1981, BIOCHEM PHARMACOL, V30, P3265, DOI 10.1016/0006-2952(81)90598-0
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yao DC, 2006, CELL, V124, P275, DOI 10.1016/j.cell.2005.11.024
   Zeng J, 2004, PROTEIN EXPRES PURIF, V37, P472, DOI 10.1016/j.pep.2004.06.021
   Zeng J, 2004, PROTEIN EXPRES PURIF, V35, P320, DOI 10.1016/j.pep.2004.01.018
NR 61
TC 27
Z9 29
U1 0
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC
PY 2013
VL 1832
IS 12
BP 2057
EP 2067
DI 10.1016/j.bbadis.2013.07.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 260AO
UT WOS:000327567600016
PM 23906978
DA 2024-02-19
ER

PT J
AU Kong, SZ
   Li, JC
   Li, SD
   Liao, MN
   Li, CP
   Zheng, PJ
   Guo, MH
   Tan, WX
   Zheng, ZH
   Hu, Z
AF Kong, Song-Zhi
   Li, Ji-Cheng
   Li, Si-Dong
   Liao, Ming-Neng
   Li, Cheng-Peng
   Zheng, Pin-Jin
   Guo, Min-Hui
   Tan, Wei-Xiang
   Zheng, Zhao-Hui
   Hu, Zhang
TI Anti-Aging Effect of Chitosan Oligosaccharide on D-Galactose-Induced
   Subacute Aging in Mice
SO MARINE DRUGS
LA English
DT Article
DE chitosan oligosaccharide; D-galactose; subacute aging; anti-aging;
   anti-oxidant; immune function
ID IN-VITRO ANTIOXIDANT; BIOLOGICAL-ACTIVITIES; IMMUNE FUNCTION;
   INFLAMMATION; PURIFICATION; ACTIVATION; INJURY; CELLS; LIVER; ACID
AB Chitosan oligosaccharide (COS), a natural polysaccharide with good antioxidant and anti-inflammatory properties, is the depolymerized product of chitosan possessing various biological activities. The present study was designed to investigate the possible anti-aging effect of COS on the aging model mouse induced by D-galactose (D-gal) and explore the underlying mechanism. In the experiment, 48 male Kunming mice (KM mice) were randomly divided into the normal group, model group, positive group, and low-medium-high dose polysaccharide groups (300, 600, 1200 mg/kg/day). The results showed that COS, by intragastric gavage after subcutaneous injection of D-gal (250 mg/kg/day) into the neck of mice consecutively for eight weeks, gradually recovered the body weight, the activity of daily living, and organ indices of mice, as well as effectively ameliorated the histological deterioration of the liver and kidney in mice triggered by D-gal. To be specific, COS obviously improved the activities of antioxidant enzymes in liver and kidney of KM mice, including catalase (CAT), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD), as well as decreased malondialdehyde (MDA) levels when compared with those in model group mice. Furthermore, COS not only elevated the diminished levels of serum immunoglobulin G (IgG) and IgM induced by D-gal, but also significantly inhibited the D-gal-caused upregulation of serum alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), uric acid (UA) and creatinine (CREA) levels as compared with those of mice in the model group. These results demonstrate that COS has an obvious anti-aging activity in D-gal-induced subacute aging mice, the mechanism of which, to some extent, is associated with enhancing the antioxidant defenses, reducing oxidative stress, and improving the immune function of aging model mice.
C1 [Kong, Song-Zhi; Li, Ji-Cheng; Li, Si-Dong; Liao, Ming-Neng; Li, Cheng-Peng; Zheng, Pin-Jin; Guo, Min-Hui; Tan, Wei-Xiang; Zheng, Zhao-Hui; Hu, Zhang] Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang 524088, Peoples R China.
C3 Guangdong Ocean University
RP Hu, Z (corresponding author), Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang 524088, Peoples R China.
EM kongsongzhi@126.com; 15702098206@163.com; 13702737491@163.com;
   gdoulmn@163.com; lcp0802@126.com; aa904855159@163.com;
   guominhui18@126.com; waysangtam@sina.com; zhengzh1017@163.com;
   qaioyx@163.com
RI Li, Jicheng/HLH-8596-2023; Li, Sidong/AAH-6955-2019
FU special foundation for excellent young teachers of Guangdong Ocean
   University [2014008]; program for scientific research start-up funds of
   Guangdong Ocean University [E15177]; special funds for the cultivation
   of Guangdong college students' scientific and technological innovation
   ("climbing program" special funds) [pdjhb0240, pdjhb0242]; "Hai Zhi Fan"
   for college students' scientific and technological innovation
   [qhjh2017zr11]
FX This work was supported by the special foundation for excellent young
   teachers of Guangdong Ocean University (No. 2014008), the program for
   scientific research start-up funds of Guangdong Ocean University (No.
   E15177), the special funds for the cultivation of Guangdong college
   students' scientific and technological innovation ("climbing program"
   special funds) (No. pdjhb0240 and No. pdjhb0242), as well as the sailing
   schemes of "Hai Zhi Fan" for college students' scientific and
   technological innovation (No. qhjh2017zr11).
CR Azuma K, 2015, J FUNCT BIOMATER, V6, P33, DOI 10.3390/jfb6010033
   Chen H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6049083
   Chen NY, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/4757520
   Clements SJ, 2018, CRIT REV FOOD SCI, V58, P651, DOI 10.1080/10408398.2016.1211086
   Conti V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00024
   Delwing-Dal Magro D, 2016, BIOMED PHARMACOTHER, V83, P1422, DOI 10.1016/j.biopha.2016.08.057
   Ding YY, 2012, J ANIM VET ADV, V11, P2817
   Fang IM, 2015, EXP EYE RES, V130, P38, DOI 10.1016/j.exer.2014.12.001
   Fang IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077323
   Ginter E, 2014, BRATISL MED J, V115, P603, DOI 10.4149/BLL_2014_116
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huang B, 2016, J AGR FOOD CHEM, V64, P245, DOI 10.1021/acs.jafc.5b05195
   Jasiulionis MG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00197
   Kim DB, 2016, FOOD CHEM, V194, P920, DOI 10.1016/j.foodchem.2015.08.094
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Kong SZ, 2018, EXP GERONTOL, V103, P27, DOI 10.1016/j.exger.2017.12.018
   Kubo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14520-8
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kunanusornchai W, 2016, PHARMACOL RES, V113, P458, DOI 10.1016/j.phrs.2016.09.016
   Ladomenou F, 2016, ARCH DIS CHILDHOOD-E, V101, P129, DOI 10.1136/archdischild-2015-309060
   Li CL, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3878740
   Li SS, 2018, INT J BIOL MACROMOL, V109, P457, DOI 10.1016/j.ijbiomac.2017.12.108
   Liu P, 2017, AGING DIS, V8, P868, DOI 10.14336/AD.2017.0816
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Sergiev PV, 2015, ACTA NATURAE, V7, P9, DOI 10.32607/20758251-2015-7-1-9-18
   Shen D, 2018, EXP GERONTOL, V102, P101, DOI 10.1016/j.exger.2017.12.002
   Tang J, 2016, J ANIM PHYSIOL AN N, V100, P768, DOI 10.1111/jpn.12385
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wan J, 2017, RSC ADV, V7, P9669, DOI 10.1039/c7ra00142h
   Wang X, 2014, PAK J PHARM SCI, V27, P1099
   Ye Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/185716
   Zhang Y, 2015, FOOD FUNCT, V6, P927, DOI [10.1039/c4fo01051e, 10.1039/C4FO01051E]
   Zhao HJ, 2017, INT J BIOL MACROMOL, V102, P351, DOI 10.1016/j.ijbiomac.2017.04.039
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
   Zou P, 2016, FOOD CHEM, V190, P1174, DOI 10.1016/j.foodchem.2015.06.076
NR 40
TC 70
Z9 77
U1 11
U2 99
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD JUN
PY 2018
VL 16
IS 6
AR 181
DI 10.3390/md16060181
PG 13
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA GK8SV
UT WOS:000436499000006
PM 29794973
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Lier, J
   Winter, K
   Bleher, J
   Grammig, J
   Mueller, WC
   Streit, W
   Bechmann, I
AF Lier, Julia
   Winter, Karsten
   Bleher, Johannes
   Grammig, Joachim
   Mueller, Wolf C.
   Streit, Wolfgang
   Bechmann, Ingo
TI Loss of IBA1-Expression in brains from individuals with obesity and
   hepatic dysfunction
SO BRAIN RESEARCH
LA English
DT Article
DE Microglia; Obesity; Liver dysfunction
ID HIGH-FAT DIET; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; BODY-WEIGHT;
   RISK-FACTOR; MICROGLIA; DEMENTIA; AGE; OVERWEIGHT; DECLINE
AB Microglia, the brain's resident immune cells, exhibit constitutive expression of the ionized calcium binding adaptor molecule 1 (IBA1), a cytoplasmic protein with actin and calcium-binding functions involved in membrane ruffling. Microglia are long-lived cells that exhibit a senescent morphology (dystrophy) with aging, which may be indicative of cell dysfunction. It has been reported that dystrophy of IBAl-positive microglia is exacerbated in obese humans. Our own preliminary studies of microglia in the medial temporal lobe of obese subjects have revealed another microglial abnormality, which is the loss of IBA1 immunoreactivity that can create large areas in the brain seemingly devoid of all microglial cells. Here, we systematically compared microglial appearance in human hippocampi derived from obese individuals compared to controls (n(obese) = 33, n(non-obese) = 30). In both groups, we found areas that were negative for IBA1, but contained P2YR12 and glutathione-peroxidase 1 (GPX)-positive microglia. The number and extent of IBA1-negative regions was increased in obese cases. Since some cases of non-obese individuals also exhibited loss of IBA-1 immunoreactivity, we searched for possible confounders and found that hepatic dysfunction strongly impacts the distribution of microglial cells: By computational analysis of scanned IBA1-stained sections, we detected increased Mean Empty Space distances (p = 0.016) and IBAl-negative areas (p = 0.090) which were independent from the cause of liver dysfunction, but also from aging. Thus, we report on a novel type of microglia pathological change, i.e. localized loss of IBA1 that is linked, at least in part, to obesity and hepatic dysfunction.
C1 [Lier, Julia; Winter, Karsten; Bechmann, Ingo] Univ Leipzig, Inst Anat, Leipzig, Germany.
   [Bleher, Johannes; Grammig, Joachim] Univ Tubingen, Dept Stat & Econometr, Tubingen, Germany.
   [Mueller, Wolf C.] Univ Leipzig, Univ Hosp, Dept Neuropathol, Leipzig, Germany.
   [Streit, Wolfgang] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.
   [Streit, Wolfgang] McKnight Brain Inst, Gainesville, FL USA.
C3 Leipzig University; Eberhard Karls University of Tubingen; Leipzig
   University; State University System of Florida; University of Florida
RP Lier, J; Bechmann, I (corresponding author), Univ Leipzig, Inst Anat, Med Fak, Oststr 25, D-04317 Leipzig, Germany.
EM julia.lier@medizin.uni-leipzig.de; Ingo.bechmann@medizin.uni-leipzig.de
OI Lier, julia/0000-0002-8454-9425
FU DFG [SFB 1052]; Medical Faculty, University of Leipzig
FX This study was supported by the DFG (SFB 1052). J.L is a recipient of a
   scholarship of the Medical Faculty, University of Leipzig.
CR Adams RD, 1953, RES PUBL ASSOC RES N, V32, P198
   Alford S, 2018, OBES REV, V19, P269, DOI 10.1111/obr.12629
   Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07
   Arias N, 2015, NEUROSCIENCE, V284, P1, DOI 10.1016/j.neuroscience.2014.08.060
   Baufeld C, 2016, ACTA NEUROPATHOL, V132, P361, DOI 10.1007/s00401-016-1595-4
   Bischof GN, 2015, PSYCHOSOM MED, V77, P697, DOI 10.1097/PSY.0000000000000212
   Bocanegra DKF, 2018, J NEURAL TRANSM, V125, P827, DOI 10.1007/s00702-017-1729-4
   Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Brigelius-Flohé R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020
   Buckman LB, 2014, BRAIN BEHAV IMMUN, V35, P33, DOI 10.1016/j.bbi.2013.06.007
   Butterworth R. F, 1987, NEUROCHEM PATHOL
   Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/642108
   De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7
   Deininger MH, 2002, FEBS LETT, V514, P115, DOI 10.1016/S0014-5793(02)02430-4
   Dennis CV, 2014, METAB BRAIN DIS, V29, P1027, DOI 10.1007/s11011-013-9469-0
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Felipo V, 2012, METAB BRAIN DIS, V27, P51, DOI 10.1007/s11011-011-9269-3
   Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597
   Gao Y, 2014, GLIA, V62, P17, DOI 10.1002/glia.22580
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496
   Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568
   Hao S, 2016, BRAIN BEHAV IMMUN, V51, P230, DOI 10.1016/j.bbi.2015.08.023
   Hersi M, 2017, NEUROTOXICOLOGY, V61, P143, DOI 10.1016/j.neuro.2017.03.006
   Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0
   Jeon BT, 2012, DIABETES, V61, P1444, DOI 10.2337/db11-1498
   Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3
   Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318
   Köhler C, 2007, CELL TISSUE RES, V330, P291, DOI 10.1007/s00441-007-0474-7
   Kuo HK, 2006, J AM GERIATR SOC, V54, P97, DOI 10.1111/j.1532-5415.2005.00522.x
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Leal-Egaña A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-24
   Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372
   Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009
   Lubos E, 2011, J BIOL CHEM, V286, P35407, DOI 10.1074/jbc.M110.205708
   Luchsinger JA, 2009, CURR OPIN CLIN NUTR, V12, P15, DOI 10.1097/MCO.0b013e32831c8c71
   Mazon JN, 2017, LIFE SCI, V182, P22, DOI 10.1016/j.lfs.2017.06.002
   Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097
   Morari J, 2014, DIABETES, V63, P3770, DOI 10.2337/db13-1495
   Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208
   Navarro V, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00140
   Norenberg M. D, 1987, NEUROCHEMICAL PATHOL
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Peters R, 2008, AGE AGEING, V37, P505, DOI 10.1093/ageing/afn095
   Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3
   Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870
   Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004
   Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325
   Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388
   Scherer H, 1933, VIRCHOWS ARCH PATHOL, P333
   Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014
   Siervo M, 2011, OBES REV, V12, P968, DOI 10.1111/j.1467-789X.2011.00903.x
   Smiljanic K, 2013, LIPIDS, V48, P1069, DOI 10.1007/s11745-013-3836-9
   Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011
   Spittau B, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00194
   Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319
   Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6
   Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015
   Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210
   West NA, 2009, J GERONTOL A-BIOL, V64, P103, DOI 10.1093/gerona/gln006
   Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641
   Zhang YQ, 2015, ARCH BIOCHEM BIOPHYS, V576, P39, DOI 10.1016/j.abb.2014.12.018
NR 65
TC 13
Z9 13
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD MAY 1
PY 2019
VL 1710
BP 220
EP 229
DI 10.1016/j.brainres.2019.01.006
PG 10
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA HR4PZ
UT WOS:000463129700023
PM 30615888
DA 2024-02-19
ER

PT J
AU Selfridge, J
   Hsia, KT
   Redhead, NJ
   Melton, DW
AF Selfridge, J
   Hsia, KT
   Redhead, NJ
   Melton, DW
TI Correction of liver dysfunction in DNA repair-deficient mice with an
   <i>ERCC1</i> transgene
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION-COUPLED REPAIR; NUCLEAR
   ABNORMALITIES; ULTRAVIOLET-B; GENE ERCC1; GROUP-A; CELLS; REMOVAL;
   LACKING; SUSCEPTIBILITY
AB The ERCC1 gene is essential for the repair of UV-induced DNA damage. Unlike most genes in the: nucleotide excision repair (NER) pathway, ERCC1 is: also involved in recombinational repair. Perhaps ford this reason, ERCC1 knockout mice are not a model for the human NER deficiency disorder, xeroderma: pigmentosum. Instead, ERCC1 null mice are severely, runted and die before weaning from liver failure with accelerated hepatocyte polyploidy that is more reminiscent of a premature ageing disorder. To permit study of the role of ERCC1 in other tissues we have corrected the liver ERCC1 deficiency with a transgene under the control of a liver-specific promoter. The transgene alleviated runting and extended the lifespan. The elevated level of oxidative DNA damage and premature liver polyploidly were reversed and liver function was corrected. A widespread mitochondrial dysfunction was identified and an essential role for ERCC1 in the kidney was also revealed with transgene-containing ERCC1-deficient animals going on to die of renal failure. The nuclei of kidney proximal tubule cells became polyploid in a similar way to the premature liver polyploidly observed in younger ERCC1-deficient animals. We believe that this is a response to the accumulation of endogenous DNA damage in these particularly susceptible tissues which cannot be repaired in ERCC1-deficient animals.
C1 Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
   Univ Edinburgh, Sir Alastair Currie CRC Labs, Mol Med Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.
C3 University of Edinburgh; University of Edinburgh
RP Melton, DW (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.
EM david.melton@ed.ac.uk
OI SELFRIDGE, JIM/0000-0003-2473-4386
CR Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552
   BRAMSON J, 1993, CANCER RES, V53, P3237
   Castilla-Cortazar I, 2000, HEPATOLOGY, V31, P592, DOI 10.1002/hep.510310308
   De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000
   DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0
   FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES
   Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56
   GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642
   Hogan B., 1986, MANIPULATING MOUSE E
   Inomata T, 1999, INT J RADIAT ONCOL, V44, P171, DOI 10.1016/S0360-3016(98)00562-8
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0
   Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200
   Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597
   Le Page F, 2000, P NATL ACAD SCI USA, V97, P8397, DOI 10.1073/pnas.140137297
   Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   MATSUURA K, 1991, BIOL TRACE ELEM RES, V31, P171, DOI 10.1007/BF02990425
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Melton DW, 1998, J CELL SCI, V111, P395
   MOORE RC, 1995, BIO-TECHNOL, V13, P999, DOI 10.1038/nbt0995-999
   NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0
   Núñez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073
   Robertson G, 1996, NUCLEIC ACIDS RES, V24, P1465, DOI 10.1093/nar/24.8.1465
   Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355
   SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0
   Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771
   SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485
   SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756
   Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370
   STEWART FA, 1989, RADIOTHER ONCOL, V15, P93, DOI 10.1016/0167-8140(89)90122-9
   VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0
   Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031
   Wood SG, 2000, METH MOLEC MED, V38, P171, DOI 10.1385/1-59259-070-5:171
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x
NR 38
TC 65
Z9 74
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD NOV 15
PY 2001
VL 29
IS 22
BP 4541
EP 4550
DI 10.1093/nar/29.22.4541
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 496CK
UT WOS:000172378000004
PM 11713303
OA Green Published
DA 2024-02-19
ER

PT J
AU Suárez, LM
   Muñoz, MD
   del Río, RM
   Solís, JM
AF Suarez, Luz M.
   Munoz, Maria-Dolores
   Martin del Rio, Rafael
   Solis, Jose M.
TI Taurine content in different brain structures during ageing: effect on
   hippocampal synaptic plasticity
SO AMINO ACIDS
LA English
DT Article
DE Ageing; Nutrition; Synaptic plasticity; LTP; D-Serine; Brain
ID LONG-TERM POTENTIATION; AMINO-ACIDS; METABONOMIC ALTERATIONS;
   BETA-ALANINE; AGE; TISSUE; SUPPLEMENTATION; BIOSYNTHESIS; TRANSMISSION;
   TRANSPORTER
AB A reduction in taurine content accompanies the ageing process in many tissues. In fact, the decline of brain taurine levels has been associated with cognitive deficits whereas chronic administration of taurine seems to ameliorate age-related deficits such as memory acquisition and retention. In the present study, using rats of three age groups (young, adult and aged) we determined whether the content of taurine and other amino acids (glutamate, serine, glutamine, glycine, alanine and GABA) was altered during ageing in different brain areas (cerebellum, cortex and hippocampus) as well non-brain tissues (heart, kidney, liver and plasma). Moreover, using hippocampal slices we tested whether ageing affects synaptic function and plasticity. These parameters were also determined in aged rats fed with either taurine-devoid or taurine-supplemented diets. With age, we found heterogeneous changes in amino acid content depending on the amino acid type and the tissue. In the case of taurine, its content was reduced in the cerebellum of adult and aged rats, but it remained unchanged in the hippocampus, cortex, heart and liver. The synaptic response amplitude decreased in aged rats, although the late phase of long-term synaptic potentiation (late-LTP), a taurine-dependent process, was not altered. Our study highlights the stability of taurine content in the hippocampus during ageing regardless of whether taurine was present in the diet, which is consistent with the lack of changes detected in late-LTP. These results indicate that the beneficial effects of taurine supplementation might be independent of the replenishment of taurine stores.
C1 [Suarez, Luz M.] Inst Cajal CSIC, Avda Doctor Arce 37, Madrid 28002, Spain.
   [Suarez, Luz M.] Inst Salud Carlos III, CIBERNED, Madrid, Spain.
   [Suarez, Luz M.; Martin del Rio, Rafael; Solis, Jose M.] Hosp Univ Ramon & Cajal, IRYCIS, Serv Neurobiol Invest, Madrid 28034, Spain.
   [Munoz, Maria-Dolores] Hosp Univ Ramon & Cajal, IRYCIS, Serv Neurol Expt, Ctra Colmenar Km 9, Madrid 28034, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   Cajal (IC); Instituto de Salud Carlos III; CIBERNED; Hospital
   Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal
RP Solís, JM (corresponding author), Hosp Univ Ramon & Cajal, IRYCIS, Serv Neurobiol Invest, Madrid 28034, Spain.
EM luz.m.suarez@cajal.csic.es; dolores.munoz@hrc.es;
   rafaelmartindelrio@gmail.com; jose.m.solis@hrc.es
RI Frausto Solis, Juan/R-5308-2017; Suarez, Luz/H-8817-2015; Munoz, Maria
   Dolores/H-7813-2015
OI Frausto Solis, Juan/0000-0001-9307-0734; Suarez,
   Luz/0000-0003-1276-2259; Solis, Jose M./0000-0001-6478-0489; Munoz,
   Maria Dolores/0000-0001-6794-2308
FU Instituto de Salud Carlos III [PIU081067]
FX This work was supported by a grant from "Instituto de Salud Carlos III"
   (PIU081067).
CR Arias N, 2015, HIPPOCAMPUS, V25, P1242, DOI 10.1002/hipo.22430
   BANAYSCHWARTZ M, 1989, NEUROCHEM RES, V14, P563, DOI 10.1007/BF00964919
   BENEDETTI MS, 1991, J NEURAL TRANSM-GEN, V86, P191, DOI 10.1007/BF01250705
   Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x
   Csernansky JG, 1996, NEUROLOGY, V46, P1715, DOI 10.1212/WNL.46.6.1715
   Dawson R, 1999, MECH AGEING DEV, V107, P73, DOI 10.1016/S0047-6374(98)00138-9
   Dawson R, 1999, BRAIN RES BULL, V48, P319, DOI 10.1016/S0361-9230(99)00003-9
   del Olmo N, 2004, EUR J NEUROSCI, V19, P1875, DOI 10.1111/j.1460-9568.2004.03309.x
   del Olmo N, 2003, NEUROPHARMACOLOGY, V44, P26, DOI 10.1016/S0028-3908(02)00310-6
   Duarte JMN, 2014, NEUROBIOL AGING, V35, P1660, DOI 10.1016/j.neurobiolaging.2014.01.135
   El Idrissi A, 2008, NEUROSCI LETT, V436, P19, DOI 10.1016/j.neulet.2008.02.070
   Idrissi A, 2013, AMINO ACIDS, V45, P735, DOI 10.1007/s00726-013-1544-7
   El Idrissi A, 2009, ADV EXP MED BIOL, V643, P199, DOI 10.1007/978-0-387-75681-3_20
   Eppler B, 2001, BIOCHEM PHARMACOL, V62, P29, DOI 10.1016/S0006-2952(01)00647-5
   Eppler B, 1998, ADV EXP MED BIOL, V442, P55
   Galarreta M, 1996, J NEUROSCI, V16, P92
   Gold PE, 2013, HIPPOCAMPUS, V23, P1053, DOI 10.1002/hipo.22182
   Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje
   Hsu KS, 2002, HIPPOCAMPUS, V12, P787, DOI 10.1002/hipo.10032
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Ito K, 2009, EXP ANIM TOKYO, V58, P175, DOI 10.1538/expanim.58.175
   Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001
   Kim HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07467
   LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145
   MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451
   Miyazaki T, 2014, AMINO ACIDS, V46, P101, DOI 10.1007/s00726-012-1381-0
   Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x
   Paban V, 2010, EUR J NEUROSCI, V31, P1063, DOI 10.1111/j.1460-9568.2010.07126.x
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Parildar H, 2008, J NUTR SCI VITAMINOL, V54, P61, DOI 10.3177/jnsv.54.61
   Pierno S, 1998, J PHARMACOL EXP THER, V286, P1183
   Potier B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.001.2010
   Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0
   Saransaari P, 1997, NEUROSCIENCE, V79, P847, DOI 10.1016/S0306-4522(97)00038-9
   Schaffer SW, 2014, AMINO ACIDS, V46, P47, DOI [10.1007/s00726-012-1414-8, 10.1007/s00726-013-1632-8]
   Suárez LM, 2014, NEUROPHARMACOLOGY, V79, P101, DOI 10.1016/j.neuropharm.2013.10.035
   Sved DW, 2007, AMINO ACIDS, V32, P459, DOI 10.1007/s00726-007-0494-3
   Tinsley MR, 2004, LEARN MEMORY, V11, P35, DOI 10.1101/lm.70204
   Zhang XR, 2013, BRAIN RES, V1507, P28, DOI 10.1016/j.brainres.2013.02.033
   Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004
   Zhou Y, 2012, J BIOL CHEM, V287, P35733, DOI 10.1074/jbc.M112.368175
NR 41
TC 20
Z9 21
U1 0
U2 19
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0939-4451
EI 1438-2199
J9 AMINO ACIDS
JI Amino Acids
PD MAY
PY 2016
VL 48
IS 5
BP 1199
EP 1208
DI 10.1007/s00726-015-2155-2
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA DJ7ES
UT WOS:000374375300007
PM 26803657
DA 2024-02-19
ER

PT J
AU Luo, CT
   Ding, WX
   Yang, CM
   Zhang, WH
   Liu, XH
   Deng, HT
AF Luo, Chengting
   Ding, Wenxi
   Yang, Changmei
   Zhang, Wenhao
   Liu, Xiaohui
   Deng, Haiteng
TI Nicotinamide Mononucleotide Administration Restores Redox Homeostasis
   via the Sirt3-Nrf2 Axis and Protects Aged Mice from Oxidative
   Stress-Induced Liver Injury
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article; Early Access
DE aging; redox adaptability; Nrf2; Sirt3; nicotinamide mononucleotide
   (NMN); liver injury
ID MANGANESE SUPEROXIDE-DISMUTASE; HEPATIC NRF2; LIFE-SPAN; MITOCHONDRIA;
   DECLINE; PATHWAY; OVEREXPRESSION; ACETAMINOPHEN; ACTIVATION; MECHANISMS
AB Altered adaptive homeostasis contributes to aging and lifespan regulation. In the present study, to characterize the mechanism of aging in mouse liver, we performed quantitative proteomics and found that the most upregulated proteins were related to the oxidation-reduction process. Further analysis revealed that malondialdehyde (MDA) and protein carbonyl (PCO) levels were increased, while nuclear Nrf2 and downstream genes were significantly increased, indicating that oxidative stress induced Nrf2 activation in aged mouse liver. Importantly, nicotinamide mononucleotide (NMN) administration decreased the oxidative stress and the nuclear Nrf2 and Nrf2 downstream gene levels. Indeed, aged mice treated with NMN improved stress resistance against acetaminophen (APAP)-induced liver injury, indicating that NMN restored Nrf2-mediated adaptive homeostasis. Further studies found that NMN increased Sirt3 activities to deacetylate age-associated acetylation at K68 and K122 in Sod2, while its effects on nuclear Nrf2 levels were diminished in Sirt3-deficient mice, suggesting that NMN-enhanced adaptive homeostasis was Sirt3-dependent. Taken together, we demonstrated that Nrf2-regulated adaptive homeostasis was decreased in aged mouse liver and NMN supplementation restored liver redox homeostasis via the Sirt3-Nrf2 axis and protected aged liver from oxidative stress-induced injury.
C1 [Luo, Chengting; Yang, Changmei; Liu, Xiaohui; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Ctr Synthet & Systemat Biol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.
   [Luo, Chengting; Ding, Wenxi; Zhang, Wenhao; Deng, Haiteng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
C3 Tsinghua University; Tsinghua University
RP Deng, HT (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Synthet & Systemat Biol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Deng, HT (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
EM dht@mail.tsinghua.edu.cn
RI Yang, Changmei/JZE-0412-2024; Zhang, Wenhao/JEO-9872-2023
OI Deng, Haiteng/0000-0001-9496-1280
FU Postdoctoral Foundation of Tsinghua-Peking Center for Life Sciences;
   Beijing Municipal Science and Technology Commission [5214025]; Ministry
   of Science and Technology of the People's Republic of China
   [2017ZX10201101, 2020YFC2002705]; National Key Research and Development
   Program of China [2017YFA0505103]; National Natural Science Foundation
   of China [21877068]
FX The authors greatly appreciate the Facility for Protein Chemistry and
   Proteomics at Tsinghua University for sample analysis. The authors
   greatly appreciate the support from Postdoctoral Foundation of
   Tsinghua-Peking Center for Life Sciences. This study was supported by
   the Beijing Municipal Science and Technology Commission (No. 5214025),
   Ministry of Science and Technology of the People's Republic of China
   (grant Nos. 2017ZX10201101 and 2020YFC2002705), National Key Research
   and Development Program of China (grant No. 2017YFA0505103), and
   National Natural Science Foundation of China (grant No. 21877068).
CR Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Feleciano DR, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1091060
   Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Gong SH, 2018, J HEPATOL, V69, P51, DOI 10.1016/j.jhep.2018.02.024
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He CX, 2019, P NATL ACAD SCI USA, V116, P23534, DOI 10.1073/pnas.1902308116
   Duong HQ, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030052
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001
   Klimova N, 2019, J NEUROSCI RES, V97, P975, DOI 10.1002/jnr.24397
   Kopacz A, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101304
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kubo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14520-8
   Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948
   Liu H, 2018, J PROTEOME RES, V17, P3143, DOI 10.1021/acs.jproteome.8b00260
   Liu J, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.702107
   Lu JQ, 2015, FREE RADICAL BIO MED, V85, P114, DOI 10.1016/j.freeradbiomed.2015.04.011
   Luo CT, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11101654
   Luo CT, 2017, EUR J CELL BIOL, V96, P567, DOI 10.1016/j.ejcb.2017.05.003
   Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885
   Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986
   Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pérez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002
   Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798
   Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110
   Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200
   Saeedi BJ, 2020, CELL METAB, V31, P956, DOI 10.1016/j.cmet.2020.03.006
   Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Sheehan WJ, 2016, NEW ENGL J MED, V375, P619, DOI 10.1056/NEJMoa1515990
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Smith EJ, 2015, FREE RADICAL BIO MED, V89, P1184, DOI 10.1016/j.freeradbiomed.2015.11.003
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047
   Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006
   Tang HP, 2016, TALANTA, V156, P163, DOI 10.1016/j.talanta.2016.04.051
   Wang WX, 2018, CELL CHEM BIOL, V25, P255, DOI 10.1016/j.chembiol.2017.12.008
   Wang XY, 2019, ANAL CHIM ACTA, V1084, P60, DOI 10.1016/j.aca.2019.07.060
   Wei CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00851-z
   Xu LN, 2018, TALANTA, V178, P287, DOI 10.1016/j.talanta.2017.09.046
   Yi MQ, 2020, AGING-US, V12, P21890, DOI 10.18632/aging.104007
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P2038, DOI 10.1016/j.freeradbiomed.2012.02.042
   Zhang LW, 2017, FREE RADICAL BIO MED, V108, P595, DOI 10.1016/j.freeradbiomed.2017.04.022
   Zong ZY, 2021, FREE RADICAL BIO MED, V162, P571, DOI 10.1016/j.freeradbiomed.2020.11.014
NR 53
TC 6
Z9 6
U1 11
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD 2022 JUN 14
PY 2022
DI 10.1021/acs.jproteome.2c00167
EA JUN 2022
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 2O9PQ
UT WOS:000819382700001
PM 35699728
DA 2024-02-19
ER

PT J
AU Wesley, UV
   Bhute, VJ
   Hatcher, JF
   Palecek, SP
   Dempsey, RJ
AF Wesley, Umadevi, V
   Bhute, Vijesh J.
   Hatcher, James F.
   Palecek, Sean P.
   Dempsey, Robert J.
TI Local and systemic metabolic alterations in brain, plasma, and liver of
   rats in response to aging and ischemic stroke, as detected by nuclear
   magnetic resonance (NMR) spectroscopy
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article
DE Ischemia reperfusion; Aging; Metabolomics; Middle cerebral artery
   occlusion; Nuclear magnetic resonance spectroscopy
ID DISEASES; SERUM; AGE
AB Metabolic dysfunction impacts stroke incidence and outcome. However, the intricate association between altered metabolic program due to aging, and focal ischemia in brain, circulation, and peripheral organs is not completely elucidated. Here we identified locally and systemically altered metabolites in brain, liver, and plasma as a result of normal aging, ischemic-stroke, and extended time of reperfusion injury. Comprehensive quantitative metabolic profiling was carried out using nuclear magnetic resonance spectroscopy. Aging, but healthy rats showed significant metabolic alterations in the brain, but only a few metabolic changes in the liver and plasma as compared to younger rats. But, ischemic stroke altered metabolites significantly in liver and plasma of older rats during early acute phase. Major metabolic changes were also seen in the brains of younger rats following ischemic stroke during early acute phase of injury. We further report that metabolic changes occur sequentially in a tissue specific manner during extended reperfusion time of late repair phase. First metabolic alterations occurred in brain due to local injury. Next, changes in circulating metabolites in plasma occurred during acute-repair phase transition time. Lastly, the delayed systemic effect was seen in the peripheral organ, liver that exhibited significant and persistent changes in selected metabolites during later reperfusion time. The metabolic pathways involved in energy/glucose, and amino acid metabolism, inflammation, and oxidative stress were mainly altered as a result of aging and ischemia/reperfusion. Biomarker analysis revealed citrate, lysine, and tyrosine as potential age-independent blood metabolic biomarkers of ischemia/reperfusion. Overall, our study elucidates the complex network of metabolic events as a function of normal aging and acute stroke. We further provide evidence for a clear transition from local to systemic metabolic dysfunction due to ischemic injury in a time dependent manner, which may altogether greatly impact the post-stroke outcome.
C1 [Wesley, Umadevi, V; Hatcher, James F.; Dempsey, Robert J.] Univ Wisconsin, Dept Neurol Surg, Box 8660 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.
   [Bhute, Vijesh J.; Palecek, Sean P.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53792 USA.
   [Bhute, Vijesh J.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge, England.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Cambridge
RP Wesley, UV (corresponding author), Univ Wisconsin, Dept Neurol Surg, Box 8660 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.
EM u.wesley@neurosurgery.wisc.edu
FU Department of Neurosurgery, University of Wisconsin, Madison; American
   Heart Association [AHA-7GRNT33700105, NIHR01CA164492]
FX This work was in part supported by the resources provided by the
   Department of Neurosurgery, University of Wisconsin, Madison, American
   Heart Association AHA-7GRNT33700105 (UVW), and NIH R01CA164492 (SPP).
CR Allen CL, 2008, INT J STROKE, V3, P105, DOI 10.1111/j.1747-4949.2008.00187.x
   Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004
   [Anonymous], GUT MICROBES
   Bake S, 2016, ENDOCRINOLOGY, V157, P61, DOI 10.1210/en.2015-1840
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   Bhute VJ, 2017, THERANOSTICS, V7, P2078, DOI 10.7150/thno.19390
   Bhute VJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36061
   Bhute VJ, 2015, METABOLOMICS, V11, P1779, DOI 10.1007/s11306-015-0831-6
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006
   Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5
   Conrad Z, 2016, CIRCULATION, V133
   Coon AL, 2006, AM J NEURORADIOL, V27, P1053
   Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c
   Eun MY, 2013, EUR NEUROL, V69, P171, DOI 10.1159/000345480
   Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S
   Gowda GAN, 2014, ANAL CHEM, V86, P5433, DOI 10.1021/ac5005103
   Jové M, 2015, NEUROLOGY, V84, P36, DOI 10.1212/WNL.0000000000001093
   Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789
   Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9
   Kim Y, 2017, CLIN EXP PHARMACOL P, V44, P671, DOI 10.1111/1440-1681.12757
   Luo L, 2016, J ETHNOPHARMACOL, V186, P257, DOI 10.1016/j.jep.2016.03.059
   Ma SB, 2015, EXP NEUROL, V272, P41, DOI 10.1016/j.expneurol.2015.05.014
   Ma YX, 2012, CURR DRUG TARGETS, V13, P222, DOI 10.2174/138945012799201711
   Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357
   Mauri-Capdevila G, 2013, REV NEUROLOGIA, V57, P29, DOI 10.33588/rn.5701.2013115
   Miyazaki T, 2014, AMINO ACIDS, V46, P101, DOI 10.1007/s00726-012-1381-0
   Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002
   Muscari A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-122
   PONZIO F, 1982, NEUROBIOL AGING, V3, P23, DOI 10.1016/0197-4580(82)90057-4
   Purroy F, 2016, EBIOMEDICINE, V14, P131, DOI 10.1016/j.ebiom.2016.11.010
   Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873
   Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   SIMPKINS JW, 1977, ENDOCRINOLOGY, V100, P1672, DOI 10.1210/endo-100-6-1672
   Wang RY, 2003, GERONTOLOGY, V49, P27, DOI 10.1159/000066505
   Wesley UV, 2017, MOL NEUROBIOL, V54, P4973, DOI 10.1007/s12035-016-0039-4
   Wolahan SM., 2015, Brain neurotrauma molecular neuropsychological and rehabilitation aspects
   XU J, 2015, NUCLEIC ACIDS RES, P1000
   Ye RD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3065263
NR 40
TC 29
Z9 30
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD JUL
PY 2019
VL 127
BP 113
EP 124
DI 10.1016/j.neuint.2019.01.025
PG 12
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA IH2LY
UT WOS:000474327500014
PM 30707914
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU ZLATANOV, IV
   FOLEY, M
   BIRMINGHAM, J
   GARLAND, PB
AF ZLATANOV, IV
   FOLEY, M
   BIRMINGHAM, J
   GARLAND, PB
TI EFFECT OF SOME POLYPEPTIDE HORMONES ON THE LATERAL MOBILITY IN
   PLASMA-MEMBRANES OF RAT TESTES, L-CELLS AND LIVER - INFLUENCE OF
   DEVELOPMENT AND AGING
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 AMERSHAM INT PLC, AMERSHAM HP7 9LL, BUCKS, ENGLAND.
   UNIV DUNDEE, INST MED SCI, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND.
C3 University of Dundee
RP ZLATANOV, IV (corresponding author), BULGARIAN ACAD SCI, CENT LAB BIOPHYS, BU-1113 SOFIA, BULGARIA.
OI Foley, Michael/0000-0003-1349-4698
CR AMSTERDAM A, 1981, P NATL ACAD SCI-BIOL, V78, P3000, DOI 10.1073/pnas.78.5.3000
   ANDRICH MP, 1976, BIOCHEMISTRY-US, V15, P1257, DOI 10.1021/bi00651a013
   BACHVAROFF RJ, 1980, P NATL ACAD SCI-BIOL, V77, P4979, DOI 10.1073/pnas.77.8.4979
   BRANTON D, 1981, CELL, V24, P24, DOI 10.1016/0092-8674(81)90497-9
   CHEVALIER M, 1981, BIOL CELL, V41, P105
   COOKE BA, 1983, CURR TOP MEMBR TRANS, V18, P143
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GALLA HJ, 1974, BIOCHIM BIOPHYS ACTA, V339, P103, DOI 10.1016/0005-2736(74)90336-8
   GARLAND P, 1981, BIOPHYS J, V33, P481, DOI 10.1016/S0006-3495(81)84910-7
   GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2
   HECHTER O, 1955, VITAM HORM, V13, P293, DOI 10.1016/S0083-6729(08)61029-8
   HEYN MP, 1979, FEBS LETT, V108, P359, DOI 10.1016/0014-5793(79)80564-5
   HOUSLAY MD, 1983, CURR TOP MEMBR TRANS, V18, P179
   JOHNSON P, 1981, FEBS LETT, V132, P252, DOI 10.1016/0014-5793(81)81172-6
   KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1
   LEVITZKI A, 1982, CURRENT REV BIOMEDIC, V2, P14
   LULY P, 1979, BIOCHEMISTRY-US, V18, P445, DOI 10.1021/bi00570a009
   MASSA EM, 1975, BIOCHEM BIOPH RES CO, V66, P115, DOI 10.1016/S0006-291X(75)80302-0
   MINTZ Y, 1978, MOL CELL ENDOCRINOL, V11, P265, DOI 10.1016/0303-7207(78)90013-8
   MORENO H, 1976, BIOCHEM BIOPH RES CO, V72, P74, DOI 10.1016/0006-291X(76)90962-1
   PETERS RA, 1937, PERSPECTIVES BIOCH, P36
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   PODO F, 1977, P NATL ACAD SCI USA, V74, P1032, DOI 10.1073/pnas.74.3.1032
   ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533
   SHINITZKY M, 1984, PHYSL MEMBRANE FLUID, V1, P1
   SPERRY W, 1957, J BIOL CHEM, V187, P97
   STRULOVICI B, 1981, BIOCHIM BIOPHYS ACTA, V640, P159, DOI 10.1016/0005-2736(81)90541-1
   TRAMONTANO D, 1982, EXP CELL RES, V137, P269, DOI 10.1016/0014-4827(82)90027-1
   VANBLITTERSWIJK WJ, 1981, BIOCHIM BIOPHYS ACTA, V644, P323, DOI 10.1016/0005-2736(81)90390-4
   VANDERKOOI JM, 1974, BIOCHEMISTRY-US, V13, P4000, DOI 10.1021/bi00716a028
   VANDERKOOI JM, 1975, J CHEM PHYS, V63, P3661, DOI 10.1063/1.431761
   WISHER MH, 1975, BIOCHEM J, V146, P375, DOI 10.1042/bj1460375
   ZENNER HP, 1976, EUR J BIOCHEM, V71, P177, DOI 10.1111/j.1432-1033.1976.tb11104.x
   ZLATANOV IV, 1986, DOKL BOLG AKAD NAUK, V39, P101
   ZLATANOV IV, 1986, DOKL BOLG AKAD NAUK, V39, P93
   ZLATANOV IV, 1987, FEBS LETT, V222, P47, DOI 10.1016/0014-5793(87)80189-8
   ZLATANOV IV, 1988, ELECTROMAGNETIC FIEL, P145
   ZOR U, 1983, ENDOCR REV, V4, P1
NR 38
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-711X
J9 INT J BIOCHEM
JI Int. J. Biochem.
PY 1989
VL 21
IS 11
BP 1269
EP 1274
DI 10.1016/0020-711X(89)90014-1
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CB713
UT WOS:A1989CB71300014
PM 2515078
DA 2024-02-19
ER

PT J
AU Rahimi, VB
   Askari, VR
   Mousavi, SH
AF Rahimi, Vafa Baradaran
   Askari, Vahid Reza
   Mousavi, Seyed Hadi
TI Ellagic acid reveals promising anti-aging effects against
   D-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A
   mechanistic study
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Ellagic acid; D-Galactose; Aging; PPAR-gamma; Anti-inflammatory;
   Metformin
ID GLYCATION END-PRODUCTS; INDUCED OXIDATIVE STRESS; FACTOR-KAPPA-B;
   COGNITIVE IMPAIRMENT; INFLAMMATORY NETWORKS; INDUCED NEUROTOXICITY;
   PERITONEAL ADHESION; GINSENOSIDE RG1; INDUCED LIVER; SENESCENCE
AB Background: Aging is a progressive, accumulative and natural phenomenon that leads to irreversible changes in all molecules, cells, tissues and organs of an organism. Previous studies have demonstrated that D-galactose (DG) imitates human natural aging. EA has also shown many pharmacological properties including anti-inflammatory and anti-oxidant activities.
   Methods: In the present study, we are aimed to evaluate anti-aging effects of EA (0.01-10 mu M) on DG-induced aging model in SH-SY5Y human neuroblastoma cells, using assessment of cell proliferation, lipid peroxidation (MDA), intra-cellular reactive oxygen species (ROS), inflammation (TNF-alpha), total glutathione content (GSH), Beta-Galactosidase (beta-GAL) and advanced glycation end products (AGEs) levels. Furthermore, the effects of EA were examined on HO-1 or PPAR-gamma pathways using their selective inhibitors ZnPP or GW9662, respectively.
   Results: The results revealed that EA (0.01-10 mu M) significantly increased cell proliferation and GSH level, while decreased the levels of ROS, MDA, TNF-alpha, beta-GAL and AGEs following DG-induced aging. Our findings also presented that pre-incubation with ZnPP exacerbates toxicity features of DG-induced aging in all measured parameters. Furthermore, we showed that pre-incubation of EA (0.1 and 1 mu M) with either GW9662 or ZnPP significantly prevents the protective activities on cell proliferation, ROS, MDA, GSH and TNF-alpha levels following DG-induced aging (p < 0.001 for all cases). Additionally, EA (0.1 and 1 mu M) along with GW9662 did not affect the levels of beta-GAL and AGES in comparison to DG-induced aging group.
   Conclusion: Although we described for the first time that EA at low concentrations (0.1-1 mu M) provides greater antiaging properties than both its high concentration (10 mu M) and metformin (2.5 mM) probably through PPAR-gamma/HO-1 signaling pathway, but additional and deeper investigations are needed to show exact involving mechanisms. It could be suggestible that EA may be as anti-aging agent at low concentrations for age-related neurological disorders such as Parkinson's and Alzheimer's diseases.
C1 [Rahimi, Vafa Baradaran] Mashhad Univ Med Sci, Dept Pharmacol, Student Res Comm, Fac Med, Mashhad, Iran.
   [Askari, Vahid Reza] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Iran.
   [Askari, Vahid Reza] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran.
   [Mousavi, Seyed Hadi] Mashhad Univ Med Sci, Med Toxicol Res Ctr, Mashhad, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science; Mashhad University Medical Science
RP Mousavi, SH (corresponding author), Mashhad Univ Med Sci, Dept Pharmacol, Fac Med, Mashhad, Iran.
EM baradaranv941@mums.ac.ir; askariv941@mums.ac.ir; mousavih@mums.ac.ir
RI Askari, Vahid Reza/ABB-8991-2020; Rahimi, Vafa Baradaran/AAR-4523-2021
OI Askari, Vahid Reza/0000-0001-9268-6270; Rahimi, Vafa
   Baradaran/0000-0003-2320-5095
FU research council of Mashhad University of Medical Sciences [960196]
FX This study financially supported by the research council of Mashhad
   University of Medical Sciences (Grant Number: 960196). This work was
   extracted from part of Ph.D. thesis of first author Vafa Baradaran
   Rahimi.
CR Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536
   Alfredsson CF, 2014, BIOMED PHARMACOTHER, V68, P129, DOI 10.1016/j.biopha.2013.08.010
   Allam G, 2016, CENT EUR J IMMUNOL, V41, P339, DOI 10.5114/ceji.2016.65132
   [Anonymous], 2015, METF LONG STUD MIL
   Askari VR, 2018, PHYTOMEDICINE, V43, P1, DOI 10.1016/j.phymed.2018.03.049
   Askari VR, 2018, BIOMED PHARMACOTHER, V99, P346, DOI 10.1016/j.biopha.2018.01.068
   Askari VR, 2018, BIOMED PHARMACOTHER, V101, P438, DOI 10.1016/j.biopha.2018.02.098
   Askari VR, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.24261
   Baeeri M, 2018, MOL CELL BIOCHEM, V441, P21, DOI 10.1007/s11010-017-3172-0
   Baeeri M, 2017, FOOD CHEM TOXICOL, V100, P8, DOI 10.1016/j.fct.2016.12.008
   Baluchnejadmojarad T, 2017, BRAIN RES, V1662, P23, DOI 10.1016/j.brainres.2017.02.021
   Bansal N, 2017, DRUG RES, V67, P425, DOI 10.1055/s-0043-108552
   Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen LB, 2018, NEUROCHEM RES, V43, P430, DOI 10.1007/s11064-017-2438-y
   Chen M, 2016, METABOLISM, V65, P441, DOI 10.1016/j.metabol.2015.11.007
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   de Oliveira MR, 2018, NEUROTOX RES, V34, P241, DOI 10.1007/s12640-018-9881-7
   Ding Y, 2014, INT J CARDIOL, V175, P508, DOI 10.1016/j.ijcard.2014.06.045
   El-Shitany NA, 2014, INT IMMUNOPHARMACOL, V19, P290, DOI 10.1016/j.intimp.2014.02.004
   Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918
   Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130
   Firdaus F, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22024
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Girish C, 2012, J PHARMACOL PHARMACO, V3, P149, DOI 10.4103/0976-500X.95515
   González-Sarrías A, 2017, J AGR FOOD CHEM, V65, P752, DOI 10.1021/acs.jafc.6b04538
   Goudarzi M, 2018, LIFE SCI, V198, P38, DOI 10.1016/j.lfs.2018.02.022
   Griveau A, 2018, AGING CELL, V17, DOI 10.1111/acel.12835
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020
   Hsieh HM, 2011, LIFE SCI, V88, P82, DOI 10.1016/j.lfs.2010.10.021
   Huang QF, 2016, J HUM HYPERTENS, V30, P430, DOI 10.1038/jhh.2015.60
   Huang TT, 2014, GENESIS, V52, P300, DOI 10.1002/dvg.22761
   Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565
   Kim YS, 2013, BIOL PHARM BULL, V36, P609, DOI 10.1248/bpb.b12-00990
   Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h
   Kuo MY, 2011, J AGR FOOD CHEM, V59, P5100, DOI 10.1021/jf1041867
   Labuzek K, 2010, PHARMACOL REP, V62, P956
   Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010
   Liu YS, 2014, WORLD J GASTROENTERO, V20, P8572, DOI 10.3748/wjg.v20.i26.8572
   Ma X., 2018, AGING CELL
   Marín M, 2013, J ETHNOPHARMACOL, V150, P925, DOI 10.1016/j.jep.2013.09.030
   Novelle MG, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025932
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Pavlica S, 2005, FREE RADICAL RES, V39, P1377, DOI 10.1080/09670260500197660
   Petrica L, 2015, INT J CLIN EXP MED, V8, P2516
   Prasad S, 2017, REDOX BIOL, V12, P58, DOI 10.1016/j.redox.2017.02.007
   Priyadarsini KI, 2002, J AGR FOOD CHEM, V50, P2200, DOI 10.1021/jf011275g
   Raghu G, 2017, J FOOD SCI TECH MYS, V54, P2411, DOI 10.1007/s13197-017-2683-8
   Raghu G, 2016, FOOD FUNCT, V7, P1574, DOI [10.1039/C5FO01372K, 10.1039/c5fo01372k]
   Rahimi V. B., BOSWELLIA SERRATA HA
   Rahimi VB, 2017, ACTA POL PHARM, V74, P1803
   Rahimi VB, 2017, BIOMED PHARMACOTHER, V92, P849, DOI 10.1016/j.biopha.2017.05.114
   Rahimi VB, 2017, IRAN J BASIC MED SCI, V20, P242, DOI [10.22038/IJBMS.2017.8350, 10.22038/ijbms.2017.8350]
   García-Niño WR, 2015, PHARMACOL RES, V97, P84, DOI 10.1016/j.phrs.2015.04.008
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Sadigh-Eteghad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184122
   Sehgal N, 2011, BIOCHEM PHARMACOL, V82, P53, DOI 10.1016/j.bcp.2011.03.025
   Shlush LI, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-16
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sun JZ, 2018, INT IMMUNOPHARMACOL, V58, P94, DOI 10.1016/j.intimp.2018.03.017
   Syed U, 2017, J CANCER RES THER, V13, P62, DOI 10.4103/0973-1482.172715
   Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Wang YM, 2016, J NEUROL SCI, V368, P223, DOI 10.1016/j.jns.2016.07.010
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu Y, 2018, TOXICOL LETT, V289, P99, DOI 10.1016/j.toxlet.2018.02.001
   Yilmaz EE, 2016, ACTA CIR BRAS, V31, P396, DOI 10.1590/S0102-865020160060000006
   Yin PP, 2018, ARAB J CHEM, V11, P1247, DOI 10.1016/j.arabjc.2017.10.002
   Yu SL, 2010, ACTA PHARMACOL SIN, V31, P1532, DOI 10.1038/aps.2010.152
   Zeb A, 2018, MOL CELL BIOCHEM, V448, P27, DOI 10.1007/s11010-018-3310-3
   Zhang XL, 2013, FOOD CHEM TOXICOL, V58, P50, DOI 10.1016/j.fct.2013.04.006
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 79
TC 39
Z9 42
U1 1
U2 29
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD DEC
PY 2018
VL 108
BP 1712
EP 1724
DI 10.1016/j.biopha.2018.10.024
PG 13
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HA2UZ
UT WOS:000450101800189
PM 30372874
OA hybrid
DA 2024-02-19
ER

PT J
AU Kwok, CM
   Chen, YT
   Lin, HT
   Su, CH
   Liu, YS
   Chiu, YC
AF Kwok, Ching-Ming
   Chen, Yen-Ting
   Lin, Han-Tso
   Su, Cheng-Hsi
   Liu, Yu-Shi
   Chiu, Yi-Chon
TI Portal vein entrance of splenic erythrocytic progenitor cells and local
   hypoxia of liver, two events cause intrahepatic splenosis
SO MEDICAL HYPOTHESES
LA English
DT Article
ID MIMICKING; TISSUE
AB Intrahepatic splenosis is a rare disorder of ectopic erythropoiesis in the liver. Although traumatic splenic rupture is the common factor in public cases, the mechanism of long latency is still unknown. The correlation between aging and hepatitis virus infection with the diagnosed occurrence was reported in a limited number of cases; nevertheless, it suggested that ectopic erythropoiesis in the liver could be induced by the hepatic disorder. Based on the susceptibility of the splenic erythropoiesis response to hypoxia and the inevitability of hypoxia caused by aging or pathological changes, we hypothesized that the two events caused the occurrence of the intrahepatic splenosis, the migration of the erythrocytic progenitor cells via the portal vein following traumatic splenic rupture, and the local induction of erythropoiesis by hypoxia. (c) 2006 Elsevier Ltd. AlI rights reserved.
C1 Cheng Hsin Rehabil Med Ctr, Dept Surg, Div Gen Surg, Taipei 112, Taiwan.
   Cheng Hsin Rehabil Med Ctr, Dept Internal Med, Div Gastroenterol, Taipei 112, Taiwan.
   Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Sch Med, Div Expt Surg, Taipei 112, Taiwan.
C3 Taipei Veterans General Hospital; National Yang Ming Chiao Tung
   University
RP Chiu, YC (corresponding author), Cheng Hsin Rehabil Med Ctr, Dept Surg, Div Gen Surg, 45,Cheng Hsin St, Taipei 112, Taiwan.
EM tuzoo@seed.net.tw
RI Kwok, Ching Ming/AAN-9741-2020
OI Kwok, Ching Ming/0000-0003-3429-2411
CR Abo T, 2002, ARCH HISTOL CYTOL, V65, P127, DOI 10.1679/aohc.65.127
   Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136
   Davidson LA, 1997, J CLIN PATHOL, V50, P532, DOI 10.1136/jcp.50.6.532
   De Vuysere S, 2000, ABDOM IMAGING, V25, P187, DOI 10.1007/s002619910042
   Gruen DR, 1997, AM J ROENTGENOL, V168, P725, DOI 10.2214/ajr.168.3.9057523
   Hierholzer J, 2001, ROFO-FORTSCHR RONTG, V173, P769, DOI 10.1055/s-2001-16408
   Khosravi MR, 2004, AM SURGEON, V70, P967
   Knostman KAB, 2003, VET PATHOL, V40, P708, DOI 10.1354/vp.40-6-708
   Kondo M, 2004, J GASTROENTEROL, V39, P1013, DOI 10.1007/s00535-004-1439-1
   LAU JTK, 1982, AUST NZ J SURG, V52, P210, DOI 10.1111/j.1445-2197.1982.tb06104.x
   Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703
   Nakata Yasuhiro, 2003, Nihon Igaku Hoshasen Gakkai Zasshi, V63, P111
   Pekkafali Z, 2002, EUR RADIOL, V12, pS62, DOI 10.1007/s00330-002-1561-5
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Stovall T G, 1988, Obstet Gynecol Surv, V43, P69
   Wynne Hilary, 2005, J Br Menopause Soc, V11, P51, DOI 10.1258/136218005775544589
   YOSHIMITSU K, 1993, ABDOM IMAGING, V18, P156
   Zhao Ming, 2004, Chin J Traumatol, V7, P62
NR 18
TC 44
Z9 47
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2006
VL 67
IS 6
BP 1330
EP 1332
DI 10.1016/j.mehy.2006.04.064
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 112XL
UT WOS:000242561200013
PM 16860491
DA 2024-02-19
ER

PT J
AU Sun, LY
   Zhao, Q
   Xiao, Y
   Liu, X
   Li, YM
   Zhang, JJ
   Pan, JH
   Zhang, ZS
AF Sun, Liyang
   Zhao, Qi
   Xiao, Yao
   Liu, Xuan
   Li, Yumeng
   Zhang, Jingjing
   Pan, Jiahui
   Zhang, Zesheng
TI Trehalose targets Nrf2 signal to alleviate d-galactose induced aging and
   improve behavioral ability
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Trehalose; Nrf2; D-galactose; Antioxidant stress; Cognitive impairment;
   Inflammation
ID OXIDATIVE STRESS; ANTIOXIDANT; ACID; AUTOPHAGY; INJURY; DAMAGE; MICE
AB As an important factor leading to aging and chronic diseases, oxidative stress has become a hot research topic. Trehalose is a natural sugar widely found in many edible plants, animals and natural microorganisms, and recent studies have suggested that trehalose is an antioxidant, although its underlying molecular mechanism is unclear. Therefore, we evaluated the protective mechanism of trehalose against oxidative stress-induced senescence. In the mouse model of d-galactose (D-gal) induced aging, we found that trehalose significantly reversed the learning and memory impairment caused by D-gal and improved the ability to explore unknown things, which was associated with a significant reduction in brain tissue damage. Further studies have shown that trehalose activates the expressions of downstream target genes HO-1, NQO1, SOD, GSH and CAT by promoting the nuclear translocation of Nrf2 in the liver. The detoxification ability of organs is increased, antioxidant enzyme activity is enhanced, lipid peroxidation is reduced, and the secretion of inflammatory factors TNF-alpha, IL-1 beta, it-6 is decreased. In conclusion, trehalose play an anti-aging role by activating genes related to Nrf2 pathway. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Sun, Liyang; Zhao, Qi; Xiao, Yao; Liu, Xuan; Li, Yumeng; Zhang, Jingjing; Pan, Jiahui; Zhang, Zesheng] Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Coll Food Sci & Engn, Tianjin 300457, Peoples R China.
C3 Tianjin University Science & Technology
RP Zhang, ZS (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety, Coll Food Sci & Engn, Tianjin 300457, Peoples R China.
EM zhangzesheng@tust.edu.cn
RI Zhang, zs/GXN-3521-2022; Liu, Shao/JFK-0166-2023; li,
   yifei/IWU-7824-2023; Wang, yl/JNR-4963-2023; Zhang, Jing/ISA-6627-2023;
   zhang, zhi/HPH-4905-2023; ZHANG, XIAOLONG/IZQ-4553-2023
OI Zhang, Jing/0009-0003-5039-5688; 
CR Amaral JH, 2019, FREE RADICAL BIO MED, V141, P261, DOI 10.1016/j.freeradbiomed.2019.06.028
   Anwar-Mohamed A, 2011, TOXICOL IN VITRO, V25, P785, DOI 10.1016/j.tiv.2011.01.014
   Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619
   Cacciatore I, 2018, NEUROPEPTIDES, V71, P11, DOI 10.1016/j.npep.2018.06.002
   Cheng JB, 2016, J THERM BIOL, V60, P103, DOI 10.1016/j.jtherbio.2016.06.011
   DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472
   Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500
   He HJ, 2012, WORLD J DIABETES, V3, P94, DOI 10.4239/wjd.v3.i5.94
   Krzysztoforska K, 2019, BEHAV BRAIN RES, V368, P16, DOI 10.1016/j.bbr.2019.04.010
   Kurzatkowski DM, 2013, ENVIRON TOXICOL PHAR, V36, P427, DOI 10.1016/j.etap.2013.04.016
   Li MQ, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110758
   Lian YG, 2017, BIOMED PHARMACOTHER, V93, P1175, DOI 10.1016/j.biopha.2017.05.148
   Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Nie XB, 2019, BIOL CONTROL, V132, P23, DOI 10.1016/j.biocontrol.2019.01.015
   Pagliassotti MJ, 2017, J NUTR BIOCHEM, V45, P15, DOI 10.1016/j.jnutbio.2017.02.022
   Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Singh S, 2019, BIOCHEM CELL BIOL, V97, P480, DOI 10.1139/bcb-2018-0159
   Tian Y, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103464
   Tripathi R, 2007, FOOD CHEM, V100, P81, DOI 10.1016/j.foodchem.2005.09.012
   Wang XH, 2019, PHARMACOL REP, V71, P929, DOI 10.1016/j.pharep.2019.05.004
   Zhao L, 2019, J FUNCT FOODS, V52, P587, DOI 10.1016/j.jff.2018.11.044
   Zheng GQ, 2016, J FUNCT FOODS, V27, P310, DOI 10.1016/j.jff.2016.09.015
NR 24
TC 37
Z9 38
U1 3
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 1
PY 2020
VL 521
IS 1
BP 113
EP 119
DI 10.1016/j.bbrc.2019.10.088
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA KB3PP
UT WOS:000506412100018
PM 31630800
DA 2024-02-19
ER

PT J
AU Lampignano, L
   Tatoli, R
   Donghia, R
   Bortone, I
   Castellana, F
   Zupo, R
   Lozupone, M
   Panza, F
   Conte, C
   Sardone, R
AF Lampignano, Luisa
   Tatoli, Rossella
   Donghia, Rossella
   Bortone, Ilaria
   Castellana, Fabio
   Zupo, Roberta
   Lozupone, Madia
   Panza, Francesco
   Conte, Caterina
   Sardone, Rodolfo
TI Nutritional patterns as machine learning predictors of liver health in a
   population of elderly subjects
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Liver; Dietary pattern; Study population; NAFLD; Aging
ID NONALCOHOLIC FATTY LIVER; DIETARY FRUCTOSE; LIPID-ACCUMULATION;
   BODY-COMPOSITION; FIBROSIS; DISEASE; SUCROSE; STEATOHEPATITIS;
   METABOLISM; MORTALITY
AB Background and aims: Non-alcoholic hepatic steatosis affects 25% of adults worldwide and its prevalence increases with age. There is currently no definitive treatment for NAFLD but in-ternational guidelines recommend a lifestyle-based approach, including a healthy diet. The aim of this study was to investigate the interactions between eating habits and the risk of steatosis and/or hepatic fibrosis, using a machine learning approach, in a non-institutionalized elderly population.Methods and results: We recruited 1929 subjects, mean age 74 years, from the population-based Sa -lus in Apulia Study. Dietary habits and the risk of steatosis and hepatic fibrosis were evaluated with a validated food frequency questionnaire, the Fatty Liver Index (FLI) and the FIB-4 score, respectively. Two dietary patterns associated with the risk of steatosis and hepatic fibrosis have been identified. They are both similar to a "western" diet, defined by a greater consumption of refined foods, with a rich content of sugars and saturated fats, and alcoholic and non-alcoholic calorie drinks.Conclusion: This study further supports the concept of dietas a factor that significantly influences the development of the most widespread liver diseases. However, longitudinal studies are needed to bet -ter understand the causal effect of the consumption of particular foods on fat accumulation in the liver.(c) 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II Univer-sity. Published by Elsevier B.V. All rights reserved.
C1 [Lampignano, Luisa; Castellana, Fabio] ASL Bari, Local Healthcare Author Bari, Bari, Italy.
   [Tatoli, Rossella; Donghia, Rossella] Res Hosp, Natl Inst Gastroenterol IRCCS Saverio Bellis, Castellana Grotte, Italy.
   [Bortone, Ilaria; Lozupone, Madia] Univ Bari Aldo Moro, Dept Translat Biomed & Neurosci DiBraiN, Bari, Italy.
   [Zupo, Roberta] Univ Aldo Moro, Dept Interdisciplinary Med, Bari, Italy.
   [Panza, Francesco] Univ Bari Aldo Moro, Cesare Frugoni Internal & Geriatr Med & Memory Uni, Bari, Italy.
   [Conte, Caterina] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy.
   [Conte, Caterina] IRCCS MultiMed, Dept Endocrinol Nutr & Metab Dis, Milan, Italy.
   [Sardone, Rodolfo] Local Hlth Author Taranto, Unit Stat & Epidemiol, Taranto, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Multimedica
RP Lampignano, L (corresponding author), ASL Bari, Local Healthcare Author Bari, Bari, Italy.
EM luisa.lampignano@planet-npo.eu
RI Sardone, Rodolfo/AAM-2727-2020
OI Sardone, Rodolfo/0000-0003-1383-1850; Donghia,
   Rossella/0000-0002-9140-673X; Zupo, Roberta/0000-0001-9885-1185; Tatoli,
   Rossella/0000-0002-7891-6057; Conte, Caterina/0000-0001-7066-5292;
   Lampignano, Luisa/0000-0001-9299-3211
FU Italian Ministry of Health - Apulia Government; Italian Ministry of
   Health with the "Ricerca Corrente 2022" Grant; Apulia Government;
   Italian Ministry of Health, under the Studies on Aging Network, at
   Italian Research Hospitals (IRCCS)
FX This study was funded by the Italian Ministry of Health with the
   "Ricerca Corrente 2022" Grant. The Salus in Apulia Study was funded by
   Apulia Government and Italian Ministry of Health, under the Studies on
   Aging Network, at Italian Research Hospitals (IRCCS) .
CR Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741
   Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535
   Abenavoli L, 2019, EXPERT REV GASTROENT, V13, P739, DOI 10.1080/17474124.2019.1634544
   Alami F, 2022, SCAND J GASTROENTERO, V57, P1238, DOI 10.1080/00365521.2022.2071109
   ALNAGDY S, 1970, NUTR METAB, V12, P193
   Alqahtani SA, 2021, CLIN INTERV AGING, V16, P1633, DOI 10.2147/CIA.S295524
   Anderson AL, 2011, J AM DIET ASSOC, V111, P84, DOI 10.1016/j.jada.2010.10.012
   Aoun C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218541
   Archer E, 2018, PROG CARDIOVASC DIS, V61, P89, DOI 10.1016/j.pcad.2018.06.002
   Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   Castellana F, 2021, J AM MED DIR ASSOC, V22, P598, DOI 10.1016/j.jamda.2020.12.026
   Castellana F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103097
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Donghia R, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1066749
   Fantin F, 2007, J GERONTOL A-BIOL, V62, P1375, DOI 10.1093/gerona/62.12.1375
   Gutiérrez-Salmeán G, 2016, INT J CARDIOL, V223, P500, DOI 10.1016/j.ijcard.2016.08.158
   Zadeh SH, 2021, J GASTROEN HEPATOL, V36, P1470, DOI 10.1111/jgh.15363
   Higashiura Yukimura, 2022, Eur Heart J Open, V2, poeac030, DOI 10.1093/ehjopen/oeac030
   Hu QH, 2012, BIOCHEM PHARMACOL, V84, P113, DOI 10.1016/j.bcp.2012.03.005
   Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622
   Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019
   Johnson RJ, 2013, J EQUINE VET SCI, V33, P120, DOI 10.1016/j.jevs.2012.05.004
   LAUBE H, 1973, NUTR METAB, V15, P273
   Loomba R, 2020, ALIMENT PHARM THER, V51, P1149, DOI 10.1111/apt.15679
   Lotfi A, 2019, CLIN NUTR ESPEN, V34, P45, DOI 10.1016/j.clnesp.2019.09.004
   MACDONALD I, 1966, AM J CLIN NUTR, V18, P369
   Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533
   McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006
   Oliveira CP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4597246
   Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Raza S, 2021, FRONT BIOSCI-LANDMRK, V26, P206, DOI 10.2741/4892
   Saab KR, 2015, J AM SOC NEPHROL, V26, P247, DOI 10.1681/ASN.2014040393
   Sánchez-Lozada LG, 2010, EUR J NUTR, V49, P1, DOI 10.1007/s00394-009-0042-x
   Sardone R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020426
   Schonmann Y, 2021, DIGEST LIVER DIS, V53, P79, DOI 10.1016/j.dld.2020.10.014
   Schwarz JM, 2017, GASTROENTEROLOGY, V153, P743, DOI 10.1053/j.gastro.2017.05.043
   Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   So-Armah KA, 2020, PROG CARDIOVASC DIS, V63, P184, DOI 10.1016/j.pcad.2020.02.010
   Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Targher G, 2020, GUT, V69, P1691, DOI 10.1136/gutjnl-2020-320622
   Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452
   Vasdev S, 2002, MOL CELL BIOCHEM, V241, P107, DOI 10.1023/A:1020835229591
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yracheta JM, 2015, MAYO CLIN PROC, V90, P813, DOI 10.1016/j.mayocp.2015.03.018
   Zupo R, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9111617
NR 53
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD NOV
PY 2023
VL 33
IS 11
BP 2233
EP 2241
DI 10.1016/j.numecd.2023.07.009
EA OCT 2023
PG 9
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA Y3MM0
UT WOS:001104342700001
PM 37541928
DA 2024-02-19
ER

PT J
AU Gravina, S
   Dollé, MET
   Wang, T
   van Steeg, H
   Hasty, P
   Hoeijmakers, J
   Vijg, J
AF Gravina, Silvia
   Dolle, Martijn E. T.
   Wang, Tao
   van Steeg, Harry
   Hasty, Paul
   Hoeijmakers, Jan
   Vijg, Jan
TI High Preservation of CpG Cytosine Methylation Patterns at Imprinted Gene
   Loci in Liver and Brain of Aged Mice
SO PLOS ONE
LA English
DT Article
ID DNA-METHYLATION; MASS-SPECTROMETRY; PRENATAL EXPOSURE; MOUSE; GENOME;
   REPAIR; SENESCENCE; EXPRESSION; TWINS
AB A gradual loss of the correct patterning of 5-methyl cytosine marks in gene promoter regions has been implicated in aging and age-related diseases, most notably cancer. While a number of studies have examined DNA methylation in aging, there is no consensus on the magnitude of the effects, particularly at imprinted loci. Imprinted genes are likely candidate to undergo age-related changes because of their demonstrated plasticity in utero, for example, in response to environmental cues. Here we quantitatively analyzed a total of 100 individual CpG sites in promoter regions of 11 imprinted and non-imprinted genes in liver and cerebral cortex of young and old mice using mass spectrometry. The results indicate a remarkably high preservation of methylation marks during the aging process in both organs. To test if increased genotoxic stress associated with premature aging would destabilize DNA methylation we analyzed two DNA repair defective mouse models showing a host of premature aging symptoms in liver and brain. However, also in these animals, at the end of their life span, we found a similarly high preservation of DNA methylation marks. We conclude that patterns of DNA methylation in gene promoters of imprinted genes are surprisingly stable over time in normal, postmitotic tissues and that the multiple documented changes with age are likely to involve exceptions to this pattern, possibly associated with specific cellular responses to age-related changes other than genotoxic stress.
C1 [Gravina, Silvia; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, New York, NY USA.
   [Dolle, Martijn E. T.; van Steeg, Harry] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.
   [Wang, Tao] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA.
   [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.
   [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78229 USA.
   [Hoeijmakers, Jan] Erasmus MC, CBG Canc Genom Ctr, MGC Dept Genet, Rotterdam, Netherlands.
C3 Yeshiva University; Netherlands National Institute for Public Health &
   the Environment; Yeshiva University; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   Erasmus University Rotterdam; Erasmus MC
RP Gravina, S (corresponding author), Albert Einstein Coll Med, Dept Genet, New York, NY USA.
EM silvia.gravina@einstein.yu.edu; jan.vijg@einstein.yu.edu
RI Hoeijmakers, Jan/AAX-6972-2021
OI Hasty, Paul/0000-0003-3046-0131
FU National Institutes of Health [AG 17242]; ERC
FX This research was supported by National Institutes of Health grant AG
   17242. JHJH was also supported by an ERC advanced grant DamAge. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876
   Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662
   Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110
   Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Gravina S, 2010, PFLUG ARCH EUR J PHY, V459, P247, DOI 10.1007/s00424-009-0730-7
   Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105
   KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3
   Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085
   Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100
   Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102
   Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   Pogribny IP, 2012, CANC LETT
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Salpea P, 2012, NUCLEIC ACIDS RES, V40, P6477, DOI 10.1093/nar/gks312
   Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895
   SLAGBOOM PE, 1992, ANN NY ACAD SCI, V673, P58, DOI 10.1111/j.1749-6632.1992.tb27437.x
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845
   Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003
   Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389
NR 30
TC 4
Z9 4
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2013
VL 8
IS 9
AR e73496
DI 10.1371/journal.pone.0073496
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 244QV
UT WOS:000326405300082
PM 24039963
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Alexandrov, IM
   Ivshina, M
   Jung, DY
   Friedline, R
   Ko, HJ
   Xu, M
   O'Sullivan-Murphy, B
   Bortell, R
   Huang, YT
   Urano, F
   Kim, JK
   Richter, JD
AF Alexandrov, Ilya M.
   Ivshina, Maria
   Jung, Dae Young
   Friedline, Randall
   Ko, Hwi Jin
   Xu, Mei
   O'Sullivan-Murphy, Bryan
   Bortell, Rita
   Huang, Yen-Tsung
   Urano, Fumihiko
   Kim, Jason K.
   Richter, Joel D.
TI Cytoplasmic Polyadenylation Element Binding Protein Deficiency
   Stimulates PTEN and Stat3 mRNA Translation and Induces Hepatic Insulin
   Resistance
SO PLOS GENETICS
LA English
DT Article
ID LARGE GENE LISTS; CELLULAR SENESCENCE; CPEB; PHOSPHORYLATION;
   MECHANISMS; MATURATION; PATHWAY; MUSCLE; MICE
AB The cytoplasmic polyadenylation element binding protein CPEB1 (CPEB) regulates germ cell development, synaptic plasticity, and cellular senescence. A microarray analysis of mRNAs regulated by CPEB unexpectedly showed that several encoded proteins are involved in insulin signaling. An investigation of Cpeb1 knockout mice revealed that the expression of two particular negative regulators of insulin action, PTEN and Stat3, were aberrantly increased. Insulin signaling to Akt was attenuated in livers of CPEB-deficient mice, suggesting that they might be defective in regulating glucose homeostasis. Indeed, when the Cpeb1 knockout mice were fed a high-fat diet, their livers became insulin-resistant. Analysis of HepG2 cells, a human liver cell line, depleted of CPEB demonstrated that this protein directly regulates the translation of PTEN and Stat3 mRNAs. Our results show that CPEB regulated translation is a key process involved in insulin signaling.
C1 [Alexandrov, Ilya M.; Ivshina, Maria; Jung, Dae Young; Friedline, Randall; Ko, Hwi Jin; O'Sullivan-Murphy, Bryan; Bortell, Rita; Urano, Fumihiko; Kim, Jason K.; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.
   [Xu, Mei] Univ Massachusetts, Sch Med, Informat Serv Dept, Worcester, MA USA.
   [O'Sullivan-Murphy, Bryan; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA.
   [Huang, Yen-Tsung] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA.
   [Huang, Yen-Tsung] Harvard Univ, Dept Biostat, Boston, MA 02115 USA.
   [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Worcester, MA USA.
C3 University of Massachusetts System; University of Massachusetts
   Worcester; University of Massachusetts System; University of
   Massachusetts Worcester; University of Massachusetts System; University
   of Massachusetts Worcester; Harvard University; Harvard University;
   University of Massachusetts System; University of Massachusetts
   Worcester
RP Alexandrov, IM (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.
EM joel.richter@umassmed.edu
RI Huang, Yen-Tsung/AAQ-3919-2021; Urano, Fumihiko/AAF-4492-2020; Huang,
   Yen-Tsung/I-1003-2014
OI Huang, Yen-Tsung/0000-0001-7657-0040; Kim, Jason/0000-0002-7185-042X;
   Ivshina, Maria/0000-0002-0999-3470; O'Sullivan-Murphy,
   Bryan/0000-0002-1426-5013
FU Institutional Postdoctoral Training Grant [2 T32 HD007439, 2 T32
   HD007312]; Diabetes Endocrinology Research Center [DK32520]; NIH
   [AG30323, HD37267, DK80756]
FX IMA was supported by Institutional Postdoctoral Training Grant 2 T32
   HD007439, and MI was supported by the Diabetes Endocrinology Research
   Center (DK32520) and an Institutional Postdoctoral Training Grant 2 T32
   HD007312. This work was supported by grants from the NIH (AG30323 and
   HD37267 to JDR and DK80756 to JKK). Additional core support for the
   UMass Mouse Phenotyping Center from the Diabetes Endocrinology Research
   Center (DK32520) is gratefully acknowledged. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704
   Anderson P, NAT REV IMMUNOL, V10, P24
   Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029
   Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864
   Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908
   Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808
   Fève B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62
   Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5
   Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906
   HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9
   Herranz H, GENES DEV, V24, P1339
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060
   Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200
   LICATALOSI DD, NAT REV GENET, V11, P75
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   LIU N, DEV CELL, V18, P510
   Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a
   Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833
   Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040
   Morris AR, WILEY INTERDISCIP RE, V2, P162
   Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173
   PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697
   Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004
   Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9
   Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004
   Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002
   WHITE MF, 1994, J BIOL CHEM, V269, P1
   Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3
NR 32
TC 46
Z9 49
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD JAN
PY 2012
VL 8
IS 1
AR e1002457
DI 10.1371/journal.pgen.1002457
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 891NH
UT WOS:000300223400023
PM 22253608
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Okada, N
   Oshima, K
   Iwasaki, Y
   Maruko, A
   Matsumura, K
   Iioka, E
   Vu, TD
   Fujitsuka, N
   Nishi, A
   Sugiyama, A
   Nishiyama, M
   Kaneko, A
   Mizoguchi, K
   Yamamoto, M
   Nishimura, S
AF Okada, Norihiro
   Oshima, Kenshiro
   Iwasaki, Yuki
   Maruko, Akiko
   Matsumura, Kenya
   Iioka, Erica
   Vu, Trieu-Duc
   Fujitsuka, Naoki
   Nishi, Akinori
   Sugiyama, Aiko
   Nishiyama, Mitsue
   Kaneko, Atsushi
   Mizoguchi, Kazushige
   Yamamoto, Masahiro
   Nishimura, Susumu
TI Intron retention as a new pre-symptomatic marker of aging and its
   recovery to the normal state by a traditional Japanese multi-herbal
   medicine
SO GENE
LA English
DT Article; Early Access
DE RNA-seq; Kampo; Premature aging; Alternative splicing; Intron retention
ID JUZEN-TAIHO-TO; GENE-EXPRESSION; RNA; MACROPHAGE; TRANSCRIPTION;
   INTEGRATORS; METABOLISM; SENESCENCE; PROGRAM; KLOTHO
AB Intron retention (IR) is an important regulatory mechanism that affects gene expression and protein functions. Using klotho mice at the pre-symptomatic state, we discovered that retained-introns accumulated in several organs including the liver and that among these retained introns in the liver a subset was recovered to the normal state by a Japanese traditional herbal medicine. This is the first report of IR recovery by a medicine. IR-recovered genes fell into two categories: those involved in liver-specific metabolism and in splicing. Metabolome analysis of the liver showed that the klotho mice were under starvation stress. In addition, our differentially expressed gene analysis showed that liver metabolism was actually recovered by the herbal medicine at the transcriptional level. By analogy with the widespread accumulation of intron-retained pre-mRNAs induced by heat shock stress, we propose a model in which retained-introns in klotho mice were induced by an aging stress and in which this medicine-related IR recovery is indicative of the actual recovery of liver-specific metabolic function to the healthy state. Accumulation of retained-introns was also observed at the pre-symptomatic state of aging in wildtype mice and may be an excellent marker for this state in general.
   Abbreviations: 3-HBA, 3-hydroxybutyric acid; Acadm, Acyl-Coenzyme A dehydrogenase; Anxa11, Annexin A11 protein; AS, Alternative splicing; CE-2, Normal diet for rodent; CE-MS, Capillary electrophoresis mass spectrometry; CE-TOFMS, Capillary electrophoresis time-of-flight mass spectrometry; Cten, cell type enrichment (analysis); Cyp27a1, Cytochrome P450 family 27 subfamily A member 1; DDX5, DEAD box protein 5; DecIR, Decreased intron retention; Decr2, Peroxisomal 2,4
C1 [Okada, Norihiro; Oshima, Kenshiro; Maruko, Akiko; Matsumura, Kenya; Vu, Trieu-Duc] Kitasato Univ, Sch Pharm, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.
   [Okada, Norihiro; Oshima, Kenshiro; Iwasaki, Yuki; Maruko, Akiko; Iioka, Erica; Vu, Trieu-Duc; Nishimura, Susumu] Fdn Adv Int Sci, 3-24-16 Kasuga, Tsukuba, Ibaraki 3050821, Japan.
   [Okada, Norihiro; Iwasaki, Yuki] Nagahama Inst Biosci & Technol, Nagahama, Japan.
   [Fujitsuka, Naoki; Nishi, Akinori; Sugiyama, Aiko; Nishiyama, Mitsue; Kaneko, Atsushi; Mizoguchi, Kazushige; Yamamoto, Masahiro] Tsumura & CO, Tsumura Kampo Res Labs, 3586 Yoshiwara, Ami, Ibaraki 3001192, Japan.
   [Nishimura, Susumu] Univ Tsukuba, Lab Anim Resource Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
C3 Kitasato University; Tsumura & Company; University of Tsukuba
RP Okada, N (corresponding author), Kitasato Univ, Sch Pharm, Sagamihara, Kanagawa, Japan.
EM okadano@pharm.kitasato-u.ac.jp
RI Nishiyama, Mitsue/ABQ-1118-2022
OI Nishiyama, Mitsue/0000-0002-3878-1290; Vu, Trieu
   Duc/0000-0001-6770-6727; Fujitsuka, Naoki/0000-0003-0856-5850; Okada,
   Norihiro/0000-0002-3655-8060
FU Foundation for Advancement of International Science; Zenick Co.
FX The present work was financially supported by the Foundation for
   Advancement of International Science and Zenick Co. represented by Mr.
   Y. Otake and Mr. T. Sugino, respectively. We thank Mr. K. Onodera for
   management and discussions and Ms. A. Koizumi for making the
   illustrations.
CR Adusumalli S, 2019, AGING CELL, V18, DOI 10.1111/acel.12928
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114
   Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114
   Deschênes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9
   Fouache A, 2019, J STEROID BIOCHEM, V190, P173, DOI 10.1016/j.jsbmb.2019.03.028
   Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9
   Fukaya S., 2018, FUNDAM TOXICOL SCI, V5, P105, DOI DOI 10.2131/FTS.5.105
   Giudice G, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw035
   Goswami C, 2019, NEUROPEPTIDES, V75, P58, DOI 10.1016/j.npep.2019.03.001
   Gunewardena SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141220
   Han H, 2017, MOL CELL, V65, P539, DOI 10.1016/j.molcel.2017.01.011
   Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Imperatore F, 2017, EMBO J, V36, P2353, DOI 10.15252/embj.201695737
   Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2
   Jacob AG, 2017, HUM GENET, V136, P1043, DOI 10.1007/s00439-017-1791-x
   Kadota Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100929
   Kaneko A, 2017, IMMUN INFLAMM DIS, V5, P265, DOI 10.1002/iid3.163
   Kataoka N, 2017, HUM GENET, V136, P1237, DOI 10.1007/s00439-017-1789-4
   Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x
   Kuro-o M, 2018, INT J NEPHROL, V2018, DOI 10.1155/2018/9679841
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002
   Liu YS, 2017, CELL REP, V20, P1229, DOI 10.1016/j.celrep.2017.07.025
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056
   Luo T, 2018, FOOD FUNCT, V9, P6258, DOI 10.1039/c8fo01718b
   Maeda T., 2019, FUND TOXICOL SCI, V6, P25, DOI [10.2131/ fts.6.25, DOI 10.2131/FTS.6.25]
   Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002
   Martin M, 2011, Embnet J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Matsumoto T, 2000, IMMUNOPHARMACOLOGY, V46, P149, DOI 10.1016/S0162-3109(99)00166-6
   MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x
   Monteuuis G, 2019, NUCLEIC ACIDS RES, V47, P11497, DOI 10.1093/nar/gkz1068
   Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2
   Naro C, 2017, DEV CELL, V41, P82, DOI 10.1016/j.devcel.2017.03.003
   Niemelä EH, 2014, NUCLEIC ACIDS RES, V42, P7358, DOI 10.1093/nar/gku391
   Ninomiya K, 2011, J CELL BIOL, V195, P27, DOI 10.1083/jcb.201107093
   Onishi Y, 1998, BIOL PHARM BULL, V21, P761, DOI 10.1248/bpb.21.761
   PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351
   Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259
   Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140
   Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168
   Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Saiki I, 2000, BIOL PHARM BULL, V23, P677, DOI 10.1248/bpb.23.677
   Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
   Shimada T, 2008, BIOL PHARM BULL, V31, P1362, DOI 10.1248/bpb.31.1362
   Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460
   Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003
   Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019
   Takeno N, 2015, INT J ONCOL, V47, P2115, DOI 10.3892/ijo.2015.3208
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Ullrich S, 2020, NUCLEIC ACIDS RES, V48, P1327, DOI 10.1093/nar/gkz1180
   UNESCO, 2011, HUANG DI NEI JING
   Vu TD, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008831
   Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002
   Wang ZX, 2018, BIOSCI TRENDS, V12, P220, DOI 10.5582/bst.2018.01144
   Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002
   Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052
   Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0
   Yamamoto M., 2021, DATA RNA SEQ TRANSCR
   Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
   Zane L, 2014, TRENDS CELL BIOL, V24, P686, DOI 10.1016/j.tcb.2014.07.001
   Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883
   Zhou X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00201
NR 75
TC 8
Z9 8
U1 1
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD 2021 AUG 20
PY 2021
VL 794
AR 145752
DI 10.1016/j.gene.2021.145752
EA JUN 2021
PG 18
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA SV3NN
UT WOS:000663729300001
PM 34082065
OA Green Submitted, hybrid
DA 2024-02-19
ER

PT S
AU Elahi, D
   Muller, DC
   Egan, JM
   Andres, R
   Veldhuis, J
   Meneilly, GS
AF Elahi, D
   Muller, DC
   Egan, JM
   Andres, R
   Veldhuis, J
   Meneilly, GS
BE Chadwick, D
TI Glucose tolerance, glucose utilization and insulin secretion in ageing
SO ENDOCRINE FACETS OF AGEING
SE Novartis Foundation Symposium
LA English
DT Article; Proceedings Paper
CT Novartis-Foundation Symposium on Endocrine Facets of Ageing
CY JAN 30-FEB 01, 2001
CL NOVARTIS FDN, LONDON, ENGLAND
HO NOVARTIS FDN
ID GLUCAGON-LIKE PEPTIDE-1(7-37); BETA-CELL; CARBOHYDRATE-METABOLISM;
   DIABETES-MELLITUS; PERIPHERAL TISSUE; BODY-FAT; AGE; RESISTANCE;
   RELEASE; POLYPEPTIDE
AB Ageing is associated with an increased incidence of hypertension, macrovascular disease and type 2 diabetes (non-insulin-dependent diabetes). It has been suggested that a common mechanism may be responsible for all of these pathological states since all of these conditions often cluster in the same individual. Epidemiological and clinical data have consistently demonstrated an association between insulin resistance and/or hyperinsulinaemia and glucose intolerance, dyslipidaemia and elevated systolic blood pressures. Therefore, insulin resistance and hyperinsulinaemia have been proposed as the causal link among the elements of the clusters. The elderly are more glucose intolerant and insulin resistant, but it remains controversial whether this decrease in function is due to an inevitable consequence of 'biological ageing' or due to environmental or lifestyle variables, noticeably increased adiposity/altered fat distribution and physical inactivity. An increase of these modifiable factors has been shown to result in increases in insulin resistance and hyperinsulinaemia and vice versa. However, insulin secretion appears to decrease with age even after adjustments for differences in adiposity, fat distribution and physical activity. The glucose intolerance of ageing may be due, in part, to decreased insulin sensitivity of pancreatic beta cells to insulinotropic gut hormones (GLP1/GIP) and in part to alterations of hepatic glucose production.
C1 Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA.
   NIA, Gerontol Res Ctr, Lab Clin Physiol, NIH, Baltimore, MD 21224 USA.
   Univ Virginia, Div Endocrinol & Metab, Charlottesville, VA 22908 USA.
   Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada.
C3 Harvard University; Harvard Medical School; Massachusetts General
   Hospital; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); University of Virginia; University of British
   Columbia
RP Muller, DC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA.
FU NIA NIH HHS [AG-00599] Funding Source: Medline
CR ANDERSEN DK, 1978, J CLIN INVEST, V62, P152, DOI 10.1172/JCI109100
   ANDRES R, 1971, MED CLIN N AM, V55, P835, DOI 10.1016/S0025-7125(16)32479-8
   [Anonymous], 1985, TECHN REP SER
   Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178
   Bennett P H, 1976, Recent Prog Horm Res, V32, P333
   BROUGHTON DL, 1991, AGE AGEING, V20, P221, DOI 10.1093/ageing/20.3.221
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   COON PJ, 1989, METABOLISM, V38, P1201, DOI 10.1016/0026-0495(89)90160-1
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   DEFRONZO RA, 1983, DIABETES, V32, P35, DOI 10.2337/diab.32.1.35
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667
   DOWSE GK, 1994, MED J AUSTRALIA, V160, P767, DOI 10.5694/j.1326-5377.1994.tb125945.x
   Egan JM, 1999, DIABETOLOGIA, V42, pA41
   ELAHI D, 1993, EXP GERONTOL, V28, P393, DOI 10.1016/0531-5565(93)90066-M
   ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8
   ELAHI D, 1984, DIABETES, V33, P950, DOI 10.2337/diabetes.33.10.950
   ELAHI D, 1979, AM J PHYSIOL, V237, pE185, DOI 10.1152/ajpendo.1979.237.2.E185
   Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032
   Elahl D, 1996, DIABETES CARE, V19, P278, DOI 10.2337/diacare.19.3.278
   ENGDAHL J, 1977, J APPL PHYSIOL, V79, P1977
   EVANS W, 2001, HDB PHYSL 7, V2, P969
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   HARRIS M, 1979, DIABETES, V28, P1039
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840
   KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514
   Loo Sonny G., 1993, Journal of Diabetes and its Complications, V7, P73, DOI 10.1016/1056-8727(93)90029-X
   MANEATIS T, 1982, J AM GERIATR SOC, V30, P178, DOI 10.1111/j.1532-5415.1982.tb01301.x
   MENEILLY G, 2001, DIABETOLOGIA, V44, pA910
   Meneilly GS, 1997, J CLIN ENDOCR METAB, V82, P4088, DOI 10.1210/jc.82.12.4088
   Meneilly GS, 1998, J CLIN ENDOCR METAB, V83, P2925, DOI 10.1210/jc.83.8.2925
   MENEILLY GS, 1987, J GERONTOL, V42, P196, DOI 10.1093/geronj/42.2.196
   Meneilly GS, 1999, J CLIN ENDOCR METAB, V84, P1938, DOI 10.1210/jc.84.6.1938
   Meneilly GS, 2001, DIABETES CARE, V24, P964, DOI 10.2337/diacare.24.5.964
   MENEILLY GS, 2001, IN PRESS DIABETES CA
   MOJSOV S, 1986, J BIOL CHEM, V261, P1880
   Natali A, 2000, DIABETOLOGIA, V43, P1266, DOI 10.1007/s001250051522
   NATHAN DM, 1992, DIABETES CARE, V15, P270, DOI 10.2337/diacare.15.2.270
   Organization WH, 1999, DEF DIAGN CLASS DI 1
   PACINI G, 1988, J AM GERIATR SOC, V36, P317, DOI 10.1111/j.1532-5415.1988.tb02358.x
   PAOLISSO G, 1996, AM J PHYSIOL, V33, pE890
   PERLEY MJ, 1967, J CLIN INVEST, V46, P1954, DOI 10.1172/JCI105685
   PIMENTA W, 1995, JAMA-J AM MED ASSOC, V273, P1855, DOI 10.1001/jama.273.23.1855
   PORKSEN N, 1995, AM J PHYSIOL-ENDOC M, V269, pE478, DOI 10.1152/ajpendo.1995.269.3.E478
   REAVEN GM, 1989, J AM GERIATR SOC, V37, P735, DOI 10.1111/j.1532-5415.1989.tb02235.x
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   RIZZA RA, 1981, AM J PHYSIOL, V240, pE630, DOI 10.1152/ajpendo.1981.240.6.E630
   ROSENTHAL M, 1985, J CHRON DIS, V38, P5, DOI 10.1016/0021-9681(85)90003-7
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Ryan AS, 1998, J CLIN ENDOCR METAB, V83, P2399, DOI 10.1210/jc.83.7.2399
   Ryan AS, 1996, J CLIN ENDOCR METAB, V81, P4433, DOI 10.1210/jc.81.12.4433
   Ryan AS, 2001, J APPL PHYSIOL, V91, P872, DOI 10.1152/jappl.2001.91.2.872
   SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44
   STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631
   WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338
   Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111
   ZAVARONI I, 1986, J AM GERIATR SOC, V34, P271, DOI 10.1111/j.1532-5415.1986.tb04223.x
   ZIMMET P, 1978, DIABETES, V27, P793, DOI 10.2337/diabetes.27.8.793
NR 64
TC 37
Z9 40
U1 0
U2 8
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, WEST SUSSEX, ENGLAND
SN 1528-2511
BN 0-471-48636-1
J9 NOVART FDN SYMP
JI Novartis Found. Symp.
PY 2002
VL 242
BP 222
EP 242
PG 21
WC Endocrinology & Metabolism; Geriatrics & Gerontology; Medicine, General
   & Internal
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Geriatrics & Gerontology; General & Internal
   Medicine
GA BU35C
UT WOS:000175745900013
PM 11855690
DA 2024-02-19
ER

PT J
AU CUTLER, RG
AF CUTLER, RG
TI ANTIOXIDANTS AND AGING
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Proceedings Paper
CT CONF ON ANTIOXIDANT VITAMINS AND BETA-CAROTENE IN DISEASE PREVENTION
CY OCT 02-04, 1989
CL LONDON, ENGLAND
DE AGING; ANTIOXIDANTS; LIFE SPAN; CAROTENOIDS; RETINOIDS; URIC ACID; FREE
   RADICALS
ID MOUSE STRAIN; LIFE-SPAN; LONGEVITY; AGE; EVOLUTION; COMPLEXITY;
   EXPRESSION; BRAIN; LIVER; MICE
AB Aging in mammalian species appears to be the result of normal developmental and metabolic processes.  In spite of the vast complexity of aging processes, relatively less complex processes such as longevity determinant genes (LDGs) may exist governing aging rate.  Much experimental data exists indicating a causative role of oxyradicals in aging processes.  In testing the hypothesis that antioxidants may represent LDGs, a positive correlation in the tissue concentration of specific antioxidants with life span of mammals was found.  These antioxidants include superoxide dismutase, carotenoids, alpha-tocopherol, and uric acid.  We also found that the resistance of tissues to spontaneous autoxidation and the amount of oxidative damage to DNA correlates inversely with life span of mammals.  These results suggest a role of oxyradicals in causing aging and that the antioxidant status of an individual could be important in determining frequency of age-dependent diseases and duration of general health maintenance.
RP CUTLER, RG (corresponding author), NIA,GERONTOL RES CTR,4940 EASTERN AVE,BALTIMORE,MD 21224, USA.
CR Altman PL, 1961, BLOOD OTHER BODY FLU, P89
   BERGTOLD DS, 1988, OXYGEN RADICALS BIOL, P483
   BERNIRSCHKE K, 1978, PATHOLOGY LABORATORY
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   CUTLER R G, 1978, P311
   CUTLER RG, 1975, P NATL ACAD SCI USA, V72, P4664, DOI 10.1073/pnas.72.11.4664
   CUTLER RG, 1976, J HUM EVOL, V5, P169, DOI 10.1016/0047-2484(76)90020-8
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   CUTLER RG, 1984, P NATL ACAD SCI-BIOL, V81, P7627, DOI 10.1073/pnas.81.23.7627
   CUTLER RG, 1979, GERONTOLOGY, V25, P69, DOI 10.1159/000212324
   Cutler RG, 1986, PHYSL OXYGEN RADICAL, P251
   CUTLER RG, 1985, MOL BIOL AGING, P15, DOI DOI 10.2307/2499207
   CUTLER RG, 1976, INTDSCPL TOPICS GERO, V9, P83
   CUTLER RG, 1985, MOL BIOL AGING GENE, P307
   CUTLER RG, 1972, ADV GERONTOL RES, V4, P219
   CUTLER RG, 1985, PRINCIPLES GERIATRIC, P22
   Cutler RG., 1982, TESTING THEORIES AGI
   CUTLER RG, 1982, AGING-US, V20, P1
   CUTLER RG, 1984, AGING CELL STRUCTURE, V2, P371
   CUTLER RG, 1985, ARCH GERONTOL GERIAT, V3, P321
   FLORINE DL, 1980, CANCER RES, V40, P519
   ONO T, 1985, GERONTOLOGY, V31, P362, DOI 10.1159/000212725
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   SEMSEI I, 1989, ONCOGENE, V4, P465
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   WILSON AC, 1976, MOL EVOLUTION, P225
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
NR 27
TC 221
Z9 242
U1 1
U2 27
PU AMER SOC CLIN NUTRITION INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998
SN 0002-9165
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD JAN
PY 1991
VL 53
IS 1
SU S
BP S373
EP S379
DI 10.1093/ajcn/53.1.373S
PG 7
WC Nutrition & Dietetics
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ER128
UT WOS:A1991ER12800031
PM 1985414
OA Bronze
DA 2024-02-19
ER

PT J
AU Rusu, ME
   Georgiu, C
   Pop, A
   Mocan, A
   Kiss, B
   Vostinaru, O
   Fizesan, I
   Stefan, MG
   Gheldiu, AM
   Mates, L
   Moldovan, R
   Muntean, DM
   Loghin, F
   Vlase, L
   Popa, DS
AF Rusu, Marius Emil
   Georgiu, Carmen
   Pop, Anca
   Mocan, Andrei
   Kiss, Bela
   Vostinaru, Oliviu
   Fizesan, Ionel
   Stefan, Maria-Georgia
   Gheldiu, Ana-Maria
   Mates, Letitia
   Moldovan, Rebeca
   Muntean, Dana Maria
   Loghin, Felicia
   Vlase, Laurian
   Popa, Daniela-Saveta
TI Antioxidant Effects of Walnut (<i>Juglans regia</i> L.) Kernel and
   Walnut Septum Extract in a D-Galactose-Induced Aging Model and in
   Naturally Aged Rats
SO ANTIOXIDANTS
LA English
DT Article
DE antiaging; by-products; oxidative stress; liver; brain; ROS; AGEs;
   malondialdehyde; acetylcholinesterase; immunohistochemistry
ID OXIDATIVE STRESS; SUBCHRONIC TOXICITY; BISPHENOL-A; BRAIN; CONSUMPTION;
   METABOLITES; COMPONENTS; PROTEIN; HEALTH; LIVER
AB Antioxidant dietary intervention is considered a potential strategy in delaying age-related dysfunctions. In this study of 56 days, we assessed the antioxidant effects of walnut kernel (WK) and walnut septum extract (WSE) in a D-galactose (D-gal)-induced aging model and in a naturally aged rat model. Young Wistar rats, treated with D-gal (1200 mg/week), and old rats received daily WK or WSE added to the feed. After 8 weeks, blood, liver, and brain samples were collected and hematological, biochemical, oxidative stress biomarkers, histological, and immunohistochemical analyses were performed. Moreover, acetylcholinesterase activity was investigated in brain homogenates. The outcomes demonstrated significant improvement in cellular antioxidant activity and/or decrease of reactive oxygen species, advanced glycation end products, nitric oxide, malondialdehyde, or increase of glutathione after WK or WSE intake in both models. Additionally, WSE showed hypoglycemic effect, and both WK and WSE lowered acetylcholinesterase activity. Both diets could protect neurons against the induced senescence and could reverse the pathological conditions in the physiological aged brain. Thus, dietary supplementation with WK or WSE can maintain the liver and brain health and reduce the risk of age-related diseases, as well as delaying the onset of aging processes.
C1 [Rusu, Marius Emil; Muntean, Dana Maria; Vlase, Laurian] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Technol & Biopharmaceut, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
   [Georgiu, Carmen] Iuliu Hatieganu Univ Med & Pharm, Dept Pathol Anat, Fac Med, 8 Victor Babes, Cluj Napoca 400012, Romania.
   [Pop, Anca; Kiss, Bela; Fizesan, Ionel; Stefan, Maria-Georgia; Mates, Letitia; Loghin, Felicia; Popa, Daniela-Saveta] Iuliu Hatieganu Univ Med & Pharm, Dept Toxicol, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
   [Mocan, Andrei; Gheldiu, Ana-Maria] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Bot, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
   [Vostinaru, Oliviu] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Physiol & Physiopathol, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
   [Moldovan, Rebeca] Iuliu Hatieganu Univ Med & Pharm, Dept Analyt Chem & Instrumental Anal, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
C3 Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu
   University of Medicine & Pharmacy; Iuliu Hatieganu University of
   Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy;
   Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu
   University of Medicine & Pharmacy
RP Vlase, L (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Technol & Biopharmaceut, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.; Pop, A (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Toxicol, Fac Pharm, 8 Victor Babes, Cluj Napoca 400012, Romania.
EM rusu.marius@umfcluj.ro; cgeorgiu@umfcluj.ro; anca.pop@umfcluj.ro;
   mocan.andrei@umfcluj.ro; kbela@umfcluj.ro; oliviu.vostinaru@umfcluj.ro;
   ionel.fizesan@umfcluj.ro; stefan.georgia@umfcluj.ro;
   gheldiu.ana@umfcluj.ro; Micu.Letitia@umfcluj.ro;
   Rebeca.Magda@umfcluj.ro; dana.muntean@umfcluj.ro; floghin@umfcluj.ro;
   laurian.vlase@umfcluj.ro; dpopa@umfcluj.ro
RI Oliviu, Vostinaru/AAO-5297-2021; Rusu, Marius Emil/E-3958-2017;
   Vostinaru, Oliviu/AFU-7619-2022; Stefan, Maria-Georgia/AAT-2884-2021;
   Kiss, Bela/C-2289-2011; Georgiu, Carmen/ABE-6716-2020; Muntean,
   Dana/AAT-6017-2020; Mocan, Andrei/AAT-8274-2021; Vostinaru,
   Oliviu/M-9004-2019; Loghin, Felicia/ABF-8808-2020; Vlase,
   Ana-Maria/F-6019-2018; Pop, Anca/ABH-6603-2020; Munteanu,
   Dana/JNR-7953-2023; Vlase, Laurian/B-6311-2011; Muntean,
   Dana/C-4220-2011
OI Rusu, Marius Emil/0000-0002-0880-9889; Vostinaru,
   Oliviu/0000-0003-4505-4005; Stefan, Maria-Georgia/0000-0001-6045-167X;
   Kiss, Bela/0000-0003-3036-5345; Vlase, Ana-Maria/0000-0003-4865-0777;
   Vlase, Laurian/0000-0002-0664-3387; (Pop) Cherfan,
   Anca/0000-0001-5375-6053; Muntean, Dana/0000-0002-3914-0110; Fizesan,
   Ionel/0000-0003-2285-128X; Mocan, Andrei/0000-0001-5848-8457; Popa,
   Daniela-Saveta/0000-0001-7449-5753; Loghin, Felicia/0000-0002-4620-2498;
   Georgiu, Carmen/0000-0001-7890-9730
CR Alasalvar C, 2015, BRIT J NUTR, V113, pS68, DOI 10.1017/S0007114514003729
   Arcan I, 2009, J FOOD COMPOS ANAL, V22, P184, DOI 10.1016/j.jfca.2008.10.016
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Banji D, 2013, BRAIN RES, V1515, P1, DOI 10.1016/j.brainres.2013.03.023
   Beigh S, 2017, BIOMED PHARMACOTHER, V94, P418, DOI 10.1016/j.biopha.2017.07.124
   Bosca AB, 2015, ROM BIOTECH LETT, V20, P10708
   Cardoso A, 2015, REJUV RES, V18, P497, DOI 10.1089/rej.2015.1684
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Choi JG, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010108
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Damiano S, 2017, FOOD CHEM, V230, P24, DOI 10.1016/j.foodchem.2017.02.141
   Dehghani F., 2012, Iranian Journal of Pharmacology and Therapeutics, V11, P10
   Feng L, 2018, MOLECULES, V23, DOI 10.3390/molecules23092308
   Fisher DR, 2017, NUTR NEUROSCI, V20, P103, DOI 10.1179/1476830514Y.0000000150
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Gheldiu AM, 2015, BIOMED ENVIRON SCI, V28, P834, DOI [10.1016/S0895-3988(15)30115-X, 10.3967/bes2015.116]
   Goldman SE, 2018, AGING CELL, V17, DOI 10.1111/acel.12818
   Gorji N, 2018, PHARMACOL RES, V129, P115, DOI 10.1016/j.phrs.2017.12.003
   Jabir NR, 2018, CNS NEUROSCI THER, V24, P753, DOI 10.1111/cns.12971
   Joseph JA, 2009, J NUTR, V139, p1813S, DOI 10.3945/jn.109.108266
   Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565
   Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123
   Koh SJ, 2019, EUR J NUTR, V58, P1603, DOI 10.1007/s00394-018-1704-3
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Maleki SJ, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125124
   Mocan A, 2018, FOOD FUNCT, V9, P160, DOI [10.1039/c7fo01514c, 10.1039/C7FO01514C]
   Mocan A, 2016, J FUNCT FOODS, V25, P94, DOI 10.1016/j.jff.2016.05.010
   Mocan A, 2016, J FUNCT FOODS, V24, P579, DOI 10.1016/j.jff.2016.05.007
   Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798
   Noritake K, 2013, J TOXICOL SCI, V38, P847
   OECD, 2008, TEST 407 REP DOS 28
   Oliveira I, 2008, FOOD CHEM TOXICOL, V46, P2326, DOI 10.1016/j.fct.2008.03.017
   Pandareesh MD, 2018, J ALZHEIMERS DIS, V64, P1295, DOI [10.3233/JAD-180361, 10.3233/jad-180361]
   Popa DS, 2014, BIOMED ENVIRON SCI, V27, P85, DOI 10.3967/bes2014.021
   Porfire AS, 2014, PHARMACOL REP, V66, P670, DOI 10.1016/j.pharep.2014.03.011
   Poulose SM, 2013, J NUTR BIOCHEM, V24, P912, DOI 10.1016/j.jnutbio.2012.06.009
   Pycia K, 2019, MOLECULES, V24, DOI 10.3390/molecules24162936
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Ramishvili L, 2016, Georgian Med News, P51
   Ravanbakhsh A, 2016, ADV PHARM BULL, V6, P541, DOI [10.15171/apb.2016.067, 10.15171/apb.2016.068]
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Rusu ME, 2020, MOLECULES, V25, DOI 10.3390/molecules25092187
   Rusu ME, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100460
   Rusu ME, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080302
   Rusu ME, 2019, TRENDS FOOD SCI TECH, V88, P104, DOI 10.1016/j.tifs.2019.03.006
   Rusu ME, 2018, MOLECULES, V23, DOI 10.3390/molecules23112814
   Rusu ME, 2018, FOOD FUNCT, V9, P2554, DOI [10.1039/c7fo01967j, 10.1039/C7FO01967J]
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Song EK, 2019, NUTR RES, V70, P60, DOI 10.1016/j.nutres.2018.09.011
   Tucker L, 2017, J NUTR HEALTH AGING, V21, P233, DOI 10.1007/s12603-017-0876-5
   Vedeanu N, 2020, ENVIRON CHEM, V17, P163, DOI 10.1071/EN19249
   Vieira V, 2017, IND CROP PROD, V107, P341, DOI 10.1016/j.indcrop.2017.06.012
   Viguiliouk E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103376
   Xia XJ, 2018, J FUNCT FOODS, V45, P355, DOI 10.1016/j.jff.2018.04.036
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Zhang X, 2019, J ETHNOPHARMACOL, V234, P44, DOI 10.1016/j.jep.2018.12.050
   Zubair H, 2017, MOLECULES, V22, DOI 10.3390/molecules22030395
NR 58
TC 43
Z9 45
U1 5
U2 41
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAY
PY 2020
VL 9
IS 5
AR 424
DI 10.3390/antiox9050424
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA LW6WJ
UT WOS:000539284200067
PM 32423149
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU MAFTAH, A
   RATINAUD, MH
   DUMAS, M
   BONTE, F
   MEYBECK, A
   JULIEN, R
AF MAFTAH, A
   RATINAUD, MH
   DUMAS, M
   BONTE, F
   MEYBECK, A
   JULIEN, R
TI HUMAN EPIDERMAL-CELLS PROGRESSIVELY LOSE THEIR CARDIOLIPINS DURING AGING
   WITHOUT CHANGE IN MITOCHONDRIAL TRANSMEMBRANE POTENTIAL
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE EPIDERMAL CELL AGING; SKIN; FLOW CYTOMETRY; NONYL ACRIDINE ORANGE;
   RHODAMINE 123
ID NONYL-ACRIDINE-ORANGE; RAT-HEART MITOCHONDRIA; DNA MUTATION;
   OXIDATIVE-PHOSPHORYLATION; INTRACELLULAR CALCIUM; HEPATIC MITOCHONDRIA;
   DEPENDENT CHANGES; LIPID-COMPOSITION; PRO-OXIDANTS; MEMBRANE
AB Mitochondria dysfunction is considered to be a major cause of the modifications that occur during cell ageing. For this reason, cardiolipin, a suitable marker of the chondriome, as well as the mitochondrial transmembrane potential were examined in keratinocytes obtained from 9- to 75-year-oId women. The study was carried out by flow cytometry using two fluorescent mitochondria probes: nonyl acridine orange, which binds specifically to cardiolipin, and rhodamine 123, which is incorporated mainly in response to transmembrane potential. Cardiolipin levels in cells from elderly donors (75 years old) would be 57% lower (r = 0.540; P = 0.0002) than those in children (9 years old), while the inner transmembrane potential remained unchanged (r = 0.0394; P = 0.8017). The stability of the membrane potential may be explained by either or both of the following hypotheses: (i) the same pool of organelles able to maintain membrane potential is conserved even when cardiolipin levels decrease (ii) mitochondria membrane potential does indeed decrease with age but is compensated by glycolysis energy production. Finally, it may be stated that the fluorescent probes nonyl acridine orange and rhodamine 123 might be of interest in testing the phenotype of senescent cells and would be useful in screening the role of certain specific genes in cell ageing.
C1 LVMH RECH,F-92752 NANTERRE,FRANCE.
RP MAFTAH, A (corresponding author), UFR SCI,INST BIOTECHNOL,123 AVE ALBERT THOMAS,F-87060 LIMOGES,FRANCE.
OI Ratinaud, Marie-Helene/0000-0003-4841-6075
CR ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   BAFFY G, 1993, J BIOL CHEM, V268, P6511
   BEREGI E, 1993, ANN GERONTOLOGIQUE, V7, P45
   BITTLES AH, 1992, MUTAT RES, V275, P217, DOI 10.1016/0921-8734(92)90025-K
   BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422
   CHEN JC, 1972, J CELL PHYSIOL, V80, P141, DOI 10.1002/jcp.1040800115
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CLANDININ MT, 1983, MECH AGEING DEV, V22, P205, DOI 10.1016/0047-6374(83)90076-3
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DUMAS M, 1990, 16TH IFSCC C NEW YOR, V2, P153
   DUMAS M, 1990, SKIN AGEING CAUSES P, P37
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   FRESHNEY RI, 1983, CULTURE ANIMAL CELLS, P99
   GILCHREST BA, 1994, ARCH DERMATOL, V130, P82, DOI 10.1001/archderm.130.1.82
   GOLSTEIN S, 1981, J CELL BIOL, V91, P392
   GREKSAK M, 1977, FOLIA MICROBIOL, V22, P30, DOI 10.1007/BF02876990
   GROSSMAN LI, 1990, AM J HUM GENET, V46, P415
   HANSFORD RG, 1982, MECH AGEING DEV, V19, P5, DOI 10.1016/0047-6374(82)90044-6
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HENNINGS H, 1981, BIOCHEM BIOPH RES CO, V102, P739, DOI 10.1016/S0006-291X(81)80194-5
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608
   LEMESHKO VV, 1982, BIOCHEMISTRY-MOSCOW+, V47, P465
   LEPRAT P, 1990, EXP CELL RES, V186, P130, DOI 10.1016/0014-4827(90)90219-Z
   LEPRAT P, 1990, MECH AGEING DEV, V52, P149, DOI 10.1016/0047-6374(90)90121-U
   LEWIN MB, 1984, MECH AGEING DEV, V24, P343, DOI 10.1016/0047-6374(84)90119-2
   LINNANE AW, 1992, MUTAT RES, V275, P195, DOI 10.1016/0921-8734(92)90023-I
   MAFTAH A, 1990, FEBS LETT, V260, P236, DOI 10.1016/0014-5793(90)80112-V
   MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2
   MAFTAH A, 1990, INT J COSMETIC SCI, V12, P253, DOI 10.1111/j.1467-2494.1990.tb00540.x
   MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4
   MARTINEZ AO, 1986, EXP CELL RES, V39, P551
   MARTINEZSERRANO A, 1992, J BIOL CHEM, V267, P4672
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MILSTONE LM, 1987, EPITHELIA, V1, P129
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   NOHL H, 1982, GERONTOLOGY, V28, P354, DOI 10.1159/000212556
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1992, INT J BIOCHEM, V25, P783
   PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x
   PETIT JM, 1994, EUR J BIOCHEM, V220, P871, DOI 10.1111/j.1432-1033.1994.tb18690.x
   POGGI P, 1987, ANAT RECORD, V217, P30, DOI 10.1002/ar.1092170106
   RATINAUD MH, 1988, CYTOMETRY, V9, P206, DOI 10.1002/cyto.990090304
   RICHTER C, 1993, FEBS LETT, V325, P104, DOI 10.1016/0014-5793(93)81423-W
   RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RUGOLO M, 1987, J BIOENERG BIOMEMBR, V19, P705, DOI 10.1007/BF00762304
   SCHACHTER F, 1993, HUM GENET, V91, P519
   Schneider E L, 1981, Int Rev Cytol, V69, P261
   SHAPIRO HM, 1988, PRACTICAL FLOW CYTOM, P181
   SKOWRONEK P, 1992, BIOCHEM BIOPH RES CO, V187, P991, DOI 10.1016/0006-291X(92)91295-2
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   VAILLANT F, 1991, BIOCHEM INT, V23, P571
   VILLEREAL ML, 1989, ANNU REV NUTR, V9, P347, DOI 10.1146/annurev.nu.09.070189.002023
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V217, P351, DOI 10.1016/0003-9861(82)90511-2
   WATT FM, 1984, J CELL BIOL, V99, P2211, DOI 10.1083/jcb.99.6.2211
   WITKOWSKI JM, 1986, IMMUNOLOGY, V56, P307
NR 70
TC 42
Z9 42
U1 0
U2 6
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC 16
PY 1994
VL 77
IS 2
BP 83
EP 96
DI 10.1016/0047-6374(94)90017-5
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA QC741
UT WOS:A1994QC74100002
PM 7745994
DA 2024-02-19
ER

PT J
AU Kochkina, EG
   Plesneva, SA
   Vasilev, DS
   Zhuravin, IA
   Turner, AJ
   Nalivaeva, NN
AF Kochkina, Ekaterina G.
   Plesneva, Svetlana A.
   Vasilev, Dmitrii S.
   Zhuravin, Igor A.
   Turner, Anthony J.
   Nalivaeva, Natalia N.
TI Effects of ageing and experimental diabetes on insulin-degrading enzyme
   expression in male rat tissues
SO BIOGERONTOLOGY
LA English
DT Article
DE Ageing; Diabetes; Alzheimer's disease; Insulin-degrading enzyme;
   Streptozotocin
ID AMYLOID PRECURSOR PROTEIN; ALZHEIMER-DISEASE; BETA-PEPTIDE;
   INTRACELLULAR DOMAIN; BRAIN; NEPRILYSIN; CLEARANCE; SUBSTRATE; RECEPTOR;
   BINDING
AB Due to an increasing life expectancy in developing countries, cases of type 2 diabetes and Alzheimer's disease (AD) in the elderly are growing exponentially. Despite a causative link between diabetes and AD, general molecular mechanisms underlying pathogenesis of these disorders are still far from being understood. One of the factors leading to cell death and cognitive impairment characteristic of AD is accumulation in the brain of toxic aggregates of amyloid-beta peptide (A beta). In the normally functioning brain A beta catabolism is regulated by a cohort of proteolytic enzymes including insulin-degrading enzyme (IDE) and their deficit with ageing can result in A beta accumulation and increased risk of AD. The aim of this study was a comparative analysis of IDE expression in the brain structures involved in AD, as well as in peripheral organs (the liver and kidney) of rats, during natural ageing and after experimentally-induced diabetes. It was found that ageing is accompanied by a significant decrease of IDE mRNA and protein content in the liver (by 32 and 81 %) and brain structures (in the cortex by 58 and 47 % and in the striatum by 53 and 68 %, respectively). In diabetic animals, IDE protein level was increased in the liver (by 36 %) and in the striatum (by 42 %) while in the brain cortex and hippocampus it was 20-30 % lower than in control animals. No significant IDE protein changes were observed in the kidney of diabetic rats. These data testify that ageing and diabetes are accompanied by a deficit of IDE in the brain structures where accumulation of A beta was reported in AD patients, which might be one of the factors predisposing to development of the sporadic form of AD in the elderly, and especially in diabetics.
C1 [Kochkina, Ekaterina G.; Plesneva, Svetlana A.; Vasilev, Dmitrii S.; Zhuravin, Igor A.; Nalivaeva, Natalia N.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia.
   [Vasilev, Dmitrii S.; Zhuravin, Igor A.] St Petersburg State Pediat Med Univ, St Petersburg, Russia.
   [Turner, Anthony J.; Nalivaeva, Natalia N.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.
C3 North-Western State Medical University named after I.I. Mechnikov;
   Russian Academy of Sciences; Sechenov Institute of Evolutionary
   Physiology & Biochemistry; Saint Petersburg State Pediatric Medical
   University; University of Leeds
RP Nalivaeva, NN (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.
EM n.n.nalivaeva@leeds.ac.uk
RI Nalivaeva, Natalia/K-6522-2018; Vasilev, Dmitri S./J-8198-2018;
   Kochkina, Ekaterina/AAN-7383-2020; Zhuravin, Igor/AAM-6649-2020
OI Nalivaeva, Natalia/0000-0002-7134-3540; Vasilev, Dmitri
   S./0000-0002-0601-2358; Kochkina, Ekaterina/0000-0003-2054-354X; 
FU RFBR [13-04-00388]; Programme of RAS "Fundamental Sciences for
   Medicine"; Royal Society (UK); Medical Council Research (UK);
   Alzheimer's Research Trust (UK); INTAS [011-0245]; YSF [04-83-2877]
FX Supported by RFBR (13-04-00388), Programme of RAS "Fundamental Sciences
   for Medicine", the Royal Society (UK), the Medical Council Research
   (UK), the Alzheimer's Research Trust (UK), INTAS 011-0245 and YSF
   04-83-2877 (EGK).
CR Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818
   Accardi G, 2012, REJUV RES, V15, P217, DOI 10.1089/rej.2011.1289
   Acharya NK, 2013, J ALZHEIMERS DIS, V35, P179, DOI 10.3233/JAD-122254
   Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007
   Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222
   Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571
   Björk BF, 2007, NEUROBIOL AGING, V28, P1374, DOI 10.1016/j.neurobiolaging.2006.06.017
   Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013
   Carter TL, 2006, NEUROSCI LETT, V392, P235, DOI 10.1016/j.neulet.2005.09.022
   Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025
   de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710
   Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1
   Duckworth WC, 1998, BIOCHEM BIOPH RES CO, V244, P390, DOI 10.1006/bbrc.1998.8276
   Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200
   Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100
   Fernández-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799
   Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2
   Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200
   Ginter E, 2013, ADV EXP MED BIOL, V771, P42
   HARADA S, 1993, ENDOCRINOLOGY, V132, P2293, DOI 10.1210/en.132.6.2293
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101
   Hooper NM, 2000, ADV EXP MED BIOL, V477, P379
   Hoyer S, 2004, ADV EXP MED BIOL, V541, P135
   Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224
   Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562
   Kerridge C, 2014, J NEUROCHEM, V130, P419, DOI 10.1111/jnc.12680
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010
   Kozina LS, 2008, NEUROCHEM J, V2, P69, DOI 10.1134/S1819712408010133
   KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604
   KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4
   Leal MC, 2013, J BIOL CHEM, V288, P12920, DOI 10.1074/jbc.M112.424820
   Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6
   Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081
   Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7
   Liu Y, 2008, NEUROSCIENCE, V153, P796, DOI 10.1016/j.neuroscience.2008.03.019
   Liu Y, 2011, J ENDOCRINOL INVEST, V34, P26, DOI [10.1007/BF03346691, 10.3275/6995]
   Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297
   Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4
   MASIELLO P, 1975, ENDOCRINOLOGY, V96, P787, DOI 10.1210/endo-96-3-787
   MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x
   Nalivaeva N N, 2012, Int J Alzheimers Dis, V2012, P383796, DOI 10.1155/2012/383796
   Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]
   Nalivaeva NN, 2012, J MOL NEUROSCI, V46, P569, DOI 10.1007/s12031-011-9644-x
   Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x
   Nalivaeva NN, 2003, LETT PEPT SCI, V10, P455, DOI 10.1007/BF02442577
   Nalivaeva NN, 2004, ANN NY ACAD SCI, V1035, P21, DOI 10.1196/annals.1332.002
   Pérez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160
   Quan QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059155
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Rezende LF, 2014, BRIT J NUTR, V112, P900, DOI 10.1017/S0007114514001238
   Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143
   Takahashi H, 2010, BRAIN RES, V1361, P146, DOI 10.1016/j.brainres.2010.09.032
   Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913
   Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468
   Taubes G, 2003, SCIENCE, V301, P40, DOI 10.1126/science.301.5629.40
   Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108
   Turner AJ, 2003, BIOCHEM SOC T, V31, P723, DOI 10.1042/bst0310723
   Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552
   Wang JQ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/796840
   Wei XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095399
   Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002
   Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038
   Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004
NR 65
TC 30
Z9 35
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2015
VL 16
IS 4
BP 473
EP 484
DI 10.1007/s10522-015-9569-9
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CL6YG
UT WOS:000357114600008
PM 25792373
DA 2024-02-19
ER

PT J
AU Di Gioia, S
   Bianchi, P
   Destro, A
   Grizzi, F
   Malesci, A
   Laghi, L
   Levrero, M
   Morabito, A
   Roncalli, M
AF Di Gioia, Sonia
   Bianchi, Paolo
   Destro, Annarita
   Grizzi, Fabio
   Malesci, Alberto
   Laghi, Luigi
   Levrero, Massimo
   Morabito, Alberto
   Roncalli, Massimo
TI Quantitative evaluation of <i>RASSFIA</i> methylation in the
   non-lesional, regenerative and neoplastic liver
SO BMC CANCER
LA English
DT Article
ID TUMOR-SUPPRESSOR GENE; FREQUENT EPIGENETIC INACTIVATION; CPG ISLAND
   HYPERMETHYLATION; HUMAN-CHROMOSOME 3P21.3; HEPATOCELLULAR-CARCINOMA;
   PROMOTER HYPERMETHYLATION; HUMAN CANCERS; HEPATITIS-B; LUNG; RAS
AB Background: Epigenetic changes during ageing and their relationship with cancer are under the focus of intense research. RASSF1A and NORE1A are novel genes acting in concert in the proapoptotic pathway of the RAS signalling. While NORE1A has not been previously investigated in the human liver, recent reports have suggested that RASSF1A is frequently epigenetically methylated not only in HCC but also in the cirrhotic liver.
   Methods: To address whether epigenetic changes take place in connection to age and/or to the underlying disease, we investigated RASSF1A and NORE1A gene promoter methylation by conventional methylation specific PCR and Real-Time MSP in a series of hepatitic and non-hepatitic livers harboring regenerative/hyperplastic (cirrhosis/focal nodular hyperplasia), dysplastic ( large regenerative, low and high grade dysplastic nodules) and neoplastic ( hepatocellular adenoma and carcinoma) growths.
   Results: In the hepatitic liver ( chronic hepatitic/cirrhosis, hepatocellular nodules and HCC) we found widespread RASSF1A gene promoter methylation with a methylation index that increased from regenerative conditions ( cirrhosis) to hepatocellular nodules ( p < 0.01) to HCC ( p < 0.001). In the non-hepatitic liver a consistent pattern of gene methylation was also found in both lesional ( focal nodular hyperplasia and hepatocellular adenoma) and non-lesional tissue. Specifically, hepatocellular adenomas ( HA) showed a methylation index significantly higher than that detected in focal nodular hyperplasia (FNH) ( p < 0.01) and in non-lesional tissue ( p < 0.001). In non-lesional liver also the methylation index gradually increased by ageing ( p = 0.002), suggesting a progressive spreading of methylated cells over time. As opposed to RASSF1A gene promoter methylation, NORE1A gene was never found epigenetically alterated in both hepatitic and non-hepatitic liver.
   Conclusion: We have shown that in non-lesional, regenerative and neoplastic liver the RASSF1A gene is increasingly methylated, that this condition takes place as an age-related phenomenon and that the early setting and spreading over time of an epigenetically methylated hepatocyte subpopulation, might be related to liver tumorigenesis.
C1 Humanitas Clin Inst Rozzano, Dept Pathol, Milan, Italy.
   Humanitas Clin Inst Rozzano, Mol Genet Lab, Milan, Italy.
   Humanitas Clin Inst Rozzano, Sci Direct, Milan, Italy.
   Humanitas Clin Inst Rozzano, Dept Gastroenterol, Milan, Italy.
   Humanitas Clin Inst Rozzano, Dept Pathol, Milan, Italy.
   Univ Roma La Sapienza, Gene Express Lab, Fdn Andrea Cesalpino, Rome, Italy.
   Univ Milan, Milan, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica
   Molecolare (IGM-CNR); Sapienza University Rome; University of Milan
RP Roncalli, M (corresponding author), Humanitas Clin Inst Rozzano, Dept Pathol, Milan, Italy.
EM sonia.digioia@unimi.it; paolo.bianchi@humanitas.it;
   annarita_destro@msn.com; fabio.grizzi@humanitas.it;
   alberto.malesci@humanitas.it; luigi.laghi@humanitas.it; levmax@tin.it;
   alberto.morabito@unimi.it; massimo.roncalli@unimi.it
RI Roncalli, Massimo/HJZ-1838-2023; Laghi, Luigi/GZM-5831-2022; Grizzi,
   Fabio/K-3448-2018; Destro, Annarita/HII-7324-2022; Bianchi,
   Paolo/E-7592-2013; Levrero, Massimo/G-5680-2016
OI Roncalli, Massimo/0000-0002-7901-8910; Laghi, Luigi/0000-0003-4187-1059;
   Grizzi, Fabio/0000-0003-0925-742X; Destro, Annarita/0000-0001-5388-0353;
   Bianchi, Paolo/0000-0001-5786-5644; Levrero, Massimo/0000-0002-4978-0875
CR Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175
   Astuti D, 2001, ONCOGENE, V20, P7573, DOI 10.1038/sj.onc.1204968
   Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691
   Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083
   Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469
   Destro A, 2004, LUNG CANCER, V44, P23, DOI 10.1016/j.lungcan.2003.10.002
   Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191
   HESSON L, 2004, ONCOGENE
   Kaneto H, 2001, GUT, V48, P372, DOI 10.1136/gut.48.3.372
   Lee MG, 2001, CANCER RES, V61, P6688
   Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5
   Lehmann U, 2005, CLIN CANCER RES, V11, P3654, DOI 10.1158/1078-0432.CCR-04-2462
   Lerman MI, 2000, CANCER RES, V60, P6116
   Lo KW, 2001, CANCER RES, V61, P3877
   Lo YMD, 1999, CANCER RES, V59, P3899
   Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097
   Maruyama R, 2001, CANCER RES, V61, P8659
   Morrissey C, 2001, CANCER RES, V61, P7277
   Nakagawa H, 2001, CANCER RES, V61, P6991
   Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192
   Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097
   Roncalli M, 2002, HEPATOLOGY, V36, P427, DOI 10.1053/jhep.2002.34852
   Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Schagdarsurengin U, 2003, ONCOGENE, V22, P1866, DOI 10.1038/sj.onc.1206338
   Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365
   Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135
   Waki T, 2003, ONCOGENE, V22, P4128, DOI 10.1038/sj.onc.1206651
   Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29
   Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076
   Zhong S, 2003, CLIN CANCER RES, V9, P3376
NR 34
TC 48
Z9 60
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2407
J9 BMC CANCER
JI BMC Cancer
PD APR 10
PY 2006
VL 6
AR 89
DI 10.1186/1471-2407-6-89
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 052LZ
UT WOS:000238236500001
PM 16606445
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Carrasco-Garcia, E
   Moreno-Cugnon, L
   Garcia, I
   Borras, C
   Revuelta, M
   Izeta, A
   Lopez-Lluch, G
   de Pancorbo, MM
   Vergara, I
   Vina, J
   Matheu, A
AF Carrasco-Garcia, Estefania
   Moreno-Cugnon, Leire
   Garcia, Idoia
   Borras, Consuelo
   Revuelta, Miren
   Izeta, Ander
   Lopez-Lluch, Guillermo
   de Pancorbo, Marian M.
   Vergara, Itziar
   Vina, Jose
   Matheu, Ander
TI SOX2 expression diminishes with ageing in several tissues in mice and
   humans
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE SOX2; Ageing; Biomarker
ID TRANSCRIPTION FACTORS; MOUSE DEVELOPMENT; STEM-CELLS; ROLES; BIOMARKERS;
   MUTATIONS; FAMILY; DIFFERENTIATION; P16(INK4A); GENERATION
AB SOX2 (Sex-determining region Y box 2) is a transcription factor expressed in several foetal and adult tissues and its deregulated activity has been linked to chronic diseases associated with ageing. Nevertheless, the level of SOX2 expression in aged individuals at the tissue level has not previously been examined. In this work, we show that SOX2 expression decreases significantly in the brain with ageing, in both humans and rodents. The administration of resveratrol for 6 months in mice partly attenuated this reduction. We also identified an age-relateddecline in SOX2 mRNA and protein expression in several other organs, namely, the lung, heart, kidney, spleen and liver, Moreover, peripheral blood mononuclear cells (PBMCs) from elderly expressed lower levels of SOX2 than those from young individuals. Mechanistically, SOX2 expression inversely correlates with p16(Ink4a) levels. Together, these data show a widespread decrease in SOX2 with age, suggesting that the decline in SOX2 expression might be used as a biomarker of ageing.
C1 [Carrasco-Garcia, Estefania; Moreno-Cugnon, Leire; Garcia, Idoia; Revuelta, Miren; Matheu, Ander] Biodonostia Hlth Res Inst, Cellular Oncol Grp, San Sebastian, Spain.
   [Borras, Consuelo; Vina, Jose] Univ Valencia, Fac Med, INCLIVA, FRESHAGE Grp, Valencia, Spain.
   [Vergara, Itziar] Biodonostia Hlth Res Inst, Hlth Res Chron Dis & Aging Grp, Primary Care Res Unit Gipuzkoa, Osakidetza,Kronikgune, San Sebastian, Spain.
   [de Pancorbo, Marian M.] Univ Basque Country, UPV EHU, Lascaray Res Ctr, BIOMICs Res Grp, Vitoria, Spain.
   [Lopez-Lluch, Guillermo] Pablo de Olavide Univ, Ctr Biomed Res Rare Dis CIBERER, Andalusian Ctr Dev Biol CABD, Dept Physiol Anat & Cell Biol, Seville, Spain.
   [Izeta, Ander] Biodonostia Hlth Res Inst, Tissue Engn Lab, San Sebastian, Spain.
   [Garcia, Idoia; Matheu, Ander] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.
   [Carrasco-Garcia, Estefania; Garcia, Idoia; Vina, Jose; Matheu, Ander] CIBERfes, Madrid, Spain.
   [Revuelta, Miren] Charite, Med Ctr, Berlin, Germany.
C3 Instituto de Investigacion Sanitaria Biodonostia; University of
   Valencia; Instituto de Investigacion Sanitaria Biodonostia; University
   of Basque Country; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Instituto de Investigacion Sanitaria Biodonostia;
   Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERFES; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin
RP Matheu, A (corresponding author), Biodonostia Hlth Res Inst, Paseo Dr Begiristain S-N, San Sebastian 20014, Gipuzcoa, Spain.
EM ander.matheu@biodonostia.org
RI Revuelta, Miren/AAW-4895-2021; Revuelta, Miren/AAH-2410-2019; borras,
   consuelo/Y-3407-2019; Lopez-Lluch, Guillermo/N-4742-2014; Izeta,
   Ander/ABG-8973-2020; Vina, Jose/AAB-3069-2021
OI Revuelta, Miren/0000-0001-8126-2050; borras,
   consuelo/0000-0003-4606-1792; Lopez-Lluch,
   Guillermo/0000-0001-9830-8502; Izeta, Ander/0000-0003-1879-7401; Vina,
   Jose/0000-0001-9709-0089; Vergara, Itziar/0000-0001-9671-7898; Carrasco
   Garcia, Estefania/0000-0002-5153-0197; moreno-cugnon,
   leire/0000-0003-1283-6414; M. de Pancorbo, Marian/0000-0002-8081-0702
FU Department of Education, University and Research of the Basque
   Government; Carlos III Health Institute [PI13/02277, CP16/00039,
   PI16/01580, DTS16/0184]; Diputacion Foral Gipuzkoa; Departments of
   Industry and Health of the Basque Government; European Union [CIG
   2012/712404, REFBIO13/BIOD/009]; European Regional Development Fund
FX LM-C and MR are recipient of a predoctoral and postdoctoral fellowship
   from the Department of Education, University and Research of the Basque
   Government. We thank the Histology Platform of Biodonostia Health
   Research Institute for assistance with immunohistochemistry experiments.
   We thank Ruben Sevillano from Basque Institute of Legal Medicine for
   help in brain samples collection. This work is supported by grants from
   the Carlos III Health Institute (PI13/02277, CP16/00039, PI16/01580,
   DTS16/0184), Diputacion Foral Gipuzkoa, and the Departments of Industry
   and Health of the Basque Government, as well as from the European Union
   (Marie Curie CIG 2012/712404 and REFBIO13/BIOD/009) and European
   Regional Development Fund to Ander Matheu.
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   de la Rocha AMA, 2014, AM J CANCER RES, V4, P312
   Alberro A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071168
   Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740
   Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004
   Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001
   Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503
   BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3
   Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465
   Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002
   Borras C, 2016, AGING-US, V8, P3185, DOI 10.18632/aging.101078
   Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x
   Bürkle A, 2015, MECH AGEING DEV, V151, P2, DOI 10.1016/j.mad.2015.03.006
   Tung BT, 2015, AGING CLIN EXP RES, V27, P775, DOI 10.1007/s40520-015-0366-8
   Capilla-Gonzalez V, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00365
   Carrasco-Garcia E, 2015, AGING CELL, V14, P710, DOI 10.1111/acel.12343
   Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801
   COMFORT A, 1969, LANCET, V2, P1411
   Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010
   Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120
   Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397
   Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204
   Gambini J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/837042
   Garros-Regulez L, 2016, EXPERT OPIN THER TAR, V20, P393, DOI 10.1517/14728222.2016.1151002
   Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5
   Hodes RJ, 2016, ANN NY ACAD SCI, V1386, P45, DOI 10.1111/nyas.13299
   Hoffmann SA, 2014, DEVELOPMENT, V141, P39, DOI 10.1242/dev.098418
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006
   Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9
   Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x
   Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Montserrat N, 2012, J BIOL CHEM, V287, P24131, DOI 10.1074/jbc.M112.350413
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Osborne RJ, 2011, MOL VIS, V17, P3097
   Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018
   Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855
   Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629
   Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007
   Sarlak G, 2016, MOL NEUROBIOL, V53, P1679, DOI 10.1007/s12035-015-9123-4
   Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906
   Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064
   Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117
   Yoon DS, 2014, STEM CELLS, V32, P3219, DOI 10.1002/stem.1811
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 56
TC 20
Z9 20
U1 0
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 2019
VL 177
SI SI
BP 30
EP 36
DI 10.1016/j.mad.2018.03.008
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HJ1DU
UT WOS:000456902900004
PM 29574045
DA 2024-02-19
ER

PT J
AU Kendrick, AA
   Choudhury, M
   Rahman, SM
   McCurdy, CE
   Friederich, M
   Van Hove, JLK
   Watson, PA
   Birdsey, N
   Bao, JJ
   Gius, D
   Sack, MN
   Jing, EX
   Kahn, CR
   Friedman, JE
   Jonscher, KR
AF Kendrick, Agnieszka A.
   Choudhury, Mahua
   Rahman, Shaikh M.
   McCurdy, Carrie E.
   Friederich, Marisa
   Van Hove, Johan L. K.
   Watson, Peter A.
   Birdsey, Nicholas
   Bao, Jianjun
   Gius, David
   Sack, Michael N.
   Jing, Enxuan
   Kahn, C. Ronald
   Friedman, Jacob E.
   Jonscher, Karen R.
TI Fatty liver is associated with reduced SIRT3 activity and mitochondrial
   protein hyperacetylation
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE cellular metabolism; mitochondrial metabolism; NAD; non-alcoholic fatty
   liver disease; obesity; proteomics; sirtuin
ID OXIDATIVE STRESS; DEACETYLASE ACTIVITY; INSULIN-RESISTANCE; ACID
   OXIDATION; ACETYLATION; METABOLISM; OBESITY; INVOLVEMENT; DYSFUNCTION;
   EXPRESSION
AB Acetylation has recently emerged as an important mechanism for controlling a broad array of proteins mediating cellular adaptation to metabolic fuels. Acetylation is governed, in part, by SIRTs (sirtuins), class III NAD(+)-dependent deacetylases that regulate lipid and glucose metabolism in liver during fasting and aging. However, the role of acetylation or SIRTs in pathogenic hepatic fuel metabolism under nutrient excess is unknown. In the present study, we isolated acetylated proteins from total liver proteome and observed 193 preferentially acetylated proteins in mice fed on an HFD (high-fat diet) compared with controls, including 11 proteins not previously identified in acetylation studies. Exposure to the HFD led to hyperacetylation of proteins involved in gluconeogenesis, mitochondrial oxidative metabolism, methionine metabolism, liver injury and the ER (endoplasmic reticulum) stress response. Livers of mice fed on the HFD had reduced SIRT3 activity, a 3-fold decrease in hepatic NAD(+) levels and increased mitochondrial protein oxidation. In contrast, neither SIRT1 nor histone acetyltransferase activities were altered, implicating SIRT3 as a dominant factor contributing to the observed phenotype. In Sirt3(-/-) mice, exposure to the HFD further increased the acetylation status of liver proteins and reduced the activity of respiratory complexes III and IV. This is the first study to identify acetylation patterns in liver proteins of HFD-fed mice. Our results suggest that SIRT3 is an integral regulator of mitochondrial function and its depletion results in hyperacetylation of critical mitochondrial proteins that protect against hepatic lipotoxicity under conditions of nutrient excess.
C1 [Kendrick, Agnieszka A.; Friedman, Jacob E.; Jonscher, Karen R.] Univ Colorado, Sch Med, Dept Anesthesiol, NORC,Mass Spectrometry Core Facil, Aurora, CO 80045 USA.
   [Choudhury, Mahua; Rahman, Shaikh M.; McCurdy, Carrie E.; Friederich, Marisa; Van Hove, Johan L. K.; Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.
   [Watson, Peter A.; Birdsey, Nicholas] Denver VA Med Ctr, Denver, CO 80220 USA.
   [Bao, Jianjun; Sack, Michael N.] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA.
   [Gius, David] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Jing, Enxuan; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Veterans Affairs Medical Center - Denver; National
   Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood
   Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); Harvard University; Joslin Diabetes
   Center, Inc.; Harvard Medical School
RP Friedman, JE (corresponding author), Univ Colorado, Sch Med, Dept Anesthesiol, NORC,Mass Spectrometry Core Facil, Aurora, CO 80045 USA.
EM jed.friedman@ucdenver.edu
RI Rahman, Shaikh Mizanoor/GLN-7518-2022; Kahn, Ronald/AAY-2435-2021
OI Rahman, Shaikh Mizanoor/0000-0002-4879-2663; Kahn,
   Ronald/0000-0002-7583-9228; Kendrick, Agnieszka/0000-0003-3254-4582;
   Jonscher, Karen/0000-0002-7929-4886
FU National Institutes of Health [DK59767, P30-DK48520, K12 HD057022];
   University of Colorado, Center for Human Nutrition [P30-DK048520-09];
   American Heart Association [09BGIA2060705]; American Diabetes
   Mentor-based Post-Doctoral Fellowship [7-08-MN-17]; Veterans
   Administration; National Heart, Lung, and Blood Institute; Center for
   Cancer Research, National Cancer Institute
FX This work was supported by the National Institutes of Health [grant
   numbers DK59767, P30-DK48520 (to J.E.F.)]; a Pilot & Feasibility Award
   from the University of Colorado, Center for Human Nutrition [grant
   number P30-DK048520-09 to K.R.J.)]; the National Institutes of Health
   Office of Research in Women's Health BIRCWH Program [grant number K12
   HD057022 (to C.E.M.)]; a Beginning Grant in Aid from the American Heart
   Association [grant number 09BGIA2060705 (to S.M.R.)]; and an American
   Diabetes Mentor-based Post-Doctoral Fellowship [grant number 7-08-MN-17
   (to MC.)]. P.W. was supported by Veterans Administration Merit Awards.
   J.B. and M.N.S. were funded by the National Heart, Lung, and Blood
   Institute. D.G. was supported by the Center for Cancer Research,
   National Cancer Institute.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Banerjee S, 2002, CANCER RES, V62, P4945
   Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009
   Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346
   Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   Civitarese AE, 2008, ENDOCRINOLOGY, V149, P950, DOI 10.1210/en.2007-1444
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319
   FERSHL A, 1985, ENZYME STRUCTURE MEC
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Jacobs KM, 2008, INT J BIOL SCI, V4, P291
   Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001
   Jitrapakdee S, 1999, BIOCHEM BIOPH RES CO, V266, P512, DOI 10.1006/bbrc.1999.1846
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026
   Koc EC, 2010, FASEB J, V24
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048
   Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730
   Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Schägger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911
   Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571
   SMITH L, 1955, Methods Biochem Anal, V2, P427, DOI 10.1002/9780470110188.ch13
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Trapp J, 2006, CURR DRUG TARGETS, V7, P1553, DOI 10.2174/1389450110607011553
   Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687
   Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596
   Yañez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183
   Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
NR 53
TC 305
Z9 352
U1 2
U2 54
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD FEB 1
PY 2011
VL 433
BP 505
EP 514
DI 10.1042/BJ20100791
PN 3
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 757AJ
UT WOS:000290055900012
PM 21044047
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Bacigalupo, ML
   Piazza, VG
   Cicconi, NS
   Carabias, P
   Bartke, A
   Fang, YM
   Sotelo, A
   Rabinovich, GA
   Troncoso, MF
   Miquet, JG
AF Bacigalupo, Maria L.
   Piazza, Veronica G.
   Cicconi, Nadia S.
   Carabias, Pablo
   Bartke, Andrzej
   Fang, Yimin
   Sotelo, Ana, I
   Rabinovich, Gabriel A.
   Troncoso, Maria F.
   Miquet, Johanna G.
TI Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver
SO ENDOCRINE CONNECTIONS
LA English
DT Article
DE growth hormone; galectin 1; hepatocellular carcinoma; liver cancer
ID HUMAN HEPATOCELLULAR-CARCINOMA; MURINE MODEL; MICE; GH; GENE;
   HEPATOCARCINOGENESIS; EXPRESSION; CANCER; ROLES; PROLIFERATION
AB Transgenic mice overexpressing growth hormone (GH) spontaneously develop liver tumors, including hepatocellular carcinoma (HCC), within a year. The preneoplastic liver pathology in these mice recapitulates that observed in humans at high risk of developing hepatic cancer. Although increased expression of galectin 1 (GAL1) in liver tissue is associated with HCC aggressiveness, a link between this glycan-binding protein and hormone-related tumor development has not yet been explored. In this study, we investigated GAL1 expression during liver tumor progression in mice continuously exposed to high levels of GH. GAL1 expression was determined by Western blotting, RT-qPCR and immunohistochemistry in the liver of transgenic mice overexpressing GH. Animals of representative ages at different stages of liver pathology were studied. GAL1 expression was upregulated in the liver of GH-transgenic mice. This effect was observed at early ages, when animals displayed no signs of liver disease or minimal histopathological alterations and was also detected in young adults with preneoplastic liver pathology. Remarkably, GAL1 upregulation was sustained during aging and its expression was particularly enhanced in liver tumors. GH also induced hepatic GAL1 expression in mice that were treated with this hormone for a short period. Moreover, GH triggered a rapid increment in GAL1 protein expression in human HCC cells, denoting a direct effect of the hormone on hepatocytes. Therefore, our results indicate that GH upregulates GAL1 expression in mouse liver, which may have critical implications in tumorigenesis. These findings suggest that this lectin could be implicated in hormone-driven liver carcinogenesis.
C1 [Bacigalupo, Maria L.; Piazza, Veronica G.; Cicconi, Nadia S.; Carabias, Pablo; Sotelo, Ana, I; Troncoso, Maria F.; Miquet, Johanna G.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol, Dept Quim Biol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina.
   [Bartke, Andrzej; Fang, Yimin] Southern Illinois Univ, Sch Med, Dept Internal Med, Geriatr Res, Springfield, IL USA.
   [Rabinovich, Gabriel A.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Inmunopatol, Buenos Aires, DF, Argentina.
   [Rabinovich, Gabriel A.] Univ Buenos Aires, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); Southern Illinois University System;
   Southern Illinois University; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental
   Medicine; University of Buenos Aires; University of Buenos Aires
RP Troncoso, MF; Miquet, JG (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fisicoquim Biol, Dept Quim Biol,Fac Farm & Bioquim, Buenos Aires, DF, Argentina.
EM fernanda@qb.ffyb.uba.ar; jmiquet@qb.ffyb.uba.ar
RI Fang, Yimin/C-3278-2018
OI Fang, Yimin/0000-0002-2735-6782; Troncoso, Maria
   Fernanda/0000-0002-4919-9976
FU Universidad de Buenos Aires [20020120200122BA, 20020150100005BA,
   20020130100208BA]; Consejo Nacional de Investigaciones Cientificas y
   Tecnicas [11220150100647]; Agencia Nacional de Promocion Cientifica y
   Tecnologica [PICT-20151100, PICT-2016-1139]; National Institute on Aging
   of the National Institutes of Health [R01AG019899]
FX This work was supported by the Universidad de Buenos Aires (grant
   numbers 20020120200122BA to J G M, 20020150100005BA to M F T,
   20020130100208BA to A I S); the Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (grant number 11220150100647 to M F T); the
   Agencia Nacional de Promocion Cientifica y Tecnologica (grant numbers
   PICT-20151100 to J G M, PICT-2016-1139 to M F T) and the National
   Institute on Aging of the National Institutes of Health (grant number
   R01AG019899 to A B).
CR Bacigalupo ML, 2017, WORLD J GASTROENTERO, V23, P5266, DOI 10.3748/wjg.v23.i29.5266
   Bacigalupo ML, 2015, J CELL PHYSIOL, V230, P1298, DOI 10.1002/jcp.24865
   Bacigalupo ML, 2013, WORLD J GASTROENTERO, V19, P8831, DOI 10.3748/wjg.v19.i47.8831
   Bartke A, 2003, NEUROENDOCRINOLOGY, V78, P210, DOI 10.1159/000073704
   Blum WF, 2018, ENDOCR CONNECT, V7, pR212, DOI 10.1530/EC-18-0099
   Bugni JM, 2001, CARCINOGENESIS, V22, P1853, DOI 10.1093/carcin/22.11.1853
   Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099
   Chung EJ, 2002, MOL CELLS, V14, P382
   Croci DO, 2012, J EXP MED, V209, P1985, DOI 10.1084/jem.20111665
   Díaz ME, 2014, J ENDOCRINOL, V221, P309, DOI 10.1530/JOE-13-0447
   Espelt MV, 2011, HEPATOLOGY, V53, P2097, DOI 10.1002/hep.24294
   Guevara-Aguirre J, 2018, GROWTH HORM IGF RES, V38, P34, DOI 10.1016/j.ghir.2017.12.006
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x
   Kondoh N, 2003, INT J ONCOL, V23, P1575
   Kong XH, 2016, ONCOTARGET, V7, P29465, DOI 10.18632/oncotarget.8781
   Kopchick JJ, 2014, MOL CELL ENDOCRINOL, V386, P34, DOI 10.1016/j.mce.2013.09.004
   Lapkina-Gendler L, 2016, ENDOCR-RELAT CANCER, V23, P399, DOI 10.1530/ERC-16-0054
   Lau-Corona D, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00301-17
   Li J, 2015, BIOCHEM PHARMACOL, V93, P92, DOI 10.1016/j.bcp.2014.10.010
   Liu B, 2019, J CELL BIOCHEM, V120, P18162, DOI 10.1002/jcb.29122
   Manzi M, 2016, J CELL PHYSIOL, V231, P1522, DOI 10.1002/jcp.25244
   Martinez CS, 2015, J MOL ENDOCRINOL, V54, P171, DOI 10.1530/JME-14-0262
   MCGRANE MM, 1988, J BIOL CHEM, V263, P11443
   Miquet JG, 2008, J ENDOCRINOL, V198, P317, DOI 10.1677/JOE-08-0002
   Miquet JG, 2013, CELL CYCLE, V12, P1042, DOI 10.4161/cc.24026
   ORIAN JM, 1990, JNCI-J NATL CANCER I, V82, P393, DOI 10.1093/jnci/82.5.393
   Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818
   Perry JK, 2013, CURR OPIN ENDOCRINOL, V20, P307, DOI 10.1097/MED.0b013e328363183a
   Potikha T, 2019, FASEB J, V33, P7995, DOI 10.1096/fj.201900017R
   Potikha T, 2016, ONCOTARGET, V7, P31738, DOI 10.18632/oncotarget.9194
   Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335
   QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40
   Snibson KJ, 1999, LIVER, V19, P242, DOI 10.1111/j.1478-3231.1999.tb00042.x
   Snibson KJ, 2002, TISSUE CELL, V34, P88, DOI 10.1016/S0040-8166(02)00012-5
   Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119
   Terzolo M, 2017, ENDOCR-RELAT CANCER, V24, P495, DOI 10.1530/ERC-16-0553
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476
   Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x
   Yeh CC, 2015, MOL CELL PROTEOMICS, V14, P1527, DOI 10.1074/mcp.M114.046417
NR 41
TC 7
Z9 7
U1 0
U2 0
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
EI 2049-3614
J9 ENDOCR CONNECT
JI Endocr. Connect.
PD AUG
PY 2019
VL 8
IS 8
BP 1108
EP 1117
DI 10.1530/EC-19-0292
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA IT8OX
UT WOS:000483142900005
PM 31272083
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU THAKUR, MK
   OKA, T
   NATORI, Y
AF THAKUR, MK
   OKA, T
   NATORI, Y
TI GENE-EXPRESSION AND AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DNA; MESSENGER RNA; GENE EXPRESSION
ID SENESCENT HUMAN-FIBROBLASTS; HUMAN-DIPLOID FIBROBLASTS;
   ALPHA-FETOPROTEIN GENE; MESSENGER-RNA LEVELS; RAT-LIVER;
   DYSDIFFERENTIATIVE NATURE; METHYLATION PATTERNS; DNA-SEQUENCE;
   LIFE-SPAN; OLD RATS
AB Considerable amount of data has accumulated during the past few years showing several changes in gene expression as a function of age. However, the basic mechanism of aging still remains poorly understood. In this review, we have mainly analysed the data pertaining to the hypothesis that aging is associated with genetic instability and have attempted further to highlight the gaps that need to be bridged in order to have a clear picture of the aging phenomenon. Extensive investigations employing new and novel approaches are needed in future to elucidate the intricately interwoven patterns of molecular control that underlie the various aspects of gene expression during aging.
C1 UNIV TOKUSHIMA, SCH MED, DEPT NUTR CHEM, TOKUSHIMA 770, JAPAN.
C3 Tokushima University
RP THAKUR, MK (corresponding author), BANARAS HINDU UNIV, CTR ADV STUDY ZOOL, BIOCHEM & MOLEC BIOL LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
CR ADLER MJ, 1991, P NATL ACAD SCI USA, V88, P16, DOI 10.1073/pnas.88.1.16
   ARMBRECHT HJ, 1989, ENDOCRINOLOGY, V125, P2950, DOI 10.1210/endo-125-6-2950
   CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537
   CAVALLIUS J, 1989, T AGING RES, V13, P125
   CHANG CD, 1991, J BIOL CHEM, V266, P8663
   CHATTERJEE B, 1990, J STEROID BIOCHEM, V37, P437, DOI 10.1016/0960-0760(90)90495-7
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHOI HS, 1990, J BIOL CHEM, V265, P18005
   COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   DEMYAN WF, 1989, BIOCHEMISTRY-US, V28, P1732, DOI 10.1021/bi00430a046
   EGILMEZ NK, 1989, J BIOL CHEM, V264, P14312
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FAZIO MJ, 1988, LAB INVEST, V58, P270
   FERNANDES G, 1990, P SOC EXP BIOL MED, V193, P16, DOI 10.3181/00379727-193-42983
   FRIEDMAN V, 1990, MECH AGEING DEV, V52, P27, DOI 10.1016/0047-6374(90)90142-3
   GAUBATZ JW, 1990, J BIOL CHEM, V265, P17753
   HADDAD IA, 1986, J BIOL CHEM, V261, P3268
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   HORBACH GJMJ, 1988, LIFE SCI, V43, P1707, DOI 10.1016/0024-3205(88)90482-1
   JAISWAL YK, 1990, BIOCHEM BIOPH RES CO, V168, P71, DOI 10.1016/0006-291X(90)91676-J
   JUMP DB, 1988, J BIOL CHEM, V263, P7254
   KANUNGO MS, 1980, BIOCH AGING, P18
   KARLSON P., 1965, P139
   KATOR K, 1985, GERONTOLOGY, V31, P355, DOI 10.1159/000212724
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407
   LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3
   MARTIN GM, 1970, LAB INVEST, V23, P86
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MEDVEDEV ZA, 1984, MECH AGEING DEV, V28, P139, DOI 10.1016/0047-6374(84)90014-9
   MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   MURTY CVR, 1988, BIOCHIM BIOPHYS ACTA, V949, P27, DOI 10.1016/0167-4781(88)90050-4
   NIEDZWIECKI A, 1991, J BIOL CHEM, V266, P9332
   OKA T, 1990, BIOMED GERONTOL, V14, P207
   OKADA A, 1985, DIFFERENTIATION, V29, P14, DOI 10.1111/j.1432-0436.1985.tb00286.x
   ONO T, 1985, GERONTOLOGY, V31, P362, DOI 10.1159/000212725
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   RATTAN SIS, 1989, INT REV CYTOL, V116, P47
   SATO AI, 1990, MECH AGEING DEV, V54, P1, DOI 10.1016/0047-6374(90)90011-4
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SLAGBOOM PE, 1990, FEBS LETT, V269, P128, DOI 10.1016/0014-5793(90)81136-C
   SLAGBOOM PE, 1989, GENOME, V31, P373, DOI 10.1139/g89-057
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   SMITH JR, 1989, GENOME, V31, P386, DOI 10.1139/g89-058
   SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
   STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0
   TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8
   TARGOVNIK HS, 1985, INT J RADIAT BIOL, V47, P255, DOI 10.1080/09553008514550381
   Thakur M K, 1983, Arch Gerontol Geriatr, V2, P1, DOI 10.1016/0167-4943(83)90012-2
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   TURNER DR, 1985, NATURE, V315, P343, DOI 10.1038/315343a0
   WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0
   YANG F, 1990, MECH AGEING DEV, V56, P187, DOI 10.1016/0047-6374(90)90009-5
   ZHANG DE, 1990, J BIOL CHEM, V265, P3382
NR 60
TC 19
Z9 22
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 1993
VL 66
IS 3
BP 283
EP 298
DI 10.1016/0047-6374(93)90015-J
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA KM258
UT WOS:A1993KM25800006
PM 8469020
DA 2024-02-19
ER

PT J
AU Wang, HL
   Lian, KQ
   Han, B
   Wang, YY
   Kuo, SH
   Geng, Y
   Qiang, J
   Sun, MY
   Wang, MW
AF Wang, Hualong
   Lian, Kaoqi
   Han, Bing
   Wang, Yanyong
   Kuo, Sheng-Han
   Geng, Yuan
   Qiang, Jing
   Sun, Meiyu
   Wang, Mingwei
TI Age-Related Alterations in the Metabolic Profile in the Hippocampus of
   the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's
   Disease Mouse Model
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE Aging; Alzheimer's disease; cholesterol; gas chromatography-mass
   spectrometry; hippocampus; metabolic profiles
ID LIVER X RECEPTORS; SAMP8 MOUSE; BRAIN; CHOLESTEROL; MICE; SPECTROSCOPY;
   PROGRESSION; PREVENTION; STATINS; MRS
AB Alzheimer's disease (AD), the most common age-dependent neurodegenerative disorder, produces a progressive decline in cognitive function. The metabolic mechanism of AD has emerged in recent years. In this study, we used multivariate analyses of gas chromatography-mass spectrometry measurements to determine that learning and retention-related metabolic profiles are altered during aging in the hippocampus of the senescence-accelerated mouse prone 8 (SAMP8). Alterations in 17 metabolites were detected in mature and aged mice compared to young mice (13 decreased and 4 increased metabolites), including metabolites related to dysfunctional lipid metabolism (significantly increased cholesterol, oleic acid, and phosphoglyceride levels), decreased amino acid (alanine, serine, glycine, aspartic acid, glutamate, and gamma-aminobutyric acid), and energy-related metabolite levels (malic acid, butanedioic acid, fumaric acid, and citric acid), and other altered metabolites (increased N-acetyl-aspartic acid and decreased pyroglutamic acid, urea, and lactic acid) in the hippocampus. All of these alterations indicated that the metabolic mechanisms of age-related cognitive impairment in SAMP8 mice were related to multiple pathways and networks. Lipid metabolism, especially cholesterol metabolism, appears to play a distinct role in the hippocampus in AD.
C1 [Wang, Hualong; Han, Bing; Wang, Yanyong; Qiang, Jing; Sun, Meiyu; Wang, Mingwei] Hebei Med Univ, Hosp 1, Dept Neurol, Shijiazhuang 050031, Hebei, Peoples R China.
   [Lian, Kaoqi] Hebei Med Univ, Sch Publ Hlth, Shijiazhuang 050031, Hebei, Peoples R China.
   [Kuo, Sheng-Han] Columbia Univ, Dept Neurol, New York, NY USA.
   [Geng, Yuan; Wang, Mingwei] Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Hebei, Peoples R China.
C3 Hebei Medical University; Hebei Medical University; Columbia University
RP Wang, MW (corresponding author), Hebei Med Univ, Hosp 1, Dept Neurol, 89 Dong Gang Rd, Shijiazhuang 050031, Hebei, Peoples R China.
EM wmwsjz@163.com
OI Kuo, Sheng-Han/0000-0002-9412-931X
FU National Natural Science Foundation of China [81302471]; Brain Aging and
   Cognitive Neuroscience Laboratory of Hebei Province
FX This work was supported by grants from the National Natural Science
   Foundation of China (81302471). This work was also supported by the
   Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province. The
   authors wish to thank Prof. David Yew (Department of Anatomy, The
   Chinese University of Hong Kong) for providing the SAMP8 mice.
CR Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x
   Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   ELLISON DW, 1986, ANN NEUROL, V20, P616, DOI 10.1002/ana.410200510
   Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1
   Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5
   Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001
   Gueli MC, 2013, NEUROL SCI, V34, P1575, DOI 10.1007/s10072-013-1289-9
   Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786
   Jansen D, 2012, J ALZHEIMERS DIS, V31, P813, DOI 10.3233/JAD-2012-120298
   Jonsson P, 2005, ANALYST, V130, P701, DOI 10.1039/b501890k
   Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049
   Koek MM, 2011, METABOLOMICS, V7, P307, DOI 10.1007/s11306-010-0254-3
   Kurata T, 2012, J NEUROL SCI, V322, P59, DOI 10.1016/j.jns.2012.06.011
   Ma QY, 2011, EXP GERONTOL, V46, P533, DOI 10.1016/j.exger.2011.02.006
   Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102
   Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y
   Morley JE, 2012, CURR PHARM DESIGN, V18, P1123
   Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015
   Nakamura S, 1992, Nihon Rinsho, V50, P1637
   Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a
   Nilsen LH, 2012, J NEUROCHEM, V123, P532, DOI 10.1111/jnc.12003
   Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8
   O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613
   Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002
   Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55
   Paban V, 2010, EUR J NEUROSCI, V31, P1063, DOI 10.1111/j.1460-9568.2010.07126.x
   Pac-Soo C, 2011, J ALZHEIMERS DIS, V27, P1, DOI [10.3233/JAD-2011-110524, 10.1097/WAD.0b013e31821f5787]
   Ricciarelli R, 2012, IUBMB LIFE, V64, P931, DOI 10.1002/iub.1091
   Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001
   Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456
   Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644
   Trushina E, 2014, BBA-MOL BASIS DIS, V1842, P1232, DOI 10.1016/j.bbadis.2013.06.014
   Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737
   Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899
   Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039
   Yao J, 2012, ADV PHARMACOL, V64, P327, DOI 10.1016/B978-0-12-394816-8.00010-6
   Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004
NR 38
TC 43
Z9 45
U1 1
U2 22
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2014
VL 39
IS 4
BP 841
EP 848
DI 10.3233/JAD-131463
PG 8
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AB5QD
UT WOS:000331842500014
PM 24284365
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Turan, ZG
   Parvizi, P
   Dönertas, HM
   Tung, J
   Khaitovich, P
   Somel, M
AF Turan, Zeliha Gozde
   Parvizi, Poorya
   Donertas, Handan Melike
   Tung, Jenny
   Khaitovich, Philipp
   Somel, Mehmet
TI Molecular footprint of Medawar's mutation accumulation process in
   mammalian aging
SO AGING CELL
LA English
DT Article
DE aging; antagonistic pleiotropy; evolution; gene expression; genetic
   drift; mutation accumulation; protein sequence conservation
ID GENE-EXPRESSION PROFILES; AGE-SPECIFIC PATTERNS;
   DROSOPHILA-MELANOGASTER; MICROARRAY ANALYSIS; VARIANCE; VERTEBRATE;
   EVOLUTION; SELECTION; SENESCENCE; SEQUENCE
AB Medawar's mutation accumulation hypothesis explains aging by the declining force of natural selection with age: Slightly deleterious germline mutations expressed in old age can drift to fixation and thereby lead to aging-related phenotypes. Although widely cited, empirical evidence for this hypothesis has remained limited. Here, we test one of its predictions that genes relatively highly expressed in old adults should be under weaker purifying selection than genes relatively highly expressed in young adults. Combining 66 transcriptome datasets (including 16 tissues from five mammalian species) with sequence conservation estimates across mammals, here we report that the overall conservation level of expressed genes is lower at old age compared to young adulthood. This age-related decrease in transcriptome conservation (ADICT) is systematically observed in diverse mammalian tissues, including the brain, liver, lung, and artery, but not in others, most notably in the muscle and heart. Where observed, ADICT is driven partly by poorly conserved genes being up-regulated during aging. In general, the more often a gene is found up-regulated with age among tissues and species, the lower its evolutionary conservation. Poorly conserved and up-regulated genes have overlapping functional properties that include responses to age-associated tissue damage, such as apoptosis and inflammation. Meanwhile, these genes do not appear to be under positive selection. Hence, genes contributing to old age phenotypes are found to harbor an excess of slightly deleterious alleles, at least in certain tissues. This supports the notion that genetic drift shapes aging in multicellular organisms, consistent with Medawar's mutation accumulation hypothesis.
C1 [Turan, Zeliha Gozde; Parvizi, Poorya; Somel, Mehmet] Middle East Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey.
   [Parvizi, Poorya] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
   [Donertas, Handan Melike] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.
   [Tung, Jenny] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA.
   [Tung, Jenny] Duke Univ, Dept Biol, Durham, NC USA.
   [Tung, Jenny] Duke Univ, Duke Populat Res Inst, Durham, NC USA.
   [Khaitovich, Philipp] Skolkovo Inst Sci & Technol, Ctr Neurobiol & Brain Restorat, Moscow, Russia.
   [Khaitovich, Philipp] Chinese Acad Sci, CAS Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.
C3 Middle East Technical University; University of Edinburgh; European
   Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute;
   Duke University; Duke University; Duke University; Skolkovo Institute of
   Science & Technology; Chinese Academy of Sciences; Max Planck Society
RP Turan, ZG; Somel, M (corresponding author), Middle East Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey.
EM turan.zelihagozde@gmail.com; somel.mehmet@gmail.com
RI Somel, Mehmet/B-1471-2016; turan, zeliha gozde/AAV-6800-2020; Parvizi,
   Parviz/I-9016-2018; Khaitovich, Philipp/HGC-8520-2022; Donertas, Handan
   Melike/J-5451-2019; Solodushenkova, Anastasia/H-1732-2019
OI Donertas, Handan Melike/0000-0002-9788-6535; Parvizi,
   Poorya/0000-0002-1282-765X; Turan, Zeliha Gozde/0000-0001-8312-7725
FU Science Academy; Scientific and Technological Research Council of Turkey
   [114C040, 215Z495]; Middle East Technical University (METU)
FX Science Academy; Scientific and Technological Research Council of
   Turkey, Grant/Award Number: 114C040 and 215Z495; Middle East Technical
   University (METU)
CR Rodríguez JA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0055
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Barnes MR, 2011, J NEUROSCI RES, V89, P1218, DOI 10.1002/jnr.22647
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105
   Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Cagan A, 2016, MOL BIOL EVOL, V33, P3268, DOI 10.1093/molbev/msw215
   Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160
   Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140
   Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045
   Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80
   Escobar JS, 2008, CURR BIOL, V18, P906, DOI 10.1016/j.cub.2008.04.070
   Flatt T, 2009, BBA-GEN SUBJECTS, V1790, P951, DOI 10.1016/j.bbagen.2009.07.010
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Hartmann A, 2009, ARCH TIERZUCHT, V52, P65, DOI 10.5194/aab-52-65-2009
   Haustead DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26846
   Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057
   Kryuchkova-Mostacci N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131673
   Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381
   Liu DM, 2013, J GERONTOL A-BIOL, V68, P1035, DOI 10.1093/gerona/glt015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Mau T, 2018, EXP GERONTOL, V105, P27, DOI 10.1016/j.exger.2017.10.014
   Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18
   Medawar P. B., 1952, COMMUNICATION
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072
   Miller SJ, 2007, AM J PHYSIOL-HEART C, V293, pH2634, DOI 10.1152/ajpheart.00397.2007
   Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007
   Moretti S, 2014, NUCLEIC ACIDS RES, V42, pD917, DOI 10.1093/nar/gkt1065
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170
   Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899
   Pál C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838
   Promislow DEL, 1996, GENETICS, V143, P839
   Qiu HY, 2007, PHYSIOL GENOMICS, V29, P169, DOI 10.1152/physiolgenomics.00229.2006
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Robins C, 2017, GENETICS, V207, P1547, DOI 10.1534/genetics.117.300217
   Rose MR, 1991, EVOLUTIONARY BIOL AG
   Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444
   Sgrò CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521
   Shaw FH, 1999, GENETICS, V152, P553
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110
   Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944
   Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033204
   Tatar M, 1996, GENETICS, V143, P849
   Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204
   Warnefors M, 2013, GENOME BIOL EVOL, V5, P1324, DOI 10.1093/gbe/evt093
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Wilson AJ, 2007, CURR BIOL, V17, P2136, DOI 10.1016/j.cub.2007.11.043
   Wit J, 2013, EXP GERONTOL, V48, P1189, DOI 10.1016/j.exger.2013.07.012
   Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237
NR 66
TC 11
Z9 14
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2019
VL 18
IS 4
AR e12965
DI 10.1111/acel.12965
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA IK7KI
UT WOS:000476767500014
PM 31062469
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Ruhland, MK
   Loza, AJ
   Capietto, AH
   Luo, XM
   Knolhoff, BL
   Flanagan, KC
   Belt, BA
   Alspach, E
   Leahy, K
   Luo, JQ
   Schaffer, A
   Edwards, JR
   Longmore, G
   Faccio, R
   DeNardo, DG
   Stewart, SA
AF Ruhland, Megan K.
   Loza, Andrew J.
   Capietto, Aude-Helene
   Luo, Xianmin
   Knolhoff, Brett L.
   Flanagan, Kevin C.
   Belt, Brian A.
   Alspach, Elise
   Leahy, Kathleen
   Luo, Jingqin
   Schaffer, Andras
   Edwards, John R.
   Longmore, Gregory
   Faccio, Roberta
   DeNardo, David G.
   Stewart, Sheila A.
TI Stromal senescence establishes an immunosuppressive microenvironment
   that drives tumorigenesis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CANCER-ASSOCIATED FIBROBLASTS; AGE-RELATED INCREASE; SUPPRESSOR-CELLS;
   CELLULAR SENESCENCE; GENE-EXPRESSION; SECRETORY PHENOTYPE; TUMOR
   SUPPRESSION; LIVER-CANCER; CRUCIAL ROLE; IN-VIVO
AB Age is a significant risk factor for the development of cancer. However, the mechanisms that drive age-related increases in cancer remain poorly understood. To determine if senescent stromal cells influence tumorigenesis, we develop a mouse model that mimics the aged skin microenvironment. Using this model, here we find that senescent stromal cells are sufficient to drive localized increases in suppressive myeloid cells that contributed to tumour promotion. Further, we find that the stromal-derived senescence-associated secretory phenotype factor interleukin-6 orchestrates both increases in suppressive myeloid cells and their ability to inhibit anti-tumour T-cell responses. Significantly, in aged, cancer-free individuals, we find similar increases in immune cells that also localize near senescent stromal cells. This work provides evidence that the accumulation of senescent stromal cells is sufficient to establish a tumour-permissive, chronic inflammatory microenvironment that can shelter incipient tumour cells, thus allowing them to proliferate and progress unabated by the immune system.
C1 [Ruhland, Megan K.; Luo, Xianmin; Flanagan, Kevin C.; Leahy, Kathleen; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Loza, Andrew J.; Knolhoff, Brett L.; Edwards, John R.; Longmore, Gregory; DeNardo, David G.; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Capietto, Aude-Helene; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthoped Surg, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Belt, Brian A.] Washington Univ, Sch Med, Dept Surg, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Alspach, Elise; Schaffer, Andras; DeNardo, David G.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Luo, Jingqin] Washington Univ, Sch Med, Div Biostat, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Luo, Jingqin; Longmore, Gregory; Faccio, Roberta; DeNardo, David G.; Stewart, Sheila A.] Washington Univ, Sch Med, Siteman Canc Ctr, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Edwards, John R.] Washington Univ, Sch Med, Ctr Pharmacogen, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Longmore, Gregory; DeNardo, David G.; Stewart, Sheila A.] Washington Univ, Sch Med, ICCE Inst, 660 South Euclid Ave, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL); Washington University (WUSTL); Washington University
   (WUSTL); Washington University (WUSTL); Siteman Cancer Center;
   Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL)
RP Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 South Euclid Ave, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Dept Med, 660 South Euclid Ave, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, 660 South Euclid Ave, St Louis, MO 63110 USA.; Stewart, SA (corresponding author), Washington Univ, Sch Med, ICCE Inst, 660 South Euclid Ave, St Louis, MO 63110 USA.
EM sheila.stewart@wustl.edu
RI Stewart, Sheila A/C-5213-2012
OI Alspach, Elise/0000-0002-2740-9768; Stewart, Sheila/0000-0002-2260-9576;
   DeNardo, David/0000-0002-3655-5783; luo, jingqin/0000-0003-2759-3072
FU American Cancer Society; NIH [5 R01CA151518, R01GM108811, CA143868, P50
   CA94056]; American Cancer Society Research Scholar Award; Alvin J.
   Siteman Cancer Research Fund at Washington University in St Louis, MO;
   Siteman Cancer Center/Barnes-Jewish Hospital Foundation; Susan G. Komen
   Breast Cancer Foundation; Washington University Center for Aging; Mary
   Kay Ash Charitable Foundation; Alvin J. Siteman Cancer Center at
   Washington University School of Medicine; Barnes-Jewish Hospital in St
   Louis, MO, USA; NCI Cancer Center [P30 CA091842]; Stewart Laboratory; 
   [T32EB018266];  [T32GM007200]
FX We thank the members of the Molecular Imaging Center and P50 CA094056
   from the NCI. We also thank Hayley Moore and Daniel Teasley for helpful
   comments on the manuscript, the entire Stewart Laboratory for helpful
   comments and support, Keith Decker for assistance with analysis of the
   RNA-seq data, and Dr Deb Novack for help with histology. Yu Zhu for
   protocol assistance. We also acknowledge the support of the American
   Cancer Society. NIH 5 R01CA151518 (S.A.S.) and R01GM108811 (J.R.E.),
   American Cancer Society Research Scholar Award (S.A.S.). The work was
   supported in part by the Alvin J. Siteman Cancer Research Fund at
   Washington University in St Louis, MO and Siteman Cancer
   Center/Barnes-Jewish Hospital Foundation (S.A.S. and R.F.), the Susan G.
   Komen Breast Cancer Foundation (S.A.S.), Washington University Center
   for Aging (S.A.S.), Mary Kay Ash Charitable Foundation (S.A.S.), NIH
   CA143868 (G.L.), ASBMR fund to R.F. Molecular imaging was funded by NIH
   P50 CA94056. Finally, we thank the Alvin J. Siteman Cancer Center at
   Washington University School of Medicine and Barnes-Jewish Hospital in
   St Louis, MO, USA for stipend support (M.K.R.). The Siteman Cancer
   Center is supported in part by NCI Cancer Center Support Grant #P30
   CA091842, Eberlein, PI. A.J.L. was supported by training grants
   T32EB018266 and T32GM007200.
CR Alspach E, 2014, CANCER DISCOV, V4, P716, DOI 10.1158/2159-8290.CD-13-0743
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x
   Capietto AH, 2013, J EXP MED, V210, P2257, DOI 10.1084/jem.20130281
   Chen SW, 2015, EXP GERONTOL, V61, P84, DOI 10.1016/j.exger.2014.12.001
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599
   Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785
   Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5
   Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003
   Grizzle WE, 2007, MECH AGEING DEV, V128, P672, DOI 10.1016/j.mad.2007.10.003
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166
   Jarrard DF, 1999, CANCER RES, V59, P2957
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lavine KJ, 2008, DEV DYNAM, V237, P713, DOI 10.1002/dvdy.21468
   Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Luo XM, 2016, CELL REP, V14, P82, DOI 10.1016/j.celrep.2015.12.016
   Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004
   Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007
   Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740
   Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621
   Shimozaki K, 1997, J BIOL CHEM, V272, P25184, DOI 10.1074/jbc.272.40.25184
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X
NR 53
TC 256
Z9 289
U1 1
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2016
VL 7
AR 11762
DI 10.1038/ncomms11762
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DO6NP
UT WOS:000377900600001
PM 27272654
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Bakala, H
   Delaval, E
   Hamelin, M
   Bismuth, J
   Borot-Laloi, C
   Corman, B
   Friguet, B
AF Bakala, H
   Delaval, E
   Hamelin, M
   Bismuth, J
   Borot-Laloi, C
   Corman, B
   Friguet, B
TI Changes in rat liver mitochondria with aging -: Lon protease-like
   activity and <i>N</i><SUP>ε</SUP>-carboxymethyllysine accumulation in
   the matrix
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE aging; mitochondria; matrix; Lon protease; carboxymethyllysine
ID ADENINE-NUCLEOTIDE TRANSLOCASE; GLYCATION END-PRODUCTS; ATP-DEPENDENT
   PROTEASE; OXIDATIVE DAMAGE; AUTOXIDATION PRODUCTS; SUPEROXIDE
   PRODUCTION; DIETARY RESTRICTION; GROWTH-FACTOR; GLYCOXIDATION; PROTEINS
AB Aging is accompanied by a gradual deterioration of cell functions. Mitochondrial dysfunction and accumulation of protein damage have been proposed to contribute to this process. The present study was carried out to examine the effects of aging in mitochondrial matrix isolated from rat liver. The activity of Lon protease, an enzyme implicated in the degradation of abnormal matrix proteins, was measured and the accumulation of oxidation and glycoxidation (N (epsilon) -carboxymethyllysine, CML) products was monitored using immunochemical assays. The function of isolated mitochondria was assessed by measuring respiratory chain activity. Mitochondria from aged (27 months) rats exhibited the same rate of oxygen consumption as those from adult (10 months) rats without any change in coupling efficiency. At the same time, the ATP-stimulated Lon protease activity, measured as fluorescent peptides released, markedly decreased from 10-month-old rats (1.15 +/- 0.15 FU.mug protein(-1) .h(-1) ) to 27-month-old-rats (0.59 +/- 0.08 FU.mug protein(-1) .h(-1) ). In parallel with this decrease in activity, oxidized proteins accumulated in the matrix upon aging while the CML-modified protein content assessed by ELISA significantly increased by 52% from 10 months (11.71 +/- 0.61 pmol CML.mug protein(-1) ) to 27 months (17.81 +/- 1.83 pmol CML.mug protein(-1) ). These results indicate that the accumulation of deleterious oxidized and carboxymethylated proteins in the matrix concomitant with loss of the Lon protease activity may affect the ability of aging mitochondria to respond to additional stress.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75252 Paris, France.
   Commissariat Energie Atom Saclay, Serv Biol Cellulaire, Gif Sur Yvette, France.
C3 Universite Paris Cite; CEA
RP Bakala, H (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, 2 Pl Jussieu, F-75252 Paris, France.
OI Friguet, Bertrand/0000-0001-8085-1961
CR APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   DESAUTELS M, 1982, J BIOL CHEM, V257, P1673
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982
   GIARDINO I, 1994, J CLIN INVEST, V94, P110, DOI 10.1172/JCI117296
   GRAY JE, 1982, J GERONTOL, V37, P142, DOI 10.1093/geronj/37.2.142
   Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550
   ISHII A, 1992, PLACENTA, V13, P343, DOI 10.1016/0143-4004(92)90058-2
   Kalous M, 1996, PHYSIOL RES, V45, P351
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677
   Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/S0006-8993(96)00708-1
   Miyata T, 1998, FEBS LETT, V437, P24, DOI 10.1016/S0014-5793(98)01079-5
   Miyata TR, 1998, KIDNEY INT, V54, P1290, DOI 10.1046/j.1523-1755.1998.00093.x
   Motomiya Y, 1998, KIDNEY INT, V54, P1357, DOI 10.1046/j.1523-1755.1998.00091.x
   Murata T, 1997, DIABETOLOGIA, V40, P764, DOI 10.1007/s001250050747
   Nagai M, 2000, BIOGERONTOLOGY, V1, P321, DOI 10.1023/A:1026590819033
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Pamplona R, 1998, EUR J BIOCHEM, V255, P685, DOI 10.1046/j.1432-1327.1998.2550685.x
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   THORNALLEY PJ, 1990, BIOCHEM J, V269, P1
   Traverso N, 1997, BBA-GEN SUBJECTS, V1336, P409, DOI 10.1016/S0304-4165(97)00052-4
   Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247
   WATABE S, 1985, J BIOL CHEM, V260, P4498
   WONG LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 44
TC 102
Z9 121
U1 0
U2 1
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD MAY
PY 2003
VL 270
IS 10
BP 2295
EP 2302
DI 10.1046/j.1432-1033.2003.03598.x
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 675VP
UT WOS:000182717400020
PM 12752449
OA Bronze
DA 2024-02-19
ER

PT J
AU Fu, HL
   Xu, HT
   Chen, H
   Li, YH
   Li, WW
   Zhu, QF
   Zhang, QQ
   Yuan, HB
   Liu, F
   Wang, QX
   Miao, MY
   Shi, XY
AF Fu, Hailong
   Xu, Haitao
   Chen, Huan
   Li, Yonghua
   Li, Weiwei
   Zhu, Qiufeng
   Zhang, Qingqing
   Yuan, Hongbin
   Liu, Fang
   Wang, Quanxing
   Miao, Mingyong
   Shi, Xueyin
TI Inhibition of glycogen synthase kinase 3 ameliorates liver
   ischemia/reperfusion injury via an energy-dependent mitochondrial
   mechanism
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Mitochondria; Signal transduction; Ischemia/reperfusion injury; Reactive
   oxygen; Energy metabolism
ID PERMEABILITY TRANSITION PORE; REPERFUSION INJURY; ISCHEMIC-INJURY;
   MOUSE-LIVER; RAT LIVERS; DAMAGE; GSK-3-BETA; HEPATOCYTES; TRANSLOCASE;
   PROTECTS
AB Background & Aims: The mechanisms of glycogen synthase kinase-3 (GSK-3)-mediated cytoprotection during liver ischemia/reperfusion (I/R) remain controversial, particularly in older organs. This study explores the role and potential mechanisms of GSK-3 in young and aging livers.
   Methods: A rodent partial warm I/R model was used to evaluate the therapeutic potential of GSK-3 modulation during hepatic I/R in young and aging Sprague-Dawley rats.
   Results: GSK-3 inhibition through IPC or SB216763 (SB21) preconditioning protected young rats from I/R-induced liver injury. This protection was absent in old animals but could be restored by glucose infusion prior to the I/R insult. The protection conferred by GSK-3 inhibition depended on mitochondrial metabolism regulation. Indeed, the inhibition of GSK-3 suppressed mitochondrial permeability transition pore (MPTP) opening, triggering mitohormesis in young animals, whereas insufficient fuel suppressed mitochondrial metabolism and inactivated the GSK-3-related protection in old animals. SB21 and glucose reactivated the mitochondrial F0F1-ATPase and subsequent protective cascades in the senescent liver. These effects were antagonized by an ATPase inhibitor and by an MPTP opener.
   Conclusions: The protection conferred by GSK-3 inhibition during hepatic I/R insult is energy dependent, particularly in senescent livers. These findings demonstrate a key role for GSK-3-related mitochondrial energy homeostasis, which may shed new light on the clinical use of GSK-3 inhibitors to protect liver function in surgical settings, particularly for older patients. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Fu, Hailong; Xu, Haitao; Li, Yonghua; Li, Weiwei; Zhu, Qiufeng; Zhang, Qingqing; Yuan, Hongbin; Shi, Xueyin] Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China.
   [Chen, Huan; Miao, Mingyong] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.
   [Liu, Fang; Wang, Quanxing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.
   [Liu, Fang; Wang, Quanxing] Second Mil Med Univ, Dept Immunol, Shanghai 200433, Peoples R China.
C3 Naval Medical University; Naval Medical University; Naval Medical
   University; Naval Medical University
RP Wang, QX (corresponding author), 800 Xiangyin Rd, Shanghai, Peoples R China.
EM wangqx@immunol.org; miaomy@163.com; shixueyin1128@163.com
RI zhang, qingqing/GXF-2381-2022; Zhang, Qing/HTT-5047-2023; Zhang,
   Qing/IZQ-5273-2023
OI , yuan/0000-0001-8468-4005; Chen, Huan/0000-0001-8648-1631
FU National Natural Scientific Foundation of China [81300344]; Key Medical
   Research Projects from the Division of Biomedicine from the Science and
   Technology Commission of Shanghai Municipality (STCSM) [10411951300];
   Medical Research Projects from STCSM [124119a3601]; Shanghai Municipal
   Health Bureau [2011227]; Key Project of the 12th Five-Year Plan of the
   PLA [BWS12J027]; Scientific Project from the 12th Five-Year Plan of the
   PLA Medicine Technology [CWS11J026]
FX This work was partially supported by grants from the National Natural
   Scientific Foundation of China (81300344 to H.L.F.), the Key Medical
   Research Projects from the Division of Biomedicine from the Science and
   Technology Commission of Shanghai Municipality (STCSM) (10411951300 to
   X.Y.S.), the Medical Research Projects from STCSM (124119a3601 to
   H.L.F.), the Projects from the Shanghai Municipal Health Bureau (2011227
   to H.L.F.), the Key Project of the 12th Five-Year Plan of the PLA
   (BWS12J027 to X.Y.S.) and the Scientific Project from the 12th Five-Year
   Plan of the PLA Medicine Technology (CWS11J026 to X.Y.S.). The funders
   did not play any role in the study design, data collection and analysis,
   decisions regarding data release or manuscript preparation.
CR CALDWELLKENKEL JC, 1991, HEPATOLOGY, V13, P83, DOI 10.1016/0270-9139(91)90219-L
   Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628
   Centurion SAR, 2007, TRANSPL P, V39, P361, DOI 10.1016/j.transproceed.2007.01.011
   Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9
   Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x
   Fu HL, 2012, MOL MED, V18, P1128, DOI 10.2119/molmed.2012.00088
   Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066
   Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021
   Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346
   Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151
   Herrero JI, 2003, AM J TRANSPLANT, V3, P1407, DOI 10.1046/j.1600-6143.2003.00227.x
   ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6
   JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4
   Kim JS, 2012, AM J PHYSIOL-GASTR L, V302, pG723, DOI 10.1152/ajpgi.00082.2011
   KRAMAR R, 1984, AGENTS ACTIONS, V15, P660, DOI 10.1007/BF01966788
   Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066
   Liu DL, 1996, ARCH SURG-CHICAGO, V131, P442
   Miura T, 2009, J PHARMACOL SCI, V109, P162, DOI 10.1254/jphs.08R27FM
   Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010
   Nishihara M, 2006, AM J PHYSIOL-HEART C, V291, pH748, DOI 10.1152/ajpheart.00837.2005
   Nishino Y, 2008, CIRC RES, V103, P307, DOI 10.1161/CIRCRESAHA.107.169953
   PIRSCH JD, 1991, TRANSPLANTATION, V51, P431, DOI 10.1097/00007890-199102000-00031
   Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419
   Rolo AP, 2009, TRANSPL INT, V22, P1081, DOI 10.1111/j.1432-2277.2009.00916.x
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Selzner N, 2003, J HEPATOL, V39, P55, DOI 10.1016/S0168-8278(03)00147-8
   Varela AT, 2010, MITOCHONDRION, V10, P456, DOI 10.1016/j.mito.2010.04.006
   VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810
   Yamada F, 2007, J GASTROEN HEPATOL, V22, P1971, DOI 10.1111/j.1440-1746.2006.04711.x
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
NR 33
TC 29
Z9 30
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD OCT
PY 2014
VL 61
IS 4
BP 816
EP 824
DI 10.1016/j.jhep.2014.05.017
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AP7IY
UT WOS:000342252200017
PM 24862449
DA 2024-02-19
ER

PT J
AU Dietrich, P
   Wormser, L
   Fritz, V
   Seitz, T
   De Maria, M
   Schambony, A
   Kremer, AE
   Günther, C
   Itzel, T
   Thasler, WE
   Teufel, A
   Trebicka, J
   Hartmann, A
   Neurath, MF
   von Hörsten, S
   Bosserhoff, AK
   Hellerbrand, C
AF Dietrich, Peter
   Wormser, Laura
   Fritz, Valerie
   Seitz, Tatjana
   De Maria, Monica
   Schambony, Alexandra
   Kremer, Andreas E.
   Guenther, Claudia
   Itzel, Timo
   Thasler, Wolfgang E.
   Teufel, Andreas
   Trebicka, Jonel
   Hartmann, Arndt
   Neurath, Markus F.
   von Hoersten, Stephan
   Bosserhoff, Anja K.
   Hellerbrand, Claus
TI Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver
   cancer
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID GROWTH-FACTOR-BETA; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION;
   THERAPEUTIC TARGET; ARCUATE NUCLEUS; PROTEIN-KINASE; CELLS; ACTIVATION;
   OBESITY; SYSTEM
AB Hepatocellular carcinoma (HCC) is clearly age-related and represents one of the deadliest cancer types worldwide. As a result of globally increasing risk factors including metabolic disorders, the incidence rates of HCC are still rising. However, the molecular hallmarks of HCC remain poorly understood. Neuropeptide Y (NPY) and NPY receptors represent a highly conserved, stress-activated system involved in diverse cancer-related hallmarks including aging and metabolic alterations, but its impact on liver cancer had been unclear. Here, we observed increased expression of NPY5 receptor (Y5R) in HCC, which correlated with tumor growth and survival. Furthermore, we found that its ligand NPY was secreted by peritumorous hepatocytes. Hepatocyte-derived NPY promoted HCC progression by Y5R activation. TGF-beta 1 was identified as a regulator of NPY in hepatocytes and induced Y5R in invasive cancer cells. Moreover, NPY conversion by dipeptidylpeptidase 4 (DPP4) augmented Y5R activation and function in liver cancer. The TGF-beta/NPY/Y5R axis and DPP4 represent attractive therapeutic targets for controlling liver cancer progression.
C1 [Dietrich, Peter; Wormser, Laura; Fritz, Valerie; Seitz, Tatjana; Bosserhoff, Anja K.; Hellerbrand, Claus] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.
   [Dietrich, Peter; Kremer, Andreas E.; Guenther, Claudia; Neurath, Markus F.] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany.
   [De Maria, Monica; Schambony, Alexandra] Friedrich Alexander Univ Erlangen Nurnberg, Biol Dept, Dev Biol, Erlangen, Germany.
   [Itzel, Timo; Teufel, Andreas] Heidelberg Univ, Med Fac Mannheim, Dept Internal Med 2, Mannheim, Germany.
   [Thasler, Wolfgang E.] Hepacult GmbH, Planegg, Germany.
   [Trebicka, Jonel] Univ Hosp Bonn, Dept Med 1, Bonn, Germany.
   [Hartmann, Arndt] Friedrich Alexander Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany.
   [Hartmann, Arndt; Neurath, Markus F.; Bosserhoff, Anja K.; Hellerbrand, Claus] Comprehens Canc Ctr Erlangen European Metropolita, Erlangen, Germany.
   [von Hoersten, Stephan] Friedrich Alexander Univ Erlangen Nurnberg, Franz Penzoldt Ctr, Dept Expt Therapy, Erlangen, Germany.
C3 University of Erlangen Nuremberg; University of Erlangen Nuremberg;
   University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg;
   University of Bonn; University of Erlangen Nuremberg; University of
   Erlangen Nuremberg; University of Erlangen Nuremberg
RP Dietrich, P; Hellerbrand, C (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.; Dietrich, P; Hellerbrand, C (corresponding author), Univ Hosp Erlangen, Dept Med 1, Ulmenweg 18, D-91054 Erlangen, Germany.
EM peter.dietrich@fau.de; claus.hellerbrand@fau.de
RI von Hörsten, Stephan/G-9005-2015; Teufel, Andreas/ABD-8000-2021;
   Bosserhoff, Anja/GNH-4801-2022
OI von Hörsten, Stephan/0000-0001-6409-0664; Trebicka,
   Jonel/0000-0002-7028-3881; Kremer, Andreas/0000-0002-9263-948X
FU German Research Association (DFG) [RTG 1962/1, FOR 2127]; German Cancer
   Aid (Deutsche Krebshilfe); Bavarian Research Network for Molecular
   Biosystems (BioSysNet); Else-Kroner-Fresenius Stiftung;
   Interdisciplinary Center for Clinical Research (IZKF) Erlangen
FX This work was supported by grants from the German Research Association
   (DFG) (Research Training Group RTG 1962/1 and FOR 2127 to PD, AKB, and
   CH), German Cancer Aid (Deutsche Krebshilfe; to PD and AKB), the
   Bavarian Research Network for Molecular Biosystems (BioSysNet; to AKB),
   the Else-Kroner-Fresenius Stiftung (to PD), and the Interdisciplinary
   Center for Clinical Research (IZKF) Erlangen (to PD, AKB, and CH). We
   thank Reiner Wiest (Inselspital, Bern, Switzerland) for valuable
   suggestions and critical discussion of the manuscript. We thank Annette
   Serwotka, Darleen Schonwalder, Sabrina Freitag, Manuel Munz, and Rudolph
   Jung for excellent technical assistance. We acknowledge the Human Tissue
   and Cell Research (HTCR) Foundation (Regensburg, Germany) for making
   human tissue available for research, as well as Hepacult GmbH
   (Planegg/Martinsried, Germany) for providing primary human hepatocytes
   for in vitro studies. We appreciate the provision of suitable samples by
   the Biobank under the administration of HTCR at the Hospital of the
   Ludwig-Maximilian University of Munich based on extensive data and
   sample analysis.
CR Abou-Alfa GK, 2019, ONCOLOGIST, V24, P161, DOI 10.1634/theoncologist.2018-0654
   Ailanen L, 2017, J ENDOCRINOL, V234, P57, DOI 10.1530/JOE-16-0223
   Amann T, 2010, AM J PATHOL, V176, P1433, DOI 10.2353/ajpath.2010.090356
   Ambrosi TH, 2017, CELL STEM CELL, V20, P771, DOI 10.1016/j.stem.2017.02.009
   Argemie J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11004-3
   Arrese M, 2018, CURR PROTEIN PEPT SC, V19, P1172, DOI 10.2174/1389203718666171117112619
   Aveleira CA, 2015, P NATL ACAD SCI USA, V112, pE1642, DOI 10.1073/pnas.1416609112
   Bárcena-Varela M, 2019, HEPATOLOGY, V69, P587, DOI 10.1002/hep.30168
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   BECKER FF, 1981, CANCER RES, V41, P3320
   BECKER FF, 1977, CANCER RES, V37, P870
   Botelho M, 2015, TRENDS NEUROSCI, V38, P701, DOI 10.1016/j.tins.2015.08.012
   Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142
   BUCHMANN A, 1991, P NATL ACAD SCI USA, V88, P911, DOI 10.1073/pnas.88.3.911
   Chaisaingmongkol J, 2017, CANCER CELL, V32, P57, DOI 10.1016/j.ccell.2017.05.009
   Chiodera P, 2000, EUR J ENDOCRINOL, V143, P715, DOI 10.1530/eje.0.1430715
   CLARKE J, 1991, CIRCULATION, V83, P774, DOI 10.1161/01.CIR.83.3.774
   Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283
   Criscione L, 1998, J CLIN INVEST, V102, P2136, DOI 10.1172/JCI4188
   de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497
   Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124
   Dietrich P, 2013, J HEPATOL, V58, P254, DOI 10.1016/j.jhep.2012.09.027
   Dietrich P, 2018, GUT, V67, P1328, DOI 10.1136/gutjnl-2017-315402
   Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008
   Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Erondu N, 2006, CELL METAB, V4, P275, DOI 10.1016/j.cmet.2006.08.002
   FREDHOLM BB, 1985, ACTA PHYSIOL SCAND, V124, P467, DOI 10.1111/j.1748-1716.1985.tb07683.x
   FUKUI Y, 1990, CELL STRUCT FUNCT, V15, P117, DOI 10.1247/csf.15.117
   Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138
   Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007
   Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243
   GRUENEWALD DA, 1994, ENDOCRINOLOGY, V134, P2383, DOI 10.1210/en.134.6.2383
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601
   Hartl J, 2015, LIVER INT, V35, P2556, DOI 10.1111/liv.12874
   Hellerbrand C, 2008, GUT, V57, P243, DOI 10.1136/gut.2007.129544
   HESTON WE, 1960, J NATL CANCER I, V24, P425
   Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z
   Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151
   JANG JJ, 1992, CARCINOGENESIS, V13, P1541
   Kallio J, 2001, FASEB J, V15, P1242, DOI 10.1096/fj.00-0436fje
   Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513
   Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008
   LEE GH, 1989, CANCER RES, V49, P403
   Li J, 2014, J HEPATOL, V60, P1225, DOI 10.1016/j.jhep.2014.02.025
   Li L, 2016, ENDOCRINOLOGY, V157, P4842, DOI 10.1210/en.2016-1662
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lv X, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0785-1
   Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361
   Mannon PJ, 1998, BIOCHEM BIOPH RES CO, V246, P91, DOI 10.1006/bbrc.1998.8577
   Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718
   Matsuyama S, 2003, CANCER RES, V63, P7791
   Minor RK, 2011, AGING CELL, V10, P483, DOI 10.1111/j.1474-9726.2011.00693.x
   Moleda L, 2011, GUT, V60, P1122, DOI 10.1136/gut.2010.226407
   Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003
   Mukai M, 2000, FEBS LETT, V484, P69, DOI 10.1016/S0014-5793(00)02129-3
   Mullins DE, 2002, REGUL PEPTIDES, V105, P65, DOI 10.1016/S0167-0115(01)00388-3
   Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004
   Nakamura Y, 2017, CELL METAB, V25, P322, DOI 10.1016/j.cmet.2016.12.002
   Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397
   Park MH, 2016, STEM CELLS, V34, P2145, DOI 10.1002/stem.2383
   Park MH, 2015, BMB REP, V48, P645, DOI 10.5483/BMBRep.2015.48.12.22
   Pérez RF, 2018, AGING CELL, V17, DOI 10.1111/acel.12744
   Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256
   Rani B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0384-5
   Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007
   Richter K, 2015, REDOX BIOL, V6, P344, DOI 10.1016/j.redox.2015.08.015
   Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716
   RUEBNER BH, 1984, J NATL CANCER I, V73, P493, DOI 10.1093/jnci/73.2.493
   Saito Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21121-6
   Schmitz V, 2004, J HEPATOL, V40, P787, DOI 10.1016/j.jhep.2004.01.010
   Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x
   Sigala B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072928
   Singh P, 2017, J CLIN INVEST, V127, P4527, DOI 10.1172/JCI94687
   Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447
   Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Turnbull AV, 2002, DIABETES, V51, P2441, DOI 10.2337/diabetes.51.8.2441
   Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4
   Wagner L, 2016, NEUROPEPTIDES, V57, P21, DOI 10.1016/j.npep.2016.02.007
   Wang WG, 2014, BIRTH DEFECTS RES C, V102, P37, DOI 10.1002/bdrc.21058
   Wiest R, 2006, J HEPATOL, V44, P512, DOI 10.1016/j.jhep.2005.08.023
   Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003
   Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392
   Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039
   Yi M, 2018, CELL PHYSIOL BIOCHEM, V45, P88, DOI 10.1159/000486225
   ZIEGLER MG, 1976, NATURE, V261, P333, DOI 10.1038/261333a0
   Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187
NR 92
TC 24
Z9 26
U1 1
U2 10
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAY 1
PY 2020
VL 130
IS 5
BP 2509
EP 2526
DI 10.1172/JCI131919
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA NQ8MD
UT WOS:000571121100036
PM 31999643
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Naiini, MR
   Shahouzehi, B
   Azizi, S
   Shafiei, B
   Nazari-Robati, M
AF Naiini, Mahdis Rahimi
   Shahouzehi, Beydolah
   Azizi, Shahrzad
   Shafiei, Bentolhoda
   Nazari-Robati, Mahdieh
TI Trehalose-induced SIRT1/AMPK activation regulates SREBP-1c/PPAR-α to
   alleviate lipid accumulation in aged liver
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article; Early Access
DE Aging; SIRT1; AMPK; SREBP-1c; PPAR-& alpha;; Trehalose
ID FATTY LIVER; AMPK; CHOLESTEROL; INHIBITION; METABOLISM; EXPRESSION;
   HALLMARKS; GLUCOSE; ROLES
AB Aging is associated with a disturbance in the regulation of the metabolic function of the liver, which increases the risk of liver and systemic diseases. Trehalose, a natural disaccharide, has been identified to reduce dyslipidemia, hepatic steatosis, and glucose intolerance. However, the roles of trehalose on lipid metabolism in aged liver are unclear which was investigated in this study. Thirty-two male Wistar rats were randomly allocated into four groups (n = 8). Two groups of aged (24 months) and young (4 months) rats were administered 2% trehalose solution orally for 30 days. Control groups of aged and young rats did not receive any treatment. At the end of the treatment period, blood samples and liver tissues were collected. Then the expression of SIRT1, AMPK, SREBP-1c, and PPAR-a and the level of AMPK phosphorylation (p-AMPK) were quantified by real-time polymerase chain reaction and western blotting. Moreover, biochemical parameters and the histopathology of livers were evaluated. Trehalose supplementation increased the level of SIRT1, p-AMPK, and PPAR-a, whereas the level of SREBP-1c was diminished in the liver of old animals. In addition, treatment with trehalose improved histopathological features of senescent livers. Taken together, our results show that old rats developed lipogenesis in the liver which was alleviated with trehalose. Therefore, trehalose may be an effective intervention to reduce the progression of aging-induced liver diseases.
C1 [Naiini, Mahdis Rahimi; Shafiei, Bentolhoda; Nazari-Robati, Mahdieh] Kerman Univ Med Sci, Fac Med, Dept Clin Biochem, Kerman, Iran.
   [Shahouzehi, Beydolah] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Cardiovasc Res Ctr, Kerman, Iran.
   [Azizi, Shahrzad] Shahid Bahonar Univ Kerman, Fac Vet Med, Dept Pathobiol, Kerman, Iran.
C3 Kerman University of Medical Sciences; Kerman University of Medical
   Sciences; Shahid Bahonar University of Kerman (SBUK)
RP Nazari-Robati, M (corresponding author), Kerman Univ Med Sci, Fac Med, Dept Clin Biochem, Kerman, Iran.
EM mnazari@kmu.ac.ir
FU Kerman University of Medical Sciences [400000186]
FX This study was funded by Kerman University of Medical Sciences (Grant
   No. 400000186).
CR Antunes LC, 2016, ARCH ENDOCRIN METAB, V60, P138
   Arai C, 2010, NUTR RES, V30, P840, DOI 10.1016/j.nutres.2010.10.009
   Attal N, 2022, BIOLOGY-BASEL, V11, DOI 10.3390/biology11111613
   Bahri F, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13931
   Barcena B, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101535
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen C, 2020, MECH AGEING DEV, V187, DOI 10.1016/j.mad.2020.111215
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80
   Eustice M, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0274076
   FRIEDEWALD WT, 1972, CLIN CHEM, V0018
   Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164
   HAUG A, 1987, J NUTR, V117, P1011, DOI 10.1093/jn/117.6.1011
   Hozhabri Y, 2022, MOL BIOL RES COMMUN, V11, P29, DOI 10.22099/mbrc.2022.42014.1688
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ismi DF., 2022, AMERTA NUTR, V6, P198, DOI [10.20473/amnt.v6i2.2022.198-205, DOI 10.20473/AMNT.V6I2.2022.198-205]
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Korolenko TA, 2022, LIFE-BASEL, V12, DOI 10.3390/life12030442
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mohammadi A, 2017, ARYA ATHEROSCLER, V13, P257
   Mollica MP, 2001, CELL MOL LIFE SCI, V58, P477, DOI 10.1007/PL00000871
   Murotomi K, 2019, J FUNCT FOODS, V56, P303, DOI 10.1016/j.jff.2019.03.017
   Narita H, 2019, BIOCHEM BIOPH RES CO, V514, P672, DOI 10.1016/j.bbrc.2019.05.017
   Nunes VS, 2022, AGING-US, V14, P1549, DOI 10.18632/aging.203880
   Pagliassotti MJ, 2017, J NUTR BIOCHEM, V45, P15, DOI 10.1016/j.jnutbio.2017.02.022
   Papsdorf K, 2019, TRENDS CELL BIOL, V29, P97, DOI 10.1016/j.tcb.2018.09.004
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009
   Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Shafiei B, 2022, NEUROCHEM RES, V47, P3309, DOI 10.1007/s11064-022-03687-w
   Stachowicz A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071552
   Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Yamazaki T, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10092199
   Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008
NR 42
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD 2024 FEB
PY 2024
VL 397
IS 2
BP 1061
EP 1070
DI 10.1007/s00210-023-02644-w
EA AUG 2023
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA EW9P5
UT WOS:001049065300001
PM 37581638
DA 2024-02-19
ER

PT J
AU Urasaki, Y
   Fiscus, RR
   Le, TT
AF Urasaki, Yasuyo
   Fiscus, Ronald R.
   Le, Thuc T.
TI Molecular classification of fatty liver by high-throughput profiling of
   protein post-translational modifications
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE capillary isoelectric focusing immunoassay; coherent anti-Stokes Raman
   scattering microscopy; fatty liver disease; liver energy metabolism;
   molecular classification; nutrient sensing
ID ACID-BINDING PROTEIN; METABOLIC DISEASES; HEPATIC STEATOSIS;
   LIPID-METABOLISM; O-GLCNAC; PHOSPHORYLATION; ACETYLATION; SYNTHASE;
   GLUCOSE; HYPERACETYLATION
AB We describe an alternative approach to classifying fatty liver by profiling protein post-translational modifications (PTMs) with high-throughput capillary isoelectric focusing (cIEF) immunoassays. Four strains of mice were studied, with fatty livers induced by different causes, such as ageing, genetic mutation, acute drug usage, and high-fat diet. Nutrient-sensitive PTMs of a panel of 12 liver metabolic and signalling proteins were simultaneously evaluated with cIEF immunoassays, using nanograms of total cellular protein per assay. Changes to liver protein acetylation, phosphorylation, and O-N-acetylglucosamine glycosylation were quantified and compared between normal and diseased states. Fatty liver tissues could be distinguished from one another by distinctive protein PTM profiles. Fatty liver is currently classified by morphological assessment of lipid droplets, without identifying the underlying molecular causes. In contrast, high-throughput profiling of protein PTMs has the potential to provide molecular classification of fatty liver. Copyright (c) 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Urasaki, Yasuyo; Fiscus, Ronald R.; Le, Thuc T.] Roseman Univ Hlth Sci, Dept Biomed Sci, Coll Med, 10530 Discovery Dr, Las Vegas, NV USA.
RP Le, TT (corresponding author), 10530 Discovery Dr, Las Vegas, NV 89135 USA.
EM tle5@roseman.edu
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Angulo Paul, 2002, Ann Hepatol, V1, P12
   [Anonymous], 2012, GUIAS ORG MUNDIAL GA
   Aspinall-O'Dea M, 2015, NAT PROTOC, V10, P149, DOI 10.1038/nprot.2015.007
   Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006
   Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521
   Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223
   Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286
   Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chen JQ, 2013, MOL CANCER THER, V12, P2601, DOI 10.1158/1535-7163.MCT-13-0074
   Córsico B, 2005, J LIPID RES, V46, P1765, DOI 10.1194/jlr.M500140-JLR200
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842
   Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903
   Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003
   Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Guarente L, 2011, CELL METAB, V14, P151, DOI 10.1016/j.cmet.2011.07.007
   Guo H, 2014, ONCOGENE, V33, P3463, DOI 10.1038/onc.2013.301
   Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200
   Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463
   HRESKO RC, 1988, P NATL ACAD SCI USA, V85, P8835, DOI 10.1073/pnas.85.23.8835
   Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119
   Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939
   Johlfs MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132105
   Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0
   Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010
   Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179
   Le TT, 2013, J LIPID RES, V54, P1044, DOI 10.1194/jlr.M034249
   Le TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051092
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Monteserin-Garcia J, 2013, FASEB J, V27, P1561, DOI 10.1096/fj.12-220129
   Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868
   NIELSEN SU, 1993, J LIPID RES, V34, P1355
   O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103
   Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999
   Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052
   Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Tikhanovich I, 2014, HEPATOLOGY, V59, P58, DOI 10.1002/hep.26618
   Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038418
   van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190
   Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305
   Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X
   Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100
   Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056
   Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
   Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398
NR 64
TC 15
Z9 16
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD APR
PY 2016
VL 238
IS 5
BP 641
EP 650
DI 10.1002/path.4685
PG 10
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA DH7QE
UT WOS:000372988100006
PM 26725750
DA 2024-02-19
ER

PT J
AU Wang, WL
   Zheng, XL
   Li, QS
   Liu, WY
   Hu, LS
   Sha, HC
   Guo, K
   Lv, Y
   Wang, B
AF Wang, Wan-Li
   Zheng, Xing-Long
   Li, Qing-Shan
   Liu, Wen-Yan
   Hu, Liang-Shuo
   Sha, Huan-Chen
   Guo, Kun
   Lv, Yi
   Wang, Bo
TI The effect of aging on VEGF/VEGFR2 signal pathway genes expression in
   rat liver sinusoidal endothelial cell
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Early Access
DE Aged; Liver sinusoidal endothelial cells; Liver regeneration; Vascular
   endothelial growth factor receptor 2; VEGFR2
ID AGE-RELATED-CHANGES; VEGF; REGENERATION; PHENOTYPE; APOPTOSIS; SURGERY
AB Liver sinusoidal endothelial cells (LSECs) play a key role in the initiation and neoangiogenesis of liver regeneration. We presume that the abnormity of the VEGF/VEGFR2 and its pathway gene Id1, Wnt2 and HGF expression in aged LSECs may be an important mechanism to affect liver regeneration of the elderly. LSECs from two different groups (adult and old) were isolated in a rodent model, and observed by SEM and TEM. The adult and old rats were underwent 70% partial hepatectomy. The proliferation of hepatocytes and LSECs were analyzed by Immunofluorescence staining. The expression of VEGF/VEGFR2 and its pathway gene in isolated LSECs and liver tissue after hepatectomy were detected by qRT-PCR and Western blot. There is a decreased number of endothelial fenestrae in the LSECs of the old group, compared to the adult group. The old group had a lower expression of VEGF/VEGFR2 and its pathway gene than the adult groups (p < 0.01). The results of western blot were consistent with those of qRT-PCR. The hepatocytes had a high proliferation rate at first 4 days after hepatectomy, and a significantly higher proliferation rate in the adult group. The LSECs began to proliferate after 4 days of hepatectomy, and showed a quantity advantage in the adult group. The adult group had a significantly higher expression of VEGF/VEGFR2 and its pathway gene after hepatectomy than the old group (p < 0.01). LSCEs turn to be defenestration in structure and have a low expression of VEGF/VEGFR2 and its pathway gene with aging.
C1 [Wang, Wan-Li; Li, Qing-Shan; Liu, Wen-Yan; Hu, Liang-Shuo; Sha, Huan-Chen; Guo, Kun; Lv, Yi; Wang, Bo] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.
   [Zheng, Xing-Long] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.
   [Wang, Wan-Li] Bazhong Cent Hosp, Dept Gen Surg, 1 Nanchi River St, Bazhong 636000, Sichuan, Peoples R China.
   [Wang, Wan-Li; Zheng, Xing-Long; Li, Qing-Shan; Liu, Wen-Yan; Hu, Liang-Shuo; Lv, Yi; Wang, Bo] Xi An Jiao Tong Univ, Res Inst Adv Surg Tech & Engn, Xian 710061, Shaanxi, Peoples R China.
C3 Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong
   University
RP Wang, WL (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Wang, WL (corresponding author), Bazhong Cent Hosp, Dept Gen Surg, 1 Nanchi River St, Bazhong 636000, Sichuan, Peoples R China.; Wang, WL (corresponding author), Xi An Jiao Tong Univ, Res Inst Adv Surg Tech & Engn, Xian 710061, Shaanxi, Peoples R China.
EM wanli-wang0728@foxmail.com; zhengxinglongmay@163.com; bobwang75@126.com
RI wang, bo/HGV-0768-2022; liu, wen/HGE-3071-2022; LI, QS/IED-7767-2023
OI Wang, Wanli/0000-0002-0291-0847
FU National Natural Science Foundation of China [81270521, 81870445]; Youth
   Creative Project of Medical Research in Sichuan Province [Q15087]
FX This study was supported by a grant from National Natural Science
   Foundation of China (No. 81270521 and 81870445). This work was also
   supported in part by the Youth Creative Project of Medical Research in
   Sichuan Province (Grant No. Q15087).
CR Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   Cheluvappa R, 2007, EXP GERONTOL, V42, P1012, DOI 10.1016/j.exger.2007.06.001
   Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156
   Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713
   DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   Harb R, 2009, GASTROENTEROLOGY, V137, P704, DOI 10.1053/j.gastro.2009.05.009
   Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880
   IJtsma AJC, 2008, J GASTROINTEST SURG, V12, P2196, DOI 10.1007/s11605-008-0563-2
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Kan Zuxing, 2008, Semin Intervent Radiol, V25, P77, DOI 10.1055/s-2008-1076685
   Karrar A, 2007, GUT, V56, P243, DOI 10.1136/gut.2006.093906
   Mackey S, 2003, HEPATOLOGY, V38, P1349, DOI 10.1016/j.hep.2003.10.007
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   MCCLOSKEY TW, 1992, HEPATOLOGY, V16, P191, DOI 10.1002/hep.1840160130
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   SMEDSROD B, 1985, CELL TISSUE RES, V241, P639
   Warren A, 2007, J HEPATOL, V46, P239, DOI 10.1016/j.jhep.2006.08.022
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Xie GH, 2010, AM J PHYSIOL-GASTR L, V299, pG1204, DOI 10.1152/ajpgi.00302.2010
   Yokomori H, 2009, LIVER INT, V29, P266, DOI 10.1111/j.1478-3231.2008.01891.x
NR 32
TC 3
Z9 3
U1 3
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD 2021 JAN
PY 2021
VL 476
IS 1
BP 269
EP 277
DI 10.1007/s11010-020-03903-7
EA SEP 2020
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA QD5UX
UT WOS:000568654200001
PM 32918705
DA 2024-02-19
ER

PT J
AU Wang, HH
   Chen, WL
   Cui, YY
   Gong, HH
   Li, H
AF Wang, Hou-Hong
   Chen, Wen-Li
   Cui, Ya-Yun
   Gong, Hui-Hui
   Li, Heng
TI Cellular senescence throws new insights into patient classification and
   pharmacological interventions for clinical management of hepatocellular
   carcinoma
SO WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
LA English
DT Article
DE Cellular senescence; Hepatocellular carcinoma; Prognosis; Subtypes;
   Tumor microenvironment; Gene signature; Pharmacological interventions
ID R PACKAGE; SIGNATURE; IMMUNOTHERAPY; PROGNOSIS; PROMOTES; LIVER; HCC
AB BACKGROUND Cellular senescence, a state of stable growth arrest, is intertwined with human cancers. However, characterization of cellular senescence-associated phenotypes in hepatocellular carcinoma (HCC) remains unexplored.AIM To address this issue, we delineated cellular senescence landscape across HCC.METHODS We enrolled two HCC datasets, TCGA-LIHC and International Cancer Genome Consortium (ICGC). Unsupervised clustering was executed to probe tumor heterogeneity based upon cellular senescence genes. Least absolute shrinkage and selection operator algorithm were utilized to define a cellular senescence-relevant scoring system. TRNP1 expression was measured in HCCs and normal tissues through immunohistochemistry, immunoblotting and quantitative real-time polymerase chain reaction. The influence of TMF-regulated nuclear protein (TRNP)1 on HCC senescence and growth was proven via a series of experiments.RESULTS TCGA-LIHC patients were classified as three cellular senescence subtypes, named C1-3. The robustness and reproducibility of these subtypes were proven in the ICGC cohort. C2 had the worst overall survival, C1 the next, and C3 the best. C2 presented the highest levels of immune checkpoints, abundance of immune cells, and immunogenetic indicators. Thus, C2 might possibly respond to immunotherapy. C2 had the lowest somatic mutation rate, while C1 presented the highest copy number variations. A cellular senescence-relevant gene signature was generated, which can predict patient survival, and chemo- or immunotherapeutic response. Experimentally, it was proven that TRNP1 presented the remarkable upregulation in HCCs. TRNP1 knockdown induced apoptosis and senescence of HCC cells and attenuated tumor growth.CONCLUSION These findings provide a systematic framework for assessing cellular senescence in HCC, which decode the tumor heterogeneity and tailor the pharmacological interventions to improve clinical management.
C1 [Wang, Hou-Hong; Chen, Wen-Li] Anhui Med Univ, Affiliated Bozhou Hosp, Dept Gen Surg, Bozhou 236800, Anhui, Peoples R China.
   [Cui, Ya-Yun] Univ Sci & Technol China, Affiliated Hosp USTC 1, Anhui Prov Canc Hosp, Div Life Sci & Med,Anhui Prov Canc Hosp, Hefei 230000, Anhui, Peoples R China.
   [Gong, Hui-Hui] Oxford Brookes Univ, Fac Hlth & Life Sci, Oxford OX3 0BP, England.
   [Li, Heng] West Dist First Affiliated Hosp USTC, Anhui Prov Canc Hosp, Dept Comprehens Surg, 17 Lujiang Rd, Hefei 230000, Anhui, Peoples R China.
C3 Anhui Medical University; Chinese Academy of Sciences; University of
   Science & Technology of China, CAS; Oxford Brookes University
RP Li, H (corresponding author), West Dist First Affiliated Hosp USTC, Anhui Prov Canc Hosp, Dept Comprehens Surg, 17 Lujiang Rd, Hefei 230000, Anhui, Peoples R China.
EM jxna36@163.com
FU Project of Bozhou Municipal Health Commission [bzwj2022A001]; Project of
   Bozhou Science and Technology Bureau [bzzc2022008]; Scientific Research
   Fund of Bozhou Hospital, Anhui Medical University [by2022001]
FX Supported by Project of Bozhou Municipal Health Commission, No.
   bzwj2022A001; Project of Bozhou Science and Technology Bureau, No.
   bzzc2022008; and Scientific Research Fund of Bozhou Hospital, Anhui
   Medical University, No. by2022001.
CR Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Basu A, 2022, PHARMACOL THERAPEUT, V230, DOI 10.1016/j.pharmthera.2021.107943
   Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467
   Cai J, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-00287-7
   Cao F, 2021, CELL SIGNAL, V87, DOI 10.1016/j.cellsig.2021.110098
   Chand V, 2022, ONCOGENE, V41, P3778, DOI 10.1038/s41388-022-02394-8
   Chatsirisupachai K, 2019, AGING CELL, V18, DOI 10.1111/acel.13041
   Chen LJ, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.739039
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Eide PW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16747-x
   Engebretsen S, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0730-1
   Geeleher P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107468
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hu B, 2020, J HEPATOCELL CARCINO, V7, P315, DOI 10.2147/JHC.S272109
   Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1
   Kang YK, 2022, LANCET ONCOL, V23, P234, DOI 10.1016/S1470-2045(21)00692-6
   Krstic J, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abh2635
   Laphanuwat P, 2023, IMMUNOL REV, V316, P160, DOI 10.1111/imr.13206
   Lee DA, 2019, IMMUNOL REV, V290, P85, DOI 10.1111/imr.12793
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Liu BY, 2019, ONCOGENE, V38, P2501, DOI 10.1038/s41388-018-0605-5
   Liu BY, 2022, J IMMUNOTHER CANCER, V10, DOI 10.1136/jitc-2021-003069
   Liu J, 2021, J ONCOL, V2021, DOI 10.1155/2021/5574150
   Liu M, 2014, PROTEIN CELL, V5, P673, DOI 10.1007/s13238-014-0065-9
   Liu XC, 2020, DNA CELL BIOL, V39, P1621, DOI 10.1089/dna.2020.5512
   Long JY, 2019, EBIOMEDICINE, V42, P363, DOI 10.1016/j.ebiom.2019.03.022
   Luo Y, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.974377
   Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118
   McGettigan SE, 2021, IMMUNOL REV, V303, P103, DOI 10.1111/imr.12991
   Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41
   Pan YL, 2022, CELL ONCOL, V45, P163, DOI 10.1007/s13402-022-00659-8
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Ren FL, 2020, J MED VIROL, V92, P53, DOI 10.1002/jmv.25572
   Sperandio RC, 2022, ANNU REV MED, V73, P267, DOI 10.1146/annurev-med-042220-021121
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tao L, 2021, FOOD FUNCT, V12, P2914, DOI [10.1039/d0fo03246h, 10.1039/D0FO03246H]
   Tian Y, 2023, MOL CANCER, V22, DOI 10.1186/s12943-022-01706-6
   Wang B., 2021, CANCER RES, V81, P6087, DOI DOI 10.1158/0008-5472.CAN-21-2032
   Wang LQ, 2022, NAT REV CANCER, V22, P340, DOI 10.1038/s41568-022-00450-9
   Wang S, 2021, HEPATOBIL SURG NUTR, V10, P172, DOI 10.21037/hbsn.2019.09.17
   Wang XM, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac118
   Wang ZN, 2022, J IMMUNOL RES, V2022, DOI 10.1155/2022/2756611
   Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170
   Wu CS, 2022, CANCER SCI, V113, P553, DOI 10.1111/cas.15242
   Xiang XH, 2021, THERANOSTICS, V11, P4929, DOI 10.7150/thno.55672
   Yamamoto-Imoto H, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110444
   Yau T, 2020, JAMA ONCOL, V6, DOI 10.1001/jamaoncol.2020.4564
   Yildiz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064016
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yu X, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1029872
   Zhang D, 2022, NAT CELL BIOL, V24, P766, DOI 10.1038/s41556-022-00894-z
NR 51
TC 0
Z9 0
U1 2
U2 2
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1948-5204
J9 WORLD J GASTRO ONCOL
JI World J. Gastrointest. Oncol.
PD SEP 15
PY 2023
VL 15
IS 9
DI 10.4251/wjgo.v15.i9.1567
PG 29
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA S8JA8
UT WOS:001073563800006
PM 37746655
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Amicarelli, F
   DiIlio, C
   Masciocco, L
   Bonfigli, A
   Zarivi, O
   DAndrea, MR
   DiGiulio, C
   Miranda, M
AF Amicarelli, F
   DiIlio, C
   Masciocco, L
   Bonfigli, A
   Zarivi, O
   DAndrea, MR
   DiGiulio, C
   Miranda, M
TI Aging and detoxifying enzymes responses to hypoxic or hyperoxic
   treatment
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE hypoxia; hyperoxia; oxidative stress; detoxifying enzymes; antioxidant
   enzymes; ageing
ID GLUTATHIONE-PEROXIDASE; OXYGEN-TOXICITY; TRANSFERASE; RADICALS
AB We studied the levels of antioxidant and detoxifying enzymes in the livers and lungs of young and old rats kept under hypoxic or hyperoxic conditions as models of oxidative stress. In particular, we investigated the levels of enzymes directly involved in active oxygen species scavenging (superoxide dismutase, catalase and glutathione peroxidase-selenium dependent) and enzymes challenged with detoxification processes (glutathione transferase, glyoxalase I and glutathione reductase) in order to obtain a wide comparative view of the defence strategies used with respect to the age of the animals. The results show that the responses of some protective enzymes in young rats are opposite to those of old ones. Some of the changes found appear mainly due to age, while others appear to be due only to the oxygen tensions and are independent of the aging process. The glutathione contents of the liver and lung from young and old rats under hypoxic and hyperoxic conditions were measured. (C) 1997 Elsevier Science Ireland Ltd.
C1 UNIV AQUILA,DEPT BASIC & APPL BIOL,I-67010 COPPITO,LAQUILA,ITALY.
   UNIV CHIETI,INST BIOCHEM SCI,CHIETI,ITALY.
   UNIV CHIETI,INST PHYSIOL,CHIETI,ITALY.
   IST SUPER EDUC FIS AQUILA,LAQUILA,ITALY.
C3 University of L'Aquila; G d'Annunzio University of Chieti-Pescara; G
   d'Annunzio University of Chieti-Pescara
RI Zarivi, Osvaldo/ABG-8795-2021; Zarivi, Osvaldo/AAB-2150-2022; , Di
   Giulio Camillo/F-5252-2014; Zarivi, Osvaldo/V-2939-2018
OI Zarivi, Osvaldo/0000-0002-8312-9955; , Di Giulio
   Camillo/0000-0003-1073-6989; Zarivi, Osvaldo/0000-0002-8312-9955;
   Amicarelli, Fernanda/0000-0003-4528-4660
CR Balentine JD, 1982, PATHOLOGY OXYGEN TOX
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   COSTA LE, 1993, AM J PHYSIOL, V264, pC1935
   CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721
   DIILIO C, 1986, J MOL CELL CARDIOL, V18, P983
   DIILIO C, 1983, BIOCHEM MED METAB B, V29, P143, DOI 10.1016/0006-2944(83)90034-0
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669
   FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693
   Gilbert DL, 1981, OXYGEN LIVING PROCES
   Habig W H, 1981, Methods Enzymol, V77, P398
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   HASSAN HM, 1980, ENZYMATIC BASIS DETO, V1, P311
   JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63
   JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415
   KALAPOS MP, 64 M BIOCH SOC LOND
   Luck H., 1965, METHOD ENZYMAT AN, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4
   Mannervik B, 1981, Methods Enzymol, V77, P297
   Mannervik B., 1980, ENZYMATIC BASIS DETO, V2, P263
   PACIFICI RE, 1990, METHOD ENZYMOL, V186, P485
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301
   SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6
   THORNALLEY PJ, 1990, BIOCHEM J, V269, P1
   Wendel A., 1980, ENZYMATIC BASIS DETO, P333
NR 26
TC 27
Z9 27
U1 2
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1997
VL 97
IS 3
BP 215
EP 226
DI 10.1016/S0047-6374(97)00061-4
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA XJ762
UT WOS:A1997XJ76200003
PM 9234235
DA 2024-02-19
ER

PT J
AU Köhler, UA
   Böhm, F
   Rolfs, F
   Egger, M
   Hornemann, T
   Pasparakis, M
   Weber, A
   Werner, S
AF Koehler, Ulrike A.
   Boehm, Friederike
   Rolfs, Frank
   Egger, Michele
   Hornemann, Thorsten
   Pasparakis, Manolis
   Weber, Achim
   Werner, Sabine
TI NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to
   prevent development of hepatocellular adenoma
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Nrf2; NF-kappa B; Hepatocellular adenoma; Inflammation; Liver fibrosis
ID INDUCED LIVER-INJURY; GENE-EXPRESSION; TRANSCRIPTION FACTORS; SIGNALING
   PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; PROSTATE-CANCER; CELLS;
   REGENERATION; ACTIVATION
AB Background & Aims: The liver is frequently challenged by toxins and reactive oxygen species. Therefore, hepatocytes require cytoprotective strategies to cope with these insults. Since the transcription factors Nrf2 and NF-kappa B regulate the cellular antioxidant defense system and important survival pathways, we determined their individual and overlapping functions in the liver.
   Methods: We generated mice lacking Nrf2 and the NF-kappa B RelA/p65 subunit in hepatocytes and we analyzed their liver by using histopathology, immunohistochemistry, quantitative RT-PCR, Western blot and Oxyblot analysis. Human inflammatory hepatocellular adenomas (iHCA) were analyzed by immunohistochemistry.
   Results: Loss of either Nrf2 or NF-kappa B/RelA had only a minor effect on liver homeostasis, but the double knockout mice spontaneously developed liver inflammation and fibrosis. Upon aging, more than one-third of the female double mutant mice developed tumors, which histologically resemble human iHCA, a tumor that predominantly occurs in women. The mouse tumors also recapitulated the immunohistochemical marker profile characteristic for human iHCA. Moreover, pNRF2 and NF-kappa B RelA/p65 was not detectable in the nuclei of iHCA tumor cells. The mouse phenotype was not due to a synergistic effect of both transcription factors on cytoprotective Nrf2 target genes. Rather, loss of Nrf2 or NF-kappa B/RelA altered the expression of different genes, and the combination of these alterations likely affects liver homeostasis in the double mutant mice.
   Conclusions: Our results provide genetic evidence for a functional cross-talk of Nrf2 and NF-kappa B/RelA in hepatocytes, which protects the liver from necrosis, inflammation and fibrosis. Furthermore, the double mutant mice represent a valuable animal model for iHCA. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Koehler, Ulrike A.; Rolfs, Frank; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland.
   [Boehm, Friederike; Egger, Michele; Weber, Achim] Univ Zurich, Inst Surg Pathol, CH-8091 Zurich, Switzerland.
   [Boehm, Friederike; Egger, Michele; Hornemann, Thorsten; Weber, Achim] Univ Zurich Hosp, CH-8091 Zurich, Switzerland.
   [Hornemann, Thorsten] Univ Zurich, Inst Clin Chem, CH-8091 Zurich, Switzerland.
   [Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany.
   [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.
   [Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; University of
   Zurich; University of Zurich; University Zurich Hospital; University of
   Zurich; University of Cologne; University of Cologne; University of
   Cologne
RP Weber, A (corresponding author), Univ Zurich, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.
EM achim.weber@usz.ch; sabine.werner@biol.ethz.ch
RI Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019
OI Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis,
   Manolis/0000-0002-9870-0966; Werner, Sabine/0000-0001-7397-8710
FU ETH Zurich [0-23123-08]; Swiss National Science Foundation
   [310030-142884]; Swiss Cancer League [KLS - 02773-02-2011]; Promedica
   Foundation Chur; Boehringer Ingelheim Fonds
FX Supported by grants from ETH Zurich (No. 0-23123-08 to S.W.), the Swiss
   National Science Foundation (310030-142884 to S.W.), the Swiss Cancer
   League (KLS - 02773-02-2011 to A.W.), the Promedica Foundation Chur (to
   A.W.), and the Boehringer Ingelheim Fonds (predoctoral fellowship to
   U.A.K.). U.A.K. was a member of the International Research Training
   Group (IRTG 1331; Konstanz/Zurich).
CR Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344
   Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950
   Bioulac-Sage P, 2010, GASTROEN CLIN BIOL, V34, P355, DOI 10.1016/j.gcb.2010.03.014
   Bioulac-Sage P, 2008, HEPATOL INT, V2, P316, DOI 10.1007/s12072-008-9075-0
   Bioulac-Sage P, 2007, WORLD J GASTROENTERO, V13, P2649, DOI 10.3748/wjg.v13.i19.2649
   Bioulac-Sage P, 2011, SEMIN LIVER DIS, V31, P91, DOI 10.1055/s-0031-1272837
   BUHLER H, 1982, GASTROENTEROLOGY, V82, P775
   Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926
   Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295
   Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943
   Choi J, 2014, FREE RADICAL BIO MED, V72, P267, DOI 10.1016/j.freeradbiomed.2014.04.020
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033
   Hensley K, 2009, METHODS MOL BIOL, V536, P457, DOI 10.1007/978-1-59745-542-8_46
   Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483
   Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf
   Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2
   Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771
   Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001
   Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136
   Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017
   Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105
   Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016
   Morito N, 2003, ONCOGENE, V22, P9275, DOI 10.1038/sj.onc.1207024
   Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004
   Pilati C, 2014, CANCER CELL, V25, P428, DOI 10.1016/j.ccr.2014.03.005
   Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475
   Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Shin SM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/763257
   Spannbauer M M, 2009, Hepatology, V49, P1387, DOI 10.1002/hep.22902
   Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211
   Stehlik C, 1998, BIOCHEM BIOPH RES CO, V243, P827, DOI 10.1006/bbrc.1998.8185
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762
   Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656
   Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75
   You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328
   Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234
   Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068
NR 42
TC 29
Z9 32
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD JAN
PY 2016
VL 64
IS 1
BP 94
EP 102
DI 10.1016/j.jhep.2015.08.033
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CY8NO
UT WOS:000366665700016
PM 26348541
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Tapper, EB
   Aberasturi, D
   Zhao, Z
   Hsu, CY
   Parikh, ND
AF Tapper, Elliot B.
   Aberasturi, Devin
   Zhao, Zhe
   Hsu, Chia-Yang
   Parikh, Neehar D.
TI Outcomes after hepatic encephalopathy in population-based cohorts of
   patients with cirrhosis
SO ALIMENTARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article; Early Access
ID HOSPITAL READMISSIONS; NATURAL-HISTORY; LIVER-DISEASE; UNITED-STATES;
   SURVIVAL; CARE; RIFAXIMIN; MODEL; RISK; PROGRESSION
AB Background Hepatic encephalopathy is a devastating complication of cirrhosis.
   Aim To describe the outcomes after developing hepatic encephalopathy among contemporary, aging patients.
   Methods We examined data for a 20% random sample of United States Medicare enrolees with cirrhosis and Part D prescription coverage from 2008 to 2014. Among 49 164 persons with hepatic encephalopathy, we evaluated the associations with transplant-free survival using Cox proportional hazard models with time-varying covariates (hazard ratios, HR) and incidence rate ratios (IRR) for healthcare utilisation measured in hospital-days and 30-day readmissions per person-year. We validated our findings in an external cohort of 2184 privately insured patients with complete laboratory values.
   Results Hepatic encephalopathy was associated with median survivals of 0.95 and 2.5 years for those >= 65 or <65 years old and 1.1 versus 3.9 years for those with and without ascites. Non-alcoholic fatty-liver disease posed the highest adjusted risk of death among aetiologies, HR 1.07 95% CI (1.02, 1.12). Both gastroenterology consultation and rifaximin utilisation were associated with lower mortality, respective adjusted-HR 0.73 95% CI (0.67, 0.80) and 0.40 95% CI (0.39, 0.42). Thirty-day readmissions were fewer for patients seen by gastroenterologists (0.71 95% CI [0.57-0.88]) and taking rifaximin (0.18 95% CI [0.08-0.40]). Lactulose alone was associated with fewer hospital-days, IRR 0.31 95% CI (0.30-0.32), than rifaximin alone, 0.49 95% CI (0.45-0.53), but the optimal therapy combination was lactulose/rifaximin, IRR 0.28 95% CI (0.27-0.30). These findings were validated in the privately insured cohort adjusting for model for endstage liver disease-sodium score and serum albumin.
   Conclusions Hepatic encephalopathy remains morbid and associated with poor outcomes among contemporary patients. Gastroenterology consultation and combination lactulose-rifaximin are both associated with improved outcomes. These data inform the development of care coordination efforts for subjects with cirrhosis.
C1 [Tapper, Elliot B.; Hsu, Chia-Yang; Parikh, Neehar D.] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.
   [Tapper, Elliot B.] VA Ann Arbor Healthcare Syst, Gastroenterol Sect, Ann Arbor, MI USA.
   [Aberasturi, Devin; Zhao, Zhe] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor
   Healthcare System; University of Michigan System; University of Michigan
RP Tapper, EB (corresponding author), MD 3912 Taubman,SPC 5362,1500 E Med Ctr, Ann Arbor, MI 48109 USA.
EM etapper@umich.edu
OI Parikh, Neehar/0000-0002-5874-9933; Zhao, Zhe/0009-0001-8023-0775
FU National Institutes of Health through the Michigan Institute for
   Clinical and Health Research [KL2TR002241]; NIDDK [1K23DK117055-01A1];
   Valeant Pharmaceuticals
FX Elliot Tapper receives funding from the National Institutes of Health
   through the Michigan Institute for Clinical and Health Research
   (KL2TR002241) and NIDDK (1K23DK117055-01A1). This work was supported in
   part by an unrestricted research grant from Valeant Pharmaceuticals
   (makers of Rifaximin). Valeant had no access to the data at any point
   and played no role in the planning of the study or the analysis or
   interpretation of the data.
CR Allen AM, 2018, HEPATOLOGY, V67, P1726, DOI 10.1002/hep.29546
   Ampuero J, 2015, GASTROENTEROLOGY, V149, P1483, DOI 10.1053/j.gastro.2015.07.067
   ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710
   Bajaj JS, 2019, ALIMENT PHARM THER, V49, P1518, DOI 10.1111/apt.15265
   Bajaj JS, 2018, AM J GASTROENTEROL, V113, P1177, DOI 10.1038/s41395-018-0085-9
   Bajaj JS, 2017, CLIN GASTROENTEROL H, V15, P565, DOI 10.1016/j.cgh.2016.09.157
   Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128
   Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893
   Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056
   Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Ezaz G, 2018, AM J MED, V131, P645, DOI 10.1016/j.amjmed.2018.01.026
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124
   Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500
   Kimer N, 2014, ALIMENT PHARM THER, V40, P123, DOI 10.1111/apt.12803
   Konerman MA, 2015, HEPATOLOGY, V61, P1832, DOI 10.1002/hep.27750
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Mellinger JL, 2018, HEPATOLOGY, V68, P872, DOI 10.1002/hep.29887
   Mellinger JL, 2016, AM J GASTROENTEROL, V111, P838, DOI 10.1038/ajg.2016.96
   Mellinger JL, 2013, CLIN GASTROENTEROL H, V11, P217, DOI 10.1016/j.cgh.2012.10.040
   Moon AM, 2017, ALIMENT PHARM THER, V45, P1201, DOI 10.1111/apt.14021
   Moon AM, 2020, CLIN GASTROENTEROL H, V18, P2650, DOI 10.1016/j.cgh.2019.07.060
   Morando F, 2013, J HEPATOL, V59, P257, DOI 10.1016/j.jhep.2013.03.010
   Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f
   Parikh ND, 2019, HEPATOLOGY, V70, P487, DOI 10.1002/hep.29473
   Patidar KR, 2014, AM J GASTROENTEROL, V109, P1757, DOI 10.1038/ajg.2014.264
   Rakoski MO, 2012, HEPATOLOGY, V55, P184, DOI 10.1002/hep.24616
   Salehi S, 2019, ALIMENT PHARM THER, V50, P435, DOI 10.1111/apt.15326
   Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208
   Sharma BC, 2013, AM J GASTROENTEROL, V108, P1458, DOI 10.1038/ajg.2013.219
   Sharpton SR, 2014, TRANSPLANTATION, V98, P557, DOI 10.1097/TP.0000000000000090
   Su GL, 2018, HEPATOLOGY, V68, P2317, DOI 10.1002/hep.30074
   Tapper EB, 2021, CLIN GASTROENTEROL H, V19, P604, DOI 10.1016/j.cgh.2019.12.017
   Tapper EB, 2020, CLIN GASTROENTEROL H, V18, P1197, DOI 10.1016/j.cgh.2019.09.033
   Tapper EB, 2019, HEPATOL COMMUN, V3, P1510, DOI 10.1002/hep4.1425
   Tapper EB, 2020, HEPATOLOGY, V71, P225, DOI 10.1002/hep.30695
   Tapper EB, 2018, BMJ-BRIT MED J, V362, DOI [10.1136/bm1k2817, 10.1136/bmj.k2817]
   Tapper EB, 2018, HEPATOLOGY, V68, P1498, DOI 10.1002/hep.29628
   Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P1181, DOI 10.1016/j.cgh.2016.04.009
   Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P753, DOI 10.1016/j.cgh.2015.08.041
   Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P1670, DOI 10.1016/j.cgh.2015.03.019
   Gomez EV, 2013, J HEPATOL, V58, P434, DOI 10.1016/j.jhep.2012.10.023
   Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314
   Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020
NR 47
TC 37
Z9 38
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-2813
EI 1365-2036
J9 ALIMENT PHARM THER
JI Aliment. Pharmacol. Ther.
PD 2020 JUN
PY 2020
VL 51
IS 12
BP 1397
EP 1405
DI 10.1111/apt.15749
EA MAY 2020
PG 9
WC Gastroenterology & Hepatology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Pharmacology & Pharmacy
GA LQ2AV
UT WOS:000529816700001
PM 32363684
OA Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Garcia-Fernandez, M
   Sierra, I
   Puche, JE
   Guerra, L
   Castilla-Cortazar, I
AF Garcia-Fernandez, Maria
   Sierra, Inma
   Puche, Juan E.
   Guerra, Lucia
   Castilla-Cortazar, Inma
TI Liver mitochondrial dysfunction is reverted by insulin-like growth
   factor II (IGF-II) in aging rats
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID CELL-DEATH; RESISTANCE; APOPTOSIS; MEMBRANE; DAMAGE
AB Background: Serum IGF-I and IGF-II levels decline with age. IGF-I replacement therapy reduces the impact of age in rats. We have recently reported that IGF-II is able to act, in part, as an analogous of IGF-I in aging rats reducing oxidative damage in brain and liver associated with a normalization of antioxidant enzyme activities. Since mitochondria seem to be the most important cellular target of IGF-I, the aim of this work was to investigate whether the cytoprotective actions of IGF-II therapy are mediated by mitochondrial protection.
   Methods: Three groups of rats were included in the experimental protocol young controls (17 weeks old); untreated old rats (103 weeks old); and aging rats (103 weeks old) treated with IGF-II (2 mu g/100 g body weight and day) for 30 days.
   Results: Compared with young controls, untreated old rats showed an increase of oxidative damage in isolated mitochondria with a dysfunction characterized by: reduction of mitochondrial membrane potential (MMP) and ATP synthesis and increase of intramitochondrial free radicals production and proton leak rates. In addition, in untreated old rats mitochondrial respiration was not blocked by atractyloside. In accordance, old rats showed an overexpression of the active fragment of caspases 3 and 9 in liver homogenates. IGF-II therapy corrected all of these parameters of mitochondrial dysfunction and reduced activation of caspases.
   Conclusions: The cytoprotective effects of IGF-II are related to mitochondrial protection leading to increased ATP production reducing free radical generation, oxidative damage and apoptosis.
C1 [Sierra, Inma; Puche, Juan E.; Guerra, Lucia; Castilla-Cortazar, Inma] CEU San Pablo Univ, Sch Med, Dept Med Physiol, Inst Appl Mol Med IMMA Boadilla del Monte, Madrid 28668, Spain.
   [Garcia-Fernandez, Maria] Univ Malaga, Sch Med, Dept Physiol, E-29071 Malaga, Spain.
C3 San Pablo CEU University; Universidad de Malaga
RP Castilla-Cortazar, I (corresponding author), CEU San Pablo Univ, Sch Med, Dept Med Physiol, Inst Appl Mol Med IMMA Boadilla del Monte, Madrid 28668, Spain.
EM iccortazar@ceu.es
RI Puche, Juan/L-9132-2014; María, garcia-fernandez/H-8196-2017;
   Castilla-Cortazar, Inma/K-7883-2017; Guerra-Menéndez, Lucía/L-9839-2015;
   Puche, Juan E/HMP-2853-2023
OI María, garcia-fernandez/0000-0002-6436-1361; Castilla-Cortazar,
   Inma/0000-0002-2230-5927; Guerra-Menéndez, Lucía/0000-0001-8724-6385; 
FU Spanish I+D Program [SAF-2009-08319]; Lilly Laboratories (Madrid, Spain)
FX This work has been supported by the Spanish I+D Program SAF-2009-08319.
   We thank Dr. Jesus Hernandez Cabrero and Dr. Jose A Sacristan, Lilly
   Laboratories (Madrid, Spain), for providing research grants and the
   IGF-II used in this study.
CR Arab K, 2004, ANAL BIOCHEM, V325, P158, DOI 10.1016/j.ab.2003.10.022
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BRAND MD, 1995, PRACTICAL APPROACH, P39
   Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   CASTILLACORTAZA.I, J TRANSLATIONAL MED
   Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667
   CORTESE JD, 1995, BBA-BIOENERGETICS, V1228, P216, DOI 10.1016/0005-2728(94)00178-8
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   Fernandez S, 2007, GROWTH HORM IGF RES, V17, P89, DOI 10.1016/j.ghir.2007.01.006
   García-Fernández M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190
   Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346
   HOFFMAN AR, 1993, GROWTH HORMONE SOMAT, P265
   Kondo T, 2002, CELL DEATH DIFFER, V9, P682, DOI 10.1038/sj.cdd.4401019
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   Liang GY, 2007, GLIA, V55, P632, DOI 10.1002/glia.20496
   LLorens-Martín M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371
   Maggio M, 2005, J ENDOCRINOL INVEST, V28, P711, DOI 10.1007/BF03347554
   Meling TR, 1996, AM J MED SCI, V311, P153, DOI 10.1097/00000441-199604000-00001
   Miller NJ, 1993, BIOCHEM SOC T, V21, P95
   Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6
   MONEMDJOU S, 1999, AM J PHYSIOL, V276, P1073
   *NAT AC SCI, 1991, GUID PRINC RES INV A
   Ness JK, 2004, GLIA, V46, P183, DOI 10.1002/glia.10360
   OCONNOR JE, 1988, BIOCHEM BIOPH RES CO, V151, P568, DOI 10.1016/0006-291X(88)90632-8
   Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563
   Sonntag WE, 2006, AM J PHYSIOL-ENDOC M, V291, pE604, DOI 10.1152/ajpendo.00012.2006
   Sullivan KA, 2008, ENDOCRINOLOGY, V149, P5963, DOI 10.1210/en.2008-1020
   Syroid DE, 1999, J NEUROSCI, V19, P2059
   Tong M, 2009, J ALZHEIMERS DIS, V16, P585, DOI 10.3233/JAD-2009-0995
   Trejo JL, 2004, GROWTH HORM IGF RES, V14, pS39, DOI 10.1016/j.ghir.2004.03.010
   Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254
   Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   Yamamura T, 2001, AM J PHYSIOL-HEART C, V280, pH1191, DOI 10.1152/ajpheart.2001.280.3.H1191
NR 36
TC 23
Z9 26
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUL 28
PY 2011
VL 9
AR 123
DI 10.1186/1479-5876-9-123
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 813AC
UT WOS:000294336700001
PM 21798010
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lee, SH
   Park, HJ
   Chun, HK
   Cho, SY
   Jung, HJ
   Cho, SM
   Kim, DY
   Kang, MS
   Lillehoj, HS
AF Lee, Sung-Hyen
   Park, Hong-Ju
   Chun, Hye-Kyung
   Cho, So-Young
   Jung, Hyun-Jin
   Cho, Soo-Muk
   Kim, Dae-Yong
   Kang, Min-Soo
   Lillehoj, Hyun Soon
TI Dietary phytic acid improves serum and hepatic lipid levels in aged ICR
   mice fed a high-cholesterol diet
SO NUTRITION RESEARCH
LA English
DT Article
DE phytic acid; aged mice; serum; liver; lipid level
ID DENSITY-LIPOPROTEIN CHOLESTEROL; RATS; TRIGLYCERIDES; ISOFLAVONES;
   PHOSPHORUS; MAGNESIUM; RESPONSES; PHYTATE; ENZYMES; PROTEIN
AB Aging is a multifactorial phenomenon. Several clinical conditions directly related to lipid metabolism that induces hypertriglycemia, hypercholesterolemia, and cardiovascular disease occur during aging. Attention has been focused on possible intervention strategies to control serum lipid levels. Phytic acid is a plant component in most grains that is the main source of energy intake for the aged, and its antioxidant and antinutrient effects have been reported. However, its effect on lipid metabolism in the aged model has not been evaluated. This study was carried out to investigate the effect of phytic acid on serum and hepatic lipid levels in aged mice. A total of 40 aged ICR male mice were fed purified diets supplemented with 0% (PO), 0.5% (P5), 1.0% (P10), and 1.5% (P15) sodium phytate for 12 weeks. There were no significant differences in food intake, body weight, and organ weight among the experimental groups. The concentrations of the serum low-density lipoprotein cholesterol, hepatic triacylglycerol, and total cholesterol, and the apparent absorption rates of total lipid and cholesterol were lower in the P15 group than in the PO group. Serum high-density lipoprotein cholesterol levels of all groups fed phytate-containing diets were higher than that of the PO group. The severity of fatty liver decreased as phytate percentage in the diet increased. The amounts of fecal total lipid, triacyglycerol, and total cholesterol were higher in the P10 and the P15 groups. These results suggested that phytate affect the serum and hepatic lipid levels in aged mice by increasing their fecal lipid content. Consuming phytate-rich foods may reduce serum and hepatic lipid levels in the aged. (c) 2007 Elsevier Inc. All rights reserved.
C1 RDA, NIAST, Natl Rural Resources Dev Inst, Suwon 441853, South Korea.
   Seoul Natl Univ, Dept Vet Pathol, Coll Vet Med, Seoul 151742, South Korea.
   USDA ARS, Beltsville Agr Res Ctr, Anim & Nat Resources Inst, Beltsville, MD 20705 USA.
C3 Rural Development Administration (RDA), Republic of Korea; Seoul
   National University (SNU); United States Department of Agriculture
   (USDA)
RP Park, HJ (corresponding author), RDA, NIAST, Natl Rural Resources Dev Inst, Suwon 441853, South Korea.
EM redpark@rda.go.kr
CR Alhassan S, 2006, METABOLISM, V55, P541, DOI 10.1016/j.metabol.2005.11.006
   [Anonymous], WORLD POP AG 1950 20
   BAINTON D, 1992, BRIT HEART J, V68, P60
   BIGGS HG, 1975, CLIN CHEM, V21, P47
   DURRINGTON PN, 2004, ARTERIOSCLEROSIS, V21, P473
   Engelman HM, 2005, AM J CLIN NUTR, V81, P590
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   FRIEDEWALD WT, 1972, CLIN CHEM, V0018
   GRAF E, 1990, FREE RADICAL BIO MED, V8, P61, DOI 10.1016/0891-5849(90)90146-A
   Hanson LN, 2006, AM J CLIN NUTR, V84, P774, DOI 10.1093/ajcn/84.4.774
   Hutson KS, 2007, PARASITOL INT, V56, P95, DOI 10.1016/j.parint.2006.12.003
   Jaouad L, 2006, ATHEROSCLEROSIS, V185, P191, DOI 10.1016/j.atherosclerosis.2005.06.012
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Katayama T, 1997, NUTR RES, V17, P721, DOI 10.1016/S0271-5317(97)00042-0
   Lee DY, 1997, ADV COMPOS MATER, V6, P261, DOI 10.1163/156855197X00139
   LEE HH, 1999, FOOD SCI BIOTECHNOL, V8, P108
   Lee SH, 2005, NUTR RES, V25, P869, DOI 10.1016/j.nutres.2005.09.004
   LEE SH, 2004, KOR J COMMUN LIV SCI, V15, P65
   Lee SH, 2006, NUTR RES, V26, P474, DOI 10.1016/j.nutres.2006.06.017
   Lee SungHyeon, 2004, Korean Journal of Nutrition, V37, P347
   Lee SungHyeon, 2003, Korean Journal of Nutrition, V36, P543
   Miyazawa E, 1996, NUTR RES, V16, P603, DOI 10.1016/0271-5317(96)00038-3
   Nanjee MN, 1996, CLIN CHEM, V42, P915
   Okazaki Y, 2003, NUTR RES, V23, P1089, DOI 10.1016/S0271-5317(03)00101-5
   Pearson Thomas, 2005, Am J Geriatr Pharmacother, V3, P218, DOI 10.1016/j.amjopharm.2005.12.009
   Porres JM, 2004, NUTRITION, V20, P794, DOI 10.1016/j.nut.2004.05.018
   Sokal R., 1994, BIOMETRY PRINCIPLES, V3, DOI DOI 10.1016/J.JIP.2003.08.007
   Zhang Z, 2005, WORLD J GASTROENTERO, V11, P5044, DOI 10.3748/wjg.v11.i32.5044
   ZLATKIS A, 1953, J LAB CLIN MED, V41, P486
   이성현, 2004, Journal of Nutrition and Health, V37, P81
NR 31
TC 32
Z9 34
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD AUG
PY 2007
VL 27
IS 8
BP 505
EP 510
DI 10.1016/j.nutres.2007.05.003
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 200QM
UT WOS:000248777900009
DA 2024-02-19
ER

PT J
AU Haak, JL
   Kregel, KC
   Bloomer, SA
AF Haak, Jodie L.
   Kregel, Kevin C.
   Bloomer, Steven A.
TI Altered accumulation of hepatic mitochondrial antioxidant proteins with
   age and environmental heat stress
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE aging; hyperthermia; Ref-1; Sirt-3; Trx-2
ID OXIDATIVE STRESS; OLD RATS; SIRT3; PROMOTES; LIVER; THIOREDOXIN-2;
   ACETYLATION; EXPRESSION; OVEREXPRESSION; DEACETYLATION
AB Aging impairs overall physiological function, particularly the response to environmental stressors. Repeated heat stress elevates reactive oxygen species and macromolecular damage in the livers of aged animals, likely due to mitochondrial dysfunction. The goal of this investigation was to determine potential mechanisms for mitochondrial dysfunction after heat stress by evaluating key redox-sensitive and antioxidant proteins (Sirt-3, MnSOD, Trx-2, and Ref-1). We hypothesized that heat stress would result in greater mitochondrial abundance of these proteins, but that aging would attenuate this response. For this purpose, young (6 mo) and old (24 mo) Fisher 344 rats were exposed to heat stress on two consecutive days. During each heating trial, colonic temperature was elevated to 41 degrees C during the first 60 min, and then clamped at this temperature for 30 min. Nonheated animals served as controls. At 2 and 24 h after the second heat stress, hepatic mitochondria were isolated from each animal, and then immunoblotted for Sirt-3, acetylated lysine residues (Ac-K), MnSOD, Trx-2, and Ref-1. Aging increased Sirt-3 and lowered Ac-K. In response to heat stress, Sirt-3, Ac-K, MnSOD, and Ref-1 increased in mitochondrial fractions in both young and old animals. At 2 h after the second heat stress, mitochondrial Trx-2 declined in old, but not in young animals. Our results suggest that some components of the response to heat stress are preserved with aging. However, the decline in Trx-2 represents a potential mechanism for age-related mitochondrial damage and dysfunction after heat stress.
C1 [Haak, Jodie L.] Drexel Univ, Hlth Sci Dept, Philadelphia, PA USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA USA.
   [Bloomer, Steven A.] Penn State Abington, Div Sci & Engn, Abington, PA 19001 USA.
C3 Drexel University; University of Iowa; Pennsylvania Commonwealth System
   of Higher Education (PCSHE); Pennsylvania State University
RP Bloomer, SA (corresponding author), Penn State Abington, Div Sci & Engn, Abington, PA 19001 USA.
EM sab320@psu.edu
FU Penn State Abington
FX We thank Dr. Ryan Savitz at Neumann University for assistance with
   statistics. We also thank Dr. Elizabeth Cramer for assistance with the
   heat stress experiments and Ms. Joan Seye for administrative assistance.
CR Becker KJ, 2016, TRANSL STROKE RES, V7, P303, DOI 10.1007/s12975-016-0455-9
   Bloomer SA, 2015, CELL BIOCHEM FUNCT, V33, P241, DOI 10.1002/cbf.3110
   Bloomer SA, 2014, ARCH GERONTOL GERIAT, V58, P145, DOI 10.1016/j.archger.2013.07.012
   Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034
   Cottle RM, 2023, J APPL PHYSIOL, V135, P292, DOI 10.1152/japplphysiol.00222.2023
   Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1
   Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159
   Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008
   He M, 2008, TOXICOL SCI, V105, P44, DOI 10.1093/toxsci/kfn116
   Huang YR, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI148852
   Ishino K, 2008, CHEM RES TOXICOL, V21, P1261, DOI 10.1021/tx800080x
   Joo HK, 2014, MITOCHONDRION, V17, P42, DOI 10.1016/j.mito.2014.05.006
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kenney WL, 2014, MED SCI SPORT EXER, V46, P1891, DOI 10.1249/MSS.0000000000000325
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kim A, 2022, FASEB J, V36, DOI 10.1096/fj.202101470R
   Koltai E, 2011, REJUV RES, V14, P585, DOI 10.1089/rej.2011.1178
   Kundu A, 2023, INT J BIOL SCI, V19, P2630, DOI 10.7150/ijbs.80743
   Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720
   Li JJ, 1997, CANCER RES, V57, P1991
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Luo CT, 2022, J PROTEOME RES, DOI 10.1021/acs.jproteome.2c00167
   McGuinness J, NASA Clocks July 2023 as Hottest Month on Record Ever Since 1880
   Minson CT, 1998, J APPL PHYSIOL, V84, P1323, DOI 10.1152/jappl.1998.84.4.1323
   Nakamura A, 2013, GERONTOLOGY, V59, P542, DOI 10.1159/000354087
   National Weather Service, Weather Related Fatality and Injury Statistics
   Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003
   Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873
   Ozaki M, 2002, FASEB J, V16, P889, DOI 10.1096/fj.01-0664fje
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039
   Pinteric M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020174
   Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036
   Ryan AS, 2023, EXP BIOL MED, V248, P302, DOI 10.1177/15353702221142619
   Schmidt GA, GISS Surface Temperature Analysis (v4)
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Sholomskas Leslee M, 2015, Int J Physiol Pathophysiol Pharmacol, V7, P14
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936
   Szczesny B, 2005, MECH AGEING DEV, V126, P1071, DOI 10.1016/j.mad.2005.04.001
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063
   Venkataraman S, 2004, FREE RADICAL RES, V38, P1119, DOI 10.1080/10715760400010470
   Von Schulze AT, 2021, FUNCTION, V2, DOI 10.1093/function/zqab001
   Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753
   Wang P, 2016, EXP PHYSIOL, V101, P410, DOI 10.1113/EP085493
   Williams AS, 2020, CELL METAB, V31, P131, DOI 10.1016/j.cmet.2019.11.003
   XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x
   Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919
   Yeo D, 2020, GEROSCIENCE, V42, P963, DOI 10.1007/s11357-020-00171-7
   Yezli S, 2023, J INTERN MED, V294, P7, DOI 10.1111/joim.13633
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Zhang HJ, 2006, J APPL PHYSIOL, V100, P1385, DOI 10.1152/japplphysiol.01046.2005
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhang JF, 2018, J ANIM SCI, V96, P867, DOI 10.1093/jas/sky009
   Zhang YL, 2020, FREE RADICAL BIO MED, V158, P60, DOI 10.1016/j.freeradbiomed.2020.06.027
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhao SC, 2023, INT IMMUNOPHARMACOL, V116, DOI 10.1016/j.intimp.2023.109876
NR 59
TC 0
Z9 0
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD DEC 26
PY 2023
VL 135
IS 6
BP 1339
EP 1347
DI 10.1152/japplphysiol.00610.2023
PG 9
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA FD1R0
UT WOS:001143729300001
PM 37881850
DA 2024-02-19
ER

PT J
AU He, J
   Zheng, HY
   Pan, DD
   Liu, T
   Sun, YY
   Cao, JX
   Wu, Z
   Zeng, XQ
AF He, Jun
   Zheng, Heyang
   Pan, Daodong
   Liu, Tao
   Sun, Yangying
   Cao, Jinxuan
   Wu, Zhen
   Zeng, Xiaoqun
TI Effects of aging on fat deposition and meat quality in Sheldrake duck
SO POULTRY SCIENCE
LA English
DT Article
DE Sheldrake duck; fat deposition; meat quality; aging; lipid metabolism
ID INTRAMUSCULAR FAT; LIPID-METABOLISM; PORK TENDERNESS; ACID SYNTHASE;
   ULTIMATE PH; CARCASS; LIPASE; ENZYME; MUSCLE
AB Sheldrake is a duck breed widely used for its meat and eggs. In this study, the quantities of abdominal fat, sebum, intramuscular fat and liver fat, meat quality (pH, cooking loss, drip loss, and shear force), and expression and activity of several enzymes at different ages were determined. The results showed that the fat content increased (P < 0.05) during the aging process (90 d, 180 d, 270 d, and 360 d). Fatty acid synthase (FAS) and malic enzyme (ME) were chosen to represent the activity of lipid biosynthesis in Sheldrake ducks. The quantitative real-time PCR and enzymic activity data showed that the expression of both FAS and ME were generally up-regulated along with aging. Based on these results, the individual ducks were selected at 180 d and 360 d for analyzing the changes of serum lipid levels and related enzymic activities in liver. The contents of triglycerides (TG), total cholesterol (TCH), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) in serum were found not significantly different (P > 0.05). However, we thought that the variation of TG/HDL (P < 0.05) might explain the increased fat deposition. Moreover, the activities of lipoprotein lipase (LPL) and hepatic lipase (HL) were both detected significantly up-regulated at 360 d (P < 0.05). The meat quality results of breast muscles indicated that pH, cooking loss, drip loss, and shear force values could all be affected by aging. Considering these results, we concluded that the best quality of Sheldrake duck meat occurs between 180 d and 270 d. These results might provide useful information for Sheldrake cultivation and research on lipid metabolism.
C1 [He, Jun; Zheng, Heyang; Pan, Daodong; Liu, Tao; Sun, Yangying; Cao, Jinxuan; Wu, Zhen; Zeng, Xiaoqun] Ningbo Univ, Key Lab Anim Prot Deep Proc Technol Zhejiang Prov, Ningbo 315211, Zhejiang, Peoples R China.
   [Pan, Daodong] Nanjing Normal Univ, Food Sci & Nutr Dept, Nanjing 210097, Jiangsu, Peoples R China.
C3 Ningbo University; Nanjing Normal University
RP Pan, DD (corresponding author), Ningbo Univ, Key Lab Anim Prot Deep Proc Technol Zhejiang Prov, Ningbo 315211, Zhejiang, Peoples R China.; Pan, DD (corresponding author), Nanjing Normal Univ, Food Sci & Nutr Dept, Nanjing 210097, Jiangsu, Peoples R China.
EM daodongpan@163.com
RI Wu, Zhen/AEC-6724-2022; Wu, Zhen/AFN-8777-2022
OI Wu, Zhen/0000-0002-3607-6440; Wu, Zhen/0000-0002-3607-6440
FU Science and Technology Program of Zhejiang [2017C02G2070312]; Modern
   Agricultural Technical Foundation of China [CARS-42-25]; Kuancheng Wong
   Magna Fund at Ningbo University
FX We acknowledge funding support from Science and Technology Program of
   Zhejiang (2017C02G2070312), Modern Agricultural Technical Foundation of
   China (CARS-42-25), and Kuancheng Wong Magna Fund at Ningbo University.
CR Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+
   Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729
   Detarsio E, 2004, BIOCHEM J, V382, P1025, DOI 10.1042/BJ20040594
   ENERBACK S, 1993, BIOCHIM BIOPHYS ACTA, V1169, P107, DOI 10.1016/0005-2760(93)90196-G
   FISHMAN PH, 1976, SCIENCE, V194, P906, DOI 10.1126/science.185697
   Gao Shi-Zheng, 2009, Recent Pat Food Nutr Agric, V1, P59
   He J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27418
   He J, 2013, MOL BIOL REP, V40, P189, DOI 10.1007/s11033-012-2048-3
   Hermier D, 1997, J NUTR, V127, pS805, DOI 10.1093/jn/127.5.805S
   Heyer A, 2007, J ANIM SCI, V85, P769, DOI 10.2527/jas.2006-164
   Jeleníková J, 2008, EUR FOOD RES TECHNOL, V227, P989, DOI 10.1007/s00217-007-0810-x
   Jo Cheorun, 2013, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V26, P117, DOI 10.9799/ksfan.2013.26.1.117
   Kim YHB, 2011, MEAT SCI, V88, P332, DOI 10.1016/j.meatsci.2010.12.020
   Lee SH, 2010, MEAT SCI, V86, P794, DOI 10.1016/j.meatsci.2010.06.024
   Li XK, 2016, FOOD CHEM, V205, P289, DOI 10.1016/j.foodchem.2016.02.133
   Lyczynski A, 2006, ANIM SCI PAP REP, V24, P195
   Pietruszka A, 2015, ANN ANIM SCI, V15, P1031, DOI 10.1515/aoas-2015-0046
   Qiu X. P., 1993, POULTRY SCI 3 VERSIO, V74
   Raj S, 2010, MEAT SCI, V86, P324, DOI 10.1016/j.meatsci.2010.04.037
   Ransamy TA, 2000, J BIOL CHEM, V275, P33480, DOI 10.1074/jbc.M005436200
   Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X
   van Laack RLJM, 2001, J ANIM SCI, V79, P392
   WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001
   WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0
   Zhang YY, 2014, PAK J ZOOL, V46, P1039
NR 25
TC 24
Z9 24
U1 1
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0032-5791
EI 1525-3171
J9 POULTRY SCI
JI Poult. Sci.
PD JUN
PY 2018
VL 97
IS 6
BP 2005
EP 2010
DI 10.3382/ps/pey077
PG 6
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA GI2XR
UT WOS:000434235700019
PM 29554357
OA hybrid
DA 2024-02-19
ER

PT J
AU Yang, MC
   McLean, AJ
   Le Couteur, DG
AF Yang, MC
   McLean, AJ
   Le Couteur, DG
TI Age-related alteration in hepatic disposition of the neurotoxin
   1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pesticides
SO PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID PARKINSONS-DISEASE; RAT-LIVER; DRUG CLEARANCE; INDUCTION;
   CYTOCHROME-P-450; POLYMORPHISMS; METAANALYSIS; EXPOSURE; COMPOUND;
   ANATOMY
AB Idiopathic Parkinson's disease may be caused by environmental neurotoxins such as pesticides, however the major risk factor is old age. We postulated that the high incidence of Parkinson's disease in older people is secondary to age-related impairment of the hepatic detoxification of xenobiotics. Previously, we have shown that there are significant differences between the hepatic disposition of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and pesticides. Here, we investigated whether there are age-related differences in the hepatic disposition of MPTP and pesticides, putatively associated with the pathogenesis of Parkinson's disease, We measured the hepatic disposition of paraquat, dichlorodiphenyltrichloroethane (DDT), malathion and MPTP using the multiple indicator dilution technique in the perfused livers of Fischer F344 rats aged 3 and 18 months. The recoveries of MPTF DDT and malathion were increased from the livers of the older rats (by 258%, 253% and 134% compared with young rats, respectively). The hepatic transport of DDT and malathion into hepatocytes was reduced with age suggesting that part of the impaired uptake of neurotoxins may be secondary to an age-related barrier to influx. Ageing may increase risk of Parkinson's disease by altering hepatic detoxification and increasing systemic bioavailability of neurotoxins.
C1 Univ Sydney, Canberra Hosp, Canberra Clin Sch, Dept Geriat Med, Garran, ACT 2605, Australia.
   Univ Sydney, Concord RG Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   Univ Sydney, Concord RG Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia.
C3 Australian National University; Canberra Hospital; University of Sydney;
   University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; Concord Repatriation General
   Hospital
RP Yang, MC (corresponding author), Univ Sydney, Canberra Hosp, Canberra Clin Sch, Dept Geriat Med, Yamba Dr, Garran, ACT 2605, Australia.
RI Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016
OI Le Couteur, David/0000-0002-4227-5817
CR Antonini A, 1998, NEUROLOGY, V51, P803, DOI 10.1212/WNL.51.3.803
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   CALNE DB, 1986, LANCET, V2, P1067, DOI 10.1016/S0140-6736(86)90469-1
   Crossman AR, 2000, J ANAT, V196, P519, DOI 10.1046/j.1469-7580.2000.19640519.x
   Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7
   Giasson BI, 2000, NAT NEUROSCI, V3, P1227, DOI 10.1038/81737
   GORESKY CA, 1992, HEPATOLOGY, V16, P173, DOI 10.1002/hep.1840160129
   GORESKY CA, 1984, FED PROC, V43, P154
   Graeber MB, 1998, J NEUROSCI RES, V52, P1
   GUO ZY, 1993, GROWTH DEVELOP AGING, V57, P85
   KETTERMAN AJ, 1987, TOXICOL APPL PHARM, V87, P389, DOI 10.1016/0041-008X(87)90243-2
   LANGSTON JW, 1989, J NEUROL NEUROSUR PS, P13
   Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S
   Le Couteur DG, 1999, BIOMED PHARMACOTHER, V53, P122, DOI 10.1016/S0753-3322(99)80077-8
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LI HC, 1995, J BIOCHEM TOXICOL, V10, P51
   Markopoulou K, 1999, ANN NEUROL, V46, P374, DOI 10.1002/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9
   McCann SJ, 1998, NEUROEPIDEMIOLOGY, V17, P310, DOI 10.1159/000026185
   McCann SJ, 1997, J NEUROL SCI, V153, P50, DOI 10.1016/S0022-510X(97)00179-2
   Modi S, 1997, BIOCHEMISTRY-US, V36, P4461, DOI 10.1021/bi962633p
   Nims RW, 1998, J TOXICOL ENV HEAL A, V53, P455, DOI 10.1080/009841098159187
   Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435
   Stroombergen MCMJ, 1999, HUM EXP TOXICOL, V18, P141, DOI 10.1191/096032799678839815
   TARLOFF JB, 1991, P SOC EXP BIOL MED, V197, P297
   Terreni L, 2001, NEUROLOGY, V56, P463, DOI 10.1212/WNL.56.4.463
   Tolwani RJ, 1999, LAB ANIM SCI, V49, P363
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, BRIT J CLIN PHARMACO, V30, P634, DOI 10.1111/j.1365-2125.1990.tb03826.x
   Yang MC, 2000, PHARMACOL TOXICOL, V87, P286, DOI 10.1034/j.1600-0773.2000.pto870608.x
NR 30
TC 16
Z9 16
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-9928
J9 PHARMACOL TOXICOL
JI Pharmacol. Toxicol.
PD APR
PY 2002
VL 90
IS 4
BP 203
EP 207
DI 10.1034/j.1600-0773.2002.900406.x
PG 5
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 551YA
UT WOS:000175590500006
PM 12076315
OA Bronze
DA 2024-02-19
ER

PT J
AU Sasaki, Y
   Ikeda, Y
   Uchikado, Y
   Akasaki, Y
   Sadoshima, J
   Ohishi, M
AF Sasaki, Yuichi
   Ikeda, Yoshiyuki
   Uchikado, Yoshihiro
   Akasaki, Yuichi
   Sadoshima, Junichi
   Ohishi, Mitsuru
TI Estrogen Plays a Crucial Role in Rab9-Dependent Mitochondrial Autophagy,
   Delaying Arterial Senescence
SO JOURNAL OF THE AMERICAN HEART ASSOCIATION
LA English
DT Article
DE autophagy; estrogen; mitochondria; vascular senescence
AB Background
   The risk of cardiovascular disease is known to increase after menopause. Mitochondria, which undergo quality control via mitochondrial autophagy, play a crucial role in the regulation of cellular senescence. The aim of this study was to investigate whether the effect of estrogen-mediated protection from senescence on arteries is attributed to the induction of mitochondrial autophagy.
   Methods and Results
   We used human umbilical vein cells, vascular smooth muscle cells, and 12-week-old female C57BL/6 mice. The administration of 17 beta-estradiol (E2) to cells inhibited cellular senescence and mitochondrial dysfunction. Furthermore, E2 increased mitochondrial autophagy, maintaining mitochondrial function, and retarding cellular senescence. Of note, E2 did not modulate LC3 (light chain 3), and ATG7 (autophagy related 7) deficiency did not suppress mitochondrial autophagy in E2-treated cells. Conversely, E2 increased the colocalization of Rab9 with LAMP2 (lysosomal-associated membrane protein 2) signals. The E2-mediated effects on mitochondrial autophagy were abolished by the knockdown of either Ulk1 or Rab9. These results suggest that E2-mediated mitochondrial autophagy is associated with Rab9-dependent alternative autophagy. E2 upregulated SIRT1 (sirtuin 1) and activated LKB1 (liver kinase B1), AMPK (adenosine monophosphate-activated protein kinase), and Ulk1, indicating that the effect of E2 on the induction of Rab9-dependent alternative autophagy is mediated by the SIRT1/LKB1/AMPK/Ulk1 pathway. Compared with the sham-operated mice, ovariectomized mice showed reduced mitochondrial autophagy and accelerated mitochondrial dysfunction and arterial senescence; these detrimental alterations were successfully rescued by the administration of E2.
   Conclusions
   We showed that E2-induced mitochondrial autophagy plays a crucial role in the delay of vascular senescence. The Rab9-dependent alternative autophagy is behind E2-induced mitochondrial autophagy.
C1 [Sasaki, Yuichi; Ikeda, Yoshiyuki; Uchikado, Yoshihiro; Akasaki, Yuichi; Ohishi, Mitsuru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Med & Hypertens, Kagoshima, Japan.
   [Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA.
C3 Kagoshima University; Rutgers University System; Rutgers University New
   Brunswick; Rutgers University Biomedical & Health Sciences
RP Ikeda, Y (corresponding author), Grad Sch Med & Dent Sci, Dept Cardiovasc Med & Hypertens, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM alltezza@m2.kufm.kagoshima-u.ac.jp
RI Akasaki, Yuichi/HMV-9330-2023
FU Japan Society for the Promotion of Science KAKENHI [JP16K09250]
FX This work was supported by the Japan Society for the Promotion of
   Science KAKENHI (Grant No., JP16K09250).
CR Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11
   [Anonymous], 2021, J AM HEART ASSOC, V10, DOI [10.1161/JAHA.120.019310, DOI 10.1161/JAHA.120.019310]
   Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894
   Barton M, 2007, ARTERIOSCL THROM VAS, V27, P1669, DOI 10.1161/ATVBAHA.106.130260
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001
   Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241
   HOFLAND LJ, 1987, MOL CELL ENDOCRINOL, V54, P43, DOI 10.1016/0303-7207(87)90138-9
   Ikeda Y, 2015, J MOL CELL CARDIOL, V78, P116, DOI 10.1016/j.yjmcc.2014.09.019
   Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004
   LaRocca TJ, 2012, J PHYSIOL-LONDON, V590, P3305, DOI 10.1113/jphysiol.2012.229690
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mihaylova MM, 2013, TRENDS ENDOCRIN MET, V24, P48, DOI 10.1016/j.tem.2012.09.003
   Miyauchi T, 2012, CIRC J, V76, P1712, DOI 10.1253/circj.CJ-11-0915
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008
   Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Saito T, 2019, J CLIN INVEST, V129, P802, DOI 10.1172/JCI122035
   Saito T, 2015, CIRC RES, V116, P1477, DOI 10.1161/CIRCRESAHA.116.303790
   Sasaki Y, 2020, J ATHEROSCLER THROMB, V27, P47, DOI 10.5551/jat.47993
   Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108
   Sheffield-Moore M, 2004, TRENDS ENDOCRIN MET, V15, P110, DOI 10.1016/j.tem.2004.02.009
   Shimizu S, 2018, MOL CELLS, V41, P50, DOI 10.14348/molcells.2018.2215
   Stevenson JC, 2011, MATURITAS, V70, P197, DOI 10.1016/j.maturitas.2011.05.017
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   Viña J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501
   Wei Y, 2019, J STEROID BIOCHEM, V191, DOI 10.1016/j.jsbmb.2019.105380
   Wesierska-Gadek J, 2007, CELL MOL BIOL LETT, V12, P280, DOI 10.2478/s11658-007-0002-5
   Wu WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132499
   Xiang J, 2019, AUTOPHAGY, V15, P197, DOI 10.1080/15548627.2018.1520549
   Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279
   Yang HJ, 2020, J CELL MOL MED, V24, P9300, DOI 10.1111/jcmm.15579
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416
NR 50
TC 19
Z9 19
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-9980
J9 J AM HEART ASSOC
JI J. Am. Heart Assoc.
PD APR 6
PY 2021
VL 10
IS 7
AR e019310
DI 10.1161/JAHA.120.019310
PG 41
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA RJ6ZI
UT WOS:000637748900034
PM 33719502
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Castillo, RD
   Bleesing, J
   McCormick, T
   Squires, JE
   Mazariegos, GV
   Squires, J
   McKiernan, PJ
AF del Brio Castillo, Rodrigo
   Bleesing, Jacob
   McCormick, Thomas
   Squires, James E.
   Mazariegos, George V.
   Squires, Judy
   McKiernan, Patrick J.
TI Successful liver transplantation in short telomere syndromes without
   bone marrow failure due to <i>DKC1</i> mutation
SO PEDIATRIC TRANSPLANTATION
LA English
DT Article
DE cell death; senescence; cirrhosis; DKC1; hepatopulmonary syndrome; liver
   transplantation; short telomere syndromes
ID DYSKERATOSIS-CONGENITA; HEPATOPULMONARY SYNDROME; DISEASE; GENE;
   IMMUNODEFICIENCY
AB Short telomere syndromes are a heterogenous spectrum of disorders leading to premature cellular aging. These may involve bone marrow failure, adult-onset idiopathic pulmonary fibrosis, and liver disease, and classical entities such as dyskeratosis congenita. We report a patient who presented with common variable immunodeficiency at 3 years of age and autoimmune cytopenias at 8 years of age. He was found to have short telomeres, and genetic testing confirmed a hemizygous mutation NM_001363.4: c.-142C > G in DKC1 gene. He subsequently developed cirrhosis with severe portal hypertension and hepatopulmonary syndrome, prompting liver transplantation at 11 years of age. He remains well 10 years after transplant with no progression of bone marrow failure or progressive lung disease. In conclusion, short telomere syndromes should be considered as a potential cause of pediatric liver disease of unknown etiology, and in severe cases, isolated liver transplantation may be both appropriate and successful.
C1 [del Brio Castillo, Rodrigo] Hosp Infantil Univ La Paz, Pediat Liver Serv, Madrid, Spain.
   [Bleesing, Jacob] Cincinnati Childrens Hosp, Immunodeficiency & Histiocytosis Program, Cincinnati, OH USA.
   [McCormick, Thomas] Growing Healhy Children Clin, Louisville, KY USA.
   [Squires, James E.; McKiernan, Patrick J.] UPMC Childrens Hosp Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15224 USA.
   [Mazariegos, George V.] UPMC Childrens Hosp Pittsburgh, Hillman Ctr Pediat Transplantat, Div Pediat Transplantat, Pittsburgh, PA USA.
   [Squires, Judy] UPMC Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA.
C3 Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP McKiernan, PJ (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15224 USA.
EM patrick.mckiernan@chp.edu
RI Mazariegos, George/I-4009-2019
OI Mazariegos, George/0000-0002-2624-8632
CR Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046
   Azzu V, 2018, J ALLERGY CLIN IMMUN, V141, P405, DOI 10.1016/j.jaci.2017.06.036
   Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x
   Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1
   Gorgy AI, 2015, CHEST, V148, P1019, DOI 10.1378/chest.15-0825
   Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32
   Jyonouchi S, 2011, PEDIAT ALLERG IMM-UK, V22, P313, DOI 10.1111/j.1399-3038.2010.01136.x
   Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494
   Mahansaria SS, 2015, J CLIN EXP HEPATOL, V5, P344, DOI 10.1016/j.jceh.2015.10.003
   Martínez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   Renoux MC, 2010, PEDIATR PULM, V45, P99, DOI 10.1002/ppul.21128
   Salowsky R, 2002, GENE, V293, P9, DOI 10.1016/S0378-1119(02)00725-4
   Silhan LL, 2014, EUR RESPIR J, V44, P178, DOI 10.1183/09031936.00060014
   Stanley SE, 2015, CURR OPIN GENET DEV, V33, P1, DOI 10.1016/j.gde.2015.06.004
   Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x
NR 20
TC 8
Z9 8
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1397-3142
EI 1399-3046
J9 PEDIATR TRANSPLANT
JI Pediatr. Transplant.
PD MAY
PY 2020
VL 24
IS 3
AR e13695
DI 10.1111/petr.13695
PG 5
WC Pediatrics; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Transplantation
GA LJ6XP
UT WOS:000530306100005
PM 32166868
DA 2024-02-19
ER

PT J
AU Mach, J
   Huizer-Pajkos, A
   Mitchell, SJ
   McKenzie, C
   Phillips, L
   Kane, A
   Jones, B
   de Cabo, R
   Cogger, V
   Le Couteur, DG
   Hilmer, SN
AF Mach, John
   Huizer-Pajkos, Aniko
   Mitchell, Sarah J.
   McKenzie, Catriona
   Phillips, Leo
   Kane, Alice
   Jones, Brett
   de Cabo, Rafael
   Cogger, Victoria
   Le Couteur, David G.
   Hilmer, Sarah N.
TI The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in
   Fischer 344 rats
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article
DE ageing; isoniazid; liver; pharmacokinetics; toxicity
ID DRUG-METABOLIZING-ENZYMES; GENETIC POLYMORPHISMS; TUBERCULOSIS PATIENTS;
   INDUCED HEPATITIS; COVALENT BINDING; LIVER-INJURY; IN-VITRO; HYDRAZINE;
   CYP2E1; CYTOCHROME-P450
AB Isoniazid is the first-line treatment for tuberculosis; however, its use is limited by hepatotoxicity. Age-related differences in isoniazid pharmacokinetics and hepatotoxicity are uncertain. We aimed to investigate these in young (3 +/- 0 months, n = 26) and old (23.0 +/- 0.2 months, n = 27) male Fischer 344 rats following a low- or high-dose toxic regimen of isoniazid or vehicle (4 doses/day over 2 days; low: 100, 75, 75, 75 mg/kg; high: 150, 105, 105, 105 mg/kg i.p. every 3 h). Fifteen hours after the last dose, animals were euthanized and sera and livers were prepared for analysis. Isoniazid treatment increased serum hepatotoxicity markers (alanine and aspartate transaminase) in young animals but not in old animals, and only reached significance with the high dose in young animals. Isoniazid treatment caused a trend towards an increase in necrosis in young animals with both doses. In contrast, microvesicular steatosis was increased in old isoniazid-treated animals, reaching significance only with the low dose (steatosis prevalence in old: vehicle 1/9, isoniazid 4/5; P < 0.05). Among isoniazid-treated animals, concentrations of toxic intermediates acetylhydrazine and hydrazine were higher in old than young animals (P < 0.05). With both doses, hepatic cytochrome P450 2E1 activity was higher in young animals compared with old (P < 0.05). There were no other age effects seen on any of the other measured enzymes involved in isoniazid metabolism (N-acetyl transferase, amidase, glutathione-S-transferase). These results show age-related changes in isoniazid pharmacokinetics may contribute towards differential patterns of toxicity and confirm that standard hepatotoxicity markers do not detect isoniazid-induced microvesicular steatosis.
C1 [Mach, John; Huizer-Pajkos, Aniko; Kane, Alice; Hilmer, Sarah N.] Kolling Inst Med Res, Lab Ageing & Pharmacol, Sydney, NSW, Australia.
   [Mach, John; Huizer-Pajkos, Aniko; Kane, Alice; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol & Aged Care, Sydney, NSW, Australia.
   [Mach, John; Kane, Alice; Jones, Brett; Cogger, Victoria; Le Couteur, David G.; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Mitchell, Sarah J.; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [McKenzie, Catriona] Royal Prince Alfred Hosp, Dept Pathol, Sydney, NSW, Australia.
   [Phillips, Leo] Kolling Inst Med Res, Mass Spec Imaging & Prote Lab, Sydney, NSW, Australia.
   [Jones, Brett] Kolling Inst Med Res, Dept Gastroenterol, Sydney, NSW, Australia.
   [Cogger, Victoria; Le Couteur, David G.] Concord Hosp, Ctr Educ & Res Ageing, Ageing & Alzheimers Inst, Sydney, NSW, Australia.
   [Cogger, Victoria; Le Couteur, David G.] Concord Hosp, Anzac Res Inst, Sydney, NSW, Australia.
   [Cogger, Victoria; Le Couteur, David G.] Univ Sydney, Sydney, NSW 2006, Australia.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North
   Shore Hospital; University of Sydney; University of Sydney; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   NSW Health; Royal Prince Alfred Hospital; University of Sydney;
   University of Sydney; Kolling Institute of Medical Research; University
   of Sydney; Kolling Institute of Medical Research; Concord Repatriation
   General Hospital; Concord Repatriation General Hospital; University of
   Sydney; ANZAC Research Institute; University of Sydney
RP Hilmer, SN (corresponding author), Kolling Inst Med Res, Lab Ageing & Pharmacol, Sydney, NSW, Australia.
EM sarah.hilmer@sydney.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; de Cabo, Rafael
   Carlos/E-7996-2010; Hilmer, Sarah/AAW-8554-2020; de Cabo,
   Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Hilmer,
   Sarah/0000-0002-5970-1501; de Cabo, Rafael/0000-0002-3354-2442;
   Mckenzie, Catriona/0000-0002-6452-4976; Le Couteur,
   David/0000-0002-4227-5817; Kane, Alice/0000-0002-4303-0491
FU National Health and Medical Research Council [570968]; Geoff and Elaine
   Penney Ageing Research Unit, Royal North Shore Hospital; Intramural
   Research Program of the National Institute on Aging; Intramural Research
   Program of the National Institute on Aging, National Institutes of
   Health
FX The work was supported by the National Health and Medical Research
   Council (project grant number #570968), the Geoff and Elaine Penney
   Ageing Research Unit, Royal North Shore Hospital and the Intramural
   Research Program of the National Institute on Aging. RdC and SJM are
   supported by the Intramural Research Program of the National Institute
   on Aging, National Institutes of Health.
CR Arvanitidis K, 2007, FUND CLIN PHARMACOL, V21, P419, DOI 10.1111/j.1472-8206.2007.00510.x
   CLARK DA, 1970, BIOCHEM PHARMACOL, V19, P1743, DOI 10.1016/0006-2952(70)90166-8
   COECKE S, 1990, MECH AGEING DEV, V55, P189, DOI 10.1016/0047-6374(90)90026-C
   Daly AK, 2003, FUND CLIN PHARMACOL, V17, P27, DOI 10.1046/j.1472-8206.2003.00119.x
   Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716
   Delaney J, 1995, XENOBIOTICA, V25, P1399, DOI 10.3109/00498259509061927
   FARAH F, 1977, BRIT MED J, V2, P155, DOI 10.1136/bmj.2.6080.155
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Fukino K, 2008, J TOXICOL SCI, V33, P187, DOI 10.2131/jts.33.187
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HAGHIGHI B, 1987, BIOCHEM PHARMACOL, V36, P1163, DOI 10.1016/0006-2952(87)90427-8
   Institute of Health Metrics and Evaluation, 2014, GLOBAL BURDEN DIS
   JENNER AM, 1994, ARCH TOXICOL, V68, P349, DOI 10.1007/s002040050081
   Jimenez-Lopez Jose M, 2005, Expert Opin Drug Metab Toxicol, V1, P671, DOI 10.1517/17425255.1.4.671
   Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014
   Kitami N., 1993, PHARMACOEPIDEM DR S, V2, pS43
   Ko HJ, 2010, MOL CELLS, V29, P485, DOI 10.1007/s10059-010-0060-9
   KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991
   Lake BG, 1998, TOXICOLOGY, V131, P9, DOI 10.1016/S0300-483X(98)00085-7
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   Lee SW, 2010, INT J TUBERC LUNG D, V14, P622
   Lucena MI, 2008, FUND CLIN PHARMACOL, V22, P141, DOI 10.1111/j.1472-8206.2008.00566.x
   Mach J, 2014, J GERONTOL A-BIOL, V69, P387, DOI 10.1093/gerona/glt095
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Metushi IG, 2011, CLIN PHARMACOL THER, V89, P911, DOI 10.1038/clpt.2010.355
   Metushi IG, 2014, HEPATOLOGY, V59, P1084, DOI 10.1002/hep.26564
   Metushi IG, 2012, CHEM RES TOXICOL, V25, P2567, DOI 10.1021/tx300341r
   MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181
   Mitchell Sarah J, 2011, Curr Gerontol Geriatr Res, V2011, P624156, DOI 10.1155/2011/624156
   Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018
   NELSON SD, 1976, SCIENCE, V193, P901, DOI 10.1126/science.7838
   PaLMS, 2013, LIV FUNCT TESTS PLAS
   PESSAYRE D, 1977, GASTROENTEROLOGY, V72, P284
   Ramappa V, 2013, J CLIN EXP HEPATOL, V3, P37, DOI 10.1016/j.jceh.2012.12.001
   ROBERTS BJ, 1995, BIOCHEM PHARMACOL, V49, P1665, DOI 10.1016/0006-2952(95)00098-K
   Sarich TC, 1996, ARCH TOXICOL, V70, P835, DOI 10.1007/s002040050347
   SARICH TC, 1995, J PHARMACOL TOX MET, V34, P109, DOI 10.1016/1056-8719(95)00044-I
   Sarich TC, 1999, J PHARMACOL EXP THER, V289, P695
   Schneider E., 2012, HDB BIOL AGING
   Singla R, 2010, INDIAN J MED RES, V132, P81
   Sotsuka T, 2011, IN VIVO, V25, P803
   Tafazoli S, 2008, TOXICOL APPL PHARM, V229, P94, DOI 10.1016/j.taap.2008.01.002
   TIMBRELL JA, 1980, J PHARMACOL EXP THER, V213, P364
   Tostmann A, 2008, INT J ANTIMICROB AG, V31, P577, DOI 10.1016/j.ijantimicag.2008.01.022
   TROUT DL, 1965, BIOCHEM PHARMACOL, V14, P813, DOI 10.1016/0006-2952(65)90100-0
   Vivekanandan P, 2007, DRUG CHEM TOXICOL, V30, P241, DOI 10.1080/01480540701375216
   Vuilleumier Nicolas, 2006, Eur J Clin Pharmacol, V62, P423
   WALUBO A, 1991, METHOD FIND EXP CLIN, V13, P545
   WARRINGTON RJ, 1982, CLIN ALLERGY, V12, P217, DOI 10.1111/j.1365-2222.1982.tb02521.x
   WARRINGTON RJ, 1978, CLIN EXP IMMUNOL, V32, P97
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   Yue J, 2004, ACTA PHARMACOL SIN, V25, P699
   Yue J, 2009, PHARMACOL RES, V59, P112, DOI 10.1016/j.phrs.2008.10.006
   Zhang ZH, 2012, ASIAN PAC J TROP MED, V5, P306, DOI 10.1016/S1995-7645(12)60044-3
   Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1
NR 56
TC 14
Z9 19
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD FEB
PY 2016
VL 30
IS 1
BP 23
EP 34
DI 10.1111/fcp.12157
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DB9IF
UT WOS:000368828900003
PM 26454000
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Shimose, S
   Hiraoka, A
   Tanaka, M
   Iwamoto, H
   Tanaka, T
   Noguchi, K
   Aino, H
   Yamaguchi, T
   Itano, S
   Suga, H
   Niizeki, T
   Moriyama, E
   Shirono, T
   Noda, Y
   Kamachi, N
   Okamura, S
   Nakano, M
   Kawaguchi, T
   Kuromatsu, R
   Koga, H
   Torimura, T
AF Shimose, Shigeo
   Hiraoka, Atsushi
   Tanaka, Masatoshi
   Iwamoto, Hideki
   Tanaka, Takaaki
   Noguchi, Kazunori
   Aino, Hajime
   Yamaguchi, Taizo
   Itano, Satoshi
   Suga, Hideya
   Niizeki, Takashi
   Moriyama, Etsuko
   Shirono, Tomotake
   Noda, Yu
   Kamachi, Naoki
   Okamura, Shusuke
   Nakano, Masahito
   Kawaguchi, Takumi
   Kuromatsu, Ryoko
   Koga, Hironori
   Torimura, Takuji
TI Deterioration of liver function and aging disturb sequential systemic
   therapy for unresectable hepatocellular carcinoma
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POST-PROGRESSION SURVIVAL; SORAFENIB; LENVATINIB; EFFICACY
AB This study aimed to investigate the clinical characteristics of patients with unresectable hepatocellular carcinoma (HCC), who were eligible for sequential systemic therapy. We evaluated 365 patients with HCC who underwent systemic therapy after 2017. The overall survival (OS) was 13.7 months, 19.2 months, and 35.6 months in the first-line, second-line, and third-line or later therapy groups, respectively. Multivariate analysis revealed that the modified-albumin-bilirubin (m-ALBI) grade, macrovascular invasion, extrahepatic spread, discontinuation due to adverse events (AEs), and sequential therapy were independent factors for OS. At the end of each therapy, the ALBI score was significantly worse among patients with discontinuation due to AEs than among those without. The conversion rate to second-line and third-line therapy among patients with discontinuation due to AEs was significantly lower than that among patients without (30.4% vs. 69.2%, p < 0.001; 6.7% vs. 58.3%; p < 0.001, respectively). In the decision tree analysis, m-ALBI grade 1 or 2a and non-advanced age were selected splitting variables, respectively, for sequential systemic therapy. In conclusion, sequential therapy prolonged the OS of unresectable HCC. Additionally, good hepatic function and non-advanced age were clinically eligible characteristics for sequential systemic therapy.
C1 [Shimose, Shigeo; Iwamoto, Hideki; Niizeki, Takashi; Moriyama, Etsuko; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Okamura, Shusuke; Nakano, Masahito; Kawaguchi, Takumi; Kuromatsu, Ryoko; Koga, Hironori; Torimura, Takuji] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
   [Hiraoka, Atsushi; Tanaka, Takaaki] Ehime Prefectural Cent Hosp, Gastroenterol Ctr, Matsuyama, Ehime 7900024, Japan.
   [Tanaka, Masatoshi] Yokokura Hosp, Clin Res Ctr, Miyama, Fukuoka 8390295, Japan.
   [Noguchi, Kazunori] Omuta City Hosp, Dept Gastroenterol, Omuta 8360861, Japan.
   [Aino, Hajime] Social Insurance Tagawa Hosp, Dept Med, Div Gastroenterol, Tagawa 8260023, Japan.
   [Iwamoto, Hideki; Yamaguchi, Taizo] Iwamoto Internal Med Clin, Kitakyushu 8020832, Japan.
   [Itano, Satoshi] Kurume Cent Hosp, Dept Gastroenterol, Kurume, Fukuoka 8300001, Japan.
   [Suga, Hideya] Yanagawa Hosp, Dept Gastroenterol & Hepatol, Yanagawa 8320077, Japan.
C3 Kurume University
RP Shimose, S (corresponding author), Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
EM shimose_shigeo@med.kurume-u.ac.jp
RI Hiraoka, Atsushi/AFR-0440-2022
OI Hiraoka, Atsushi/0000-0003-1989-0480; Iwamoto,
   Hideki/0000-0001-5688-1335
CR Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002
   Ando Y, 2020, ONCOLOGY-BASEL, V98, P787, DOI 10.1159/000509387
   Bang Y, 2021, TARGET ONCOL, V16, P411, DOI 10.1007/s11523-021-00808-3
   Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9
   Cabibbo G, 2022, DIGEST LIVER DIS, V54, P452, DOI 10.1016/j.dld.2022.01.122
   Cabibbo G, 2021, LIVER CANCER, DOI 10.1159/000520278
   Cabibbo G, 2017, J HEPATOL, V67, P65, DOI 10.1016/j.jhep.2017.01.033
   Cui TM, 2020, ONCOTARGETS THER, V13, P11725, DOI 10.2147/OTT.S279858
   Dale W, 2012, JNCI-J NATL CANCER I, V104, P581, DOI 10.1093/jnci/djs145
   Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745
   Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
   Fuchigami A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231427
   Hatanaka T, 2022, HEPATOL RES, V52, P462, DOI 10.1111/hepr.13748
   Hatanaka T, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14010036
   Hiraoka A, 2021, HEPATOL RES, V51, P880, DOI 10.1111/hepr.13644
   Hiraoka A, 2019, ONCOLOGY-BASEL, V97, P277, DOI 10.1159/000501281
   Hiraoka A, 2019, LIVER CANCER, V8, P312, DOI 10.1159/000494844
   Hiraoka A, 2019, CANCER MED-US, V8, P3719, DOI 10.1002/cam4.2241
   Iavarone M, 2015, HEPATOLOGY, V62, P784, DOI 10.1002/hep.27729
   Iwamoto H, 2020, CANCERS, V12, DOI 10.3390/cancers12041010
   Kobayashi K, 2021, LIVER CANCER, DOI 10.1159/000519868
   Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1
   Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Llovet JM, 2021, HEPATOLOGY, V73, P158, DOI 10.1002/hep.31327
   Marta GN, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e2498
   Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x
   Ochi H, 2021, HEPATOL RES, V51, P1219, DOI 10.1111/hepr.13713
   Ogasawara S, 2020, INVEST NEW DRUG, V38, P172, DOI 10.1007/s10637-019-00801-8
   Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9
   Porta C, 2014, CANCER MED-US, V3, P1517, DOI 10.1002/cam4.302
   Rapposelli IG, 2021, LIVER INT, V41, P2997, DOI 10.1111/liv.15014
   Reig M, 2022, J HEPATOL, V76, P681, DOI 10.1016/j.jhep.2021.11.018
   Shimose S, 2021, CANCER MED-US, V10, P8530, DOI 10.1002/cam4.4367
   Shimose S, 2021, ONCOLOGY-BASEL, V99, P756, DOI 10.1159/000518612
   Shimose S, 2020, ONCOL LETT, V20, P2257, DOI 10.3892/ol.2020.11758
   Shimose S, 2020, CANCERS, V12, DOI 10.3390/cancers12071867
   Shomura M, 2014, WORLD J HEPATOL, V6, P670, DOI 10.4254/wjh.v6.i9.670
   Tada T, 2020, HEPATOL RES, V50, P75, DOI 10.1111/hepr.13427
   Terashima T, 2016, HEPATOL RES, V46, P650, DOI 10.1111/hepr.12601
   Uchikawa S, 2020, ONCOLOGY-BASEL, V98, P727, DOI 10.1159/000507815
   Ueshima K, 2019, CANCERS, V11, DOI 10.3390/cancers11070952
   Yamada S, 2014, HEPATOL RES, V44, P837, DOI 10.1111/hepr.12192
   Yoo C, 2021, LIVER CANCER, V10, P107, DOI 10.1159/000512781
   Zhu AX, 2019, LANCET ONCOL, V20, P282, DOI 10.1016/S1470-2045(18)30937-9
   Ziogas DC, 2017, EUR J GASTROEN HEPAT, V29, P48, DOI 10.1097/MEG.0000000000000739
NR 46
TC 5
Z9 5
U1 0
U2 0
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 11
PY 2022
VL 12
IS 1
AR 17018
DI 10.1038/s41598-022-21528-2
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 5F2WK
UT WOS:000866180700049
PM 36220865
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Nahata, M
   Fujitsuka, N
   Sekine, H
   Shimobori, C
   Ohbuchi, K
   Iizuka, S
   Mogami, S
   Ohnishi, S
   Takeda, H
AF Nahata, Miwa
   Fujitsuka, Naoki
   Sekine, Hitomi
   Shimobori, Chika
   Ohbuchi, Katsuya
   Iizuka, Seiichi
   Mogami, Sachiko
   Ohnishi, Shunsuke
   Takeda, Hiroshi
TI Decline in Liver Mitochondria Metabolic Function Is Restored by
   Hochuekkito Through Sirtuin 1 in Aged Mice With Malnutrition
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE aging; hochuekkito; metabolomics; mitochondria; sirtuin1
ID JAPANESE HERBAL MEDICINE; BILE-ACIDS; BETAINE ALDEHYDE;
   HYDROGEN-SULFIDE; BIOGENESIS; HOMEOSTASIS; SYNTHASE; HYPERAMMONEMIA;
   MODULATION; PATHWAY
AB Malnutrition impairs basic daily activities and leads to physical frailty, which is aggravated in the elderly compared with young adults. It is also well-known that the elderly are more vulnerable to metabolic stress. Therefore, in this study, using a food restricted (FR) mouse, we aimed to evaluate the effect of aging on locomotor activity and liver metabolic function. Further, we also investigated the involvement of hepatic mitochondria in liver metabolic function during aging, as well as the therapeutic benefit of the traditional Japanese medicine, hochuekkito (HET). Our findings indicated that following food restriction provided as 30% of ad libitum intake for 5 days, the locomotor activity was lower in 23-26-month-old (aged) mice than in 9-week-old (young) mice. Further, compared with young mice, aged mice exhibited significant decreases in the levels of metabolites related to the urea cycle, mitochondrial function, and anti-oxidative stress. The livers of the aged mice also showed a greater decrease in mitochondrial DNA copy number than young mice. Furthermore, the gene expression levels of sirtuin 1 (SIRT1) and mitochondrial biogenesis-related regulators were attenuated in aged mice. However, these changes were partially restored by HET treatment, which also improved locomotor activity, and combined treatment with alanine resulted in more significant effects in this regard. Therefore, our findings suggested that the decrease in locomotor activity in aged FR mice was associated with a decline in the metabolic function of hepatic mitochondria via decreased SIRT1 expression, which was restored by HET treatment. This implies that enhancing the metabolic function of liver mitochondria can contribute to alleviating energy deficiency in the elderly.
C1 [Nahata, Miwa; Fujitsuka, Naoki; Sekine, Hitomi; Iizuka, Seiichi; Mogami, Sachiko] Tsumura & Co, Tsumura Kampo Res Labs, Ibaraki, Japan.
   [Shimobori, Chika; Ohbuchi, Katsuya] Tsumura & Co, Tsumura Adv Technol Res Labs, Ibaraki, Japan.
   [Ohnishi, Shunsuke; Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.
   [Takeda, Hiroshi] Tokeidai Mem Hosp, Gastroenterol, Sapporo, Hokkaido, Japan.
C3 Tsumura & Company; Tsumura & Company; Hokkaido University
RP Fujitsuka, N (corresponding author), Tsumura & Co, Tsumura Kampo Res Labs, Ibaraki, Japan.
EM fujitsuka_naoki@mail.tsumura.co.jp
OI Mogami, Sachiko/0000-0001-7914-4928
CR Akita S, 2019, WOUND REPAIR REGEN, V27, P672, DOI 10.1111/wrr.12753
   Allen SL, 2020, AM J PHYSIOL-GASTR L, V320, pG241, DOI 10.1152/ajpgi.00373.2020
   Cai M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112644
   Castro-Portuguez R, 2020, EXP GERONTOL, V132, DOI 10.1016/j.exger.2020.110841
   Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004
   Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001
   Chiang JYL, 2019, ANNU REV NUTR, V39, P175, DOI 10.1146/annurev-nutr-082018-124344
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   COHEN NS, 1992, BIOCHEM J, V282, P173, DOI 10.1042/bj2820173
   Comai S, 2005, CLIN CHIM ACTA, V360, P67, DOI 10.1016/j.cccn.2005.04.013
   Davinelli S, 2020, TRENDS ENDOCRIN MET, V31, P536, DOI 10.1016/j.tem.2020.02.011
   Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004
   Desideri E, 2012, AUTOPHAGY, V8, P1769, DOI 10.4161/auto.22037
   Ebadi M, 2019, J GASTROENTEROL, V54, P845, DOI 10.1007/s00535-019-01605-6
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Fujitsuka N, 2016, MOL PSYCHIATR, V21, P1613, DOI 10.1038/mp.2015.220
   Hamada H, 2018, EXP THER MED, V16, P5236, DOI 10.3892/etm.2018.6837
   Han QH, 2021, AGING CELL, V20, DOI 10.1111/acel.13425
   He ZY, 2015, ONCOTARGET, V6, P33178, DOI 10.18632/oncotarget.5090
   Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1
   Holecek M, 2011, AMINO ACIDS, V40, P575, DOI 10.1007/s00726-010-0679-z
   Hou CL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7570489
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Isago H, 2021, BIOL PHARM BULL, V44, P39, DOI 10.1248/bpb.b20-00556
   Iwasawa T, 2021, REGEN THER, V18, P231, DOI 10.1016/j.reth.2021.07.002
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kohno J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90890-4
   Kumar R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094363
   Kuroiwa A, 2004, INT IMMUNOPHARMACOL, V4, P317, DOI 10.1016/j.intimp.2003.12.004
   Lee G, 2016, J CHROMATOGR B, V1031, P37, DOI 10.1016/j.jchromb.2016.07.017
   LEPAGNOL JM, 1993, ANN NY ACAD SCI, V695, P86, DOI 10.1111/j.1749-6632.1993.tb23034.x
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Luo ZX, 2021, J CELL MOL MED, V25, P8863, DOI 10.1111/jcmm.16847
   Ma JL, 2020, GUT MICROBES, V11, P1450, DOI 10.1080/19490976.2020.1763770
   Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005
   MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415
   Mezhnina V, 2020, AGING CELL, V19, DOI 10.1111/acel.13266
   Nahata M, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00065-8
   Ng F, 2013, J CELL PHYSIOL, V228, P2262, DOI 10.1002/jcp.24399
   Nirwane A, 2018, ARCH PHYSIOL BIOCHEM, V124, P194, DOI 10.1080/13813455.2017.1391847
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Park E, 2017, MOLECULES, V22, DOI 10.3390/molecules22060978
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Pietruszko R, 2001, CHEM-BIOL INTERACT, V130, P193, DOI 10.1016/S0009-2797(00)00277-5
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Popov LD, 2020, J CELL MOL MED, V24, P4892, DOI 10.1111/jcmm.15194
   Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rose AV, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-037240
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Saka B, 2010, CLIN NUTR, V29, P745, DOI 10.1016/j.clnu.2010.04.006
   Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014
   Satoh N, 2005, PHYTOMEDICINE, V12, P549, DOI 10.1016/j.phymed.2004.06.014
   SHIZGAL HM, 1992, AM J CLIN NUTR, V55, P783, DOI 10.1093/ajcn/55.4.783
   Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868
   Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Takanashi K, 2017, PHARMACOLOGY, V99, P240, DOI 10.1159/000455918
   Vicente JB, 2016, BBA-BIOENERGETICS, V1857, P1127, DOI 10.1016/j.bbabio.2016.03.030
   Wang F, 2020, ARCH PHARM RES, V43, P1031, DOI 10.1007/s12272-020-01279-2
   WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T
   Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009
   Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003
   ZHANG J, 1992, BIOCHIM BIOPHYS ACTA, V1117, P333, DOI 10.1016/0304-4165(92)90033-Q
   Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12
   Zhou Y, 2021, NAT CHEM BIOL, V17, P1027, DOI 10.1038/s41589-021-00837-z
NR 68
TC 0
Z9 0
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD MAR 1
PY 2022
VL 13
AR 848960
DI 10.3389/fphys.2022.848960
PG 14
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 0A0UX
UT WOS:000773679200001
PM 35299665
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chaurasia, P
   Thakur, MK
AF Chaurasia, P
   Thakur, MK
TI Nucleosome positioning and periodicity of satellite DNA in the liver of
   aging rats - Nucleosome positioning and periodicity of satellite DNA
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE aging; satellite DNA; nucleosome positioning; restriction mapping; rat
   liver
ID CHROMATIN; SEQUENCE; PROMOTER; ENHANCER; ELEMENTS
AB The positioning of nucleosomes has been analysed by comparing the pattern of cutting sites of a probing reagent on chromatin and naked DNA. For this purpose, high molecular weight DNA and nuclei from the liver of young (18 +/- 2 weeks) and old (100 +/- 5 weeks) Wistar male rats were digested with micrococcal nuclease (MNase) and hybridized with P-32-labelled rat satellite DNA probe. A comparison of the ladder generated by MNase with chromatin and nuclei indicates long range organization of the satellite chromatin fiber with distinct non-random positioning of nucleosomes. However, the positioning of nucleosomes on satellite DNA does not vary with age. For studying the periodicity and subunit structure of satellite DNA, high molecular weight DNA from the liver of young and old rats were digested with different restriction enzymes. Surprisingly, no noteworthy age-related change is visible in the periodicity and subunit structural organization of the satellite DNA. These results suggest that the nucleosome positioning and the periodicity of liver satellite DNA do not vary with age.
C1 Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Thakur, MK (corresponding author), Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
CR Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BOCK H, 1984, J MOL BIOL, V176, P131, DOI 10.1016/0022-2836(84)90385-1
   BURGOYNE LA, 1978, CELL NUCLEUS, V4, P48
   ENGLANDER EW, 1995, J BIOL CHEM, V270, P10091, DOI 10.1074/jbc.270.17.10091
   ENRIETTO PJ, 1983, CELL, V35, P369, DOI 10.1016/0092-8674(83)90170-8
   Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370
   GOTTESFELD JM, 1978, NATURE, V273, P317, DOI 10.1038/273317a0
   HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405
   IGOKEMENES T, 1985, STRUCTURE FUNCTION G, P55
   JACKSON JR, 1993, NUCLEIC ACIDS RES, V21, P957, DOI 10.1093/nar/21.4.957
   LAPEYRE JN, 1980, GENE, V10, P339, DOI 10.1016/0378-1119(80)90154-7
   LEVY A, 1980, NUCLEIC ACIDS RES, V10, P4845
   McPherson CE, 1996, NUCLEIC ACIDS RES, V24, P397, DOI 10.1093/nar/24.3.397
   Mori N, 1982, Arch Gerontol Geriatr, V1, P143, DOI 10.1016/0167-4943(82)90014-0
   MUSICH PR, 1977, J MOL BIOL, V117, P657, DOI 10.1016/0022-2836(77)90063-8
   NELSON PP, 1979, J BIOL CHEM, V254, P9194
   OMORI A, 1980, NUCLEIC ACIDS RES, V8, P5363, DOI 10.1093/nar/8.22.5363
   PECH M, 1979, NUCLEIC ACIDS RES, V7, P417, DOI 10.1093/nar/7.2.417
   PRUNELL A, 1977, COLD SPRING HARB SYM, V42, P103, DOI 10.1101/SQB.1978.042.01.011
   RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x
   ROTH SY, 1991, METHOD CELL BIOL, V53, P301
   SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x
   THAKUR MK, 1987, J BIOSCIENCE, V12, P41, DOI 10.1007/BF02716952
   THAKUR MK, 1996, AGING INDIAN PERSPEC, P413
   THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9
   WITNEY FR, 1983, NUCLEIC ACIDS RES, V11, P291, DOI 10.1093/nar/11.2.291
NR 26
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JAN
PY 1998
VL 25
IS 1
BP 63
EP 69
DI 10.1023/A:1006835732729
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ZA769
UT WOS:000072399000006
PM 9540067
DA 2024-02-19
ER

PT J
AU Zeng, R
   Farooq, MU
   Zhang, G
   Tang, ZC
   Zheng, TD
   Su, Y
   Hussain, S
   Liang, YK
   Ye, XY
   Jia, XM
   Zhu, JQ
AF Zeng, Rui
   Farooq, Muhammad Umer
   Zhang, Guo
   Tang, Zhichen
   Zheng, Tengda
   Su, Yang
   Hussain, Sajad
   Liang, Yuanke
   Ye, Xiaoying
   Jia, Xiaomei
   Zhu, Jianqing
TI Dissecting the Potential of Selenoproteins Extracted from
   Selenium-Enriched Rice on Physiological, Biochemical and Anti-Ageing
   Effects In Vivo
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article; Early Access
DE Selenium-rich rice; Selenoproteins; d-Galactose-induced ageing mice;
   Antioxidation; Organ indices; Relative gene expression
ID OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; TOXICITY; PURIFICATION; VITRO;
   SE
AB Ageing is an irreversible phenomenon and the processes which can delay it are under consideration for a long time by the scientific community. Selenium is an important candidate for it, but the impact of selenoprotein on nutritional changes and ageing has not been reported well. In this regard, antioxidant activities and free radical scavenging effect of selenoproteins extracted from selenium-rich rice were studied. Mice were administered a subcutaneous abdominal injection of d-galactose to induce the ageing model and fed with different selenoprotein dosage diet. Deviations among biochemical activities (total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and malondialdehyde (MDA)) in liver and serum of the mice were assessed. The degree of liver injury, antioxidant genes and protein relative expression were estimated. The protein content, selenium content, hydroxyl scavenging and DPPH radicals were accessed in selenoprotein components. The selenoprotein constituent had protein and selenium contents in different components as water-soluble proteins > alkali-soluble proteins > salt-soluble proteins > ethanol-soluble proteins. The enzymatic activity (total antioxidant capacity, GSH-Px and SOD) in liver and serum of mice was significantly enhanced in selenoprotein diet groups. d-Galactose-induced liver injury was significantly reduced by selenoprotein diet of 25 mu g/(kg day). Real-time qPCR and Western blot disclosed the enhanced relative expression of antioxidant genes (SOD2, GPX1, TrxR2 and Nrf2) and HO-1 protein in the positive control (Vc) and selenoprotein diet groups. In conclusion, selenoprotein treatment was found to have a positive influence on liver hepatocytes and biochemical features in mice. It might be used as a potential diet in scavenging oxidative injury and supporting enzymatic antioxidant system.
C1 [Zeng, Rui; Farooq, Muhammad Umer; Tang, Zhichen; Zheng, Tengda; Su, Yang; Liang, Yuanke; Ye, Xiaoying; Jia, Xiaomei; Zhu, Jianqing] Sichuan Agr Univ, Rice Res Inst, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.
   [Zeng, Rui] Dujiangyan Agr & Rural Bur, Dujiangyan 611830, Sichuan, Peoples R China.
   [Zhang, Guo] Chengdu Agr Coll, Chengdu 611130, Sichuan, Peoples R China.
   [Hussain, Sajad] Sichuan Agr Univ, Coll Agron, Chengdu 611130, Sichuan, Peoples R China.
C3 Sichuan Agricultural University; Sichuan Agricultural University
RP Zhu, JQ (corresponding author), Sichuan Agr Univ, Rice Res Inst, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.
EM zhujianqing1963@163.com
RI Zeng, Rui/GRY-0646-2022; Hussain, Sajad/S-4261-2019; Farooq, Muhammad
   Umer/AAO-7222-2020; Hussain, Sajad/GZL-5573-2022
OI Zeng, Rui/0000-0003-1188-3198; Hussain, Sajad/0000-0001-9100-360X;
   Farooq, Muhammad Umer/0000-0003-1482-0985; Liang,
   Yuanke/0000-0001-9457-7342
FU International Cooperation and Exchanges Research Program of the
   Department of S&T of Sichuan Province [2015HH0028]; Technology R&D
   Program of Sichuan Province [2016NZ0106]; International R&D Cooperation
   and Exchange Projects of Sichuan Province [2018HH0016]
FX This work was supported by the International Cooperation and Exchanges
   Research Program of the Department of S&T of Sichuan Province
   (2015HH0028), Technology R&D Program of Sichuan Province (2016NZ0106)
   and International R&D Cooperation and Exchange Projects of Sichuan
   Province (2018HH0016).
CR Aldosary BM, 2012, CLIN TOXICOL, V50, P57, DOI 10.3109/15563650.2011.641560
   Bae HJ, 2014, J KOREAN SOC APPL BI, V57, P685, DOI 10.1007/s13765-014-4095-z
   Bai KK, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0324-z
   Cai ZL, 2019, AGING CLIN EXP RES, V31, P1035, DOI 10.1007/s40520-018-1086-7
   Carmona JJ, 2016, REV INVEST CLIN, V68, P7
   Chen HY, 2015, MODERN FOOD SCI TECH, V31, P7
   de Souza D, 2016, FOOD CHEM, V191, P36, DOI 10.1016/j.foodchem.2015.03.032
   Diamanti-Kandarakis E, 2017, EUR J ENDOCRINOL, V176, pR283, DOI 10.1530/EJE-16-1061
   Faiz A, 2015, INT J AGRIC BIOL, V17, P741, DOI 10.17957/IJAB/14.0013
   Farooq MU, 2019, ENVIRON SCI POLLUT R, V26, P22421, DOI 10.1007/s11356-019-05467-6
   Farooq MU, 2019, J SCI FOOD AGR, V99, P2892, DOI 10.1002/jsfa.9502
   Gajcevic Z, 2009, ITAL J ANIM SCI, V8, P189
   HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476
   [胡瞬 Hu Shun], 2011, [食品科学, Food Science], V32, P232
   K-x H, 2008, CHINESE J INORG CHEM, V24, P1213
   Kou XJ, 2016, ONCOTARGET, V7, P74484, DOI 10.18632/oncotarget.12811
   Li SS, 2018, INT J BIOL MACROMOL, V109, P457, DOI 10.1016/j.ijbiomac.2017.12.108
   Liang YK, 2018, FOOD SCI TECHNOL RES, V24, P687, DOI 10.3136/fstr.24.687
   Liang YK, 2018, INT J AGRIC BIOL, V20, P1005, DOI 10.17957/IJAB/15.0592
   Liu J, 2010, CARBOHYD POLYM, V82, P1278, DOI 10.1016/j.carbpol.2010.07.008
   Liu KL, 2015, FOOD CHEM, V187, P424, DOI 10.1016/j.foodchem.2015.04.086
   Liu KL, 2011, FOOD CHEM, V127, P1526, DOI 10.1016/j.foodchem.2011.02.010
   Mironczuk-Chodakowska I, 2018, ADV MED SCI-POLAND, V63, P68, DOI 10.1016/j.advms.2017.05.005
   Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010
   Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024
   Ostádalová I, 2010, PHYSIOL RES, V59, P881, DOI 10.33549/physiolres.931935
   Rafieian-Kopaei M, 2013, J RES MED SCI, V18, P628
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Sethy NK, 2011, FUNCT INTEGR GENOMIC, V11, P119, DOI 10.1007/s10142-010-0195-y
   Shi LG, 2011, SMALL RUMINANT RES, V96, P49, DOI 10.1016/j.smallrumres.2010.11.005
   Sors TG, 2005, PLANT J, V42, P785, DOI 10.1111/j.1365-313X.2005.02413.x
   Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800
   Wan Q, 2013, MOD FOOD SCI TECHNOL, V29, P2075
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wang L, 2015, PROGR SELENIUM METAB
   Wang PP, 2016, PHYTOMEDICINE, V23, P460, DOI 10.1016/j.phymed.2016.02.014
   Yoon I, 2007, POULTRY SCI, V86, P727, DOI 10.1093/ps/86.4.727
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Yue J, 2010, STUDIES ANTIOXIDATIO
   Zeng R, 2019, ENVIRON SCI POLLUT R, V26, P17834, DOI 10.1007/s11356-019-05226-7
   Zhang ES, 2005, LIFE SCI, V76, P1099, DOI 10.1016/j.lfs.2004.08.015
   Zhao P, 2016, SAUDI J BIOL SCI, V23, P353, DOI 10.1016/j.sjbs.2015.08.007
   Zheng GQ, 2016, J FUNCT FOODS, V27, P310, DOI 10.1016/j.jff.2016.09.015
   Zoidis E, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7050066
NR 44
TC 30
Z9 32
U1 6
U2 47
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD 2020 JUL
PY 2020
VL 196
IS 1
BP 119
EP 130
DI 10.1007/s12011-019-01896-z
EA NOV 2019
PG 12
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA LY0KB
UT WOS:000499557000003
PM 31786753
DA 2024-02-19
ER

PT J
AU Bordoni, A
   Hrelia, S
   Lorenzini, A
   Bergami, R
   Cabrini, L
   Biagi, PL
   Tolomelli, B
AF Bordoni, A
   Hrelia, S
   Lorenzini, A
   Bergami, R
   Cabrini, L
   Biagi, PL
   Tolomelli, B
TI Dual influence of aging and vitamin B<sub>6</sub> deficiency on
   delta-6-desaturation of essential fatty acids in rat liver microsomes
SO PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
LA English
DT Article
ID SUPPLEMENTATION; DESATURATION; LIPIDS
AB Delta-6-desaturase (D6D) activity is influenced by many nutritional and non-nutritional factors, among which one of the most important is aging. D6D activity could be susceptible to the dual influence of aging itself and of nutritional deficiencies, due to the reduced intake and/or absorption of essential nutrients. Particularly, vitamin B-6 deficiency might be a crucial factor for D6D activity in aged people. Using 20 month old Sprague-Dawly rats fed a diet with a subnormal lever of vitamin B-6, we evaluated D6D activity for linoleic acid (LA) and alpha-linolenic acid (ALA) in liver microsomes, and the fatty acid composition of microsomal total lipids. We observed a diminished D6D activity for LA and also for ALA in vitamin B-6-deficient animals, being approximately 63% and 81% respectively of the corresponding activity in control rats. As a consequence, significant modifications in the relative molar content of microsomal fatty acids were observed. The content of arachidonic and docosahexaenoic acid, the main products of the conversion of LA and ALA respectively, decreased, LA content increased and a decrease in the unsaturation index was observed in liver microsomes of B-6-deficient rats. The foregoing results suggest that the impairment of D6D activity by vitamin B-6 deficiency might be an important factor in decreasing the synthesis of n-6 and n-3 PUFAs. This may be particularly important in aging, where D6D activity is already impaired.
C1 Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
RP Bordoni, A (corresponding author), Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
RI Hrelia, Silvana/P-2864-2015; Bordoni, Alessandra/J-3047-2012; Lorenzini,
   Antonello/G-4463-2012; LORENZINI, ANTONELLO/E-6582-2016
OI Hrelia, Silvana/0000-0001-7857-4512; LORENZINI,
   ANTONELLO/0000-0001-9615-9697; Bordoni, Alessandra/0000-0003-4579-1662
CR BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BIAGI PL, 1993, J NUTR BIOCHEM, V4, P690, DOI 10.1016/0955-2863(93)90108-9
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   CUNNANE SC, 1984, J NUTR, V114, P1754, DOI 10.1093/jn/114.10.1754
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FURTHWALKER D, 1989, J NUTR, V119, P750, DOI 10.1093/jn/119.5.750
   HRELIA S, 1995, BIOCHEM BIOPH RES CO, V216, P11, DOI 10.1006/bbrc.1995.2585
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   MARANESI M, 1993, PROSTAG LEUKOTR ESS, V49, P531, DOI 10.1016/0952-3278(93)90043-V
   MILLER LT, 1990, ANN NY ACAD SCI, V587, P49, DOI 10.1111/j.1749-6632.1990.tb00132.x
   PREGNOLATO P, 1994, INT J VITAM NUTR RES, V64, P263
   Salmon W.D., 1938, J BIOL CHEM, V123, P104
   SATO Y, NAGOYA J MED SCI, V33, P105
   SHE QB, 1994, BIOSCI BIOTECH BIOCH, V58, P459, DOI 10.1271/bbb.58.459
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
NR 15
TC 37
Z9 41
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0952-3278
EI 1532-2823
J9 PROSTAG LEUKOTR ESS
JI Prostaglandins Leukot. Essent. Fatty Acids
PD JUN
PY 1998
VL 58
IS 6
BP 417
EP 420
DI 10.1016/S0952-3278(98)90163-6
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
GA 111HT
UT WOS:000075431800006
PM 10189072
DA 2024-02-19
ER

PT J
AU Xiang, XH
   Yang, L
   Zhang, X
   Ma, XH
   Miao, RC
   Gu, JX
   Fu, YN
   Yao, Q
   Zhang, JY
   Liu, C
   Lin, T
   Qu, K
AF Xiang, Xiao-Hong
   Yang, Li
   Zhang, Xing
   Ma, Xiao-Hua
   Miao, Run-Chen
   Gu, Jing-Xian
   Fu, Yu-Nong
   Yao, Qing
   Zhang, Jing-Yao
   Liu, Chang
   Lin, Ting
   Qu, Kai
TI Seven-senescence-associated gene signature predicts overall survival for
   Asian patients with hepatocellular carcinoma
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Senescence-associated genes; Hepatocellular carcinoma; Overall survival;
   Risk model; Asian patients
ID LIVER-TRANSPLANTATION; CELLULAR SENESCENCE; ALPHA-FETOPROTEIN;
   EXPRESSION; CEP55; EZH2; MCM7
AB BACKGROUND
   Cellular senescence is a recognized barrier for progression of chronic liver diseases to hepatocellular carcinoma (HCC). The expression of a cluster of genes is altered in response to environmental factors during senescence. However, it is questionable whether these genes could serve as biomarkers for HCC patients.
   AIM
   To develop a signature of senescence-associated genes (SAGs) that predicts patients' overall survival (OS) to improve prognosis prediction of HCC.
   METHODS
   SAGs were identified using two senescent cell models. Univariate COX regression analysis was performed to screen the candidate genes significantly associated with OS of HCC in a discovery cohort (GSE14520) for the least absolute shrinkage and selection operator modelling. Prognostic value of this seven-gene signature was evaluated using two independent cohorts retrieved from the GEO (GSE14520) and the Cancer Genome Atlas datasets, respectively. Time-dependent receiver operating characteristic (ROC) curve analysis was conducted to compare the predictive accuracy of the seven-SAG signature and serum alpha-fetoprotein (AFP).
   RESULTS
   A total of 42 SAGs were screened and seven of them, including KIF18B, CEP55, CIT, MCM7, CDC45, EZH2, and MCM5, were used to construct a prognostic formula. All seven genes were significantly downregulated in senescent cells and upregulated in HCC tissues. Survival analysis indicated that our seven-SAG signature was strongly associated with OS, especially in Asian populations, both in discovery and validation cohorts. Moreover, time-dependent ROC curve analysis suggested the seven-gene signature had a better predictive accuracy than serum AFP in predicting HCC patients' 1-, 3-, and 5-year OS.
   CONCLUSION
   We developed a seven-SAG signature, which could predict OS of Asian HCC patients. This risk model provides new clinical evidence for the accurate diagnosis and targeted treatment of HCC.
C1 [Xiang, Xiao-Hong; Zhang, Xing; Ma, Xiao-Hua; Miao, Run-Chen; Gu, Jing-Xian; Fu, Yu-Nong; Yao, Qing; Zhang, Jing-Yao; Liu, Chang; Lin, Ting; Qu, Kai] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.
   [Yang, Li] Taishan Med Coll, Liaocheng Peoples Hosp, Dept Clin Lab, Liaocheng 252000, Shandong, Peoples R China.
C3 Xi'an Jiaotong University; Shandong First Medical University & Shandong
   Academy of Medical Sciences
RP Qu, K (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.
EM qukai@xjtu.edu.cn
RI Liu, Chang/ISV-3950-2023; jiang, lei/IWE-1124-2023; wei,
   xiao/ISB-6027-2023; Jiang, Tao/IWM-7503-2023; liu, chang/HCI-5413-2022;
   MA, XIAO/HHN-5611-2022; Liu, Chang/HOC-0971-2023; wang,
   dong/HMP-1439-2023
FU National Natural Science Foundation of China [81773128, 81871998];
   Natural Science Basic Research Plan in Shaanxi Province of China
   [2018JM7013, 2017JM8039]; Research Fund for Young Star of Science and
   Technology in Shaanxi Province [2018KJXX-022]; China Postdoctoral
   Science Foundation [2018M641000]
FX Supported by the National Natural Science Foundation of China, No.
   81773128 and No. 81871998; the Natural Science Basic Research Plan in
   Shaanxi Province of China, No. 2018JM7013 and No. 2017JM8039; the
   Research Fund for Young Star of Science and Technology in Shaanxi
   Province, No. 2018KJXX-022; and China Postdoctoral Science Foundation,
   No. 2018M641000.
CR Ali FA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10708
   Arbet J, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0533-3
   Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627
   Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107
   Dong PX, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00471
   Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Guo M, 2017, BIOMED PHARMACOTHER, V96, P1527, DOI 10.1016/j.biopha.2017.11.075
   Ishimi Y, 2018, GENES GENET SYST, V93, P125, DOI 10.1266/ggs.18-00026
   Jiang N, 2018, CELL PHYSIOL BIOCHEM, V48, P317, DOI 10.1159/000491731
   Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036
   Kim Y, 2018, J BIOPHARM STAT, V28, P612, DOI 10.1080/10543406.2017.1372768
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee SH, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12852
   Lee YM, 2010, GENE, V466, P16, DOI 10.1016/j.gene.2010.06.007
   Liu GH, 2015, J GASTROEN HEPATOL, V30, P1405, DOI 10.1111/jgh.12953
   Liu HF, 2003, J BIOL CHEM, V278, P2541, DOI 10.1074/jbc.M210391200
   Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]
   Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006
   Park H, 2014, LIVER INT, V34, P313, DOI 10.1111/liv.12274
   Qu K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.352
   Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536
   Su M, 2018, J CANCER, V9, P4156, DOI 10.7150/jca.27098
   Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1
   Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65
   Wei WQ, 2018, J CELL PHYSIOL, V233, P9121, DOI 10.1002/jcp.26956
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu YQ, 2018, ONCOTARGETS THER, V11, P1707, DOI 10.2147/OTT.S157440
   Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398
   You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200
   Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18
   Zhou YM, 2012, LIVER INT, V32, P1505, DOI 10.1111/j.1478-3231.2012.02846.x
NR 34
TC 28
Z9 30
U1 0
U2 9
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD APR 14
PY 2019
VL 25
IS 14
BP 1715
EP 1728
DI 10.3748/wjg.v25.i14.1715
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HT2FX
UT WOS:000464379700006
PM 31011256
OA hybrid, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Salam, R
   Saliou, A
   Bielle, F
   Bertrand, M
   Antoniewski, C
   Carpentier, C
   Alentorn, A
   Capelle, L
   Sanson, M
   Huillard, E
   Bellenger, L
   Guégan, J
   Le Roux, I
AF Salam, Rana
   Saliou, Alexa
   Bielle, Franck
   Bertrand, Mathilde
   Antoniewski, Christophe
   Carpentier, Catherine
   Alentorn, Agusti
   Capelle, Laurent
   Sanson, Marc
   Huillard, Emmanuelle
   Bellenger, Lea
   Guegan, Justine
   Le Roux, Isabelle
TI Cellular senescence in malignant cells promotes tumor progression in
   mouse and patient Glioblastoma
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SET ENRICHMENT ANALYSIS; SECRETORY PHENOTYPE; LIVER-CANCER; RADIAL GLIA;
   STEM-CELLS; IN-VITRO; EXPRESSION; NRF2; CLEARANCE; PTEN
AB Senescence can have beneficial and detrimental impact on cancer progression depending on the cellular context. Here the authors show that NRF2 regulates the senescence phenotype in malignant cells which consequently contribute to glioblastoma progression.
   Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, yet it remains refractory to systemic therapy. Elimination of senescent cells has emerged as a promising new treatment approach against cancer. Here, we investigated the contribution of senescent cells to GBM progression. Senescent cells are identified in patient and mouse GBMs. Partial removal of p16(Ink4a)-expressing malignant senescent cells, which make up less than 7 % of the tumor, modifies the tumor ecosystem and improves the survival of GBM-bearing female mice. By combining single cell and bulk RNA sequencing, immunohistochemistry and genetic knockdowns, we identify the NRF2 transcription factor as a determinant of the senescent phenotype. Remarkably, our mouse senescent transcriptional signature and underlying mechanisms of senescence are conserved in patient GBMs, in whom higher senescence scores correlate with shorter survival times. These findings suggest that senolytic drug therapy may be a beneficial adjuvant therapy for patients with GBM.
C1 [Salam, Rana; Saliou, Alexa; Bielle, Franck; Carpentier, Catherine; Alentorn, Agusti; Sanson, Marc; Huillard, Emmanuelle; Le Roux, Isabelle] Sorbonne Univ, Hop Pitie Salpetriere, Paris Brain Inst ICM,CNRS, Genet & Dev Brain Tumors Team,INSERM,U 1127, Paris, France.
   [Bielle, Franck] Hop Pitie Salpetriere Charles Foix, AP HP, Dept Neuropathol, Paris, France.
   [Bielle, Franck; Sanson, Marc] Sorbonne Univ, Hop Pitie Salpetriere, Paris Brain Inst ICM,Onconeurotek Tumor Bank, INSERM,U 1127,CNRS UMR 7225, Paris, France.
   [Bertrand, Mathilde; Guegan, Justine] Sorbonne Univ, Hop Pitie Salpetriere, Paris Brain Inst ICM, INSERM,U 1127,CNRS,UMR 7225,Data Anal Core Platfo, Paris, France.
   [Antoniewski, Christophe; Bellenger, Lea] Sorbonne Univ, Inst Biol Paris Seine IBPS, Inst Francais Bioinformat IFB, CNRS FR3631,INSERM,US037, Paris, France.
   [Alentorn, Agusti; Sanson, Marc] Hop Pitie Salpetriere Charles Foix, AP HP, Serv Neurol, 2 Mazarin, Paris, France.
   [Capelle, Laurent] Hop Pitie Salpetriere Charles Foix, Serv Neurochirurg, AP HP, Paris, France.
C3 Sorbonne Universite; Centre National de la Recherche Scientifique
   (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Pitie-Salpetriere - APHP; Hopital Universitaire
   Paul-Brousse - APHP; Hopital Universitaire Charles-Foix - APHP; Sorbonne
   Universite; Universite Paris Cite; Hopital Universitaire Hotel-Dieu -
   APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Sorbonne Universite; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Charles-Foix - APHP; Sorbonne Universite; Hopital Universitaire
   Pitie-Salpetriere - APHP; Hopital Universitaire Paul-Brousse - APHP;
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire
   Charles-Foix - APHP; Hopital Universitaire Pitie-Salpetriere - APHP;
   Hopital Universitaire Paul-Brousse - APHP; Sorbonne Universite
RP Le Roux, I (corresponding author), Sorbonne Univ, Hop Pitie Salpetriere, Paris Brain Inst ICM,CNRS, Genet & Dev Brain Tumors Team,INSERM,U 1127, Paris, France.
EM isabelle.leroux@icm-institute.org
RI Bielle, Franck/AFN-9280-2022
OI Bielle, Franck/0000-0001-6564-6388; Salam, Rana/0000-0002-0155-6081;
   Alentorn, Agusti/0000-0002-7220-2686; Bellenger, Lea/0000-0002-5332-7870
FU Paris Brain Institute (ICM); Institut National de la Sante Et de la
   Recherche Medicale; Centre National de la Recherche Scientifique;
   ATIP-AVENIR; Canceropole Ile de France; Ligue contre le cancer; comite
   Ile de France; Fondation ARC pour la Recherche sur le Cancer; French
   Ministry of Education and Research and the Ligue Nationale Contre le
   Cancer; Ligue Nationale Contre le Cancer
FX The authors acknowledge the service of the ICM platforms: iGenSeq,
   iVector especially Phillippe Ravassard, icm-QUAN-Imaging, Pheno-ICMice,
   Histomics-Histology, Celis-Cell culture, the Data Analysis Core platform
   for their expertise in statistics, in particular, Francois-Xavier
   Lejeune and the service of the animal facility UMS28 (Sorbonne
   University) and the service of the flow cytometry platform CYTO-ICAN
   especially Florence Deknuydt (Hppital Pitie-Salpetriere). The authors
   are grateful to Judith Campisi, Inder Verma, Magdalena Goetz, Anton
   Berns, and the Centro Nacional de Investigaciones Oncologicas (CNIO) for
   providing reagents and Carol Schuurmans for comments on the manuscript.
   We also thank members of the Huillard-Sanson laboratory for discussions,
   and help with the experiments, in particular Sophie Paris for teaching
   the intracranial injection. This work was supported by institutional
   fundings from Paris Brain Institute (ICM), the Institut National de la
   Sante Et de la Recherche Medicale and the Centre National de la
   Recherche Scientifique and grants from the ATIP-AVENIR (E.H.), the
   Canceropole Ile de France (Emergence Program, I.L.R.), the Ligue contre
   le cancer, comite Ile de France (I.L.R.); the Fondation ARC pour la
   Recherche sur le Cancer (E.H., I.L.R.); the SIRIC-CURAMUS (joint
   Emergence program I.L.R. and C.A.). R. Salam was supported by
   fellowships from the French Ministry of Education and Research and the
   Ligue Nationale Contre le Cancer; A. Saliou was supported by a
   fellowship from the Ligue Nationale Contre le Cancer.
CR Aasland D, 2019, CANCER RES, V79, P99, DOI 10.1158/0008-5472.CAN-18-1733
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Angel I, 2020, ONCOGENE, V39, P6990, DOI 10.1038/s41388-020-01506-6
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Balakrishnan I, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108286
   Banasavadi-Siddegowda YK, 2017, ONCOGENE, V36, P263, DOI 10.1038/onc.2016.199
   Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bhaduri A, 2020, CELL STEM CELL, V26, P48, DOI 10.1016/j.stem.2019.11.015
   Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001
   Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052
   Brösicke N, 2015, CELL ADHES MIGR, V9, P131, DOI 10.1080/19336918.2014.1000071
   Castellan M, 2021, NAT CANCER, V2, DOI 10.1038/s43018-020-00150-z
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Couturier CP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17186-5
   Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030
   de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022
   De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Di Stefano AL, 2020, NEURO-ONCOLOGY, V22, P1614, DOI 10.1093/neuonc/noaa121
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Fleury H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10460-1
   Friedmann-Morvinski D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501292
   Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929
   Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gilder AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21358-1
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guerrero A, 2019, NAT METAB, V1, P1074, DOI 10.1038/s42255-019-0122-z
   Hara T, 2021, CANCER CELL, V39, P779, DOI 10.1016/j.ccell.2021.05.002
   Harris IS, 2020, TRENDS CELL BIOL, V30, P440, DOI 10.1016/j.tcb.2020.03.002
   Hayashi M, 2020, CANCER RES, V80, P3331, DOI 10.1158/0008-5472.CAN-19-2888
   Hiebert P, 2018, DEV CELL, V46, P145, DOI 10.1016/j.devcel.2018.06.012
   Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x
   Johnson KC, 2021, NAT GENET, V53, P1456, DOI 10.1038/s41588-021-00926-8
   Kaefer A, 2014, CANCER CHEMOTH PHARM, V74, P593, DOI 10.1007/s00280-014-2530-9
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karpel-Massler G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00984-9
   Karpel-Massler G, 2015, ONCOTARGET, V6, P36456, DOI 10.18632/oncotarget.5505
   Karpel-Massler G, 2015, ONCOTARGET, V6, P14507, DOI 10.18632/oncotarget.3993
   Kohlhapp FJ, 2021, CANCER DISCOV, V11, P68, DOI 10.1158/2159-8290.CD-19-0759
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   L'Hôte V, 2021, AGING CELL, V20, DOI 10.1111/acel.13447
   Le Roux I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9528
   Litak J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215347
   Liu Y, 2015, CLIN CANCER RES, V21, P5338, DOI 10.1158/1078-0432.CCR-15-0293
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Louis DN, 2021, NEURO-ONCOLOGY, V23, P1231, DOI 10.1093/neuonc/noab106
   Marino S, 2002, DEVELOPMENT, V129, P3513
   Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863
   Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002
   Mirzaei R, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1478647
   Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Morán I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010
   Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350
   Morita T, 2018, MOL CANCER RES, V16, P880, DOI 10.1158/1541-7786.MCR-17-0715
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024
   Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]
   Osswald M, 2015, NATURE, V528, P93, DOI 10.1038/nature16071
   Ostrom QT, 2016, NEURO-ONCOLOGY, V18, pv1, DOI [10.1093/neuonc/now207, 10.1093/neuonc/nov189]
   Pölönen P, 2019, ONCOGENE, V38, P7473, DOI 10.1038/s41388-019-0956-6
   Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009
   Rahman M, 2022, MOL CANCER RES, V20, P938, DOI 10.1158/1541-7786.MCR-21-0029
   Reardon DA, 2020, JAMA ONCOL, V6, P1003, DOI 10.1001/jamaoncol.2020.1024
   Richards LM, 2021, NAT CANCER, V2, DOI 10.1038/s43018-020-00154-9
   Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Saleh T, 2020, MOL ONCOL, V14, P2504, DOI 10.1002/1878-0261.12761
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmitt MJ, 2021, CANCER DISCOV, V11, P754, DOI 10.1158/2159-8290.CD-20-0219
   Schwarzenbach C, 2021, CANCERS, V13, DOI 10.3390/cancers13143585
   Sharanek A, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109647
   Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181
   Sieben CJ, 2018, TRENDS CELL BIOL, V28, P723, DOI 10.1016/j.tcb.2018.04.006
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259
   Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Triana-Martínez F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12888-x
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188
   Wang L, 2019, CANCER DISCOV, V9, P1708, DOI 10.1158/2159-8290.CD-19-0329
   Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003
   Weng Q., 2019, SINGLE CELL TRANSCRI, DOI [10.1016/j.stem.2019.03.006, DOI 10.1016/J.STEM.2019.03.006]
   Weng QJ, 2019, CELL STEM CELL, V24, P707, DOI 10.1016/j.stem.2019.03.006
   Wyld L, 2020, CANCERS, V12, DOI 10.3390/cancers12082134
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yuan ZS, 2017, EUR REV MED PHARMACO, V21, P5072, DOI 10.26355/eurrev_201711_13821
   Yue HS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009538
   Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9
   Zhou PC, 2015, ONCOTARGET, V6, P29675, DOI 10.18632/oncotarget.4896
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 103
TC 11
Z9 11
U1 7
U2 25
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 27
PY 2023
VL 14
IS 1
AR 441
DI 10.1038/s41467-023-36124-9
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 8K5YU
UT WOS:000923177700011
PM 36707509
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Naggie, S
   Swiderska-Syn, M
   Choi, S
   Lusk, S
   Lan, A
   Ferrari, G
   Syn, WK
   Guy, CD
   Diehl, AM
AF Naggie, Susanna
   Swiderska-Syn, Marzena
   Choi, Steve
   Lusk, Sam
   Lan, Audrey
   Ferrari, Guido
   Syn, Wing-Kin
   Guy, Cynthia D.
   Diehl, Anna Mae
TI Markers of Tissue Repair and Cellular Aging Are Increased in the Liver
   Tissue of Patients With HIV Infection Regardless of Presence of HCV
   Coinfection
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE fibrogenesis; GLI; Hedgehog; hepatitis C virus; human immunodeficiency
   virus; patched; pathogenesis; Sonic Hedgehog; wound repair
ID HEDGEHOG PATHWAY ACTIVATION; C VIRUS-INFECTION; HEPATITIS; FIBROSIS
AB Liver disease is a leading cause of HIV-related mortality. Hepatitis C virus (HCV)-related fibrogenesis is accelerated in the setting of HIV coinfection, yet the mechanisms underlying this aggressive pathogenesis are unclear. We identified formalin-fixed paraffin-embedded liver tissue for HIV-infected patients, HCV-infected patients, HIV/HCV-coinfected patients, and controls at Duke University Medical Center. De-identified sections were stained for markers against the wound repair Hedgehog (Hh) pathway, resident T-lymphocytes, and immune activation and cellular aging. HIV infection was independently associated with Hh activation and markers of immune dysregulation in the liver tissue.
C1 [Naggie, Susanna; Choi, Steve; Ferrari, Guido; Guy, Cynthia D.; Diehl, Anna Mae] Duke Univ, Sch Med, Durham, NC USA.
   [Naggie, Susanna; Lusk, Sam] Duke Clin Res Inst, Durham, NC USA.
   [Swiderska-Syn, Marzena; Syn, Wing-Kin] Med Univ South Carolina, Charleston, SC 29425 USA.
   [Choi, Steve] Durham VA Med Ctr, Durham, NC USA.
   [Lan, Audrey] Univ N Carolina, Sch Med, Chapel Hill, NC USA.
   [Syn, Wing-Kin] Ralph H Johnson VA Med Ctr, Charleston, SC USA.
C3 Duke University; Duke University; Medical University of South Carolina;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Durham VA Medical Center; University of North Carolina School of
   Medicine; University of North Carolina; University of North Carolina
   Chapel Hill; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Ralph H Johnson VA Medical Center
RP Naggie, S (corresponding author), Duke Clin Res Inst, Infect Dis Sect, 2400 Pratt St, Durham, NC 27705 USA.
EM susanna.naggie@duke.edu
RI Syn, Wing-Kin/AAB-8406-2020; Ferrari, Guido/Z-2137-2019; Choi,
   Steve/GZH-1598-2022; Ferrari, Guido/A-6088-2015
OI Ferrari, Guido/0000-0001-7747-3349
FU National Institute of Allergy and Infectious Diseases [K23-AI096913];
   Duke Center for AIDS Research [AI064518]; Department of Veteran Affairs
   (Ralph H Johnson VAMC, Charleston); MUSC GI Division Start-Up Funds
   [MUCU-2220300-35876-6125-00]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases K23-AI096913 and Duke Center for AIDS Research
   (AI064518) to S.N.; Department of Veteran Affairs (Ralph H Johnson VAMC,
   Charleston) and MUSC GI Division Start-Up Funds
   (MUCU-2220300-35876-6125-00) to W.S.
CR Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100
   Braune J, 2017, DIABETOLOGIA, V60, P889, DOI 10.1007/s00125-017-4223-5
   Choi SS, 2011, HEPATOLOGY, V54, P1580, DOI 10.1002/hep.24576
   Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015
   Desbois AC, 2017, WORLD J GASTROENTERO, V23, P1697, DOI 10.3748/wjg.v23.i9.1697
   Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874
   Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559
   Hadigan CM, 2016, 18 INT WORKSH COM AD
   Lan XQ, 2017, EXP CELL RES, V352, P193, DOI 10.1016/j.yexcr.2017.01.019
   Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926
   Pereira TD, 2010, LAB INVEST, V90, P1690, DOI 10.1038/labinvest.2010.147
   Salloum S, 2016, HEPATOLOGY, V64, P1951, DOI 10.1002/hep.28766
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Syn WK, 2009, EUR J IMMUNOL, V39, P1879, DOI 10.1002/eji.200838890
   Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51
NR 15
TC 1
Z9 1
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JUL
PY 2018
VL 5
IS 7
AR ofy138
DI 10.1093/ofid/ofy138
PG 5
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA GP5YK
UT WOS:000440953400008
PM 29992177
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Lim, JS
   Park, SH
   Jang, KL
AF Lim, Joo Song
   Park, Sun-Hye
   Jang, Kyung Lib
TI Hepatitis C virus Core protein overcomes stress-induced premature
   senescence by down-regulating p16 expression via DNA methylation
SO CANCER LETTERS
LA English
DT Article
DE Cellular senescence; Core; DNA methylation; Hepatitis C virus; p16
ID HUMAN-DIPLOID FIBROBLASTS; CYCLIN-DEPENDENT KINASE;
   HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; CELLULAR SENESCENCE;
   GENE-EXPRESSION; CELLS; PATHOGENESIS; P16(INK4A); ACTIVATION
AB Hepatitis C virus Core plays a vital role in the development of hepatocellular carcinoma; however, the mechanism is still controversial. Here, we show that Core overcomes premature senescence provoked by a reactive oxygen species inducer, H2O2, in human liver cells. For this effect, Core down-regulated levels of p16 via promoter hypermethylation and subsequently induced phosphorylation of Rb in the presence of H2O2. Levels of p21 and p27, however, were little affected by Core under the condition. The potentials of Core to inactivate Rb and suppress H2O2-mediated cellular senescence were abolished when levels of p16 were recovered by either exogenous complementation or inhibition of DNA methylation. Considering that cellular senescence provoked by oxidative stresses is an important tumor suppression process, our present study provides a new strategy by which HCV promotes development of hepatocellular carcinoma. (c) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Lim, Joo Song; Park, Sun-Hye; Jang, Kyung Lib] Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea.
C3 Pusan National University
RP Jang, KL (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea.
EM kljang@pusan.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2009-0070867]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korea government (MEST) (No. 2009-0070867).
CR Arora P, 2008, CANCER LETT, V261, P244, DOI 10.1016/j.canlet.2007.11.033
   Baek MJ, 2000, CANCER, V89, P60, DOI 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3
   BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112
   Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8
   Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289
   Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317
   Bumann J., 1995, Strahlentherapie und Onkologie, V171, P35
   Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801
   Caselmann WH, 1996, J HEPATOL, V24, P61
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400
   Farinati F, 2007, J VIRAL HEPATITIS, V14, P821, DOI 10.1111/1365-2893.2007.00878.x
   Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002
   Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hemann MT, 2007, GENE DEV, V21, P1, DOI 10.1101/gad.1514207
   Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821
   Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529
   Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198
   Kim YJ, 2010, CANCER LETT, V288, P226, DOI 10.1016/j.canlet.2009.07.007
   Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x
   Kwun HJ, 2003, J VIRAL HEPATITIS, V10, P249, DOI 10.1046/j.1365-2893.2003.00434.x
   Liang TJ, 2004, GASTROENTEROLOGY, V127, pS62, DOI 10.1053/j.gastro.2004.09.017
   Lunz JG, 2005, HEPATOLOGY, V41, P1262, DOI 10.1002/hep.20709
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Muriel P, 2009, HEPATOL INT, V3, P526, DOI 10.1007/s12072-009-9158-6
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Paradis V, 1997, HEPATOLOGY, V26, P135
   Park S.H., 2011, CANC LETT
   Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105
   Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498
   Ray RB, 1996, J VIROL, V70, P4438, DOI 10.1128/JVI.70.7.4438-4443.1996
   Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1
   Severi T, 2007, CHEM-BIOL INTERACT, V168, P128, DOI 10.1016/j.cbi.2007.03.006
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   TOUSSAINT O, 1992, MECH AGEING DEV, V65, P65, DOI 10.1016/0047-6374(92)90126-X
   Vendemiale G, 2001, EUR J CLIN INVEST, V31, P54, DOI 10.1046/j.1365-2362.2001.00747.x
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
NR 45
TC 44
Z9 49
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD AUG 28
PY 2012
VL 321
IS 2
BP 154
EP 161
DI 10.1016/j.canlet.2012.01.044
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 953UV
UT WOS:000304899600007
PM 22326283
DA 2024-02-19
ER

PT J
AU Mocchegiani, E
   Giacconi, R
   Cipriano, C
   Gasparini, N
   Bernardini, G
   Malavolta, M
   Menegazzi, M
   Cavalieri, E
   Muzzioli, M
   Ciampa, AR
   Suzukic, H
AF Mocchegiani, E
   Giacconi, R
   Cipriano, C
   Gasparini, N
   Bernardini, G
   Malavolta, M
   Menegazzi, M
   Cavalieri, E
   Muzzioli, M
   Ciampa, AR
   Suzukic, H
TI The variations during the circadian cycle of liver CD1d-unrestricted
   NK1.1+TCRg/d, cells lead to successful ageing. Role of
   metallothionein/IL-6/gp130/PARP-1 interplay in very old mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE metallothionein; IL-6; gp130; poly(ADP-ribose) polymerase-1; IFN-,g;
   IL-12; liver NKT cells; T-cell receptors; successful ageing
ID V-ALPHA-14 NKT CELLS; DELTA-T-LYMPHOCYTES; POLY(ADP-RIBOSE) POLYMERASE;
   IN-VIVO; GENE-EXPRESSION; ZINC; INNATE; GAMMA; BETA; THYMUS
AB NKT cells derive from the thymus and home to the liver. Liver NKT cells can be divided in two groups: 'classical' and 'non-classical'. The first is CD1d-restricted, the second is CD1d-unrestriced. NKT cells (classical and non-classical) co-express T-cell receptor (TCR) and NK-cell marker (NK1.1), display cytotoxicity and produce IFN-gamma under IL-12 stimulation affecting, thereby, Th1 response and innate immunity. NK1.1(+)TCRalpha/beta(+) cells belong to both groups. NK1.1(+)TCR-gamma/delta(+) cells belong to the second group. Anyway, both NKT cell subtypes, via IFN-gamma production, protect against viruses and bacteria from early in life. Immune variations as well as zinc rhythmicity during the circadian cycle confer the immune plasticity, which is essential for successful ageing. Liver NK1.1(+)TCRgamma/delta(+) cells, rather than TCRalpha/beta(+), from young and very old mice display 'in vitro' (under IL-12 stimulation) nocturnal peaks in cytotoxicity and IFN-gamma production. The acrophase of liver NK1.1(+)TCRgamma/delta(+) cells is present in young and very old mice, not in old. The interplay among zinc-bound metallothionein (MT)/ IL-6/gp130/poly(ADP-ribose) polymerase-1 (PARP-1) may be involved in conferring plasticity to liver NKL1.1(+)TCRgamma/delta(+) cells. IL-6, via sub-unit receptor gp130, induces MTmRNA. At night, gene expressions of MT, IL-6, gp130 are lower in very old mice than old and young MT-I transgenic mice (MT-I*). In very old mice, this phenomenon allows limited sequester of intracellular zinc from NIT leading to good free zinc ion bioavailability for immune efficiency and zinc-dependent PARP-I activity. Indeed (1) in vitro, high IL-6 provokes strong accumulation of MT, impaired cytotoxicity and low zinc ion bioavailability in liver NK1.1(+)TCRgamma/delta(+) cells exclusively from old and MT-I* mice. (2) The ratio total/endogen PARP-1 activity is higher in very old than in old and MT-I* mice, suggesting a higher capacity of PARP-1 in base excision DNA-repair in very old age thanks to low zinc-bound MT. Cytotoxicity and IFN-gamma production from liver NK1.1(+)TCRgamma/delta(+) cells are thus preserved leading to successful ageing. In conclusion, MT/IL-6/gp130/PARP-1 interplay may confer plasticity to liver CD1d-unrestricted NK1.1(+)TCRgamma/delta(+) cells, where MT, IL-6, gp130 are the main upstream protagonists, and PARP-1 is the main downstream protagonist in immunosenescence. (C) 2004 Elsevier Inc. All rights reserved.
C1 Italian Natl Res Ctr Ageing, Dept Res, Ctr Immunol, Sect Nutr Immun & Ageing, I-60121 Ancona, Italy.
   INRCA Ancona, Cytofluorimetr Serv, Dept Res, Ancona, Italy.
   Univ Verona, Dept Vis & Neurobiol, Biochem Sect, Verona, Italy.
C3 IRCCS INRCA; IRCCS INRCA; University of Verona
RP Mocchegiani, E (corresponding author), Italian Natl Res Ctr Ageing, Dept Res, Ctr Immunol, Sect Nutr Immun & Ageing, Via Birarelli 8, I-60121 Ancona, Italy.
EM e.mocchegiani@inrca.it
RI Malavolta, Marco/J-8215-2012; Menegazzi, Marta/AAE-7079-2019; Giacconi,
   Robertina/J-5349-2018
OI Malavolta, Marco/0000-0002-8442-1763; Menegazzi,
   Marta/0000-0003-1310-9227; Giacconi, Robertina/0000-0002-1468-2140
CR Abo T, 2001, INT IMMUNOPHARMACOL, V1, P1261, DOI 10.1016/S1567-5769(01)00057-1
   Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9
   Argentati K, 2002, J LEUKOCYTE BIOL, V72, P65
   Bagnara GP, 2000, J GERONTOL A-BIOL, V55, pB61
   Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535
   BERTON G, 1991, BIOCHIM BIOPHYS ACTA, V1091, P101, DOI 10.1016/0167-4889(91)90228-P
   Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   BRYANT J, 1992, J IMMUNOL METHODS, V146, P91, DOI 10.1016/0022-1759(92)90052-U
   Bürkle A, 2000, ANN NY ACAD SCI, V908, P126
   Carnaud C, 1999, J IMMUNOL, V163, P4647
   Chen YL, 2001, J IMMUNOASS IMMUNOCH, V22, P353, DOI 10.1081/IAS-100107400
   Cipriani B, 2000, BLOOD, V95, P39
   Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412
   COYLE P, 1995, BIOCHEM J, V309, P25, DOI 10.1042/bj3090025
   Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623
   Dantzer F, 1998, NUCLEIC ACIDS RES, V26, P1891, DOI 10.1093/nar/26.8.1891
   DelaRosa O, 2002, EXP GERONTOL, V37, P213, DOI 10.1016/S0531-5565(01)00186-3
   DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1
   Deng DX, 1999, TOXICOLOGY, V134, P39
   DESHPANDE J, 1992, EXP BRAIN RES, V88, P91, DOI 10.1007/BF02259131
   Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91
   DRIESSEN C, 1994, LYMPHOKINE CYTOK RES, V13, P15
   Emoto M, 2000, EUR J IMMUNOL, V30, P3049, DOI 10.1002/1521-4141(200010)30:10<3049::AID-IMMU3049>3.0.CO;2-F
   Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5
   Emoto M, 2001, HEPATOLOGY, V33, P887, DOI 10.1053/jhep.2001.23504
   FABRIS N, 1985, CELL IMMUNOL, V91, P325, DOI 10.1016/0008-8749(85)90230-8
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5
   Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7
   GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759
   Guo BL, 2002, CANCER IMMUNOL IMMUN, V50, P625, DOI 10.1007/s00262-001-0244-4
   Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639
   HASHIMOTO W, 1995, J IMMUNOL, V154, P4333
   Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012
   Houlston RS, 1998, EUR J HUM GENET, V6, P80, DOI 10.1038/sj.ejhg.5200156
   Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127
   KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001
   Kawamura H, 1999, J IMMUNOL, V162, P5957
   KUBO RT, 1989, J IMMUNOL, V142, P2736
   Mariani E, 1999, CLIN EXP IMMUNOL, V116, P19
   Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778
   Maruo S, 1996, J IMMUNOL, V156, P1748
   MENEGAZZI M, 1991, EXP CELL RES, V197, P66, DOI 10.1016/0014-4827(91)90480-I
   Miyaji C, 2000, HUM IMMUNOL, V61, P908, DOI 10.1016/S0198-8859(00)00153-1
   Mocchegiani E, 1998, MECH AGEING DEV, V106, P183, DOI 10.1016/S0047-6374(98)00115-8
   Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0
   Mocchegiani E, 2003, MECH AGEING DEV, V124, P459, DOI 10.1016/S0047-6374(03)00023-X
   Mocchegiani E, 2002, EXP GERONTOL, V37, P349, DOI 10.1016/S0531-5565(01)00202-9
   Mocchegiani E, 1998, J NEUROIMMUNOL, V86, P111, DOI 10.1016/S0165-5728(97)00253-1
   Mocchegiani E, 2002, MECH AGEING DEV, V123, P675, DOI 10.1016/S0047-6374(01)00414-6
   MOCCHEGIANI E, 1995, INT J IMMUNOPHARMACO, V17, P745, DOI 10.1016/0192-0561(95)00064-9
   MOCCHEGIANI E, 2003, METAL IONS NEURODEGE, P139
   Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904
   NELSON W, 1979, CHRONOBIOLOGIA, V6, P305
   OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699
   Poccia F, 1998, IMMUNOL TODAY, V19, P253, DOI 10.1016/S0167-5699(98)01266-3
   Potestio M, 1999, EXP GERONTOL, V34, P659, DOI 10.1016/S0531-5565(99)00041-8
   Quaife CJ, 1998, TOXICOL APPL PHARM, V148, P148, DOI 10.1006/taap.1997.8321
   Rea IM, 2000, CYTOKINE, V12, P156, DOI 10.1006/cyto.1999.0537
   Romano GC, 2000, MECH AGEING DEV, V121, P231
   Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439
   Seki S, 1997, IMMUNOLOGY, V92, P561, DOI 10.1046/j.1365-2567.1997.00383.x
   Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S
   Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206
   Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057
   Tsukahara A, 1997, HEPATOLOGY, V26, P301, DOI 10.1002/hep.510260208
   Wang XJ, 1998, BLOOD, V91, P3308, DOI 10.1182/blood.V91.9.3308.3308_3308_3314
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   WATANABE H, 1995, J IMMUNOL, V155, P2972
NR 70
TC 41
Z9 45
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2004
VL 39
IS 5
BP 775
EP 788
DI 10.1016/j.exger.2004.01.014
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 823SM
UT WOS:000221633400011
PM 15130672
DA 2024-02-19
ER

PT J
AU Qazi, MR
   Abedi, MR
   Nelson, BD
   DePierre, JW
   Abedi-Valugerdi, M
AF Qazi, M. R.
   Abedi, M. R.
   Nelson, B. D.
   DePierre, J. W.
   Abedi-Valugerdi, M.
TI Characterization of the Hepatic and Splenic Immune Status and
   Immunoglobulin Synthesis in Aged Male Mice Lacking the Peroxisome
   Proliferator-Activated Receptor-Alpha (PPARα)
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID BONE-MARROW; SYSTEM; LIVER; INFLAMMATION; DISRUPTION; OXIDATION; SITE;
   BETA
AB It is now well established that the nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR alpha) is expressed in different types of immune cells and plays a pivotal role in the regulation of age-related production of inflammatory cytokines. However, the role(s) of this receptor in the regulation of immune cell homoeostasis in ageing non-lymphoid and lymphoid organs has not yet been resolved. We examine this issue here by evaluating the hepatic and splenic immune status and immunoglobulin (Ig) production in male PPAR alpha-null mice and their wild-type littermates at one and 2 years of age. In comparison with the age-matched control animals, PPAR alpha-null mice exhibited age-related elevations in the numbers of total, as well as of phenotypically distinct subpopulations of intrahepatic immune cells (IHIC) and splenocytes. Moreover, at 2 years of age, these alterations in hepatic immune cells were accompanied by significant increases in hepatic levels of the pro-inflammatory cytokines tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interferon-gamma (IFN-gamma), in combination with the development of hepatic inflammatory loci containing mixtures of leucocytes. Alterations in splenocytes of old PPAR alpha-null mice were also accompanied by increases in cellularity of both white and red pulps of the spleen. Furthermore, these same animals exhibited pronounced increases in the numbers of splenic plasma cells and enhanced production of Ig of different isotypes, including IgG1, IgG2a and IgE. Thus, our findings indicate that upon ageing, PPAR alpha plays a crucial role in regulating the total numbers, compositions and functions of immune cells in both lymphoid and non-lymphoid immune organs of mice.
C1 [Qazi, M. R.; Nelson, B. D.; DePierre, J. W.; Abedi-Valugerdi, M.] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden.
   [Abedi, M. R.] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden.
C3 Stockholm University; Orebro University
RP Abedi-Valugerdi, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, SE-10691 Stockholm, Sweden.
EM abedi@dbb.su.se
RI Abedi-Valugerdi, Manuchehr/HMW-0784-2023
OI Abedi-Valugerdi, Manuchehr/0000-0002-4122-2879
FU 3M Company (St. Paul, Minnesota, USA)
FX This study was financed by an unrestricted grant from the 3M Company
   (St. Paul, Minnesota, USA). We thank Dr. Ricardo Feinstein (Department
   of Pathology and Wildlife Diseases, National Veterinary Institute,
   Uppsala, Sweden) for his skilful help with the histopathological
   evaluation of liver sections.
CR AKIYAMA TE, 2001, J BIOL CHEM, V19, P276
   BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1
   Blom KG, 2009, CLIN EXP IMMUNOL, V155, P320, DOI 10.1111/j.1365-2249.2008.03815.x
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   CHINETTI G, 1998, J BIOL CHEM, V2, P273
   COSTET P, 1998, J BIOL CHEM, V6, P273
   Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912
   Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016
   Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013
   ISSEMANN I, 1990, NATURE, V18, P347
   Jones DC, 2002, P NUTR SOC, V61, P363, DOI 10.1079/PNS2002173
   JONES DC, 2002, J BIOL CHEM, V1, P277
   JONES DC, 2003, J IMMUNOL, V1, P171
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   POYNTER ME, 1998, J BIOL CHEM, V4, P273
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193
   Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572
   SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   SZABO SJ, 2000, CELL, V17, P100
   Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   ZHU J, 2008, BLOOD, V1, P112
NR 26
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD MAR
PY 2011
VL 73
IS 3
BP 198
EP 207
DI 10.1111/j.1365-3083.2010.02495.x
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 718AQ
UT WOS:000287092100003
PM 21204894
OA Bronze
DA 2024-02-19
ER

PT J
AU Vanhooren, V
   Desmyter, L
   Liu, XE
   Cardelli, M
   Franceschi, C
   FederiCo, A
   Libert, C
   Laroy, W
   Dewaele, S
   Contreras, R
   Chen, CY
AF Vanhooren, Valerie
   Desmyter, Liesbeth
   Liu, Xue-En
   Cardelli, Maurizio
   Franceschi, Claudio
   FederiCo, Antonio
   Libert, Claude
   Laroy, Wouter
   Dewaele, Sylviane
   Contreras, Roland
   Chen, Cuiying
TI N-glycomic changes in serum proteins during human aging
SO REJUVENATION RESEARCH
LA English
DT Article
ID WERNER-SYNDROME; LINKED OLIGOSACCHARIDES; OXIDATIVE DAMAGE; DNA-REPAIR;
   GLYCOSYLATION; IGG; GALACTOSYLATION; SENESCENCE; BIOMARKERS; LONGEVITY
AB N-glycan profiling of the human serum glycoproteins including immunoglobulin fraction on different age groups of healthy persons shows substantial changes with increasing age in three major N-glycan structures. In individuals more than 40-50 years of age, there is an increase in under-galactosylated glycans and a decrease in the core alpha-1,6-fucosylated bi-galac-tosylated biantermary structure. These three glycan structures are also substantially changed in a Werner syndrome patient, to a level comparable or even more pronounced than those observed in a healthy Italian centenarian population. These data show that the glycosylation machineries in both liver cells and B-cells are affected in a similar way by the aging process despite their highly different nature. The observed changes in the glycan structures are indicative that biosynthetic processes are at the basis of the changes, possibly together with changes in serum clearing of glycan-altered proteins. Our data suggest that measurement of the N-glycan level changes could provide a noninvasive surrogate marker for general health or for age-related disease progression, and for monitoring the improvement of health after therapy.
C1 Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium.
   [Vanhooren, Valerie; Desmyter, Liesbeth; Liu, Xue-En; Libert, Claude; Laroy, Wouter; Dewaele, Sylviane; Contreras, Roland; Chen, Cuiying] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium.
   [Cardelli, Maurizio] INRCA Ancona, Res Dept, Ancona, Italy.
   [Franceschi, Claudio] Dept Expt Pathol, Bologna, Italy.
   [FederiCo, Antonio] Univ Siena, Dipartimento Sci Neurol, I-53100 Siena, Italy.
C3 Ghent University; Ghent University; Flanders Institute for Biotechnology
   (VIB); IRCCS INRCA; University of Siena
RP Chen, CY (corresponding author), Univ Ghent, Dept Mol Biol, Technol Pk 927, B-9052 Ghent, Belgium.
EM chitty@dmbr.ugent.be
RI Cardelli, Maurizio/I-5505-2014; Franceschi, Claudio/L-4484-2017; Libert,
   Claude/A-6504-2010
OI Cardelli, Maurizio/0000-0002-4480-2473; Liu, Xue-en/0000-0002-6574-4989
CR Battisti C, 2000, EXP GERONTOL, V35, P605, DOI 10.1016/S0531-5565(00)00099-1
   Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688
   Bohr VA, 2005, MUTAT RES-FUND MOL M, V577, P252, DOI 10.1016/j.mrfmmm.2005.03.021
   Butler RN, 2004, J GERONTOL A-BIOL, V59, P560
   Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275
   Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006
   Candore G, 2006, REJUV RES, V9, P143, DOI 10.1089/rej.2006.9.143
   Comai L, 2004, MECH AGEING DEV, V125, P521, DOI 10.1016/j.mad.2004.06.004
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   De Stefano N, 2003, J NEUROL, V250, P1169, DOI 10.1007/s00415-003-0167-4
   Deiana L, 1999, AGING CLIN EXP RES, V11, P142, DOI 10.1007/BF03399655
   DIMRI GP, 2004, SCI AGING KNOWLEDGE, V40
   FIELD MC, 1994, BIOCHEM J, V299, P261, DOI 10.1042/bj2990261
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457
   Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894
   Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010
   Hefti FF, 2006, AGING CELL, V5, P3, DOI 10.1111/j.1474-9726.2006.00193.x
   Isidori A M, 2005, J Endocrinol Invest, V28, P73
   Kobata A, 2003, BIOCHIMIE, V85, P13, DOI 10.1016/S0300-9084(03)00003-8
   Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301
   Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60
   Lautenschlager NT, 2006, CURR OPIN PSYCHIATR, V19, P190, DOI 10.1097/01.yco.0000214347.38787.37
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011
   Lenaz G, 2006, ANTIOXID REDOX SIGN, V8, P417, DOI 10.1089/ars.2006.8.417
   Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855
   Malandrini A, 2000, EUR NEUROL, V44, P187, DOI 10.1159/000008234
   Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023
   Martin I, 2006, MECH AGEING DEV, V127, P411, DOI 10.1016/j.mad.2006.01.008
   Martin K, 2001, J RHEUMATOL, V28, P1531
   Matei L, 1997, Rom J Intern Med, V35, P3
   Nehlin JO, 2000, ANN NY ACAD SCI, V908, P167
   Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034
   PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731
   Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50
   Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477
   Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807
   Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370
   Spindler SR, 2006, AGING CELL, V5, P39, DOI 10.1111/j.1474-9726.2006.00194.x
   Srikanth V, 2005, DRUGS TODAY, V41, P815, DOI 10.1358/dot.2005.41.12.933473
   Toussaint O, 2000, ANN NY ACAD SCI, V908, P85, DOI 10.1111/j.1749-6632.2000.tb06638.x
   TSUCHIYA N, 1994, CLIN IMMUNOL IMMUNOP, V70, P47, DOI 10.1006/clin.1994.1009
   Yarema KJ, 2001, GENOME BIOL, V2
NR 44
TC 88
Z9 95
U1 2
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD DEC
PY 2007
VL 10
IS 4
BP 521
EP 531
DI 10.1089/rej.2007.0556
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 248RW
UT WOS:000252173800009
PM 18047421
DA 2024-02-19
ER

PT J
AU Xu, L
   Yang, CY
   Wang, J
   Li, Z
   Huang, R
   Ma, HH
   Ma, J
   Wang, QZ
   Xiong, XW
AF Xu, Lin
   Yang, Chenyan
   Wang, Jing
   Li, Zun
   Huang, Rong
   Ma, Honghui
   Ma, Jie
   Wang, Qingzhi
   Xiong, Xiwen
TI Persistent mTORC1 activation via<i> Depdc5</i> deletion results in
   spontaneous hepatocellular carcinoma but does not exacerbate carcinogen-
   and high-fat diet-induced hepatic carcinogenesis in mice
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE DEPDC5; mTORC1; Hepatocellular carcinoma (HCC); Liver; High-fat diet
   (HFD); Diethylnitrosamine (DEN)
ID PI3K/AKT/MTOR PATHWAY; MAMMALIAN TARGET; DEPDC5; INFLAMMATION;
   PROGRESSION
AB The mechanistic target of rapamycin complex 1 (mTORC1) acts as a central regulator of metabolic pathways that drive cellular growth. Abnormal activation of mTORC1 occurs at high frequency in human and mouse hepatocellular carcinoma (HCC). DEP domain-containing protein 5 (DEPDC5), a component of GATOR1 complex, is a repressor of amino acid-sensing branch of the mTORC1 pathway. In the current study, we found that persistent activation of hepatic mTORC1 signaling caused by Depdc5 ablation was sufficient to induce a pathological program of liver damage, inflammation and fibrosis that triggers spontaneous HCC development. Take advantage of the combinatory treatment with a single dose of diethylnitrosamine (DEN) and chronic feeding with high-fat diet (HFD), we demonstrated that hepatic depdc5 deletion did not aggravate DEN&HFD induced liver tumorigenesis, probably due to its protective effects on diet-induced liver steatosis. In addition, we further showed that chronic rapamycin treatment did not have any apparent tumor-suppressing effects on DEN&HFD treated control mice, whereas it dramatically reduced the tumor burden in mice with hepatic Depdc5 ablation. This study provides the novel in vivo evidence for Depdc5 deletion mediated mTORC1 hyperactivation in liver tumorigenesis caused by aging or DEN&HFD treatment. Moreover, our findings also propose that pharmacological in-hibition of mTORC1 signaling maybe a promising strategy to treat HCC patients with mutations in DEPDC5 gene. (c) 2021 Elsevier Inc. All rights reserved.
C1 [Xu, Lin; Yang, Chenyan; Wang, Jing; Li, Zun; Huang, Rong; Ma, Honghui; Wang, Qingzhi; Xiong, Xiwen] Xinxiang Med Univ, Sch Forens Med, 601 Jinsui Rd, Xinxiang 453003, Henan, Peoples R China.
   [Xu, Lin; Yang, Chenyan; Wang, Jing; Li, Zun; Huang, Rong; Ma, Honghui; Xiong, Xiwen] Xinxiang Med Univ, Xinxiang Key Lab Metab & Integrat Physiol, Xinxiang, Henan, Peoples R China.
   [Ma, Jie] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China.
C3 Xinxiang Medical University; Xinxiang Medical University; Xinxiang
   Medical University
RP Xiong, XW (corresponding author), Xinxiang Med Univ, Sch Forens Med, 601 Jinsui Rd, Xinxiang 453003, Henan, Peoples R China.
EM xwxiong@xxmu.edu.cn
RI Xiong, Xiwen/GSN-0686-2022
OI Xiong, Xiwen/0000-0001-5802-4994
FU Program for Science & Technology Innovation Talents in Higher Education
   of Henan Province [20HASTIT046]; National Natural and Science Foundation
   of China [U1904132]; Training Program for Excellent Young Teachers in
   Higher Education of Henan province [2017GGJS110]; Key Science and
   Technology Project of Xinxiang [GG2019008]; Key Scientific Research
   Project of Universities in Henan [19A180005]
FX We thank Xiyu Yang for animal husbandry; Xinge Zhang for mouse
   genotyping; Yue Xin for intraperitoneal injections of rapa-mycin. This
   work was supported by grants from Program for Sci-ence & Technology
   Innovation Talents in Higher Education of Henan Province (20HASTIT046) ,
   National Natural and Science Foundation of China (U1904132) , Training
   Program for Excellent Young Teachers in Higher Education of Henan
   province (2017GGJS110) , Key Science and Technology Project of Xinxiang
   (GG2019008) , and Key Scientific Research Project of Universities in
   Henan (19A180005) .
CR Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798
   Ashworth RE, 2014, WORLD J HEPATOL, V6, P776, DOI 10.4254/wjh.v6.i11.776
   Baldassari S, 2016, J MED GENET, V53, P503, DOI 10.1136/jmedgenet-2016-103883
   Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012
   Benjamin D, 2014, CELL, V156, P627, DOI 10.1016/j.cell.2014.01.057
   Bishayee A, 2014, ADV EXP MED BIOL, V816, P401, DOI 10.1007/978-3-0348-0837-8_16
   Blagotinsek K, 2017, CURR PHARM DESIGN, V23, P170, DOI 10.2174/1381612822666161006160005
   Burza MA, 2016, HEPATOLOGY, V63, P418, DOI 10.1002/hep.28322
   Chen K, 2019, BBA-REV CANCER, V1871, P117, DOI 10.1016/j.bbcan.2018.11.005
   Cho CS, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0131-9
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2
   Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075
   Kim H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094495
   Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260
   LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003
   Lu XJ, 2021, HEPATOLOGY, V73, P49, DOI 10.1002/hep.31310
   Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739
   Miki D, 2011, NAT GENET, V43, P797, DOI 10.1038/ng.876
   Mizuno Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18323-9
   Mroweh M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041794
   Myers KA, 2017, EXPERT OPIN THER TAR, V21, P591, DOI 10.1080/14728222.2017.1316715
   Oura K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218362
   Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330
   Suresh D, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.601710
   Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001
   Wu YT, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105195
   Xiong XW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212523
   Xu L, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03980-6
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
NR 30
TC 4
Z9 5
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD 2021 NOV 12
PY 2021
VL 578
BP 142
EP 149
DI 10.1016/j.bbrc.2021.09.036
EA SEP 2021
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA WJ8ST
UT WOS:000709309000001
PM 34562654
DA 2024-02-19
ER

PT J
AU Molpeceres, V
   Mauriz, JL
   García-Mediavilla, MV
   González, P
   Barrio, JP
   González-Gallego, J
AF Molpeceres, Virginia
   Mauriz, Jose L.
   Garcia-Mediavilla, Maria V.
   Gonzalez, Paquita
   Barrio, Juan P.
   Gonzalez-Gallego, Javier
TI Melatonin is able to reduce the apoptotic liver changes induced by aging
   via inhibition of the intrinsic pathway of apoptosis
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; CELL-DEATH;
   LIPID-PEROXIDATION; ANTIOXIDANT ENZYMES; REACTIVE OXYGEN; RAT-BRAIN;
   GLUTATHIONE; ACTIVATION; INJURY
AB We examined the effect of daily melatonin supplementation on liver apoptosis induced by aging in rats. Young (3-month-old) and aged (24-month-old) Wistar rats were supplemented daily with melatonin in their drinking water (20 mg/L) for 4 weeks. Aged rats showed increases in the liver concentration of thiobarbituric acid-reactive substances and in the oxidized/reduced glutathione ratio. These increases were accompanied by apoptotic ultrastructural alterations and increases in cytochrome c mitochondrial release, Bax to Bcl-2 relative expression, and activity of caspase-3. No significant changes were observed in Fas-ligand (Fas-L) expression and caspase-8 activity. Melatonin administration was able to abrogate changes detected in aged rats. Data suggest that liver apoptotic cell death is induced by reactive oxygen species, via the intrinsic signalling pathway, and that the antiapoptotic action provided by melatonin is related to its antioxidant effect, with reduction of cytochrome c release by the modulation of Bcl-2 and Bax genes.
C1 [Molpeceres, Virginia; Mauriz, Jose L.; Garcia-Mediavilla, Maria V.; Gonzalez, Paquita; Barrio, Juan P.; Gonzalez-Gallego, Javier] Univ Leon, Dept Biomed Sci, Ciberehd & Inst Biomed, E-24071 Leon, Spain.
C3 Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEREHD
RP González-Gallego, J (corresponding author), Univ Leon, Dept Biomed Sci, Ciberehd & Inst Biomed, E-24071 Leon, Spain.
EM jgonga@unileon.es
RI Mauriz, Jose L/G-9970-2014; Barrio, Juan Pablo/O-8890-2017;
   Garcia-Mediavilla, María Victoria/F-9641-2015; Gonzalez-Gallego,
   Javier/D-8219-2012
OI Mauriz, Jose L/0000-0003-3160-8599; Barrio, Juan
   Pablo/0000-0002-1039-0175; Garcia-Mediavilla, María
   Victoria/0000-0002-5722-7500; Gonzalez-Gallego,
   Javier/0000-0002-4386-9342
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   Anisimov VN, 2001, J GERONTOL A-BIOL, V56, pB311, DOI 10.1093/gerona/56.7.B311
   Baydas G, 2005, NEUROSCIENCE, V135, P879, DOI 10.1016/j.neuroscience.2005.05.048
   Gutiérrez MB, 2006, TOXICOLOGY, V222, P125, DOI 10.1016/j.tox.2006.02.002
   Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x
   Bridgham JT, 2003, CELL DEATH DIFFER, V10, P19, DOI 10.1038/sj.cdd.4401174
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Butler RN, 2002, J GERONTOL A-BIOL, V57, pB333, DOI 10.1093/gerona/57.9.B333
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Castillo C, 2005, BIOGERONTOLOGY, V6, P313, DOI 10.1007/s10522-005-4806-2
   CHATTERJEE SN, 1988, FREE RADICAL BIO MED, V4, P51, DOI 10.1016/0891-5849(88)90011-1
   Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909
   De Butte M, 2007, NEUROBIOL AGING, V28, P306, DOI 10.1016/j.neurobiolaging.2005.12.004
   de la Lastra CA, 1999, J PINEAL RES, V26, P101
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   Feldmann G, 2000, HEPATOLOGY, V31, P674, DOI 10.1002/hep.510310318
   Feng Z, 2006, FREE RADICAL BIO MED, V40, P101, DOI 10.1016/j.freeradbiomed.2005.08.014
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Higami Y, 1997, AM J PATHOL, V151, P659
   Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/S0968-0004(96)20008-8
   Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x
   Juknat AA, 2005, J PINEAL RES, V38, P84, DOI 10.1111/j.1600-079X.2004.00166.x
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Leon J, 2004, LIFE SCI, V75, P765, DOI 10.1016/j.lfs.2004.03.003
   León J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x
   Liu XW, 2002, AM J PHYSIOL-HEART C, V283, pH254, DOI 10.1152/ajpheart.01023.2001
   Luchetti F, 2006, J PINEAL RES, V40, P158, DOI 10.1111/j.1600-079X.2005.00293.x
   Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062
   Martín M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8
   Martín M, 2000, FASEB J, V14, P1677
   Meki ARMA, 2001, NEUROENDOCRINOL LETT, V22, P417
   MIYASHITA T, 1995, CELL, V80, P293
   MIYASHITA T, 1994, CANCER RES, V54, P3131
   Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103
   Montilla P, 2001, J PINEAL RES, V31, P138, DOI 10.1034/j.1600-079x.2001.310207.x
   Muñoz-Casares FC, 2006, J PINEAL RES, V40, P195, DOI 10.1111/j.1600-079X.2005.00291.x
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Padillo FJ, 2004, FREE RADICAL RES, V38, P697, DOI 10.1080/10715760410001705131
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Poeggeler B, 2005, ENDOCRINE, V27, P201, DOI 10.1385/ENDO:27:2:201
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009
   Reiter RJ, 2003, CARDIOVASC RES, V58, P10, DOI 10.1016/S0008-6363(02)00827-1
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   Reiter RJ, 2002, FREE RADICAL RES, V36, P1323, DOI 10.1080/1071576021000038504
   REITER RJ, 1992, BIOESSAYS, V14, P169, DOI 10.1002/bies.950140307
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   San-Miguel B, 2006, APOPTOSIS, V11, P1945, DOI 10.1007/s10495-006-0090-0
   SATO N, 1995, J IMMUNOL, V154, P3194
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Semsei I, 2000, MECH AGEING DEV, V117, P93, DOI 10.1016/S0047-6374(00)00147-0
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sies H., 1985, Oxidative Stress, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Trubiani O, 2005, J PINEAL RES, V39, P425, DOI 10.1111/j.1600-079X.2005.00270.x
   Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901
   Xu MF, 2002, J MOL CELL CARDIOL, V34, P75, DOI 10.1006/jmcc.2001.1485
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 64
TC 62
Z9 64
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUL
PY 2007
VL 62
IS 7
BP 687
EP 695
DI 10.1093/gerona/62.7.687
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 272AB
UT WOS:000253828700001
PM 17634314
OA Bronze
DA 2024-02-19
ER

PT J
AU Kavok, NS
   Krasilnikova, OA
   Babenko, NA
AF Kavok, NS
   Krasilnikova, OA
   Babenko, NA
TI Increase in diacylglycerol production by liver and liver cell nuclei at
   old age
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE diacylglycerol; phosphatidylcholine; sphingomyelin; liver; hepatocyte;
   nuclei; aging
ID PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAY; PHOSPHOLIPASE-D; INOSITOL
   1,4,5-TRISPHOSPHATE; RAT HEPATOCYTES; PHOSPHATIDYLCHOLINE; FIBROBLASTS;
   MEMBRANE; STIMULATION; HYDROLYSIS
AB Early experiments have shown that sustained elevation of diacylglycerol (DAG) level in liver cell plasma membranes of aged rats is an essential prerequisite for disturbances in agonist responsiveness of hepatocytes. However, the mechanisms responsible for the age-related rise in DAG content in liver cells have not been clearly identified. The aim of the present study was to determine if phospholipid degradation by endogenous phospholipases precedes the DAG accumulation in liver cells and cell nuclei. The DAG formation in liver slices, hepatocytes and liver cell nuclei has been studied in 90-and 720-day-old rats. The experiments were performed in either the [C-14]CH3COOH-labeled rat liver or liver slices, or hepatocytes pre-labeled by [C-14] linoleic or [C-14] oleic or/and [H-3] arachidonic acid. The metabolism of C-14-linoleil]phosphatidylcholine (PC) and [C-14-methyl] PC was investigated in isolated liver cell nuclei. The [C-14]DAG production in pre-labeled liver slices and in hepatocytes increased significantly and [C-14] phosphatidylethanol formation decreased with age. DAG formed in liver of old animals showed labeling ratios (C-14/H-3) close to those of PC, pointing to PC as the primary DAG source in senescent liver. The liver slices of old rats, pre-labeled in situ by [C-14]CH3COOH, demonstrated the enhanced ability to produce DAG and sphingomyelin (SM) in a time-dependent manner while the PC level decreased in liver of old rats. The production of [C-14]DAG, [C-14]SM and [C-14] phosphocholine in the nuclei of old rats was significantly higher than that in adult animals. These results suggest that PLC and SM synthase activities play a key role in a regulation of DAG basal levels present in the liver cells and in the nuclei of old rats. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Kharkov Natl Univ, Inst Biol, UA-61077 Kharkov, Ukraine.
C3 Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National
   University
RP Babenko, NA (corresponding author), Kharkov Natl Univ, Inst Biol, 4 Svobody Pl, UA-61077 Kharkov, Ukraine.
OI Krasilnikova, Oksana A./0000-0002-5887-6721; Kavok,
   Nataliya/0000-0002-2429-2832
CR Albi E, 1999, BIOCHEM BIOPH RES CO, V265, P640, DOI 10.1006/bbrc.1999.1710
   Albi E, 1999, FEBS LETT, V460, P369, DOI 10.1016/S0014-5793(99)01378-2
   ANDOS S, 1987, CHROMATOGR LIPIDS BI, P226
   ANDREWS WV, 1987, METHOD ENZYMOL, V141, P156
   Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396
   BABENKO NA, 1991, BIOCHEMISTRY-MOSCOW+, V56, P214
   BABENKO NA, 1992, BIOCHEMISTRY-MOSCOW+, V57, P242
   BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662
   BONEH A, 1990, ISRAEL J MED SCI, V26, P293
   D'Santos CS, 1999, CURR BIOL, V9, P437, DOI 10.1016/S0960-9822(99)80193-6
   DACOSTA KA, 1993, J BIOL CHEM, V268, P2100
   deBoland AR, 1996, CELL SIGNAL, V8, P153, DOI 10.1016/0898-6568(95)02048-9
   Divecha N, 1997, BIOCHEM SOC T, V25, P571, DOI 10.1042/bst0250571
   Facchinetti MM, 1998, MOL CELL ENDOCRINOL, V136, P131, DOI 10.1016/S0303-7207(97)00221-9
   FINDAY JBC, 1990, BIOL MEMBRANES PRACT, P38
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FULOP T, 1994, IMMUNOL LETT, V40, P259, DOI 10.1016/0165-2478(94)00064-6
   Fulop T, 2001, PATHOL BIOL, V49, P339, DOI 10.1016/S0369-8114(01)00143-2
   Gentili C, 2001, CELL SIGNAL, V13, P131, DOI 10.1016/S0898-6568(00)00145-5
   GUSTAVSSON L, 1994, J BIOL CHEM, V269, P849
   HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6
   Igwe OJ, 1997, MOL BRAIN RES, V46, P39, DOI 10.1016/S0169-328X(96)00269-0
   IGWE OJ, 1993, NEUROSCI LETT, V164, P167, DOI 10.1016/0304-3940(93)90883-M
   ISHIZUKA Y, 1984, BIOCHEM BIOPH RES CO, V123, P875, DOI 10.1016/S0006-291X(84)80216-8
   Kates M., 1972, TECHNIQUES LIPIDOLOG
   Kavok N. S., 2001, Ukrainskii Biokhimicheskii Zhurnal, V73, P80
   KISS Z, 1994, ARCH BIOCHEM BIOPHYS, V311, P430, DOI 10.1006/abbi.1994.1258
   Krasilnikova Oksana A, 2002, BMC Physiol, V2, P12, DOI 10.1186/1472-6793-2-12
   Miller CJ, 2001, J GERONTOL A-BIOL, V56, pB8, DOI 10.1093/gerona/56.1.B8
   NAKAMURA S, 1995, NATO ASI SERIES H, V92, P29
   Pasquaré SJ, 2001, EXP GERONTOL, V36, P1387, DOI 10.1016/S0531-5565(01)00106-1
   Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354
   PEVIATI M, 1994, CELL SIGNAL, V6, P393
   Qu XQ, 1999, CLIN SCI, V97, P355, DOI 10.1042/cs0970355
   SANCHEZARIAS JA, 1993, EUR J BIOCHEM, V211, P431, DOI 10.1111/j.1432-1033.1993.tb17568.x
   Shimoni Y, 1999, J PHYSIOL-LONDON, V520, P439, DOI 10.1111/j.1469-7793.1999.00439.x
   Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509
   STROSZNAJDER J, 1994, MOL CHEM NEUROPATHOL, V21, P95, DOI 10.1007/BF03160088
   Utsuyama M, 1997, MECH AGEING DEV, V93, P131, DOI 10.1016/S0047-6374(96)01837-4
   VANNINI F, 1994, MECH AGEING DEV, V76, P101, DOI 10.1016/0047-6374(94)91585-7
   VENABLE ME, 1994, J BIOL CHEM, V269, P26040
NR 41
TC 12
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2003
VL 38
IS 4
BP 441
EP 447
AR PII S0531-5565(02)00246-2
DI 10.1016/S0531-5565(02)00246-2
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 673AK
UT WOS:000182556200012
PM 12670631
DA 2024-02-19
ER

PT J
AU Yuan, WW
   Xu, YM
   Wu, ZH
   Huang, Y
   Meng, L
   Dai, SP
   Ying, SC
   Chen, ZM
   Xu, AM
AF Yuan, Weiwei
   Xu, Yuanmin
   Wu, Zhiheng
   Huang, Yang
   Meng, Lei
   Dai, Shiping
   Ying, Songcheng
   Chen, Zhangming
   Xu, Aman
TI Cellular senescence-related genes: predicting prognosis in
   hepatocellular carcinoma
SO BMC CANCER
LA English
DT Article
DE Cellular Senescence; Immunotherapy; Hepatocellular Carcinoma (HCC);
   Biomarkers; Chemotherapy
ID THERAPY; IMMUNOTHERAPY; METASTASIS; CANCER
AB Recent studies have shown that the high incidence and low cure rate of hepatocellular carcinoma (HCC) have not improved significantly. Surgery and liver transplantation are the mainstays of prolonging the survival of HCC patients. However, the surgical resection rate of HCC patients is very low, and even after radical surgical resection, the recurrence rate at 5 years postoperatively remains high and the prognosis is very poor, so more treatment options are urgently needed. Increasing evidence suggests that cellular senescence is not only related to cancer development but may also be one of its primary driving factors. We aimed to establish a prognostic signature of senescence-associated genes to predict the prognosis and therapeutic response of HCC patients. The aim of this study was to develop a risk model associated with cellular senescence and to search for potential strategies to treat HCC. We divided HCC patients into two clusters and identified differentially expressed genes (DEGs) between clusters. In this study, low-risk patients had a better prognosis, higher levels of immune cell infiltration, and better efficacy to fluorouracil, Paclitaxel and Cytarabine chemotherapy compared to high-risk patients. To further identify potential biomarkers for HCC, we further validated the expression levels of the four signature genes in HCC and neighbouring normal tissues by in vitro experiments. In conclusion, we identified and constructed a relevant prognostic signature, which performed well in predicting the survival and treatment response of HCC patients. This helps to differentiate between low-score and high-risk HCC, and the results may contribute to precise treatment protocols in clinical practice.
C1 [Yuan, Weiwei; Wu, Zhiheng; Huang, Yang] Anhui Med Univ, Anhui Publ Hlth Clin Ctr, Dept Gen Surg, Affiliated Hosp 1, Hefei 230012, Peoples R China.
   [Xu, Yuanmin; Meng, Lei; Ying, Songcheng; Chen, Zhangming; Xu, Aman] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.
   [Dai, Shiping] Wuwei City Peoples Hosp, Dept Gen Surg, Wuhu 241000, Peoples R China.
   [Ying, Songcheng] Anhui Med Univ, Sch Basic Med Sci, Dept Immunol, Hefei 230032, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University
RP Ying, SC; Chen, ZM; Xu, AM (corresponding author), Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei 230022, Anhui, Peoples R China.; Ying, SC (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Dept Immunol, Hefei 230032, Peoples R China.
EM yingsc@ahmu.edu.cn; Zhangmingchen@ahmu.edu.cn; xuaman@ahmu.edu.cn
OI Wu, Zhiheng/0000-0003-1966-8249
FU We would like to thank all members of our department for their helpful
   comments and general support.
FX We would like to thank all members of our department for their helpful
   comments and general support.
CR Arnold M, 2020, GASTROENTEROLOGY, V159, P335, DOI 10.1053/j.gastro.2020.02.068
   Ascierto PA, 2023, J TRANSL MED, V21, DOI 10.1186/s12967-023-04329-7
   Borden ES, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.836821
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Demir T, 2021, ADV CANCER RES, V149, P257, DOI 10.1016/bs.acr.2020.12.001
   Devan AR, 2022, WORLD J GASTROENTERO, V28, P5250, DOI 10.3748/wjg.v28.i36.5250
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dolgormaa G, 2020, BRIT J CANCER, V123, P1145, DOI 10.1038/s41416-020-0971-y
   Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937
   Hong JY, 2022, CANCER RES, V82, P4624, DOI 10.1158/0008-5472.CAN-22-0736
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2023, NUCLEIC ACIDS RES, V51, pD587, DOI 10.1093/nar/gkac963
   Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Lin QY, 2023, CANCER LETT, V569, DOI 10.1016/j.canlet.2023.216318
   Liu TK, 2023, BIOFABRICATION, V15, DOI 10.1088/1758-5090/ace3f9
   Liu ZY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1412-8
   Lv J, 2020, CANCER LETT, V469, P22, DOI 10.1016/j.canlet.2019.10.025
   Marquardt JU, 2015, NAT REV CANCER, V15, P653, DOI 10.1038/nrc4017
   Matsuda-Lennikov M, 2022, CURR OPIN IMMUNOL, V77, DOI 10.1016/j.coi.2022.102217
   Mehraj U, 2021, CELL ONCOL, V44, P1209, DOI 10.1007/s13402-021-00634-9
   Pan BL, 2023, CELL ONCOL, V46, P1625, DOI 10.1007/s13402-023-00830-9
   Petrick JL, 2020, INT J CANCER, V147, P317, DOI 10.1002/ijc.32723
   Qu XD, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.994019
   Song MJ, 2020, BRIT J CANCER, V123, P1521, DOI 10.1038/s41416-020-1022-4
   Song TQ, 2021, AM J CANCER RES, V11, P4711
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Wang LY, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1227797
   Wang PY, 2022, BIOSCIENCE REP, V42, DOI 10.1042/BSR20220674
   Wolf NK, 2023, NAT REV IMMUNOL, V23, P90, DOI 10.1038/s41577-022-00732-1
   Wong TLM, 2023, CELL MOL GASTROENTER, V15, P13, DOI 10.1016/j.jcmgh.2022.09.015
   Wu SY, 2022, BMC IMMUNOL, V23, DOI 10.1186/s12865-022-00502-7
   Xie SQ, 2023, FRONT ONCOL, V13, DOI 10.3389/fonc.2023.1197698
   Xue WJ, 2022, EXP MOL PATHOL, V128, DOI 10.1016/j.yexmp.2022.104832
   Xue WJ, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.634841
   Zhang L, 2022, CANCER LETT, V548, DOI 10.1016/j.canlet.2022.215899
   Zhang Q, 2022, INT J MED SCI, V19, P47, DOI 10.7150/ijms.58902
   Zhu R, 2018, CANCER LETT, V418, P125, DOI 10.1016/j.canlet.2018.01.025
   Zhu YH, 2023, CELL ONCOL, V46, P17, DOI 10.1007/s13402-022-00741-1
   Zimmerman SM, 2022, ONCOGENE, V41, P4983, DOI 10.1038/s41388-022-02492-7
NR 43
TC 0
Z9 0
U1 5
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2407
J9 BMC CANCER
JI BMC Cancer
PD OCT 18
PY 2023
VL 23
IS 1
AR 1001
DI 10.1186/s12885-023-11288-1
PG 16
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA X0YW9
UT WOS:001095802700004
PM 37853322
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Olona, A
   Terra, X
   Ko, JH
   Grau-Bové, C
   Pinent, M
   Ardevol, A
   Diaz, AG
   Moreno-Moral, A
   Edin, M
   Bishop-Bailey, D
   Zeldin, DC
   Aitman, TJ
   Petretto, E
   Blay, M
   Behmoaras, J
AF Olona, Antoni
   Terra, Ximena
   Ko, Jeong-Hun
   Grau-Bove, Carme
   Pinent, Montserrat
   Ardevol, Anna
   Diaz, Ana Garcia
   Moreno-Moral, Aida
   Edin, Matthew
   Bishop-Bailey, David
   Zeldin, Darryl C.
   Aitman, Timothy J.
   Petretto, Enrico
   Blay, Mayte
   Behmoaras, Jacques
TI Epoxygenase inactivation exacerbates diet and aging-associated metabolic
   dysfunction resulting from impaired adipogenesis
SO MOLECULAR METABOLISM
LA English
DT Article
DE Adipogenesis; Cytochrome P450 2j4; Cafeteria diet; Aging; Steatosis;
   Arachidonic acid
ID SOLUBLE EPOXIDE HYDROLASE; ADIPOSE-TISSUE DYSFUNCTION; ACTIVATED
   RECEPTOR-GAMMA; HIGH-FAT DIET; EPOXYEICOSATRIENOIC ACIDS; PPAR-GAMMA;
   ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; CAFETERIA DIET;
   THERAPEUTIC TARGET
AB Objective: When molecular drivers of healthy adipogenesis are perturbed, this can cause hepatic steatosis. The role of arachidonic acid (AA) and its downstream enzymatic cascades, such as cyclooxygenase, in adipogenesis is well established. The exact contribution of the P450 epoxygenase pathway, however, remains to be established. Enzymes belonging to this pathway are mainly encoded by the CYP2J locus which shows extensive allelic expansion in mice. Here we aimed to establish the role of endogenous epoxygenase during adipogenesis under homeostatic and metabolic stress conditions.
   Methods: We took advantage of the simpler genetic architecture of the Cyp2j locus in the rat and used a Cyp2j4 (orthologue of human CYP2J2) knockout rat in two models of metabolic dysfunction: physiological aging and cafeteria diet (CAF). The phenotyping of Cyp2j4(-/-) rats under CAF was integrated with proteomics (LC-MS/MS) and lipidomics (LC-MS) analyses in the liver and the adipose tissue.
   Results: We report that Cyp2j4 deletion causes adipocyte dysfunction under metabolic challenges. This is characterized by (i) down-regulation of white adipose tissue (WAT) PPARg and C/EBPa, (ii) adipocyte hypertrophy, (iii) extracellular matrix remodeling, and (iv) alternative usage of AA pathway. Specifically, in Cyp2j4(-/-) rats treated with a cafeteria diet, the dysfunctional adipogenesis is accompanied by exacerbated weight gain, hepatic lipid accumulation, and dysregulated gluconeogenesis.
   Conclusion: These results suggest that AA epoxygenases are essential regulators of healthy adipogenesis. Our results uncover their synergistic role in fine-tuning AA pathway in obesity-mediated hepatic steatosis. (C) 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license.
C1 [Olona, Antoni; Terra, Ximena; Ko, Jeong-Hun; Grau-Bove, Carme; Behmoaras, Jacques] Imperial Coll London, Ctr Complement & Inflammat Res, London W12 0NN, England.
   [Terra, Ximena; Grau-Bove, Carme; Pinent, Montserrat; Ardevol, Anna; Blay, Mayte] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Mobiofood Res Grp, E-43007 Tarragona, Spain.
   [Diaz, Ana Garcia] Imperial Coll London, Dept Med, Renal & Vasc Inflammat Sect, London W12 0NN, England.
   [Moreno-Moral, Aida; Petretto, Enrico] Natl Univ Singapore, Duke NUS Med Sch, Singapore 169857, Singapore.
   [Edin, Matthew; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Bishop-Bailey, David] Royal Vet Coll, Comparat Biomed Sci, London NW1 0TU, England.
   [Aitman, Timothy J.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland.
C3 Imperial College London; Universitat Rovira i Virgili; Imperial College
   London; National University of Singapore; National Institutes of Health
   (NIH) - USA; NIH National Institute of Environmental Health Sciences
   (NIEHS); University of London; University of London Royal Veterinary
   College; University of Edinburgh
RP Behmoaras, J (corresponding author), Imperial Coll London, Ctr Complement & Inflammat Res, London W12 0NN, England.; Behmoaras, J (corresponding author), Imperial Coll London, Hammersmith Hosp, CCIR, Du Cane Rd, London W12 0NN, England.
EM jacques.behmoaras@imperial.ac.uk
RI Edin, Matthew/AAI-1934-2019; Ardévol, Anna/AAO-6194-2021; Zeldin, Darryl
   C/Y-7091-2018; Terra, Ximena/K-3918-2014; Pinent,
   Montserrat/C-7109-2011; Blay, Maria Teresa/B-1680-2009; Olona Ferrer,
   Antoni/JGD-2463-2023; Pinent, Montserrat/ABE-6178-2021
OI Ardévol, Anna/0000-0003-0156-7538; Zeldin, Darryl C/0000-0002-2087-7307;
   Terra, Ximena/0000-0003-1043-5844; Pinent,
   Montserrat/0000-0003-3550-5378; Blay, Maria Teresa/0000-0002-6256-9847;
   Pinent, Montserrat/0000-0003-3550-5378; Edin,
   Matthew/0000-0002-7042-500X; Grau-Bove, Carme/0000-0001-5128-9607;
   Bishop-Bailey, David/0000-0003-2455-596X; Petretto,
   Enrico/0000-0003-2163-5921; Aitman, Timothy/0000-0002-7875-4502
FU Medical Research Council [MR/M004716/1, MR/N01121X/1]; Division of
   Intramural Research, National Institute of Environmental Health
   Sciences, NIH [Z01 ES025034]; Spanish government [AGL2014-55347-R];
   European Research Council [ERC-2010-AdG_20100317]; MRC [MR/M004716/1,
   MC_PC_15080, MR/N005902/1, MR/N01121X/1] Funding Source: UKRI
FX This work was supported by the Medical Research Council (MR/M004716/1
   and MR/N01121X/1 to J.B.) and, in part, by the Division of Intramural
   Research, National Institute of Environmental Health Sciences, NIH (Z01
   ES025034 to D.C.Z.) and by a grant from the Spanish government
   (AGL2014-55347-R to A. A. and M.B.). We acknowledge funding from
   Advanced Grant ERC-2010-AdG_20100317 (ELABORATE) from the European
   Research Council (to T.J.A.). M.P. is a Serra Hunter fellow.
CR Abraham NG, 2014, HYPERTENSION, V64, P1352, DOI 10.1161/HYPERTENSIONAHA.114.03884
   Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433
   Asterholm IW, 2016, OBESITY, V24, P552, DOI 10.1002/oby.21430
   Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005
   Behmoaras J, 2015, J IMMUNOL, V194, P4705, DOI 10.4049/jimmunol.1402979
   Behmoaras J, 2010, J AM SOC NEPHROL, V21, P1136, DOI 10.1681/ASN.2009090968
   Brons C, 2017, EUR J ENDOCRINOL, V176, pR67, DOI 10.1530/EJE-16-0488
   Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057
   Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859
   du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Fleming I, 2008, TRENDS CARDIOVAS MED, V18, P20, DOI 10.1016/j.tcm.2007.11.002
   Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781
   FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0
   Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38
   Fujimori K, 2012, PPAR RES, V2012, DOI 10.1155/2012/527607
   Giordano A, 2013, J LIPID RES, V54, P2423, DOI 10.1194/jlr.M038638
   Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875
   Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kim DH, 2010, STEM CELLS DEV, V19, P1863, DOI 10.1089/scd.2010.0098
   KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9
   Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75
   Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09
   Li PL, 2015, NATURE, V523, P468, DOI 10.1038/nature14569
   Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102
   Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544
   Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108
   Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4
   Martínez-Micaelo N, 2016, J MOL ENDOCRINOL, V56, P1, DOI 10.1530/JME-15-0089
   Martínez-Micaelo N, 2016, DIS MODEL MECH, V9, P1231, DOI 10.1242/dmm.025528
   Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064
   Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244
   Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371
   Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839
   Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721
   Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066
   Otero YF, 2014, J BIOL CHEM, V289, P20462, DOI 10.1074/jbc.R114.576355
   Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013
   Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110
   Panigrahy D, 2011, CANCER METAST REV, V30, P525, DOI 10.1007/s10555-011-9315-y
   Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18
   Schäfer A, 2015, MOL CELL PROTEOMICS, V14, P2764, DOI 10.1074/mcp.M115.049064
   Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263
   Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Soccio RE, 2017, J CLIN INVEST, V127, P1451, DOI 10.1172/JCI91211
   Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016
   Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Tanaka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5982
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644
   van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350
   Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671
   Waldman M, 2016, STEM CELLS DEV, V25, P1084, DOI 10.1089/scd.2016.0072
   Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112
   Wang QA, 2015, NAT CELL BIOL, V17, P1099, DOI 10.1038/ncb3217
   Wang WC, 2017, OBESITY, V25, P132, DOI 10.1002/oby.21692
   Wei J, 2010, CURR OPIN RHEUMATOL, V22, P671, DOI 10.1097/BOR.0b013e32833de1a7
   Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551
   Yaghootkar H, 2016, DIABETES, V65, P2448, DOI 10.2337/db15-1671
   Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200
   Zha WB, 2014, J LIPID RES, V55, P2124, DOI 10.1194/jlr.M053199
   Zhang FR, 2015, TOXICOL APPL PHARM, V289, P495, DOI 10.1016/j.taap.2015.10.011
   Zhang SS, 2015, OBESITY, V23, P1401, DOI 10.1002/oby.21115
   Zhou GL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003950
NR 72
TC 12
Z9 13
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD MAY
PY 2018
VL 11
BP 18
EP 32
DI 10.1016/j.molmet.2018.03.003
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA GN9SS
UT WOS:000439548700002
PM 29656108
OA Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Ghezzo-Schöneich, E
   Esch, SW
   Sharov, VS
   Schöneich, C
AF Ghezzo-Schöneich, E
   Esch, SW
   Sharov, VS
   Schöneich, C
TI Biological aging does not lead to the accumulation of oxidized
   Cu,Zn-superoxide dismutase in the liver of F344 rats
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Cu,Zn-superoxide dismutase; reactive oxygen species; aging; mass
   spectrometry; free radicals
ID SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; SKELETAL-MUSCLE;
   CAENORHABDITIS-ELEGANS; PROTEIN OXIDATION; ANTIOXIDANT; EXPRESSION;
   HISTIDINE; 2-OXO-HISTIDINE; INACTIVATION
AB Cu,Zn-Superoxide dismutase (SOD) was isolated from the liver of 3-, 12-, and 26-month-old Fisher 344 (F344) rats. Specific activity and metal content of the enzyme, purified by ion-exchange and size-exclusion chromatography, did not significantly change with age. Electrospray ionization-mass spectrometry and amino acid analysis of Cu,Zn-SOD apoprotein, further purified by reverse-phase HPLC, showed neither significant loss of amino acids nor accumulation of oxidized isoforms with age. When bovine Cu,Zn-SOD, oxidized with H2O2 in vitro, was added to rat liver homogenate, we reisolated circa 70% of the oxidized bovine Cu,Zn-SOD together with the rat isoform, showing that oxidized Cu,Zn-SOD can be recovered from tissue homogenate. Therefore, our data do not confirm an earlier hypothesis that oxidatively modified Cu,Zn-SOD protein accumulates in the liver of aged F344 rats. (C) 2001 Elsevier Science Inc.
C1 Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.
C3 University of Kansas
RP Schöneich, C (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Simons Bldg 236,2095 Constant Ave, Lawrence, KS 66047 USA.
FU NIA NIH HHS [P01AG12993] Funding Source: Medline
CR Arking R, 2000, EXP GERONTOL, V35, P167, DOI 10.1016/S0531-5565(99)00094-7
   Crapo J D, 1978, Methods Enzymol, V53, P382
   Crow JP, 1997, J NEUROCHEM, V69, P1936
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Gao J, 1998, BIOPHYS J, V74, P1115, DOI 10.1016/S0006-3495(98)77830-0
   HASSELGREN PO, J SURG RES, V45, P389
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   LAWLER JM, 1993, AM J PHYSIOL, V265, pR1344, DOI 10.1152/ajpregu.1993.265.6.R1344
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LEVINE RL, 1983, J BIOL CHEM, V258, P1823
   Maria CS, 1996, FREE RADICAL RES, V25, P401, DOI 10.3109/10715769609149062
   MAVELLI I, 1983, BIOCHEM BIOPH RES CO, V117, P677, DOI 10.1016/0006-291X(83)91650-9
   MELTZER NM, 1987, ANAL BIOCHEM, V160, P356, DOI 10.1016/0003-2697(87)90060-1
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   SALO DC, 1990, J BIOL CHEM, V265, P11919
   SANTAMARIA C, 1995, FEBS LETT, V374, P85
   SAYEGH JF, 1989, NEUROCHEM RES, V14, P1165, DOI 10.1007/BF00965625
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   UCHIDA K, 1994, J BIOL CHEM, V269, P2405
   UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Yan LJ, 2000, FREE RADICAL BIO MED, V29, P90, DOI 10.1016/S0891-5849(00)00323-3
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   YANO S, 1990, ARCH BIOCHEM BIOPHYS, V279, P60, DOI 10.1016/0003-9861(90)90463-9
   Zhao F, 1997, J BIOL CHEM, V272, P9019
NR 35
TC 8
Z9 9
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD APR 15
PY 2001
VL 30
IS 8
BP 858
EP 864
DI 10.1016/S0891-5849(01)00473-7
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 421KG
UT WOS:000168063100005
PM 11295528
DA 2024-02-19
ER

PT J
AU Bhat, S
   Adiga, D
   Shukla, V
   Guruprasad, KP
   Kabekkodu, SP
   Satyamoorthy, K
AF Bhat, Samatha
   Adiga, Divya
   Shukla, Vaibhav
   Guruprasad, Kanive Parashiva
   Kabekkodu, Shama Prasada
   Satyamoorthy, Kapaettu
TI Metastatic suppression by DOC2B is mediated by inhibition of
   epithelial-mesenchymal transition and induction of senescence
SO CELL BIOLOGY AND TOXICOLOGY
LA English
DT Article; Early Access
DE DOC2B; Epithelial-mesenchymal transition; Metastasis; Senescence;
   Calcium; Cervical cancer; Abbreviations;
   BAPTA-AM-1,2-bis(o-aminophenoxy) ethane-N,N,N ',N ''-tetraacetic acid
   ester; SA-beta ga-ISeneseence-associated beta galactosidase;
   SASP-Senescence-associated secretory phenotype; EMT-Epithelial to
   mesenchymal transition
ID TUMOR-SUPPRESSOR; CERVICAL-CANCER; CELL SENESCENCE; SMALL GTPASES;
   BETA-CATENIN; INDUCED EMT; GROWTH; PROTEIN; DOMAIN; EXPRESSION
AB Senescence induction and epithelial-mesenchymal transition (EMT) events are the opposite sides of the spectrum of cancer phenotypes. The key molecules involved in these processes may get influenced or altered by genetic and epigenetic changes during tumor progression. Double C2-like domain beta (DOC2B), an intracellular vesicle trafficking protein of the double C2 protein family, plays a critical role in exocytosis, neurotransmitter release, and intracellular vesicle trafficking. DOC2B is repressed by DNA promoter hypermethylation and functions as a tumor growth regulator in cervical cancer. To date, the molecular mechanisms of DOC2B in cervical cancer progression and metastasis is elusive. Herein, the biological fimctions and molecular mechanisms regulated by DOC2B and its impact on senescence and EMT are described. DOC2B inhibition promotes proliferation, growth, and migration by relieving G0/G1-S arrest, actin remodeling, and anoikis resistance in Cal27 cells. It enhanced tumor growth and liver metastasis in nude mice with the concomitant increase in metastasis-associated CD55 and CD61 expression. Inhibition of EMT and promotion of senescence by DOC2B is a calcium-dependent process and accompanied by calcium-mediated interaction between DOC2B and CDH1. In addition, we have identified several EMT and senescence regulators as targets of DOC2B. We show that DOC2B may act as a metastatic suppressor by inhibiting EMT through induction of senescence via DOC2B-calcium-EMT-senescence axis.
C1 [Bhat, Samatha; Adiga, Divya; Shukla, Vaibhav; Kabekkodu, Shama Prasada; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Dept Cell & Mol Biol, Manipal Sch Life Sci, Manipal 576104, Karnataka, India.
   [Guruprasad, Kanive Parashiva] Manipal Acad Higher Educ, Dept Ageing Res, Manipal Sch Life Sci, Manipal 576104, Karnataka, India.
C3 Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher
   Education (MAHE)
RP Kabekkodu, SP; Satyamoorthy, K (corresponding author), Manipal Acad Higher Educ, Dept Cell & Mol Biol, Manipal Sch Life Sci, Manipal 576104, Karnataka, India.
EM spbhat81@gmail.com; ksatyamoorthy@manipal.edu
RI Shukla, Vaibhav/AAE-6098-2021; Prasada, Shama/HHC-4983-2022; Kabekkodu,
   Shama Prasada/AAD-2947-2021; Satyamoorthy, Kapaettu/H-3254-2015
OI Shukla, Vaibhav/0000-0003-4881-9894; Prasada, Shama/0000-0002-7934-0643;
   Kabekkodu, Shama Prasada/0000-0002-4158-3893; Satyamoorthy,
   Kapaettu/0000-0002-2368-5490
FU Manipal Academy of Higher Education, Manipal; DBT, Government of India
   [6242-P8/RGCB/PMD/DBT/SPDK/2015]
FX Open access funding provided by Manipal Academy of Higher Education,
   Manipal. Study was funded by DBT, Government of India under pilot
   project on cancer (Sanction number: 6242-P8/RGCB/PMD/DBT/SPDK/2015).Data
   availabilityThe authors declare that the data supporting the findings of
   this study are available within the paper and its Supplementary
   information files. All other data are available from the corresponding
   author upon reasonable request.
CR Adiga D, 2021, CRIT REV ONCOL HEMAT, V157, DOI 10.1016/j.critrevonc.2020.103178
   Adiga D, 2022, CELLS TISSUES ORGANS, V211, P134, DOI 10.1159/000512277
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Alexander A, 2017, ONCOTARGET, V8, P14897, DOI 10.18632/oncotarget.14689
   Aslamy A, 2018, DIABETES, V67, P1332, DOI 10.2337/db17-1352
   Aslamy A, 2017, AM J PHYSIOL-REG I, V312, pR739, DOI 10.1152/ajpregu.00002.2017
   Aspenström P, 2004, BBA-MOL CELL RES, V1742, P51, DOI 10.1016/j.bbamcr.2004.09.029
   Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072
   Bhat S, 2021, CELL BIOL TOXICOL
   Chen SD, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00478
   Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015
   Deep G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-37
   DHO S, 2019, ONCOL REP
   Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4
   Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524
   Giladi M, 2013, J MOL BIOL, V425, P4629, DOI 10.1016/j.jmb.2013.08.017
   Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189
   Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200
   He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566
   Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914
   Houy S, 2017, ELIFE, V6, DOI 10.7554/eLife.27000
   Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974
   Hu XT, 2013, J PATHOL, V229, P62, DOI 10.1002/path.4093
   Hu XR, 2019, MED SCI MONITOR, V25, P3617, DOI 10.12659/MSM.914295
   Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481
   Jay KE, 2004, CELL RES, V14, P268, DOI 10.1038/sj.cr.7290228
   Kabekkodu SP, 2014, J BIOL CHEM, V289, P10637, DOI 10.1074/jbc.M113.491506
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543
   Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957
   Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389
   Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671
   Kuroda T, 2006, CANCER RES, V66, P10127, DOI 10.1158/0008-5472.CAN-06-2744
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091
   Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234
   Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397
   Leung THY, 2018, J PATHOL, V244, P151, DOI 10.1002/path.4991
   Loberg RD, 2006, NEOPLASIA, V8, P69, DOI 10.1593/neo.05679
   Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x
   Martin N, 2018, CELL CALCIUM, V70, P16, DOI 10.1016/j.ceca.2017.04.001
   Michaeli L, 2017, TRAFFIC, V18, P825, DOI 10.1111/tra.12528
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524
   Patki S, 2010, HUM CELL, V23, P35, DOI 10.1111/j.1749-0774.2010.00083.x
   Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344
   Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200
   Qureshi R, 2015, CANCER LETT, V356, P321, DOI 10.1016/j.canlet.2014.09.021
   Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876
   Saleh T, 2020, CANCERS, V12, DOI 10.3390/cancers12040822
   Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964
   Smit MA, 2010, AGING-US, V2, P735, DOI 10.18632/aging.100209
   Sominidi-Damodaran S, 2016, MAYO CLIN PROC, V91, P1147, DOI 10.1016/j.mayocp.2016.05.012
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stewart TA, 2015, BBA-BIOMEMBRANES, V1848, P2502, DOI 10.1016/j.bbamem.2014.08.016
   Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822
   Toft-Bertelsen TL, 2016, MOL BIOL CELL, V27, P3329, DOI 10.1091/mbc.E16-03-0184
   Tripathi K, 2018, J CELL COMMUN SIGNAL, V12, P513, DOI 10.1007/s12079-017-0441-3
   Ungefroren H, 2018, DEV DYNAM, V247, P451, DOI 10.1002/dvdy.24505
   Wen FC, 2014, CARCINOGENESIS, V35, P1481, DOI 10.1093/carcin/bgu009
   Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009
   Wu YY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020013
   Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Yang W-H, 2013, BIO-PROTOCOL, V3, DOI 10.21769/BioProtoc.885
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
   Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200
   Zhou YJ, 2016, J CANCER, V7, P2100, DOI 10.7150/jca.16198
NR 68
TC 8
Z9 8
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0742-2091
EI 1573-6822
J9 CELL BIOL TOXICOL
JI Cell Biol. Toxicol.
PD 2022 APR
PY 2022
VL 38
IS 2
BP 237
EP 258
DI 10.1007/s10565-021-09598-w
EA MAR 2021
PG 22
WC Cell Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Toxicology
GA 0I5EP
UT WOS:000631780200001
PM 33758996
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Naiki-Ito, A
   Kato, H
   Asamoto, M
   Naiki, T
   Shirai, T
AF Naiki-Ito, Aya
   Kato, Hiroyuki
   Asamoto, Makoto
   Naiki, Taku
   Shirai, Tomoyuki
TI Age-Dependent Carcinogenic Susceptibility in Rat Liver Is Related to
   Potential of Gap Junctional Intercellular Communication
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE aging; liver; carcinogenesis; animal models; gap junction
ID MUTANT TRANSGENIC RATS; RENAL-CELL CARCINOMA; IN-VIVO; CONNEXIN-32 GENE;
   CANCER; HEPATOCARCINOGENESIS; EXPRESSION; PROTEIN; DIETHYLNITROSAMINE;
   METASTASIS
AB Connexin 32 (Cx32) is a major gap junction protein in the liver. The authors previously demonstrated that transgenic rats carrying a dominant negative mutant of Cx32 (Cx32 Delta Tg) have much decreased capacity for gap junctional intercellular communication (GJIC) and increased susceptibility to diethylnitrosamine (DEN)-induced hepatocarcinogenesis as compared to littermate wild-type (wt) rats. To evaluate the age-dependent susceptibility to DEN-induced hepatocarcinogenesis and alteration of GJIC function, male Cx32 Delta Tg and wt rats at 10, 30, or 85 weeks old were given a single intraperitoneal administration of DEN (40 mg/rat) and sacrificed 12 weeks later. The number and area of glutathione S-transferase placental form (GST-P)-positive preneoplastic foci were significantly increased in the liver of 10- and 30-wk-old Cx32 Delta Tg rats compared with age-matched wt. However, in the 85-wk-old rats, both Cx32 Delta Tg and wt rats had similarly large number and area of GST-P-positive foci, and the difference was not significant. Interestingly, function of hepatic GJIC was reduced and protein and mRNA expression of Cx32 were decreased with aging in wt rats. These results suggest that a decline of hepatic intercellular communication through gap junction results in increased susceptibility to DEN-induced hepatocarcinogenesis in aged rats.
C1 [Naiki-Ito, Aya; Kato, Hiroyuki; Asamoto, Makoto; Naiki, Taku; Shirai, Tomoyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.
   [Naiki, Taku] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Mizuho Ku, Nagoya, Aichi 4678601, Japan.
C3 Nagoya City University; Nagoya City University
RP Naiki-Ito, A (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.
EM ayaito@med.nagoya-cu.ac.jp
RI Naiki, Taku/AEC-7521-2022
OI Naiki, Taku/0000-0002-7638-6048
FU Ministry of Education, Culture, Sports Science and Technology of Japan
   [23790449]; Grant-in-Aid for Research at Nagoya City University;
   Grants-in-Aid for Scientific Research [23790449] Funding Source: KAKEN
FX This work was supported in part by a Grant-Aid from the Ministry of
   Education, Culture, Sports Science and Technology of Japan (Grant Number
   23790449) and by a Grant-in-Aid for Research at Nagoya City University.
CR Asamoto M, 2004, HEPATOLOGY, V40, P205, DOI 10.1002/hep.20256
   Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675
   BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q
   Cotrina ML, 2001, BRAIN RES, V901, P55, DOI 10.1016/S0006-8993(01)02258-2
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839
   FUKUSHIMA S, 1987, JNCI-J NATL CANCER I, V79, P263
   GILULA NB, 1972, NATURE, V235, P262, DOI 10.1038/235262a0
   HASEGAWA R, 1991, JPN J CANCER RES, V82, P293, DOI 10.1111/j.1349-7006.1991.tb01845.x
   Hokaiwado N, 2005, TOXICOL PATHOL, V33, P695, DOI 10.1080/01926230500330313
   Hokaiwado N, 2007, J MEMBRANE BIOL, V218, P101, DOI 10.1007/s00232-007-9053-9
   Huang TY, 2006, NEUROSCIENCE, V137, P1185, DOI 10.1016/j.neuroscience.2005.10.020
   Jee H, 2011, DIGEST DIS SCI, V56, P1323, DOI 10.1007/s10620-010-1467-z
   KRUTOVSKIKH VA, 1995, LAB INVEST, V72, P571
   KRUTOVSKIKH VA, 1991, CARCINOGENESIS, V12, P1701, DOI 10.1093/carcin/12.9.1701
   LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829
   Nakashima Y, 2004, J GASTROENTEROL, V39, P763, DOI 10.1007/s00535-003-1386-2
   NICHOLSON B, 1987, NATURE, V329, P732, DOI 10.1038/329732a0
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123
   PETO R, 1975, BRIT J CANCER, V32, P411, DOI 10.1038/bjc.1975.242
   Plante I, 2002, CARCINOGENESIS, V23, P1243, DOI 10.1093/carcin/23.7.1243
   Plante I, 2007, TOXICOL SCI, V96, P47, DOI 10.1093/toxsci/kfl181
   REUBER MD, 1976, EXP CELL BIOL, V44, P65
   Ries LAG, 2003, ONCOLOGIST, V8, P541
   Sai K, 2000, CARCINOGENESIS, V21, P1671, DOI 10.1093/carcin/21.9.1671
   SAKAMOTO H, 1992, JPN J CANCER RES, V83, P1210, DOI 10.1111/j.1349-7006.1992.tb02747.x
   Sato H, 2007, J MEMBRANE BIOL, V216, P17, DOI 10.1007/s00232-007-9020-5
   Sato H, 2008, MOL CARCINOGEN, V47, P403, DOI 10.1002/mc.20396
   Vinken M, 2008, HEPATOLOGY, V47, P1077, DOI 10.1002/hep.22049
NR 30
TC 8
Z9 9
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD JUL
PY 2012
VL 40
IS 5
BP 715
EP 721
DI 10.1177/0192623312441402
PG 7
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 119CX
UT WOS:000317075900002
PM 22569583
DA 2024-02-19
ER

PT J
AU Wang, ST
   Huang, SW
   Liu, KT
   Lee, TY
   Shieh, JJ
   Wu, CY
AF Wang, Sin-Ting
   Huang, Shi-Wei
   Liu, Kuang-Ting
   Lee, Teng-Yu
   Shieh, Jeng-Jer
   Wu, Chun-Ying
TI Atorvastatin-induced senescence of hepatocellular carcinoma is mediated
   by downregulation of hTERT through the suppression of the IL-6/STAT3
   pathway
SO CELL DEATH DISCOVERY
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; TELOMERASE REVERSE-TRANSCRIPTASE;
   CELLULAR SENESCENCE; INCREASED EXPRESSION; SECRETORY PHENOTYPE;
   BREAST-CANCER; PROLIFERATION; INTERLEUKIN-6; CYTOKINES; STATINS
AB Hepatocellular carcinoma (HCC), a hepatic malignancy, has a poor prognosis and contributes to cancer-related death worldwide. Cellular senescence is an anticancer therapeutic strategy that causes irreversible cell cycle arrest and enables immune-mediated clearance of cancer cells. Atorvastatin, an HMG-CoA reductase inhibitor, has been shown to inhibit tumor growth and induce apoptosis or autophagy in malignant tumors. However, whether atorvastatin can induce HCC cell senescence and the mechanisms involved are poorly understood. The effects of atorvastatin-induced senescence were examined in both HCC cells and mouse xenograft models. The phenomenon and mechanism of senescence were examined by cell cycle analysis, senescence-associated beta-galactosidase (SA-beta-gal) staining and western blotting in HCC cells, and HCC tissues from mice were analyzed by immunohistochemical (IHC) staining. We demonstrated that atorvastatin induced cell growth inhibition and G0/G1 phase cell cycle arrest, leading to senescence in HCC cells. Atorvastatin-induced senescence was independent of p53, p14, and p16, and atorvastatin not only decreased the secretion of IL-6, a major senescence-associated secretory phenotype (SASP) factor, and the phosphorylation of STAT3 but also inhibited the expression of hTERT, a catalytic subunit of telomerase. Supplementation with exogenous IL-6 reversed both atorvastatin-induced suppression of STAT3 phosphorylation and hTERT expression and atorvastatin-induced senescence. Overexpression of constitutively activated STAT3 rescued HCC cells from atorvastatin-induced hTERT suppression and senescence. Moreover, atorvastatin decreased tumor growth in mouse xenograft models. Consistent with these results, atorvastatin decreased the IL-6, p-STAT3, and hTERT levels and increased beta-gal expression in tumor sections. Taken together, these data indicate that atorvastatin can induce atypical cellular senescence in HCC cells to inhibit tumor growth, an effect mediated by downregulation of hTERT through suppression of the IL-6/STAT3 pathway.
C1 [Wang, Sin-Ting; Wu, Chun-Ying] Taipei Vet Gen Hosp, Div Translat Res, Taipei, Taiwan.
   [Wang, Sin-Ting; Wu, Chun-Ying] Taipei Vet Gen Hosp, Ctr Excellence Canc Res, Taipei, Taiwan.
   [Huang, Shi-Wei] China Med Univ Hosp, Ctr Cell Therapy & Translat Res, Taichung, Taiwan.
   [Liu, Kuang-Ting; Shieh, Jeng-Jer] Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan.
   [Liu, Kuang-Ting] Taoyuan Armed Forces Gen Hosp, Dept Pathol & Lab Med, Taoyuan, Taiwan.
   [Lee, Teng-Yu] Taichung Vet Gen Hosp, Div Gastroenterol & Hepatol, Taichung, Taiwan.
   [Lee, Teng-Yu] Chung Shan Med Univ, Dept Med, Taichung, Taiwan.
   [Shieh, Jeng-Jer] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.
   [Shieh, Jeng-Jer] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.
   [Shieh, Jeng-Jer] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.
   [Wu, Chun-Ying] Natl Yang Ming Univ, Inst Clin Med, Inst Biomed Informat, Taipei, Taiwan.
   [Wu, Chun-Ying] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.
   [Wu, Chun-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan.
   [Wu, Chun-Ying] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.
   [Wu, Chun-Ying] Taiwan Microbiota Consortium, Taipei, Taiwan.
C3 Taipei Veterans General Hospital; Taipei Veterans General Hospital;
   China Medical University Taiwan; China Medical University Hospital -
   Taiwan; National Chung Hsing University; Taichung Veterans General
   Hospital; Chung Shan Medical University; Taichung Veterans General
   Hospital; National Chung Hsing University; National Chung Hsing
   University; National Yang Ming Chiao Tung University; National Yang Ming
   Chiao Tung University; China Medical University Taiwan; National Health
   Research Institutes - Taiwan
RP Wu, CY (corresponding author), Taipei Vet Gen Hosp, Div Translat Res, Taipei, Taiwan.; Wu, CY (corresponding author), Taipei Vet Gen Hosp, Ctr Excellence Canc Res, Taipei, Taiwan.; Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Dept Biomed Sci, Taichung, Taiwan.; Shieh, JJ (corresponding author), Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.; Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.; Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Inst Biomed Informat, Taipei, Taiwan.; Wu, CY (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Wu, CY (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Wu, CY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.; Wu, CY (corresponding author), Taiwan Microbiota Consortium, Taipei, Taiwan.
EM shiehjj@dragon.nchu.edu.tw; dr.wu.taiwan@gmail.com
RI Wu, Chun-Ying/AAX-5077-2021; Huang, Shiwei/JPK-4210-2023; Kuang-Ting,
   Liu/HGE-9321-2022; Shieh, Jeng-Jer/AAX-6903-2020
OI Wu, Chun-Ying/0000-0001-5053-1801; Shieh, Jeng-Jer/0000-0001-8412-3603;
   Huang, Shi-Wei/0000-0002-0050-0959
FU Taichung Veterans General Hospital/National Chung Hsing University Joint
   Research Program [TCVGHNCHU-1087605]; Ministry of Science and
   Technology, Taiwan [MOST106-2314-B-010-061-MY3]
FX This work was supported by grants from the Taichung Veterans General
   Hospital/National Chung Hsing University Joint Research Program
   (TCVGHNCHU-1087605) and the Ministry of Science and Technology, Taiwan
   (MOST106-2314-B-010-061-MY3). Technical support was provided by the
   Instrument Center of the Department of Medical Research of Taichung
   Veterans General Hospital.
CR Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C
   Bayat N, 2016, BIOMED PHARMACOTHER, V84, P1959, DOI 10.1016/j.biopha.2016.11.003
   Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen ZY, 2014, BRIT J CANCER, V110, P733, DOI 10.1038/bjc.2013.781
   Chung SS, 2017, MEDIAT INFLAMM, V2017, P1, DOI DOI 10.1155/2017/5958429
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Guterres FADB, 2013, EXP CELL RES, V319, P2977, DOI 10.1016/j.yexcr.2013.07.026
   Deichmann R, 2010, OCHSNER J, V10, P16
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Grimes A, 2009, CANCER RES TREAT, V41, P187, DOI 10.4143/crt.2009.41.4.187
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431
   Jones HM, 2017, AM J CANCER RES, V7, P2478
   Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x
   Kang M, 2014, INT J MOL SCI, V15, P8106, DOI 10.3390/ijms15058106
   Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106
   Kong Yahui, 2011, J Aging Res, V2011, P963172, DOI 10.4061/2011/963172
   Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee J, 2006, BIOCHEM BIOPH RES CO, V339, P748, DOI 10.1016/j.bbrc.2005.11.075
   Liu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17895
   Liu Y, 2010, CELL CYCLE, V9, P3423, DOI 10.4161/cc.9.17.12946
   Loppnow H, 2011, J CELL MOL MED, V15, P994, DOI 10.1111/j.1582-4934.2010.01036.x
   Pare R, 2016, HISTOPATHOLOGY, V69, P479, DOI 10.1111/his.12948
   Peng XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070442
   Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Relja B, 2010, INT J MOL MED, V26, P733, DOI 10.3892/ijmm_00000520
   Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC
   Roy M, 2011, AM J CANCER RES, V1, P542
   Ruhland MK, 2016, BBA-REV CANCER, V1865, P14, DOI 10.1016/j.bbcan.2015.10.001
   Sachdeva M, 2015, WORLD J HEPATOL, V7, P2080, DOI 10.4254/wjh.v7.i17.2080
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Urbano F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11070-x
   Wang ST, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.472
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xi Z, 2007, CLIN CANCER RES, V13, P5480, DOI 10.1158/1078-0432.CCR-07-0242
   Yamagiwa Y, 2006, LIFE SCI, V78, P2494, DOI 10.1016/j.lfs.2005.10.015
   Yuan FJ, 2011, ASIAN PAC J CANCER P, V12, P3361
   Zhang L, 2014, HEPATOLOGY, V59, P178, DOI 10.1002/hep.26628
   Zhou JZ, 2014, BMB REP, V47, P8, DOI 10.5483/BMBRep.2014.47.1.284
NR 45
TC 15
Z9 15
U1 0
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD MAR 30
PY 2020
VL 6
IS 1
AR 17
DI 10.1038/s41420-020-0252-9
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA LB0NX
UT WOS:000524335900001
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, C
   Song, XL
   Cui, WJ
   Yang, QH
AF Zhang, Chen
   Song, Xinling
   Cui, Weijun
   Yang, Qihang
TI Antioxidant and anti-ageing effects of enzymatic polysaccharide from
   <i>Pleurotus</i> <i>eryngii</i> residue
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article; Early Access
DE Pleurotus eryngii; Mushroom residues; Enzymatic residues
   polysaccharides; Anti-ageing; Antioxidant
AB The wide industrial cultivation of Pleurotus eryngii (P. eryngii) has resulted in the massive production of mushroomresidues (MR) with low-efficiency utilization. In the present study, the P. eryngii enzymatic residue polysaccharide (PERP) was obtained from the P. eryngii residues. The characterization analysis showed that PERP was polysaccharides comprised of five kinds of monosaccharides with molecular weight of 2.05 x 10(3) Da. PERP also showed rough surface and appeared as spherical structure dispersed in aqueous solution. The animal experiment analysis demonstrated that PERP exhibited potential anti-ageing effects on the brain, liver, kidney and skin, possibly by scavenging reactive radicals, improving the antioxidant status, supressing lipid peroxidation, enhancing organ functions and ameliorating histopathological damage. These results may provide a reference for the efficient utilization of P. eryngii residues in exploring MR-derived functional foods or drugs that delay the ageing process. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Zhang, Chen] Shandong Agr Univ, Coll Food Sci & Engn, Key Lab Food Proc Technol & Qual Control Shandong, Tai An 271081, Shandong, Peoples R China.
   [Song, Xinling; Cui, Weijun; Yang, Qihang] Shandong Agr Univ, Coll Life Sci, Tai An 271081, Shandong, Peoples R China.
C3 Shandong Agricultural University; Shandong Agricultural University
RP Zhang, C (corresponding author), Shandong Agr Univ, Coll Food Sci & Engn, Key Lab Food Proc Technol & Qual Control Shandong, Tai An 271081, Shandong, Peoples R China.
EM zhangchensdau@163.com
FU National Natural Science Foundation of China [31901644]; Postdoctoral
   Research Foundation of China [2020M672095]; Incubation Programof Youth
   Innovation in Shandong Province
FX This work was supported by the National Natural Science Foundation of
   China (31901644), Postdoctoral Research Foundation of China (GrantNo.
   2020M672095) and Incubation Programof Youth Innovation in Shandong
   Province.
CR Argyropoulou A, 2013, NAT PROD REP, V30, P1412, DOI 10.1039/c3np70031c
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Chaplin M.F., 1994, CARBOHYDRATE ANAL, Vsecond, P1
   Chen L, 2018, ACTA ALIMENT HUNG, V47, P210, DOI 10.1556/066.2018.47.2.10
   Chen L, 2016, INT J BIOL MACROMOL, V93, P1206, DOI 10.1016/j.ijbiomac.2016.09.094
   Chen YX, 2018, CARBOHYD POLYM, V185, P120, DOI 10.1016/j.carbpol.2017.12.077
   Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005
   Dong W, 2016, AGING CLIN EXP RES, V28, P303, DOI 10.1007/s40520-015-0398-0
   Gil P, 2002, GERONTOLOGY, V48, P209, DOI 10.1159/000058352
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Kuehnel W., 2003, COLOR ATLAS CYTOLOGY, P34
   Li B, 2013, CARBOHYD POLYM, V92, P1991, DOI 10.1016/j.carbpol.2012.11.088
   Li GJ, 2004, MACROMOL SYMP, V216, P165, DOI 10.1002/masy.200451216
   Li JE, 2013, INT IMMUNOPHARMACOL, V17, P267, DOI 10.1016/j.intimp.2013.05.033
   Li X., 2018, INT J BIOL MACROMOL, V111
   Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9
   Ma Z, 2015, INT J BIOL MACROMOL, V73, P236, DOI 10.1016/j.ijbiomac.2014.11.028
   Manuela M, 1983, EUR J HISTOCHEM, V151, P311
   MARTINEZCAYUELA M, 1995, BIOCHIMIE, V77, P147, DOI 10.1016/0300-9084(96)88119-3
   Meng L, 2015, CARBOHYD POLYM, V117, P452, DOI 10.1016/j.carbpol.2014.09.076
   Miao SS, 2013, INT J BIOL MACROMOL, V60, P235, DOI 10.1016/j.ijbiomac.2013.05.033
   Najafi B, 2018, RESOUR CONSERV RECY, V133, P169, DOI 10.1016/j.resconrec.2018.02.025
   Nakajima VM, 2018, BIOCATAL AGRIC BIOTE, V13, P58, DOI 10.1016/j.bcab.2017.11.011
   Paredes C, 2009, COMMUN SOIL SCI PLAN, V40, P150, DOI 10.1080/00103620802625575
   Phan CW, 2012, APPL MICROBIOL BIOT, V96, P863, DOI 10.1007/s00253-012-4446-9
   Ren DY, 2016, CARBOHYD POLYM, V138, P123, DOI 10.1016/j.carbpol.2015.11.051
   Seedevi P, 2018, CARBOHYD POLYM, V195, P486, DOI 10.1016/j.carbpol.2018.05.002
   Shabtay A, 2009, BIORESOURCE TECHNOL, V100, P6457, DOI 10.1016/j.biortech.2009.07.044
   Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004
   Taylor J, 2008, CLIN NEUROPHYSIOL, V119, P492
   Wang J, 2015, NUTR RES PRACT, V9, P489, DOI 10.4162/nrp.2015.9.5.489
   Wang QJ, 2008, BIORESOURCE TECHNOL, V99, P3318, DOI 10.1016/j.biortech.2007.05.052
   Wei Q, 2010, J ANAL APPL PYROL, V88, P149, DOI 10.1016/j.jaap.2010.03.008
   Xia MY, 2017, FEBS OPEN BIO, V7, P759, DOI 10.1002/2211-5463.12220
   Xu DD, 2016, INT J BIOL MACROMOL, V92, P30, DOI 10.1016/j.ijbiomac.2016.07.016
   Yang XB, 2005, BIOCHIMIE, V87, P747, DOI 10.1016/j.biochi.2005.03.004
   Zhang C, 2016, INT J BIOL MACROMOL, V91, P568, DOI 10.1016/j.ijbiomac.2016.05.104
   Zhang J, 2017, POL J MICROBIOL, V66, P57, DOI 10.5604/17331331.1234993
   Zhang L, 2018, INT J BIOL MACROMOL, V113, P1, DOI 10.1016/j.ijbiomac.2018.02.084
   Zhang Y, 2017, REJUV RES, V20, P462, DOI 10.1089/rej.2017.1960
NR 42
TC 22
Z9 23
U1 7
U2 72
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD 2021 MAR 15
PY 2021
VL 173
BP 341
EP 350
DI 10.1016/j.ijbiomac.2021.01.030
EA JAN 2021
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA QO6FE
UT WOS:000623235400033
PM 33434551
DA 2024-02-19
ER

PT J
AU Jäger, D
   Holtz, J
   Redpath, NT
   Müller, SP
   Pönicke, K
   Heinroth-Hoffmann, I
   Werdan, K
   Müller-Werdan, U
AF Jäger, D
   Holtz, J
   Redpath, NT
   Müller, SP
   Pönicke, K
   Heinroth-Hoffmann, I
   Werdan, K
   Müller-Werdan, U
TI The ageing heart:: influence of cellular and tissue ageing on total
   content and distribution of the variants of elongation factor-2
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE eucaryotic elongation factor-2; ageing heart; rat cardiac myocytes;
   phosphorylated eEF-2; ADP-ribosylation; one-dimensional isoelectric
   focusing
ID PROTEIN KINASE-III; ADP-RIBOSYLATION; RAT-HEART; TRANSLATION; CELLS;
   LIVER; PHOSPHORYLATION; TURNOVER; CARDIOMYOCYTES; HETEROGENEITY
AB The involvement of elongation factor-2 (EEF-2), a key-protein of peptide-chain elongation, in the slowing down of protein synthesis during cardiac ageing was addressed. EEF-2 was measured in rat heart extracts and isolated rat cardiomyocytes (CM) from newborn and adult rats using sodium-dodecylsulphate polyacrylamide gel electrophoresis after specific labeling with [P-32]ADP-ribosylation or immunoblot. The age-dependent proportional content of several eucaryotic elongation factor-2 (eEF-2) subtypes in rat CM and rat heart extracts was compared using one-dimensional isoelectric focusing. EEF-2 was considerably reduced in the hearts of adult compared to neonatal rats (P < 0.01). EEF-2 was also significantly decreased in isolated CM from adult versus newborn rats and during prolonged cultivation of neonatal CM. Cellular ageing was combined with reduced protein synthesis. During adolescence the eEF-2 variants shifted to acidic subtypes. Young adult and old rats revealed similar amounts and subtype distribution of cardiac eEF-2. Only the more acidic eEF-2 variants appeared to contain phosphorylated eEF-2. We concluded that total cardiac eEF-2 and its subtype pattern might play an important role in developmental and age-related proteomic changes. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Halle Wittenberg, Dept Med 111, D-06097 Halle Saale, Germany.
   Univ Halle Wittenberg, Inst Pharmacol, Halle Saale, Germany.
   Univ Halle Wittenberg, Inst Pathophysiol, Halle Saale, Germany.
   Univ Halle Wittenberg, Inst Environm Toxicol, Halle Saale, Germany.
C3 Martin Luther University Halle Wittenberg; Martin Luther University
   Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin
   Luther University Halle Wittenberg
RP Jäger, D (corresponding author), Univ Halle Wittenberg, Dept Med 111, Ernst Grube St 40, D-06097 Halle Saale, Germany.
CR CARLSSON L, 1990, INT IMMUNOL, V2, P639, DOI 10.1093/intimm/2.7.639
   CAVALLIUS J, 1986, EXP GERONTOL, V21, P149, DOI 10.1016/0531-5565(86)90068-9
   CELIS JE, 1990, P NATL ACAD SCI USA, V87, P4231, DOI 10.1073/pnas.87.11.4231
   DERVENTZI A, 1993, MECH AGEING DEV, V69, P193, DOI 10.1016/0047-6374(93)90023-K
   FENDRICK JL, 1992, EUR J BIOCHEM, V205, P25, DOI 10.1111/j.1432-1033.1992.tb16748.x
   Galicka A, 2000, BIOCHEM BIOPH RES CO, V269, P553, DOI 10.1006/bbrc.2000.2322
   Gorg A, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P386
   Hovland R, 1999, FEBS LETT, V444, P97, DOI 10.1016/S0014-5793(99)00039-3
   Hudson EK, 1998, MECH AGEING DEV, V103, P179, DOI 10.1016/S0047-6374(98)00043-8
   IGLEWSKI WJ, 1994, MOL CELL BIOCHEM, V138, P131, DOI 10.1007/BF00928454
   Jäger D, 2000, ELECTROPHORESIS, V21, P2729
   LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marin P, 1997, J NEUROSCI, V17, P3445
   MARZOUKI A, 1989, FEBS LETT, V255, P72, DOI 10.1016/0014-5793(89)81063-4
   MAYS PK, 1991, MECH AGEING DEV, V59, P229, DOI 10.1016/0047-6374(91)90134-L
   MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.bi.54.070185.005333
   MullerWerdan U, 1997, J MOL CELL CARDIOL, V29, P799, DOI 10.1006/jmcc.1996.0324
   NAIRN AC, 1987, J BIOL CHEM, V262, P17299
   Parrado J, 1999, FREE RADICAL BIO MED, V26, P362, DOI 10.1016/S0891-5849(98)00202-0
   Ponicke K, 1997, BRIT J PHARMACOL, V121, P118, DOI 10.1038/sj.bjp.0701084
   Pönicke K, 2000, BRIT J PHARMACOL, V129, P1723, DOI 10.1038/sj.bjp.0703243
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   RATTAN SIS, 1991, MUTAT RES, V256, P115, DOI 10.1016/0921-8734(91)90005-V
   RATTAN SIS, 1992, EUR J GERONTOL, V1, P128
   REDPATH NT, 1991, BIOCHIM BIOPHYS ACTA, V1093, P36, DOI 10.1016/0167-4889(91)90135-K
   REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x
   REDPATH NT, 1992, ANAL BIOCHEM, V202, P340, DOI 10.1016/0003-2697(92)90115-N
   Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x
   RICHARDSON A, 1987, REV BIOL RES AGING, V3, P467
   RIIS B, 1990, FEBS LETT, V266, P45, DOI 10.1016/0014-5793(90)81502-F
   RIIS B, 1993, BIOCHEM BIOPH RES CO, V192, P1210, DOI 10.1006/bbrc.1993.1545
   RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0
   SAYHAN O, 1986, BIOCHEM BIOPH RES CO, V139, P1210, DOI 10.1016/S0006-291X(86)80306-0
   Short K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P39, DOI 10.1097/00075197-200001000-00007
   STARNES JW, 1983, J GERONTOL, V38, P660, DOI 10.1093/geronj/38.6.660
   TAKAHASHI R, 1985, EXP GERONTOL, V20, P325, DOI 10.1016/0531-5565(85)90012-9
   Van Remmen Holly, 1995, P171
   VARY TC, 1994, AM J PHYSIOL, V266, pE628, DOI 10.1152/ajpendo.1994.266.4.E628
   Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119
   WEBSTER GC, 1985, MOL BIOL AGING GENE, P263
NR 43
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL
PY 2002
VL 123
IS 10
BP 1305
EP 1319
AR PII S0047-6374(02)00040-4
DI 10.1016/S0047-6374(02)00040-4
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 607FC
UT WOS:000178780300002
PM 12297334
DA 2024-02-19
ER

PT J
AU de Souza-Pinto, NC
   Hogue, BA
   Bohr, VA
AF de Souza-Pinto, NC
   Hogue, BA
   Bohr, VA
TI DND repair and aging in mouse liver: 8-oxodG glycosylase activity
   increase in mitochondrial but not in nuclear extracts
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE free radicals; mitochondria; DNA repair; 8-oxodG; aging
ID BASE EXCISION-REPAIR; OXIDATIVE DAMAGE; ESCHERICHIA-COLI; ABASIC SITES;
   RAT; ENDONUCLEASE; MUTATIONS; 8-OXOGUANINE; NUCLEOTIDE; CELLS
AB 8-oxo-deoxyguanosine (8-oxodG) is one of the major DNA lesions formed upon oxidative attack of DNA. It is a mutagenic adduct that has been associated with pathological states such as cancer and aging. Base excision repair (BER) is the main pathway for the repair of 8-oxodG. There is a great deal of interest in the question about age-associated accumulation of this DNA lesion and its intracellular distribution, particularly with respect to mitochondrial or nuclear localization. We have previously shown that 8-oxodG-incision activity increases with age in rat mitochondria obtained from both liver and heart. In this study, we have investigated the age-associated changes in DNA repair activities in both mitochondrial and nuclear extracts obtained from mouse liver. We observed that 8-oxodG incision activity of mitochondrial extracts increases significantly with age, from 13.4 +/- 2.2 fmoles of oligomer/100 mug of protein/16 h at 6 to 18.6 +/- 4.9 at 14 and 23.7 +/- 3.8 at 23 months of age. In contrast, the nuclear 8-oxoda incision activity showed no significant change with age, and in fact slightly decreased from 11.8 +/- 3 fmoles/50 mug of protein/2 h at 6 months to 9.7 +/- 0.8 at 14 months. Uracil DNA glycosylase and endonuclease G activities did not change with age in nucleus or mitochondria. Our results show that the repair of 8-oxodG is regulated differently in nucleus and mitochondria during the aging process. The specific increase in 8-oxodG-incision activity in mitochondria, rather than a general up-regulation of DNA metabolizing enzymes in those organelles, suggests that this pathway may be up regulated during aging in mice. (C) 2001 Elsevier Science inc.
C1 NIA, Mol Genet Lab, GRC, NIH, Baltimore, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Bohr, VA (corresponding author), NIA, Mol Genet Lab, GRC, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
RI Souza-Pinto, Nadja/T-3050-2019; Souza-Pinto, Nadja C./C-3462-2013; Bohr,
   Vilhelm/AAP-5931-2020
OI Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja
   C./0000-0003-4206-964X; 
CR Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686
   Chen KH, 1998, NUCLEIC ACIDS RES, V26, P2001, DOI 10.1093/nar/26.8.2001
   Collins A, 1997, CARCINOGENESIS, V18, P1833, DOI 10.1093/carcin/18.9.1833
   Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
   Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338
   DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915
   Dianov G, 1998, J BIOL CHEM, V273, P33811, DOI 10.1074/jbc.273.50.33811
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   HANSFORD RG, 1982, MECH AGEING DEV, V19, P191, DOI 10.1016/0047-6374(82)90010-0
   HOUMIEL KL, 1991, BIOCHIM BIOPHYS ACTA, V1079, P197, DOI 10.1016/0167-4838(91)90125-J
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   KAWAKAMI K, 1993, FEBS LETT, V335, P251, DOI 10.1016/0014-5793(93)80740-L
   Kim HS, 1996, MUTAT RES-DNA REPAIR, V363, P115, DOI 10.1016/0921-8777(96)00006-7
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Lee YS, 1996, MUTAT RES-DNA REPAIR, V364, P227, DOI 10.1016/S0921-8777(96)00038-9
   MALINS DC, 1991, CANCER RES, V51, P5430
   MarinGarcia J, 1997, BIOCHEM CELL BIOL, V75, P137, DOI 10.1139/bcb-75-2-137
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2
   Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010
   Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061
   Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   Stierum RH, 1999, NUCLEIC ACIDS RES, V27, P3712, DOI 10.1093/nar/27.18.3712
   Taffe BG, 1996, MUTAT RES-DNA REPAIR, V364, P183, DOI 10.1016/S0921-8777(96)00031-6
   TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
NR 30
TC 96
Z9 104
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD APR 15
PY 2001
VL 30
IS 8
BP 916
EP 923
DI 10.1016/S0891-5849(01)00483-X
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 421KG
UT WOS:000168063100011
PM 11295534
DA 2024-02-19
ER

PT J
AU TATEISHI, T
   FUJIMURA, A
   SHIGA, T
   OHASHI, K
   EBIHARA, A
AF TATEISHI, T
   FUJIMURA, A
   SHIGA, T
   OHASHI, K
   EBIHARA, A
TI INFLUENCE OF AGING ON THE OXIDATIVE AND CONJUGATIVE METABOLISM OF
   PROPRANOLOL
SO INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH
LA English
DT Article
ID LIVER-DISEASE; AGE; PHARMACOKINETICS; DISPOSITION; KINETICS; HEALTHY
AB The influence of aging on the hepatic metabolism of propranolol, i.e. conjugation, side-chain oxidation and ring oxidation, was investigated in 32 in-patients aged 30 to 84 yrs. Plasma propranolol concentration and main urinary metabolites [propranolol glucuronide (PPLG), naphthoxylactic acid (NLA), and 4-hydroxypropranolol (40HP)] were determined after a single oral dose of 20 mg propranolol. There were significant correlations between age and 1) maximum propranolol concentration, 2) area under the plasma concentration-time curve, and 3) elimination half-life. The apparent oral clearance of propranolol was inversely correlated with age. Partial metabolic clearance (PMC) to 40HP (ring oxidation) and PMC to NLA (side-chain oxidation) were significantly correlated with age, while PMC to PPLG was not. These observations suggest that there are age-related reductions in two oxidizing capacities, while there is no significant influence of aging on the conjugating capacity. The age-related reduction in oral clearance of propranolol may be mainly caused by the decline in the capacity of two different oxidation pathways.
C1 JICHI MED SCH,DEPT CLIN PHARMACOL & THERAPEUT,MINAMI KAWACHI,TOCHIGI 32904,JAPAN.
C3 Jichi Medical University
CR ANGUS PW, 1989, BIOCHEM PHARMACOL, V38, P1443, DOI 10.1016/0006-2952(89)90183-4
   CASTLEDEN CM, 1979, BRIT J CLIN PHARMACO, V7, P49, DOI 10.1111/j.1365-2125.1979.tb00896.x
   ELALLAF D, 1986, INT J CLIN PHARM RES, V6, P303
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   GREENBLATT DJ, 1980, J PHARMACOL EXP THER, V215, P86
   KELLY JG, 1982, BR J CLIN PHARM, V13, P1037
   KRAUS JW, 1978, CLIN PHARMACOL THER, V24, P411
   LARSSON M, 1984, EUR J CLIN PHARMACOL, V27, P217, DOI 10.1007/BF00544048
   MCLEAN AJ, 1991, CLIN PHARMACOKINET, V21, P42, DOI 10.2165/00003088-199121010-00004
   NIERENBERG DW, 1992, MELMON MORRELLIS CLI, P1
   TATEISHI T, 1992, J CLIN PHARMACOL, V32, P1099
   WALLE T, 1985, DRUG METAB DISPOS, V13, P204
   WARD SA, 1989, CLIN PHARMACOL THER, V45, P72, DOI 10.1038/clpt.1989.11
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 15
TC 14
Z9 14
U1 0
U2 1
PU BIOSCIENCE EDIPRINT INC
PI CAROUGE
PA RUE ALEXANDRE-GAVARD 16, 1227 CAROUGE, SWITZERLAND
SN 0251-1649
J9 INT J CLIN PHARM RES
JI Int. J. Clin. Pharmacol. Res.
PY 1995
VL 15
IS 3
BP 95
EP 101
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TJ997
UT WOS:A1995TJ99700001
PM 8847155
DA 2024-02-19
ER

PT J
AU Di Cicco, E
   Tozzini, ET
   Rossi, G
   Cellerino, A
AF Di Cicco, Emiliano
   Tozzini, Eva Terzibasi
   Rossi, Giacomo
   Cellerino, Alessandro
TI The short-lived annual fish <i>Nothobranchius furzeri</i> shows a
   typical teleost aging process reinforced by high incidence of
   age-dependent neoplasias
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Pathology; Animal model; Accelerated aging; Fish models
ID LEBISTES-RETICULATUS PETERS; ANNUAL CYPRINODONT FISH; GUPPY
   POECILIA-RETICULATUS; LIFE-SPAN; MODEL SYSTEM; GUENTHERI; LONGEVITY;
   MORTALITY; GROWTH; SENESCENCE
AB The annual fish Nothobranchius furzeri is the shortest-lived vertebrate which can be cultured in captivity. Here, we performed a histopathological analysis of age-related lesions in this species. Post-mortem analysis revealed lesions in liver (similar to 90%), kidney (similar to 75%), heart (similar to 70%) and gonads (similar to 40%) which are similar to those previously described in the small teleost Poecilia reticulata. In addition, a high incidence of neoplasias was observed in liver (similar to 35%) and kidney (similar to 25%).
   Different laboratory strains of N. furzeri show large genetic differences in longevity. Cross-sectional analysis revealed a clear age-dependent increase in the incidence of liver neoplasias which was accelerated in a short-lived strain. Cross-sectional analysis of gonads revealed sex-specific differences in the occurrence of lesions, with males being more severely affected than females.
   In conclusion, our analysis demonstrates that short life span in N. furzeri is a consequence of a typical teleost aging process which determines systemic failure of homeostasis functions rather than of a single organ or apparatus. Unlike other teleosts, however, this scenario is reinforced by high incidence of age-dependent neoplasias, making this species a promising model to analyze the molecular pathways of age-dependent spontaneous tumorigenesis. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Cellerino, Alessandro] CNR, Scuola Normale Super, Ist Neurosci, I-56100 Pisa, Italy.
   [Di Cicco, Emiliano; Rossi, Giacomo] Univ Camerino, Dept Vet Sci, Fac Vet Med, I-62032 Camerino, Italy.
   [Tozzini, Eva Terzibasi; Cellerino, Alessandro] Fritz Lipmann Inst, Leibniz Insitute Age Res, Jena, Germany.
C3 Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche
   (CNR); Istituto di Neuroscienze (IN-CNR); University of Camerino;
   Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)
RP Cellerino, A (corresponding author), CNR, Scuola Normale Super, Ist Neurosci, Via Moruzzi 1, I-56100 Pisa, Italy.
EM a.cellerino@sns.it
RI Tozzini, Eva Terzibasi/J-9466-2016; Cellerino, Alessandro/M-9380-2013;
   Rossi, Giacomo/HCI-9726-2022; terzibasi tozzini, eva/AEA-0204-2022;
   Cellerino, Alessandro/AAJ-7453-2020; Tozzini, Eva/JQI-3406-2023;
   Cellerino, Alessandro/AAB-4398-2020
OI Tozzini, Eva Terzibasi/0000-0003-3317-1538; Cellerino,
   Alessandro/0000-0003-3834-0097; terzibasi tozzini,
   eva/0000-0003-3317-1538; Cellerino, Alessandro/0000-0003-3834-0097;
   Cellerino, Alessandro/0000-0003-3834-0097; rossi,
   giacomo/0000-0001-8617-5984
FU DFG [CE 46/6-1]
FX This work is supported by a DFG grant CE 46/6-1 to A.C. and the animal
   work is approved by the State of Thuringia (Auth. Nr. 03-001/09).
CR COMFORT A, 1961, GERONTOLOGY, V5, P209, DOI 10.1159/000211060
   COOPER EL, 1983, EXP GERONTOL, V18, P29, DOI 10.1016/0531-5565(83)90048-7
   GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003
   Herrera M, 2004, J GERONTOL A-BIOL, V59, P101
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169
   LIU RK, 1970, EXP GERONTOL, V5, P241, DOI 10.1016/0531-5565(70)90044-6
   MARKOFSKY J, 1973, EXP GERONTOL, V8, P65, DOI 10.1016/0531-5565(73)90016-8
   MARKOFSKY J, 1979, EXP GERONTOL, V14, P149, DOI 10.1016/0531-5565(79)90030-5
   MARKOFSKY J, 1972, EXP GERONTOL, V7, P131, DOI 10.1016/0531-5565(72)90007-1
   MARKOFSKY J, 1979, EXP GERONTOL, V14, P11, DOI 10.1016/0531-5565(79)90003-2
   Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16
   Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936
   RUIJTER JM, 1987, CELL TISSUE RES, V248, P689, DOI 10.1007/BF00216500
   STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X
   Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039
   Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x
   Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866
   Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Walford RL, 1965, EXP GERONTOL, V1, P161, DOI 10.1016/0531-5565(65)90019-7
   WOODHEAD AD, 1979, EXP GERONTOL, V14, P211, DOI 10.1016/0531-5565(79)90022-6
   WOODHEAD AD, 1978, EXP GERONTOL, V13, P37, DOI 10.1016/0531-5565(78)90028-1
   WOODHEAD AD, 1969, EXP GERONTOL, V4, P17, DOI 10.1016/0531-5565(69)90022-9
   WOODHEAD AD, 1984, EXP GERONTOL, V19, P383, DOI 10.1016/0531-5565(84)90048-2
   WOODHEAD AD, 1969, EXP GERONTOL, V4, P197, DOI 10.1016/0531-5565(69)90008-4
   WOODHEAD AD, 1983, EXP GERONTOL, V18, P211, DOI 10.1016/0531-5565(83)90033-5
NR 32
TC 101
Z9 106
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2011
VL 46
IS 4
BP 249
EP 256
DI 10.1016/j.exger.2010.10.011
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 751GJ
UT WOS:000289605200006
PM 21056099
DA 2024-02-19
ER

PT J
AU Ito, E
   Kondo, F
   Harada, KI
AF Ito, E
   Kondo, F
   Harada, KI
TI Hepatic necrosis in aged mice by oral administration of microcystin-LR
SO TOXICON
LA English
DT Article
ID ALGAL TOXINS; CYANOBACTERIA; AERUGINOSA; PEPTIDE; DEPSIPEPTIDES;
   EXCRETION
AB Aged mice (32 weeks) were orally administered microcystin-LR at 500 mu g/kg, and injuries of the liver were estimated by microscopy 2 hr after treatment. Sixty-two per cent of aged mice proved to be sensitive to microcystin-LR, whereas such changes in the liver were not found in young mice (5 weeks). Uptake of the toxin into the liver was confirmed by high-performance liquid chromatography and frit-fast atom bombardment liquid chromatography/mass spectrometry after clean-up with an immunoaffinity column. To verify the difference in sensitivity to microcystin-LR between aged and young mice, non-treated mice were examined, and among them aged mice were confirmed to have a rough surface of the stomach and small intestinal mucosa. These results suggested that the hepatotoxicity by oral administration of microcystin-IR is deeply related to aging, and particularly to conditions in the small intestine such as the permeability of capillaries in the villi. (C) 1997 Elsevier Science Ltd.
C1 AICHI PREFECTURAL INST PUBL HLTH,NAGOYA,AICHI 462,JAPAN.
   MEIJO UNIV,FAC PHARM,TEMPAKU KU,NAGOYA,AICHI 468,JAPAN.
C3 Meijo University
RP Ito, E (corresponding author), CHIBA UNIV,PATHOGEN FUNGI & MICROBIAL TOXICOSES RES CTR,CHUO KU,1-8-1 INOHANA,CHIBA 260,JAPAN.
CR [Anonymous], WATER ENV
   CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x
   CARMICHAEL WW, 1985, CRIT REV ENV CONTR, V15, P275, DOI 10.1080/10643388509381734
   DABHOLKAR AS, 1987, TOXICON, V25, P285, DOI 10.1016/0041-0101(87)90257-1
   DONE SH, 1993, VET REC, V133, P600
   ERIKSSON JE, 1990, BIOCHIM BIOPHYS ACTA, V1025, P60, DOI 10.1016/0005-2736(90)90190-Y
   FALCONER IR, 1988, J TOXICOL ENV HEALTH, V24, P291, DOI 10.1080/15287398809531163
   FALCONER IR, 1992, TOXICON, V30, P790, DOI 10.1016/0041-0101(92)90016-X
   FALCONER IR, 1986, AUST J BIOL SCI, V39, P17
   FALCONER IR, 1981, AUST J BIOL SCI, V34, P179
   FITZGERALD SD, 1993, J VET DIAGN INVEST, V5, P651, DOI 10.1177/104063879300500433
   HARADA K, 1993, TETRAHEDRON LETT, V34, P6091, DOI 10.1016/S0040-4039(00)61736-7
   HARADA K, 1995, TETRAHEDRON LETT, V36, P1511, DOI 10.1016/0040-4039(95)00073-L
   HARADA KI, 1988, TOXICON, V26, P433, DOI 10.1016/0041-0101(88)90182-1
   Ito E, 1996, TOXICON, V34, P111, DOI 10.1016/0041-0101(95)00112-3
   Ito Emiko, 1994, Natural Toxins, V2, P371
   KONDO F, 1992, TOXICON, V30, P227, DOI 10.1016/0041-0101(92)90865-3
   Kondo Fumio, 1995, Natural Toxins, V3, P41, DOI 10.1002/nt.2620030109
   MARTIN C, 1993, J ANTIBIOT, V46, P1550, DOI 10.7164/antibiotics.46.1550
   Nagata Satoshi, 1995, Natural Toxins, V3, P78, DOI 10.1002/nt.2620030204
   NISHIWAKI R, 1994, CANCER LETT, V83, P283, DOI 10.1016/0304-3835(94)90331-X
   PACE JG, 1991, TOXICOL APPL PHARM, V107, P391, DOI 10.1016/0041-008X(91)90303-V
   ROBINSON NA, 1991, J PHARMACOL EXP THER, V256, P176
   SANO T, 1995, TETRAHEDRON LETT, V36, P5933, DOI 10.1016/00404-0399(50)1198Q-
   SHIN HJ, 1995, TETRAHEDRON LETT, V36, P5235
   SLATKIN DN, 1983, SCIENCE, V220, P1383, DOI 10.1126/science.6407109
   THESIS WC, 1988, TOXICON, V26, P603
NR 27
TC 52
Z9 55
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PD FEB
PY 1997
VL 35
IS 2
BP 231
EP 239
DI 10.1016/S0041-0101(96)00129-8
PG 9
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA WQ923
UT WOS:A1997WQ92300010
PM 9080580
DA 2024-02-19
ER

PT J
AU Li, RT
   Cheng, XJ
   Schwebel, DC
   Yang, Y
   Ning, PS
   Cheng, PX
   Hu, GQ
AF Li, Ruotong
   Cheng, Xunjie
   Schwebel, David C.
   Yang, Yang
   Ning, Peishan
   Cheng, Peixia
   Hu, Guoqing
TI Disability-adjusted life years associated with population ageing in
   China, 1990-2017
SO BMC GERIATRICS
LA English
DT Article
DE Population ageing; Health burden; Disability adjusted life years; China
ID CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; PREVALENCE; HEALTH; PROJECTIONS;
   COUNTRIES; MORTALITY; DEMENTIA; DEATHS; TRENDS
AB BackgroundThe Chinese population has aged significantly in the last few decades. Comprehensive health losses including both fatal and non-fatal health outcomes associated with ageing in China have not been detailed.MethodsBased on freely accessible disability adjusted life years (DALYs) estimated by the Global Burden of Diseases (GBD) 2017, we adopted a robust decomposition method that ascribes changes in DALYs in any given country across two time points to changes resulting from three sources: population size, age structure, and age-specific DALYs rate per 100,000 population. Using the method, we calculated DALYs associated with population ageing in China from 1990 to 2017 and examined the counteraction between the effects of DALYs rate change and population ageing. This method extends previous work through attributing the change in DALYs to the three sources.ResultsPopulation ageing was associated with 92.8 million DALYs between 1990 and 2017 in China, of which 65.8% (61.1 million) were years of life lost (YLLs). Males had comparatively more DALYs associated with population ageing than females in the study period. The five leading causes of DALYs associated with population ageing between 1990 and 2017 were stroke (23.6 million), chronic obstructive pulmonary disease (COPD) (18.3 million), ischemic heart disease (13.0 million), tracheal, bronchus, and lung cancer (6.1 million) and liver cancer (5.0 million). Between 1990 and 2017, changes in DALYs associated with age-specific DALY rate reductions far exceeded those related to population ageing (-196.2 million versus 92.8 million); 57.5% (-112.8 million) of DALYs were caused by decreases in rates attributed to 84 modifiable risk factors.ConclusionPopulation ageing was associated with growing health loss in China from 1990 to 2017. Despite the recent progress in alleviating health loss associated with population ageing, the government should encourage scientific research on effective and affordable prevention and control strategies and should consider investment in resources to implement strategies nationwide to address the future challenge of population ageing.
C1 [Li, Ruotong; Ning, Peishan; Cheng, Peixia; Hu, Guoqing] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hunan Prov Key Lab Clin Epidemiol, Changsha 410078, Peoples R China.
   [Cheng, Xunjie] Cent South Univ, Xiangya Hosp, Dept Geriatr Med, Changsha, Peoples R China.
   [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.
   [Yang, Yang] Univ Florida, Dept Biostat, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Yang, Yang] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Hu, Guoqing] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China.
C3 Central South University; Central South University; University of
   Alabama System; University of Alabama Birmingham; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; Central South University
RP Hu, GQ (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hunan Prov Key Lab Clin Epidemiol, Changsha 410078, Peoples R China.; Hu, GQ (corresponding author), Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China.
EM huguoqing009@gmail.com
RI Schwebel, David C./GXH-9944-2022
OI Schwebel, David C./0000-0002-2141-8970
FU Natural Science Foundation of Hunan Province, China [2020JJ4764];
   Project Program of National Clinical Research Center for Geriatric
   Disorders (Xiangya Hospital) [2020LNJJ14]
FX This study was funded by the Natural Science Foundation of Hunan
   Province, China (Grant No. 2020JJ4764) and the Project Program of
   National Clinical Research Center for Geriatric Disorders (Xiangya
   Hospital) (Grant No. 2020LNJJ14).
CR Al-Houqani M, 2012, CHEST, V141, P190, DOI 10.1378/chest.11-0089
   Assogba FGA, 2014, DIABETOLOGIA, V57, P718, DOI 10.1007/s00125-014-3160-9
   Batljan I, 2009, EUR J AGEING, V6, P201, DOI 10.1007/s10433-009-0120-1
   Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4
   Bhalla K, 2015, INT J EPIDEMIOL, V44, P1648, DOI 10.1093/ije/dyv019
   Bone AE, 2018, PALLIATIVE MED, V32, P329, DOI 10.1177/0269216317734435
   Carioli G, 2017, ANN ONCOL, V28, P2286, DOI 10.1093/annonc/mdx301
   Cheng J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-30
   Cheng XJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003138
   Cheng XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216613
   Cheng XJ, 2018, ACCIDENT ANAL PREV, V121, P129, DOI 10.1016/j.aap.2018.09.012
   Cooper RS, 1998, LANCET, V351, P208, DOI 10.1016/S0140-6736(97)06512-4
   Deeg DJH, 2014, EUR J AGEING, V11, P1, DOI 10.1007/s10433-014-0309-9
   Fitzmaurice C, 2018, INT J PUBLIC HEALTH, V63, P151, DOI 10.1007/s00038-017-0999-9
   Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]
   Frisina RD, 2016, AGING-US, V8, P2081, DOI 10.18632/aging.101045
   Gale SA, 2018, AM J MED, V131, P1161, DOI 10.1016/j.amjmed.2018.01.022
   Global Health Data Exchange, 2020, GBD RES TOOL
   Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3
   Li Z, 2016, INT J CARDIOL, V215, P257, DOI 10.1016/j.ijcard.2016.04.095
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McDonald SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-120
   Modig K, 2012, EUR J EPIDEMIOL, V27, P139, DOI 10.1007/s10654-012-9653-2
   Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711
   Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32278-5]
   Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127
   Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8
   Rossi A, 2018, MOVEMENT DISORD, V33, P156, DOI 10.1002/mds.27063
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7
   Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656
   Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9
   Stevens W, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1420-8
   Wang MH, 2019, LANCET RESP MED, V7, P35, DOI [10.1016/S2213-2600(18)30432-6, 10.1016/s2213-2600(18)30432-6]
   World Health Organisation, 2018, AG HLTH
   Xu JF, 2017, B WORLD HEALTH ORGAN, V95, P18, DOI [10.2471/blt.15.167726, 10.2471/BLT.15.167726]
   Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1
   Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6
NR 38
TC 7
Z9 8
U1 5
U2 29
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2318
J9 BMC GERIATR
JI BMC Geriatr.
PD JUN 16
PY 2021
VL 21
IS 1
AR 369
DI 10.1186/s12877-021-02322-7
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA SW6HT
UT WOS:000664615600004
PM 34134664
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bajaj, A
   Zheng, QX
   Adam, A
   Vincent, P
   Pumiglia, K
AF Bajaj, Anshika
   Zheng, Qingxia
   Adam, Alejandro
   Vincent, Peter
   Pumiglia, Kevin
TI Activation of Endothelial Ras Signaling Bypasses Senescence and Causes
   Abnormal Vascular Morphogenesis
SO CANCER RESEARCH
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; CELL-CYCLE ARREST; TUMOR SUPPRESSION;
   VINYL-CHLORIDE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE;
   LIVER-TUMORS; IN-VIVO; ANGIOGENESIS; PROTEIN
AB Angiogenesis is crucial for embryogenesis, reproduction, and wound healing and is a critical determinant of tumor growth and metastasis. The multifunctional signal transducer Ras is a proto-oncogene and frequently becomes mutated in a variety of human cancers, including angiosarcomas. Regulation of Ras is important for endothelial cell function and angiogenesis. Hyperactivation of Ras is linked with oncogene-induced senescence in many cell types. Given links between vascular malformations and angiosarcoma with activated Ras signaling, we sought to determine the consequence of sustained Ras activation on endothelial cell function. We find that sustained Ras activation in primary endothelial cells leads to prolonged activation of progrowth signaling, accompanied by a senescence bypass, enhanced proliferation, autonomous growth, and increased survival. Moreover, Ras severely compromises the ability of these cells to organize into vascular structures, instead promoting formation of planar endothelial sheets. This abnormal phenotype is regulated by phosphoinositide 3-kinase signaling, highlighting the therapeutic potential of agents targeting this axis in dealing with vascular morphogenic disorders and vascular normalization of tumors. Cancer Res; 70( 9); 3803-12. (C) 2010 AACR.
C1 [Bajaj, Anshika; Zheng, Qingxia; Pumiglia, Kevin] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.
   [Adam, Alejandro; Vincent, Peter] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.
C3 Albany Medical College; Albany Medical College
RP Pumiglia, K (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res MC 165, 47 New Scotland Ave, Albany, NY 12208 USA.
EM pumiglk@mail.amc.edu
RI Adam, Alejandro/M-6541-2013
OI Adam, Alejandro/0000-0001-6285-7235; Pumiglia, Kevin/0000-0003-4655-0334
FU USPHS [CA81419, HL077870]; American Heart Association [0825888D]; David
   E. Bryant Trust
FX USPHS grants CA81419 (K. Pumiglia) and HL077870 (P. Vincent), American
   Heart Association grant 0825888D (A. Bajaj), and David E. Bryant Trust.
CR Benjamin LE, 2000, CANCER METAST REV, V19, P75, DOI 10.1023/A:1026552415576
   Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962
   Boivin-Angèle S, 2000, INT J CANCER, V85, P223, DOI 10.1002/(SICI)1097-0215(20000115)85:2<223::AID-IJC12>3.0.CO;2-H
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019
   Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260
   Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036
   Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793
   Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002
   FROMENT O, 1994, CANCER RES, V54, P5340
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059
   HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0
   Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Koch M, 2008, J SURG ONCOL, V97, P321, DOI 10.1002/jso.20973
   LEMOINE NR, 1990, ONCOGENE, V5, P1833
   Lin AE, 2000, AM J MED GENET, V95, P108, DOI 10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0
   Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020
   Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921
   Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   MULLIKEN JB, 1982, SURGERY, V92, P348
   Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003
   Przygodzki RM, 1997, LAB INVEST, V76, P153
   Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448
   Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567
   Serban D, 2008, CIRC RES, V102, P1350, DOI 10.1161/CIRCRESAHA.107.169664
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588
   Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F
   Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050
   Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002
   Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6
   Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002
   Weihrauch M, 2002, ENVIRON MOL MUTAGEN, V40, P36, DOI 10.1002/em.10084
   Wu M, 2006, ONCOGENE, V25, P2297, DOI 10.1038/sj.onc.1209264
   Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.0.CO;2-S
   Zeng HY, 2002, J BIOL CHEM, V277, P4003, DOI 10.1074/jbc.M110842200
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
NR 47
TC 22
Z9 28
U1 0
U2 7
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 2010
VL 70
IS 9
BP 3803
EP 3812
DI 10.1158/0008-5472.CAN-09-2648
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 607GD
UT WOS:000278486200039
PM 20388785
OA Green Submitted, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU DAVIS, LJ
   TADOLINI, B
   BIAGI, PL
   WALFORD, R
   LICASTRO, F
AF DAVIS, LJ
   TADOLINI, B
   BIAGI, PL
   WALFORD, R
   LICASTRO, F
TI EFFECT OF AGE AND EXTENT OF DIETARY RESTRICTION ON HEPATIC-MICROSOMAL
   LIPID-PEROXIDATION POTENTIAL IN MICE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; FOOD RESTRICTION; LIPID PEROXIDATION; LIPID COMPOSITION;
   THIOBARBITURIC ACID
ID ACID
AB Lipid peroxidation potential in hepatic microsomes from young and old mice following two different caloric restriction regimens was measured by a colorimetric thiobarbituric acid method under conditions where Fe2+ autoxidation and free oxygen radical production were undetectable. Peroxidation was highest in the young (3.5-month-old) slightly restricted group (caloric intake 75% of ad libitum mice) but very low in young severely restricted (caloric intake 50% of ad libitum mice) and in both old (27-month-old) slightly and severely restricted groups. Very old (45-month-old) severely restricted animals had intermediate lipid peroxidation potentials. Fatty acid composition of liver homogenates was also determined. Significant differences between groups were found for only three fatty acids.;linoleic acid (18:2(n-6)) decreased in aged slightly restricted animals while it remained stable in severely restricted animals during aging. Dihomo-gamma-linolenic acid (20:3(n-6)) was higher in very old restricted animals than in old slightly restricted animals. Docosahexaenoic acid (22:6(n-3)) decreased in old slightly restricted animals. These results indicated that the effect of diets on hepatic fatty acid composition and the potential for microsomal lipid peroxidation in mice was dependent on the degree of caloric restriction and age.
C1 UNIV CALIF LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90024.
   UNIV BOLOGNA,DEPT EXPTL PATHOL,I-40127 BOLOGNA,ITALY.
C3 University of California System; University of California Los Angeles;
   University of Bologna
RP DAVIS, LJ (corresponding author), UNIV BOLOGNA,DEPT BIOCHEM,VIA IRNERIO 48,I-40128 BOLOGNA,ITALY.
CR AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
   BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   Buege J A, 1978, Methods Enzymol, V52, P302
   Davis L J, 1991, Aging (Milano), V3, P405
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GUTTERIDGE JMC, 1982, BRIT J PHARMACOL, V76, P459, DOI 10.1111/j.1476-5381.1982.tb09240.x
   GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   JIMENEZ JAL, 1993, BIOCHEM BIOPH RES CO, V192, P1037, DOI 10.1006/bbrc.1993.1521
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LICASTRO F, 1988, AGE, V11, P48, DOI 10.1007/BF02431772
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   Tadolini B, 1987, Free Radic Res Commun, V4, P149, DOI 10.3109/10715768709088100
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
NR 16
TC 27
Z9 27
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC 15
PY 1993
VL 72
IS 2
BP 155
EP 163
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MN336
UT WOS:A1993MN33600007
PM 8152319
DA 2024-02-19
ER

PT J
AU Shokrzadeh, M
   Bagheri, A
   Ghassemi-Barghi, N
   Rahmanian, N
   Eskandani, M
AF Shokrzadeh, Mohammad
   Bagheri, Abouzar
   Ghassemi-Barghi, Nasrin
   Rahmanian, Nazanin
   Eskandani, Morteza
TI Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by
   enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in
   male Wistar rats
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article; Early Access
DE Senescence; Doxorubicin; Doxorubicin-loaded nanoliposome;
   Hepatotoxicity; Genotoxicity; Oxidative stress
ID REDUCED CARDIOTOXICITY; LIPID-PEROXIDATION; APOPTOSIS; CANCER;
   NEPHROTOXICITY; DOXIL(R); EXTRACT
AB The senescence phenomenon is historically considered as a tumor-suppressing mechanism that can permanently arrest the proliferation of damaged cells, and prevent tumor eradication by activating cell cycle regulatory pathways. Doxorubicin (DX) as an antineoplastic agent has been used for the treatment of solid and hematological malignancies for a long time, but its clinical use is limited due to irreversible toxicity on off-target tissues. Thereby, the encapsulation of plain drugs in a vehicle may decrease the side effects while increasing their permeability and availability in target cells. Here, we aimed to investigate and compare the effects of DX and DX-loaded nanoliposome (NLDX) on the induction of senescence via assessment of the occurrence of apoptosis/necrosis, genomic damage, oxidative stress, and liver pathologies. The study groups included DX (0.75, 0.5, 0.1 mg/kg/BW), NLDX groups (0.1, 0.05, 0.025 mg/kg/BW), and an untreated control group. The liver tissues were used to investigate the oxidative stress parameters and probable biochemical and histopathological alterations. Annexin V/PI staining was carried out to find the type of cellular death in the liver tissue of healthy rats exposed to different concentrations of DOX and LDOX. Data revealed that the highest dose of NLDX (0.1 mg/kg/BW) could significantly induce cellular senescence throughout significant increasing the level of genotoxic damage (p < 0.0001) and the oxidative stress (p < 0.001) compared with a similar dose of DX, in which the obtained results were further confirmed by flow cytometry and histopathological assessments of the liver tissue. This investigation provides sufficient evidence of improved therapeutic efficacy of NLDX compared with plain DX in male Wistar rats.
C1 [Shokrzadeh, Mohammad; Ghassemi-Barghi, Nasrin] Mazandaran Univ Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Sari, Iran.
   [Bagheri, Abouzar] Mazandaran Univ Med Sci, Fac Med, Dept Clin Biochem & Genet, Sari, Iran.
   [Rahmanian, Nazanin] Mazandaran Univ Med Sci, Student Res Comm, Pharmaceut Sci Res Ctr, Sari, Iran.
   [Eskandani, Morteza] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran.
C3 Mazandaran University Medical Sciences; Mazandaran University Medical
   Sciences; Mazandaran University Medical Sciences; Tehran University of
   Medical Sciences; Tabriz University of Medical Science
RP Rahmanian, N (corresponding author), Mazandaran Univ Med Sci, Student Res Comm, Pharmaceut Sci Res Ctr, Sari, Iran.; Eskandani, M (corresponding author), Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran.
EM rahmanian_n@mazums.ac.ir; eskandanim@tbzmed.ac.ir
RI Rahmanian, Nazanin/AAR-4680-2021; Eskandani, Morteza/P-6209-2016
OI Eskandani, Morteza/0000-0003-2282-4871
FU Student Research Committee, Mazandaran University of Medical Sciences,
   Sari, Iran; Pharmaceutical Sciences Research Center
FX This work was funded by the Pharmaceutical Sciences Research Center and
   Student Research Committee, Mazandaran University of Medical Sciences,
   Sari, Iran.
CR Aan GJ, 2013, ELECTROPHORESIS, V34, P2209, DOI 10.1002/elps.201300086
   Aasland D, 2019, CANCER RES, V79, P99, DOI 10.1158/0008-5472.CAN-18-1733
   Abdel-Sattar E, 2019, PHARMACOGN MAG, V15, P545, DOI 10.4103/pm.pm_670_18
   Abilash V, 2020, LIFE SCI
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Al-Baqami NM, 2021, HUM EXP TOXICOL, V40, P183, DOI 10.1177/0960327120943267
   AliNejad, 2017, EFFECT REGULAR SWIMM
   Asghari MH, 2017, ARCH TOXICOL, V91, DOI 10.1007/s00204-017-2029-3
   Asghari MH, 2015, RES PHARM SCI, V10, P429
   Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   CAMAGGI CM, 1988, CANCER CHEMOTH PHARM, V21, P221
   Chen XY, 2016, MOL MED REP, V13, P3953, DOI 10.3892/mmr.2016.5017
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Fallah M, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116677
   Guo S, 2015, MOL CELL ENDOCRINOL, V412, P85, DOI 10.1016/j.mce.2015.05.034
   GUTTERIDGE JMC, 1984, BIOCHEM PHARMACOL, V33, P1725, DOI 10.1016/0006-2952(84)90340-X
   Hajra S, 2018, BIOMED PHARMACOTHER, V101, P228, DOI 10.1016/j.biopha.2018.02.088
   Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756
   Jung CH, 2005, J ETHNOPHARMACOL, V98, P245, DOI 10.1016/j.jep.2004.12.030
   Kandemir FM, 2020, FOOD CHEM TOXICOL, V138, DOI 10.1016/j.fct.2020.111190
   Kou LF, 2020, ACS APPL MATER INTER, V12, P30031, DOI 10.1021/acsami.0c03564
   Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93
   Mitry MA, 2020, AM J PHYSIOL-CELL PH, V318, pC380, DOI 10.1152/ajpcell.00073.2019
   Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104
   Nagai K, 2016, ANTI-CANCER DRUG, V27, P17, DOI 10.1097/CAD.0000000000000299
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097
   Omobowale Temidayo Olutayo, 2018, Journal of Dietary Supplements, V15, P183, DOI 10.1080/19390211.2017.1335822
   Segredo MPD, 2014, HUM EXP TOXICOL, V33, P748, DOI 10.1177/0960327113512342
   Rashid S, 2013, TOXICOL MECH METHOD, V23, P337, DOI 10.3109/15376516.2012.759306
   Rehman MU, 2014, EXP BIOL MED, V239, P465, DOI 10.1177/1535370213520112
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   Rieger Aja M, 2011, J Vis Exp, DOI 10.3791/2597
   Saad SY, 2001, PHARMACOL RES, V43, P211, DOI 10.1006/phrs.2000.0769
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   Shokrzadeh M, 2017, IRAN J BASIC MED SCI, V20, P497, DOI 10.22038/IJBMS.2017.8673
   Sikandar Abeera, 2020, J Ayub Med Coll Abbottabad, V32, P304
   Sioud F, 2020, ENVIRON SCI POLLUT R, V27, P12792, DOI 10.1007/s11356-020-07904-3
   Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011
   van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030
   VANHOESEL QGCM, 1984, CANCER RES, V44, P3698
   Wang Z, 2020, ONCOGENE, V39, P1572, DOI 10.1038/s41388-019-1080-3
   Wided K., 2015, Journal of Biologically Active Product from Nature, V5, P331, DOI [10.1080/22311866.2014.957076, DOI 10.1080/22311866.2014.957076]
   Zhong GX, 2019, BIOCHEM BIOPH RES CO, V514, P1204, DOI 10.1016/j.bbrc.2019.05.098
NR 45
TC 7
Z9 8
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD 2021 AUG
PY 2021
VL 394
IS 8
BP 1803
EP 1813
DI 10.1007/s00210-021-02119-w
EA JUL 2021
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TS2ER
UT WOS:000669406000001
PM 34219194
DA 2024-02-19
ER

PT J
AU Izgi, H
   Han, DD
   Isildak, U
   Huang, SY
   Kocabiyik, E
   Khaitovich, P
   Somel, M
   Dönertas, HM
AF Izgi, Hamit
   Han, Dingding
   Isildak, Ulas
   Huang, Shuyun
   Kocabiyik, Ece
   Khaitovich, Philipp
   Somel, Mehmet
   Doenertas, Handan Melike
TI Inter-tissue convergence of gene expression during ageing suggests
   age-related loss of tissue and cellular identity
SO ELIFE
LA English
DT Article
DE ageing; development; transcriptome; mouse; reversal; Human; Mouse
ID RNA; TRANSFAC(R); VARIABILITY; PACKAGE
AB Developmental trajectories of gene expression may reverse in their direction during ageing, a phenomenon previously linked to cellular identity loss. Our analysis of cerebral cortex, lung, liver, and muscle transcriptomes of 16 mice, covering development and ageing intervals, revealed widespread but tissue-specific ageing-associated expression reversals. Cumulatively, these reversals create a unique phenomenon: mammalian tissue transcriptomes diverge from each other during postnatal development, but during ageing, they tend to converge towards similar expression levels, a process we term Divergence followed by Convergence (DiCo). We found that DiCo was most prevalent among tissue-specific genes and associated with loss of tissue identity, which is confirmed using data from independent mouse and human datasets. Further, using publicly available single-cell transcriptome data, we showed that DiCo could be driven both by alterations in tissue cell-type composition and also by cell-autonomous expression changes within particular cell types.
C1 [Izgi, Hamit; Isildak, Ulas; Kocabiyik, Ece; Somel, Mehmet] Middle East Tech Univ, Dept Biol Sci, Ankara, Turkey.
   [Han, Dingding; Huang, Shuyun] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, CAS Key Lab Computat Biol, Shanghai, Peoples R China.
   [Khaitovich, Philipp] Skolkovo Inst Sci & Technol, Ctr Neurobiol & Brain Restorat, Moscow, Russia.
   [Doenertas, Handan Melike] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.
   [Doenertas, Handan Melike] Leibniz Inst Aging Fritz Lipmann Inst FLI, Jena, Germany.
C3 Middle East Technical University; Chinese Academy of Sciences; Max
   Planck Society; Skolkovo Institute of Science & Technology; Wellcome
   Trust Sanger Institute; European Molecular Biology Laboratory (EMBL);
   Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)
RP Somel, M (corresponding author), Middle East Tech Univ, Dept Biol Sci, Ankara, Turkey.; Khaitovich, P (corresponding author), Skolkovo Inst Sci & Technol, Ctr Neurobiol & Brain Restorat, Moscow, Russia.; Dönertas, HM (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.; Dönertas, HM (corresponding author), Leibniz Inst Aging Fritz Lipmann Inst FLI, Jena, Germany.
EM p.khaitovich@skoltech.ru; somel.mehmet@googlemail.com
RI Khaitovich, Philipp/HGC-8520-2022; Han, Dingding/HGD-2042-2022; Somel,
   Mehmet/B-1471-2016; izgi, hamit/F-3379-2014; Jiang, Tao/IWM-7503-2023;
   Donertas, Handan Melike/J-5451-2019
OI Han, Dingding/0000-0003-0963-6286; izgi, hamit/0000-0002-4030-3132;
   Donertas, Handan Melike/0000-0002-9788-6535; Somel,
   Mehmet/0000-0002-3138-1307
FU European Molecular Biology Laboratory; Scientific and Technological
   Council of Turkey [2232]; Science Academy (Turkey) BAGEP Awards; METU
   Internal Grant; Leibniz Institute on Aging - Fritz Lipmann Institute
   (FLI); Leibniz Association
FX European Molecular Biology Laboratory Handan Melike Donertas; Scientific
   and Technological Council of Turkey 2232 Mehmet Somel; Science Academy
   (Turkey) BAGEP Awards Mehmet Somel; METU Internal Grant Mehmet Somel;
   Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Open Access
   Fund Handan Melike Donertas; Leibniz Association Open Access Fund Handan
   Melike Donertas; The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
   Alexa A., 2019, TOPGO
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Anders S., 2010, GENOME BIOL, V11, pR106, DOI DOI 10.1186/gb-2010-11-10-r106
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Angelidis I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08831-9
   Anisimova AS, 2020, P NATL ACAD SCI USA, V117, P15581, DOI 10.1073/pnas.2001788117
   [Anonymous], 1953, Med J Aust, V1, P854
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bolstad, 2020, PREPROCESSCORE COLLE
   Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532
   Cardoso-Moreira M, 2019, NATURE, V571, P505, DOI 10.1038/s41586-019-1338-5
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524
   de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dönertas HM, 2021, NATURE AGING, V1, P400, DOI 10.1038/s43587-021-00051-5
   Dönertas HM, 2018, AGING CELL, V17, DOI 10.1111/acel.12819
   Dönertas HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05927-4
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   Ezcurra M, 2018, CURR BIOL, V28, P3352, DOI 10.1016/j.cub.2018.10.003
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Fisher RA, 1930, GENETICAL THEORY NAT, P318, DOI [10.5962/bhl.title.27468, DOI 10.5962/BHL.TITLE.27468]
   Flurkey K., 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1
   Fox J., 2018, APPENDIX NONPARAMETR
   Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712
   Hernando-Herraez I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12293-4
   hmtzg, 2022, BIRNBAUMLAB
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107
   Isildak U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60998-0
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kedlian VR, 2019, AGING-US, V11, P2253, DOI 10.18632/aging.101912
   Kim S, 1996, BIOCHEM BIOPH RES CO, V219, P370, DOI 10.1006/bbrc.1996.0240
   Lind MI, 2019, EVOL LETT, V3, P207, DOI 10.1002/evl3.108
   Liu XL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002558
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399
   Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Pisco A., 2020, **DATA OBJECT**, DOI 10.6084/m9.figshare.12654728.v1
   Raivo K, 2019, PHEATMAP PRETTY HEAT
   Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100
   Sampathkumar NK, 2020, HUM GENET, V139, P333, DOI 10.1007/s00439-019-02082-w
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024
   Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Tacutu R, 2018, NUCLEIC ACIDS RES, V46, pD1083, DOI 10.1093/nar/gkx1042
   Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Turan ZG, 2019, AGING CELL, V18, DOI 10.1111/acel.12965
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Yang J, 2019, EROSION EPIGENETIC L, DOI [10.1101/808642, DOI 10.1101/808642]
   Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yuan Y, 2012, AGING CELL, V11, P894, DOI 10.1111/j.1474-9726.2012.00859.x
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
NR 65
TC 12
Z9 14
U1 2
U2 7
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 31
PY 2022
VL 11
AR e68048
DI 10.7554/eLife.68048; 10.7554/eLife.68048.sa0; 10.7554/eLife.68048.sa1;
   10.7554/eLife.68048.sa2
PG 30
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA ZN7WU
UT WOS:000765240500001
PM 35098922
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Jiménez-Romero, C
   Maestro, OC
   Molero, FC
   Alonso, IJ
   Torrado, CA
   Municio, AM
   Pulido, JC
   Segurola, CL
   González, EM
AF Jimenez-Romero, Carlos
   Caso Maestro, Oscar
   Cambra Molero, Felix
   Justo Alonso, Iago
   Alegre Torrado, Cristina
   Manrique Municio, Alejandro
   Calvo Pulido, Jorge
   Loinaz Segurola, Carmelo
   Moreno Gonzalez, Enrique
TI Using old liver grafts for liver transplantation: Where are the limits?
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Old liver donors; Liver transplantation; Aging liver; Liver graft; Liver
   disease; Aging; Donor management; Septuagenarian donors; Octogenarian
   donors
ID HEPATITIS-C VIRUS; ADVANCED DONOR AGE; EXTENDED CRITERIA; PATIENT
   SURVIVAL; MARGINAL DONORS; RISK-FACTORS; ARTERY THROMBOSIS; ELDERLY
   DONORS; SAFELY EXPANDS; BLOOD-FLOW
AB The scarcity of ideal liver grafts for orthotopic liver transplantation (OLT) has led transplant teams to investigate other sources of grafts in order to augment the donor liver pool. One way to get more liver grafts is to use marginal donors, a not well-defined group which includes mainly donors > 60 years, donors with hypernatremia or macrosteatosis > 30%, donors with hepatitis C virus or hepatitis B virus positive serologies, cold ischemia time > 12 h, non-heart-beating donors, and grafts from split-livers or living-related donations. Perhaps the most practical and frequent measure to increase the liver pool, and thus to reduce waiting list mortality, is to use older livers. In the past years the results of OLT with old livers have improved, mainly due to better selection and maintenance of donors, improvements in surgical techniques in donors and recipients, and intra-and post-OLT management. At the present time, sexagenarian livers are generally accepted, but there still exists some controversy regarding the use of septuagenarian and octogenarian liver grafts. The aim of this paper is to briefly review the aging process of the liver and reported experiences using old livers for OLT. Fundamentally, the series of septuagenarian and octogenarian livers will be addressed to see if there is a limit to using these aged grafts. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
C1 [Jimenez-Romero, Carlos; Caso Maestro, Oscar; Cambra Molero, Felix; Justo Alonso, Iago; Alegre Torrado, Cristina; Manrique Municio, Alejandro; Calvo Pulido, Jorge; Loinaz Segurola, Carmelo; Moreno Gonzalez, Enrique] Univ Hosp, Serv Gen & Digest Surg & Abdominal Organ Transpla, Madrid 28041, Spain.
RP Jiménez-Romero, C (corresponding author), Univ Hosp, UCM, Serv Gen & Digest Surg & Abdominal Organ Transpla, Ctra Andalucia Km 5, Madrid 28041, Spain.
EM carlos.jimenez@inforboe.es
RI Justo, Iago/AAL-5709-2020
OI Justo, Iago/0000-0002-0553-5835; Alegre Torrado,
   Cristina/0000-0002-3700-5062; Calvo, Jorge/0000-0003-3144-4555
CR ADAM R, 1991, TRANSPLANT P, V23, P2602
   ADAM R, 1995, TRANSPLANT P, V27, P1181
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Anderson CD, 2008, J AM COLL SURGEONS, V207, P847, DOI 10.1016/j.jamcollsurg.2008.08.009
   Avolio AW, 2005, TRANSPL P, V37, P2584, DOI 10.1016/j.transproceed.2005.06.054
   AVOLIO AW, 1991, TRANSPLANT P, V23, P2451
   BENDER AD, 1965, J AM GERIATR SOC, V13, P192, DOI 10.1111/j.1532-5415.1965.tb02665.x
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x
   Borchert DH, 2005, TRANSPL P, V37, P1186, DOI 10.1016/j.transproceed.2004.12.261
   Briceño J, 2002, TRANSPLANTATION, V74, P522, DOI 10.1097/01.TP.0000026307.14572.8D
   Briceno J, 2000, TRANSPL INT, V13, pS249, DOI [10.1111/j.1432-2277.2000.tb02029.x, DOI 10.1111/J.1432-2277.2000.TB02029.X]]
   Burra P, 2006, J HEPATOL, V45, P488, DOI 10.1016/j.jhep.2006.07.021
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   BUSUTTIL RW, 1994, ANN SURG, V219, P490, DOI 10.1097/00000658-199405000-00007
   Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105
   Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3
   Cassuto JR, 2008, J SURG RES, V148, P38, DOI 10.1016/j.jss.2008.03.018
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Cescon M, 2011, TRANSPLANTATION, V92, P439, DOI 10.1097/TP.0b013e3182252800
   Condron SL, 2005, TRANSPLANTATION, V80, P145, DOI 10.1097/01.TP.0000164291.35925.7A
   Cucchetti A, 2009, CLIN TRANSPLANT, V23, P519, DOI 10.1111/j.1399-0012.2009.00987.x
   DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024
   Darius T, 2012, TRANSPL P, V44, P2861, DOI 10.1016/j.transproceed.2012.09.076
   DEBAKEY ME, 1985, ANN SURG, V201, P115
   Deroose JP, 2011, HPB, V13, P417, DOI 10.1111/j.1477-2574.2011.00310.x
   Doyle MBM, 2008, ARCH SURG-CHICAGO, V143, P679, DOI 10.1001/archsurg.143.7.679
   Durand F, 2008, LIVER TRANSPLANT, V14, P1694, DOI 10.1002/lt.21668
   Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013
   Faber W, 2011, TRANSPL P, V43, P3789, DOI 10.1016/j.transproceed.2011.10.048
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Figueras J, 1996, TRANSPLANTATION, V61, P410, DOI 10.1097/00007890-199602150-00016
   FINDOR J, 1973, ACTA HEPATO-GASTRO, V20, P200
   Fishbein TM, 1997, TRANSPLANTATION, V64, P248, DOI 10.1097/00007890-199707270-00012
   Fouzas I, 2008, TRANSPL P, V40, P3198, DOI 10.1016/j.transproceed.2008.08.061
   Gastaca M, 2005, TRANSPLANT P, V37, P3851, DOI 10.1016/j.transproceed.2005.10.040
   Ghobrial RM, 2002, ANN SURG, V236, P315, DOI 10.1097/00000658-200209000-00008
   González FR, 2002, TRANSPL P, V34, P233, DOI 10.1016/S0041-1345(01)02738-5
   GONZALEZ FX, 1994, HEPATOLOGY, V20, P565, DOI 10.1002/hep.1840200304
   Grande L, 1997, TRANSPLANT P, V29, P3289, DOI 10.1016/S0041-1345(97)00914-7
   Grande L, 1998, Clin Transpl, P297
   Grazi GL, 2008, AM J TRANSPLANT, V8, P725, DOI 10.1111/j.1600-6143.2007.02114.x
   GREIG PD, 1990, TRANSPLANT P, V22, P2072
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Iacob S, 2007, TRANSPLANTATION, V84, P56, DOI 10.1097/01.tp.0000267916.36343.ca
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   Jiménez-Romero C, 2013, WORLD J SURG, V37, P2211, DOI 10.1007/s00268-013-2085-7
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172
   KARAYALCIN K, 1994, TRANSPLANTATION, V57, P1323, DOI 10.1097/00007890-199405150-00006
   Karpen SJ, 2010, HEPATOLOGY, V51, P364, DOI 10.1002/hep.23447
   Kim DY, 2005, TRANSPLANT INT, V18, P73, DOI 10.1111/j.1432-2277.2004.00017.x
   KLINTMALM GBG, 1988, TRANSPLANT P, V20, P9
   Lai Q, 2011, J GASTROINTEST LIVER, V20, P383
   Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x
   Landowne M, 1960, AGING SOME SOCIAL BI, P159
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   López-Navidad A, 2003, CLIN TRANSPLANT, V17, P308, DOI 10.1034/j.1399-0012.2003.00119.x
   Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1002/hep.1840220622
   MARINO IR, 1995, TRANSPLANT P, V27, P1184
   MARKIN RS, 1993, TRANSPLANTATION, V56, P1403, DOI 10.1097/00007890-199312000-00025
   Markmann JF, 2001, TRANSPLANTATION, V72, P1113, DOI 10.1097/00007890-200109270-00023
   Martins PN, 2011, HPB, V13, P212, DOI 10.1111/j.1477-2574.2010.00275.x
   McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MIRZA DF, 1994, LANCET, V344, P1480, DOI 10.1016/S0140-6736(94)90294-1
   MOONEY H, 1985, CLIN GASTROENTEROL, V14, P757
   Moore DE, 2005, ARCH SURG-CHICAGO, V140, P273, DOI 10.1001/archsurg.140.3.273
   MOR E, 1992, TRANSPLANTATION, V53, P383, DOI 10.1097/00007890-199202010-00022
   Moreno Sanz C., 1999, Revista Espanola de Enfermedades Digestivas, V91, P401
   Mutimer DJ, 2006, TRANSPLANTATION, V81, P7, DOI 10.1097/01.tp.0000188619.30677.84
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Neipp M, 2004, TRANSPLANT INT, V17, P416, DOI 10.1007/s00147-004-0735-2
   Nocito A, 2006, J HEPATOL, V45, P494, DOI 10.1016/j.jhep.2006.07.017
   NOVITZKY D, 1988, TRANSPLANT P, V20, P33
   Petridis I, 2008, TRANSPL P, V40, P1976, DOI 10.1016/j.transproceed.2008.05.063
   Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   POPPER H, 1985, HEPATOLOGY, V5, P1224, DOI 10.1002/hep.1840050627
   Rauchfuss F, 2010, TRANSPL P, V42, P175, DOI 10.1016/j.transproceed.2009.11.020
   Ravaioli M, 2009, TRANSPL INT, V22, P423, DOI 10.1111/j.1432-2277.2008.00812.x
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Renz JF, 2005, ANN SURG, V242, P556, DOI 10.1097/01.sla.0000183973.49899.b1
   Romagnoli J, 2001, TRANSPL P, V33, P3797, DOI 10.1016/S0041-1345(01)02607-0
   Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021
   Rull R, 2003, LIVER TRANSPLANT, V9, P389, DOI 10.1053/jlts.2003.50050
   Russo MW, 2004, AM J TRANSPLANT, V4, P1133, DOI 10.1111/j.1600-6143.2004.00470.x
   Sampedro B, 2011, TRANSPL P, V43, P679, DOI 10.1016/j.transproceed.2011.01.084
   SATO T, 1970, GERONTOLOGY, V16, P368, DOI 10.1159/000211799
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Segev DL, 2007, HEPATOLOGY, V46, P1907, DOI 10.1002/hep.21888
   SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x
   Singhal A, 2010, EXP CLIN TRANSPLANT, V8, P196
   Stewart ZA, 2009, LIVER TRANSPLANT, V15, P1688, DOI 10.1002/lt.21946
   STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410
   Tector AJ, 2006, ANN SURG, V244, P439, DOI 10.1097/01.sla.0000234896.18207.fa
   Ureña MAG, 1998, WORLD J SURG, V22, P837, DOI 10.1007/s002689900479
   Ureña MAG, 1998, TRANSPLANT P, V30, P3288, DOI 10.1016/S0041-1345(98)01033-1
   Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   WALL W, 1993, LANCET, V341, P121, DOI 10.1016/0140-6736(93)92604-R
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   Wall WJ, 1999, LIVER TRANSPLANT SUR, V5, P458, DOI 10.1002/lt.500050511
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   Watt KDS, 2006, LIVER TRANSPLANT, V12, P134, DOI 10.1002/lt.20583
   Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879
   WINGERD J, 1977, CLIN CHEM, V23, P1310
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P1, DOI 10.1093/ageing/19.1.1
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
   Yersiz H, 2003, ANN SURG, V238, P496, DOI 10.1097/01.sla.0000089852.29654.72
   Zapletal C, 2005, TRANSPL P, V37, P1182, DOI 10.1016/j.transproceed.2004.11.056
NR 116
TC 62
Z9 65
U1 0
U2 8
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD AUG 21
PY 2014
VL 20
IS 31
BP 10691
EP 10702
DI 10.3748/wjg.v20.i31.10691
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AN6TL
UT WOS:000340730400005
PM 25152573
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Lowe, R
   Danson, AF
   Rakyan, VK
   Yildizoglu, S
   Saldmann, F
   Viltard, M
   Friedlander, G
   Faulkes, CG
AF Lowe, Robert
   Danson, Amy F.
   Rakyan, Vardhman K.
   Yildizoglu, Selin
   Saldmann, Frederic
   Viltard, Melanie
   Friedlander, Gerard
   Faulkes, Chris G.
TI DNA methylation clocks as a predictor for ageing and age estimation in
   naked mole-rats, <i>Heterocephalus glaber</i>
SO AGING-US
LA English
DT Article
DE naked mole-rat; Heterocephalus glaber; methylation clocks; epigenetic
   clocks; ageing
ID LONGEST-LIVING RODENT
AB The naked mole-rat, Heterocephalus glaber (NMR), the longest-lived rodent, is of significance and interest in the study of biomarkers for ageing. Recent breakthroughs in this field have revealed 'epigenetic clocks' that are based on the temporal accumulation of DNA methylation at specific genomic sites. Here, we validate the hypothesis of an epigenetic clock in NMRs based on changes in methylation of targeted CpG sites. We initially analysed 51 CpGs in NMR livers spanning an age range of 39-1,144 weeks and found 23 to be significantly associated with age (p<0.05). We then built a predictor of age using these sites. To test the accuracy of this model, we analysed an additional set of liver samples, and were successfully able to predict their age with a root mean squared error of 166 weeks. We also profiled skin samples with the same age range, finding a striking correlation between their predicted age versus their actual age (R=0.93), but which was lower when compared to the liver, suggesting that skin ages slower than the liver in NMRs. Our model will enable the prediction of age in wild-caught and captive NMRs of unknown age, and will be invaluable for further mechanistic studies of mammalian ageing.
C1 [Lowe, Robert; Danson, Amy F.; Rakyan, Vardhman K.; Yildizoglu, Selin] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.
   [Rakyan, Vardhman K.] Queen Mary Univ London, Ctr Genom Hlth, London, England.
   [Saldmann, Frederic; Viltard, Melanie] Fondat Rech Physiol, Brussels, Belgium.
   [Saldmann, Frederic; Friedlander, Gerard] Hop Europeen Georges Pompidou, AP HP, Serv Physiol & Explorat Fonct, Paris, France.
   [Friedlander, Gerard] Univ Paris 05, Fac Med, Paris, France.
   [Friedlander, Gerard] INEM, INSERM, UMR S1151, CNRS,UMR8253, Paris, France.
   [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England.
C3 University of London; Queen Mary University London; University of
   London; Queen Mary University London; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP;
   Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital
   Universitaire Paul-Brousse - APHP; Universite Paris Cite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Paris Cite; University of London; Queen
   Mary University London
RP Faulkes, CG (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.
EM c.g.faulkes@qmul.ac.uk
RI Viltard, Melanie/HLH-0215-2023
OI Danson, Amy/0000-0002-6882-8723
FU QMUL Research-IT
FX This research utilised Queen Mary's Apocrita HPC facility, supported by
   QMUL Research-IT. https://doi.org/10.5281/zenodo.438045.
CR Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x
   BENNETT NC, 1990, J ZOOL, V220, P469, DOI 10.1111/j.1469-7998.1990.tb04319.x
   Buffenstein R, 2007, FASEB J, V21
   Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5
   Buffenstein Rochelle, 2002, Sci Aging Knowledge Environ, V2002, ppe7, DOI 10.1126/sageke.2002.21.pe7
   Christiansen L, 2016, AGING CELL, V15, P149, DOI 10.1111/acel.12421
   Csiszar A, 2007, AM J PHYSIOL-HEART C, V293, pH919, DOI 10.1152/ajpheart.01287.2006
   Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102
   Ecker S, 2019, AGING-US, V11, P833, DOI 10.18632/aging.101712
   Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41
   Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lee Y, 2019, AGING-US, V11, P4238, DOI 10.18632/aging.102049
   Lewis KN, 2012, GERONTOLOGY, V58, P453, DOI 10.1159/000335966
   LEWIS P, 2016, HDB BIOL AGING, P179, DOI DOI 10.1016/B978-0-12-411596-5.00006-X
   Lowe R, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1397-1
   MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Maierhofer A, 2017, AGING-US, V9, P1143, DOI 10.18632/aging.101217
   Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896
   Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013
   Polanowski AM, 2014, MOL ECOL RESOUR, V14, P976, DOI 10.1111/1755-0998.12247
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890
   Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157
   Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232
   Stoll EA, 2016, AGING-US, V8, P3468, DOI 10.18632/aging.101140
   Team RC, 2020, R: A Language and Environment for Statistical
   Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590
   Thompson MJ, 2017, AGING-US, V9, P1055, DOI 10.18632/aging.101211
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Wagner W, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00303
   Zhu TY, 2018, AGING-US, V10, P3541, DOI 10.18632/aging.101666
NR 37
TC 16
Z9 18
U1 2
U2 20
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAR 15
PY 2020
VL 12
IS 5
BP 4394
EP 4406
DI 10.18632/aging.102892
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA KW3GV
UT WOS:000521056200026
PM 32126024
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Colak, Y
   Senates, E
   Ozturk, O
   Yilmaz, Y
   Zemheri, E
   Enc, FY
   Ulasoglu, C
   Aksaray, S
   Bozbeyoglu, SG
   Kiziltas, S
   Kurdas, OO
   Tuncer, I
AF Colak, Yasar
   Senates, Ebubekir
   Ozturk, Oguzhan
   Yilmaz, Yusuf
   Zemheri, Ebru
   Enc, Feruze Yilmaz
   Ulasoglu, Celal
   Aksaray, Sebahat
   Bozbeyoglu, Sabriye Gulcin
   Kiziltas, Safak
   Kurdas, Oya Ovunc
   Tuncer, Ilyas
TI Serum concentrations of human insulin-like growth factor-1 and levels of
   insulin-like growth factor-binding protein-5 in patients with
   nonalcoholic fatty liver disease: association with liver histology
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE fatty liver; insulin-like growth factor-I; insulin-like growth factor
   binding protein-5
ID NECROSIS-FACTOR-ALPHA; IGF-I; HEPATOCELLULAR-CARCINOMA; HEPATOCYTE
   APOPTOSIS; CELLULAR SENESCENCE; PULMONARY-FIBROSIS; METABOLIC SYNDROME;
   SIMPLE STEATOSIS; STEATOHEPATITIS; POPULATION
AB Objective In this study, we aimed to investigate the relationship between the histological features of nonalcoholic fatty liver disease (NAFLD) and serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-5 (IGFBP-5) to determine the usefulness of this relationship in clinical practice.
   Materials and methods Serum samples were collected from 92 patients with biopsy-proven NAFLD and 51 healthy controls and serum levels of IGF-1 and IGFBP-5 were assayed by enzyme-linked immunosorbent assay.
   Result Serum IGFBP-5 levels were correlated with liver steatosis, fibrosis, and nonalcoholic steatohepatitis scores. IGF-1 levels were significantly decreased in patients with moderate-to-severe fibrosis compared with patients with no or mild fibrosis.
   Conclusion Serum IGFBP-5 levels may be useful to differentiate both advanced fibrosis and definite nonalcoholic steatohepatitis from other NAFLD groups. Also, serum IGF-1 levels may be useful to differentiate advanced fibrosis in patients with NAFLD. Eur J Gastroenterol Hepatol 24:255-261 (C) 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.
C1 [Colak, Yasar; Ozturk, Oguzhan; Enc, Feruze Yilmaz; Ulasoglu, Celal; Kiziltas, Safak; Tuncer, Ilyas] Istanbul Goztepe Educ & Res Hosp, Dept Gastroenterol, TR-34730 Istanbul, Turkey.
   [Zemheri, Ebru] Istanbul Goztepe Educ & Res Hosp, Dept Pathol, TR-34730 Istanbul, Turkey.
   [Bozbeyoglu, Sabriye Gulcin] Istanbul Goztepe Educ & Res Hosp, Dept Radiol, TR-34730 Istanbul, Turkey.
   [Senates, Ebubekir; Kurdas, Oya Ovunc] Haydarpasa Educ & Res Hosp, Dept Gastroenterol, Istanbul, Turkey.
   [Aksaray, Sebahat] Haydarpasa Educ & Res Hosp, Dept Clin Microbiol, Istanbul, Turkey.
   [Yilmaz, Yusuf] Marmara Univ, Fac Med, Dept Gastroenterol, Istanbul, Turkey.
   [Yilmaz, Yusuf] Marmara Univ, Inst Gastroenterol, Istanbul, Turkey.
C3 Istanbul Goztepe Training and Research Hospital; Istanbul Goztepe
   Training and Research Hospital; Istanbul Goztepe Training and Research
   Hospital; Istanbul Haydarpasa Numune Training & Research Hospital;
   Istanbul Haydarpasa Numune Training & Research Hospital; Marmara
   University; Marmara University
RP Colak, Y (corresponding author), Istanbul Goztepe Educ & Res Hosp, Dept Gastroenterol, TR-34730 Istanbul, Turkey.
EM dryasarcolak@yahoo.com
RI Ozturk, Oguzhan/IQV-3416-2023; Bozbeyoğlu, Sabriye Gülçin/HII-6684-2022;
   Senates, Ebubekir/G-6073-2010; Kiziltas, Safak/Y-1366-2018; enç,
   feruze/AAH-4205-2020; Ulasoglu, Celal/E-5004-2019; Yilmaz,
   Yusuf/K-6651-2012; Öztürk, Oğuzhan/JVN-9476-2024; Zemheri, Itır
   Ebru/JRY-6674-2023; Tuncer, Ilyas/L-3470-2013
OI Ozturk, Oguzhan/0000-0002-7718-8684; Bozbeyoğlu, Sabriye
   Gülçin/0000-0003-1593-4351; Ulasoglu, Celal/0000-0002-2104-6783; Yilmaz,
   Yusuf/0000-0003-4518-5283; Zemheri, Itır Ebru/0000-0003-0247-0332;
   aksaray, sebahat/0000-0002-0552-1337
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Allan GJ, 2008, J ENDOCRINOL, V199, P155, DOI 10.1677/JOE-08-0269
   Anwar A, 2002, CIRCULATION, V105, P1220, DOI 10.1161/hc1002.105187
   Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Fleming JM, 2007, J ENDOCRINOL, V194, P349, DOI 10.1677/JOE-06-0121
   Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913
   GRESSNER AM, 1991, EUR J CLIN CHEM CLIN, V29, P293
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984
   Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4
   Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640
   Janssen JAMJL, 1998, ARTERIOSCL THROM VAS, V18, P277, DOI 10.1161/01.ATV.18.2.277
   Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC
   Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967
   Lelbach A, 2001, J HEPATOL, V35, P558, DOI 10.1016/S0168-8278(01)00170-2
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
   Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8
   Rafiq N, 2009, CLIN LIVER DIS, V13, P249, DOI 10.1016/j.cld.2009.02.009
   Saydah S, 2009, CANCER CAUSE CONTROL, V20, P1309, DOI 10.1007/s10552-009-9351-x
   Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556
   Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008
   Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412
   Sokolovic A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-3
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Thissen JP, 1997, ENDOCRINOLOGY, V138, P1078, DOI 10.1210/en.138.3.1078
   Völzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Yasuoka H, 2006, AM J PATHOL, V169, P1633, DOI 10.2353/ajpath.2006.060501
   Yasuoka H, 2006, ARTHRITIS RHEUM-US, V54, P3001, DOI 10.1002/art.22084
   Yilmaz Y, 2011, CURR MED CHEM, V18, P725, DOI 10.2174/092986711794480122
   Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837
   Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y
NR 38
TC 34
Z9 35
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0954-691X
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD MAR
PY 2012
VL 24
IS 3
BP 255
EP 261
DI 10.1097/MEG.0b013e32834e8041
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 888ZJ
UT WOS:000300043000005
PM 22157234
DA 2024-02-19
ER

PT J
AU Kang, MJ
   Kim, HJ
   Kim, HK
   Lee, JY
   Kim, DH
   Jung, KJ
   Kim, KW
   Baik, HS
   Yoo, MA
   Yu, BP
   Chung, HY
AF Kang, MJ
   Kim, HJ
   Kim, HK
   Lee, JY
   Kim, DH
   Jung, KJ
   Kim, KW
   Baik, HS
   Yoo, MA
   Yu, BP
   Chung, HY
TI The effect of age and calorie restriction on HIF-1-responsive genes in
   aged liver
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; CR; EPO; HIF-1; HO-1; iNOS; VEGF
ID INDUCIBLE FACTOR-I; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; HYPOXIA;
   HIF-1-ALPHA; EXPRESSION; CYCLOOXYGENASE; MODULATION; PROTEIN; DAMAGE
AB Hypoxia inducible factor-1 (HIF-1) regulates transactivation of several genes in response to hypoxia condition. We explore hepatic HIF-1 responsive gene regulation during aging and the age-related changes of the HIF-1 related gene activation in young and old rats. Results indicate that the aging process induces the activation of HIF-1 alpha, which is accompanied by increased HIF-1 DNA binding. This increased binding activity is accompanied by the increase of HIF-1-dependent genes, heme oxygenase-1 (HO-1), vascular endothelial growth factor (VEGF), erythropoietin (EPO), and inducible nitric oxide synthase (iNOS), which all showed remarkable up-regulation during aging process. In contrast, the increased HIF-1 related gene expression was effectively blunted by the anti-oxidative action of calorie restriction in aged rat liver. We propose that age-related HIF-1 binding activity may well be influenced by the increased pro-oxidative conditions of aged animals, which up-regulate HIF-1-dependent gene expression.
C1 Pusan Natl Univ, Coll Pharm, Aging Tissue Bang, Pusan 609735, South Korea.
   Pusan Natl Univ, Genet Engn Res Inst, Pusan 609735, South Korea.
   Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
C3 Pusan National University; Pusan National University; Seoul National
   University (SNU); University of Texas System; University of Texas Health
   Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Aging Tissue Bang, Pusan 609735, South Korea.
EM hyjung@pusan.ac.kr
CR Agani FH, 2002, AM J PHYSIOL-CELL PH, V283, pC178, DOI 10.1152/ajpcell.00381.2001
   Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung HY, 1999, MECH AGEING DEV, V111, P97, DOI 10.1016/S0047-6374(99)00061-5
   Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5
   FENG L, 1993, ARCH BIOCHEM BIOPHYS, V307, P361, DOI 10.1006/abbi.1993.1601
   Frenkel-Denkberg G, 1999, FEBS LETT, V462, P341, DOI 10.1016/S0014-5793(99)01552-5
   HABIB A, 1993, J BIOL CHEM, V268, P23448
   Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253
   IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103
   IWASAKI K, 1988, J GERONTOL, V43, P5
   Jeong HJ, 2003, BIOCHEM BIOPH RES CO, V306, P805, DOI 10.1016/S0006-291X(03)01073-8
   Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375
   Lee YM, 2003, BIOCHEM BIOPH RES CO, V300, P241, DOI 10.1016/S0006-291X(02)02787-0
   LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Niwa K, 1999, NEUROSCI LETT, V271, P109, DOI 10.1016/S0304-3940(99)00534-0
   Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212
   PEKKA K, 1997, P NATL ACAD SCI USA, V94, P5667
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200
   Royer C, 2000, BRAIN RES, V856, P119, DOI 10.1016/S0006-8993(99)02365-3
   SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447
   Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9
   Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6
   Sumbayev VV, 2003, FEBS LETT, V535, P106, DOI 10.1016/S0014-5793(02)03887-5
   Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Yu BP, 2000, METH MOLEC MED, V38, P353, DOI 10.1385/1-59259-070-5:353
NR 36
TC 43
Z9 47
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JAN
PY 2005
VL 6
IS 1
BP 27
EP 37
DI 10.1007/s10522-004-7381-z
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 917ZG
UT WOS:000228507300003
PM 15834661
DA 2024-02-19
ER

PT J
AU Sivasubramaniyam, T
   Yang, JQ
   Pollock, E
   Chon, J
   Schroer, SA
   Li, YZ
   Metherel, AH
   Dodington, DW
   Bazinet, RP
   Woo, M
AF Sivasubramaniyam, Tharini
   Yang, Jiaqi
   Pollock, Evan
   Chon, Joseph
   Schroer, Stephanie A.
   Li, Yu Zhe
   Metherel, Adam H.
   Dodington, David W.
   Bazinet, Richard P.
   Woo, Minna
TI Hepatic <i>Igf1</i>-Deficiency Protects Against Atherosclerosis in
   Female Mice
SO ENDOCRINOLOGY
LA English
DT Article
DE IGF-1; atherosclerosis; NAFLD; obesity; adipokine
ID GROWTH-FACTOR-I; SUBCUTANEOUS ADIPOSE-TISSUE; ESTROGEN-RECEPTOR-ALPHA;
   IMPROVES INSULIN SENSITIVITY; NECROSIS-FACTOR-ALPHA; SEX-DIFFERENCES;
   IGF-I; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; FATTY LIVER
AB Atherosclerosis is the leading cause of cardiovascular disease (CVD), with distinct sex-specific pathogenic mechanisms that are poorly understood. Aging, a major independent risk factor for atherosclerosis, correlates with a decline in circulating insulin-like growth factor-1 (IGF-1). However, the precise effects of lgf1 on atherosclerosis remain unclear. In the present study, we assessed the essential role of hepatic Igf1, the major source of circulating IGF-1, in atherogenesis. We generated hepatic lgf1-deficient atherosclerosisprone apolipoprotein E (ApoE)-null mice (L-Igf1(-/-) ApoE(-/-)) using the Cre-loxP system driven by the Albumin promoter. Starting at 6 weeks of age, these mice and their littermate controls, separated into male and female groups, were placed on an atherogenic diet for 18 to 19 weeks. We show that hepatic Igf1-deficiency led to atheroprotection with reduced plaque macrophages in females, without significant effects in males. This protection from atherosclerosis in females was associated with increased subcutaneous adiposity and with impaired lipolysis. Moreover, this impaired lipid homeostasis was associated with disrupted adipokine secretion with reduced circulating interleukin-6 (11,6) levels. Together, our data show that endogenous hepatic Igf1 plays a sex-specific regulatory role in atherogenesis, potentially through athero-promoting effects of adipose tissue-derived IL-6 secretion. These data provide potential novel sex-specific mechanisms in the pathogenesis of atherosclerosis.
C1 [Sivasubramaniyam, Tharini; Yang, Jiaqi; Pollock, Evan; Chon, Joseph; Schroer, Stephanie A.; Li, Yu Zhe; Dodington, David W.; Woo, Minna] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada.
   [Li, Yu Zhe; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada.
   [Metherel, Adam H.; Bazinet, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada.
   [Woo, Minna] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada.
   [Woo, Minna] Univ Toronto, Univ Hlth Network, Dept Med, Div Endocrinol & Metab,Sinai Hlth Syst, Toronto, ON M5G 2C4, Canada.
C3 University of Toronto; University Health Network Toronto; Toronto
   General Hospital; University of Toronto; University of Toronto;
   University of Toronto; University of Toronto; University Health Network
   Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum Research
   Institute
RP Woo, M (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.
EM mwoo@uhnresearch.ca
RI Li, Yuzhe/P-4154-2019; Dodington, David W/GNM-6943-2022
OI Woo, Minna/0000-0003-2255-1025
FU Canadian Institute of Health Research [MOP-142193, PJT-159505]; Heart
   and Stroke Foundation of Canada; Canada Research Chair in Signal
   Transduction in Diabetes Pathogenesis; Soham and Shaila Ajmera Family
   Chair in Molecular Diabetes Research; Canadian Diabetes Association
   Doctoral Research Award; Canadian Institute of Health Research Doctoral
   Research Award; Banting and Best Diabetes Centre Novo Nordisk
   Studentship; Canadian Liver Foundation Graduate Studentship; Institute
   of Medical Science Summer Undergraduate Research Program
FX This work was supported by operating grants to M.W. from the Canadian
   Institute of Health Research (MOP-142193 and PJT-159505) and the Heart
   and Stroke Foundation of Canada. M.W. is supported by the Canada
   Research Chair in Signal Transduction in Diabetes Pathogenesis and The
   Soham and Shaila Ajmera Family Chair in Molecular Diabetes Research.
   T.S. was supported by the Canadian Diabetes Association Doctoral
   Research Award, the Canadian Institute of Health Research Doctoral
   Research Award, the Banting and Best Diabetes Centre Novo Nordisk
   Studentship and the Canadian Liver Foundation Graduate Studentship. J.C.
   was supported by the Institute of Medical Science Summer Undergraduate
   Research Program.
CR Aguirre GA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0762-z
   Andreassen M, 2009, EUR J ENDOCRINOL, V160, P25, DOI 10.1530/EJE-08-0452
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   BRISMAR K, 1994, J CLIN ENDOCR METAB, V79, P872, DOI 10.1210/jc.79.3.872
   Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2
   Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x
   Che WY, 2002, CIRC RES, V90, P1222, DOI 10.1161/01.RES.0000021127.83364.7D
   CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395
   Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002
   Du T, 2017, NUTR METAB CARDIOVAS, V27, P63, DOI 10.1016/j.numecd.2016.10.004
   Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15
   Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847
   Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424
   García-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1
   González B, 2001, ENDOCRINOLOGY, V142, P4852, DOI 10.1210/en.142.11.4852
   Gormsen LC, 2012, EUR J ENDOCRINOL, V167, P543, DOI 10.1530/EJE-12-0422
   Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135
   Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Higashi Y, 2016, CIRCULATION, V133, P2263, DOI 10.1161/CIRCULATIONAHA.116.021805
   Hirai H, 2011, LIFE SCI, V88, P425, DOI 10.1016/j.lfs.2010.12.021
   HOCHBERG Z, 1992, ENDOCRINOLOGY, V131, P430, DOI 10.1210/en.131.1.430
   Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290
   Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364
   Isenovic ER, 2003, METABOLISM, V52, P482, DOI 10.1053/meta.2003.50079
   Kassem M, 1996, J BONE MINER RES, V11, P193
   Kavanagh K, 2009, ARTERIOSCL THROM VAS, V29, P1471, DOI 10.1161/ATVBAHA.109.191825
   Kawachi S, 2005, ARTERIOSCL THROM VAS, V25, P617, DOI 10.1161/01.ATV.0000154486.03017.35
   Kramer PR, 2004, ARTHRITIS RHEUM, V50, P1967, DOI 10.1002/art.20309
   Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB
   Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360
   Marino JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048643
   Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045
   Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062
   Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173
   Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196
   Nishizawa H, 2012, BIOCHEM BIOPH RES CO, V423, P295, DOI 10.1016/j.bbrc.2012.05.115
   Pradhan AD, 2014, CLIN CHEM, V60, P44, DOI 10.1373/clinchem.2013.202549
   Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963
   Renier G, 1996, ENDOCRINOLOGY, V137, P4611, DOI 10.1210/en.137.11.4611
   Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108
   Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9
   Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931
   Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831
   Shen W, 2003, OBES RES, V11, P5, DOI 10.1038/oby.2003.3
   Shi SY, 2014, DIABETOLOGIA, V57, P1016, DOI 10.1007/s00125-014-3185-0
   Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59
   Shlipak MG, 2008, AM J MED, V121, P50, DOI 10.1016/j.amjmed.2007.06.030
   Sidhom S, 2021, J GERONTOL A-BIOL, V76, P778, DOI 10.1093/gerona/glaa215
   Sivasubramaniyam T, 2021, HEPATIC LGF1 DEFICIE, DOI [10.6084/m9, DOI 10.6084/M9]
   Sivasubramaniyam T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93735
   Sjögren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539
   Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211
   Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4
   Succurro E, 2010, EUR J ENDOCRINOL, V163, P75, DOI 10.1530/EJE-10-0113
   Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257
   Toniolo A, 2015, J CLIN ENDOCR METAB, V100, pE50, DOI 10.1210/jc.2014-2751
   Venegas-Pino DE, 2013, JOVE-J VIS EXP, DOI 10.3791/50933
   Vestergaard PF, 2014, EUR J ENDOCRINOL, V170, P229, DOI 10.1530/EJE-13-0661
   Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109
   von der Thüsen JH, 2011, AM J PATHOL, V178, P924, DOI 10.1016/j.ajpath.2010.10.007
   Wagner JD, 1997, ARTERIOSCL THROM VAS, V17, P1128, DOI 10.1161/01.ATV.17.6.1128
   Wang LY, 2014, NAT MED, V20, P488, DOI 10.1038/nm.3527
   Wang LL, 2016, J LIPID RES, V57, P1243, DOI 10.1194/jlr.M067397
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Wong JH, 2008, J CLIN INVEST, V118, P2969, DOI 10.1172/JCI34957
   Yahagi K, 2015, ATHEROSCLEROSIS, V239, P260, DOI 10.1016/j.atherosclerosis.2015.01.017
   Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110
   Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096
NR 73
TC 2
Z9 2
U1 1
U2 5
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAY
PY 2021
VL 162
IS 5
AR bgab040
DI 10.1210/endocr/bgab040
PG 18
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA SK8VT
UT WOS:000656498200005
PM 33647942
DA 2024-02-19
ER

PT J
AU Chen, YZ
   Huang, YX
   Huang, RF
   Chen, ZX
   Wang, XZ
   Chen, FL
   Huang, YH
AF Chen, Yizhen
   Huang, Yixuan
   Huang, Rongfeng
   Chen, Zhixin
   Wang, Xiaozhong
   Chen, Fenglin
   Huang, Yuehong
TI Interleukin-10 gene intervention ameliorates liver fibrosis by enhancing
   the immune function of natural killer cells in liver tissue
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Interleukin-10; Gene treatment; Natural killer cells; Immunological
   surveillance; Liver fibrosis
ID HEPATIC STELLATE CELL; NK-CELL; SENESCENCE
AB Background and aims: Interleukin 10 (IL-10) and natural killer (NK) cells have the potential to combat liver fibrosis. However, whether NK cells play an important role in the anti-fibrotic effects of IL-10 is not sufficiently elucidated. In this study, we investigated the regulatory effects of IL-10 on NK cells during liver fibrosis.Methods: Fibrotic mice induced with carbon tetrachloride were treated with or without IL-10 in the presence or absence of NK cells. Liver damage and fibrosis were assessed using hematoxylin and eosin and Sirius Red staining and serum transaminase and liver hydroxyproline assays, respectively. NK cell distribution, quantity, activation, cytotoxicity, development, and origin were analyzed using immunohistochemistry, immunofluorescence, and flow cytometry. Enzyme-linked immunosorbent assay was used to determine chemokine levels.Results: In the presence of NK cells, IL-10 gene intervention improved liver fibrosis and enhanced NK cell accumulation and function in the liver, as evidenced by increased NKG2D, interferon-gamma, and CD107a expression. Furthermore, IL-10 promoted the migration of circulating NK cells to the fibrotic liver and elevated C-C motif ligand 5 levels. However, depletion of NK cells exacerbated liver fibrosis and impaired the anti-fibrotic effect of IL-10.Conclusions: The anti-fibrotic effect of IL-10 relies on the enhancement of NK cell immune function, including activation, cytotoxicity, development, and migration. These results provide valuable insights into the mechanisms through which IL-10 regulates NK cells to limit the progression of liver fibrosis.
C1 [Huang, Yuehong] Fujian Med Univ, Dept Gastroenterol, Union Hosp, Fuzhou 350001, Fujian, Peoples R China.
   Fujian Clin Med Res Ctr Heart & Macrovasc Dis, Fuzhou 350001, Fujian, Peoples R China.
C3 Fujian Medical University
RP Huang, YH (corresponding author), Fujian Med Univ, Dept Gastroenterol, Union Hosp, Fuzhou 350001, Fujian, Peoples R China.
EM chenyizhen1998@foxmail.com; 1308833535@qq.com; dr_hrf@sina.com;
   czx8482@sina.com; drwangxz@163.com; drchenflxiehe@163.com;
   huangyh0391@fjmu.edu.cn
FU Joint Funds for the Innovation of Science and Technology, Fujian
   Province [2019Y9064, 2020Y9093]; Natural Science Foundation of Fujian
   Province [2021J01768, 2022J01715]; Construction Project of Fujian
   Province Minimally Invasive Medical Center [2021-76]; National Key
   Clinical Specialty Construction Projects of Fujian Province, China
   [2023-1594]
FX This work was supported by the Joint Funds for the Innovation of Science
   and Technology, Fujian Province (grant numbers: 2019Y9064, 2020Y9093) ,
   Natural Science Foundation of Fujian Province (grant numbers: 2021J01768
   and 2022J01715) , Construction Project of Fujian Province Minimally
   Invasive Medical Center (grant number: 2021-76) , and National Key
   Clinical Specialty Construction Projects of Fujian Province, China
   (grant number: 2023-1594) .
CR Baghaei K, 2022, DRUG DISCOV TODAY, V27, P1044, DOI 10.1016/j.drudis.2021.12.012
   Bi JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01999
   Chang CM, 2021, TZU CHI MED J, V33, P203, DOI 10.4103/tcmj.tcmj_162_20
   Chen DM, 2022, EXP BIOL MED, V247, P832, DOI 10.1177/15353702221080435
   Choi WM, 2021, HEPATOLOGY, V74, P2170, DOI 10.1002/hep.31875
   Crinier A, 2020, CELL, V180, P1280, DOI 10.1016/j.cell.2020.02.029
   Duriancik DM, 2018, NUTR RES, V55, P81, DOI 10.1016/j.nutres.2018.04.009
   Fisher BS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006871
   Gao JH, 2021, HEPATOLOGY, V73, P2468, DOI 10.1002/hep.31617
   Ginès P, 2022, HEPATOLOGY, V75, P219, DOI 10.1002/hep.32163
   Guo QL, 2021, EXP BIOL MED, V246, P447, DOI 10.1177/1535370220960391
   Nga HT, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.672658
   Hatfield SD, 2018, VIROLOGY, V519, P131, DOI 10.1016/j.virol.2018.04.012
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Huang YH, 2018, MOL MED REP, V17, P5700, DOI 10.3892/mmr.2018.8592
   Jangra A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11091500
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Kamm DR, 2022, J PHYSIOL-LONDON, V600, P1825, DOI 10.1113/JP281061
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Koda Y, 2022, SEMIN LIVER DIS, V42, P475, DOI 10.1055/a-1957-6384
   Korbecki J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207619
   Li F, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000131
   Li WH, 2020, SCI CHINA LIFE SCI, V63, P1725, DOI 10.1007/s11427-019-1665-1
   Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262
   Millan AJ, 2021, J IMMUNOL, V206, P1215, DOI 10.4049/jimmunol.2000613
   Mirzaee V, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.12458
   Mollazadeh H, 2019, CRIT REV FOOD SCI, V59, P89, DOI 10.1080/10408398.2017.1358139
   Ni YH, 2022, METABOLISM, V136, DOI 10.1016/j.metabol.2022.155272
   Oh HR, 2023, BIOMEDICINES, V11, DOI 10.3390/biomedicines11041090
   Pinhas N, 2016, EUR J IMMUNOL, V46, P1258, DOI 10.1002/eji.201545847
   Ridiandries A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103217
   Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4
   Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006
   Sepulveda-Crespo D, 2021, DRUGS, V81, P419, DOI 10.1007/s40265-020-01458-x
   Shih LJ, 2023, VIRULENCE, V14, DOI 10.1080/21505594.2023.2190650
   Steen EH, 2020, ADV WOUND CARE, V9, P184, DOI 10.1089/wound.2019.1032
   Sung CC, 2021, CELL MOL IMMUNOL, V18, P1772, DOI 10.1038/s41423-020-0376-0
   Tan SY, 2020, CANCER RES, V80, P1130, DOI 10.1158/0008-5472.CAN-19-2332
   Tao XX, 2022, J EXP MED, V219, DOI 10.1084/jem.20212414
   Wang L, 2020, HUM CELL, V33, P582, DOI 10.1007/s13577-020-00371-5
   Wang XT, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028548
   Wang ZX, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.619195
   Xia SL, 2023, J CONTROL RELEASE, V355, P54, DOI 10.1016/j.jconrel.2023.01.052
   Xu L, 2021, METABOLISM, V125, DOI 10.1016/j.metabol.2021.154914
   Yuan W, 2022, EXP BIOL MED, V247, P1235, DOI 10.1177/15353702221092672
   Zhang Y, 2022, MOL MED REP, V25, DOI 10.3892/mmr.2022.12724
   Zhao XA, 2021, TURK J GASTROENTEROL, V32, P76, DOI 10.5152/tjg.2020.19566
NR 47
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD JAN 25
PY 2024
VL 127
AR 111341
DI 10.1016/j.intimp.2023.111341
EA DEC 2023
PG 9
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA EA5O4
UT WOS:001136196700001
PM 38081103
OA hybrid
DA 2024-02-19
ER

PT J
AU Hernández-Corbacho, MJ
   Jenkins, RW
   Clarke, CJ
   Hannun, YA
   Obeid, LM
   Snider, AJ
   Siskind, LJ
AF Hernandez-Corbacho, Maria Jose
   Jenkins, Russell W.
   Clarke, Christopher J.
   Hannun, Yusuf A.
   Obeid, Lina M.
   Snider, Ashley J.
   Siskind, Leah J.
TI Accumulation of Long-Chain Glycosphingolipids during Aging Is Prevented
   by Caloric Restriction
SO PLOS ONE
LA English
DT Article
ID RENAL-CELL CARCINOMA; MEMBRANE-ASSOCIATED SIALIDASE; OXIDATIVE STRESS;
   INSULIN SENSITIVITY; RAT-KIDNEY; T-CELLS; NUTRITIONAL INFLUENCES;
   DIABETIC-NEPHROPATHY; ALZHEIMERS-DISEASE; FISCHER-344 RATS
AB Background: Chronic kidney disease and end-stage renal disease are major causes of morbidity and mortality that are seen far more commonly in the aged population. Interestingly, kidney function declines during aging even in the absence of underlying renal disease. Declining renal function has been associated with age-related cellular damage and dysfunction with reports of increased levels of apoptosis, necrosis, and inflammation in the aged kidney. Bioactive sphingolipids have been shown to regulate these same cellular processes, and have also been suggested to play a role in aging and cellular senescence.
   Methodology/Principal Findings: We hypothesized that alterations in kidney sphingolipids play a role in the declining kidney function that occurs during aging. To begin to address this, the sphingolipid profile was measured in young (3 mo), middle aged (9 mo) and old (17 mo) C57BL/6 male mice. Interestingly, while modest changes in ceramides and sphingoid bases were evident in kidneys from older mice, the most dramatic elevations were seen in long-chain hexosylceramides (HexCer) and lactosylceramides (LacCer), with C14-and C16-lactosylceramides elevated as much as 8 and 12-fold, respectively. Increases in long-chain LacCers during aging are not exclusive to the kidney, as they also occur in the liver and brain. Importantly, caloric restriction, previously shown to prevent the declining kidney function seen in aging, inhibits accumulation of long-chain HexCer/LacCers and prevents the age-associated elevation of enzymes involved in their synthesis. Additionally, long-chain LacCers are also significantly elevated in human fibroblasts isolated from elderly individuals.
   Conclusion/Significance: This study demonstrates accumulation of the glycosphingolipids HexCer and LacCer in several different organs in rodents and humans during aging. In addition, data demonstrate that HexCer and LacCer metabolism is regulated by caloric restriction. Taken together, data suggest that HexCer/LacCers are important mediators of cellular processes fundamental to mammalian aging.
C1 [Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Snider, Ashley J.; Siskind, Leah J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.
   [Jenkins, Russell W.; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.
   [Obeid, Lina M.; Snider, Ashley J.; Siskind, Leah J.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA.
C3 Medical University of South Carolina; Medical University of South
   Carolina; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Ralph H Johnson VA Medical Center
RP Hernández-Corbacho, MJ (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.
EM siskind@musc.edu
OI obeid, lina/0000-0002-0734-0847; Siskind, Leah/0000-0001-5026-5187
FU VA Merit; VA; VA REAP; American Cancer Society [IRG-97-219-11]; NIH/NCRR
   [P30 CA138313, P20 RR17677]; American Heart Association [AHA 081509E];
   NIH [GM08716, GM-43825]; MUSC Hollings Cancer Center Abney Foundation;
   NIH/NIA [R01 AG016583]
FX This work is supported by: VA Merit (to L.M.O.), VA CDA-2 Awards (to
   L.J.S. and A.J.S.), pilot project from the VA REAP (to L.J.S., A.J.S.,
   and L.M.O.), the American Cancer Society Institutional Research Grant #
   IRG-97-219-11 (subaward to L.J.S.), Lipidomics Shared Resource of the
   Hollings Cancer Center supported by a Cancer Center Support Grant (P30
   CA138313), pilot project (to L.J.S) from the NIH/NCRR P20 RR17677 COBRE
   in Lipidomics and Pathobiology, American Heart Association Pre-Doctoral
   Fellowship (AHA 081509E - to R.W.J.), NIH MSTP Training Grant (GM08716 -
   to R.W.J.), MUSC Hollings Cancer Center Abney Foundation Scholarship (to
   R.W.J.), and NIH/NIA R01 AG016583 (L.M.O.) and NIH GM-43825 (YAH). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619
   Alessenko AV, 2004, BIOCHEM SOC T, V32, P144, DOI 10.1042/BST0320144
   Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004
   Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250
   Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259
   Breunig F, 2008, J NEPHROL, V21, P32
   CADENAS S, 1994, EXP GERONTOL, V29, P77, DOI 10.1016/0531-5565(94)90064-7
   Chatteriee S, 2008, BBA-GEN SUBJECTS, V1780, P370, DOI 10.1016/j.bbagen.2007.08.010
   Chatterjee S, 2003, METHOD ENZYMOL, V363, P300
   Chatterjee S, 1996, J LIPID RES, V37, P1334
   Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018
   Covington MD, 2009, AM J PHYSIOL-RENAL, V296, pF478, DOI 10.1152/ajprenal.90477.2008
   Csiszar A, 2007, ACTA PHYSIOL HUNG, V94, P107, DOI 10.1556/APhysiol.94.2007.1-2.10
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037
   Dave GS, 2007, CELL MOL BIOL, V53, P68, DOI 10.1170/T820
   Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007
   DMELLO NP, 1994, J BIOL CHEM, V269, P15451
   Fernandez-Checa Jose C, 2003, Ann Hepatol, V2, P69
   Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057
   García-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010
   GIUSTO NM, 1992, LIPIDS, V27, P835, DOI 10.1007/BF02535859
   Gredilla R, 2004, ANN NY ACAD SCI, V1019, P333, DOI 10.1196/annals.1297.057
   GRONE EF, 1994, ATHEROSCLEROSIS, V107, P1, DOI 10.1016/0021-9150(94)90136-8
   Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   GUPTA G, FEBS LETT, V584, P1634
   Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x
   HAMMAD SM, J LIPID RES, V51, P3074
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Hedlund M, 1998, MOL MICROBIOL, V29, P1297, DOI 10.1046/j.1365-2958.1998.01017.x
   Huwiler A, 2001, BIOCHEM BIOPH RES CO, V284, P404, DOI 10.1006/bbrc.2001.4941
   Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701
   Jung JU, 2009, EXP MOL MED, V41, P935, DOI 10.3858/emm.2009.41.12.099
   Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu B, 2000, METHOD ENZYMOL, V311, P156
   Lochhead KM, 1998, KIDNEY INT, V54, P373, DOI 10.1046/j.1523-1755.1998.00022.x
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Martin SF, 2006, GLYCOCONJUGATE J, V23, P147, DOI 10.1007/s10719-006-7920-8
   Maruyama R, 2007, ANTICANCER RES, V27, P4345
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   MATHER AR, 2011, LANDES BIOS IN PRESS
   Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002
   Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016
   Mühlberg W, 1999, GERONTOLOGY, V45, P243, DOI 10.1159/000022097
   NATOLI TA, NAT MED
   Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18
   Ogiso M, 1999, EXP EYE RES, V68, P229, DOI 10.1006/exer.1998.0598
   Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104
   Ravussin E, 2007, Journ Annu Diabetol Hotel Dieu, P111
   Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001
   Razzaque MS, 1998, CELL TISSUE RES, V293, P471, DOI 10.1007/s004410051139
   Ruiz-Torres MP, 1998, J AM SOC NEPHROL, V9, P782
   Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200
   Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776
   Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Senda M, 2007, BIOCHEM J, V402, P459, DOI 10.1042/BJ20061118
   Sessa A, 2001, J INHERIT METAB DIS, V24, P66, DOI 10.1023/A:1012423924648
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121
   Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200
   Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002
   Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894
   Thornton MV, 2004, J IMMUNOL, V172, P3480, DOI 10.4049/jimmunol.172.6.3480
   Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200
   van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Vogtländer NPJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005979
   VOGTLANDER NP, NEPHROL DIAL TRANSPL, V25, P478
   WENNEKES T, J MED CHEM, V53, P689
   Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620
   Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100
   YANG Q, CELL MOL LIFE SCI, V67, P1477
   YEW NS, PLOS ONE, V5
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   ZADOR IZ, 1993, J CLIN INVEST, V91, P797, DOI 10.1172/JCI116299
   Zager RA, 1998, J AM SOC NEPHROL, V9, P1670
   Zager RA, 1998, KIDNEY INT, V53, P573, DOI 10.1046/j.1523-1755.1998.00772.x
   Zager RA, 1997, KIDNEY INT, V52, P60, DOI 10.1038/ki.1997.304
   Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5
   Zhang XB, 2004, ANN CLIN LAB SCI, V34, P3
   Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719
NR 88
TC 35
Z9 41
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2011
VL 6
IS 6
AR e20411
DI 10.1371/journal.pone.0020411
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 777JJ
UT WOS:000291611500023
PM 21687659
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU BITTLES, AH
AF BITTLES, AH
TI EVIDENCE FOR AND AGAINST THE CAUSAL INVOLVEMENT OF MITOCHONDRIAL-DNA
   MUTATION IN MAMMALIAN AGING
SO MUTATION RESEARCH
LA English
DT Article
DE MAMMALIAN AGING; MITOCHONDRIAL DNA; GENOME MUTATION; FREE RADICALS;
   MEMBRANE DAMAGE
ID HUMAN-DIPLOID FIBROBLASTS; RAT-LIVER MITOCHONDRIA; DEGENERATIVE
   DISEASES; DEPENDENT CHANGES; SKIN FIBROBLASTS; SKELETAL-MUSCLE;
   SENESCENT RAT; INVITRO; DECLINE; TISSUES
AB Current experimental evidence on the role of mitochondrial DNA mutation in ageing is assessed alongside reports implicating other genetic and non-genetic causes, including inter-relationships between the mitochondrial and nuclear genomes and their potential effect on mitochondrial structure and function. The role of a 5-kb mtDNA deletion, identified as age-dependent in a variety of human and other mammalian species, is specifically evaluated in the context of its functional effect in mitotic and non-mitotic adult tissue. Downstream effects of mitochondrial decline are considered in terms of the maintenance of ATP production. Associated sequelae then are discussed specifically with reference to restrictions in the supply of ribose moieties for DNA and RNA synthesis, and to disruption of NADPH production and hence cellular anti-oxidant defences.
RP BITTLES, AH (corresponding author), UNIV LONDON KINGS COLL,DIV BIOMED SCI,ANAT & HUMAN BIOL GRP,STRAND,LONDON WC2R 2LS,ENGLAND.
OI Bittles, Alan/0000-0002-8176-2730
CR ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157
   ADENUGA GA, 1989, HORM METAB RES, V21, P309, DOI 10.1055/s-2007-1009222
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1981, TRENDS BIOCHEM SCI, V6, P100, DOI 10.1016/0968-0004(81)90037-2
   BAILEY PJ, 1984, MECH AGEING DEV, V24, P233, DOI 10.1016/0047-6374(84)90074-5
   BELL E, 1978, SCIENCE, V202, P1158, DOI 10.1126/science.725592
   BENDER MA, 1989, MUTAT RES, V212, P149, DOI 10.1016/0027-5107(89)90065-1
   Beregi E, 1983, Aktuelle Gerontol, V13, P226
   BEREGI E, 1986, DIMENSIONS AGEING, P35
   BIRKY CW, 1983, SCIENCE, V222, P468, DOI 10.1126/science.6353578
   BITTLES AH, 1984, BIOSCIENCE REP, V4, P751, DOI 10.1007/BF01128816
   BITTLES AH, 1988, GERONTOLOGY, V34, P236, DOI 10.1159/000212961
   BITTLES AH, 1991, PSYCHIATRY ELDERLY, P3
   BITTLES AH, 1989, HUMAN AGEING LATER L, P29
   BOGENHAGEN D, 1974, J BIOL CHEM, V251, P2938
   CATANIA J, 1991, MUTAT RES, V256, P283, DOI 10.1016/0921-8734(91)90019-8
   CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430
   CLANDININ MT, 1983, MECH AGEING DEV, V22, P205, DOI 10.1016/0047-6374(83)90076-3
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORBISIER P, 1990, MECH AGEING DEV, V51, P249, DOI 10.1016/0047-6374(90)90075-Q
   CORBISIER P, 1990, EUR J CELL BIOL, V51, P173
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DESHMUKH DR, 1982, MECH AGEING DEV, V20, P343, DOI 10.1016/0047-6374(82)90101-4
   FERNANDEZSILVA P, 1991, BIOCHEM BIOPH RES CO, V176, P645, DOI 10.1016/S0006-291X(05)80233-5
   FLANNERY GR, 1989, ANN HUM BIOL, V16, P259, DOI 10.1080/03014468900000372
   FLEMING JE, 1986, MECH AGEING DEV, V34, P63, DOI 10.1016/0047-6374(86)90105-3
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GOLDSTEIN S, 1981, J CELL BIOL, V91, P392, DOI 10.1083/jcb.91.2.392
   GUTTERIDGE JMC, 1986, FREE RADICALS AGING, V8, P99
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HARPER N, 1987, BIOCHEM SOC T, V15, P1176, DOI 10.1042/bst0151176
   HART R W, 1987, P15
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   HORTON AA, 1981, MECH AGEING DEV, V17, P253, DOI 10.1016/0047-6374(81)90062-2
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   JONGKIND JF, 1987, GERONTOLOGY, V33, P281, DOI 10.1159/000212891
   KIESSLING KH, 1973, CLIN SCI, V44, P547, DOI 10.1042/cs0440547
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255
   LEPRAT P, 1990, MECH AGEING DEV, V52, P149, DOI 10.1016/0047-6374(90)90121-U
   LEWIN MB, 1984, MECH AGEING DEV, V24, P343, DOI 10.1016/0047-6374(84)90119-2
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MARCUS DL, 1982, EXP GERONTOL, V17, P333, DOI 10.1016/0531-5565(82)90033-X
   MARTINEZ AO, 1986, EXP CELL RES, V164, P551, DOI 10.1016/0014-4827(86)90053-4
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   MERTENSSTRIJTHAGEN J, 1989, ARCH BIOCHEM BIOPHYS, V274, P37, DOI 10.1016/0003-9861(89)90412-8
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MURRAY MA, 1982, MECH AGEING DEV, V20, P233, DOI 10.1016/0047-6374(82)90090-2
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   PARADIES G, 1992, IN PRESS BIOCH BIOPH
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PETERSON C, 1986, P NATL ACAD SCI USA, V83, P2758, DOI 10.1073/pnas.83.8.2758
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   POOT M, 1991, MUTAT RES, V256, P177, DOI 10.1016/0921-8734(91)90010-9
   PUVIONDUTILLEUL F, 1982, MECH AGEING DEV, V20, P75, DOI 10.1016/0047-6374(82)90076-8
   REIS RJS, 1983, J BIOL CHEM, V258, P9078
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   RUGOLO M, 1987, J BIOENERG BIOMEMBR, V19, P705, DOI 10.1007/BF00762304
   SATO T, 1982, MECH AGEING DEV, V20, P111, DOI 10.1016/0047-6374(82)90063-X
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SLAGBOOM PE, 1991, MUTAT RES, V256, P311, DOI 10.1016/0921-8734(91)90022-4
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0
   TAUCHI H, 1985, THRESHOLDS AGEING, P91
   TRIBE MA, 1972, J CELL SCI, V10, P443
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.biochem.55.1.249
   TZAGOLOFF A, 1982, MITOCHONDRIA, P132
   VAILLANT F, 1991, BIOCHEM INT, V23, P571
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 86
TC 18
Z9 19
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD SEP
PY 1992
VL 275
IS 3-6
BP 217
EP 225
DI 10.1016/0921-8734(92)90025-K
PG 9
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA JV302
UT WOS:A1992JV30200011
PM 1383763
DA 2024-02-19
ER

PT J
AU Takahashi, K
   Yanai, S
   Shimokado, K
   Ishigami, A
AF Takahashi, Keita
   Yanai, Shuichi
   Shimokado, Kentaro
   Ishigami, Akihito
TI Coffee consumption in aged mice increases energy production and
   decreases hepatic mTOR levels
SO NUTRITION
LA English
DT Article
DE Aging; Coffee; Decaffeinated coffee; Energy metabolism; Lipid
   metabolism; mTOR
ID LIPID-METABOLISM; GENE-EXPRESSION; AMPK ACTIVATION; CAFFEINE INTAKE;
   LIFE-SPAN; DISEASE; ACID; RISK; CHOLESTEROL; RAPAMYCIN
AB Objective: Coffee, one of the world's most consumed beverages, has many benefits. Some studies have reported the effects of coffee on aging. The aim of this study was to investigate the locomotor activity, energy metabolism, and lipid metabolism of aged (20-mo-old) mice given coffee.
   Methods: Aged C57 BL/6 NCr mice were divided into three groups: controls that were not given coffee (n = 9), a group that received 0.1% caffeinated coffee (n = 9), and a group that received 0.1% decaffeinated coffee (n = 9). This regimen continued for 17 wk until mice reached the age of 24 mo.
   Results: Regular and decaffeinated coffee consumption decreased plasma-free fatty acid levels, increased hepatic adenosine triphosphate content, and decreased total mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) protein content in the liver. However, no differences were found in the protein or activity levels of Akt, adenosine monophosphate-activated protein kinase (AMPK), p70 S6 kinase, or sterol regulatory element-binding protein 1, proteins that are upstream or downstream of the mTOR complex 1 (mTORC1)-related pathways. Regular coffee consumption increased food and water intake, locomotor activity, the volume of carbon dioxide production, and the respiration exchange ratio.
   Conclusion: Regular and decaffeinated coffee consumption decreased hepatic total mTOR and p-mTOR levels independently of Akt and AMPK pathways in aged mice. Because decreased mTORC1 activity is known to have antiaging effects, coffee consumption during old age may retard aging. Moreover, coffee consumption by the aged population had a positive effect on behavioral energy and lipid metabolism. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Takahashi, Keita; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.
   [Takahashi, Keita; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Tokyo, Japan.
   [Yanai, Shuichi] Tokyo Metropolitan Inst Gerontol, Aging Neurosci Res Team, Tokyo, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU); Tokyo Metropolitan Institute of Gerontology
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.
EM Ishigami@tmig.or.jp
OI Ishigami, Akihito/0000-0001-7875-7482; Yanai,
   Shuichi/0000-0002-4604-5525
FU All Japan Coffee Association (AJCA); Japan Society for the Promotion of
   Science (JSPS) KAKENHI [15 H04505, 15 K15104]
FX This study was supported by a research grant from the All Japan Coffee
   Association (AJCA) and the Japan Society for the Promotion of Science
   (JSPS) KAKENHI Grant Numbers 15 H04505 and 15 K15104 (AI). KT and Al
   were involved with the study concept and design. KT, SY, KS, and Al were
   involved with the acquisition of data, analysis and interpretation of
   data, provided critical revision of the manuscript for important
   intellectual content, as well as administrative, technical, and material
   support; and study supervision KT and Al drafted the manuscript and
   provided statistical analysis. AI obtained funding.
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125
   Cao CH, 2009, J ALZHEIMERS DIS, V17, P681, DOI 10.3233/JAD-2009-1071
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chotechuang N, 2009, AM J PHYSIOL-ENDOC M, V297, pE1313, DOI 10.1152/ajpendo.91000.2008
   Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding WX, 2014, HEPATOLOGY, V59, P1235, DOI 10.1002/hep.26736
   Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Grabacka M, 2013, CURR PHARM BIOTECHNO, V14, P342, DOI 10.2174/1389201011314030009
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Iwama M, 2012, J NUTR SCI VITAMINOL, V58, P169, DOI 10.3177/jnsv.58.169
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kandasamy AD, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.18
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004
   Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010
   Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080
   Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509
   Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273
   Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200
   Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   SHIMIZU S, 1979, BIOCHEM BIOPH RES CO, V91, P108, DOI 10.1016/0006-291X(79)90589-8
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Solfrizzi V, 2015, J ALZHEIMERS DIS, V47, P889, DOI 10.3233/JAD-150333
   SPAYD RW, 1978, CLIN CHEM, V24, P1343
   Takahashi K, 2014, BBA-GEN SUBJECTS, V1840, P2289, DOI 10.1016/j.bbagen.2014.03.019
   TAKAYAMA M, 1977, Clinica Chimica Acta, V79, P93
   Uto-Kondo H, 2010, CIRC RES, V106, P779, DOI 10.1161/CIRCRESAHA.109.206615
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
NR 46
TC 12
Z9 12
U1 0
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUN
PY 2017
VL 38
BP 1
EP 8
DI 10.1016/j.nut.2016.12.021
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EW1BD
UT WOS:000402224000003
PM 28526373
DA 2024-02-19
ER

PT J
AU BIAGI, PL
   BORDONI, A
   HRELIA, S
   CELADON, M
   HORROBIN, DF
AF BIAGI, PL
   BORDONI, A
   HRELIA, S
   CELADON, M
   HORROBIN, DF
TI GAMMA-LINOLENIC ACID DIETARY SUPPLEMENTATION CAN REVERSE THE AGING
   INFLUENCE ON RAT-LIVER MICROSOME DELTA-6-DESATURASE ACTIVITY
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE ESSENTIAL FATTY ACID; DESATURATION; EVENING PRIMROSE OIL; AGING; (RAT
   LIVER MICROSOME)
ID FATTY-ACIDS; METABOLISM; LIPIDS; BLOOD
AB We have recently demonstrated that in rats the process of DELTA-6-desaturation of linoleic and alpha-linolenic acids slows with aging.  One method of counteracting the effect of slowed desaturation of linoleic acid would be to provide the 6-desaturated metabolite, gamma-linolenic acid (18:3(n - 6) GLA) directly.  We have here investigated the 6-desaturation of both linoleic and alpha-linolenic acids in liver microsomes of young and old rats given GLA in the form of evening primrose oil (EPO) (B diet) in comparison to animals given soy bean oil alone (A diet), monitoring also the fatty acid composition of liver microsomes and relating this to the microviscosity of the membranes.  In young rats the different experimental diets did not produce any difference in DELTA-6-desaturase (D6D) activity on either substrate suggesting that, when D6D activity is at or near its peak, the variations in diet tested are unable to influence it.  In the old animals the rate of 6-desaturation of linoleic and particularly of alpha-linolenic acid was significantly greater in the B diet fed animals than in the A diet fed.  The effects of the diets on the fatty acid composition of liver microsomes were consistent with the findings with regard to 6-desaturation.  Administration of GLA partially corrected the abnormalities of n - 6 essential fatty acid (EFA) metabolism by raising the concentration of 20:4(n - 6) and other 6-desaturated EFAs.  Furthermore, the GLA rich diet also increased the levels of dihomo-gamma-linolenic acid and of 6-desaturated n - 3 EFAs in the liver microsomes.  The microviscosity of microsomal membranes as indicated by DPH polarization was correlated with the unsaturation index of the same membranes.  There was a very strong correlation between the two.  In both young and old rats the B diet reduced the microviscosity and increased the unsaturation index.  However, the effect was much greater in the old animals.
C1 EFAMOL RES CTR,GUILDFORD,ENGLAND.
RP BIAGI, PL (corresponding author), UNIV BOLOGNA,CTR RIC NUTR,DIPARTIMENTO BIOCHIM,VIA IRNERIO,48,I-40126 BOLOGNA,ITALY.
RI Hrelia, Silvana/P-2864-2015; Bordoni, Alessandra/J-3047-2012
OI Hrelia, Silvana/0000-0001-7857-4512; Bordoni,
   Alessandra/0000-0003-4579-1662
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BAUER EL, 1960, STATISTICAL MANUAL C, P39
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   CHOI YS, 1988, ANN NUTR METAB, V32, P169, DOI 10.1159/000177430
   DARCET P, 1980, ANN NUTR ALIMENT, V34, P277
   DAVIDSON B, 1988, EUR J PHARMACOL, V149, P317, DOI 10.1016/0014-2999(88)90662-0
   DUMM INTD, 1984, LIPIDS, V19, P91, DOI 10.1007/BF02534497
   DUTTAROY AK, 1990, OMEGA 6 ESSENTIAL FA
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5
   HORROBIN DF, 1989, PROSTAG LEUKOTR ESS, V37, P255, DOI 10.1016/0952-3278(89)90036-7
   HOY CE, 1983, LIPIDS, V18, P760, DOI 10.1007/BF02534633
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   HRELIA S, 1986, BIOCHEM INT, V12, P741
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   PELUFFO R O, 1970, American Journal of Physiology, V218, P669
   SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8
   SIMPSON LO, 1984, P U OTAGO MED SCH, V62, P122
   SIMPSON LO, 1988, MUSCLE NERVE, V11, P725, DOI 10.1002/mus.880110709
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
   VERICEL E, 1987, NUTR RES, V7, P569, DOI 10.1016/S0271-5317(87)80050-7
   ZANNONI C, 1901, MOL PHYS, V42, P1303
NR 22
TC 59
Z9 62
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD MAY 8
PY 1991
VL 1083
IS 2
BP 187
EP 192
DI 10.1016/0005-2760(91)90041-F
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FP591
UT WOS:A1991FP59100010
PM 1674661
DA 2024-02-19
ER

PT J
AU Zahn, RK
   Zahn-Daimler, G
   Ax, S
   Hosokawa, M
   Takeda, T
AF Zahn, RK
   Zahn-Daimler, G
   Ax, S
   Hosokawa, M
   Takeda, T
TI Assessment of DNA-protein crosslinks in the course of aging in two mouse
   strains by use of a modified alkaline filter elution applied to whole
   tissue samples
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE age dependance in different organs; DNA-protein crosslinks; mouse;
   senescence acceleration
ID SINGLE-STRAND BREAKS; ACCELERATED SENESCENCE; MAMMALIAN-CELLS; MURINE
   MODEL; LIFE-SPAN; DAMAGE; REPAIR; RADIATION; ASSAY; QUANTITATION
AB Two different mouse strains have been used for determination of age dependence of DNA-protein crosslinks by alkaline filter elution: a long lived laboratory strain, NMRI and an accelerated senescence-prone, short lived strain, SAMP1. Five organs were selected: Brain, kidney, lung, heart and liver. Remarkably in all five organs of short lived SAMP1 mice crosslinks increased significantly with age. In NMRI however only in brain and heart a significant rise in old age has been observed, while in the other organs there was no increase in DNA-protein crosslinking. Appreciable mitotic activity which is lacking in brain and heart could be the reason for this difference. Poor repair in all five organs could be an important component for the multiple ailments and shortened life span in SAMP1 mice. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Johannes Gutenberg Univ Mainz, Acad Sci & Literature, Project 3C, D-55101 Mainz, Germany.
   Johannes Gutenberg Univ Mainz, Inst Physiol Chem, D-55101 Mainz, Germany.
   Kyoto Univ, Chest Dis Res Inst, Dept Senescence Biol, Kyoto 606, Japan.
C3 Kyoto University
RP Zahn, RK (corresponding author), Johannes Gutenberg Univ Mainz, Acad Sci & Literature, Project 3C, D-55101 Mainz, Germany.
CR BIRNBOIM HC, 1981, CANCER RES, V41, P1889
   COOK PR, 1976, NATURE, V263, P679, DOI 10.1038/263679a0
   CUTLER RG, 1976, AGING CARCINOGENESIS, P443
   FREEMAN SE, 1986, ANAL BIOCHEM, V158, P119, DOI 10.1016/0003-2697(86)90599-3
   FRIEDBERG EF, 1995, DNA REPAIR MUTAGENSI, V36, P214
   FUJISAWA H, 1988, J GERONTOL A-BIOL, V53, pB11
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   HEIL J, 1988, WASSER ABWASSER GWF, V129, P398
   HENSON P, 1978, J MOL BIOL, V119, P487, DOI 10.1016/0022-2836(78)90198-5
   HERBERT A, 1989, ANGEW ZOOL, V75, P143
   HERGENROEDER M, 1990, Zeitschrift fuer Angewandte Zoologie, V77, P151
   HOENIG W, 1973, ANAL BIOCHEM, V95, P34
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   Hosokawa M, 1997, EXP GERONTOL, V32, P197, DOI 10.1016/S0531-5565(96)00069-1
   JOHNSON R, 1972, NATURE, V240, P412, DOI 10.1038/240412a0
   JUNGBLUT HD, 1987, CHEM-BIOL INTERACT, V63, P265, DOI 10.1016/0009-2797(87)90046-9
   KANTER PM, 1979, ANAL BIOCHEM, V97, P77, DOI 10.1016/0003-2697(79)90330-0
   KOHN KW, 1976, BIOCHEMISTRY-US, V15, P4629, DOI 10.1021/bi00666a013
   KOHN KW, 1991, PHARMACOL THERAPEUT, V49, P55, DOI 10.1016/0163-7258(91)90022-E
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   LARSEN KH, 1982, MUTAT RES, V98, P287, DOI 10.1016/0165-1110(82)90037-9
   LEHMANN AR, 1970, BIOCHIM BIOPHYS ACTA, V217, P268, DOI 10.1016/0005-2787(70)90526-5
   MATSUMOTO K, 1991, PHOTOCHEM PHOTOBIOL, V54, P389, DOI 10.1111/j.1751-1097.1991.tb02032.x
   MULLAART E, 1990, MUTAT RES, V237, P189, DOI 10.1016/0921-8734(90)90001-8
   NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A
   OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587
   OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X
   PAINTER RB, 1977, NATURE, V265, P650, DOI 10.1038/265650a0
   PAINTER RB, 1969, RADIAT RES, V37, P451, DOI 10.2307/3572686
   PATIERNO SR, 1985, CANCER RES, V45, P5787
   REID TM, 1993, P NATL ACAD SCI USA, V90, P3904, DOI 10.1073/pnas.90.9.3904
   SHARPE PT, 1988, LAB TECHNIQUES BIOCH, V18, P260
   Strehler B. L., 1977, Time, Cells, and Aging, P1
   STREHLER BL, 1979, MECH AGEING DEV, V11, P371, DOI 10.1016/0047-6374(79)90012-5
   STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TSAPAKOS MJ, 1983, CANCER RES, V43, P5662
   WECHEZAK AR, 1994, J CELL PHYSIOL, V159, P83, DOI 10.1002/jcp.1041590112
   WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.1093/biomet/34.1-2.28
   WERNER D, 1980, BIOCHIM BIOPHYS ACTA, V608, P243, DOI 10.1016/0005-2787(80)90170-7
   WHITAKER SJ, 1992, EUR J CANCER, V28A, P273, DOI 10.1016/0959-8049(92)90432-2
   WITTIG B, 1987, THESIS U MAINZ GERMA
   YAMASHIRO S, 1991, BIOESSAYS, V13, P563, DOI 10.1002/bies.950131103
   ZAHN RK, 1987, MECH AGEING DEV, V41, P73, DOI 10.1016/0047-6374(87)90055-8
   Zahn RK, 1996, MECH AGEING DEV, V89, P79, DOI 10.1016/0047-6374(96)01738-1
   ZAHN RK, 1983, SCI TOTAL ENVIRON, V26, P137, DOI 10.1016/0048-9697(83)90107-9
   ZAHN-DAIMLER G, 1975, Science of the Total Environment, V4, P299, DOI 10.1016/0048-9697(75)90007-8
   ZHITKOVICH A, 1992, CARCINOGENESIS, V13, P1485, DOI 10.1093/carcin/13.8.1485
NR 51
TC 16
Z9 24
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 3
PY 1999
VL 108
IS 2
BP 99
EP 112
DI 10.1016/S0047-6374(98)00151-1
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 202RL
UT WOS:000080665900001
PM 10400304
DA 2024-02-19
ER

PT J
AU Zhang, HJ
   Drake, VJ
   Morrison, JP
   Oberley, LW
   Kregel, KC
AF Zhang, HJ
   Drake, VJ
   Morrison, JP
   Oberley, LW
   Kregel, KC
TI Selected contribution: Differential expression of stress-related genes
   with aging and hyperthermia
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE heat stress; DNA array; antioxidant enzymes; stress proteins;
   senescence; DNA microarray; gene regulation
ID CALORIC RESTRICTION; OXIDATIVE STRESS; HEAT-STRESS; DAMAGE; LIVER;
   BIOLOGY; RATS; MITOCHONDRIA; OXIDANTS; DISEASE
AB Aging is associated with a reduced capacity to cope with physiological stress. To study the molecular mechanisms associated with the decline in stress tolerance that accompanies aging, differences in gene expression between young and old Fischer 344 rats under euthermic control conditions or in response to hyperthermic challenge were evaluated using a cDNA array containing 207 stress-related genes. In the non-stressed control condition, aging resulted in selective upregulation of stress protein genes and transcripts involved in cell growth, death, and signaling, along with a downregulation of genes involved in antioxidant defenses and drug metabolism. Heat stress resulted in a broad induction of genes in the antioxidant and drug metabolism categories and transcripts involved in DNA, RNA, and protein synthesis for both age groups. Old animals had a robust upregulation of genes involved in cell growth, death, and signaling after heat challenge, along with a blunted expression of stress-response genes. In contrast, young animals had a strong induction of stress-response genes after hyperthermic challenge. Changes in expression of selected genes were confirmed by RT-PCR analysis. These findings suggest that aging results in altered gene expression in response to heat stress that is indicative of decreased stress protein transcription and increased expression of oxidative stress-related genes. Thus our findings support the postulate that transcriptional changes in response to a physiological challenge such as hyperthermia contribute to the loss of stress tolerance in older organisms.
C1 Univ Iowa, Dept Exercise Sci, Integrat Physiol Lab, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Dept Exercise Sci, Integrat Physiol Lab, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
FU NIA NIH HHS [AG-12350, AG-14687] Funding Source: Medline
CR Adryan B, 1999, BIOTECHNIQUES, V26, P1174, DOI 10.2144/99266bc03
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BLAKE MJ, 1990, J BIOL CHEM, V265, P15275
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   GRANGER DN, 1986, ACTA PHYSIOL SCAND, V126, P47
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232
   Issels R D, 1986, Free Radic Res Commun, V2, P7, DOI 10.3109/10715768609088051
   JANSSEN YMW, 1993, LAB INVEST, V69, P261
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kregel K. C., 1996, J APPL PHYSIOL, V80, P262
   KREGEL KC, 1990, J APPL PHYSIOL, V68, P1337, DOI 10.1152/jappl.1990.68.4.1337
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LEVINE JA, 1969, AM J MED, V47, P251, DOI 10.1016/0002-9343(69)90151-X
   Lyn D, 2000, PHYSIOL GENOMICS, V2, P93, DOI 10.1152/physiolgenomics.2000.2.3.93
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   Rhee CH, 1999, ONCOGENE, V18, P2711, DOI 10.1038/sj.onc.1202623
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SKIBBA JL, 1989, J BIOCHEM TOXICOL, V4, P119, DOI 10.1002/jbt.2570040208
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Soukas A, 2000, GENE DEV, V14, P963
   Wang YX, 1999, FEBS LETT, V445, P269, DOI 10.1016/S0014-5793(99)00136-2
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
NR 33
TC 28
Z9 36
U1 0
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD APR
PY 2002
VL 92
IS 4
BP 1762
EP 1769
DI 10.1152/japplphysiol.00733.2001
PG 8
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 534EX
UT WOS:000174572600052
PM 11896047
DA 2024-02-19
ER

PT J
AU Pallottini, V
   Marino, M
   Cavallini, G
   Bergamini, E
   Trentalance, A
AF Pallottini, V
   Marino, M
   Cavallini, G
   Bergamini, E
   Trentalance, A
TI Age-related changes of isoprenoid biosynthesis in rat liver and brain
SO BIOGERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd European Congress of Biogerontology
CY NOV 08-11, 2002
CL MONTECATINI TERME, ITALY
DE aged rat; brain; caloric restriction; 3-hydroxy-3-methyl-glutaryl CoA
   reductase; liver
ID DOLICHYL PHOSPHATE; HUMAN-TISSUES; CHOLESTEROL; METABOLISM;
   ACCUMULATION; REGENERATION; RESTRICTION
AB The physiological role of dolichol is not yet known but its accumulation in several tissues has been extensively reported in various physiological states or pathological conditions. Increased dolichol concentration in mammalian tissues during ageing has been also reported; in particular, we have previously indicated dolichol accumulation in liver as a new biomarker of ageing. However, the mechanism and the role of this accumulation is unknown. The aim of this work was to study the mechanism of the age- dependent dolichol accumulation analysing, in the liver and in the brain, the activity of the rate- limiting enzyme of isoprenoid biosynthesis, the 3- hydroxy 3- methylglutaryl CoA reductase, the dolichol and cholesterol synthesis on aged rats both fed ad libitum and caloric restricted. Furthermore, the dolichol and cholesterol levels in the plasma were assayed. The data shows that during ageing, the tissue dolichol accumulation is connected with the increase of 3- hydroxy 3- methylglutaryl CoA reductase activity and only in liver affected by diet restriction. In addition the aged rats maintain the capability to regulate their tissue cholesterol content by modifying cholesterol delivery into the blood. The amount of the 3- hydroxy 3- methylglutaryl CoA reductase enzyme detectable in liver and brain by Western blot analysis does not show significant changes during ageing. The presented data show that the accumulation of dolichol is related to the loss of enzymatic regulation characteristic of ageing. In fact, a higher mevalonate availability deriving from an increased expressed activity of HMGCoA- R could cause an increased production of dolichol.
C1 Univ Roma Tre, Dept Biol, Rome, Italy.
   Univ Pisa, Dept Expt Pathol, I-56100 Pisa, Italy.
C3 Roma Tre University; University of Pisa
RP Trentalance, A (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.
RI Pallottini, Valentina/AAA-3218-2021
OI Pallottini, Valentina/0000-0003-2511-6168
CR ADAIR WL, 1982, J BIOL CHEM, V257, P8990
   BRUSCALUPI G, 1985, CELL MOL BIOL, V31, P365
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   CONCONI M, 1996, ARCH BIOCHEM BIOPHYS, V309, P24
   EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1
   ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535
   ERICSSON J, 1993, BIOCHIMIE, V75, P167, DOI 10.1016/0300-9084(93)90074-3
   Gruenler Jacob, 1994, Biochimica et Biophysica Acta, V1212, P259
   KIN NMKNY, 1983, J NEUROCHEM, V40, P1465, DOI 10.1111/j.1471-4159.1983.tb13592.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   MARINO M, 1990, BIOCHIM BIOPHYS ACTA, V1047, P192, DOI 10.1016/0005-2760(90)90047-2
   MARINO M, 1994, METABOLISM, V43, P677, DOI 10.1016/0026-0495(94)90114-7
   MARINO M, 1986, BIOSCIENCE REP, V257, P409
   MASORO EJ, 1995, HDB PHYSL AGEING
   Nanni G, 2000, LIFE SCI, V67, P2293, DOI 10.1016/S0024-3205(00)00819-5
   RIP JW, 1985, BIOCHEM J, V227, P705, DOI 10.1042/bj2270705
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   VIGO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P221, DOI 10.1016/0005-2736(84)90295-5
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
NR 26
TC 22
Z9 24
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2003
VL 4
IS 6
BP 371
EP 378
DI 10.1023/B:BGEN.0000006557.92558.60
PG 8
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 750BM
UT WOS:000186971500006
PM 14739708
DA 2024-02-19
ER

PT J
AU Merkt, W
   Zhou, Y
   Han, HW
   Lagares, D
AF Merkt, Wolfgang
   Zhou, Yan
   Han, Hongwei
   Lagares, David
TI Myofibroblast fate plasticity in tissue repair and fibrosis:
   Deactivation, apoptosis, senescence and reprogramming
SO WOUND REPAIR AND REGENERATION
LA English
DT Article; Early Access
DE apoptosis; cellular senescence; fate; fibrosis; myofibroblast;
   plasticity; reprogramming; tissue repair
ID ACTIVATED STELLATE CELLS; FOCAL ADHESION KINASE; GROWTH-FACTOR BETA-1;
   SMOOTH-MUSCLE ACTIN; CELLULAR SENESCENCE; PULMONARY-FIBROSIS; LUNG
   FIBROBLASTS; SYSTEMIC-SCLEROSIS; LIVER FIBROSIS; MATRICELLULAR PROTEIN
AB In response to tissue injury, fibroblasts differentiate into professional repair cells called myofibroblasts, which orchestrate many aspects of the normal tissue repair programme including synthesis, deposition and contraction of extracellular matrix proteins, leading to wound closure. Successful tissue repair responses involve termination of myofibroblast activities in order to prevent pathologic fibrotic scarring. Here, we discuss the cellular and molecular mechanisms limiting myofibroblast activities during physiological tissue repair, including myofibroblast deactivation, apoptosis, reprogramming and immune clearance of senescent myofibroblasts. In addition, we summarize pathological mechanisms leading to myofibroblast persistence and survival, a hallmark of fibrotic diseases. Finally, we discuss emerging anti-fibrotic therapies aimed at targeting myofibroblast fate such as senolytics, gene therapy, cellular immunotherapy and CAR-T cells.
C1 [Merkt, Wolfgang; Zhou, Yan; Han, Hongwei; Lagares, David] Harvard Med Sch, Fibrosis Res Ctr, Ctr Immunol & Inflammatory Dis, Div Pulm & Crit Care Med,Massachusetts Gen Hosp, Boston, MA 02115 USA.
   [Merkt, Wolfgang] Univ Hosp Heidelberg, Internal Med 5, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany.
   [Zhou, Yan] Cent South Univ, Xiangya Med Sch, Dept Physiol, Changsha, Peoples R China.
C3 Harvard University; Harvard Medical School; Massachusetts General
   Hospital; Ruprecht Karls University Heidelberg; Central South University
RP Lagares, D (corresponding author), Harvard Med Sch, Fibrosis Res Ctr, Ctr Immunol & Inflammatory Dis, Div Pulm & Crit Care Med,Massachusetts Gen Hosp, Boston, MA 02115 USA.
EM dlagares@mgh.harvard.edu
RI Merkt, Wolfgang/IUO-9144-2023
OI Lagares, David/0000-0002-7317-8796; Zhou, Yan/0000-0002-8822-5276
FU NIH [R01 HL147059-01]; Boehringer Ingelheim; Merck Co.
FX D.L. gratefully acknowledges funding support from the NIH (grant R01
   HL147059-01) and Sponsored Research Grants from Boehringer Ingelheim and
   Merck & Co.
CR Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z
   Aguado BA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav3233
   Altorok N, 2015, ANN RHEUM DIS, V74, P1612, DOI 10.1136/annrheumdis-2014-205303
   Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Antonangeli F, 2019, J LEUKOCYTE BIOL, V105, P1275, DOI 10.1002/JLB.MR0718-299R
   Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053
   Azad AI, 2020, HEPATOLOGY, V72, P1013, DOI 10.1002/hep.31211
   Bai L, 2019, AM J RESP CELL MOL, V60, P49, DOI 10.1165/rcmb.2018-0180OC
   Bansal R, 2011, HEPATOLOGY, V54, P586, DOI 10.1002/hep.24395
   Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444
   Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984
   Binet F, 2020, SCIENCE, V369, P934, DOI 10.1126/science.aay5356
   Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2
   Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC
   Carlson MA, 2003, J SURG RES, V110, P304, DOI 10.1016/S0022-4804(02)00098-7
   Chan CJ, 2014, CELL DEATH DIFFER, V21, P5, DOI 10.1038/cdd.2013.26
   Cisneros J, 2012, AM J PHYSIOL-LUNG C, V303, pL295, DOI 10.1152/ajplung.00332.2011
   Conte E, 2014, EUR J PHARM SCI, V58, P13, DOI 10.1016/j.ejps.2014.02.014
   DARBY I, 1990, LAB INVEST, V63, P21
   Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046
   Davan-Wetton CSA, 2021, CELL MOL LIFE SCI, V78, P3333, DOI 10.1007/s00018-020-03746-x
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076
   Dookun E, 2020, AGING CELL, V19, DOI 10.1111/acel.13249
   Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6
   Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Duong TE, 2018, CURR PATHOBIOL REP, V6, P79, DOI 10.1007/s40139-018-0155-0
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004
   Fitzner B, 2012, J CELL MOL MED, V16, P2620, DOI 10.1111/j.1582-4934.2012.01573.x
   Frangogiannis NG, 2020, J EXP MED, V217, DOI 10.1084/jem.20190103
   Frankel SK, 2006, AM J RESP CELL MOL, V34, P293, DOI 10.1165/rcmb.2005-0155OC
   Gerarduzzi C, 2017, INFLAMM RES, V66, P451, DOI 10.1007/s00011-016-1019-x
   Ghosh AK, 2013, J INVEST DERMATOL, V133, P1302, DOI 10.1038/jid.2012.479
   Gibb AA, 2020, CIRC RES, V127, P427, DOI 10.1161/CIRCRESAHA.120.316958
   Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016
   Granato G, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.38
   Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440
   Hamsanathan S, 2019, AM J RESP CELL MOL, V61, P21, DOI 10.1165/rcmb.2018-0410TR
   Harding Keith G, 2005, Int Wound J, V2, P364, DOI 10.1111/j.1742-4801.2005.00149.x
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016
   Henderson J, 2020, J CELL MOL MED, V24, P14026, DOI 10.1111/jcmm.16013
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5
   Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009
   Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124
   Hoerst K, 2019, J MOL MED, V97, P761, DOI 10.1007/s00109-019-01772-2
   Hohmann MS, 2019, AM J RESP CELL MOL, V60, P28, DOI 10.1165/rcmb.2017-0289OC
   Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200
   Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001
   Horowitz JC, 2019, PHYSIOLOGY, V34, P43, DOI 10.1152/physiol.00033.2018
   Horowitz JC, 2012, INT J BIOCHEM CELL B, V44, P158, DOI 10.1016/j.biocel.2011.10.011
   Hu B, 2010, AM J PATHOL, V177, P21, DOI 10.2353/ajpath.2010.090999
   Huang SK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.146
   Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006
   Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Jafarinejad-Farsangi S, 2015, AUTOIMMUNITY, V48, P369, DOI 10.3109/08916934.2015.1030616
   Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9
   Jelaska A, 2000, ARTHRITIS RHEUM-US, V43, P2230, DOI 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8
   Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034
   Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190
   Jia KN, 2020, J CARDIOVASC PHARM, V76, P452, DOI 10.1097/FJC.0000000000000878
   Jiang DS, 2018, NAT CELL BIOL, V20, P422, DOI 10.1038/s41556-018-0073-8
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260
   Karimizadeh E, 2015, MOL CELL BIOCHEM, V405, P169, DOI 10.1007/s11010-015-2408-0
   Kaur H, 2009, EXP EYE RES, V89, P152, DOI 10.1016/j.exer.2009.03.001
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108
   Koh HB, 2016, J BIOL CHEM, V291, P19287, DOI 10.1074/jbc.M116.723080
   Kosla J, 2013, EUR J CELL BIOL, V92, P363, DOI 10.1016/j.ejcb.2013.10.013
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuehl T, 2018, MATRIX BIOL, V68-69, P94, DOI 10.1016/j.matbio.2018.01.020
   Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC
   Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909
   Kural MH, 2016, ACTA BIOMATER, V32, P223, DOI 10.1016/j.actbio.2015.12.031
   Lagares D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3765
   Lagares D, 2017, NAT MED, V23, P1405, DOI 10.1038/nm.4419
   Lagares D, 2013, BIODRUGS, V27, P15, DOI 10.1007/s40259-012-0003-4
   Lagares D, 2012, AM J RESP CELL MOL, V47, P834, DOI 10.1165/rcmb.2011-0446OC
   Lagares D, 2012, ARTHRITIS RHEUM-US, V64, P1653, DOI 10.1002/art.33482
   Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307
   Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069
   Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016
   Lerbs T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140458
   Li CX, 2017, NAT MATER, V16, P379, DOI [10.1038/NMAT4780, 10.1038/nmat4780]
   Li YJ, 2016, MATRIX BIOL, V55, P35, DOI 10.1016/j.matbio.2016.03.004
   Ligresti G, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127111
   Linge C, 2005, J INVEST DERMATOL, V125, P72, DOI 10.1111/j.0022-202X.2005.23771.x
   Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014
   Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082
   Liu XQ, 2017, LAB INVEST, V97, P256, DOI 10.1038/labinvest.2016.145
   Logtenberg MEW, 2020, IMMUNITY, V52, P742, DOI 10.1016/j.immuni.2020.04.011
   Lombardi AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12103-x
   Maher TM, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1161-4
   Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC
   Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002
   Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Merkt W, 2020, SEMIN CELL DEV BIOL, V101, P104, DOI 10.1016/j.semcdb.2019.12.008
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Mullard A, 2017, NAT REV DRUG DISCOV, V16, P669, DOI 10.1038/nrd.2017.196
   Müller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010
   Nakano Y, 2020, HEPATOLOGY, V71, P1437, DOI 10.1002/hep.30965
   Negmadjanov U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123046
   Oh YM, 2016, HEPATOLOGY, V64, P209, DOI 10.1002/hep.28432
   Pan J, 2017, INT J RADIAT ONCOL, V99, P353, DOI 10.1016/j.ijrobp.2017.02.216
   Park CM, 2006, J AM CHEM SOC, V128, P16206, DOI 10.1021/ja0650347
   Park IH, 2012, INT ARCH ALLERGY IMM, V159, P278, DOI 10.1159/000337460
   Park JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09101-4
   Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5
   Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532
   Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839
   Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792
   POLUNOVSKY VA, 1993, J CLIN INVEST, V92, P388, DOI 10.1172/JCI116578
   Qu J, 2021, J EXP MED, V218, DOI 10.1084/jem.20202033
   Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Raffetto JD, 1999, AM J SURG, V178, P107, DOI 10.1016/S0002-9610(99)00134-8
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Rangarajan S, 2018, NAT MED, V24, P1121, DOI 10.1038/s41591-018-0087-6
   Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC
   Redente EF, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.141618
   Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005
   Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584
   Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151
   Rizvi S, 2014, J BIOL CHEM, V289, P22835, DOI 10.1074/jbc.M114.563064
   Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848
   Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Sagiv A, 2013, BIOGERONTOLOGY, V14, P617, DOI 10.1007/s10522-013-9473-0
   Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340
   Samuel GH, 2012, J DERMATOL SCI, V67, P166, DOI 10.1016/j.jdermsci.2012.06.001
   Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113
   Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC
   Santiago B, 2001, ARTHRITIS RHEUM-US, V44, P1667, DOI 10.1002/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y
   Santos A, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0710-z
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012
   Song GQ, 2016, CELL STEM CELL, V18, P797, DOI 10.1016/j.stem.2016.01.010
   Song P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030671
   Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Suzuki K, 2020, MOL MED REP, V22, P1518, DOI 10.3892/mmr.2020.11218
   Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tschumperlin DJ, 2020, PHARMACOL THERAPEUT, V212, DOI 10.1016/j.pharmthera.2020.107575
   Tschumperlin DJ, 2013, CURR OPIN RHEUMATOL, V25, P92, DOI 10.1097/BOR.0b013e32835b13cd
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Ugai K, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00192
   Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393
   Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687
   Walaszczyk A, 2019, AGING CELL, V18, DOI 10.1111/acel.12945
   Wallach-Dayan SB, 2015, J AUTOIMMUN, V59, P67, DOI 10.1016/j.jaut.2015.02.006
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Wang YQ, 2006, ARTHRITIS RHEUM-US, V54, P2271, DOI 10.1002/art.21948
   Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC
   Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yanai H, 2015, AGING-US, V7, P664, DOI 10.18632/aging.100807
   Yang IV, 2014, AM J RESP CRIT CARE, V190, P1263, DOI 10.1164/rccm.201408-1452OC
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720
   Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001
   Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 185
TC 20
Z9 22
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD 2021 JUL
PY 2021
VL 29
IS 4
SI SI
BP 678
EP 691
DI 10.1111/wrr.12952
EA JUN 2021
PG 14
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA TC5WB
UT WOS:000663331200001
PM 34117675
DA 2024-02-19
ER

PT J
AU Bardag-Gorce, F
   Farout, L
   Veyrat-Durebex, C
   Briand, Y
   Briand, M
AF Bardag-Gorce, F
   Farout, L
   Veyrat-Durebex, C
   Briand, Y
   Briand, M
TI Changes in 20S proteasome activity during ageing of the LOU rat
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE ageing; LOU rat; muscle atrophy; proteasome
ID MUSCLE PROTEIN-DEGRADATION; SKELETAL-MUSCLE; MYOFIBRILLAR PROTEINS;
   PROTEOLYTIC PATHWAY; OLD RATS; UBIQUITIN; ATROPHY; LIVER; RNA
AB Muscular functions decline and muscle mass decreases during ageing. In the rat, there is a 27% decrease in muscle protein between 18 and 34 months of age. We examined age-related changes in the proteasome-dependent proteolytic pathway in rats at 4, 18, 24, 29 and 34 months of age. The three best characterised activities of the proteasome (chymotrypsin-like, trypsin-like and peptidylglutamyl peptide hydrolase) increased to 29 months and then decreased in the senescent animal. These variations in activity were accompanied by an identical change in the quantity of 20S proteasome measured by Western blot, whereas the S4 subunit of the 19S regulator and the quantity of ubiquitin-linked proteins remained constant. mRNA of subunits C3, C5, C9, and S4 increased in the senescent animal, but ubiquitin mRNA levels were unchanged. These findings suggest that the 20S proteasome may be partly responsible for the muscular atrophy observed during ageing in the rat.
C1 Univ Clermont Ferrand 2, Lab Biochim Appl, F-63177 Clermont Ferrand, France.
C3 Universite Clermont Auvergne (UCA)
RP Briand, Y (corresponding author), Univ Clermont Ferrand 2, Lab Biochim Appl, EA 995, F-63177 Clermont Ferrand, France.
RI Veyrat-Durebex, Christelle/E-2558-2013
OI Veyrat-Durebex, Christelle/0000-0001-5301-6493
CR BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264
   DAWSON SP, 1995, J BIOL CHEM, V270, P1850, DOI 10.1074/jbc.270.4.1850
   FORUNO N, 1990, J BIOL CHEM, V265, P8550
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100
   ILIAN MA, 1994, J NUTR BIOCHEM, V5, P529, DOI 10.1016/0955-2863(94)90050-7
   Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401
   Matsuishi M, 1997, MEAT SCI, V45, P451, DOI 10.1016/S0309-1740(96)00126-X
   MAYASHI T, 1998, MECH AGEING DEV, V102, P55
   MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631
   MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208
   MYKLES DL, 1995, BIOCHEM J, V306, P285, DOI 10.1042/bj3060285
   PRICE SR, 1994, J PHYSL A, V26, pC955
   Robert N, 1999, MEAT SCI, V51, P149, DOI 10.1016/S0309-1740(98)00113-2
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690
   Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065
   TAYLOR RG, 1995, MOL BIOL REP, V21, P71, DOI 10.1007/BF00990974
   TEMPARIS S, 1994, CANCER RES, V54, P5568
   Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 26
TC 54
Z9 56
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD APR
PY 1999
VL 26
IS 1-2
BP 89
EP 93
DI 10.1023/A:1006968208077
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 194HP
UT WOS:000080186800016
PM 10363653
DA 2024-02-19
ER

PT J
AU Li, F
   Huang, GB
   Tan, F
   Yi, RK
   Zhou, XR
   Mu, JF
   Zhao, X
AF Li, Fang
   Huang, Guangbin
   Tan, Fang
   Yi, Ruokun
   Zhou, Xianrong
   Mu, Jianfei
   Zhao, Xin
TI <i>Lactobacillus plantarum</i> KSFY06 on d-galactose-induced oxidation
   and aging in Kunming mice
SO FOOD SCIENCE & NUTRITION
LA English
DT Article; Early Access
DE aging; Lactobacillus plantarum KSFY06; mice; oxidation
ID LACTIC-ACID BACTERIA; INDUCED LIVER; STRESS; XINJIANG; INFLAMMATION;
   ANTIOXIDANT; DAMAGE; DAIRY; MODEL; MILK
AB Yogurt from Xinjiang, China, is a traditional Chinese fermented food rich in beneficial microorganisms, such as Lactobacillus plantarum KSFY06. In this study, the effect of KSFY06 on oxidative aging was investigated using live animal experiments. Molecular biological methods were used to analyze the serum and tissues of mice with oxidative aging induced by d-galactose, which showed that KSFY06 can inhibit the decline of heart, liver, spleen, and kidney caused by aging. The KSFY06 strain increased the activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), and glutathione (GSH) in serum and liver of aging mice, while the content of malondialdehyde (MDA) is reduced. Pathological observation showed that KSFY06 alleviated damage to the liver, spleen, and skin of oxidative aging mice. qPCR showed that, at high dose (2 x 10(9) cfu/kg per day), KSFY06 upregulates copper/zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), catalase (CAT) mRNA expression, and its downstream inducible nitric oxide synthase (iNOS) mRNA expression in liver and spleen tissues induced by d-gal. To a certain extent, these findings indicate that L. plantarum KSFY06 is able to protect against oxidative stress in the d-gal-induced aging model. In conclusion, L. plantarum KSFY06 may provide a potential research value in the prevention or alleviation of related diseases caused by oxidative stress.
C1 [Li, Fang; Yi, Ruokun; Zhou, Xianrong; Mu, Jianfei; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Li, Fang; Yi, Ruokun; Zhou, Xianrong; Mu, Jianfei; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing, Peoples R China.
   [Li, Fang; Yi, Ruokun; Zhou, Xianrong; Mu, Jianfei; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing, Peoples R China.
   [Li, Fang] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing, Peoples R China.
   [Huang, Guangbin] Chongqing Univ, Affiliated Cent Hosp, Emergency Med Ctr Chongqing, Dept Trauma Surg, Chongqing, Peoples R China.
   [Tan, Fang] Our Lady Fatima Univ, Dept Publ Hlth, Valenzuela, Philippines.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Chongqing University of Education;
   Chongqing University; Our Lady of Fatima University
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
EM zhaoxin@cque.edu.cn
OI Tan, Fang/0000-0003-2406-129X
FU Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing [CXTDX201601040]; Research Project of Chongqing University
   of Education [KY2015TBZC, KY201919C]; Scientific and Technological
   Projects of Chongqing Education Committee [KJZD-K201901601]
FX Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing, Grant/Award Number: CXTDX201601040; Research Project of
   Chongqing University of Education, Grant/Award Number: KY2015TBZC and
   KY201919C; Scientific and Technological Projects of Chongqing Education
   Committee, Grant/Award Number: KJZD-K201901601
CR Abushelaibi A, 2017, LWT-FOOD SCI TECHNOL, V79, P316, DOI 10.1016/j.lwt.2017.01.041
   Badgujar PC, 2016, ENVIRON TOXICOL, V31, P1147, DOI 10.1002/tox.22125
   Bonthius DJ, 2015, NEUROTOXICOLOGY, V46, P60, DOI 10.1016/j.neuro.2014.11.009
   Cardiff R. D., 2014, COLD SPRING HARBOR P, V2014, ppdb, DOI [10.1101/pdb.prot073411, 10.1101/pdb.proto73411, DOI 10.1101/PDB.PROTO73411]
   Chen XY, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081249
   Chen XY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060545
   Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x
   Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049
   Dong X, 2017, GERIATR GERONTOL INT, V17, P338, DOI 10.1111/ggi.12699
   Eroglu E, 2017, NITRIC OXIDE-BIOL CH, V70, P59, DOI 10.1016/j.niox.2017.09.001
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Hart P, 2015, FASEB J S1, V29, P884
   [何捷 He Jie], 2015, [食品科学, Food Science], V36, P130
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hosen MB, 2015, INT J REPROD BIOMED, V13, P525
   Kalantar-Zadeh K, 2017, NEW ENGL J MED, V377, P1765, DOI [10.1056/NEJMra1700312, 10.1056/nejmra1700312]
   Kenfack HMC, 2018, AM J MICROBIOL RES, V6, P1, DOI [10.12691/ajmr-6-1-1, DOI 10.12691/AJMR-6-1-1]
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   Kumar BV, 2015, J FOOD SCI TECH MYS, V52, P6112, DOI 10.1007/s13197-015-1795-2
   Leite AMO, 2015, J DAIRY SCI, V98, P3622, DOI 10.3168/jds.2014-9265
   Li W, 2012, EUR FOOD RES TECHNOL, V235, P497, DOI 10.1007/s00217-012-1779-7
   Li Y. H., 2013, FOOD FERMENTATION IN, V7, P20
   Linares DM, 2011, CRIT REV FOOD SCI, V51, P691, DOI 10.1080/10408398.2011.582813
   Liu HY, 2018, FOOD AGR IMMUNOL, V29, P316, DOI 10.1080/09540105.2017.1376037
   Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902
   Landete JM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5939818
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23113026
   Ren XP, 2016, CURR MICROBIOL, V73, P374, DOI 10.1007/s00284-016-1065-1
   Sang Y, 2017, FOOD FUNCT, V8, P2331, DOI [10.1039/c7fo00037e, 10.1039/C7FO00037E]
   Selvaratnam JS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141671
   Suo HY, 2018, J DAIRY SCI, V101, P10664, DOI 10.3168/jds.2018-14758
   Tang W, 2017, FOOD CHEM, V221, P1642, DOI 10.1016/j.foodchem.2016.10.124
   Wa YC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01312
   Wang Y, 2016, INT DAIRY J, V62, P28, DOI 10.1016/j.idairyj.2016.07.001
   Wang YZ, 2016, EUR J NUTR, V55, P821, DOI 10.1007/s00394-015-0904-3
   Xu C, 2018, FISH SHELLFISH IMMUN, V76, P48, DOI 10.1016/j.fsi.2018.02.041
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Zhang J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8091498
   Zhang Q, 2005, NEUROL RES, V27, P672, DOI 10.1179/ner.2005.27.6.672
   Zhang XL, 2008, PHYTOMEDICINE, V15, P484, DOI 10.1016/j.phymed.2008.01.001
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhao JC, 2017, J FUNCT FOODS, V39, P44, DOI 10.1016/j.jff.2017.09.055
   Zhao X, 2019, J DAIRY SCI, V102, P5899, DOI 10.3168/jds.2018-16033
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
   Zhou Y, 2017, J NUTR HEALTH AGING, V21, P1314, DOI 10.1007/s12603-016-0862-3
   Zhu YP, 2019, J FOOD SCI TECH MYS, V56, P340, DOI 10.1007/s13197-018-3494-2
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 48
TC 24
Z9 26
U1 4
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD 2020 JAN
PY 2020
VL 8
IS 1
BP 379
EP 389
DI 10.1002/fsn3.1318
EA DEC 2019
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA KF8WW
UT WOS:000500641100001
PM 31993164
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ding, BS
   Yang, DW
   Swendeman, SL
   Christoffersen, C
   Nielsen, LB
   Friedman, SL
   Powell, CA
   Hla, T
   Cao, ZW
AF Ding, Bi-Sen
   Yang, Dawei
   Swendeman, Steve L.
   Christoffersen, Christina
   Nielsen, Lars B.
   Friedman, Scott L.
   Powell, Charles A.
   Hla, Timothy
   Cao, Zhongwei
TI Aging Suppresses Sphingosine-1-Phosphate Chaperone ApoM in Circulation
   Resulting in Maladaptive Organ Repair
SO DEVELOPMENTAL CELL
LA English
DT Article
ID CAPILLARY VASCULAR NICHE; APOLIPOPROTEIN-M; ANGIOCRINE SIGNALS;
   MECHANISMS; REGENERATION; FIBROSIS; LIVER; CELLS; HDL; PROLIFERATION
AB Here, we show that the liver-derived apolipoprotein M (ApoM) protects the lung and kidney from pro-fibrotic insults and that this circulating factor is attenuated in aged mice. Aged mouse hepatocytes exhibit transcriptional suppression of ApoM. This leads to reduced sphingosine-1-phosphate (SIP) signaling via the S1P receptor 1 (S1PR1) in the vascular endothelial cells of lung and kidney. Suboptimal S1PR1 angiocrine signaling causes reduced resistance to injury-induced vascular leak and leads to organ fibrosis. Plasma transfusion from Apom transgenic mice but not Apom knockout mice blocked fibrosis in the lung. Similarly, infusion of recombinant therapeutics, ApoM-Fc fusion protein enhanced kidney and lung regeneration and attenuated fibrosis in aged mouse after injury. Furthermore, we identified that aging alters Sirtuin-1-hepatic nuclear factor 4 alpha circuit in hepatocytes to downregulate ApoM. These data reveal an integrative organ adaptation that involves circulating S1P chaperone ApoM(+) high density lipoprotein (HDL), which signals via endothelial niche S1PR1 to spur regeneration over fibrosis.
C1 [Ding, Bi-Sen; Yang, Dawei; Powell, Charles A.; Cao, Zhongwei] Icahn Sch Med Mt Sinai, Fibrosis Res Ctr, Mt Sinai Natl Jewish Resp Inst, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA.
   [Ding, Bi-Sen; Cao, Zhongwei] Weill Cornell Med, Dept Med, Div Regenerat Med, Ansary Stem Cell Inst, New York, NY 10065 USA.
   [Swendeman, Steve L.; Hla, Timothy] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.
   [Christoffersen, Christina; Nielsen, Lars B.] Univ Copenhagen, Righosiptalet, Dept Clin Biochem, DK-2200 Copenhagen, Denmark.
   [Christoffersen, Christina; Nielsen, Lars B.] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.
   [Nielsen, Lars B.] Aarhus Univ, DK-8000 Aarhus, Denmark.
   [Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; Cornell University; Weill
   Cornell Medicine; Harvard University; Boston Children's Hospital;
   Harvard Medical School; University of Copenhagen; University of
   Copenhagen; Aarhus University; Icahn School of Medicine at Mount Sinai
RP Ding, BS; Cao, ZW (corresponding author), Icahn Sch Med Mt Sinai, Fibrosis Res Ctr, Mt Sinai Natl Jewish Resp Inst, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA.; Ding, BS; Cao, ZW (corresponding author), Weill Cornell Med, Dept Med, Div Regenerat Med, Ansary Stem Cell Inst, New York, NY 10065 USA.
EM bsding@outlook.com; zhongwei.cao@outlook.com
RI fang, li/JNS-8415-2023; Cao, Zhongwei/JYP-4941-2024; Christoffersen,
   Christina/AGD-0854-2022; Hla, Timothy T/G-5873-2012
OI Christoffersen, Christina/0000-0003-3751-5203; Hla, Timothy
   T/0000-0001-8355-4065; Yang, Dawei/0000-0002-8928-143X
FU National Cancer Institute [R01CA163772-01, P30CA165979, R21CA230098];
   National Institute of Diabetes and Digestive and Kidney Disease
   [R01DK56621]; Novo Nordisk Foundation [NNF13OC0003898]; National Heart
   Lung and Blood Institute [R01HL130826, NIH-R35-HL135821]; NYSTEM
   [C34052GG]; Fondation Leducq
FX C.A.P. is supported by the National Cancer Institute (R01CA163772-01).
   S.L.F. is supported by the National Institute of Diabetes and Digestive
   and Kidney Disease (R01DK56621) and National Cancer Institute
   (P30CA165979). C.C. is funded by Novo Nordisk Foundation
   (NNF13OC0003898). This work was supported by National Heart Lung and
   Blood Institute (R01HL130826), NYSTEM (C34052GG), and National Cancer
   Institute (R21CA230098). T.H. is supported by National Heart Lung and
   Blood Institute (NIH-R35-HL135821) and Fondation Leducq transatlantic
   network proposal (SphingoNet).
CR Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460
   Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001
   Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Burg N, 2018, ARTHRITIS RHEUMATOL, V70, P1879, DOI 10.1002/art.40558
   Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710
   Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035
   Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551
   Chen HZ, 2016, CIRC RES, V119, P1076, DOI 10.1161/CIRCRESAHA.116.308895
   Christensen PM, 2016, FASEB J, V30, P2351, DOI 10.1096/fj.201500064
   Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200
   Christoffersen C, 2013, CURR OPIN LIPIDOL, V24, P295, DOI 10.1097/MOL.0b013e328361f6ad
   Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108
   Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006
   Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039
   Ding BS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87058
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042
   Ellis LV, 2020, DEV CELL, V52, P617, DOI 10.1016/j.devcel.2020.01.009
   Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700
   Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005
   Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581
   Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Han YM, 2018, MOL CELL, V71, P1064, DOI 10.1016/j.molcel.2018.07.036
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146
   Jin YM, 2012, NAT MED, V18, P580, DOI 10.1038/nm.2685
   Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194
   Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642
   Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004
   Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638
   Lechner AJ, 2017, CELL STEM CELL, V21, P120, DOI 10.1016/j.stem.2017.03.024
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Martinod K, 2017, J EXP MED, V214, P439, DOI 10.1084/jem.20160530
   Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771
   Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298
   Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323
   Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017
   Obinata H, 2019, J LIPID RES, V60, P1912, DOI 10.1194/jlr.RA119000277
   Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403
   Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061
   Palu RAS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005978
   Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553
   Paris AJ, 2016, AM J PHYSIOL-LUNG C, V311, pL1062, DOI 10.1152/ajplung.00327.2016
   Pébay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338
   Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879
   Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369
   Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040
   Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096
   Rajagopal J, 2016, DEV CELL, V36, P133, DOI 10.1016/j.devcel.2015.12.021
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Sousounis K, 2014, CURR TOP DEV BIOL, V108, P217, DOI 10.1016/B978-0-12-391498-9.00008-5
   Sun W, 2011, HEPATOLOGY, V54, P1259, DOI 10.1002/hep.24530
   Swendeman SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2722
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002
   Wells JM, 2018, NATURE, V557, P322, DOI 10.1038/s41586-018-0073-7
   Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yanagida K, 2020, DEV CELL, V52, P779, DOI 10.1016/j.devcel.2020.01.016
   Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144
   Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613
NR 75
TC 19
Z9 21
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JUN 22
PY 2020
VL 53
IS 6
BP 677
EP +
DI 10.1016/j.devcel.2020.05.024
PG 18
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA MC5MO
UT WOS:000543330900008
PM 32544390
OA hybrid, Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Atif, F
   Yousuf, S
   Espinosa-Garcia, C
   Sergeeva, E
   Stein, DG
AF Atif, Fahim
   Yousuf, Seema
   Espinosa-Garcia, Claudia
   Sergeeva, Elena
   Stein, Donald G.
TI Progesterone Treatment Attenuates Glycolytic Metabolism and Induces
   Senescence in Glioblastoma
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TRANSCRIPTION-FACTOR; CONSTITUTIVE PHOSPHORYLATION; TUMOR PROGRESSION;
   OVARIAN-CANCER; UP-REGULATION; CELLS; P53; ANGIOGENESIS; METASTASIS;
   INHIBITION
AB We examined the effect of progesterone treatments on glycolytic metabolism and senescence as possible mechanisms in controlling the growth of glioblastoma multiforme (GBM). In an orthotopic mouse model, after tumor establishment, athymic nude mice received treatment with progesterone or vehicle for 40 days. Compared to controls, high-dose progesterone administration produced a significant reduction in tumor size (similar to 47%) and an increased survival rate (similar to 43%) without any demonstrable toxicity to peripheral organs (liver, kidney). This was accompanied by a significant improvement in spontaneous locomotor activity and reduced anxiety-like behavior. In a follow-up in vitro study of U87MG-luc, U87dEGFR and U118MG tumor cells, we observed that high-dose progesterone inhibited expression of Glut1, which facilitated glucose transport into the cytoplasm; glyceraldehyde 3-phosphate dehydrogenase (GAPDH; a glycolysis enzyme); ATP levels; and cytoplasmic FoxO1 and Phospho-FoxO1, both of which control glycolytic metabolism through upstream PI3K/Akt/mTOR signaling in GBM. In addition, progesterone administration attenuated EGFR/PI3K/Akt/mTOR signaling, which is highly activated in grade IV GBM. High-dose progesterone also induced senescence in GBM as evidenced by changes in cell morphology and beta-galactocidase accumulation. In conclusion, progesterone inhibits the modulators of glycolytic metabolism and induces premature senescence in GBM cells and this can help to reduce/slow tumor progression.
C1 [Atif, Fahim; Yousuf, Seema; Espinosa-Garcia, Claudia; Sergeeva, Elena; Stein, Donald G.] Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA.
C3 Emory University
RP Atif, F (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA.
EM fatif@emory.edu
RI Stein, Donald/AAJ-5139-2020
OI Espinosa-Garcia, Claudia/0000-0002-9909-9092
CR Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764
   American Brain Tumor Association, 2014, AM BRAIN TUM ASS BRA
   [Anonymous], 8 US NAT COMB M W ST
   Atif F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131441
   Atif F, 2015, J STEROID BIOCHEM, V146, P62, DOI 10.1016/j.jsbmb.2014.04.007
   Bao JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139298
   Bu SZ, 1997, CANCER, V79, P1944, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1944::AID-CNCR15>3.0.CO;2-V
   Carmo A, 2011, ONCOL LETT, V2, P1165, DOI 10.3892/ol.2011.406
   Central Brain Tumor Registry of the United States, 2010, CBTRUS STAIST REP PR
   Cheong JW, 2003, LEUKEMIA RES, V27, P1159, DOI 10.1016/S0145-2126(03)00102-4
   Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014
   Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com
   Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550
   Dressing GE, 2009, STEROIDS, V74, P573, DOI 10.1016/j.steroids.2008.12.001
   Dumas JF, 2017, SEMIN CANCER BIOL, V43, P90, DOI 10.1016/j.semcancer.2017.03.004
   Formby B, 1999, MOL CELL BIOCHEM, V202, P53, DOI 10.1023/A:1007081021483
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726
   Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743
   Hirose Y, 2001, CANCER RES, V61, P1957
   Horita K, 2001, ANTICANCER RES, V21, P3871
   Kanazawa M, 2011, J CEREBR BLOOD F MET, V31, P1461, DOI 10.1038/jcbfm.2011.9
   Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998
   Kim JH, 2007, MODERN PATHOL, V20, P835, DOI 10.1038/modpathol.3800789
   Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036
   Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016
   Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926
   Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001
   Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013
   Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115
   Medina D, 2007, Ernst Schering Found Symp Proc, P109
   Nilsen J, 2005, DRUG NEWS PERSPECT, V18, P545, DOI 10.1358/dnp.2005.18.9.948450
   Payen VL, 2016, CELL MOL LIFE SCI, V73, P1333, DOI 10.1007/s00018-015-2098-5
   Peck JD, 2002, CANCER EPIDEM BIOMAR, V11, P361
   Porporato PE, 2016, CELL MOL LIFE SCI, V73, P1349, DOI 10.1007/s00018-015-2100-2
   Ramos D, 2015, ANTICANCER RES, V35, P439
   Reynolds AR, 2010, DOSE-RESPONSE, V8, P253, DOI 10.2203/dose-response.09-049.Reynolds
   Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137
   Stein DG, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 5: DEVELOPMENT OF HORMONE-BEHAVIOR RELATIONSHIPS, 3RD EDITION, P411, DOI 10.1016/B978-0-12-803592-4.00110-3
   Strickaert A, 2017, ONCOGENE, V36, P2637, DOI 10.1038/onc.2016.411
   Sun T, 2014, J CLIN INVEST, V124, P4123, DOI 10.1172/JCI71048
   Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Veschini L, 2007, BLOOD, V109, P2565, DOI 10.1182/blood-2006-06-032664
   Wang DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063659
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393
   Weis SM, 2009, CANCER CELL, V15, P359, DOI 10.1016/j.ccr.2009.04.005
   Wu NYY, 2017, CELL REP, V18, P2557, DOI 10.1016/j.celrep.2017.02.049
   Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198
   Zhang B, 2009, ANN SURG ONCOL, V16, P1925, DOI 10.1245/s10434-009-0481-x
   Zheng H, 2007, INT J GYNECOL CANCER, V17, P325, DOI 10.1111/j.1525-1438.2006.00749.x
NR 52
TC 21
Z9 24
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 30
PY 2019
VL 9
AR 988
DI 10.1038/s41598-018-37399-5
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HJ4FF
UT WOS:000457128700064
PM 30700763
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhou, QJ
   Wang, Y
   Yang, LL
   Wang, Y
   Chen, P
   Wang, YQ
   Dong, XG
   Xie, LX
AF Zhou, Qingjun
   Wang, Yao
   Yang, Lingling
   Wang, Ye
   Chen, Peng
   Wang, Yiqiang
   Dong, Xiaoguang
   Xie, Lixin
TI Histone deacetylase inhibitors blocked activation and caused senescence
   of corneal stromal cells
SO MOLECULAR VISION
LA English
DT Article
ID HEPATIC STELLATE CELLS; IN-VITRO; MYOFIBROBLASTIC DIFFERENTIATION;
   REPLICATIVE SENESCENCE; SODIUM-BUTYRATE; GENE-EXPRESSION;
   TRICHOSTATIN-A; FIBROBLASTS; KERATOCYTES; PHENOTYPE
AB Purpose: Corneal myofibroblasts differentiated from activated corneal stromal cells are the major cellular sources of extracellular matrix synthesis for the repair of corneal injury. In this study, the effects of histone deacetylase (HDAC) inhibitors on the activation, proliferation, migration and senescence of corneal stromal cells were evaluated.
   Methods: Primary human and mouse corneal stromal cells were harvested by sequential digestion with dispase and collagenase, and cultured in DMEM/F-12 media under serum-free (keratocytes), serum- (corneal fibroblasts) and TGF beta 1-supplemented (corneal myofibroblasts) conditions. The responses of corneal stromal cells to HDAC inhibitors were characterized by cDNA microarray, real time PCR, immunocytochemistry, and western blot analysis. The effects of HDAC inhibitors on corneal fibroblast proliferation, cell cycle distribution, migration and senescence were also assessed in vitro.
   Results: Fetal bovine serum and TGF beta 1 activated the transdifferentiation of corneal stromal cells into fibroblasts and myofibroblasts, indicated by cell spreading, renewed assembly of actin filaments and enhanced expression of extracellular matrix components, all of which were suppressed by the addition of HDAC inhibitors. HDAC inhibitors inhibited the proliferation of corneal fibroblasts by decreasing the proportion in the S-phase and increasing the proportion in the G0/G1 and G2/M cell cycle checkpoints. HDAC inhibitors showed a dose-dependent inhibitory effects on the migration of corneal fibroblasts. In addition, HDAC inhibitors induced the senescence of corneal myofibroblasts as shown by enhanced staining of beta-galactosidase and upregulated expression of p16(ink4a).
   Conclusions: HDAC inhibitors may affect corneal stromal cells by inhibiting myofibroblastic differentiation, cell proliferation, migration and by inducing cell senescence. Thus, this has implications for future studies in the development of promising drugs in the prevention or treatment of corneal haze and scar formation.
C1 [Zhou, Qingjun; Wang, Yao; Yang, Lingling; Wang, Ye; Chen, Peng; Wang, Yiqiang; Dong, Xiaoguang; Xie, Lixin] Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, Qingdao 266071, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical Sciences
RP Xie, LX (corresponding author), Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, 5 Yanerdao Rd, Qingdao 266071, Peoples R China.
EM Lixinxie@public.qd.sd.cn
RI yang, lingling/AAP-9608-2020; Xie, li/HGE-6052-2022
OI Wang, Yiqiang/0000-0003-1552-7529; chen, peng/0000-0001-7522-3813
FU State Key Basic Research (973) Project of China [2007CB516705]; Key
   Science and Technology Foundation of Shandong Province [2006GG1102020];
   National Natural Science Foundation of China [30700924]; Taishan Scholar
   Program QDU-EYE, Qingdao University, China
FX This work was supported by grants from the State Key Basic Research
   (973) Project of China (2007CB516705), the Key Science and Technology
   Foundation of Shandong Province (2006GG1102020), the National Natural
   Science Foundation of China (30700924). Qingjun Zhou and Yiqiang Wang
   are partially supported by the Taishan Scholar Program QDU-EYE, Qingdao
   University, China.
CR Albert DM, 2007, INVEST OPHTH VIS SCI, V48, P2327, DOI 10.1167/iovs.06-1210
   Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912
   Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035
   Bülow R, 2007, BIOCHEM PHARMACOL, V74, P1747, DOI 10.1016/j.bcp.2007.08.023
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carrington LM, 2006, INVEST OPHTH VIS SCI, V47, P1886, DOI 10.1167/iovs.05-0635
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Espana EM, 2005, INVEST OPHTH VIS SCI, V46, P4528, DOI 10.1167/iovs.05-0117
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003
   Ghosh AK, 2007, BIOCHEM BIOPH RES CO, V354, P420, DOI 10.1016/j.bbrc.2006.12.204
   Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003
   Huber LC, 2007, ARTHRITIS RHEUM, V56, P2755, DOI 10.1002/art.22759
   Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973
   Kawakita T, 2006, INVEST OPHTH VIS SCI, V47, P1918, DOI 10.1167/iovs.05-1040
   Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x
   Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006
   KOSAKA M, 1991, EXP CELL RES, V192, P46, DOI 10.1016/0014-4827(91)90155-N
   Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3
   Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497
   Masamune A, 2006, J CELL BIOCHEM, V97, P1080, DOI 10.1002/jcb.20698
   Munro J, 2004, EXP CELL RES, V295, P525, DOI 10.1016/j.yexcr.2004.01.017
   Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328
   Pei Y, 2004, EXP EYE RES, V79, P705, DOI 10.1016/j.exer.2004.08.002
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102
   West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010
   Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8
   Xiang GX, 2007, J CELL PHYSIOL, V212, P126, DOI 10.1002/jcp.21008
   Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620
   YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4
   Zhao HJ, 2004, MOL BIOL CELL, V15, P506, DOI 10.1091/mbc.E03-07-0501
   Zhou QJ, 2007, J CELL BIOCHEM, V100, P29, DOI 10.1002/jcb.20970
   Zieske JD, 2001, CURR OPIN OPHTHALMOL, V12, P237, DOI 10.1097/00055735-200108000-00001
NR 36
TC 31
Z9 34
U1 0
U2 10
PU MOLECULAR VISION
PI ATLANTA
PA C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E,
   ATLANTA, GA 30322 USA
SN 1090-0535
J9 MOL VIS
JI Mol. Vis.
PD DEC 30
PY 2008
VL 14
IS 291-95
BP 2556
EP 2565
PG 10
WC Biochemistry & Molecular Biology; Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Ophthalmology
GA 414IX
UT WOS:000263858200004
PM 19122829
DA 2024-02-19
ER

PT J
AU Mirzavi, F
   Rajabian, A
   Boroumand-Noughabi, S
   Hosseini, A
   Boroushaki, MT
   Hassanzadeh, S
AF Mirzavi, Farshad
   Rajabian, Arezoo
   Boroumand-Noughabi, Samaneh
   Hosseini, Azar
   Boroushaki, Mohammad Taher
   Hassanzadeh, Sonita
TI Standardized extract of <i>Sanguisorba minor</i> attenuates injury in
   aging rat model <i>via</i> the Nrf2/HO-1 pathway
SO ACTA NEUROBIOLOGIAE EXPERIMENTALIS
LA English
DT Article
DE Sanguisorba minor; aging; D-galactose; liver function; neurodegeneration
ID INDUCED OXIDATIVE STRESS; MEDICINAL-PLANTS; IN-VITRO;
   ACETYLCHOLINESTERASE; APOPTOSIS; PROTECTS
AB Aging promotes damage to vulnerable organs like brain and liver. Sanguisorba minor has been traditionally used to cure various ailments. Few studies have reported pharmacological activities of this medicinal plant. This research aimed to investigate the effects of Sanguisorba minor extract (SME) on brain and liver injury in aging rats and identify the underlying mechanisms. The aging model was developed by subcutaneously injecting D-galactose and simultaneously treating them with SME. After biochemical and pathological assessments, mRNA expression levels of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) and Nrf2- regulated gene, heme oxygenase-1 (HO-1), in the brain and liver tissues were determined. As a result, malondialdehyde and acetylcholinesterase levels were elevated while total thiol content and superoxide dismutase were reduced in the aging rats. Treatment with the extract remarkably attenuated oxidative injury and pathological changes in liver and brain tissues. Concomitantly, the extract up-regulated Nrf2 and HO-1 genes. Our findings exhibited SME may improve the aging-related brain and liver damage through the Nrf2-HO-1 pathway.
C1 [Mirzavi, Farshad] Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran.
   [Rajabian, Arezoo] Mashhad Univ Med Sci, Fac Med, Dept Internal Med, Mashhad, Razavi Khorasan, Iran.
   [Boroumand-Noughabi, Samaneh] Mashhad Univ Med Sci, Dept Pathol, Mashhad, Razavi Khorasan, Iran.
   [Boroumand-Noughabi, Samaneh] Mashhad Univ Med Sci, Fac Med, Dept Hematol & Blood Banking, Mashhad, Razavi Khorasan, Iran.
   [Hosseini, Azar; Boroushaki, Mohammad Taher; Hassanzadeh, Sonita] Mashhad Univ Med Sci, Fac Med, Dept Pharmacol, Mashhad, Razavi Khorasan, Iran.
   [Hosseini, Azar; Boroushaki, Mohammad Taher] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science
RP Rajabian, A (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Internal Med, Mashhad, Razavi Khorasan, Iran.
EM rajabianar@mums.ac.ir
RI Mirzavi, Farshad/AAA-3336-2022
OI Mirzavi, Farshad/0000-0003-4686-1511; Boroumand-Noughabi,
   Samaneh/0000-0002-5522-6176
FU Mashhad University of Medical Sciences [990936]
FX This study was originated from MD project of Sonita Hassanzadeh. The
   authors appreciate the Vice Chancellor for Research and Technology,
   Mashhad University of Medical Sciences for financial support (Grant No.
   990936).; This project was financially supported by Vice Chancellery for
   Research and Technology, Mashhad University of Medical Sciences for
   financial support (Grant No. 990936).
CR Ademosun AO, 2016, J EVID-BASED INTEGR, V21, pNP11, DOI 10.1177/2156587215610032
   Akbari S., 2019, J. Herbmed Pharmacol, V8, P248, DOI [10.15171/jhp.2019.36, DOI 10.15171/JHP.2019.36]
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Beheshti F, 2021, CLIN EXP HYPERTENS, V43, P505, DOI 10.1080/10641963.2021.1901112
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Cirovic T, 2020, ACTA POL PHARM, V77, P745, DOI 10.32383/appdr/127765
   Dornelles GL, 2020, NEUROCHEM RES, V45, P2456, DOI 10.1007/s11064-020-03105-z
   Ferreira A, 2006, J ETHNOPHARMACOL, V108, P31, DOI 10.1016/j.jep.2006.04.010
   Finimundy TC, 2020, FOOD CHEM, V327, DOI 10.1016/j.foodchem.2020.127043
   Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2
   Hosseini M, 2015, CHIN J INTEGR MED, V21, P438, DOI 10.1007/s11655-014-1742-5
   Khan H, 2018, BIOMED PHARMACOTHER, V101, P860, DOI 10.1016/j.biopha.2018.03.007
   Li B, 2020, BIOMED PHARMACOTHER, V126, DOI 10.1016/j.biopha.2020.110074
   Li TT, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103594
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moradzadeh M, 2019, JUNDISHAPUR J NAT PH, V14, DOI 10.5812/jjnpp.12198
   Nguyen TTH, 2008, BIOL PHARM BULL, V31, P2028, DOI 10.1248/bpb.31.2028
   Rajabian Arezoo, 2019, Prev Nutr Food Sci, V24, P363, DOI 10.3746/pnf.2019.24.4.363
   Rajabian A, 2016, DNA CELL BIOL, V35, P666, DOI 10.1089/dna.2016.3332
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Soodi M, 2017, RES J PHARMACOGN, V4, P15
   Szwajgier D, 2013, Z NATURFORSCH C, V68, P125, DOI 10.5560/ZNC.2013.68c0125
   Wei HY, 2017, MAR DRUGS, V15, DOI 10.3390/md15030077
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhao ZF, 2017, AM J CHINESE MED, V45, P199, DOI 10.1142/S0192415X17500136
NR 28
TC 1
Z9 1
U1 0
U2 1
PU NENCKI INST EXPERIMENTAL BIOLOGY
PI WARSAW
PA UL PASTEURA 3, 02-093 WARSAW, POLAND
SN 0065-1400
EI 1689-0035
J9 ACTA NEUROBIOL EXP
JI Acta Neurobiol. Exp.
PY 2022
VL 82
IS 4
BP 433
EP 441
DI 10.55782/ane-2022-041
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 8R0OO
UT WOS:000927598500003
PM 36748966
OA gold
DA 2024-02-19
ER

PT J
AU Schmucker, DL
   Sachs, H
AF Schmucker, DL
   Sachs, H
TI Quantifying dense bodies and lipofuscin during aging: a morphologist's
   perspective
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Lipofuscin and Ceroid Pigments
CY MAY 19-22, 2001
CL UNIV HAWAII, HONOLULU, HI
HO UNIV HAWAII
DE dense bodies; lysosomes; lipofuscin; age pigment; stereology; cathepsin
ID AGE-DEPENDENT ALTERATIONS; RAT-LIVER; OLD RATS; STEREOLOGICAL ANALYSIS;
   QUANTITATIVE-ANALYSIS; LYSOSOMAL-ENZYMES; FINE-STRUCTURE; ANIMAL AGE;
   CELLS; ACCUMULATION
AB Secondary lysosomes, residual or dense bodies containing lipofuscin or age pigment accumulate in post-mitotic and inter-mitotic cells during aging, The consensus is that the accumulation of this auto-fluorescent material is an index of cellular senescence. Biochemical and morphological studies have independently demonstrated marked age-related increases in the cell and tissue contents of lipofuscin. Most morphological studies on aging have been qualitative, have included only two or three age groups and have not yielded data that are easily correlated with biochemical analyses. One of the best documented age-related changes in hepatocytes and cardiac myocytes is the accumulation of dense bodies and lipofuscin inclusions. Independent stereologic studies reported two- to eightfold age-related increases in the dense body volume fraction of rat hepatocytes. Furthermore, we reported a fourfold increase in the dense body volume fraction of cardiac myocytes in rats between 6 and 30 months of age, These and other studies confirm the use of quantitative morphology to estimate the increases in dense body and lipofuscin inclusions as indices of age. Whether or not the accumulated lipofuscin compromises cell functions in senescent animals has not been adequately addressed. On the one hand, there is little evidence that several-fold increases in this subcellular compartment impair the functional capacities of either hepatocytes or cardiac myocytcs. On the other hand, the age-related accumulation of immunoprecipitable, but catalytically inactive, lysosomal enzymes in both liver and heart muscle may be a reflection of increased lipofuscin deposits in the dense bodies. (C) 2002 Published by Elsevier Science Ireland Ltd.
C1 Vet Affairs Med Ctr, Cell Biol & Aging Sect 151E, San Francisco, CA 94121 USA.
   Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   Penn State Univ, Milton S Hershey Med Ctr, Dept Anat & Neurosci, Hershey, PA 17033 USA.
   Penn State Univ, Office Dean, Harrisburg, PA USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Penn State Health; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University
RP Schmucker, DL (corresponding author), Vet Affairs Med Ctr, Cell Biol & Aging Sect 151E, 4150 Clement St, San Francisco, CA 94121 USA.
EM coach@itsa.ucsf.edu
CR DAVID H, 1985, HEPATOCYTE DEV DIFFE
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   IKEDA H, 1985, MECH AGEING DEV, V31, P139, DOI 10.1016/S0047-6374(85)80024-5
   IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IWASAKI K, 1988, ACTA PATHOL JAPON, V38, P1119
   KNOOK DL, 1976, MECH AGEING DEV, V5, P389, DOI 10.1016/0047-6374(76)90036-1
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MERTENSSTRIJTHAGEN J, 1989, ARCH BIOCHEM BIOPHYS, V274, P37, DOI 10.1016/0003-9861(89)90412-8
   PORTA EA, 1982, MECH AGEING DEV, V18, P159, DOI 10.1016/0047-6374(82)90085-9
   PORTA EA, 1991, INT CONGR SER, V940, P89
   PORTAL J, 1995, ORIENTAL ART, V41, P2
   SACHS HG, 1977, AM J ANAT, V150, P63, DOI 10.1002/aja.1001500105
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHMUCKER DL, 1979, AGE, V2, P93, DOI 10.1007/BF02432213
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SCHMUCKER DL, 1985, MECH AGEING DEV, V31, P89, DOI 10.1016/0047-6374(85)90028-4
   Sheehy MRJ, 1996, EXP GERONTOL, V31, P421, DOI 10.1016/0531-5565(95)02034-9
   TRAVIS DF, 1972, J ULTRA MOL STRUCT R, V39, P124, DOI 10.1016/S0022-5320(72)80013-3
   WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X
NR 22
TC 54
Z9 60
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAY-JUN
PY 2002
VL 34
IS 3
BP 249
EP 261
AR PII S0167-4943(01)00218-7
DI 10.1016/S0167-4943(01)00218-7
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 539PY
UT WOS:000174880700008
PM 14764327
DA 2024-02-19
ER

PT S
AU Malatesta, M
   Bertoni-Freddari, C
   Fattoretti, P
   Baldelli, B
   Fakan, S
   Gazzanelli, G
AF Malatesta, M
   Bertoni-Freddari, C
   Fattoretti, P
   Baldelli, B
   Fakan, S
   Gazzanelli, G
BE DeGrey, ADN
TI Aging and vitamin E deficiency are responsible for altered RNA pathways
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE aging; vitamin E deficiency; hepatocyte; nucleus; nucleolus; RNA
ID DAMAGE; CELLS
AB Fibrillar centers (FCs), dense fibrillar (DFC) and granular (GC) components in nucleoli, and perichromatin granules (PGs) in nucleoplasm were measured by morphometry. FC size and their nucleolar surface fraction significantly decreased in aging and vitamin E deficiency. The GC and DFC nucleolar fraction was unchanged in adult and old rats, but in vitamin E-deficient animals GC increased and DFC decreased significantly. PG density significantly increased in aging and decreased in vitamin E deficiency. The quantitative evaluation of immunolabeled transcription and splicing factors revealed that polymerase II and SC-35 significantly decreased in old and vitamin E-deficient versus adult animals. Fibrillarin and snRNPs did not change between adult and old rats, but were significantly lower in vitamin E-deficient rats. These data document altered RNA pathways in aging and vitamin E deficiency. Considering the antioxidant role of vitamin E, they lend further support to the importance of free radical production and control in the aging process.
C1 INRCA Res Dept, Neurobiol Aging Lab, I-60121 Ancona, Italy.
   Univ Urbino, Ist Istol & Anal Lab, I-61029 Urbino, Italy.
   Univ Lausanne, Ctr Electron Microscopy, CH-1015 Lausanne, Switzerland.
C3 IRCCS INRCA; University of Urbino; University of Lausanne
RP Bertoni-Freddari, C (corresponding author), INRCA Res Dept, Neurobiol Aging Lab, Via Birarelli 8, I-60121 Ancona, Italy.
EM c.bertoni@inrca.it
RI Fattoretti, Patrizia/A-8152-2011
OI MALATESTA, Manuela/0000-0001-8196-9232; Fattoretti,
   Patrizia/0000-0003-1998-0080
CR BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   BERTONIFREDDARI C, 1995, SCANNING MICROSCOPY, V9, P289
   Biggiogera M, 2001, J CELL SCI, V114, P3199
   BURTON GW, 1989, ANN NY ACAD SCI, V570, P7
   Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437
   Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5
   FRAGA CG, 1989, ARCH BIOCHEM BIOPHYS, V270, P84, DOI 10.1016/0003-9861(89)90010-6
   SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515
   SUMMERFIELD FW, 1984, ARCH BIOCHEM BIOPHYS, V233, P408, DOI 10.1016/0003-9861(84)90462-4
   VAZQUEZNIN GH, 1979, BIOL CELLULAIRE, V35, P221
NR 10
TC 12
Z9 12
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-497-8; 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 379
EP 382
DI 10.1196/annals.1297.067
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700067
PM 15247049
DA 2024-02-19
ER

PT J
AU Mocchegiani, E
   Giacconi, R
   Cipriano, C
   Muzzioli, M
   Fattoretti, P
   Bertoni-Freddari, C
   Isani, G
   Zambenedetti, P
   Zatta, P
AF Mocchegiani, E
   Giacconi, R
   Cipriano, C
   Muzzioli, M
   Fattoretti, P
   Bertoni-Freddari, C
   Isani, G
   Zambenedetti, P
   Zatta, P
TI Zinc-bound metallothioneins as potential biological markers of ageing
SO BRAIN RESEARCH BULLETIN
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Metals and the Brain
CY SEP 20-23, 2000
CL UNIV PADOVA, PADUA, ITALY
SP UN Educ, Sci & Cultural Org, Natl Res Council Italy, European Union Project Metals Med
HO UNIV PADOVA
DE immune system; endocrine system; nervous system; metallothionein
   isoforms; neuroprotection; neurotoxicity
ID PROTEIN-KINASE-C; ALZHEIMERS-DISEASE; GENE-EXPRESSION; RAT-BRAIN;
   STRESS; CELLS; MOUSE; SUPPLEMENTATION; LOCALIZATION; DEFICIENCY
AB Metallothioneins (MTs) (I+II) play pivotal roles in metal-related cell homeostasis because of their high affinity for metals forming clusters. The main functional role of MTs is to sequester and/or dispense zinc participating in zinc homeostasis. Consistent with this role, MT gene expression is trascriptionally induced by a variety of stressing agents to protect cells from reactive oxygen species. In order to accomplish this task, MTs induce the secretion of pro-inflammatory cytokines by immune and brain cells, such as astrocytes, for a prompt response against oxidative stress. These cytokines are in turn involved in new synthesis of MTs in the liver and brain. Such protective mechanism occurs in the young-adult age, when stresses are transient. Stress-like condition is instead constant in the old age, and this causes continuous stealing of intracellular zinc by MTs and consequent low bioavailability of zinc ions for immune, endocrine, and cerebral functions. Therefore, a protective role of zinc-bound MTs (I+II) during ageing can be questioned. Because free zinc ions are required for optimal efficiency of the immune-endocrine-nervous network, zinc-bound MTs (I+II) may play a different role during ageing, switching from a protective to a deleterious one in immune, endocrine, and cerebral activities. Physiological zinc supply, performed cautiously, can correct deficiencies in the immune-neuroendocrine network and can improve cognitive performances during ageing and accelerated ageing. Altogether these data indicate that zinc-bound MTs (I+II) can be considered as novel potential markers of ageing. (C) 2001 Elsevier Science Inc.
C1 Italian Natl Res Ctr Ageing, Dept Res, Sect Nutr Immun & Ageing, Ctr Immunol, I-60121 Ancona, Italy.
   Italian Natl Res Ctr Ageing, Dept Res, Neurobiol Ctr, I-60121 Ancona, Italy.
   Univ Bologna, Fac Vet Med, Inst Biochem, Bologna, Italy.
   Univ Padua, Dept Biol, CNR, Ctr Metalloprot, Padua, Italy.
C3 IRCCS INRCA; IRCCS INRCA; University of Bologna; Consiglio Nazionale
   delle Ricerche (CNR); University of Padua
RP Mocchegiani, E (corresponding author), Italian Natl Res Ctr Ageing, Dept Res, Sect Nutr Immun & Ageing, Ctr Immunol, Via Birarelli 8, I-60121 Ancona, Italy.
EM e.mocchegiani@inrca.it
RI Fattoretti, Patrizia/A-8152-2011; Giacconi, Robertina/J-5349-2018
OI Giacconi, Robertina/0000-0002-1468-2140; Isani,
   Gloria/0000-0002-3911-8749
CR Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Becher B, 2000, GLIA, V29, P293
   Belloso E, 1996, NEUROENDOCRINOLOGY, V64, P430, DOI 10.1159/000127149
   Brady F O, 1987, Experientia Suppl, V52, P555
   BUI LM, 1994, P SOC EXP BIOL MED, V206, P438, DOI 10.3181/00379727-206-43784
   BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293
   Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870
   Carrasco J, 1998, MOL BRAIN RES, V57, P221, DOI 10.1016/S0169-328X(98)00087-4
   Carrasco J, 1999, J NEUROTRAUM, V16, P1115, DOI 10.1089/neu.1999.16.1115
   Cherian MG, 2000, CELL MOL BIOL, V46, P347
   CLAUSEN J, 1989, BIOL TRACE ELEM RES, V20, P135, DOI 10.1007/BF02919106
   COTO JA, 1992, P NATL ACAD SCI USA, V89, P7752, DOI 10.1073/pnas.89.16.7752
   Cousins RJ, 1998, P NUTR SOC, V57, P307, DOI 10.1079/PNS19980045
   Cui L, 1998, J NUTR, V128, P1092, DOI 10.1093/jn/128.7.1092
   Dawson TM, 1996, ANNU REV MED, V47, P219, DOI 10.1146/annurev.med.47.1.219
   DeMoor JM, 2000, CELL MOL BIOL, V46, P367
   Deng DX, 1999, TOXICOLOGY, V134, P39
   DUGUID JR, 1989, P NATL ACAD SCI USA, V86, P7260, DOI 10.1073/pnas.86.18.7260
   Fabris N, 1997, EXP GERONTOL, V32, P415, DOI 10.1016/S0531-5565(96)00166-0
   FABRIS N, 1994, GROWTH HORMONE TREAT, P203
   HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913
   Hidalgo J, 1998, NEUROTOXICOLOGY, V19, P661
   Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S
   JACOB RA, 1985, HDB NUTR AGED, P77
   Jacob ST, 1999, GENE EXPRESSION, V7, P301
   KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001
   Kelly EJ, 1996, J NUTR, V126, P1782
   KLAASSEN CD, 1994, ENVIRON HEALTH PERSP, V102, P141, DOI 10.2307/3431778
   Kojima S, 1999, J VET MED SCI, V61, P343, DOI 10.1292/jvms.61.343
   Kramer JR, 2000, ANN BEHAV MED, V22, P17, DOI 10.1007/BF02895164
   Leverenz JB, 1998, EXP NEUROL, V150, P296, DOI 10.1006/exnr.1997.6777
   MANCINI M, 1992, NEUROBIOL AGING, V13, P501, DOI 10.1016/0197-4580(92)90078-C
   Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478
   MASTERS BA, 1994, J NEUROSCI, V14, P5844
   Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X
   Minami T, 1999, TOXICOLOGY, V132, P33, DOI 10.1016/S0300-483X(98)00138-3
   Mocchegiani E, 1998, MECH AGEING DEV, V106, P183, DOI 10.1016/S0047-6374(98)00115-8
   Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0
   Mocchegiani E, 2000, MECH AGEING DEV, V121, P21
   MOCCHEGIANI E, 2000, METAL IONS BIOL MED, V6, P150
   MOCCHEGIANI E, 2000, J CHEMOTHERAPY S6, V12, P160
   Molinero A, 1998, NEUROCHEM INT, V33, P559, DOI 10.1016/S0197-0186(98)00065-5
   Nishino H., 1995, Neurobiology (Budapest), V3, P257
   OTVOS JD, 1993, METALLOTHIONEIN, V3, P57
   Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428
   PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333
   Penkowa M, 2000, EXP NEUROL, V163, P72, DOI 10.1006/exnr.2000.7383
   Penkowa M, 1999, J COMP NEUROL, V412, P303, DOI 10.1002/(SICI)1096-9861(19990920)412:2<303::AID-CNE9>3.0.CO;2-G
   Rabbitt P, 2000, PSYCHOL RES-PSYCH FO, V63, P308, DOI 10.1007/s004269900009
   Roesijadi G, 2000, CELL MOL BIOL, V46, P393
   Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9
   Sato M, 1996, INT J IMMUNOPHARMACO, V18, P167, DOI 10.1016/0192-0561(95)00118-2
   SCORTENGAGNA M, 1998, BRAIN RES, V32, P169
   SMITT PAES, 1992, NEUROSCI LETT, V144, P107, DOI 10.1016/0304-3940(92)90727-O
   SUZUKI K, 1992, ACTA HISTOCHEM CYTOC, V25, P617, DOI 10.1267/ahc.25.617
   SUZUKI KT, 1995, RES COMMUN MOL PATH, V87, P287
   Tohei A, 1997, J ENDOCRINOL, V152, P147, DOI 10.1677/joe.0.1520147
   Tomita T, 2000, MODERN PATHOL, V13, P389, DOI 10.1038/modpathol.3880064
   VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79
   Viticchi C, 1999, GERONTOLOGY, V45, P265, DOI 10.1159/000022099
   Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8
   Yamada M, 1996, BRAIN RES, V735, P257, DOI 10.1016/0006-8993(96)00586-0
   Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25
   Yu CW, 1997, FEBS LETT, V420, P69, DOI 10.1016/S0014-5793(97)01489-0
   Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6
NR 66
TC 53
Z9 64
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD MAY 15
PY 2001
VL 55
IS 2
BP 147
EP 153
DI 10.1016/S0361-9230(01)00468-3
PG 7
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Neurosciences & Neurology
GA 456ZL
UT WOS:000170112600004
PM 11470310
DA 2024-02-19
ER

PT J
AU Mirzavi, F
   Rajabian, A
   Boroumand-Noughabi, S
   Hosseini, A
   Boroushaki, MT
   Hassanzadeh, S
AF Mirzavi, Farshad
   Rajabian, Arezoo
   Boroumand-Noughabi, Samaneh
   Hosseini, Azar
   Boroushaki, Mohammad Taher
   Hassanzadeh, Sonita
TI Standardized extract of <i>Sanguisorba minor</i> attenuates injury in
   aging rat model <i>via</i> the Nrf2/HO-1 pathway
SO ACTA NEUROBIOLOGIAE EXPERIMENTALIS
LA English
DT Article
DE Sanguisorba minor; aging; D-galactose; liver function; neurodegeneration
ID INDUCED OXIDATIVE STRESS; MEDICINAL-PLANTS; IN-VITRO;
   ACETYLCHOLINESTERASE; APOPTOSIS; PROTECTS
AB Aging promotes damage to vulnerable organs like brain and liver. Sanguisorba minor has been traditionally used to cure various ailments. Few studies have reported pharmacological activities of this medicinal plant. This research aimed to investigate the effects of Sanguisorba minor extract (SME) on brain and liver injury in aging rats and identify the underlying mechanisms. The aging model was developed by subcutaneously injecting D-galactose and simultaneously treating them with SME. After biochemical and pathological assessments, mRNA expression levels of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) and Nrf2- regulated gene, heme oxygenase-1 (HO-1), in the brain and liver tissues were determined. As a result, malondialdehyde and acetylcholinesterase levels were elevated while total thiol content and superoxide dismutase were reduced in the aging rats. Treatment with the extract remarkably attenuated oxidative injury and pathological changes in liver and brain tissues. Concomitantly, the extract up-regulated Nrf2 and HO-1 genes. Our findings exhibited SME may improve the aging-related brain and liver damage through the Nrf2-HO-1 pathway.
C1 [Mirzavi, Farshad] Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran.
   [Rajabian, Arezoo] Mashhad Univ Med Sci, Fac Med, Dept Internal Med, Mashhad, Razavi Khorasan, Iran.
   [Boroumand-Noughabi, Samaneh] Mashhad Univ Med Sci, Dept Pathol, Mashhad, Razavi Khorasan, Iran.
   [Boroumand-Noughabi, Samaneh] Mashhad Univ Med Sci, Fac Med, Dept Hematol & Blood Banking, Mashhad, Razavi Khorasan, Iran.
   [Hosseini, Azar; Boroushaki, Mohammad Taher; Hassanzadeh, Sonita] Mashhad Univ Med Sci, Fac Med, Dept Pharmacol, Mashhad, Razavi Khorasan, Iran.
   [Hosseini, Azar; Boroushaki, Mohammad Taher] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran.
C3 Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science; Mashhad University Medical Science;
   Mashhad University Medical Science
RP Rajabian, A (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Internal Med, Mashhad, Razavi Khorasan, Iran.
EM rajabianar@mums.ac.ir
RI Mirzavi, Farshad/AAA-3336-2022
OI Mirzavi, Farshad/0000-0003-4686-1511
FU Mashhad University of Medical Sciences [990936]
FX This study was originated from MD project of Sonita Hassanzadeh. The
   authors appreciate the Vice Chancellor for Research and Technology,
   Mashhad University of Medical Sciences for financial support (Grant No.
   990936).; This project was financially supported by Vice Chancellery for
   Research and Technology, Mashhad University of Medical Sciences for
   financial support (Grant No. 990936).
CR Ademosun AO, 2016, J EVID-BASED INTEGR, V21, pNP11, DOI 10.1177/2156587215610032
   Akbari S., 2019, J. Herbmed Pharmacol, V8, P248, DOI [10.15171/jhp.2019.36, DOI 10.15171/JHP.2019.36]
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Beheshti F, 2021, CLIN EXP HYPERTENS, V43, P505, DOI 10.1080/10641963.2021.1901112
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Cirovic T, 2020, ACTA POL PHARM, V77, P745, DOI 10.32383/appdr/127765
   Dornelles GL, 2020, NEUROCHEM RES, V45, P2456, DOI 10.1007/s11064-020-03105-z
   Ferreira A, 2006, J ETHNOPHARMACOL, V108, P31, DOI 10.1016/j.jep.2006.04.010
   Finimundy TC, 2020, FOOD CHEM, V327, DOI 10.1016/j.foodchem.2020.127043
   Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2
   Hosseini M, 2015, CHIN J INTEGR MED, V21, P438, DOI 10.1007/s11655-014-1742-5
   Khan H, 2018, BIOMED PHARMACOTHER, V101, P860, DOI 10.1016/j.biopha.2018.03.007
   Li B, 2020, BIOMED PHARMACOTHER, V126, DOI 10.1016/j.biopha.2020.110074
   Li TT, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103594
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moradzadeh M, 2019, JUNDISHAPUR J NAT PH, V14, DOI 10.5812/jjnpp.12198
   Nguyen TTH, 2008, BIOL PHARM BULL, V31, P2028, DOI 10.1248/bpb.31.2028
   Rajabian Arezoo, 2019, Prev Nutr Food Sci, V24, P363, DOI 10.3746/pnf.2019.24.4.363
   Rajabian A, 2016, DNA CELL BIOL, V35, P666, DOI 10.1089/dna.2016.3332
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Soodi M, 2017, RES J PHARMACOGN, V4, P15
   Szwajgier D, 2013, Z NATURFORSCH C, V68, P125, DOI 10.5560/ZNC.2013.68c0125
   Wei HY, 2017, MAR DRUGS, V15, DOI 10.3390/md15030077
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhao ZF, 2017, AM J CHINESE MED, V45, P199, DOI 10.1142/S0192415X17500136
NR 28
TC 0
Z9 0
U1 0
U2 1
PU NENCKI INST EXPERIMENTAL BIOLOGY
PI WARSAW
PA UL PASTEURA 3, 02-093 WARSAW, POLAND
SN 0065-1400
EI 1689-0035
J9 ACTA NEUROBIOL EXP
JI Acta Neurobiol. Exp.
PY 2022
VL 82
IS 4
PG 9
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 8R0OO
UT WOS:000927598500006
DA 2024-02-19
ER

PT J
AU Taddei, TH
   Lo Re, V
   Justice, AC
AF Taddei, Tamar H.
   Lo Re, Vincent, III
   Justice, Amy C.
TI HIV, Aging, and Viral Coinfections: Taking the Long View
SO CURRENT HIV/AIDS REPORTS
LA English
DT Article
DE HIV; Viral hepatitis; Liver disease; HPV; Cancer; Aging; Coinfection
ID HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; SUSTAINED VIROLOGICAL
   RESPONSE; ORAL HPV INFECTION; HEPATOCELLULAR-CARCINOMA; B-VIRUS;
   ANTIRETROVIRAL THERAPY; RISK-FACTORS; T-CELLS; HUMAN-PAPILLOMAVIRUS
AB Viral suppression of human immunodeficiency virus (HIV) with combination antiviral therapy (cART) has led to increasing longevity but has not enabled a complete return to health among aging HIV-infected individuals (HIV+). Viral coinfections are prevalent in the HIV+ host and are implicated in cancer, liver disease, and accelerated aging. We must move beyond a simplistic notion of HIV becoming a "chronic controllable illness" and develop an understanding of how viral suppression alters the natural history of HIV infection, especially at the intersection of HIV with other common viral coinfections in the context of an altered, aging immune system.
C1 [Taddei, Tamar H.] VA Connecticut Healthcare Syst, Sect Digest Dis, West Haven, CT USA.
   [Taddei, Tamar H.] Yale Univ, Sch Med, Sect Digest Dis, 333 Cedar St,POB 208019, New Haven, CT 06520 USA.
   [Lo Re, Vincent, III] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Perelman Sch, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
   [Justice, Amy C.] VA Connecticut Healthcare Syst, Vet Aging Cohort Study Coordinating Ctr, West Haven, CT 06516 USA.
   [Justice, Amy C.] Yale Univ, Sch Med, Div Gen Internal Med, 333 Cedar St, New Haven, CT 06520 USA.
   [Justice, Amy C.] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.
   [Justice, Amy C.] Yale Sch Med, Bldg 35A,Room 2-212,11 ACSLG,950 Campbell Ave, West Haven, CT 06516 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Connecticut Healthcare System; Yale University; University of
   Pennsylvania; University of Pennsylvania; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare
   System; Yale University; Yale University; Yale University
RP Justice, AC (corresponding author), VA Connecticut Healthcare Syst, Vet Aging Cohort Study Coordinating Ctr, West Haven, CT 06516 USA.; Justice, AC (corresponding author), Yale Univ, Sch Med, Div Gen Internal Med, 333 Cedar St, New Haven, CT 06520 USA.; Justice, AC (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.; Justice, AC (corresponding author), Yale Sch Med, Bldg 35A,Room 2-212,11 ACSLG,950 Campbell Ave, West Haven, CT 06516 USA.
EM tamar.taddei@yale.edu; vincentl@mail.med.upenn.edu; amy.justice2@va.gov
OI Taddei, Tamar/0000-0002-6500-1739
FU Bayer Healthcare Pharmaceuticals; Onyx (Amgen) Pharmaceuticals;
   NIH-NIAAA
FX Tamar H. Taddei reports grants from Bayer Healthcare Pharmaceuticals and
   consulting fees from Onyx (Amgen) Pharmaceuticals.; Amy C. Justice
   reports grants from NIH-NIAAA.
CR Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234
   Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004
   Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869
   Anderson JP, 2014, CLIN INFECT DIS, V58, P719, DOI 10.1093/cid/cit779
   [Anonymous], 2014, J AIDS CLIN RES
   Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595
   Bailony MR, 2013, J INFECT DIS, V208, P1776, DOI 10.1093/infdis/jit357
   Beachler DC, 2015, AM J EPIDEMIOL, V181, P40, DOI 10.1093/aje/kwu247
   Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170
   Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734
   Berretta M, 2011, ONCOLOGIST, V16, P1258, DOI 10.1634/theoncologist.2010-0400
   Bourcier V, 2012, CLIN RES HEPATOL GAS, V36, P214, DOI 10.1016/j.clinre.2011.11.002
   Bräu N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010
   Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596
   Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65
   Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17
   Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039
   Childs K, 2016, AIDS, V30, P975, DOI 10.1097/QAD.0000000000001042
   Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Collins JM, 2015, CLIN INFECT DIS, V61, P1304, DOI 10.1093/cid/civ474
   Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d
   DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6
   Diop-Ndiaye H, 2008, J MED VIROL, V80, P1332, DOI 10.1002/jmv.21236
   Dubrow R, 2012, CURR OPIN ONCOL, V24, P506, DOI 10.1097/CCO.0b013e328355e131
   Effros RB, 2015, SILENT WAR CMV AGING
   El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001
   European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007
   Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   Gramenzi A, 2013, DIGEST LIVER DIS, V45, P516, DOI 10.1016/j.dld.2012.12.010
   Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800
   Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6
   Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135
   Kim RH, 2008, INT J ONCOL, V33, P777, DOI 10.3892/ijo_00000064
   Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe
   Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239
   Kwo Paul Y, 2015, Gastroenterology, V148, P1470, DOI 10.1053/j.gastro.2015.04.031
   Labarga P, 2015, ANTIVIR THER, V20, P65, DOI 10.3851/IMP2827
   Lee HC, 2008, J FORMOS MED ASSOC, V107, P404, DOI 10.1016/S0929-6646(08)60106-0
   Lee SH, 2016, LAB INVEST
   Lim JK, 2014, CLIN INFECT DIS, V58, P1449, DOI 10.1093/cid/ciu097
   Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005
   Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926
   Lo Re V, 2016, ANN INTERN MED, V164, P64, DOI 10.7326/M15-2722
   Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829
   López-Diéguez M, 2011, AIDS, V25, P899, DOI 10.1097/QAD.0b013e3283454174
   Lu M, 2016, CLIN GASTROENTEROL H
   Mandorfer M, 2015, LIVER INT, V35, P876, DOI 10.1111/liv.12615
   Marcellin F, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu525
   McGlynn KA, 2011, CLIN LIVER DIS, V15, P223, DOI 10.1016/j.cld.2011.03.006
   Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1
   Merchante N, 2009, GUT, V58, P1654, DOI 10.1136/gut.2009.179085
   Merchante N, 2013, CLIN INFECT DIS, V56, P143, DOI 10.1093/cid/cis777
   Ramírez MLM, 2014, JAIDS-J ACQ IMM DEF, V65, P82, DOI 10.1097/QAI.0b013e3182a685dc
   Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744
   Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073
   Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886
   Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315
   Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004
   Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373
   Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481
   Park LS, 2016, AIDS, V30, P273, DOI 10.1097/QAD.0000000000000922
   Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582
   Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276
   Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Perrillo RP, 2015, JAMA-J AM MED ASSOC, V313, P1617, DOI 10.1001/jama.2015.2571
   Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626
   Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502
   Raffetti E, 2016, LIVER INT
   Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4
   Rector JL, 2015, DIABETOLOGIA, V58, P2596, DOI 10.1007/s00125-015-3731-4
   Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x
   Robbins HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143698
   Robbins HA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju503
   Romeo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092062
   Ryom L, 2016, AIDS
   Sahasrabuddhe VV, 2012, CANCER-AM CANCER SOC, V118, P6226, DOI 10.1002/cncr.27694
   Salmon D, 2015, AIDS, V29, P1821, DOI 10.1097/QAD.0000000000000787
   Sanmartin R, 2014, HIV MED, V15, P203, DOI 10.1111/hiv.12105
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128
   Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076
   Shoham N, 2003, VIRUS RES, V98, P57, DOI 10.1016/j.virusres.2003.08.016
   Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012
   Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f
   Soriano V, 2015, CURR HIV-AIDS REP, V12, P344, DOI 10.1007/s11904-015-0275-7
   Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328
   Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734
   Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1
   Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018
   van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026
   van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878
   van Manen Danielle, 2012, Retrovirology, V9, P70, DOI 10.1186/1742-4690-9-70
   Fernández-Montero JV, 2014, CLIN INFECT DIS, V58, P1549, DOI 10.1093/cid/ciu167
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x
   Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048
   Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153
   Yopp AC, 2012, CLIN GASTROENTEROL H, V10, P1284, DOI 10.1016/j.cgh.2012.08.010
   Zator ZA, 2013, CURR HIV-AIDS REP, V10, P428, DOI 10.1007/s11904-013-0181-9
   Zhong R, 2015, CANCER RES, V75, P3958, DOI 10.1158/0008-5472.CAN-15-0199
NR 112
TC 18
Z9 20
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1548-3568
EI 1548-3576
J9 CURR HIV-AIDS REP
JI Curr. Hiv/Aids Rep.
PD OCT
PY 2016
VL 13
IS 5
BP 269
EP 278
DI 10.1007/s11904-016-0327-7
PG 10
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA DX7CO
UT WOS:000384544000005
PM 27614654
DA 2024-02-19
ER

PT J
AU Zhou, L
   Ding, XM
   Wang, JP
   Bai, SP
   Zeng, QF
   Su, ZW
   Xuan, Y
   Zhang, KY
AF Zhou, Ling
   Ding, Xuemei
   Wang, Jianping
   Bai, Shiping
   Zeng, Qiufeng
   Su, Zuowei
   Xuan, Yue
   Zhang, Keying
TI Tea polyphenols increase the antioxidant status of laying hens fed diets
   with different levels of ageing corn
SO ANIMAL NUTRITION
LA English
DT Article
DE Tea polyphenol; Antioxidant capacity; Laying hen; Ageing corn
ID ALPHA-TOCOPHERYL ACETATE; EGG-YOLK; OXIDATIVE STRESS; FATTY-ACIDS; GREEN
   TEA; GENE-EXPRESSION; PERFORMANCE; QUALITY; PRODUCTS; CAPACITY
AB This study was conducted to evaluate the effects of ageing corn levels (stored for 4 years) with or without the supplementation of tea polyphenols (TPP) on the performance, egg quality and antioxidant status of laying hens. A total of 288 Lohmann commercial laying hens (63-week-old) were used under a 2 x 4 factorial arrangement with 4 levels of dietary ageing corn (0%, 25%, 50%, or 100%) and 2 levels of TPP (0 and 600 mg/kg) for 8 wk. Dietary ageing corn linearly decreased (P < 0.05) the egg production, serum total antioxidant capacity (T-AOC), liver glutathione peroxidase (GSH-Px) of laying hens, yolk index, yolk colour, 1,1-diphenyl-2-picrylhydrazyl (DPPH) value and the reducing power value of egg yolk, but it linearly increased (P < 0.05) the feed conversion rate, ovary malondialdehyde (MDA) content of laying hens, and the protein carbonyl content of egg yolk. Tea polyphenol supplementation increased (P < 0.05) the serum T-AOC, serum superoxide dismutase (SOD), liver SOD, liver GSH-Px, ovary SOD, GSH-Px, the expression of antioxidant-related genes of laying hens, albumen height, Haugh unit, DPPH value and the majority free amino acids of egg yolk, but it decreased (P < 0.05) the serum MDA content of laying hens, MDA and protein carbonyl of egg yolk. In conclusion, the ageing corn significantly reduced the performance, egg quality, antioxidant status and egg antioxidant capacity of laying hens, while TPP supplementation partially counteracted the adverse effects, especially antioxidant status and egg antioxidant capacity of laying hens. (C) 2021 Chinese Association of Animal Science and Veterinary Medicine. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
C1 [Zhou, Ling; Ding, Xuemei; Wang, Jianping; Bai, Shiping; Zeng, Qiufeng; Su, Zuowei; Xuan, Yue; Zhang, Keying] Sichuan Agr Univ, China Minist Educ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, 211 Huimin Rd, Chengdu 611130, Peoples R China.
   [Zhou, Ling] Yibin Univ, Fac Qual Management & Inspect & Quarantine, Yibin 644007, Peoples R China.
C3 Sichuan Agricultural University; Yibin University
RP Zhang, KY (corresponding author), Sichuan Agr Univ, China Minist Educ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, 211 Huimin Rd, Chengdu 611130, Peoples R China.
EM zkeying@sicau.edu.cn
RI Ding, Xuemei/B-6619-2013
OI Ding, Xuemei/0000-0002-1830-1990
FU National Science and Technology Project [2014BAD13B04]; Sichuan
   Provincial Science and Technology Project [2018NZ20009]
FX This workwas financially supported by the National Science and
   Technology Project (2014BAD13B04), Sichuan Provincial Science and
   Technology Project (2018NZ20009).
CR [Anonymous], 2004, NYT332004 MIN AGR PE
   AOAC International, 2006, OFFICIAL METHODS ANA
   Ariana M, 2011, J MED PLANTS RES, V5, P2710
   Attia YA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00181
   Attia YA, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3294
   Attia YA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0133-z
   Baskol M, 2008, J CLIN GASTROENTEROL, V42, P687, DOI 10.1097/MCG.0b013e318074f91f
   Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7
   Botsoglou E, 2012, FOOD CHEM, V134, P1059, DOI 10.1016/j.foodchem.2012.03.014
   Chaudhury S, 2015, INT J BIOL MACROMOL, V77, P287, DOI 10.1016/j.ijbiomac.2015.03.040
   Cherian G, 2007, POULTRY SCI, V86, P953, DOI 10.1093/ps/86.5.953
   Coimbra S, 2006, CLIN NUTR, V25, P790, DOI 10.1016/j.clnu.2006.01.022
   Dávalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939
   de Oliveira GPR, 2007, J FOOD SCI, V72, pS79, DOI 10.1111/j.1750-3841.2006.00235.x
   del Angel SS, 2003, FOOD CHEM, V83, P531, DOI 10.1016/S0308-8146(03)00149-3
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   FUNK EM, 1948, POULTRY SCI, V27, P367, DOI 10.3382/ps.0270367
   Gladkowski W, 2011, FOOD CHEM, V126, P1013, DOI 10.1016/j.foodchem.2010.11.112
   Katayama S, 2007, J AGR FOOD CHEM, V55, P2829, DOI 10.1021/jf0628936
   Kirunda DFK, 2000, POULTRY SCI, V79, P1189, DOI 10.1093/ps/79.8.1189
   Klompong V, 2008, INT J FOOD SCI TECH, V43, P1019, DOI 10.1111/j.1365-2621.2007.01555.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Ministry of Health of the People's Republic of China and Standardization Administration of China, 2016, 50091682016 NAT HLTH
   Ministry of Health of the People's Republic of China and Standardization Administration of China, 2015, GUIDELINES EVALUATIO
   Moros EE, 2002, J AGR FOOD CHEM, V50, P5787, DOI 10.1021/jf020109l
   Morrison WR, 2006, J AGR FOOD CHEM, V14, P870
   Mu YD, 2019, J ANIM PHYSIOL AN N, V103, P135, DOI 10.1111/jpn.13017
   Nimalaratne C, 2016, FOOD CHEM, V194, P111, DOI 10.1016/j.foodchem.2015.07.116
   Nimalaratne C, 2015, NUTRIENTS, V7, P8274, DOI 10.3390/nu7105394
   Nimalaratne C, 2011, FOOD CHEM, V129, P155, DOI 10.1016/j.foodchem.2011.04.058
   Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006
   Qi GY, 2017, RSC ADV, V7, P32198, DOI 10.1039/c7ra05000c
   Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008
   Rehman ZU, 2002, FOOD CHEM, V77, P197, DOI 10.1016/S0308-8146(01)00337-5
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   Wang FW, 2012, PLANT GROWTH REGUL, V66, P49, DOI 10.1007/s10725-011-9628-4
   Wang JP, 2020, FOOD FUNCT, V11, P534, DOI [10.1039/C9FO02157D, 10.1039/c9fo02157d]
   Warnants N, 1996, MEAT SCI, V44, P125, DOI 10.1016/S0309-1740(96)00029-0
   Wu DW, 2014, POULTRY SCI, V93, P326, DOI 10.3382/ps.2013-03507
   Yan L, 2011, DIABETES RES CLIN PR, V93, P214
   Yang J, 2018, FOOD CHEM, V240, P1063, DOI 10.1016/j.foodchem.2017.07.127
   Yin DF, 2017, ANIM NUTR, V3, P252, DOI 10.1016/j.aninu.2017.04.007
   Yuan ZH, 2016, POULTRY SCI, V95, P1709, DOI 10.3382/ps/pew097
   Yue HY, 2011, POULTRY SCI, V90, P1728, DOI 10.3382/ps.2011-01354
   Zhang T, 2011, FOOD CHEM, V128, P28, DOI 10.1016/j.foodchem.2011.02.072
   Zhang Y, 2020, J AGR FOOD CHEM, V68, P530, DOI 10.1021/acs.jafc.9b05104
   Zhou L, 2019, ANIM FEED SCI TECH, V256, DOI 10.1016/j.anifeedsci.2019.114242
   Zhou X, 2019, FOOD CHEM, V272, P109, DOI 10.1016/j.foodchem.2018.08.019
   Zhou Z, 2002, J CEREAL SCI, V35, P65, DOI 10.1006/jcrs.2001.0418
   Zia-Ur-Rehman, 2006, FOOD CHEM, V95, P53, DOI 10.1016/j.foodchem.2004.12.017
NR 52
TC 10
Z9 10
U1 11
U2 45
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG
   DISTRICT 100009, PEOPLES R CHINA
SN 2405-6383
EI 2405-6545
J9 ANIM NUTR
JI Anim. Nutr.
PD SEP
PY 2021
VL 7
IS 3
BP 650
EP 660
DI 10.1016/j.aninu.2020.08.013
PG 11
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Veterinary Sciences
GA UY7PU
UT WOS:000701712000007
PM 34401543
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yao, J
   Chen, N
   Wang, XJ
   Zhang, LS
   Huo, JL
   Chi, Y
   Li, ZJ
   Han, ZC
AF Yao, Jun
   Chen, Nan
   Wang, Xiaojing
   Zhang, Leisheng
   Huo, Jiali
   Chi, Ying
   Li, Zongjin
   Han, Zhongchao
TI Human Supernumerary Teeth-Derived Apical Papillary Stem Cells Possess
   Preferable Characteristics and Efficacy on Hepatic Fibrosis in Mice
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID MESENCHYMAL STROMAL CELLS; DENTAL-PULP
AB Dental tissue has been acknowledged as an advantaged source for high-quality dental pulp stem cell (DPSC) preparation. However, despite the accomplishment of the separation of DPSCs from permanent teeth and supernumerary teeth, the deficiency of rigorous and systematic clarification on the signatures and efficacy will hinder their prospects in regenerative medicine. In this study, we primitively isolated permanent teeth-derived DPSCs and supernumerary teeth-derived apical papillary stem cells (SCAP-Ss) with parental consent. Immunophenotype of DPSCs and SCAP-Ss was determined by a flow cytometry assay, and the cell viability was verified by multidimensional detections including cell proliferation, cell cycle, apoptosis, and senescence. The migration and clonogenic capacity were examined by a wound healing test and crystal violet staining, respectively. The multilineage differentiation potential was quantitated by utilizing Oil Red O staining and Alizarin Red staining, together with real-time PCR analysis. The efficacy on a mouse hepatic fibrosis model was evaluated by using histologic sections and liver function tests. Herein, we showed that SCAP-Ss exhibited comparable immunophenotype and adipogenic differentiation capacity as DPSCs. However, different from DPSCs, SCAP-Ss exhibited superiority in cell viability and osteogenic differentiation. Simultaneously, injection of DPSCs and SCAP-Ss significantly reduced inflammatory infiltration, enhanced liver-associated gene expression, and finally relieved symptoms of hepatic fibrosis. In conclusion, SCAP-Ss possess preferable characteristics and efficacy on hepatic fibrosis in mice. Our findings suggest that SCAP-Ss are an easily accessible postnatal stem cell source with multifaceted characteristics for regenerative medicine.
C1 [Yao, Jun; Chen, Nan; Wang, Xiaojing] Fujian Med Univ, Sch & Hosp Stomatol, Fuzhou, Peoples R China.
   [Zhang, Leisheng] Nankai Univ, Med Coll, Postdoctoral Res Stn, Tianjin, Peoples R China.
   [Zhang, Leisheng; Li, Zongjin] Hlth Biotech Tianjin Stem Cell Res Inst Co Ltd, Precis Med Div, Tianjin 301700, Peoples R China.
   [Zhang, Leisheng; Huo, Jiali; Chi, Ying; Han, Zhongchao] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Tianjin, Peoples R China.
   [Zhang, Leisheng; Huo, Jiali; Chi, Ying; Han, Zhongchao] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China.
   [Zhang, Leisheng; Huo, Jiali; Chi, Ying; Han, Zhongchao] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China.
C3 Fujian Medical University; Nankai University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Peking Union Medical College;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; Institute of Hematology & Blood Diseases
   Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Institute of Hematology & Blood Diseases Hospital -
   CAMS; Peking Union Medical College
RP Zhang, LS (corresponding author), Nankai Univ, Med Coll, Postdoctoral Res Stn, Tianjin, Peoples R China.; Zhang, LS (corresponding author), Hlth Biotech Tianjin Stem Cell Res Inst Co Ltd, Precis Med Div, Tianjin 301700, Peoples R China.; Zhang, LS (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Zhang, LS (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China.; Zhang, LS (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China.
EM dentyao@163.com; 398577287@qq.com; wangxj2925@foxmail.com;
   zhangleisheng@health-biotech.com; huojiali1990@163.com;
   chiying@ihcams.ac.cn; zongjinli@nankai.edu.cn;
   hanzhongchao@health-biotech.com
RI Zhang, Leisheng/AAM-1258-2020; Li, Zongjin/G-3118-2010; Li,
   Zongjin/A-1115-2014
OI Zhang, Leisheng/0000-0001-6540-0943; Li, Zongjin/0000-0002-4603-3743;
   Li, Zongjin/0000-0002-4603-3743
FU Natural Science Foundation of Tianjin - China Postdoctoral Science
   Foundation [19JCQNJC12500, 2019M661033]; Science and Technology Project
   of Tianjin [17ZXSCSY00030]; Wuqing Innovation Fund for Science and
   Technology Enterprises [WQKW-2018-HB10]; Nanyang Science and Technology
   Project of Henan Province [JCQY012]; National Natural Science Foundation
   of China [81330015, 81900126]
FX The work was supported by the Natural Science Foundation of Tianjin
   (19JCQNJC12500), project funded by the China Postdoctoral Science
   Foundation (2019M661033), Science and Technology Project of Tianjin
   (17ZXSCSY00030), Wuqing Innovation Fund for Science and Technology
   Enterprises (WQKW-2018-HB10), Nanyang Science and Technology Project of
   Henan Province (JCQY012), and National Natural Science Foundation of
   China (81330015 and 81900126). The authors thank Professor Dengke Liu in
   the Enterprise Postdoctoral Working Station of Tianjin Chase Sun
   Pharmaceutical Co., Ltd. for their constructive suggestions. Also, we
   thank the Health-Biotech (Tianjin) Stem Cell Research Institute Co.,
   Ltd. and Postdoctoral Workstation of Wuqing Development Zone for their
   technical support.
CR Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048
   El Agha E, 2017, CELL STEM CELL, V21, P166, DOI 10.1016/j.stem.2017.07.011
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gomes CDO, 2008, INT J PAEDIATR DENT, V18, P98, DOI 10.1111/j.1365-263X.2007.00862.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x
   Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019
   Lan XY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00824
   Leco Berrocal Maria Isabel, 2007, Med Oral Patol Oral Cir Bucal, V12, pE134
   Lee S, 2011, REGEN MED, V6, P689, DOI [10.2217/RME.11.95, 10.2217/rme.11.95]
   Lei M, 2014, BIOMATERIALS, V35, P6332, DOI 10.1016/j.biomaterials.2014.04.071
   Lim M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0888-z
   Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049
   Rodas-Junco BA, 2017, TISSUE ENG REGEN MED, V14, P333
   Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shi X, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1336-4
   Shi YF, 2018, NAT REV NEPHROL, V14, P493, DOI 10.1038/s41581-018-0023-5
   Wei YM, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1302-1
   Wu QQ, 2015, CELL RES, V25, P1314, DOI 10.1038/cr.2015.118
   Yamada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051132
   Zhang KY, 2018, ACS APPL MATER INTER, V10, P30081, DOI 10.1021/acsami.8b08449
   Zhang LS, 2018, STEM CELL REP, V11, P497, DOI 10.1016/j.stemcr.2018.06.019
   Zhang LS, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0926-x
   Zhang WX, 2019, BLOOD CELL MOL DIS, V76, P66, DOI 10.1016/j.bcmd.2019.02.003
   Zhang XL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0397-z
   Zhao QJ, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1478-4
NR 27
TC 17
Z9 18
U1 2
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PD JAN 30
PY 2020
VL 2020
AR 6489396
DI 10.1155/2020/6489396
PG 12
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KM8FZ
UT WOS:000514377500002
PM 32399047
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Rancan, L
   Linillos-Pradillo, B
   Centeno, J
   Paredes, SD
   Vara, E
   Tresguerres, JAF
AF Rancan, Lisa
   Linillos-Pradillo, Beatriz
   Centeno, Julia
   Paredes, Sergio D.
   Vara, Elena
   Tresguerres, Jesus A. F.
TI Protective Actions of Cannabidiol on Aging-Related Inflammation,
   Oxidative Stress and Apoptosis Alterations in Liver and Lung of Long
   Evans Rats
SO ANTIOXIDANTS
LA English
DT Article
DE CBD; aging; liver; lung
ID MITOCHONDRIA; GLUTATHIONE; DISEASE; BRAIN; AGE
AB Background: Aging is characterised by the progressive accumulation of oxidative damage which leads to inflammation and apoptosis in cells. This affects all tissues in the body causing the deterioration of several organs. Previous studies observed that cannabidiol (CBD) could extend lifespan and health span by its antioxidant, anti-inflammatory and autophagy properties. However, research on the anti-aging effect of CBD is still in the beginning stages. This study aimed to investigate the role of cannabidiol (CBD) in the prevention of age-related alterations in liver and lung using a murine model. Methods: 15-month-old Long Evans rats were treated with 10 mg/kg b.w./day of CBD for 10 weeks and compared to animals of the same age as old control and 2-month-old animals as young control. Gene and/or protein expressions, by RT-qPCR and Western blotting, respectively, were assessed in terms of molecules related to oxidative stress (GST, GPx, GR and HO-1d), inflammation (NF kappa B, IL-1 beta and TNF-alpha) and apoptosis (BAX, Bcl-2, AIF, and CASP-1). In addition, MDA and MPO levels were measured by colorimetric assay. Results were analysed by ANOVA followed by Tukey-Kramer test, considering statistically significant a p < 0.05. Results: GST, GPx and GR expressions were significantly reduced (p < 0.01) in liver samples from old animals compared to young ones and CBD treatment was able to revert it. A significant increase was observed in old animals compared to young ones in relation to oxidative stress markers (MDA and HO-1d), proinflammatory molecules (NF kappa B, IL-1 beta and TNF-alpha), MPO levels and proapoptotic molecules (BAX, AIF and CASP-1), while no significant alterations were observed in the antiapoptotic molecules (Bcl-2). All these changes were more noticeable in the liver, while the lung seemed to be less affected. In almost all the measured parameters, CBD treatment was able to revert the alterations caused by age restoring the levels to those observed in the group of young animals. Conclusions: Chronic treatment with CBD in 15-month-old rats showed beneficial effects in lung and more significantly in liver by reducing the levels of inflammatory, oxidative and apoptotic mediators, and hence the cell damage associated with these three processes inherent to aging.
C1 [Rancan, Lisa; Linillos-Pradillo, Beatriz; Centeno, Julia; Vara, Elena] Univ Complutense Madrid, Sch Med, Dept Biochem & Mol Biol, Madrid 28040, Spain.
   [Paredes, Sergio D.; Tresguerres, Jesus A. F.] Univ Complutense Madrid, Sch Med, Dept Physiol, Madrid 28040, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense Madrid, Sch Med, Dept Physiol, Madrid 28040, Spain.
EM lisaranc@ucm.es; beatlini@ucm.es; spared01@ucm.es; evaraami@ucm.es;
   guerres@ucm.es
RI Paredes, Sergio D./P-2225-2014
OI Paredes, Sergio D./0000-0002-4646-4199
CR Acuña-Castroviejo D, 2012, AGE, V34, P681, DOI 10.1007/s11357-011-9267-8
   Atalay S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010021
   Bernal GM, 2022, CELL BIOSCI, V12, DOI 10.1186/s13578-022-00779-6
   Böckmann S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071703
   Chernyak BV, 1996, EUR J BIOCHEM, V238, P623, DOI 10.1111/j.1432-1033.1996.0623w.x
   Cho SJ, 2020, ANNU REV PHYSIOL, V82, P433, DOI 10.1146/annurev-physiol-021119-034610
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   de Almeida DL, 2020, PHARMACOL RES PERSPE, V8, DOI 10.1002/prp2.682
   Dhainaut JF, 2001, CRIT CARE MED, V29, pS42, DOI 10.1097/00003246-200107001-00016
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Fernández-García C, 2019, EUR J NUTR, V58, P653, DOI 10.1007/s00394-018-1657-6
   García-García VA, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081906
   Gimenez VMM, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.888292
   Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217
   He F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134777
   Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5
   Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mazzoli A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112670
   Mejias NH, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0198-3
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Muthumalage T, 2019, TOXICOL APPL PHARM, V382, DOI 10.1016/j.taap.2019.114713
   Ni BB, 2023, BIOMED PHARMACOTHER, V165, DOI 10.1016/j.biopha.2023.115074
   Nna VU, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100465
   Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014
   Park JH, 2015, KOREAN J PHYSIOL PHA, V19, P269, DOI 10.4196/kjpp.2015.19.3.269
   Park SY, 2010, CELL MOL BIOL LETT, V15, P1, DOI 10.2478/s11658-009-0030-4
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pereira Sonia R, 2021, Neuronal Signal, V5, pNS20200080, DOI 10.1042/NS20200080
   PEREZ R, 1991, FREE RADICAL BIO MED, V10, P35, DOI 10.1016/0891-5849(91)90019-Y
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Puig A, 2016, EXP GERONTOL, V75, P1, DOI 10.1016/j.exger.2015.11.021
   Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007
   Salminen LE, 2014, REV NEUROSCIENCE, V25, P805, DOI 10.1515/revneuro-2014-0046
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schneider JL, 2021, CELL, V184, P1990, DOI 10.1016/j.cell.2021.03.005
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Silva RL, 2019, TOXICOL APPL PHARM, V368, P63, DOI 10.1016/j.taap.2019.02.011
   Steves CJ, 2012, AGE AGEING, V41, P581, DOI 10.1093/ageing/afs097
   Su TH, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040182
   Vallée A, 2021, AGING-US, V13, P10796, DOI 10.18632/aging.202951
   Webster JD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00365
   WINROW VR, 1993, BRIT MED BULL, V49, P506, DOI 10.1093/oxfordjournals.bmb.a072627
   Yang CB, 2020, PHARMACOL THERAPEUT, V216, DOI 10.1016/j.pharmthera.2020.107673
   Yang Wei, 2015, EXCLI J, V14, P1273, DOI 10.17179/excli2015-734
NR 45
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD OCT
PY 2023
VL 12
IS 10
AR 1837
DI 10.3390/antiox12101837
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA X6SN3
UT WOS:001099727900001
PM 37891916
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sasaki, M
   Miyakoshi, M
   Sato, Y
   Nakanuma, Y
AF Sasaki, Motoko
   Miyakoshi, Masami
   Sato, Yasunori
   Nakanuma, Yasuni
TI Autophagy mediates the process of cellular senescence characterizing
   bile duct damages in primary biliary cirrhosis
SO LABORATORY INVESTIGATION
LA English
DT Article
DE autophagy; cellular senescence; p16(INK4a); p21(WAF1/Cip1); primary
   biliary cirrhosis
ID ONCOGENE-INDUCED SENESCENCE; EPITHELIAL-CELLS; MITOCHONDRIAL
   AUTOANTIGENS; EXPRESSION; IDENTIFICATION; CULTURE; LIVER; TREE;
   PATHOGENESIS; HEPATOCYTES
AB Recent studies disclosed that autophagy is induced during and facilitates the process of senescence. Given that biliary epithelial cells (BECs) in damaged small bile ducts in primary biliary cirrhosis (PBC) show senescent features, we examined an involvement of autophagy in the process of biliary epithelial senescence in PBC. We examined immunohistochemically the expression of microtubule-associated proteins-light chain 3 beta (LC3), a marker of autophagy, in livers taken from the patients with PBC (n = 37) and control livers (n = 75). We also examined the co-localization of LC3 with autophagy-related cathepsin D, lysosome-associated membrane protein-1 (LAMP-1), and senescent markers, p16(INK4a) and p21(WAF1/Cip1). We examined the effect of autophagy inhibitor (3-methyladenine) on the induction of cellular senescence and senescence-associated secretion (CCL2 and CX3CL1) in cultured murine BECs. The expression of LC3 was specifically seen in vesicles in BECs in the inflamed and damaged small bile ducts in PBC, when compared with non-inflamed small bile ducts in PBC and in control livers (P<0.01). The expression of LC3 was closely related to the expression of cathepsin D, LAMP-1, and senescent markers. In cultured BECs, oxidative stress, DNA damage, and serum deprivation induced cellular senescence, when compared with control and the inhibition of autophagy significantly decreased the stress-induced cellular senescence (P<0.01). Furthermore, the secretion level of CCL2 and CX3CL1 increased significantly by various stress and suppressed by the inhibition of autophagy (P<0.01). In conclusion, autophagy is specifically seen in the damaged small bile ducts along with cellular senescence in PBC. The inhibition of autophagy suppressed cellular senescence in cultured cells. These findings suggest that autophagy may mediate the process of biliary epithelial senescence and involve in the pathogenesis of bile duct lesions in PBC. Laboratory Investigation (2010) 90, 835-843; doi:10.1038/labinvest.2010.56; published online 8 March 2010
C1 [Sasaki, Motoko; Miyakoshi, Masami; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
C3 Kanazawa University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
FU Ministry of Education, Culture, Sports and Science and Technology of
   Japan [18590325, 2590366]; Grants-in-Aid for Scientific Research
   [18590325] Funding Source: KAKEN
FX This study was supported in part by a Grant-in Aid for Scientific
   Research (C) from the Ministry of Education, Culture, Sports and Science
   and Technology of Japan (18590325 and 2590366).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Allina J, 2006, J AUTOIMMUN, V27, P232, DOI 10.1016/j.jaut.2006.11.004
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   [Anonymous], 2001, PATHOLOGY LIVER
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FUSSEY SPM, 1988, P NATL ACAD SCI USA, V85, P8654, DOI 10.1073/pnas.85.22.8654
   GERSHWIN ME, 1987, J IMMUNOL, V138, P3525
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kaplan MM, 1996, NEW ENGL J MED, V335, P1570, DOI 10.1056/NEJM199611213352107
   Katayanagi K, 1998, LIVER, V18, P90
   Kita H, 2002, J CLIN INVEST, V109, P1231, DOI 10.1172/JCI200214698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   LUDWIG J, 1991, SEMIN LIVER DIS, V11, P11, DOI 10.1055/s-2008-1040417
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326
   NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2001, HEPATOLOGY, V34, P631, DOI 10.1053/jhep.2001.27544
   Sasaki M, 2008, J AUTOIMMUN, V31, P73, DOI 10.1016/j.jaut.2008.03.005
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Shimoda S, 1998, J CLIN INVEST, V102, P1831, DOI 10.1172/JCI4213
   Shimoda S, 2008, HEPATOLOGY, V47, P958, DOI 10.1002/hep.22102
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tsuneyama K, 2001, J PATHOL, V193, P102, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH725>3.0.CO;2-P
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309
   Yasoshima M, 1998, LAB INVEST, V78, P89
   Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
NR 37
TC 89
Z9 93
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
J9 LAB INVEST
JI Lab. Invest.
PD JUN
PY 2010
VL 90
IS 6
BP 835
EP 843
DI 10.1038/labinvest.2010.56
PG 9
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 601UV
UT WOS:000278091300003
PM 20212459
OA hybrid
DA 2024-02-19
ER

PT J
AU BORST, SE
   SCARPACE, PJ
AF BORST, SE
   SCARPACE, PJ
TI ALPHA-1-ADRENERGIC STIMULATION OF INOSITIDE HYDROLYSIS IN LIVER OF
   SENESCENT RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; ALPHA-ADRENERGIC RECEPTOR; PHOSPHATIDYL INOSITIDES;
   PHOSPHOLIPASE-C
ID PHOSPHOINOSITIDE HYDROLYSIS; BETA-ADRENOCEPTORS; RECEPTOR; ACTIVATION;
   SYSTEM; BRAIN; AGE
AB Hydrolysis of phosphatidyl inositides (PI) was measured in response to alpha-1-adrenergic agonist in slices of liver prepared from F-344 female rats aged 6-, 15- and 25 months. Tissue was labeled with [H-3]inositol and release of inositol phosphates was measured following a 60-min incubation with a range of concentrations of l-epinephrine. The response to epinephrine was completely blocked by prazosin, indicating the involvement of alpha-1-adrenergic receptors. The maximum response to epinephrine represented release of 13-15% of radioactivity incorporated into the pool of cellular lipids and was unchanged with age. The concentration of epinephrine required for half-maximal stimulation was 1-1.5 mu-M and was also unchanged with age. These data suggest that, although senescence is accompanied by alterations with age in the liver alpha-1-receptor, alpha-1-stimulation of PI hydrolysis is unchanged.
C1 UNIV FLORIDA, DEPT PHARMACOL, GAINESVILLE, FL 32611 USA.
C3 State University System of Florida; University of Florida
RP BORST, SE (corresponding author), DEPT VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, ARCHER RD, GAINESVILLE, FL 32608 USA.
CR AMERINI S, 1985, DEV PHARMACOL THERAP, V8, P34, DOI 10.1159/000457019
   CREWS FT, 1988, ANN NY ACAD SCI, V522, P88
   CREWS FT, 1986, PSYCHOPHARMACOL BULL, V22, P775
   GOODHARDT M, 1982, J BIOL CHEM, V257, P1577
   HYLAND L, 1987, N-S ARCH PHARMACOL, V335, P50, DOI 10.1007/BF00165035
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   LITOSCH I, 1985, J BIOL CHEM, V260, P5464
   LYNCH CJ, 1988, FEBS LETT, V229, P54, DOI 10.1016/0014-5793(88)80796-8
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   PUSCHEL GP, 1988, EUR J BIOCHEM, V175, P187, DOI 10.1111/j.1432-1033.1988.tb14182.x
   STEVENS MJ, 1985, BR J CLIN PHARM, V14, P750
   TAYLOR CW, 1986, TRENDS PHARMACOL SCI, V7, P238, DOI 10.1016/0165-6147(86)90331-7
   UHING RJ, 1986, J BIOL CHEM, V261, P2140
NR 13
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD DEC
PY 1990
VL 56
IS 3
BP 275
EP 280
DI 10.1016/0047-6374(90)90088-W
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EQ276
UT WOS:A1990EQ27600007
PM 1965214
DA 2024-02-19
ER

PT J
AU Traverso, N
   Menini, S
   Odetti, P
   Pronzato, MA
   Cottalasso, D
   Marinari, UM
AF Traverso, N
   Menini, S
   Odetti, P
   Pronzato, MA
   Cottalasso, D
   Marinari, UM
TI Lipoperoxidation in hepatic subcellular compartments of diabetic rats
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE mitochondria; microsomes; lipid peroxidation; diabetes; malondialdehyde
   (MDA); 4-hydroxynonenal (HNE); fluorescent chromolipids
ID LIPID-PEROXIDATION PRODUCTS; ALDEHYDE DEHYDROGENASE; OXIDATIVE STRESS;
   LIVER-MICROSOMES; MITOCHONDRIAL TRANSCRIPTION; CLINICAL IMPLICATIONS;
   METABOLIC PATHWAYS; ENERGY-METABOLISM; KIDNEY CORTEX; VITAMIN-E
AB It is known that an accumulation of lipoperoxidative aldehydes malondialdehyde (MDA) and 4-hydroxynonenal (HNE) takes place in liver mitochondria during aging. The existence and role of an increased extra- and intra-cellular oxidative stress in diabetes, an aging-accelerating disease, is currently under discussion. This report offers evidence that lipoperoxidative aldehydes accumulate in liver microsomes and mitochondria at a higher rate in spontaneously diabetic BB/WOR rats than in control non-diabetic animals (HNE content, diabetes vs control: microsomes 80.6 +/- 19.9 vs 25.75 +/- 3.6 pmol/mg prot, p =.024; mitochondria 77.4 +/- 15.4 vs 26.5 +/- 3.5 pmol/mg prot, p =.0103). Liver subcellular fractions from diabetic rats, when exposed to the peroxidative stimulus ADP/Fe, developed more lipoperoxidative aldehydes than those from non diabetic rats (HNE amount, diabetes vs control: microsomes 3.60 +/- 0.37 vs 2.33 +/- 0.22 nmol/mg prot, p =.014; mitochondria 3.62 +/- 0.26 vs 2.30 +/- 0.17 nmol/mg prot, p =.0009). Liver subcellular fractions of diabetic rats developed more fluorescent chromolipids related to HNE-phospholipid adducts, either after in vitro peroxidation (microsomes: p =.0045; mitochondria: p =.0023) or by exposure to exogenous HNE (microsomes: p =.049; mitochondria: p =.0338). This higher susceptibility of diabetic liver membranes to the non-enzymatic attack of HNE may be due to an altered phospholipid composition. Moreover, a decreased activity of the HNE-metabolizing systems can be involved: diabetic liver mitochondria and microsomes were unable to consume exogenous HNE at the same rate as non-diabetic membranes; the difference was already significant after 5' incubation (microsomes p <.001; mitochondria p <.001). These data show an increased oxidative stress inside the hepatocytes of diabetic rats; the impairment of the HNE-metabolizing systems can play a key role in the maintenance and propagation of the damage. (C) 1999 Elsevier Science Inc.
C1 Univ Genoa, Dept Expt Med, Sect Gen Pathol, I-16132 Genoa, Italy.
   Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.
C3 University of Genoa; University of Genoa
RP Traverso, N (corresponding author), Univ Genoa, Dept Expt Med, Sect Gen Pathol, Via Leon Batista Alberti 2, I-16132 Genoa, Italy.
EM ntravers@medicina.unige.it
RI Menini, Stefano/G-1130-2010; MARINARI, UMBERTO M/C-9254-2011
OI Menini, Stefano/0000-0001-7328-2385; ODETTI,
   PATRIZIO/0000-0001-9559-7273
CR BARNETT CR, 1994, J BIOCHEM TOXICOL, V9, P63, DOI 10.1002/jbt.2570090203
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   BEHRENS WA, 1986, ANN NUTR METAB, V30, P157, DOI 10.1159/000177189
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Brignone JA, 1996, DIABETES RES CLIN PR, V32, P141, DOI 10.1016/0168-8227(96)01264-8
   CANUTO RA, 1993, CELL BIOCHEM FUNCT, V11, P79, DOI 10.1002/cbf.290110202
   CANUTO RA, 1994, CARCINOGENESIS, V15, P1359, DOI 10.1093/carcin/15.7.1359
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Chen JJ, 1996, AGING CLIN EXP RES, V8, P334, DOI 10.1007/BF03339590
   Chen TL, 1996, ARCH TOXICOL, V70, P202, DOI 10.1007/s002040050261
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   ESTERBAUER H, 1986, BIOCHEM J, V239, P405, DOI 10.1042/bj2390405
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   ESTERBAUER H, 1985, BIOCHEM J, V228, P363, DOI 10.1042/bj2280363
   Flarsheim CE, 1996, AM J PHYSIOL-HEART C, V271, pH192, DOI 10.1152/ajpheart.1996.271.1.H192
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   FU MX, 1992, DIABETES, V41, P42, DOI 10.2337/diab.41.2.S42
   GALLOU G, 1993, CLIN CHIM ACTA, V214, P227, DOI 10.1016/0009-8981(93)90114-J
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   Grune T, 1997, J LIPID RES, V38, P1660
   HALL JC, 1960, J BIOL CHEM, V235, P1536
   Harman D, 1998, EXP GERONTOL, V33, P95, DOI 10.1016/S0531-5565(97)00059-4
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028
   HARTLEY DP, 1993, ADV EXP MED BIOL, V328, P27
   KIM JW, 1989, MECH AGEING DEV, V50, P277, DOI 10.1016/0047-6374(89)90105-X
   Kristal BS, 1997, FREE RADICAL BIO MED, V22, P823, DOI 10.1016/S0891-5849(96)00428-5
   Kristal BS, 1997, FREE RADICAL BIO MED, V22, P813, DOI 10.1016/S0891-5849(96)00429-7
   KRISTAL BS, 1994, FREE RADICAL BIO MED, V16, P323, DOI 10.1016/0891-5849(94)90033-7
   KUME E, 1994, EXP TOXICOL PATHOL, V46, P368, DOI 10.1016/S0940-2993(11)80119-3
   Kuo CL, 1997, J BIOL CHEM, V272, P22611, DOI 10.1074/jbc.272.36.22611
   LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4
   LIU ZQ, 1994, BIOCHEM BIOPH RES CO, V205, P680, DOI 10.1006/bbrc.1994.2719
   MITCHELL DY, 1991, HEPATOLOGY, V13, P728, DOI 10.1016/0270-9139(91)92572-P
   MITCHELL DY, 1989, ARCH BIOCHEM BIOPHYS, V269, P11, DOI 10.1016/0003-9861(89)90081-7
   NAKHOODA AF, 1977, DIABETES, V26, P100, DOI 10.2337/diabetes.26.2.100
   NOHL H, 1979, Z GERONTOL, V12, P9
   Nohl H, 1997, EXP GERONTOL, V32, P485, DOI 10.1016/S0531-5565(96)00169-6
   NOUROOZZADEH J, 1995, DIABETES, V44, P1054, DOI 10.2337/diabetes.44.9.1054
   Odetti P, 1996, DIABETOLOGIA, V39, P1440, DOI 10.1007/s001250050596
   ODETTI PR, 1990, DIABETES, V39, P796, DOI 10.2337/diabetes.39.7.796
   PRONZATO MA, 1990, FREE RADICAL RES COM, V11, P267, DOI 10.3109/10715769009088924
   Sastre J, 1998, FREE RADICAL BIO MED, V24, P298, DOI 10.1016/S0891-5849(97)00228-1
   SHIMOJO N, 1993, BIOCHEM PHARMACOL, V46, P621, DOI 10.1016/0006-2952(93)90547-A
   SHIN CS, 1995, DIABETES RES CLIN PR, V29, P93, DOI 10.1016/0168-8227(95)01125-0
   Siems WG, 1997, J LIPID RES, V38, P612
   Siman CM, 1997, DIABETES, V46, P1054, DOI 10.2337/diabetes.46.6.1054
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Spiteller G, 1996, FREE RADICAL BIO MED, V21, P1003, DOI 10.1016/S0891-5849(96)00268-7
   Spycher S, 1996, BIOCHEM BIOPH RES CO, V226, P512, DOI 10.1006/bbrc.1996.1386
   Suchocka Z, 1995, Acta Pol Pharm, V52, P207
   SUKALSKI KA, 1993, FREE RADICAL BIO MED, V14, P57, DOI 10.1016/0891-5849(93)90509-S
   THOMPSON KH, 1992, BIOL TRACE ELEM RES, V35, P213, DOI 10.1007/BF02783767
   TODA A, 1993, BIOCHIM BIOPHYS ACTA, V1141, P245, DOI 10.1016/0005-2728(93)90049-L
   Traverso N, 1998, DIABETOLOGIA, V41, P265, DOI 10.1007/s001250050902
   Ullrich O, 1996, FREE RADICAL RES, V24, P421, DOI 10.3109/10715769609088041
   ULLRICH O, 1994, FEBS LETT, V352, P84, DOI 10.1016/0014-5793(94)00922-8
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801
   YAMAZOE Y, 1989, ARCH BIOCHEM BIOPHYS, V268, P567, DOI 10.1016/0003-9861(89)90324-X
NR 63
TC 38
Z9 39
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAR
PY 1999
VL 26
IS 5-6
BP 538
EP 547
DI 10.1016/S0891-5849(98)00238-X
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 177UJ
UT WOS:000079229200006
PM 10218642
DA 2024-02-19
ER

PT J
AU MENEGUZ, A
   MICHALEK, H
AF MENEGUZ, A
   MICHALEK, H
TI AGE-RELATED-CHANGES IN HEPATIC-MICROSOMAL MIXED-FUNCTION OXIDASE IN 3
   STRAINS OF RATS
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 3RD JOINT MEETING OF THE HUNGARIAN, ITALIAN AND POLISH PHARMACOLOGICAL
   SOCIETIES
CY JUN 08-10, 1992
CL MODENA, ITALY
SP HUNGARIAN PHARM SOC, ITALIAN PHARM SOC, POLISH PHARM SOC
DE MIXED FUNCTION OXIDASE; AGING; RAT STRAINS
ID METABOLISM
RP MENEGUZ, A (corresponding author), IST SUPER SANITA,PHARMACOL LAB,I-00161 ROME,ITALY.
CR AUGUSTINE JA, 1989, GEN PHARMACOL, V20, P137, DOI 10.1016/0306-3623(89)90005-0
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   MENEGUZ A, 1990, B ENVIRON CONTAM TOX, V44, P924, DOI 10.1007/BF01702185
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   VANGEEL CAJF, 1990, MECH AGEING DEV, V53, P169, DOI 10.1016/0047-6374(90)90068-Q
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD MAY-JUN
PY 1992
VL 25
SU 2
BP 283
EP 284
DI 10.1016/1043-6618(92)90406-2
PG 2
WC Pharmacology & Pharmacy
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HY937
UT WOS:A1992HY93700155
DA 2024-02-19
ER

PT J
AU Uehara, T
   Ainslie, GR
   Kutanzi, K
   Pogribny, IP
   Muskhelishvili, L
   Izawa, T
   Yamate, J
   Kosyk, O
   Shymonyak, S
   Bradford, BU
   Boorman, GA
   Bataller, R
   Rusyn, I
AF Uehara, Takeki
   Ainslie, Garrett R.
   Kutanzi, Kristi
   Pogribny, Igor P.
   Muskhelishvili, Levan
   Izawa, Takeshi
   Yamate, Jyoji
   Kosyk, Oksana
   Shymonyak, Svitlana
   Bradford, Blair U.
   Boorman, Gary A.
   Bataller, Ramon
   Rusyn, Ivan
TI Molecular Mechanisms of Fibrosis-Associated Promotion of Liver
   Carcinogenesis
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE liver; fibrosis; cancer; mechanisms; genotoxic
ID HEPATOCELLULAR-CARCINOMA; CARBON-TETRACHLORIDE; MOUSE MODELS;
   STEM-CELLS; OXIDATIVE STRESS; CANCER-RISK; EXPRESSION;
   HEPATOCARCINOGENESIS; IDENTIFICATION; GENES
AB Hepatocellular carcinoma (HCC) mostly develops in patients with advanced fibrosis; however, the mechanisms of interaction between a genotoxic insult and fibrogenesis are not well understood. This study tested a hypothesis that fibrosis promotes HCC via a mechanism that involves activation of liver stem cells. First, B6C3F1 mice were administered diethylnitrosamine (DEN; single ip injection of 1mg/kg at 14 days of age). Second, carbon tetrachloride (CCl4; 0.2ml/kg, 2/week ip starting at 8 weeks of age) was administered for 9 or 14 weeks to develop advanced liver fibrosis. In animals treated with DEN as neonates, presence of liver fibrosis led to more than doubling (to 100%) of the liver tumor incidence as early as 5 months of age. This effect was associated with activation of cells with progenitor features in noncancerous liver tissue, including markers of replicative senescence (p16), oncofetal transformation (Afp, H19, and Bex1), and increased stemness (Prom1 and Epcam). In contrast, the dose of DEN used did not modify the extent of liver inflammation, fibrogenesis, oxidative stress, proliferation, or apoptosis induced by subchronic CCl4 administration. This study demonstrates the potential role of liver stem-like cells in the mechanisms of chemical-induced, fibrosis-promoted HCC. We posit that the combination of genotoxic and fibrogenic insults is a sensible approach to model liver carcinogenesis in experimental animals. These results may contribute to identification of cirrhotic patients predisposed to HCC by analyzing the expression of hepatic progenitor cell markers in the noncancerous liver tissue.
C1 [Uehara, Takeki; Ainslie, Garrett R.; Kosyk, Oksana; Shymonyak, Svitlana; Bradford, Blair U.; Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.
   [Kutanzi, Kristi; Pogribny, Igor P.; Muskhelishvili, Levan] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   [Izawa, Takeshi; Yamate, Jyoji] Osaka Prefecture Univ, Dept Vet Pathol, Osaka, Japan.
   [Boorman, Gary A.] Covance, Chantilly, VA USA.
   [Bataller, Ramon] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   US Food & Drug Administration (FDA); Osaka Metropolitan University;
   Covance; University of North Carolina; University of North Carolina
   Chapel Hill
RP Rusyn, I (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.
EM iir@unc.edu
RI Rusyn, Ivan/S-2426-2016; Ainslie, Garrett/Z-5321-2019
OI Rusyn, Ivan/0000-0001-9340-7384; Bataller, Ramon/0000-0002-1119-7799;
   Izawa, Takeshi/0000-0003-3236-6050
FU National Institutes of Health [P42 ES005948, R01 ES015241, P30 ES010126]
FX National Institutes of Health (P42 ES005948, R01 ES015241, P30
   ES010126).
CR Alkofer B, 2011, J VISC SURG, V148, P3, DOI 10.1016/j.jviscsurg.2010.12.012
   Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795
   BECKER FF, 1983, J NATL CANCER I, V71, P553
   Braeuning A, 2006, TOXICOLOGY, V227, P127, DOI 10.1016/j.tox.2006.07.024
   Bucher JR, 1998, ENVIRON HEALTH PERSP, V106, P619, DOI 10.2307/3434087
   Cabré M, 2000, CLIN EXP PHARMACOL P, V27, P694, DOI 10.1046/j.1440-1681.2000.03322.x
   Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643
   Chazal M, 2002, ONCOGENE, V21, P2652, DOI 10.1038/sj.onc.1205349
   Della Corte C, 2012, SEMIN ONCOL, V39, P384, DOI 10.1053/j.seminoncol.2012.05.002
   DRAGANI TA, 1986, CANCER LETT, V31, P171, DOI 10.1016/0304-3835(86)90008-X
   DRUCKREY H., 1964, Z KREBSFORSCH, V66, P1, DOI 10.1007/BF00525556
   Eastmond DA, 2008, ENVIRON MOL MUTAGEN, V49, P132, DOI 10.1002/em.20368
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Fausto N, 2010, SEMIN LIVER DIS, V30, P87, DOI 10.1055/s-0030-1247135
   Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79
   Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391
   Greenbaum LE, 2011, INT J BIOCHEM CELL B, V43, P222, DOI 10.1016/j.biocel.2009.11.006
   Guzman G, 2011, PATHOL ONCOL RES, V17, P191, DOI 10.1007/s12253-010-9296-0
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x
   Hoenerhoff MJ, 2011, TOXICOL PATHOL, V39, P678, DOI 10.1177/0192623311407213
   HUFF J, 1991, ENVIRON HEALTH PERSP, V93, P247, DOI 10.2307/3431195
   Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107
   Jacobson-Kram D, 2010, TOXICOL PATHOL, V38, P169, DOI 10.1177/0192623309351892
   Jepsen P, 2007, INT J CANCER, V121, P1624, DOI 10.1002/ijc.22860
   Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011
   Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x
   Kossatz U, 2010, J CLIN INVEST, V120, P3820, DOI 10.1172/JCI41959
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Lee T. K., 2012, CANC LETT IN PRESS
   Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e
   Loeb LA, 2001, CANCER RES, V61, P3230
   Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025
   Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114
   Marquardt JU, 2010, SEMIN LIVER DIS, V30, P26, DOI 10.1055/s-0030-1247130
   Nagano K, 2007, INHAL TOXICOL, V19, P1089, DOI 10.1080/08958370701628770
   Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646
   Oh JY, 2002, EXP MOL PATHOL, V73, P67, DOI 10.1006/exmp.2002.2434
   Oishi N, 2011, INT J BIOL SCI, V7, P517, DOI 10.7150/ijbs.7.517
   PITOT HC, 1977, AM J PATHOL, V89, P402
   Powell CL, 2006, TOXICOL SCI, V93, P213, DOI 10.1093/toxsci/kfl030
   Rusyn I, 2004, CANCER RES, V64, P1050, DOI 10.1158/0008-5472.CAN-03-3027
   Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   STOWELL RE, 1951, CANCER RES, V11, P345
   VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253
   Vucur M, 2010, ONCOTARGET, V1, P373
   Wang B, 2011, GENOME MED, V3, DOI 10.1186/gm225
   Wells MY, 2009, REGUL TOXICOL PHARM, V53, P150, DOI 10.1016/j.yrtph.2008.12.006
   Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
NR 53
TC 66
Z9 71
U1 0
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAR
PY 2013
VL 132
IS 1
BP 53
EP 63
DI 10.1093/toxsci/kfs342
PG 11
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 096WB
UT WOS:000315434300006
PM 23288052
OA Green Published
DA 2024-02-19
ER

PT J
AU Liu, XT
   Lin, X
   Mi, YL
   Zeng, WD
   Zhang, CQ
AF Liu, Xing-ting
   Lin, Xin
   Mi, Yu-ling
   Zeng, Wei-dong
   Zhang, Cai-qiao
TI Age-related changes of yolk precursor formation in the liver of laying
   hens
SO JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
LA English
DT Article
DE Lipid metabolism; Yolk precursor formation; 17 beta-Estradiol;
   Antioxidant; Hen
ID EGG-PRODUCTION; DOMESTIC HEN; GALLUS-DOMESTICUS; APOLIPOPROTEIN II;
   ER-ALPHA; ESTROGEN; VITELLOGENIN; EXPRESSION; RATS; SENESCENCE
AB A rapid decline in egg production of laying hens begins after 480 d of age. Such a rapid decrease results predominantly from the ovarian aging, accompanied by endocrine changes, decreased yolk synthesis and accumulation, and the reduction in follicles selected into the preovulatory hierarchy. In this study, hens at 90, 150, 280, and 580 d old (D90, D150, D280, and D580, respectively) were compared for yolk precursor formation in the liver to elucidate effects of aging on laying performance. The results showed that liver lipid synthesis increased remarkably in hens from D90 to D150, but decreased sharply at D580 as indicated by the changes in triglyceride (TG) levels. This result was consistent with the age-related changes of the laying performance. The levels of liver antioxidants and total antioxidant capacity decreased significantly in D580 hens and the methane dicarboxylic aldehyde in D580 hens was much higher than that at other stages. The serum 17 beta-estradiol level increased from D90 to D280, but decreased at D580 (P < 0.05). The expression of estrogen receptor alpha and beta mRNAs in the liver displayed similar changes to the serum 17 beta-estradiol in D580 hens. Expressions of the genes related to yolk precursor formation and enzymes responsible for fat acid synthesis were all decreased in D580 hens. These results indicated that decreased yolk precursor formation in the liver of the aged hens resulted from concomitant decreases of serum 17 beta-estradiol level, transcription levels of estrogen receptors and critical genes involved in yolk precursor synthesis, and liver antioxidant status.
C1 [Liu, Xing-ting; Lin, Xin; Mi, Yu-ling; Zeng, Wei-dong; Zhang, Cai-qiao] Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China.
C3 Zhejiang University
RP Zhang, CQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Dept Vet Med, Hangzhou 310058, Zhejiang, Peoples R China.
EM cqzhang@zju.edu.cn
RI lin, xin/GPX-7394-2022
OI Lin, Xin/0000-0003-1376-3456
FU National Natural Science Foundation of China [31472160, 31272525]
FX Project supported by the National Natural Science Foundation of China
   (Nos. 31472160 and 31272525)
CR BAHR JM, 1984, J EXP ZOOL, V232, P495, DOI 10.1002/jez.1402320316
   Bai J, 2015, MOL NUTR FOOD RES, V59, P1171, DOI 10.1002/mnfr.201400918
   Ben-Meir A, 2015, AGING CELL, V14, P887, DOI 10.1111/acel.12368
   Buyuk E, 2010, SEMIN REPROD MED, V28, P370, DOI 10.1055/s-0030-1262896
   Cohen A, 2014, ZEBRAFISH, V11, P462, DOI 10.1089/zeb.2013.0873
   D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43
   Ge CT, 2012, ENDOCRINOLOGY, V153, P3504, DOI 10.1210/en.2012-1200
   Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200
   Hess RA, 2011, J ANDROL, V32, P600, DOI 10.2164/jandrol.110.012872
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Ishii M, 2012, J TOXICOL SCI, V37, P631
   Johnson AL, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P635
   JOYNER CJ, 1987, GEN COMP ENDOCR, V65, P331, DOI 10.1016/0016-6480(87)90117-1
   Khalil HA, 2009, J REPROD DEVELOP, V55, P523, DOI 10.1262/jrd.20137
   Kim ChangHo, 2014, International Journal of Poultry Science, V13, P510
   Leaños-Castañeda O, 2007, TOXICOL APPL PHARM, V224, P116, DOI 10.1016/j.taap.2007.06.017
   Li J, 2014, THERIOGENOLOGY, V82, P517, DOI 10.1016/j.theriogenology.2014.05.003
   LILLPERS K, 1993, POULTRY SCI, V72, P2005, DOI 10.3382/ps.0722005
   Mariailaria V, 2010, GEN COMP ENDOCR, V168, P231, DOI 10.1016/j.ygcen.2010.04.014
   NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217
   Okudan N, 2016, ARCH PHYSIOL BIOCHEM, V122, P180, DOI 10.1080/13813455.2016.1199574
   PALMER SS, 1992, BRIT POULTRY SCI, V33, P403, DOI 10.1080/00071669208417478
   Ratna WN, 2016, THERIOGENOLOGY, V85, P376, DOI 10.1016/j.theriogenology.2015.08.015
   Reddy IJ, 2002, GEN COMP ENDOCR, V127, P249, DOI 10.1016/S0016-6480(02)00034-5
   Subramanian MV, 2010, CELL STRESS CHAPERON, V15, P743, DOI 10.1007/s12192-010-0177-y
   Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008
   Yilmaz O, 2015, GEN COMP ENDOCR, V221, P16, DOI 10.1016/j.ygcen.2015.01.018
   ZAKARIA AH, 1983, POULTRY SCI, V62, P670, DOI 10.3382/ps.0620670
   Zhang RD, 2016, COMP BIOCHEM PHYS B, V200, P28, DOI 10.1016/j.cbpb.2016.05.001
NR 29
TC 44
Z9 53
U1 1
U2 43
PU ZHEJIANG UNIV
PI HANGZHOU
PA EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA
SN 1673-1581
EI 1862-1783
J9 J ZHEJIANG UNIV-SC B
JI J. Zhejiang Univ.-SCI. B
PD MAY
PY 2018
VL 19
IS 5
BP 390
EP 399
DI 10.1631/jzus.B1700054
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Research & Experimental Medicine
GA GG0DW
UT WOS:000432349700008
PM 29732750
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Lee, AK
   Kim, DH
   Bang, E
   Choi, YJ
   Chung, HY
AF Lee, A. Kyoung
   Kim, Dae Hyun
   Bang, EunJin
   Choi, Yeon Ja
   Chung, Hae Young
TI β-Hydroxybutyrate Suppresses Lipid Accumulation in Aged Liver through
   GPR109A-mediated Signaling
SO AGING AND DISEASE
LA English
DT Article
DE beta-hydroxybutyrate; GPR109A; AMPK; ER stress; lipid accumulation; aged
   liver
ID ENDOPLASMIC-RETICULUM STRESS; KETONE-BODIES; ACTIVATION; RESTRICTION;
   GPR109A; HORMONE; LIFE
AB Dietary interventions such as prolonged calorie restriction (CR) and intermittent fasting provide health benefits including a reduction in the inflammatory burden and regulation of energy metabolism. During CR, beta-hydroxybutyrate (BHB) level is elevated in the serum. BHB is a ligand of GPR109A, which inhibits lipoly sis and exerts anti-inflammatory effects on cells. During aging, comorbidities related to dyslipidemia are significantly associated with fatty liver. However, the underlying mechanisms of BHB in hepatic ER stress and dyslipidemia are unclear and remain to be elucidated. Here, we used aged rats that were administered with BHB and compared the modulatory effects of BHB through the GPR109A/AMPK pathway on the hepatic endoplasmic reticulum (ER) stress and lipid accumulation to CR rats. BHB caused suppression of hepatic ER stress and lipid accumulation through GPR109AJAMPK pathway in the aged rats. Aged rats of both treatment groups showed reduced cAMP level and PKA phosphorylation. Furthermore, AMPK-Ser173 phosphorylation via PKA was decreased, whereas AMPK-Thr172 phosphorylation was increased by BHB and CR Further supporting evidence was provided in HepG2 cells that BHB inhibited ER stress and lipid accumulation induced by palmitate. These results suggest that BHB activates GPR109A and regulates the activation of AMPK. These findings were further confirmed by GPR109A-siRNA transfection in vitro. In addition, BHB treatment elevated the protein levels of AMPK leading to significant inhibition of hepatic steatosis, whereas AMPK-siRNA treatment abolished these effects. Taken together, these findings suggest that BHB could be a effective molecule that mimics CR in ameliorating age-related hepatic lipid accumulation via GPR109A signaling pathway.
C1 [Lee, A. Kyoung; Kim, Dae Hyun; Bang, EunJin; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 46241, South Korea.
   [Choi, Yeon Ja] Dongguk Univ, Dept Biopharmaceut Engn, Div Chem & Biotechnol, Gyeongju 38066, South Korea.
C3 Pusan National University; Dongguk University
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 46241, South Korea.
EM hyjung@pusan.ac.kr
FU "Cooperative Research Program for Agriculture Science & Technology
   Development" Rural Development Administration, Republic of Korea
   [PJ006522132013]
FX This work was supported by "Cooperative Research Program for Agriculture
   Science & Technology Development (Project No. PJ006522132013)" Rural
   Development Administration, Republic of Korea. The authors are grateful
   to the Aging Tissue Bank (Busan, Korea) for supplying the research
   materials used in this work.
CR Al-Regaiey KA, 2016, EUR REV MED PHARMACO, V20, P2468
   Aw DKL, 2014, BIOCHEM BIOPH RES CO, V447, P569, DOI 10.1016/j.bbrc.2014.04.031
   Bae HR, 2016, ONCOTARGET, V7, P66444, DOI 10.18632/oncotarget.12119
   Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013
   CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481
   Chatrath H, 2012, SEMIN LIVER DIS, V32, P22, DOI 10.1055/s-0032-1306423
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339
   Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637
   Fang DL, 2013, MOL CELL BIOCHEM, V381, P127, DOI 10.1007/s11010-013-1694-7
   Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826
   Fu SP, 2015, INT J MOL SCI, V16, P4265, DOI 10.3390/ijms16024265
   Hardie DG, 1999, BIOCHEM SOC SYMP, P13
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Jadeja RN, 2019, AGING-US, V11, P386, DOI 10.18632/aging.101743
   Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494
   Kim DH, 2019, AGING-US, V11, P1283, DOI 10.18632/aging.101838
   Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111
   Kim SH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124114
   Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004
   Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002
   Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003
   Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623
   Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002
   Pike NB, 2005, J CLIN INVEST, V115, P3400, DOI 10.1172/JCI27160
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166
   Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Veech RL, 2017, IUBMB LIFE, V69, P305, DOI 10.1002/iub.1627
   Veech RL, 2001, IUBMB LIFE, V51, P241
   Wong TP, 2015, NUTRIENTS, V7, P7543, DOI 10.3390/nu7095352
   Woods A, 2017, CELL REP, V18, P3043, DOI 10.1016/j.celrep.2017.03.011
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112
NR 35
TC 19
Z9 21
U1 2
U2 22
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD AUG
PY 2020
VL 11
IS 4
BP 777
EP 790
DI 10.14336/AD.2019.0926
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA MV9JM
UT WOS:000556664900009
PM 32765945
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Esler, M
   Lambert, G
   Kaye, D
   Rumantir, M
   Hastings, J
   Seals, DR
AF Esler, M
   Lambert, G
   Kaye, D
   Rumantir, M
   Hastings, J
   Seals, DR
TI Influence of ageing on the sympathetic nervous system and adrenal
   medulla at rest and during stress
SO BIOGERONTOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Biotechnology the Genome and Human Ageing
CY MAR 19-22, 2001
CL MELBOURNE, AUSTRALIA
SP Australian Soc Cellular Molec Gerontol (ASCMG)
DE brain; epinephrine; heart; kidneys; norepinephrine
ID ESSENTIAL-HYPERTENSION; RELEASE; NORADRENALINE; ASSOCIATION; HEART; RATS
AB The influence of ageing on the sympathetic nervous system and adrenal medulla was studied neurochemically in humans, using isotopic dilution measurement of regional and whole body catecholamine release to plasma in humans. With ageing, sympathetic activation was evident in the heart, and the gut and liver at rest. The mechanism appeared to be by activation of sympathoexcitatory noradrenergic suprabulbar projections from the brainstem. Sympathetic nervous responses with stressors were augmented. Conversely, adrenal medullary release of epinephrine was subnormal in the elderly, at rest and during stress.
C1 Baker Med Res Inst, Melbourne, Vic, Australia.
   Univ Colorado, Dept Kinesiol, Boulder, CO 80309 USA.
C3 Baker Heart and Diabetes Institute; University of Colorado System;
   University of Colorado Boulder
RP Esler, M (corresponding author), Baker Med Res Inst, Melbourne, Vic, Australia.
RI Kaye, David/AAF-1202-2021; Lambert, Gavin W/E-7384-2010; Lambert,
   Gavin/Q-4869-2017
OI Lambert, Gavin W/0000-0003-0315-645X; Lambert,
   Gavin/0000-0003-0315-645X; Kaye, David/0000-0003-4058-0372
CR Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001
   ESLER M, 1995, J CLIN ENDOCR METAB, V80, P435, DOI 10.1210/jc.80.2.435
   ESLER M, 1990, PHYSIOL REV, V70, P963, DOI 10.1152/physrev.1990.70.4.963
   ESLER M, 1986, J CARDIOVASC PHAR S5, V8, P539
   ESLER MD, 1995, CIRCULATION, V91, P351, DOI 10.1161/01.CIR.91.2.351
   ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278
   FERRIER C, 1993, J HYPERTENS, V11, P1217
   HUANGFU D, 1991, AM J PHYSIOL, V261, pR393, DOI 10.1152/ajpregu.1991.261.2.R393
   Lambert GW, 1998, ACTA PHYSIOL SCAND, V163, P155
   LAMBERT GW, 1995, CIRCULATION, V92, P1813, DOI 10.1161/01.CIR.92.7.1813
   Rumantir MS, 1999, J HYPERTENS, V17, P1125, DOI 10.1097/00004872-199917080-00012
   Rumantir MS, 2000, HYPERTENSION, V36, P824, DOI 10.1161/01.HYP.36.5.824
   Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x
   VANHUYSSE JW, 1991, AM J PHYSIOL, V260, pR1071, DOI 10.1152/ajpregu.1991.260.6.R1071
NR 14
TC 22
Z9 27
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2002
VL 3
IS 1-2
BP 45
EP 49
DI 10.1023/A:1015203328878
PG 5
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 541LT
UT WOS:000174986600010
PM 12014841
DA 2024-02-19
ER

PT J
AU Rusli, F
   Lute, C
   Boekschoten, MV
   van Dijk, M
   van Norren, K
   Menke, AL
   Müller, M
   Steegenga, WT
AF Rusli, Fenni
   Lute, Carolien
   Boekschoten, Mark V.
   van Dijk, Miriam
   van Norren, Klaske
   Menke, Aswin L.
   Mueller, Michael
   Steegenga, Wilma T.
TI Intermittent calorie restriction largely counteracts the adverse health
   effects of a moderate-fat diet in aging C57BL/6J mice
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Aging; Intermittent calorie restriction; Liver; Moderate-fat diet;
   Obesity; Transcriptomics
ID GENE-EXPRESSION; LIVER-DISEASE; ENERGY RESTRICTION; METABOLIC DISEASE;
   MODEL ORGANISMS; MEAL FREQUENCY; LIFE-SPAN; INTERVENTION; CANCER; HUMANS
AB Scope: Calorie restriction (CR) has been shown to extend life-and health-span in model species. For most humans, a life-long CR diet is too arduous to adhere to. The aim of this study was to explore whether weekly intermittent CR can (1) provide long-term beneficial effects and (2) counteract diet-induced obesity in male aging mice.
   Methods and results: In this study, we have exposed C57Bl/6J mice for 24 months to an intermittent (INT) diet, alternating weekly between CR of a control diet and ad libitum moderate fat (MF) feeding. This weekly intermittent CR significantly counteracted the adverse effects of the MF diet on mortality, body weight, and liver health markers in 24-month-old male mice. Hepatic gene expression profiles of INT-exposed animals appeared much more comparable to CR-than to MF-exposed mice. At 12 months of age, a subgroup of MF-exposed mice was transferred to the INT diet. Gene expression profiles in the liver of the 24-month-old diet switch mice were highly similar to the INT-exposed mice. However, a small subset of genes was consistently changed by the MF diet during the first phase of life.
   Conclusion: Weekly intermittent CR largely, but not completely, reversed adverse effects caused by a MF diet.
C1 [Rusli, Fenni; Lute, Carolien; Boekschoten, Mark V.; Steegenga, Wilma T.] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands.
   [van Dijk, Miriam; van Norren, Klaske] Wageningen Univ, Div Human Nutr, Nutr & Pharmacol Grp, Wageningen, Netherlands.
   [van Norren, Klaske] Nutricia Res, Utrecht, Netherlands.
   [Menke, Aswin L.] TNO Triskel, Zeist, Netherlands.
   [Mueller, Michael] Univ East Anglia, Norwich Med Sch, Nutrigen & Syst Nutr Grp, Norwich NR4 7UQ, Norfolk, England.
C3 Wageningen University & Research; Wageningen University & Research;
   Danone Nutricia; Netherlands Organization Applied Science Research;
   University of East Anglia
RP Steegenga, WT (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands.
EM wilma.steegenga@wur.nl
RI Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; van Norren,
   Klaske/ABH-8842-2020; Menke, Aswin/AAC-6809-2021; Boekschoten,
   Mark/AAS-4597-2021
OI Muller, Michael/0000-0002-5930-9905; Muller,
   Michael/0000-0002-5930-9905; van Norren, Klaske/0000-0002-6281-9455;
   Menke, Aswin/0000-0002-0724-0897; Boekschoten, Mark/0000-0002-2139-0795
FU European Union's Seventh Framework Programme IDEAL (FP7) [259679]
FX This work was financially supported by the European Union's Seventh
   Framework Programme IDEAL (FP7/2007-2011) under grant agreement no:
   259679.
CR Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100
   Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bonorden M. J. L., 2006, CANCER EPIDEM BIOMAR, V15, pB224
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa
   Cave MC, 2016, BIOCH BIOPHYS ACTA
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   Cleary MP, 2002, CANCER EPIDEM BIOMAR, V11, P836
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239
   Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101
   Duseja A, 2013, HEPATOL INT, V7, pS755, DOI 10.1007/s12072-013-9480-x
   Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1
   Fisher CP, 2014, WORLD J GASTROENTERO, V20, P15070, DOI 10.3748/wjg.v20.i41.15070
   Fontán-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Franz MJ, 2015, J ACAD NUTR DIET, V115, P1447, DOI 10.1016/j.jand.2015.02.031
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Giller K, 2013, FREE RADICAL BIO MED, V61, P170, DOI 10.1016/j.freeradbiomed.2013.03.023
   Gotthardt JD, 2016, ENDOCRINOLOGY, V157, P679, DOI 10.1210/en.2015-1622
   Hao ZL, 2012, TUMOR BIOL, V33, P723, DOI 10.1007/s13277-011-0291-1
   Harvie MN, 2016, ADV NUTR, V7, P690, DOI 10.3945/an.115.011767
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599
   Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176
   Horne BD, 2015, AM J CLIN NUTR, V102, P464, DOI 10.3945/ajcn.115.109553
   Hunt ND, 2012, AGE, V34, P1453, DOI 10.1007/s11357-011-9321-6
   Ieta K, 2007, INT J CANCER, V121, P33, DOI 10.1002/ijc.22605
   Ingram DK, 2015, AGEING RES REV, V20, P46, DOI 10.1016/j.arr.2014.11.005
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Joslin P. M., 2016, J ANIM PHYSL ANIM NU
   Kristan DM, 2008, AGE, V30, P147, DOI 10.1007/s11357-008-9056-1
   Lanza-Jacoby S, 2013, EXP BIOL MED, V238, P787, DOI 10.1177/1535370213493727
   Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008
   Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com
   Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005
   Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161
   Mattson MP, 2014, DOSE-RESPONSE, V12, P600, DOI 10.2203/dose-response.14-028.Mattson
   Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111
   Naik Adviti, 2013, Frontiers in Genetics, V4, P2, DOI 10.3389/fgene.2013.00002
   Nair Pradeep M K, 2016, J Midlife Health, V7, P61, DOI 10.4103/0976-7800.185325
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   NUNESSOUZA V, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/1987960
   Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027
   Pape-Ansorge KA, 2002, NUTR CANCER, V44, P161, DOI 10.1207/S15327914NC4402_07
   Paschos P, 2009, HIPPOKRATIA, V13, P9
   Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839
   Rattan SIS, 2008, HUM EXP TOXICOL, V27, P151, DOI 10.1177/0960327107083409
   Rogozina OP, 2011, CANCER PREV RES, V4, P568, DOI 10.1158/1940-6207.CAPR-10-0140
   Rogozina OP, 2009, CANCER PREV RES, V2, P712, DOI 10.1158/1940-6207.CAPR-09-0028
   Rothschild J, 2014, NUTR REV, V72, P308, DOI 10.1111/nure.12104
   Rusli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30484
   Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5
   Safdie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044603
   Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538
   Schloesser A, 2015, REJUV RES, V18, P30, DOI 10.1089/rej.2014.1630
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Sullivan S, 2010, CURR OPIN GASTROEN, V26, P160, DOI 10.1097/MOG.0b013e3283358a58
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010
   Tinsley GM, 2015, NUTR REV, V73, P661, DOI 10.1093/nutrit/nuv041
   Tsutsumi A, 2011, BIOCHEM BIOPH RES CO, V404, P339, DOI 10.1016/j.bbrc.2010.11.120
   van Dijk M, 2016, ONCOTARGET, V7, P17338, DOI 10.18632/oncotarget.7800
   van Norren K, 2015, J CACHEXIA SARCOPENI, V6, P253, DOI 10.1002/jcsm.12024
   Varady KA, 2007, J LIPID RES, V48, P2212, DOI 10.1194/jlr.M700223-JLR200
   Varady KA, 2016, CURR OPIN ENDOCRINOL, V23, P379, DOI 10.1097/MED.0000000000000280
   Varady KA, 2009, METABOLISM, V58, P803, DOI 10.1016/j.metabol.2009.01.018
   Wan RQ, 2003, FASEB J, V17, P1133, DOI 10.1096/fj.02-0996fje
   Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154
   Xie CL, 2014, INT J BIOCHEM CELL B, V47, P113, DOI 10.1016/j.biocel.2013.11.023
NR 80
TC 15
Z9 17
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD MAY
PY 2017
VL 61
IS 5
AR 1600677
DI 10.1002/mnfr.201600677
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA EX2VG
UT WOS:000403086800014
PM 27995741
OA Green Published, hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Guo, W
   Fu, JX
   Chen, XL
   Gao, BB
   Fu, ZZ
   Fan, HQ
   Cui, Q
   Zhu, XH
   Zhao, Y
   Yang, T
   Fan, DP
   Zhou, HG
AF Guo, Wen
   Fu, Jinxiang
   Chen, Xiaoli
   Gao, Beibei
   Fu, Zhenzhen
   Fan, Hongqi
   Cui, Qin
   Zhu, Xiaohui
   Zhao, Yang
   Yang, Tao
   Fan, Daping
   Zhou, Hon Gwen
TI The Effects of Estrogen on Serum Level and Hepatocyte Expression of
   PCSK9
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Proprotein convertase subtilisin/kexin type 9 (PCSK9); Estrogen;
   Low-density lipoprotein cholesterol (LDL-C); Low-density lipoprotein
   receptor (LDLR)
ID SUBTILISIN/KEXIN TYPE 9; PLASMA PCSK9; RAT-LIVER; DISEASE; LDL;
   LIPOPROTEINS; METABOLISM; WOMEN
AB Objective. We previously reported that serum PCSK9 levels are higher in postmenopausal women than in premenopausal women in a Han Chinese population. Whether this difference is related to estrogen has not been well-characterized. This study aims to examine if the alteration in estrogen level is responsible for the changes of serum PCSK9 concentration.
   Materials/Methods. A sandwich ELISA assay was used to measure serum PCSK9 levels in 727 healthy women aged from 26 to 85 years old. Anthropometric and biochemical examination of parameters such as estrogen and serum lipids was also performed for these individuals. Next, we measured serum PCSK9 and estrogen levels of 30 healthy fertile women (24-26 years old) in their menstrual cycles and analyzed the correlation between serum PCSK9 level and estrogen concentration. Moreover, cell culture studies were carried out to examine if estrogen at physiological and non-physiological concentrations regulates hepatocyte PCSK9 expression.
   Results. Serum PCSK9 concentrations were significantly increased with aging. Aged group had higher serum PCSK9 levels than the middle aged group and the young group (60.29 +/- 28.47 vs 71.38 +/- 34.22 vs 83.81 +/- 33.50 ng/ml). Serum PCSK9 levels were positively correlated with age, BMI, serum total cholesterol and LDL-cholesterol (P < 0.01), but not correlated with estrogen levels. There was no significantly difference of PCSK9 levels between the lower and the upper estradiol (E2) tertiles in the 727 women. There was either no significant difference in PCSK9 levels during the menstrual, ovulatory, luteal phases in the 30 healthy fertile women. Cell culture studies showed that 17 beta-estradiol at physiological concentrations did not significantly alter PCSK9 expression in human hepatocytes.
   Conclusion. The serum PCSK9 levels were higher in postmenopausal women than those in pre-menopausal women. However, the difference in serum PCSK9 levels between postmenopausal and premenopausal woman appeared to be independent of estrogen status, and estrogen at physiological concentrations does not affect human hepatocyte PCSK9 expression. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Guo, Wen; Fu, Jinxiang; Chen, Xiaoli; Gao, Beibei; Fu, Zhenzhen; Fan, Hongqi; Zhu, Xiaohui; Yang, Tao; Zhou, Hon Gwen] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing 210029, Jiangsu, Peoples R China.
   [Guo, Wen] Nanjing Municipal Hosp Govt Org, Dept Endocrinol, Nanjing 210018, Peoples R China.
   [Cui, Qin] Tong Ling Peoples Hosp, Dept Geriatr, Dept Cadres, Tongling 244009, Peoples R China.
   [Zhao, Yang] Nanjing Med Univ, Sch Publ Hlth, Nanjing 210029, Jiangsu, Peoples R China.
   [Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA.
C3 Nanjing Medical University; Nanjing Medical University; University of
   South Carolina System; University of South Carolina Columbia
RP Zhou, HG (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.
EM drhongwenzhou@njmu.edu.cn
RI zhao, yang/HTN-4320-2023; zhao, yang/GXF-4424-2022
FU National Natural Sciences Foundation of China [81170747]; Health
   Promotion Foundation of Jiangsu Province [H201106]; Office of Human
   Resources and Social Security of Jiangsu Province (Peak of the Six
   Personnel in Jiangsu Province); Priority Academic Program Development of
   Jiangsu Higher Education Institutions
FX The study was supported by grant 81170747 from the National Natural
   Sciences Foundation of China, grant H201106 from Health Promotion
   Foundation of Jiangsu Province, grant from the Office of Human Resources
   and Social Security of Jiangsu Province (Peak of the Six Personnel in
   Jiangsu Province) to Hongwen Zhou, and A Project Funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions.
CR Arjuman A, 2011, CONTRACEPTION, V84, P160, DOI [10.1016/j.contraception.2010.11.020, 10.1016/j.contraception.2011.05.017]
   Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013
   Cui Q, 2010, ATHEROSCLEROSIS, V213, P632, DOI 10.1016/j.atherosclerosis.2010.09.027
   Driancourt MA, 2013, THERIOGENOLOGY, V80, P391, DOI 10.1016/j.theriogenology.2013.05.002
   Gencer B, 2014, Rev Med Suisse, V10, P539
   GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016
   KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447
   Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141
   Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200
   Lee CJ, 2013, METABOLISM, V62, P845, DOI 10.1016/j.metabol.2013.01.005
   Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E
   Palacios L, 2012, ATHEROSCLEROSIS, V221, P137, DOI 10.1016/j.atherosclerosis.2011.12.021
   Persson L, 2012, ARTERIOSCL THROM VAS, V32, P810, DOI 10.1161/ATVBAHA.111.242461
   Persson L, 2009, ENDOCRINOLOGY, V150, P1140, DOI 10.1210/en.2008-1281
   SCHAEFER EJ, 1983, J CLIN ENDOCR METAB, V57, P262, DOI 10.1210/jcem-57-2-262
   Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI [10.1517/14728220802600715, 10.1517/14728220802600715 ]
   Sock ETN, 2014, HORM METAB RES, V46, P550, DOI 10.1055/s-0034-1370910
   Stein EA, 2014, EUR HEART J, V35, P2249, DOI 10.1093/eurheartj/ehu085
   Tamada M, 2010, METABOLISM, V59, P653, DOI 10.1016/j.metabol.2009.09.009
   WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702
   WINDLER EET, 1980, J BIOL CHEM, V255, P464
NR 21
TC 18
Z9 19
U1 1
U2 15
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD APR
PY 2015
VL 64
IS 4
BP 554
EP 560
DI 10.1016/j.metabol.2015.01.009
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CC8IZ
UT WOS:000350613000011
PM 25665485
DA 2024-02-19
ER

PT J
AU VANERMEN, A
   FRAEYMAN, N
AF VANERMEN, A
   FRAEYMAN, N
TI DESENSITIZATION OF ALPHA(1)-RECEPTOR, BETA-RECEPTOR AND
   GLUCAGON-RECEPTOR IN RAT HEPATOCYTES - INFLUENCE OF AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; GLUCAGON; GLYCOGENOLYSIS; DESENSITIZATION; HEPATOCYTES;
   ADRENERGIC RECEPTORS
ID INOSITOL PHOSPHOLIPID-METABOLISM; PROTEIN-KINASE-C; STIMULATED
   ADENYLATE-CYCLASE; MOLECULAR MECHANISMS; PHOSPHORYLATION; LIVER;
   GLYCOGENOLYSIS; RESENSITIZATION; VASOPRESSIN; ANGIOTENSIN
AB The alpha(1)-agonist phenylephrine in hepatocytes from mature and senescent rats, and the beta-agonist isoproterenol in hepatocytes from senescent rats, elicited a time-dependent, homologous desensitization of alpha(1)- and beta-receptor-mediated glycogenolysis respectively, which was maximal after 20 min of exposure to the agonists. Glucagon triggered desensitization of the glycogenolytic response to glucagon, isoproterenol and phenylephrine, which was maximal after less than 5 min; this was followed by resensitization of the glucagon response only. After 20 min of treatment with phenylephrine or isoproterenol, no change in cellular distribution of alpha(1)- or beta-receptors was noticed, using sucrose gradient centrifugation. After a 1-h exposure to both agonists, a shift of both receptors to a light density fraction was found, reflecting receptor internalization. Neither the rate of functional desensitization, nor the degree of receptor internalization was altered upon ageing. We conclude that functional desensitization and internalization of adrenergic receptors in rat hepatocytes are separate events in time and are largely unaffected by the ageing process. Thus, despite the absence of a beta-receptor-mediated glycogenolytic response in hepatocytes from mature rats, isoproterenol triggers the internalization of beta-receptors.
C1 STATE UNIV GHENT,SCH MED,HEYMANS INST PHARMACOL,B-9000 GHENT,BELGIUM.
C3 Ghent University
CR BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BERGMEYER HU, 1965, METHOD ENZYMAT AN, V3, P1205
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BOLLEN M, 1983, BIOCHEM J, V210, P783, DOI 10.1042/bj2100783
   BREANT B, 1981, BIOCHEM J, V200, P509, DOI 10.1042/bj2000509
   DIXON TF, 1954, J CLIN PATHOL, V7, P341, DOI 10.1136/jcp.7.4.341
   ELREFAI MF, 1984, BIOCHIM BIOPHYS ACTA, V775, P356, DOI 10.1016/0005-2736(84)90191-3
   FRAEYMAN N, 1993, MECH AGEING DEV, V70, P115, DOI 10.1016/0047-6374(93)90063-W
   GARCIASAINZ JA, 1986, BIOCHIM BIOPHYS ACTA, V887, P73, DOI 10.1016/0167-4889(86)90124-2
   HARDEN TK, 1980, SCIENCE, V210, P411
   HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947
   HERNANDEZSOTOMAYOR SMT, 1988, BIOCHIM BIOPHYS ACTA, V972, P311, DOI 10.1016/0167-4889(88)90207-8
   HEYWORTH CM, 1983, BIOCHEM J, V214, P93, DOI 10.1042/bj2140093
   HOUSLAY MD, 1991, EUR J BIOCHEM, V195, P9, DOI 10.1111/j.1432-1033.1991.tb15671.x
   INGLESE J, 1993, J BIOL CHEM, V268, P23735
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322
   LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098
   LEEBLUNDBERG LMF, 1985, P NATL ACAD SCI USA, V82, P5651, DOI 10.1073/pnas.82.17.5651
   LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M
   LUDBROOK J, 1991, CLIN EXP PHARMACOL P, V18, P379, DOI 10.1111/j.1440-1681.1991.tb01468.x
   MACART M, 1982, CLIN CHIM ACTA, V122, P93, DOI 10.1016/0009-8981(82)90100-0
   Miller R.G., 1969, SIMULTANEOUS STAT IN
   MURPHY GJ, 1987, BIOCHEM J, V243, P39, DOI 10.1042/bj2430039
   MURPHY GJ, 1988, BIOCHEM J, V249, P543, DOI 10.1042/bj2490543
   NEWLANDS C, 1991, FEBS LETT, V289, P129, DOI 10.1016/0014-5793(91)81051-9
   PIPPIG S, 1993, J BIOL CHEM, V268, P3201
   PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021
   SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4
   SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0
   SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408
   TANG EKY, 1992, BIOCHEM J, V283, P341, DOI 10.1042/bj2830341
   TOEWS ML, 1984, J BIOL CHEM, V259, P1844
   VANERMEN A, 1994, J GERONTOL, V49, pB12, DOI 10.1093/geronj/49.1.B12
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   VANERMEN A, 1991, DRUG METABOLISM LIVE, V16, P65
   YU SS, 1993, J BIOL CHEM, V268, P337
NR 37
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUL
PY 1994
VL 75
IS 1
BP 45
EP 58
DI 10.1016/0047-6374(94)90027-2
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PB062
UT WOS:A1994PB06200005
PM 9128753
DA 2024-02-19
ER

PT J
AU Zhou, XR
   Du, HH
   Jiang, MQ
   Zhou, CLK
   Deng, YH
   Long, XY
   Zhao, X
AF Zhou, Xianrong
   Du, Hang-hang
   Jiang, Meiqing
   Zhou, Chaolekang
   Deng, Yuhan
   Long, Xingyao
   Zhao, Xin
TI Antioxidant Effect of <i>Lactobacillus fermentum</i> CQPC04-Fermented
   Soy Milk on D-Galactose-Induced Oxidative Aging Mice
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE soy isoflavones; peptides; Lactobacillus fermentum; soy milk;
   D-galactose
ID STRESS; SKIN; SENESCENCE; PEPTIDES; MODEL; ACID
AB The aim of this study is to evaluate the changes in soy isoflavones and peptides in soy milk after lactic acid bacterial fermentation, and explore the positive effects of fermented soy milk on an oxidative aging mouse model induced with D-galactose. We found that free soybean isoflavones and peptides increased after soy milk was fermented by Lactobacillus fermentum CQPC04. The in vivo results indicated that L. fermentum CQPC04-fermented soy milk enhanced the organ index of the liver and spleen, and improved the pathological morphology of the liver, spleen, and skin. L. fermentum CQPC04-fermented soy milk increased the enzymatic activity of glutathione peroxidase (GSH-Px), total superoxide dismutase (T-SOD), and catalase (CAT), increased glutathione (GSH), but decreased the levels of nitric oxide (NO) and malondialdehyde (MDA) in serum, liver, and brain tissues of oxidative aging mice. The above mentioned fermented soy milk also increased the levels of collagen I (Col I), hyaluronic acid (HA), and collagen III (Col III), and decreased the levels of advanced glycation End products (AGEs) and hydrogen peroxide (H2O2). The RT-qPCR results showed that L. fermentum CQPC04-fermented soy milk upregulated the mRNA expression of nuclear factor erythroid 2?related factor (Nrf2), heme oxygenase-1 (HMOX1), quinone oxido-reductase 1 (Nqo1), neuronal nitric oxide synthase (NOS1), endothelial nitric oxide synthase (NOS3), Cu/Zn-superoxide dismutase (Cu/Zn-SOD), Mn-superoxide dismutase (Mn-SOD), and CAT, but downregulated the expression of inducible nitric oxide synthase (NOS2) and glutamate cysteine ligase modifier subunit (Gclm) in liver and spleen tissues. Lastly, the fermented soy milk also increased the gene expression of Cu/Zn-SOD, Mn-SOD, CAT, GSH-Px, matrix metalloproteinases 1 (TIMP1), and matrix metalloproteinases 2 (TIMP2), and decreased the expression of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) in skin tissue. In conclusion, L. fermentum CQPC04-fermented soy milk was able to satisfactorily delay oxidative aging effects, and its mechanism may be related to the increase in free soy isoflavones and peptides.
C1 [Zhou, Xianrong; Jiang, Meiqing; Zhou, Chaolekang; Deng, Yuhan; Long, Xingyao; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing Engn Lab Res & Dev Funct Food, Chongqing, Peoples R China.
   [Zhou, Xianrong] Silla Univ, Coll Med & Life Sci, Dept Food & Nutr, Busan, South Korea.
   [Du, Hang-hang] Chongqing Huamei Plast Surg Hosp, Dept Plast Surg, Chongqing, Peoples R China.
C3 Chongqing University of Education; Silla University
RP Long, XY; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing Engn Lab Res & Dev Funct Food, Chongqing, Peoples R China.
EM longyaoyao@foods.ac.cn; zhaoxin@cque.edu.cn
FU Chongqing University Innovation Research Group Project [CXQTP20033];
   Science and Technology Project of Chongqing Education Commission
   [KJQN202001604]; Scientific and Technological Innovation Project of
   Construction of Double City Economic Circle in Chengdu-Chongqing Area of
   Chongqing Education Commission [KJCX2020052]
FX This research was funded by Chongqing University Innovation Research
   Group Project (CXQTP20033), the Science and Technology Project of
   Chongqing Education Commission (KJQN202001604), and Scientific and
   Technological Innovation Project of Construction of Double City Economic
   Circle in Chengdu-Chongqing Area of Chongqing Education Commission
   (KJCX2020052), China.
CR Alonso-Miravalles L, 2018, FOODS, V7, DOI 10.3390/foods7050073
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bayat M, 2019, PROBIOTICS ANTIMICRO, V11, P1172, DOI 10.1007/s12602-018-9482-z
   Berhow MA, 2020, FOOD CHEM, V317, DOI 10.1016/j.foodchem.2020.126373
   Cao ZH, 2019, BIOTECHNOL ADV, V37, P223, DOI 10.1016/j.biotechadv.2018.12.001
   Chen C, 2018, P NATL ACAD SCI USA, V115, P9169, DOI 10.1073/pnas.1806260115
   Chen JM, 2017, MECH AGEING DEV, V164, P1, DOI 10.1016/j.mad.2017.03.007
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Feng JC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00904
   Gao YX, 2020, FOOD RES INT, V138, DOI 10.1016/j.foodres.2020.109686
   Ho V, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01894-0
   Hwang CE, 2021, FOOD CHEM, V340, DOI 10.1016/j.foodchem.2020.128199
   Jung JY, 2015, INT IMMUNOPHARMACOL, V28, P88, DOI 10.1016/j.intimp.2015.05.037
   Juritsch AF, 2018, NUTR REV, V76, P618, DOI 10.1093/nutrit/nuy021
   Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kushida M, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201701054
   Lee JH, 2018, J FOOD DRUG ANAL, V26, P1054, DOI 10.1016/j.jfda.2017.12.003
   Li Y, 2017, FOOD FUNCT, V8, P2935, DOI 10.1039/c7fo00342k
   Li YF, 2018, THERANOSTICS, V8, P5713, DOI 10.7150/thno.28778
   Liu BH, 2019, FOODS, V8, DOI 10.3390/foods8010036
   Liu LB, 2022, CRIT REV FOOD SCI, V62, P1971, DOI 10.1080/10408398.2020.1848792
   Liu XT, 2018, AGING-US, V10, P2016, DOI 10.18632/aging.101526
   Lorz LR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051043
   Martinez-Villaluenga C, 2012, J AGR FOOD CHEM, V60, P10235, DOI 10.1021/jf302751m
   Matsuda A, 2012, J DERMATOL SCI, V67, P130, DOI 10.1016/j.jdermsci.2012.05.011
   Nam SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010176
   Panwar P, 2018, MATRIX BIOL, V65, P30, DOI 10.1016/j.matbio.2017.06.004
   Penha CB, 2020, FOOD RES INT, V137, DOI 10.1016/j.foodres.2020.109624
   Polito F, 2012, BRIT J PHARMACOL, V165, P994, DOI 10.1111/j.1476-5381.2011.01619.x
   Qiao J, 2019, PLAST RECONSTR SURG, V144, p189E, DOI 10.1097/PRS.0000000000005848
   Sanlier N, 2019, CRIT REV FOOD SCI, V59, P506, DOI 10.1080/10408398.2017.1383355
   Shin JW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092126
   Tokudome Y, 2012, INT J FOOD SCI NUTR, V63, P689, DOI 10.3109/09637486.2011.652597
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Wang ZQ, 2017, J AGR FOOD CHEM, V65, P10844, DOI 10.1021/acs.jafc.7b05026
   Wu H, 2021, FOOD CHEM, V334, DOI 10.1016/j.foodchem.2020.127484
   Yamamoto N, 2019, BIOSCI MICROB FOOD H, V38, P97, DOI 10.12938/bmfh.18-017
   Yang HJ, 2013, FOOD FUNCT, V4, P1675, DOI 10.1039/c3fo60198f
   Yang J, 2019, FOOD CHEM, V272, P396, DOI 10.1016/j.foodchem.2018.08.037
   Yi GF, 2020, FOOD FUNCT, V11, P2725, DOI 10.1039/c9fo01466g
   Yi RK, 2019, J MED FOOD, V22, P1208, DOI 10.1089/jmf.2019.4467
   Yokose U, 2012, J INVEST DERMATOL, V132, P2800, DOI 10.1038/jid.2012.204
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhou XR, 2019, J DAIRY SCI, V102, P9570, DOI 10.3168/jds.2019-16840
NR 47
TC 15
Z9 18
U1 11
U2 64
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 27
PY 2021
VL 8
AR 727467
DI 10.3389/fnut.2021.727467
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UT9SX
UT WOS:000698448700001
PM 34513906
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fleet, T
   Stashi, E
   Zhu, BK
   Rajapakshe, K
   Marcelo, KL
   Kettner, NM
   Gorman, BK
   Coarfa, C
   Fu, LN
   O'Malley, BW
   York, B
AF Fleet, Tiffany
   Stashi, Erin
   Zhu, Bokai
   Rajapakshe, Kimal
   Marcelo, Kathrina L.
   Kettner, Nicole M.
   Gorman, Blythe K.
   Coarfa, Cristian
   Fu, Loning
   O'Malley, Bert W.
   York, Brian
TI Genetic and Environmental Models of Circadian Disruption Link SRC-2
   Function to Hepatic Pathology
SO JOURNAL OF BIOLOGICAL RHYTHMS
LA English
DT Article
DE SRC-2; non-alcoholic fatty liver disease; NAFLD; chronic circadian
   disruption; liver; metabolism
ID FATTY LIVER-DISEASE; SHIFT WORK; CLOCK; COACTIVATOR; METABOLISM;
   EXPRESSION; ENERGY; POPULATION; COMPONENT; DISTINCT
AB Circadian rhythmicity is a fundamental process that synchronizes behavioral cues with metabolic homeostasis. Disruption of daily cycles due to jet lag or shift work results in severe physiological consequences including advanced aging, metabolic syndrome, and even cancer. Our understanding of the molecular clock, which is regulated by intricate positive feedforward and negative feedback loops, has expanded to include an important metabolic transcriptional coregulator, Steroid Receptor Coactivator-2 (SRC-2), that regulates both the central clock of the suprachiasmatic nucleus (SCN) and peripheral clocks including the liver. We hypothesized that an environmental uncoupling of the light-dark phases, termed chronic circadian disruption (CCD), would lead to pathology similar to the genetic circadian disruption observed with loss of SRC-2. We found that CCD and ablation of SRC-2 in mice led to a common comorbidity of metabolic syndrome also found in humans with circadian disruption, non-alcoholic fatty liver disease (NAFLD). The combination of SRC-2(-/-) and CCD results in a more robust phenotype that correlates with human non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) gene signatures. Either CCD or SRC-2 ablation produces an advanced aging phenotype leading to increased mortality consistent with other circadian mutant mouse models. Collectively, our studies demonstrate that SRC-2 provides an essential link between the behavioral activities influenced by light cues and the metabolic homeostasis maintained by the liver.
C1 [Fleet, Tiffany] Baylor Coll Med, Interdept Dept Translat Biol & Mol Med, Houston, TX 77030 USA.
   [Stashi, Erin; Zhu, Bokai; Rajapakshe, Kimal; Marcelo, Kathrina L.; Kettner, Nicole M.; Coarfa, Cristian; Fu, Loning; O'Malley, Bert W.; York, Brian] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Gorman, Blythe K.] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA.
   [Gorman, Blythe K.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
   [O'Malley, Bert W.; York, Brian] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; The Methodist
   Hospital System; The Methodist Hospital - Houston; Cornell University;
   Weill Cornell Medicine; Baylor College of Medicine
RP O'Malley, BW; York, B (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
EM york@bcm.edu
RI Rajapakshe, Kimal I/P-1592-2015; Zhu, Bokai/AAF-7502-2020
OI Zhu, Bokai/0000-0003-0827-5757; Kettner, Nicole/0000-0003-2043-4407
FU NIH [F31DK107254, F31CA171350, P01 DK59820, 3U19DK062434-10W1,
   GM033976]; Diabetes Research Center (DRC) [NIDDK-P30 DK079638]; Welch
   Foundation [Q1521]; Center for the Advancement of Science in Space
   (CASIS) Integrated OMICs Award; Baylor College of Medicine from the
   Howard Hughes Medical Institutes through the Med into Grad Initiative;
   Medical Scientist Training Program [NIGMS T32 GM7330]
FX We thank Rainer Lanz for lessons on relational database management. We
   thank Sean McGuire for critical reading of the manuscript. We thank Dr.
   Corey Reynolds from the Mouse Phenotyping Core at BCM for technical
   support. This research was supported by grants from the NIH (F31DK107254
   to T.F., F31CA171350 to E.S., P01 DK59820 and 3U19DK062434-10W1 to
   B.W.O.) and Diabetes Research Center (DRC) grant NIDDK-P30 DK079638.
   Partial support was provided by NIH grant GM033976. Additionally,
   research support was provided by the Welch Foundation (Q1521) and from
   the Center for the Advancement of Science in Space (CASIS) Integrated
   OMICs Award to B.Y. and B.W.O. Partial support for this work was
   provided by a grant to Baylor College of Medicine from the Howard Hughes
   Medical Institutes through the Med into Grad Initiative, and to the
   Medical Scientist Training Program NIGMS T32 GM7330.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925
   Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048
   Cho K, 2000, J NEUROSCI, V20, part. no.
   Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847
   Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001
   Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241
   Duteil D, 2010, CELL METAB, V12, P496, DOI 10.1016/j.cmet.2010.09.016
   ECHAVELLANOS JM, 1970, JNCI-J NATL CANCER I, V44, P581
   Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109
   Fleet T, 2015, P NATL ACAD SCI USA, V112, pE6068, DOI 10.1073/pnas.1519073112
   Froy O, 2013, AGEING RES REV, V12, P931, DOI 10.1016/j.arr.2013.09.002
   Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6
   Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002
   Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110
   Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10
   Hatoum IJ, 2013, AM J HUM GENET, V92, P827, DOI 10.1016/j.ajhg.2013.04.009
   Jeong JW, 2006, MOL ENDOCRINOL, V20, P1138, DOI 10.1210/me.2005-0407
   Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747
   Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005
   Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Lin YC, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1765, DOI 10.1177/1010539512469248
   Lin YC, 2014, CHRONOBIOL INT, V31, P487, DOI 10.3109/07420528.2013.872120
   Mazzoccoli G, 2014, LIVER INT, V34, P1133, DOI 10.1111/liv.12534
   Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010
   O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109
   Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754
   Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201
   Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002
   Reddy AB, 2002, J NEUROSCI, V22, P7326
   Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039
   Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607
   Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377
   Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106
   Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Sookoian S, 2009, ATHEROSCLEROSIS, V207, P346, DOI 10.1016/j.atherosclerosis.2009.06.008
   Starmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046584
   Stashi E, 2014, CELL REP, V6, P633, DOI 10.1016/j.celrep.2014.01.027
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   TAPP WN, 1989, AM J PHYSIOL, V257, pR796, DOI 10.1152/ajpregu.1989.257.4.R796
   *US DEP LAB, 2005, WORK FLEX SHIFT SCHE
   Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001
   Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323
   Zhang DQ, 2014, J BIOL CHEM, V289, P25925, DOI 10.1074/jbc.M114.567628
   Zhu BK, 2015, MOL CELL, V60, P769, DOI 10.1016/j.molcel.2015.10.024
NR 55
TC 15
Z9 16
U1 3
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0748-7304
EI 1552-4531
J9 J BIOL RHYTHM
JI J. Biol. Rhythms
PD OCT
PY 2016
VL 31
IS 5
BP 443
EP 460
DI 10.1177/0748730416657921
PG 18
WC Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA DW1XK
UT WOS:000383436700003
PM 27432117
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Liu, J
   Chen, D
   Wang, ZK
   Chen, CY
   Ning, DL
   Zhao, SL
AF Liu, Ji
   Chen, Dan
   Wang, Zukun
   Chen, Chaoyin
   Ning, Delu
   Zhao, Shenglan
TI Protective effect of walnut on d-galactose-induced aging mouse model
SO FOOD SCIENCE & NUTRITION
LA English
DT Article
DE cognitive function; d-galactose; oxidative stress; walnut
ID COGNITIVE IMPAIRMENT; DL0410; MEMORY; RATS; MICE
AB Objective (s): Accumulating evidence has suggested that oxidative stress and apoptosis are involved in the aging process. D-galactose (gal) has been reported to cause symptoms of aging in mice, accompanied by liver and brain injuries. Our present work was to study the potential anti-oxidative and anti-apoptotic effects of walnut and to explore how these effects act on mice in a D-gal-induced aging model.
   Materials and Methods: Aging mice were induced by subcutaneous injection of D-gal (200 mg kg(-1) d(-1) for 8 weeks). Walnut samples were simultaneously administered to the D-gal-induced aging mice once daily by intragastric gavage. Finally, body weight, organ index, cognitive function, levels of antioxidative enzymes, and liver function were monitored.
   Results: The kernel pellicles of walnut could not only improve the learning and memory ability, and the organ index, but also significantly decrease body weight and normalize the levels of activity of anti-oxidative enzymes in aging mice. Further, the walnut seed coat would protect damages of hippocampus and liver in aging mice.
   Highlights: In the current study, we investigated the effects of walnut kernels and walnut seed coats (WSCs) on D-galactose-induced aging mice. WSC was firstly found to have beneficial effects on D-gal-treated mouse's brain with learning and memory impairment, which probably through the underlying mechanism reduces oxidative damage and limits neuroinflammation. In addition, WSC had a protective effect on liver damage in D-galactose sensing mice.
C1 [Liu, Ji; Wang, Zukun; Zhao, Shenglan] Yunnan Univ Tradit Chinese Med, Sch Chinese Mat Med, Kunming, Yunnan, Peoples R China.
   [Chen, Dan] Yunnan Inst Tobacco Qual Inspect & Supervis, Kunming, Yunnan, Peoples R China.
   [Chen, Chaoyin; Ning, Delu] Yunnan Acad Forestry, Kunming, Yunnan, Peoples R China.
C3 Yunnan University of Chinese Medicine
RP Zhao, SL (corresponding author), Yunnan Univ Tradit Chinese Med, Kunming, Yunnan, Peoples R China.
EM zsl13330431529@126.com
FU National Natural Science Foundation of China [21466037, 81760735]
FX The National Natural Science Foundation of China, Grant/Award Number:
   21466037; 81760735
CR Baeta-Corral R, 2018, J GERONTOL A-BIOL, V73, P1147, DOI 10.1093/gerona/gly031
   Carvalho M, 2010, FOOD CHEM TOXICOL, V48, P441, DOI 10.1016/j.fct.2009.10.043
   Chen P., 2018, SCI REPORTS, V8, P1645
   ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Fukuda T, 2003, PHYTOCHEMISTRY, V63, P795, DOI 10.1016/S0031-9422(03)00333-9
   Huang Y., 2001, LAB ANIM SCI, V5, P3
   Ito H, 2007, J AGR FOOD CHEM, V55, P672, DOI 10.1021/jf062872b
   Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007
   Lakshmi BVS, 2015, BIOL TRACE ELEM RES, V165, P67, DOI 10.1007/s12011-015-0229-3
   Li L, 2006, J AGR FOOD CHEM, V54, P8033, DOI 10.1021/jf0612171
   Li YJ, 2016, ONCOTARGET, V7, P17393, DOI 10.18632/oncotarget.8165
   Lian WW, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00409
   Liang X, 2017, J FUNCT FOODS, V31, P89, DOI 10.1016/j.jff.2017.01.026
   Rathod R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0241-8
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2
   Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c
   Song, 2014, J FOOD NUTR RES, V2, P450, DOI [10.12691/jfnr-2-8-4, DOI 10.12691/JFNR-2-8-4]
   Yamamuro Y, 2004, EXP ANIM TOKYO, V53, P145, DOI 10.1538/expanim.53.145
   Yang RY, 2015, PHARMACOL BIOCHEM BE, V139, P15, DOI 10.1016/j.pbb.2015.10.009
   Yin YY, 2010, J ALZHEIMERS DIS, V19, P735, DOI 10.3233/JAD-2010-1272
   Zhang HY, 2018, APPL MICROBIOL BIOT, V102, P2791, DOI 10.1007/s00253-018-8775-1
   Zhang ZeSheng, 2017, Food Research and Development, V38, P190
   Zhou D, 2016, ACTA PHARMACOL SIN, V37, P1401, DOI 10.1038/aps.2016.87
NR 25
TC 30
Z9 31
U1 5
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD MAR
PY 2019
VL 7
IS 3
BP 969
EP 976
DI 10.1002/fsn3.907
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA HP1ST
UT WOS:000461448300008
PM 30918639
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU O'Reilly, JN
   Cogger, VC
   Le Couteur, DG
AF O'Reilly, Jennifer N.
   Cogger, Victoria C.
   Le Couteur, David G.
TI Old age is associated with ultrastructural changes in isolated rat liver
   sinusoidal endothelial cells
SO JOURNAL OF ELECTRON MICROSCOPY
LA English
DT Article
DE sinusoidal endothelial cell; fenestration; aging
ID PSEUDOCAPILLARIZATION; FENESTRATIONS; SIEVE; ATHEROSCLEROSIS
AB Old age is associated with ultrastructural changes in the hepatic sinusoid called pseudocapillarization, which include defenestration and thickening of the sinusoidal endothelium. We investigated whether such changes also occur in isolated and cultured liver sinusoidal endothelial cells. Liver sinusoidal endothelial cells were isolated from young (6-10 months, n = 4) and old (24-26 months, n = 4) F344 rats and fenestrations evaluated using scanning electron microscopy. Fenestration diameter was reduced in old age from 194 +/- 1 nm to 185 +/- 1 nm (P < 0.001) and there was an age-related increase in the number fused fenestrations and large gaps. Age-related changes in the diameter of fenestrations in the liver sinusoidal endothelial cell are maintained following isolation and culture. This suggests that this age-related change may be intrinsic to the liver endothelial cell and/or irreversible.
C1 [Le Couteur, David G.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia.
   Concord RG Hosp, Sydney, NSW 2139, Australia.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital
RP Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022
OI Le Couteur, David/0000-0002-4227-5817
FU National Health and Medical Research Council of Australia [464834];
   Ageing and Alzheimers Research Foundation
FX National Health and Medical Research Council of Australia (464834);
   Ageing and Alzheimers Research Foundation (a division of the Medical
   Foundation of the University of Sydney).
CR Arias I M, 1990, Prog Liver Dis, V9, P11
   Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401
   Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1980, BRIT J EXP PATHOL, V61, P222
   Frenzel H., 1977, KUPFFER OTHER LIVER, P213
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   MARCH S, 2009, HEPATOLOGY
   Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4
   MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MONTESANO R, 1978, ANAT REC, V190, P861, DOI 10.1002/ar.1091900407
   MORI T, 1993, HEPATOLOGY, V17, P891
   Oda M, 2003, CLIN HEMORHEOL MICRO, V29, P167
   Oda M., 1986, CELLS HEPATIC SINUSO, P511
   OHATA M, 1984, ARCH HISTOL JAPON, V47, P359, DOI 10.1679/aohc.47.359
   Shin YC, 1997, ANAT RECORD, V247, P206, DOI 10.1002/(SICI)1097-0185(199702)247:2<206::AID-AR7>3.0.CO;2-V
   Stacchiotti A, 2008, EXP GERONTOL, V43, P330, DOI 10.1016/j.exger.2008.01.009
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   WISSE E, 1983, SCAN ELECTRON MICROS, P1441
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   WRIGHT PL, 1983, ANAT REC, V206, P385, DOI 10.1002/ar.1092060405
   Yokomori H, 2009, LIVER INT, V29, P266, DOI 10.1111/j.1478-3231.2008.01891.x
   YOUNGCHUL S, 1997, ANAT REC, V247, P206
NR 35
TC 16
Z9 17
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-0744
EI 1477-9986
J9 J ELECTRON MICROSC
JI J. Electron Microsc.
PD FEB
PY 2010
VL 59
IS 1
BP 65
EP 69
DI 10.1093/jmicro/dfp039
PG 5
WC Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy
GA 553DJ
UT WOS:000274345300007
PM 19648606
DA 2024-02-19
ER

PT J
AU Cazzagon, N
   Sarcognato, S
   Floreani, A
   Corrà, G
   De Martin, S
   Guzzardo, V
   Russo, FP
   Guido, M
AF Cazzagon, Nora
   Sarcognato, Samantha
   Floreani, Annarosa
   Corra, Giorgia
   De Martin, Sara
   Guzzardo, Vincenza
   Russo, Francesco Paolo
   Guido, Maria
TI Cholangiocyte senescence in primary sclerosing cholangitis is associated
   with disease severity and prognosis
SO JHEP REPORTS
LA English
DT Article; Early Access
DE PSC; p16; p21; Senescent cholangiocytes; Fibrosing cholangiopathy;
   Prognosis
ID HISTOLOGIC SCORING SYSTEMS; PRIMARY BILIARY-CIRRHOSIS; SMALL BILE-DUCTS;
   CELLULAR SENESCENCE; VALIDATION
AB Background & Aims: Primary sclerosing cholangitis (PSC) is a rare cholangiopathy of unknown aetiopathogenesis. The aim of this study was to evaluate cellular senescence (CS) marker expression in cholangiocytes of patients with PSC and their correlation with clinical-pathological features and prognosis.
   Methods: Thirty-five patients with PSC with at least 1 available liver sampling were included. Clinical laboratory data at the time of liver sampling were collected. The endpoints were survival without liver transplantation (LT), time to LT, and survival without LT or cirrhosis decompensation. Histological grading and staging were assessed according to Nakanuma. Immunohistochemical stains for CS markers, p16(INK4A) (p16) and p21(WAF1/Cip1)(p21), were performed and scored by a 3-tier scale based on positivity extent in native bile duct (NBD) and ductular reaction (DR).
   Results: p16 expression in NBD and DR was directly correlated with fibrosis (p <- 0.001 for both) and stage (p = 0.006 and p <0.001, respectively). Moreover, p16 in NBD was positively correlated with hepatitis activity (HA) (p = 0.026), whereas p16 in DR was directly correlated with bile duct loss (BDL) (p = 0.005) and metaplastic hepatocytes (MH) (p <0.01). p21 expression in NBD and DR was directly correlated with HA (p = 0.004 and p = 0.043, respectively), fibrosis (p = 0.006 and p <0.001, respectively), stage (p = 0.006 and p = 0.001, respectively), BDL (p = 0.002 and p = 0.03, respectively), and DR and MH (p <= 0.004 for all). By multivariate analysis, p16 expression in DR was independently associated with stage (p = 0.001), fibrosis (p = 0.001), and BDL (p = 0.011). p21 expression in NBD was independently associated with HA (p = 0.012), BDL (p = 0.04), and DR (p = 0.014). Finally, p21 expression in DR was independently associated with LT-free survival, time to LT, and adverse outcome-free survival (p = 0.001, p = 0.017, and p = 0.001, respectively).
   Conclusions: Cholangiocyte senescence is detectable in all stages of PSC and is associated with histological and clinical disease severity, potentially representing a new prognostic and therapeutic target.
   Lay summary: In this study, we showed that cholangiocyte senescence (CS), previously demonstrated in liver of patients with end-stage primary sclerosing cholangitis (PSC), is an early event and is detectable in all disease stages. Moreover, we observed that CS is associated with histological and clinical disease severity and patients' outcome. Thus, we suggest that CS may represent a new prognostic tool and a potential therapeutic target in PSC. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
C1 [Cazzagon, Nora; Corra, Giorgia; Russo, Francesco Paolo] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy.
   [Sarcognato, Samantha; Guzzardo, Vincenza; Guido, Maria] Univ Padua, Dept Med DIMED, Padua, Italy.
   [Sarcognato, Samantha; Guido, Maria] Azienda ULSS2 Marca Trevigiana, Dept Pathol, Treviso, Italy.
   [Floreani, Annarosa] Univ Padua, Padua, Italy.
   [Floreani, Annarosa] IRCCS Negrar, Verona, Italy.
   [De Martin, Sara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.
C3 University of Padua; University of Padua; ULSS 2 Marca TV; Ospedale Ca'
   Foncello Treviso; University of Padua; University of Padua
RP Cazzagon, N; Russo, FP (corresponding author), Dipartimento Sci Chirurg Oncol & Gastroenterol, Via N Giustiniani 2, I-35128 Padua, Italy.
EM nora.cazzagon@gmail.com; francescopaolo.russo@unipd.it
RI De Martin, Sara/AAC-7396-2022; RUSSO, FRANCESCO PAOLO/AAO-4597-2020
OI De Martin, Sara/0000-0001-6398-8237; RUSSO, FRANCESCO
   PAOLO/0000-0003-4127-8941; Cazzagon, Nora/0000-0002-6937-8664; guido,
   maria/0000-0002-8558-0723
FU Department of Surgery, Oncology and Gastroenterology, University of
   Padova, Padova (DOR 2020)
FX FPR was funded by the Department of Surgery, Oncology and
   Gastroenterology, University of Padova, Padova (DOR 2020).
CR Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4
   Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009
   Boberg KM, 2011, J HEPATOL, V54, P374, DOI 10.1016/j.jhep.2010.09.002
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   de Vries EMG, 2017, HEPATOLOGY, V65, P907, DOI 10.1002/hep.28963
   de Vries EMG, 2015, J HEPATOL, V63, P1212, DOI 10.1016/j.jhep.2015.06.008
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   Harada K, 2013, J CLIN GASTROENTEROL, V47, P174, DOI 10.1097/MCG.0b013e31827234e4
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Ponsioen CY, 2016, HEPATOLOGY, V63, P1357, DOI 10.1002/hep.28256
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Soto-Gamez A, 2019, J MOL BIOL, V431, P2629, DOI 10.1016/j.jmb.2019.05.036
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Weismüller TJ, 2017, GASTROENTEROLOGY, V152, P1975, DOI 10.1053/j.gastro.2017.02.038
NR 24
TC 20
Z9 22
U1 1
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5559
J9 JHEP REP
JI JHEP Rep.
PD 2021 JUN
PY 2021
VL 3
IS 3
AR 100286
DI 10.1016/j.jhepr.2021.100286
EA MAY 2021
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA SN4VX
UT WOS:000658290100025
PM 34041468
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shive, CL
   Kowal, CM
   Desotelle, AF
   Nguyen, Y
   Carbone, S
   Kostadinova, L
   Davitkov, P
   O'Mara, M
   Reihs, A
   Siddiqui, H
   Wilson, BM
   Anthony, DD
AF Shive, Carey L.
   Kowal, Corinne M.
   Desotelle, Alexandra F.
   Nguyen, Ynez
   Carbone, Sarah
   Kostadinova, Lenche
   Davitkov, Perica
   O'Mara, Megan
   Reihs, Alexandra
   Siddiqui, Hinnah
   Wilson, Brigid M.
   Anthony, Donald D.
TI Endotoxemia Associated with Liver Disease Correlates with Systemic
   Inflammation and T Cell Exhaustion in Hepatitis C Virus Infection
SO CELLS
LA English
DT Article
DE 3-10 HCV; T cell exhaustion; inflammation; EndoCab; LBP; FABP; transient
   elastography; liver disease
ID SOLUBLE CD163; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; HCV
   INFECTION; HIV; EXPRESSION; SENESCENCE; MARKER; DYSFUNCTION; PROGRESSION
AB Both acute and chronic hepatitis C virus (HCV) infections are characterized by inflammation. HCV and reduced liver blood filtration contribute to inflammation; however, the mechanisms of systemic immune activation and dysfunction as a result of HCV infection are not clear. We measured circulating inflammatory mediators (IL-6, IP10, sCD163, sCD14), indices of endotoxemia (EndoCab, LBP, FABP), and T cell markers of exhaustion and senescence (PD-1, TIGIT, CD57, KLRG-1) in HCV-infected participants, and followed a small cohort after direct-acting anti-viral therapy. IL-6, IP10, Endocab, LBP, and FABP were elevated in HCV participants, as were T cell co-expression of exhaustion and senescence markers. We found positive associations between IL-6, IP10, EndoCab, LBP, and co-expression of T cell markers of exhaustion and senescence. We also found numerous associations between reduced liver function, as measured by plasma albumin levels, and T cell exhaustion/senescence, inflammation, and endotoxemia. We found positive associations between liver stiffness (TE score) and plasma levels of IL-6, IP10, and LBP. Lastly, plasma IP10 and the proportion of CD8 T cells co-expressing PD-1 and CD57 decreased after initiation of direct-acting anti-viral therapy. Although associations do not prove causality, our results support the model that translocation of microbial products, resulting from decreased liver blood filtration, during HCV infection drives chronic inflammation that results in T cell exhaustion/senescence and contributes to systemic immune dysfunction.
C1 [Shive, Carey L.; Kowal, Corinne M.; Desotelle, Alexandra F.; Nguyen, Ynez; Carbone, Sarah; Kostadinova, Lenche; Davitkov, Perica; O'Mara, Megan; Reihs, Alexandra; Siddiqui, Hinnah; Wilson, Brigid M.; Anthony, Donald D.] Cleveland VA Med Ctr, Cleveland, OH 44106 USA.
   [Shive, Carey L.] Case Western Reserve Univ, Sch Med, Pathol Dept, Cleveland, OH 44106 USA.
   [Wilson, Brigid M.; Anthony, Donald D.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Louis Stokes Cleveland Veterans Affairs Medical Center; University
   System of Ohio; Case Western Reserve University; University System of
   Ohio; Case Western Reserve University
RP Shive, CL (corresponding author), Cleveland VA Med Ctr, Cleveland, OH 44106 USA.; Shive, CL (corresponding author), Case Western Reserve Univ, Sch Med, Pathol Dept, Cleveland, OH 44106 USA.
EM carey.shive@case.edu; corinne.kowal@va.gov; alexandra.desotelle@va.gov;
   ynez.nguyen@va.gov; sarah.carbone@va.gov; lenche.kostadinova@va.gov;
   perica.davitkov@va.gov; megan.omara@va.gov; ahr51@case.edu;
   hinnah.siddiqui@va.gov; brigid.wilson@va.gov; dda3@case.edu
OI Shive, Carey/0000-0002-6908-1246
FU Graphical Abstract created using <uri>BioRender.com</uri>.
FX Graphical Abstract created using <URI>BioRender.com</URI>.
CR Alanio C, 2015, ELIFE, V4, DOI 10.7554/eLife.07916
   Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010
   Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022
   Barclay G R, 1995, Prog Clin Biol Res, V392, P263
   Bartek J, 2008, NAT CELL BIOL, V10, P887, DOI 10.1038/ncb0808-887
   BASS NM, 1985, CHEM PHYS LIPIDS, V38, P95, DOI 10.1016/0009-3084(85)90060-X
   Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103
   Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1
   Davitkov P, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0280647
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438
   French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225
   Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637
   Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09
   Henson SM, 2009, AGE, V31, P285, DOI 10.1007/s11357-009-9100-9
   Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588
   Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129
   Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025
   Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565
   Kostadinova Lenche, 2018, Pathog Immun, V3, P149, DOI 10.20411/pai.v3i1.242
   Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372
   Lee H, 2022, NAT IMMUNOL, V23, P13, DOI 10.1038/s41590-021-00985-3
   Lin JC, 2014, J INFECT DIS, V210, P1881, DOI 10.1093/infdis/jiu325
   Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8
   LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207
   Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269
   Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028
   Mascia C, 2017, CLIN RES HEPATOL GAS, V41, P644, DOI 10.1016/j.clinre.2017.04.007
   Moorman JP, 2011, VACCINE, V29, P3169, DOI 10.1016/j.vaccine.2011.02.052
   Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200
   Pulko V, 2016, NAT IMMUNOL, V17, P966, DOI 10.1038/ni.3483
   Reiner AP, 2013, ARTERIOSCL THROM VAS, V33, P158, DOI 10.1161/ATVBAHA.112.300421
   Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307
   Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051
   Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063
   Shive CL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.638010
   Shive CL, 2018, VACCINE, V36, P453, DOI 10.1016/j.vaccine.2017.12.018
   Shive CL, 2016, JAIDS-J ACQ IMM DEF, V71, P483, DOI 10.1097/QAI.0000000000000913
   Shive CL, 2015, AIDS, V29, P1263, DOI 10.1097/QAD.0000000000000735
   Song YZ, 2018, AGING CELL, V17, DOI 10.1111/acel.12716
   Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254
   Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006
   Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050
   Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Ye H, 2013, WORLD J GASTROENTERO, V19, P2818, DOI 10.3748/wjg.v19.i18.2818
NR 50
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG
PY 2023
VL 12
IS 16
AR 2034
DI 10.3390/cells12162034
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA Q4DK7
UT WOS:001057038500001
PM 37626844
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Galkin, F
   Kochetov, K
   Koldasbayeva, D
   Faria, M
   Fung, HH
   Chen, AX
   Zhavoronkov, A
AF Galkin, Fedor
   Kochetov, Kirill
   Koldasbayeva, Diana
   Faria, Manuel
   Fung, Helene H.
   Chen, Amber X.
   Zhavoronkov, Alex
TI Psychological factors substantially contribute to biological aging:
   evidence from the aging rate in Chinese older adults
SO AGING-US
LA English
DT Article
DE psychological aging; lifespan psychology; aging clocks; longevity
ID NEURAL-NETWORKS; LIFE; HEALTH; IDENTIFICATION; BIOMARKER; EDUCATION;
   ONSET; DIET
AB We have developed a deep learning aging clock using blood test data from the China Health and Retirement Longitudinal Study, which has a mean absolute error of 5.68 years. We used the aging clock to demonstrate the connection between the physical and psychological aspects of aging. The clock detects accelerated aging in people with heart, liver, and lung conditions. We demonstrate that psychological factors, such as feeling unhappy or being lonely, add up to 1.65 years to one's biological age, and the aggregate effect exceeds the effects of biological sex, living area, marital status, and smoking status. We conclude that the psychological component should not be ignored in aging studies due to its significant impact on biological age.
C1 [Galkin, Fedor; Kochetov, Kirill; Koldasbayeva, Diana; Zhavoronkov, Alex] Deep Longev Ltd, Hong Kong, Peoples R China.
   [Faria, Manuel] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.
   [Fung, Helene H.; Chen, Amber X.] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China.
   [Zhavoronkov, Alex] Insilico Med, Hong Kong, Peoples R China.
   [Zhavoronkov, Alex] Buck Inst Res Aging, Novato, CA 94945 USA.
C3 Stanford University; Chinese University of Hong Kong; Buck Institute for
   Research on Aging
RP Galkin, F (corresponding author), Deep Longev Ltd, Hong Kong, Peoples R China.
EM fedor@deeplongevity.com
OI Chen, Amber Xuqian/0000-0003-3359-9075; Koldasbayeva,
   Diana/0000-0001-8788-6024
CR ALIPER A, 2020, Patent No. [WO2020060603A1, 2020060603]
   Aliper AM, 2022, Patent No. [US11260078B2, 11260078]
   Aliper AM, 2018, Patent No. [US20190034581A1, 20190034581]
   Aliper AM, 2020, Patent No. [US20200075127A1, 20200075127]
   Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134
   Anderson JA, 2021, ELIFE, V10, DOI 10.7554/eLife.66128
   [Anonymous], 1968, Behavioral Science, DOI [DOI 10.1002/BS.3830140209, 10.1002/bs.3830140209]
   Arora I, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091094
   Asian Perspectives, 2015, SUCCESSFUL AGING, DOI [10.1007/978-94-017-9331-5, DOI 10.1007/978-94-017-9331-5]
   Boks MP, 2015, PSYCHONEUROENDOCRINO, V51, P506, DOI 10.1016/j.psyneuen.2014.07.011
   Brody GH, 2016, J CHILD PSYCHOL PSYC, V57, P566, DOI 10.1111/jcpp.12495
   Carstensen LL, 2021, GERONTOLOGIST, V61, P1188, DOI 10.1093/geront/gnab116
   Clevert D-A., 2016, ARXIV151107289, P1, DOI [10.48550/ ARXIV.1511.07289, DOI 10.3233/978-1-61499-672-9-1760]
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Feitelson MA, 2015, SEMIN CANCER BIOL, V35, pS25, DOI 10.1016/j.semcancer.2015.02.006
   Fitzgerald KN, 2021, AGING-US, V13, P9419, DOI 10.18632/aging.202913
   Fung HH, 2013, GERONTOLOGIST, V53, P369, DOI 10.1093/geront/gnt024
   Galkin F, 2022, Patent No. [US20220005552A1, 20220005552]
   Galkin F, 2022, AGING-US, V14, P4935, DOI 10.18632/aging.204061
   Galkin F, 2021, LIFE-BASEL, V11, DOI 10.3390/life11080730
   Galkin F, 2021, AGING DIS, V12, P1252, DOI 10.14336/AD.2020.1202
   Galkin F, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101050
   Han LKM, 2019, PSYCHONEUROENDOCRINO, V106, P293, DOI 10.1016/j.psyneuen.2019.04.004
   Harvanek ZM, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01735-7
   Hatton SN, 2018, NEUROBIOL AGING, V67, P1, DOI 10.1016/j.neurobiolaging.2018.03.004
   Horvath S, 2021, Patent No. [EP3049535B1, 3049535]
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hu Y, 2018, INNOV AGING, V2, P510, DOI [10.1093/geroni/igy023.1892, DOI 10.1093/GERONI/IGY023.1892]
   Hu YY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215907
   Jiang D., 2019, Work Across the Lifespan, P135, DOI [10.1016/B978-0-12-812756-8.00006-2, DOI 10.1016/B978-0-12-812756-8.00006-2]
   Jiang N, 2019, SOC INDIC RES, V145, P257, DOI 10.1007/s11205-019-02109-9
   Jin Q, 2018, SOC INDIC RES, V140, P1159, DOI 10.1007/s11205-017-1803-1
   Jovanovic T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09235-9
   Kong T, 2019, J AGING SOC POLICY, V31, P271, DOI 10.1080/08959420.2018.1485391
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Li HB, 2019, PSYCHIAT RES, V273, P75, DOI 10.1016/j.psychres.2019.01.009
   Li JJ, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0969-3
   Li M, 2019, J NUTR HEALTH AGING, V23, P211, DOI 10.1007/s12603-018-1122-5
   Li TY, 2020, PSYCHOL ASSESSMENT, V32, P211, DOI 10.1037/pas0000779
   Li TY, 2011, REV GEN PSYCHOL, V15, P246, DOI 10.1037/a0024694
   Lin B, 2018, 2018 C, DOI [10.22004/ag.econ.275997, DOI 10.22004/AG.ECON.275997]
   Liu Y, 2017, INNOV AGING, V1, P814, DOI [10.1093/geroni/igx004.2938, DOI 10.1093/GERONI/IGX004.2938]
   Malone JC, 2016, DEV PSYCHOL, V52, P496, DOI 10.1037/a0039875
   Mamoshina P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35704-w
   Mamoshina P, 2018, J GERONTOL A-BIOL, V73, P1482, DOI 10.1093/gerona/gly005
   Mamoshina P, 2016, MOL PHARMACEUT, V13, P1445, DOI 10.1021/acs.molpharmaceut.5b00982
   Manczak EM, 2023, DEV PSYCHOPATHOL, V35, P109, DOI 10.1017/S0954579421000614
   McCrory C, 2021, J GERONTOL A-BIOL, V76, P741, DOI 10.1093/gerona/glaa286
   Mikolov T, 2012, ARXIV
   Mitina M, 2020, AGING-US, V12, P18765, DOI 10.18632/aging.103880
   Moskalev A, 2017, AGING-US, V9, P21, DOI 10.18632/aging.101163
   Mutz J, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02097-z
   Nakagawa T, 2021, J GERONTOL B-PSYCHOL, V76, pS17, DOI 10.1093/geronb/gbaa042
   Pan X, 2020, AGING MENT HEALTH, V24, P1046, DOI 10.1080/13607863.2019.1597015
   Pavanello S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173074
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968
   Quach A, 2017, AGING-US, V9, P419, DOI 10.18632/aging.101168
   Robertson T, 2013, EPIDEMIOL REV, V35, P98, DOI 10.1093/epirev/mxs001
   Scott AJ, 2021, NATURE AGING, V1, P616, DOI 10.1038/s43587-021-00080-0
   Shen YP, 2019, CLIN BIOCHEM, V65, P7, DOI 10.1016/j.clinbiochem.2018.12.012
   Singh V., 2018, CHINESE STUD HIST, V7, P242, DOI [10.4236/chnstd.2018.73021, DOI 10.4236/CHNSTD.2018.73021]
   Srivastava N, 2014, J MACH LEARN RES, V15, P1929
   Strachey J, 1953, STANDARD EDITION COM, P123
   Gottlieb MGV, 2018, CRIT REV FOOD SCI, V58, P1557, DOI 10.1080/10408398.2016.1269054
   Wang Q, 2019, SOC SCI MED, V220, P387, DOI 10.1016/j.socscimed.2018.11.031
   Wertz J, 2021, JAMA PSYCHIAT, V78, P530, DOI 10.1001/jamapsychiatry.2020.4626
   Wurm S, 2013, PSYCHOL AGING, V28, P1088, DOI 10.1037/a0032845
   Yeung GTY, 2007, EUR J AGEING, V4, P219, DOI 10.1007/s10433-007-0065-1
   You XY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024080
   Zannas AS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0828-5
   Zhang CC, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.707062
   Zhang K, 2015, Patent No. [US20150259742A1, 20150259742]
   Zhang ZM, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2018.100329
   Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203
   Zhavoronkov A, 2020, AGING-US, V12, P23548, DOI 10.18632/aging.202344
   Zhavoronkov A, 2019, NAT BIOTECHNOL, V37, P1038, DOI 10.1038/s41587-019-0224-x
NR 78
TC 11
Z9 11
U1 8
U2 31
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP 29
PY 2022
VL 14
IS 18
BP 7206
EP 7222
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 5U3XH
UT WOS:000876483400003
PM 36170009
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Belsky, DW
   Caspi, A
   Houts, R
   Cohen, HJ
   Corcoran, DL
   Danese, A
   Harrington, H
   Israel, S
   Levine, ME
   Schaefer, JD
   Sugden, K
   Williams, B
   Yashin, AI
   Poulton, R
   Moffitt, TE
AF Belsky, Daniel W.
   Caspi, Avshalom
   Houts, Renate
   Cohen, Harvey J.
   Corcoran, David L.
   Danese, Andrea
   Harrington, HonaLee
   Israel, Salomon
   Levine, Morgan E.
   Schaefer, Jonathan D.
   Sugden, Karen
   Williams, Ben
   Yashin, Anatoli I.
   Poulton, Richie
   Moffitt, Terrie E.
TI Quantification of biological aging in young adults
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biological aging; cognitive aging; aging; healthspan; geroscience
ID RETINAL VASCULAR CALIBER; CREATININE CLEARANCE; VESSEL DIAMETERS;
   ALLOSTATIC LOAD; NORMATIVE DATA; AGE; BIOMARKER; STRENGTH; HEALTH;
   ABNORMALITIES
AB Antiaging therapies show promise in model organism research. Translation to humans is needed to address the challenges of an aging global population. Interventions to slow human aging will need to be applied to still-young individuals. However, most human aging research examines older adults, many with chronic disease. As a result, little is known about aging in young humans. We studied aging in 954 young humans, the Dunedin Study birth cohort, tracking multiple biomarkers across three time points spanning their third and fourth decades of life. We developed and validated two methods by which aging can be measured in young adults, one cross-sectional and one longitudinal. Our longitudinal measure allows quantification of the pace of coordinated physiological deterioration across multiple organ systems (e.g., pulmonary, periodontal, cardiovascular, renal, hepatic, and immune function). We applied these methods to assess biological aging in young humans who had not yet developed age-related diseases. Young individuals of the same chronological age varied in their "biological aging" (declining integrity of multiple organ systems). Already, before midlife, individuals who were aging more rapidly were less physically able, showed cognitive decline and brain aging, self-reported worse health, and looked older. Measured biological aging in young adults can be used to identify causes of aging and evaluate rejuvenation therapies.
C1 [Belsky, Daniel W.; Cohen, Harvey J.] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA.
   [Belsky, Daniel W.; Yashin, Anatoli I.] Duke Univ, Social Sci Res Inst, Durham, NC 27708 USA.
   [Caspi, Avshalom; Houts, Renate; Harrington, HonaLee; Schaefer, Jonathan D.; Sugden, Karen; Williams, Ben; Moffitt, Terrie E.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.
   [Caspi, Avshalom; Moffitt, Terrie E.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.
   [Caspi, Avshalom; Corcoran, David L.; Moffitt, Terrie E.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.
   [Caspi, Avshalom; Danese, Andrea; Moffitt, Terrie E.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England.
   [Danese, Andrea] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England.
   [Israel, Salomon] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.
   [Levine, Morgan E.] Univ Calif Los Angeles, David Geffen Sch Med, Gonda Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Poulton, Richie] Univ Otago, Dept Psychol, Dunedin 9016, New Zealand.
C3 Duke University; Duke University; Duke University; Duke University; Duke
   University; University of London; King's College London; University of
   London; King's College London; Hebrew University of Jerusalem;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of Otago
RP Belsky, DW (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA.
EM dbelsky@duke.edu
RI Moffitt, Terrie E/D-5295-2011; Belsky, Daniel/AAB-4785-2021; Sugden,
   Karen/I-8531-2016; Sugden, Karen/O-6046-2019; caspi,
   avshalom/AAJ-5874-2020; Danese, Andrea/ABF-1471-2020; Belsky,
   Daniel/HDN-5118-2022; Houts, Renate/AAC-5304-2019; Schaefer,
   Jonathan/O-7885-2018
OI Moffitt, Terrie E/0000-0002-8589-6760; Belsky,
   Daniel/0000-0001-5463-2212; Sugden, Karen/0000-0002-4076-5927; Sugden,
   Karen/0000-0002-4076-5927; caspi, avshalom/0000-0003-0082-4600; Danese,
   Andrea/0000-0001-8718-5412; Houts, Renate/0000-0002-1518-2631; Israel,
   Salomon/0000-0003-3629-2466; Schaefer, Jonathan/0000-0003-4112-9268
FU New Zealand Health Research Council; US National Institute on Aging
   (NIA) [AG032282, AG048895]; UK Medical Research Council [MR/K00381X];
   Jacobs Foundation; NIA [T32 AG000029, P30 AG028716-08]; Yad Hanadiv
   Rothschild Foundation; ESRC [ES/M010309/1] Funding Source: UKRI; MRC
   [G0100527, G9806489, G0601483, MR/K00381X/1] Funding Source: UKRI;
   Economic and Social Research Council [ES/M010309/1] Funding Source:
   researchfish; Medical Research Council [MR/K00381X/1, G9806489,
   G0100527, G9817803B, G0601483] Funding Source: researchfish
FX We thank Dunedin Study members, their families, unit research staff, and
   Dunedin Study founder Phil Silva. The Dunedin Multidisciplinary Health
   and Development Research Unit is supported by the New Zealand Health
   Research Council. This research received support from US National
   Institute on Aging (NIA) Grants AG032282 and AG048895 and UK Medical
   Research Council Grant MR/K00381X. Additional support was provided by
   the Jacobs Foundation. D.W.B. received support from NIA through a
   post-doctoral fellowship T32 AG000029 and P30 AG028716-08. S.I. was
   supported by a Rothschild Fellowship from the Yad Hanadiv Rothschild
   Foundation.
CR [Anonymous], 2013, WORLD POP AG 2013
   APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207
   Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235
   Barzilai N, 2012, NAT REV GENET, V13, P589, DOI 10.1038/nrg3290
   Belsky DW, 2013, AM J EPIDEMIOL, V178, P1461, DOI 10.1093/aje/kwt135
   BOHANNON RW, 1984, PHYS THER, V64, P1067, DOI 10.1093/ptj/64.7.1067
   BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0
   Brown DL, 2013, ANN PHARMACOTHER, V47, P1039, DOI 10.1345/aph.1S176
   Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c
   Cheung CYL, 2010, MICROCIRCULATION, V17, P495, DOI 10.1111/j.1549-8719.2010.00048.x
   Cho IH, 2010, MECH AGEING DEV, V131, P69, DOI 10.1016/j.mad.2009.12.001
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116489
   Cullinane E M, 1988, Med Sci Sports Exerc, V20, P317, DOI 10.1249/00005768-198806000-00017
   Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   De Jong FJ, 2008, OPHTHALMOLOGY, V115, P887, DOI 10.1016/j.ophtha.2007.06.036
   Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a
   Gavrilov LA, 2004, ANN NY ACAD SCI, V1019, P496, DOI 10.1196/annals.1297.091
   Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430
   Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749
   Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187
   Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052
   Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103
   Harper S, 2014, SCIENCE, V346, P587, DOI 10.1126/science.1254405
   Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339
   Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709
   Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Ikram MK, 2012, J NEUROL NEUROSUR PS, V83, P917, DOI 10.1136/jnnp-2011-301628
   Institute for Health Metrics and Evaluation, 2013, GBD CAUS PATT
   Jackson SHD, 2003, ARCH GERONTOL GERIAT, V36, P103, DOI 10.1016/S0167-4943(02)00060-2
   JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006
   Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004
   Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049
   Levine ME, 2014, SOC SCI MED, V118, P27, DOI 10.1016/j.socscimed.2014.07.022
   Levine ME, 2014, J GERONTOL A-BIOL, V69, P297, DOI 10.1093/gerona/glt138
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   Lezak MD, 1995, NEUROPSYCHOLOGICAL A
   Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672
   Liew G, 2009, J AM GERIATR SOC, V57, P1892, DOI 10.1111/j.1532-5415.2009.02459.x
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180
   MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69
   Mitnitski A, 2014, J GERONTOL A-BIOL, V69, P295, DOI 10.1093/gerona/glt137
   Moffitt T.E., 2001, SEX DIFFERENCES ANTI
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Poulton Richie, 2006, N Z Med J, V119, pU2002
   Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558
   Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x
   Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32
   Shalev I, 2013, PSYCHOL SCI, V24, P1198, DOI 10.1177/0956797612470959
   Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034
   Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127
   Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8
   Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008
   Strandberg TE, 2007, LANCET, V369, P1328, DOI [10.1016/S0140-6736(07)60613-8, 10.1016/S0140-6736(12)62167-9]
   Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003
   Verbeke G, 2014, STAT METHODS MED RES, V23, P42, DOI 10.1177/0962280212445834
   Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wechsler D., 2008, Wechsler adult intelligence scale-revised (WAIS-R), V4th
   Wechsler D., 2003, Wechsler Intelligence Scale for Children
   Winter MA, 2012, PHARMACOTHERAPY, V32, P604, DOI 10.1002/j.1875-9114.2012.01098.x
   Wong TY, 2004, AM J OPHTHALMOL, V137, P1050, DOI 10.1016/j.ajo.2004.01.035
   Wong TY, 2004, LANCET NEUROL, V3, P179, DOI 10.1016/S1474-4422(04)00682-9
   Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5
   Yashin AI, 2012, REJUV RES, V15, P374, DOI 10.1089/rej.2011.1290
NR 74
TC 498
Z9 535
U1 9
U2 103
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
EI 1091-6490
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 28
PY 2015
VL 112
IS 30
BP E4104
EP E4110
DI 10.1073/pnas.1506264112
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CN7ZW
UT WOS:000358656500018
PM 26150497
OA Green Published, Bronze
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Nasiri, L
   Vaez-Mahdavi, MR
   Hassanpour, H
   Ardestani, SK
   Askari, N
AF Nasiri, Leila
   Vaez-Mahdavi, Mohammad-Reza
   Hassanpour, Hossein
   Ardestani, Sussan Kaboudanian
   Askari, Nayere
TI Sulfur mustard and biological ageing: A multisystem biological health
   score approach as an extension of the allostatic load in Sardasht
   chemical veterans
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Mustard gas; Biological Health Score; Allostatic load; Ageing; Sardasht
ID ALL-CAUSE; STRESS; POPULATION; MORTALITY; EXPOSURE; VICTIMS; COHORT;
   ADULTS; RISK
AB Background: Mustard gas as a chemical weapon has been used in wars and its long-term side effects are substantial in the human body. This study was aimed to apply an extension of allostatic load, known as synthetic biological health score (BHS), including the wear-and-tear of four physiological systems (endocrine, inflammatory, cardiovascular and metabolic systems) and two organs (liver and kidney) to estimate biological aging caused by sulfur mustard (SM) gas poisoning.
   Methods: The plasma samples were prepared from two following groups of people; 1) 446 individuals exposed to SM gas in 1987. 2) 115 healthy members, at the same range of age and residence, as the non-exposed group. These people were chosen from the same patients' families and have not had any exposure to SM or pulmonary dysfunction. To estimate BHS, 18 blood-derived biomarkers of the mentioned systems and organs were measured and the relative contribution of many social and body parameters across the age groups was explored.
   Results: It was revealed, in BHS calculation, the cardiovascular system had the most effect. Also, in the SM group, BHS was significantly higher than in the control group. This feature has a positive correlation with physical parameter (BMI) and a negative correlation with social parameters (salary and educational levels).
   Conclusion: The multisystem BHS could be useful in the evaluation of biological aging due to SM exposure. Social (education, good-paying job) and physical (BMI) parameters could influence BHS and the higher BHS indicates the progress of biological aging due to mustard gas.
C1 [Nasiri, Leila] Shahed Univ, Fac Basic Sci, Dept Biol, Tehran, Iran.
   [Vaez-Mahdavi, Mohammad-Reza] Shahed Univ, Med Fac, Dept Physiol, Tehran, Iran.
   [Vaez-Mahdavi, Mohammad-Reza; Ardestani, Sussan Kaboudanian; Askari, Nayere] Shahed Univ, Immunoregulat Res Ctr, Tehran, Iran.
   [Hassanpour, Hossein] Shahrekord Univ, Res Inst Anim Embryo Technol, Dept Gametes & Cloning, Shahrekord, Iran.
   [Ardestani, Sussan Kaboudanian] Univ Tehran, Inst Biochem & Biophys, Dept Biochem, Tehran, Iran.
   [Askari, Nayere] Shahid Bahonar Univ Kerman, Fac Basic Sci, Dept Biol, Kerman, Iran.
C3 Shahed University; Shahed University; Shahed University; Shahrekord
   University; University of Tehran; Shahid Bahonar University of Kerman
   (SBUK)
RP Vaez-Mahdavi, MR (corresponding author), Shahed Univ, Med Fac, Dept Physiol, Tehran, Iran.; Vaez-Mahdavi, MR (corresponding author), Shahed Univ, Immunoregulat Res Ctr, Med Fac, Tehran, Iran.
EM vaezmahdavi@shahed.ac.ir
RI askari, nayere/AAC-5163-2022
OI askari, nayere/0000-0002-2966-3954
FU Shahed University; Janbazan Medical and Engineering Research Center
   (JMERC); Iranian Foundation of Martyr and Veterans Affairs; Ministry of
   Health and Medical Education, Tehran, Iran
FX Immunoregulation Research Center of Shahed University has carried out
   this study and acknowledged the spiritual and financial supports of
   Shahed University and Janbazan Medical and Engineering Research Center
   (JMERC), Iranian Foundation of Martyr and Veterans Affairs and the
   Ministry of Health and Medical Education, Tehran, Iran. We would like to
   kindly thank all the participants who took part in this study.
CR Abbasi M., 2012, QOM U MED SCI J, V5, P34
   Attaran D, 2009, HUM EXP TOXICOL, V28, P739, DOI 10.1177/0960327109354311
   Azizi F., 2001, IRAN J ENDOCRINOL ME, V3, P211
   Barrett ES, 2018, HUM REPROD, V33, P1757, DOI 10.1093/humrep/dey261
   Behboudi H, 2018, INT IMMUNOPHARMACOL, V61, P37, DOI 10.1016/j.intimp.2018.05.008
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Castagné R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38705
   Castagné R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25170
   Cheraghian Bahman, 2015, Med J Islam Repub Iran, V29, P160
   Clough AR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-15
   Crimmins EM, 2009, J GERONTOL A-BIOL, V64, P286, DOI 10.1093/gerona/gln010
   Edes AN, 2018, J ZOO WILDLIFE MED, V49, P272, DOI 10.1638/2016-0070.1
   Edes AN, 2017, AM J PHYS ANTHROPOL, V162, P44, DOI 10.1002/ajpa.23146
   Eghtedardoost M, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.105896
   Ghanei M, 2007, INHAL TOXICOL, V19, P451, DOI 10.1080/08958370601174990
   Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278
   Ghasemi Hassan, 2018, Iran J Pathol, V13, P157
   Ghazanfari T, 2009, ARCH IRAN MED, V12, P5
   Ghazanfari T, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.105895
   Ghazanfari T, 2009, INT IMMUNOPHARMACOL, V9, P1471, DOI 10.1016/j.intimp.2009.08.022
   Ghazanfari Z, 2009, TOXIN REV, V28, P48, DOI 10.1080/15569540802691960
   Gholamrezanezhad A, 2007, INT J CARDIOVAS IMAG, V23, P197, DOI 10.1007/s10554-006-9122-7
   Gizlice Z., 2002, SCHS STUDIES, P1
   Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037
   Hashemian F, 2006, JAMA-J AM MED ASSOC, V296, P560, DOI 10.1001/jama.296.5.560
   Hawes NJ, 2019, PUBLIC HEALTH NURS, V36, P270, DOI 10.1111/phn.12587
   Horan JM, 2015, CHILD MALTREATMENT, V20, P229, DOI 10.1177/1077559515597063
   Hwang AC, 2014, J AM MED DIR ASSOC, V15, P490, DOI 10.1016/j.jamda.2014.02.001
   Jafari F., 2012, IRANIAN J WAR PUBLIC, V4, P46
   Karbasi-Afshar R, 2017, TRAUMA MON, V22, DOI 10.5812/traumamon.34011
   Karimi M, 2019, J EPIDEMIOL COMMUN H, V73, P693, DOI 10.1136/jech-2018-212010
   Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82
   Kehe K., 2008, J PLASTIC SURG, V8, P312
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   Liarte S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020306
   Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032
   Mattei J, 2010, SOC SCI MED, V70, P1988, DOI 10.1016/j.socscimed.2010.02.024
   McEwen BS, 2015, METABOLISM, V64, pS2, DOI 10.1016/j.metabol.2014.10.029
   MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093
   Mousavi B, 2011, J MED CBR DEF, V8
   Nillni YI, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.04.022
   Petrovic D, 2016, PSYCHONEUROENDOCRINO, V67, P76, DOI 10.1016/j.psyneuen.2016.02.003
   Pourfarzam S, 2009, INT IMMUNOPHARMACOL, V9, P1482, DOI 10.1016/j.intimp.2009.09.002
   Razavi SM, 2014, IRAN J PSYCHIATR BEH, V8, P11
   Rodriquez EJ, 2018, PREV MED, V110, P9, DOI 10.1016/j.ypmed.2018.02.002
   Rohani A, 2010, INDIAN J CRIT CARE M, V14, P109, DOI 10.4103/0972-5229.74168
   Roshan R, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-69
   Saeed KB, 2014, TRAUMA MON, V19, DOI 10.5812/traumamon.13800
   Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277
   Sezigen S, 2020, TOXICOL LETT, V318, P92, DOI 10.1016/j.toxlet.2019.10.017
   Shayan H. Ranjebar, 2008, J MILIT MED, V10, P99
   Shiels PG, 2017, PRACT LAB MED, V7, P49, DOI 10.1016/j.plabm.2016.04.002
   Solís CB, 2016, PSYCHONEUROENDOCRINO, V74, P24, DOI 10.1016/j.psyneuen.2016.08.018
   Solís CB, 2015, P NATL ACAD SCI USA, V112, pE738, DOI 10.1073/pnas.1417325112
   Sturmberg JP, 2017, J EVAL CLIN PRACT, V23, P199, DOI 10.1111/jep.12587
   TAHMASBPOUR E, 2016, ASIAN PAC J REPROD, V5, P1, DOI DOI 10.1016/j.apjr.2015.12.001
   Tavalie S., 2008, J BEHAV SCI, V1, P19
   Tavallaii S., 2005, RAZI J MED SCI, V12, P29
   Wallace M, 2020, AIDS BEHAV, V24, P1653, DOI 10.1007/s10461-019-02684-5
   Wang FF, 2012, ASIAN J ANDROL, V14, P643, DOI 10.1038/aja.2011.183
NR 60
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD DEC
PY 2021
VL 101
AR 108375
DI 10.1016/j.intimp.2021.108375
PN B
PG 7
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Immunology; Pharmacology & Pharmacy
GA 0A5WZ
UT WOS:000774025900040
PM 34810125
DA 2024-02-19
ER

PT J
AU LUSTYIK, G
   ZSNAGY, I
AF LUSTYIK, G
   ZSNAGY, I
TI ALTERATIONS OF THE INTRACELLULAR WATER AND ION CONCENTRATIONS IN BRAIN
   AND LIVER-CELLS DURING AGING AS REVEALED BY ENERGY DISPERSIVE-X-RAY
   MICROANALYSIS OF BULK SPECIMENS
SO SCANNING ELECTRON MICROSCOPY
LA English
DT Article
C1 UNIV DEBRECEN, SCH MED, F VERZAR INT LAB EXPTL GERONTOL, HUNGARIAN SECT, H-4012 DEBRECEN, HUNGARY.
C3 University of Debrecen
CR ANDERSEN C. A., 1967, METHODS BIOCHEM ANAL, V15, P147, DOI 10.1002/9780470110331.ch4
   APPLETON T C, 1978, P148
   ARMITAGE P, 1971, STATISTICAL METHODS, P189
   BARNARD T, 1978, J MICROSC-OXFORD, V112, P281, DOI 10.1111/j.1365-2818.1978.tb00078.x
   BERENDSEN HJ, 1973, ANN NY ACAD SCI, V204, P459, DOI 10.1111/j.1749-6632.1973.tb30799.x
   BROMBACH JD, 1975, J MICROSC BIOL CELL, V22, P233
   BUHRLE CP, 1983, PFLUG ARCH EUR J PHY, V396, P144, DOI 10.1007/BF00615519
   BULGER RE, 1981, J CELL BIOL, V88, P274, DOI 10.1083/jcb.88.2.274
   BURT CT, 1982, LIFE SCI, V31, P2793
   CALA PM, 1980, J GEN PHYSIOL, V76, P683, DOI 10.1085/jgp.76.6.683
   CAUCHY D, 1980, THEOR CHIM ACTA, V57, P323, DOI 10.1007/BF00552744
   CHEUNG RK, 1982, J CELL PHYSIOL, V112, P189, DOI 10.1002/jcp.1041120206
   CLARK ME, 1982, BIOPHYS J, V39, P289, DOI 10.1016/S0006-3495(82)84519-0
   COPE FW, 1965, P NATL ACAD SCI USA, V54, P225, DOI 10.1073/pnas.54.1.225
   COPE FW, 1967, J GEN PHYSIOL, V50, P1353, DOI 10.1085/jgp.50.5.1353
   DAMJANOVICH S, 1973, J THEOR BIOL, V41, P567
   DOUZOU P, 1977, TRENDS BIOCHEM SCI, V2, P14, DOI 10.1016/0968-0004(77)90318-8
   ECHLIN P, 1975, J MICROSC BIOL CELL, V22, P215
   ECHLIN P, 1978, MICROSCOPICA ACTA  S, V2, P1
   EDELMAN L, 1984, PHYSIOL CHEM PHYS M, V15, P337
   EISENBERG H, 1976, BIOL MACROMOL, P1
   FRANKS F, 1972, PHYSICS PHYSICAL CHE, P115
   GLEN AIM, 1978, J PHYSL, V279, pP39
   GRINSTEIN S, 1982, J GEN PHYSIOL, V79, P849, DOI 10.1085/jgp.79.5.849
   Gross L., 1966, CHEM PHYSICS IONIC S, P361
   Gupta B.L., 1977, P83
   GUPTA BL, 1978, J EXP BIOL, V72, P261
   GUPTA BL, 1981, TISSUE CELL, V13, P623, DOI 10.1016/S0040-8166(81)80001-8
   GUPTA BL, 1976, NATURE, V264, P284, DOI 10.1038/264284a0
   GUPTA BL, 1978, NATURE, V272, P70, DOI 10.1038/272070a0
   GUPTA BL, 1980, J EXP BIOL, V88, P21
   GUPTA BL, 1979, P FEDN AM SOC EXP BI, V38, P144
   GUPTA BL, 1980, XRAY OPTICS MICROANA, P446
   GUPTA BL, 1978, MICROSCOPICA ACTA S, V2, P46
   GUPTA BL, 1981, WATER TRANSPORT EPIT, P1
   GUPTA RK, 1984, ANNU REV BIOPHYS BIO, V13, P221
   GYENES M, 1984, ARCH GERONTOL GERIAT, V3, P11, DOI 10.1016/0167-4943(84)90012-8
   HALL TA, 1975, J MICROSC BIOL CELL, V22, P271
   HALL TA, 1982, J MICROSC-OXFORD, V126, P333, DOI 10.1111/j.1365-2818.1982.tb00389.x
   HALL TA, 1983, Q REV BIOPHYS, V16, P279, DOI 10.1017/S0033583500005114
   HALL TA, 1979, J MICROSC-OXFORD, V117, P145, DOI 10.1111/j.1365-2818.1979.tb00236.x
   HEY MJ, 1976, NATURE, V262, P807, DOI 10.1038/262807a0
   HILL A, 1979, Q REV BIOPHYS, V12, P67, DOI 10.1017/S0033583500002602
   Hochmuth R.M., 1978, CURR TOP MEMBR TRANS, V10, P1
   HUANG HW, 1979, SCIENCE, V204, P191, DOI 10.1126/science.311948
   KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5
   KEDEM O, 1961, J GEN PHYSIOL, V45, P143, DOI 10.1085/jgp.45.1.143
   KIIL F, 1982, KIDNEY INT, V21, P303, DOI 10.1038/ki.1982.22
   Ling G. N., 1962, PHYSICAL THEORY LIVI, P1
   LING GN, 1984, PHYSIOL CHEM PHYS, V16, P257
   LING GN, 1969, SCIENCE, V163, P1335, DOI 10.1126/science.163.3873.1335
   Ling GN, 1984, SEARCH PHYSICAL BASI, P227
   LUSTYIK G, 1981, EDAX EDITOR, V11, P1
   MACKNIGHT ADC, 1977, PHYSIOL REV, V57, P510, DOI 10.1152/physrev.1977.57.3.510
   MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031
   MARSHALL AT, 1974, MICRON, V5, P275, DOI 10.1016/0047-7206(74)90003-X
   MARSHALL AT, 1977, MICROSC ACTA, V79, P254
   MARSHALL AT, 1973, MICRON, V4, P31
   MATHURDEVRE R, 1979, BIOPHYS MOL BIOL, V35, P103
   MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6
   MONOI H, 1974, BIOPHYS J, V14, P653, DOI 10.1016/S0006-3495(74)85942-4
   MONOI H, 1974, BIOPHYS J, V14, P645, DOI 10.1016/S0006-3495(74)85941-2
   MORETON RB, 1981, BIOL REV, V56, P409, DOI 10.1111/j.1469-185X.1981.tb00355.x
   PALMER LG, 1977, J MEMBRANE BIOL, V33, P41, DOI 10.1007/BF01869511
   PAULY H, 1973, BIOPHYSIK, V10, P7, DOI 10.1007/BF01189907
   PETERSEN NO, 1982, P NATL ACAD SCI-BIOL, V79, P5327, DOI 10.1073/pnas.79.17.5327
   PIERI C, 1975, EXP GERONTOL, V10, P341, DOI 10.1016/0531-5565(75)90024-8
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   PIERI C, 1977, J ULTRA MOL STRUCT R, V59, P320, DOI 10.1016/S0022-5320(77)90042-9
   POLLOCK AS, 1980, AM J PHYSIOL, V239, pF195, DOI 10.1152/ajprenal.1980.239.3.F195
   PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341
   RAPOPORT SI, 1976, BLOOD BRAIN BARRIER, P87
   ROOMANS GM, 1980, SCANNING ELECTRON MI, V2, P309
   ROOMANS GM, 1981, SCANNING ELECTRON MI, V2, P345
   ROSS A, 1981, J MICROSC-OXFORD, V121, P261, DOI 10.1111/j.1365-2818.1981.tb01223.x
   RUSS JC, 1974, J SUBMICR CYTOL PATH, V6, P55
   SAUBERMANN AJ, 1981, J CELL BIOL, V88, P268, DOI 10.1083/jcb.88.2.268
   SAUBERMANN AJ, 1981, J CELL BIOL, V88, P257, DOI 10.1083/jcb.88.2.257
   SEVEUS L, 1978, J MICROSC-OXFORD, V112, P269, DOI 10.1111/j.1365-2818.1978.tb00077.x
   SOMOGYI B, 1975, J THEOR BIOL, V51, P393, DOI 10.1016/0022-5193(75)90068-5
   STAVERMAN AJ, 1951, RECL TRAV CHIM PAY B, V70, P344
   SZOLLOSI J, 1981, J HISTOCHEM CYTOCHEM, V29, P503
   TALMON Y, 1979, J MICROSC-OXFORD, V117, P321, DOI 10.1111/j.1365-2818.1979.tb04689.x
   UMRATH W, 1983, MIKROSKOPIE, V40, P9
   WALTER JA, 1971, PROGR BIOPHYS MOL BI, V23, P3
   WELCH GR, 1983, PROG BIOPHYS MOL BIO, V39, P109
   WELCH GR, 1977, PROG BIOPHYS MOL BIO, V32, P103
   ZIEROLD K, 1982, ULTRAMICROSCOPY, V10, P45, DOI 10.1016/0304-3991(82)90186-3
   ZSNAGY I, 1977, J ULTRA MOL STRUCT R, V58, P22, DOI 10.1016/S0022-5320(77)80004-X
   ZSNAGY I, 1982, TISSUE CELL, V14, P47, DOI 10.1016/0040-8166(82)90006-4
   ZSNAGY I, 1979, GERONTOLOGY, V25, P94, DOI 10.1159/000212326
   ZSNAGY I, 1984, ARCH GERONTOL GERIAT, V3, P297, DOI 10.1016/0167-4943(84)90031-1
   ZSNAGY I, 1980, MECH AGEING DEV, V14, P245, DOI 10.1016/0047-6374(80)90124-4
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
   ZSNAGY I, 1981, EXP GERONTOL, V16, P229, DOI 10.1016/0531-5565(81)90018-8
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
   ZSNAGY I, 1984, EXP GERONTOL
   ZSNAGY I, 1983, SCANNING ELECTRON MI, V3, P1255
   ZSNAGY I, 1976, EDAX EDITOR, V6, P28
   ZSNAGY I, 1982, EXP BRAIN RES S, V5, P118
   ZSNAGY I, 1982, LIVER AGING 1982, P215
NR 101
TC 9
Z9 9
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 0891-7035
J9 SCAN ELECTRON MICROS
PY 1985
BP 323
EP 337
PN 1
PG 15
WC Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microscopy
GA APB76
UT WOS:A1985APB7600032
PM 3923609
DA 2024-02-19
ER

PT J
AU Gerardo-Ramírez, M
   German-Ramirez, N
   Escobedo-Calvario, A
   Chávez-Rodríguez, L
   Bucio-Ortiz, L
   Souza-Arroyo, V
   Miranda-Labra, RU
   Gutiérrez-Ruiz, MC
   Gomez-Quiroz, LE
AF Gerardo-Ramirez, Monserrat
   German-Ramirez, Natanael
   Escobedo-Calvario, Alejandro
   Chavez-Rodriguez, Lisette
   Bucio-Ortiz, Leticia
   Souza-Arroyo, Ver onica
   Miranda-Labra, Roxana U.
   Gutierrez-Ruiz, Maria Concepcion
   Gomez-Quiroz, Luis E.
TI The hepatic effects of GDF11 on health and disease
SO BIOCHIMIE
LA English
DT Article
DE GDF11; Liver; Hepatocytes; HCC; Lipogenesis
ID DIFFERENTIATION FACTOR 11; SKELETAL-MUSCLE; FREE-CHOLESTEROL;
   DOWN-REGULATION; GROWTH; MYOSTATIN; AGE; ERYTHROPOIESIS; FIBROSIS;
   BIOLOGY
AB The growth differentiation factor 11 (GDF11), a member of the superfamily of the transforming growth factor b, has gained relevance in the last few years due to its remarkable effects in cellular biology, particularly in the nervous system, skeletal muscle, the heart, and many epithelial tissues. Some controversies have been raised about this growth factor. Many of them have been related to technical factors but also the nature of the cellular target. In liver biology and pathobiology, the GDF11 has shown to be related in many molecular aspects, with a significant impact on the physiology and the initiation and progression of the natural history of liver diseases. GDF11 has been involved as a critical regulator in lipid homeostasis, which, as it is well known, is the first step in the progression of liver disease. However, also it has been reported that the GDF11 is involved in fibrosis, senescence, and cancer. Although there are some controversies, much of the literature indicates that GDF11 displays effects tending to solve or mitigate pathological states of the liver, with reasonable evidence of correlation with other organs or systems. To a large extent, the controversy, as mentioned, is due to technical problems, such as the specificity of GDF11 antibodies, confusion with its closer family member, myostatin, and the state of differentiation in the tissues. In the present work, we reviewed the specific effects of GDF11 in the biology and pathobiology of the liver as a potential and promising factor for therapeutic intervention shortly. (c) 2022 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
C1 [Gerardo-Ramirez, Monserrat; German-Ramirez, Natanael; Escobedo-Calvario, Alejandro; Chavez-Rodriguez, Lisette; Bucio-Ortiz, Leticia; Souza-Arroyo, Ver onica; Miranda-Labra, Roxana U.; Gutierrez-Ruiz, Maria Concepcion; Gomez-Quiroz, Luis E.] Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Lab Med Expt & Carcinogenesis, Mexico City, Mexico.
   [Gerardo-Ramirez, Monserrat] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany.
   [German-Ramirez, Natanael; Escobedo-Calvario, Alejandro; Chavez-Rodriguez, Lisette] Univ Autonoma Metrolitana Iztapalapa, Posgrad Biol Expt, DCBS, Mexico City, Mexico.
   [Bucio-Ortiz, Leticia; Souza-Arroyo, Ver onica; Miranda-Labra, Roxana U.; Gutierrez-Ruiz, Maria Concepcion; Gomez-Quiroz, Luis E.] Univ Nacl Autonoma Mexico, Lab Med Expt, Unidad Med Traslac IIB, Inst Nacl Cardiol Ignacio Chavez, Mexico City, Mexico.
C3 Universidad Autonoma Metropolitana - Mexico; Johannes Gutenberg
   University of Mainz; Universidad Nacional Autonoma de Mexico; National
   Institute of Cardiology - Mexico
RP Gomez-Quiroz, LE (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Ave San Rafael Atlixco 186, Mexico City 09340, Mexico.
EM legq@xanum.uam.mx
OI Gerardo-Ramirez, Monserrat/0000-0001-7773-9848
CR Añón-Hidalgo J, 2019, AGING-US, V11, P1733, DOI 10.18632/aging.101865
   Bajikar SS, 2017, DEV CELL, V43, P418, DOI 10.1016/j.devcel.2017.10.027
   Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008
   Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016
   Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006
   Chavez-Rodriguez L., 2021, Livers, V1, P250, DOI 10.3390/livers1040020
   Chen L, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01412
   Chen WH, 2020, MOL THER-NUCL ACIDS, V22, P673, DOI 10.1016/j.omtn.2020.09.032
   Dai Z, 2020, GUT, V69, P1104, DOI 10.1136/gutjnl-2019-318812
   Domínguez-Pérez M, 2019, J CELL PHYSIOL, V234, P7213, DOI 10.1002/jcp.27474
   Egerman MA, 2019, CRIT REV BIOCHEM MOL, V54, P174, DOI 10.1080/10409238.2019.1610722
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Enríquez-Cortina C, 2017, ONCOTARGET, V8, P104136, DOI 10.18632/oncotarget.22024
   Fan XL, 2017, MECH AGEING DEV, V164, P108, DOI 10.1016/j.mad.2017.04.009
   Fang Z, 2020, BRIT J HAEMATOL, V188, P321, DOI 10.1111/bjh.16156
   Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034
   Frohlich J, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158920
   Frohlich J, 2020, AGING-US, V12, P20024, DOI 10.18632/aging.104182
   G??mez-Quiroz LE., 2017, LIVER PATHOPHYSIOL T, DOI [10.1016/B978-0-12-804274-8.00029-1, DOI 10.1016/B978-0-12-804274-8.00029-1]
   Gerardo-Ramírez M, 2019, BBA-MOL BASIS DIS, V1865, P1540, DOI 10.1016/j.bbadis.2019.03.003
   Ghurburrun Elsa, 2018, Gene Expression, V18, P149, DOI 10.3727/105221618X15216414278706
   Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870
   Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231
   Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535
   Henley SJ, 2020, CANCER-AM CANCER SOC, V126, P2225, DOI [10.1002/cncr.32802, 10.1002/cncr.31551]
   Hernandez S, 2021, J CELL PHYSIOL, V236, P4076, DOI 10.1002/jcp.30151
   Hernandez-Rizo S., 2018, ANN HEPATOL, V17, P683
   Hinken AC, 2016, AGING CELL, V15, P582, DOI 10.1111/acel.12475
   Jia QQ, 2022, REPROD BIOL ENDOCRIN, V20, DOI 10.1186/s12958-022-00912-7
   Jones JE, 2018, CELL REP, V22, P3375, DOI 10.1016/j.celrep.2018.03.024
   Kunts E., 2006, HEPATOLOGY PRINCIPLE
   Liu AD, 2018, FASEB J, V32, P5186, DOI 10.1096/fj.201800195R
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lu BX, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02166-1
   Marí M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006
   Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320
   McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217
   Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588
   Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521
   Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y
   Reig M, 2022, J HEPATOL, V76, P681, DOI 10.1016/j.jhep.2021.11.018
   Ribas V, 2021, CANCERS, V13, DOI 10.3390/cancers13164091
   Rochette L, 2015, PHARMACOL THERAPEUT, V156, P26, DOI 10.1016/j.pharmthera.2015.10.006
   Simoni-Nieves A, 2021, CANCERS, V13, DOI 10.3390/cancers13071721
   Simoni-Nieves A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01039
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Song LL, 2022, BIOGERONTOLOGY, V23, P341, DOI 10.1007/s10522-022-09967-w
   Suh J, 2020, EXP MOL MED, V52, P1673, DOI 10.1038/s12276-020-00516-4
   Sun BY, 2020, HISTOL HISTOPATHOL, V35, P1473, DOI 10.14670/HH-18-278
   Sun J, 2022, AGING CELL, V21, DOI 10.1111/acel.13532
   Suragani RNVS, 2014, BLOOD, V123, P3864, DOI 10.1182/blood-2013-06-511238
   Walker RG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61443-y
   Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1
   Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391
   Wang H, 2022, BONE JOINT RES, V11, P453, DOI 10.1302/2046-3758.117.BJR-2022-0019.R1
   Wang WJ, 2019, CLIN SCI, V133, P2069, DOI 10.1042/CS20190441
   Yamagishi S, 2016, BIORESEARCH OPEN ACC, V5, P155, DOI 10.1089/biores.2016.0015
   Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004
   Zhang YH, 2018, EXP THER MED, V15, P3495, DOI 10.3892/etm.2018.5861
   Zhang YH, 2017, ONCOTARGET, V8, P81604, DOI 10.18632/oncotarget.20258
NR 63
TC 2
Z9 2
U1 0
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD MAY
PY 2023
VL 208
BP 129
EP 140
DI 10.1016/j.biochi.2022.12.017
EA MAY 2023
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA P2LM8
UT WOS:001049006400001
PM 36584866
DA 2024-02-19
ER

PT J
AU DEAN, RG
   SOCHER, SH
   CUTLER, RG
AF DEAN, RG
   SOCHER, SH
   CUTLER, RG
TI DYSDIFFERENTIATIVE NATURE OF AGING - AGE-DEPENDENT EXPRESSION OF MOUSE
   MAMMARY-TUMOR VIRUS AND CASEIN GENES IN BRAIN AND LIVER-TISSUES OF THE
   C57BL/6J MOUSE STRAIN
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
C1 NIA,FRANCIS SCOTT KEY MED CTR,GERONTOL RES CTR,BALTIMORE,MD 21224.
   UNIV NEW MEXICO,SCH MED,DEPT FAMILY COMMUNITY & EMERGENCY MED,ALBUQUERQUE,NM 87131.
   BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); University of New Mexico; Baylor College of Medicine
FU NCI NIH HHS [CA-27293] Funding Source: Medline
CR BANTLE JA, 1976, ANAL BIOCHEM, V72, P413, DOI 10.1016/0003-2697(76)90549-2
   Burnet FM, 1974, INTRINSIC MUTAGENESI
   COMFORT A, 1979, BIOL SENESCENCE
   COOPER GM, 1982, SCIENCE, V218, P801
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   Cutler R G, 1980, Adv Pathobiol, V7, P43
   CUTLER RG, 1984, P NATL ACAD SCI-BIOL, V81, P7627, DOI 10.1073/pnas.81.23.7627
   CUTLER RG, 1982, AGING BRAIN CELLULAR, P1
   CUTLER RG, 1984, AGING CELL STRUCTURE, V2, P1
   Cutler RG., 1982, TESTING THEORIES AGI
   CUTLER RG, 1985, ARCH GERIATR GERONTO
   FAHMY MJ, 1983, CANCER RES, V43, P801
   FAHMY MJ, 1983, TERATOGEN CARCIN MUT, V3, P27, DOI 10.1002/1520-6866(1990)3:1<27::AID-TCM1770030105>3.0.CO;2-U
   FAHMY MJ, 1980, CANCER RES, V40, P3374
   FISHMAN WH, 1976, ONCODEVELOPMENTAL GE
   FLORINE DL, 1980, CANCER RES, V40, P519
   GETZ MJ, 1981, NIH812194 NATL I AG, P226
   HALL A, 1984, J ROY SOC MED, V77, P410
   HARLEY CB, 1980, P NATL ACAD SCI-BIOL, V77, P1885, DOI 10.1073/pnas.77.4.1885
   HARTMAN PE, 1983, ENVIRON MUTAGEN, V5, P111, DOI 10.1002/em.2860050112
   HARTMAN PE, 1982, CHEM MUTAGENS, V7, P211
   HUMPHRIES S, 1976, CELL, V7, P267, DOI 10.1016/0092-8674(76)90026-X
   KLEIN G, 1984, CARCINOGENESIS, V5, P429, DOI 10.1093/carcin/5.4.429
   LEHMANN FG, 1979, CARCINO EMBRYONIC PR
   MEREDITH PJ, 1979, MECH AGEING DEV, V9, P61, DOI 10.1016/0047-6374(79)90120-9
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   PAULEY RJ, 1980, CANCER RES, V40, P362
   PAULEY RJ, 1979, J VIROL, V29, P483, DOI 10.1128/JVI.29.2.483-493.1979
   Peto R, 1977, ORIGINS HUMAN CANCER, P1403
   ROTH GS, 1982, MECH AGEING DEV, V20, P175, DOI 10.1016/0047-6374(82)90086-0
   SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2
   SCHLOM J, 1978, PROG EXP TUMOR RES, V21, P140
   SINEX FM, 1975, HDB BIOL AGING, P37
   SOHAL RS, 1981, EXP GERONTOL, V16, P157, DOI 10.1016/0531-5565(81)90040-1
   STORB U, 1977, BIOCHEMISTRY-US, V16, P5432, DOI 10.1021/bi00644a005
   STREHLER BL, 1979, TIME CELLS AGING
   SUGIMURA T, 1972, ISOZYMES ENZYME REGU, P31
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   WISNIEWSKI HM, 1976, NEUROBIOL AGING, P265
   YOSHIMOTO Y, 1977, SCIENCE, V197, P575, DOI 10.1126/science.195341
NR 42
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1985
VL 4
IS 1
BP 43
EP 51
DI 10.1016/0167-4943(85)90017-2
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AGF09
UT WOS:A1985AGF0900006
PM 2408592
DA 2024-02-19
ER

PT J
AU Thiagarajan, D
   Quadri, N
   Jawahar, S
   Zirpoli, H
   del Pozo, CH
   López-Díez, R
   Hasan, SN
   Yepuri, G
   Gugger, PF
   Finlin, BS
   Kern, PA
   Gabbay, K
   Schmidt, AM
   Ramasamy, R
AF Thiagarajan, Devi
   Quadri, Nosirudeen
   Jawahar, Shabnam
   Zirpoli, Hylde
   del Pozo, Carmen Hurtado
   Lopez-Diez, Raquel
   Hasan, Syed Nurul
   Yepuri, Gautham
   Gugger, Paul F.
   Finlin, Brian S.
   Kern, Philip A.
   Gabbay, Kenneth
   Schmidt, Ann Marie
   Ramasamy, Ravichandran
TI Aldose reductase promotes diet-induced obesity via induction of
   senescence in subcutaneous adipose tissue
SO OBESITY
LA English
DT Article
ID HORMONE-SENSITIVE LIPASE; CRUCIAL ROLE; PPAR-GAMMA; FAT; LIPOLYSIS;
   EXPRESSION; CONTRIBUTES; DYSFUNCTION; ADIPOCYTES; DISEASE
AB Objective Aldose reductase (AKR1B1 in humans; Akr1b3 in mice), a key enzyme of the polyol pathway, mediates lipid accumulation in the murine heart and liver. The study objective was to explore potential roles for AKR1B1/Akr1b3 in the pathogenesis of obesity and its complications. Methods The study employed mice treated with an inhibitor of aldose reductase or mice devoid of Akr1b3 were used to determine their response to a high-fat diet. The study used subcutaneous adipose tissue-derived adipocytes to investigate mechanisms by which AKR1B1/Akr1b3 promotes diet-induced obesity. Results Increased expression of aldose reductase and senescence in the adipose tissue of humans and mice with obesity were demonstrated. Genetic deletion of Akr1b3 or pharmacological blockade of AKRIB3 with zopolrestat reduced high-fat-diet-induced obesity, attenuated markers of adipose tissue senescence, and increased lipolysis. Conclusions AKR1B1/Akr1b3 modulation of senescence in subcutaneous adipose tissue contributes to aberrant metabolic responses to high-fat feeding. These data unveil new opportunities to target these pathways to combat obesity.
C1 [Thiagarajan, Devi; Quadri, Nosirudeen; Jawahar, Shabnam; Zirpoli, Hylde; del Pozo, Carmen Hurtado; Lopez-Diez, Raquel; Hasan, Syed Nurul; Yepuri, Gautham; Gugger, Paul F.; Schmidt, Ann Marie; Ramasamy, Ravichandran] NYU, Grossman Sch Med, Dept Med, Diabet Res Program, 435 East 30th St, New York, NY 10016 USA.
   [Thiagarajan, Devi] Univ Kentucky, Saha Cardiovasc Res Ctr, Dept Physiol, Lexington, KY USA.
   [Finlin, Brian S.; Kern, Philip A.] Univ Kentucky, Ctr Clin & Translat Sci, Lexington, KY USA.
   [Gabbay, Kenneth] Baylor Coll Med, Houston, TX 77030 USA.
C3 New York University; University of Kentucky; University of Kentucky;
   Baylor College of Medicine
RP Ramasamy, R (corresponding author), NYU, Grossman Sch Med, Dept Med, Diabet Res Program, 435 East 30th St, New York, NY 10016 USA.
EM ravichandran.ramasamy@nyulangone.org
RI Lopez-Diez, Raquel/E-8795-2013
OI Lopez-Diez, Raquel/0000-0003-4468-4654; HASAN, SYED
   NURUL/0000-0002-4564-872X
FU National Institutes of Health [AG026467, DK107646, DK109675, HL131481,
   HL132516, HL143697]
FX National Institutes of Health, Grant/Award Numbers: AG026467, DK107646,
   DK109675, HL131481, HL132516, HL143697
CR Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011
   Alili L, 2014, AGE, V36, P1329, DOI 10.1007/s11357-014-9658-8
   Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004
   Bastien M, 2019, AM J PHYSIOL-ENDOC M, V317, pE65, DOI 10.1152/ajpendo.00505.2018
   Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023
   Bonamichi BD, 2017, DIABETES METAB J, V41, P229
   Braud L, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101805
   Camell CD, 2019, CELL METAB, V30, P1024, DOI 10.1016/j.cmet.2019.10.006
   Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647
   DAX EM, 1981, J LIPID RES, V22, P934
   del Pozo CH, 2019, CELL REP, V28, P773, DOI 10.1016/j.celrep.2019.06.061
   Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498
   Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510
   Fortier M, 2005, J LIPID RES, V46, P1860, DOI 10.1194/jlr.M500081-JLR200
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gao H, 2020, CELL METAB, V32, P1, DOI 10.1016/j.cmet.2020.06.007
   Gaztanaga J, 2021, DIAB MET SYND CLIN R, V15, DOI 10.1016/j.dsx.2021.102328
   Hallam KM, 2010, AGING CELL, V9, P776, DOI 10.1111/j.1474-9726.2010.00606.x
   Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811
   Hotta N, 2006, DIABETES CARE, V29, P1538, DOI 10.2337/dc05-2370
   Jannapureddy S, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.636267
   Kang ES, 2011, FREE RADICAL BIO MED, V50, P680, DOI 10.1016/j.freeradbiomed.2010.12.021
   KLEIN S, 1986, J CLIN INVEST, V78, P928, DOI 10.1172/JCI112682
   Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434
   LONNQVIST F, 1990, J CLIN INVEST, V85, P1614, DOI 10.1172/JCI114612
   Lu Y, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0249-z
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   MANN PL, 1981, MECH AGEING DEV, V17, P195, DOI 10.1016/0047-6374(81)90085-3
   Mardinoglu A, 2014, J PROTEOME RES, V13, P5106, DOI 10.1021/pr500586e
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thiagarajan D, 2016, CELL REP, V15, P181, DOI 10.1016/j.celrep.2016.02.086
   Vedantham S, 2014, DIABETES, V63, P761, DOI 10.2337/db13-0032
   Vedantham S, 2011, ARTERIOSCL THROM VAS, V31, P1805, DOI 10.1161/ATVBAHA.111.226902
   Wei XJ, 2020, J NUTR BIOCHEM, V80, DOI 10.1016/j.jnutbio.2020.108377
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
NR 44
TC 2
Z9 2
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD AUG
PY 2022
VL 30
IS 8
BP 1647
EP 1658
DI 10.1002/oby.23496
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 3F0UI
UT WOS:000830388800015
PM 35894077
DA 2024-02-19
ER

PT J
AU Ding, H
   Yang, XH
   Tian, JM
   Wang, XR
   Ji, YS
   El-Ashram, S
   Ren, CP
   Shen, JJ
   Liu, M
AF Ding, Han
   Yang, Xuhan
   Tian, Jiaming
   Wang, Xinran
   Ji, Yongsheng
   El-Ashram, Saeed
   Ren, Cuiping
   Shen, Jijia
   Liu, Miao
TI JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and
   STAT3 activation
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE Schistosoma japonicum; Fibrosis; JQ-1; JAK2; STAT3
ID HEPATIC STELLATE CELLS
AB Schistosomiasis is a serious parasitic infection caused by Schistosoma. The parasite deposits eggs in the host liver, causing inflammation that activates hepatic stellate cells (HSCs), which leads to liver fibrosis. Currently, there is no effective therapy for liver fibrosis; thus, treatments are urgently needed. Therefore, in the present study, mice infected with Schistosoma japonicum were treated with JQ-1, a small-molecule bromodomain inhibitor with reliable anti-tumor and anti-inflammatory activities. The fibrotic area of the liver measured by computer-assisted morphometric analysis and the expression levels of the cytoskeletal protein alpha smooth muscle actin (alpha-SMA) and of collagen assessed by quantitative PCR, Western blot and immunohistochemistry were significantly decreased in the liver following JQ-1 treatment compared with vehicle-treated controls. Total RNA was extracted from the liver of JQ-1-treated Schistosoma-infected mice for RNA-sequencing analysis. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses indicated that JQ-1 affected biological processes and the expression of cellular components known to play key roles in the transdifferentiation of HSCs to myofibroblasts. In vitro treatment with JQ-1 of JS-1 cells, a mouse HSC line, indicated that JQ-1 significantly inhibited JS-1 proliferation but had no effect on JS-1 activity, senescence, or apoptosis. Western blot results showed that JQ1 inhibited the expression levels of phosphorylated JAK2 and phosphorylated STAT3 without altering expression levels of these non-phosphorylated proteins. Taken together, these findings suggested that JQ-1 treatment ameliorated S. japonicum egg-induced liver fibrosis, at least in part, by suppressing HSC activation and proliferation through the inhibition of JAK2/STAT3 signaling. These results lay a foundation for the development of novel approaches to treat and control liver fibrosis caused by S. japonicum.
C1 [Ding, Han; Yang, Xuhan; Tian, Jiaming; Ji, Yongsheng; Ren, Cuiping; Shen, Jijia; Liu, Miao] Anhui Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Anhui Prov Lab Microbiol & Parasitol,Anhui Key La, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
   [Wang, Xinran] Anhui Med Univ, Clin Med Coll 2, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
   [El-Ashram, Saeed] Foshan Univ, Coll Life Sci & Engn, 18 Jiangwan St, Foshan 528231, Guangdong, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Foshan University
RP Shen, JJ; Liu, M (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Anhui Prov Lab Microbiol & Parasitol,Anhui Key La, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
EM shenjijia@ahmu.edu.cn; iammiaoliu@126.com
RI El-Ashram, Saeed/AAC-6060-2021
OI El-Ashram, Saeed/0000-0003-0389-1980; Ji, Yongsheng/0000-0002-3273-5947
FU National Natural Science Foundation of China [81471982, 81802027]; Key
   University Science Research Project of Anhui Province of China
   [KJ2019A0223]
FX We thank a native English speaker (Onboard Editing) for modifying the
   language in this manuscript. This work was supported by grants from the
   National Natural Science Foundation of China (http://www.nsfc.gov.cn)
   (Grant no. 81471982, 81802027) and from the Key University Science
   Research Project of Anhui Province of China (KJ2019A0223). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256
   Cao G, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153055
   Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027
   Carson JP, 2018, TRENDS PARASITOL, V34, P524, DOI 10.1016/j.pt.2018.02.005
   Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013
   Ding N, 2015, P NATL ACAD SCI USA, V112, P15713, DOI 10.1073/pnas.1522163112
   Ferri E, 2016, BIOCHEM PHARMACOL, V106, P1, DOI 10.1016/j.bcp.2015.12.005
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Hassan R, 2019, EUR J PHARM BIOPHARM, V134, P96, DOI 10.1016/j.ejpb.2018.11.018
   Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047
   Li H, 2016, J HUAZHONG U SCI-MED, V36, P372, DOI 10.1007/s11596-016-1594-7
   McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8
   Molenaar Martijn R, 2017, Lipid Insights, V10, p1178635317747281, DOI 10.1177/1178635317747281
   Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519
   Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves
   Sanders YY, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137127
   Sathiyamoorthy G, 2017, SOUTH MED J, V110, P393, DOI 10.14423/SMJ.0000000000000655
   Song LJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.570524
   Tang XY, 2013, AM J PATHOL, V183, P470, DOI 10.1016/j.ajpath.2013.04.020
   Wu W, 2015, PARASITOL RES, V114, P17, DOI 10.1007/s00436-014-4225-x
   Yang YZ, 2019, ACTA PHARMACOL SIN, V40, P879, DOI 10.1038/s41401-018-0194-4
   Zhang BB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00066
NR 24
TC 7
Z9 7
U1 0
U2 9
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2021 DEC
PY 2021
VL 144
AR 112281
DI 10.1016/j.biopha.2021.112281
EA OCT 2021
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA WO7MI
UT WOS:000712633500007
PM 34624676
OA Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Chatterjee, B
   Song, CS
   Jung, MH
   Chen, S
   Walter, CA
   Herbert, DC
   Weaker, FJ
   Mancini, MA
   Roy, AK
AF Chatterjee, B
   Song, CS
   Jung, MH
   Chen, S
   Walter, CA
   Herbert, DC
   Weaker, FJ
   Mancini, MA
   Roy, AK
TI Targeted overexpression of androgen receptor with a liver-specific
   promoter in transgenic mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE steroid receptor; hepatocarcinogen activation; dehydroepiandrosterone
   sulfotransferase; aging
ID MESSENGER-RIBONUCLEIC-ACID; RAT-LIVER; ESTROGEN SULFOTRANSFERASE;
   EXPRESSION; ACTIVATION; GENE; RNA; LOCALIZATION; HORMONE; PROTEIN
AB The rodent liver displays marked age- and sex-dependent changes in androgen sensitivity due to the sexually dimorphic and temporally programmed expression of the androgen receptor (AR) gene. We have altered this normal phenotype by constitutive overexpression of the rat AR transgene in the mouse liver by targeting it via the human phenylalanine hydroxylase (hPAH) gene promoter. These transgenic animals in their heterozygous state produce an approximate to 30-fold higher level of the AR in the liver as compared with the nontransgenic control, Androgen inactivation via sulfonation of the hormone by dehydroepiandrosterone sulfotransferase (DST), an androgen repressible enzyme, also contributes to the age- and sex-dependent regulation of hepatic androgen sensitivity. DST has a broad range of substrate specificity and is responsible for the age- and sex-specific activation of certain polycyclic aromatic hepatocarcinogens as well, by converting them to electrophilic sulfonated derivatives. In the transgenic female, the hepatic expression of DST was approximate to 4-fold lower than in normal females, a level comparable to that in normal males. The hPAH-AR mice will serve as a valuable model for studying the sex- and age-invariant expression of liver-specific genes, particularly those involved in the activation of environmental hepatocarcinogens such as the aromatic hydrocarbons.
RP Chatterjee, B (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [R01-AG03527, P01-AG06822] Funding Source: Medline; NIDDK
   NIH HHS [R37-DK14744] Funding Source: Medline
CR BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191
   CHAN J, 1995, 77TH END SOC M WASH
   CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211
   CHATTERJEE B, 1994, CHEM-BIOL INTERACT, V92, P273, DOI 10.1016/0009-2797(94)90069-8
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Colby H., 1980, ADV SEX HORMONE RES, V4, P27
   DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589
   DIPPLE A, 1976, ACS MONOGR SER, V173, P245
   Falany C N, 1994, Adv Pharmacol, V27, P301, DOI 10.1016/S1054-3589(08)61037-6
   GORSKI J, 1994, ENDOCRINE, V2, P99
   GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x
   Hogan B., 1986, MANIPULATING MOUSE E
   JEFFERY S, 1990, BIOCHEM J, V266, P69, DOI 10.1042/bj2660069
   JENSEN EV, 1968, P NATL ACAD SCI USA, V59, P632, DOI 10.1073/pnas.59.2.632
   KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968
   LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162
   MANCINI MA, 1989, J HISTOCHEM CYTOCHEM, V37, P149, DOI 10.1177/37.2.2463299
   MANCINI MA, 1992, ENDOCRINOLOGY, V131, P1541, DOI 10.1210/en.131.3.1541
   MILLER JA, 1994, CHEM-BIOL INTERACT, V92, P329, DOI 10.1016/0009-2797(94)90074-4
   NAGATA K, 1993, J BIOL CHEM, V268, P24720
   OKUDA H, 1989, BIOCHEM PHARMACOL, V38, P3003, DOI 10.1016/0006-2952(89)90008-7
   PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478
   POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936
   PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187
   ROY AK, 1995, CRIT REV EUKAR GENE, V5, P157, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.30
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1977, EUR J BIOCHEM, V73, P537, DOI 10.1111/j.1432-1033.1977.tb11348.x
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   ROY AK, 1995, IN PRESS EXP GERONTO
   SCARLETT CO, 1995, MOL ENDOCRINOL, V9, P413, DOI 10.1210/me.9.4.413
   SCHWARTZ AG, 1988, ADV CANCER RES, V51, P391, DOI 10.1016/S0065-230X(08)60227-4
   SHERIDAN PJ, 1979, NATURE, V282, P579, DOI 10.1038/282579a0
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   SURH YJ, 1991, BIOCHEM PHARMACOL, V41, P213, DOI 10.1016/0006-2952(91)90479-O
   TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   Walter C A, 1989, Biotechniques, V7, P1065
   WANG YB, 1992, J BIOL CHEM, V267, P15105
   WATABE T, 1994, CHEM-BIOL INTERACT, V92, P87, DOI 10.1016/0009-2797(94)90056-6
   WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3
NR 43
TC 24
Z9 30
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 23
PY 1996
VL 93
IS 2
BP 728
EP 733
DI 10.1073/pnas.93.2.728
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA TR326
UT WOS:A1996TR32600037
PM 8570624
OA Green Published
DA 2024-02-19
ER

PT J
AU Kireev, RA
   Tresguerres, ACF
   Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Kireev, R. A.
   Tresguerres, A. C. F.
   Castillo, C.
   Salazar, V.
   Ariznavarreta, C.
   Vara, E.
   Tresguerres, J. A. F.
TI Effect of exogenous administration of melatonin and growth hormone on
   pro-antioxidant functions of the liver in aging male rats
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; antioxidant status; cytochrome C; growth hormone; male;
   melatonin; nitric oxide
ID OXIDATIVE STRESS; CYTOCHROME-C; FACTOR-I; DIETARY RESTRICTION;
   LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; DWARF MICE;
   LIFE-SPAN; OLD MALE
AB Aging is accompanied by changes in the morphology and physiology of organs and tissues, such as the liver. This process might be due to the accumulation of oxidative damage induced by reactive oxygen (ROS) and reactive nitrogen species (RNS). Hepatocytes are very rich in mitochondria and have a high respiratory rate, so they are exposed to large amounts of ROS and permanent oxidative stress. Twenty-four male Wistar rats of 22 months of age were divided into three groups. One group remained untreated and acted as the control group. The second was treated with growth hormone (GH) (2 mg/kg/d sc) and the third was submitted to treatment wit 1 mg/kg/d of melatonin in the drinking water. A group of 2-months-old male rats was used as young controls. After 10 wk of treatment the rats were killed by decapitation, and the liver was dissected and homogenized. Mitochondrial, cytosolic and microsomal fractions were obtained and cytochrome C, glutathione peroxidase, s-transferase and nitric oxide (NO) were measured. Aging induced a significant increase in mitochondrial nitric oxide. An increase in cytochrome C in the cytosolic fraction and a reduction in the mitochondrial fraction with age was also observed. Both GH and melatonin treatments significantly reduced the enhanced measures and increased the reduced values. A reduction in glutathione peroxidase and glutathione S-transferase was found in old control rats when compared with the group of young animals. Treatment for 2.5 months of old rats with GH and melatonin were able to increase the enzymes reaching values similar to those found in young animals. In conclusion, GH and melatonin treatment seems to have beneficial effects against age-induced damage in the liver.
C1 Univ Complutense, Sch Med, Dept Physiol, Lab Expt Endocrinol, E-28040 Madrid, Spain.
   Saratov NG Chernyshevskii State Univ, Dept Biochem & Biophys, Saratov, Russia.
   Univ Complutense, Sch Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Saratov State University; Complutense
   University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Sch Med, Dept Physiol, Lab Expt Endocrinol, Avda Complutense S-N, E-28040 Madrid, Spain.
EM guerres@med.ucm.es
OI Kireev, Roman/0000-0002-6105-2440
CR Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x
   Ariznavarreta C, 2003, HOMO, V54, P132, DOI 10.1078/0018-442X-00065
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x
   Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7
   Brown-Borg HM, 2003, MECH AGEING DEV, V124, P1013, DOI 10.1016/j.mad.2003.07.001
   Brown-Borg HM, 2002, EXP BIOL MED, V227, P94, DOI 10.1177/153537020222700203
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   Castillo C, 2005, BIOGERONTOLOGY, V6, P303, DOI 10.1007/s10522-005-4805-3
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Castillo C, 2005, J PINEAL RES, V38, P240, DOI 10.1111/j.1600-079X.2004.00199.x
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Dafre AL, 1996, ARCH BIOCHEM BIOPHYS, V332, P288, DOI 10.1006/abbi.1996.0344
   DEGROOT H, 1994, HEPATO-GASTROENTEROL, V41, P328
   Dröge W, 2003, ADV EXP MED BIOL, V543, P191
   Dykens JA, 1997, NEURODEGENER DIS, P29
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Gil P, 2002, GERONTOLOGY, V48, P209, DOI 10.1159/000058352
   Gilad E, 1997, LIFE SCI, V60, pPL169, DOI 10.1016/S0024-3205(97)00008-8
   Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119
   HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851
   Hess M L, 1985, Adv Myocardiol, V5, P177
   Ignarro L.J., 2000, NITRIC OXIDE BIOL PA
   JAESCHKE H, 1992, AM J PHYSIOL, V263, pG60, DOI 10.1152/ajpgi.1992.263.1.G60
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Ji YB, 1996, BIOCHEM J, V313, P377, DOI 10.1042/bj3130377
   JOHNSON TE, 1992, J AM GERIATR SOC, V40, P936, DOI 10.1111/j.1532-5415.1992.tb01993.x
   Jou MJ, 2004, J PINEAL RES, V37, P55, DOI 10.1111/j.1600-079X.2004.00140.x
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Kim HG, 2003, MOL CELLS, V16, P278
   Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   León J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x
   Ma YX, 1999, FREE RADICAL BIO MED, V27, P227, DOI 10.1016/S0891-5849(99)00083-0
   Manda K, 2003, CELL BIOL TOXICOL, V19, P367, DOI 10.1023/B:CBTO.0000013342.17370.16
   Mayo JC, 2005, ENDOCRINE, V27, P169, DOI 10.1385/ENDO:27:2:169
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Miyamoto Y, 2003, BIOL CHEM, V384, P567, DOI 10.1515/BC.2003.064
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   NEDERGAARD J, 1980, AM J PHYSIOL, V239, pC208, DOI 10.1152/ajpcell.1980.239.5.C208
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146
   Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112
   Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1
   Reiter RJ, 2005, EXP BIOL MED, V230, P104
   Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688
   Sener G, 2003, J PINEAL RES, V35, P61, DOI 10.1034/j.1600-079X.2003.00050.x
   Sener G, 2003, LIFE SCI, V74, P563, DOI 10.1016/j.lfs.2003.05.011
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x
   VARA E, 1994, TRANSPL P, V26, P3364
   Wu YH, 2005, J PINEAL RES, V38, P145, DOI 10.1111/j.1600-079X.2004.00196.x
   YAGI K, 1993, ACTIVE OXYGENS LIPID, P1
   Yin ZM, 2000, CANCER RES, V60, P4053
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
NR 68
TC 29
Z9 29
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD JAN
PY 2007
VL 42
IS 1
BP 64
EP 70
DI 10.1111/j.1600-079X.2006.00385.x
PG 7
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 116WW
UT WOS:000242835500008
PM 17198540
DA 2024-02-19
ER

PT J
AU Jeong, DH
   Goo, MJ
   Hong, IH
   Yang, HJ
   Ki, MR
   Do, SH
   Ha, JH
   Lee, SS
   Park, JK
   Jeong, KS
AF Jeong, Da-Hee
   Goo, Moon-Jung
   Hong, II-Hwa
   Yang, Hai-Jie
   Ki, Mi-Ran
   Do, Sun-Hee
   Ha, Jeoung-Hee
   Lee, Seung-Sook
   Park, Jin-Kyu
   Jeong, Kyun-Shik
TI Inhibition of Radiation-Induced Apoptosis via Overexpression of SMP30 in
   Smad3-Knockout Mice Liver
SO JOURNAL OF RADIATION RESEARCH
LA English
DT Article
ID TRANSFORMING-GROWTH-FACTOR; MARKER PROTEIN-30 SMP30; HEP G2 CELLS;
   IONIZING-RADIATION; FACTOR-BETA; TGF-BETA; OXIDATIVE STRESS;
   GENE-EXPRESSION; LACKING SMAD3; RAT-LIVER
AB Gamma-radiation/Liver injury/Smad3/Apoptosis/SMP30.
   Apoptosis occurs early after irradiation and may be a (good indicator of radiation damages. Since elevated levels of TGF-beta are associated with radiation-induced inflammation, the null mice of Smad3, a key downstream mediator of TGF-beta, show accelerated healing of irradiated injury. In order to evaluate resistance to radiation-induced liver injuries in Smad3-null mice, we determined the Occurrence of apoptosis and the expression of senescence marker protein-30 (SMP30), as in anti-apoptotic marker, after irradiation to the liver. The livers of Smad3-mutant mice were exposed to local irradiation of 15 gray, from a Co-60-gamma radiation. One week after irradiation, in Smad3-KO mice, radiation-induced apoptosis was at lower levels compared to those of irradiated WT mice. These Findings were well matched with the expression of CYP2E1. which plays a role in hepatic injuries produced by oxidative stress. In addition. antioxidant related protein. the SMP30 levels were reduced by gamma irradiation in both groups. Interestingly. the increased expression of SMP30 expression in Smad3-KO mice liver was preserved at a higher level than that of the WT mice after irradiation. Therefore, these results suggest that the interruption of TGF-beta signaling by deletion of Smad3 brings about inhibition of hepatic apoptosis alter ionizing irradiation. Moreover. the protective effect to ionizing radiation might be in correlation with the overexpression of SMP30 in the Smad3-null mice, which may act as an anti-apoptotic signaling Molecule. The alteration of SMP30 by interruption of Smad3 might be a useful therapeutic tar-et and diagnostic marker for radiation-induced liver damages.
C1 [Jeong, Da-Hee; Goo, Moon-Jung; Hong, II-Hwa; Yang, Hai-Jie; Ki, Mi-Ran; Park, Jin-Kyu; Jeong, Kyun-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu, South Korea.
   [Do, Sun-Hee] Konkuk Univ, Coll Vet Med, Dept Clin Pathol, Seoul, South Korea.
   [Ha, Jeoung-Hee] Kyungpook Natl Univ, Coll Med, Dept Pharmacol, Taegu, South Korea.
   [Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Dept Pathol, Seoul, South Korea.
C3 Kyungpook National University; Konkuk University; Konkuk University
   Medical Center; Kyungpook National University; Korea Institute of
   Radiological & Medical Sciences
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu, South Korea.
EM jeongks@knu.ac.kr
OI Do, Sun Hee/0000-0003-2372-5269
FU Ministry of Science and Technology [M2-0504-00-0001]
FX This work was supported by the Brain Korea 21 Project in 2006 and the
   "Establishment of medical care protocol for improving survival of
   high-dose radiation exposure" (Study ID. M2-0504-00-0001) of Ministry of
   Science and Technology.
CR ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586
   Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971
   BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045
   Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001
   CARR BI, 1986, CANCER RES, V46, P2330
   Chi CH, 2005, WORLD J GASTROENTERO, V11, P1496
   Chung HC, 2001, TOXICOLOGY, V161, P79, DOI 10.1016/S0300-483X(01)00332-8
   Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117
   Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485
   Falanga V, 2004, WOUND REPAIR REGEN, V12, P320, DOI 10.1111/j.1067-1927.2004.012316.x
   Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074
   Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021
   Hauer-Jensen M, 1998, RADIAT RES, V150, P673, DOI 10.2307/3579890
   Imamura T, 2004, BIOCHEM BIOPH RES CO, V318, P289, DOI 10.1016/j.bbrc.2004.04.029
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jagetia GC, 2005, LIFE SCI, V77, P780, DOI 10.1016/j.lfs.2005.01.015
   Kim SG, 1997, MOL PHARMACOL, V51, P225, DOI 10.1124/mol.51.2.225
   Kraft M, 1996, RADIAT RES, V146, P619, DOI 10.2307/3579377
   Kremer M, 2008, HEPATOLOGY, V47, P113, DOI 10.1002/hep.21956
   Lee JH, 2005, BIOCHEM BIOPH RES CO, V334, P298, DOI 10.1016/j.bbrc.2005.06.102
   Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068
   Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085
   Reddy VN, 2004, EXP EYE RES, V79, P859, DOI 10.1016/j.exer.2004.04.005
   ROY D, 1989, CANCER RES, V49, P1475
   Sit KH, 1996, EXPERIENTIA, V52, P778, DOI 10.1007/BF01923989
   Somosy Z, 2002, MICRON, V33, P167, DOI 10.1016/S0968-4328(01)00013-0
   Vodovotz Y, 2000, INT J CANCER, V90, P13, DOI 10.1002/(SICI)1097-0215(20000220)90:1<13::AID-IJC2>3.3.CO;2-L
   Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280
   Yi ES, 1996, INFLAMMATION, V20, P339, DOI 10.1007/BF01486737
   Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483
NR 35
TC 15
Z9 18
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0449-3060
EI 1349-9157
J9 J RADIAT RES
JI J. Radiat. Res.
PD NOV
PY 2008
VL 49
IS 6
BP 653
EP 660
DI 10.1269/jrr.08042
PG 8
WC Biology; Oncology; Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Oncology; Radiology, Nuclear
   Medicine & Medical Imaging
GA 381IT
UT WOS:000261530200010
PM 19001783
OA Green Submitted, gold
DA 2024-02-19
ER

PT S
AU Cassano, P
   Lezza, AMS
   Leeuwenburgh, C
   Cantatore, P
   Gadaleta, MN
AF Cassano, P
   Lezza, AMS
   Leeuwenburgh, C
   Cantatore, P
   Gadaleta, MN
BE DeGrey, ADN
TI Measurement of the 4,834-bp mitochondrial DNA deletion level in aging
   rat liver and brain subjected or not to caloric restriction diet
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE caloric restriction; rat liver; rat brain; skeletal muscle;
   mitochondrial DNA
ID AGE; EXPRESSION; DAMAGE
AB Several studies have demonstrated an age-related accumulation of the amount of a specific 4834-bp mitochondrial DNA (mtDNA) deletion in different tissues of rat (liver, brain, and skeletal muscle). We investigated the influence of a caloric restriction diet (CR) on a selected age-associated marker of mtDNA damage, as the 4834-bp deletion, using quantitative real-time PCR. The mtDNA deleted level has been determined with respect to the mitochondrial D-loop level, using specific primers and TaqMan probes for each target. In liver we found an age-related increase of the deletion level (twofold) that was reversed and brought back to the adult level by a CR diet. On the contrary, in the brain the age-related increase of the deletion level (eightfold) was not affected by CR at all. The different effect of the CR on the deletion level in liver and brain might be a further element supporting the tissue-specificity of the aging process.
C1 Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.
   Univ Florida, Biochem Aging Lab, Coll & Human Performance, Ctr Exercise Sci, Gainesville, FL USA.
   CNR, Inst Biomembrane & Bioenerget, Bari, Italy.
C3 Universita degli Studi di Bari Aldo Moro; State University System of
   Florida; University of Florida; Consiglio Nazionale delle Ricerche (CNR)
RP Cassano, P (corresponding author), Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.
EM cspr01b1@uniba.it
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003
   Gadaleta MN, 1995, PROG CELL R, V5, P231
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lezza AMS, 1999, FASEB J, V13, P1083, DOI 10.1096/fasebj.13.9.1083
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
NR 10
TC 30
Z9 32
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-497-8; 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 269
EP 273
DI 10.1196/annals.1297.045
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700045
PM 15247027
DA 2024-02-19
ER

PT J
AU ROGUE, PJ
   RITZ, MF
   MALVIYA, AN
AF ROGUE, PJ
   RITZ, MF
   MALVIYA, AN
TI IMPAIRED GENE-TRANSCRIPTION AND NUCLEAR-PROTEIN KINASE-C ACTIVATION IN
   THE BRAIN AND LIVER OF AGED RATS
SO FEBS LETTERS
LA English
DT Article
DE AGING; HEAT SHOCK; NUCLEAR PKC; GENE TRANSCRIPTION
ID HEAT-SHOCK FACTOR; EXPRESSION; FIBROBLASTS; PHOSPHORYLATION; FOS;
   PROMOTER; DISEASE; CELLS; SITES
AB The expression of the hsp70 and c-fos genes and the activation of nuclear protein kinase C (PKC) were studied in young and aged whole rats under heat-shock conditions. The induction of hsp70 and c-fos genes by heat shock were decreased several fold in the brain as well as in the liver of senescent animals. Nuclear run-off transcription assay indicated that this age-related impairment could be attributed to a block at the level of transcription. Nuclear PKC activation by heat shock was not apparent in old animals. Nuclear PKC involvement in the repression of transcription during senescence is postulated.
C1 CTR NEUROCHIM,NEUROBIOL MOLEC INTERACT CELLULAIRES LAB,CNRS,UPR 416,5 RUE BLAISE PASCAL,F-67084 STRASBOURG,FRANCE.
C3 Centre National de la Recherche Scientifique (CNRS); Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg
RI Ritz, Marie-FranÃ§oise/IAQ-5673-2023
OI Ritz, Marie-Francoise/0000-0002-5650-9987
CR ABATE C, 1993, P NATL ACAD SCI USA, V90, P6766, DOI 10.1073/pnas.90.14.6766
   ADLER MJ, 1991, P NATL ACAD SCI USA, V88, P16, DOI 10.1073/pnas.88.1.16
   AUSUBEL F, 1987, CURRENT PROTOCOLS MO, P42
   BLAKE MJ, 1989, J IBOL CHEM, V264, P15275
   BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P
   COLOTTA F, 1990, BIOCHEM BIOPH RES CO, V168, P1013, DOI 10.1016/0006-291X(90)91130-K
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FUTREAL PA, 1991, ONCOGENE, V6, P1109
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6
   KANTENGWA S, 1991, BIOCHEM BIOPH RES CO, V180, P308, DOI 10.1016/S0006-291X(05)81293-8
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LUM LSY, 1990, MOL CELL BIOL, V10, P6709, DOI 10.1128/MCB.10.12.6709
   MAHONEY CW, 1992, J BIOL CHEM, V267
   MALVIYA AN, 1990, INT J CANCER, V45, P580, DOI 10.1002/ijc.2910450335
   MASLIAH E, 1991, J NEUROSCI, V11, P2759
   MEEK DW, 1992, BIOCHEM J, V287, P1
   NIEDZWIECKI A, 1991, J BIOL CHEM, V266, P9332
   RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906
   RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316
   RITZ MF, IN PRESS RECEPTOR
   ROGUE P, 1990, J BIOL CHEM, V265, P4161
   SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0
   SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   WOOTEN MW, 1991, EXP CELL RES, V193, P274, DOI 10.1016/0014-4827(91)90096-D
   WU BJ, 1987, P NATL ACAD SCI USA, V84, P2203, DOI 10.1073/pnas.84.8.2203
NR 27
TC 26
Z9 27
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD NOV 22
PY 1993
VL 334
IS 3
BP 351
EP 354
DI 10.1016/0014-5793(93)80710-C
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA MH650
UT WOS:A1993MH65000023
PM 8243646
OA Bronze
DA 2024-02-19
ER

PT J
AU DUNN, MA
   CHEEVER, AW
   PAGLIA, LM
   KELLY, EP
   DUVALL, RH
   ANDRADE, ZA
   GOLDNER, FH
AF DUNN, MA
   CHEEVER, AW
   PAGLIA, LM
   KELLY, EP
   DUVALL, RH
   ANDRADE, ZA
   GOLDNER, FH
TI REVERSAL OF ADVANCED LIVER FIBROSIS IN RABBITS WITH
   SCHISTOSOMIASIS-JAPONICA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MURINE SCHISTOSOMIASIS; HEPATIC-FIBROSIS; COLLAGEN-SYNTHESIS;
   PRAZIQUANTEL; MANSONI
AB Advanced liver fibrosis is generally considered to be irreversible. We studied the reversibility of marked liver fibrosis in rabbits infected with Schistosoma japonicum. We determined liver collagen content, collagen biosynthesis, and collagenase activity using serial biopsy specimens obtained 20, 40, and 60 weeks after infection. Reversibility of this process was investigated in rabbits cured of infection at 21 weeks; control rabbits not cured of infection were also studied. At 20 weeks, liver collagen content was 16-fold greater than normal, with accumulation of collagen types I, III, and V. Synthesis of collagen within fibrotic liver slices was 10-fold greater than normal. Liver collagenolytic activity for a type I substrate was 19-fold greater than normal. After parasitologic cure, a striking morphologic reversal of fibrosis occurred during the subsequent 40 weeks, with the return of liver collagen content to three-fold greater than normal and a 75% decrease in synthetic rates compared with those at 20 weeks (P < 0.01). Collagenolytic activity remained elevated to the same degree noted at 20 weeks. A similar but lesser resolution of fibrosis also occurred in untreated control rabbits, coincident with a spontaneous decrease in new egg deposition known to occur in this model system. We conclude that advanced liver fibrosis in S. japonicum-infected rabbits is slowly reversible after cure or senescence of the infection. A possible mechanism for this reversal is persistently increased collagenolysis as collagen synthesis diminishes.
C1 NIAID, PARASIT DIS LAB, BETHESDA, MD 20892 USA.
   BAYNE JONES ARMY COMMUNITY HOSP, FT POLK, LA 71459 USA.
   WALTER REED ARMY INST RES, DEPT GASTROENTEROL, DIV MED, WASHINGTON, DC 20307 USA.
   ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, BRONX, NY 10461 USA.
   UNIFORMED SERV UNIV HLTH SCI, DEPT MED, DIV DIGEST DIS, BETHESDA, MD 20852 USA.
   GONCALO MONIZ RES CTR, DEPT PATHOL, BR-41945 SALVADOR, BA, BRAZIL.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Allergy & Infectious Diseases (NIAID); Walter Reed Army Institute of
   Research (WRAIR); United States Department of Defense; United States
   Army; Yeshiva University; Albert Einstein College of Medicine; Uniformed
   Services University of the Health Sciences - USA
CR ANDRADE ZA, 1992, HUM PATHOL, V23, P566, DOI 10.1016/0046-8177(92)90135-P
   BENTZ H, 1978, EUR J BIOCHEM, V92, P563, DOI 10.1111/j.1432-1033.1978.tb12778.x
   BIEMPICA L, 1983, AM J TROP MED HYG, V32, P316, DOI 10.4269/ajtmh.1983.32.316
   CHEEVER AW, 1980, AM J TROP MED HYG, V29, P1307, DOI 10.4269/ajtmh.1980.29.1307
   CHEEVER AW, 1974, AM J TROP MED HYG, V23, P51, DOI 10.4269/ajtmh.1974.23.51
   CHEEVER AW, 1980, AM J TROP MED HYG, V29, P1327, DOI 10.4269/ajtmh.1980.29.1327
   CHUNG E, 1976, BIOCHEM BIOPH RES CO, V71, P1167, DOI 10.1016/0006-291X(76)90776-2
   DOEHRINGSCHWERDTFEGER E, 1992, AM J TROP MED HYG, V46, P409, DOI 10.4269/ajtmh.1992.46.409
   DUNN MA, 1977, J CLIN INVEST, V59, P666, DOI 10.1172/JCI108685
   DUNN MA, 1979, GASTROENTEROLOGY, V76, P978
   HOMEIDA MA, 1991, AM J TROP MED HYG, V45, P360, DOI 10.4269/ajtmh.1991.45.360
   KOJIMA S, 1970, Japanese Journal of Parasitology, V19, P54
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MEREDITH SC, 1981, BIOCHIM BIOPHYS ACTA, V668, P357, DOI 10.1016/0005-2795(81)90169-0
   MORCOS SH, 1985, AM J TROP MED HYG, V34, P314, DOI 10.4269/ajtmh.1985.34.314
   OHMAE H, 1992, AM J TROP MED HYG, V46, P99, DOI 10.4269/ajtmh.1992.46.99
   OLDS GR, 1985, GASTROENTEROLOGY, V89, P617, DOI 10.1016/0016-5085(85)90459-7
   ROBINSON A, 1981, T ROY SOC TROP MED H, V75, P415, DOI 10.1016/0035-9203(81)90108-5
   ROJKIND M, 1979, GASTROENTEROLOGY, V76, P849
   SCHIFF ER, 1991, NEW ENGL J MED, V324, P987, DOI 10.1056/NEJM199104043241409
   SNEDECOR GW, 1958, STATISTICAL METHODS, P75
   SULIT Y. S. M., 1964, Journal of the Philippine Islands Medical Association, V40, P1021
   TAKAHASHI S, 1980, GASTROENTEROLOGY, V78, P1425
   Tsutsumi H., 1972, Research in filariasis and schistosomiasis. Volume 2., P133
   WYLER DJ, 1982, J IMMUNOL, V129, P1706
   YANG Y, 1982, ACTA ACAD MED SINICA, V4, P37
NR 26
TC 18
Z9 20
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD APR
PY 1994
VL 50
IS 4
BP 499
EP 505
DI 10.4269/ajtmh.1994.50.499
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Tropical Medicine
GA NK485
UT WOS:A1994NK48500015
PM 8166357
DA 2024-02-19
ER

PT J
AU Blaber, EA
   Pecaut, MJ
   Jonscher, KR
AF Blaber, Elizabeth A.
   Pecaut, Michael J.
   Jonscher, Karen R.
TI Spaceflight Activates Autophagy Programs and the Proteasome in Mouse
   Liver
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE spaceflight; autophagy; proteasome; metabolomics; tRNA biosynthesis;
   senescence
ID YOUNG-ADULT RATS; OXIDATIVE STRESS; SPACE; METABOLISM; MICROGRAVITY;
   PEROXISOMES; SYSTEM; CELLS; REGENERATION; SUBEPENDYMA
AB Increased oxidative stress is an unavoidable consequence of exposure to the space environment. Our previous studies showed that mice exposed to space for 13.5 days had decreased glutathione levels, suggesting impairments in oxidative defense. Here we performed unbiased, unsupervised and integrated multi-'omic analyses of metabolomic and transcriptomic datasets from mice flown aboard the Space Shuttle Atlantis. Enrichment analyses of metabolite and gene sets showed significant changes in osmolyte concentrations and pathways related to glycerophospholipid and sphingolipid metabolism, likely consequences of relative dehydration of the spaceflight mice. However, we also found increased enrichment of aminoacyl-tRNA biosynthesis and purine metabolic pathways, concomitant with enrichment of genes associated with autophagy and the ubiquitin-proteasome. When taken together with a downregulation in nuclear factor (erythroid-derived 2)-like 2-mediated signaling, our analyses suggest that decreased hepatic oxidative defense may lead to aberrant tRNA post-translational processing, induction of degradation programs and senescence-associated mitochondrial dysfunction in response to the spaceflight environment.
C1 [Blaber, Elizabeth A.] Univ Space Res Assoc, Mountain View, CA 94040 USA.
   [Blaber, Elizabeth A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.
   [Pecaut, Michael J.] Loma Linda Univ, Div Radiat Res, Dept Basic Sci, Sch Med, Loma Linda, CA 92350 USA.
   [Jonscher, Karen R.] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO 80045 USA.
C3 Universities Space Research Association (USRA); National Aeronautics &
   Space Administration (NASA); NASA Ames Research Center; Loma Linda
   University; University of Colorado System; University of Colorado
   Anschutz Medical Campus
RP Jonscher, KR (corresponding author), Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO 80045 USA.
EM e.blaber@nasa.gov; mpecaut@llu.edu; karen.jonscher@ucdenver.edu
RI Pecaut, Michael J/P-6481-2015; Blaber, Elizabeth A/N-2841-2015
OI Pecaut, Michael J/0000-0002-2915-9686; Blaber, Elizabeth
   A/0000-0002-1924-0587; Jonscher, Karen/0000-0002-7929-4886
FU NASA [NNX13AN34G]; NASA [NNX13AN34G, 468592] Funding Source: Federal
   RePORTER
FX The authors thank Amgen and their support team for the opportunity to
   participate in this study, and Virginia Ferguson, Mary Bouxsein, Ted
   Bateman, Louis Stodieck and BioServe Space Technologies at the
   University of Colorado at Boulder for organizing the tissue sharing
   project. We also appreciate Naomi Clayman, Paula Dumars and Vera Vizir
   of the University of Colorado Denver and NASA, as well as support staff
   at the Kennedy Space Center who assisted with and organized tissue
   collection. We are grateful to David Orlicky at the University of
   Colorado Anschutz Medical Campus for histological expertise. Michael J.
   Pecaut appreciates funding from NASA (NNX13AN34G).
CR Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005
   Alwood Joshua S, 2012, J Aging Res, V2012, P481983, DOI 10.1155/2012/481983
   Anselm V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081763
   Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996
   Apostolopoulou M., 2017, SERUM HEPATIC SPHING, pS1
   Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008
   Bellinzona M, 1996, NEUROSCI LETT, V208, P163, DOI 10.1016/0304-3940(96)12572-6
   Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144
   Blaber E. A., 2014, CELL RES, V13, P181, DOI [10.1016/j.scr.2014.05.00525011075, DOI 10.1016/J.SCR.2014.05.00525011075]
   Blaber E, 2014, STEM CELLS DEV, V23, P73, DOI 10.1089/scd.2014.0408
   Blaber EA, 2015, STEM CELLS DEV, V24, P2605, DOI 10.1089/scd.2015.0218
   Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48
   Borchers AT, 2002, NUTRITION, V18, P889, DOI 10.1016/S0899-9007(02)00913-9
   Chandler TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171080
   Chanfreau Guillaume F, 2017, Enzymes, V41, P299, DOI 10.1016/bs.enz.2017.03.008
   Csányi G, 2014, INT J MOL SCI, V15, P6002, DOI 10.3390/ijms15046002
   Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2
   Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2
   Davis TA, 1996, J LEUKOCYTE BIOL, V60, P69, DOI 10.1002/jlb.60.1.69
   DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9
   Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008
   Dewe JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00214-17
   Diehl AM, 2013, J CLIN INVEST, V123, P1858, DOI 10.1172/JCI69966
   Duda W, 2016, NEUROTOX RES, V30, P173, DOI 10.1007/s12640-016-9614-8
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001
   Gobbel GT, 1998, J NEUROSCI, V18, P147
   Hudoyo AW, 2017, MOL GENET METAB REP, V13, P23, DOI 10.1016/j.ymgmr.2017.07.006
   Jafari M, 2014, EXCLI J, V13, P161
   Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877
   Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910
   Kondo H, 2007, Radiats Biol Radioecol, V47, P281
   Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836
   Kriegenburg F, 2011, ANTIOXID REDOX SIGN, V15, P2265, DOI 10.1089/ars.2010.3590
   Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563
   Levillain O, 2002, PFLUG ARCH EUR J PHY, V444, P143, DOI 10.1007/s00424-002-0787-z
   Levillain O, 2001, PFLUG ARCH EUR J PHY, V442, P558, DOI 10.1007/s004240100581
   Lobley GE, 1996, BRIT J NUTR, V75, P47, DOI 10.1079/BJN19960109
   Madamanchi N. R., 2005, THROMB VASC BIOL, V25-29, P38, DOI [10.1161/01.ATV.0000150649.39934.1315539615, DOI 10.1161/01.ATV.0000150649.39934.1315539615]
   Manivannan S, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00050
   Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086
   Mao XW, 2013, RADIAT RES, V180, P340, DOI 10.1667/RR3309.1
   MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236
   Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358
   Monticone M, 2010, J CELL BIOCHEM, V111, P442, DOI 10.1002/jcb.22765
   Navarro-González C, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006921
   Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837
   Nordgren M, 2014, BIOCHIMIE, V98, P56, DOI 10.1016/j.biochi.2013.07.026
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656
   Pecaut MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174174
   Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002
   Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200
   Shinohara C, 1997, CANCER RES, V57, P2694
   Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350
   Tobin BW, 2002, NUTRITION, V18, P842, DOI 10.1016/S0899-9007(02)00940-1
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Väre VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029
   Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
   Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x
NR 65
TC 40
Z9 44
U1 2
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD OCT
PY 2017
VL 18
IS 10
AR 2062
DI 10.3390/ijms18102062
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA FM0QL
UT WOS:000414671800046
PM 28953266
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Schädel, P
   Troisi, F
   Czapka, A
   Gebert, N
   Pace, S
   Ori, A
   Werz, O
AF Schaedel, Patrick
   Troisi, Fabiana
   Czapka, Anna
   Gebert, Nadja
   Pace, Simona
   Ori, Alessandro
   Werz, Oliver
TI Aging drives organ-specific alterations of the inflammatory
   microenvironment guided by immunomodulatory mediators in mice
SO FASEB JOURNAL
LA English
DT Article
DE aging; cytokines; inflammation; lipid mediators; resolution
ID HEPATIC STELLATE CELLS; EXTRACELLULAR VESICLES; LIVER FIBROSIS; SIGNAL
   TRANSDUCER; TRANSCRIPTION 3; EXOSOMES; DELIVERY; ACTIVATION; MECHANISMS;
   STAT3
AB Aging is accompanied by chronic, low-grade systemic inflammation, termed inflammaging, a main driver of age-associated diseases. Such sterile inflammation is typically characterized by elevated levels of pro-inflammatory mediators, such as cytokines, chemokines and reactive oxygen species causing organ damage. Lipid mediators play important roles in the fine-tuning of both the promotion and the resolution of inflammation. Yet, it remains unclear how lipid mediators fit within the concept of inflammaging and how their biosynthesis and function is affected by aging. Here, we provide comprehensive signature profiles of inflammatory markers in organs afflicted with inflammation of young and old C57BL/6 mice. We reveal an organ-specific footprint of inflammation-related cytokines, chemokines and lipid mediators, which are distinctively affected by aging. While some organs are characterized by a pronounced pro-inflammatory microenvironment and impaired resolution during aging, others display elevated levels of pro-resolving mediators or an overall decrease in inflammatory signaling. Our results demonstrate that it proves difficult to establish a unifying concept for alterations of immunomodulatory mediators as consequence of aging and that organ specificity needs to be considered. Moreover, our data imply that inclusion of lipid mediators into the concept of inflammaging provides a comprehensive tool to characterize the inflammatory microenvironment during aging on a broader and yet, more detailed scope.
C1 [Schaedel, Patrick; Troisi, Fabiana; Czapka, Anna; Pace, Simona; Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany.
   [Troisi, Fabiana] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany.
   [Troisi, Fabiana] Helmholtz Ctr Munich, Munich, Germany.
   [Gebert, Nadja; Ori, Alessandro] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Jena, Germany.
C3 Friedrich Schiller University of Jena; Technical University of Munich;
   Helmholtz Association; Helmholtz-Center Munich - German Research Center
   for Environmental Health; Leibniz Institut fur Alternsforschung -
   Fritz-Lipmann-Institut (FLI)
RP Werz, O (corresponding author), Friedrich Schiller Univ Jena, Inst Pharm, Dept Pharmaceut Med Chem, Philosophenweg 14, D-07743 Jena, Germany.
EM oliver.werz@uni-jena.de
RI Ori, Alessandro/M-8586-2019
OI Ori, Alessandro/0000-0002-3046-0871; Schadel,
   Patrick/0000-0002-9586-6653
FU Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging");
   Deutsche Forschungsgemeinschaft; Europaischer Fonds fur regionale
   Entwicklung [2019FGR0095];  [SFB 1278/1 PolyTarget-316213987];  [C02]; 
   [SFB 1127/2 ChemBioSys-239748522];  [A04]
FX Free State of Thuringia; ProExcellence Initiative 2 ("RegenerAging");
   Deutsche Forschungsgemeinschaft; SFB 1278/1 PolyTarget-316213987,
   Grant/Award Number: C02; SFB 1127/2 ChemBioSys-239748522, Grant/Award
   Number: A04; Europaischer Fonds fur regionale Entwicklung, Grant/Award
   Number: 2019FGR0095
CR Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Arriazu E, 2017, GUT, V66, P1123, DOI 10.1136/gutjnl-2015-310752
   Bartneck M., 2014, HEPATOBILIARY SURG N, V3, p364
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beebe JD, 2018, PHARMACOL THERAPEUT, V191, P74, DOI 10.1016/j.pharmthera.2018.06.006
   Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031
   Breitkopf K, 2005, GUT, V54, P673, DOI 10.1136/gut.2004.042911
   Busatto S, 2019, BIOMED MICRODEVICES, V21, DOI 10.1007/s10544-019-0396-7
   Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6
   Choi S, 2019, BIOCHEM BIOPH RES CO, V513, P49, DOI 10.1016/j.bbrc.2019.03.156
   Gong XH, 2014, CELL PHYSIOL BIOCHEM, V33, P97, DOI 10.1159/000356653
   He WW, 2019, ONCOL LETT, V17, P5608, DOI 10.3892/ol.2019.10236
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005
   Jung KH, 2017, CLIN CANCER RES, V23, P5537, DOI 10.1158/1078-0432.CCR-16-2253
   Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977
   Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004
   Krishna Murli, 2017, Clin Liver Dis (Hoboken), V10, P53, DOI 10.1002/cld.653
   Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026
   LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007
   Lötvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913
   Lou GH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1512-5
   Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902
   Lu YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00243
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Mendt M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99263
   Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48
   Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641
   O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y
   Ogiso H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162183
   Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022
   Qu Y, 2017, J CELL MOL MED, V21, P2491, DOI 10.1111/jcmm.13170
   Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006
   Su TH, 2015, P NATL ACAD SCI USA, V112, P7243, DOI 10.1073/pnas.1507499112
   Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043
   Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006
   van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830
   Viñas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392
   Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005
   Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536
   WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278
   Xiang DM, 2018, GUT, V67, P1704, DOI 10.1136/gutjnl-2016-313392
   Zeybel M, 2017, MOL THER, V25, P218, DOI 10.1016/j.ymthe.2016.10.004
   Zhai XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49287-7
   Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240
NR 47
TC 12
Z9 12
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAY
PY 2021
VL 35
IS 5
AR e21558
DI 10.1096/fj.202002684R
PG 16
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA RU6MM
UT WOS:000645260100073
PM 33855766
DA 2024-02-19
ER

PT J
AU Xie, W
   Ma, LL
   Xu, YQ
   Wang, BH
   Li, SM
AF Xie, Wei
   Ma, Lei Lei
   Xu, Yue Qing
   Wang, Bao Hua
   Li, Sai Mei
TI METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine
   modification of Fasn mRNA and promoting fatty acid metabolism
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Type 2 diabetes; N6-Methyladenosine; METTL3; Fasn
ID SUBSTRATE; CANCER; PHOSPHORYLATION; IRS1
AB Type 2 diabetes (T2D) is characterized by lack of insulin, insulin resistance and high blood sugar. However, the underlying mechanisms of insulin resistance during T2D development remains unclear. As the most common mRNAs modification, N6-Methyladenosine (m6A) is involved in many of pathological processes in aging disease. However, it remains unclear whether m6A is involved in T2D development and what is the regulatory mechanism. This study is aimed to illustrate the roles of m6A and its methyltransferase METTL3 in the regulation of blood glucose homeostasis and insulin sensitivity. The results showed that m6A methylated RNA level and its N6-methyladenosine methylase METTL3 were consistently up-regulated in the liver tissues from patients with T2D. Moreover, both m6A methylated RNA and METTL3 levels showed positive correlation with HOMA-IR and negative correlation with HOMA-beta. The m6A methylated RNA and METTL3 levels were also up-regulated in mouse with 16 weeks high-fat diet (HFD), compared with mice fed a standard chow diet (CD). Hepatocyte-specific knockout of METTL3 in mice fed a HFD improved insulin sensitivity and decreased fatty acid synthesis. Furthermore, mechanism analysis demonstrates that METTL3 silence decreased the m6A methylated and total mRNA level of Fatty acid synthase (Fasn), subsequently inhibited fatty acid metabolism. Adeno-associated virus mediated Fasn overexpression in METTL3 knockout mice abrogates the improved insulin sensitivity and decreased fatty acid synthesis. Collectively, these results reveal that RNA N6-methyladenosine methylase METTL3 inhibits hepatic insulin sensitivity via N6-methylation of Fasn mRNA and promoting fatty acid metabolism. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Xie, Wei; Ma, Lei Lei; Wang, Bao Hua; Li, Sai Mei] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Clin Sch 1, Guangzhou 510000, Guangdong, Peoples R China.
   [Xie, Wei] Guangzhou Univ Chinese Med, Shenzhen Baoan Tradit Chinese Med Hosp, Guangzhou 510000, Guangdong, Peoples R China.
   [Ma, Lei Lei] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.
   [Ma, Lei Lei] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.
   [Xu, Yue Qing] Wuhan Univ, Hubei Key Lab Tumor Biol Behav, Dept Radiat & Med Oncol, Zhongnan Hosp, Wuhan 430000, Hubei, Peoples R China.
   [Xu, Yue Qing] Wuhan Univ, Zhongnan Hosp, Ctr Med Sci Res, Wuhan 430000, Hubei, Peoples R China.
C3 Guangzhou University of Chinese Medicine; Guangzhou University of
   Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou
   University of Chinese Medicine; Wuhan University; Wuhan University
RP Li, SM (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Clin Sch 1, Guangzhou 510000, Guangdong, Peoples R China.
EM lsm@gzucm.edu.cn
RI xu, yue/JDD-1638-2023; xu, ye/JYO-6282-2024
FU National Natural Science Foundation of China [81760377, 81373368]
FX This work was supported by the National Natural Science Foundation of
   China (81760377 and 81373368).
CR Bruning U, 2018, CELL METAB, V28, P866, DOI 10.1016/j.cmet.2018.07.019
   Chen C, 2019, MICRO NANO LETT, V14, P1, DOI 10.1049/mnl.2018.5243
   Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683
   Cheng MS, 2019, ONCOGENE, V38, P3667, DOI 10.1038/s41388-019-0683-z
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Copps KD, 2016, J BIOL CHEM, V291, P8602, DOI 10.1074/jbc.M116.714915
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dorn LE, 2019, CIRCULATION, V139, P533, DOI 10.1161/CIRCULATIONAHA.118.036146
   Hua F, 2016, CANCER LETT, V374, P54, DOI 10.1016/j.canlet.2016.02.006
   Jaacks LM, 2016, BEST PRACT RES CL EN, V30, P331, DOI 10.1016/j.beem.2016.05.003
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689
   Li J, 2019, BIOCHEM BIOPH RES CO, V512, P479, DOI 10.1016/j.bbrc.2019.03.093
   Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13
   Liang JQ, 2015, MOL CANCER RES, V13, P681, DOI 10.1158/1541-7786.MCR-14-0503
   Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021
   Luo J, 2019, LANCET, V393, P2116, DOI 10.1016/S0140-6736(19)31090-6
   Pan YT, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0590-8
   Peri-Okonny P, 2019, CIRCULATION, V139, P1422, DOI 10.1161/CIRCULATIONAHA.118.037550
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1
   Vu LP, 2019, CANCER DISCOV, V9, P25, DOI 10.1158/2159-8290.CD-18-0959
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117
   Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4
   Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
NR 27
TC 87
Z9 96
U1 2
U2 57
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 8
PY 2019
VL 518
IS 1
BP 120
EP 126
DI 10.1016/j.bbrc.2019.08.018
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA KB3LP
UT WOS:000506401600019
PM 31405565
DA 2024-02-19
ER

PT J
AU Kitano, S
   Venable, S
   Smith, JR
   Reed, TD
   Roth, GS
AF Kitano, S
   Venable, S
   Smith, JR
   Reed, TD
   Roth, GS
TI Effect of aging on regulation of sdi-1 in rat hepatocytes
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID DNA-SYNTHESIS; KINASE; EXPRESSION; INHIBITOR; PROTEINS; P21
AB We examined basal and EGF stimulated DNA synthesis as well as sdi-1 mRNA and protein in primary hepatocyte cultures, and basal levels of sdi-1 mRNA and protein in whole liver homogenates from 6 and 24 month old rats. Since EGF stimulated DNA synthesis decreases with age, it was hypothesized that basal and EGF stimulated levels of sdi-1 mRNA and protein, an inhibitor of DNA synthesis, might increase. Surprisingly, however, both sdi-1 mRNA and protein actually decreased both in cells and homogenates of old rats. These results indicate that the age-related impairment in EGF stimulated DNA synthesis in hepatocytes appears to occur prior to or parallel with sdi-1 expression and cannot be explained on the basis of increased inhibition due to elevated levels of this protein. (C) 1996 Academic Press, Inc.
C1 GERONTOL RES CTR,CELLULAR & MOL BIOL LAB,MOLEC PHYSIOL & GENET SECT,BALTIMORE,MD 21222.
   BAYLOR COLL MED,TEXAS MED CTR,DIV MOL VIROL,HOUSTON,TX 77030.
C3 Baylor College of Medicine
CR [Anonymous], 1989, MOL CLONING LAB MANU
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CRISTOFALO VJ, 1985, CRC HDB CELL BIOL AG
   DUTARTRE P, 1991, MECH AGEING DEV, V59, P275, DOI 10.1016/0047-6374(91)90138-P
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   HARPER JW, 1993, CELL, V75, P805
   HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877
   HAYFLICK L, 1980, MECH AGEING DEV, V14, P59, DOI 10.1016/0047-6374(80)90106-2
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   JAZWINSKI SM, 1995, J GERONTOL A-BIOL, V50, pB1, DOI 10.1093/gerona/50A.1.B1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maniatis T., 1982, MOL CLONING
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   PECK VM, 1993, BIOCHEM BIOPH RES CO, V190, P325, DOI 10.1006/bbrc.1993.1051
   SAWADA N, 1988, CANCER RES, V48, P1618
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
NR 25
TC 6
Z9 7
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 5
PY 1996
VL 225
IS 1
BP 122
EP 127
DI 10.1006/bbrc.1996.1140
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA VE983
UT WOS:A1996VE98300020
PM 8769104
DA 2024-02-19
ER

PT J
AU Takasugi, M
   Hayakawa, K
   Arai, D
   Shiota, K
AF Takasugi, Masaki
   Hayakawa, Koji
   Arai, Daisuke
   Shiota, Kunio
TI Age- and sex-dependent DNA hypomethylation controlled by growth hormone
   in mouse liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Aging; DNA hypomethylation; Growth hormone; Liver; Sex-difference
ID HEPATIC GENE-EXPRESSION; PARTIAL-HEPATECTOMY; RAT-LIVER; MICROARRAY
   ANALYSIS; SIGNAL TRANSDUCER; TRANSCRIPTION 5B; STEM-CELLS; METHYLATION;
   METHYLTRANSFERASES; MICE
AB In mammals, differences in liver function and aging have been observed between sexes; however, the epigenetic mechanisms underlying such differences remain largely unexplored. In this study, we investigated sex- and age-dependent DNA methylation status in the mouse liver. We analyzed 90 known sex-differentially expressed genes, and identified sex-dependent methylation in Zfp809, Hsd3b5, Treh, Cxcl11, Cyp17a1, and Nnmt genes. After 4 weeks of age, we noted the gradual establishment of sex-dependent hypomethylation in each of these genes in either males or females. The exposure of male mice to female-like growth hormone (GH) profile repressed male-predominant hypomethylation and promoted female-predominant hypomethylation. The occurrence of age-dependent hypomethylation, including at loci for which we also observed sex-dependent changes in DNA methylation, was accompanied by the downregulation of DNMT3A/B. In addition, we found that age-dependent hypomethylation was promoted through liver regeneration induced by partial hepatectomy, suggesting that DNMT activities were not enough to retain methylation levels. In conclusion, our results demonstrate that sex-dependent GH profiles influence the age-progressive hypomethylation under decreased DNMT3A/B levels in certain regions of the genome. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Takasugi, Masaki; Hayakawa, Koji; Arai, Daisuke; Shiota, Kunio] Univ Tokyo, Lab Cellular Biochem, Dept Anim Resource Sci Vet Med Sci, Tokyo 1138657, Japan.
C3 University of Tokyo
RP Shiota, K (corresponding author), Univ Tokyo, Lab Cellular Biochem, Dept Anim Resource Sci Vet Med Sci, Tokyo 1138657, Japan.
EM ashiota@mail.ecc.u-tokyo.ac.jp
RI Arai, Daisuke/AAZ-6229-2021; Takasugi, Masaki/AAN-8590-2020
OI Arai, Daisuke/0000-0002-1723-5389; Hayakawa, Koji/0000-0003-0453-1303;
   Takasugi, Masaki/0000-0001-9880-1225
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan [21221008, 23-2966]; Grants-in-Aid for Scientific Research
   [21221008] Funding Source: KAKEN
FX We thank Dr. Shoji Tajima for DNMT3A antibody. This work was supported
   by Grants-in-Aid for Scientific Research (S) [21221008] and for JSPS
   Fellows [23-2966] from the Ministry of Education, Culture, Sports,
   Science, and Technology (MEXT) of Japan.
CR Ahluwalia A, 2004, MOL ENDOCRINOL, V18, P747, DOI 10.1210/me.2003-0138
   Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Chowen JA, 1996, CELL MOL NEUROBIOL, V16, P297, DOI 10.1007/BF02088097
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546
   EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555
   Hattori N, 2004, GENOME RES, V14, P1733, DOI 10.1101/gr.2431504
   Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309
   Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192
   Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002
   Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10
   MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   MORLEY CGD, 1975, BIOCHEM BIOPH RES CO, V67, P653, DOI 10.1016/0006-291X(75)90862-1
   Nugent BM, 2011, HORM BEHAV, V59, P338, DOI 10.1016/j.yhbeh.2010.08.009
   Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   Tadic SD, 2002, J APPL PHYSIOL, V93, P1057, DOI 10.1152/japplphysiol.00568.2001
   Takasugi M, 2011, MECH AGEING DEV, V132, P65, DOI 10.1016/j.mad.2010.12.003
   Takasugi M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-481
   TSUKAMOTO I, 1990, BIOCHIM BIOPHYS ACTA, V1033, P287, DOI 10.1016/0304-4165(90)90135-J
   Veldhuis JD, 1998, GROWTH HORM IGF RES, V8, P49, DOI 10.1016/S1096-6374(98)80024-5
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262
   Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506
   YOKOMORI N, 1995, P NATL ACAD SCI USA, V92, P1302, DOI 10.1073/pnas.92.5.1302
   YOKOMORI N, 1995, MOL CELL BIOL, V15, P5355
NR 35
TC 21
Z9 23
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL-AUG
PY 2013
VL 134
IS 7-8
BP 331
EP 337
DI 10.1016/j.mad.2013.05.003
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 186OT
UT WOS:000322054700006
PM 23707638
DA 2024-02-19
ER

PT J
AU Huang, KR
   Chen, WH
   Zhu, F
   Li, PWL
   Kapahi, P
   Bai, H
AF Huang, Kerui
   Chen, Wenhao
   Zhu, Fang
   Li, Patrick Wai-Lun
   Kapahi, Pankaj
   Bai, Hua
TI RiboTag translatomic profiling of <i>Drosophila</i> oenocytes under
   aging and induced oxidative stress
SO BMC GENOMICS
LA English
DT Article
DE Oenocyte; Fat body; Liver; Aging; Ribosomal profiling; Peroxisome; Fatty
   acid beta-oxidation; Ras; MAPK signaling
ID PEROXISOMAL BETA-OXIDATION; EXTENDS LIFE-SPAN; FAT-BODY;
   IMMUNE-RESPONSE; RAT-LIVER; RNA-SEQ; EXPRESSION; GENE; AGE; MELANOGASTER
AB BackgroundAging is accompanied with loss of tissue homeostasis and accumulation of cellular damages. As one of the important metabolic centers, liver shows age-related dysregulation of lipid metabolism, impaired detoxification pathway, increased inflammation and oxidative stress response. However, the mechanisms for these age-related changes still remain unclear. In the fruit fly, Drosophila melanogaster, liver-like functions are controlled by two distinct tissues, fat body and oenocytes. Compared to fat body, little is known about how oenocytes age and what are their roles in aging regulation. To characterize age- and stress-regulated gene expression in oenocytes, we performed cell-type-specific ribosome profiling (RiboTag) to examine the impacts of aging and oxidative stress on oenocyte translatome in Drosophila.ResultsWe show that aging and oxidant paraquat significantly increased the levels of reactive oxygen species (ROS) in adult oenocytes of Drosophila, and aged oenocytes exhibited reduced sensitivity to paraquat treatment. Through RiboTag sequencing, we identified 3324 and 949 differentially expressed genes in oenocytes under aging and paraquat treatment, respectively. Aging and paraquat exhibit both shared and distinct regulations on oenocyte translatome. Among all age-regulated genes, oxidative phosphorylation, ribosome, proteasome, fatty acid metabolism, and cytochrome P450 pathways were down-regulated, whereas DNA replication and immune response pathways were up-regulated. In addition, most of the peroxisomal genes were down-regulated in aged oenocytes, including genes involved in peroxisomal biogenesis factors and fatty acid beta-oxidation. Many age-related mRNA translational changes in oenocytes are similar to aged mammalian liver, such as up-regulation of innate immune response and Ras/MAPK signaling pathway and down-regulation of peroxisome and fatty acid metabolism. Furthermore, oenocytes highly expressed genes involving in liver-like processes (e.g., ketogenesis).ConclusionsOur oenocyte-specific translatome analysis identified many genes and pathways that are shared between Drosophila oenocytes and mammalian liver, highlighting the molecular and functional similarities between the two tissues. Many of these genes were altered in both oenocytes and liver during aging. Thus, our translatome analysis provide important genomic resource for future dissection of oenocyte function and its role in lipid metabolism, stress response and aging regulation.
C1 [Huang, Kerui; Bai, Hua] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.
   [Huang, Kerui; Chen, Wenhao] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA.
   [Zhu, Fang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
   [Li, Patrick Wai-Lun; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA 94945 USA.
C3 Iowa State University; Iowa State University; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); Pennsylvania State University;
   Pennsylvania State University - University Park; Buck Institute for
   Research on Aging
RP Huang, KR; Bai, H (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.
EM keruih@iastate.edu; hbai@iastate.edu
RI Zhu, Fang/IRY-9603-2023; Bai, Hua/A-6665-2012
OI Bai, Hua/0000-0003-2221-7545
FU NIH/NIA [R00 AG048016]; AFAR Research Grants for Junior Faculty;
   Glenn/AFAR Scholarships for Research in the Biology of Aging
FX This work was supported by NIH/NIA R00 AG048016 to HB, AFAR Research
   Grants for Junior Faculty to HB, and Glenn/AFAR Scholarships for
   Research in the Biology of Aging to KH.
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Alonso J, 2006, J PROTEOME RES, V5, P2025, DOI 10.1021/pr0601483
   Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000
   BAILEY EJ, 1971, LIFE SCI 2-BIOCH GEN, V10, P1415, DOI 10.1016/0024-3205(71)90351-1
   Banerjee U, 2008, PROTOC EXCH, V10, P1, DOI DOI 10.1038/NPROT.2008.23
   Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495
   Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   Chatterjee D, 2014, P NATL ACAD SCI USA, V111, P17959, DOI 10.1073/pnas.1409241111
   Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028
   Chiang YN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006126
   Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Cinnamon E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006154
   Di Cara F, 2017, IMMUNITY, V47, P93, DOI 10.1016/j.immuni.2017.06.016
   Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307
   Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   Hall H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4304-3
   He Y, 2014, METHODS, V68, P129, DOI 10.1016/j.ymeth.2014.04.008
   Heinze I, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0547-y
   HILL L, 1972, J INSECT PHYSIOL, V18, P1265, DOI 10.1016/0022-1910(72)90256-9
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359
   Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357
   Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549
   Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001
   Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919
   JACKSON A, 1989, TISSUE CELL, V21, P463, DOI 10.1016/0040-8166(89)90059-1
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009
   JOHNSON MB, 1985, J MORPHOL, V184, P51, DOI 10.1002/jmor.1051840106
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8
   Leader DP, 2018, NUCLEIC ACIDS RES, V46, pD809, DOI 10.1093/nar/gkx976
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   Li ZL, 2011, EXP GERONTOL, V46, P694, DOI 10.1016/j.exger.2011.04.005
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Makki R, 2014, ANNU REV ENTOMOL, V59, P405, DOI 10.1146/annurev-ento-011613-162056
   Martins GF, 2012, ISJ-INVERT SURVIV J, V9, P139
   Martins GF, 2011, TISSUE CELL, V43, P83, DOI 10.1016/j.tice.2010.12.003
   Martins GF, 2011, MEM I OSWALDO CRUZ, V106, P308, DOI 10.1590/S0074-02762011000300009
   Monnier V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003081
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Nanji M, 2005, AGING CELL, V4, P235, DOI 10.1111/j.1474-9726.2005.00166.x
   Narayan V, 2016, CELL SYST, V3, P144, DOI 10.1016/j.cels.2016.06.011
   Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102
   Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293
   Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003
   Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925
   Peleg S, 2016, TRENDS BIOCHEM SCI, V41, P700, DOI 10.1016/j.tibs.2016.05.008
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4
   Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034
   Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499
   Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109
   Resnik-Docampo M, 2017, NAT CELL BIOL, V19, P52, DOI 10.1038/ncb3454
   ROMER F, 1974, J INSECT PHYSIOL, V20, P1975, DOI 10.1016/0022-1910(74)90105-X
   Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHAH J, 1976, INSECT BIOCHEM, V6, P251, DOI 10.1016/0020-1790(76)90091-3
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh J, 2009, J LIPID RES, V50, P135, DOI 10.1194/jlr.M800321-JLR200
   Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   SUN JY, 1994, J BIOL CHEM, V269, P18638
   Thyagarajan B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001125
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Tower J, 2014, J GERONTOL A-BIOL, V69, P253, DOI 10.1093/gerona/glt078
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Uryu O, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0031-2
   Vrailas-Mortimer A, 2011, DEV CELL, V21, P783, DOI 10.1016/j.devcel.2011.09.002
   Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329
   Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   XIA EN, 1995, J NUTR, V125, P195
   Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789
   Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005
   Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zheng WJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0532-5
NR 100
TC 29
Z9 35
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD JAN 16
PY 2019
VL 20
AR 50
DI 10.1186/s12864-018-5404-4
PG 19
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA HH7CQ
UT WOS:000455888500001
PM 30651069
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Wilkie, SE
   Marcu, DE
   Carter, RN
   Morton, NM
   Gonzalo, S
   Selman, C
AF Wilkie, Stephen E.
   Marcu, Diana E.
   Carter, Roderick N.
   Morton, Nicholas M.
   Gonzalo, Susana
   Selman, Colin
TI Hepatic hydrogen sulfide levels are reduced in mouse model of
   Hutchinson-Gilford progeria syndrome
SO AGING-US
LA English
DT Article
DE progeria; hydrogen sulfide; high-fat diet; ageing; lamin A
ID METHIONINE RESTRICTION; LIFE-SPAN; ACCUMULATION; STRESS; CELLS; MICE;
   H2S
AB Hutchinson-Gilford progeria syndrome (HGPS) is a rare human disease characterised by accelerated biological ageing. Current treatments are limited, and most patients die before 15 years of age. Hydrogen sulfide (H2S) is an important gaseous signalling molecule that it central to multiple cellular homeostasis mechanisms. Dysregulation of tissue H2S levels is thought to contribute to an ageing phenotype in many tissues across animal models. Whether H2S is altered in HGPS is unknown. We investigated hepatic H2S production capacity and transcript, protein and enzymatic activity of proteins that regulate hepatic H2S production and disposal in a mouse model of HGPS (G609G mice, mutated Lmna gene equivalent to a causative mutation in HGPS patients). G609G mice were maintained on either regular chow (RC) or high fat diet (HFD), as HFD has been previously shown to significantly extend lifespan of G609G mice, and compared to wild type (WT) mice maintained on RC. RC fed G609G mice had significantly reduced hepatic H2S production capacity relative to WT mice, with a compensatory elevation in mRNA transcripts associated with several H2S production enzymes, including cystathionine-& gamma;-lyase (CSE). H2S levels and CSE protein were partially rescued in HFD fed G609G mice. As current treatments for patients with HGPS have failed to confer significant improvements to symptoms or longevity, the need for novel therapeutic targets is acute and the regulation of H2S through dietary or pharmacological means may be a promising new avenue for research.
C1 [Wilkie, Stephen E.; Marcu, Diana E.; Selman, Colin] Univ Glasgow, Coll Med Vet & Life Sci, Sch Biodivers Hlth & Vet Med 1, Glasgow Ageing Res Network GARNER, Glasgow City G12 8QQ, Scotland.
   [Carter, Roderick N.; Morton, Nicholas M.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, Queens Med Res Inst, Mol Metab Grp, Edinburgh EH16 4TJ, Scotland.
   [Gonzalo, Susana] St Louis Univ, Edward A Doisy Res Ctr, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.
   [Wilkie, Stephen E.] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Metab, S-17165 Solna, Sweden.
C3 University of Glasgow; University of Edinburgh; Saint Louis University;
   Karolinska Institutet
RP Selman, C (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Sch Biodivers Hlth & Vet Med 1, Glasgow Ageing Res Network GARNER, Glasgow City G12 8QQ, Scotland.
EM colin.selman@glasgow.ac.uk
OI Gonzalo, Susana/0000-0001-9631-1206; Wilkie, Stephen/0000-0002-1826-7737
FU Medical Research Council Precision Medicine Doctoral Training Program in
   Precision Medicine [MR/N013166/1]; Wellcome Trust Biomedical Vacation
   Scholarship [213310/Z/18/Z]; Wellcome Trust [100981/Z/13/Z]; University
   of Glasgow (College of Medical, Veterinary and Life Sciences); Wellcome
   Trust [213310/Z/18/Z] Funding Source: Wellcome Trust
FX & nbsp;SEW was supported through a Medical Research Council Precision
   Medicine Doctoral Training Program in Precision Medicine to CS and NMM
   (Reference MR/N013166/1) , and DEM was supported through a Wellcome
   Trust Biomedical Vacation Scholarship to CS (Reference 213310/Z/18/Z) .
   The authors also wish to acknowledge support through a Wellcome Trust
   New Investigator award (Reference 100981/Z/13/Z) to NMM, and start-up
   funds from the University of Glasgow (College of Medical, Veterinary and
   Life Sciences) to CS.
CR Bai L, 2019, BIOCHEM BIOPH RES CO, V514, P907, DOI 10.1016/j.bbrc.2019.05.021
   Bárcena C, 2019, AUTOPHAGY, V15, P558, DOI 10.1080/15548627.2018.1533059
   Bárcena C, 2018, CELL REP, V24, P2392, DOI 10.1016/j.celrep.2018.07.089
   Beltowski J, 2015, PHARMACOL REP, V67, P647, DOI 10.1016/j.pharep.2015.01.005
   Brassard JA, 2016, BIOGERONTOLOGY, V17, P129, DOI 10.1007/s10522-015-9602-z
   Carter RN, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109958
   Casasola A, 2016, NUCLEUS-PHILA, V7, P84, DOI 10.1080/19491034.2016.1150397
   Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957
   Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094
   Gong H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38513
   Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346
   Hine C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2382
   Hine C, 2018, ANTIOXID REDOX SIGN, V28, P1483, DOI 10.1089/ars.2017.7434
   Hine C, 2017, CELL METAB, V25, P1320, DOI 10.1016/j.cmet.2017.05.003
   Hine C, 2015, EXP GERONTOL, V68, P26, DOI 10.1016/j.exger.2014.12.010
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781
   Kang SM, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01540-w
   Katsouda A, 2022, J EXP MED, V219, DOI 10.1084/jem.20211894
   Kreienkamp Ray, 2019, Subcell Biochem, V91, P435, DOI 10.1007/978-981-13-3681-2_15
   Kreienkamp R, 2019, AGING CELL, V18, DOI 10.1111/acel.12852
   Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68
   Latorre E, 2018, AGING-US, V10, P1666, DOI 10.18632/aging.101500
   Lee JY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0092-3
   Li HL, 2019, EXP GERONTOL, V120, P88, DOI 10.1016/j.exger.2019.03.002
   Morton NM, 2016, NAT MED, V22, P771, DOI 10.1038/nm.4115
   Ng LT, 2018, BIOCHEM PHARMACOL, V149, P91, DOI 10.1016/j.bcp.2018.01.030
   Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847
   Peh MT, 2014, NITRIC OXIDE-BIOL CH, V41, P138, DOI 10.1016/j.niox.2014.03.002
   Progeria Research Foundation, 2021, NUTR INCR CAL HLTH H
   Qabazard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080135
   Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Shaposhnikov M, 2018, AGING-US, V10, P3260, DOI 10.18632/aging.101630
   Testai L, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105125
   Togo M, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0217-z
   Villa-Bellosta R, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012423
   Wang MX, 2012, GENE EXPRESSION, V15, P235, DOI 10.3727/105221613X13571653093286
   Wilkie SE, 2021, BIOCHEM J, V478, P3485, DOI 10.1042/BCJ20210517
   Wu DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2715718
   Xu XL, 2019, THERANOSTICS, V9, P2252, DOI 10.7150/thno.30658
   Zaghini A, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110784
   Zhao MF, 2022, MOL NEUROBIOL, V59, P6903, DOI 10.1007/s12035-022-03004-0
   Zhu XY, 2013, MENOPAUSE, V20, P1084, DOI [10.1097/GME.0b013e3182874732, 10.1097/gme.0b013e3182874732]
   Zivanovic J, 2019, CELL METAB, V30, P1152, DOI 10.1016/j.cmet.2019.10.007
NR 47
TC 0
Z9 0
U1 1
U2 2
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN 30
PY 2023
VL 15
IS 12
BP 5266
EP 5278
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA L8MI6
UT WOS:001025746600006
PM 37354210
OA gold, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Mc Auley, MT
   Mooney, KM
AF Mc Auley, Mark T.
   Mooney, Kathleen M.
TI LDL-C levels in older people: Cholesterol homeostasis and the free
   radical theory of ageing converge
SO MEDICAL HYPOTHESES
LA English
DT Article
ID CORONARY HEART-DISEASE; FATTY LIVER-DISEASE; LIPOPROTEIN CHOLESTEROL;
   REDUCTASE DEREGULATION; METABOLISM; ATHEROSCLEROSIS; AGE; OXYGEN; ROS;
   HYPERCHOLESTEROLEMIA
AB The cardiovascular disease (CVD) risk factor, low density lipoprotein cholesterol (LDL-C) increases with age, up until the midpoint of life in males and females. However, LDL-C can decrease with age in older men and women. Intriguingly, a recent systematic review also revealed an inverse association between LDL-C levels and cardiovascular mortality in older people; low levels of LDL-C were associated with reduced risk of mortality. Such findings are puzzling and require a biological explanation. In this paper a hypothesis is proposed to explain these observations. We hypothesize that the free radical theory of ageing (FRTA) together with disrupted cholesterol homeostasis can account for these observations. Based on this hypothesis, dysregulated hepatic cholesterol homeostasis in older people is characterised by two distinct metabolic states. The first state accounts for an older person who has elevated plasma LDL-C. This state is underpinned by the FRTA which suggests there is a decrease in cellular antioxidant capacity with age. This deficiency enables hepatic reactive oxidative species (ROS) to induce the total activation of HMG-CoA reductase, the key rate limiting enzyme in cholesterol biosynthesis. An increase in cholesterol synthesis elicits a corresponding rise in LDL-C, due to the downregulation of LDL receptor synthesis, and increased production of very low density lipoprotein cholesterol (VLDL-C). In the second state of dysregulation, ROS also trigger the total activation of HMG-CoA reductase. However, due to an age associated decrease in the activity of cholesterol-esterifying enzyme, acyl CoA: cholesterol acyltransferase, there is restricted conversion of excess free cholesterol (FC) to cholesterol esters. Consequently, the secretion of VLDL-C drops, and there is a corresponding decrease in LDL-C. As intracellular levels of FC accumulate, this state progresses to a pathophysiological condition akin to nonalcoholic fatty liver disease. It is our conjecture this deleterious state has the potential to account for the inverse association between LDL-C level and CVD risk observed in older people. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Mc Auley, Mark T.] Univ Chester, Fac Sci & Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
   [Mooney, Kathleen M.] Edge Hill Univ, Fac Hlth & Social Care, Ormskirk L39 4QP, Lancs, England.
C3 University of Chester; Edge Hill University
RP Mc Auley, MT (corresponding author), Univ Chester, Fac Sci & Engn, Thornton Sci Pk, Chester CH2 4NU, Cheshire, England.
EM mancauley@chesterac.uk
CR [Anonymous], ROLE LIPIDS LIPOPROT
   Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005
   Brown AJ, 2010, EVOLUTION, V64, P2179, DOI 10.1111/j.1558-5646.2010.01011.x
   Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773
   Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M
   CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835
   CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Félix-Redondo FJ, 2013, AGING DIS, V4, P154
   Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Harman D, 1955, AGING THEORY BASED F
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Kilner J, 2016, MOL BIOSYST, V12, P93, DOI 10.1039/c5mb00211g
   Kruth HS, 1997, CURR OPIN LIPIDOL, V8, P246, DOI 10.1097/00041433-199710000-00002
   Kummerow F. A., 2014, CHOLESTEROL IS NOT C
   Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X
   Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Mc Auley MT, 2014, EXPERT REV ENDOCRINO, V9, P357, DOI 10.1586/17446651.2014.921569
   Mc Auley MT, 2015, METABOLITES, V5, P232, DOI 10.3390/metabo5020232
   Mc Auley MT, 2015, COMPUT STRUCT BIOTEC, V13, P38, DOI 10.1016/j.csbj.2014.11.006
   Mc Auley MT, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-130
   Mc Auley MT, 2015, J INTEGR CARDIOL, V1, P76, DOI 10.15761/jic.1000122
   Mc Auley MT, 2016, BRIEF BIOINFORM
   McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Morgan AE, 2016, BIOSYSTEMS, V145, P19, DOI 10.1016/j.biosystems.2016.05.001
   Morgan AE, 2016, AGEING RES REV, V27, P108, DOI 10.1016/j.arr.2016.03.008
   Morgan A.J.L, 2016, P NUTR SOC, P1
   Morita S, 2016, BIOL PHARM BULL, V39, P1, DOI 10.1248/bpb.b15-00716
   Pallottini V, 2006, J HEPATOL, V44, P368, DOI 10.1016/j.jhep.2005.06.011
   Pallottini V, 2005, MECH AGEING DEV, V126, P845, DOI 10.1016/j.mad.2005.02.009
   Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Proctor C. J., 2013, J COMPUT SCI SYST BI, V6, P271, DOI DOI 10.4172/JCSB.1000122
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Rosch P., FAT CHOLESTEROL DONT
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Shiomi M, 2000, METABOLISM, V49, P552, DOI 10.1016/S0026-0495(00)80025-6
   SMITH LL, 1991, FREE RADICAL BIO MED, V11, P47, DOI 10.1016/0891-5849(91)90187-8
   Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052
   Targher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021
   Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957
   Trapani L., 2010, CURR GERONTOL GERIAT
   Trapani L, 2010, EXP GERONTOL, V45, P119, DOI 10.1016/j.exger.2009.10.014
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538
   Weverling-Rijnsburger AWE, 2003, ARCH INTERN MED, V163, P1549, DOI 10.1001/archinte.163.13.1549
NR 52
TC 16
Z9 16
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JUL
PY 2017
VL 104
BP 15
EP 19
DI 10.1016/j.mehy.2017.05.013
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FB2KZ
UT WOS:000405974000004
PM 28673574
OA Green Submitted
DA 2024-02-19
ER

PT S
AU Barzilai, N
   Gupta, G
AF Barzilai, N
   Gupta, G
BE Hansen, BC
   Saye, J
   Wennogle, LP
TI Interaction between aging and Syndrome X: New insights on the
   pathophysiology of fat distribution
SO THE METABOLIC SYNDROME X: CONVERGENCE OF INSULIN RESISTANCE, GLUCOSE
   INTOLERANCE, HYPERTENSION, OBESITY, AND DYSLIPIDEMIAS-SEARCHING FOR THE
   UNDERLYING DEFECTS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on The Metabolic Syndrome X - Convergence of Insulin
   Resistance, Glucose Intolerance, Hypertension, Obesity, and
   Dyslipidemias-Searching for the Underlying Defects
CY FEB 19-22, 1999
CL JACKSONVILLE, FLORIDA
SP New York Acad Sci, Parke Davis Pharmaceut Res Inst, Janssen Res Fdn, Knoll Pharmaceut Co, Novartis Pharma AG, Amer Heart Assoc Council Circulat, Bristol Myers Squibb, Pharmaceut Res Inst, DuPont Pharmaceut Co, GelTex Pharmaceut Inc, Genome Therapeut Corp, Inst Diabet Discovery Inc, Lilly Res Labs, Div Endocrine Res & Clin Invest, Merck Res Labs, Schering Plough Res Inst, Smithkline Beecham Pharmaceut
ID PERIPHERAL GLUCOSE-METABOLISM; DEPENDENT DIABETES-MELLITUS; INVIVO
   INSULIN ACTION; NECROSIS-FACTOR-ALPHA; BODY-FAT; VISCERAL FAT; CALORIC
   RESTRICTION; COMPUTED-TOMOGRAPHY; ADIPOSE-TISSUE; LEPTIN ACTION
AB Increased fat mass (PM), and in particular a specific increase in visceral fat (VF), may account for the age-associated decrease in insulin action and the development of syndrome X. Utilizing chronic caloric restriction (CR) with aging in a rodent model, we dissociated the effects of VF and FM, and demonstrated that the decrease in VF accumulation was sufficient to prevent the marked decrease in hepatic insulin action. This suggests that the typical increase In VF with aging, rather than aging per se, determines hepatic insulin resistance. To directly assess the role of VF, we studied rats after surgical removal of VF or sham operation. Surgical extraction of VF (which accounts for similar to 10% of total fat) improved hepatic insulin action by more than twofold. We studied the role of fat-derived peptides in the regulation of body composition and insulin action. While VF extraction resulted In decreased gene expression for leptin and TNF-alpha in the subcutaneous adipose, administration of leptin selectively decreased visceral fat (similar to 60%), and enhanced the action of insulin on inhibiting hepatic glucose production (similar to 80%). Thus, the cause-effect relationship between the age-related increase in VF and the decrease in hepatic insulin action may involve the failure of leptin to "cross talk" with other fat depots to regulate fat distribution.
C1 Albert Einstein Coll Med, Dept Med, Div Geriatr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Dept Med, Div Geriatr, Belfer Bldg 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.
FU NIA NIH HHS [R29-AG15003, KO8-AG00639] Funding Source: Medline
CR Andres R., 1985, PRINCIPLES GERIATRIC, P311
   Banerjee S, 1997, AM J PHYSIOL-REG I, V273, pR1534, DOI 10.1152/ajpregu.1997.273.4.R1534
   BANERJI MA, 1995, DIABETES, V44, P141, DOI 10.2337/diabetes.44.2.141
   BARON H, 1992, NUTR METAB CARDIOVAS, V2, P75
   BARZILAI N, 1995, BIOCHEM J, V310, P819, DOI 10.1042/bj3100819
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   BARZILAI N, 1989, AGE, V12, P13, DOI 10.1007/BF02432513
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132
   BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728
   BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   Bouchard C, 1996, INT J OBESITY, V20, P420
   BRANCHOROMERO E, 1977, J AM GERIATR SOC, V25, P299
   CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778
   Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633
   CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443, DOI 10.1152/ajpregu.1994.266.5.R1443
   CARTER WJ, 1994, J GERONTOL, V49, pB162, DOI 10.1093/geronj/49.4.B162
   COHN SH, 1980, AM J PHYSIOL, V239, pE524, DOI 10.1152/ajpendo.1980.239.6.E524
   COLBERG SR, 1995, J CLIN INVEST, V95, P1427
   COLMAN E, 1995, INT J OBESITY, V19, P798
   CONSIDINE RV, 1996, NEW ENGL J MED, V334, P324
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208
   Dua A, 1996, DIABETES, V45, P1635, DOI 10.2337/diabetes.45.11.1635
   EIFFERT KC, 1993, J GERONTOL, V48, pB206, DOI 10.1093/geronj/48.6.B206
   ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINK RI, 1986, J CLIN INVEST, V77, P2034, DOI 10.1172/JCI112533
   FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483
   FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311
   HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   IVY JL, 1991, MECH AGEING DEV, V61, P123, DOI 10.1016/0047-6374(91)90011-N
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840
   KISSEBAH AH, 1991, INT J OBESITY, V15, P109
   KOHRT WM, 1992, J GERONTOL, V47, pM99, DOI 10.1093/geronj/47.4.M99
   KritzSilverstein D, 1996, JAMA-J AM MED ASSOC, V275, P46
   KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P238
   LARSON B, 1992, ACTA MED SCAND, V723, P45
   LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950
   Ljung T, 1996, OBES RES, V4, P277, DOI 10.1002/j.1550-8528.1996.tb00546.x
   MARIN P, 1992, INT J OBESITY, V16, P991
   Marin P, 1992, Eur J Med, V1, P329
   MASORO EJ, 1980, EXP AGING RES, V6, P219, DOI 10.1080/03610738008258359
   MENEILLY GS, 1987, J GERONTOL, V42, P196, DOI 10.1093/geronj/42.2.196
   NORRIS AH, 1963, ANN NY ACAD SCI, V110, P623, DOI 10.1111/j.1749-6632.1963.tb15784.x
   OSHAUGHNESSY IM, 1992, J CLIN ENDOCR METAB, V74, P1075, DOI 10.1210/jc.74.5.1075
   PAGANO G, 1984, METABOLISM, V33, P976, DOI 10.1016/0026-0495(84)90223-3
   PEIRIS AN, 1988, J CLIN ENDOCR METAB, V67, P760, DOI 10.1210/jcem-67-4-760
   POEHLMAN ET, 1995, J APPL PHYSIOL, V78, P802, DOI 10.1152/jappl.1995.78.3.802
   POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005
   POEHLMAN ET, 1995, ARCH INTERN MED, V155, P2443, DOI 10.1001/archinte.155.22.2443
   Prineas R J, 1993, Ann Epidemiol, V3, P35, DOI 10.1016/1047-2797(93)90007-Q
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   REAVEN GM, 1985, J AM GERIATR SOC, V33, P286, DOI 10.1111/j.1532-5415.1985.tb07118.x
   ROBERT JJ, 1982, DIABETES, V31, P203, DOI 10.2337/diabetes.31.3.203
   ROSENTHAL M, 1982, J AM GERIATR SOC, V30, P562, DOI 10.1111/j.1532-5415.1982.tb05662.x
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891
   SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   VILAVARAGHAVAN S, 1997, PEDIATR RES, V41, P1
   WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254
   ZAVARONI I, 1989, NEW ENGL J MED, V320, P702, DOI 10.1056/NEJM198903163201105
NR 77
TC 51
Z9 57
U1 0
U2 3
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-207-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1999
VL 892
BP 58
EP 72
DI 10.1111/j.1749-6632.1999.tb07785.x
PG 15
WC Cell Biology; Endocrinology & Metabolism; Multidisciplinary Sciences;
   Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism; Science & Technology - Other
   Topics; Physiology
GA BP20K
UT WOS:000084392400005
PM 10842652
DA 2024-02-19
ER

PT J
AU Sadria, M
   Layton, AT
AF Sadria, Mehrshad
   Layton, Anita T.
TI Aging affects circadian clock and metabolism and modulates timing of
   medication
SO ISCIENCE
LA English
DT Article
ID REV-ERB-ALPHA; SMALL-MOLECULE ACTIVATORS; GENE-EXPRESSION;
   SUPRACHIASMATIC NUCLEUS; TIME; NAD(+); LIVER; AGE; RHYTHMS; SIRT1
AB Aging is associated with impairments in the circadian rhythms, and with energy deregulation that affects multiple metabolic pathways. The goal of this study is to unravel the complex interactions among aging, metabolism, and the circadian clock. We seek to identify key factors that inform the liver circadian clock of cellular energy status and to reveal the mechanisms by which variations in food intake may disrupt the clock. To address these questions, we develop a comprehensive mathematical model that represents the circadian pathway in the mouse liver, together with the insulin/IGF-1 pathway, mTORC1, AMPK, NAD+, and the NAD+ -consuming factor SIRT1. The model is age-specific and can simulate the liver of a young mouse or an aged mouse. Simulation results suggest that the reduced NAD+ and SIRT1 bioavailability may explain the shortened circadian period in aged rodents. Importantly, the model identifies the dosing schedules for maximizing the efficacy of anti-aging medications.
C1 [Sadria, Mehrshad; Layton, Anita T.] Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada.
   [Layton, Anita T.] Univ Waterloo, Cheriton Sch Comp Sci, Dept Biol, Waterloo, ON, Canada.
   [Layton, Anita T.] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada.
C3 University of Waterloo; University of Waterloo; University of Waterloo
RP Sadria, M (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada.
EM msadria@uwaterloo.ca
FU Canada 150 Research Chair program; NSERC Discovery award
FX This research was supported by the Canada 150 Research Chair program and
   the NSERC Discovery award.
CR Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X
   Boden G, 1999, DIABETES, V48, P2182, DOI 10.2337/diabetes.48.11.2182
   Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3
   Braidy N, 2014, BIOGERONTOLOGY, V15, P177, DOI 10.1007/s10522-013-9489-5
   BROCK MA, 1991, J AM GERIATR SOC, V39, P74, DOI 10.1111/j.1532-5415.1991.tb05909.x
   Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112
   Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027
   Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048
   Dallmann R, 2014, ANNU REV PHARMACOL, V54, P339, DOI 10.1146/annurev-pharmtox-011613-135923
   Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500
   DeBruyne JP, 2014, J BIOL RHYTHM, V29, P277, DOI 10.1177/0748730414544740
   Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821
   Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929
   Garzón C, 2009, AGING CLIN EXP RES, V21, P38
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1
   Guerrero-Morín JG, 2020, J THEOR BIOL, V501, DOI 10.1016/j.jtbi.2020.110360
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jensen E, 1998, J SLEEP RES, V7, P183, DOI 10.1046/j.1365-2869.1998.00118.x
   Johnson BP, 2014, P NATL ACAD SCI USA, V111, P18757, DOI 10.1073/pnas.1421708111
   KAMINSKY YG, 1984, INT J BIOCHEM, V16, P629, DOI 10.1016/0020-711X(84)90032-6
   Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686
   Kim TW, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/591729
   Kloth JSL, 2015, CLIN PHARMACOKINET, V54, P851, DOI 10.1007/s40262-015-0239-5
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Li ZJ, 2012, CLIN CANCER RES, V18, P3603, DOI 10.1158/1078-0432.CCR-11-3321
   Lipton JO, 2017, CELL REP, V20, P868, DOI 10.1016/j.celrep.2017.07.008
   Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023
   Massudi H, 2012, REDOX REP, V17, P28, DOI 10.1179/1351000212Y.0000000001
   Masuda T, 2018, AM J PHYSIOL-RENAL, V315, pF653, DOI 10.1152/ajprenal.00143.2018
   MILLARCRAIG MW, 1978, LANCET, V1, P795
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Mishima E, 2018, AM J PHYSIOL-RENAL, V315, pF824, DOI 10.1152/ajprenal.00314.2017
   Miyazaki M, 2011, DRUG METAB PHARMACOK, V26, P503, DOI 10.2133/dmpk.DMPK-11-RG-021
   MOE KE, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00145.x
   MORIN LP, 1988, J BIOL RHYTHM, V3, P237, DOI 10.1177/074873048800300302
   Mukherji A, 2019, J HEPATOL, V71, P200, DOI 10.1016/j.jhep.2019.03.020
   MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103
   Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803
   Nakamura TJ, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0064-15.2015
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Okazaki H, 2014, CANCER RES, V74, P543, DOI 10.1158/0008-5472.CAN-12-3241
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   PITTENDRIGH CS, 1974, SCIENCE, V186, P548, DOI 10.1126/science.186.4163.548
   Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5
   Ramanathan C, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007369
   REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8
   Relógio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309
   Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451
   ROBINSON JL, 1981, J NUTR, V111, P1711, DOI 10.1093/jn/111.10.1711
   Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019
   ROSENBERG RS, 1991, AM J PHYSIOL, V261, pR491, DOI 10.1152/ajpregu.1991.261.2.R491
   SADRIA M., 2021, CELL COMM SIGNAL
   Sadria M., 2021, CELL COMM SIGNAL, DOI [10.1101/2020.10.07.330308v1.abstract, DOI 10.1101/2020.10.07.330308V1.ABSTRACT]
   Satinoff Evelyn, 1993, American Journal of Physiology, V265, pR1216
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Scarbrough Kathryn, 1997, American Journal of Physiology, V272, pR1219
   Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106
   Souayed N, 2015, BIOMED PHARMACOTHER, V71, P233, DOI 10.1016/j.biopha.2015.02.026
   Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
   SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2
   Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554
   Tulsian R, 2018, AGING-US, V10, P1640, DOI 10.18632/aging.101498
   Wallace E, 2018, EPILEPSIA, V59, P1527, DOI 10.1111/epi.14513
   Wang RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28633
   WEITZMAN ED, 1982, NEUROBIOL AGING, V3, P299, DOI 10.1016/0197-4580(82)90018-5
   Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919
   WITTING W, 1994, CHRONOBIOL INT, V11, P103, DOI 10.3109/07420529409055896
   Woller A, 2016, CELL REP, V17, P1087, DOI 10.1016/j.celrep.2016.09.060
   Wu R, 2019, CELL METAB, V29, P653, DOI 10.1016/j.cmet.2018.11.006
   Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Zappe DH, 2015, J HYPERTENS, V33, P385, DOI 10.1097/HJH.0000000000000397
   ZEE PC, 1992, AM J PHYSIOL, V263, pR1099, DOI 10.1152/ajpregu.1992.263.5.R1099
   Zhang Y, 1996, NEUROSCIENCE, V70, P951, DOI 10.1016/0306-4522(95)00408-4
   Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4
   Zhou JN, 1999, MICROSC RES TECHNIQ, V44, P36, DOI 10.1002/(SICI)1097-0029(19990101)44:1<36::AID-JEMT5>3.0.CO;2-F
NR 88
TC 12
Z9 12
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD APR 23
PY 2021
VL 24
IS 4
AR 102245
DI 10.1016/j.isci.2021.102245
PG 27
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RQ2PJ
UT WOS:000642261700001
PM 33796837
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU JENA, BS
   PATNAIK, BK
AF JENA, BS
   PATNAIK, BK
TI EFFECT OF THERMAL INACTIVATION AND ATP ON AGE-RELATED-CHANGES IN HEPATIC
   GLUTAMATE-DEHYDROGENASE ACTIVITY OF MALE GARDEN LIZARD
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE LIZARD; GLUTAMATE DEHYDROGENASE; THERMOLABILITY; ATP; AGING
ID RAT-BRAIN; METABOLISM; LIVER; ENZYMES; KIDNEY
AB The total glutamate dehydrogenase (GDH) activity of the liver of the male garden lizard did not change during maturation (young to middle-aged) but showed a decline in later phase of the life span (middle-aged to old). On the other hand, the heat stable GDH activity increased during maturation and declined thereafter. The degree of thermal inactivation of the total GDH activity at 45-degrees +/- 1-degrees-C was not age-dependent. ATP stimulation of total GDH activity was about three times higher in old than in middle-aged lizards.
C1 BERHAMPUR UNIV,DEPT ZOOL,BERHAMPUR 760007,ORISSA,INDIA.
C3 Berhampur University
CR AGADZHANYAN S A, 1986, Molekulyarnaya Biologiya (Moscow), V20, P737
   BABY TG, 1976, PHYSIOL ZOOL, V49, P286, DOI 10.1086/physzool.49.3.30155688
   BARID MB, 1975, GERONTOLOGIA, V21, P240
   BRONZETTI E, 1990, ARCH GERONTOL GERIAT, V10, P221, DOI 10.1016/0167-4943(90)90023-Y
   CAMPBELL JW, 1973, COMP ANIMAL PHYSL, P279
   CHITRA K C, 1990, Indian Journal of Comparative Animal Physiology, V8, P14
   DANH HC, 1985, GERONTOLOGY, V31, P95, DOI 10.1159/000212686
   DEKONINGVEREST IF, 1980, MECH AGEING DEV, V13, P83, DOI 10.1016/0047-6374(80)90132-3
   DESHMUKH DR, 1980, MECH AGEING DEV, V13, P75, DOI 10.1016/0047-6374(80)90131-1
   DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FRIEDEN C, 1965, J BIOL CHEM, V240, P2028
   Frieden C., 1963, ENZYMES 7, P3
   GUROFF G, 1980, MOL NEUROBIOL, P105
   HERBERT JD, 1972, COMP BIOCHEM PHYSIOL, V42, P463, DOI 10.1016/0305-0491(72)90262-3
   Himwich W A, 1973, Prog Brain Res, V40, P13
   IWATSUJI K, 1989, GERONTOLOGY, V35, P218, DOI 10.1159/000213026
   JEAN BS, 1992, GERONTOLOGY, V38, P252
   JENA BS, 1991, GERONTOLOGY, V37, P299
   KARA TC, 1981, GERONTOLOGY, V27, P187, DOI 10.1159/000212472
   KAUR G, 1970, CAN J BIOCHEM CELL B, V48, P203, DOI 10.1139/o70-033
   KONAGAYA Y, 1986, J NEUROL SCI, V74, P231, DOI 10.1016/0022-510X(86)90108-5
   LAKSHMIPATHI V, 1984, P INDIAN AS-ANIM SCI, V93, P65, DOI 10.1007/BF03186228
   LAURA F, 1989, MECH AGEING DEV, V47, P199
   LEHNINGER AL, 1983, BIOCHEMISTRY-US, P559
   LICHT P, 1964, COMP BIOCHEM PHYSIOL, V12, P331, DOI 10.1016/0010-406X(64)90063-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANIBABU PV, 1991, ARCH GERONTOL GERIAT, V13, P43, DOI 10.1016/0167-4943(91)90014-H
   MCGILVERY RW, 1970, BIOCHEMISTRY-US, P351
   MEHLER AH, 1986, TXB BIOCH, P437
   NEERAJA P, 1984, Indian Journal of Physiology and Pharmacology, V28, P133
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   ORGEL LE, 1973, NATURE, V243, P441
   PATNAIK BK, 1981, EXP GERONTOL, V16, P295, DOI 10.1016/0531-5565(81)90048-6
   PLAITAKIS A, 1984, ANN NEUROL, V15, P144, DOI 10.1002/ana.410150206
   RAWN JD, 1989, BIOCHEMISTRY-US, P457
   SAHU N, 1989, ARCH GERONTOL GERIAT, V8, P55, DOI 10.1016/0167-4943(89)90070-8
   Scheffer WC, 1980, STAT BIOL SCI, P121
   Schmidt E, 1974, Methods of Enzymatic Analysis, P650, DOI DOI 10.1016/B978-0-12-091302-2.50028-1
   SMITH EL, 1985, PRINCIPLES BIOCH, P599
   STRYER L, 1988, BIOCHEMISTRY-US, P485
   USHAKOV BP, 1967, MOL MECHANISMS TEMPE, V84, P107
   WEST ES, 1966, TXB BIOCH, P1143
NR 43
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 1993
VL 16
IS 1
BP 51
EP 58
DI 10.1016/0167-4943(93)90026-E
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KV985
UT WOS:A1993KV98500006
PM 15374354
DA 2024-02-19
ER

PT J
AU Huang, Y
   Yan, HM
   Yang, YQ
   Zhou, JF
   Xu, QJ
   Hu, M
AF Huang, Yan
   Yan, Huimin
   Yang, Yanqing
   Zhou, Jinfei
   Xu, Qijun
   Hu, Meng
TI Downregulated miR-181a alleviates H<sub>2</sub>O<sub>2</sub>-induced
   oxidative stress and cellular senescence by targeting PDIA6 in human
   foreskin fibroblasts
SO ANAIS BRASILEIROS DE DERMATOLOGIA
LA English
DT Article
DE Cellular senescence; Oxidative stress; Protein disulfide-isomerases
ID SKIN; EXPRESSION; LIVER
AB Background: Oxidative stress is strongly associated with cellular senescence. Numerous studies have indicated that microRNAs (miRNAs) play a critical part in cellular senescence. MiR-181a was reported to induce cellular senescence, however, the potential mechanism of miR-181a in hydrogen peroxide (H2O2)-induced cellular senescence remains obscure. Objective: The aim of this study is to investigate the role and regulatory mechanism of miR-181a in H2O2-induced cellular senescence. Methods: Human foreskin fibroblasts (HFF) transfected with miR-181a inhibitor/miR-NC with or without H2O2 treatment were divided into four groups: control + miR-NC/miR-181a inhibitor, H2O2 + miR-NC/miR-181a inhibitor. CCK-8 assay was utilized to evaluate the viability of HFF. RT-qPCR was used to measure the expression of miR-181a and its target genes. Protein levels of protein disulfide isomerase family A member 6 (PDIA6) and senescence markers were assessed by western blotting. Senescence-associated 13-galactosidase (SA-13-gal) staining was applied for detecting SA-13-gal activity. The activities of SOD, GPx, and CAT were detected by correspond-ing assay kits. The binding relation between PDIA6 and miR-181a was identified by luciferase reporter assay. Results: MiR-181a inhibition suppressed H2O2-induced oxidative stress and cellular senescence in HFF. PDIA6 was targeted by miR-181a and lowly expressed in H2O2-treated HFF. Knocking down PDIA6 reversed miR-181a inhibition-mediated suppressive impact on H2O2-induced oxidative stress and cellular senescence in HFF. Study limitations: Signaling pathways that might be mediated by miR-181a/PDIA6 axis were not investigated. Conclusion: Downregulated miR-181a attenuates H2O2-induced oxidative stress and cellular senescence in HFF by targeting PDIA6. (c) 2022 Sociedade Brasileira de Dermatologia. Published by Elsevier Espan tilde a, S.L.U. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Huang, Yan; Yan, Huimin; Yang, Yanqing; Xu, Qijun; Hu, Meng] Wuhan Third Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China.
   [Zhou, Jinfei] Xiangyang Yilaimei Med Beauty Clin, Dept Aesthet Dermatol, Wuhan, Hubei, Peoples R China.
RP Hu, M (corresponding author), Wuhan Third Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China.
EM humeng7622@163.com
RI XU, QI/JXX-1861-2024
FU Medical Science Research Project of the Wuhan Municipal Health
   Commission [WX20Q03]
FX The study was supported by the Medical Science Research Project of the
   Wuhan Municipal Health Commission (grant n<SUP>o</SUP> WX20Q03) .
CR Baker JR, 2019, FASEB J, V33, P1605, DOI 10.1096/fj.201800965R
   Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858
   Chen XB, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000027187
   Chhabra NF, 2021, MOL METAB, V54, DOI 10.1016/j.molmet.2021.101334
   Choi JY, 2018, BIOCHEM BIOPH RES CO, V505, P1134, DOI 10.1016/j.bbrc.2018.10.010
   Gana NHT, 2012, GENES CELLS, V17, P11, DOI 10.1111/j.1365-2443.2011.01564.x
   Gerasymchuk M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155281
   Gu YP, 2020, AGEING RES REV, V59, DOI 10.1016/j.arr.2020.101036
   Kabekkodu SP, 2018, BIOL REV, V93, P1955, DOI 10.1111/brv.12428
   Kemp MG, 2017, MOLECULES, V22, DOI 10.3390/molecules22030356
   Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440
   Li BS, 2021, MOL CELL BIOCHEM, V476, P863, DOI 10.1007/s11010-020-03951-z
   Li Y, 2021, FREE RADICAL BIO MED, V169, P99, DOI 10.1016/j.freeradbiomed.2021.03.035
   Liu GM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152510
   Low E, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101456
   Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508
   Mellis D, 2018, BIOCHEM SOC T, V46, P11, DOI 10.1042/BST20170037
   Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104
   Noren Hooten N, 2017, JOVE-J VIS EXP, DOI 10.3791/55533
   Pljesa-Ercegovac M, 2008, UROL ONCOL-SEMIN ORI, V26, P175, DOI 10.1016/j.urolonc.2007.02.007
   Regulski MJ, 2017, WOUNDS, V29, P168
   Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837
   Röck K, 2015, J INVEST DERMATOL, V135, P369, DOI 10.1038/jid.2014.422
   Senevirathne M, 2012, CARBOHYD POLYM, V87, P876, DOI 10.1016/j.carbpol.2011.08.080
   Shitara Y, 2012, J BIOCHEM, V152, P73, DOI 10.1093/jb/mvs034
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Sikora Ewa, 2018, Postepy Biochem, V64, P110, DOI 10.18388/pb.2018_120
   Spandau DF, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150972
   Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093
   Tai LH, 2020, INT J MED SCI, V17, P457, DOI 10.7150/ijms.38832
   Toutfaire M, 2017, BIOCHEM PHARMACOL, V142, P1, DOI 10.1016/j.bcp.2017.04.011
   Wang B, 2017, ONCOTARGET, V8, P33475, DOI 10.18632/oncotarget.16509
   Yoo JK, 2013, EXP GERONTOL, V48, P464, DOI 10.1016/j.exger.2013.02.022
   Zhong YG, 2016, MOL BIOSYST, V12, P598, DOI 10.1039/c5mb00703h
   Zhou Y, 2021, J GERIATR CARDIOL, V18, P426, DOI 10.11909/j.issn.1671-5411.2021.06.007
   Zuo XL, 2006, BIOL TRACE ELEM RES, V114, P41, DOI 10.1385/BTER:114:1:41
NR 36
TC 1
Z9 1
U1 3
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0365-0596
EI 1806-4841
J9 AN BRAS DERMATOL
JI An. Brasil. Dermatol.
PD JAN-FEB
PY 2023
VL 98
IS 1
BP 17
EP 25
DI 10.1016/j.abd.2021.12.007
EA JAN 2023
PG 9
WC Dermatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology
GA 8N4XU
UT WOS:000925153500001
PM 36244946
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Nunes, B
   Miranda, AF
   Ozório, ROA
   Gonçalves, F
   Gonçalves, JFM
   Correia, AT
AF Nunes, B.
   Miranda, A. F.
   Ozorio, R. O. A.
   Goncalves, F.
   Goncalves, J. F. M.
   Correia, A. T.
TI Modulation of neuronal activity and hepatic metabolism by ploidy and
   L-carnitine supplement in rainbow trout (<i>Oncorhynchus mykiss</i>)
SO AQUACULTURE NUTRITION
LA English
DT Article
DE anti-aging; aquaculture; liver histology; metabolism; oxidative stress
ID ACUTE STRESS-RESPONSE; ACETYL-L-CARNITINE; ENZYME-ACTIVITIES; OXIDATIVE
   STRESS; BROOK TROUT; LIVER; FISH; ACETYLCHOLINESTERASE;
   ACYLTRANSFERASES; TEMPERATURE
AB l-carnitine, a multiphysiological, bioactive and pollution-free additive, is known to act as a growth-enhancer and appears to act as an antioxidant compound. However, high dosages may cause detrimental physiological effects to fish. Considering such, a feeding trial was carried out to evaluate the effects of dietary l-carnitine content on neuronal activity (acetylcholinesterasic activity), hepatic metabolism (catalase activity) and liver histological markers in both diploid and triploid trout (Oncorhynchus mykiss) juveniles. Fish were hand-fed for 56days on three nutritionally identical diets, varying in l-carnitine content; unsupplemented diet (15mgkg(-1)) and supplemented (200 or 530mg kg(-1)) diets. Moderate to severe glycogen/lipid depletion was the major liver histopathological disorder observed in all dietary groups. This cause-effect relationship appeared to be dose and time-dependent, suggesting an important role of l-carnitine in the liver metabolism. Moreover, the hepatocite size and nuclear diameter appeared to be larger in l-carnitine supplemented groups than in control group. l-carnitine caused significant induction of catalase activity and inhibition of AChE. Diploid and triploid trouts showed marked differences in enzymatic activities, reflected by consistently higher values of AChE activities for triploid animals.
C1 [Nunes, B.; Miranda, A. F.; Goncalves, F.] Univ Aveiro, CESAM, Ctr Estudos Ambientais & Mar, Dept Biol, P-3810193 Aveiro, Portugal.
   [Ozorio, R. O. A.; Goncalves, J. F. M.; Correia, A. T.] Univ Porto, CIMAR CIIMAR, P-4100 Oporto, Portugal.
   [Goncalves, J. F. M.] Univ Porto, ICBAS, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal.
   [Correia, A. T.] Univ Fernando Pessoa, Ctr Res Global Changes Energy Environm & Bioengn, CIAGEB, Fac Hlth Sci, Oporto, Portugal.
C3 Universidade de Aveiro; Universidade do Porto; Universidade do Porto;
   Universidade Fernando Pessoa
RP Nunes, B (corresponding author), Univ Aveiro, CESAM, Ctr Estudos Ambientais & Mar, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.
EM nunes.b@ua.pt
RI Quality, Aquaculture Seafood/AAD-7718-2019; ozorio, rodrigo O.
   A./G-9410-2012; Goncalves, Fernando J. M./B-8000-2008; Correia, Alberto
   Teodorico/J-3665-2012; Gonçalves, Jose Fernando Magalhaes/AGK-4538-2022;
   Nunes, Bruno/J-4579-2013
OI ozorio, rodrigo O. A./0000-0002-3533-3126; Goncalves, Fernando J.
   M./0000-0002-9326-187X; Correia, Alberto Teodorico/0000-0002-2831-025X;
   Nunes, Bruno/0000-0002-6743-2321; Goncalves, Jose/0000-0002-1418-7940
FU Project BiOtoMetal [PTDC/AMB/70431/2006]; FCT (Foundation for Science
   and Technology, Portugal); Fundação para a Ciência e a Tecnologia
   [PTDC/AMB/70431/2006] Funding Source: FCT
FX The present manuscript was partially funded by Project BiOtoMetal
   (PTDC/AMB/70431/2006) and by the FCT (Foundation for Science and
   Technology, Portugal) plurianual funding. The funding source did not
   have any role in the conduct of the research and/or preparation of the
   article; it was not involved in study design, in the collection,
   analysis and interpretation of data, in the writing of the report; and
   in the decision to submit the article for publication.
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Almroth BC, 2008, MAR ENVIRON RES, V66, P90, DOI 10.1016/j.marenvres.2008.02.032
   Atkins ME, 2008, COMP BIOCHEM PHYS A, V149, P157, DOI 10.1016/j.cbpa.2007.11.004
   AUDIT I, 1976, BIOCHEM GENET, V14, P759, DOI 10.1007/BF00485339
   Bajgar J., 1997, EUR NEUROPSYCHOPHARM, V7, pS245, DOI DOI 10.1016/S0924-977X(97)88810-4
   Benfey Tillmann J., 1999, Reviews in Fisheries Science, V7, P39, DOI 10.1080/10641269991319162
   Benfey TJ, 2000, AQUACULTURE, V184, P167, DOI 10.1016/S0044-8486(99)00314-2
   Biswas A, 2006, FISH PHYSIOL BIOCHEM, V32, P73, DOI 10.1007/s10695-006-7657-0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Casals-Casas C, 2008, INT J OBESITY, V32, pS53, DOI 10.1038/ijo.2008.207
   CASTORINA M, 1994, LIFE SCI, V54, P1205, DOI 10.1016/0024-3205(94)00847-7
   CHUNG CD, 1993, J BIOL CHEM, V268, P4519
   Cooley HM, 2001, AQUAT TOXICOL, V54, P81, DOI 10.1016/S0166-445X(00)00172-7
   Dowling K, 2001, AQUAT TOXICOL, V53, P279, DOI 10.1016/S0166-445X(01)00172-2
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Fairchild JF, 2009, ARCH ENVIRON CON TOX, V56, P754, DOI 10.1007/s00244-008-9281-8
   Ferguson H. W., 1989, Systemic pathology of fish. A text and atlas of comparative tissue responses in diseases of teleosts.
   Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002
   Gingerich W.H., 1982, Aquatic Toxicology (New York), V1, P55
   Guilhermino L, 1998, BIOMARKERS, V3, P157, DOI 10.1080/135475098231318
   Harpaz S, 2005, AQUACULTURE, V249, P3, DOI 10.1016/j.aquaculture.2005.04.007
   Hinton David E., 2001, P224
   HOBDEN BR, 1977, COMP BIOCHEM PHYS C, V57, P131, DOI 10.1016/0306-4492(77)90058-2
   Hogstrand C, 2002, COMP BIOCHEM PHYS B, V133, P523, DOI 10.1016/S1096-4959(02)00125-2
   Hyndman CA, 2003, COMP BIOCHEM PHYS A, V134, P167, DOI 10.1016/S1095-6433(02)00245-3
   Ji H, 1996, J NUTR, V126, P1937
   Karlic H, 2002, J HISTOCHEM CYTOCHEM, V50, P205, DOI 10.1177/002215540205000208
   Kong Lingfeng, 2007, Journal of Ocean University of China, V6, P383, DOI 10.1007/s11802-007-0383-0
   Li JL, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-32
   Lolic MM, 1997, ANN EMERG MED, V29, P758, DOI 10.1016/S0196-0644(97)70197-5
   LOWEJINDE L, 1984, ARCH ENVIRON CON TOX, V13, P759, DOI 10.1007/BF01055940
   Maxime V, 2008, FISH FISH, V9, P67, DOI 10.1111/j.1467-2979.2007.00269.x
   MUIR DCG, 1992, TOXICOL APPL PHARM, V117, P65, DOI 10.1016/0041-008X(92)90218-H
   Nunes B, 2008, ECOTOX ENVIRON SAFE, V71, P341, DOI 10.1016/j.ecoenv.2007.12.006
   O'Flynn FM, 1997, ICES J MAR SCI, V54, P1160
   OECD, 2019, Test No. 203: Fish, Acute Toxicity Test, DOI [10.1787/9789264069961-en, DOI 10.1787/9789264069961-EN]
   OLIVATELES A, 1990, AQUACULTURE, V84, P373, DOI 10.1016/0044-8486(90)90102-S
   Oppedal F, 2003, AQUACULTURE, V215, P145, DOI 10.1016/S0044-8486(02)00223-5
   Ozório ROA, 2012, AQUACULT NUTR, V18, P189, DOI 10.1111/j.1365-2095.2011.00888.x
   Ozório ROA, 2009, CURR NUTR FOOD SCI, V5, P40, DOI 10.2174/157340109787314758
   Pagot Y, 1996, APPL ENVIRON MICROB, V62, P3864, DOI 10.1128/AEM.62.10.3864-3867.1996
   Qin JG, 1998, AQUACULTURE, V166, P247, DOI 10.1016/S0044-8486(98)00287-7
   Rani PJA, 2001, J GERONTOL A-BIOL, V56, pB140, DOI 10.1093/gerona/56.3.B140
   Simon R. C., 1967, Research Report United States Fish and Wildlife Service, V70, P18
   STRUSSMANN CA, 1990, J FISH BIOL, V36, P59, DOI 10.1111/j.1095-8649.1990.tb03519.x
   Taylor JF, 2007, GEN COMP ENDOCR, V152, P314, DOI 10.1016/j.ygcen.2007.02.029
   THORGAARD GH, 1986, AQUACULTURE, V57, P57, DOI 10.1016/0044-8486(86)90180-8
   US EPA (United States Environmental Protection Agency), 1996, EC EFF TEST GUID OPP
   Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187
NR 49
TC 8
Z9 12
U1 0
U2 21
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1353-5773
EI 1365-2095
J9 AQUACULT NUTR
JI Aquac. Nutr.
PD JUN
PY 2014
VL 20
IS 3
BP 242
EP 252
DI 10.1111/anu.12070
PG 11
WC Fisheries
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Fisheries
GA AH6RL
UT WOS:000336258300002
OA gold
DA 2024-02-19
ER

PT J
AU Kumar, SA
   Albrecht, T
   Kauzál, O
   Tomásek, O
AF Kumar, Sampath A.
   Albrecht, Tomas
   Kauzal, Ondrej
   Tomasek, Oldrich
TI No Evidence for Trade-Offs Between Lifespan, Fecundity, and Basal
   Metabolic Rate Mediated by Liver Fatty Acid Composition in Birds
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE membrane pacemaker hypothesis; life-history trade-offs; pace-of-life
   syndromes; membrane unsaturation; evolution of longevity; ageing; aging;
   senescence
ID NA+-K+-ATPASE; HISTORY TRAITS; LONGEVITY; MEMBRANES; PACE; FUEL;
   PERSPECTIVES; TEMPERATE; OXIDATION; PROFILES
AB The fatty acid composition of biological membranes has been hypothesised to be a key molecular adaptation associated with the evolution of metabolic rates, ageing, and life span - the basis of the membrane pacemaker hypothesis (MPH). MPH proposes that highly unsaturated membranes enhance cellular metabolic processes while being more prone to oxidative damage, thereby increasing the rates of metabolism and ageing. MPH could, therefore, provide a mechanistic explanation for trade-offs between longevity, fecundity, and metabolic rates, predicting that short-lived species with fast metabolic rates and higher fecundity would have greater levels of membrane unsaturation. However, previous comparative studies testing MPH provide mixed evidence regarding the direction of covariation between fatty acid unsaturation and life span or metabolic rate. Moreover, some empirical studies suggest that an n-3/n-6 PUFA ratio or the fatty acid chain length, rather than the overall unsaturation, could be the key traits coevolving with life span. In this study, we tested the coevolution of liver fatty acid composition with maximum life span, annual fecundity, and basal metabolic rate (BMR), using a recently published data set comprising liver fatty acid composition of 106 avian species. While statistically controlling for the confounding effects of body mass and phylogeny, we found no support for long life span evolving with low fatty acid unsaturation and only very weak support for fatty acid unsaturation acting as a pacemaker of BMR. Moreover, our analysis provided no evidence for the previously reported links between life span and n-3 PUFA/total PUFA or MUFA proportion. Our results rather suggest that long life span evolves with long-chain fatty acids irrespective of their degree of unsaturation as life span was positively associated with at least one long-chain fatty acid of each type (i.e., SFA, MUFA, n-6 PUFA, and n-3 PUFA). Importantly, maximum life span, annual fecundity, and BMR were associated with different fatty acids or fatty acid indices, indicating that longevity, fecundity, and BMR coevolve with different aspects of fatty acid composition. Therefore, in addition to posing significant challenges to MPH, our results imply that fatty acid composition does not pose an evolutionary constraint underpinning life-history trade-offs at the molecular level.
C1 [Kumar, Sampath A.; Albrecht, Tomas; Kauzal, Ondrej; Tomasek, Oldrich] Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.
   [Kumar, Sampath A.; Tomasek, Oldrich] Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.
   [Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.
   [Kauzal, Ondrej] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.
C3 Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech
   Academy of Sciences; Masaryk University Brno; Charles University Prague;
   Charles University Prague
RP Tomásek, O (corresponding author), Czech Acad Sci, Inst Vertebrate Biol, Brno, Czech Republic.; Tomásek, O (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Brno, Czech Republic.
EM tomasek@ivb.cz
RI Tomášek, Oldřich/A-6725-2012
OI Tomášek, Oldřich/0000-0002-2657-5916; Kauzal,
   Ondrej/0000-0003-0456-2345; Albrecht, Tomas/0000-0002-9213-0034;
   Anandan, Sampath Kumar/0000-0002-4539-5814
FU Czech Science Foundation [GA17-24782S, GA21-22160S]
FX This study was funded through the Czech Science Foundation (GA17-24782S
   to TA and GA21-22160S to TA and OT).
CR Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Berry DA, 1999, J STAT PLAN INFER, V82, P215, DOI 10.1016/S0378-3758(99)00044-0
   BirdLife International and Handbook of the Birds of the World, 2018, BIRDLIFE INT HDB BIR
   Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650
   Bozek K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00037-7
   BRYANT DM, 1994, ANIM BEHAV, V48, P447, DOI 10.1006/anbe.1994.1258
   Bürkner PC, 2018, R J, V10, P395
   Bürkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01
   Calhoon EA, 2015, CHEM PHYS LIPIDS, V191, P48, DOI 10.1016/j.chemphyslip.2015.08.008
   Calhoon EA, 2014, PHYSIOL BIOCHEM ZOOL, V87, P265, DOI 10.1086/674696
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   Douma JC, 2019, METHODS ECOL EVOL, V10, P1412, DOI 10.1111/2041-210X.13234
   DRENT RH, 1980, ARDEA, V68, P225
   Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132
   Fransson T., 2017, EURING List of Longevity Records for European Birds
   Furness LJ, 2008, AGE, V30, P75, DOI 10.1007/s11357-008-9054-3
   Gaillard J.-M., 2016, Encyclopedia of evolutionary biology, P312, DOI DOI 10.1016/B978-0-12-800049-6.00085-8
   Galván I, 2015, EVOLUTION, V69, P2776, DOI 10.1111/evo.12754
   Garamszegi LZ., 2014, Modern Phylogenetic Comparative Methods and Their Application in Evolutionary Biology: Concepts and Practice, DOI [10.1007/978-3-662-43550-2, DOI 10.1007/978-3-662-43550-2]
   Gavrilov VM, 2014, Q REV BIOL, V89, P107, DOI 10.1086/676046
   Gelman A., 1992, Stat. Sci., V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]
   Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213
   Gonzalez A, 2015, J EXP BIOL, V218, P2563, DOI 10.1242/jeb.117630
   GRANDE F, 1970, AM J PHYSIOL, V218, P1406, DOI 10.1152/ajplegacy.1970.218.5.1406
   Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029
   Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097
   Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704
   Hespanhol L, 2019, BRAZ J PHYS THER, V23, P290, DOI 10.1016/j.bjpt.2018.12.006
   Holman R.T., 1954, Prog. Chem. Fats Other Lipids, V2, P51, DOI [10.1016/0079-6832(54)90004-X, DOI 10.1016/0079-6832(54)90004-X]
   Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014
   Hulbert AJ, 2010, INTEGR COMP BIOL, V50, P808, DOI 10.1093/icb/icq007
   Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955
   Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024
   Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399
   Jaureguiberry MS, 2014, ACTA BIOCH BIOPH SIN, V46, P273, DOI 10.1093/abbs/gmt155
   Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171
   Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631
   Jimenez AG, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.221804
   Jimenez AG, 2014, J COMP PHYSIOL B, V184, P545, DOI 10.1007/s00360-014-0825-0
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Jové M, 2020, MOLECULES, V25, DOI 10.3390/molecules25184343
   Jové M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03346
   Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8
   Lingwood D, 2005, J BIOL CHEM, V280, P36545, DOI 10.1074/jbc.M506670200
   McKechnie AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P502, DOI 10.1086/383511
   Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021
   Mène-Saffrané L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200
   Moller AP, 2008, J EVOLUTION BIOL, V21, P1379, DOI 10.1111/j.1420-9101.2008.01556.x
   MONKKONEN M, 1992, ORNIS FENNICA, V69, P161
   Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.13009
   Naudí A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00372
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pamplona R, 2011, BIOGERONTOLOGY, V12, P409, DOI 10.1007/s10522-011-9348-1
   Papsdorf K, 2019, TRENDS CELL BIOL, V29, P97, DOI 10.1016/j.tcb.2018.09.004
   Pearl R., 1928, RATE LIVING
   Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131
   Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002
   Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8
   Schmid-Siegert E, 2016, J BIOL CHEM, V291, P13005, DOI 10.1074/jbc.M116.729921
   Schroeder EA, 2015, TRENDS ENDOCRIN MET, V26, P589, DOI 10.1016/j.tem.2015.08.007
   Shaikh SR, 2015, BBA-BIOMEMBRANES, V1848, P211, DOI 10.1016/j.bbamem.2014.04.020
   Sjölander A, 2019, EUR J EPIDEMIOL, V34, P809, DOI 10.1007/s10654-019-00517-2
   Sollberger S, 2016, PSYCHONEUROENDOCRINO, V63, P385, DOI 10.1016/j.psyneuen.2015.09.031
   Soriano-Redondo A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19256-0
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   Speakman JR, 2005, AGING CELL, V4, P167, DOI 10.1111/j.1474-9726.2005.00162.x
   Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556
   Stearns S.C., 1992, pi
   STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364
   Storchová L, 2018, GLOBAL ECOL BIOGEOGR, V27, P400, DOI 10.1111/geb.12709
   Tomasek O, 2019, FUNCT ECOL, V33, P239, DOI 10.1111/1365-2435.13238
   Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z
   Valencak TG, 2007, AGING CELL, V6, P15, DOI 10.1111/j.1474-9726.2006.00257.x
   Valencak Teresa G, 2014, Longev Healthspan, V3, P3, DOI 10.1186/2046-2395-3-3
   Visioli F, 1998, BIOCHEM BIOPH RES CO, V245, P487, DOI 10.1006/bbrc.1998.8463
   Weijers RNM, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0235-9
   Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006
   Williams JB, 2010, INTEGR COMP BIOL, V50, P855, DOI 10.1093/icb/icq024
NR 81
TC 5
Z9 5
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD MAR 29
PY 2021
VL 9
AR 638501
DI 10.3389/fcell.2021.638501
PG 12
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA RM8UL
UT WOS:000639932000001
PM 33869185
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Karabicici, M
   Alptekin, S
   Karagonlar, ZF
   Erdal, E
AF Karabicici, Mustafa
   Alptekin, Sena
   Firtina Karagonlar, Zeynep
   Erdal, Esra
TI Doxorubicin-induced senescence promotes stemness and tumorigenicity in
   EpCAM-/CD133-nonstem cell population in hepatocellular carcinoma cell
   line, HuH-7
SO MOLECULAR ONCOLOGY
LA English
DT Article; Early Access
DE cancer stem cell; EpCAM; hepatocellular carcinoma; therapy&#8208;
   induced senescence; WNT
ID TERMINAL PROLIFERATION ARREST; CATENIN SIGNALING PROMOTES; TUMOR-CELLS;
   SECRETORY PHENOTYPE; DOWN-REGULATION; NONSTEM CELLS; CANCER; RESISTANCE;
   P53; SURVEILLANCE
AB The therapeutic induction of senescence is a potential means to treat cancer, primarily acting through the induction of a persistent growth-arrested state in tumors. However, recent studies have indicated that therapy-induced senescence (TIS) in tumor cells allows for the prolonged survival of a subgroup of cells in a dormant state, with the potential to re-enter the cell cycle along with an increased stemness gene expression. Residual cells after TIS with increased cancer stem cell phenotype may have profound implications for tumor aggressiveness and disease recurrence. Herein, we investigated senescence-associated stemness in EpCAM+/CD133+ liver cancer stem cell and EpCAM-/CD133- nonstem cell populations in HuH7 cell line. We demonstrated that treatment with doxorubicin induces senescence in both cell populations, accompanied by a significant increase in the expression of reprogramming genes SOX2, KLF4, and c-MYC as well as liver stemness-related genes EpCAM, CK19, and ANXA3 and the multidrug resistance-related gene ABCG2. Moreover, doxorubicin treatment significantly increased EpCAM + population in nonstem cells indicating senescence-associated reprogramming of nonstem cell population. Also, Wnt/beta-catenin target genes were increased in these cells, while inhibition of this signaling pathway decreased stem cell gene expression. Importantly, Dox-treated EpCAM-/CD133- nonstem cells had increased in vivo tumor-forming ability. In addition, when SASP-CM from Dox-treated cells were applied onto hIPSC-derived hepatocytes, senescence was induced in hepatocytes along with an increased expression of TGF-beta, KLF4, and AXIN2. Importantly, SASP-CM was not able to induce senescence in Hep3B-TR cells, a derivative line rendered resistant to TGF-beta signaling. Furthermore, ELISA experiments revealed that the SASP-CM of Dox-treated cells contain inflammatory cytokines IL8 and IP10. In summary, our findings further emphasize the importance of carefully dissecting the beneficial and detrimental aspects of prosenescence therapy in HCC and support the potential use of senolytic drugs in HCC treatment in order to eliminate adverse effects of TIS.
C1 [Karabicici, Mustafa; Alptekin, Sena; Erdal, Esra] Izmir Biomed & Genome Ctr, Izmir, Turkey.
   [Firtina Karagonlar, Zeynep] Izmir Univ Econ, Genet & Bioengn Dept, Izmir, Turkey.
   [Erdal, Esra] Dokuz Eylul Univ, Dept Med Biol & Genet, Fac Med, Izmir, Turkey.
   [Alptekin, Sena] Univ Ulm, Dept Internal Med 3, Albert Einstein Allee 23, D-89081 Ulm, Germany.
C3 Izmir Ekonomi Universitesi; Dokuz Eylul University; Ulm University
RP Erdal, E (corresponding author), Dokuz Eylul Univ Hlth Campus, Izmir Biomed & Genome Ctr, TR-35340 Izmir, Turkey.
EM mustafa.karabicici@msfr.ibg.edu.tr; esra.erdal@ibg.edu.tr
RI Erdal, Esra/T-9057-2018; Karabiçici, Mustafa/AAM-6699-2021
OI Erdal, Esra/0000-0001-7264-0574; Alptekin, Sena/0000-0001-8216-2078;
   Karabicici, Mustafa/0000-0002-0359-7645; FIRTINA KARAGONLAR,
   ZEYNEP/0000-0002-6608-365X
FU TUBITAK [112T173, BIDEB 2209-A]
FX We would like to thank Dr. Xiaozhou Hu at Izmir Biomedicine and Genome
   Center (IBG) Flow Cytometry Core for her support in the flow cytometry
   experiments, Dr. Umur Keles at IBG Animal Core for his help in tumor
   xenograft studies, Dr. Melek Ucuncu at IBG Optical Imaging Unit for her
   help in the image acquisitions, and Dr. Ender Avci at IBG-NEVCELL for
   his help with ELISA experiments. pSBE4-Luc and pRL-TK plasmids were
   gifts from Dr. Serif Sent_urk at IBG. We thank Dr. Soheil Akbari for his
   help in production of hiPSC-derived hepatocytes. This research was
   funded by TUBITAK grant number 112T173 to EE and BIDEB 2209-A grant to
   SA.
CR Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675
   Akbari S, 2019, STEM CELL REP, V13, P627, DOI 10.1016/j.stemcr.2019.08.007
   Al-Khalaf HH, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00359-18
   Bertolo A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38546-2
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108
   Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599
   Chang BD, 1999, CANCER RES, V59, P3761
   Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078
   Chen W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1740936
   Chen Y, 2012, INT J BIOL SCI, V8, P992, DOI 10.7150/ijbs.4454
   Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Doherty MR, 2016, CANCERS, V8, DOI 10.3390/cancers8010008
   Dou ZX, 2018, CELL METAB, V27, P710, DOI 10.1016/j.cmet.2018.03.009
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007
   Friemel J, 2015, CLIN CANCER RES, V21, P1951, DOI 10.1158/1078-0432.CCR-14-0122
   Geng W, 2015, ONCOTARGET, V6, P28042, DOI 10.18632/oncotarget.4832
   Hewitt G, 2013, METHODS MOL BIOL, V1048, P31, DOI 10.1007/978-1-62703-556-9_4
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Jayachandran A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0307-9
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karagonlar ZF, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051198
   Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108
   Phi LTH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5416923
   Lee SC, 2015, ONCOTARGET, V6, P27146, DOI 10.18632/oncotarget.4354
   Li ZL, 2019, J CELL BIOCHEM, V120, P12519, DOI 10.1002/jcb.28518
   Losic B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14050-z
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Malaquin N, 2019, METHODS MOL BIOL, V1896, P45, DOI 10.1007/978-1-4939-8931-7_6
   Man K, 2010, ANN SURG, V251, P1154, DOI 10.1097/SLA.0b013e3181d96e3d
   Milanovic M, 2018, TRENDS CELL BIOL, V28, P1049, DOI 10.1016/j.tcb.2018.09.001
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003
   Muñoz-Galván S, 2019, ONCOGENE, V38, P1309, DOI 10.1038/s41388-018-0527-2
   Ohtani N, 2019, J BIOCHEM, V166, P289, DOI 10.1093/jb/mvz055
   Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103
   Pandit H, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4683-0
   Park SY, 2014, EUR J CANCER, V50, P341, DOI 10.1016/j.ejca.2013.09.021
   Passos Joao F, 2007, Methods Mol Biol, V371, P33
   Perez-Amill L., 2018, TURKISH J HEMATOL
   Prieto-Vila M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122574
   Rao SG, 2016, TRENDS CANCER, V2, P676, DOI 10.1016/j.trecan.2016.10.001
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Sabisz M, 2009, CELL CYCLE, V8, P3208, DOI 10.4161/cc.8.19.9758
   Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081
   Shojaie N, 2016, CELL J, V17, P730
   Sun Y, 2018, TRENDS MOL MED, V24, P871, DOI 10.1016/j.molmed.2018.08.002
   Tiainen L, 2019, CLIN BREAST CANCER, V19, pE522, DOI 10.1016/j.clbc.2019.03.006
   Triana-Martínez F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020346
   Tsolou A, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116562
   Vilgelm AE, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv406
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Wang RH, 2016, ONCOTARGET, V7, P5754, DOI 10.18632/oncotarget.6805
   Wang T, 2017, MOL CANCER RES, V15, P3, DOI 10.1158/1541-7786.MCR-16-0192
   Wang WJ, 2017, ONCOTARGET, V8, P64520, DOI 10.18632/oncotarget.17327
   Wolter K, 2020, NAT REV GASTRO HEPAT, V17, P135, DOI 10.1038/s41575-020-0262-3
   Xu ZJ, 2016, P NATL ACAD SCI USA, V113, pE6382, DOI 10.1073/pnas.1613849113
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
NR 72
TC 37
Z9 42
U1 6
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1574-7891
EI 1878-0261
J9 MOL ONCOL
JI Mol. Oncol.
PD 2021 AUG
PY 2021
VL 15
IS 8
BP 2185
EP 2202
DI 10.1002/1878-0261.12916
EA MAR 2021
PG 18
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA TU0DG
UT WOS:000626278200001
PM 33524223
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fraeyman, N
   Van de Velde, E
   Van Ermen, A
   Bazan, A
   Vanderheyden, P
   Van Emmelo, L
   Vandekerckhove, J
AF Fraeyman, N
   Van de Velde, E
   Van Ermen, A
   Bazan, A
   Vanderheyden, P
   Van Emmelo, L
   Vandekerckhove, J
TI Effect of maturation and aging on β-adrenergic signal transduction in
   rat kidney and liver
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE G-proteins; aging; rat; beta-adrenergic system; kidney and liver
ID MESSENGER-RNA LEVELS; NUCLEOTIDE-BINDING PROTEINS; STIMULATORY
   G-PROTEIN; ADENYLATE-CYCLASE; REGULATORY PROTEINS; SPLICE VARIANTS;
   ALPHA-SUBUNITS; RECEPTORS; EXPRESSION; AGE
AB The characteristics of the beta -adrenergic signal transduction system were analyzed in kidney and liver membrane preparations from neonatal (2-3 days), mature (2 months), and old (2 years) rats. When comparing kidneys from adult to neonatal rats, we found a higher beta -receptor density and a higher percentage of beta (1)-receptor subtype, lower immunoreactive G(s alpha)-protein, a lower ratio between the high and low molecular weight splice Variant of G(s alpha), lower immunoreactive G(i alpha)-protein, and lower basal adenylate cyclase activity. When comparing livers from adult to neonatal rats, we found lower beta -receptor density and basal adenylate cyclase activity. Very few differences could be detected when comparing mature to old kidneys or livers. Stimulated adenosine 3',5'-cyclic monophosphate (cAMP) synthesis was tissue- and age dependent. In liver, G-protein- and beta -receptor-stimulated cAMP synthesis mirrored basal adenylate cyclase activity and was highest in liver from neonatal animals. In contrast, cAMP synthesis was significantly more stimulated in kidneys from mature animals than from neonatal and senescent rats. We conclude that: (i) the stoichiometry of the components within the beta -receptor/G-protein/adenylate cyclase complex is not fixed but is both tissue- and age-dependent; (ii) adenylate cyclase enzyme activity is possibly but not necessarily the rate-limiting step in the beta -receptor-mediated synthesis of cAMP; and (iii) there is in vivo evidence for a preferential co-expression of the large splice variant of the G(s)-protein and beta (2)-receptor subtype. It is speculated that this could have important physiological consequences for the development of the kidney. BIOCHEM PHARMACOL 60;12:1787-1795, 2000. (C) 2000 Elsevier Science Inc.
C1 State Univ Ghent, Heymans Inst Pharmacol, Sch Med, B-9000 Ghent, Belgium.
   State Univ Ghent, Clin Chem Lab, Sch Med, B-9000 Ghent, Belgium.
   State Univ Ghent, Immunol Lab, Sch Med, B-9000 Ghent, Belgium.
   State Univ Ghent, Physiol Chem Lab, Sch Med, B-9000 Ghent, Belgium.
   Free Univ Brussels, Dept Prot Chem, B-1640 Rhode St Genese, Belgium.
C3 Ghent University; Ghent University; Ghent University; Ghent University
RP Fraeyman, N (corresponding author), State Univ Ghent, Heymans Inst Pharmacol, Sch Med, De Pintelaan 185, B-9000 Ghent, Belgium.
RI Bazan, Ariane/O-2166-2019; Bazan, Ariane/A-3080-2017
OI Bazan, Ariane/0000-0003-3896-9223
CR ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314
   Bazan A, 1996, BIOCHIMIE, V78, P273, DOI 10.1016/0300-9084(96)82191-2
   BAZAN A, 1994, BIOCHEM PHARMACOL, V48, P479, DOI 10.1016/0006-2952(94)90277-1
   CHANG YC, 1992, ANAL BIOCHEM, V205, P22, DOI 10.1016/0003-2697(92)90573-P
   CHEN LA, 1991, J CLIN INVEST, V87, P293, DOI 10.1172/JCI114985
   EuropeFinner GN, 1997, J MOL ENDOCRINOL, V18, P15, DOI 10.1677/jme.0.0180015
   FELDMAN AM, 1991, CIRCULATION, V84, P1852, DOI 10.1161/01.CIR.84.4.1852
   FRAEYMAN N, 1993, LIFE SCI, V53, P153, DOI 10.1016/0024-3205(93)90662-M
   FRAEYMAN N, 1991, J RECEPTOR RES, V11, P985, DOI 10.3109/10799899109064692
   FRAEYMAN N, 1991, P NATO ADV RES I BIO, P193
   GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L
   GRANNEMAN JG, 1990, ENDOCRINOLOGY, V127, P1596, DOI 10.1210/endo-127-4-1596
   GREEN A, 1989, BIOCHEM J, V258, P607, DOI 10.1042/bj2580607
   Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429
   GURDAL H, 1995, MOL PHARMACOL, V47, P772
   INSEL PA, 1993, EXP GERONTOL, V28, P341, DOI 10.1016/0531-5565(93)90061-H
   ITOH H, 1986, P NATL ACAD SCI USA, V83, P3776, DOI 10.1073/pnas.83.11.3776
   KAWAI Y, 1991, BIOCHEM J, V274, P439, DOI 10.1042/bj2740439
   KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081
   KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LARSSON L, 1980, J ULTRA MOL STRUCT R, V72, P392, DOI 10.1016/S0022-5320(80)90074-X
   LIANG CT, 1993, AM J PHYSIOL, V264, pF770, DOI 10.1152/ajprenal.1993.264.5.F770
   LONGABAUGH JP, 1989, MOL PHARMACOL, V36, P681
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCFARLANEANDERSON N, 1992, BIOCHEM J, V282, P15, DOI 10.1042/bj2820015
   MICHEL MC, 1994, HYPERTENSION, V23, P653, DOI 10.1161/01.HYP.23.5.653
   MONTEITH MS, 1995, CLIN SCI, V89, P487, DOI 10.1042/cs0890487
   MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265
   Novotny J, 1998, J MOL ENDOCRINOL, V20, P163, DOI 10.1677/jme.0.0200163
   ODONNELL JK, 1991, MOL PHARMACOL, V39, P702
   OGINO Y, 1992, MOL PHARMACOL, V42, P6
   OLATE J, 1991, PHARMACOL THERAPEUT, V51, P403, DOI 10.1016/0163-7258(91)90068-W
   RAPIEJKO PJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P348, DOI 10.1016/0167-4889(90)90233-4
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109
   STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517
   STOW JL, 1991, AM J PHYSIOL, V261, pF831, DOI 10.1152/ajprenal.1991.261.5.F831
   SUNDARESAN PR, 1988, BIOCHEM PHARMACOL, V37, P4513, DOI 10.1016/0006-2952(88)90667-3
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   URASAWA K, 1991, JPN CIRC J, V55, P676, DOI 10.1253/jcj.55.676
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   VANSCHEEUWIJCK P, 1989, EUR J PHARM-MOLEC PH, V172, P373, DOI 10.1016/0922-4106(89)90018-7
   VANSCHEEUWIJCK P, 1990, EUR J PHARM-MOLEC PH, V188, P129, DOI 10.1016/0922-4106(90)90048-3
   Weihe W.H, 1987, UFAW HDB CARE MANAGE, V6th
   Wintour EM, 1997, TRENDS ENDOCRIN MET, V8, P199
   YAGAMI T, 1995, MOL PHARMACOL, V48, P849
   YOUNG LT, 1991, DEV BRAIN RES, V61, P243
NR 48
TC 11
Z9 11
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD DEC 15
PY 2000
VL 60
IS 12
BP 1787
EP 1795
DI 10.1016/S0006-2952(00)00493-7
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 383HW
UT WOS:000165877900006
PM 11108793
DA 2024-02-19
ER

PT J
AU Pagliassotti, MJ
   Estrada, AL
   Hudson, WM
   Wei, YR
   Wang, D
   Seals, DR
   Zigler, ML
   LaRocca, TJ
AF Pagliassotti, Michael J.
   Estrada, Andrea L.
   Hudson, William M.
   Wei, Yuren
   Wang, Dong
   Seals, Douglas R.
   Zigler, Melanie L.
   LaRocca, Thomas J.
TI Trehalose supplementation reduces hepatic endoplasmic reticulum stress
   and inflammatory signaling in old mice
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Aging; Inflammation; Unfolded protein response; Liver; Hexosamine
   biosynthetic pathway; Proteostasis
ID NLRP3 INFLAMMASOME; MESSENGER-RNA; BETA-CELLS; TNF-ALPHA; LIFE-SPAN;
   PROTEIN; NICOTINAMIDE; AUTOPHAGY; ER; INCREASES
AB The accumulation of damaged proteins can perturb cellular homeostasis and provoke aging and cellular damage. Quality control systems, such as the unfolded protein response (UPR), inflammatory signaling and protein degradation, mitigate the residence time of damaged proteins. In the present study, we have examined the UPR and inflammatory signaling in the liver of young (similar to 6 months) and old (similar to 28 months) mice (n=8/group), and the ability of trehalose, a compound linked to increased protein stability and autophagy, to counteract age-induced effects on these systems. When used, trehalose was provided for 4 weeks in the drinking water immediately prior to sacrifice (n=7/group). Livers from old mice were characterized by activation of the UPR, increased inflammatory signaling and indices of liver injury. Trehalose treatment reduced the activation of the UPR and inflammatory signaling, and reduced liver injury. Reductions in proteins involved in autophagy and proteasome activity observed in old mice were restored following trehalose treatment. The autophagy marker, LC3B-II, was increased in old mice treated with trehalose. Metabolomics analyses demonstrated that reductions in hexosamine biosynthetic pathway metabolites and nicotinamide in old mice were restored following trehalose treatment. Trehalose appears to be an effective intervention to reduce age-associated liver injury and mitigate the need for activation of quality control systems that respond to disruption of proteostasis. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Pagliassotti, Michael J.; Estrada, Andrea L.; Hudson, William M.; Wei, Yuren; Wang, Dong] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA.
   [Seals, Douglas R.; Zigler, Melanie L.; LaRocca, Thomas J.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.
C3 Colorado State University; University of Colorado System; University of
   Colorado Boulder
RP Pagliassotti, MJ (corresponding author), Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA.
EM michael.pagliassotti@colostate.edu
RI Pagliassotti, Michael/AAV-8238-2021; Estrada, Andrea/HZH-3981-2023
CR Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578
   Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584
   de Gonzalo-Calvo D, 2010, FREE RADICAL BIO MED, V49, P733, DOI 10.1016/j.freeradbiomed.2010.05.019
   DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472
   Decuypere Jean-Paul, 2011, J Aging Res, V2011, P920178, DOI 10.4061/2011/920178
   Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407
   Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061
   ELSLIGER MA, 1993, CLIN CHIM ACTA, V216, P91, DOI 10.1016/0009-8981(93)90142-Q
   EZE LC, 1989, BIOCHEM GENET, V27, P487, DOI 10.1007/BF02396146
   Fu SN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002902
   Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3
   Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   LaRocca TJ, 2012, J PHYSIOL-LONDON, V590, P3305, DOI 10.1113/jphysiol.2012.229690
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lee SJ, 2013, ARCH BIOCHEM BIOPHYS, V535, P187, DOI 10.1016/j.abb.2013.03.011
   Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marchalant Y, 2008, BIOMED PHARMACOTHER, V62, P212, DOI 10.1016/j.biopha.2008.02.004
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Moskalev A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00080
   Muller PY, 2002, BIOTECHNIQUES, V32, P1372
   Murray IA, 2000, BRIT J NUTR, V83, P241, DOI 10.1017/S0007114500000313
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170
   Park JH, 2014, AGING CELL, V13, P709, DOI 10.1111/acel.12224
   Pérez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Rodríguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014
   Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138
   Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001
   Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035
   Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440
   Tucci M, 2014, EXP HEMATOL, V42, P897, DOI 10.1016/j.exphem.2014.06.005
   Vanhooren V, 2013, AGEING RES REV, V12, P8, DOI 10.1016/j.arr.2012.03.010
   Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
NR 51
TC 41
Z9 41
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUL
PY 2017
VL 45
BP 15
EP 23
DI 10.1016/j.jnutbio.2017.02.022
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA EY4VS
UT WOS:000403976300002
PM 28431320
OA Green Accepted
DA 2024-02-19
ER

PT J
AU RIBONI, L
   ACQUOTTI, D
   CASELLATO, R
   GHIDONI, R
   MONTAGNOLO, G
   BENEVENTO, A
   ZECCA, L
   RUBINO, F
   SONNINO, S
AF RIBONI, L
   ACQUOTTI, D
   CASELLATO, R
   GHIDONI, R
   MONTAGNOLO, G
   BENEVENTO, A
   ZECCA, L
   RUBINO, F
   SONNINO, S
TI CHANGES OF THE HUMAN LIVER GM3 GANGLIOSIDE MOLECULAR-SPECIES DURING
   AGING
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID BRAIN GANGLIOSIDES; CERAMIDE; ACID; GLYCOSPHINGOLIPIDS; HYDROXYLATION;
   PURIFICATION; CONFORMATION; HEMATOSIDE
AB Sialosyl-lactosylceramide, G(M3), is the major ganglioside of human liver, where it constitutes more than 90% of the total lipid-bound sialic acid.  When analyzed by thin-layer chromatography, human liver G(M3) migrates as two main spots.  They are representative of ganglioside molecular species which differ in the acyl moiety.  The faster running spot is mainly composed of molecular species with non-hydroxylated C22 - C24 acyl chains; the other contains mainly molecular species bearing non-hydroxylated C16 - C18 and alpha-hydroxylated C16 - C24 acyl chains.
   In this study the content of the two G(M3) molecular species groups was investigated in 31 subjects ranging from 19 to 85 years of age.  By thin-layer chromatography we observed that the group of molecular species containing non-hydroxylated C22 - C24 acyl chains, decreased linearly with subject age, while that of non-hydroxylated C16 - C18 acyl chains and hydroxylated C16 - C24 acyl chains increased linearly.
   Fast-atom-bombardment mass spectrometry performed on seven samples from subjects ranging from 21 to 78 years of age demonstrated that the age-dependent increase of the lower spot is caused by an increase in the hydroxylated fatty acid form of G(M3), the content of non-hydroxylated C16 - C18 fatty acid species remaining constant with age.
C1 UNIV MILAN,SCH MED,DEPT MED CHEM & BIOCHEM,VIA SALDINI 50,I-20133 MILAN,ITALY.
   UNIV MILAN,SCH MED,INST EMERGENCY SURG,I-20133 MILAN,ITALY.
   UNIV MILAN,SCH MED,DEPT SURG L SACCO,I-20133 MILAN,ITALY.
   CNR,INST ADV BIOMED TECHNOL,I-20133 MILAN,ITALY.
C3 University of Milan; University of Milan; University of Milan; Consiglio
   Nazionale delle Ricerche (CNR)
RI Sonnino, Sandro/R-4154-2017; Rubino, Federico Maria/A-6277-2008; Zecca,
   Luigi/AFL-6369-2022; Riboni, Laura/R-4281-2017
OI Sonnino, Sandro/0000-0001-8180-5908; Rubino, Federico
   Maria/0000-0001-9620-1883; Riboni, Laura/0000-0002-4149-8226; GHIDONI,
   RICCARDO/0000-0002-6300-5867
CR BOUHOURS D, 1983, J BIOL CHEM, V258, P299
   CARTER HE, 1967, J LIPID RES, V8, P391
   CHIGORNO V, 1982, NEUROCHEM INT, V4, P397, DOI 10.1016/0197-0186(82)90082-1
   GHIDONI R, 1980, J BIOL CHEM, V255, P6990
   IUB-IUPAC Joint Commission on Biochemical Nomenclature (JCBN), 1982, J BIOL CHEM, V257, P3347, DOI [10.1016/S0021-9258(18)34777-X, DOI 10.1016/S0021-9258(18)34777-X]
   KANNAGI R, 1982, P NATL ACAD SCI-BIOL, V79, P3470, DOI 10.1073/pnas.79.11.3470
   LADISCH S, 1989, J BIOL CHEM, V264, P12097
   LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1
   MACHER BA, 1988, J BIOL CHEM, V263, P10186
   MASSERINI M, 1986, BIOCHEMISTRY-US, V25, P1043, DOI 10.1021/bi00353a014
   MIETTINEN T, 1959, ACTA CHEM SCAND, V13, P856, DOI 10.3891/acta.chem.scand.13-0856
   NILSSON O, 1982, J LIPID RES, V23, P327
   NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9
   PASCHER I, 1976, BIOCHIM BIOPHYS ACTA, V455, P433, DOI 10.1016/0005-2736(76)90316-3
   SEYFRIED TN, 1978, J LIPID RES, V19, P538
   SONNINO S, 1986, CHEM PHYS LIPIDS, V42, P3, DOI 10.1016/0009-3084(86)90040-X
   SONNINO S, 1985, J LIPID RES, V26, P248
   SONNINO S, 1990, CHEM PHYS LIPIDS, V55, P231
   SORENSEN OW, 1984, J MAGN RESON, V56, P527, DOI 10.1016/0022-2364(84)90317-2
   SUBRAMANIAN S, 1987, J MAGN RESON, V71, P325, DOI 10.1016/0022-2364(87)90063-1
   Svennerholm L, 1980, Adv Exp Med Biol, V125, P11
   SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8
   TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6
   WIEGANDT H, 1985, NEW COMPREHENSIVE BI, V10, P199
   YOHE HC, 1976, J BIOL CHEM, V251, P7083
   YU RK, 1972, J LIPID RES, V13, P680
   1977, LIPIDS, V12, P455
NR 27
TC 31
Z9 33
U1 0
U2 3
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JAN 15
PY 1992
VL 203
IS 1-2
BP 107
EP 113
DI 10.1111/j.1432-1033.1992.tb19834.x
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA HA780
UT WOS:A1992HA78000012
PM 1730216
OA Bronze
DA 2024-02-19
ER

PT J
AU López-Torres, M
   Gredilla, R
   Sanz, A
   Barja, G
AF López-Torres, M
   Gredilla, R
   Sanz, A
   Barja, G
TI Influence of aging and long-term caloric restriction on oxygen radical
   generation and oxidative DNA damage in rat liver mitochondria
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE ROS production; oxidative stress; 8-OxodG; free radicals
ID HYDROGEN-PEROXIDE PRODUCTION; HEART-MITOCHONDRIA; DIETARY RESTRICTION;
   H2O2 PRODUCTION; FISCHER-344 RATS; METABOLIC-RATE; COMPLEX-I;
   SUPEROXIDE; BRAIN; MECHANISMS
AB The effect of long-term caloric restriction and aging on the rates of mitochondrial H2O2 production and oxygen consumption as well as on oxidative damage to nuclear (nDNA) and mitochondrial DNA (mtDNA) was studied in rat liver tissue. Long-term caloric restriction significantly decreased H2O2 production of rat liver mitochondria (47% reduction) and significantly reduced oxidative damage to mtDNA (46% reduction) with no changes in nDNA. The decrease in ROS production was located at complex I because it only took place with complex I-linked substrates (pyruvate/malate) but not with complex II-linked substrates (succinate). The mechanism responsible for that decrease in ROS production was not a decrease in mitochondrial oxygen consumption because it did not change after long-term restriction. Instead, the caloric restricted mitochondria released less ROS per unit electron flow, due to a decrease in the reduction degree of the complex I generator. On the other hand, increased ROS production with aging in state 3 was observed in succinate-supplemented mitochondria because old control animals were unable to suppress H2O2. production during the energy transition from state 4 to state 3. The levels of 8-oxodG in mtDNA increased with age in old animals and this increase was abolished by caloric restriction. These results support the idea that caloric restriction reduces the aging rate at least in part by decreasing the rate of mitochondrial ROS production and so, the rate of oxidative attack to biological macromolecules like mtDNA. (C) 2002 Elsevier Science Inc.
C1 Univ Complutense Madrid, Fac Biol, Dept Anim Biol 2 Anim Physiol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
EM mltorres@bio.ucm.es
RI SANZ, ALBERTO/F-8432-2011; Sanz, Alberto/O-2329-2015; Gustavo,
   Barja/B-5591-2012; Barja, Gustavo/AAA-5903-2019
OI Sanz, Alberto/0000-0003-2149-1753; Barja, Gustavo/0000-0001-5736-4735;
   GREDILLA, RICARDO/0000-0003-4501-1355
CR Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   Barja G, 1999, METHODS AGING RES, P533
   Beckman K B, 1996, Methods Enzymol, V264, P442, DOI 10.1016/S0076-6879(96)64040-3
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   DJURIC Z, 1992, TOXICOL APPL PHARM, V115, P156, DOI 10.1016/0041-008X(92)90318-M
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9
   GUARNIERI C, 1992, FREE RADICALS AGING, P73
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803
   Herrero A, 1997, J BIOENERG BIOMEMBR, V29, P241, DOI 10.1023/A:1022458010266
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   Loft S, 1999, METHOD ENZYMOL, V300, P166
   MCCARTER R, 1985, AM J PHYSIOL, V248, pE488
   Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1
   NOHL H, 1986, MODERN AGING RES FRE, P77
   Orr W. C., 2000, ANTIOXIDANTS REDOX R, P517
   RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Wanagat J, 1999, TOXICOL SCI, V52, P35
   Weindruch R., 1988, RETARDATION AGING DI
   Zhou GD, 1999, NUTR CANCER, V35, P87, DOI 10.1207/S1532791487-95
NR 46
TC 224
Z9 258
U1 1
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 1
PY 2002
VL 32
IS 9
BP 882
EP 889
AR PII S0891-5849(02)00773-6
DI 10.1016/S0891-5849(02)00773-6
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 546TV
UT WOS:000175291200011
PM 11978489
DA 2024-02-19
ER

PT S
AU Nakamura, A
   Kawakami, K
   Kametani, F
   Nakamoto, H
   Goto, S
AF Nakamura, Akihiro
   Kawakami, Kyojiro
   Kametani, Fuyuki
   Nakamoto, Hideko
   Goto, Sataro
BE Tanguay, RM
TI Biological significance of protein modifications in aging and calorie
   restriction
SO AGING, CANCER, AND AGE-RELATED DISEASES: COMMON MECHANISM?
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 13th Congress of the International-Association-of-Biomedical-Gerontology
   on Aging, Cancer and Age-Related Diseases
CY MAY 18-20, 2009
CL Quebec City, CANADA
SP Int Assoc Biomed Gerontol
DE acetylation; carbonylation; epigenetics; histones
ID AGE-RELATED-CHANGES; HISTONE H4; LYSINE ACETYLATION; ENZYME-ACTIVITIES;
   LYSYL OXIDASE; LIFE-SPAN; RAT; OXIDATION; METABOLISM; LIVER
AB By virtue of the progress in proteomics, the involvement of posttranslational modifications in aging has been more clearly demonstrated in recent years. We describe here that (1) carbonylation, a hallmark of protein oxidation in general, is paradoxically decreased in histone with aging and increased by calorie restriction (CR), (2) acetylation of lysine 9 and phosphorylation of serine 10 in histone H3 are decreased and increased, respectively, with aging, and (3) the acetylation level of multiple extranuclear proteins decreases significantly with aging, and the change was not only retarded but increased remarkably by CR in rat liver. Based on these findings, we discuss possible implications of the posttranslational protein modifications in biochemical processes underlying aging and CR-induced extension of life span.
C1 [Nakamura, Akihiro] Keio Univ, Inst Adv Biosci, Yamagata, Japan.
C3 Keio University
RP Goto, S (corresponding author), Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Hiragagakuendai 1-1, Inbamura, Chiba 2701695, Japan.
EM gotosataro@sakura.juntendo.ac.jp
RI Kametani, Fuyuki/G-4752-2011
OI Kametani, Fuyuki/0000-0001-9125-7001; Kawakami,
   Kyojiro/0000-0002-2822-3252
CR Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085
   Dattani RG, 2004, EUR J CLIN PHARMACOL, V60, P679, DOI 10.1007/s00228-004-0828-y
   Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497
   Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200
   FIFKOVA E, 1992, EXP GERONTOL, V27, P125, DOI 10.1016/0531-5565(92)90034-W
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gokulrangan G, 2007, J NEUROCHEM, V100, P1494, DOI 10.1111/j.1471-4159.2006.04334.x
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   GROLLEAUJULIUS A, 2009, CLIN REV ALLERG IMMU
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413
   Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   KIM SK, 2008, MOL BIOL AG, P215
   Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026
   Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Lindner H, 2001, EXP GERONTOL, V36, P1551, DOI 10.1016/S0531-5565(01)00140-1
   MacDonald VE, 2009, EPIGENETICS-US, V4, P139, DOI 10.4161/epi.4.3.8484
   Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736
   MORI S, 1988, MECH AGEING DEV, V44, P175, DOI 10.1016/0047-6374(88)90089-9
   MORIMOTO S, 1993, ARCH GERONTOL GERIAT, V16, P217, DOI 10.1016/0167-4943(93)90033-E
   Nagai M, 2000, BIOGERONTOLOGY, V1, P321, DOI 10.1023/A:1026590819033
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Ning JY, 2008, J CELL BIOCHEM, V103, P730, DOI 10.1002/jcb.21444
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   OHTSUKA H, 1995, J GERONTOL A-BIOL, V50, pB277, DOI 10.1093/gerona/50A.5.B277
   Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039
   Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043
   Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Saha S, 2000, CELL TISSUE RES, V300, P29, DOI 10.1007/s004410050045
   Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200
   Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048
   Schöneich C, 2006, EXP GERONTOL, V41, P807, DOI 10.1016/j.exger.2006.07.002
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Sharma R, 2006, FREE RADICAL BIO MED, V40, P1179, DOI 10.1016/j.freeradbiomed.2005.11.013
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06
   Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650
   SUO L, 2009, FERTIL STERIL
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313
   Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260
   YANG SY, 1987, J BIOL CHEM, V262, P13027
   Zaidi G, 2005, BIOGERONTOLOGY, V6, P141, DOI 10.1007/s10522-005-3459-5
   Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9
NR 61
TC 34
Z9 36
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-796-2
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2010
VL 1197
BP 33
EP 39
DI 10.1111/j.1749-6632.2009.05374.x
PG 7
WC Geriatrics & Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics
GA BQO13
UT WOS:000281415100005
PM 20536830
DA 2024-02-19
ER

PT J
AU Nunes-Souza, V
   César-Gomes, CJ
   Da Fonseca, LJS
   Guedes, GD
   Smaniotto, S
   Rabelo, LA
AF Nunes-Souza, Valeria
   Cesar-Gomes, Cheila Juliana
   Sa Da Fonseca, Lucas Jose
   Guedes, Glaucevane Da Silva
   Smaniotto, Salete
   Rabelo, Luiza Antas
TI Aging Increases Susceptibility to High Fat Diet-Induced Metabolic
   Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile
   after Antioxidant Therapy
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID INCREASED OXIDATIVE STRESS; AIN-93 PURIFIED DIETS; INSULIN-RESISTANCE;
   ENDOTHELIAL DYSFUNCTION; NAD(P)H OXIDASE; HEPATIC STEATOSIS;
   LIVER-DISEASE; B DEGRADATION; GLUCOSE; RODENTS
AB Nonalcoholic fatty liver disease (NAFLD) has been considered a novel component of the metabolic syndrome (MetS), with the oxidative stress participating in its progression. This study aimed to evaluate the metabolic profile in young and old mice with MetS, and the effects of apocynin and tempol on glycemic and lipid parameters. Young and old C57BL/6 mice with high fat diet- (HFD-) induced MetS received apocynin and tempol 50 mg.kg(-1)/day in their drinking water for 10 weeks. After HFD, the young group showed elevated fasting glucose, worsened lipid profile in plasma, steatosis, and hepatic lipid peroxidation. Nevertheless, the old group presented significant increase in fasting insulin levels, insulin resistance, plasma and hepatic lipid peroxidation, and pronounced steatosis. The hepatic superoxide dismutase and catalase activity did not differ between the groups. Tempol and apocynin seemed to prevent hepatic lipid deposition in both groups. Furthermore, apocynin improved glucose tolerance and insulin sensitivity in old mice. In summary, old mice are more susceptible to HFD-induced metabolic changes than their young counterparts. Also, the antioxidant therapy improved insulin sensitivity and glucose tolerance, and in addition, apocynin seemed to prevent the HFD-induced hepatic fat deposition, suggesting an important role of oxidative stress in the induction of NAFLD.
C1 [Nunes-Souza, Valeria; Cesar-Gomes, Cheila Juliana; Sa Da Fonseca, Lucas Jose; Guedes, Glaucevane Da Silva; Rabelo, Luiza Antas] Univ Fed Alagoas UFAL, LRC, ICBS, Nucleo Sindrome Metab, Ave Lourival Melo Mota S-N,Cidade Univ, BR-57072900 Maceio, AL, Brazil.
   [Nunes-Souza, Valeria; Cesar-Gomes, Cheila Juliana; Sa Da Fonseca, Lucas Jose; Guedes, Glaucevane Da Silva; Rabelo, Luiza Antas] Natl Inst Sci & Technol Nanobiopharmaceut N BIOFA, Ave Antonio Carlos S-N, BR-31270901 Belo Horizonte, MG, Brazil.
   [Nunes-Souza, Valeria] Univ Fed Pernambuco UFPE, CCB, Dept Fisiol & Farmacol, Ave Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
   [Guedes, Glaucevane Da Silva] Univ Fed Alagoas UFAL, Fac Nutr FANUT, Ave Lourival Melo Mota S-N,Cidade Univ, BR-57072900 Maceio, AL, Brazil.
   [Smaniotto, Salete] Univ Fed Alagoas UFAL, ICBS, Lab Biol Celular, Ave Lourival Melo Mota S-N,Cidade Univ, BR-57072900 Maceio, AL, Brazil.
   [Rabelo, Luiza Antas] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.
C3 Universidade Federal de Pernambuco; Helmholtz Association; Max Delbruck
   Center for Molecular Medicine
RP Rabelo, LA (corresponding author), Univ Fed Alagoas UFAL, LRC, ICBS, Nucleo Sindrome Metab, Ave Lourival Melo Mota S-N,Cidade Univ, BR-57072900 Maceio, AL, Brazil.; Rabelo, LA (corresponding author), Natl Inst Sci & Technol Nanobiopharmaceut N BIOFA, Ave Antonio Carlos S-N, BR-31270901 Belo Horizonte, MG, Brazil.; Rabelo, LA (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.
EM luizaa.rabelo@gmail.com
RI Rabêlo, Luiza A./S-4050-2019; Smaniotto, Salete/AAT-4056-2020;
   Smaniotto, Salete/T-3796-2017
OI Smaniotto, Salete/0000-0003-1527-5894
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES;
   PROCAD-NF) [2450/2008]; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq) [483049/2009-3]; CNPq; FAPEAL; CAPES
FX The authors wish to thank Maria de Fatima Maia Sarmento and Delma Paes
   de Souza for their technical assistance during histology preparation and
   Iris Apostel-Krause for their assistance with the English revision of
   the paper. The authors wish to thank Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES; PROCAD-NF 2450/2008) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq;
   483049/2009-3), for the financial support, and Professor Dr. Michael
   Bader and Dr. Natalia Alenina (Max Delbruck Center for Molecular
   Medicine, Berlin, Germany) for the donation of some reagents used during
   the assessment of the oxidative status. Valeria Nunes-Souza, Cheila
   Juliana Cesar-Gomes, and Lucas Jose Sa Da Fonseca received a Master's
   Scholarship from CNPq, FAPEAL, and CAPES, respectively.
CR Banday AA, 2005, DIABETES, V54, P2219, DOI 10.2337/diabetes.54.7.2219
   Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771
   den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e
   Dorman RB, 2006, AM J PHYSIOL-GASTR L, V290, pG1025, DOI 10.1152/ajpgi.00246.2005
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Espinosa A, 2013, INT J MOL SCI, V14, P15740, DOI 10.3390/ijms140815740
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696
   Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288
   Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941
   Gupte S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011800
   Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje
   Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538
   Lim K, 2013, HYPERTENSION, V61, P628, DOI 10.1161/HYPERTENSIONAHA.111.00705
   Lob HE, 2013, HYPERTENSION, V61, P382, DOI 10.1161/HYPERTENSIONAHA.111.00546
   Lu LS, 2007, LIVER INT, V27, P529, DOI 10.1111/j.1478-3231.2007.01451.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meng R, 2011, ANN CLIN LAB SCI, V41, P236
   Meng R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/858735
   Molnar J, 2005, CIRC RES, V96, P1178, DOI 10.1161/01.RES.0000168634.74330.ed
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Polakof S, 2013, J NUTR BIOCHEM, V24, P1920, DOI 10.1016/j.jnutbio.2013.05.008
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Rabêlo LA, 2010, ARQ BRAS CARDIOL, V94, P684, DOI 10.1590/S0066-782X2010000500018
   Raval J, 2006, FREE RADICAL BIO MED, V41, P1645, DOI 10.1016/j.freeradbiomed.2006.07.023
   REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001
   Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010
   Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200
   Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285
   Wanagat J, 1999, TOXICOL SCI, V52, P35
   Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003
   Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764
NR 47
TC 27
Z9 29
U1 2
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2016
VL 2016
AR 1987960
DI 10.1155/2016/1987960
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DK4EG
UT WOS:000374869300001
PM 27057272
OA Green Submitted, Green Published, gold, Green Accepted
DA 2024-02-19
ER

EF